PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mitsuhashi, M; Taub, DD; Kapogiannis, D; Eitan, E; Zukley, L; Mattson, MP; Ferrucci, L; Schwartz, JB; Goetzl, EJ				Mitsuhashi, Masato; Taub, Dennis D.; Kapogiannis, Dimitrios; Eitan, Erez; Zukley, Linda; Mattson, Mark P.; Ferrucci, Luigi; Schwartz, Janice B.; Goetzl, Edward J.			Aging enhances release of exosomal cytokine mRNAs by A beta(1-42)-stimulated macrophages	FASEB JOURNAL			English	Article						membrane vesicle; T cells; immunosenescence; neural proteinopathy; dementia	CELL-DERIVED EXOSOMES; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; TNF-ALPHA; IMMUNE-RESPONSES; MIGRATION; BLOOD; INDIVIDUALS; MEMBRANE; PROFILES	Amyloid-beta(1-42) (A beta) peptide effects on human models of central nervous system (CNS)-patrolling macrophages (Ms) and CD4 memory T-cells (CD4-Tms) were investigated to examine immune responses to A beta in Alzheimer's disease. A beta and lipopolysaccharide (LPS) elicited similar M cytokine and exosomal mRNA (ex-mRNA) responses. A beta- and LPS-stimulated Ms from 20 >= 65-yr-old subjects generated significantly more IL-1, TNF-alpha, and IL-6, but not IL-8 or IL-12, and significantly more ex-mRNAs for IL-6, TNF-alpha, and IL-12, but not for IL-8 or IL-1, than Ms from 20 matched 21- to 45-yr-old subjects. CD4-Tm generation of IL-2, IL-4, and IFN-gamma and, for young subjects, IL-10, but not IL-6, evoked by A beta was significantly lower than with anti-T-cell antigen receptor antibodies (Abs). Abs significantly increased all CD4-Tm ex-mRNAs, but only IL-2 and IL-6 ex-mRNAs were increased by A beta. There were no significant differences between cytokine and ex-mRNA responses of CD4-Tms from the old compared to the young subjects. M-derived serum exosomes from the old subjects had significantly higher IL-6 and IL-12 ex-mRNA levels than those from the young subjects, whereas there were no differences for CD4-Tm-derived serum exosomes. An A beta level relevant to neurodegeneration elicited broad M cytokine and ex-mRNA responses that were significantly greater in the old subjects, but only narrow and age-independent CD4-Tm responses.	[Mitsuhashi, Masato] Hitachi Chem Res Ctr, Irvine, CA USA; [Taub, Dennis D.; Kapogiannis, Dimitrios; Eitan, Erez; Zukley, Linda; Mattson, Mark P.; Ferrucci, Luigi; Goetzl, Edward J.] NIA, NIH, Baltimore, MD 21224 USA; [Schwartz, Janice B.; Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.; Goetzl, Edward J.] Univ Calif San Francisco, Geriatr Res Labs, San Francisco, CA 94143 USA	Hitachi Limited; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Goetzl, EJ (corresponding author), UCSF Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Schwartz, Janice/K-6354-2019; Kapogiannis, Dimitrios/AAW-4934-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118	Jewish Home of San Francisco; Intramural Research Program of the U.S. National Institute on Aging; Edward A. Dickson Professorship at the University of California, San Francisco; NATIONAL INSTITUTE ON AGING [ZIAAG000975] Funding Source: NIH RePORTER	Jewish Home of San Francisco; Intramural Research Program of the U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Edward A. Dickson Professorship at the University of California, San Francisco; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by endowment fund income of the Jewish Home of San Francisco, by the Intramural Research Program of the U.S. National Institute on Aging, and by funds from the Edward A. Dickson Professorship at the University of California, San Francisco. The authors are grateful to Judith H. Goetzl for expert preparation of the graphic illustrations. Dr. Charles Hesdorffer (Veterans Affairs Medical Center, Washington, DC, USA) provided constant support for the research.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Baril L, 2004, NEUROSCI LETT, V355, P226, DOI 10.1016/j.neulet.2003.10.071; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Bonotis K, 2008, J NEUROIMMUNOL, V193, P183, DOI 10.1016/j.jneuroim.2007.10.020; Britschgi M, 2007, INT REV NEUROBIOL, V82, P205, DOI 10.1016/S0074-7742(07)82011-3; Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V121, P255, DOI 10.1046/j.1365-2249.2000.01281.x; Bruunsgaard H, 2000, LIFE SCI, V67, P2721, DOI 10.1016/S0024-3205(00)00851-1; Fiala M, 1998, MOL MED, V4, P480, DOI 10.1007/BF03401753; Giubilei F, 2003, DEMENT GERIATR COGN, V16, P35, DOI 10.1159/000069991; Goetzl EJ, 2010, FASEB J, V24, P3580, DOI 10.1096/fj.10-160911; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Huang MC, 2011, CLIN IMMUNOL, V138, P201, DOI 10.1016/j.clim.2010.11.002; Jozwik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033276; Kadiu I, 2012, J IMMUNOL, V189, P744, DOI 10.4049/jimmunol.1102244; Kirwan JP, 2001, AM J PHYSIOL-ENDOC M, V281, pE1137, DOI 10.1152/ajpendo.2001.281.6.E1137; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Lombardi VRM, 1999, J NEUROIMMUNOL, V97, P163, DOI 10.1016/S0165-5728(99)00046-6; Lugini L, 2012, J IMMUNOL, V189, P2833, DOI 10.4049/jimmunol.1101988; Lutter D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-100; Miscia S, 2009, NEUROBIOL AGING, V30, P394, DOI 10.1016/j.neurobiolaging.2007.07.011; Mitsuhashi M, 2010, J IMMUNOL METHODS, V363, P95, DOI 10.1016/j.jim.2010.10.002; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Naslund TI, 2013, J IMMUNOL, V190, P2712, DOI 10.4049/jimmunol.1203082; Pedersen M, 2003, MECH AGEING DEV, V124, P495, DOI 10.1016/S0047-6374(03)00027-7; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Rea IM, 2000, CYTOKINE, V12, P156, DOI 10.1006/cyto.1999.0537; Richartz-Salzburger E, 2007, J PSYCHIATR RES, V41, P174, DOI 10.1016/j.jpsychires.2006.01.010; Smyth L. A., 2013, EUR J IMMUNOL; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Strohmeyer R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-18; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trieb K, 1996, NEUROBIOL AGING, V17, P541; Turola E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00149; Verdier Y, 2004, CURR PROTEIN PEPT SC, V5, P19, DOI 10.2174/1389203043486937; Wahlgren J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks463; Walters SB, 2013, J IMMUNOL, V190, P669, DOI 10.4049/jimmunol.1201856; Zhang HF, 2011, CELL MOL IMMUNOL, V8, P23, DOI 10.1038/cmi.2010.59	40	48	50	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					5141	5150		10.1096/fj.13-238980	http://dx.doi.org/10.1096/fj.13-238980			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24014820	Green Published			2022-12-25	WOS:000329999000046
J	Griffith, JD				Griffith, Jack D.			Many Ways to Loop DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRAND DNA; RECA PROTEIN; REPLICATION COMPLEX; HOLLIDAY JUNCTIONS; TELOMERIC CIRCLES; BINDING PROTEIN; IN-VITRO; VISUALIZATION; CHROMATIN; HELIX	In the 1960s, I developed methods for directly visualizing DNA and DNA-protein complexes using an electron microscope. This made it possible to examine the shape of DNA and to visualize proteins as they fold and loop DNA. Early applications included the first visualization of true nucleosomes and linkers and the demonstration that repeating tracts of adenines can cause a curvature in DNA. The binding of DNA repair proteins, including p53 and BRCA2, has been visualized at three-and four-way junctions in DNA. The trombone model of DNA replication was directly verified, and the looping of DNA at telomeres was discovered.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	There are many colleagues who I have not mentioned specifically, yet who have been a strong part of our work for many years, in particular Tom Broker and Louise Chow. Alexander Makhov and Smaranda Willcox have contributed greatly to my success. I thank many colleagues who have critically read this article and provided very helpful suggestions. Much of this work was supported by a long-standing grant from the National Institutes of Health (GM31819).	Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; CHASE JW, 1980, NUCLEIC ACIDS RES, V8, P3215, DOI 10.1093/nar/8.14.3215; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Chastain PD, 2004, J BIOL CHEM, V279, P36354, DOI 10.1074/jbc.M403501200; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Chen SH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1343; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; CHRISTIANSEN G, 1986, P NATL ACAD SCI USA, V83, P2066, DOI 10.1073/pnas.83.7.2066; CLAYTON DA, 1967, NATURE, V216, P652, DOI 10.1038/216652a0; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; Doksani Y., 2013, CELL IN PRESS, V155; Egelman EH, 2003, NAT REV MOL CELL BIO, V4, P621, DOI 10.1038/nrm1176; EISENBERG S, 1977, P NATL ACAD SCI USA, V74, P3198, DOI 10.1073/pnas.74.8.3198; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; GRIFFITH J, 1986, CELL, V46, P717, DOI 10.1016/0092-8674(86)90347-8; GRIFFITH J, 1971, J MOL BIOL, V55, P209, DOI 10.1016/0022-2836(71)90192-6; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1975, SCIENCE, V187, P1202, DOI 10.1126/science.187.4182.1202; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; HALL MR, 1973, J VIROL, V12, P901, DOI 10.1128/JVI.12.4.901-908.1973; Hamdan SM, 2010, J BIOL CHEM, V285, P18979, DOI 10.1074/jbc.R109.022939; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HARRIS LD, 1987, J BIOL CHEM, V262, P9285; Heuser JE, 2011, J ELECTRON MICROSC, V60, pS3, DOI 10.1093/jmicro/dfr044; HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; KLEINSCHMIDT A, 1962, BIOCHIM BIOPHYS ACTA, V61, P857, DOI 10.1016/0926-6550(62)90001-4; Kornberg A., 1974, DNA REPLICATION; LAKE RS, 1973, BIOCHEM BIOPH RES CO, V54, P640, DOI 10.1016/0006-291X(73)91471-X; LAUNDON CH, 1988, CELL, V52, P545, DOI 10.1016/0092-8674(88)90467-9; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024; Lee SH, 2013, P NATL ACAD SCI USA, V110, pE3587, DOI 10.1073/pnas.1304103110; LOBBAN PE, 1973, J MOL BIOL, V78, P453, DOI 10.1016/0022-2836(73)90468-3; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Marsischky GT, 1999, J BIOL CHEM, V274, P7200, DOI 10.1074/jbc.274.11.7200; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; NAKAMURA TM, 1995, EMBO J, V14, P4849, DOI 10.1002/j.1460-2075.1995.tb00166.x; Natarajan S, 2002, MOL CELL BIOL, V22, P4512, DOI 10.1128/MCB.22.13.4512-4521.2002; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; NOSEK J, 1995, MOL GEN GENET, V247, P61, DOI 10.1007/BF00425822; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; REGISTER JC, 1987, J BIOL CHEM, V262, P12812; SANCAR A, 1979, BIOCHEM BIOPH RES CO, V90, P123, DOI 10.1016/0006-291X(79)91598-5; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; SINHA NK, 1980, J BIOL CHEM, V255, P4290; STASIAK A, 1984, COLD SPRING HARB SYM, V49, P561, DOI 10.1101/SQB.1984.049.01.063; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tomaska L, 2000, NUCLEIC ACIDS RES, V28, P4479, DOI 10.1093/nar/28.22.4479; Tomaska L, 2009, NAT STRUCT MOL BIOL, V16, P1010, DOI 10.1038/nsmb.1660; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; VINOGRAD J, 1965, P NATL ACAD SCI USA, V53, P1104, DOI 10.1073/pnas.53.5.1104; WANG YH, 1994, J MOL BIOL, V236, P64, DOI 10.1006/jmbi.1994.1118; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; Wang YH, 1996, J MOL BIOL, V263, P511, DOI 10.1006/jmbi.1996.0593; WANG YH, 1993, J BIOL CHEM, V268, P17571; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	81	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29724	29735		10.1074/jbc.X113.515981	http://dx.doi.org/10.1074/jbc.X113.515981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005675	hybrid, Green Published			2022-12-25	WOS:000330615300048
J	Haynes, AC; Qian, J; Reisz, JA; Furdui, CM; Lowther, WT				Haynes, Alexina C.; Qian, Jiang; Reisz, Julie A.; Furdui, Cristina M.; Lowther, W. Todd			Molecular Basis for the Resistance of Human Mitochondrial 2-Cys Peroxiredoxin 3 to Hyperoxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX-SENSITIVE OLIGOMERIZATION; IONIZATION MASS-SPECTROMETRY; TYROSINE-PHOSPHATASE 1B; CYSTEINE-SULFINIC ACID; SULFENIC-ACID; HYDROGEN-PEROXIDE; TRYPAREDOXIN PEROXIDASE; CRYSTAL-STRUCTURE; ENZYME CATALYSIS; SITE CYSTEINE	Peroxiredoxins (Prxs) detoxify peroxides and modulate H2O2-mediated cell signaling in normal and numerous pathophysiological contexts. The typical 2-Cys subclass of Prxs (human Prx1-4) utilizes a Cys sulfenic acid (Cys-SOH) intermediate and disulfide bond formation across two subunits during catalysis. During oxidative stress, however, the Cys-SOH moiety can react with H2O2 to form Cys sulfinic acid (Cys-SO2H), resulting in inactivation. The propensity to hyperoxidize varies greatly among human Prxs. Mitochondrial Prx3 is the most resistant to inactivation, but the molecular basis for this property is unknown. A panel of chimeras and Cys variants of Prx2 and Prx3 were treated with H2O2 and analyzed by rapid chemical quench and time-resolved electrospray ionization-TOF mass spectrometry. The latter utilized an on-line rapid-mixing setup to collect data on the low seconds time scale. These approaches enabled the first direct observation of the Cys-SOH intermediate and a putative Cys sulfenamide (Cys-SN) for Prx2 and Prx3 during catalysis. The substitution of C-terminal residues in Prx3, residues adjacent to the resolving Cys residue, resulted in a Prx2-like protein with increased sensitivity to hyperoxidation and decreased ability to form the intermolecular disulfide bond between subunits. The corresponding Prx2 chimera became more resistant to hyperoxidation. Taken together, the results of this study support that the kinetics of the Cys-SOH intermediate is key to determine the probability of hyperoxidation or disulfide formation. Given the oxidizing environment of the mitochondrion, it makes sense that Prx3 would favor disulfide bond formation as a protection mechanism against hyperoxidation and inactivation.	[Haynes, Alexina C.; Lowther, W. Todd] Wake Forest Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA; [Haynes, Alexina C.; Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Qian, Jiang; Reisz, Julie A.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Furdui, CM (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cfurdui@wakehealth.edu; tlowther@wakehealth.edu		Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health from NIGMS [R01 GM072866]; National Institutes of Health from NCI [R01 CA136810]; NATIONAL CANCER INSTITUTE [R01CA136810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072866] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM072866 from NIGMS (to W. T. L.) and Grant R01 CA136810 from NCI (to C. M. F.).	Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Jarvela S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-104; Jeong W, 2012, FREE RADICAL BIO MED, V53, P447, DOI 10.1016/j.freeradbiomed.2012.05.020; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee KW, 2011, J BIOL CHEM, V286, P8394, DOI 10.1074/jbc.M110.179416; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Li ZL, 2003, J AM CHEM SOC, V125, P9938, DOI 10.1021/ja0354768; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nonn L, 2003, MOL CANCER RES, V1, P682; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Qian J, 2012, CHEM COMMUN, V48, P4091, DOI 10.1039/c2cc17868k; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salsbury FR, 2012, J PHYS CHEM B, V116, P6832, DOI 10.1021/jp212606k; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Song IS, 2011, INT J MOL SCI, V12, P7163, DOI 10.3390/ijms12107163; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yuan Y, 2010, J BIOMOL STRUCT DYN, V28, P51, DOI 10.1080/07391102.2010.10507343	49	54	55	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29714	29723		10.1074/jbc.M113.473470	http://dx.doi.org/10.1074/jbc.M113.473470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003226	Green Published, hybrid			2022-12-25	WOS:000330615300047
J	Hachmeister, M; Bobowski, KD; Hogl, S; Dislich, B; Fukumori, A; Eggert, C; Mack, B; Kremling, H; Sarrach, S; Coscia, F; Zimmermann, W; Steiner, H; Lichtenthaler, SF; Gires, O				Hachmeister, Matthias; Bobowski, Karolina D.; Hogl, Sebastian; Dislich, Bastian; Fukumori, Akio; Eggert, Carola; Mack, Brigitte; Kremling, Heidi; Sarrach, Sannia; Coscia, Fabian; Zimmermann, Wolfgang; Steiner, Harald; Lichtenthaler, Stefan F.; Gires, Olivier			Regulated Intramembrane Proteolysis and Degradation of Murine Epithelial Cell Adhesion Molecule mEpCAM	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NOTCH1 INTRACELLULAR DOMAIN; DEPENDENT GAMMA-SECRETASE; EP-CAM; BETA-SECRETASE; BREAST-CANCER; ANTIGEN EPCAM; ALZHEIMERS-DISEASE; HUMAN CARCINOMAS; S3 CLEAVAGE	Epithelial cell adhesion molecule EpCAM is a transmembrane glycoprotein, which is highly and frequently expressed in carcinomas and (cancer-)stem cells, and which plays an important role in the regulation of stem cell pluripotency. We show here that murine EpCAM (mEpCAM) is subject to regulated intramembrane proteolysis in various cells including embryonic stem cells and teratocarcinomas. As shown with ectopically expressed EpCAM variants, cleavages occur at alpha-, beta-, gamma-, and epsilon-sites to generate soluble ectodomains, soluble A beta-like-, and intracellular fragments termed mEpEX, mEp-beta, and mEpICD, respectively. Proteolytic sites in the extracellular part of mEpCAM were mapped using mass spectrometry and represent cleavages at the alpha- and beta-sites by metalloproteases and the b-secretase BACE1, respectively. Resulting C-terminal fragments (CTF) are further processed to soluble A beta-like fragments mEp-beta and cytoplasmic mEpICD variants by the g-secretase complex. Noteworthy, cytoplasmic mEpICD fragments were subject to efficient degradation in a proteasome-dependent manner. In addition the gamma-secretase complex dependent cleavage of EpCAM CTF liberates different EpICDs with different stabilities towards proteasomal degradation. Generation of CTF and EpICD fragments and the degradation of hEpICD via the proteasome were similarly demonstrated for the human EpCAM ortholog. Additional EpCAM orthologs have been unequivocally identified in silico in 52 species. Sequence comparisons across species disclosed highest homology of BACE1 cleavage sites and in presenilin-dependent gamma-cleavage sites, whereas strongest heterogeneity was observed in metalloprotease cleavage sites. In summary, EpCAM is a highly conserved protein present in fishes, amphibians, reptiles, birds, marsupials, and placental mammals, and is subject to shedding, gamma-secretase-dependent regulated intramembrane proteolysis, and proteasome-mediated degradation.	[Hachmeister, Matthias; Bobowski, Karolina D.; Eggert, Carola; Mack, Brigitte; Kremling, Heidi; Sarrach, Sannia; Coscia, Fabian; Gires, Olivier] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Hogl, Sebastian; Dislich, Bastian; Fukumori, Akio; Steiner, Harald; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Dislich, Bastian; Lichtenthaler, Stefan F.] Tech Univ Munich, D-80290 Munich, Germany; [Zimmermann, Wolfgang] Univ Munich, Klinikum Grosshadern, Tumor Immunol Lab, LIFE Ctr, D-80539 Munich, Germany; [Steiner, Harald] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Lichtenthaler, Stefan F.] Munich Ctr Syst Neurol SyNergy, Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; University of Munich	Gires, O (corresponding author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	Olivier.gires@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016; Gires, Olivier/V-2689-2017; Coscia, Fabian/AAD-3899-2020	Lichtenthaler, Stefan F/0000-0003-2211-2575; Gires, Olivier/0000-0002-2292-7064; Coscia, Fabian/0000-0002-2244-5081	Deutsche Forschungsgemeinschaft (DFG) [DFG 540-2/1]; Deutsche Krebshilfe (DKH) [109080]; Bundesministerium fur Bildung und Forschung (BMBF; KNDD)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe (DKH)(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung (BMBF; KNDD)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; DFG 540-2/1) and Deutsche Krebshilfe (DKH; 109080) to OG, and by the Bundesministerium fur Bildung und Forschung (BMBF; KNDD) to HS and SFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Chaves-Perez A, 2012, ONCOGENE; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Eckert A, 2001, J NEUROSCI RES, V64, P183, DOI 10.1002/jnr.1064; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Hogl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021337; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Litvinov SV, 1996, AM J PATHOL, V148, P865; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2008, FRONT BIOSCI-LANDMRK, V13, P5195, DOI 10.2741/3075; Ng V. Y., 2009, STEM CELLS; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Riedle S, 2009, BIOCH J; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schnell U, 2013, BIOSCI REP; Schnell U, 2013, HUM MOL GENET; SCHON MP, 1994, J INVEST DERMATOL, V102, P987, DOI 10.1111/1523-1747.ep12384258; Shimizu H, 2008, MOL CELL BIOL, V28, P3663, DOI 10.1128/MCB.02185-07; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Soysal SD, 2013, BRIT J CANCER, V108, P1480, DOI 10.1038/bjc.2013.80; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; SPIZZO G, 2006, GYNECOL ONCOL; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tsujikawa M, 1999, NAT GENET, V21, P420, DOI 10.1038/7759; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947	56	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71836	10.1371/journal.pone.0071836	http://dx.doi.org/10.1371/journal.pone.0071836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009667	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000323734600009
J	Durand, K; Baudouin, JY; Lewkowicz, DJ; Goubet, N; Schaal, B				Durand, Karine; Baudouin, Jean-Yves; Lewkowicz, David J.; Goubet, Nathalie; Schaal, Benoist			Eye-Catching Odors: Olfaction Elicits Sustained Gazing to Faces and Eyes in 4-Month-Old Infants	PLOS ONE			English	Article							MOTHERS FACE; DEVELOPMENTAL-CHANGES; VISUAL PREFERENCE; MEMORY RETRIEVAL; NEWBORNS; RECOGNITION; CONTACT; STIMULI; OBJECT; DISCRIMINATION	This study investigated whether an odor can affect infants' attention to visually presented objects and whether it can selectively direct visual gaze at visual targets as a function of their meaning. Four-month-old infants (n = 48) were exposed to their mother's body odors while their visual exploration was recorded with an eye-movement tracking system. Two groups of infants, who were assigned to either an odor condition or a control condition, looked at a scene composed of still pictures of faces and cars. As expected, infants looked longer at the faces than at the cars but this spontaneous preference for faces was significantly enhanced in presence of the odor. As expected also, when looking at the face, the infants looked longer at the eyes than at any other facial regions, but, again, they looked at the eyes significantly longer in the presence of the odor. Thus, 4-month-old infants are sensitive to the contextual effects of odors while looking at faces. This suggests that early social attention to faces is mediated by visual as well as non-visual cues.	[Durand, Karine; Baudouin, Jean-Yves; Schaal, Benoist] Ctr Smell Taste & Food Sci, Dev Ethol & Cognit Psychol Grp, Dijon, France; [Lewkowicz, David J.] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA; [Goubet, Nathalie] Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA; [Baudouin, Jean-Yves] Inst Univ France, Paris, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; State University System of Florida; Florida Atlantic University; Gettysburg College; Institut Universitaire de France	Durand, K (corresponding author), Ctr Smell Taste & Food Sci, Dev Ethol & Cognit Psychol Grp, Dijon, France.	karine.durand@u-bourgogne.fr		Baudouin, Jean-Yves/0000-0002-4405-7987; Lewkowicz, David/0000-0001-6685-3178	Centre National de la Recherche Scientifique, Paris; French National Agency for Research; Regional Council of Burgundy, Dijon (PARI grant); Institut Universitaire de France; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057116] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique, Paris; French National Agency for Research(French National Research Agency (ANR)); Regional Council of Burgundy, Dijon (PARI grant)(Region Bourgogne-Franche-Comte); Institut Universitaire de France; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was financially supported by the Centre National de la Recherche Scientifique, Paris, the French National Agency for Research, the Regional Council of Burgundy, Dijon (PARI grant), and the Institut Universitaire de France (to JYB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MDE, 2006, INFANT BEHAV DEV, V29, P308, DOI 10.1016/j.infbeh.2005.12.008; Allam MDE, 2010, DEVELOPMENTAL SCI, V13, P849, DOI 10.1111/j.1467-7687.2009.00941.x; Bahrick L.E., 2012, MULTISENSORY DEV, P183; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Bartrip J, 2001, BRIT J DEV PSYCHOL, V19, P219, DOI 10.1348/026151001166047; Bristow D, 2009, J COGNITIVE NEUROSCI, V21, P905, DOI 10.1162/jocn.2009.21076; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; Coulon M, 2011, INT J BEHAV DEV, V35, P282, DOI 10.1177/0165025410396765; Degel J, 1999, CHEM SENSES, V24, P317, DOI 10.1093/chemse/24.3.317; Doucet S, 2007, DEV PSYCHOBIOL, V49, P129, DOI 10.1002/dev.20210; Doucet S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007579; Durand K, 2008, INFANT BEHAV DEV, V31, P629, DOI 10.1016/j.infbeh.2008.07.002; Easterbrook MA, 1999, CAN J EXP PSYCHOL, V53, P231, DOI 10.1037/h0087312; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Engen T, 2012, PERCEPTION ODORS; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; FERNANDEZ M, 1994, INFANT BEHAV DEV, V17, P471, DOI 10.1016/0163-6383(94)90040-X; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; Gallay M, 2006, CHILD DEV, V77, P984, DOI 10.1111/j.1467-8624.2006.00914.x; Gava L, 2008, DEVELOPMENTAL SCI, V11, P563, DOI 10.1111/j.1467-7687.2008.00702.x; GOREN CC, 1975, PEDIATRICS, V56, P544; Guellai B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018610; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Hepper PG, 2013, DEV PSYCHOBIOL, V55, P568, DOI 10.1002/dev.21059; Herz RS, 2002, OLFACTION, TASTE, AND COGNITION, P160, DOI 10.1017/CBO9780511546389.016; Herz RS, 1996, PSYCHON B REV, V3, P300, DOI 10.3758/BF03210754; Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x; Hunnius S, 2004, INFANCY, V6, P231, DOI 10.1207/s15327078in0602_5; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; Libertus K, 2011, DEVELOPMENTAL SCI, V14, P1355, DOI 10.1111/j.1467-7687.2011.01084.x; LUDVIGSON HW, 1989, CHEM SENSES, V14, P525, DOI 10.1093/chemse/14.4.525; Macfarlane A, 1975, Ciba Found Symp, P103; Marlier L, 1998, CHILD DEV, V69, P611, DOI 10.1111/j.1467-8624.1998.00611.x; Marlier L, 2005, CHILD DEV, V76, P155, DOI 10.1111/j.1467-8624.2005.00836.x; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; MAURER D, 1983, INFANT BEHAV DEV, V6, P127, DOI 10.1016/S0163-6383(83)80018-6; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mennella JA, 1991, NEW ENGL J MED, V325, P8; Mizuno K, 2005, DEV MED CHILD NEUROL, V47, P299, DOI 10.1017/S0012162205000587; Nelson CA, 2003, DEVELOPMENT OF FACE PROCESSING IN INFACY AND EARLY CHILDHOOD: CURRENT PERSPECTIVES, P79; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Pascalis O., 2003, DEV FACE PROCESSING; Paul K, 1996, DEV PSYCHOBIOL, V29, P563, DOI 10.1002/(SICI)1098-2302(199611)29:7<563::AID-DEV2>3.0.CO;2-S; PORTER RH, 1991, PHYSIOL BEHAV, V50, P907, DOI 10.1016/0031-9384(91)90413-I; Quinn PC, 2004, CHILD DEV, V75, P886, DOI 10.1111/j.1467-8624.2004.00712.x; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Rattaz C, 2005, J DEV BEHAV PEDIATR, V26, P86, DOI 10.1097/00004703-200504000-00003; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Rubin GB, 1998, INFANT BEHAV DEV, V21, P641, DOI 10.1016/S0163-6383(98)90035-2; RUSSELL MJ, 1976, NATURE, V260, P520, DOI 10.1038/260520a0; Sai FZ, 2005, INFANT CHILD DEV, V14, P29, DOI 10.1002/icd.376; SCHAAL B, 1988, CHEM SENSES, V13, P145, DOI 10.1093/chemse/13.2.145; SCHAAL B, 1995, BIOL NEONATE, V67, P397; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135, DOI 10.1016/S0065-3454(08)60321-6; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; Schaal B, 2013, HDB OLFACTION GUSTAT; Schaal B., 2012, MULTISENSORY DEV, P29, DOI [DOI 10.1093/ACPROF:OSO/9780199586059.003.0002, 10.1093/acprof:oso/9780199586059.003.0002]; Schroers M, 2007, INFANT BEHAV DEV, V30, P685, DOI 10.1016/j.infbeh.2007.05.001; Seigneuric A, 2010, PERCEPTION, V39, P1541, DOI 10.1068/p6740; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Simion F, 1998, J EXP PSYCHOL HUMAN, V24, P1399, DOI 10.1037/0096-1523.24.5.1399; Simion F, 2007, PROG BRAIN RES, V164, P169, DOI 10.1016/S0079-6123(07)64009-6; Slater A, 2010, CHILD DEV PERSPECT, V4, P205, DOI 10.1111/j.1750-8606.2010.00147.x; STACK DM, 1992, CHILD DEV, V63, P1509; Steiner J E, 1979, Adv Child Dev Behav, V13, P257, DOI 10.1016/S0065-2407(08)60349-3; Sullivan RM, 1998, BIOL NEONATE, V74, P402, DOI 10.1159/000014061; Suss C, 2012, INFANT BEHAV DEV, V35, P580, DOI 10.1016/j.infbeh.2012.05.004; TODRANK J, 1995, LEARN MOTIV, V26, P116, DOI 10.1016/0023-9690(95)90001-2; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2005, J EXP CHILD PSYCHOL, V90, P255, DOI 10.1016/j.jecp.2004.11.001; Turati C, 2002, J EXP CHILD PSYCHOL, V83, P239, DOI 10.1016/S0022-0965(02)00148-0; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Vouloumanos A, 2004, DEVELOPMENTAL SCI, V7, P270, DOI 10.1111/j.1467-7687.2004.00345.x; Wada Y, 2012, APPETITE, V58, P1070, DOI 10.1016/j.appet.2012.02.002; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Walla P, 2008, PROG NEUROBIOL, V84, P192, DOI 10.1016/j.pneurobio.2007.10.005; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; Windhager S, 2010, COLLEGIUM ANTROPOL, V34, P1075; Wood JN, 2005, COGNITION, V97, P23, DOI 10.1016/j.cognition.2004.06.007; Zucco GM, 2012, ADV CONSC RES, V85, P1	87	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e70677	10.1371/journal.pone.0070677	http://dx.doi.org/10.1371/journal.pone.0070677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015175	gold, Green Published			2022-12-25	WOS:000323733800002
J	Hotomi, M; Togawa, A; Kono, M; Sugita, G; Sugita, R; Fujimaki, Y; Kamide, Y; Uchizono, A; Kanesada, K; Sawada, S; Okitsu, N; Masuda, H; Tanaka, H; Tanaka, Y; Yamanaka, N				Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Sugita, Gen; Sugita, Rinya; Fujimaki, Yutaka; Kamide, Yosuke; Uchizono, Akihiro; Kanesada, Keiko; Sawada, Shoichi; Okitsu, Naohiro; Masuda, Hisayo; Tanaka, Hideaki; Tanaka, Yumi; Yamanaka, Noboru			An Application of Outer Membrane Protein P6-Specific Enzyme-Linked Immunosorbent Assay for Detection of Haemophilus influenzae in Middle Ear Fluids and Nasopharyngeal Secretions	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; RESPIRATORY-TRACT; STREPTOCOCCUS-PNEUMONIAE; P6; HAEMOLYTICUS; CHILDREN; STRAINS; HEMOPHILUS; IDENTIFICATION; AGGLUTINATION	An enzyme-linked immunosorbent assay specific to outer membrane protein P6 (P6-ELISA) was applied for detecting Haemophilus influenzae in middle ear fluids (MEFs) from acute otitis media (AOM) patients and in nasopharyngeal secretions (NPSs) from acute rhinosinusitis patients. P6-ELISA had a sensitivity of 83.3% for MEFs and 71.5% for NPSs and a specificity of 85.6% for MEFs and 92.5% for NPSs, respectively. Real-time PCR exhibited significant differences in the number of ompP1 gene copies among samples determined by P6-ELISA to be positive and negative for H. influenzae. However, because the P6-ELISA test has the reactivity in Haemophilus species include two commensals H. haemolyticus and H. parainfluenzae, it is thus a weak method in order to detect only NTHi correctly. Consequently, diagnosis using the P6-ELISA should be based on an overall evaluation, including the results of other related examinations and clinical symptoms to prevent misleading conclusions in clinical setting.	[Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Sugita, Gen; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Sugita, Rinya] Sugita ENT Clin, Chiba, Japan; [Fujimaki, Yutaka] Fujimaki ENT Clin, Chiba, Japan; [Kamide, Yosuke] Kamide ENT Clin, Shizuoka, Japan; [Uchizono, Akihiro] Sendai ENT Clin, Kagoshima, Japan; [Kanesada, Keiko] Nonohana ENT Clin, Yamaguchi, Japan; [Sawada, Shoichi] Sawada ENT Clin, Kochi, Japan; [Okitsu, Naohiro] Tohoku Rosai Hosp, Dept Otolaryngol, Tohoku, Miyagi, Japan; [Masuda, Hisayo; Tanaka, Hideaki; Tanaka, Yumi] Otsuka Pharmaceut Co Ltd, Tokyo, Japan	Wakayama Medical University; Otsuka Pharmaceutical	Hotomi, M (corresponding author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan.	mhotomi@wakayama-med.ac.jp			Otsuka Pharmaceutical Co. Ltd., Tokyo Japan	Otsuka Pharmaceutical Co. Ltd., Tokyo Japan(Otsuka Pharmaceutical)	This study was funded by Otsuka Pharmaceutical Co. Ltd., Tokyo Japan, whose role, though the employment of Hisayo Masuda, Hideaki Tanaka, and Yumi Tanaka, involved technical assistance for performing this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billal DS, 2007, INT J PEDIATR OTORHI, V71, P269, DOI 10.1016/j.ijporl.2006.10.009; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Chang A, 2011, HUM VACCINES, V7, P102, DOI 10.4161/hv.7.1.13351; Chang A, 2010, J CLIN MICROBIOL, V48, P3756, DOI 10.1128/JCM.01255-10; DROW DL, 1983, DIAGN MICR INFEC DIS, V1, P317, DOI 10.1016/0732-8893(83)90007-X; Eldan M, 2000, PEDIATR INFECT DIS J, V19, P298, DOI 10.1097/00006454-200004000-00007; Faden H, 2002, J CLIN MICROBIOL, V40, P4748, DOI 10.1128/JCM.40.12.4748-4749.2002; FADEN H, 1994, PEDIATR INFECT DIS J, V13, P609, DOI 10.1097/00006454-199407000-00005; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Gehanno P, 1996, PEDIATR INFECT DIS J, V15, P329, DOI 10.1097/00006454-199604000-00009; Gisselsson-Solen M, 2007, J CLIN MICROBIOL, V45, P3003, DOI 10.1128/JCM.00299-07; Holt JG, 1994, GENUS HAEMOPHILUS BE, P195; HOTOMI M, 1993, INT J PEDIATR OTORHI, V27, P119, DOI 10.1016/0165-5876(93)90127-O; Hotomi M, 1998, VACCINE, V16, P1950, DOI 10.1016/S0264-410X(98)00122-4; Hotomi M, 2007, ANTIMICROB AGENTS CH, V51, P3969, DOI 10.1128/AAC.00422-07; Hotomi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033620; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Izumikawa K, 2009, CLIN VACCINE IMMUNOL, V16, P672, DOI 10.1128/CVI.00308-08; Johnston JW, 2009, HAEMOPHILUS INFLUENZ, P153; KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9; Kirkham LAS, 2010, J CLIN MICROBIOL, V48, P2557, DOI 10.1128/JCM.00069-10; MACONE AB, 1985, J CLIN MICROBIOL, V21, P711, DOI 10.1128/JCM.21.5.711-714.1985; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Michel LV, 2011, VACCINE, V29, P1624, DOI 10.1016/j.vaccine.2010.12.082; Mukundan D, 2007, J CLIN MICROBIOL, V45, P3207, DOI 10.1128/JCM.00492-07; MUNSON RS, 1985, INFECT IMMUN, V49, P544, DOI 10.1128/IAI.49.3.544-549.1985; MURPHY TF, 1986, J CLIN INVEST, V78, P1020, DOI 10.1172/JCI112656; MURPHY TF, 1986, INFECT IMMUN, V54, P774, DOI 10.1128/IAI.54.3.774-779.1986; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; NELSON MB, 1991, INFECT IMMUN, V59, P2658, DOI 10.1128/IAI.59.8.2658-2663.1991; Norskov-Lauritsen N, 2009, J CLIN MICROBIOL, V47, P2590, DOI 10.1128/JCM.00013-09; Norskov-Lauritsen N, 2009, J BACTERIOL, V191, P822, DOI 10.1128/JB.00782-08; Prymula R, 2009, VACCINE, V28, P71, DOI 10.1016/j.vaccine.2009.09.113; TAYLOR DC, 1992, J MED MICROBIOL, V36, P279, DOI 10.1099/00222615-36-4-279; Ubukata K, 2001, ANTIMICROB AGENTS CH, V45, P1693, DOI 10.1128/AAC.45.6.1693-1699.2001; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Witt CS, 1990, REV INFECT DIS S, V8, pS1001; Yamanaka Noboru, 2008, Journal of Infection and Chemotherapy, V14, P180, DOI 10.1007/s10156-007-0599-3	39	3	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71774	10.1371/journal.pone.0071774	http://dx.doi.org/10.1371/journal.pone.0071774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015192	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800014
J	Fagoonee, S; Bearzi, C; Di Cunto, F; Clohessy, JG; Rizzi, R; Reschke, M; Tolosano, E; Provero, P; Pandolfi, PP; Silengo, L; Altruda, F				Fagoonee, Sharmila; Bearzi, Claudia; Di Cunto, Ferdinando; Clohessy, John G.; Rizzi, Roberto; Reschke, Markus; Tolosano, Emanuela; Provero, Paolo; Pandolfi, Pier Paolo; Silengo, Lorenzo; Altruda, Fiorella			The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; SPLICING PROGRAM; TUMOR-SUPPRESSOR; MESSENGER-RNA; SOX2; DIFFERENTIATION; NETWORK; SALL4; OCT4	In pluripotent stem cells, there is increasing evidence for crosstalk between post-transcriptional and transcriptional networks, offering multifold steps at which pluripotency can be controlled. In addition to well-studied transcription factors, chromatin modifiers and miRNAs, RNA-binding proteins are emerging as fundamental players in pluripotency regulation. Here, we report a new role for the RNA-binding protein ESRP1 in the control of pluripotency. Knockdown of Esrp1 in mouse embryonic stem cells induces, other than the well-documented epithelial to mesenchymal-like state, also an increase in expression of the core transcription factors Oct4, Nanog and Sox2, thereby enhancing self-renewal of these cells. Esrp1-depleted embryonic stem cells displayed impaired early differentiation in vitro and formed larger teratomas in vivo when compared to control embryonic stem cells. We also show that ESRP1 binds to Oct4 and Sox2 mRNAs and decreases their polysomal loading. ESRP1 thus acts as a physiological regulator of the finely-tuned balance between self-renewal and commitment to a restricted developmental fate. Importantly, both mouse and human epithelial stem cells highly express ESRP1, pinpointing the importance of this RNA-binding protein in stem cell biology.	[Fagoonee, Sharmila; Di Cunto, Ferdinando; Tolosano, Emanuela; Provero, Paolo; Silengo, Lorenzo; Altruda, Fiorella] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Bearzi, Claudia; Rizzi, Roberto] Multimed IRCCS, Milan, Italy; [Bearzi, Claudia; Rizzi, Roberto] CNR, Inst Cellular Biol & Neurobiol, Rome, Italy; [Clohessy, John G.; Reschke, Markus; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Clohessy, John G.; Reschke, Markus; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	University of Turin; IRCCS Multimedica; Consiglio Nazionale delle Ricerche (CNR); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Altruda, F (corresponding author), Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	fiorella.altruda@unito.it	Tolosano, Emanuela/L-8080-2019; Di Cunto, Ferdinando/K-5575-2016; Provero, Paolo/AAC-1930-2019; Fagoonee, Sharmila/L-1940-2019; Tolosano, Emanuela/A-4684-2015	Tolosano, Emanuela/0000-0002-1622-2340; Fagoonee, Sharmila/0000-0001-6070-6716; Tolosano, Emanuela/0000-0002-1622-2340; RIZZI, ROBERTO/0000-0001-6084-7199; Pandolfi, Pier Paolo/0000-0002-5352-5295; Clohessy, John/0000-0001-5186-9775; di cunto, ferdinando/0000-0001-9367-6357	Prin; Regione Piemonte "PiStem: Piattaforme Innovative per le Scienze della Vita" linea attivita I.1.1 del POR F.E.S.R.; Italian Ministry of Health - Giovani Ricercatori [GR-2009-1606636]	Prin(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Piemonte "PiStem: Piattaforme Innovative per le Scienze della Vita" linea attivita I.1.1 del POR F.E.S.R.; Italian Ministry of Health - Giovani Ricercatori(Ministry of Health, Italy)	This study was supported by Prin 2010-2011 and by Regione Piemonte "PiStem: Piattaforme Innovative per le Scienze della Vita" linea attivita I.1.1 del POR F.E.S.R. 2007/2013 to F. A. and by the Italian Ministry of Health - Giovani Ricercatori 2009, grant GR-2009-1606636 to C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Bussolati B, 2012, AM J PHYSIOL-RENAL, V302, pF116, DOI 10.1152/ajprenal.00184.2011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Elatmani H, 2011, STEM CELLS, V29, P1504, DOI 10.1002/stem.712; Fagoonee S, 2010, STEM CELLS DEV, V19, P1183, DOI 10.1089/scd.2009.0496; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kang NY, 2011, NAT PROTOC, V6, P1044, DOI 10.1038/nprot.2011.350; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Leontieva OV, 2009, CELL CYCLE, V8, P490, DOI 10.4161/cc.8.3.7679; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Piro RM, 2011, EUR J HUM GENET, V19, P1173, DOI 10.1038/ejhg.2011.96; Rizzi R, 2012, CELL DEATH DIFFER, V19, P1162, DOI 10.1038/cdd.2011.205; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Tanimura N, 2013, J BIOL CHEM, V288, P5027, DOI 10.1074/jbc.M112.411173; Tolkunova E N, 2009, Tsitologiia, V51, P212; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wright JE, 2013, TRENDS GENET, V29, P99, DOI 10.1016/j.tig.2012.10.007; Wurth L, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/178525; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	48	28	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72300	10.1371/journal.pone.0072300	http://dx.doi.org/10.1371/journal.pone.0072300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015231	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200034
J	Jiang, FR; Jiang, RL; Zhu, XJ; Zhang, X; Zhan, Z				Jiang, Fengrong; Jiang, Rilei; Zhu, Xiaojia; Zhang, Xu; Zhan, Zhan			Genipin Inhibits TNF-alpha-Induced Vascular Smooth Muscle Cell Proliferation and Migration via Induction of HO-1	PLOS ONE			English	Article							HEME OXYGENASE-1 PROTECTS; GENE-EXPRESSION PATTERNS; UNCOUPLING PROTEIN-2; RAT-BRAIN; MECHANISMS; OVEREXPRESSION; DYSFUNCTION; INJURY; ARTERY; ROLES	Vascular smooth muscle cell (VSMC) proliferation and migration triggered by inflammatory stimuli contributes importantly to the pathogenesis of atherosclerosis and restenosis. On the other hand, genipin, an aglycon of geniposide, exhibits diverse pharmacological functions such as antitumor and anti-inflammatory effects. The protective effects of genipin on the cardiovascular system have also been reported. However, the molecular mechanism involved remains unknown. This study aimed to elucidate the precise function of genipin in VSMCs, focusing particularly on the role of heme oxygenase-1 (HO-1), a potent anti-inflammatory enzyme. We found that pretreatment of genipin induced HO-1 mRNA and protein levels, as well as its activity in VSMCs. Genipin inhibited TNF-alpha-induced VSMC proliferation and migration in a dose-dependent manner. At the molecular level, genipin prevented ERK/MAPK and Akt phosphorylation while left p38 MAPK and JNK unchanged. Genipin also blocked the increase of ROS generation induced by TNF-alpha. More importantly, the specific HO-1 siRNA partially abolished the beneficial effects of genipin on VSMCs. These results suggest that genipin may serve as a novel drug in the treatment of these pathologies by inducing HO-1 expression/activity and subsequently decreasing VSMC proliferation and migration.	[Jiang, Fengrong; Jiang, Rilei; Zhu, Xiaojia; Zhang, Xu; Zhan, Zhan] Nanjing Univ Chinese Med, Discipline Chinese & Western Integrat Med, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Zhang, X (corresponding author), Nanjing Univ Chinese Med, Discipline Chinese & Western Integrat Med, Nanjing, Jiangsu, Peoples R China.	zhangxutcm@gmail.com; zhanzhan5607@sina.com		Jiang, Rilei/0000-0002-5923-3912; Zhang, Xu/0000-0002-1959-1758	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing-Lan Project of Jiangsu Province	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing-Lan Project of Jiangsu Province	This work was supported by grants from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Qing-Lan Project of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Bo H, 2008, FREE RADICAL BIO MED, V44, P1373, DOI 10.1016/j.freeradbiomed.2007.12.033; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chandrashekhar Y, 2004, J AM COLL CARDIOL, V43, P295, DOI 10.1016/j.jacc.2003.09.026; Chen SY, 2012, FOOD CHEM TOXICOL, V50, P3025, DOI 10.1016/j.fct.2012.06.006; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Dugourd C, 2003, HYPERTENSION, V41, P882, DOI 10.1161/01.HYP.0000060821.62417.35; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Jeon WK, 2011, ARCH BIOCHEM BIOPHYS, V512, P119, DOI 10.1016/j.abb.2011.05.016; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Kim HS, 2007, DIABETES RES CLIN PR, V77, pS46, DOI 10.1016/j.diabres.2007.01.032; Kim JE, 2009, BIOL PHARM BULL, V32, P1047, DOI 10.1248/bpb.32.1047; Kondo K, 2002, EUR J PHARMACOL, V455, P53, DOI 10.1016/S0014-2999(02)02449-4; Lee JH, 2009, FOOD CHEM TOXICOL, V47, P1127, DOI 10.1016/j.fct.2009.01.037; Mizuno T, 2000, BIOCHEM BIOPH RES CO, V278, P691, DOI 10.1006/bbrc.2000.3859; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Nam KN, 2010, INT IMMUNOPHARMACOL, V10, P493, DOI 10.1016/j.intimp.2010.01.011; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; PAK O, 2013, AM J RESP CELL MOL B, P90303; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Rogers PAW, 2003, MICROSC RES TECHNIQ, V60, P412, DOI 10.1002/jemt.10279; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tian JS, 2010, NEUROSCI LETT, V479, P236, DOI 10.1016/j.neulet.2010.05.069; Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31; Wen JK, 2002, LIFE SCI, V70, P799, DOI 10.1016/S0024-3205(01)01446-1; Yang XP, 2006, ARTERIOSCL THROM VAS, V26, P85, DOI 10.1161/01.ATV.0000191635.00744.b6; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang M, 2002, CELL RES, V12, P123, DOI 10.1038/sj.cr.7290118	36	27	32	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e74826	10.1371/journal.pone.0074826	http://dx.doi.org/10.1371/journal.pone.0074826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013271	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200094
J	Watanabe, TM; Imada, K; Yoshizawa, K; Nishiyama, M; Kato, C; Abe, F; Morikawa, TJ; Kinoshita, M; Fujita, H; Yanagida, T				Watanabe, Tomonobu M.; Imada, Katsumi; Yoshizawa, Keiko; Nishiyama, Masayoshi; Kato, Chiaki; Abe, Fumiyoshi; Morikawa, Takamitsu J.; Kinoshita, Miki; Fujita, Hideaki; Yanagida, Toshio			Glycine Insertion Makes Yellow Fluorescent Protein Sensitive to Hydrostatic Pressure	PLOS ONE			English	Article							STRUCTURAL BASIS; BINDING; SHIFTS; TEMPERATURE; VARIANTS	Fluorescent protein-based indicators for intracellular environment conditions such as pH and ion concentrations are commonly used to study the status and dynamics of living cells. Despite being an important factor in many biological processes, the development of an indicator for the physicochemical state of water, such as pressure, viscosity and temperature, however, has been neglected. We here found a novel mutation that dramatically enhances the pressure dependency of the yellow fluorescent protein (YFP) by inserting several glycines into it. The crystal structure of the mutant showed that the tyrosine near the chromophore flipped toward the outside of the beta-can structure, resulting in the entry of a few water molecules near the chromophore. In response to changes in hydrostatic pressure, a spectrum shift and an intensity change of the fluorescence were observed. By measuring the fluorescence of the YFP mutant, we succeeded in measuring the intracellular pressure change in living cell. This study shows a new strategy of design to engineer fluorescent protein indicators to sense hydrostatic pressure.	[Watanabe, Tomonobu M.; Yoshizawa, Keiko; Fujita, Hideaki; Yanagida, Toshio] RIKEN Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Fujita, Hideaki; Yanagida, Toshio] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Watanabe, Tomonobu M.; Yanagida, Toshio] Osaka Univ, WPI, Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Morikawa, Takamitsu J.; Kinoshita, Miki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Imada, Katsumi] Osaka Univ, Dept Macromol Sci, Grad Sch Sci, Toyonaka, Osaka 560, Japan; [Nishiyama, Masayoshi] Kyoto Univ, Inst Integrated Cell Mat Sci, HAKUBI Ctr Adv Res, Kyoto 6068501, Japan; [Kato, Chiaki; Abe, Fumiyoshi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Abe, Fumiyoshi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa, Japan	RIKEN; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Osaka University; Kyoto University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Aoyama Gakuin University	Watanabe, TM (corresponding author), RIKEN Quantitat Biol Ctr QBiC, Suita, Osaka, Japan.	tomowatanabe@riken.jp	Nishiyama, Masayoshi/AAI-4579-2021; Watanabe, Tomonobu/J-4812-2013; Fujita, Hideaki/B-7633-2008; Nishiyama, Masayoshi/F-8857-2012	Fujita, Hideaki/0000-0003-3430-5681; Nishiyama, Masayoshi/0000-0002-0525-3766; Watanabe, Tomonobu/0000-0002-2420-4230; Imada, Katsumi/0000-0003-1342-8885	PRESTO, the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25117511] Funding Source: KAKEN	PRESTO, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by PRESTO, the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barstow B, 2008, P NATL ACAD SCI USA, V105, P13362, DOI 10.1073/pnas.0802252105; Barstow B, 2009, BIOPHYS J, V97, P1719, DOI 10.1016/j.bpj.2009.06.039; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cetinkaya M, 2006, CHEM PHYS LETT, V419, P48, DOI 10.1016/j.cplett.2005.11.046; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frazer JCW, 1916, J AM CHEM SOC, V38, P1907, DOI 10.1021/ja02267a001; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245; Horner VL, 2008, DEV BIOL, V316, P100, DOI 10.1016/j.ydbio.2008.01.014; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Ichimura T, 2012, CHEM COMMUN, V48, P7871, DOI 10.1039/c2cc32541a; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nifosi R, 2007, J COMPUT CHEM, V28, P2366, DOI 10.1002/jcc.20764; Nishiyama M, 2012, INT J MOL SCI, V13, P9225, DOI 10.3390/ijms13079225; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Paschek D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238105; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Tomos D, 2000, BIOTECHNOL LETT, V22, P437, DOI 10.1023/A:1005631921364; Topell Simon, 2002, Methods Mol Biol, V183, P31; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verkhusha VV, 2003, BBA-GEN SUBJECTS, V1622, P192, DOI 10.1016/S0304-4165(03)00140-5; Voityuk AA, 1998, CHEM PHYS, V231, P13, DOI 10.1016/S0301-0104(98)00080-9; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Wiedersich J, 2008, P NATL ACAD SCI USA, V105, P5756, DOI 10.1073/pnas.0710409105; ZHANG B, 1985, APPL OPTICS, V24, P2779, DOI 10.1364/AO.24.002779	37	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73212	10.1371/journal.pone.0073212	http://dx.doi.org/10.1371/journal.pone.0073212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014139	gold, Green Published, Green Submitted			2022-12-25	WOS:000323815200074
J	Billong, SC; Fokam, J; Aghokeng, AF; Milenge, P; Kembou, E; Abessouguie, I; Meva'a-Onglene, FB; Bissek, ACZK; Colizzi, V; Mpoudi, EN; Elat, JBN; Shiro, KS				Billong, Serge C.; Fokam, Joseph; Aghokeng, Avelin F.; Milenge, Pascal; Kembou, Etienne; Abessouguie, Ibile; Meva'a-Onglene, Flore Beatrice; Bissek, Anne C. Zoung-Kanyi; Colizzi, Vittorio; Mpoudi, Eitel N.; Elat, Jean-Bosco N.; Shiro, Koulla S.			Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; MUTATIONS; NAIVE	Background: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically reduced HIV-related morbidity and mortality. However, challenges in long-term ART, adherence and HIV drug resistance (HIVDR) itself, require monitoring to limit HIVDR emergence among ART-experienced populations, in order to ensure regimen efficacy. Methods: A longitudinal study was conducted from 2009-2011 in a cohort of 141 HIV-infected adult patients (aged >21) at the national social insurance centre hospital in Yaounde, Cameroon. As per-WHO HIVDR protocol, HIV-1 protease-reverse transcriptase genotyping was performed at baseline and at endpoint (12 months) on first-line ART using ViroSeq (TM) Genotyping kit. Results: At baseline, a prevalence of 3.6% (5/139) HIVDR was observed [protease inhibitors M46I (1/5), G73A (1/5), L90LM (1/5); nucleoside reverse transcriptase inhibitors: M184V (1/5), T215F (1/5); non-nucleoside reverse transcriptase inhibitors: K103N (1/5), Y181Y/C (2/5), M230ML (1/5)]. At endpoint, 54.0% (76) patients were followed-up, 9.2% (13) died, and 3.5% (5) transferred, 38.5% (47) lost to follow-up (LTFU). 69.7% (53/76) of those followed-up had viremia <40 copies/ml and 90.8% (69/76) <1000 copies/ml. 4/7 patients with viremia >= 1000 copies/ml harbored HIVDR (prevalence: 5.3%; 4/76), with M184V/I (4/4) and K103K/N (3/4) being the most prevalent mutations. LTFU was favored by costs for consultation/laboratory tests, drug shortages, workload (physician/patient ratio: 1/180) and community disengagement. Conclusions: Low levels of HIVDR at baseline and at endpoint suggest a probable effectiveness of ART regimens used in Cameroon. However the possible high rate of HIVDR among LTFUs limited the strengths of our findings. Evaluating HIVDR among LTFU, improving adherence, task shifting, subsidizing/harmonizing costs for routine follow-up, are urgent measures to ensure an improved success of the country ART performance.	[Billong, Serge C.; Fokam, Joseph; Aghokeng, Avelin F.; Milenge, Pascal; Kembou, Etienne; Abessouguie, Ibile; Bissek, Anne C. Zoung-Kanyi; Elat, Jean-Bosco N.] Natl HIV Drug Resistance Prevent & Surveillance W, Yaounde, Cameroon; [Billong, Serge C.; Abessouguie, Ibile; Elat, Jean-Bosco N.] Cent Tech Grp, Natl AIDS Control Comm, Yaounde, Cameroon; [Billong, Serge C.; Fokam, Joseph; Shiro, Koulla S.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Fokam, Joseph; Colizzi, Vittorio] CIRCB Chantal BIYA Int Reference Ctr Res HIV AIDS, Mol Biol Lab, Sequencing Unit, Yaounde, Cameroon; [Aghokeng, Avelin F.; Mpoudi, Eitel N.] Ctr Rech Malad Emergentes & Re Emergentes CREMER, Virol Lab, Yaounde, Cameroon; [Aghokeng, Avelin F.] Univ Montpellier I, IRD, UMI TransVIHMI 233, Montpellier, France; [Milenge, Pascal; Kembou, Etienne] WHO, Afro, Yaounde, Cameroon; [Meva'a-Onglene, Flore Beatrice] Natl Social Insurance Ctr Hosp, Approved Treatment Ctr, Yaounde, Cameroon; [Bissek, Anne C. Zoung-Kanyi] Minist Publ Hlth, Dept Dis Control, Yaounde, Cameroon; [Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, Fac Sci, Lab Immunol & Mol Pathol, I-00173 Rome, Italy; [Shiro, Koulla S.] Yaounde Cent Hosp, Serv Infectiol, Yaounde, Cameroon; [Shiro, Koulla S.] Minist Publ Hlth, Div Operat Hlth Res, Yaounde, Cameroon; [Shiro, Koulla S.] Minist Publ Hlth, Gen Secretariat, Yaounde, Cameroon; [Shiro, Koulla S.] Agence Natl Rech Sida & Hepatites Virales ANRS Su, Yaounde, Cameroon	University of Yaounde I; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; World Health Organization; University of Rome Tor Vergata	Billong, SC (corresponding author), Natl HIV Drug Resistance Prevent & Surveillance W, Yaounde, Cameroon.	sergebillong@yahoo.fr; josephfokam@gmail.com		AGHOKENG FOBANG, Avelin/0000-0002-1414-0237	ResNet, the World Health Organization (WHO) Global HIV Drug Resistance Surveillance network	ResNet, the World Health Organization (WHO) Global HIV Drug Resistance Surveillance network	This work was supported by ResNet, the World Health Organization (WHO) Global HIV Drug Resistance Surveillance network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Aghokeng AF, 2011, J CLIN MICROBIOL, V49, P1635, DOI 10.1128/JCM.01478-10; [Anonymous], 2006, WORK TOG HLTH; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Billong SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036777, DOI 10.1371/J0URNAL.P0NE.0036777]; Ceccarelli L, 2012, J MED VIROL, V84, P721, DOI 10.1002/jmv.23244; Comite Nationale de Lutte contre le SIDA au Cameroun, 2010, PROP VIH CAM SER, V10; Comite Nationale de Lutte contre le SIDA au Cameroun, 2012, RAPP ACT 2012 LUTT V; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Fokam J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-308; Fokam J, 2011, PEDIATR INFECT DIS J, V30, P1062, DOI 10.1097/INF.0b013e31822db54c; Gupta RK, 2012, LANCET; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kates J., 2011, FINANCING RESPONSE A; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Ministry of Public Health Cameroon, 2010, NAT GUID MAN PEOPL A; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; New Delhi National AIDS Control Organisation, 2012, NAT AIDS CONTR PROGR; Republique du Cameroun Institut National de la Statistique, 2011, RAPP 2011 ENQ DEM SA; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Tsertsvadze Tengiz, 2009, Central European Journal of Public Health, V17, P25; UNAIDS, 2012, WHO LIB CAT PUBL DAT; UNAIDS, 2011, POL DECL HIV AIDS IN; WHO, 2010, ANT THER HIV INF AD; *WHO UNAIDS, 2003, WHO UNAIDS GLOB IN P; WHO/ UNAIDS, 2006, UN ACC COMPR PREV PR; World Health Organization, 2011, THRESH VAL INT COST; World Health Organization (WHO), 2012, HIV DRUG RES REP	28	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72680	10.1371/journal.pone.0072680	http://dx.doi.org/10.1371/journal.pone.0072680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991142	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800084
J	Katayama, KI; Imai, F; Suto, F; Yoshida, Y				Katayama, Kei-ichi; Imai, Fumiyasu; Suto, Fumikazu; Yoshida, Yutaka			Deletion of Sema3a or plexinA1/plexinA3 Causes Defects in Sensory Afferent Projections of Statoacoustic Ganglion Neurons	PLOS ONE			English	Article							LAMINA-RESTRICTED PROJECTION; HIPPOCAMPAL MOSSY FIBERS; DEVELOPING SPINAL-CORD; INNER-EAR; AXON GUIDANCE; SEMAPHORIN; PLEXIN-A2; CELLS; INNERVATION; CONNECTIONS	Statoacoustic ganglion (SAG) neurons project sensory afferents to appropriate targets in the inner ear to form functional vestibular and auditory circuits. Neuropilin1 (Npn1), a receptor for class 3 semaphorins, is required to generate appropriate afferent projections in SAG neurons; however, the ligands and coreceptors involved in Npn1 functioning remain unknown. Here we show that both plexinA1 and plexinA3 are expressed by SAG neurons, and plexinA1/plexinA3 double mutant mice show defects in afferent projections of SAG neurons in the inner ear. In control mice, sensory afferents of SAG neurons terminate at the vestibular sensory patches, whereas in plexinA1/plexinA3 double mutants, they extend more dorsally in the inner ear beyond normal vestibular target areas. Moreover, we find that semaphorin3a (Sema3a) is expressed in the dorsal otocyst, and Sema3a mutant mice show defects in afferent projections of SAG neurons similar to those observed in plexinA1/plexinA3 double mutants and in mice lacking a functional Npn1 receptor. Taken together, these genetic findings demonstrate that Sema3a repellent signaling plays a role in the establishment of proper afferent projections in SAG neurons, and this signaling likely occurs through a receptor complex involving Npn1 and either plexinA1 or plexinA3.	[Katayama, Kei-ichi; Imai, Fumiyasu; Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Suto, Fumikazu] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan	Cincinnati Children's Hospital Medical Center; National Center for Neurology & Psychiatry - Japan	Katayama, KI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	katayama-vet@umin.ac.jp; yutaka.yoshida@cchmc.org	Katayama, Kei-ichi/J-4699-2013	Katayama, Kei-ichi/0000-0003-0527-4644	JSPS Postdoctoral Fellowships for Research Abroad; NINDS [NS065048]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	JSPS Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	KK and YY are supported by JSPS Postdoctoral Fellowships for Research Abroad and a grant from NINDS (NS065048), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Defourny J, 2011, AM J PHYSIOL-CELL PH, V301, pC750, DOI 10.1152/ajpcell.00516.2010; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Katayama KI, 2012, J NEUROSCI, V32, P10396, DOI 10.1523/JNEUROSCI.6474-11.2012; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Katayama K, 2009, PLOS ONE, V4, pA151, DOI 10.1371/journal.pone.0007786; Leslie JR, 2011, DEVELOPMENT, V138, P4085, DOI 10.1242/dev.066076; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Miyazaki N, 1999, NEUROSCI LETT, V261, P127, DOI 10.1016/S0304-3940(98)00988-4; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schwarz Q, 2008, DEV BIOL, V324, P1, DOI 10.1016/j.ydbio.2008.08.020; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Webber A, 2006, ANAT REC PART A, V288A, P390, DOI 10.1002/ar.a.20299; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Yoshida Y, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmo1.2012.00071, 10.3389/fnmol.2012.00071]	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72512	10.1371/journal.pone.0072512	http://dx.doi.org/10.1371/journal.pone.0072512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991118	Green Submitted, gold, Green Published			2022-12-25	WOS:000324228800076
J	Leclerc, GM; Leclerc, GJ; Kuznetsov, JN; DeSalvo, J; Barredo, JC				Leclerc, Gilles M.; Leclerc, Guy J.; Kuznetsov, Jeffim N.; DeSalvo, Joanna; Barredo, Julio C.			Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; UPSTREAM KINASE; CELL-DEATH; COMPLEX 1; PIM; LEUKEMIA; AKT; RAPAMYCIN; TARGET	The outcome of patients with resistant phenotypes of acute lymphoblastic leukemia (ALL) or those who relapse remains poor. We investigated the mechanism of cell death induced by metformin in Bp- and T-ALL cell models and primary cells, and show that metformin effectively induces apoptosis in ALL cells. Metformin activated AMPK, down-regulated the unfolded protein response (UPR) demonstrated by significant decrease in the main UPR regulator GRP78, and led to UPR-mediated cell death via up-regulation of the ER stress/UPR cell death mediators IRE1 alpha and CHOP. Using shRNA, we demonstrate that metformin-induced apoptosis is AMPK-dependent since AMPK knockdown rescued ALL cells, which correlated with down-regulation of IRE1 alpha and CHOP and restoration of the UPR/GRP78 function. Additionally rapamycin, a known inhibitor of mTOR-dependent protein synthesis, rescued cells from metformin-induced apoptosis and down-regulated CHOP expression. Finally, metformin induced PIM-2 kinase activity and co-treatment of ALL cells with a PIM-1/2 kinase inhibitor plus metformin synergistically increased cell death, suggesting a buffering role for PIM-2 in metformin's cytotoxicity. Similar synergism was seen with agents targeting Akt in combination with metformin, supporting our original postulate that AMPK and Akt exert opposite regulatory roles on UPR activity in ALL. Taken together, our data indicate that metformin induces ALL cell death by triggering ER and proteotoxic stress and simultaneously down-regulating the physiologic UPR response responsible for effectively buffering proteotoxic stress. Our findings provide evidence for a role of metformin in ALL therapy and support strategies targeting synthetic lethal interactions with Akt and PIM kinases as suitable for future consideration for clinical translation in ALL.	[Leclerc, Gilles M.; Leclerc, Guy J.; DeSalvo, Joanna; Barredo, Julio C.] Univ Miami, Miller Sch Med, Dept Pediat Hematol & Oncol, Miami, FL 33136 USA; [Kuznetsov, Jeffim N.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Barredo, Julio C.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Barredo, Julio C.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Barredo, JC (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat Hematol & Oncol, Miami, FL 33136 USA.	jbarredo@med.miami.edu		Kuznetsoff, Jeffim/0000-0002-6197-2642	Leukemia & Lymphoma Society [6168-09]; Micah Batchelor Award	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Micah Batchelor Award	This research was supported by grants from the Leukemia & Lymphoma Society (grant number 6168-09), and the Micah Batchelor Award to Julio C. Barredo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; DeSalvo J, 2012, MOL CANCER RES, V10, P969, DOI 10.1158/1541-7786.MCR-12-0125; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fay JR, 2009, CANCER PREV RES, V2, P301, DOI 10.1158/1940-6207.CAPR-08-0166; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Korets SB, 2011, CLIN CANCER RES, V17, P7518, DOI 10.1158/1078-0432.CCR-11-1664; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Matsuo J, 2012, MOL CANCER THER, V11, P1082, DOI 10.1158/1535-7163.MCT-11-0871; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Theriault JR, 2011, BIOCHEM BIOPH RES CO, V409, P500, DOI 10.1016/j.bbrc.2011.05.034; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yeh CH, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/130636; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	51	68	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74420	10.1371/journal.pone.0074420	http://dx.doi.org/10.1371/journal.pone.0074420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009772	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200055
J	Salleh, MZ; Teh, LK; Lee, LS; Ismet, RI; Patowary, A; Joshi, K; Pasha, A; Ahmed, AZ; Janor, RM; Hamzah, AS; Adam, A; Yusoff, K; Hoh, BP; Hatta, FHM; Ismail, MI; Scaria, V; Sivasubbu, S				Salleh, Mohd Zaki; Teh, Lay Kek; Lee, Lian Shien; Ismet, Rose Iszati; Patowary, Ashok; Joshi, Kandarp; Pasha, Ayesha; Ahmed, Azni Zain; Janor, Roziah Mohd; Hamzah, Ahmad Sazali; Adam, Aishah; Yusoff, Khalid; Hoh, Boon Peng; Hatta, Fazleen Haslinda Mohd; Ismail, Mohamad Izwan; Scaria, Vinod; Sivasubbu, Sridhar			Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine	PLOS ONE			English	Article							FUNCTIONAL ANNOTATION; GENETIC-VARIANTS; SEQUENCE; DATABASE; FORMAT	Background: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient to patient variability in pharmacokinetics and pharmacodynamics responses towards drugs would be the next step in future medicine in line with the vision of personalizing medicine. Methods: Genomic DNA obtained from a 55 years old, self-declared healthy, anonymous male of Malay descent was sequenced. The subject's mother died of lung cancer and the father had a history of schizophrenia and deceased at the age of 65 years old. A systematic, intuitive computational workflow/pipeline integrating custom algorithm in tandem with large datasets of variant annotations and gene functions for genetic variations with pharmacogenomics impact was developed. A comprehensive pathway map of drug transport, metabolism and action was used as a template to map non-synonymous variations with potential functional consequences. Principal Findings: Over 3 million known variations and 100,898 novel variations in the Malay genome were identified. Further in-depth pharmacogenetics analysis revealed a total of 607 unique variants in 563 proteins, with the eventual identification of 4 drug transport genes, 2 drug metabolizing enzyme genes and 33 target genes harboring deleterious SNVs involved in pharmacological pathways, which could have a potential role in clinical settings. Conclusions: The current study successfully unravels the potential of personal genome sequencing in understanding the functionally relevant variations with potential influence on drug transport, metabolism and differential therapeutic outcomes. These will be essential for realizing personalized medicine through the use of comprehensive computational pipeline for systematic data mining and analysis.	[Salleh, Mohd Zaki; Teh, Lay Kek; Lee, Lian Shien; Ismet, Rose Iszati; Ismail, Mohamad Izwan] Univ Teknol MARA UiTM Malaysia, Integrat Pharmacogen Inst iPROMISE, Puncak Alam, Selangor, Malaysia; [Patowary, Ashok; Scaria, Vinod] CSIR IGIB, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Joshi, Kandarp; Pasha, Ayesha; Sivasubbu, Sridhar] CSIR IGIB, Delhi, India; [Ahmed, Azni Zain; Hamzah, Ahmad Sazali] Univ Teknol MARA UiTM Malaysia, Inst Sci, Shah Alam, Selangor, Malaysia; [Janor, Roziah Mohd] Univ Teknol MARA UiTM Malaysia, Fac Comp & Math Sci, Shah Alam, Selangor, Malaysia; [Salleh, Mohd Zaki; Teh, Lay Kek; Adam, Aishah; Hatta, Fazleen Haslinda Mohd] Univ Teknol MARA UiTM Malaysia, Fac Pharm, Puncak Alam, Selangor, Malaysia; [Yusoff, Khalid] Univ Teknol MARA UiTM Malaysia, Fac Med, Sg Buloh, Selangor, Malaysia; [Hoh, Boon Peng] Univ Teknol MARA UiTM Malaysia, Fac Med, IMMB, Sg Buloh, Selangor, Malaysia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Universiti Teknologi MARA; Universiti Teknologi MARA	Salleh, MZ (corresponding author), Univ Teknol MARA UiTM Malaysia, Integrat Pharmacogen Inst iPROMISE, Puncak Alam, Selangor, Malaysia.	zakisalleh@puncakalam.uitm.edu.my; vinod@igib.in; sivasubbu@igib.res.in	Scaria, Vinod/AAS-3151-2021; hamzah, ahmad sazali/AAZ-5380-2021; Salleh, Mohd Zaki/ABD-4784-2020; Hoh, Boon-Peng/H-8682-2016; Teh, Lay Kek/AAV-2790-2020; Teh, Lay Kek/ABH-6209-2020; Salleh, Mohd Zaki/D-3287-2009; Patowary, Ashok/AAT-5305-2020; Yusoff, Khalid/I-7029-2019	Hoh, Boon-Peng/0000-0001-9249-4965; Patowary, Ashok/0000-0001-7507-3907; Yusoff, Khalid/0000-0001-5669-5188; Teh, Lay Kek/0000-0002-2830-4263; MOHD JANOR, PROFESOR DR ROZIAH/0000-0002-9435-2781; Ismet, Rose Iszati/0000-0003-3996-8708; Scaria, Vinod/0000-0001-7644-7181; Mohd Hatta, Fazleen Haslinda/0000-0002-0331-1037	Universiti Teknologi MARA; Ministry of Higher Education Malaysia [LRGS 600-RMI/LRGS 5/3 (1/2011)-1]; CSIR India through CARDIOMED [BSC0122]; CSIR, India; CSIR Open Source Drug Discovery Programme	Universiti Teknologi MARA; Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); CSIR India through CARDIOMED; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR Open Source Drug Discovery Programme	The authors acknowledge the funding from both the Universiti Teknologi MARA and Ministry of Higher Education Malaysia (LRGS 600-RMI/LRGS 5/3 (1/2011)-1). VS and SS acknowledge funding support from CSIR India through CARDIOMED (BSC0122). AP acknowledges a Senior Research Fellowship from CSIR, India. KJ and AP acknowledge fellowships from the CSIR Open Source Drug Discovery Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Belle DJ, 2008, AM FAM PHYS; Cariaso M, 2012, NUCLEIC ACIDS RES, V40, pD1308, DOI 10.1093/nar/gkr798; Cordero P, 2012, CLIN PHARMACOL THER, V91, P1001, DOI 10.1038/clpt.2012.51; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dissanayake VHW, 2011, SRI LANKA J BIOMEDIC, V2; Donlin MJ, 2002, USING GENERIC GENOME; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gupta R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-440; Hatin WI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018312; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kawamoto K, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-17; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Moore B, 2010, NUCLEIC ACIDS RES, V38, pW161, DOI 10.1093/nar/gkq426; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Patowary A, 2012, HUM MUTAT, V33, P1133, DOI 10.1002/humu.22091; Pirmohamed M, 2001, BR J CLIN PHARM; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Sangkuhl K, 2008, DRUG METAB REV, V40, P539, DOI 10.1080/03602530802413338 ; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shukla P, 2012, J CANCER RES THER, V8, P40, DOI 10.4103/0973-1482.95172; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Van Hemert JL, 2010, BIOINFORMATICS, V26, P2345, DOI 10.1093/bioinformatics/btq423; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yoo HD, 2011, ARCH PHARM RES, V34, P1817, DOI 10.1007/s12272-011-1104-1; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	38	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71554	10.1371/journal.pone.0071554	http://dx.doi.org/10.1371/journal.pone.0071554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009664	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200011
J	Lin, LF; Li, CF; Wang, WJ; Yang, WM; Wang, DDH; Chang, WC; Lee, WH; Wang, JM				Lin, Li-Fang; Li, Chien-Feng; Wang, Wei-Jan; Yang, Wen-Ming; Wang, Dennis Ding-Hwa; Chang, Wen-Chang; Lee, Wen-Hwa; Wang, Ju-Ming			Loss of ZBRK1 Contributes to the Increase of KAP1 and Promotes KAP1-Mediated Metastasis and Invasion in Cervical Cancer	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; NUCLEAR COREPRESSOR KAP1; REPRESSOR COMPLEX; EPITHELIAL-CELLS; BREAST-CANCER; DOMAIN; GENE; TRANSCRIPTION; BRCA1; SUPPRESSOR	ZBRK1, a zinc finger protein that interacts with breast cancer 1 (BRCA1) and KRAB-ZFP-associated protein 1 (KAP1), has been suggested to serve as a tumor suppressor via repression of tumor metastasis/invasion. To date, the detailed molecular mechanisms for how BRCA1 and KAP1 participate in ZBRK1-mediated transcriptional repression, metastasis and invasion as well as the associated clinical relevance remain unclear. In this study, we demonstrated that both the N- and C-terminal domains of ZBRK1 are important for inhibiting cell proliferation and anchorage-independent growth in cervical cancer. Specifically, the N- terminal KRAB domain of ZBRK1 displayed a more crucial role in inhibiting metastasis and invasion through modulation of KAP1 function in a transcriptionally dependent manner. The loss of ZBRK1 results in an increase of KAP1 expression, which enhanced migration and invasion of cervical cancer cells both the in vitro and in vivo. Moreover, an inverse correlation of expression levels was observed between ZBRK1 and KAP1 following tumor progression from in situ carcinoma to invasive/metastatic cervical cancer specimens. Taken together, the current results indicate that a loss of ZBRK1 contributes to the increased expression of KAP1, potentiating its role to enhance metastasis and invasion.	[Lin, Li-Fang; Wang, Wei-Jan] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Wang, Ju-Ming] Natl Cheng Kung Univ, Mol Inflammat Res Ctr, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan; [Yang, Wen-Ming] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Dennis Ding-Hwa; Lee, Wen-Hwa] Union Council Irvine Sch Med, Dept Biol Chem, Irvine, CA USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; National Chung Hsing University; Taipei Medical University	Wang, JM (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan.	yumingw@mail.ncku.edu.tw	Lee, Wen Hwa/GZA-8183-2022; wang, ju-ming/A-1875-2011	Lee, Wen Hwa/0000-0002-4098-5225; Wang, Wei-Jan/0000-0002-0811-8199; Li, Chien-Feng/0000-0002-9527-7576; Yang, Wen-Ming/0000-0002-5871-5979	NSC [101-2320-B-006-020-MY3]; National Cheng Kung University landmark (Taiwan) [C007]; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER	NSC(Ministry of Science and Technology, Taiwan); National Cheng Kung University landmark (Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NSC grant 101-2320-B-006-020-MY3 and National Cheng Kung University landmark grant C007 (Taiwan). Fund for Open Access publication was provided by the NSC grant 101-2320-B-006-020-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Furuta S, 2006, CANCER CELL, V10, P13, DOI 10.1016/j.ccr.2006.05.022; Jimenez-Palop M, 2010, ANN RHEUM DIS, V69, P879, DOI 10.1136/ard.2009.113555; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Liao GL, 2005, J VIROL, V79, P245, DOI 10.1128/JVI.79.1.245-256.2005; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Yun JH, 2003, MOL CELL BIOL, V23, P7305, DOI 10.1128/MCB.23.20.7305-7314.2003; Zhang XY, 2005, J BIOL CHEM, V280, P33165, DOI 10.1074/jbc.M505124200; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	26	29	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73033	10.1371/journal.pone.0073033	http://dx.doi.org/10.1371/journal.pone.0073033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991171	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470700055
J	Pelullo, CP; Di Giuseppe, G; Angelillo, IF				Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.			Frequency of Discrimination, Harassment, and Violence in Lesbian, Gay Men, and Bisexual in Italy	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SUBSTANCE USE DISORDERS; PSYCHIATRIC-DISORDERS; SEXUAL ORIENTATION; DOMESTIC VIOLENCE; HEALTH-SERVICES; SAME-SEX; VICTIMIZATION; ADULTS; RISK	Background: This cross-sectional study assessed the frequency of discrimination, harassment, and violence and the associated factors among a random sample of 1000 lesbian, gay men, and bisexual women and men recruited from randomly selected public venues in Italy. Methods: A face-to-face interview sought information about: socio-demographics, frequency of discrimination, verbal harassment, and physical and sexual violence because of their sexual orientation, and their fear of suffering each types of victimization. Results: In the whole sample, 28.3% and 11.9% self-reported at least one episode of victimization because of the sexual orientation in their lifetime and in the last year. Those unmarried, compared to the others, and with a college degree or higher, compared to less educated respondents, were more likely to have experienced an episode of victimization in their lifetime. Lesbians, compared to bisexual, had almost twice the odds of experiencing an episode of victimization. The most commonly reported experiences across the lifetime were verbal harassment, discrimination, and physical or sexual violence. Among those who had experienced one episode of victimization in their lifetime, 42.1% self-reported one episode in the last year. Perceived fear of suffering violence because of their sexual orientation, measured on a 10-point Likert scale with a higher score indicative of greater fear, ranges from 5.7 for verbal harassment to 6.4 for discrimination. Participants were more likely to have fear of suffering victimization because of their sexual orientation if they were female (compared to male), lesbian and gay men (compared to bisexual women and men), unmarried (compared to the others), and if they have already suffered an episode of victimization (compared to those who have not suffered an episode). Conclusions: The study provides important insights into the violence experiences of lesbian, gay men, and bisexual women and men and the results may serve for improving policy initiatives to reduce such episodes.	[Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683	Second University of Naples (Naples, Italy)	Second University of Naples (Naples, Italy)	This study was supported by a research grant from the Second University of Naples (Naples, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SB, 2008, J WOMENS HEALTH, V17, P597, DOI 10.1089/jwh.2007.0450; Babu BV, 2010, PUBLIC HEALTH, V124, P136, DOI 10.1016/j.puhe.2010.01.014; Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Birkett M, 2009, J YOUTH ADOLESCENCE, V38, P989, DOI 10.1007/s10964-008-9389-1; Blosnich JR, 2011, NICOTINE TOB RES, V13, P1284, DOI 10.1093/ntr/ntr183; Blosnich JR, 2009, AM J PUBLIC HEALTH, V99, P2182, DOI 10.2105/AJPH.2008.139535; Boyce S, 2012, CULT HEALTH SEX, V14, P313, DOI 10.1080/13691058.2011.639393; Coker TR, 2010, ANNU REV PUBL HEALTH, V31, P457, DOI 10.1146/annurev.publhealth.012809.103636; Daley AE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-40; Eliason MJ, 2011, J HOMOSEXUAL, V58, P1355, DOI 10.1080/00918369.2011.614902; Hatzenbuehler ML, 2011, ARCH PEDIAT ADOL MED, V165, P527, DOI 10.1001/archpediatrics.2011.64; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Herek GM, 2009, J INTERPERS VIOLENCE, V24, P54, DOI 10.1177/0886260508316477; Huebner DM, 2004, AM J PUBLIC HEALTH, V94, P1200, DOI 10.2105/AJPH.94.7.1200; Hughes T, 2010, ADDICTION, V105, P2130, DOI 10.1111/j.1360-0443.2010.03088.x; Koenig MA, 2006, AM J PUBLIC HEALTH, V96, P132, DOI 10.2105/AJPH.2004.050872; Mak WWS, 2010, PUBLIC HEALTH, V124, P149, DOI 10.1016/j.puhe.2010.02.002; Mayer KH, 2008, AM J PUBLIC HEALTH, V98, P989, DOI 10.2105/AJPH.2007.127811; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McCabe SE, 2010, AM J PUBLIC HEALTH, V100, P1946, DOI 10.2105/AJPH.2009.163147; McLaughlin KA, 2010, AM J PUBLIC HEALTH, V100, P1477, DOI 10.2105/AJPH.2009.181586; Mizuno Y, 2012, AIDS BEHAV, V16, P724, DOI 10.1007/s10461-011-9967-1; Otis MD, 2007, J INTERPERS VIOLENCE, V22, P198, DOI 10.1177/0886260506295346; Parrott DJ, 2008, CLIN PSYCHOL REV, V28, P933, DOI 10.1016/j.cpr.2008.02.001; Pelullo CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042856; Ragins BR, 2007, J APPL PSYCHOL, V92, P1103, DOI 10.1037/0021-9010.92.4.1103; Shields JP, 2012, J ADOLESCENT HEALTH, V50, P418, DOI 10.1016/j.jadohealth.2011.07.009; Silenzio VMB, 2007, AM J PUBLIC HEALTH, V97, P2017, DOI 10.2105/AJPH.2006.095943; Stata Corporation, 2007, STAT REF MAN REL 10; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-399; US Department of Health and Human Services, 2012, EALTH PEOPL 2020 LES; World Health Organization, 2002, WORLD REPORT VIOLENC	32	11	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e74446	10.1371/journal.pone.0074446	http://dx.doi.org/10.1371/journal.pone.0074446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23991220	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700068
J	Yin, YS; Withers, TR; Wang, X; Yu, HWD				Yin, Yeshi; Withers, T. Ryan; Wang, Xin; Yu, Hongwei D.			Evidence for Sigma Factor Competition in the Regulation of Alginate Production by Pseudomonas aeruginosa	PLOS ONE			English	Article							COLI RNA-POLYMERASE; BACTERIOPHAGE-T4 MIDDLE TRANSCRIPTION; CYSTIC-FIBROSIS PATIENTS; SENSOR KINASE KINB; ESCHERICHIA-COLI; MUCOID CONVERSION; EXOPOLYSACCHARIDE ALGINATE; FUNCTIONAL-ANALYSIS; ALGT ALGU; PROTEIN	Alginate overproduction, or mucoidy, plays an important role in the pathogenesis of P. aeruginosa lung infection in cystic fibrosis (CF). Mucoid strains with mucA mutations predominantly populate in chronically-infected patients. However, the mucoid strains can revert to nonmucoidy in vitro through suppressor mutations. We screened a mariner transposon library using CF149, a non-mucoid clinical isolate with a misssense mutation in algU (AlgU(A61V)). The wild type AlgU is a stress-related sigma factor that activates transcription of alginate biosynthesis. Three mucoid mutants were identified with transposon insertions that caused 1) an overexpression of AlgU(A61V), 2) an overexpression of the stringent starvation protein A (SspA), and 3) a reduced expression of the major sigma factor RpoD (sigma(70)). Induction of AlgU(A61V) in trans caused conversion to mucoidy in CF149 and PAO1DalgU, suggesting that AlgU(A61V) is functional in activating alginate production. Furthermore, the level of AlgU(A61V) was increased in all three mutants relative to CF149. However, compared to the wild type AlgU, AlgU(A61V) had a reduced activity in promoting alginate production in PAO1 Delta algU. SspA and three other anti-sigma(70) orthologues, P. aeruginosa AlgQ, E. coli Rsd, and T4 phage AsiA, all induced mucoidy, suggesting that reducing activity of RpoD is linked to mucoid conversion in CF149. Conversely, RpoD overexpression resulted in suppression of mucoidy in all mucoid strains tested, indicating that sigma factor competition can regulate mucoidy. Additionally, an RpoD-dependent promoter (P-ssrA) was more active in non-mucoid strains than in isogenic mucoid variants. Altogether, our results indicate that the anti-sigma(70) factors can induce conversion to mucoidy in P. aeruginosa CF149 with algU-suppressor mutation via modulation of RpoD.	[Yin, Yeshi; Withers, T. Ryan; Yu, Hongwei D.] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV USA; [Yu, Hongwei D.] Marshall Univ, Dept Pediat, Joan C Edwards Sch Med, Huntington, WV USA; [Wang, Xin] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Yu, Hongwei D.] Progenesis Technol LLC, Huntington, WV USA	Marshall University; Marshall University; Zhejiang Academy of Agricultural Sciences	Yu, HWD (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV USA.	yuh@marshall.edu		Yu, Hongwei/0000-0002-8546-0158	National Aeronautics and Space Administration West Virginia Space Grant Consortium (NASA WVSGC); Cystic Fibrosis Foundation [CFF-YU11G0]; National Institutes of Health [P20RR016477, P20GM103434]; NASA WVSGC Graduate Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	National Aeronautics and Space Administration West Virginia Space Grant Consortium (NASA WVSGC); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA WVSGC Graduate Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Aeronautics and Space Administration West Virginia Space Grant Consortium (NASA WVSGC) and the Cystic Fibrosis Foundation (CFF-YU11G0). H.D.Y. was supported by National Institutes of Health P20RR016477 and P20GM103434 to the West Virginia IDeA Network for Biomedical Research Excellence. T.R.W. was supported through the NASA WVSGC Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 1998, P NATL ACAD SCI USA, V95, P15247, DOI 10.1073/pnas.95.26.15247; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; BODEY GP, 1983, REV INFECT DIS, V5, P279; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; Damron FH, 2012, MOL MICROBIOL, V84, P595, DOI 10.1111/j.1365-2958.2012.08049.x; Damron FH, 2012, J BACTERIOL, V194, P1317, DOI 10.1128/JB.06105-11; Damron FH, 2011, MOL MICROBIOL, V81, P554, DOI 10.1111/j.1365-2958.2011.07715.x; Damron FH, 2009, MICROBIOL-SGM, V155, P1028, DOI 10.1099/mic.0.025833-0; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; Dove SL, 2001, J BACTERIOL, V183, P6413, DOI 10.1128/JB.183.21.6413-6421.2001; EVANS LR, 1973, J BACTERIOL, V116, P915, DOI 10.1128/JB.116.2.915-924.1973; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hansen AM, 2003, MOL MICROBIOL, V48, P1621, DOI 10.1046/j.1365-2958.2003.03533.x; Head NE, 2004, INFECT IMMUN, V72, P133, DOI 10.1128/IAI.72.1.133-144.2004; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; Hinton DM, 1996, METHOD ENZYMOL, V274, P43; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; MACGEORGE J, 1986, J MED MICROBIOL, V21, P331, DOI 10.1099/00222615-21-4-331; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MARTIN DW, 1993, J BACTERIOL, V175, P1153, DOI 10.1128/JB.175.4.1153-1164.1993; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; MAY TB, 1991, CLIN MICROBIOL REV, V4, P191, DOI 10.1128/CMR.4.2.191-206.1991; Miller JH., 1972, EXPT MOL GENETICS; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; ORSINI G, 1993, J BACTERIOL, V175, P85, DOI 10.1128/JB.175.1.85-93.1993; OUHAMMOUCH M, 1995, P NATL ACAD SCI USA, V92, P1451, DOI 10.1073/pnas.92.5.1451; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Pineda M, 2004, J MOL BIOL, V344, P1183, DOI 10.1016/j.jmb.2004.10.003; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Qiu DR, 2008, MICROBIOL-SGM, V154, P2119, DOI 10.1099/mic.0.2008/017368-0; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; ROYCHOUDHURY S, 1992, P NATL ACAD SCI USA, V89, P2659, DOI 10.1073/pnas.89.7.2659; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Sautter R, 2012, GENE, V498, P242, DOI 10.1016/j.gene.2011.11.005; SCHLICTMAN D, 1995, MOL MICROBIOL, V16, P309, DOI 10.1111/j.1365-2958.1995.tb02303.x; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; Schurr MJ, 1996, J BACTERIOL, V178, P4997, DOI 10.1128/jb.178.16.4997-5004.1996; Sharma UK, 2008, J BACTERIOL, V190, P3434, DOI 10.1128/JB.01792-07; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; TERRY JM, 1991, INFECT IMMUN, V59, P471, DOI 10.1128/IAI.59.2.471-477.1991; Testerman TL, 2002, MOL MICROBIOL, V43, P771, DOI 10.1046/j.1365-2958.2002.02787.x; WILLIAMS MD, 1994, MOL MICROBIOL, V11, P1029, DOI 10.1111/j.1365-2958.1994.tb00381.x; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yuan AH, 2008, MOL MICROBIOL, V70, P1136, DOI 10.1111/j.1365-2958.2008.06462.x	58	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72329	10.1371/journal.pone.0072329	http://dx.doi.org/10.1371/journal.pone.0072329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991093	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470700037
J	Liu, J; Visser-Grieve, S; Boudreau, J; Yeung, B; Lo, S; Chamberlain, G; Yu, F; Sun, T; Papanicolaou, T; Lam, A; Yang, X; Chin-Sang, I				Liu, J.; Visser-Grieve, S.; Boudreau, J.; Yeung, B.; Lo, S.; Chamberlain, G.; Yu, F.; Sun, T.; Papanicolaou, T.; Lam, A.; Yang, X.; Chin-Sang, I.			Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor	ONCOGENE			English	Article						PTEN; C. elegans; tumour suppressor; cancer; insulin signaling; genetics	GROWTH-FACTOR RECEPTOR; CAENORHABDITIS-ELEGANS; C-ELEGANS; BREAST-CANCER; LIFE-SPAN; SIGNALING PATHWAY; DAUER FORMATION; CELL-MIGRATION; DAF-2; PHOSPHATASE	Insulin and insulin-like growth factor-1 signaling have fundamental roles in energy metabolism, growth and development. Recent research suggests hyperactive insulin receptor (IR) and hyperinsulinemia are cancer risk factors. However, the mechanisms that account for the link between the hyperactive insulin signaling and cancer risk are not well understood. Here we show that an insulin-like signaling inhibits the DAF-18/(phosphatase and tensin homolog) PTEN tumour suppressor in Caenorhabditis elegans and that this regulation is conserved in human breast cancer cells. We show that inhibiting the IR increases PTEN protein levels, while increasing insulin signaling decreases PTEN protein levels. Our results show that the kinase region of IR beta subunit physically binds to PTEN and phosphorylates on Y27 and Y174. Our genetic results also show that DAF-2/IR negatively regulates DAF-18/PTEN during C. elegans axon guidance. As PTEN is an important tumour suppressor, our results therefore suggest a possible mechanism for increased cancer risk observed in hyperinsulinemia and hyperactive IR individuals.	[Liu, J.; Boudreau, J.; Lo, S.; Chamberlain, G.; Yu, F.; Papanicolaou, T.; Lam, A.; Chin-Sang, I.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Visser-Grieve, S.; Yeung, B.; Yang, X.] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; [Sun, T.] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Chin-Sang, I (corresponding author), Queens Univ, Dept Biol, 116 Barrie St, Kingston, ON K7L 3N6, Canada.	chinsang@queensu.ca		Liu, Jun/0000-0001-6472-3871; Yu, Fabian/0000-0002-0358-2793; Chin-Sang, Ian/0000-0001-7480-9775; Grieve, Stacy/0000-0003-3090-5583	Natural Sciences and Engineering Research Council of Canada [NSERC 249779]; Canadian Cancer Society Research Institute [CCSRI 700219]; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work in the Chin-Sang lab is supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC 249779) and the Canadian Cancer Society Research Institute (CCSRI 700219). We are grateful to Caenorhabditis Genomic Center for providing strains, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). The daf-18 (ok480) mutant was obtained from the C. elegans knockout consortium (Oklahoma Medical Research Foundation). We thank Drs Mei Zhen and Scott Clark for sharing strains. We thank all members of the Chin-Sang Lab, and Drs William Bendena and Hanzhi Wang for helpful discussion.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; BRENNER S, 1974, GENETICS, V77, P71; Brisbin S, 2009, DEV CELL, V17, P459, DOI 10.1016/j.devcel.2009.08.009; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Christensen R, 2011, DEVELOPMENT, V138, P5257, DOI 10.1242/dev.069062; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; DORMAN JB, 1995, GENETICS, V141, P1399; Eckardt K, 2007, DIABETOLOGIA, V50, P2534, DOI 10.1007/s00125-007-0815-9; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Malone EA, 1996, GENETICS, V143, P1193; MILAZZO G, 1992, CANCER RES, V52, P3924; Mohamed AM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002513; Mohamed AM, 2006, DEV BIOL, V290, P164, DOI 10.1016/j.ydbio.2005.11.019; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Naguib A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-123; Nakdimon I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002881; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tibarewal P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002138; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhang H, 2010, ONCOGENE, V29, P2517, DOI 10.1038/onc.2010.17	47	19	21	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3878	3885		10.1038/onc.2013.347	http://dx.doi.org/10.1038/onc.2013.347			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23995781				2022-12-25	WOS:000339394100014
J	Kubo, M; Nakashima, S; Yamaguchi, S; Ogura, T; Mochizuki, M; Kang, J; Tateno, M; Shinzawa-Itoh, K; Kato, K; Yoshikawa, S				Kubo, Minoru; Nakashima, Satoru; Yamaguchi, Satoru; Ogura, Takashi; Mochizuki, Masao; Kang, Jiyoung; Tateno, Masaru; Shinzawa-Itoh, Kyoko; Kato, Koji; Yoshikawa, Shinya			Effective Pumping Proton Collection Facilitated by a Copper Site (CUB) of Bovine Heart Cytochrome c Oxidase, Revealed by a Newly Developed Time-resolved Infrared System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Biophysics; Infrared Spectroscopy; Membrane Proteins; Respiratory Chain	FTIR DIFFERENCE SPECTROSCOPY; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; SIDE-CHAINS; O-2 REDUCTION; WATER H2O; HEME; MECHANISM; STEP; IR	Background: Cytochrome c oxidase reduces O-2 coupled with proton pumping. Results: A newly developed time-resolved infrared system reveals transient conformational changes in the proton-pumping pathway upon CO binding to Cu-B in the O-2 reduction site. Conclusion: Cu-B promotes proton collection and effective blockage of back-leak of pumping protons. Significance: These critical findings in bioenergetics stimulate the new infrared approach for mechanistic investigation of any other protein function. X-ray structural and mutational analyses have shown that bovine heart cytochrome c oxidase (CcO) pumps protons electrostatically through a hydrogen bond network using net positive charges created upon oxidation of a heme iron (located near the hydrogen bond network) for O-2 reduction. Pumping protons are transferred by mobile water molecules from the negative side of the mitochondrial inner membrane through a water channel into the hydrogen bond network. For blockage of spontaneous proton back-leak, the water channel is closed upon O-2 binding to the second heme (heme a(3)) after complete collection of the pumping protons in the hydrogen bond network. For elucidation of the structural bases for the mechanism of the proton collection and timely closure of the water channel, conformational dynamics after photolysis of CO (an O-2 analog)-bound CcO was examined using a newly developed time-resolved infrared system feasible for accurate detection of a single C=O stretch band of -helices of CcO in H2O medium. The present results indicate that migration of CO from heme a(3) to Cu-B in the O-2 reduction site induces an intermediate state in which a bulge conformation at Ser-382 in a transmembrane helix is eliminated to open the water channel. The structural changes suggest that, using a conformational relay system, including Cu-B, O-2, heme a(3), and two helix turns extending to Ser-382, Cu-B induces the conformational changes of the water channel that stimulate the proton collection, and senses complete proton loading into the hydrogen bond network to trigger the timely channel closure by O-2 transfer from Cu-B to heme a(3).	[Kubo, Minoru; Nakashima, Satoru; Ogura, Takashi; Mochizuki, Masao; Kang, Jiyoung; Tateno, Masaru; Shinzawa-Itoh, Kyoko; Kato, Koji; Yoshikawa, Shinya] Univ Hyogo, Picobiol Inst, Akoh, Hyogo 6781297, Japan; [Yamaguchi, Satoru; Ogura, Takashi] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Akoh, Hyogo 6781297, Japan; [Kubo, Minoru] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ogura, Takashi; Tateno, Masaru; Yoshikawa, Shinya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Hyogo; University of Hyogo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Yoshikawa, S (corresponding author), Univ Hyogo, Picobiol Inst, Grad Sch Life Sci, 3-2-1 Kouto, Akoh, Hyogo 6781297, Japan.	yoshi@sci.u-hyogo.ac.jp	Kato, Koji/H-8502-2017	Kato, Koji/0000-0001-9846-5903; Nakashima, Satoru/0000-0001-8378-1153	Global Center of Excellence Program; Targeted Protein Research Program; Scientific Research Grant [2247012]; Young Scientists Grants [23685040, 21750022, 22770154]; Japanese Ministry of Education, Culture, Sports, Science and Technology; PRESTO; CREST; Grants-in-Aid for Scientific Research [23685040] Funding Source: KAKEN	Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Protein Research Program; Scientific Research Grant; Young Scientists Grants; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO; CREST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Global Center of Excellence Program (to S. Y.), the Targeted Protein Research Program (to S. Y. and T. O.), Scientific Research Grant (A) 2247012 (to S. Y.), Young Scientists Grants (A) 23685040 and (B) 21750022 (to M. K.) and (B) 22770154 (to S. Y.), the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Science and Technology Agency, PRESTO and CREST.	ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; Aminaka R, 2012, BBA-BIOENERGETICS, V1817, pS104, DOI 10.1016/j.bbabio.2012.06.281; ANSARI A, 1993, BIOPHYS J, V64, P838, DOI 10.1016/S0006-3495(93)81445-0; ANSARI A, 1993, BIOPHYS J, V64, P852, DOI 10.1016/S0006-3495(93)81446-2; Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; Babcock G. T., 1988, BIOL APPLICATIONS RA, V3, P293; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; Behr J, 2000, BIOCHEMISTRY-US, V39, P1356, DOI 10.1021/bi991504g; Bene P., 2010, CAVER 2 1; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Braiman MS, 1999, J PHYS CHEM B, V103, P4744, DOI 10.1021/jp983011b; Brzezinski P, 2003, BBA-BIOENERGETICS, V1605, P1, DOI 10.1016/S0005-2728(03)00079-3; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; DYER RB, 1994, BIOCHEMISTRY-US, V33, P500, DOI 10.1021/bi00168a015; EINARSDOTTIR O, 1993, BIOCHEMISTRY-US, V32, P12013, DOI 10.1021/bi00096a011; FINDSEN EW, 1987, J AM CHEM SOC, V109, P5367, DOI 10.1021/ja00252a011; Groot ML, 2007, PHOTOCH PHOTOBIO SCI, V6, P501, DOI 10.1039/b613023b; HAMM P, 1995, P NATL ACAD SCI USA, V92, P1826, DOI 10.1073/pnas.92.6.1826; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P1685, DOI 10.1021/bi982282+; Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Kang JY, 2011, BBA-BIOENERGETICS, V1807, P1314, DOI 10.1016/j.bbabio.2011.06.014; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; Koutsoupakis C, 2004, BBA-BIOENERGETICS, V1655, P347, DOI 10.1016/j.bbabio.2003.06.004; Lee HM, 2000, BIOCHEMISTRY-US, V39, P2989, DOI 10.1021/bi9924821; Locke B., 1993, ADV SPECTROSC, V21, P1; Magana D, 2011, APPL SPECTROSC, V65, P535, DOI 10.1366/10-06179; MATSUKAWA S, 1985, J AM CHEM SOC, V107, P1108, DOI 10.1021/ja00291a004; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; NAGAI K, 1980, J MOL BIOL, V136, P271, DOI 10.1016/0022-2836(80)90374-5; Nagarajan S, 2011, J AM CHEM SOC, V133, P20335, DOI 10.1021/ja2071362; Okuno D, 2003, J AM CHEM SOC, V125, P7209, DOI 10.1021/ja021302z; PALMER RA, 1989, APPL SPECTROSC, V43, P193, DOI 10.1366/0003702894203101; Qin L, 2009, BIOCHEMISTRY-US, V48, P5121, DOI 10.1021/bi9001387; Radu I, 2009, PHOTOCH PHOTOBIO SCI, V8, P1517, DOI 10.1039/b9pp00050j; Salomonsson L, 2005, P NATL ACAD SCI USA, V102, P17624, DOI 10.1073/pnas.0505431102; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Siegbahn PEM, 2007, BBA-BIOENERGETICS, V1767, P1143, DOI 10.1016/j.bbabio.2007.06.009; Slayton RM, 1997, CURR OPIN STRUC BIOL, V7, P717, DOI 10.1016/S0959-440X(97)80083-8; TORII H, 1992, J CHEM PHYS, V97, P92, DOI 10.1063/1.463528; TORII H, 1992, J CHEM PHYS, V96, P3379, DOI 10.1063/1.461939; Treuffet J, 2007, P NATL ACAD SCI USA, V104, P15705, DOI 10.1073/pnas.0703279104; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; UHMANN W, 1991, APPL SPECTROSC, V45, P390, DOI 10.1366/0003702914337128; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; Venyaminov SY, 1997, ANAL BIOCHEM, V248, P234, DOI 10.1006/abio.1997.2136; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1259, DOI 10.1002/bip.360301310; Waegele MM, 2010, BIOCHEMISTRY-US, V49, P7659, DOI 10.1021/bi100851c; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341	58	26	27	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30259	30269		10.1074/jbc.M113.473983	http://dx.doi.org/10.1074/jbc.M113.473983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23996000	Green Published, hybrid			2022-12-25	WOS:000329868100024
J	Nedielkov, R; Steffen, W; Steuber, J; Moller, HM				Nedielkov, Ruslan; Steffen, Wojtek; Steuber, Julia; Moeller, Heiko M.			NMR Reveals Double Occupancy of Quinone-type Ligands in the Catalytic Quinone Binding Site of the Na+-translocating NADH:Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Enzymes; NMR; Redox; Sodium Transport; Ubiquinone; DBMIB; Interligand NOE	CYTOCHROME B(6)F COMPLEX; BC(1) COMPLEX; SUBUNIT-B; UBIQUINONE; INHIBITOR; ELECTRON; DIBROMOTHYMOQUINONE; ALGINOLYTICUS; LOCALIZATION; SPECTROSCOPY	The sodium ion-translocating NADH:quinone oxidoreductase (Na+-NQR) from the pathogen Vibrio cholerae exploits the free energy liberated during oxidation of NADH with ubiquinone to pump sodium ions across the cytoplasmic membrane. The Na+-NQR consists of four membrane-bound subunits NqrBCDE and the peripheral NqrF and NqrA subunits. NqrA binds ubiquinone-8 as well as quinones with shorter prenyl chains (ubiquinone-1 and ubiquinone-2). Here we show that the quinone derivative 2,5-dibromo-3-methyl-6-isopropyl-p-benzoquinone (DBMIB), a known inhibitor of the bc(1) and b(6)f complexes found in mitochondria and chloroplasts, also inhibits quinone reduction by the Na+-NQR in a mixed inhibition mode. Tryptophan fluorescence quenching and saturation transfer difference NMR experiments in the presence of Na+-NQR inhibitor (DBMIB or 2-n-heptyl-4-hydroxyquinoline N-oxide) indicate that two quinone analog ligands are bound simultaneously by the NqrA subunit with very similar interaction constants as observed with the holoenzyme complex. We conclude that the catalytic site of quinone reduction is located on NqrA. The two ligands bind to an extended binding pocket in direct vicinity to each other as demonstrated by interligand Overhauser effects between ubiquinone-1 and DBMIB or 2-n-heptyl-4-hydroxyquinoline N-oxide, respectively. We propose that a similar spatially close arrangement of the native quinone substrates is also operational in vivo, enhancing the catalytic efficiency during the final electron transfer steps in the Na+-NQR.	[Nedielkov, Ruslan; Moeller, Heiko M.] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Steffen, Wojtek; Steuber, Julia] Univ Stuttgart Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany	University of Konstanz; University Hohenheim	Steuber, J (corresponding author), Univ Stuttgart Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany.	julia.steuber@uni-hohenheim.de; heiko.moeller@uni-konstanz.de	Möller, Heiko/AAX-1075-2020	Möller, Heiko/0000-0002-5795-1195	Baden-Wurttemberg Stiftung [P-LS-Meth/4]; Deutsche Forschungsgemeinschaft [FR 1321/3-1]; Young Scholar Fund; Research School Chemical Biology of the University of Konstanz	Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Young Scholar Fund; Research School Chemical Biology of the University of Konstanz	This work was supported in part by contract research of the Baden-Wurttemberg Stiftung, Forschungsprogramm P-LS-Meth/4 (to J. S. and H. M. M.), and Deutsche Forschungsgemeinschaft Grant FR 1321/3-1 (to J. S.).; Supported by the Young Scholar Fund and the Research School Chemical Biology of the University of Konstanz.	Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bartoschek S, 2001, J BIOL CHEM, V276, P35231, DOI 10.1074/jbc.C100365200; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, ACTA CRYSTALLOGR F, V66, P1677, DOI [10.1107/S1744309110043125, 10.1107/S17443091100431]; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; CHAIN RK, 1979, ARCH BIOCHEM BIOPHYS, V197, P52, DOI 10.1016/0003-9861(79)90217-0; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; ESPOSTI MD, 1984, BIOCHIM BIOPHYS ACTA, V767, P10, DOI 10.1016/0005-2728(84)90074-4; ESPOSTI MD, 1983, FEBS LETT, V156, P15, DOI 10.1016/0014-5793(83)80238-5; Feng Y, 2012, NATURE, V491, P478, DOI 10.1038/nature11541; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; HORE PJ, 1989, METHOD ENZYMOL, V176, P64; HOULT DI, 1976, J MAGN RESON, V21, P337, DOI 10.1016/0022-2364(76)90081-0; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iwata M, 2012, P NATL ACAD SCI USA, V109, P15247, DOI 10.1073/pnas.1210059109; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0; Li DW, 1999, J BIOMOL NMR, V15, P71, DOI 10.1023/A:1008360208627; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; LOSCHEN G, 1974, FEBS LETT, V41, P115, DOI 10.1016/0014-5793(74)80967-1; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Roberts AG, 2004, BIOCHEMISTRY-US, V43, P7707, DOI 10.1021/bi049521f; Roberts AG, 2001, BIOCHEMISTRY-US, V40, P13407, DOI 10.1021/bi015774m; Sanchez-Pedregal VM, 2005, ANGEW CHEM INT EDIT, V44, P4172, DOI 10.1002/anie.200500503; Simkovic M, 2004, BIOCHEM J, V378, P633, DOI 10.1042/BJ20031272; STONEHOUSE J, 1994, J AM CHEM SOC, V116, P6037, DOI 10.1021/ja00092a092; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; TREBST A, 1970, Z NATURFORSCH PT B, VB 25, P1157; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Voet D, 2011, BIOCHEMISTRY-US, P482	38	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30597	30606		10.1074/jbc.M112.435750	http://dx.doi.org/10.1074/jbc.M112.435750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003222	hybrid, Green Published			2022-12-25	WOS:000329868100060
J	Taniguchi, T; Tanaka, S; Ishii, A; Watanabe, M; Fujitani, N; Sugeo, A; Gotoh, S; Ohta, T; Hiyoshi, M; Matsuzaki, H; Sakai, N; Konishi, H				Taniguchi, Tomonori; Tanaka, Shigeru; Ishii, Ayumi; Watanabe, Miyuki; Fujitani, Noriko; Sugeo, Ayusa; Gotoh, Shuhei; Ohta, Takeshi; Hiyoshi, Mineyoshi; Matsuzaki, Hideki; Sakai, Norio; Konishi, Hiroaki			A Brain-specific Grb2-associated Regulator of Extracellular Signal-regulated Kinase (Erk)/Mitogen-activated Protein Kinase (MAPK) (GAREM) Subtype, GAREM2, Contributes to Neurite Outgrowth of Neuroblastoma Cells by Regulating Erk Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; NERVE GROWTH-FACTOR; NUCLEAR-LOCALIZATION; IRS PROTEINS; IN-VIVO; ACTIVATION; NETWORKS; CANCER; PHOSPHORYLATION; DIFFERENTIATION	Grb2-associated regulator of Erk/MAPK1 (GAREM) is an adaptor molecule in the EGF-mediated signaling pathway. GAREM is expressed ubiquitously in human organs and cultured cells. Two GAREM homologues are encoded by the human genome. Therefore, previously identified GAREM is named GAREM1. Here we characterized a new subtype of GAREM, GAREM2, that is specifically expressed in the mouse, rat, and human brain. Three GAREM2 tyrosines (Tyr-102, Tyr-429, and Tyr-551) are phosphorylated upon EGF stimulation and are necessary for binding to Grb2. Furthermore, GAREM2 and Shp2 regulate Erk activity in EGF-stimulated cells. These characteristics are similar to those of GAREM1. GAREM2 is expressed in some neuroblastoma cell lines and is also tyrosine-phosphorylated and bound to Grb2 after treatment with EGF. Eventually, GAREM2 regulates Erk activation in the presence of EGF or insulin like growth factor 1. GAREM2 also regulates insulin-like growth factor 1-induced neuronal differentiation of the SH-SY5Y neuroblastoma cell line. Although the structure and function of both GAREM subtypes are similar, GAREM1 is recruited into the nucleus and GAREM2 is not. Nuclear localization of GAREM1 might be controlled by a GAREM1-specific nuclear localization sequence and 14-3-3 epsilon binding. The N-terminal 20 amino acids of GAREM1 make up its nuclear localization sequence that is also a 14-3-3 epsilon binding site. The GAREM family is a new class of adaptor molecules with subtype-specific biological functions.	[Taniguchi, Tomonori; Ishii, Ayumi; Watanabe, Miyuki; Fujitani, Noriko; Sugeo, Ayusa; Gotoh, Shuhei; Ohta, Takeshi; Konishi, Hiroaki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima 7270023, Japan; [Tanaka, Shigeru; Sakai, Norio] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348553, Japan; [Hiyoshi, Mineyoshi] Shimane Univ, Fac Med Izumo, Dept Biochem, Matsue, Shimane 6938501, Japan; [Matsuzaki, Hideki] Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba, Ibaraki 3058568, Japan	Hiroshima University; Shimane University; National Institute of Advanced Industrial Science & Technology (AIST)	Konishi, H (corresponding author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Hiroshima 7270023, Japan.	hkonishi@pu-hiroshima.ac.jp	Tanaka, Shigeru/O-3908-2015; Sakai, Norio/AAM-5822-2021	Tanaka, Shigeru/0000-0003-3247-9098; Sakai, Norio/0000-0002-6648-8761	Satake Technical Foundation; Grants-in-Aid for Scientific Research [25293061] Funding Source: KAKEN	Satake Technical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Satake Technical Foundation.	BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; JALAVA A, 1992, FEBS LETT, V300, P114, DOI 10.1016/0014-5793(92)80176-H; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Konishi H, 2006, J BIOL CHEM, V281, P28919, DOI 10.1074/jbc.M605693200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; RECIOPINTO E, 1984, BRAIN RES, V302, P323, DOI 10.1016/0006-8993(84)90246-4; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; ROGERS MV, 1994, NEUROSCIENCE, V60, P479, DOI 10.1016/0306-4522(94)90259-3; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Seiffert M, 2003, MOL CELL BIOL, V23, P2415, DOI 10.1128/MCB.23.7.2415-2424.2003; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; SPINELLI W, 1982, CANCER RES, V42, P5067; Tashiro K, 2009, J BIOL CHEM, V284, P20206, DOI 10.1074/jbc.M109.021139; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; Tzouros M., 2013, MOL CELL PROTEOMICS, DOI [10.1074/mcp.O113.027342, DOI 10.1074/MCP.0113.027342]; Verma S, 2012, ADV HEMATOL, V2012, P380635; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036023; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	39	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29934	29942		10.1074/jbc.M113.492520	http://dx.doi.org/10.1074/jbc.M113.492520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003223	Green Published, hybrid			2022-12-25	WOS:000330615300066
J	Brazhe, NA; Treiman, M; Faricelli, B; Vestergaard, JH; Sosnovtseva, O				Brazhe, Nadezda A.; Treiman, Marek; Faricelli, Barbara; Vestergaard, Jakob H.; Sosnovtseva, Olga			In Situ Raman Study of Redox State Changes of Mitochondrial Cytochromes in a Perfused Rat Heart	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; COMPLEX; INTACT; GLP-1; OXYGENATION; SPECTRA; TISSUE; VIVO	We developed a Raman spectroscopy-based approach for simultaneous study of redox changes in c-and b-type cytochromes and for a semiquantitative estimation of the amount of oxygenated myoglobin in a perfused rat heart. Excitation at 532 nm was used to obtain Raman scattering of the myocardial surface of the isolated heart at normal and hypoxic conditions. Raman spectra of the heart under normal pO(2) demonstrate unique peaks attributable to reduced c-and b-type cytochromes and oxymyoglobin (oMb). The cytochrome peaks decreased in intensity upon FCCP treatment, as predicted from uncoupling mitochondrial respiration. Conversely, transient hypoxia causes the reversible increase in the intensity of peaks assigned to cytochromes c and c1, reflecting electron stacking proximal to cytochrome oxidase due to the lack of terminal electron acceptor O-2. Intensities of peaks assigned to oxy- and deoxyhemoglobin were used for the semiquantitative estimation of oMb deoxygenation that was found to be of approximately 50% under hypoxia conditions.	[Brazhe, Nadezda A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Moscow, Russia; [Brazhe, Nadezda A.; Treiman, Marek; Faricelli, Barbara; Vestergaard, Jakob H.; Sosnovtseva, Olga] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Treiman, Marek; Faricelli, Barbara; Vestergaard, Jakob H.] Danish Natl Fdn Res Ctr Heart Arrhythmia, Copenhagen, Denmark	Lomonosov Moscow State University; University of Copenhagen	Sosnovtseva, O (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark.	olga@sund.ku.dk	Sosnovtseva, Olga/H-5115-2016; Brazhe, Nadezda/K-1369-2015	Sosnovtseva, Olga/0000-0001-7334-9869; 	Danish Council for Independent Research \ Natural Sciences; Danish National Research Foundation for Heart Arrhythmia; A. and E. Danielsens Foundation; E. and H. Fraenkels Memorial Foundation; Federal Target Program Research and development in priority areas of scientific-technological complex of Russia [14.512.11.0035]; Russian Foundation for Basic Research [12-04-31133 (mol-a))]	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation for Heart Arrhythmia(Danmarks Grundforskningsfond); A. and E. Danielsens Foundation; E. and H. Fraenkels Memorial Foundation; Federal Target Program Research and development in priority areas of scientific-technological complex of Russia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Support for this work came from The Danish Council for Independent Research vertical bar Natural Sciences (to NAB and OVS). MT, BF, and JHV were supported by The Danish National Research Foundation for Heart Arrhythmia, the A. and E. Danielsens Foundation and E. and H. Fraenkels Memorial Foundation. NAB acknowledges financial support from Federal Target Program Research and development in priority areas of scientific-technological complex of Russia for 2007{2013, goverment contract 14.512.11.0035 and Russian Foundation for Basic Research, project 12-04-31133 (mol-a)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR F, 1977, FEBS LETT, V80, P195, DOI 10.1016/0014-5793(77)80438-9; ADAR F, 1974, ARCH BIOCHEM BIOPHYS, V165, P570, DOI 10.1016/0003-9861(74)90284-7; Berezhna S, 2003, BIOCHEMISTRY-US, V42, P6149, DOI 10.1021/bi027387y; Borchert GH, 2008, AM J PHYSIOL-HEART C, V294, pH1948, DOI 10.1152/ajpheart.01209.2007; Brazhe NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041990; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Davidson SM, 2012, CARDIOVASC RES, V93, P445, DOI 10.1093/cvr/cvr349; Dedkova EN, 2012, J MOL CELL CARDIOL, V52, P48, DOI 10.1016/j.yjmcc.2011.08.030; Flogel U, 2010, J EXP BIOL, V213, P2726, DOI 10.1242/jeb.041681; Guiffo-Soh G, 2007, J PHYS CHEM B, V111, P12563, DOI 10.1021/jp074264k; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Ilangovan G, 2004, MAGNET RESON MED, V51, P835, DOI 10.1002/mrm.20000; Kakita M, 2012, J BIOPHOTONICS, V5, P20, DOI 10.1002/jbio.201100087; KITAGAWA T, 1976, J AM CHEM SOC, V98, P5169, DOI 10.1021/ja00433a019; Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Lyon AR, 2010, J MOL CELL CARDIOL, V49, P565, DOI 10.1016/j.yjmcc.2010.07.002; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakano M, 2012, CASE STUDY INFLUENCE, P1; Nicholls D., 2002, BIOENERGETICS; Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; Ossum A, 2009, PHARMACOL RES, V60, P411, DOI 10.1016/j.phrs.2009.06.004; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Salling HK, 2012, REGUL PEPTIDES, V178, P51, DOI 10.1016/j.regpep.2012.06.007; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; SPIRO TG, 1974, ACCOUNTS CHEM RES, V7, P339, DOI 10.1021/ar50082a004; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; Vikram DS, 2010, METHODS MOL BIOL, V610, P3, DOI 10.1007/978-1-60327-029-8_1; Ward KR, 2007, ANAL CHEM, V79, P1514, DOI 10.1021/ac061072x; WILSON DF, 1988, J BIOL CHEM, V263, P2712	36	39	39	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e70488	10.1371/journal.pone.0070488	http://dx.doi.org/10.1371/journal.pone.0070488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009655	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600001
J	Kamau, E; Alemayehu, S; Feghali, KC; Saunders, D; Ockenhouse, CF				Kamau, Edwin; Alemayehu, Saba; Feghali, Karla C.; Saunders, David; Ockenhouse, Christian F.			Multiplex qPCR for Detection and Absolute Quantification of Malaria	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM; QUANTITATIVE PCR; DIAGNOSIS; SENSITIVITY; PARASITES; TRIALS; IMPACT; ASSAY; VIVO	We describe development of an absolute multiplex quantitative real-time PCR for detection of Plasmodium spp., P. falciparum and P. vivax targets in order to produce an assay amenable to high throughput but with reduced costs. Important qPCR experimental details and information that is critical to performance and reliability of assay results were investigated. Inhibition studies were performed to test and compare co-purification of PCR inhibitors in samples extracted from whole blood using either the manual or automated methods. To establish the most optimal qPCR reaction volume, volume titration of the reaction master mix was performed starting at 10 mu l to 1 mu l reaction master mix with 1 mu l of template DNA in each reaction. As the reaction volume decreased, qPCR assays became more efficient with 1 mu l reaction master mix being the most efficient. For more accurate quantification of parasites in a sample, we developed plasmid DNAs for all the three assay targets for absolute quantification. All of absolute qPCR assays performed with efficiency of more than 94%, R-2 values greater than 0.99 and the STDEV of each replicate was <0.167. Linear regression plots generated from absolute qPCR assays were used to estimate the corresponding parasite density from relative qPCR in terms of parasite/mu l. One copy of plasmid DNA was established to be equivalent to 0.1 parasite/mu l for Plasmodium spp. assay, 0.281 parasites for P. falciparum assay and 0.127 parasite/mu l for P. vivax assay. This study demonstrates for the first time use of plasmid DNA in absolute quantification of malaria parasite. The use of plasmid DNA standard in quantification of malaria parasite will be critical as efforts are underway to harmonize molecular assays used in diagnosis of malaria.	[Kamau, Edwin; Alemayehu, Saba; Feghali, Karla C.; Ockenhouse, Christian F.] Walter Reed Army Inst Res, Mil Malaria Res Program, Malaria Vaccine Branch, Silver Spring, MD 20910 USA; [Saunders, David] USAMC, AFRIMS, Dept Immunol & Med, Bangkok, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Kamau, E (corresponding author), Walter Reed Army Inst Res, Mil Malaria Res Program, Malaria Vaccine Branch, Silver Spring, MD 20910 USA.	edwin.kamau@us.army.mil						Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Berry A, 2008, PARASITE, V15, P484, DOI 10.1051/parasite/2008153484; Bialasiewicz S, 2007, J CLIN MICROBIOL, V45, P1621, DOI 10.1128/JCM.02145-06; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Durrheim DN, 1997, S AFR MED J, V87, P1016; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Hawkes M, 2007, EXPERT REV ANTI-INFE, V5, P485, DOI 10.1586/14787210.5.3.485; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; JAUREGUIBERRY G, 1990, MOL CELL PROBE, V4, P409, DOI 10.1016/0890-8508(90)90031-T; Kamau E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-23; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Lee MA, 2002, J CLIN MICROBIOL, V40, P4343, DOI 10.1128/JCM.40.11.4343-4345.2002; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029101; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Tyner SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-198; Veron V, 2009, EXP PARASITOL, V121, P346, DOI 10.1016/j.exppara.2008.12.012; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032	20	82	84	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71539	10.1371/journal.pone.0071539	http://dx.doi.org/10.1371/journal.pone.0071539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009663	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600006
J	Bonnavion, R; Jaafar, R; Kerr-Conte, J; Assade, F; van Stralen, E; Leteurtre, E; Pouponnot, C; Gargani, S; Pattou, F; Bertolino, P; Cordier-Bussat, M; Lu, JL; Zhang, CX				Bonnavion, Remy; Jaafar, Rami; Kerr-Conte, Julie; Assade, Fouzia; van Stralen, Esther; Leteurtre, Emmanuelle; Pouponnot, Celio; Gargani, Sofia; Pattou, Francois; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian			Both PAX4 and MAFA Are Expressed in a Substantial Proportion of Normal Human Pancreatic Alpha Cells and Deregulated in Patients with Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELLS; GENE; SURVIVAL; ISLETS	Pax4 and MafA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A) are two transcription factors crucial for normal functions of islet beta cells in the mouse. Intriguingly, recent studies indicate the existence of notable difference between human and rodent islet in terms of gene expression and functions. To better understand the biological role of human PAX4 and MAFA, we investigated their expression in normal and diseased human islets, using validated antibodies. PAX4 was detected in 43.0 +/- 5.0% and 39.1 +/- 4.0% of normal human alpha and beta cells respectively. We found that MAFA, detected in 88.3 +/- 6.3% insulin(+) cells as in the mouse, turned out to be also expressed in 61.2 +/- 6.4% of human glucagons(+) cells with less intensity than in insulin(+) cells, whereas MAFB expression was found not only in the majority of glucagon(+) cells (67.2 +/- 7.6%), but also in 53.6 +/- 10.5% of human insulin(+) cells. Interestingly, MAFA nuclear expression in both alpha and beta cells, and the percentage of alpha cells expressing PAX4 were found altered in a substantial proportion of patients with type 2 diabetes. Both MAFA and PAX4 display, therefore, a distinct expression pattern in human islet cells, suggesting more potential plasticity of human islets as compared with rodent islets.	[Bonnavion, Remy; Jaafar, Rami; Assade, Fouzia; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian] INSERM, U1052, F-69008 Lyon, France; [Bonnavion, Remy; Jaafar, Rami; Assade, Fouzia; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian] CNRS, UMR5286, Lyon, France; [Bonnavion, Remy; Jaafar, Rami; Assade, Fouzia; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian] Univ Lyon, Lyon, France; [Lu, Jieli; Zhang, Chang Xian] Ruijin Hosp, Sino French Life Sci & Genom Ctr, E Inst Shanghai, Shanghai, Peoples R China; [Lu, Jieli] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai 200030, Peoples R China; [Kerr-Conte, Julie; Gargani, Sofia; Pattou, Francois] Univ Lille Nord France, INSERM, Biotherapies Diabet U859, Fac Med, Lille, France; [Leteurtre, Emmanuelle] Ctr Hosp Reg & Univ Lille, Dept Pathol, F-59037 Lille, France; [Pouponnot, Celio] Univ Paris 11, INSERM, Inst Curie, CNRS,UMR3347,U1021, F-91405 Orsay, France; [van Stralen, Esther] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [van Stralen, Esther] Univ Med Ctr Utrecht, Utrecht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Shanghai Jiao Tong University; Shanghai Jiao Tong University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Lu, JL (corresponding author), INSERM, U1052, F-69008 Lyon, France.	ljl11319@rjh.com.cn; chang.zhang@lyon.unicancer.fr	Bertolino, philippe/M-8977-2019; ZHANG, Chang Xian/G-2905-2013; Cordier-Bussat, Martine/G-4019-2014; Bertolino, philippe/D-4072-2018; Pattou, Francois/O-6151-2017; Jaafar, Rami/K-1027-2019	Bertolino, philippe/0000-0001-8064-8269; Bertolino, philippe/0000-0001-8064-8269; Pattou, Francois/0000-0001-8388-3766; Jaafar, Rami/0000-0002-1649-4792; GARGANI, SOFIA/0000-0002-4280-0933; Zhang, Chang Xian/0000-0002-5443-8951; Bonnavion, Remy/0000-0002-7389-4282	Fondation ARC pour la recherche sur le cancer, France [SFI20101201530]; Ligue contre le Cancer du Rhone; de la Loire; Agence National de Recherche [SVSE2 ANR 10 BLAN 1240 04]; CMIRA program of Region Rhone-Alpes [12004959-01]; National Nature Science Foundation of China [NSFC30900700, 81170719]; Shanghai New Excellent Youth Program [XYQ2011009]; French Ministry of Higher Education and Research	Fondation ARC pour la recherche sur le cancer, France; Ligue contre le Cancer du Rhone; de la Loire(Region Auvergne-Rhone-Alpes); Agence National de Recherche(French National Research Agency (ANR)); CMIRA program of Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai New Excellent Youth Program; French Ministry of Higher Education and Research	This study was supported by the Fondation ARC pour la recherche sur le cancer, France (SFI20101201530); the Ligue contre le Cancer du Rhone (to CXZ) and de la Loire (to PB); Agence National de Recherche (grant SVSE2 ANR 10 BLAN 1240 04), the CMIRA program of Region Rhone-Alpes (12004959-01); National Nature Science Foundation of China (NSFC30900700, 81170719) and Shanghai New Excellent Youth Program (XYQ2011009). R. Bonnavion was the recipient of a PhD-fellowship from French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Brun T, 2008, J MOL ENDOCRINOL, V40, P37, DOI 10.1677/JME-07-0134; Butler AE, 2012, DIABETOLOGIA, V55, P2985, DOI 10.1007/s00125-012-2666-2; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Dor Y, 2013, NEW ENGL J MED, V368, P572, DOI 10.1056/NEJMcibr1214034; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Lu J, 2011, ONCOGENE; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Olsson R, 2011, DIABETES, V60, P2068, DOI 10.2337/db09-0877; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stralen E, 2009, LEUKEMIA, V23, P801, DOI 10.1038/leu.2008.284; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vantyghem MC, 2009, DIABETES CARE, V32, P1473, DOI 10.2337/dc08-1685; Wang Q, 2008, DEV DYNAM, V237, P51, DOI 10.1002/dvdy.21379	20	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72194	10.1371/journal.pone.0072194	http://dx.doi.org/10.1371/journal.pone.0072194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013263	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200029
J	Scheitz, CJF; Guo, Y; Early, AM; Harshman, LG; Clark, AG				Scheitz, Cornelia J. F.; Guo, Yu; Early, Angela M.; Harshman, Lawrence G.; Clark, Andrew G.			Heritability and Inter-Population Differences in Lipid Profiles of Drosophila melanogaster	PLOS ONE			English	Article							MEMBRANE-LIPIDS; HOMEOVISCOUS ADAPTATION; ETHANOL; TOLERANCE; INSECT; TEMPERATURE; EXPRESSION; PROTEINS; SHOCK; ACCLIMATION	Characterizing and understanding the complex spectrum of lipids in higher organisms lags far behind our analysis of genome and transcriptome sequences. Here we generate and evaluate comprehensive lipid profiles (>200 lipids) of 92 inbred lines from five different Drosophila melanogaster populations. We find that the majority of lipid species are highly heritable, and even lipids with odd-chain fatty acids, which cannot be generated by the fly itself, also have high heritabilities. Abundance of the endosymbiont Wolbachia, a potential provider of odd-chained lipids, was positively correlated with this group of lipids. Additionally, we show that despite years of laboratory rearing on the same medium, the lipid profiles of the five geographic populations are sufficiently distinct for population discrimination. Our data predicts a strikingly different membrane fluidity for flies from the Netherlands, which is supported by their increased ethanol tolerance. We find that 18% of lipids show strong concentration differences between males and females. Through an analysis of the correlation structure of the lipid classes, we find modules of co-regulated lipids and begin to associate these with metabolic constraints. Our data provide a foundation for developing associations between variation in lipid composition with variation in other metabolic attributes, with genome-wide variation, and with metrics of health and overall reproductive fitness.	[Scheitz, Cornelia J. F.; Guo, Yu; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Guo, Yu] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [Early, Angela M.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Harshman, Lawrence G.] Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE USA	Cornell University; Cornell University; Cornell University; University of Nebraska System; University of Nebraska Lincoln	Scheitz, CJF (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	cjs282@cornell.edu		Clark, Andrew/0000-0001-7159-8511	National Institutes of Health [DK074136]; National Science Foundation [MCB 0455318, MCB 0920663, DBI 0521587]; Kansas INBRE (NIH from INBRE program of the National Center for Research Resources) [P20 RR16475]; NSF EPSCoR [EPS-0236913]; Kansas Technology Enterprise Corporation; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kansas INBRE (NIH from INBRE program of the National Center for Research Resources); NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); Kansas Technology Enterprise Corporation; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health grant DK074136 to AGC and LGH. Instrument acquisition and method development at KLRC was supported by National Science Foundation grants MCB 0455318, MCB 0920663, and DBI 0521587, Kansas INBRE (NIH Grant P20 RR16475 from the INBRE program of the National Center for Research Resources), NSF EPSCoR grant EPS-0236913, Kansas Technology Enterprise Corporation, and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Baker RC, 1999, ANNU REV PHARMACOL, V39, P127, DOI 10.1146/annurev.pharmtox.39.1.127; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Charmantier A, 2005, P ROY SOC B-BIOL SCI, V272, P1415, DOI 10.1098/rspb.2005.3117; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cooper BS, 2012, EVOLUTION, V66, P1976, DOI 10.1111/j.1558-5646.2011.01566.x; Cossins A R, 1987, Symp Soc Exp Biol, V41, P95; Cossins AR, 2002, BIOCHEM SOC T, V30, P1082, DOI 10.1042/bst0301082; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; FAST PG, 1966, LIPIDS, V1, P209, DOI 10.1007/BF02531874; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Greenberg AJ, 2010, GENETICS, V185, P361, DOI 10.1534/genetics.110.115055; Guan XL, 2013, DEV CELL, V24, P98, DOI 10.1016/j.devcel.2012.11.012; GUSTAVSSON L, 1995, ALCOHOL ALCOHOLISM, V30, P391; Hammad LA, 2011, RAPID COMMUN MASS SP, V25, P2959, DOI 10.1002/rcm.5187; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HAZEL JR, 1988, AM J PHYSIOL, V255, pR628, DOI 10.1152/ajpregu.1988.255.4.R628; HOEK JB, 1990, ALCOHOL ALCOHOLISM, V25, P143, DOI 10.1093/oxfordjournals.alcalc.a044989; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; JONES HE, 1992, LIPIDS, V27, P984, DOI 10.1007/BF02535576; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MCELHANEY RN, 1976, BIOCHIM BIOPHYS ACTA, V443, P348, DOI 10.1016/0005-2787(76)90499-8; Montooth KL, 2006, J EXP BIOL, V209, P3837, DOI 10.1242/jeb.02448; Ohtsu T, 1998, EUR J BIOCHEM, V252, P608, DOI 10.1046/j.1432-1327.1998.2520608.x; OKANO G, 1979, LIPIDS, V14, P541, DOI 10.1007/BF02533529; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; PRUITT NL, 1988, AM J PHYSIOL, V254, pR870, DOI 10.1152/ajpregu.1988.254.6.R870; Punj V, 2003, CELL MICROBIOL, V5, P225, DOI 10.1046/j.1462-5822.2003.00269.x; Quanbeck SM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00015; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; RUBIN E, 1982, FED PROC, V41, P2465; Scherer A, 2009, BATCH EFFECTS NOISE, DOI [10.1002/9780470685983.fmatter, DOI 10.1002/9780470685983.FMATTER]; Shukla SD, 2001, ALCOHOL CLIN EXP RES, V25, p33S, DOI 10.1111/j.1530-0277.2001.tb02370.x; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Skwarek LC, 2009, DEV CELL, V16, P12, DOI 10.1016/j.devcel.2008.12.006; Sowell RA, 2007, J PROTEOME RES, V6, P3637, DOI 10.1021/pr070224h; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; SUN GY, 1985, ALCOHOL CLIN EXP RES, V9, P164, DOI 10.1111/j.1530-0277.1985.tb05543.x; TARASCHI TF, 1985, LAB INVEST, V52, P120; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Vance JE, 2003, PROG NUCLEIC ACID RE, V75, P69, DOI 10.1016/S0079-6603(03)75003-X; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Welti R, 2005, FUNCTIONAL LIPIDOMIC, P307; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	63	28	29	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72726	10.1371/journal.pone.0072726	http://dx.doi.org/10.1371/journal.pone.0072726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013349	Green Published, gold			2022-12-25	WOS:000323815200054
J	Waudby, CA; Camilloni, C; Fitzpatrick, AWP; Cabrita, LD; Dobson, CM; Vendruscolo, M; Christodoulou, J				Waudby, Christopher A.; Camilloni, Carlo; Fitzpatrick, Anthony W. P.; Cabrita, Lisa D.; Dobson, Christopher M.; Vendruscolo, Michele; Christodoulou, John			In-Cell NMR Characterization of the Secondary Structure Populations of a Disordered Conformation of alpha-Synuclein within E. coli Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; LIVING CELLS; IMAGE-RECONSTRUCTION; PARKINSONS-DISEASE; BIOMOLECULAR NMR; CHEMICAL-SHIFTS; SPECTROSCOPY; PROTEIN; AGGREGATION; DIFFUSION	alpha-Synuclein is a small protein strongly implicated in the pathogenesis of Parkinson's disease and related neurodegenerative disorders. We report here the use of in-cell NMR spectroscopy to observe directly the structure and dynamics of this protein within E. coli cells. To improve the accuracy in the measurement of backbone chemical shifts within crowded in-cell NMR spectra, we have developed a deconvolution method to reduce inhomogeneous line broadening within cellular samples. The resulting chemical shift values were then used to evaluate the distribution of secondary structure populations which, in the absence of stable tertiary contacts, are a most effective way to describe the conformational fluctuations of disordered proteins. The results indicate that, at least within the bacterial cytosol, alpha-synuclein populates a highly dynamic state that, despite the highly crowded environment, has the same characteristics as the disordered monomeric form observed in aqueous solution.	[Waudby, Christopher A.; Cabrita, Lisa D.; Christodoulou, John] UCL, Inst Struct & Mol Biol, London, England; [Waudby, Christopher A.; Cabrita, Lisa D.; Christodoulou, John] Univ London Birkbeck Coll, London WC1E 7HX, England; [Camilloni, Carlo; Fitzpatrick, Anthony W. P.; Dobson, Christopher M.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; University of Cambridge	Christodoulou, J (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	j.christodoulou@ucl.ac.uk	Vendruscolo, Michele/F-5901-2012; Waudby, Christopher/AAT-1736-2021; Camilloni, Carlo/A-4395-2009	Vendruscolo, Michele/0000-0002-3616-1610; Waudby, Christopher/0000-0001-7810-3753; Camilloni, Carlo/0000-0002-9923-8590; Cabrita, Lisa/0000-0003-2963-8078; Christodoulou, John/0000-0002-6710-3843	Wellcome Trust [WT097806MA]; BBSRC [BB/H003843/1, BB/G015651/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H003843/1, BB/G015651/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (WT097806MA, www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JR, 2009, J AM CHEM SOC, V131, P18314, DOI 10.1021/ja904716h; Barnes CO, 2011, PROTEINS, V79, P347, DOI 10.1002/prot.22906; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Bertini I, 2011, ANGEW CHEM INT EDIT, V50, P2339, DOI 10.1002/anie.201006636; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Biggs DSC, 1997, APPL OPTICS, V36, P1766, DOI 10.1364/AO.36.001766; Binolfi A, 2012, BIOCHEM SOC T, V40, P950, DOI 10.1042/BST20120096; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferrage F, 2003, J AM CHEM SOC, V125, P2541, DOI 10.1021/ja0211407; GULL SF, 1978, NATURE, V272, P686, DOI 10.1038/272686a0; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Li CG, 2010, J AM CHEM SOC, V132, P321, DOI 10.1021/ja907966n; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Metz KR, 2000, CONCEPT MAGNETIC RES, V12, P21; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Puetter RC, 2005, ANNU REV ASTRON ASTR, V43, P139, DOI 10.1146/annurev.astro.43.112904.104850; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Sarder P, 2006, IEEE SIGNAL PROC MAG, V23, P32, DOI 10.1109/MSP.2006.1628876; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Slade KM, 2009, BIOCHEMISTRY-US, V48, P5083, DOI 10.1021/bi9004107; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Waudby CA, 2012, J AM CHEM SOC, V134, P11312, DOI 10.1021/ja304912c; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	50	77	77	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72286	10.1371/journal.pone.0072286	http://dx.doi.org/10.1371/journal.pone.0072286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991082	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000324228800056
J	Podda, MV; Piacentini, R; Barbati, SA; Mastrodonato, A; Puzzo, D; D'Ascenzo, M; Leone, L; Grassi, C				Podda, Maria Vittoria; Piacentini, Roberto; Barbati, Saviana Antonella; Mastrodonato, Alessia; Puzzo, Daniela; D'Ascenzo, Marcello; Leone, Lucia; Grassi, Claudio			Role of Cyclic Nucleotide-Gated Channels in the Modulation of Mouse Hippocampal Neurogenesis	PLOS ONE			English	Article							NITRIC-OXIDE; SYNAPTIC PLASTICITY; IN-VITRO; FUNCTIONAL EXPRESSION; ADULT NEUROGENESIS; CATION CONDUCTANCE; ION CHANNELS; NEURONS; BRAIN; PROLIFERATION	Neural stem cells generate neurons in the hippocampal dentate gyrus in mammals, including humans, throughout adulthood. Adult hippocampal neurogenesis has been the focus of many studies due to its relevance in processes such as learning and memory and its documented impairment in some neurodegenerative diseases. However, we are still far from having a complete picture of the mechanism regulating this process. Our study focused on the possible role of cyclic nucleotide-gated (CNG) channels. These voltage-independent channels activated by cyclic nucleotides, first described in retinal and olfactory receptors, have been receiving increasing attention for their involvement in several brain functions. Here we show that the rod-type, CNGA1, and olfactory-type, CNGA2, subunits are expressed in hippocampal neural stem cells in culture and in situ in the hippocampal neurogenic niche of adult mice. Pharmacological blockade of CNG channels did not affect cultured neural stem cell proliferation but reduced their differentiation towards the neuronal phenotype. The membrane permeant cGMP analogue, 8-Br-cGMP, enhanced neural stem cell differentiation to neurons and this effect was prevented by CNG channel blockade. In addition, patch-clamp recording from neuron-like differentiating neural stem cells revealed cGMP-activated currents attributable to ion flow through CNG channels. The current work provides novel insights into the role of CNG channels in promoting hippocampal neurogenesis, which may prove to be relevant for stem cell-based treatment of cognitive impairment and brain damage.	[Podda, Maria Vittoria; Piacentini, Roberto; Barbati, Saviana Antonella; Mastrodonato, Alessia; D'Ascenzo, Marcello; Leone, Lucia; Grassi, Claudio] Univ Cattolica Sacro Cuore, Sch Med, Inst Human Physiol, I-00168 Rome, Italy; [Puzzo, Daniela] Univ Catania, Dept Biomed Sci, Physiol Sect, Catania, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Catania	Grassi, C (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Human Physiol, I-00168 Rome, Italy.	grassi@rm.unicatt.it	Leone, Lucia/AAZ-2951-2021; Puzzo, Daniela/AAF-5026-2019; D'Ascenzo, Marcello/J-3989-2018; Piacentini, Roberto/K-7526-2016; Grassi, Claudio/C-3188-2017; Barbati, Saviana Antonella/AAB-5221-2022; Podda, Maria V/K-8947-2016	Puzzo, Daniela/0000-0002-9542-2251; Piacentini, Roberto/0000-0003-4215-1643; Grassi, Claudio/0000-0001-7253-1685; Barbati, Saviana Antonella/0000-0002-7574-0201; Podda, Maria V/0000-0002-2779-8417; D'ASCENZO, Marcello/0000-0003-0073-412X; LEONE, Lucia/0000-0002-0695-7212; Mastrodonato, Alessia/0000-0003-3999-5159	Catholic University	Catholic University	This work was supported by grants from the Catholic University (D3.2 and D1 funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1994, NEURON, V12, P155, DOI 10.1016/0896-6273(94)90160-0; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Borgmann-Winter KE, 2009, NEUROSCIENCE, V158, P642, DOI 10.1016/j.neuroscience.2008.09.059; Bradley J, 1997, J NEUROSCI, V17, P1993; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Broillet MC, 1999, ANN NY ACAD SCI, V868, P730, DOI 10.1111/j.1749-6632.1999.tb11352.x; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Carreira BP, 2013, NEUROSIGNALS, V21, P1, DOI 10.1159/000332811; Carreira BP, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/895659; Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444; Charles A, 2001, MOL ENDOCRINOL, V15, P997, DOI 10.1210/me.15.6.997; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Curcio L, 2013, BRAIN, V136, P1216, DOI 10.1093/brain/awt036; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; El Majdoubi M, 2002, ENDOCRINOLOGY, V143, P2441, DOI 10.1210/en.143.6.2441; Lopez-Jimenez ME, 2012, J CELL PHYSIOL, V227, P2252, DOI 10.1002/jcp.22964; ELHUSSEINI AED, 1995, NEUROREPORT, V6, P1459, DOI 10.1097/00001756-199507100-00024; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gomez-Pinedo U, 2010, NEUROSCIENCE, V165, P1275, DOI 10.1016/j.neuroscience.2009.11.046; Grassi C, 2004, NEUROCHEM INT, V45, P885, DOI 10.1016/j.neuint.2004.03.019; Gupta VK, 2012, AM J PHYSIOL-ENDOC M, V303, pE1363, DOI 10.1152/ajpendo.00199.2012; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; IMURA H, 1992, FRONT NEUROENDOCRIN, V13, P217; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; Kingston PA, 1996, P NATL ACAD SCI USA, V93, P10440, DOI 10.1073/pnas.93.19.10440; Kusaka S, 1996, J PHYSIOL-LONDON, V497, P813, DOI 10.1113/jphysiol.1996.sp021812; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; LEINDERSZUFALL T, 1995, NEUROREPORT, V6, P1761, DOI 10.1097/00001756-199509000-00013; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Luo CX, 2010, STEM CELLS, V28, P2041, DOI 10.1002/stem.522; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Michalakis S, 2011, GENES BRAIN BEHAV, V10, P137, DOI 10.1111/j.1601-183X.2010.00646.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Muller D, 2009, ENDOCRINOLOGY, V150, P5520, DOI 10.1210/en.2009-0490; Murphy GJ, 2003, NEURON, V37, P639, DOI 10.1016/S0896-6273(03)00057-6; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Palmeri A, 2013, BEHAV BRAIN RES, V240, P11, DOI 10.1016/j.bbr.2012.10.060; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Pifferi S, 2006, FEBS LETT, V580, P2853, DOI 10.1016/j.febslet.2006.03.086; Podda MV, 2008, J PHYSIOL-LONDON, V586, P803, DOI 10.1113/jphysiol.2007.146019; Podda MV, 2012, GLIA, V60, P1391, DOI 10.1002/glia.22360; Podda MV, 2004, EUR J NEUROSCI, V20, P2124, DOI 10.1111/j.1460-9568.2004.03674.x; Puzzo D, 2006, REV NEUROSCIENCE, V17, P497; Puzzo Daniela, 2008, Neuropsychiatr Dis Treat, V4, P371; Reierson GW, 2011, CURR NEUROPHARMACOL, V9, P715, DOI 10.2174/157015911798376271; Roy DRS, 1999, CEREB CORTEX, V9, P340, DOI 10.1093/cercor/9.4.340; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sasaki T, 2007, STROKE, V38, P1597, DOI 10.1161/STROKEAHA.106.476754; Shors TJ, 2012, BEHAV BRAIN RES, V227, P450, DOI 10.1016/j.bbr.2011.04.023; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Strijbos PJLM, 1999, EUR J NEUROSCI, V11, P4463, DOI 10.1046/j.1460-9568.1999.00893.x; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wei JY, 1998, PROG NEUROBIOL, V56, P37, DOI 10.1016/S0301-0082(98)00029-X; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zhu DY, 2003, J NEUROSCI, V23, P223; Zielinska M, 2007, NEUROTOXICOLOGY, V28, P1260, DOI 10.1016/j.neuro.2007.05.012	80	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73246	10.1371/journal.pone.0073246	http://dx.doi.org/10.1371/journal.pone.0073246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991183	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700060
J	Zotes, TM; Arias, CF; Fuster, JJ; Spada, R; Perez-Yague, S; Hirsch, E; Wymann, M; Carrera, AC; Andres, V; Barber, DF				Zotes, Teresa M.; Arias, Cristina F.; Fuster, Jose J.; Spada, Roberto; Perez-Yaguee, Sonia; Hirsch, Emilio; Wymann, Matthias; Carrera, Ana C.; Andres, Vicente; Barber, Domingo F.			PI3K p110 gamma Deletion Attenuates Murine Atherosclerosis by Reducing Macrophage Proliferation but Not Polarization or Apoptosis in Lesions	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PHOSPHOINOSITIDE 3-KINASE GAMMA; REGULATORY T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; HUMAN MONOCYTES; FACTOR-I; ACTIVATION; KINASE; EXPRESSION; GRANULOCYTE	Atherosclerosis is an inflammatory disease regulated by infiltrating monocytes and T cells, among other cell types. Macrophage recruitment to atherosclerotic lesions is controlled by monocyte infiltration into plaques. Once in the lesion, macrophage proliferation in situ, apoptosis, and differentiation to an inflammatory (M1) or anti-inflammatory phenotype (M2) are involved in progression to advanced atherosclerotic lesions. We studied the role of phosphoinositol-3-kinase (PI3K) p110 gamma in the regulation of in situ apoptosis, macrophage proliferation and polarization towards M1 or M2 phenotypes in atherosclerotic lesions. We analyzed atherosclerosis development in LDLR(-/-)p110 gamma(+/-) and LDLR(-/-)p110 gamma(-/-) mice, and performed expression and functional assays in tissues and primary cells from these and from p110 gamma(+/-) and p110 gamma(-/-) mice. Lack of p110 gamma in LDLR-/- mice reduces the atherosclerosis burden. Atherosclerotic lesions in fat-fed LDLR(-/-)p110 gamma(-/-) mice were smaller than in LDLR(-/-)p110 gamma(+/-) controls, which coincided with decreased macrophage proliferation in LDLR(-/-)p110 gamma(-/-) mouse lesions. This proliferation defect was also observed in p110 gamma(-/-) bone marrow-derived macrophages (BMM) stimulated with macrophage colony-stimulating factor (M-CSF), and was associated with higher intracellular cyclic adenosine monophosphate (cAMP) levels. In contrast, T cell proliferation was unaffected in LDLR(-/-)p110 gamma(-/-) mice. Moreover, p110 gamma deficiency did not affect macrophage polarization towards the M1 or M2 phenotypes or apoptosis in atherosclerotic plaques, or polarization in cultured BMM. Our results suggest that higher cAMP levels and the ensuing inhibition of macrophage proliferation contribute to atheroprotection in LDLR-/- mice lacking p110 gamma. Nonetheless, p110 gamma deletion does not appear to be involved in apoptosis, in macrophage polarization or in T cell proliferation.	[Zotes, Teresa M.; Arias, Cristina F.; Spada, Roberto; Perez-Yaguee, Sonia; Carrera, Ana C.; Barber, Domingo F.] CSIC, CNB, Dept Immunol & Oncol, Madrid, Spain; [Fuster, Jose J.; Andres, Vicente] CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Hirsch, Emilio] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, Turin, Italy; [Wymann, Matthias] Univ Basel, Dept Clin & Biol Sci, Inst Biochem & Genet, Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Turin; University of Basel	Barber, DF (corresponding author), CSIC, CNB, Dept Immunol & Oncol, Madrid, Spain.	dfbarber@cnb.csic.es	Wymann, Matthias P/C-3227-2008; Fernandez-Arias, Cristina/D-1618-2018; Barber, Domingo F./G-1257-2010; Andres, Vicente/I-6440-2014; Fuster, José J/D-3685-2011; Hirsch, Emilio/F-4848-2013	Wymann, Matthias P/0000-0003-3349-4281; Barber, Domingo F./0000-0001-8824-5405; Andres, Vicente/0000-0002-0125-7209; Fuster, José J/0000-0002-5970-629X; Carrera, Ana/0000-0002-3999-5434; Hirsch, Emilio/0000-0002-9073-6024	Spanish Ministry of Science and Innovation [SAF-2007-60498, SAF-2008-00471, SAF-2011-23639, SAF2010-16044, AP2007-01711, BES-2009-016547]; Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program [RD08/0075/0015]; Madrid Regional Government [200520M040]; Thematic Research Network in Cardiovascular Diseases (RECAVA) [RD06/0014/0021]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program; Madrid Regional Government; Thematic Research Network in Cardiovascular Diseases (RECAVA)	This work was supported by the Spanish Ministry of Science and Innovation (SAF-2007-60498, SAF-2008-00471, SAF-2011-23639 to DFB, SAF2010-16044 to VA, AP2007-01711 to TMZ, BES-2009-016547 to RS), the Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program (RD08/0075/0015 to DFB), the Madrid Regional Government (200520M040 to DFB) and the Thematic Research Network in Cardiovascular Diseases (RECAVA; RD06/0014/0021 to VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Antonov AS, 1997, J CLIN INVEST, V99, P2867, DOI 10.1172/JCI119480; Barber DF, 2006, J IMMUNOL, V176, P589, DOI 10.4049/jimmunol.176.1.589; Beer-Hammer S, 2010, J LEUKOCYTE BIOL, V87, P1083, DOI 10.1189/jlb.0809585; Biwa T, 2000, J BIOL CHEM, V275, P5810, DOI 10.1074/jbc.275.8.5810; Biwa T, 2000, J Atheroscler Thromb, V7, P14; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; FALK LA, 1988, J LEUKOCYTE BIOL, V43, P148, DOI 10.1002/jlb.43.2.148; Fougerat A, 2008, CIRCULATION, V117, P1310, DOI 10.1161/CIRCULATIONAHA.107.720466; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Guerreiro AS, 2011, MOL CANCER RES, V9, P925, DOI 10.1158/1541-7786.MCR-10-0200; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kwon EM, 2000, BLOOD, V95, P2552, DOI 10.1182/blood.V95.8.2552.008k30_2552_2558; Lamharzi N, 2004, DIABETES, V53, P3217, DOI 10.2337/diabetes.53.12.3217; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martin AL, 2008, J IMMUNOL, V180, P2081, DOI 10.4049/jimmunol.180.4.2081; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; ROCK CO, 1992, MOL CELL BIOL, V12, P2351, DOI 10.1128/MCB.12.5.2351; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sakai M, 2000, CURR OPIN LIPIDOL, V11, P503, DOI 10.1097/00041433-200010000-00008; SALEEM A, 1995, J BIOL CHEM, V270, P10380, DOI 10.1074/jbc.270.18.10380; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schmidt C, 2013, NEUROSCIENCE, V233, P44, DOI 10.1016/j.neuroscience.2012.12.036; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Witztum JL, 1999, CLIN IMMUNOL, V90, P153, DOI 10.1006/clim.1998.4682; Xaus J, 1999, J IMMUNOL, V163, P4140; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	50	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72674	10.1371/journal.pone.0072674	http://dx.doi.org/10.1371/journal.pone.0072674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991137	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470700045
J	Gong, ZH; Quan, L; Yao, S; Zirpoli, G; Bandera, EV; Roberts, M; Coignet, JG; Cabasag, C; Sucheston, L; Hwang, H; Ciupak, G; Davis, W; Pawlish, K; Jandorf, L; Bovbjerg, DH; Ambrosone, CB; Hong, CC				Gong, Zhihong; Quan, Lei; Yao, Song; Zirpoli, Gary; Bandera, Elisa V.; Roberts, Michelle; Coignet, Jean-Gabriel; Cabasag, Citadel; Sucheston, Lara; Hwang, Helena; Ciupak, Gregory; Davis, Warren; Pawlish, Karen; Jandorf, Lina; Bovbjerg, Dana H.; Ambrosone, Christine B.; Hong, Chi-Chen			Innate Immunity Pathways and Breast Cancer Risk in African American and European-American Women in the Women's Circle of Health Study (WCHS)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; CAUCASIAN WOMEN; SERUM-LEVELS; FACTOR-ALPHA; TNF-LTA; DISEASE	African American (AA) women are more likely than European American (EA) women to be diagnosed with early, aggressive breast cancer. Possible differences in innate immune pathways (e. g., inflammatory responses) have received little attention as potential mechanisms underlying this disparity. We evaluated distributions of selected genetic variants in innate immune pathways in AA and EA women, and examined their associations with breast cancer risk within the Women's Circle of Health Study (WCHS). In stage I of the study (864 AA and 650 EA women) we found that genotype frequencies for 35 of 42 tested SNPs (18 candidate genes) differed between AAs and EAs (corroborated by ancestry informative markers). Among premenopausal AA women, comparing variant allele carriers to non-carriers, reduced breast cancer risk was associated with CXCL5-rs425535 (OR = 0.61, P = 0.02), while among EA women, there were associations with TNFA-rs1799724 (OR = 2.31, P = 0.002) and CRP-rs1205 (OR = 0.54, P = 0.01). For postmenopausal women, IL1B-rs1143627 (OR = 1.80, P = 0.02) and IL1B-rs16944 (OR = 1.85, P = 0.02) were associated with risk among EA women, with significant associations for TNFA-rs1799724 limited to estrogen receptor (ER) positive cancers (OR= 2.0, P = 0.001). However, none of the SNPs retained significance after Bonferroni adjustment for multiple testing at the level of P0.0012 (0.05/42) except for TNFA-rs1799724 in ER positive cancers. In a stage II validation (1,365 AA and 1,307 EA women), we extended evaluations for four SNPs (CCL2-rs4586, CRP-rs1205, CXCL5-rs425535, and IL1RN-rs4251961), which yielded similar results. In summary, distributions of variants in genes involved in innate immune pathways were found to differ between AA and EA populations, and showed differential associations with breast cancer according to menopausal or ER status. These results suggest that immune adaptations suited to ancestral environments may differentially influence breast cancer risk among EA and AA women.	[Gong, Zhihong; Quan, Lei; Yao, Song; Zirpoli, Gary; Roberts, Michelle; Coignet, Jean-Gabriel; Cabasag, Citadel; Sucheston, Lara; Hwang, Helena; Ciupak, Gregory; Davis, Warren; Ambrosone, Christine B.; Hong, Chi-Chen] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [Pawlish, Karen] New Jersey Dept Hlth, Trenton, NJ USA; [Jandorf, Lina] Icahn Sch Med Mt Sinai, New York, NY USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; New Jersey Department of Health & Senior Services; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gong, ZH (corresponding author), Roswell Pk Canc Inst, Buffalo, NY 14263 USA.	Zhihong.gong@roswellpark.org	Cabasag, Citadel Jungco/GOH-1428-2022; Quan, Lei/GXN-1280-2022; Bandera, Elisa V/M-4169-2014	Bandera, Elisa V/0000-0002-8789-2755; Yao, Song/0000-0001-9442-1313; Quan, Lei/0000-0002-6572-0530	United States Army Medical Research and Material Command [DAMD-17-01-1-0334]; National Cancer Institute [R01 CA100598, P01 CA151135, K22 CA138563, P30CA072720, P30 CA016056]; Breast Cancer Research Foundation; Centers for Disease Control and Prevention [DP07-703]; National Cancer Institute's SEER Program [N01-PC-95001-20]; NATIONAL CANCER INSTITUTE [R01CA100598, P30CA072720, P01CA151135, K22CA138563, P30CA016056] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute's SEER Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the United States Army Medical Research and Material Command (DAMD-17-01-1-0334), the National Cancer Institute (R01 CA100598, P01 CA151135, K22 CA138563, P30CA072720, P30 CA016056), the Breast Cancer Research Foundation and a gift from the Philip L Hubbell family. The New Jersey State Cancer Registry (NJSCR) is a participant in the Centers for Disease Control and Prevention's National Program of Cancer Registries and is a National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Expansion Registry. The NJSCR is supported by the Centers for Disease Control and Prevention under cooperative agreement DP07-703 awarded to the New Jersey Department of Health & Senior Services. The collection of New Jersey cancer incidence data is also supported by the National Cancer Institute's SEER Program under contract N01-PC-95001-20 and the State of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson A, 2012, J CLIN ENDOCR METAB, V97, pE2044, DOI 10.1210/jc.2012-2288; Aliyu Muktar H, 2005, J Natl Med Assoc, V97, P799; Ambrosone CB, 2009, J ONCOL, V2009, DOI 10.1155/2009/871250; Anderson WF, 2008, JNCI-J NATL CANCER I, V100, P1804, DOI 10.1093/jnci/djn411; Arora P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-95; Azenshtein E, 2002, CANCER RES, V62, P1093; Balasubramanian SP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-188; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Carroll JF, 2009, OBESITY, V17, P1420, DOI 10.1038/oby.2008.657; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Crawford DC, 2006, HUM GENET, V119, P496, DOI 10.1007/s00439-006-0160-y; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Eklund C, 2003, EUR CYTOKINE NETW, V14, P168; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Fregene A, 2005, CANCER-AM CANCER SOC, V103, P1540, DOI 10.1002/cncr.20978; Gaj P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-81; Gaudet MM, 2007, HUM GENET, V121, P483, DOI 10.1007/s00439-006-0315-x; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Ghilardi G, 2005, CLIN CHEM, V51, P452, DOI 10.1373/clinchem.2004.041657; Giordani L, 2003, CLIN CHEM, V49, P1664, DOI 10.1373/49.10.1664; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Hall IJ, 2005, AM J EPIDEMIOL, V161, P40, DOI 10.1093/aje/kwh331; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Hildebrandt MAT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012402; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Ito LS, 2002, JPN J CLIN ONCOL, V32, P398, DOI 10.1093/jjco/hyf081; Kanda N, 2003, J INVEST DERMATOL, V120, P1058, DOI 10.1046/j.1523-1747.2003.12255.x; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kidd LR, 2011, CANCER EPIDEM BIOMAR, V20, pA70, DOI [10.1158/1055-9965.EPI-10-0892, DOI 10.1158/1055-9965.EPI-10-0892]; Kohaar I, 2009, BREAST CANCER RES TR, V114, P347, DOI 10.1007/s10549-008-0006-5; Kruszyna L, 2011, MOL BIOL REP, V38, P1263, DOI 10.1007/s11033-010-0225-9; Lim EM, 2010, INT J LAB HEMATOL, V32, P590, DOI 10.1111/j.1751-553X.2010.01223.x; Liu JY, 2006, INT J CANCER, V118, P2554, DOI 10.1002/ijc.21652; Lowe DB, 2011, IMMUNOTHERAPY-UK, V3, P1265, DOI [10.2217/IMT.11.113, 10.2217/imt.11.113]; Lv K, 2006, SCAND J IMMUNOL, V64, P164, DOI 10.1111/j.1365-3083.2006.01786.x; Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c; Madeleine MM, 2011, BREAST CANCER RES TR, V129, P887, DOI 10.1007/s10549-011-1520-4; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Marsh EE, 2011, J CLIN ENDOCR METAB, V96, P3199, DOI 10.1210/jc.2011-1314; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Munoz-Cruz S, 2011, CURR TOP MED CHEM, V11, P1714; Park KS, 2002, EUR J IMMUNOGENET, V29, P7, DOI 10.1046/j.0960-7420.2001.00260.x; Pennington R, 2009, INFECT GENET EVOL, V9, P1371, DOI 10.1016/j.meegid.2009.09.017; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rose DP, 2010, MATURITAS, V66, P33, DOI 10.1016/j.maturitas.2010.01.019; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Ruiz-Narvaez EA, 2011, AM J EPIDEMIOL, V173, P587, DOI 10.1093/aje/kwq401; Sato H, 2007, J ALLERGY CLIN IMMUN, V119, P687, DOI 10.1016/j.jaci.2006.10.028; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Steiner JL, 2012, INT J BIOL MARKER, V27, P179, DOI 10.5301/JBM.2012.9345; Stork S, 2002, CARDIOVASC RES, V53, P642, DOI 10.1016/S0008-6363(01)00461-8; Van Dyke AL, 2009, CYTOKINE, V46, P236, DOI 10.1016/j.cyto.2009.02.003; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Yang Y, 2011, BREAST CANCER RES TR, V129, P513, DOI 10.1007/s10549-011-1494-2; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zabaleta J, 2008, CANCER IMMUNOL IMMUN, V57, P107, DOI 10.1007/s00262-007-0358-4; Zineh I, 2006, CYTOKINE, V33, P258, DOI 10.1016/j.cyto.2006.02.008	71	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72619	10.1371/journal.pone.0072619	http://dx.doi.org/10.1371/journal.pone.0072619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991131	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000324470100110
J	Saito, J; Hirota, T; Furuta, S; Kobayashi, D; Takane, H; Ieiri, I				Saito, Jumpei; Hirota, Takeshi; Furuta, Shinji; Kobayashi, Daisuke; Takane, Hiroshi; Ieiri, Ichiro			Association between DNA Methylation in the miR-328 5 '-Flanking Region and Inter-individual Differences in miR-328 and BCRP Expression in Human Placenta	PLOS ONE			English	Article							CANCER-RESISTANCE-PROTEIN; SINGLE NUCLEOTIDE POLYMORPHISMS; LIMITS FETAL DISTRIBUTION; BREAST-CANCER; PROMOTER METHYLATION; ABCG2 EXPRESSION; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TRANSPORTER	MicroRNA (miRNA) are non-coding small RNA that regulate gene expression. MiR-328 is reported to influence breast cancer resistance protein (BCRP) expression in cancer cells. As a large inter-individual difference in BCRP levels is observed in various human tissues, the contribution of miR-328 to these differences is of interest. We hypothesized that DNA methylation in the miR-328 promoter region is responsible for the difference in miR-328 levels, leading to inter-individual variability in BCRP levels in human placenta. The association between placental miR-328 and BCRP levels was analyzed, and then DNA methylation in the miR-328 5'-flanking region and regulatory mechanisms causing inter-individual differences in miR-328 and BCRP levels were examined. MiR-328 expression was significantly correlated with BCRP mRNA (Rs = -0.560, P < 0.01) and protein (Rs = -0.730, P < 0.01) levels. It was also up-regulated by the demethylating agent 5-aza-2'-deoxycytidine in BCRP-expressing cells. Luciferase assays with differentially methylated reporter constructs indicated that methylation in the miR-328 5'-flanking region including a predicted CpG island remarkably decreased transcriptional activity compared to that in unmethylated constructs. We selected CCAAT/enhancer binding protein alpha (C/EBP alpha), located within the predicted CpG island, by in silico analysis. To elucidate the role of C/EBPa in miR-328 expression, a chromatin immunoprecipitation assay, promoter deletion analysis, and electrophoretic mobility shift assay (EMSA) were performed. C/EBP alpha-binding site-truncated constructs showed significantly decreased promoter activity, and EMSA indicated that the C/EBP alpha-binding sites were located in the CpG island. Finally, the methylation patterns of several CpG dinucleotides proximal to two C/EBP alpha-binding sites in the miR-328 5'-flanking region were correlated negatively with miR-328 levels, and positively with BCRP levels in human placental samples. These results suggest that methylation patterns in the miR-328 5'-flanking region are involved in the inter-individual difference in BCRP levels in human placenta.	[Saito, Jumpei; Hirota, Takeshi; Furuta, Shinji; Kobayashi, Daisuke; Ieiri, Ichiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan; [Takane, Hiroshi] Tottori Univ Hosp, Dept Pharm, Yonago, Tottori, Japan	Kyushu University; Tottori University	Ieiri, I (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan.	ieiri-ttr@umin.ac.jp	Saito, Jumpei/R-1154-2019	Saito, Jumpei/0000-0003-4799-5562	Japan Society for the Promotion of Science KAKENHI [23590186]; Grants-in-Aid for Scientific Research [23590186] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23590186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2002, MOL CANCER THER, V1, P427; Bao LL, 2012, AM J PATHOL, V180, P2490, DOI 10.1016/j.ajpath.2012.02.024; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Ceckova M, 2006, CLIN EXP PHARMACOL P, V33, P58, DOI 10.1111/j.1440-1681.2006.04324.x; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Dudziec E, 2011, CLIN CANCER RES, V17, P1287, DOI 10.1158/1078-0432.CCR-10-2017; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Enokizono J, 2007, MOL PHARMACOL, V72, P967, DOI 10.1124/mol.107.034751; Evseenko DA, 2007, PLACENTA, V28, pS116, DOI 10.1016/j.placenta.2006.12.003; Evseenko DA, 2007, FASEB J, V21, P3592, DOI 10.1096/fj.07-8688com; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Hahnova-Cygalova L, 2011, DRUG METAB REV, V43, P53, DOI 10.3109/03602532.2010.512293; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hirota T, 2012, LUNG CANCER, V77, P16, DOI 10.1016/j.lungcan.2011.12.018; Ikemura K, 2013, MOL PHARMACOL, V83, P399, DOI 10.1124/mol.112.081844; Imai Y, 2002, MOL CANCER THER, V1, P611; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; Komagata S, 2009, MOL PHARMACOL, V76, P702, DOI 10.1124/mol.109.056986; Kondo C, 2004, PHARM RES-DORDR, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Li WQ, 2010, MED SCI MONITOR, V16, pHY27; LI X, 2010, BIOCHEM PHARMACOL, V15, P783; Liang Zhongxing, 2010, Biochem Pharmacol, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Lujambio A, 2007, CELL CYCLE, V6, P1455; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mishra PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008445; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; Nakamichi N, 2009, LAB INVEST, V89, P327, DOI 10.1038/labinvest.2008.157; Nakano H, 2008, CANCER-AM CANCER SOC, V112, P1122, DOI 10.1002/cncr.23285; Novakovic B, 2012, PLACENTA, V33, P959, DOI 10.1016/j.placenta.2012.10.003; Novakovic B, 2013, J NUTR BIOCHEM, V24, P282, DOI 10.1016/j.jnutbio.2012.06.006; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; NYCE J, 1989, CANCER RES, V49, P5829; NYCE J, 1993, P NATL ACAD SCI USA, V90, P2960, DOI 10.1073/pnas.90.7.2960; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; To KKW, 2006, MOL CELL BIOL, V26, P8572, DOI 10.1128/MCB.00650-06; Tokarz P, 2012, ACTA BIOCHIM POL, V59, P467; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Turner JG, 2006, BLOOD, V108, P3881, DOI 10.1182/blood-2005-10-009084; Vore M, 2008, MOL PHARMACOL, V73, P613, DOI 10.1124/mol.107.044289; Wang H, 2008, MOL PHARMACOL, V73, P845, DOI 10.1124/mol.107.041087; Wang XD, 2010, FEBS LETT, V584, P3392, DOI 10.1016/j.febslet.2010.06.033; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047270; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Yokoi T, 2011, TOXICOL SCI, V123, P1, DOI 10.1093/toxsci/kfr168; Yoshioka S, 2007, PHARM RES, V24, P1108, DOI 10.1007/s11095-007-9235-2; Yuen RKC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007389; Zhang Y, 2007, DRUG METAB DISPOS, V35, P2154, DOI 10.1124/dmd.107.018044; Zhou L, 2008, MOL PHARMACOL, V73, P949, DOI 10.1124/mol.107.041616; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	65	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72906	10.1371/journal.pone.0072906	http://dx.doi.org/10.1371/journal.pone.0072906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991164	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100124
J	Vorjohann, S; Pitetti, JL; Nef, S; Gonelle-Gispert, C; Buhler, L; Fish, RJ; Neerman-Arbez, M				Vorjohann, Silja; Pitetti, Jean-Luc; Nef, Serge; Gonelle-Gispert, Carmen; Buhler, Leo; Fish, Richard J.; Neerman-Arbez, Marguerite			DNA Methylation Profiling of the Fibrinogen Gene Landscape in Human Cells and during Mouse and Zebrafish Development	PLOS ONE			English	Article							HUMAN GENOME; HISTONE METHYLATION; CPG ISLANDS; EXPRESSION; PROMOTER; LIVER; DEMETHYLATION; HEPATOCYTES; MECHANISMS; ENHANCER	The fibrinogen genes FGA, FGB and FGG show coordinated expression in hepatocytes. Understanding the underlying transcriptional regulation may elucidate how their tissue-specific expression is maintained and explain the high variability in fibrinogen blood levels. DNA methylation of CpG-poor gene promoters is dynamic with low methylation correlating with tissue-specific gene expression but its direct effect on gene regulation as well as implications of non-promoter CpG methylation are not clear. Here we compared methylation of CpG sites throughout the fibrinogen gene cluster in human cells and mouse and zebrafish tissues. We observed low DNA methylation of the CpG-poor fibrinogen promoters and of additional regulatory elements (the liver enhancers CNC12 and PFE2) in fibrinogen-expressing samples. In a gene reporter assay, CpG-methylation in the FGA promoter reduced promoter activity, suggesting a repressive function for DNA methylation in the fibrinogen locus. In mouse and zebrafish livers we measured reductions in DNA methylation around fibrinogen genes during development that were preceded by increased fibrinogen expression and tri-methylation of Histone3 lysine4 (H3K4me3) in fibrinogen promoters. Our data support a model where changes in hepatic transcription factor expression and histone modification provide the switch for increased fibrinogen gene expression in the developing liver which is followed by reduction of CpG methylation.	[Vorjohann, Silja; Pitetti, Jean-Luc; Nef, Serge; Fish, Richard J.; Neerman-Arbez, Marguerite] Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Vorjohann, Silja; Pitetti, Jean-Luc; Nef, Serge; Fish, Richard J.; Neerman-Arbez, Marguerite] Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Gonelle-Gispert, Carmen; Buhler, Leo] Univ Hosp, Dept Surg, Surg Res Unit, Geneva, Switzerland; [Neerman-Arbez, Marguerite] Univ Hosp, Div Angiol & Hemostasis, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Neerman-Arbez, M (corresponding author), Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Marguerite.Neerman-Arbez@unige.ch	Nef, Serge/AAV-6445-2020	Nef, Serge/0000-0001-5462-0676; Buhler, Leo/0000-0002-9461-8498; Neerman-Arbez, Marguerite/0000-0002-9351-4195	Swiss National Science Foundation [3100A0-119845, 31003A-134967]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants 3100A0-119845 and 31003A-134967 to MNA from the Swiss National Science Foundation (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; D'Anello L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-300; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P427, DOI 10.1160/TH12-04-0274; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P419, DOI 10.1160/TH12-04-0273; Fish RJ, 2012, THROMB HAEMOSTASIS, V107, P158, DOI 10.1160/TH11-04-0221; Fort A, 2011, BLOOD, V117, P276, DOI 10.1182/blood-2010-07-295410; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FRIEDLANDER Y, 1995, AM J HUM GENET, V56, P1194; FULLER GM, 1985, J CELL BIOL, V101, P1481, DOI 10.1083/jcb.101.4.1481; Fuller GM, 2001, ANN NY ACAD SCI, V936, P469; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Green F, 1989, Baillieres Clin Haematol, V2, P945, DOI 10.1016/S0950-3536(89)80053-8; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Herceg Z, 2011, MUTAT RES-REV MUTAT, V727, P55, DOI 10.1016/j.mrrev.2011.04.001; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lathrop MJ, 2009, EXP HEMATOL, V37, P807, DOI 10.1016/j.exphem.2009.04.005; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mai G, 2005, XENOTRANSPLANTATION, V12, P457, DOI 10.1111/j.1399-3089.2005.00248.x; Neerman-Arbez M, 2004, BLOOD, V104, P3618, DOI 10.1182/blood-2004-06-2312; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Nguyen TH, 2002, MOL THER, V6, P199, DOI 10.1006/mthe.2002.0653; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Perisic T, 2010, NEUROPSYCHOPHARMACOL, V35, P792, DOI 10.1038/npp.2009.188; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saferali A, 2010, EPIGENETICS-US, V5, P50, DOI 10.4161/epi.5.1.10436; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047081; Zorn A.M., 2008, LIVER DEV	52	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73089	10.1371/journal.pone.0073089	http://dx.doi.org/10.1371/journal.pone.0073089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991173	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100126
J	Cappellari, M; Bielli, P; Paronetto, MP; Ciccosanti, F; Fimia, GM; Saarikettu, J; Silvennoinen, O; Sette, C				Cappellari, M.; Bielli, P.; Paronetto, M. P.; Ciccosanti, F.; Fimia, G. M.; Saarikettu, J.; Silvennoinen, O.; Sette, C.			The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells	ONCOGENE			English	Article						alternative splicing; SND1; SAM68; CD44; prostate cancer	BINDING PROTEIN SAM68; RNA-POLYMERASE-II; MALE GERM-CELLS; ANDROGEN RECEPTOR; MESSENGER-RNAS; IN-VIVO; ELONGATION; CD44; P100; SPERMATOGENESIS	Splicing abnormalities have profound impact in human cancer. Several splicing factors, including SAM68, have pro-oncogenic functions, and their increased expression often correlates with human cancer development and progression. Herein, we have identified using mass spectrometry proteins that interact with endogenous SAM68 in prostate cancer (PCa) cells. Among other interesting proteins, we have characterized the interaction of SAM68 with SND1, a transcriptional co-activator that binds spliceosome components, thus coupling transcription and splicing. We found that both SAM68 and SND1 are upregulated in PCa cells with respect to benign prostate cells. Upregulation of SND1 exerts a synergic effect with SAM68 on exon v5 inclusion in the CD44 mRNA. The effect of SND1 on CD44 splicing required SAM68, as it was compromised after knockdown of this protein or mutation of the SAM68-binding sites in the CD44 pre-mRNA. More generally, we found that SND1 promotes the inclusion of CD44 variable exons by recruiting SAM68 and spliceosomal components on CD44 pre-mRNA. Inclusion of the variable exons in CD44 correlates with increased proliferation, motility and invasiveness of cancer cells. Strikingly, we found that knockdown of SND1, or SAM68, reduced proliferation and migration of PCa cells. Thus, our findings strongly suggest that SND1 is a novel regulator of alternative splicing that promotes PCa cell growth and survival.	[Cappellari, M.; Bielli, P.; Sette, C.] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Cappellari, M.; Bielli, P.; Sette, C.] Fdn Santa Lucia, Lab Neuroembryol, Rome, Italy; [Paronetto, M. P.] Fdn Santa Lucia, Lab Cellular & Mol Neurobiol, Rome, Italy; [Paronetto, M. P.] Univ Rome Foro Italico, Dept Hlth Sci, Rome, Italy; [Ciccosanti, F.; Fimia, G. M.] Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol & Preclin Res, Rome, Italy; [Saarikettu, J.; Silvennoinen, O.] Tampere Univ, Fac Med, Lab Mol Immunol, FIN-33101 Tampere, Finland; [Silvennoinen, O.] Tampere Univ, Inst Biomed Technol Biomeditech, Tampere, Finland; [Silvennoinen, O.] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland	University of Rome Tor Vergata; IRCCS Santa Lucia; IRCCS Santa Lucia; Foro Italico University of Rome; IRCCS Lazzaro Spallanzani; Tampere University; Tampere University; Tampere University; Tampere University Hospital	Sette, C (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.	claudio.sette@uniroma2.it	Fimia, Gian Maria/K-3232-2016; Sette, Claudio/S-4307-2019; Ciccosanti, Fabiola/B-5284-2017; Paronetto, Maria Paola/A-9578-2012; Bielli, Pamela/K-1208-2018	Fimia, Gian Maria/0000-0003-4438-3325; Sette, Claudio/0000-0003-2864-8266; Ciccosanti, Fabiola/0000-0003-0481-6878; Paronetto, Maria Paola/0000-0001-5324-0903; Bielli, Pamela/0000-0003-3347-8345	Association for International Cancer Research (AICR) [12-0150]; Associazione Italiana Ricerca sul Cancro (AIRC) [10348]; Associazione Italiana Ricerca sul Cancro (MFAG) [11658]; Worldwide Cancer Research [12-0150] Funding Source: researchfish	Association for International Cancer Research (AICR); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro (MFAG)(Fondazione AIRC per la ricerca sul cancro); Worldwide Cancer Research	We wish to thank Dr Roberta Busa for suggestions with chromatin immunoprecipitation experiments and Dr Maria Loiarro for assistance with luciferase reporter assays. This work was supported by the Association for International Cancer Research (AICR grant no. 12-0150 to CS) and the Associazione Italiana Ricerca sul Cancro (AIRC grant no. 10348 to CS and MFAG no. 11658 to MPP).	Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Busa R, 2010, NUCLEIC ACIDS RES, V38, P3005, DOI 10.1093/nar/gkq004; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Elliott DJ, 2010, J PATHOL, V222, P223, DOI 10.1002/path.2753; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Gao XJ, 2012, J BIOL CHEM, V287, P18130, DOI 10.1074/jbc.M111.311852; Germann S, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/269570; Grange J, 2009, J NEUROSCI RES, V87, P12, DOI 10.1002/jnr.21824; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Hong W, 2002, MOL CANCER RES, V1, P48; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huot ME, 2009, J BIOL CHEM, V284, P31903, DOI 10.1074/jbc.M109.018465; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Messina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039729; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2011, NUCLEIC ACIDS RES, V39, P4961, DOI 10.1093/nar/gkr085; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138; Paronetto MP, 2006, MOL BIOL CELL, V17, P14, DOI 10.1091/mbc.e05-06-0548; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Rajan P, 2008, J PATHOL, V215, P67, DOI 10.1002/path.2324; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Sette C, 1998, J CELL BIOL, V142, P1063, DOI 10.1083/jcb.142.4.1063; Sette C, 2010, ADV EXP MED BIOL, V693, P54; Shukla S, 2012, BBA-GENE REGUL MECH, V1819, P673, DOI 10.1016/j.bbagrm.2012.01.014; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Song LB, 2010, J PATHOL, V222, P227, DOI 10.1002/path.2751; Taylor SJ, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-5; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yang HP, 2002, ONCOGENE, V21, P7187, DOI 10.1038/sj.onc.1205759; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	60	58	60	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3794	3802		10.1038/onc.2013.360	http://dx.doi.org/10.1038/onc.2013.360			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23995791				2022-12-25	WOS:000339394100005
J	Hoshina, S; Yura, K; Teranishi, H; Kiyasu, N; Tominaga, A; Kadoma, H; Nakatsuka, A; Kunichika, T; Obuse, C; Waga, S				Hoshina, Shoko; Yura, Kei; Teranishi, Honami; Kiyasu, Noriko; Tominaga, Ayumi; Kadoma, Haruka; Nakatsuka, Ayaka; Kunichika, Tomoko; Obuse, Chikashi; Waga, Shou			Human Origin Recognition Complex Binds Preferentially to G-quadruplex-preferable RNA and Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Methyltransferase; DNA Replication; Protein Structure; RNA-binding Protein; G-quadruplex; ORC; Replication Origin	REPLICATION INITIATION; ORC6 PROTEIN; TRANSCRIPTION; REVEALS; RECRUITMENT; SEQUENCE; ORGANIZATION; CHROMATIN; HOMOLOGY; SITE	Background: ORC binds to replication origins, but human ORC does not exhibit apparent sequence-specificity. Results: G-quadruplex (G4)-preferable RNA or single-stranded DNA competes for DNA binding of ORC. Conclusion: Human ORC binds preferentially to RNA and single-stranded DNA that form G4, and the certain domain in ORC1 is involved in this binding. Significance: This ability may correlate with the G4-formable motif in human replication origins. Origin recognition complex (ORC), consisting of six subunits ORC1-6, is known to bind to replication origins and function in the initiation of DNA replication in eukaryotic cells. In contrast to the fact that Saccharomyces cerevisiae ORC recognizes the replication origin in a sequence-specific manner, metazoan ORC has not exhibited strict sequence-specificity for DNA binding. Here we report that human ORC binds preferentially to G-quadruplex (G4)-preferable G-rich RNA or single-stranded DNA (ssDNA). We mapped the G-rich RNA-binding domain in the ORC1 subunit, in a region adjacent to its ATPase domain. This domain itself has an ability to preferentially recognize G4-preferable sequences of ssDNA. Furthermore, we found, by structure modeling, that the G-rich RNA-binding domain is similar to the N-terminal portion of AdoMet_MTase domain of mammalian DNA methyltransferase 1. Therefore, in contrast with the binding to double-stranded DNA, human ORC has an apparent sequence preference with respect to its RNA/ssDNA binding. Interestingly, this specificity coincides with the common signature present in most of the human replication origins. We expect that our findings provide new insights into the regulations of function and chromatin binding of metazoan ORCs.	[Hoshina, Shoko; Teranishi, Honami; Kiyasu, Noriko; Tominaga, Ayumi; Kadoma, Haruka; Nakatsuka, Ayaka; Waga, Shou] Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Tokyo 1128681, Japan; [Yura, Kei] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan; [Kunichika, Tomoko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0010021, Japan	Japan Womens University; Ochanomizu University; Osaka University; Hokkaido University	Waga, S (corresponding author), Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	swaga@fc.jwu.ac.jp	Yura, Kei/S-1030-2018	Yura, Kei/0000-0003-0197-5478; Waga, Shou/0000-0003-4986-8735	KAKENHI from the Japan Society for the Promotion of Science (JSPS) [21657045, 24570200]; Science Research Promotion Fund; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science Research Promotion Fund; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)	This work was supported in part by KAKENHI Grants 21657045 and 24570200 from the Japan Society for the Promotion of Science (JSPS) (to S. W.), the Science Research Promotion Fund (to S. W.), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT) (to K. Y.).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Bell S. D., 2013, DNA REPLICATION; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Dellino GI, 2013, GENOME RES, V23, P1, DOI 10.1101/gr.142331.112; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Kusic J, 2010, MOL BIOL REP, V37, P2317, DOI 10.1007/s11033-009-9735-8; Lee DG, 2000, EMBO J, V19, P4774, DOI 10.1093/emboj/19.17.4774; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Martin MM, 2011, GENOME RES, V21, P1822, DOI 10.1101/gr.124644.111; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Minami H, 2006, MOL CELL BIOL, V26, P8770, DOI 10.1128/MCB.00949-06; Mohammad MM, 2007, EMBO J, V26, P5048, DOI 10.1038/sj.emboj.7601919; Moriyama K, 2012, J BIOL CHEM, V287, P23977, DOI 10.1074/jbc.M112.368456; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Thomae AW, 2008, P NATL ACAD SCI USA, V105, P1692, DOI 10.1073/pnas.0707260105; Valenzuela MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017308; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Yabuki T, 2001, GENE, V264, P123, DOI 10.1016/S0378-1119(00)00592-8; Zheng KW, 2013, NUCLEIC ACIDS RES, V41, P5533, DOI 10.1093/nar/gkt264	44	64	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30161	30171		10.1074/jbc.M113.492504	http://dx.doi.org/10.1074/jbc.M113.492504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003239	Green Published, hybrid			2022-12-25	WOS:000329868100016
J	Li, XP; Kahn, PC; Kahn, JN; Grela, P; Tumer, NE				Li, Xiao-Ping; Kahn, Peter C.; Kahn, Jennifer Nielsen; Grela, Przemyslaw; Tumer, Nilgun E.			Arginine Residues on the Opposite Side of the Active Site Stimulate the Catalysis of Ribosome Depurination by Ricin A Chain by Interacting with the P-protein Stalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Synthesis; Ribosomal RNA (rRNA); Ribosomes; RIP; Toxins; Ribosome-inactivating Protein; Ricin	TOXIN-A-CHAIN; CIRCULAR-DICHROISM SPECTROSCOPY; N-GLYCOSIDASE ACTIVITY; SYNTHESIS IN-VITRO; SECONDARY STRUCTURE; ENZYMATIC INACTIVATION; GLUTAMIC ACID-177; SUBSTRATE-ANALOGS; AMINO-ACIDS; RNA	Background: Ricin A chain (RTA) uses the ribosomal stalk to access the sarcin/ricin loop (SRL). Results: Arginine residues at the interface of RTB are critical for RTA to bind to the stalk and to stimulate depurination of the SRL. Conclusion: Stalk binding stimulates depurination by orienting RTA toward the SRL. Significance: We propose a model that describes how RTA accesses the SRL. Ricin inhibits protein synthesis by depurinating the -sarcin/ricin loop (SRL). Ricin holotoxin does not inhibit translation unless the disulfide bond between the A (RTA) and B (RTB) subunits is reduced. Ricin holotoxin did not bind ribosomes or depurinate them but could depurinate free RNA. When RTA is separated from RTB, arginine residues located at the interface are exposed to the solvent. Because this positively charged region, but not the active site, is blocked by RTB, we mutated arginine residues at or near the interface of RTB to determine if they are critical for ribosome binding. These variants were structurally similar to wild type RTA but could not bind ribosomes. Their K-m values and catalytic rates (k(cat)) for an SRL mimic RNA were similar to those of wild type, indicating that their activity was not altered. However, they showed an up to 5-fold increase in K-m and up to 38-fold decrease in k(cat) toward ribosomes. These results suggest that the stalk binding stimulates the catalysis of ribosome depurination by RTA. The mutated arginines have side chains behind the active site cleft, indicating that the ribosome binding surface of RTA is on the opposite side of the surface that interacts with the SRL. We propose that stalk binding stimulates the catalysis of ribosome depurination by orienting the active site of RTA toward the SRL and thereby allows docking of the target adenine into the active site. This model may apply to the translation factors that interact with the stalk.	[Li, Xiao-Ping; Kahn, Jennifer Nielsen; Grela, Przemyslaw; Tumer, Nilgun E.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08901 USA; [Kahn, Peter C.] Rutgers State Univ, Dept Biochem & Microbiol, Sch Environm & Biol Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Tumer, NE (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tumer@aesop.rutgers.edu		Grela, Przemyslaw/0000-0002-5930-416X	National Institutes of Health [AI072425]; New Jersey Agriculture Experiment Station; FOGARTY INTERNATIONAL CENTER [R03TW008418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Agriculture Experiment Station; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072425 (to N. E. T.). This work was also supported by a grant from the New Jersey Agriculture Experiment Station (to P. C. K.).	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Battelli MG, 2004, MINI-REV MED CHEM, V4, P513, DOI 10.2174/1389557043403819; CAWLEY DB, 1979, BIOCHEMISTRY-US, V18, P2648, DOI 10.1021/bi00579a034; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chen XY, 1998, BIOCHEMISTRY-US, V37, P11605, DOI 10.1021/bi980990p; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Clementi N, 2010, NAT CHEM BIOL, V6, P344, DOI 10.1038/nchembio.341; Dai JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196584; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FRANKEL A, 1990, MOL CELL BIOL, V10, P6257, DOI 10.1128/MCB.10.12.6257; Frigerio L, 1998, J BIOL CHEM, V273, P14194, DOI 10.1074/jbc.273.23.14194; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; GOSS NH, 1980, BIOCHEMISTRY-US, V19, P5805, DOI 10.1021/bi00566a022; Grela P, 2010, BIOCHEMISTRY-US, V49, P924, DOI 10.1021/bi901811s; Guarinos E, 2003, MOL MICROBIOL, V50, P703, DOI 10.1046/j.1365-2958.2003.03733.x; HEDBLOM ML, 1976, ARCH BIOCHEM BIOPHYS, V177, P46, DOI 10.1016/0003-9861(76)90414-8; Honjo E, 2002, J BIOCHEM, V131, P267, DOI 10.1093/oxfordjournals.jbchem.a003098; Kahn P C, 1979, Methods Enzymol, V61, P339; KIM Y, 1992, PROTEIN ENG, V5, P775, DOI 10.1093/protein/5.8.775; Kitaoka Y, 1998, EUR J BIOCHEM, V257, P255, DOI 10.1046/j.1432-1327.1998.2570255.x; Korennykh AV, 2007, RNA, V13, P1391, DOI 10.1261/rna.619707; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; Lapadula WJ, 2012, TOXICON, V59, P427, DOI 10.1016/j.toxicon.2011.12.014; Lee K. M., 2013, NUCL ACIDS IN PRESS; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li XP, 2007, INFECT IMMUN, V75, P417, DOI 10.1128/IAI.01295-06; Li XP, 2010, J BIOL CHEM, V285, P41463, DOI 10.1074/jbc.M110.171793; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; LUGNIER AAJ, 1977, FEBS LETT, V76, P166, DOI 10.1016/0014-5793(77)80144-0; Marsden CJ, 2004, EUR J BIOCHEM, V271, P153, DOI 10.1046/j.1432-1033.2003.03914.x; May KL, 2012, FEBS J, V279, P3925, DOI 10.1111/j.1742-4658.2012.08752.x; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McCluskey AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031191; MLSNA D, 1993, PROTEIN SCI, V2, P429; MONTANARO L, 1973, BIOCHEM J, V136, P677, DOI 10.1042/bj1360677; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; Nomura N, 2012, P NATL ACAD SCI USA, V109, P3748, DOI 10.1073/pnas.1112934109; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0; Olson MA, 1997, PROTEINS, V27, P80, DOI 10.1002/(SICI)1097-0134(199701)27:1<80::AID-PROT9>3.0.CO;2-R; Olson MA, 1999, BIOPHYS J, V76, P28, DOI 10.1016/S0006-3495(99)77175-4; Pierce M, 2011, RNA, V17, P201, DOI 10.1261/rna.2375411; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; READY MP, 1991, PROTEINS, V10, P270, DOI 10.1002/prot.340100311; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; SCHLOSSMAN D, 1989, MOL CELL BIOL, V9, P5012, DOI 10.1128/MCB.9.11.5012; Shi WX, 2001, BIOCHEMISTRY-US, V40, P10800, DOI 10.1021/bi010465h; Shi XY, 2012, J MOL BIOL, V419, P125, DOI 10.1016/j.jmb.2012.03.016; SPERTI S, 1973, BIOCHEM J, V136, P813, DOI 10.1042/bj1360813; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; Suh JK, 1998, BIOCHEMISTRY-US, V37, P9394, DOI 10.1021/bi980424u; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; Tumer NE, 2012, CURR TOP MICROBIOL, V357, P1, DOI 10.1007/82_2011_174; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; WANG HC, 1988, BIOCHEMISTRY-US, V27, P625, DOI 10.1021/bi00402a020; WATANABE K, 1994, BIOSCI BIOTECH BIOCH, V58, P716, DOI 10.1271/bbb.58.716; WATANABE K, 1986, FEBS LETT, V204, P219, DOI 10.1016/0014-5793(86)80815-8; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yan Q, 2012, TRAFFIC, V13, P1508, DOI 10.1111/j.1600-0854.2012.01404.x; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905	69	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30270	30284		10.1074/jbc.M113.510966	http://dx.doi.org/10.1074/jbc.M113.510966			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003229	hybrid, Green Published			2022-12-25	WOS:000329868100025
J	ter Beek, J; Krause, N; Reimann, J; Lachmann, P; Adelroth, P				ter Beek, Josy; Krause, Nils; Reimann, Joachim; Lachmann, Peter; Adelroth, Pia			The Nitric-oxide Reductase from Paracoccus denitrificans Uses a Single Specific Proton Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Electron Transfer; Enzyme Kinetics; Membrane Biophysics; Nitric Oxide; Proton Transport; Flow-Flash; Heme-Copper Oxidase; Kinetic Isotope Effect	CYTOCHROME-C-OXIDASE; STRUCTURAL BASIS; GENERATION; MECHANISM; RESIDUES	The NO reductase from Paracoccus denitrificans reduces NO to N2O (2NO + 2H(+) + 2e(-) N2O + H2O) with electrons donated by periplasmic cytochrome c (cytochrome c-dependent NO reductase; cNOR). cNORs are members of the heme-copper oxidase superfamily of integral membrane proteins, comprising the O-2-reducing, proton-pumping respiratory enzymes. In contrast, although NO reduction is as exergonic as O-2 reduction, there are no protons pumped in cNOR, and in addition, protons needed for NO reduction are derived from the periplasmic solution (no contribution to the electrochemical gradient is made). cNOR thus only needs to transport protons from the periplasm into the active site without the requirement to control the timing of opening and closing (gating) of proton pathways as is needed in a proton pump. Based on the crystal structure of a closely related cNOR and molecular dynamics simulations, several proton transfer pathways were suggested, and in principle, these could all be functional. In this work, we show that residues in one of the suggested pathways (denoted pathway 1) are sensitive to site-directed mutation, whereas residues in the other proposed pathways (pathways 2 and 3) could be exchanged without severe effects on turnover activity with either NO or O-2. We further show that electron transfer during single-turnover reduction of O-2 is limited by proton transfer and can thus be used to study alterations in proton transfer rates. The exchange of residues along pathway 1 showed specific slowing of this proton-coupled electron transfer as well as changes in its pH dependence. Our results indicate that only pathway 1 is used to transfer protons in cNOR.	[ter Beek, Josy; Krause, Nils; Reimann, Joachim; Lachmann, Peter; Adelroth, Pia] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Adelroth, P (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	piaa@dbb.su.se	Beek, Josy ter/AAG-8291-2021	Beek, Josy ter/0000-0003-4165-9277	Faculty of Science at Stockholm University; Swedish Research Council; Carl Trygger Foundation; Stockholm University	Faculty of Science at Stockholm University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Stockholm University	This work was supported by grants from the Faculty of Science at Stockholm University and the Swedish Research Council (to P. A.).; Supported in part by a grant from the Carl Trygger Foundation and from Stockholm University.	BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Bergaust L, 2010, APPL ENVIRON MICROB, V76, P6387, DOI 10.1128/AEM.00608-10; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Chang HY, 2012, P NATL ACAD SCI USA, V109, P5259, DOI 10.1073/pnas.1107345109; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; Fujiwara T, 1996, J BACTERIOL, V178, P1866, DOI 10.1128/jb.178.7.1866-1871.1996; Gribaldo S, 2009, TRENDS BIOCHEM SCI, V34, P375, DOI 10.1016/j.tibs.2009.04.002; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; HARMS N, 1985, J BACTERIOL, V164, P1064, DOI 10.1128/JB.164.3.1064-1070.1985; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Karpefors M, 2000, BIOCHEMISTRY-US, V39, P6850, DOI 10.1021/bi992719t; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; Krishtalik LI, 2000, BBA-BIOENERGETICS, V1458, P6, DOI 10.1016/S0005-2728(00)00057-8; Lachmann P, 2010, J BIOL CHEM, V285, P25531, DOI 10.1074/jbc.M110.123984; Lee HJ, 2012, BBA-BIOENERGETICS, V1817, P537, DOI 10.1016/j.bbabio.2011.10.007; Pisliakov AV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002674; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Schurig-Briccio LA, 2013, P NATL ACAD SCI USA, V110, P12613, DOI 10.1073/pnas.1301731110; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Shiro Y, 2012, BBA-BIOENERGETICS, V1817, P1907, DOI 10.1016/j.bbabio.2012.03.001; Shiro Y, 2012, PHILOS T R SOC B, V367, P1195, DOI 10.1098/rstb.2011.0310; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856	28	19	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30626	30635		10.1074/jbc.M113.497347	http://dx.doi.org/10.1074/jbc.M113.497347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014024	Green Published, hybrid			2022-12-25	WOS:000329868100063
J	Calhoun, VD; Potluru, VK; Phlypo, R; Silva, RF; Pearlmutter, BA; Caprihan, A; Plis, SM; Adali, T				Calhoun, Vince D.; Potluru, Vamsi K.; Phlypo, Ronald; Silva, Rogers F.; Pearlmutter, Barak A.; Caprihan, Arvind; Plis, Sergey M.; Adali, Tuelay			Independent Component Analysis for Brain fMRI Does Indeed Select for Maximal Independence	PLOS ONE			English	Article							BLIND SOURCE SEPARATION; MATRIX FACTORIZATION; FUNCTIONAL MRI; ALGORITHM; SIGNAL	A recent paper by Daubechies et al. claims that two independent component analysis (ICA) algorithms, Infomax and FastICA, which are widely used for functional magnetic resonance imaging (fMRI) analysis, select for sparsity rather than independence. The argument was supported by a series of experiments on synthetic data. We show that these experiments fall short of proving this claim and that the ICA algorithms are indeed doing what they are designed to do: identify maximally independent sources.	[Calhoun, Vince D.; Potluru, Vamsi K.; Silva, Rogers F.; Caprihan, Arvind; Plis, Sergey M.] Mind Res Network, Med Image Anal Lab, Albuquerque, NM USA; [Calhoun, Vince D.; Silva, Rogers F.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Calhoun, Vince D.; Potluru, Vamsi K.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Pearlmutter, Barak A.] Natl Univ Ireland Maynooth, Hamilton Inst, Hamilton, Ireland; [Pearlmutter, Barak A.] Natl Univ Ireland Maynooth, Dept Comp Sci, Hamilton, Ireland; [Phlypo, Ronald; Adali, Tuelay] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21228 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University System of Maryland; University of Maryland Baltimore County	Calhoun, VD (corresponding author), Mind Res Network, Med Image Anal Lab, Albuquerque, NM USA.	vcalhoun@unm.edu	Pearlmutter, Barak A./AAL-8999-2020; Calhoun, Vince D./ACN-9399-2022; Pearlmutter, Barak A/M-8791-2014; Plis, Sergey/AAA-9928-2022; Silva, Rogers/R-9112-2019	Calhoun, Vince D./0000-0001-9058-0747; Pearlmutter, Barak A/0000-0003-0521-4553; Plis, Sergey/0000-0003-0040-0365; Silva, Rogers/0000-0002-7271-1288	National Institutes of Health [2R01EB000840, 5P20RR021938]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by National Institutes of Health grants 2R01EB000840 & 5P20RR021938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 1999, NEURAL COMPUT, V11, P803, DOI 10.1162/089976699300016458; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, IEEE REV BI IN PRESS; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; Du W, 2011, ICA FMRI DATA PERFOR; Hong BM, 2005, HUM BRAIN MAPP, V25, P297, DOI 10.1002/hbm.20100; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Li H, 2010, FLEXIBLE COMPLEX ICA; Li HL, 2011, IEEE T BIO-MED ENG, V58, P2794, DOI 10.1109/TBME.2011.2159841; Li XL, 2010, IEEE T CIRCUITS-I, V57, P1417, DOI 10.1109/TCSI.2010.2046207; Macchi O, 1995, SELF ADAPTIVE SOURCE, P122; Mairal J, 2010, J MACH LEARN RES, V11, P19; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Zibulevsky M, 2001, NEURAL COMPUT, V13, P863, DOI 10.1162/089976601300014385	20	61	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73309	10.1371/journal.pone.0073309	http://dx.doi.org/10.1371/journal.pone.0073309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009746	gold, Green Accepted, Green Published			2022-12-25	WOS:000323734600065
J	Ruby, NF; Fernandez, F; Garrett, A; Klima, J; Zhang, P; Sapolsky, R; Heller, HC				Ruby, Norman F.; Fernandez, Fabian; Garrett, Alex; Klima, Jessy; Zhang, Pei; Sapolsky, Robert; Heller, H. Craig			Spatial Memory and Long-Term Object Recognition Are Impaired by Circadian Arrhythmia and Restored by the GABA(A)Antagonist Pentylenetetrazole	PLOS ONE			English	Article							CONTINUOUS ALTERNATION TASK; SUPRACHIASMATIC NUCLEUS; PERIRHINAL CORTEX; SEX-DIFFERENCES; MEDIAL SEPTUM; RAT; SLEEP; MICE; HIPPOCAMPUS; RHYTHMS	Performance on many memory tests varies across the day and is severely impaired by disruptions in circadian timing. We developed a noninvasive method to permanently eliminate circadian rhythms in Siberian hamsters (Phodopussungorus) so that we could investigate the contribution of the circadian system to learning and memory in animals that are neurologically and genetically intact. Male and female adult hamsters were rendered arrhythmic by a disruptive phase shift protocol that eliminates cycling of clock genes within the suprachiasmatic nucleus (SCN), but preserves sleep architecture. These arrhythmic animals have deficits in spatial working memory and in long-term object recognition memory. In a T-maze, rhythmic control hamsters exhibited spontaneous alternation behavior late in the day and at night, but made random arm choices early in the day. By contrast, arrhythmic animals made only random arm choices at all time points. Control animals readily discriminated novel objects from familiar ones, whereas arrhythmic hamsters could not. Since the SCN is primarily a GABAergic nucleus, we hypothesized that an arrhythmic SCN could interfere with memory by increasing inhibition in hippocampal circuits. To evaluate this possibility, we administered the GABA(A) antagonist pentylenetetrazole (PTZ; 0.3 or 1.0 mg/kg/day) to arrhythmic hamsters for 10 days, which is a regimen previously shown to produce long-term improvements in hippocampal physiology and behavior in Ts65Dn (Down syndrome) mice. PTZ restored long-term object recognition and spatial working memory for at least 30 days after drug treatment without restoring circadian rhythms. PTZ did not augment memory in control (entrained) animals, but did increase their activity during the memory tests. Our findings support the hypothesis that circadian arrhythmia impairs declarative memory by increasing the relative influence of GABAergic inhibition in the hippocampus.	[Ruby, Norman F.; Garrett, Alex; Klima, Jessy; Zhang, Pei; Sapolsky, Robert; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fernandez, Fabian] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Ruby, NF (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ruby@stanford.edu		Heller, H Craig/0000-0003-4479-5880; Fernandez, Fabian-Xose/0000-0002-4288-5383	National Institute of Mental Health [MH095837]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095837] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a grant from the National Institute of Mental Health (#MH095837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Bolon B, 2010, SCIENCE, V328, P1103, DOI 10.1126/science.328.5982.1103-a; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Burke SN, 2012, HIPPOCAMPUS, V22, P2032, DOI 10.1002/hipo.22060; Burke SN, 2011, BEHAV NEUROSCI, V125, P836, DOI 10.1037/a0026238; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Castel M, 2000, J ANAT, V196, P1, DOI 10.1046/j.1469-7580.2000.19610001.x; Clark RE, 2000, J NEUROSCI, V20, P8853; Clark RE, 2005, CURR OPIN NEUROBIOL, V15, P593, DOI 10.1016/j.conb.2005.08.014; Colas D, 2013, BRIT J PHARMACOL, V169, P963, DOI 10.1111/bph.12169; Craig LA, 2008, BRAIN RES BULL, V76, P141, DOI 10.1016/j.brainresbull.2008.02.013; Czlonkowska A, 2006, ENDOCRINE, V29, P243, DOI 10.1385/ENDO:29:2:243; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Degroot A, 2010, LEARN MEMORY, V7, P293; Dember W.N., 1989, SPONTANEOUS ALTERNAT; DEMBER WN, 1958, PSYCHOL BULL, V55, P412, DOI 10.1037/h0045446; DEPRESBRUMMER P, 1995, AM J PHYSIOL-REG I, V268, pR1111, DOI 10.1152/ajpregu.1995.268.5.R1111; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Neto SPD, 2008, PHYSIOL BEHAV, V94, P523, DOI 10.1016/j.physbeh.2008.03.013; Easton A, 2013, BRAIN RES BULL, V92, P21, DOI 10.1016/j.brainresbull.2011.09.008; Easton A, 2011, HIPPOCAMPUS, V21, P1021, DOI 10.1002/hipo.20814; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Fernandez F, 2007, TRENDS NEUROSCI, V30, P497, DOI 10.1016/j.tins.2007.07.005; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Galea LAM, 1996, J EXP BIOL, V199, P195; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; Grone BP, 2011, J BIOL RHYTHM, V26, P78, DOI 10.1177/0748730410388404; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Hughes R.N., 1989, P39; IRWIN S, 1966, SCIENCE, V152, P100, DOI 10.1126/science.152.3718.100; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; JUN HW, 1976, J PHARM SCI, V65, P1038, DOI 10.1002/jps.2600650720; JUN HW, 1975, J PHARM SCI, V64, P1843, DOI 10.1002/jps.2600641120; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Keppel G., 1982, DESIGN ANAL RES HDB; Kretschmannova K, 2005, ANN NY ACAD SCI, V1048, P103, DOI 10.1196/annals.1342.010; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; Larkin JE, 2004, AM J PHYSIOL-REG I, V287, pR104, DOI 10.1152/ajpregu.00676.2003; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; MCGAUGH JL, 1973, ANNU REV PHARMACOL, V13, P229, DOI 10.1146/annurev.pa.13.040173.001305; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Mundy ME, 2013, J NEUROSCI, V33, P10490, DOI 10.1523/JNEUROSCI.2958-12.2013; Naylor E, 2000, J NEUROSCI, V20, P8138; Parent MB, 1997, NEUROBIOL LEARN MEM, V68, P75, DOI 10.1006/nlme.1997.3769; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ralph MR, 2013, CHRONOBIOL INT, V30, P540, DOI 10.3109/07420528.2012.754449; RAMZAN IM, 1985, J PHARMACOL EXP THER, V234, P624; Reijmers LGJE, 2001, PHYSIOL BEHAV, V72, P305, DOI 10.1016/S0031-9384(00)00434-0; Roland JJ, 2009, PHARMACOL BIOCHEM BE, V92, P480, DOI 10.1016/j.pbb.2009.01.022; Ruby NF, 2004, J BIOL RHYTHM, V19, P530, DOI 10.1177/0748730404268055; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; Shaw PJ, 2003, J NEUROBIOL, V54, P179, DOI 10.1002/neu.10167; Spowart-Manning L, 2004, BEHAV BRAIN RES, V151, P37, DOI 10.1016/j.bbr.2003.08.004; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Steinlechner S, 2002, J BIOL RHYTHM, V17, P248, DOI 10.1177/07430402017003008; Szyndler J, 2013, PHARMACOL REP, V65, P368, DOI 10.1016/S1734-1140(13)71012-0; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Voskuhl RR, 2002, CURRNEUROLNEUROSCI R, V2, P227; Wald C, 2010, SCIENCE, V327, P1571, DOI 10.1126/science.327.5973.1571; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Welberg L, 2006, PSYCHONEUROENDOCRINO, V31, P553, DOI 10.1016/j.psyneuen.2005.11.011; White HS, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s7.10.x; Winters BD, 2008, NEUROSCIBIOBEHAV REV, V32; WITTING W, 1995, BIOL RHYTHM RES, V26, P477, DOI 10.1080/09291019509360351; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508	81	52	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72433	10.1371/journal.pone.0072433	http://dx.doi.org/10.1371/journal.pone.0072433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009680	Green Submitted, gold, Green Published			2022-12-25	WOS:000323734600019
J	Schugar, RC; Huang, XJ; Moll, AR; Brunt, EM; Crawford, PA				Schugar, Rebecca C.; Huang, Xiaojing; Moll, Ashley R.; Brunt, Elizabeth M.; Crawford, Peter A.			Role of Choline Deficiency in the Fatty Liver Phenotype of Mice Fed a Low Protein, Very Low Carbohydrate Ketogenic Diet	PLOS ONE			English	Article							KETONE-BODY METABOLISM; INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; CONTROL MECHANISMS; ACID OXIDATION; RAT; WEIGHT; METHIONINE; DISEASE; GLUCONEOGENESIS	Though widely employed for clinical intervention in obesity, metabolic syndrome, seizure disorders and other neurodegenerative diseases, the mechanisms through which low carbohydrate ketogenic diets exert their ameliorative effects still remain to be elucidated. Rodent models have been used to identify the metabolic and physiologic alterations provoked by ketogenic diets. A commonly used rodent ketogenic diet (Bio-Serv F3666) that is very high in fat (similar to 94% kcal), very low in carbohydrate (similar to 1% kcal), low in protein (similar to 5% kcal), and choline restricted (similar to 300 mg/kg) provokes robust ketosis and weight loss in mice, but through unknown mechanisms, also causes significant hepatic steatosis, inflammation, and cellular injury. To understand the independent and synergistic roles of protein restriction and choline deficiency on the pleiotropic effects of rodent ketogenic diets, we studied four custom diets that differ only in protein (5% kcal vs. 10% kcal) and choline contents (300 mg/kg vs. 5 g/kg). C57BL/6J mice maintained on the two 5% kcal protein diets induced the most significant ketoses, which was only partially diminished by choline replacement. Choline restriction in the setting of 10% kcal protein also caused moderate ketosis and hepatic fat accumulation, which were again attenuated when choline was replete. Key effects of the 5% kcal protein diet - weight loss, hepatic fat accumulation, and mitochondrial ultrastructural disarray and bioenergetic dysfunction - were mitigated by choline repletion. These studies indicate that synergistic effects of protein restriction and choline deficiency influence integrated metabolism and hepatic pathology in mice when nutritional fat content is very high, and support the consideration of dietary choline content in ketogenic diet studies in rodents to limit hepatic mitochondrial dysfunction and fat accumulation.	[Schugar, Rebecca C.; Huang, Xiaojing; Moll, Ashley R.; Crawford, Peter A.] Washington Univ, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63130 USA; [Brunt, Elizabeth M.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Crawford, Peter A.] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), Washington Univ, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63130 USA.	pcrawford@wustl.edu	Huang, Xiaojing/GOV-3212-2022	Crawford, Peter/0000-0001-8597-4426; Huang, Xiaojing/0000-0003-0107-0783	NIH [HL007275, DK091538]; Diabetic Cardiovascular Disease Center at Washington University; David and Deborah Winston Fellowship in Diabetic Cardiovascular Disease; Diabetic Research Center [DK020579]; Nutrition and Obesity Research Center at Washington University School of Medicine [DK056341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK020579, P30DK056341, R01DK091538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetic Cardiovascular Disease Center at Washington University; David and Deborah Winston Fellowship in Diabetic Cardiovascular Disease; Diabetic Research Center; Nutrition and Obesity Research Center at Washington University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants HL007275 (a training grant that supports RCS), DK091538 (to PAC), and a grant from the Diabetic Cardiovascular Disease Center at Washington University (to PAC), the David and Deborah Winston Fellowship in Diabetic Cardiovascular Disease (to RCS), the Diabetic Research Center (DK020579), and the Nutrition and Obesity Research Center (DK056341) at Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357; Aguila M, 2003, LIVER INT, V23, P363, DOI 10.1034/j.1478-3231.2003.00858.x; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Arendt BM, 2013, APPL PHYSIOL NUTR ME, V38, P334, DOI 10.1139/apnm-2012-0261; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Browning JD, 2011, AM J CLIN NUTR, V93, P1048, DOI 10.3945/ajcn.110.007674; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DANIAL NN, 2013, J CHILD NEUROL, P70253; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; FLORES H, 1970, BRIT J NUTR, V24, P1005, DOI 10.1079/BJN19700103; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Freeman John M, 2010, Adv Pediatr, V57, P315, DOI 10.1016/j.yapd.2010.08.003; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; GOETTSCH M, 1960, J NUTR, V70, P307; Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156; Handler Philip, 1946, JOUR NUTRITION, V31, P141, DOI 10.1093/jn/31.2.141; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kirk JK, 2008, J AM DIET ASSOC, V108, P91, DOI 10.1016/j.jada.2007.10.003; KREBS HA, 1970, BIOCHEM J, V119, P525, DOI 10.1042/bj1190525; Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; MCMAHON KE, 1986, J NUTR, V116, P936, DOI 10.1093/jn/116.6.936; Oliveira CPMS, 2006, BRAZ J MED BIOL RES, V39, P189, DOI 10.1590/S0100-879X2006000200004; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011; Pickens MK, 2010, LIVER INT, V30, P1229, DOI 10.1111/j.1478-3231.2010.02285.x; Pickens MK, 2009, J LIPID RES, V50, P2072, DOI 10.1194/jlr.M900022-JLR200; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Raubenheimer PJ, 2006, DIABETES, V55, P2015, DOI 10.2337/db06-0097; Romestaing C, 2008, AM J PHYSIOL-ENDOC M, V294, pE110, DOI 10.1152/ajpendo.00407.2007; Ruskin DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065021; Sanchez-Garrido MA, 2009, INNATE IMMUN-LONDON, V15, P337, DOI 10.1177/1753425909104900; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Seyfried TN, 2011, BBA-BIOENERGETICS, V1807, P577, DOI 10.1016/j.bbabio.2010.08.009; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; SHIEMKE AK, 1995, ARCH BIOCHEM BIOPHYS, V321, P421, DOI 10.1006/abbi.1995.1413; Srivastava S, 2013, IUBMB LIFE, V65, P58, DOI 10.1002/iub.1102; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Teodoro JS, 2008, MITOCHONDRION, V8, P367, DOI 10.1016/j.mito.2008.07.008; Thio LL, 2006, PEDIATR RES, V60, P413, DOI 10.1203/01.pdr.0000238244.54610.27; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; Westman EC, 2007, AM J CLIN NUTR, V86, P276, DOI 10.1093/ajcn/86.2.276; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4617; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; Wu GS, 2012, J OBES, V2012, DOI 10.1155/2012/319172; Yang XX, 2010, J MOL NEUROSCI, V42, P145, DOI 10.1007/s12031-010-9336-y; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	65	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74806	10.1371/journal.pone.0074806	http://dx.doi.org/10.1371/journal.pone.0074806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009777	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600087
J	Lau, DH; Shipp, NJ; Kelly, DJ; Thanigaimani, S; Neo, M; Kuklik, P; Lim, HS; Zhang, Y; Drury, K; Wong, CX; Chia, NH; Brooks, AG; Dimitri, H; Saint, DA; Brown, L; Sanders, P				Lau, Dennis H.; Shipp, Nicholas J.; Kelly, Darren J.; Thanigaimani, Shivshankar; Neo, Melissa; Kuklik, Pawel; Lim, Han S.; Zhang, Yuan; Drury, Karen; Wong, Christopher X.; Chia, Nicholas H.; Brooks, Anthony G.; Dimitri, Hany; Saint, David A.; Brown, Lindsay; Sanders, Prashanthan			Atrial Arrhythmia in Ageing Spontaneously Hypertensive Rats: Unraveling the Substrate in Hypertension and Ageing	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ELECTROPHYSIOLOGIC PROPERTIES; DIASTOLIC DYSFUNCTION; HUMANS IMPLICATIONS; OVINE MODEL; FIBRILLATION; AGE; HEART; MECHANISMS; EXPRESSION	Background: Both ageing and hypertension are known risk factors for atrial fibrillation (AF) although the pathophysiological contribution or interaction of the individual factors remains poorly understood. Here we aim to delineate the arrhythmogenic atrial substrate in mature spontaneously hypertensive rats (SHR). Methods: SHR were studied at 12 and 15 months of age (n = 8 per group) together with equal numbers of age-matched normotensive Wistar-Kyoto control rats (WKY). Electrophysiologic study was performed on superfused isolated right and left atrial preparations using a custom built high-density multiple-electrode array to determine effective refractory periods (ERP), atrial conduction and atrial arrhythmia inducibility. Tissue specimens were harvested for structural analysis. Results: Compared to WKY controls, the SHR demonstrated: Higher systolic blood pressure (p<0.0001), bi-atrial enlargement (p<0.05), bi-ventricular hypertrophy (p<0.05), lower atrial ERP (p = 0.008), increased atrial conduction heterogeneity (p = 0.001) and increased atrial interstitial fibrosis (p = 0.006) & CD68-positive macrophages infiltration (p<0.0001). These changes resulted in higher atrial arrhythmia inducibility (p = 0.01) and longer induced AF episodes (p = 0.02) in 15-month old SHR. Ageing contributed to incremental bi-atrial hypertrophy (p<0.01) and atrial conduction heterogeneity (p<0.01) without affecting atrial ERP, fibrosis and arrhythmia inducibility. The limited effect of ageing on the atrial substrate may be secondary to the reduction in CD68-positive macrophages. Conclusions: Significant atrial electrical and structural remodeling is evident in the ageing spontaneously hypertensive rat atria. Concomitant hypertension appears to play a greater pathophysiological role than ageing despite their compounding effect on the atrial substrate. Inflammation is pathophysiologically linked to the pro-fibrotic changes in the hypertensive atria.	[Lau, Dennis H.; Shipp, Nicholas J.; Thanigaimani, Shivshankar; Neo, Melissa; Kuklik, Pawel; Lim, Han S.; Drury, Karen; Wong, Christopher X.; Chia, Nicholas H.; Brooks, Anthony G.; Dimitri, Hany; Saint, David A.; Sanders, Prashanthan] Univ Adelaide, CHRD, Adelaide, SA, Australia; [Lau, Dennis H.; Shipp, Nicholas J.; Thanigaimani, Shivshankar; Neo, Melissa; Kuklik, Pawel; Lim, Han S.; Drury, Karen; Wong, Christopher X.; Chia, Nicholas H.; Brooks, Anthony G.; Dimitri, Hany; Saint, David A.; Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kelly, Darren J.; Zhang, Yuan] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Brown, Lindsay] Univ So Queensland, Toowoomba, Qld 4350, Australia	University of Adelaide; Royal Adelaide Hospital; St Vincent's Hospital Melbourne; University of Melbourne; University of Southern Queensland	Sanders, P (corresponding author), Univ Adelaide, CHRD, Adelaide, SA, Australia.	prash.sanders@adelaide.edu.au	Wong, Christopher X/A-3227-2011; Lau, Dennis H/G-6234-2013; Thanigaimani, shivshankar/L-3475-2019; Kuklik, Pawel/A-8813-2011; Sanders, Prashanthan/D-7641-2013	Lau, Dennis H/0000-0001-7753-1318; Thanigaimani, shivshankar/0000-0003-0322-6147; Kuklik, Pawel/0000-0001-8440-654X; Sanders, Prashanthan/0000-0003-3803-8429; Wong, Christopher/0000-0002-1913-6675; Kelly, Darren/0000-0003-4850-3929; Neo, Melissa/0000-0001-9296-6985; Chia, Nicholas/0000-0001-7089-188X	Heart Foundation of Australia [G08A3653]; National Health and Medical Research Council of Australia; University of Adelaide; Cardiac Society of Australia and New Zealand	Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; Cardiac Society of Australia and New Zealand	This work was supported by the Heart Foundation of Australia [Grant-in-Aid G08A3653, H. D., P. K., A. G. B. & P. S.]; National Health and Medical Research Council of Australia [Postdoctoral Fellowship to D. H. L., Senior Research Fellowship to D.J.K., Postgraduate Medical Scholarship to H. S. L, H. D.]; The University of Adelaide [Peter Hetzel Electrophysiology Scholarship to S. T.]; and Cardiac Society of Australia and New Zealand [Postgraduate Medical Scholarship to H. D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyukhovsky EP, 2005, CARDIOVASC RES, V66, P353, DOI 10.1016/j.cardiores.2004.10.033; Anyukhovsky EP, 2002, CARDIOVASC RES, V54, P462, DOI 10.1016/S0008-6363(02)00271-7; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Brown Lindsay, 2002, Heart Lung Circ, V11, P167, DOI 10.1046/j.1444-2892.2002.00148.x; Chan V, 2011, J CARDIOVASC PHARM, V57, P469, DOI 10.1097/FJC.0b013e3182102c3b; Chen MC, 2008, AM J CARDIOL, V102, P861, DOI 10.1016/j.amjcard.2008.05.038; Choisy SCM, 2007, HYPERTENSION, V49, P498, DOI 10.1161/01.HYP.0000257123.95372.ab; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; Dimitri H, 2012, HEART RHYTHM, V9, P321, DOI 10.1016/j.hrthm.2011.10.017; Diness JG, 2011, HYPERTENSION, V57, P1129, DOI 10.1161/HYPERTENSIONAHA.111.170613; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Friedrichs K, 2011, TRENDS MOL MED, V17, P556, DOI 10.1016/j.molmed.2011.05.007; Garrey WE, 1914, AM J PHYSIOL, V33, P397, DOI 10.1152/ajplegacy.1914.33.3.397; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; John B, 2008, EUR HEART J, V29, P2234, DOI 10.1093/eurheartj/ehn329; John B, 2010, J AM COLL CARDIOL, V55, P1217, DOI 10.1016/j.jacc.2009.10.046; Kanagaratnam P, 2002, J AM COLL CARDIOL, V39, P116, DOI 10.1016/S0735-1097(01)01710-7; KAVANAGH KM, 1989, J ELECTROCARDIOL, V22, P221, DOI 10.1016/0022-0736(89)90032-0; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Kistler PM, 2006, EUR HEART J, V27, P3045, DOI 10.1093/eurheartj/ehl360; Kistler PM, 2004, J AM COLL CARDIOL, V44, P109, DOI 10.1016/j.jacc.2004.03.044; Kojodjojo P, 2006, J CARDIOVASC ELECTR, V17, P120, DOI 10.1111/j.1540-8167.2005.00293.x; Kume O, 2011, HEART RHYTHM, V8, P278, DOI 10.1016/j.hrthm.2010.10.029; Lader JM, 2011, AM J PHYSIOL-HEART C, V301, pH964, DOI 10.1152/ajpheart.00410.2011; LAMMERS WJEP, 1990, AM J PHYSIOL, V259, pH1254, DOI 10.1152/ajpheart.1990.259.4.H1254; Lau DH, 2011, J CARDIOVASC ELECTR, V22, P175, DOI 10.1111/j.1540-8167.2010.01851.x; Lau DH, 2011, HEART RHYTHM, V8, P575, DOI 10.1016/j.hrthm.2010.12.009; Lau DH, 2010, CLIN EXP PHARMACOL P, V37, P1023, DOI 10.1111/j.1440-1681.2010.05435.x; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Lau DH, 2010, HEART RHYTHM, V7, P396, DOI 10.1016/j.hrthm.2009.11.031; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Lloberas J, 2002, EXP GERONTOL, V37, P1325, DOI 10.1016/S0531-5565(02)00125-0; Matsuyama N, 2009, HYPERTENS RES, V32, P721, DOI 10.1038/hr.2009.89; Medi C, 2011, J CARDIOVASC ELECTR, V22, P1317, DOI 10.1111/j.1540-8167.2011.02125.x; MICHELUCCI A, 1984, INT J CARDIOL, V5, P75, DOI 10.1016/0167-5273(84)90060-3; Nabauer M, 2009, EUROPACE, V11, P423, DOI 10.1093/europace/eun369; PFEFFER JM, 1979, AM J PHYSIOL, V237, pH461; Roberts-Thomson KC, 2009, HEART RHYTHM, V6, P1000, DOI 10.1016/j.hrthm.2009.03.050; Roberts-Thomson KC, 2009, HEART RHYTHM, V6, P587, DOI 10.1016/j.hrthm.2009.02.023; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Sakabe K, 2003, PACE, V26, P1238, DOI 10.1046/j.1460-9592.2003.t01-1-00174.x; Sanders P, 2004, CIRCULATION, V109, P1514, DOI 10.1161/01.CIR.0000121734.47409.AA; Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Stiles MK, 2009, J AM COLL CARDIOL, V53, P1182, DOI 10.1016/j.jacc.2008.11.054; Verheule S, 2003, CIRCULATION, V107, P2615, DOI 10.1161/01.CIR.0000066915.15187.51; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wongcharoen W, 2007, J CARDIOVASC ELECTR, V18, P526, DOI 10.1111/j.1540-8167.2007.00781.x; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644	52	63	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72416	10.1371/journal.pone.0072416	http://dx.doi.org/10.1371/journal.pone.0072416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013508	Green Accepted, Green Published, gold			2022-12-25	WOS:000323815200041
J	Mercado, CP; Byrum, S; Beggs, ML; Ziu, E; Singh, P; Raj, VR; Haun, RS; Kilic, F				Mercado, Charles P.; Byrum, Stephanie; Beggs, Marjorie L.; Ziu, Endrit; Singh, Preeti; Raj, Vinay R.; Haun, Randy S.; Kilic, Fusun			Impact of Elevated Plasma Serotonin on Global Gene Expression of Murine Megakaryocytes	PLOS ONE			English	Article							ALPHA-GRANULE SECRETION; CALDAG-GEFI; PLATELETS; TRANSPORTER; RECEPTOR; INHIBITION; MECHANISMS; THROMBOSIS; RELEASE; PATHWAY	Background: Serotonin (5-HT) is a biogenic amine that also acts as a mitogen and a developmental signal early in rodent embryogenesis. Genetic and pharmacological disruption of 5-HT signaling causes various diseases and disorders via mediating central nervous system, cardiovascular system, and serious abnormalities on a growing embryo. Today, neither the effective modulators on 5-HT signaling pathways nor the genes affected by 5-HT signal are well known yet. Methodology/Principal Findings: In an attempt to identify the genes altered by 5-HT signaling pathways, we analyzed the global gene expression via the Illumina array platform using the mouse WG-6 v2.0 Expression BeadChip containing 45,281 probe sets representing 30,854 genes in megakaryocytes isolated from mice infused with 5-HT or saline. We identified 723 differentially expressed genes of which 706 were induced and 17 were repressed by elevated plasma 5-HT. Conclusions/Significance: Hierarchical gene clustering analysis was utilized to represent relations between groups and clusters. Using gene ontology mining tools and canonical pathway analyses, we identified multiple biological pathways that are regulated by 5-HT: (i) cytoskeletal remodeling, (ii) G-protein signaling, (iii) vesicular transport, and (iv) apoptosis and survival. Our data encompass the first extensive genome-wide based profiling in the progenitors of platelets in response to 5-HT elevation in vivo.	[Mercado, Charles P.; Byrum, Stephanie; Ziu, Endrit; Singh, Preeti; Kilic, Fusun] Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA; [Beggs, Marjorie L.; Raj, Vinay R.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Beggs, Marjorie L.; Raj, Vinay R.] Univ Arkansas Med Sci, Coll Med, Pharmacogen Core, Little Rock, AR 72205 USA; [Haun, Randy S.] Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kilic, F (corresponding author), Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA.	kilicfusun@uams.edu			National Institutes of Health (NIH) [F32GM093614]; VA Merit Award [BX000828]; NIH from the National Center for Research Resources [UL1RR029884]; American Heart Association (AHA) [0660032Z]; NIH [HD058697, HD053477, HL091196, HL091196-01A2W1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053477, R03HD058697] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093614] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health (NIH) F32GM093614 to S.B., VA Merit Award BX000828 to R. S. H., NIH UL1RR029884 from the National Center for Research Resources and American Heart Association (AHA) 0660032Z and NIH HD058697, HD053477, HL091196 and HL091196-01A2W1 to F. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Catricala S, 2011, THROMB RES, V127, P171, DOI 10.1016/j.thromres.2010.08.004; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; FUJIMOTO T, 1993, BLOOD, V82, P1758; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Gordge MP, 2005, BRIT J PHARMACOL, V145, P271, DOI 10.1038/sj.bjp.0706202; HOLMSEN H, 1989, METHOD ENZYMOL, V169, P205; Jones BJ, 2002, PHARMACOL BIOCHEM BE, V71, P555, DOI 10.1016/S0091-3057(01)00745-6; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LAUDER JM, 1988, DEVELOPMENT, V102, P709; LIU JP, 1992, J NEUROSCI RES, V33, P248, DOI 10.1002/jnr.490330208; McGeer P L, 1973, Prog Neurobiol, V2, P69, DOI 10.1016/0301-0082(73)90007-5; Mercado CP, 2011, CURR OPIN PHARMACOL, V11, P23, DOI 10.1016/j.coph.2011.01.006; Mercado CP, 2010, MOL INTERV, V10, P231, DOI 10.1124/mi.10.4.6; Neurauter AA, 2007, ADV BIOCHEM ENG BIOT, V106, P41, DOI 10.1007/10_2007_072; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; PIETRASZEK MH, 1992, THROMB RES, V66, P765, DOI 10.1016/0049-3848(92)90052-C; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Reed G. L, 2006, PLATELETS, P309; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shikama Y, 1990, Fukushima J Med Sci, V36, P59; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Stolla M, 2011, BLOOD, V118, P1113, DOI 10.1182/blood-2011-03-342352; TANAKA H, 1989, BRIT J HAEMATOL, V73, P18, DOI 10.1111/j.1365-2141.1989.tb00212.x; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Tolhurst G, 2012, METHODS MOL BIOL, V788, P259, DOI 10.1007/978-1-61779-307-3_18; VANDENBERG EK, 1989, CIRCULATION, V79, P116, DOI 10.1161/01.CIR.79.1.116; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; White MJ, 2012, BLOOD, V119, P4283, DOI 10.1182/blood-2011-11-394858; Woronowicz K, 2010, BIOCHEMISTRY-US, V49, P4533, DOI 10.1021/bi100541t; Yang M, 1996, BLOOD COAGUL FIBRIN, V7, P127, DOI 10.1097/00001721-199603000-00004; Ziu E, 2012, J MOL CELL CARDIOL, V52, P1112, DOI 10.1016/j.yjmcc.2012.02.004	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72580	10.1371/journal.pone.0072580	http://dx.doi.org/10.1371/journal.pone.0072580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013211	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200049
J	Yan, GL; Wang, QJ; Shi, H; Han, YS; Ma, GS; Tang, CC; Gu, YC				Yan, Gaoliang; Wang, Qingjie; Shi, Hui; Han, Yeshan; Ma, Genshan; Tang, Chengchun; Gu, Yuchun			Regulation of Rat Intrapulmonary Arterial Tone by Arachidonic Acid and Prostaglandin E2 during Hypoxia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN PULMONARY-ARTERY; PROSTANOID RECEPTORS; VASOCONSTRICTION; CHANNELS; HYPERTENSION; LUNG; CYCLOOXYGENASE-2; SENSITIZATION; INHIBITION	Aims: Arachidonic acid (AA) and its metabolites, prostaglandins (PG) are known to be involved in regulation of vascular homeostasis including vascular tone and vessel wall tension, but their potential role in Hypoxic pulmonary vasoconstriction (HPV) remains unclear. In this study, we examined the effects of AA and PGE2 on the hypoxic response in isolated rat intrapulmonary arteries (IPAs). Methods and Results: We carried out the investigation on IPAs by vessel tension measurement. Isotetrandrine (20 mu M) significantly inhibited phase I, phase IIb and phase IIc of hypoxic vasoconstriction. Both indomethacin (100 mu M) and NS398 attenuated KPSS-induced vessel contraction and phase I, phase IIb and phase IIc of HPV, implying that COX-2 plays a primary role in the hypoxic response of rat IPAs. PGE2 alone caused a significant vasoconstriction in isolated rat IPAs. This constriction is mediated by EP4. Blockage of EP4 by L-161982 (1 mu M) significantly inhibited phase I, phase IIb and phase IIc of hypoxic vasoconstriction. However, AH6809 (3 mu M), an antagonist of EP1, EP2, EP3 and DP1 receptors, exerted no effect on KPSS or hypoxia induced vessel contraction. Increase of cellular cAMP by forskolin could significantly reduce KPSS-induced vessel contraction and abolish phase I, phase IIb and phase II c of HPV. Conclusion: Our results demonstrated a vasoconstrictive effect of PGE2 on rat IPAs and this effect is via activation of EP4. Furthermore, our results suggest that intracellular cAMP plays dual roles in regulation of vascular tone, depending on the spatial distribution of cAMP and its coupling with EP receptor and Ca2+ channels.	[Yan, Gaoliang; Wang, Qingjie; Ma, Genshan; Tang, Chengchun] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Han, Yeshan] Changzhou Peoples Hosp, Dept Anaesthesiol, Changzhou, Peoples R China; [Yan, Gaoliang; Wang, Qingjie; Shi, Hui; Gu, Yuchun] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Southeast University - China; Peking University	Tang, CC (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	tangchengchun@medmail.com.cn; ycgu@pku.edu.cn	Wang, Qingjie/GRJ-3168-2022	gu, yuchun/0000-0002-7558-0447	Natural Science Foundation of China [81170105, H0214]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants to CT from the Natural Science Foundation of China (research Grant #81170105) and grants to YCG from the Natural Science Foundation of China (research Grant #H0214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson PI, 2002, RESP PHYSIOL NEUROBI, V132, P107, DOI 10.1016/S1569-9048(02)00053-8; Becker S, 2007, AM J PHYSIOL-LUNG C, V293, pL982, DOI 10.1152/ajplung.00361.2006; Beech DJ, 2005, CLIN EXP PHARMACOL P, V32, P597, DOI 10.1111/j.1440-1681.2005.04251.x; Benza RL, 2011, J HEART LUNG TRANSPL, V30, P1327, DOI 10.1016/j.healun.2011.08.019; Bradbury DA, 2004, FEBS LETT, V560, P30, DOI 10.1016/S0014-5793(04)00064-X; Bradbury DA, 2002, AM J PHYSIOL-LUNG C, V283, pL717, DOI 10.1152/ajplung.00070.2002; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Foudi N, 2008, BRIT J PHARMACOL, V154, P1631, DOI 10.1038/bjp.2008.214; Frazziano G, 2011, J CELL PHYSIOL, V226, P2633, DOI 10.1002/jcp.22611; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; Grimm C, 2005, MOL PHARMACOL, V67, P798, DOI 10.1124/mol.104.006734; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Ichinose F, 2002, J CLIN INVEST, V109, P1493, DOI 10.1172/JCI200214294; Jakoubek V, 2006, PLACENTA, V27, P1030, DOI 10.1016/j.placenta.2005.10.006; Li XQ, 2009, PFLUG ARCH EUR J PHY, V457, P771, DOI 10.1007/s00424-008-0556-8; Madden JA, 2012, J APPL PHYSIOL, V112, P411, DOI 10.1152/japplphysiol.01049.2011; Meng F, 2008, RESP PHYSIOL NEUROBI, V162, P18, DOI 10.1016/j.resp.2008.03.007; Miniati DN, 2000, J CARDIAC SURG, V15, P129; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Norel X, 2004, PROSTAG OTH LIPID M, V74, P101, DOI 10.1016/j.prostaglandins.2004.07.003; Norel X, 2007, THESCIENTIFICWORLDJO, V7, P1359, DOI 10.1100/tsw.2007.184; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Oudiz RJ, 2009, AM HEART J, V157, P625, DOI 10.1016/j.ahj.2008.10.029; Ramos-Alves FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050593; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Robertson TP, 2007, J APPL PHYSIOL, V102, P2071, DOI 10.1152/japplphysiol.01258.2006; Robertson TP, 2000, J PHYSIOL-LONDON, V525, P669, DOI 10.1111/j.1469-7793.2000.t01-1-00669.x; Robertson TP, 2003, AM J PHYSIOL-LUNG C, V284, pL1121, DOI 10.1152/ajplung.00422.2002; Safdar Z, 2009, RESP MED, V103, P1688, DOI 10.1016/j.rmed.2009.05.009; Snetkov VA, 2006, J PHYSIOL-LONDON, V571, P147, DOI 10.1113/jphysiol.2005.101394; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Walch L, 1999, BRIT J PHARMACOL, V126, P859, DOI 10.1038/sj.bjp.0702393; Wang J, 2007, AM J PHYSIOL-LUNG C, V293, pL674, DOI 10.1152/ajplung.00141.2007; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Weigand L, 2011, AM J PHYSIOL-LUNG C, V301, pL380, DOI 10.1152/ajplung.00068.2011; Weir EK, 2006, CARDIOVASC RES, V71, P630, DOI 10.1016/j.cardiores.2006.04.014; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Yang SN, 2001, FASEB J, V15, P1753, DOI 10.1096/fj.00-0799com	39	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73839	10.1371/journal.pone.0073839	http://dx.doi.org/10.1371/journal.pone.0073839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013220	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200091
J	Li, DL; Huang, B; Liu, JD; Li, L; Li, XG				Li, Dongliang; Huang, Bin; Liu, Jiangdong; Li, Liang; Li, Xingang			Decreased Brain K-ATP Channel Contributes to Exacerbating Ischemic Brain Injury and the Failure of Neuroprotection by Sevoflurane Post-Conditioning in Diabetic Rats	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; PANCREATIC BETA-CELLS; POTASSIUM CHANNEL; HEART-MITOCHONDRIA; FATTY RATS; IN-VIVO; EXPRESSION; HYPERGLYCEMIA; STROKE; SUBUNIT	Diabetes leads to exacerbating brain injury after ischemic stroke, but the underlying mechanisms and whether therapeutic intervention with anesthetic post-conditioning can induce neuroprotection in this population are not known. We tested the hypothesis that alteration of brain mitochondrial (mito) K-ATP channels might cause exacerbating brain injury after ischemic stroke and attenuate anesthetic post-conditioning induced neuroprotection in diabetes. We also examined whether hyperglycemic correction with insulin would restore anesthetic post-conditioning in diabetes. Non-diabetic rats and diabetic rats treated with or without insulin were subjected to focal cerebral ischemia for 2 h followed by 24 h of reperfusion. Post-conditioning was performed by exposure to sevoflurane for 15 min, immediately at the onset of reperfusion. The role of the mitoK(ATP) channel was assessed by administration of a selective blocker 5-hydroxydecanoate (5-HD) before sevoflurane post-conditioning or by diazoxide (DZX), a mitoK(ATP) channel opener, given in place of sevoflurane. Compared with non-diabetic rats, diabetic rats had larger infarct volume and worse neurological outcome at 24 h after ischemia. Sevoflurane or DZX reduced the infarct volume and improved neurological outcome in non-diabetic rats but not in diabetic rats, and the protective effects of sevoflurane in nondiabetic rats were inhibited by pretreatment with 5-HD. Molecular studies revealed that expression of Kir6.2, an important mitoK(ATP) channel component, was decreased in the brain of diabetic rats as compared to non-diabetic rats. In contrast, hyperglycemic correction with insulin in diabetic rats normalized expression of brain Kir6.2, reduced ischemic brain damage and restored neuroprotective effects of sevoflurane post-conditioning. Our findings suggest that decreased brain mitoK(ATP) channel contributes to exacerbating ischemic brain injury and the failure of neuroprotection by anesthetic post-conditioning in diabetes. Insulin glycemic control in diabetes may restore the neuroprotective effects of anesthetic post-conditioning by modulation of brain mitoK(ATP) channel.	[Li, Dongliang; Li, Liang] Shandong Univ, Dept Anesthesiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Huang, Bin; Li, Xingang] Shandong Univ, Dept Neurosurg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Huang, Bin; Li, Xingang] Shandong Univ, Brain Sci Res Inst, Jinan 250100, Shandong, Peoples R China; [Liu, Jiangdong] Peoples Hosp Gaomi, Dept Anesthesiol, Gaomi City, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, XG (corresponding author), Shandong Univ, Dept Neurosurg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	lixg-sdu@hotmail.com	Huang, Bin/AAT-4514-2021		National Natural Science Foundation of China [81072062, 81172404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Natural Science Foundation of China (Grant No. 81072062 and 81172404 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1801, DOI 10.1152/ajpendo.00700.2006; Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Arrick DM, 2012, J APPL PHYSIOL, V113, P1121, DOI 10.1152/japplphysiol.00437.2012; Arrick DM, 2011, AM J PHYSIOL-HEART C, V301, pH696, DOI 10.1152/ajpheart.00312.2011; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Baird TA, 2002, J CLIN NEUROSCI, V9, P618, DOI 10.1054/jocn.2002.1081; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BOMONT L, 1995, NEUROSCI LETT, V197, P53, DOI 10.1016/0304-3940(95)11899-8; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; CHUKWUMA C, 1993, J DIABETES COMPLICAT, V7, P250, DOI 10.1016/0891-6632(93)90009-6; Costa ADT, 2006, AM J PHYSIOL-HEART C, V290, pH406, DOI 10.1152/ajpheart.00794.2005; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Drenger B, 2011, ANESTHESIOLOGY, V114, P1364, DOI 10.1097/ALN.0b013e31820efafd; Gyte A, 2007, J NEUROENDOCRINOL, V19, P941, DOI 10.1111/j.1365-2826.2007.01607.x; Hassouna A, 2006, CARDIOVASC RES, V69, P450, DOI 10.1016/j.cardiores.2005.11.004; Havel PJ, 2000, DIABETES, V49, P244, DOI 10.2337/diabetes.49.2.244; JORGENSEN HS, 1994, LANCET, V344, P156; Katakam PVG, 2007, AM J PHYSIOL-REG I, V292, pR920, DOI 10.1152/ajpregu.00520.2006; Kersten JR, 2001, AM J PHYSIOL-HEART C, V280, pH1744, DOI 10.1152/ajpheart.2001.280.4.H1744; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li L, 2004, ENDOCRINOLOGY, V145, P4408, DOI 10.1210/en.2004-0285; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Matsumoto S, 2009, CARDIOVASC DRUG THER, V23, P263, DOI 10.1007/s10557-009-6184-5; Mayhan WG, 2011, AM J PHYSIOL-HEART C, V300, pH1013, DOI 10.1152/ajpheart.00873.2010; Miki T, 1999, J MOL ENDOCRINOL, V22, P113, DOI 10.1677/jme.0.0220113; Mizoguchi K, 2002, PHARMACOL BIOCHEM BE, V71, P79, DOI 10.1016/S0091-3057(01)00636-0; Moritz W, 2001, ENDOCRINOLOGY, V142, P129, DOI 10.1210/en.142.1.129; Obal D, 2005, ANESTH ANALG, V101, P1252, DOI 10.1213/01.ANE.0000181336.96511.32; Ploug KB, 2010, EUR J PHARMACOL, V637, P109, DOI 10.1016/j.ejphar.2010.03.027; Quindry JC, 2010, AM J PHYSIOL-HEART C, V299, pH175, DOI 10.1152/ajpheart.01211.2009; Raphael J, 2010, J CARDIOVASC PHARM, V55, P348, DOI 10.1097/FJC.0b013e3181d26583; Riess ML, 2004, AM J PHYSIOL-HEART C, V286, pH1603, DOI 10.1152/ajpheart.00963.2003; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Smith AJ, 2006, BIOCHEM BIOPH RES CO, V348, P1123, DOI 10.1016/j.bbrc.2006.07.170; STEGMAYR B, 1995, DIABETOLOGIA, V38, P1061, DOI 10.1007/BF00402176; Sun HS, 2007, NEUROSCIENCE, V144, P1509, DOI 10.1016/j.neuroscience.2006.10.043; Tokuyama Y, 1996, BIOCHEM BIOPH RES CO, V220, P532, DOI 10.1006/bbrc.1996.0439; Vinokur V, 2007, REDOX REP, V12, P246, DOI 10.1179/135100007X239289; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	41	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73334	10.1371/journal.pone.0073334	http://dx.doi.org/10.1371/journal.pone.0073334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991188	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800100
J	Schinasi, L; Wing, S; MacDonald, PDM; Richardson, DB; Stewart, JR; Augustino, KL; Nobles, DL; Ramsey, KM				Schinasi, Leah; Wing, Steve; MacDonald, Pia D. M.; Richardson, David B.; Stewart, Jill R.; Augustino, Kerri L.; Nobles, Delores L.; Ramsey, Keith M.			Medical and Household Characteristics Associated with Methicillin Resistant Staphylococcus aureus Nasal Carriage among Patients Admitted to a Rural Tertiary Care Hospital	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; RAPID DETECTION; UNITED-STATES; MRSA ASSAY; ACTIVE SURVEILLANCE; CHROMAGAR MRSA; PCR ASSAY; COLONIZATION; TRANSMISSION; RISK	Background: Methicillin resistant Staphylococcus aureus (MRSA) poses a threat to patient safety and public health. Understanding how MRSA is acquired is important for prevention efforts. This study investigates risk factors for MRSA nasal carriage among patients at an eastern North Carolina hospital in 2011. Methods: Using a case-control design, hospitalized patients ages 18 - 65 years were enrolled between July 25, 2011 and December 15, 2011 at Vidant Medical Center, a tertiary care hospital that screens all admitted patients for nasal MRSA carriage. Cases, defined as MRSA nasal carriers, were age and gender matched to controls, non-MRSA carriers. In-hospital interviews were conducted, and medical records were reviewed to obtain information on medical and household exposures. Multivariable conditional logistic regression was used to derive odds ratio (OR) estimates of association between MRSA carriage and medical and household exposures. Results: In total, 117 cases and 119 controls were recruited to participate. Risk factors for MRSA carriage included having household members who took antibiotics or were hospitalized (OR: 3.27; 95% Confidence Interval (CI): 1.24-8.57) and prior hospitalization with a positive MRSA screen (OR: 3.21; 95% CI: 1.12-9.23). A lower proportion of cases than controls were previously hospitalized without a past positive MRSA screen (OR: 0.40; 95% CI: 0.19-0.87). Conclusion: These findings suggest that household exposures are important determinants of MRSA nasal carriage in hospitalized patients screened at admission.	[Schinasi, Leah; Wing, Steve; MacDonald, Pia D. M.; Richardson, David B.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [MacDonald, Pia D. M.] Social & Sci Syst Inc, Durham, NC USA; [Stewart, Jill R.] Univ NC Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Augustino, Kerri L.; Nobles, Delores L.; Ramsey, Keith M.] Vidant Med Ctr, Dept Infect Control, Greenville, NC USA; [Augustino, Kerri L.; Nobles, Delores L.; Ramsey, Keith M.] E Carolina Univ, Brody Sch Med, Div Infect Dis, Greenville, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Social & Scientific Systems; University of North Carolina; East Carolina University	Schinasi, L (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	schinasi@email.unc.edu		MacDonald, Pia/0000-0003-1340-8905	National Center for Research Resources [UL1RR025747]; NC Occupational Safety and Health Education Research Center [5-52665]; H. Michael and Barbara Arrighi Endowed Scholarship Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NC Occupational Safety and Health Education Research Center; H. Michael and Barbara Arrighi Endowed Scholarship Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources (grant number UL1RR025747), the NC Occupational Safety and Health Education Research Center (5-52665), and the H. Michael and Barbara Arrighi Endowed Scholarship Fund. The content is the sole responsibility of the authors and does not represent the official views of the National Center for Research Resources, the National Institutes of Health, or the National Institutes for Occupational Safety and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2007, J CLIN MICROBIOL, V45, P1798, DOI 10.1128/JCM.01747-06; Boyce JM, 2008, J CLIN MICROBIOL, V46, P350, DOI 10.1128/JCM.02130-07; Casey JA, 2013, EPIDEMIOL INFECT, V141, P1166, DOI 10.1017/S0950268812001872; Cohen PR, 2008, CLIN DERMATOL, V26, P16, DOI 10.1016/j.clindermatol.2007.10.006; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Farley JE, 2008, J CLIN MICROBIOL, V46, P743, DOI 10.1128/JCM.02071-07; Ferreira JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026978; French GL, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.03092.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Grisold AJ, 2010, DIAGN MICR INFEC DIS, V66, P217, DOI 10.1016/j.diagmicrobio.2009.09.006; Gupta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053674; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hidron AI, 2005, CLIN INFECT DIS, V41, P159, DOI 10.1086/430910; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lautenbach E, 2010, EPIDEMIOL INFECT, V138, P683, DOI 10.1017/S0950268810000099; Lucke K, 2010, J CLIN MICROBIOL, V48, P981, DOI 10.1128/JCM.01990-09; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Mongkolrattanothai K, 2011, J MED MICROBIOL, V60, P317, DOI 10.1099/jmm.0.025841-0; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Peterson AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038354; Pofahl WE, 2009, J AM COLL SURGEONS, V208, P981, DOI 10.1016/j.jamcollsurg.2008.12.025; Popovich KJ, 2012, CLIN INFECT DIS, V54, P1296, DOI 10.1093/cid/cis030; Rossney AS, 2007, EUR J CLIN MICROBIOL, V26, P459, DOI 10.1007/s10096-007-0303-7; Sarda V, 2009, INFECT CONT HOSP EP, V30, P854, DOI 10.1086/605321; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Statistical Analysis Software, 2012, MAPS ONL ZIPC DAT; Stenhem M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-30; Tenover FC, 2009, J CLIN MICROBIOL, V47, P2452, DOI 10.1128/JCM.00476-09; The North Carolina Rural Center, 2012, RUR DAT BANK CUST DA; Uhlemann AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022407; Van Heirstraeten L, 2009, J CLIN MICROBIOL, V47, P3326, DOI 10.1128/JCM.01088-09; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73595	10.1371/journal.pone.0073595	http://dx.doi.org/10.1371/journal.pone.0073595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991200	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800107
J	Vilas-Boas, V; Silva, R; Palmeira, A; Sousa, E; Ferreira, LM; Branco, PS; Carvalho, F; Bastos, MD; Remiao, F				Vilas-Boas, Vania; Silva, Renata; Palmeira, Andreia; Sousa, Emilia; Ferreira, Luisa Maria; Branco, Paula Serio; Carvalho, Felix; Bastos, Maria de Lourdes; Remiao, Fernando			Development of Novel Rifampicin-Derived P-Glycoprotein Activators/Inducers. Synthesis, In Silico Analysis and Application in the RBE4 Cell Model, Using Paraquat as Substrate	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RESISTANCE PROTEIN; CYCLOSPORINE-A; EXPRESSION; INDUCTION; SITES; TRANSPORT; MICE; PERMEABILITY; PENETRATION	P-glycoprotein (P-gp) is a 170 kDa transmembrane protein involved in the outward transport of many structurally unrelated substrates. P-gp activation/induction may function as an antidotal pathway to prevent the cytotoxicity of these substrates. In the present study we aimed at testing rifampicin (Rif) and three newly synthesized Rif derivatives (a mono-methoxylated derivative, MeORif, a peracetylated derivative, PerAcRif, and a reduced derivative, RedRif) to establish their ability to modulate P-gp expression and activity in a cellular model of the rat's blood-brain barrier, the RBE4 cell line P-gp expression was assessed by western blot using C219 anti-P-gp antibody. P-gp function was evaluated by flow cytometry measuring the accumulation of rhodamine123. Whenever P-gp activation/induction ability was detected in a tested compound, its antidotal effect was further tested using paraquat as cytotoxicity model. Interactions between Rif or its derivatives and P-gp were also investigated by computational analysis. Rif led to a significant increase in P-gp expression at 72 h and RedRif significantly increased both P-gp expression and activity. No significant differences were observed for the other derivatives. Pre-or simultaneous treatment with RedRif protected cells against paraquat-induced cytotoxicity, an effect reverted by GF120918, a P-gp inhibitor, corroborating the observed P-gp activation ability. Interaction of RedRif with P-gp drug-binding pocket was consistent with an activation mechanism of action, which was confirmed with docking studies. Therefore, RedRif protection against paraquat-induced cytotoxicity in RBE4 cells, through P-gp activation/induction, suggests that it may be useful as an antidote for cytotoxic substrates of P-gp.	[Vilas-Boas, Vania; Silva, Renata; Carvalho, Felix; Bastos, Maria de Lourdes; Remiao, Fernando] Univ Porto, Fac Farm, Dept Ciencias Biol, Toxicol Lab,REQUIMTE, P-4100 Porto, Portugal; [Palmeira, Andreia; Sousa, Emilia] Univ Porto, Fac Farm, Dept Quim, Lab Quim Organ & Farmaceut, P-4100 Porto, Portugal; [Palmeira, Andreia; Sousa, Emilia] Univ Porto, Ctr Quim Med CEQUIMED UP, P-4100 Porto, Portugal; [Ferreira, Luisa Maria; Branco, Paula Serio] Univ Nova Lisboa, FCT, REQUIMTE, Dept Quim, Caparica, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade Nova de Lisboa	Vilas-Boas, V (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, Toxicol Lab,REQUIMTE, Rua Campo Alegre 823, P-4100 Porto, Portugal.	vvilasboas@ff.up.pt; remiao@ff.up.pt	Remião, Fernando/D-8646-2013; Silva, Renata/I-7439-2015; Branco, Paula/I-6567-2012; de Lourdes Bastos, Maria/D-8588-2013; Vilas-Boas, Vânia/J-6474-2015; Carvalho, Félix/D-4914-2013; Sousa, Maria/HCI-9642-2022; Ferreira, Luísa Maria/I-7086-2012; Sousa, Emília/L-1126-2014	Remião, Fernando/0000-0003-1382-5119; Silva, Renata/0000-0001-9962-7548; Branco, Paula/0000-0002-7312-8596; de Lourdes Bastos, Maria/0000-0001-9895-503X; Vilas-Boas, Vânia/0000-0002-4798-2158; Carvalho, Félix/0000-0003-3858-3494; Ferreira, Luísa Maria/0000-0001-8474-3925; Sousa, Emília/0000-0002-5397-4672; Palmeira, Andreia/0000-0002-1391-2143	Fundacao para a Ciencia e Tecnologia (FCT) - QREN initiative [PTDC/SAU-OSM/101437/2008]; EU/FEDER through COMPETE - Operational Programme for Competitiveness Factors; FCT [Pest C/EQB/LA0006/2011, Pest-OE/SAU/UI4040/2011, SFRH/BD/82556/2011, SFRH/BD/29559/2006]	Fundacao para a Ciencia e Tecnologia (FCT) - QREN initiative; EU/FEDER through COMPETE - Operational Programme for Competitiveness Factors; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT) - project PTDC/SAU-OSM/101437/2008 - QREN initiative with EU/FEDER financing through COMPETE - Operational Programme for Competitiveness Factors. The authors are grateful to FCT for grants no. Pest C/EQB/LA0006/2011 and Pest-OE/SAU/UI4040/2011. Vania Vilas-Boas and Renata Silva acknowledge FCT for their PhD grants SFRH/BD/82556/2011 and SFRH/BD/29559/2006, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DJ, 1995, INVEST NEW DRUG, V13, P13, DOI 10.1007/BF02614215; Ansbro MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060334; Bachmeier CJ, 2011, BIOPHARM DRUG DISPOS, V32, P233, DOI 10.1002/bdd.753; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Daoud R, 2000, BIOCHEMISTRY-US, V39, P15344, DOI 10.1021/bi0020574; de Vries NA, 2012, INVEST NEW DRUG, V30, P443, DOI 10.1007/s10637-010-9569-1; Dinis-Oliveira RJ, 2006, FREE RADICAL BIO MED, V41, P1213, DOI 10.1016/j.freeradbiomed.2006.06.012; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Henmi K, 2008, BIOL PHARM BULL, V31, P873, DOI 10.1248/bpb.31.873; Hirayama C, 2008, PHARM RES, V25, P827, DOI 10.1007/s11095-007-9376-3; Hung CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059419; Hung CC, 2011, INVEST NEW DRUG, V29, P1337, DOI 10.1007/s10637-010-9496-1; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; LORIAN V, 1969, APPL MICROBIOL, V17, P202, DOI 10.1128/AEM.17.2.202-207.1969; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnarin M, 2004, EUR J PHARMACOL, V483, P19, DOI 10.1016/j.ejphar.2003.10.010; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Martin P, 2010, ACTA PHARMACOL SIN, V31, P51, DOI 10.1038/aps.2009.187; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meena AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061524; MILLER TP, 1991, J CLIN ONCOL, V9, P17, DOI 10.1200/JCO.1991.9.1.17; MOORE JA, 1973, ORG SYN COLL, V5, P351; Owen A, 2006, BRIT J CLIN PHARMACO, V62, P237, DOI 10.1111/j.1365-2125.2006.02587.x; Palmeira A, 2012, BIOCHEM PHARMACOL, V83, P57, DOI 10.1016/j.bcp.2011.10.004; Palmeira A, 2011, CHEM BIOL DRUG DES, V78, P57, DOI 10.1111/j.1747-0285.2011.01089.x; Pyta K, 2012, ORG BIOMOL CHEM, V10, P2385, DOI 10.1039/c2ob00008c; Qadir M, 2005, CLIN CANCER RES, V11, P2320, DOI 10.1158/1078-0432.CCR-04-1725; REES RJW, 1970, BRIT MED J, V1, P89, DOI 10.1136/bmj.1.5688.89; Regina A, 1998, J NEUROCHEM, V71, P705; Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Safa Ahmad R., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P1, DOI 10.2174/1568011043482142; SAFA AR, 1993, CANCER INVEST, V11, P46, DOI 10.3109/07357909309020260; Safa AR, 1998, METHOD ENZYMOL, V292, P289; Salje K, 2012, BASIC CLIN PHARMACOL, V111, P99, DOI 10.1111/j.1742-7843.2012.00866.x; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1997, BIOCHEM PHARMACOL, V53, P587, DOI 10.1016/S0006-2952(96)00826-X; Silva R, 2013, TOXICOL LETT, V217, P34, DOI 10.1016/j.toxlet.2012.11.028; Silva R, 2011, ARCH TOXICOL, V85, P315, DOI 10.1007/s00204-010-0587-8; SLATER LM, 1986, J CLIN INVEST, V77, P1405, DOI 10.1172/JCI112450; Sterz K, 2009, CHEMMEDCHEM, V4, P1897, DOI 10.1002/cmdc.200900283; Storch CH, 2007, N-S ARCH PHARMACOL, V376, P135, DOI 10.1007/s00210-007-0177-3; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Vilas-Boas V, 2011, CYTOM PART A, V79A, P912, DOI 10.1002/cyto.a.21135; VILASBOAS V, 2013, TOXICOL LETT; VILASBOAS V, 2013, J APPL TOXI IN PRESS; Yang L, 2012, MOL PHARMACEUT, V9, P29, DOI 10.1021/mp200201y	55	19	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74425	10.1371/journal.pone.0074425	http://dx.doi.org/10.1371/journal.pone.0074425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991219	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800118
J	Zick, G; Elke, G; Becher, T; Schadler, D; Pulletz, S; Freitag-Wolf, S; Weiler, N; Frerichs, I				Zick, Guenther; Elke, Gunnar; Becher, Tobias; Schaedler, Dirk; Pulletz, Sven; Freitag-Wolf, Sandra; Weiler, Norbert; Frerichs, Inez			Effect of PEEP and Tidal Volume on Ventilation Distribution and End-Expiratory Lung Volume: A Prospective Experimental Animal and Pilot Clinical Study	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE TOMOGRAPHY; RESPIRATORY-DISTRESS-SYNDROME; COMPUTED-TOMOGRAPHY; MECHANICAL VENTILATION; RECRUITMENT MANEUVERS; REGIONAL VENTILATION; SPATIAL-DISTRIBUTION; PORCINE MODEL; GAS-EXCHANGE; PRESSURE	Introduction: Lung-protective ventilation aims at using low tidal volumes (V-T) at optimum positive end-expiratory pressures (PEEP). Optimum PEEP should recruit atelectatic lung regions and avoid tidal recruitment and end-inspiratory overinflation. We examined the effect of V-T and PEEP on ventilation distribution, regional respiratory system compliance (C-RS), and end-expiratory lung volume (EELV) in an animal model of acute lung injury (ALI) and patients with ARDS by using electrical impedance tomography (EIT) with the aim to assess tidal recruitment and overinflation. Methods: EIT examinations were performed in 10 anaesthetized pigs with normal lungs ventilated at 5 and 10 ml/kg body weight V-T and 5 cmH(2)O PEEP. After ALI induction, 10 ml/kg V-T and 10 cmH(2)O PEEP were applied. Afterwards, PEEP was set according to the pressure-volume curve. Animals were randomized to either low or high V-T ventilation changed after 30 minutes in a crossover design. Ventilation distribution, regional CRS and changes in EELV were analyzed. The same measures were determined in five ARDS patients examined during low and high V-T ventilation (6 and 10 (8) ml/kg) at three PEEP levels. Results: In healthy animals, high compared to low V-T increased C-RS and ventilation in dependent lung regions implying tidal recruitment. ALI reduced C-RS and EELV in all regions without changing ventilation distribution. Pressure-volume curve-derived PEEP of 21 +/- 4 cmH(2)O (mean +/- SD) resulted in comparable increase in C-RS in dependent and decrease in non-dependent regions at both V-T. This implied that tidal recruitment was avoided but end-inspiratory overinflation was present irrespective of V-T. In patients, regional C-RS differences between low and high V-T revealed high degree of tidal recruitment and low overinflation at 3 +/- 1 cmH(2)O PEEP. Tidal recruitment decreased at 10 +/- 1 cmH(2)O and was further reduced at 15 +/- 2 cmH(2)O PEEP. Conclusions: Tidal recruitment and end-inspiratory overinflation can be assessed by EIT-based analysis of regional C-RS.	[Zick, Guenther; Elke, Gunnar; Becher, Tobias; Schaedler, Dirk; Pulletz, Sven; Weiler, Norbert; Frerichs, Inez] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Freitag-Wolf, Sandra] Univ Med Ctr Schleswig Holstein, Inst Med Informat & Stat, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Zick, G (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	guenther.zick@uksh.de	Frerichs, I./AAT-3685-2021; Becher, Tobias/AAW-8491-2021; Elke, Gunnar/S-8579-2016; Schädler, Dirk/A-7253-2012	Frerichs, I./0000-0002-7712-6539; Becher, Tobias/0000-0003-2026-7629; Elke, Gunnar/0000-0002-4948-1605; Schädler, Dirk/0000-0002-5745-4797	Novalung, Hechingen, Germany	Novalung, Hechingen, Germany	The study was partially supported by Novalung, Hechingen, Germany (www.novalung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Andersson B, 2011, ACTA ANAESTH SCAND, V55, P157, DOI 10.1111/j.1399-6576.2010.02337.x; BARBER DC, 1990, CLIN PHYS PHYSIOL M, V11, P45, DOI 10.1088/0143-0815/11/4A/306; Bein T, 2006, CRIT CARE MED, V34, P1372, DOI 10.1097/01.CCM.0000215111.85483.BD; Bikker IG, 2011, CRIT CARE, V15, DOI 10.1186/cc10354; Bikker IG, 2009, INTENS CARE MED, V35, P1749, DOI 10.1007/s00134-009-1579-0; Bikker IG, 2009, INTENS CARE MED, V35, P1362, DOI 10.1007/s00134-009-1512-6; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown BH, 1996, PHYSIOL MEAS, V17, pA117, DOI 10.1088/0967-3334/17/4A/016; Caironi P, 2010, AM J RESP CRIT CARE, V181, P578, DOI 10.1164/rccm.200905-0787OC; Costa ELV, 2009, INTENS CARE MED, V35, P1132, DOI 10.1007/s00134-009-1447-y; Czaplik M, 2012, RESP PHYSIOL NEUROBI, V184, P16, DOI 10.1016/j.resp.2012.07.006; Dargaville PA, 2010, INTENS CARE MED, V36, P1953, DOI 10.1007/s00134-010-1995-1; Dembinski R, 2007, CRIT CARE MED, V35, P2359, DOI 10.1097/01.CCM.0000281857.87354.A5; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Foti G, 2000, INTENS CARE MED, V26, P501, DOI 10.1007/s001340051196; Frerichs I, 2007, PHYSIOL MEAS, V28, pS261, DOI 10.1088/0967-3334/28/7/S19; Frerichs I, 1999, IEEE T MED IMAGING, V18, P764, DOI 10.1109/42.802754; Frerichs I, 1998, ACTA ANAESTH SCAND, V42, P721, DOI 10.1111/j.1399-6576.1998.tb05308.x; Frerichs I, 1998, INTENS CARE MED, V24, P829, DOI 10.1007/s001340050673; Frerichs I, 2006, AM J RESP CRIT CARE, V174, P772, DOI 10.1164/rccm.200512-1942OC; Grasso S, 2002, ANESTHESIOLOGY, V96, P795, DOI 10.1097/00000542-200204000-00005; Grasso S, 2004, CRIT CARE MED, V32, P1018, DOI 10.1097/01.CCM.0000120059.94009.AD; Grasso S, 2009, AM J RESP CRIT CARE, V180, P415, DOI 10.1164/rccm.200901-0156OC; Halter JM, 2007, CRIT CARE, V11, DOI 10.1186/cc5695; Hinz J, 2007, EUR J ANAESTH, V24, P414, DOI 10.1017/S0265021506001517; Hinz J, 2003, CHEST, V124, P314, DOI 10.1378/chest.124.1.314; Hinz J, 2003, INTENS CARE MED, V29, P37, DOI 10.1007/s00134-002-1555-4; Karsten J, 2011, ACTA ANAESTH SCAND, V55, P878, DOI 10.1111/j.1399-6576.2011.02467.x; Kunst PWA, 1998, PHYSIOL MEAS, V19, P481, DOI 10.1088/0967-3334/19/4/003; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Meier T, 2008, INTENS CARE MED, V34, P543, DOI 10.1007/s00134-007-0786-9; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Miedema M, 2011, AM J RESP CRIT CARE, V184, P100, DOI 10.1164/rccm.201103-0375OC; Muders T, 2012, CRIT CARE MED, V40, P903, DOI 10.1097/CCM.0b013e318236f452; Pulletz S, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.09.002; RABBANI KS, 1991, CLIN PHYS PHYSIOL M, V12, P393, DOI 10.1088/0143-0815/12/4/009; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Richard JC, 2009, CRIT CARE, V13, DOI 10.1186/cc7900; Sinclair SE, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-25; Tusman G, 1999, BRIT J ANAESTH, V82, P8, DOI 10.1093/bja/82.1.8; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Wrigge H, 2008, CRIT CARE MED, V36, P903, DOI 10.1097/CCM.0B013E3181652EDD; Zick G, 2006, CRIT CARE, V10, DOI 10.1186/cc4889; Zick G, 2009, CRIT CARE, V13, DOI 10.1186/cc7716	48	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72675	10.1371/journal.pone.0072675	http://dx.doi.org/10.1371/journal.pone.0072675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991138	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470700046
J	Siraichi, JTG; Felipe, DF; Brambilla, LZS; Gatto, MJ; Terra, VA; Cecchini, AL; Cortez, LER; Rodrigues, E; Cortez, DAG				Guinoza Siraichi, Jackeline Tiemy; Felipe, Daniele Fernanda; Serra Brambilla, Lara Zampar; Gatto, Melissa Junqueira; Terra, Vania Aparecida; Cecchini, Alessandra Lourenco; Ranieri Cortez, Lucia Elaine; Rodrigues-Filho, Edson; Garcia Cortez, Diogenes Aparicio			Antioxidant Capacity of the Leaf Extract Obtained from Arrabidaea chica Cultivated in Southern Brazil	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; IN-VITRO ASSAYS; FLAVONOIDS; LEAVES; HPLC; IDENTIFICATION; PHENOLICS; SPICES; FOODS	Arrabidaea chica leaf extract has been used by people as an anti-inflammatory and astringent agent as well as a remedy for intestinal colic, diarrhea, leucorrhea, anemia, and leukemia. A. chica is known to be a good producer of phenolics. Therefore, in the present study, we investigated its antioxidant activity. The phenolic composition of A. chica leaves was studied by liquid chromatography coupled to diode array detection (LC-DAD) and liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), and isoscutellarein, 6-hydroxyluteolin, hispidulin, scutellarein, luteolin, and apigenin were identified. The extract from leaves of A. chica was tested for antioxidant activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, beta-carotene bleaching test, and total reactive antioxidant potential (TRAP) method. The crude extract quenched DPPH free radicals in a dose-dependent manner, and the IC50 of the extract was 13.51 mu g/mL. The beta-carotene bleaching test showed that the addition of the A. chica extract in different concentrations (200 and 500 mg/mL) prevented the bleaching of beta-carotene at different degrees (51.2% +/- 3.38% and 94% +/- 4.61%, respectively). The TRAP test showed dose-dependent correlation between the increasing concentrations of A. chica extract (0.1, 0.5, and 1.0 mu g/mL) and the TRAP values obtained by trolox (hydro-soluble vitamin E) 0.4738 +/- 0.0466, 1.981 +/- 0.1603, and 6.877 +/- 1.445 mu M, respectively. The 2 main flavonoids, scutellarein and apigenin, were separated, and their antioxidant activity was found to be the same as that of the plant extract. These 2 flavonoids were quantified in the plant extract by using a validated HPLC-UV method. The results of these tests showed that the extract of A. chica had a significant antioxidant activity, which could be attributed to the presence of the mixture of flavonoids in the plant extract, with the main contribution of scutellarein and apigenin.	[Guinoza Siraichi, Jackeline Tiemy; Felipe, Daniele Fernanda; Serra Brambilla, Lara Zampar; Garcia Cortez, Diogenes Aparicio] Univ Estadual Maringa, Pharmaceut Sci Postgrad Program, Maringa, Parana, Brazil; [Gatto, Melissa Junqueira] Univ Estadual Maringa, Dept Pharm, Maringa, Parana, Brazil; [Guinoza Siraichi, Jackeline Tiemy] Inst Fed Parana, Londrina, Parana, Brazil; [Terra, Vania Aparecida; Cecchini, Alessandra Lourenco] Univ Estadual Londrina, Dept Pathol Sci, Londrina, Parana, Brazil; [Ranieri Cortez, Lucia Elaine] Ctr Univ Maringa, Postgrad Program Hlth Promot, State Of Maringa, Parana, Brazil; [Rodrigues-Filho, Edson] Univ Fed Sao Carlos, Dept Chem, BR-13560 Sao Carlos, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Instituto Federal do Parana; Universidade Estadual de Londrina; Universidade Federal de Sao Carlos	Cortez, DAG (corresponding author), Univ Estadual Maringa, Pharmaceut Sci Postgrad Program, Maringa, Parana, Brazil.	dagcortez@uem.br	Rodrigues-Filho, Edson/C-5024-2009; Rodrigues-Filho, Edson/M-7657-2019	Rodrigues-Filho, Edson/0000-0003-4305-0326; Cecchini, Alessandra/0000-0003-0575-9879	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Estadual de Maringa; Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Estadual de Maringa; Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Estadual de Maringa, and Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondet W, 1997, LEBENSM WISS TECHNOL, V30, P609; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Calvo MI, 1997, CHROMATOGRAPHIA, V46, P241, DOI 10.1007/BF02496313; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3; Ciz M, 2010, FOOD CONTROL, V21, P518, DOI 10.1016/j.foodcont.2009.07.017; de Souza AS, 2009, PHARM BIOL, V47, P154, DOI 10.1080/13880200802436281; Devia B, 2002, PHYTOCHEM ANALYSIS, V13, P114, DOI 10.1002/pca.632; Engida AM, 2013, IND CROP PROD, V41, P392, DOI 10.1016/j.indcrop.2012.04.043; Fecka I, 2008, FOOD CHEM, V108, P1039, DOI 10.1016/j.foodchem.2007.11.035; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Greenham J, 2003, PHYTOCHEM ANALYSIS, V14, P100, DOI 10.1002/pca.693; Gu LW, 2001, FOOD CHEM, V73, P299, DOI 10.1016/S0308-8146(00)00300-9; Guvenc A, 2010, FOOD CHEM, V118, P686, DOI 10.1016/j.foodchem.2009.05.034; Hidalgo M, 2010, FOOD CHEM, V121, P691, DOI 10.1016/j.foodchem.2009.12.097; Jorge MP, 2008, J ETHNOPHARMACOL, V118, P361, DOI 10.1016/j.jep.2008.04.024; Kandasamy S, 2011, MOL PHYS, V109, P839, DOI 10.1080/00268976.2011.556576; Kumaran A, 2006, FOOD CHEM, V97, P109, DOI 10.1016/j.foodchem.2005.03.032; Lancas FM, 2004, VALIDATION CHROMATOG; Li YH, 2008, FOOD CHEM, V106, P444, DOI 10.1016/j.foodchem.2007.04.067; Magalhaes WV, 2011, BRAZ J PHARM SCI, V47, P693, DOI 10.1590/S1984-82502011000400005; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Montoro P, 2005, FOOD CHEM, V92, P349, DOI 10.1016/j.foodchem.2004.07.028; Pauletti PM, 2003, J NAT PROD, V66, P1384, DOI 10.1021/np030100t; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067; Peng ZF, 2003, PHYTOCHEMISTRY, V62, P219, DOI 10.1016/S0031-9422(02)00504-6; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Qui F, 2007, PLANTA MED, V73, P363; Barbosa WLR, 2008, REV BRAS FARMACOGN, V18, P544, DOI 10.1590/S0102-695X2008000400008; Ribeiro AFC, 2012, REV BRAS FARMACOGN, V22, P364, DOI 10.1590/S0102-695X2011005000225; Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026; Schiozer AL, 2008, ANAL LETT, V41, P1592, DOI 10.1080/00032710802122198; Schiozer AL, 2012, J BRAZIL CHEM SOC, V23, P409, DOI 10.1590/S0103-50532012000300006; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; Sharififar F, 2009, FOOD CHEM, V112, P885, DOI 10.1016/j.foodchem.2008.06.064; Silva EM, 2007, FOOD CHEM, V101, P1012, DOI 10.1016/j.foodchem.2006.02.055; Simirgiotis MJ, 2013, MOLECULES, V18, P1672, DOI 10.3390/molecules18021672; TAKEMURA OS, 1995, PHYTOCHEMISTRY, V38, P1299, DOI 10.1016/0031-9422(94)00786-S; Terashima M, 2012, PLANT CELL REP, V31, P291, DOI 10.1007/s00299-011-1163-2; Yan RY, 2011, FITOTERAPIA, V82, P841, DOI 10.1016/j.fitote.2011.04.006; Yan ZX, 2011, ANAL CHIM ACTA, V691, P110, DOI 10.1016/j.aca.2011.02.046; Yokozawa T, 1997, PHYTOTHER RES, V11, P446, DOI 10.1002/(SICI)1099-1573(199709)11:6<446::AID-PTR128>3.3.CO;2-#; Zorn B, 2001, PHYTOCHEMISTRY, V56, P831, DOI 10.1016/S0031-9422(01)00038-3	45	39	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72733	10.1371/journal.pone.0072733	http://dx.doi.org/10.1371/journal.pone.0072733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009700	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600034
J	Murrant, MN; Bowman, J; Garroway, CJ; Prinzen, B; Mayberry, H; Faure, PA				Murrant, Meghan N.; Bowman, Jeff; Garroway, Colin J.; Prinzen, Brian; Mayberry, Heather; Faure, Paul A.			Ultrasonic Vocalizations Emitted by Flying Squirrels	PLOS ONE			English	Article							EVOLUTION; ECHOLOCATION; BEHAVIOR; HEARING; WINTER; CALLS; OWL	Anecdotal reports of ultrasound use by flying squirrels have existed for decades, yet there has been little detailed analysis of their vocalizations. Here we demonstrate that two species of flying squirrel emit ultrasonic vocalizations. We recorded vocalizations from northern (Glaucomys sabrinus) and southern (G. volans) flying squirrels calling in both the laboratory and at a field site in central Ontario, Canada. We demonstrate that flying squirrels produce ultrasonic emissions through recorded bursts of broadband noise and time-frequency structured frequency modulated (FM) vocalizations, some of which were purely ultrasonic. Squirrels emitted three types of ultrasonic calls in laboratory recordings and one type in the field. The variety of signals that were recorded suggest that flying squirrels may use ultrasonic vocalizations to transfer information. Thus, vocalizations may be an important, although still poorly understood, aspect of flying squirrel social biology.	[Murrant, Meghan N.; Garroway, Colin J.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada; [Prinzen, Brian; Mayberry, Heather; Faure, Paul A.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	Trent University; Ministry of Natural Resources & Forestry; McMaster University	Bowman, J (corresponding author), Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada.	jeff.bowman@ontario.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Garroway, Colin/0000-0002-0955-0688; Mayberry, Heather/0000-0003-4721-5431	Natural Sciences and Engineering Research Council (NSERC) Discovery Grants; Ontario Ministry of Natural Resources	Natural Sciences and Engineering Research Council (NSERC) Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Natural Resources	Financial support was provided by Natural Sciences and Engineering Research Council (NSERC) Discovery Grants to JB and PAF, and by the Ontario Ministry of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake BH, 2012, J MAMMAL, V93, P1051, DOI 10.1644/11-MAMM-A-356.2; Blumstein DT, 1999, BEHAVIOUR, V136, P731, DOI 10.1163/156853999501540; Bowman J, 2005, CAN J ZOOL, V83, P1486, DOI 10.1139/Z05-144; Bradbury Jack W., 1998, pi; Briggs JR, 2011, ANIM BEHAV, V82, P1263, DOI 10.1016/j.anbehav.2011.09.003; Brittan-Powell EF, 2005, J ACOUST SOC AM, V118, P314, DOI 10.1121/1.1928767; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; Chattin D, 1969, THESIS, P76; Coombs AB, 2010, J WILDLIFE MANAGE, V74, P1875, DOI 10.2193/2009-560; Cowan I. McT., 1942, Murrelet Seattle, V23, P48, DOI 10.2307/3535583; DOLAN P G, 1977, Mammalian Species, V78, P1; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Dyson ML, 1998, J COMP PHYSIOL A, V182, P695, DOI 10.1007/s003590050214; Fenton MB, 2012, J EXP BIOL, V215, P2935, DOI 10.1242/jeb.073171; Gadziola MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044550; Garroway CJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P113, DOI 10.1007/s00265-012-1431-3; Gilley, 2013, THESIS AUBURN U AUBU; Heffner H. E., 2008, HDB SENSES AUDITION, P55, DOI DOI 10.1016/B978-012370880-9; IHNAT R, 1995, BEHAV PROCESS, V33, P257, DOI 10.1016/0376-6357(94)00028-F; Kalcounis-Rueppell Matina C, 2006, Front Zool, V3, P3, DOI 10.1186/1742-9994-3-3; KONISHI M, 1993, SCI AM, V268, P66, DOI 10.1038/scientificamerican0493-66; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; LAYNE JN, 1994, J MAMMAL, V75, P110, DOI 10.2307/1382242; MARLER P, 1975, Zeitschrift fuer Tierpsychologie, V38, P97; MASTERTO.B, 1969, J ACOUST SOC AM, V45, P966, DOI 10.1121/1.1911574; Matrosova VA, 2009, J MAMMAL, V90, P158, DOI 10.1644/08-MAMM-A-032.1; MCINTOSH TK, 1978, NATURE, V272, P163, DOI 10.1038/272163a0; MCINTOSH TK, 1980, BEHAV NEURAL BIOL, V29, P349, DOI 10.1016/S0163-1047(80)90259-9; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Murrant M, 2012, THESIS TRENT U PETER; MUUL ILLAR, 1963, NAT HIST, V72, P18; OWINGS DH, 1978, Z TIERPSYCHOL, V46, P58; Sales GD, 1974, ULTRASONIC COMMUNICA; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Thorington KK, 2011, J MAMMAL, V92, P179, DOI 10.1644/10-MAMM-A-062.1; Valone TJ, 1996, OIKOS, V77, P153, DOI 10.2307/3545595; Van Dijk T., 1973, Netherlands J Zool, V23, P131; VANDERPOEL AM, 1991, BEHAVIOUR, V119, P127, DOI 10.1163/156853991X00409; Wilson DR, 2006, CAN J ZOOL, V84, P1322, DOI 10.1139/Z06-120; Wilson DR, 2004, NATURE, V430, P523, DOI 10.1038/430523a	43	12	12	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73045	10.1371/journal.pone.0073045	http://dx.doi.org/10.1371/journal.pone.0073045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009728	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600052
J	Antunes-Carvalho, C; Lopes-Andrade, C				Antunes-Carvalho, Caio; Lopes-Andrade, Cristiano			Two Invaders Instead of One: The True Identity of Species under the Name Ceracis cucullatus (Coleoptera: Ciidae)	PLOS ONE			English	Article							INVASION; EVOLUTION; HOST; PEST; BEETLES; HISTORY; SUCCESS; TRAITS	The Neotropical obligate fungivorous beetle Ceracis cucullatus (Mellie) has attracted attention of coleopterists due to the increasing number of records of populations in Africa. Although its disjunct populations have been interpreted as a cohesive taxonomic unity, previous comparisons between African and Neotropical specimens revealed differences in their external morphology, causing uncertainty about the true unity of the species. Here, we compare the external morphology of specimens named Cer. cucullatus from several localities of the Neotropical, Palearctic, Afrotropical, Afrotemperate and Oriental regions. As results, we reverse three previous junior synonymies of Cer. cucullatus, proposing Cer. lamellatus (Pic) and Cer. tabellifer (Mellie), both reinstated status and new combinations, as separate species. We also propose Enn. bilamellatum Pic as a new synonym of Cer. tabellifer. In face of these taxonomic changes, we identify Cer. tabellifer as the actual invasive species on African lands, instead of Cer. cucullatus as was previously accepted. Then, through historical records gathered from scientific collections and literature, and through examination of recently collected specimens from South Africa and Brazil, we provide data on host fungi and geographic distribution of Cer. tabellifer. Based on these data, we discuss possible explanations to the successful invasion of Cer. tabellifer in Africa and elsewhere and its potential threat to native faunas of ciids. This study helps to fulfil an old gap in the literature on biological invasions, with considerably more studies on predatory species, disease vectors or potential pests of agricultural crops, than on non-pest fungivorous organisms.	[Antunes-Carvalho, Caio] Univ Fed Vicosa, Dept Entomol, Programa Posgrad Entomol, Vicosa, MG, Brazil; [Lopes-Andrade, Cristiano] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Antunes-Carvalho, C (corresponding author), Univ Fed Vicosa, Dept Entomol, Programa Posgrad Entomol, Vicosa, MG, Brazil.	cantunescarvalho@gmail.com	Lopes-Andrade, Cristiano/A-5525-2013; Antunes-Carvalho, Caio/AAN-9365-2020	Lopes-Andrade, Cristiano/0000-0001-9652-1369; Antunes-Carvalho, Caio/0000-0002-0124-2509	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [Edital PPP 21/2008 2008, APQ-00049-09, Edital PPM 03/2010, PPM-00017-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [562229/2010-8, 131453/2010-6, 302480/2012-9]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG: Edital PPP 21/2008 2008, APQ-00049-09; Edital PPM 03/2010, PPM-00017-10) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: PROTAX 52/2010 no 562229/2010-8, master grant no 131453/2010-6 to CAC and research grant to CLA no 302480/2012-9). Publication costs were partially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	Abeille de Perrin E, 1874, ESSAI MONOGRAPHIQUE; Ahern RG, 2009, BIOL INVASIONS, V11, P959, DOI 10.1007/s10530-008-9308-0; Antunes-Carvalho C, 2012, CR BIOL, V335, P107, DOI 10.1016/j.crvi.2011.11.006; Antunes-Carvalho C, 2011, ZOOKEYS, P51, DOI [10.3897/zookeys.66.1570, 10.3897/zookeys.132.1570]; Blackburn TM, 2009, GLOBAL CHANGE BIOL, V15, P2852, DOI 10.1111/j.1365-2486.2008.01841.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Evenhuis Neal L., 2008, Bishop Museum Technical Report, V41, P1; Graf-Peters LV, 2011, FLA ENTOMOL, V94, P553, DOI 10.1653/024.094.0320; Guevara R, 2000, PHYSIOL ENTOMOL, V25, P288, DOI 10.1046/j.1365-3032.2000.00194.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Heger Tina, 2003, Biological Invasions, V5, P313; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LAWRENCE J F, 1973, Bulletin of the Museum of Comparative Zoology, V145, P163; LAWRENCE J F, 1967, Bulletin of the Museum of Comparative Zoology, V136, P91; LAWRENCE J F, 1971, Bulletin of the Museum of Comparative Zoology, V142, P419; LAWRENCE JF, 1991, COLEOPTS BULL, V45, P286; Lawrence JF, 2010, HBK ZOOL, P504; LAWRENCE JOHN F., 1967, BREVOIRA MUS COMP ZOOL [HARVARD], V258, P1; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lesne P., 1917, Bulletin de la Societe Entomologique de France, V1917; Lopes-Andrade C, 2010, ZOOTAXA, P53; Lopes-Andrade C, 2011, ZOOKEYS, P27, DOI 10.3897/zookeys.81.940; Lopes-Andrade Cristiano, 2005, Zootaxa, V1034, P43; Lopes-Andrade Cristiano, 2008, Zootaxa, V1755, P35; Lopes-Andrade C, 2009, ZOOTAXA, P56; MADENJIAN JJ, 1993, J STORED PROD RES, V29, P45, DOI 10.1016/0022-474X(93)90020-5; Majerus M, 2006, ECOL ENTOMOL, V31, P207, DOI 10.1111/j.1365-2311.2006.00734.x; Majka Christopher G., 2007, Zootaxa, V1654, P1; Mayr E., 1991, PRINCIPLES SYSTEMATI; Mellie MJ, 1849, ANN SOC ENTOMOL FR 2, V6, P205; Muller C., 2001, ZOOSYST EVOL, V77, P303; Neser Ottilie C., 2012, Zootaxa, V3183, P49; Orledge Glenda M., 2006, Coleopterist, V15, P1; Orledge GM, 2010, BIOL INVASIONS, V12, P515, DOI 10.1007/s10530-009-9455-y; Orledge GM, 2005, ECOL ENTOMOL, V30, P620, DOI 10.1111/j.0307-6946.2005.00727.x; Rose Olivier, 2009, Entomologiste (Paris), V65, P281; Rosecchi E, 2001, FRESHWATER BIOL, V46, P845, DOI 10.1046/j.1365-2427.2001.00715.x; Scott H, 1926, ZOOLOGY, V19, P1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Westley PAH, 2011, AM NAT, V177, P496, DOI 10.1086/658902; Wick M., 2012, GEONAMES GEOGRAPHICA; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9	48	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72319	10.1371/journal.pone.0072319	http://dx.doi.org/10.1371/journal.pone.0072319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015233	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800046
J	Butler, AM; Buzhardt, MLS; Li, SH; Smith, KE; Fields, AP; Murray, NR				Butler, Amanda M.; Buzhardt, Michele L. Scotti; Li, Shuhua; Smith, Kristin E.; Fields, Alan P.; Murray, Nicole R.			Protein Kinase C Zeta Regulates Human Pancreatic Cancer Cell Transformed Growth and Invasion through a STAT3-Dependent Mechanism	PLOS ONE			English	Article							LUNG-CANCER; OVARIAN-CANCER; PKC-ZETA; SIGNAL TRANSDUCER; FACTOR RECEPTOR; PIF-POCKET; IN-VIVO; STAT3; ACTIVATION; IOTA	Pancreatic cancer is a very aggressive disease with few therapeutic options. In this study, we investigate the role of protein kinase C zeta (PKC zeta) in pancreatic cancer cells. PKC zeta has been shown to act as either a tumor suppressor or tumor promoter depending upon the cellular context. We find that PKC zeta expression is either maintained or elevated in primary human pancreatic tumors, but is never lost, consistent with PKC zeta playing a promotive role in the pancreatic cancer phenotype. Genetic inhibition of PKC zeta reduced adherent growth, cell survival and anchorage-independent growth of human pancreatic cancer cells in vitro. Furthermore, PKC zeta inhibition reduced orthotopic tumor size in vivo by inhibiting tumor cell proliferation and increasing tumor necrosis. In addition, PKC zeta inhibition reduced tumor metastases in vivo, and caused a corresponding reduction in pancreatic cancer cell invasion in vitro. Signal transducer and activator of transcription 3 (STAT3) is often constitutively active in pancreatic cancer, and plays an important role in pancreatic cancer cell survival and metastasis. Interestingly, inhibition of PKC zeta significantly reduced constitutive STAT3 activation in pancreatic cancer cells in vitro and in vivo. Pharmacologic inhibition of STAT3 mimicked the phenotype of PKC zeta inhibition, and expression of a constitutively active STAT3 construct rescued the transformed phenotype in PKC zeta-deficient cells. We conclude that PKC zeta is required for pancreatic cancer cell transformed growth and invasion in vitro and tumorigenesis in vivo, and that STAT3 is an important downstream mediator of the pro-carcinogenic effects of PKC zeta in pancreatic cancer cells.	[Butler, Amanda M.; Buzhardt, Michele L. Scotti; Li, Shuhua; Smith, Kristin E.; Fields, Alan P.; Murray, Nicole R.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Murray, NR (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	murray.nicole@mayo.edu		Saravia-Butler, Amanda M./0000-0001-7505-2743	NIH/NCI [R03 CA143164, R01CA140290, F31 CA168117, R01 CA081436-16]; Daniel Foundation of Alabama Postdoctoral Fellowship; Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE [R01CA081436, R01CA140290, R03CA143164, F31CA168117, P50CA102701] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Daniel Foundation of Alabama Postdoctoral Fellowship; Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by: NIH/NCI R03 CA143164, NIH/NCI R01CA140290 (NRM), Daniel Foundation of Alabama Postdoctoral Fellowship (MLS), NIH/NCI F31 CA168117 (AMB), NIH/NCI R01 CA081436-16 (APF), The Mayo Clinic Foundation (NRM, APF). APF is the Monica Flynn Jacoby Endowed Professor of Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Luna-Ulloa LB, 2011, CARCINOGENESIS, V32, P1615, DOI 10.1093/carcin/bgr190; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; Calcagno SR, 2011, INFLAMM BOWEL DIS, V17, P1685, DOI 10.1002/ibd.21547; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cohen EEW, 2006, CANCER RES, V66, P6296, DOI 10.1158/0008-5472.CAN-05-3139; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; DeArmond D, 2003, ONCOGENE, V22, P7781, DOI 10.1038/sj.onc.1206966; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Fernandez N, 2000, ENDOCRINOLOGY, V141, P146, DOI 10.1210/en.141.1.146; Fields AP, 2008, ADV ENZYME REGUL, V48, P166, DOI 10.1016/j.advenzreg.2007.11.014; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Frohner W, 2011, J MED CHEM, V54, P6714, DOI 10.1021/jm2005892; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hasegawa K, 2006, CLIN CANCER RES, V12, P6170, DOI 10.1158/1078-0432.CCR-06-0992; Huang SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029124; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lebedeva IV, 2006, CANCER RES, V66, P2403, DOI 10.1158/0008-5472.CAN-05-3510; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Murray NR, 2009, CANCER RES, V69, P656, DOI 10.1158/0008-5472.CAN-08-3001; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Mustafi R, 2006, MOL CANCER RES, V4, P683, DOI 10.1158/1541-7786.MCR-06-0057; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nam S, 2012, MOL ONCOLOGY; Nazarenko I, 2010, MOL CANCER RES, V8, P919, DOI 10.1158/1541-7786.MCR-09-0358; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Valkov A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017507; Valkova C, 2010, MOL CANCER RES, V8, P783, DOI 10.1158/1541-7786.MCR-09-0164; Xiao HL, 2013, J CELL PHYSIOL, V228, P416, DOI 10.1002/jcp.24146; Yao Sheng, 2010, Genes Cancer, V1, P444, DOI 10.1177/1947601910376079; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001	50	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72061	10.1371/journal.pone.0072061	http://dx.doi.org/10.1371/journal.pone.0072061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015205	Green Submitted, gold, Green Published			2022-12-25	WOS:000323733800025
J	de Kleijn, S; Langereis, JD; Leentjens, J; Kox, M; Netea, MG; Koenderman, L; Ferwerda, G; Pickkers, P; Hermans, PWM				de Kleijn, Stan; Langereis, Jeroen D.; Leentjens, Jenneke; Kox, Matthijs; Netea, Mihai G.; Koenderman, Leo; Ferwerda, Gerben; Pickkers, Peter; Hermans, Peter W. M.			IFN-gamma-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; INFLUENZA INFECTION; INTERFERON-GAMMA; UP-REGULATION; ACTIVATION; TUBERCULOSIS; IMMUNITY; LIGANDS; BLOOD	During systemic inflammation different neutrophil subsets are mobilized to the peripheral blood. These neutrophil subsets can be distinguished from normal circulating neutrophils (CD16(bright)/CD62L(bright)), based on either an immature CD16(dim)/CD62L(bright) or a CD16(bright)/CD62L(dim) phenotype. Interestingly, the latter neutrophil subset is known to suppress lymphocyte proliferation ex vivo, but how neutrophils become suppressive is unknown. We performed transcriptome analysis on the different neutrophil subsets to identify changes in mRNA expression that are relevant for their functions. Neutrophil subsets were isolated by fluorescence-activated cell sorting from blood of healthy volunteers that were administered a single dose of lipopolysaccharide (2 ng/kg i.v.) and the transcriptome was determined by microarray analysis. Interestingly, the CD16(bright)/CD62L(dim) suppressive neutrophils showed an interferon-induced transcriptome profile. More importantly, IFN-gamma, but not IFN-alpha or IFN-beta stimulated neutrophils, acquired the capacity to suppress lymphocyte proliferation through the expression of programmed death ligand 1 (PD-L1). These data demonstrate that IFN-gamma-induced expression of PD-L1 on neutrophils enables suppression of lymphocyte proliferation. Specific stimulation of neutrophils present at the inflammatory sites might therefore have a pivotal role in regulating lymphocyte-mediated inflammation and autoimmune disease.	[de Kleijn, Stan; Langereis, Jeroen D.; Ferwerda, Gerben; Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Leentjens, Jenneke; Kox, Matthijs; Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands; [Leentjens, Jenneke; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Kox, Matthijs] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, NL-6525 ED Nijmegen, Netherlands; [Koenderman, Leo] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Langereis, JD (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	j.langereis@cukz.umcn.nl	Langereis, Jeroen/H-1042-2013; Leentjens, Jenneke/P-8300-2015; Netea, Mihai/N-5155-2014; Pickkers, P./H-8080-2014; Ferwerda, J.G./L-4305-2015; Hermans, Peter W.M./H-8042-2014; Kox, Matthijs/L-4454-2015; Koenderman, Leo/AAE-7870-2020	Langereis, Jeroen/0000-0001-5317-3202; Leentjens, Jenneke/0000-0003-3356-3910; Pickkers, P./0000-0002-1104-4303; Koenderman, Leo/0000-0002-5636-6453	ZonMw, the Netherlands [85100003]; Nano Cluster of Technology Foundation [STW FES0901: FES HTSM]	ZonMw, the Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Nano Cluster of Technology Foundation	SdK is supported by ZonMw, the Netherlands Grant No. 85100003. JL was supported by the Nano Cluster of Technology Foundation (STW FES0901: FES HTSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankey PE, 2010, IMMUNOL LETT, V129, P100, DOI 10.1016/j.imlet.2010.01.006; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; de Kleijn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038255; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gellert P, 2009, BIOINFORMATICS, V25, P3323, DOI 10.1093/bioinformatics/btp577; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kotz KT, 2010, NAT MED, V16, P1042, DOI 10.1038/nm.2205; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Langereis JD, 2011, CYTOKINE, V56, P422, DOI 10.1016/j.cyto.2011.06.025; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421; Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Rorvig S., 2013, J LEUKOC BIOL; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; Yoshimura T, 2007, J IMMUNOL, V179, P1942, DOI 10.4049/jimmunol.179.3.1942; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059	28	128	128	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72249	10.1371/journal.pone.0072249	http://dx.doi.org/10.1371/journal.pone.0072249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015224	gold, Green Published, Green Submitted			2022-12-25	WOS:000323733800039
J	Gorska, M; Gammazza, AM; Zmijewski, MA; Campanella, C; Cappello, F; Wasiewicz, T; Kuban-Jankowska, A; Daca, A; Sielicka, A; Popowska, U; Knap, N; Antoniewicz, J; Wakabayashi, T; Wozniak, M				Gorska, Magdalena; Gammazza, Antonella Marino; Zmijewski, Michal Aleksander; Campanella, Claudia; Cappello, Francesco; Wasiewicz, Tomasz; Kuban-Jankowska, Alicja; Daca, Agnieszka; Sielicka, Alicja; Popowska, Urszula; Knap, Narcyz; Antoniewicz, Jakub; Wakabayashi, Takashi; Wozniak, Michal			Geldanamycin-Induced Osteosarcoma Cell Death Is Associated with Hyperacetylation and Loss of Mitochondrial Pool of Heat Shock Protein 60 (Hsp60)	PLOS ONE			English	Article							SHOCK-PROTEIN EXPRESSION; MOLECULAR CHAPERONES; DRUG-RESISTANCE; HSP90 ISOFORMS; INDUCTION; INHIBITOR; BIOGENESIS; ACTIVATION; SENESCENCE; APOPTOSIS	Osteosarcoma is one of the most malignant tumors of childhood and adolescence that is often resistant to standard chemo- and radio-therapy. Geldanamycin and geldanamycin analogs have been recently studied as potential anticancer agents for osteosarcoma treatment. Here, for the first time, we have presented novel anticancer mechanisms of geldanamycin biological activity. Moreover, we demonstrated an association between the effects of geldanamycin on the major heat shock proteins (HSPs) and the overall survival of highly metastatic human osteosarcoma 143B cells. We demonstrated that the treatment of 143B cells with geldanamycin caused a subsequent upregulation of cytoplasmic Hsp90 and Hsp70 whose activity is at least partly responsible for cancer development and drug resistance. On the other hand, geldanamycin induced upregulation of Hsp60 gene expression, and a simultaneous loss of hyperacetylated Hsp60 mitochondrial protein pool resulting in decreased viability and augmented cancer cell death. Hyperacetylation of Hsp60 seems to be associated with anticancer activity of geldanamycin. In light of the fact that mitochondrial dysfunction plays a critical role in the apoptotic signaling pathway, the presented data may support a hypothesis that Hsp60 can be another functional part of mitochondria-related acetylome being a potential target for developing novel anticancer strategies.	[Gorska, Magdalena; Popowska, Urszula; Knap, Narcyz; Wakabayashi, Takashi; Wozniak, Michal] Med Univ Gdansk, Dept Med Chem, Gdansk, Poland; [Gammazza, Antonella Marino; Campanella, Claudia; Cappello, Francesco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Sect Human Anat Emer Luna, Palermo, Italy; [Gammazza, Antonella Marino; Zmijewski, Michal Aleksander; Campanella, Claudia] Euro Mediterranean Inst Sci & Technol, Palermo, Italy; [Zmijewski, Michal Aleksander; Wasiewicz, Tomasz; Antoniewicz, Jakub] Med Univ Gdansk, Dept Histol, Gdansk, Poland; [Daca, Agnieszka] Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland; [Daca, Agnieszka] Med Univ Gdansk, Dept Pathol & Expt Rheumatol, Gdansk, Poland; [Sielicka, Alicja] Med Univ Gdansk, Dept Biochem, Gdansk, Poland; [Sielicka, Alicja] Med Univ Gdansk, Dept Bioenerget & Physiol, Gdansk, Poland; [Popowska, Urszula; Wozniak, Michal] Coll Hlth Beauty Care & Educ Poznan, Fac Gdynia, Gdynia, Poland; [Wakabayashi, Takashi] Nagoya Univ, Sch Med, Dept Cell Biol & Mol Pathol, Nagoya, Aichi 4648601, Japan	Fahrenheit Universities; Medical University Gdansk; University of Palermo; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Nagoya University	Gorska, M (corresponding author), Med Univ Gdansk, Dept Med Chem, Gdansk, Poland.	m.gorska@gumed.edu.pl	Wakabayashi, Toshihiko/I-3526-2012; Daca, Agnieszka/AAW-8557-2020; Gammazza, Antonella Marino/AAV-3123-2020; Cappello, Francesco/F-9153-2012	Wakabayashi, Toshihiko/0000-0001-5254-2088; Daca, Agnieszka/0000-0003-1485-3090; Marino Gammazza, Antonella/0000-0002-1683-3803; Wozniak, Michal/0000-0001-7083-6792; Cappello, Francesco/0000-0001-9288-1148; Knap, Narcyz/0000-0002-6162-3987; Zmijewski, Michal/0000-0003-2206-3531; gorska-ponikowska, magdalena/0000-0002-7366-8429	Ministry of Science and Higher Education [N N401 634140, N N401 572640]; Medical University of Gdansk [ST46]; Euro-Mediterranean Institute of Science and Technology, Palermo, Italy; Polish Ministry of Science and Higher Education [N405 623238, N402 662840]; College of Health, Beauty Care and Education in Poznan; TEAM program of Foundation for Polish Science [TEAM/2011-8/7]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Medical University of Gdansk(Medical University Gdansk); Euro-Mediterranean Institute of Science and Technology, Palermo, Italy; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); College of Health, Beauty Care and Education in Poznan; TEAM program of Foundation for Polish Science	This work was supported by grant of the Ministry of Science and Higher Education No. N N401 634140, and by Medical University of Gdansk Funding No. ST46. FC, AMG, and CC acknowledge support from Euro-Mediterranean Institute of Science and Technology, Palermo, Italy. MAZ acknowledges support from grant from Polish Ministry of Science and Higher Education, projects No. N405 623238 and N402 662840. MW and UP acknowledge support from College of Health, Beauty Care and Education in Poznan. AS acknowledges support from TEAM program of Foundation for Polish Science (TEAM/2011-8/7). NK acknowledges support from grant of the Ministry of Science and Higher Education No. N N401 572640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MB, 2011, BIOMED PHARMACOTHER, V65, P239, DOI 10.1016/j.biopha.2011.04.025; Bertram J, 1996, ANTI-CANCER DRUG, V7, P838, DOI 10.1097/00001813-199611000-00004; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Campanella C, 2008, EUR J HISTOCHEM, V52, P221; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2005, CELL STRESS CHAPERON, V10, P263, DOI 10.1379/1466-1268(2005)10[263:HEDCAM]2.0.CO;2; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Chang YS, 2006, BIOCHEM BIOPH RES CO, V344, P37, DOI 10.1016/j.bbrc.2006.03.157; Chao CC, 2008, J CELL BIOCHEM, V104, P1286, DOI 10.1002/jcb.21705; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Demidenko ZN, 2006, CELL DEATH DIFFER, V13, P1434, DOI 10.1038/sj.cdd.4401812; Finley LWS, 2012, TRENDS MOL MED, V18, P516, DOI 10.1016/j.molmed.2012.05.004; Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705; Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003; Gorska M, 2012, FRONT BIOSCI-LANDMRK, V17, P2269, DOI 10.2741/4050; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Karbowski M, 2001, J CELL SCI, V114, P281; Karkoulis PK, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-11; Kaul Z, 2006, ANN NY ACAD SCI, V1067, P469, DOI 10.1196/annals.1354.067; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lu Z, 2011, EMBO REPORTS, V8, P841; Macario AJL, 2010, ANN NY ACAD SCI, V1197, P85, DOI 10.1111/j.1749-6632.2010.05187.x; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McCollum AK, 2008, MOL CANCER THER, V7, P3256, DOI 10.1158/1535-7163.MCT-08-0157; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; Nahleh Z, 2012, FUTURE MED CHEM, V4, P1766; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neuwelt A, 2009, NEOPLASIA, V11, P1003, DOI 10.1593/neo.09688; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Rao R, 2012, ADV CANCER RES, V116, P239, DOI 10.1016/B978-0-12-394387-3.00007-0; Rappa F, 2012, ANTICANCER RES, V32, P5139; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Uozaki H, 2000, PATHOL RES PRACT, V196, P665, DOI 10.1016/S0344-0338(00)80118-1; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Xie QA, 2011, P NATL ACAD SCI USA, V108, P4105, DOI 10.1073/pnas.1015181108; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U	43	52	53	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71135	10.1371/journal.pone.0071135	http://dx.doi.org/10.1371/journal.pone.0071135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015183	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800005
J	Hussein, SZ; Yusoff, KM; Makpol, S; Yusof, YAM				Hussein, Saba Zuhair; Yusoff, Kamaruddin Mohd; Makpol, Suzana; Yusof, Yasmin Anum Mohd			Gelam Honey Attenuates Carrageenan-Induced Rat Paw Inflammation via NF-kappa B Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ANTIINFLAMMATORY ACTIVITY; ANTIBACTERIAL ACTIVITY; TRANSCRIPTION FACTOR; GAMMA-IRRADIATION; TNF-ALPHA; IN-VIVO; ANTIOXIDANT; CURCUMIN; CYCLOOXYGENASE-2	The activation of nuclear factor kappa B (NF-kappa B) plays a major role in the pathogenesis of a number of inflammatory diseases. In this study, we investigated the anti-inflammatory mechanism of Gelam honey in inflammation induced rats via NF-kappa B signalling pathway. Rats paw edema was induced by subplantar injection of 1% carrageenan into the right hind paw. Rats were pre-treated with Gelam honey at different doses (1 or 2 g/kg, p.o.) and NSAID Indomethacin (10 mg/kg, p.o.), in two time points (1 and 7 days). Our results showed that Gelam honey at both concentrations suppressed the gene expressions of NF-kappa B (p65 & p50) and I kappa B alpha in inflamed rats paw tissues. In addition, Gelam honey inhibited the nuclear translocation and activation of NF-kappa B and decreased the cytosolic degradation of I kappa B alpha dose dependently in inflamed rats paw tissues. The immunohistochemical expressions of pro-inflammatory mediators COX-2 and TNF-alpha were also decreased in inflamed rats paw tissues when treated with Gelam honey. The results of our findings suggest that Gelam honey exhibits its inhibitory effects by attenuating NF-kappa B translocation to the nucleus and inhibiting I kappa B alpha degradation, with subsequent decrease of inflammatory mediators COX-2 and TNF-alpha.	[Hussein, Saba Zuhair; Makpol, Suzana; Yusof, Yasmin Anum Mohd] Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Kuala Lumpur, Malaysia; [Yusoff, Kamaruddin Mohd] Canik Basari Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Samsun, Turkey	Universiti Kebangsaan Malaysia; Canik Basari University	Yusof, YAM (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Kuala Lumpur, Malaysia.	anum@medic.ukm.my	MAKPOL, SUZANA/AAN-4709-2021; Hussein, Saba Zuhair/Y-9096-2019	Hussein, Saba Zuhair/0000-0002-6750-8437	Universiti Kebangsaan Malaysia [FF-03-FRGS0039-2010]; Universiti Kebangsaan Malaysia Fundamental Fund [FF-156-2010]	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia Fundamental Fund	This research was supported financially by the Fundamental Research Grant Scheme, (FF-03-FRGS0039-2010) Universiti Kebangsaan Malaysia, and Universiti Kebangsaan Malaysia Fundamental Fund (FF-156-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Waili NS, 2011, THESCIENTIFICWORLDJO, V11, P766, DOI 10.1100/tsw.2011.78; Ali Abu Taib Mohammad Mobarok, 2003, Saudi J Gastroenterol, V9, P117; Alvarez-Suarez JM, 2012, FOOD CHEM TOXICOL, V50, P1508, DOI 10.1016/j.fct.2012.01.042; Alvarez-Suarez JM, 2010, FOOD CHEM TOXICOL, V48, P2490, DOI 10.1016/j.fct.2010.06.021; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; Batumalaie K, 2014, CLIN EXP MED, V14, P185, DOI 10.1007/s10238-013-0236-7; Blasa M, 2006, FOOD CHEM, V97, P217, DOI 10.1016/j.foodchem.2005.03.039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Cha DS, 2011, J ETHNOPHARMACOL, V134, P305, DOI 10.1016/j.jep.2010.12.017; Chang Heng-Yuan, 2011, Evid Based Complement Alternat Med, V2011, P478246, DOI 10.1093/ecam/nep027; Chen F, 1999, CLIN CHEM, V45, P7; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Cuzzocrea S, 2006, J LEUKOCYTE BIOL, V79, P999, DOI 10.1189/jlb.0605341; Estevinho L, 2008, FOOD CHEM TOXICOL, V46, P3774, DOI 10.1016/j.fct.2008.09.062; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goncalves DO, 2011, BRAZ J MED BIOL RES, V44, P173, DOI 10.1590/S0100-879X2011007500001; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Gyurkovska V, 2011, FOOD CHEM, V125, P171, DOI 10.1016/j.foodchem.2010.08.056; Habib SHM, 2008, CLINICS, V63, P807, DOI 10.1590/S1807-59322008000600017; Himaya SWA, 2011, EUR J PHARMACOL, V670, P608, DOI 10.1016/j.ejphar.2011.09.013; Hsu A, 2011, J NUTR BIOCHEM, V22, P502, DOI 10.1016/j.jnutbio.2010.04.006; Hung TM, 2009, BIOORG MED CHEM LETT, V19, P4389, DOI 10.1016/j.bmcl.2009.05.070; Hussein SZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/109636; Hussein SZ, 2011, MOLECULES, V16, P6378, DOI [10.3390/molecules16086378, 10.3390/molecules16066378]; Igbe I, 2010, ACTA POL PHARM, V67, P81; Irish J, 2008, INT J ANTIMICROB AG, V32, P89, DOI 10.1016/j.ijantimicag.2008.02.012; Iwalewa EO, 2007, AFR J BIOTECHNOL, V6, P2868; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kassim M, 2010, FITOTERAPIA, V81, P1196, DOI 10.1016/j.fitote.2010.07.024; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Leal WS, 2013, P NATL ACAD SCI USA, V110, P8763, DOI 10.1073/pnas.1306617110; Lee CW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/892943; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Lucetti DL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-60; Molan P, 2001, BEE WORLD, V82, P22, DOI 10.1080/0005772X.2001.11099498; Molan PC, 1996, J PHARM PHARMACOL, V48, P1206, DOI 10.1111/j.2042-7158.1996.tb03922.x; Mueller M, 2010, FOOD CHEM, V122, P987, DOI 10.1016/j.foodchem.2010.03.041; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Nantel F, 1999, BRIT J PHARMACOL, V128, P853, DOI 10.1038/sj.bjp.0702866; Oh BK, 2011, J ETHNOPHARMACOL, V134, P288, DOI 10.1016/j.jep.2010.12.020; Orhan F, 2003, ANN ALLERG ASTHMA IM, V90, P611, DOI 10.1016/S1081-1206(10)61864-9; Owoyele Bamidele Victor, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P447, DOI 10.3736/jcim20110415; Park KI, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/828521; Park SJ, 2002, CELL BIOL TOXICOL, V18, P121, DOI 10.1023/A:1015384201785; Park YM, 2006, BIOL PHARM BULL, V29, P985, DOI 10.1248/bpb.29.985; Patricia V., 2002, APIACTA, V3, P1; Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067; Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Schramm DD, 2003, J AGR FOOD CHEM, V51, P1732, DOI 10.1021/jf025928k; Sindhu G, 2012, INT IMMUNOPHARMACOL, V12, P205, DOI 10.1016/j.intimp.2011.11.012; Swellam T, 2003, INT J UROL, V10, P213, DOI 10.1046/j.0919-8172.2003.00602.x; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tan HT, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-34; Ukil A, 2003, BRIT J PHARMACOL, V139, P209, DOI 10.1038/sj.bjp.0705241; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005; Zhou YH, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/92642	69	66	69	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72365	10.1371/journal.pone.0072365	http://dx.doi.org/10.1371/journal.pone.0072365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015236	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800048
J	Ponce, E; Aquino, NB; Louie, MC				Ponce, Esmeralda; Aquino, Natalie B.; Louie, Maggie C.			Chronic Cadmium Exposure Stimulates SDF-1 Expression in an ER alpha Dependent Manner	PLOS ONE			English	Article							BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; CYCLIN D1 GENE; TARGET GENES; HEAVY-METALS; TUMOR-CELLS; IN-VIVO; C-JUN; ACTIVATION; TRANSCRIPTION	Cadmium is an omnipotent environmental contaminant associated with the development of breast cancer. Studies suggest that cadmium functions as an endocrine disruptor, mimicking the actions of estrogen in breast cancer cells and activating the receptor to promote cell growth. Although acute cadmium exposure is known to promote estrogen receptor-mediated gene expression associated with growth, the consequence of chronic cadmium exposure is unclear. Since heavy metals are known to bioaccumulate, it is necessary to understand the effects of prolonged cadmium exposure. This study aims to investigate the effects of chronic cadmium exposure on breast cancer progression. A MCF7 breast cancer cell line chronically exposed to 10(-7) M CdCl2 serves as our model system. Data suggest that prolonged cadmium exposures result in the development of more aggressive cancer phenotypes - increased cell growth, migration and invasion. The results from this study show for the first time that chronic cadmium exposure stimulates the expression of SDF-1 by altering the molecular interactions between ER alpha, c-jun and c-fos. This study provides a mechanistic link between chronic cadmium exposure and ER alpha and demonstrates that prolonged, low-level cadmium exposure contributes to breast cancer progression.	[Ponce, Esmeralda; Aquino, Natalie B.; Louie, Maggie C.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA USA		Louie, MC (corresponding author), Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA USA.	maggie.louie@dominican.edu		Ponce, Esmeralda/0000-0002-4174-356X	National Science Foundation [1039728]; National Cancer Institute [CA121983-02, CA121983-02S1]; NATIONAL CANCER INSTITUTE [R15CA121983] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Science Foundation (1039728 to MCL) and the National Cancer Institute (CA121983-02 to MCL and CA121983-02S1 to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 2001, CANCER RES, V61, P455; Ali I, 2010, ENVIRON HEALTH PERSP, V118, P1389, DOI 10.1289/ehp.1001967; Alonso-Gonzalez C, 2007, J PINEAL RES, V42, P403, DOI 10.1111/j.1600-079X.2007.00434.x; Antila E, 1996, SCI TOTAL ENVIRON, V186, P251, DOI 10.1016/0048-9697(96)05119-4; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Choe SY, 2003, SCI TOTAL ENVIRON, V312, P15, DOI 10.1016/S0048-9697(03)00190-6; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; GUNN SA, 1964, P SOC EXP BIOL MED, V115, P653; Haga A, 1996, EUR J CANCER, V32A, P2342, DOI 10.1016/S0959-8049(96)00349-8; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hofer N, 2009, TOXICOL LETT, V191, P123, DOI 10.1016/j.toxlet.2009.08.014; Ionescu JG, 2006, NEUROENDOCRINOL LETT, V27, P36; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; Mukherjee D, 2013, AM J CANCER RES, V3, P46; POIRIER LA, 1983, CANCER RES, V43, P4575; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Romanowicz-Makowska H, 2011, POL J PATHOL, V62, P257; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Siewit CL, 2010, MOL ENDOCRINOL, V24, P981, DOI 10.1210/me.2009-0410; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Strumylaite L, 2008, MEDICINA-LITHUANIA, V44, P415, DOI 10.3390/medicina44060054; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Waalkes MP, 1999, CARCINOGENESIS, V20, P65, DOI 10.1093/carcin/20.1.65; Waalkes MP, 2000, TOXICOL SCI, V54, P110, DOI 10.1093/toxsci/54.1.110; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Yu XY, 2010, TOXICOL APPL PHARM, V245, P83, DOI 10.1016/j.taap.2010.02.005; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	39	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72639	10.1371/journal.pone.0072639	http://dx.doi.org/10.1371/journal.pone.0072639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015267	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800072
J	Roodenburg, AJC; van Ballegooijen, AJ; Dotsch-Klerk, M; van der Voet, H; Seidell, JC				Roodenburg, Annet J. C.; van Ballegooijen, Adriana J.; Dotsch-Klerk, Mariska; van der Voet, Hilko; Seidell, Jacob C.			Modelling of Usual Nutrient Intakes: Potential Impact of the Choices Programme on Nutrient Intakes in Young Dutch Adults	PLOS ONE			English	Article							SATURATED FAT; FOODS; FRONT; SIMULATION; PROFILES; CRITERIA; IMPROVE; ENERGY; LOGO	Introduction: The Choices Programme is an internationally applicable nutrient profiling system with nutrition criteria for trans fatty acids (TFA), saturated fatty acids, sodium, added sugar and for some product groups energy and fibre. These criteria determine whether foods are eligible to carry a "healthier option" stamp. In this paper a nutrient intake modelling method is described to evaluate these nutritional criteria by investigating the potential effect on nutrient intakes. Methods: Data were combined from the 2003 Dutch food consumption survey in young adults (aged 19-30) and the Dutch food composition table into the Monte Carlo Risk Assessment model. Three scenarios were calculated: the "actual intakes" (scenario 1) were compared to scenario 2, where all foods that did not comply were replaced by similar foods that did comply with the Choices criteria. Scenario 3 was the same as scenario 2 adjusted for the difference in energy density between the original and replacement food. Additional scenarios were calculated where snacks were not or partially replaced and stratified analyses for gender, age, Body Mass Index (BMI) and education. Results: Calculated intake distributions showed that median energy intake was reduced by 16% by replacing normally consumed foods with Choices compliant foods. Intakes of nutrients with a maximal intake limit were also reduced (ranging from -23% for sodium and -62% for TFA). Effects on intakes of beneficial nutrients varied from an unintentional reduction in fat soluble vitamin intakes (-15 to -28%) to an increase of 28% for fibre and 17% calcium. Stratified analyses in this homogeneous study population showed only small differences across gender, age, BMI and education. Conclusions: This intake modelling method showed that with consumption of Choices compliant foods, nutrient intakes shift towards population intake goals for the nutrients for which nutrition criteria were defined, while effects on beneficial nutrients were diverse.	[Roodenburg, Annet J. C.; van Ballegooijen, Adriana J.; Dotsch-Klerk, Mariska] Unilever, Unilever Res & Dev Vlaardingen, Vlaardingen, Netherlands; [Roodenburg, Annet J. C.; Seidell, Jacob C.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Roodenburg, Annet J. C.] HAS Univ Appl Sci, Sect Food, Den Bosch, Netherlands; [van Ballegooijen, Adriana J.] Wageningen UR, Dept Human Nutr, Wageningen, Netherlands; [van der Voet, Hilko] Wageningen UR, Biometris, Wageningen, Netherlands	Unilever; Vrije Universiteit Amsterdam; Wageningen University & Research; Wageningen University & Research	Roodenburg, AJC (corresponding author), Unilever, Unilever Res & Dev Vlaardingen, Vlaardingen, Netherlands.	a.roodenburg@has.nl	van der Voet, Hilko/W-8531-2019; seidell, jacob/AAF-5362-2019; van der Voet, Hilko/A-4073-2013; seidell, jacob c/N-7427-2013	van der Voet, Hilko/0000-0003-0802-7382; seidell, jacob/0000-0002-9262-9062; van der Voet, Hilko/0000-0003-0802-7382; 	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant of The Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural Research Service USDA, 2008, NAT NUTR DAT STAND R; [Anonymous], 2006, NEVO TAB NED VOED; Beaton G.H, 1994, CRITERIA ADEQUATE DI, P1491; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; De Boer W.J., 2011, WEB BASED PROGRAM MO; de Boer WJ, 2009, FOOD ADDIT CONTAM A, V26, P1433, DOI 10.1080/02652030903161606; de Lauzon B, 2004, PUBLIC HEALTH NUTR, V7, P893, DOI 10.1079/PHN2004616; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Drewnowski A, 2008, J FOOD SCI, V73, pH222, DOI 10.1111/j.1750-3841.2008.00963.x; *FAO WHO, 2003, WHO TECH REP SER, V916; Health Council of the Netherlands, 2006, HLTH COUNC NETH PUBL; Heerstrass DW, 1998, INT J EPIDEMIOL, V27, P186, DOI 10.1093/ije/27.2.186; Holt R, 2003, DIABETES OBES METAB, V5, P354, DOI 10.1046/j.1463-1326.2003.00247.x; Institute of Medicine (IOM), 2000, DIET REF INT APPL DI; King JC, 2007, FOOD NUTR BULL, V28, pS16, DOI 10.1177/15648265070281S103; Lloyd-Williams F, 2009, PUBLIC HEALTH NUTR, V12, P871, DOI 10.1017/S1368980008003054; *NAT HEART FDN NZ, 2002, PICK TICK FOOD INF P; Nijman CAJ, 2007, EUR J CLIN NUTR, V61, P461, DOI 10.1038/sj.ejcn.1602548; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Ocke M.C., 2004, FOOD CONSUMPTION SUR; Roodenburg AJC, 2011, EUR J CLIN NUTR, V65, P1190, DOI 10.1038/ejcn.2011.101; Roodenburg AJC, 2009, NUTR BULL, V34, P318, DOI 10.1111/j.1467-3010.2009.01767.x; Roodenburg AJC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014721; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P330, DOI 10.1017/S1368980007223870; Schakel Sally F., 1997, Journal of Food Composition and Analysis, V10, P102, DOI 10.1006/jfca.1997.0527; Schickenberg B, 2009, BRIT J NUTR, V102, P478, DOI 10.1017/S0007114508190298; Temme EHM, 2011, PUBLIC HEALTH NUTR, V14, P635, DOI 10.1017/S1368980010002089; Trichterborn J, 2012, EUR J CLIN NUTR, V66, P466, DOI 10.1038/ejcn.2011.180; van der Voet H, 2007, FOOD CHEM TOXICOL, V45, P1496, DOI 10.1016/j.fct.2007.02.009; van Rossum CTM., 2011, 3500500062011 NAT I; Vyth EL, 2012, EUR J CLIN NUTR, V66, P510, DOI 10.1038/ejcn.2011.193; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; Vyth EL, 2009, J HEALTH COMMUN, V14, P631, DOI 10.1080/10810730903204247; Waxman Amalia, 2004, Food and Nutrition Bulletin, V25, P292	35	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72378	10.1371/journal.pone.0072378	http://dx.doi.org/10.1371/journal.pone.0072378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015237	Green Submitted, Green Published, gold			2022-12-25	WOS:000323733800049
J	Scott, CA; Iyer, HS; Bwalya, DL; Bweupe, M; Rosen, SB; Scott, N; Larson, BA				Scott, Callie A.; Iyer, Hari S.; Bwalya, Deophine Lembela; Bweupe, Maximillian; Rosen, Sydney B.; Scott, Nancy; Larson, Bruce A.			Uptake, Outcomes, and Costs of Antenatal, Well-Baby, and Prevention of Mother-to-Child Transmission of HIV Services under Routine Care Conditions in Zambia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY	Background: Zambia adopted Option A for prevention of mother-to-child transmission of HIV (PMTCT) in 2010 and announced a move to Option B+ in 2013. We evaluated the uptake, outcomes, and costs of antenatal, well-baby, and PMTCT services under routine care conditions in Zambia after the adoption of Option A. Methods: We enrolled 99 HIV-infected/HIV-exposed (index) mother/baby pairs with a first antenatal visit in April-September 2011 at four study sites and 99 HIV-uninfected/HIV-unexposed (comparison) mother/baby pairs matched on site, gestational age, and calendar month at first visit. Data on patient outcomes and resources utilized from the first antenatal visit through six months postpartum were extracted from site registers. Costs in 2011 USD were estimated from the provider's perspective. Results: Index mothers presented for antenatal care at a mean 23.6 weeks gestation; 55% were considered to have initiated triple-drug antiretroviral therapy (ART) based on information recorded in site registers. Six months postpartum, 62% of index and 30% of comparison mother/baby pairs were retained in care; 67% of index babies retained had an unknown HIV status. Comparison and index mother/baby pairs utilized fewer resources than under fully guideline-concordant care; index babies utilized more well-baby resources than comparison babies. The average cost per comparison pair retained in care six months postpartum was $52 for antenatal and well-baby services. The average cost per index pair retained was $88 for antenatal, well-baby, and PMTCT services and increased to $185 when costs of triple-drug ART services were included. Conclusions: HIV-infected mothers present to care late in pregnancy and many are lost to follow up by six months postpartum. HIV-exposed babies are more likely to remain in care and receive non-HIV, well-baby care than HIV-unexposed babies. Improving retention in care, guideline concordance, and moving to Option B+ will result in increased service delivery costs in the short term.	[Scott, Callie A.; Rosen, Sydney B.; Scott, Nancy; Larson, Bruce A.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Scott, Callie A.; Iyer, Hari S.; Bwalya, Deophine Lembela] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia; [Bweupe, Maximillian] Zambian Minist Hlth, Lusaka, Zambia; [Rosen, Sydney B.] Univ Witwatersrand, Fac Hlth Sci, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Larson, Bruce A.] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA 02215 USA	Boston University; University of Zambia; University of Witwatersrand; Boston University	Larson, BA (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	blarson@bu.edu	Iyer, Hari S./AAZ-1563-2020	Rosen, Sydney/0000-0002-6560-2964; Scott, Nancy/0000-0002-4713-4642; Larson, Bruce/0000-0002-9322-2387	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U2GPS001418-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (5U2GPS001418-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, HIGH POSS COST COVID; Binagwaho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054180; Bratt JH, 2011, TROP MED INT HEALTH, V16, P110, DOI 10.1111/j.1365-3156.2010.02640.x; Chi BH, 2011, INT J GYNECOL OBSTET, V113, P131, DOI 10.1016/j.ijgo.2010.11.013; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Government of the Republic of Zambia Ministry of Health, 2010, 2010 NAT PROT GUID I; Government of the Republic of Zambia Ministry of Health, 2013, LIF ANT DRUGS ARVS A; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; International Monetary Fund, 2012, WORLD EC OUTL DAT OC; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Limited MS, 2010, MED STOR LTD 2010 CA; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Oanda Corporation, 2012, HIST EXCH RAT DAIL M; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; Torpey K, 2010, JAIDS-J ACQ IMM DEF, V54, P415, DOI 10.1097/QAI.0b013e3181e36616; Torpey K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-29; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2021, ANT DRUGS TREAT PREG	22	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72444	10.1371/journal.pone.0072444	http://dx.doi.org/10.1371/journal.pone.0072444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015245	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800053
J	Raisanen, S; Cartwright, R; Gissler, M; Kramer, MR; Heinonen, S				Raisanen, Sari; Cartwright, Rufus; Gissler, Mika; Kramer, Michael R.; Heinonen, Seppo			The Burden of OASIS Increases along with Socioeconomic Position - Register-Based Analysis of 980,733 Births in Finland	PLOS ONE			English	Article							RISK-FACTORS; SPHINCTER INJURY; URINARY-INCONTINENCE; MEDIOLATERAL EPISIOTOMY; NORDIC COUNTRIES; SMOKING; PREVALENCE; PREGNANCY; WOMEN; RUPTURES	Background: Obstetric anal sphincter injury (OASIS) has been identified as a major preventable risk factor for anal incontinence. Objective: Aim was to measure national variation in incidence of OASIS by socioeconomic status (SES). Methods: A retrospective population based case-control study using the data derived from the Finnish Medical Birth Register for the years 1991-2010. A total population of singleton vaginal births was reviewed. We calculated unadjusted incidences of OASIS stratified by SES and vaginal parity, and adjusted risks for OASIS in each social class, after controlling for parity, birthweight, mode of delivery, maternal age and maternal smoking. SES was recorded into five categories based on mother's occupation at time of birth; upper white-collar workers such as physicians, lower white-collar workers such as nurses, blue-collar workers such as cleaners, others such as students, and cases with missing information. Results: Seven per thousand (6,404 of 980,733) singleton births were affected by OASIS. In nulliparae the incidence of OASIS was 18% higher (adjusted OR 1.18 95% CI 1.04-1.34) for upper white-collar workers and 12% higher (adjusted OR 1.12 95% CI 1.02-1.24) for lower white-collar workers compared with blue-collar workers. Among women in these higher SES groups, 40% of the excess OASIS risk was explained by age, non-smoking, birthweight and mode of delivery. Despite the large effect of SES on OASIS, inclusion of SES in multivariable models caused only small changes in estimated adjusted effects for other established risk factors. Conclusions: OASIS at the first vaginal delivery demonstrates a strong positive social gradient. Higher SES is associated with a number of risk factors for OASIS, including higher birthweight and non-smoking, but only 40% of the excess incidence is explained by these known risk factors. Further research should address other underlying causes including differences in lifestyle or environmental factors, and inequalities in healthcare provision.	[Raisanen, Sari; Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland; [Cartwright, Rufus] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Gissler, Mika] Natl Inst Hlth & Welf THL, Dept Informat, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Kramer, Michael R.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Heinonen, Seppo] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Imperial College London; Finland National Institute for Health & Welfare; Emory University; Rollins School Public Health; University of Eastern Finland	Raisanen, S (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland.	shraisan@student.uef.fi	Kramer, Michael R/A-3195-2013	Kramer, Michael R/0000-0002-6372-6170; Gissler, Mika/0000-0001-8254-7525; Cartwright, Rufus/0000-0001-5501-319X	National Institute for Health Research [ACF-2008-21-040] Funding Source: researchfish; Medical Research Council [MR/K006525/1, G1100377] Funding Source: Medline; MRC [G1100377, MR/K006525/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrews V, 2006, BIRTH-ISS PERINAT C, V33, P117, DOI 10.1111/j.0730-7659.2006.00088.x; Aukee P, 2006, ACTA OBSTET GYN SCAN, V85, P856, DOI 10.1080/00016340500408283; Baghestan E, 2010, OBSTET GYNECOL, V116, P25, DOI 10.1097/AOG.0b013e3181e2f50b; BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Braekken IH, 2009, BJOG-INT J OBSTET GY, V116, P1706, DOI 10.1111/j.1471-0528.2009.02379.x; Cartwright R, 2010, BJOG-INT J OBSTET GY, V117, P627; Dandolu V, 2005, INT UROGYNECOL J, V16, P304, DOI 10.1007/s00192-005-1297-2; de Leeuw JW, 2008, BJOG-INT J OBSTET GY, V115, P104, DOI 10.1111/j.1471-0528.2007.01554.x; de Leeuw JW, 2001, BRIT J OBSTET GYNAEC, V108, P383, DOI 10.1016/S0306-5456(00)00090-5; Dudding TC, 2008, ANN SURG, V247, P224, DOI 10.1097/SLA.0b013e318142cdf4; FitzGerald MP, 2007, OBSTET GYNECOL, V109, P29, DOI 10.1097/01.AOG.0000242616.56617.ff; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; Gissler M., 2004, NOR EPIDEMIOL, V14, P113; Handa VL, 2001, OBSTET GYNECOL, V98, P225, DOI 10.1016/S0029-7844(01)01445-4; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Jaakkola N, 2001, AM J PUBLIC HEALTH, V91, P284, DOI 10.2105/AJPH.91.2.284; Keyes KM, 2013, SOC SCI MED, V76, P101, DOI 10.1016/j.socscimed.2012.10.011; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Laine K, 2013, ACTA OBSTET GYN SCAN, V92, P94, DOI 10.1111/aogs.12024; Laine K, 2009, EUR J OBSTET GYN R B, V146, P71, DOI 10.1016/j.ejogrb.2009.04.033; Larranaga I, 2012, MATERN CHILD HLTH J, DOI [10.1007/s10995-012-1134-4, DOI 10.1007/S10995-012-1134-4.IN]; Mishra GD, 2010, BJU INT, V106, P1170, DOI 10.1111/j.1464-410X.2010.09321.x; Mortensen LH, 2010, SCAND J PUBLIC HEALT, V38, P40, DOI 10.1177/1403494809353820; Nygaard I, 2004, OBSTET GYNECOL, V104, P489, DOI 10.1097/01.AOG.0000136100.10818.d8; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Raisanen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041014; Raisanen SH, 2009, ACTA OBSTET GYN SCAN, V88, P1365, DOI 10.3109/00016340903295626; Revicky V, 2010, EUR J OBSTET GYN R B, V150, P142, DOI 10.1016/j.ejogrb.2010.03.002; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; Samuelsson E, 2000, BRIT J OBSTET GYNAEC, V107, P926, DOI 10.1111/j.1471-0528.2000.tb11093.x; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Sultan AH, 1999, CLIN RISK, V5, P193, DOI DOI 10.1177/135626229900500601; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tahtinen RM, 2011, OBSTET GYNECOL, V118, P643, DOI 10.1097/AOG.0b013e318227b7ac; Townsend MK, 2013, AM J GASTROENTEROL, V108, P113, DOI 10.1038/ajg.2012.364; Woodman PJ, 2006, INT UROGYNECOL J, V17, P340, DOI 10.1007/s00192-005-0009-2	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73515	10.1371/journal.pone.0073515	http://dx.doi.org/10.1371/journal.pone.0073515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24013645	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200082
J	De, DD; Datta, A; Bhattacharjya, S; Roychoudhury, S				De, Dipanjana Datta; Datta, Arindam; Bhattacharjya, Sumana; Roychoudhury, Susanta			NF-kappaB Mediated Transcriptional Repression of Acid Modifying Hormone Gastrin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEATH GENE BNIP3; B ACTIVATION; HELICOBACTER-PYLORI; IKK-BETA; PHOSPHORYLATION; RECEPTOR; P65; INDUCTION; SUBUNIT	Helicobacter pylori is a major pathogen associated with the development of gastroduodenal diseases. It has been reported that H. pylori induced pro-inflammatory cytokine IL1B is one of the various modulators of acid secretion in the gut. Earlier we reported that IL1B-activated NFkB down-regulates gastrin, the major hormonal regulator of acid secretion. In this study, the probable pathway by which IL1B induces NFkB and affects gastrin expression has been elucidated. IL1B-treated AGS cells showed nine-fold activation of MyD88 followed by phosphorylation of TAK1 within 15 min of IL1B treatment. Furthermore, it was observed that activated TAK1 significantly up-regulates the NFkB subunits p50 and p65. Ectopic expression of NFkB p65 in AGS cells resulted in about nine-fold transcriptional repression of gastrin both in the presence and absence of IL1B. The S536A mutant of NFkB p65 is significantly less effective in repressing gastrin. These observations show that a functional NFkB p65 is important for IL1B-mediated repression of gastrin. ChIP assays revealed the presence of HDAC1 and NFkB p65 along with NCoR on the gastrin promoter. Thus, the study provides mechanistic insight into the IL1B-mediated gastrin repression via NFkB.	[De, Dipanjana Datta; Datta, Arindam; Bhattacharjya, Sumana; Roychoudhury, Susanta] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roychoudhury, S (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India.	susanta@iicb.res.in	Datta, Arindam/ADR-8763-2022; Roychoudhury, Susanta/AAD-7946-2021	Datta, Arindam/0000-0002-0617-9908; 	Indian Council of Medical Research [63/147/2001-BMS]; Council of Scientific and Industrial Research, India [IAP 001]; Council of Scientific and Industrial Research, India; University Grant Commission, India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, India(University Grants Commission, India)	This study was partially supported by research grants from the Indian Council of Medical Research (63/147/2001-BMS) and the Council of Scientific and Industrial Research, India (IAP 001), awarded to SR. DDD and AD are supported by research fellowship form Council of Scientific and Industrial Research, India. SB is supported by fellowship from University Grant Commission, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BARON JH, 1998, CLIN TESTS GASTRIC S; Beales ILP, 2000, DIGEST DIS SCI, V45, P289, DOI 10.1023/A:1005452307860; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Chakravorty M, 2009, INT J BIOCHEM CELL B, V41, P1502, DOI 10.1016/j.biocel.2008.12.017; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Datta De D, 2011, PLOS ONE, V6, pe14775, DOI [10.1371/journal.pone.0014775, DOI 10.1371/J0URNAL.P0NE.0014775.PUBMED:21445336]; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Harris AW, 1996, GUT, V38, P663, DOI 10.1136/gut.38.5.663; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; ISRAEL A, 1995, TRENDS GENET, V11, P203, DOI 10.1016/S0168-9525(00)89045-9; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Morlon A, 2005, HUM MOL GENET, V14, P3751, DOI 10.1093/hmg/ddi405; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nedrud JG, 1997, GASTROENTEROLOGY, V112, P670, DOI 10.1053/gast.1997.v112.agast970670a; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Seto E, 2003, METHODS, V31, P1, DOI 10.1016/S1046-2023(03)00081-1; Shaw J, 2006, CIRC RES, V99, P1347, DOI 10.1161/01.RES.0000251744.06138.50; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Tominaga K, 2000, ALIMENT PHARM THERAP, V14, P101, DOI 10.1046/j.1365-2036.2000.014s1101.x; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	43	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73409	10.1371/journal.pone.0073409	http://dx.doi.org/10.1371/journal.pone.0073409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009751	Green Submitted, Green Published, gold			2022-12-25	WOS:000324403200049
J	Weaver, EA; Barry, MA				Weaver, Eric A.; Barry, Michael A.			Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; NEUTRALIZING ANTIBODIES; GENE-THERAPY; VIRUS; VACCINATION; INTRANASAL; CHILDREN; TRANSMISSION; ADAPTATION; EFFICACY	Seasonal and pandemic influenza remains a constant threat. While standard influenza vaccines have great utility, the need for improved vaccine technologies have been brought to light by the 2009 swine flu pandemic, highly pathogenic avian influenza infections, and the most recent early and widespread influenza activity. Species C adenoviruses based on serotype 5 (AD5) are potent vehicles for gene-based vaccination. While potent, most humans are already immune to this virus. In this study, low seroprevalent species D adenoviruses Ad26, 28, and 48 were cloned and modified to express the influenza virus A/PR/8/34 hemagglutinin gene for vaccine studies. When studied in vivo, these species D Ad vectors performed quite differently as compared to species C Ad vectors depending on the route of immunization. By intramuscular injection, species D vaccines were markedly weaker than species C vaccines. In contrast, the species D vaccines were equally efficient as species C when delivered mucosally by the intranasal route. Intranasal adenovirus vaccine doses as low as 10(8) virus particles per mouse induced complete protection against a stringent lethal challenge dose of influenza. These data support translation of species D adenoviruses as mucosal vaccines and highlight the fundamental effects of differences in virus tropism on vaccine applications.	[Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Translat Immunovirol & Biodefense Program, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Weaver, EA (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	weaver.eric@mayo.edu			National Institutes of Health National Institute of Allergy and Infectious Diseases [AI097241]; Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097241] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health National Institute of Allergy and Infectious Diseases grant AI097241 and the Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Anne Schuchat MDMD, 2011, H1N1 PREPAREDNESS OV; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Bardiya N, 2005, APPL MICROBIOL BIOT, V67, P299, DOI 10.1007/s00253-004-1874-1; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Belsey MJ, 2006, NAT REV DRUG DISCOV, V5, P183, DOI 10.1038/nrd1988; Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1; Campos SK, 2004, HUM GENE THER, V15, P1125, DOI 10.1089/1043034042431182; Campos SK, 2004, MOL THER, V9, P942, DOI 10.1016/j.ymthe.2004.03.006; Check E, 2005, NATURE, V435, P404, DOI 10.1038/435404a; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Daems R, 2005, VACCINE, V23, P5732, DOI 10.1016/j.vaccine.2005.10.011; Esparza J, 2013, EXPERT REV VACCINES, V12, P477, DOI [10.1586/ERV.13.26, 10.1586/erv.13.26]; GITELMAN AK, 1984, VIROLOGY, V134, P230, DOI 10.1016/0042-6822(84)90288-5; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holterman L, 2004, J VIROL, V78, P13207, DOI 10.1128/JVI.78.23.13207-13215.2004; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Lin SW, 2007, VACCINE, V25, P2187, DOI 10.1016/j.vaccine.2006.11.044; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Muszkat M, 2003, VACCINE, V21, P1180, DOI 10.1016/S0264-410X(02)00481-4; Muszkat M, 2000, VACCINE, V18, P1696, DOI 10.1016/S0264-410X(99)00509-5; Nicholson KG, 2003, PEDIATR INFECT DIS J, V22, pS228, DOI 10.1097/01.inf.0000092193.91306.2f; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Potter C W, 1977, Dev Biol Stand, V39, P323; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Subbarao K, 1999, ADV VIRUS RES, V54, P349, DOI 10.1016/S0065-3527(08)60371-1; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Weaver EA, 2011, VIROLOGY, V412, P19, DOI 10.1016/j.virol.2010.10.041; WOOD JM, 1985, AVIAN DIS, V29, P867, DOI 10.2307/1590681; Zhang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022605	42	35	36	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73313	10.1371/journal.pone.0073313	http://dx.doi.org/10.1371/journal.pone.0073313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991187	Green Published, gold			2022-12-25	WOS:000324470700061
J	Wolf, EV; Zeissler, A; Vosyka, O; Zeiler, E; Sieber, S; Verhelst, SHL				Wolf, Eliane V.; Zeissler, Annett; Vosyka, Oliver; Zeiler, Evelyn; Sieber, Stephan; Verhelst, Steven H. L.			A New Class of Rhomboid Protease Inhibitors Discovered by Activity-Based Fluorescence Polarization	PLOS ONE			English	Article							ACTIVITY-BASED PROBES; INTRAMEMBRANE SERINE PROTEASES; BETA-LACTONES; LISTERIA-MONOCYTOGENES; STRUCTURAL BASIS; PROTEOLYSIS; GLPG; MECHANISM; FAMILY; SPECIFICITY	Rhomboids are intramembrane serine proteases that play diverse biological roles, including some that are of potential therapeutical relevance. Up to date, rhomboid inhibitor assays are based on protein substrate cleavage. Although rhomboids have an overlapping substrate specificity, substrates cannot be used universally. To overcome the need for substrates, we developed a screening assay using fluorescence polarization activity-based protein profiling (FluoPol ABPP) that is compatible with membrane proteases. With FluoPol ABPP, we identified new inhibitors for the E. coli rhomboid GlpG. Among these was a structural class that has not yet been reported as rhomboid inhibitors: beta-lactones. They form covalent and irreversible complexes with the active site serine of GlpG. The presence of alkyne handles on the beta-lactones also allowed activity-based labeling. Overall, these molecules represent a new scaffold for future inhibitor and activity-based probe development, whereas the assay will allow inhibitor screening of ill-characterized membrane proteases.	[Wolf, Eliane V.; Zeissler, Annett; Vosyka, Oliver; Verhelst, Steven H. L.] Tech Univ Munich, Lehrstuhl Chem Biopolymere, Freising Weihenstephan, Germany; [Zeiler, Evelyn; Sieber, Stephan] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Inst Adv Studies, Dept Chem, Garching, Germany	Technical University of Munich; Technical University of Munich	Verhelst, SHL (corresponding author), Tech Univ Munich, Lehrstuhl Chem Biopolymere, Freising Weihenstephan, Germany.	verhelst@wzw.tum.de		Verhelst, Steven/0000-0002-7400-1319	Elite Network of Bavaria; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft [VE502/1-1]	Elite Network of Bavaria; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a research scholarschip of the Elite Network of Bavaria (to EVW), the Center for Integrated Protein Science Munich (to SAS and SHV), and an Emmy Noether Grant of the Deutsche Forschungsgemeinschaft VE502/1-1 (to SHV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bachovchin DA, 2010, BIOORG MED CHEM LETT, V20, P2254, DOI 10.1016/j.bmcl.2010.02.011; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Bottcher T, 2009, CHEMMEDCHEM, V4, P1260, DOI 10.1002/cmdc.200900157; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Haedke U, 2012, BIOORGAN MED CHEM, V20, P633, DOI 10.1016/j.bmc.2011.03.014; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2011, TRAFFIC, V12, P1109, DOI 10.1111/j.1600-0854.2011.01219.x; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lone AM, 2011, J AM CHEM SOC, V133, P11665, DOI 10.1021/ja2036095; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Pierrat OA, 2011, ACS CHEM BIOL, V6, P325, DOI 10.1021/cb100314y; Pitscheider M, 2012, CHEM SCI, V3, P2035, DOI 10.1039/c2sc20290e; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Sadaghiani AM, 2007, CURR OPIN CHEM BIOL, V11, P20, DOI 10.1016/j.cbpa.2006.11.030; Serim S, 2012, CHEMMEDCHEM, V7, P1146, DOI 10.1002/cmdc.201200057; Sherratt AR, 2012, BIOCHEMISTRY-US, V51, P7794, DOI 10.1021/bi301087c; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vinothkumar KR, 2013, STRUCTURE, V21, P1051, DOI 10.1016/j.str.2013.03.013; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Vosyka O, 2013, P NATL ACAD SCI USA, V110, P2472, DOI 10.1073/pnas.1215076110; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Zeiler E, 2011, ANGEW CHEM INT EDIT, V50, P11001, DOI 10.1002/anie.201104391; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	37	37	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72307	10.1371/journal.pone.0072307	http://dx.doi.org/10.1371/journal.pone.0072307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991088	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470700035
J	Ghangal, R; Chaudhary, S; Jain, M; Purty, RS; Sharma, PC				Ghangal, Rajesh; Chaudhary, Saurabh; Jain, Mukesh; Purty, Ram Singh; Sharma, Prakash Chand			Optimization of De Novo Short Read Assembly of Seabuckthorn (Hippophae rhamnoides L.) Transcriptome	PLOS ONE			English	Article							TOOLS	Seabuckthorn (Hippophae rhamnoides L.) is known for its medicinal, nutritional and environmental importance since ancient times. However, very limited efforts have been made to characterize the genome and transcriptome of this wonder plant. Here, we report the use of next generation massive parallel sequencing technology (Illumina platform) and de novo assembly to gain a comprehensive view of the seabuckthorn transcriptome. We assembled 86,253,874 high quality short reads using six assembly tools. At our hand, assembly of non-redundant short reads following a two-step procedure was found to be the best considering various assembly quality parameters. Initially, ABySS tool was used following an additive k-mer approach. The assembled transcripts were subsequently subjected to TGICL suite. Finally, de novo short read assembly yielded 88,297 transcripts (>= 100 bp), representing about 53 Mb of seabuckthorn transcriptome. The average length of transcripts was 610 bp, N50 length 1198 BP and 91% of the short reads uniquely mapped back to seabuckthorn transcriptome. A total of 41,340 (46.8%) transcripts showed significant similarity with sequences present in nr protein databases of NCBI (E-value <= 1E-06). We also screened the assembled transcripts for the presence of transcription factors and simple sequence repeats. Our strategy involving the use of short read assembler (ABySS) followed by TGICL will be useful for the researchers working with a non-model organism's transcriptome in terms of saving time and reducing complexity in data management. The seabuckthorn transcriptome data generated here provide a valuable resource for gene discovery and development of functional molecular markers.	[Ghangal, Rajesh; Chaudhary, Saurabh; Purty, Ram Singh; Sharma, Prakash Chand] Guru Gobind Singh Indraprastha Univ, Univ Sch Biotechnol, New Delhi, India; [Jain, Mukesh] Natl Inst Plant Genome Res, New Delhi, India	GGS Indraprastha University; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Sharma, PC (corresponding author), Guru Gobind Singh Indraprastha Univ, Univ Sch Biotechnol, New Delhi, India.	prof.pcsharma@gmail.com	Purty, Ram/W-4854-2019; Jain, Mukesh/AAP-5816-2021	Purty, Ram/0000-0003-4468-9199; Jain, Mukesh/0000-0002-7622-1083	Department of Biotechnology, Government of India, New Delhi [BT/PR10798/NDB/51/170/2008]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Government of India, New Delhi (BT/PR10798/NDB/51/170/2008); http://dbtindia.nic.in/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKERMANS ADL, 1983, CAN J BOT, V61, P2793, DOI 10.1139/b83-309; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dhyani D, 2007, CURR SCI INDIA, V92, P1148; Fatima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034099; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ghangal R, 2012, PLANT PHYSIOL BIOCH, V51, P123, DOI 10.1016/j.plaphy.2011.10.005; Ghangal R, 2009, PLANT PHYSIOL BIOCH, V47, P1113, DOI 10.1016/j.plaphy.2009.09.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Jiang YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-629; LEDWOOD JS, 1971, ANN BOT-LONDON, V35, P1053, DOI 10.1093/oxfordjournals.aob.a084541; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lian YS., 2000, J NW NORMAL U NATURA, V36, P113; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lu R, 1997, WORLDWIDE RES DEV SE, P11; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sezik E, 2004, J ETHNOPHARMACOL, V92, P197, DOI 10.1016/j.jep.2004.02.016; Shinwari ZK, 2003, J ETHNOPHARMACOL, V84, P289, DOI 10.1016/S0378-8741(02)00333-1; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh KN, 2008, J ETHNOPHARMACOL, V115, P147, DOI 10.1016/j.jep.2007.09.017; Stobdan T, 2008, CURR SCI INDIA, V94, P1236; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Thakur V., 2010, J COMPUT SCI SYST BI, V3, P40, DOI DOI 10.4172/JCSB.1000053; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Truta E, 2011, CARYOLOGIA, V64, P189, DOI 10.1080/00087114.2002.10589783; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	34	29	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72516	10.1371/journal.pone.0072516	http://dx.doi.org/10.1371/journal.pone.0072516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991119	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100104
J	Shi, YJ; Yuan, H; Kim, D; Chanana, V; Baba, A; Matsuda, T; Cengiz, P; Ferrazzano, P; Sun, DD				Shi, Yejie; Yuan, Hui; Kim, Dong; Chanana, Vishal; Baba, Akemichi; Matsuda, Toshio; Cengiz, Pelin; Ferrazzano, Peter; Sun, Dandan			Stimulation of Na+/H+ Exchanger Isoform 1 Promotes Microglial Migration	PLOS ONE			English	Article							ERM PROTEINS; ACTIN POLYMERIZATION; INCREASED TOLERANCE; IN-VITRO; CELLS; RECEPTORS; CHEMOTAXIS; EXPRESSION; BRADYKININ; GROWTH	Regulation of microglial migration is not well understood. In this study, we proposed that Na+/H+ exchanger isoform 1 (NHE-1) is important in microglial migration. NHE-1 protein was co-localized with cytoskeletal protein ezrin in lamellipodia of microglia and maintained its more alkaline intracellular pH (pH(i)). Chemoattractant bradykinin (BK) stimulated microglial migration by increasing lamellipodial area and protrusion rate, but reducing lamellipodial persistence time. Interestingly, blocking NHE-1 activity with its potent inhibitor HOE 642 not only acidified microglia, abolished the BK-triggered dynamic changes of lamellipodia, but also reduced microglial motility and microchemotaxis in response to BK. In addition, NHE-1 activation resulted in intracellular Na+ loading as well as intracellular Ca2+ elevation mediated by stimulating reverse mode operation of Na+/Ca2+ exchange (NCXrev). Taken together, our study shows that NHE-1 protein is abundantly expressed in microglial lamellipodia and maintains alkaline pHi in response to BK stimulation. In addition, NHE-1 and NCXrev play a concerted role in BK-induced microglial migration via Na+ and Ca2+ signaling.	[Shi, Yejie; Yuan, Hui; Kim, Dong; Sun, Dandan] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Shi, Yejie; Sun, Dandan] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Sun, Dandan] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA; [Chanana, Vishal; Cengiz, Pelin; Ferrazzano, Peter] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Baba, Akemichi; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Osaka University	Sun, DD (corresponding author), Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA.	sund@upmc.edu	chanana, vishal/F-3738-2014; sun, dandan/GZG-6540-2022; Shi, Yejie/C-2355-2018	Shi, Yejie/0000-0001-7502-9201	National Institutes of Health [R01NS 48216, R01NS 38118]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038118, R01NS048216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R01NS 48216 and R01NS 38118 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chen H, 2007, J NEUROCHEM, V102, P1783, DOI 10.1111/j.1471-4159.2007.04638.x; Choi CH, 2010, MOL BIOL CELL, V21, P3162, DOI 10.1091/mbc.E09-12-1058; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Ifuku M, 2007, J NEUROSCI, V27, P13065, DOI 10.1523/JNEUROSCI.3467-07.2007; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Kintner DB, 2004, AM J PHYSIOL-CELL PH, V287, pC12, DOI 10.1152/ajpcell.00560.2003; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Luo J, 2008, J CEREBR BLOOD F MET, V28, P737, DOI 10.1038/sj.jcbfm.9600561; Luo J, 2007, ANN NY ACAD SCI, V1099, P292, DOI 10.1196/annals.1387.016; Martin C, 2011, AM J PHYSIOL-CELL PH, V300, pC490, DOI 10.1152/ajpcell.00280.2010; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Noda M, 2003, LIFE SCI, V72, P1573, DOI 10.1016/S0024-3205(02)02449-9; Noda M, 2007, NEUROCHEM INT, V51, P185, DOI 10.1016/j.neuint.2007.06.017; Nolte C, 1997, EUR J NEUROSCI, V9, P1690, DOI 10.1111/j.1460-9568.1997.tb01526.x; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; TAKEUCHI K, 1994, J CELL SCI, V107, P1921; Tucker PK, 2011, DIS MODEL MECH, V4, P126, DOI 10.1242/dmm.005694; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Woodward AM, 2001, CELL BIOL INT, V25, P205, DOI 10.1006/cbir.2000.0635; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; Yu LY, 2011, AM J RESP CELL MOL, V45, P923, DOI 10.1165/rcmb.2011-0032OC	41	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e74201	10.1371/journal.pone.0074201	http://dx.doi.org/10.1371/journal.pone.0074201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991215	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000324470100134
J	He, T; Haapa-Paananen, S; Kaminskyy, VO; Kohonen, P; Fey, V; Zhivotovsky, B; Kallioniemi, O; Perala, M				He, T.; Haapa-Paananen, S.; Kaminskyy, V. O.; Kohonen, P.; Fey, V.; Zhivotovsky, B.; Kallioniemi, O.; Perala, M.			Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis	ONCOGENE			English	Article						doxorubicin; pyrimidine pathway; mitochondria; brequinar; DHODH; TRAIL	DEATH RECEPTORS; CASPASE-8 EXPRESSION; UP-REGULATION; C-FLIP; LIGAND; IDENTIFICATION; MODULATORS; COMPLEX; TARGETS; SODIUM	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent in selectively killing tumor cells. However, TRAIL monotherapy has not been successful as many cancer cells are resistant to TRAIL. Chemotherapeutic agents, such as doxorubicin have been shown to act synergistically with TRAIL, but the exact mechanisms of actions are poorly understood. In this study, we performed high-throughput small interfering RNA screening and genome-wide gene expression profiling on doxorubicin-treated U1690 cells to explore novel mechanisms underlying doxorubicin-TRAIL synergy. The screening and expression profiling results were integrated and dihydroorotate dehydrogenase (DHODH) was identified as a potential candidate. DHODH is the rate-limiting enzyme in the pyrimidine synthesis pathway, and its expression was downregulated by doxorubicin. We demonstrated that silencing of DHODH or inhibition of DHODH activity by brequinar dramatically increased the sensitivity of U1690 cells to TRAIL-induced apoptosis both in 2D and 3D cultures, and was accompanied by downregulation of c-FLIPL as well as by mitochondrial depolarization. In addition, uridine, an end product of the pyrimidine synthesis pathway was able to rescue the sensitization effects initiated by both brequinar and doxorubicin. Furthermore, several other cancer cell lines, LNCaP, MCF-7 and HT-29 were also shown to be sensitized to TRAIL by brequinar. Taken together, our findings have identified a novel protein target and its inhibitor, brequinar, as a potential agent in TRAIL-based combinatorial cancer therapy and highlighted for the first time the importance of mitochondrial DHODH enzyme and pyrimidine pathway in mediating TRAIL sensitization in cancer cells.	[He, T.; Haapa-Paananen, S.; Kohonen, P.; Fey, V.; Kallioniemi, O.; Perala, M.] VTT Tech Res Ctr Finland, FI-20521 Turku, Finland; [Kaminskyy, V. O.; Zhivotovsky, B.] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden; [Kohonen, P.] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden; [Kallioniemi, O.] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland	VTT Technical Research Center Finland; Karolinska Institutet; Karolinska Institutet; University of Helsinki	He, T (corresponding author), VTT Tech Res Ctr Finland, Itainen Pitkakatu 4C,POB 106, FI-20521 Turku, Finland.	tao.he@vtt.fi	Kohonen, Pekka/F-9596-2011; Zhivotovsky, Boris/A-4346-2014; Kallioniemi, Olli P/H-5111-2011	Kohonen, Pekka/0000-0002-7845-3611; Zhivotovsky, Boris/0000-0002-2238-3482; Kallioniemi, Olli P/0000-0002-3231-0332; Kaminskyy, Vitaliy/0000-0002-8151-5270	EU-APOSYS [HEALTH-F4-2007-200767]; EU (CHEMORES) project; Swedish Research Foundation; Swedish Cancer Foundation; Swedish Childhood Cancer Foundation; Stockholm Cancer Foundation	EU-APOSYS(European CommissionEuropean Commission Joint Research Centre); EU (CHEMORES) project; Swedish Research Foundation; Swedish Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Stockholm Cancer Foundation	We acknowledge Jouni Latoniitty and Rami Makela for robotic technical assistance, Ville Harma and Johannes Virtanen for advices and help in 3D experiments, Pirjo Kapyla for excellent technical support and Drs I Lavrik and P Krammer for antibodies. Finnish DNA Microarray Centre is acknowledged for performing TaqMan qRT-PCR and Illumina gene expression analysis. This work was supported by EU-APOSYS project (contract HEALTH-F4-2007-200767), EU (CHEMORES) project, the Swedish Research Foundation, the Swedish and Stockholm Cancer Foundations, and the Swedish Childhood Cancer Foundation.	Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Baumann P, 2009, MOL CANCER THER, V8, P366, DOI 10.1158/1535-7163.MCT-08-0664; Booth NL, 2009, CANCER IMMUNOL IMMUN, V58, P1229, DOI 10.1007/s00262-008-0637-8; Cleaveland ES, 1996, BIOCHEM BIOPH RES CO, V223, P654, DOI 10.1006/bbrc.1996.0950; Coussens MJ, 2011, JOVE-J VIS EXP, DOI 10.3791/3305; CRAMER DV, 1995, PEDIATR NEPHROL, V9, pS52, DOI 10.1007/BF00867685; Evans ME, 2005, AM J PHYSIOL-GASTR L, V289, pG388, DOI 10.1152/ajpgi.00072.2005; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Finlay D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013375; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kaminskyy VO, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.51; Kaminskyy VO, 2011, CARCINOGENESIS, V32, P1450, DOI 10.1093/carcin/bgr135; Kawasumi M, 2007, J INVEST DERMATOL, V127, P1577, DOI 10.1038/sj.jid.5700853; Kisim A, 2012, J CANCER RES CLIN, V138, P1155, DOI 10.1007/s00432-012-1187-1; Kojima Y, 2011, J BIOL CHEM, V286, P43383, DOI 10.1074/jbc.M111.309377; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lee SC, 2011, ANTICANCER RES, V31, P3385; Lee YJ, 2011, MOL MED REP, V4, P1255, DOI 10.3892/mmr.2011.558; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Mahmood Z, 2010, EXP CELL RES, V316, P887, DOI 10.1016/j.yexcr.2009.12.011; MAROUN J, 1993, CANCER CHEMOTH PHARM, V32, P64, DOI 10.1007/BF00685878; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Merrill JE, 2009, J NEUROL, V256, P89, DOI 10.1007/s00415-009-0075-3; O'Donnell EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040926; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Papenfuss K, 2008, J CELL MOL MED, V12, P2566, DOI 10.1111/j.1582-4934.2008.00514.x; PETERS GJ, 1990, BIOCHEM PHARMACOL, V39, P135, DOI 10.1016/0006-2952(90)90657-7; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Safa A. R., 2012, Experimental Oncology, V34, P176; Shawver LK, 1997, CLIN CANCER RES, V3, P1167; Shivapurkar N, 2002, ONCOGENE, V21, P8510, DOI 10.1038/sj.onc.1205941; Szliszka E, 2012, INT J ONCOL, V41, P818, DOI 10.3892/ijo.2012.1527; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Taylor DJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-470; Vaculova A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-87; Vyas VK, 2011, MINI-REV MED CHEM, V11, P1039; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yan SC, 2012, J CANCER RES CLIN, V138, P1279, DOI 10.1007/s00432-012-1204-4; Zhu H, 2012, INT J MOL MED, V30, P1087, DOI 10.3892/ijmm.2012.1105	46	26	27	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2014	33	27					3538	3549		10.1038/onc.2013.313	http://dx.doi.org/10.1038/onc.2013.313			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2FK	24013224				2022-12-25	WOS:000338941100006
J	Akin, BL; Hurley, TD; Chen, ZH; Jones, LR				Akin, Brandy L.; Hurley, Thomas D.; Chen, Zhenhui; Jones, Larry R.			The Structural Basis for Phospholamban Inhibition of the Calcium Pump in Sarcoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium ATPase; Calcium Transport; Crystal Structure; Protein Cross-linking; Protein Crystallization; Sarcoplasmic Reticulum (SR); SERCA; Phospholamban; Sarcolipin	CARDIAC CA2+ PUMP; BETA-ADRENERGIC STIMULATION; CROSS-LINKING; FUNCTIONAL INTERACTIONS; PROTEIN-STRUCTURE; TRANSMEMBRANE DOMAIN; ATPASE SERCA; CA2+-ATPASE; PHOSPHORYLATION; SARCOLIPIN	Background: Phospholamban (PLB) regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) activity and is thus a key regulator of cardiac contractility. Results: We present the crystal structure of SERCA in complex with PLB at 2.8- resolution. Conclusion: PLB stabilizes a divalent cation-free conformation of SERCA with collapsed Ca2+ binding sites. We call the structure E2-PLB. Significance: The E2-PLB structure explains how PLB decreases Ca2+ affinity and depresses cardiac contractility. P-type ATPases are a large family of enzymes that actively transport ions across biological membranes by interconverting between high (E1) and low (E2) ion-affinity states; these transmembrane transporters carry out critical processes in nearly all forms of life. In striated muscle, the archetype P-type ATPase, SERCA (sarco(endo)plasmic reticulum Ca2+-ATPase), pumps contractile-dependent Ca2+ ions into the lumen of sarcoplasmic reticulum, which initiates myocyte relaxation and refills the sarcoplasmic reticulum in preparation for the next contraction. In cardiac muscle, SERCA is regulated by phospholamban (PLB), a small inhibitory phosphoprotein that decreases the Ca2+ affinity of SERCA and attenuates contractile strength. cAMP-dependent phosphorylation of PLB reverses Ca2+-ATPase inhibition with powerful contractile effects. Here we present the long sought crystal structure of the PLB-SERCA complex at 2.8- resolution. The structure was solved in the absence of Ca2+ in a novel detergent system employing alkyl mannosides. The structure shows PLB bound to a previously undescribed conformation of SERCA in which the Ca2+ binding sites are collapsed and devoid of divalent cations (E2-PLB). This new structure represents one of the key unsolved conformational states of SERCA and provides a structural explanation for how dephosphorylated PLB decreases Ca2+ affinity and depresses cardiac contractility.	Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Akin, Brandy L.; Chen, Zhenhui; Jones, Larry R.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Hurley, Thomas D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Akin, BL (corresponding author), 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	bbudryns@iu.edu; lrjones@iu.edu		HURLEY, THOMAS/0000-0002-5942-1163	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027281] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018123] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. We thank Stephan Ginell and Marianne Cuff for assistance at SBC-CAT 19ID. We also thank Glen Schmeisser.	Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Bublitz M, 2013, J BIOL CHEM, V288, P10759, DOI 10.1074/jbc.R112.436550; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1978, J BIOL CHEM, V253, P1643; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; JONES LR, 1985, J BIOL CHEM, V260, P7721; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montigny C, 2010, BIOCHEM BIOPH RES CO, V391, P1067, DOI 10.1016/j.bbrc.2009.12.021; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Young HS, 2004, J MEMBRANE BIOL, V198, P55, DOI 10.1007/s00232-004-0666-y	48	87	88	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30181	30191		10.1074/jbc.M113.501585	http://dx.doi.org/10.1074/jbc.M113.501585			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23996003	Green Published, hybrid			2022-12-25	WOS:000329868100018
J	Lee, D; Goldberg, AL				Lee, Donghoon; Goldberg, Alfred L.			SIRT1 Protein, by Blocking the Activities of Transcription Factors FoxO1 and FoxO3, Inhibits Muscle Atrophy and Promotes Muscle Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FoxO; Muscle Atrophy; Sirt1; Skeletal Muscle; Transcription Factors; FoxO3; Deacetylase; Hypertrophy	FATTY-ACID OXIDATION; SKELETAL-MUSCLE; UBIQUITIN LIGASES; MITOCHONDRIAL-FUNCTION; ACTIVATING SIRT1; CANCER CACHEXIA; HYPERTROPHY; DEGRADATION; PGC-1-ALPHA; PREVENTS	In several cell types, the protein deacetylase SIRT1 regulates the activities of FoxO transcription factors whose activation is critical in muscle atrophy. However, the possible effects of SIRT1 on the activity of FoxOs in skeletal muscle and on the regulation of muscle size have not been investigated. Here, we show that after food deprivation, SIRT1 levels fall dramatically in type II skeletal muscles (tibialis anterior), which show marked atrophy, unlike in the liver (where SIRT1 rises) or heart or the soleus, a type I muscle (where SIRT1 is unchanged). Maintenance of high SIRT1 levels by electroporation in mouse muscle inhibits markedly the muscle wasting induced by fasting as well as by denervation, and these protective effects require its deacetylase activity. SIRT1 overexpression reduces muscle wasting by blocking the activation of FoxO1 and 3. It thus prevents the induction of key atrogenes, including the muscle-specific ubiquitin ligases, atrogin1 and MuRF1, and multiple autophagy (Atg) genes and the increase in overall proteolysis. In normal muscle, SIRT1 overexpression by electroporation causes rapid fiber hypertrophy without, surprisingly, activation of the PI3K-AKT signaling pathway. Thus, SIRT1 activation favors postnatal muscle growth, and its fall appears to be critical for atrophy during fasting. Consequently, SIRT1 activation represents an attractive possible pharmacological approach to prevent muscle wasting and cachexia.	[Lee, Donghoon; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu			National Institutes of Health [1R01 AR055255-04]; Amyotrophic Lateral Sclerosis Association; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amyotrophic Lateral Sclerosis Association; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 AR055255-04. This work was also supported by the Amyotrophic Lateral Sclerosis Association and the Muscular Dystrophy Association.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	50	126	140	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30515	30526		10.1074/jbc.M113.489716	http://dx.doi.org/10.1074/jbc.M113.489716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003218	Green Published, hybrid			2022-12-25	WOS:000329868100054
J	Ma, Y; Krueger, JJ; Redmon, SN; Uppuganti, S; Nyman, JS; Hahn, MK; Elefteriou, F				Ma, Yun; Krueger, Jessica J.; Redmon, Sara N.; Uppuganti, Sasidhar; Nyman, Jeffry S.; Hahn, Maureen K.; Elefteriou, Florent			Extracellular Norepinephrine Clearance by the Norepinephrine Transporter Is Required for Skeletal Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Knockout; Mouse; Nerve; Neurotransmitter Transport; Osteoblasts; ADHD; Bone Remodeling; Norepinephrine Transporter; Sympathetic Nervous System	SYMPATHETIC-NERVOUS-SYSTEM; REGULATES BONE-FORMATION; BLOOD-PRESSURE; BETA-BLOCKERS; MASS; MICE; DIFFERENTIATION; IMMOBILIZATION; HYPERACTIVITY; OSTEOPOROSIS	Background: The contribution of endogenous norepinephrine (NE) to skeletal homeostasis is unclear. Results: Bone forming cells, not only neurons, express the norepinephrine transporter (NET), and blockade of extracellular NE clearance causes alterations in bone homeostasis. Conclusion: NE clearance by NET is a component of the homeostatic machinery by which sympathetic nerves and osteoblasts control bone remodeling. Significance: NET blockers may increase fracture risk. Changes in bone remodeling induced by pharmacological and genetic manipulation of -adrenergic receptor (AR) signaling in osteoblasts support a role of sympathetic nerves in the regulation of bone remodeling. However, the contribution of endogenous sympathetic outflow and nerve-derived norepinephrine (NE) to bone remodeling under pathophysiological conditions remains unclear. We show here that differentiated osteoblasts, like neurons, express the norepinephrine transporter (NET), exhibit specific NE uptake activity via NET and can catabolize, but not generate, NE. Pharmacological blockade of NE transport by reboxetine induced bone loss in WT mice. Similarly, lack of NE reuptake in norepinephrine transporter (Net)-deficient mice led to reduced bone formation and increased bone resorption, resulting in suboptimal peak bone mass and mechanical properties associated with low sympathetic outflow and high plasma NE levels. Last, daily sympathetic activation induced by mild chronic stress was unable to induce bone loss, unless NET activity was blocked. These findings indicate that the control of endogenous NE release and reuptake by presynaptic neurons and osteoblasts is an important component of the complex homeostatic machinery by which the sympathetic nervous system controls bone remodeling. These findings also suggest that drugs antagonizing NET activity, used for the treatment of hyperactivity disorders, may have deleterious effects on bone accrual.	[Ma, Yun; Elefteriou, Florent] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Nashville, TN 37232 USA; [Ma, Yun; Uppuganti, Sasidhar; Nyman, Jeffry S.; Elefteriou, Florent] Vanderbilt Ctr Bone Biol, Nashville, TN 37232 USA; [Krueger, Jessica J.; Redmon, Sara N.; Hahn, Maureen K.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN 37232 USA; [Hahn, Maureen K.; Elefteriou, Florent] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Hahn, Maureen K.] Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Uppuganti, Sasidhar; Nyman, Jeffry S.] Dept Orthopaed Surg & Rehabil, Nashville, TN 37232 USA; [Elefteriou, Florent] Dept Canc Biol, Nashville, TN 37232 USA; [Nyman, Jeffry S.] Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Elefteriou, F (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Bone Biol, 2215 Garland Ave,Light Hall,Room 1255H, Nashville, TN 37232 USA.	florent.elefteriou@vanderbilt.edu	Elefteriou, Florent/GMW-8429-2022; Elefteriou, Florent/P-2586-2017	Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633; Nyman, Jeffry/0000-0001-7403-7605	National Institutes of Health; NIDDK [5R01DK082471-03]; Clinical and Translational Science Awards (CTSA) [UL11R000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clinical and Translational Science Awards (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK Grant 5R01DK082471-03 and Grant UL11R000445 from the Clinical and Translational Science Awards (CTSA).	Aitken SJ, 2009, ARCH BIOCHEM BIOPHYS, V482, P96, DOI 10.1016/j.abb.2008.11.012; Bertram D, 2000, AM J PHYSIOL-REG I, V279, pR1257, DOI 10.1152/ajpregu.2000.279.4.R1257; Bonnet N, 2008, J CELL PHYSIOL, V217, P819, DOI 10.1002/jcp.21564; Bonnet N, 2007, J APPL PHYSIOL, V102, P1502, DOI 10.1152/japplphysiol.00815.2006; Bonnet N, 2007, BONE, V40, P1209, DOI 10.1016/j.bone.2007.01.006; Bonnet N, 2006, J PHARMACOL EXP THER, V318, P1118, DOI 10.1124/jpet.106.105437; Bonnet N, 2005, BONE, V37, P622, DOI 10.1016/j.bone.2005.07.012; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Camporeale A, 2013, DRUG SAFETY, V36, P663, DOI 10.1007/s40264-013-0074-2; Carson RP, 2002, J APPL PHYSIOL, V93, P2192, DOI 10.1152/japplphysiol.00033.2002; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cuscito C, 2011, ANN NY ACAD SCI, V1237, P53, DOI 10.1111/j.1749-6632.2011.06235.x; Dziedzicka-Wasylewska M, 2006, NEUROPSYCHOPHARMACOL, V31, P2424, DOI 10.1038/sj.npp.1301064; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fonseca TL, 2011, J BONE MINER RES, V26, P591, DOI 10.1002/jbmr.243; Franquinho F, 2010, FEBS J, V277, P3664, DOI 10.1111/j.1742-4658.2010.07774.x; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gilsbach R, 2006, J NEUROCHEM, V96, P1111, DOI 10.1111/j.1471-4159.2005.03598.x; Gotoh M, 2005, HYPERTENS RES, V28, P565, DOI 10.1291/hypres.28.565; Graham S, 2008, EXPERT OPIN INV DRUG, V17, P1281, DOI [10.1517/13543784.17.9.1281, 10.1517/13543784.17.9.1281 ]; Hahn MK, 2009, NEUROPHARMACOLOGY, V57, P694, DOI 10.1016/j.neuropharm.2009.08.002; Hahn MK, 2005, MOL PHARMACOL, V68, P457, DOI 10.1124/mol.105.011270; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; HEAL DJ, 1989, BRIT J PHARMACOL, V97, P111, DOI 10.1111/j.1476-5381.1989.tb11930.x; Hinojosa-Laborde CM, 1999, CLIN EXP PHARMACOL P, V26, P122, DOI 10.1046/j.1440-1681.1999.02995.x; Horvath G, 2003, AM J PHYSIOL-LUNG C, V285, pL829, DOI 10.1152/ajplung.00054.2003; Huang H, 2009, DYNAMICS OF SURFACE WAVES IN COASTAL WATERS: WAVE-CURRENT-BOTTOM INTERACTIONS, P1; JOHNSTON CC, 1990, NEW ENGL J MED, V323, P1271, DOI 10.1056/NEJM199011013231809; Joo Y, 2009, NEUROSCI LETT, V461, P121, DOI 10.1016/j.neulet.2009.06.025; Kajimura D, 2011, J EXP MED, V208, P841, DOI 10.1084/jem.20102608; Keller NR, 2004, CIRCULATION, V110, P1191, DOI 10.1161/01.CIR.0000141804.90845.E6; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kondo H, 2011, CALCIFIED TISSUE INT, V88, P23, DOI 10.1007/s00223-010-9421-9; Lee NJ, 2009, NEUROPEPTIDES, V43, P457, DOI 10.1016/j.npep.2009.08.006; Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021; Lin SF, 2012, NUCL MED BIOL, V39, P1081, DOI 10.1016/j.nucmedbio.2012.04.005; MATKOVIC V, 1994, J CLIN INVEST, V93, P799, DOI 10.1172/JCI117034; Moldovanova I, 2008, HYPERTENSION, V51, P1203, DOI 10.1161/HYPERTENSIONAHA.107.107433; Pierroz DD, 2012, J BONE MINER RES, V27, P1252, DOI 10.1002/jbmr.1594; Reid I. R., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P105; Ren ZG, 2003, DEV NEUROSCI-BASEL, V25, P1, DOI 10.1159/000071462; Sato T, 2010, J PHARMACOL EXP THER, V334, P99, DOI 10.1124/jpet.110.167643; Schroeder C, 2004, AM J PHYSIOL-REG I, V286, pR851, DOI 10.1152/ajpregu.00689.2003; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Tank J, 2003, CIRCULATION, V107, P2949, DOI 10.1161/01.CIR.0000072786.99163.FE; Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416; Veldhuis-Vlug AG, 2012, J CLIN ENDOCR METAB, V97, pE2093, DOI 10.1210/jc.2012-2823; WANG TM, 1993, BONE MINER, V20, P251, DOI 10.1016/S0169-6009(08)80006-2; Watkins MP, 2012, BONE, V51, P787, DOI 10.1016/j.bone.2012.06.018; Ziere G, 2008, J CLIN PSYCHOPHARM, V28, P411, DOI 10.1097/JCP.0b013e31817e0ecb	53	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30105	30113		10.1074/jbc.M113.481309	http://dx.doi.org/10.1074/jbc.M113.481309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005671	Green Published, hybrid			2022-12-25	WOS:000329868100011
J	Majorek, KA; Kuhn, ML; Chruszcz, M; Anderson, WF; Minor, W				Majorek, Karolina A.; Kuhn, Misty L.; Chruszcz, Maksymilian; Anderson, Wayne F.; Minor, Wladek			Structural, Functional, and Inhibition Studies of a Gcn5-related N-Acetyltransferase (GNAT) Superfamily Protein PA4794 A NEW C-TERMINAL LYSINE PROTEIN ACETYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Crystal Structure; Enzyme inhibitors; High Throughput Screening (HTS); Pseudomonas; GNAT; Gcn5-related N-Acetyltransferase; Acetyltransferase; Cephalosporin; Lysine Acetylation	ACETYLATION; DIFFRACTION; MODEL	Background: Gcn5-related N-acetyltransferases (GNATs) are involved in small molecule and protein acetylation in all organisms. Results: Crystallographic and biochemical characterization of PA4794 is shown, including identification of substrates and inhibitors. Conclusion: PA4794 is a new bacterial C-terminal lysine protein acetyltransferase inhibited by cephalosporins. Significance: PA4794 is the first identified acetyltransferase specific for C-terminal lysine; identified interactions with cephalosporins may be of clinical relevance. The Gcn5-related N-acetyltransferase (GNAT) superfamily is a large group of evolutionarily related acetyltransferases, with multiple paralogs in organisms from all kingdoms of life. The functionally characterized GNATs have been shown to catalyze the transfer of an acetyl group from acetyl-coenzyme A (Ac-CoA) to the amine of a wide range of substrates, including small molecules and proteins. GNATs are prevalent and implicated in a myriad of aspects of eukaryotic and prokaryotic physiology, but functions of many GNATs remain unknown. In this work, we used a multi-pronged approach of x-ray crystallography and biochemical characterization to elucidate the sequence-structure-function relationship of the GNAT superfamily member PA4794 from Pseudomonas aeruginosa. We determined that PA4794 acetylates the NE amine of a C-terminal lysine residue of a peptide, suggesting it is a protein acetyltransferase specific for a C-terminal lysine of a substrate protein or proteins. Furthermore, we identified a number of molecules, including cephalosporin antibiotics, which are inhibitors of PA4794 and bind in its substrate-binding site. Often, these molecules mimic the conformation of the acetylated peptide product. We have determined structures of PA4794 in the apo-form, in complexes with Ac-CoA, CoA, several antibiotics and other small molecules, and a ternary complex with the products of the reaction: CoA and acetylated peptide. Also, we analyzed PA4794 mutants to identify residues important for substrate binding and catalysis.	[Majorek, Karolina A.; Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Majorek, Karolina A.] Adam Mickiewicz Univ, Bioinformat Lab, Inst Mol Biol & Biotechnol, Fac Biol, PL-61614 Poznan, Poland; [Kuhn, Misty L.; Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Chruszcz, Maksymilian] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Majorek, Karolina A.; Chruszcz, Maksymilian; Anderson, Wayne F.; Minor, Wladek] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA	University of Virginia; Adam Mickiewicz University; Northwestern University; Feinberg School of Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; United States Department of Energy (DOE); Argonne National Laboratory	Minor, W (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	wladek@iwonka.med.virginia.edu	Chruszcz, Maksymilian/E-6407-2011; Minor, Wladek/F-3096-2014	Chruszcz, Maksymilian/0000-0001-7521-5485; Minor, Wladek/0000-0001-7075-7090	United States DOE Office of Biological and Environmental Research [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	United States DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Igor Shumilin and Przemyslaw Porebski for valuable discussions and Dr. Matthew D. Zimmerman for critically reading the manuscript. Additionally, we thank Drs. Sergii Pshenychnyi and Izolda Popova at the Recombinant Protein Production Core at Northwestern University for expression and purification services. Some results shown in this report are derived from work performed at the Structural Biology Center Sector 19 and LS-CAT Sector 21 at the Advanced Photon Source. The Advanced Photon Source, an Office of Science User Facility, is operated for the United States Dept. of Energy (DOE) Office of Science by Argonne National Laboratory. Argonne is operated by University of Chicago Argonne, LLC, for the United States DOE Office of Biological and Environmental Research under contract DE-AC02-06CH11357. Use of LS-CAT Sector 21 was also supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brent MM, 2009, J BIOL CHEM, V284, P19412, DOI 10.1074/jbc.M109.014951; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim C, 2007, BIOCHEMISTRY-US, V46, P5270, DOI 10.1021/bi700111z; Kuhn ML, 2013, PROTEIN SCI, V22, P222, DOI 10.1002/pro.2199; Lin SK, 2004, MOL PHARMACOL, V66, P612; Malmsten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016400; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naghmouchi K, 2012, RES MICROBIOL, V163, P101, DOI 10.1016/j.resmic.2011.11.002; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sajjan US, 2001, ANTIMICROB AGENTS CH, V45, P3437, DOI 10.1128/AAC.45.12.3437-3444.2001; Shumilin IA, 2012, STRUCTURE, V20, P1715, DOI 10.1016/j.str.2012.07.016; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Vetting MW, 2004, CHEM BIOL, V11, P565, DOI 10.1016/j.chembiol.2004.03.017; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zimmerman M, 2005, ACTA CRYSTALLOGR A, V61, pC178, DOI 10.1107/S0108767305092391	35	31	31	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30223	30235		10.1074/jbc.M113.501353	http://dx.doi.org/10.1074/jbc.M113.501353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003232	Green Published, hybrid			2022-12-25	WOS:000329868100021
J	Ramirez-Peinado, S; Leon-Annicchiarico, CL; Galindo-Moreno, J; Iurlaro, R; Caro-Maldonado, A; Prehn, JHM; Ryan, KM; Munoz-Pinedo, C				Ramirez-Peinado, Silvia; Lucia Leon-Annicchiarico, Clara; Galindo-Moreno, Javier; Iurlaro, Raffaella; Caro-Maldonado, Alfredo; Prehn, Jochen H. M.; Ryan, Kevin M.; Munoz-Pinedo, Cristina			Glucose-starved Cells Do Not Engage in Prosurvival Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Glucose; mTOR; Necrosis (Necrotic Death)	ACTIVATED PROTEIN-KINASE; STARVATION; APOPTOSIS; DEATH; PHOSPHORYLATION; PROMOTES; STRESS; CANCER; AMPK; 2-DEOXYGLUCOSE	In response to nutrient shortage or organelle damage, cells undergo macroautophagy. Starvation of glucose, an essential nutrient, is thought to promote autophagy in mammalian cells. We thus aimed to determine the role of autophagy in cell death induced by glucose deprivation. Glucose withdrawal induces cell death that can occur by apoptosis (in Bax, Bak-deficient mouse embryonic fibroblasts or HeLa cells) or by necrosis (in Rh4 rhabdomyosarcoma cells). Inhibition of autophagy by chemical or genetic means by using 3-methyladenine, chloroquine, a dominant negative form of ATG4B or silencing Beclin-1, Atg7, or p62 indicated that macroautophagy does not protect cells undergoing necrosis or apoptosis upon glucose deprivation. Moreover, glucose deprivation did not induce autophagic flux in any of the four cell lines analyzed, even though mTOR was inhibited. Indeed, glucose deprivation inhibited basal autophagic flux. In contrast, the glycolytic inhibitor 2-deoxyglucose induced prosurvival autophagy. Further analyses indicated that in the absence of glucose, autophagic flux induced by other stimuli is inhibited. These data suggest that the role of autophagy in response to nutrient starvation should be reconsidered.	[Ramirez-Peinado, Silvia; Lucia Leon-Annicchiarico, Clara; Galindo-Moreno, Javier; Iurlaro, Raffaella; Caro-Maldonado, Alfredo; Munoz-Pinedo, Cristina] IDIBELL Bellvitge Biomed Res Inst, Cell Death Regulat Grp, Barcelona 08908, Spain; [Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Ryan, Kevin M.] Canc Res UK Beatson Inst, Tumour Cell Death Lab, Glasgow G61 1BD, Lanark, Scotland	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Royal College of Surgeons - Ireland; Beatson Institute	Munoz-Pinedo, C (corresponding author), Hosp Duran & Reynals 3A Planta, IDIBELL, Gran Via LHospitalet 199, Barcelona 08908, Spain.	cmunoz@idibell.cat	Prehn, Jochen HM/A-3928-2010; Munoz-Pinedo, Cristina/B-6118-2008; Caro-Maldonado, Alfredo/D-3288-2014; Caro-Maldonado, Alfredo/A-7364-2010	Prehn, Jochen HM/0000-0003-3479-7794; Munoz-Pinedo, Cristina/0000-0002-9120-664X; Caro-Maldonado, Alfredo/0000-0002-5431-7949; Iurlaro, Raffaella/0000-0003-1019-6679; Ryan, Kevin M./0000-0002-1059-9681	Fundacio Marato TV3 Grant [111630/31]; Secretaria for Universities and Research (SUR) of the ECO of the Government of Catalonia fellowship; Fondo de Investigaciones Sanitarias of Spain [PI10/00104]; Cancer Research UK [15816] Funding Source: researchfish	Fundacio Marato TV3 Grant; Secretaria for Universities and Research (SUR) of the ECO of the Government of Catalonia fellowship; Fondo de Investigaciones Sanitarias of Spain(Instituto de Salud Carlos III); Cancer Research UK(Cancer Research UK)	This work was supported by Fundacio Marato TV3 Grant 111630/31 (to C. M.-P. and J. H. M. P.), Secretaria for Universities and Research (SUR) of the ECO of the Government of Catalonia fellowship (to R. I.), and Fondo de Investigaciones Sanitarias of Spain Grant PI10/00104 (to C. M.-P.).	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Altman BJ, 2011, ONCOGENE, V30, P1855, DOI 10.1038/onc.2010.561; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Caro-Maldonado A., 2011, OPEN CELL SIGNAL J, V3, P42, DOI DOI 10.2174/1876390101103010042; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Decuypere JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061020; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Ramirez-Peinado S, 2011, CANCER RES, V71, P6796, DOI 10.1158/0008-5472.CAN-11-0759; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xi HB, 2013, BIOCHEM PHARMACOL, V85, P1463, DOI 10.1016/j.bcp.2013.02.037; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0	37	48	48	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30387	30398		10.1074/jbc.M113.490581	http://dx.doi.org/10.1074/jbc.M113.490581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014036	hybrid, Green Published			2022-12-25	WOS:000329868100035
J	Zeng, LY; Wan, YH; Li, D; Wu, J; Shao, ML; Chen, J; Hui, LJ; Ji, HB; Zhu, XL				Zeng, Liyong; Wan, Yihan; Li, Dan; Wu, Jing; Shao, Mengle; Chen, Jiong; Hui, Lijian; Ji, Hongbin; Zhu, Xueliang			The m Subunit of Murine Translation Initiation Factor elF3 Maintains the Integrity of the elF3 Complex and Is Required for Embryonic Development, Homeostasis, and Organ Size Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryo; Mouse Genetics; Protein Complexes; Protein Stability; Translation Initiation Factors; Eukaryotic Initiation Factor; Knock-out Mice	NEURONAL MIGRATION DEFECTS; FACTOR EIF3; IN-VIVO; EXPRESSION; REVEALS; BINDING; INHIBITION; GROWTH; CANCER; GENES	Background: eIF3m is a non-core subunit of eIF3. Results: eIF3m deficiency in mice results in animal death and instability of other eIF3 subunits; haploinsufficiency reduces organ size. Conclusion: eIF3m is critical for eIF3 structure and function. Significance: Understanding the mechanism of eIF3 complex formation and its role in embryonic development and homeostasis is crucial for determining the physiological function of this eukaryotic translation factor. Mammalian eIF3 is composed of 13 subunits and is the largest eukaryotic initiation factor. eIF3 plays a key role in protein biosynthesis. However, it is not fully understood how different subunits contribute to the structural integrity and function of the eIF3 complex. Whether eIF3 is essential for embryonic development and homeostasis is also not known. Here, we show that eIF3m null embryos are lethal at the peri-implantation stage. Compound heterozygotes (eIF3m(flox/-)) or FABP4-Cre-mediated conditional knock-out mice are lethal at mid-gestation stages. Although the heterozygotes are viable, they show markedly reduced organ size and diminished body weight. Acute ablation of eIF3m in adult mouse liver leads to rapidly decreased body weight and death within 2 weeks; these effects are correlated with a severe decline of protein biogenesis in the liver. Protein analyses reveal that eIF3m deficiency significantly impairs the integrity of the eIF3 complex due to down-regulation of multiple other subunits. Two of the subunits, eIF3f and eIF3h, are stabilized by eIF3m through subcomplex formation. Therefore, eIF3m is required for the structural integrity and translation initiation function of eIF3. Furthermore, not only is eIF3m an essential gene, but its expression level is also important for mouse embryonic development and the control of organ size.	[Zeng, Liyong; Wan, Yihan; Li, Dan; Hui, Lijian; Ji, Hongbin; Zhu, Xueliang] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Shao, Mengle] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wu, Jing; Chen, Jiong] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Zhu, XL (corresponding author), Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhu@sibcb.ac.cn	Shao, Mengle/AAH-8392-2019; Shao, Mengle/D-9951-2014	Shao, Mengle/0000-0002-5488-9904; Shao, Mengle/0000-0002-5488-9904; Li, Dan/0000-0002-8777-4580; Wan, Yihan/0000-0003-4272-0340	Chinese Academy of Sciences [XDA01010107]; Ministry of Science and Technology of China [2012CB945003, 2006BAI23B02]; Shanghai Municipal Science and Technology Commission [12JC1409900]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Chinese Academy of Sciences Grant XDA01010107, Ministry of Science and Technology of China Grants 2012CB945003 and 2006BAI23B02, and Shanghai Municipal Science and Technology Commission Grant 12JC1409900.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Chaudhuri J, 1999, J BIOL CHEM, V274, P17975, DOI 10.1074/jbc.274.25.17975; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Goh SH, 2011, ONCOGENE, V30, P398, DOI 10.1038/onc.2010.422; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Satterfield MC, 2011, FRONT BIOSCI-LANDMRK, V16, P1589, DOI 10.2741/3807; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Wang FB, 2008, EXP CELL RES, V314, P213, DOI 10.1016/j.yexcr.2007.09.022; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu S, 2012, CELL RES, V22, P1270, DOI 10.1038/cr.2012.47; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30087	30093		10.1074/jbc.M113.506147	http://dx.doi.org/10.1074/jbc.M113.506147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003236	Green Published, hybrid			2022-12-25	WOS:000329868100009
J	Capraro, V				Capraro, Valerio			A Model of Human Cooperation in Social Dilemmas	PLOS ONE			English	Article							VALUE ORIENTATION; GAME	Social dilemmas are situations in which collective interests are at odds with private interests: pollution, depletion of natural resources, and intergroup conflicts, are at their core social dilemmas. Because of their multidisciplinarity and their importance, social dilemmas have been studied by economists, biologists, psychologists, sociologists, and political scientists. These studies typically explain tendency to cooperation by dividing people in proself and prosocial types, or appealing to forms of external control or, in iterated social dilemmas, to long-term strategies. But recent experiments have shown that cooperation is possible even in one-shot social dilemmas without forms of external control and the rate of cooperation typically depends on the payoffs. This makes impossible a predictive division between proself and prosocial people and proves that people have attitude to cooperation by nature. The key innovation of this article is in fact to postulate that humans have attitude to cooperation by nature and consequently they do not act a priori as single agents, as assumed by standard economic models, but they forecast how a social dilemma would evolve if they formed coalitions and then they act according to their most optimistic forecast. Formalizing this idea we propose the first predictive model of human cooperation able to organize a number of different experimental findings that are not explained by the standard model. We show also that the model makes satisfactorily accurate quantitative predictions of population average behavior in one-shot social dilemmas.	Univ Southampton, Dept Math, Southampton SO9 5NH, Hants, England	University of Southampton	Capraro, V (corresponding author), Univ Southampton, Dept Math, Southampton SO9 5NH, Hants, England.	V.Capraro@soton.ac.uk						[Anonymous], 1986, EXPT SOCIAL DILEMMAS; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BASU K, 1994, AM ECON REV, V84, P391; Basu K, 2011, SOC CHOICE WELFARE, V37, P575, DOI 10.1007/s00355-011-0577-7; Becker T, 2006, 252 HOH U I EC; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BONACICH P, 1976, J CONFLICT RESOLUT, V20, P687, DOI 10.1177/002200277602000406; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Capra CM, 1999, AM ECON REV, V89, P678, DOI 10.1257/aer.89.3.678; Capraro V, 2013, P 6 INT S A IN PRESS; Capraro V, 2013, SOLUTION CONCEPT GAM; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Costa-Gomes M, 2001, ECONOMETRICA, V69, P1193, DOI 10.1111/1468-0262.00239; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Dreber A, 2013, EXPT EC IN PRESS; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Goeree JK, 2004, GAME ECON BEHAV, V46, P365, DOI 10.1016/S0899-8256(03)00145-3; Goeree JK, 2002, J PUBLIC ECON, V83, P255, DOI 10.1016/S0047-2727(00)00160-2; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Gunnthorsdottir A, 2007, J ECON BEHAV ORGAN, V62, P304, DOI 10.1016/j.jebo.2005.03.008; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; ISAAC RM, 1984, PUBLIC CHOICE, V43, P113, DOI 10.1007/BF00140829; KELLEY HH, 1972, J PERS SOC PSYCHOL, V21, P190, DOI 10.1037/h0032224; KERR NL, 1983, J PERS SOC PSYCHOL, V45, P819, DOI 10.1037/0022-3514.45.4.819; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; KOMORITA SS, 1980, J PERS SOC PSYCHOL, V38, P504, DOI 10.1037/0022-3514.38.3.504; KRAMER RM, 1986, J PERS, V54, P576, DOI 10.1111/j.1467-6494.1986.tb00413.x; Kummerli R, 2007, P R SOC B, V274, P2965, DOI 10.1098/rspb.2007.0793; Liebrand W, 1984, EUR J SOC PSYCHOL; LIEBRAND WBG, 1986, J CONFLICT RESOLUT, V30, P77, DOI 10.1177/0022002786030001006; Manapat ML, 2012, J THEOR BIOL, V303, P119, DOI 10.1016/j.jtbi.2012.03.014; MARWELL G, 1981, J PUBLIC ECON, V15, P295, DOI 10.1016/0047-2727(81)90013-X; MCCLINTOCK CG, 1988, J PERS SOC PSYCHOL, V55, P396, DOI 10.1037/0022-3514.55.3.396; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Olson M., 1965, LOGIC COLLECTIVE ACT; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; STAHL DO, 1994, J ECON BEHAV ORGAN, V25, P309, DOI 10.1016/0167-2681(94)90103-1	41	83	84	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72427	10.1371/journal.pone.0072427	http://dx.doi.org/10.1371/journal.pone.0072427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009679	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600018
J	Pages, DS; Groh, JM				Pages, Daniel S.; Groh, Jennifer M.			Looking at the Ventriloquist: Visual Outcome of Eye Movements Calibrates Sound Localization	PLOS ONE			English	Article								A general problem in learning is how the brain determines what lesson to learn (and what lessons not to learn). For example, sound localization is a behavior that is partially learned with the aid of vision. This process requires correctly matching a visual location to that of a sound. This is an intrinsically circular problem when sound location is itself uncertain and the visual scene is rife with possible visual matches. Here, we develop a simple paradigm using visual guidance of sound localization to gain insight into how the brain confronts this type of circularity. We tested two competing hypotheses. 1: The brain guides sound location learning based on the synchrony or simultaneity of auditory-visual stimuli, potentially involving a Hebbian associative mechanism. 2: The brain uses a 'guess and check' heuristic in which visual feedback that is obtained after an eye movement to a sound alters future performance, perhaps by recruiting the brain's reward-related circuitry. We assessed the effects of exposure to visual stimuli spatially mismatched from sounds on performance of an interleaved auditory-only saccade task. We found that when humans and monkeys were provided the visual stimulus asynchronously with the sound but as feedback to an auditory-guided saccade, they shifted their subsequent auditory-only performance toward the direction of the visual cue by 1.3-1.7 degrees, or 22-28% of the original 6 degree visual-auditory mismatch. In contrast when the visual stimulus was presented synchronously with the sound but extinguished too quickly to provide this feedback, there was little change in subsequent auditory-only performance. Our results suggest that the outcome of our own actions is vital to localizing sounds correctly. Contrary to previous expectations, visual calibration of auditory space does not appear to require visual-auditory associations based on synchrony/simultaneity.	[Pages, Daniel S.; Groh, Jennifer M.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Pages, Daniel S.; Groh, Jennifer M.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Groh, Jennifer M.] Duke Univ, Dept Neurobiol, Durham, NC USA	Duke University; Duke University; Duke University	Pages, DS (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	dspages@gmail.com		Groh, Jennifer/0000-0002-6435-3935	National Institutes of Health [EY016478]; National Science Foundation [NSF 0924750]; NATIONAL EYE INSTITUTE [R01EY016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work supported by National Institutes of Health (www.nih.gov) grant EY016478 and National Science Foundation (www.nsf.gov) grant NSF 0924750 to JMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P6; Banks M, 2002, NAT NEUROSCI, V415, P5; Bergan J, 2005, J NEUROSCI, V25, P5; Bertelson P, 2000, NEUROPSYCHOLOGIA, V38, P1634, DOI 10.1016/S0028-3932(00)00067-1; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bertelson P, 2004, ACTA PSYCHOL, V118, P8; Bi G, 1998, J NEUROSCI, V18, P9; Collins T, 2012, J NEUROPHYSIOL, V107, P3342, DOI 10.1152/jn.00746.2011; de Gelder B, 2006, PERCEPT PSYCHOPHYS, V68, P9; Fuchs A, 1998, J NEUROPHYSIOL, V80, P12; Fuchs A, 1966, J APPL PHYSIOL, V21, P3; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Gruters KG, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00096; Gutfreund Y, 2002, SCIENCE, V297, P1556, DOI 10.1126/science.1073712; Hartmann W, 2003, J ACOUST SOC AM, V114, P11; Hebb Donald O., 1949, ORG BEHAV; Jack C, 1973, PERCEPT MOTOR SKILL, V37, P13; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; King A, 2010, NAT NEUROSCI, V13, P8; Knoth E, 2008, PROG BRAIN RES, V171, P6; Knudsen E, 1989, J NEUROSCI, V9, P8; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Lin I, 2009, J NEUROSCI, V29, P6; McLaughlin S, 1967, PERCEPTION AND PSYCH, V2, P4; Metzger R, 2006, J NEUROSCI, V26, P9; Mullette-Gillman O, 2004, J NEUROPHYSIOL, V92, P6; Paige G, 2003, NAT NEUROSCI, V6, P7; Porter K, 2007, P NATL ACAD SCI USA, V104, P6; RADEAU M, 1974, Q J EXP PSYCHOL, V26, P63, DOI 10.1080/14640747408400388; Recanzone G, 1998, P NATL ACAD SCI USA, V95, P7; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Richmond B, 1980, VISION RES, V20, P4; Selezneva E, 2005, J NEUROSCI, V25, P10; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Stevens SS, 1936, AM J PSYCHOL, V48, P297, DOI 10.2307/1415748; Templeton W, 1981, J EXP PSYCHOL HUMAN, V7, P11; Thurlow W. R. G., 1973, PERCEPT MOTOR SKILL, V36, P14; Tollin D, 2011, JARO-J ASSOC RES OTO, V12, P14; Usher S, 1997, J NEUROPHYSIOL, V77, P22; Van Barneveld DCPBM, 2013, EUR J NEUROSCI, V37, P1501, DOI 10.1111/ejn.12176; Vroomen J, 2001, ACTA PSYCHOL, V108, P21, DOI 10.1016/S0001-6918(00)00068-8; Wozny DR, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00075	42	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72562	10.1371/journal.pone.0072562	http://dx.doi.org/10.1371/journal.pone.0072562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009691	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600029
J	Price, O; Bradstock, R				Price, Owen; Bradstock, Ross			Landscape Scale Influences of Forest Area and Housing Density on House Loss in the 2009 Victorian Bushfires	PLOS ONE			English	Article							FUEL TREATMENT; RISK MITIGATION; WILDFIRES; INSIGHTS	Previous investigations into the factors associated with house loss in wildfires have focused on the house construction and its immediate environment (e.g. gardens). Here, we examine how nearby native forest and other houses can influence house loss. Specifically, we used a sample of 3500 houses affected by the Victorian bushfires of February 7th 2009 to explore how the amount of forest, proportion of forest burned by crown fire and the number of nearby houses affected house loss and how far from the house this influence was exerted. These fires were the most destructive in Australian history and so represent the extreme of fire risk. Using generalized linear modeling we found that the probability of house loss increased with forest extent and the proportion burnt by crown fire and this relationship was strongest for forest measured 1 km from the houses. Houses were more likely to be destroyed if there were other houses within 50 m and if they were on a slope. A model containing these variables predicted house loss with 72% accuracy. Our findings have three important implications: i) management to change the occurrence of crown fire will be effective in reducing house loss; ii) this management may be required up to 1 km away from houses in some situations (a much larger zone than is currently used); iii) high density of houses may increase risk of loss. Given the potentially large width of this management zone and the hazard from nearby houses, it may be more sensible to concentrate on modification of buildings to reduce their vulnerability.	[Price, Owen; Bradstock, Ross] Univ Wollongong, Ctr Environm Risk Management Bushfires, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia	University of Wollongong	Price, O (corresponding author), Univ Wollongong, Ctr Environm Risk Management Bushfires, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	oprice@uow.edu.au	Price, Owen F/H-4033-2012	Price, Owen F/0000-0001-5327-568X	Rural Fire Service of NSW, The Office of Environment and Heritage of NSW; Victorian Bushfires Royal Commission	Rural Fire Service of NSW, The Office of Environment and Heritage of NSW; Victorian Bushfires Royal Commission	The study was supported by the Rural Fire Service of NSW, The Office of Environment and Heritage of NSW and the 2009 Victorian Bushfires Royal Commission, who provided funding but were not involved in the design or execution of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern A, 1999, FAR DO BUSHFIRES PEN; Bhandary U, 2009, J ENVIRON PLANN MAN, V52, P939, DOI 10.1080/09640560903181147; Bradstock RA, 2012, J ENVIRON MANAGE, V105, P66, DOI 10.1016/j.jenvman.2012.03.050; Bradstock RA, 2001, J MEDITERRANEAN ECOL, V2, P179; Brillinger DR, 2009, ENVIRONMETRICS, V20, P607, DOI 10.1002/env.959; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chen KP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020244; Cohen JD, 2001, WILDLAND URBAN FIRE; Cohen J, 2008, SALES MARK MANAG, V160, P26; Collins L, 2012, BIOL CONSERV, V149, P23, DOI 10.1016/j.biocon.2012.01.065; CUNNINGHAM CJ, 1984, APPL GEOGR, V4, P5, DOI 10.1016/0143-6228(84)90002-X; DSE, 2009, REM SENS GUID ASS LA; Ellis PFM, 2011, INT J WILDLAND FIRE, V20, P897, DOI 10.1071/WF10052; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; GILL AM, 1987, AUST J ECOL, V12, P299, DOI 10.1111/j.1442-9993.1987.tb00950.x; Haining R, 2003, SPATIAL DATA ANAL; Harris S, 2012, NAT HAZARDS, V63, P391, DOI 10.1007/s11069-012-0156-y; Koo E, 2010, INT J WILDLAND FIRE, V19, P818, DOI 10.1071/WF07119; Leonard J., 2009, BUILDING LAND USE PL; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McCullagh P., 1983, MONOGRAPHS STAT APPL; Mell WE, 2010, INT J WILDLAND FIRE, V19, P238, DOI 10.1071/WF07131; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; R CDT, 2007, LANG ENV STAT COMP; Reinhardt ED, 2008, FOREST ECOL MANAG, V256, P1997, DOI 10.1016/j.foreco.2008.09.016; Syphard AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033954; Teague B., 2010, 2009 VICTORIAN BUSHF; WILSON AAG, 1986, J ENVIRON MANAGE, V23, P259	28	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73421	10.1371/journal.pone.0073421	http://dx.doi.org/10.1371/journal.pone.0073421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009753	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600068
J	Bottcher, T; Rolfs, A; Tanislav, C; Bitsch, A; Kohler, W; Gaedeke, J; Giese, AK; Kolodny, EH; Duning, T				Boettcher, Tobias; Rolfs, Arndt; Tanislav, Christian; Bitsch, Andreas; Koehler, Wolfgang; Gaedeke, Jens; Giese, Anne-Katrin; Kolodny, Edwin H.; Duning, Thomas			Fabry Disease - Underestimated in the Differential Diagnosis of Multiple Sclerosis?	PLOS ONE			English	Article							NERVOUS-SYSTEM INVOLVEMENT; CHRONIC MENINGITIS; REPLACEMENT THERAPY; ALPHA-GALACTOSIDASE; STROKE; CRITERIA; MRI	Objective: Fabry disease is a rare X-linked inherited lysosomal storage disorder affecting multiple organ systems. It includes central nervous system involvement via micro-and macroangiopathic cerebral changes. Due to its clinical symptoms and frequent MRI lesions, Fabry disease is commonly misdiagnosed as multiple sclerosis. We present an overview of cases from Fabry centres in Germany initially misdiagnosed with multiple sclerosis and report the clinical, MR-tomographical, and laboratory findings. Methods: Eleven Fabry patients (one male, ten females) initially diagnosed with multiple sclerosis were identified from 187 patient records (5.9%) and analyzed for presenting symptoms, results of the initial diagnostic workup, and the clinical course of the disease. Results: Four patients were identified as having a "possible" history of MS, and 7 patients as "definite" cases of multiple sclerosis (revised McDonald criteria). On average, Fabry disease was diagnosed 8.2 years (+/- 9.8 years) after the MS diagnosis, and 12.8 years after onset of first symptoms (+/- 10.3 years). All patients revealed white matter lesions on MRI. The lesion pattern and results of cerebrospinal fluid examination were inconsistent and non-specific. White matter lesion volumes ranged from 8.9 mL to 34.8 mL (mean 17.8 mL +/- 11.4 mL). There was no association between extra-neurological manifestations or enzyme activity and lesion load. Conclusion: There are several anamnestic and clinical hints indicating when Fabry disease should be considered a relevant differential diagnosis of multiple sclerosis, e. g. female patients with asymmetric, confluent white matter lesions on MRI, normal spinal MR imaging, ectatic vertebrobasilar arteries, proteinuria, or lack of intrathecally derived immunoglobulin synthesis.	[Boettcher, Tobias; Rolfs, Arndt; Giese, Anne-Katrin] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany; [Boettcher, Tobias] Dietrich Bonhoeffer Klinikum, Dept Neurol, Neubrandenburg, Germany; [Tanislav, Christian] Univ Hosp, Dept Neurol, Giessen, Germany; [Bitsch, Andreas] Ruppiner Kliniken GmbH, Dept Neurol, Neuruppin, Germany; [Koehler, Wolfgang] Fachkrankenhaus Hubertusburg, Dept Neurol, Wermsdorf, Germany; [Gaedeke, Jens] Charite, Dept Nephrol, D-13353 Berlin, Germany; [Kolodny, Edwin H.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Duning, Thomas] Univ Hosp, Dept Neurol, Munster, Germany	University of Rostock; Ruppiner Kliniken GmbH; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; University of Munster	Rolfs, A (corresponding author), Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany.	arndt.rolfs@med.uni-rostock.de	Koehler, Wolfgang/AAW-2278-2020	Koehler, Wolfgang/0000-0002-6058-9545; Giese, A.K./0000-0002-8500-2376				Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; Buechner S, 2008, J NEUROL NEUROSUR PS, V79, P1249, DOI 10.1136/jnnp.2008.143693; Cabrera-Salazar MA, 2005, J PEDIATR-US, V147, P102, DOI 10.1016/j.jpeds.2005.03.004; Callegaro D, 2006, Int MS J, V13, P27; DAWSON DM, 1984, NEW ENGL J MED, V310, P106; DUBOST JJ, 1985, J NEUROL NEUROSUR PS, V48, P714, DOI 10.1136/jnnp.48.7.714; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fabry J., 1898, ARCH DERMATOL SYPHIL, V43, P187; Falke K, 2009, GRAEF ARCH CLIN EXP, V247, P523, DOI 10.1007/s00417-008-0962-9; Fellgiebel A, 2009, NEUROLOGY, V72, P63, DOI 10.1212/01.wnl.0000338566.54190.8a; Fellgiebel A, 2007, ACTA PAEDIATR, V96, P33, DOI 10.1111/j.1651-2227.2007.00203.x; Fellgiebel A, 2011, CEREBROVASC DIS, V31, P294, DOI 10.1159/000322558; Ginsberg L., 2006, FABRY DIS PERSPECTIV; Invernizzi P, 2008, MULT SCLER J, V14, P1003, DOI 10.1177/1352458508092355; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Lehmann HC, 2006, LANCET NEUROL, V5, P97, DOI 10.1016/S1474-4422(05)70287-8; Lidove O, 2009, INT J CLIN PRACT, V63, P1663, DOI 10.1111/j.1742-1241.2009.02115.x; Lidove O, 2007, J NEUROL NEUROSUR PS, V78, P1007, DOI 10.1136/jnnp.2006.108464; LYON MF, 1963, LANCET, V2, P1120; Marchesoni CL, 2010, J PEDIATR-US, V156, P828, DOI 10.1016/j.jpeds.2010.02.012; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Saip S, 2007, CLIN NEUROL NEUROSUR, V109, P361, DOI 10.1016/j.clineuro.2006.12.006; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schreiber W, 2007, J NEUROL, V254, P1447, DOI 10.1007/s00415-007-0533-8; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Tondel Camilla, 2003, Tidsskr Nor Laegeforen, V123, P3388; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; WISE D, 1962, Q J MED, V31, P177	34	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71894	10.1371/journal.pone.0071894	http://dx.doi.org/10.1371/journal.pone.0071894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015197	gold, Green Published, Green Submitted			2022-12-25	WOS:000323733800019
J	Goffin, JM; Jenkins, PJ; Ramaesh, R; Pankaj, P; Simpson, AH				Goffin, Jerome M.; Jenkins, Paul J.; Ramaesh, Rishikesan; Pankaj, Pankaj; Simpson, A. Hamish			What Is the Relevance of the Tip-Apex Distance as a Predictor of Lag Screw Cut-Out?	PLOS ONE			English	Article							SLIDING HIP SCREW; INTERTROCHANTERIC FRACTURES; FIXATION; HEAD; MICROARCHITECTURE; FEMUR; RISK	Using a simple mathematical formulation, the relationship between the position of the lag screw tip (relevant to both intramedullary and extramedullary devices) and the concept of tip-apex distance (TAD) was derived. TAD is widely used in operating theaters as a surgical guideline in relation to the fixation of trochanteric fractures, and in clinical studies as a predictor of lag screw cut-out. In order to visualize better this concept, the locus of points having the same TAD was plotted and the dependence of TAD on the location of the lag screw tip was also reported. It was shown that TAD should be adjusted for the size of the femoral head (a variable which varies a lot according to the sex of the patient) while no correlation was found between TAD and bone morphometry indices obtained from micro-CT data (BV/TV and Tb.Th). Therefore, these results seem to suggest that TAD lacks mechanical justification and that predictors which are based on mechanical properties, such as bone density, should be investigated further.	[Goffin, Jerome M.; Simpson, A. Hamish] Univ Edinburgh, Dept Orthopaed Surg, Edinburgh, Midlothian, Scotland; [Jenkins, Paul J.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Ramaesh, Rishikesan] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Pankaj, Pankaj] Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Goffin, JM (corresponding author), Univ Edinburgh, Dept Orthopaed Surg, Edinburgh, Midlothian, Scotland.	j.goffin@ed.ac.uk	, Pankaj/K-4144-2019; Simpson, Hamish/F-1887-2013	Pankaj, Pankaj/0000-0002-9317-3909; Simpson, Hamish/0000-0001-7793-642X; Ramaesh, Rishi/0000-0001-9456-113X	University of Edinburgh	University of Edinburgh	The first author was supported by a Principal's Career Development Scholarship awarded by the University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asala SA, 2001, FORENSIC SCI INT, V117, P15, DOI 10.1016/S0379-0738(00)00444-8; BAUMGAERTNER MR, 1995, J BONE JOINT SURG AM, V77A, P1058, DOI 10.2106/00004623-199507000-00012; CLEVELAND M, 1959, J BONE JOINT SURG AM, V41, P1399, DOI 10.2106/00004623-195941080-00003; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Geller JA, 2010, INT ORTHOP, V34, P719, DOI 10.1007/s00264-009-0837-7; Goffin JM, 2013, J ORTHOP RES, V31, P596, DOI 10.1002/jor.22266; Herman A, 2012, INJURY, V43, P856, DOI 10.1016/j.injury.2011.10.030; Hsueh KK, 2010, INT ORTHOP, V34, P1273, DOI 10.1007/s00264-009-0866-2; Jeffery JA, 2000, INJURY, V31, P135, DOI 10.1016/S0020-1383(99)00242-9; Jenkins P, 2013, BONE JOINT J ORT B S, V95-B, P168; Kumar AJS, 2007, INJURY, V38, P792, DOI 10.1016/j.injury.2006.12.002; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Lobo-Escolar A, 2010, INJURY, V41, P1312, DOI 10.1016/j.injury.2010.08.009; Lorich Dean G, 2004, Instr Course Lect, V53, P441; Tanck E, 2009, BONE, V44, P590, DOI 10.1016/j.bone.2008.12.022; Tanner DA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-12; Wright D, 2011, CLIN ORTHOP RELAT R, V469, P2583, DOI 10.1007/s11999-010-1754-1	18	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71195	10.1371/journal.pone.0071195	http://dx.doi.org/10.1371/journal.pone.0071195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015184	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800006
J	Kumar, N; Kanchan, T; Unnikrishnan, B; Rekha, T; Mithra, P; Kulkarni, V; Papanna, MK; Holla, R; Uppal, S				Kumar, Nithin; Kanchan, Tanuj; Unnikrishnan, Bhaskaran; Rekha, T.; Mithra, Prasanna; Kulkarni, Vaman; Papanna, Mohan Kumar; Holla, Ramesh; Uppal, Surabhi			Perceptions and Practices of Self-Medication among Medical Students in Coastal South India	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; ANTIBIOTICS; PATTERNS; COLLEGE	Self-medication is a common practice worldwide and the irrational use of drugs is a cause of concern. This study assessed the prevalence of self-medication among the medical students in South India. The data was analysed using SPSS version 11.5. A total of 440 students were included in the study. The prevalence of self-medication was 78.6%. A larger number of females were self-medicating (81.2%) than males (75.3%). The majority of the students self-medicated because of the illness being too trivial for consultation (70.5%). Antipyretics were most commonly self-medicated by the participants (74.8%). Only 47% of the participants opined that self-medication was a part of self-care and it needs to be encouraged. 39.3% of the participants perceived that the supply of medicine without prescription by the pharmacist can prevent the growing trend of self-medication. Easy availability and accessibility to health care facilities remains the cornerstone for reducing the practice of self-medication.	[Kumar, Nithin; Unnikrishnan, Bhaskaran; Rekha, T.; Mithra, Prasanna; Kulkarni, Vaman; Papanna, Mohan Kumar; Holla, Ramesh] Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India; [Kanchan, Tanuj] Manipal Univ, Kasturba Med Coll, Dept Forens Med, Mangalore, Karnataka, India; [Uppal, Surabhi] Manipal Univ, Kasturba Med Coll, Mangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Kumar, N (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India.	nithin.gatty@manipal.edu	KANCHAN, TANUJ/L-8547-2015; Prasanna Mithra, MBBS/J-9621-2018; Kumar, Nithin/P-2781-2015; Holla, Ramesh/P-2785-2015; Unnikrishnan, Bhaskaran/O-1025-2015; Thapar, Rekha/A-7098-2016	KANCHAN, TANUJ/0000-0003-0346-1075; Prasanna Mithra, MBBS/0000-0002-7153-411X; Kumar, Nithin/0000-0003-4665-9401; Holla, Ramesh/0000-0002-2296-3719; Unnikrishnan, Bhaskaran/0000-0003-0892-8551; Thapar, Rekha/0000-0003-2278-1445; Kulkarni, Vaman/0000-0002-6518-2277	Department of Community Medicine, Kasturba Medical College, Mangalore; Manipal University; FOGARTY INTERNATIONAL CENTER [D43TW008332] Funding Source: NIH RePORTER	Department of Community Medicine, Kasturba Medical College, Mangalore; Manipal University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors are grateful to the study participants who voluntarily took part in the study. We wish to acknowledge the support provided by the Department of Community Medicine, Kasturba Medical College, Mangalore and Manipal University for encouraging research and its publication in international journals of repute.	Abay SM, 2010, J YOUNG PHARM, V2, P306, DOI 10.4103/0975-1483.66798; Ali Sohair E., 2010, Pharmacy Pract (Granada), V8, P226; Azevedo MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-359; Badiger S, 2012, AUSTRALAS MED J, V5, P217, DOI 10.4066/AMJ.2012.1007; Balamurugan E., 2011, British Journal of Medical Practitioners, V4, pa428; Banerjee I, 2012, J POSTGRAD MED, V58, P127, DOI 10.4103/0022-3859.97175; Belachew G., 2011, J APPL PHARM SCI, V1, P183; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Burak LJ, 2000, J AM COLL HEALTH, V49, P118, DOI 10.1080/07448480009596293; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Ehigiator O., 2013, EUR J GEN DENT, V2, P54, DOI [10.4103/2278-9626.106813, DOI 10.4103/2278-9626.106813]; El Ezz NF, 2011, EGYPT J PREV MED HYG, V52, P196; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; Fadare J. O., 2011, Journal of Public Health and Epidemiology, V3, P217; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Gupta V., 2011, J DRUG DELIV THER, V1, P27; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; Klemenc-Ketis Z, 2011, COLLEGIUM ANTROPOL, V35, P329; Loyola Filho Antônio I. de, 2004, Cad. Saúde Pública, V20, P1661, DOI 10.1590/S0102-311X2004000600025; Lucas R, 2007, CAD SAUDE PUBLICA, V23, P2845, DOI 10.1590/S0102-311X2007001200005; Olayemi OJ, 2010, RES J APPL SCI ENG T, V2, P35; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041314; Sarahroodi S, 2012, J FAM COMMUNITY MED, V19, P125, DOI 10.4103/2230-8229.98302; Sarkar P, 2006, DRUGS, V66, P893, DOI 10.2165/00003495-200666070-00001; Selley P, 1988, Health Trends, V20, P128; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; Smogavec M, 2010, ZDR VESTN, V79, P757; Sontakke SD, 2011, INT J BIOL MED RES, V2, P561; Verma RK, 2010, ASIAN J PHARM CLIN R, V3, P60; Vizhi SK, 2010, INT J ENTREP INNOV M, V3, P40; World Health Organization, 2000, REG GUID TEL PROD; Zafar SN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-162	32	81	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72247	10.1371/journal.pone.0072247	http://dx.doi.org/10.1371/journal.pone.0072247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015223	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800038
J	Martin, NJ; Smith, PA; Achee, NL; DeLong, GT				Martin, Nicholas J.; Smith, Philip A.; Achee, Nicole L.; DeLong, Gerald T.			Determining Airborne Concentrations of Spatial Repellent Chemicals in Mosquito Behavior Assay Systems	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CONTACT IRRITANT; RESPONSES; VECTOR; CULICIDAE; DDT	Background: Mosquito behavior assays have been used to evaluate the efficacy of vector control interventions to include spatial repellents (SR). Current analytical methods are not optimized to determine short duration concentrations of SR active ingredients (AI) in air spaces during entomological evaluations. The aim of this study was to expand on our previous research to further validate a novel air sampling method to detect and quantitate airborne concentrations of a SR under laboratory and field conditions. Methodology/Principal Findings: A thermal desorption (TD) gas chromatography-mass spectrometry (GC-MS) method was used to determine the amount of dichlorodiphenyltrichloroethane (DDT) in samples of air. During laboratory experiments, 1 L volumes of air were collected over 10 min intervals from a three-chamber mosquito behavior assay system. Significantly higher levels of airborne DDT were measured in the chamber containing textiles treated with DDT compared to chambers free of AI. In the field, 57 samples of air were collected from experimental huts with and without DDT for onsite analysis. Airborne DDT was detected in samples collected from treated huts. The mean DDT air concentrations in these two huts over a period of four days with variable ambient temperature were 0.74 mu g/m(3) (n = 17; SD = 0.45) and 1.42 mu g/m(3) (n = 30; SD = 0.96). Conclusions/Significance: The results from laboratory experiments confirmed that significantly different DDT exposure conditions existed in the three-chamber system establishing a chemical gradient to evaluate mosquito deterrency. The TD GC-MS method addresses a need to measure short-term (<1 h) SR concentrations in small volume (<100 L) samples of air and should be considered for standard evaluation of airborne AI levels in mosquito behavior assay systems. Future studies include the use of TD GC-MS to measure other semi-volatile vector control compounds.	[Martin, Nicholas J.] US Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Martin, Nicholas J.; Smith, Philip A.; Achee, Nicole L.; DeLong, Gerald T.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Smith, Philip A.] Occupat Safety & Hlth Adm, Hlth Response Team, US Dept Labor, Sandy, UT USA; [DeLong, Gerald T.] US Naval Inspector Gen, Portsmouth, VA USA	Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; United States Department of Labor	Martin, NJ (corresponding author), US Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA.	nicholas.martin@med.navy.mil		Achee, Nicole/0000-0001-6939-2055	Uniformed Services University of the Health Sciences [R087Y5]; Bill and Melinda Gates Foundation [48513]	Uniformed Services University of the Health Sciences; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by Uniformed Services University of the Health Sciences intramural (Grant R087Y5) and the Bill and Melinda Gates Foundation (Grant #48513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee N, 2012, OUTLOOKS PEST MANAGE, V23, P283; Achee N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-300; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; [Anonymous], 2000, E74100 ASTM INT; [Anonymous], 2000, QUANTIFYING UNCERTAI; [Anonymous], 2000, 8081B EPA; [Anonymous], 2006, PESTICIDES THEIR APP; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chareonviriyaphap T, 2002, J VECTOR ECOL, V27, P250; Chareonviriyaphap T, 2005, J VECTOR ECOL, V30, P344; Das Bina Pani, 1997, Journal of Communicable Diseases, V29, P225; Environmental Protection Agency (EPA), 1996, 8000B EPA; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P404, DOI 10.2987/8756-971X(2006)21[404:ANHSST]2.0.CO;2; Grieco JP, 2007, PLOS ONE, V8, P1; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Manda H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002074; Martin NJ, 2012, PEST MANAG SCI, V68, P1360, DOI 10.1002/ps.3313; Occupational Safety and Health Administration, 1988, OCC SAF HLTH GUID DD; Roberts DR, 1997, J AM MOSQUITO CONTR, V13, P13; Roberts DR, 2000, J VECTOR ECOL, V25, P48; Said SH, 2009, J AM MOSQUITO CONTR, V25, P436, DOI 10.2987/09-5895.1; Tainchum K, 2013, J MED ENTOMOL, V50, P59, DOI 10.1603/ME11027; Thanispong K, 2009, J MED ENTOMOL, V46, P1407, DOI 10.1603/033.046.0622; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; WANIA F, 1994, J CHEM ENG DATA, V39, P572, DOI 10.1021/je00015a039; WHO, 2011, WORLD MALARIA REPORT 2011, P1; [WHO World Health Organization (WHO)], 2011, US DDT MAL VECT CONT; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2013, GUID EFF TEST SPAT R	29	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71884	10.1371/journal.pone.0071884	http://dx.doi.org/10.1371/journal.pone.0071884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015195	gold, Green Submitted, Green Published			2022-12-25	WOS:000323733800017
J	Wagner, M; Schlusener, MP; Ternes, TA; Oehlmann, J				Wagner, Martin; Schluesener, Michael P.; Ternes, Thomas A.; Oehlmann, Joerg			Identification of Putative Steroid Receptor Antagonists in Bottled Water: Combining Bioassays and High-Resolution Mass Spectrometry	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; ESTROGENIC ACTIVITY; BISPHENOL-A; URINARY	Endocrine disrupting chemicals (EDCs) are man-made compounds interfering with hormone signaling and thereby adversely affecting human health. Recent reports provide evidence for the presence of EDCs in commercially available bottled water, including steroid receptor agonists and antagonists. However, since these findings are based on biological data the causative chemicals remain unidentified and, therefore, inaccessible for toxicological evaluation. Thus, the aim of this study is to assess the antiestrogenic and antiandrogenic activity of bottled water and to identify the causative steroid receptor antagonists. We evaluated the antiestrogenic and antiandrogenic activity of 18 bottled water products in reporter gene assays for human estrogen receptor alpha and androgen receptor. Using nontarget high-resolution mass spectrometry (LTQ-Orbitrap Velos), we acquired corresponding analytical data. We combined the biological and chemical information to determine the exact mass of the tentative steroid receptor antagonist. Further MSn experiments elucidated the molecule's structure and enabled its identification. We detected significant antiestrogenicity in 13 of 18 products. 16 samples were antiandrogenic inhibiting the androgen receptor by up to 90%. Nontarget chemical analysis revealed that out of 24520 candidates present in bottled water one was consistently correlated with the antagonistic activity. By combining experimental and in silico MSn data we identified this compound as di(2-ethylhexyl) fumarate (DEHF). We confirmed the identity and biological activity of DEHF and additional isomers of dioctyl fumarate and maleate using authentic standards. Since DEHF is antiestrogenic but not antiandrogenic we conclude that additional, yet unidentified EDCs must contribute to the antagonistic effect of bottled water. Applying a novel approach to combine biological and chemical analysis this is the first study to identify so far unknown EDCs in bottled water. Notably, dioctyl fumarates and maleates have been overlooked by science and regulation to date. This illustrates the need to identify novel toxicologically relevant compounds to establish a more holistic picture of the human exposome.	[Wagner, Martin; Oehlmann, Joerg] Goethe Univ Frankfurt, Fac Biol Sci, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany; [Schluesener, Michael P.; Ternes, Thomas A.] Fed Inst Hydrol BfG, Koblenz, Germany	Goethe University Frankfurt	Wagner, M (corresponding author), Goethe Univ Frankfurt, Fac Biol Sci, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany.	wagner@bio.uni-frankfurt.de	Wagner, Martin/E-9893-2011; Oehlmann, Jörg/B-4565-2010	Wagner, Martin/0000-0002-4402-3234; Oehlmann, Jörg/0000-0002-6075-2701	German Federal Environment Agency [206 67 448/04]	German Federal Environment Agency	This study was in part supported by the German Federal Environment Agency (www.uba.de, Research & Development Project 206 67 448/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Behr M, 2011, FOOD CHEM TOXICOL, V49, P2681, DOI 10.1016/j.fct.2011.07.039; Bohmler G., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P325, DOI 10.1007/s00003-006-0055-9; Bopp K, 2010, DEUT LEBENSM-RUNDSCH, V106, P489; Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Erythropel HC, 2012, CHEMOSPHERE, V86, P759, DOI 10.1016/j.chemosphere.2011.10.054; Fiselier K, 2010, EUR FOOD RES TECHNOL, V230, P619, DOI 10.1007/s00217-009-1200-3; Heinze J, 2011, J STEROID BIOCHEM, V127, P136, DOI 10.1016/j.jsbmb.2011.06.004; Hong G, 2012, DENT MATER J, V31, P139, DOI 10.4012/dmj.2011-185; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Naidenko O., 2008, BOTTLED WATER QUALIT; Pinto B, 2009, INT J HYG ENVIR HEAL, V212, P228, DOI 10.1016/j.ijheh.2008.06.004; Plotan M, 2013, FOOD CHEM, V136, P1590, DOI 10.1016/j.foodchem.2012.01.115; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Stalter D, 2011, WATER RES, V45, P1015, DOI 10.1016/j.watres.2010.10.008; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Wagner M, 2013, ENVIRON TOXICOL CHEM, V32, P1906, DOI 10.1002/etc.2256; Wagner M, 2011, J STEROID BIOCHEM, V127, P137; Wagner M, 2011, J STEROID BIOCHEM, V127, P128, DOI 10.1016/j.jsbmb.2010.10.007; Wagner M, 2009, ENVIRON SCI POLLUT R, V16, P278, DOI 10.1007/s11356-009-0107-7; Yang CZ, 2011, ENVIRON HEALTH PERSP, V119, P989, DOI 10.1289/ehp.1003220; Zhang JF, 2004, J APPL POLYM SCI, V94, P1697, DOI 10.1002/app.21078	32	22	23	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72472	10.1371/journal.pone.0072472	http://dx.doi.org/10.1371/journal.pone.0072472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015248	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800056
J	Fraga, FJ; Falk, TH; Kanda, PAM; Anghinah, R				Fraga, Francisco J.; Falk, Tiago H.; Kanda, Paulo A. M.; Anghinah, Renato			Characterizing Alzheimer's Disease Severity via Resting-Awake EEG Amplitude Modulation Analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEURONAL OSCILLATIONS; DEMENTIA; DIAGNOSIS; ASSOCIATION; PREVALENCE; MOTIVATION; SLEEP; ALPHA; MODEL	Changes in electroencephalography (EEG) amplitude modulations have recently been linked with early-stage Alzheimer's disease (AD). Existing tools available to perform such analysis (e.g., detrended fluctuation analysis), however, provide limited gains in discriminability power over traditional spectral based EEG analysis. In this paper, we explore the use of an innovative EEG amplitude modulation analysis technique based on spectro-temporal signal processing. More specifically, full-band EEG signals are first decomposed into the five well-known frequency bands and the envelopes are then extracted via a Hilbert transform. Each of the five envelopes are further decomposed into four so-called modulation bands, which were chosen to coincide with the delta, theta, alpha and beta frequency bands. Experiments on a resting-awake EEG dataset collected from 76 participants (27 healthy controls, 27 diagnosed with mild-AD, and 22 with moderate-AD) showed significant differences in amplitude modulations between the three groups. Most notably, i) delta modulation of the beta frequency band disappeared with an increase in disease severity (from mild to moderate AD), ii) delta modulation of the theta band appeared with an increase in severity, and iii) delta modulation of the beta frequency band showed to be a reliable discriminant feature between healthy controls and mild-AD patients. Taken together, it is hoped that the developed tool can be used to assist clinicians not only with early detection of Alzheimer's disease, but also to monitor its progression.	[Fraga, Francisco J.; Falk, Tiago H.] Univ Quebec, EMT, INRS, Montreal, PQ H3C 3P8, Canada; [Fraga, Francisco J.] Univ Fed ABC, Engn Modelling & Appl Social Sci Ctr, Sao Paulo, Brazil; [Kanda, Paulo A. M.; Anghinah, Renato] Univ Sao Paulo, Sch Med, Reference Ctr Behav Disturbances & Dementia, Sao Paulo, Brazil	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec Montreal; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Falk, TH (corresponding author), Univ Quebec, EMT, INRS, Montreal, PQ H3C 3P8, Canada.	falk@emt.inrs.ca	FRAGA, FRANCISCO J./F-8214-2012	FRAGA, FRANCISCO J./0000-0002-4895-807X; Falk, Tiago/0000-0002-5739-2514	Natural Sciences and Engineering Research Council of Canada (NSERC); Foundation for Research Support of the State of Sao Paulo (FAPESP)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Foundation for Research Support of the State of Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo D, 2008, IEEE T BIO-MED ENG, V55, P2171, DOI 10.1109/TBME.2008.923145; Adeli H, 2005, CLIN EEG NEUROSCI, V36, P131, DOI 10.1177/155005940503600303; Aghajani H, 2013, IEEE J BIOMEDICAL HL, V99; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Association A.P., 2000, DIAGN STAT MAN MENT, VFourth; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P252, DOI 10.1016/j.clinph.2005.09.019; Boashash B., 2003, TIME FREQUENCY SIGNA; BRAAK H, 1989, ACTA NEUROPATHOL, V77, P494, DOI 10.1007/BF00687251; BRENNER RP, 1986, ELECTROEN CLIN NEURO, V64, P483, DOI 10.1016/0013-4694(86)90184-7; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chow T W, 2000, Curr Psychiatry Rep, V2, P446, DOI 10.1007/s11920-000-0031-5; Cibils D., 2002, SUPPLEMENTS CLIN NEU, VVolume 54, P289, DOI [10.1016/S1567-424X(09)70463-5, DOI 10.1016/S1567-424X(09)70463-5]; COBEN LA, 1983, ELECTROEN CLIN NEURO, V55, P372, DOI 10.1016/0013-4694(83)90124-4; Dauwels J, 2011, INT J ALZHEIMERS DIS, V10; Deb P, 1996, ECON LETT, V51, P123, DOI 10.1016/0165-1765(95)00784-9; Falk TH, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-192; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007; Huang C, 2000, CLIN NEUROPHYSIOL, V111, P1961, DOI 10.1016/S1388-2457(00)00454-5; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hwang TJ, 2004, ALZ DIS ASSOC DIS, V18, P17, DOI 10.1097/00002093-200401000-00004; Illan IA, 2012, ARTIFICIAL INTELLIGE; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Kwak YT, 2006, J CLIN NEUROPHYSIOL, V23, P456; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Leifer BP, 2003, J AM GERIATR SOC, V51, pS281, DOI 10.1046/j.1532-5415.5153.x; Lopes MA, 2012, J ALZHEIMERS DIS, V32, P307, DOI 10.3233/JAD-2012-120847; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miskovic V, 2010, BIOL PSYCHOL, V83, P125, DOI 10.1016/j.biopsycho.2009.11.010; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Palmer K, 2007, NEUROLOGY, V68, P1596, DOI 10.1212/01.wnl.0000260968.92345.3f; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Payami H, 1996, AM J HUM GENET, V58, P803; PENTTILA M, 1985, ELECTROEN CLIN NEURO, V60, P1, DOI 10.1016/0013-4694(85)90942-3; Putman P, 2010, BIOL PSYCHOL, V83, P73, DOI 10.1016/j.biopsycho.2009.10.008; Robert PH, 2006, EUR J NEUROL, V13, P729, DOI 10.1111/j.1468-1331.2006.01088.x; Saner S, 2007, EEG SIGNAL PROCESSIN; Sankari Z, 2012, CLIN EEG NEUROSCI, V43, P268, DOI 10.1177/1550059412444970; Schonheit B, 2004, NEUROBIOL AGING, V25, P697, DOI 10.1016/j.neurobioalging.2003.09.009; SCHREITERGASSER U, 1993, ELECTROEN CLIN NEURO, V86, P15, DOI 10.1016/0013-4694(93)90063-2; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Schutter DJLG, 2006, CLIN NEUROPHYSIOL, V117, P381, DOI 10.1016/j.clinph.2005.09.021; Smit DJA, 2011, J NEUROSCI, V31, P13128, DOI 10.1523/JNEUROSCI.1678-11.2011; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; TERRY RD, 1994, PROG BRAIN RES, V101, P383; Trambaiolli L R, 2011, Int J Alzheimers Dis, V2011, P761891, DOI 10.4061/2011/761891; Trambaiolli LR, 2011, IEEE ENG MED BIO, P3828, DOI 10.1109/IEMBS.2011.6090951; Tsai PH, 2012, J NEUROSCI METH, V210, P230, DOI 10.1016/j.jneumeth.2012.07.002; WHO, 2012, TECHNICAL REPORT; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018	58	53	54	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72240	10.1371/journal.pone.0072240	http://dx.doi.org/10.1371/journal.pone.0072240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015222	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200032
J	Zhang, ZH; Ma, JY; Tao, XH; Zhou, YY; Liu, X; Su, H				Zhang, Zhihong; Ma, Jianyong; Tao, Xuehua; Zhou, Yueying; Liu, Xin; Su, Hai			The Prevalence and Influence Factors of Inter-Ankle Systolic Blood Pressure Difference in Community Population	PLOS ONE			English	Article							MORTALITY; ARM; ASSOCIATION	Aim: The aim of this study was to investigate the prevalence of interankle systolic blood pressure difference (sIAND) and its influencing factors in community population. Methods: This study included 2849 (65.1 +/- 9.4 y) subjects. Blood pressure (BPs) of four limbs was simultaneously measured with 4 electronic sphygmomanometers after 10 min rest in supine position. The difference of systolic BP (SBP) between two ankles was calculated as DETASBP. The criterion for abnormal sIAND was >= 10 mmHg of absolute DeltaSBP, in which the criterion for 1o sIAND was 10-19 mmHg and for 2o sIAND was >= 20 mmHg. Age, gender, smoking, hypertension, family histories of hypertension and diabetes were recorded. Fasting blood glucose and lipids, circumference of hip and waist, and body mass index (BMI) were measured. Results: The SBP was higher in the right ankle than in the left ankle (158.9 +/- 21.8 vs 157.3 +/- 21.6 mmHg, P < 0.05) and mean DeltaSBP was 6.08 +/- 6.26 mmHg. Similar difference was found in both genders. The prevalence of abnormal was 18.5%, in which, the prevalence 1o sIAND was 15.3% and that of 2o sIAND was 3.1%. Multivariate regression analysis showed that age, waist circumference and blood glucose level were the positive factors for DeltaSBP. The normal upper limit for DeltaSBP was 16.7 mmHg in this population, the prevalence of sIAND by >= 16 mmHg was 5.8%. Conclusion: Aging, hypertension, obesity and abnormal glucose metabolism are positive factors for inter-ankle SBP difference.	[Zhang, Zhihong; Ma, Jianyong; Su, Hai] Nanchang Univ, Affiliated Hosp 2, Res Inst Cardiovasc Dis, Nanchang, Jiangxi, Peoples R China; [Zhang, Zhihong; Ma, Jianyong; Su, Hai] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China; [Zhang, Zhihong; Liu, Xin] Nanchang Univ, Fuzhou Med Coll, Stat Teaching Grp, Fuzhou, Jiangxi, Peoples R China; [Tao, Xuehua] Sixth Hosp Nanchang City, Dept Med, Nanchang, Jiangxi, Peoples R China; [Zhou, Yueying] Guizhou Hosp Fushan City, Dept Med, Fushan, Guangdong, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Su, H (corresponding author), Nanchang Univ, Affiliated Hosp 2, Res Inst Cardiovasc Dis, Nanchang, Jiangxi, Peoples R China.	suyihappy@sohu.com	Ma, Jianyong/V-2054-2019	Ma, Jianyong/0000-0003-1145-7121	National High Technology Research and Development Program of China (863 Program) [2012AA02A516]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This project was supported by a grant from the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SC, 2012, CLIN J AM SOC NEPHRO, V7, P1646, DOI 10.2215/CJN.04570512; Clark CE, 2002, FAM PRACT, V19, P439, DOI 10.1093/fampra/19.5.439; Clark CE, 2007, FAM PRACT, V24, P420, DOI 10.1093/fampra/cmm035; Clark CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1327; Daskalopoulou SS, 2012, CAN J CARDIOL, V28, P270, DOI 10.1016/j.cjca.2012.02.018; Gallego P, 2012, EUR J CLIN INVEST, V42, P1302, DOI 10.1111/eci.12004; Gemignani T, 2012, AM J HYPERTENS, V25, P1083, DOI 10.1038/ajh.2012.101; Hietanen H, 2010, J HUM HYPERTENS, V24, P577, DOI 10.1038/jhh.2009.102; Hietanen HJ, 2011, STROKE RES TREA 0117, V17, DOI [10.4061/2010/729391, DOI 10.4061/2010/729391]; Igarashi Yuko, 2007, J Cardiol, V50, P281; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Sheng CS, 2013, HYPERTENSION; Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041173; Su YJ, 2007, INT J GERONTOL, V1, P153, DOI 10.1016/S1873-9598(08)70039-5; Tarumi T, 2011, J HUM HYPERTENS, V25, P539, DOI 10.1038/jhh.2010.100; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125	17	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70777	10.1371/journal.pone.0070777	http://dx.doi.org/10.1371/journal.pone.0070777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015177	gold, Green Published, Green Submitted			2022-12-25	WOS:000323815200008
J	Kolb, H; Luckemeyer, K; Heise, T; Herder, C; Schloot, NC; Koenig, W; Heinemann, L; Martin, S				Kolb, Hubert; Lueckemeyer, Kathrin; Heise, Tim; Herder, Christian; Schloot, Nanette C.; Koenig, Wolfgang; Heinemann, Lutz; Martin, Stephan		DIATOR Study Grp	The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-4; BETA-CELL FUNCTION; ENDOTHELIAL DYSFUNCTION; RHEUMATOID-ARTHRITIS; SERUM CONCENTRATIONS; CHRONIC INFLAMMATION; E-SELECTIN; IFN-GAMMA; TNF-ALPHA; C-PEPTIDE	Background: The hypothesis was tested that the systemic immune milieu in recent-onset type 1 diabetes is associated with residual beta cell function and other metabolic patient characteristics. Methods and Findings: All patients (n = 89, 40% female) of the Diabetes and Atorvastatin (DIATOR) Trial were analyzed at recruitment, i.e. prior to receiving the study medication. Inclusion criteria were insulin dependent diabetes for 2 weeks to 3 months, age range 18-39 years, and islet cell autoantibodies. Blood samples were analyzed for 14 immune mediators by standard methods. Concentrations of all mediators correlated with at least one other mediator (p<0.05, Spearman correlation) giving rise to a network. Interleukin 1 receptor antagonist (IL1-RA) held a central position and was associated with both pro-and anti-inflammatory mediators. Further central elements were the pro-inflammatory mediators CRP and IL-6, the soluble adhesion molecules sICAM-1 and E-selectin, and MCP-4 which held a central position in the chemokine network. The two Th1-associated mediators IFN gamma and IP-10 remained outside the network but correlated with each other. All correlations were positive (r = 0.25-0.72), i.e., high levels of pro-inflammatory mediators were accompanied by increased levels of anti-inflammatory mediators. IL-1RA was the only mediator associated with fasting and liquid mixed meal stimulated C-peptide concentrations (r = 0.31 and 0.24, p = 0.003 and 0.025, after adjustment for age, sex, BMI). There were associations between the immune mediator network and BMI (IL-1RA, CRP, IL-6, MCP-4, MIP-1 beta) but few or no associations with HbA1c, insulin dose, lipid parameters, age or sex. Conclusions: In patients with recent onset type 1 diabetes, systemic acute phase proteins, cytokines, chemokines and soluble adhesion molecules form a network. Among the few central elements IL-1RA has a dominant role. IL-1RA is associated with all other groups of mediators and is the only mediator which correlates (positively) with residual beta cell function.	[Kolb, Hubert; Martin, Stephan] Verbund Katholischer Kliniken Dusseldorf, West German Ctr Diabet & Hlth, Dusseldorf, Germany; [Lueckemeyer, Kathrin; Heise, Tim; Heinemann, Lutz] Profil Inst Metab Res, Neuss, Germany; [Herder, Christian; Schloot, Nanette C.] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany	Profil; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ulm University	Kolb, H (corresponding author), Verbund Katholischer Kliniken Dusseldorf, West German Ctr Diabet & Hlth, Dusseldorf, Germany.	hubert.kolb@uni-duesseldorf.de	; Stefanadis, Christodoulos/ABH-2232-2020	Koenig, Wolfgang/0000-0002-2064-9603; Stefanadis, Christodoulos/0000-0001-5974-6454	Pfizer Pharma GmbH, Berlin, Germany	Pfizer Pharma GmbH, Berlin, Germany	The trial was supported by an unrestricted grant from Pfizer Pharma GmbH, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansar W, 2013, IMMUNOL RES; Atkinson MJ, 2009, MED RADIOL RADIAT ON, P1, DOI 10.1007/978-3-540-74386-6_1; Bending D, 2012, INT IMMUNOL, V24, P339, DOI 10.1093/intimm/dxs049; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Cartier A, 2009, ANN MED, V41, P471, DOI 10.1080/07853890903022801; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eisenbarth GS, 2012, ENDOCR PRACT, V18, P745, DOI 10.4158/EP12080.OR; El Amine M, 2010, Endocr Regul, V44, P17; FOULIS AK, 1986, DIABETES, V35, P1215, DOI 10.2337/diabetes.35.11.1215; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Hammad H, 2003, EUR CYTOKINE NETW, V14, P219; Hashimoto I, 2006, OBESITY, V14, P799, DOI 10.1038/oby.2006.93; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2009, DIABETOLOGIA, V52, P433, DOI 10.1007/s00125-008-1243-1; Hino R, 2005, J DERMATOL SCI, V38, P189, DOI 10.1016/j.jdermsci.2005.01.005; Iwamoto T, 2007, FEBS J, V274, P4904, DOI 10.1111/j.1742-4658.2007.06013.x; Jilma B, 2000, J LAB CLIN MED, V135, P270, DOI 10.1067/mlc.2000.105214; Kalayci O, 2004, J ASTHMA, V41, P27, DOI 10.1081/JAS-120024590; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kolb H, 2012, NAT REV ENDOCRINOL, V8, P183, DOI 10.1038/nrendo.2011.158; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Kusterer K, 1998, AM J PHYSIOL-GASTR L, V275, pG377, DOI 10.1152/ajpgi.1998.275.2.G377; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Loughrey B, 2012, CLIN ENDOCRINOL OXF; Martin S, 1998, DIABETOLOGIA, V41, P1298, DOI 10.1007/s001250051068; Martin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017554; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mukaida N, 2000, INT J HEMATOL, V72, P391; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Nadar S, 2004, CURR PHARM DESIGN, V10, P3591, DOI 10.2174/1381612043382765; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Pfleger C, 2008, CLIN IMMUNOL, V128, P57, DOI 10.1016/j.clim.2008.03.458; Pfleger C, 2008, DIABETES, V57, P929, DOI 10.2337/db07-1697; Pham MN, 2013, DIABETOLOGIA, V56, P1356, DOI 10.1007/s00125-013-2883-3; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675; Thorand B, 2006, ATHEROSCLEROSIS, V184, P216, DOI 10.1016/j.atherosclerosis.2005.04.011; Troseid M, 2005, SCAND J CLIN LAB INV, V65, P283, DOI 10.1080/00365510510013811; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van den Engel NK, 2002, J MOL MED, V80, P301, DOI 10.1007/s00109-002-0324-8; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Xu F, 2012, CARDIOLOGY, V121, P12, DOI 10.1159/000335886; Yamashita U, 2002, CRIT REV IMMUNOL, V22, P105	53	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72440	10.1371/journal.pone.0072440	http://dx.doi.org/10.1371/journal.pone.0072440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991111	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800072
J	Li, WW; Wei, YH; Li, H; Lai, DM; Lin, TN				Li, Wen-Wen; Wei, Yau-Huei; Li, Hung; Lai, Dar-Ming; Lin, Teng-Nan			Isolation and Characterization of a Novel Strain of Mesenchymal Stem Cells from Mouse Umbilical Cord: Potential Application in Cell-Based Therapy	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; ADIPOSE-TISSUE; HEPATIC DIFFERENTIATION; LIVER-FAILURE; IN-VITRO; ISCHEMIC-STROKE; HUMAN PLACENTA; MATRIX CELLS; SPINAL-CORD	Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have recently been recognized as a potential source for cell-based therapy in various preclinical animal models, such as Parkinson's disease, cerebral ischemia, spinal cord injury, and liver failure; however, the precise cellular and molecular mechanisms underlying the beneficial outcomes remain under investigation. There is a growing concern regarding rejection and alteration of genetic code using this xenotransplantation approach. In this study, a novel strain of murine MSCs derived from the umbilical cord of wild-type and green fluorescent protein (GFP) transgenic mice have been successfully isolated, expanded, and characterized. After 10 passages, the mUC-MSCs developed a rather homogeneous, triangular, spindle-shaped morphology, and were sub-cultured up to 7 months (over 50 passages) without overt changes in morphology and doubling time. Cell surface markers are quite similar to MSCs isolated from other tissue origins as well as hUC-MSCs. These mUC-MSCs can differentiate into osteoblasts, adipocytes, neurons, and astrocytes in vitro, as well as hematopoietic lineage cells in vivo. mUC-MSCs also possess therapeutic potential against two disease models, focal ischemic stroke induced by middle cerebral artery occlusion (MCAo) and acute hepatic failure. Subtle differences in the expression of cytokine-related genes exist between mUC-MSCs and hUC-MSCs, which may retard and jeopardize the advance of cell therapy. Allografts of these newly established mUC-MSCs into various mouse disease models may deepen our insights into the development of more effective cell therapy regimens.	[Li, Wen-Wen; Wei, Yau-Huei] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wei, Yau-Huei] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Li, Hung] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lai, Dar-Ming] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Lin, Teng-Nan] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Lin, Teng-Nan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Medical College; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Lai, DM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan.	dmdlai@ntu.edu.tw; bmltn@ibms.sinica.edu.tw	Lin, Teng-nan/Q-4566-2018; Wei, Yau-Huei/ABA-6841-2021	Lin, Teng-nan/0000-0002-4009-0798; Wei, Yau-Huei/0000-0002-6429-2546	Academia Sinica; National Science Council of Taiwan Government	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan Government(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and National Science Council of Taiwan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CY, 2013, MOL CELL BIOCHEM, V376, P95, DOI 10.1007/s11010-012-1553-y; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cardoso TC, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-18; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Castillo MD, 2008, CTS-CLIN TRANSL SCI, V1, P27, DOI 10.1111/j.1752-8062.2008.00018.x; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chao YH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/759503; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; de Miranda AS, 2010, ARQ NEURO-PSIQUIAT, V68, P597, DOI 10.1590/S0004-282X2010000400022; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Harting MT, 2009, STEM CELLS DEV, V18, P127, DOI 10.1089/scd.2008.0046; Hu Y, 2003, J LAB CLIN MED, V141, P342, DOI 10.1016/S0022-2143(03)00022-2; Hwang S, 2012, CELL BIOL INT, V36, P279, DOI 10.1042/CBI20110325; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kim SJ, 2011, J KOREAN SURG SOC, V81, P176, DOI 10.4174/jkss.2011.81.3.176; Koh SH, 2008, BRAIN RES, V1229, P233, DOI 10.1016/j.brainres.2008.06.087; Lee KS, 2013, RES VET SCI, V94, P144, DOI 10.1016/j.rvsc.2012.07.033; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055487; LURIA EA, 1971, TRANSFUSION, V11, P345, DOI 10.1111/j.1537-2995.1971.tb04426.x; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sigrist S, 2005, TRANSPL P, V37, P3516, DOI 10.1016/j.transproceed.2005.09.048; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205; Yu J, 2012, BIOCHEM BIOPH RES CO, V422, P539, DOI 10.1016/j.bbrc.2012.04.156; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175; Zhang SC, 2012, TISSUE ENG PT A, V18, P1352, DOI [10.1089/ten.tea.2011.0516, 10.1089/ten.TEA.2011.0516]; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	64	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74478	10.1371/journal.pone.0074478	http://dx.doi.org/10.1371/journal.pone.0074478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991222	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800120
J	Ma, YH; Yuan, XL; Deng, L; Xu, WP; Zheng, YX; Yue, CY; Zhang, GH; Xie, F; Yang, YH; Gantier, MP; Liu, JP; Xu, DK; Shen, LS				Ma, Yanhui; Yuan, Xiangliang; Deng, Lin; Xu, Weiping; Zheng, Yingxia; Yue, Chaoyan; Zhang, Guanghui; Xie, Fang; Yang, Yuan H.; Gantier, Michael P.; Liu, JunPing; Xu, Dakang; Shen, Lisong			Imbalanced Frequencies of Th17 and Treg Cells in Acute Coronary Syndromes Are Mediated by IL-6-STAT3 Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; T-CELLS; TGF-BETA; INTERLEUKIN-6; DIFFERENTIATION; T(H)17; BLOCKADE; GAMMA; GENE	Aims: Extensive evidence suggests inflammatory components participate in the pathogenic processes of acute coronary syndromes (ACS). In this study, we aimed to elucidate the role and mechanism underlying the imbalance of Th17 and Treg cell peripheral populations in the pathogenesis of ACS. Methods and Results: Using a flow cytometric analysis, we observed a significantly increased frequency of Th17 cells and a concurrently decreased CD4(+)CD25(+)Foxp3(+) Treg cells in patients with ACS. To elucidate the mechanism of Th17/Treg imbalance in ACS, 22 inflammatory cytokines were measured using multiplexed immunobead-based assays. Of six elevated cytokines in ACS patients, only IL-6 was positively correlated with a higher Th17 cell level (r=0.39, P<0.01). Relying on IL-6 stimulating and neutralizing studies, we demonstrated a direct role for IL-6 in sera from ACS patients with an increased frequency of Th17 cells. IL-6 induces the differentiation of Th17 cells from naive CD4(+) T cells through STAT3 activation and ROR gamma t induction. However, we observed that high levels of TGF-beta 1 inhibited IL-6-dependent Th17 cell differentiation, indicating a complex interplay between the two cytokines in the control of Th17 and Treg cell populations. Conclusions: Our results demonstrate the role of IL-6-STAT3 signaling in ACS through increased Th17 cell differentiation. These findings indicate that IL-6 neutralizing strategies could present novel therapeutic avenues in the treatment of ACS.	[Ma, Yanhui; Yuan, Xiangliang; Deng, Lin; Zheng, Yingxia; Yue, Chaoyan; Zhang, Guanghui; Xie, Fang; Shen, Lisong] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Clin Lab, Shanghai 200030, Peoples R China; [Xu, Weiping] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Internal Cardiol, Shanghai 200030, Peoples R China; [Yang, Yuan H.] Monash Univ, Dept Med, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [Gantier, Michael P.; Xu, Dakang] Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Liu, JunPing; Xu, Dakang] Hangzhou Normal Univ, Sch Med, Inst Ageing Res, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Monash University; Monash University; Hangzhou Normal University	Xu, DK (corresponding author), Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	dakang.xu@monash.edu; lisongshen@hotmail.com	Gantier, Michael/B-7512-2011; Gantier, Michael/H-7954-2019	Gantier, Michael/0000-0003-3740-698X; Gantier, Michael/0000-0003-3740-698X; Liu, Jun-Ping/0000-0001-7442-2116	National Natural Science Foundation of China [81072009, 21035004, 81202009, 81201768]; Basic Research Project of Shanghai Science and Technology Commission [11jc1408300]; Australian National Health and Medical Research Council [606425, 1006588]; Victorian Government's Operational Infrastructure Support Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by grants from the National Natural Science Foundation of China (81072009, 21035004, 81202009 and 81201768) and the Basic Research Project of Shanghai Science and Technology Commission (11jc1408300). This work was also supported by a grant from the Australian National Health and Medical Research Council (606425 and 1006588) and the Victorian Government's Operational Infrastructure Support Program. D.X. is a recipient of a Longjiang Scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ammirati E, 2012, CIRC RES, V111, P1336, DOI 10.1161/CIRCRESAHA.111.262477; Becker KL, 2001, PRINCIPLES PRACTICE, P2077; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Feldmann M, 2010, ANN RHEUM DIS, V69, P97, DOI 10.1136/ard.2009.117143; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li Q, 2010, BIOCHEM BIOPH RES CO, V394, P836, DOI 10.1016/j.bbrc.2010.03.090; Liang J, 2009, J INT MED RES, V37, P862, DOI 10.1177/147323000903700331; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu ZD, 2012, ATHEROSCLEROSIS, V221, P232, DOI 10.1016/j.atherosclerosis.2011.12.026; Liuzzo G, 2013, EUR HEART J, V34, P556, DOI 10.1093/eurheartj/ehs399; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Maseri A, 2003, CIRCULATION, V107, P2068, DOI 10.1161/01.CIR.0000070585.48035.D1; Ndrepepa G, 2012, CLIN RES CARDIOL, V101, P1003, DOI 10.1007/s00392-012-0490-9; NG SB, 1994, J BIOL CHEM, V269, P19021; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Shen LS, 2009, CLIN IMMUNOL, V131, P109, DOI 10.1016/j.clim.2008.11.010; Simon T, 2013, EUR HEART J, V34, P570, DOI 10.1093/eurheartj/ehs263; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; von Vietinghoff S, 2010, CYTOKINE GROWTH F R, V21, P463, DOI 10.1016/j.cytogfr.2010.10.003; Watanabe E, 2005, CRIT CARE MED, V33, P89, DOI 10.1097/01.CCM.0000150025.79100.7D; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zhao Z, 2011, ATHEROSCLEROSIS, V217, P518, DOI 10.1016/j.atherosclerosis.2011.03.043	51	17	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72804	10.1371/journal.pone.0072804	http://dx.doi.org/10.1371/journal.pone.0072804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991153	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800087
J	Mekkaoui, C; Porayette, P; Jackowski, MP; Kostis, WJ; Dai, GP; Sanders, S; Sosnovik, DE				Mekkaoui, Choukri; Porayette, Prashob; Jackowski, Marcel P.; Kostis, William J.; Dai, Guangping; Sanders, Stephen; Sosnovik, David E.			Diffusion MRI Tractography of the Developing Human Fetal Heart	PLOS ONE			English	Article							MYOCARDIAL MICROSTRUCTURE; HISTOLOGICAL VALIDATION; LEFT-VENTRICLE; TENSOR MRI; ARCHITECTURE; ARRANGEMENT; INFARCTION; MYOFIBERS	Objective: Human myocardium has a complex and anisotropic 3D fiber pattern. It remains unknown, however, when in fetal life this anisotropic pattern develops and whether the human heart is structurally fully mature at birth. We aimed here to use diffusion tensor MRI (DTI) tractography to characterize the evolution of fiber architecture in the developing human fetal heart. Methods: Human fetal hearts (n = 5) between 10-19 weeks of gestation were studied. The heart from a 6-day old neonate and an adult human heart served as controls. The degree of myocardial anisotropy was measured by calculating the fractional anisotropy (FA) index. In addition, fiber tracts were created by numerically integrating the primary eigenvector field in the heart into coherent streamlines. Results: At 10-14 weeks the fetal hearts were highly isotropic and few tracts could be resolved. Between 14-19 weeks the anisotropy seen in the adult heart began to develop. Coherent fiber tracts were well resolved by 19 weeks. The 19-week myocardium, however, remained weakly anisotropic with a low FA and no discernable sheet structure. Conclusions: The human fetal heart remains highly isotropic until 14-19 weeks, at which time cardiomyocytes self-align into coherent tracts. This process lags 2-3 months behind the onset of cardiac contraction, which may be a prerequisite for cardiomyocyte maturation and alignment. No evidence of a connective tissue scaffold guiding this process could be identified by DTI. Maturation of the heart's sheet structure occurs late in gestation and evolves further after birth.	[Mekkaoui, Choukri; Kostis, William J.; Dai, Guangping; Sosnovik, David E.] Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Mekkaoui, Choukri; Kostis, William J.; Dai, Guangping; Sosnovik, David E.] Harvard Univ, Sch Med, Boston, MA USA; [Porayette, Prashob; Sanders, Stephen] Harvard Univ, Sch Med, Boston Childrens Hosp, Pathol Registry,Dept Cardiol, Boston, MA USA; [Porayette, Prashob; Sanders, Stephen] Harvard Univ, Sch Med, Dept Pathol, Boston Childrens Hosp,Pathol Registry, Boston, MA 02115 USA; [Porayette, Prashob; Sanders, Stephen] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Cardiac Surg,Pathol Registry, Boston, MA 02115 USA; [Jackowski, Marcel P.] Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil; [Kostis, William J.; Sosnovik, David E.] Massachusetts Gen Hosp, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade de Sao Paulo; Harvard University; Massachusetts General Hospital	Sosnovik, DE (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.	sosnovik@nmr.mgh.harvard.edu	Cesar-Jr, Roberto M/I-8222-2015; Jackowski, Marcel/G-7602-2012; Porayette, Prashob/N-5034-2018	Porayette, Prashob/0000-0001-9078-5128; Sanders, Stephen/0000-0003-3521-4044; Kostis, William/0000-0002-0543-9798	National Institutes of Health [R01 HL093038, P41RR14075]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by the following grants from the National Institutes of Health: R01 HL093038 and P41RR14075. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Chen JJ, 2003, AM J PHYSIOL-HEART C, V285, pH946, DOI 10.1152/ajpheart.00889.2002; Helm PA, 2006, CIRC RES, V98, P125, DOI 10.1161/01.RES.0000199396.30688.eb; Henderson DJ, 2011, BIRTH DEFECTS RES A, V91, P460, DOI 10.1002/bdra.20792; Henderson DJ, 2009, PEDIATR CARDIOL, V30, P588, DOI 10.1007/s00246-009-9390-9; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Jouk PS, 2000, ANAT EMBRYOL, V202, P103, DOI 10.1007/s004290000103; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Mekkaoui C, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-70; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Roy CW, 2013, MAGN RESON MED, V70, P1598, DOI 10.1002/mrm.24614; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; Smerup M, 2009, ANAT REC, V292, P1, DOI 10.1002/ar.20798; Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P206, DOI 10.1161/CIRCIMAGING.108.815050; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Tobita K, 2005, ANAT REC PART A, V283A, P193, DOI 10.1002/ar.a.20133; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Wu MT, 2009, CIRC-CARDIOVASC IMAG, V2, P32, DOI 10.1161/CIRCIMAGING.108.778902; Zhang L, 2013, AM J PHYSIOL-HEART C, V304, pH246, DOI 10.1152/ajpheart.00129.2012	20	33	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72795	10.1371/journal.pone.0072795	http://dx.doi.org/10.1371/journal.pone.0072795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991152	Green Submitted, gold, Green Published			2022-12-25	WOS:000324228800086
J	Morello, A; Daburon, S; Castroviejo, M; Moreau, JF; Dechanet-Merville, J; Taupin, JL				Morello, Aurore; Daburon, Sophie; Castroviejo, Michel; Moreau, Jean-Francois; Dechanet-Merville, Julie; Taupin, Jean-Luc			Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL	PLOS ONE			English	Article							FUSION PROTEIN; CALCIUM-PHOSPHATE; MAMMALIAN-CELLS; DOWN-REGULATION; LIGAND; ANTIBODY; CONVERSION; APOPTOSIS; TOXICITY; RECEPTOR	Membrane FasL is the natural trigger of Fas-mediated apoptosis. A soluble homotrimeric counterpart (sFasL) also exists which is very weakly active, and needs oligomerization beyond its trimeric state to induce apoptosis. We recently generated a soluble FasL chimera by fusing the immunoglobulin-like domain of the leukemia inhibitory factor receptor gp190 to the extracellular region of human FasL, which enabled spontaneous dodecameric homotypic polymerization of FasL. This polymeric soluble human FasL (pFasL) displayed anti-tumoral activity in vitro and in vivo without systemic cytotoxicity in mouse. In the present work, we focused on the improvement of pFasL, with two complementary objectives. First, we developed more complex pFasL-based chimeras that contained a cell-targeting module. Secondly, we attempted to improve the production and/or the specific activity of pFasL and of the cell-targeting chimeras. We designed two chimeras by fusing to pFasL the extracellular portions of the HLA-A2 molecule or of a human gamma-delta TCR, and analyzed the consequences of co-expressing these molecules or pFasL together with sFasL on their heterotopic cell production. This strategy significantly enhanced the production of pFasL and of the two chimeras, as well as the cytotoxic activity of the two chimeras but not of pFasL. These results provide the proof of concept for an optimization of FasL-based chimeric proteins for a therapeutic use.	[Morello, Aurore; Daburon, Sophie; Moreau, Jean-Francois; Dechanet-Merville, Julie; Taupin, Jean-Luc] Univ Bordeaux Segalen, CIRID, UMR 5164, CNRS, Bordeaux, France; [Castroviejo, Michel] Univ Bordeaux Segalen, UMR 5234, CNRS, Bordeaux, France; [Moreau, Jean-Francois; Taupin, Jean-Luc] CHU Bordeaux, Lab Immunol & Immunogenet, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Taupin, JL (corresponding author), Univ Bordeaux Segalen, CIRID, UMR 5164, CNRS, Bordeaux, France.	jean-luc.taupin@chu-bordeaux.fr			Ligue Nationale Contre le Cancer (Comites de la Gironde et des Charentes); Conseil Regional d'Aquitaine; Centre National de la Recherche Scientifique	Ligue Nationale Contre le Cancer (Comites de la Gironde et des Charentes); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Ligue Nationale Contre le Cancer (Comites de la Gironde et des Charentes). AM was supported by grants from the Conseil Regional d'Aquitaine and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Belmont HJ, 2006, CLIN IMMUNOL, V121, P29, DOI 10.1016/j.clim.2006.05.005; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Daburon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054000; de Bruyn M, 2011, CANC LETT, V332, P175; Eisele G, 2011, NEURO-ONCOLOGY, V13, P155, DOI 10.1093/neuonc/noq176; Elhalel MD, 2003, J IMMUNOL, V170, P5842, DOI 10.4049/jimmunol.170.12.5842; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Huang JH, 2001, INT IMMUNOL, V13, P529, DOI 10.1093/intimm/13.4.529; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Saito-Yabe M, 2009, BRIT J PHARMACOL, V158, P548, DOI 10.1111/j.1476-5381.2009.00326.x; Samel D, 2003, J BIOL CHEM, V278, P32077, DOI 10.1074/jbc.M304866200; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Sieg S, 1999, CELL IMMUNOL, V195, P89, DOI 10.1006/cimm.1999.1530; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Taupin JL, 1997, CYTOKINE, V9, P112, DOI 10.1006/cyto.1996.0144; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; VIVIER E, 1992, INT IMMUNOL, V4, P1313, DOI 10.1093/intimm/4.11.1313; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Yolcu ES, 2002, IMMUNITY, V17, P795, DOI 10.1016/S1074-7613(02)00482-X; Zhang W, 2012, INT IMMUNOL, V24, P379, DOI 10.1093/intimm/dxs041	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73375	10.1371/journal.pone.0073375	http://dx.doi.org/10.1371/journal.pone.0073375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991192	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800102
J	Poutahidis, T; Cappelle, K; Levkovich, T; Lee, CW; Doulberis, M; Ge, ZM; Fox, JG; Horwitz, BH; Erdman, SE				Poutahidis, Theofilos; Cappelle, Kelsey; Levkovich, Tatiana; Lee, Chung-Wei; Doulberis, Michael; Ge, Zhongming; Fox, James G.; Horwitz, Bruce H.; Erdman, Susan E.			Pathogenic Intestinal Bacteria Enhance Prostate Cancer Development via Systemic Activation of Immune Cells in Mice	PLOS ONE			English	Article							T-CELLS; INFLAMMATION; ADENOCARCINOMA; PROGRESSION; NEOPLASIA	A role for microbes has been suspected in prostate cancer but difficult to confirm in human patients. We show here that a gastrointestinal (GI) tract bacterial infection is sufficient to enhance prostate intraepithelial neoplasia (PIN) and microinvasive carcinoma in a mouse model. We found that animals with a genetic predilection for dysregulation of wnt signaling, Apc(Min/+) mutant mice, were significantly susceptible to prostate cancer in an inflammation-dependent manner following infection with Helicobacter hepaticus. Further, early neoplasia observed in infected Apc(Min/+) mice was transmissible to uninfected mice by intraperitoneal injection of mesenteric lymph node (MLN) cells alone from H. hepaticus-infected mutant mice. Transmissibility of neoplasia was preventable by prior neutralization of inflammation using anti-TNF-alpha antibody in infected MLN donor mice. Taken together, these data confirm that systemic inflammation triggered by GI tract bacteria plays a pivotal role in tumorigenesis of the prostate gland.	[Poutahidis, Theofilos; Cappelle, Kelsey; Levkovich, Tatiana; Lee, Chung-Wei; Ge, Zhongming; Fox, James G.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos; Doulberis, Michael] Aristotle Univ Thessaloniki, Fac Vet Med, Pathol Lab, Thessaloniki, Greece; [Horwitz, Bruce H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Immunopathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Erdman, SE (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	serdman@mit.edu	Doulberis, Michael/Y-5118-2018	Doulberis, Michael/0000-0002-0396-5081; Ge, Zhongming/0000-0003-0924-7563	CEHS pilot project [P30-ES002109]; CEHS (Center for Environmental Health Sciences) by NIH-NIEHS (National Institute of Environmental Health Sciences);  [RO1CA108854]; NATIONAL CANCER INSTITUTE [U01CA164337, R01CA108854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011141] Funding Source: NIH RePORTER	CEHS pilot project; CEHS (Center for Environmental Health Sciences) by NIH-NIEHS (National Institute of Environmental Health Sciences); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by RO1CA108854 (SEE) and a CEHS pilot project award P30-ES002109 (SEE). CEHS (Center for Environmental Health Sciences) is a center grant awarded to MIT by NIH-NIEHS (National Institute of Environmental Health Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Correa P, 2005, INT J EPIDEMIOL, V34, P197, DOI 10.1093/ije/dyh403; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Derhovanessian E, 2009, INT J CANCER, V125, P1372, DOI 10.1002/ijc.24497; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2010, INT J CANCER, V126, P1651, DOI 10.1002/ijc.24923; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Giri D, 2000, AM J PATHOL, V157, P249, DOI 10.1016/S0002-9440(10)64535-X; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Jerde TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000338; MONTIE JE, 1989, CANCER, V63, P381, DOI 10.1002/1097-0142(19890115)63:2<381::AID-CNCR2820630230>3.0.CO;2-O; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Peled A, 1998, BLOOD, V91, P1909, DOI 10.1182/blood.V91.6.1909.1909_1909_1916; Poutahidis T, 2009, INT J CANCER, V125, P868, DOI 10.1002/ijc.24452; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Rook GAW, 2011, IMMUNOL REV, V240, P141, DOI 10.1111/j.1600-065X.2010.00987.x; Royuela M, 2008, HISTOL HISTOPATHOL, V23, P1279, DOI 10.14670/HH-23.1279; SAKR WA, 1994, IN VIVO, V8, P439; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Steiner GE, 2003, PROSTATE, V56, P171, DOI 10.1002/pros.10238; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhang Q, 2012, CANC RES	34	37	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73933	10.1371/journal.pone.0073933	http://dx.doi.org/10.1371/journal.pone.0073933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991210	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800112
J	Wang, YE; Marinov, GK; Wold, BJ; Chan, DC				Wang, Yun E.; Marinov, Georgi K.; Wold, Barbara J.; Chan, David C.			Genome-Wide Analysis Reveals Coating of the Mitochondrial Genome by TFAM	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-A; L-STRAND REPLICATION; DNA DAMAGE; CHIP-SEQ; OVEREXPRESSION; DYSFUNCTION; UPSTREAM; BINDING; ORIGIN; ACCUMULATION	Mitochondria contain a 16.6 kb circular genome encoding 13 proteins as well as mitochondrial tRNAs and rRNAs. Copies of the genome are organized into nucleoids containing both DNA and proteins, including the machinery required for mtDNA replication and transcription. The transcription factor TFAM is critical for initiation of transcription and replication of the genome, and is also thought to perform a packaging function. Although specific binding sites required for initiation of transcription have been identified in the D-loop, little is known about the characteristics of TFAM binding in its nonspecific packaging state. In addition, it is unclear whether TFAM also plays a role in the regulation of nuclear gene expression. Here we investigate these questions by using ChIP-seq to directly localize TFAM binding to DNA in human cells. Our results demonstrate that TFAM uniformly coats the whole mitochondrial genome, with no evidence of robust TFAM binding to the nuclear genome. Our study represents the first high-resolution assessment of TFAM binding on a genome-wide scale in human cells.	[Wang, Yun E.; Marinov, Georgi K.; Wold, Barbara J.; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dchan@caltech.edu		Marinov, Georgi/0000-0003-1822-7273	NIH [GM062967, U54 HG004576, U54 HG006998]; Beckman Foundation; Donald Bren Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006998, U54HG004576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Donald Bren Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM062967 (DCC), U54 HG004576 (BJW), U54 HG006998 (BJW), the Beckman Foundation, and the Donald Bren Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Cingolani G, 1997, BIOCHEM BIOPH RES CO, V231, P856, DOI 10.1006/bbrc.1997.6203; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dong XC, 2002, J BIOL CHEM, V277, P43309, DOI 10.1074/jbc.M206958200; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Gadaleta G, 1996, J BIOL CHEM, V271, P13537, DOI 10.1074/jbc.271.23.13537; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717; Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Karamanlidis G, 2011, CIRC-HEART FAIL, V4, P707, DOI 10.1161/CIRCHEARTFAILURE.111.961474; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Piao Y, 2012, BBA-GEN SUBJECTS, V1820, P577, DOI 10.1016/j.bbagen.2011.08.007; Pierro P, 1999, FEBS LETT, V457, P307, DOI 10.1016/S0014-5793(99)01055-8; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; STUMPF JD, 2013, COLD SPRING HARB PER, V4, P11395; Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008; SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74513	10.1371/journal.pone.0074513	http://dx.doi.org/10.1371/journal.pone.0074513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991223	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800121
J	Yong, R; Chen, XM; Shen, S; Vijayaraj, S; Ma, Q; Pollock, CA; Saad, S				Yong, Rachel; Chen, Xin-Ming; Shen, Sylvie; Vijayaraj, Swarna; Ma, Qing; Pollock, Carol A.; Saad, Sonia			Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling	PLOS ONE			English	Article							PROXIMAL TUBULE CELLS; TISSUE-GROWTH-FACTOR; TO-MESENCHYMAL TRANSITION; PPAR-GAMMA AGONISTS; HIGH GLUCOSE; NAD(P)H OXIDASE; KIDNEY-DISEASE; NADPH OXIDASE; EPITHELIAL-CELLS; CHRONIC HYPOXIA	NADPH oxidase 4 (Nox4) is reported to be the major source of reactive oxygen species (ROS) in the kidneys during the early stages of diabetic nephropathy. It has been shown to mediate TGF beta 1-induced differentiation of cardiac fibroblasts into myofibroblasts. Despite TGF beta 1 being recognised as a mediator of renal fibrosis and functional decline role in diabetic nephropathy, the renal interaction between Nox 4 and TGF beta 1 is not well characterised. The aim of this study was to investigate the role of Nox4 inhibition on TGF beta 1-induced fibrotic responses in proximal tubular cells and in a mouse model of diabetic nephropathy. Immortalised human proximal tubular cells (HK2) were incubated with TGF beta 1 6 plumbagin (an inhibitor of Nox4) or specific Nox4 siRNA. Collagen IV and fibronectin mRNA and protein expression were measured. Streptozotocin (STZ) induced diabetic C57BL/6J mice were administered plumbagin (2 mg/kg/day) or vehicle (DMSO; 50 ml/mouse) for 24 weeks. Metabolic, physiological and histological markers of nephropathy were determined. TGF beta 1 increased Nox4 mRNA expression and plumbagin and Nox4 siRNA significantly inhibited TGF-beta 1 induced fibronectin and collagen IV expression in human HK2 cells. STZ-induced diabetic C57BL/6J mice developed physiological features of diabetic nephropathy at 24 weeks, which were reversed with concomitant plumbagin treatment. Histologically, plumbagin ameliorated diabetes induced upregulation of extracellular matrix protein expression compared to control. This study demonstrates that plumbagin ameliorates the development of diabetic nephropathy through pathways that include Nox4 signalling.	[Yong, Rachel; Chen, Xin-Ming; Shen, Sylvie; Vijayaraj, Swarna; Ma, Qing; Pollock, Carol A.; Saad, Sonia] Univ Sydney, Northern Clin Sch, Kolling Inst Med Res, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; Kolling Institute of Medical Research	Saad, S (corresponding author), Univ Sydney, Northern Clin Sch, Kolling Inst Med Res, Dept Med, Sydney, NSW 2006, Australia.	sonia.saad@sydney.edu.au	Saad, Sonia/D-2914-2015	Saad, Sonia/0000-0001-8067-8046	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the support of the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Aziz MH, 2008, CANCER RES, V68, P9024, DOI 10.1158/0008-5472.CAN-08-2494; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Basile DP, 1999, CURR OPIN NEPHROL HY, V8, P21, DOI 10.1097/00041552-199901000-00005; Bin Hafeez B, 2012, INT J CANCER, V131, P2175, DOI 10.1002/ijc.27478; BOHLE A, 1991, PATHOL RES PRACT, V187, P251; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Brandes RP, 2011, ARTERIOSCL THROM VAS, V31, P1255, DOI 10.1161/ATVBAHA.111.226894; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Ding YX, 2005, J PHARM PHARMACOL, V57, P111, DOI 10.1211/0022357055119; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Ekoe JM, 2001, EPIDEMIOLOGY DIABETE; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Hartner A, 2002, AM J PATHOL, V160, P861, DOI 10.1016/S0002-9440(10)64909-7; Haurani MJ, 2007, CARDIOVASC RES, V75, P679, DOI 10.1016/j.cardiores.2007.06.016; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; International c United States Renal Data System, 2007, ANN DAT REP ATL CHRO, P239; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Langham RG, 2008, DIABETOLOGIA, V51, P668, DOI 10.1007/s00125-008-0927-x; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045023; Liang HL, 2009, APOPTOSIS, V14, P1176, DOI 10.1007/s10495-009-0393-z; Maranchie JK, 2005, CANCER RES, V65, P9190, DOI 10.1158/0008-5472.CAN-05-2105; Mather A, 2009, INT J BIOCHEM CELL B, V41, P561, DOI 10.1016/j.biocel.2008.07.007; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Nangaku M, 2008, CHINESE MED J-PEKING, V121, P257; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nazeem S, 2009, MUTAGENESIS, V24, P413, DOI 10.1093/mutage/gep023; Orient A, 2007, NEPHROL DIAL TRANSPL, V22, P1281, DOI 10.1093/ndt/gfm077; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Qi W, 2006, KIDNEY INT, V69, P989, DOI 10.1038/sj.ki.5000189; Qi W, 2006, AM J PHYSIOL-RENAL, V290, pF703, DOI 10.1152/ajprenal.00254.2005; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Qi W, 2007, NEPHROL DIAL TRANSPL, V22, P3147, DOI 10.1093/ndt/gfm365; Qi W, 2007, AM J PATHOL, V171, P744, DOI 10.2353/ajpath.2007.060813; Qi W, 2006, AM J PHYSIOL-RENAL, V291, pF1070, DOI 10.1152/ajprenal.00013.2006; Qi W, 2009, AM J PATHOL, V175, P1858, DOI 10.2353/ajpath.2009.090263; RASCH R, 1983, DIABETOLOGIA, V25, P280, DOI 10.1007/BF00279944; Rossary A, 2007, BIOCHEM J, V406, P77, DOI 10.1042/BJ20061009; Roy S, 2010, J DENT RES, V89, P116, DOI 10.1177/0022034509355765; Saad S, 2005, KIDNEY INT, V68, P985, DOI 10.1111/j.1523-1755.2005.00492.x; Saad S, 2009, NEPHROL DIAL TRANSPL, V24, P1130, DOI 10.1093/ndt/gfn614; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Singh DK, 2008, NAT CLIN PRACT NEPHR, V4, P216, DOI 10.1038/ncpneph0757; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107	63	33	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73428	10.1371/journal.pone.0073428	http://dx.doi.org/10.1371/journal.pone.0073428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991195	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800105
J	Zhang, Y; Yan, XH; Aruga, Y				Zhang, Yuan; Yan, Xing-hong; Aruga, Yusho			The Sex and Sex Determination in Pyropia haitanensis (Bangiales, Rhodophyta)	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; GENETIC-ANALYSIS; MISMATCH REPAIR; ZHENG BANGIALES; PORPHYRA; MEIOSIS; MUTANTS; CONVERSION; CHANG	Pyropia haitanensis has a biphasic life cycle with macroscopic gametophytic blade (n) and microscopic filamentous conchocelis (2n) phase. Its gametophytic blades have long been believed to be mainly dioecious. However, when crossing the red mutant (R, female) with the wild type (W, male), the parental colors were segregated in F-1 blades, of which 96.1% were linearly sectored with 2-4 color sectors. When color sectors were excised from the color-sectored blades and cultured singly, 99.7% of the color sectors appeared to be unisexual with an equal sex ratio. Although the sex of color sector did not genetically link with its color, the boundaries of both sex and color sectors coincided precisely. About 87.9% of the examined color-sectored blades were monoecious and the percentage increased with the number of color sectors of a blade. The gametophytic blades from each conchocelis strain produced by parthenogenesis of the excised color sectors were unisexual and unicolor, showing the same sex and color as their original sectors. These results indicate that most of the sexually reproduced Py. haitanensis blades are monoecious, and their sex is controlled by segregation of a pair of alleles during meiosis of conchospore, forming a sex-sectored tetrad. During the subsequent development of blades, one or two lower cell(s) of the tetrad contribute mainly to rhizoid formation, and rarely show their sexual phenotype, leading to reduced frequency of full sex phenotype of the meiotic blades. Moreover, the aberrant segregations of sex genes or color genes in a few of F-1 blades were probably due to gene conversions, but there was no sex transfer in Py. haitanensis.	[Zhang, Yuan; Yan, Xing-hong] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Yan, Xing-hong] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University	Yan, XH (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China.	xhyan@shou.edu.cn			National High Technology Research & Development Program of China (''863'' Program) [2012AA10A411]; National Natural Science Foundation of China [31072208]; Ministry of Agriculture of China [200903030]; State Oceanic Administration of China [201105008?201105023]; Science and Technology Commission of Shanghai Municipality [10391901100]; Shanghai Universities First-class Disciplines Project of Fisheries	National High Technology Research & Development Program of China (''863'' Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); State Oceanic Administration of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Universities First-class Disciplines Project of Fisheries	The study was supported in part by the National High Technology Research & Development Program of China (''863'' Program) (grant no. 2012AA10A411), the National Natural Science Foundation of China (grant no. 31072208), Ministry of Agriculture of China (grant no. 200903030), State Oceanic Administration of China (grant no. 201105008?201105023), Science and Technology Commission of Shanghai Municipality (grant no. 10391901100), and Shanghai Universities First-class Disciplines Project of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1994, GENETICS, V137, P19; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Aruga Y., 1993, KOREAN J PHYCOL, V8, P217; DETLOFF P, 1991, MOL CELL BIOL, V11, P737, DOI 10.1128/MCB.11.2.737; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; KOLODKIN AL, 1986, CELL, V46, P733, DOI 10.1016/0092-8674(86)90349-1; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; Ma JH, 2005, GENETICS MARINE ALGA, P184; MITCHELL MB, 1955, P NATL ACAD SCI USA, V41, P215, DOI 10.1073/pnas.41.4.215; MITMAN GG, 1994, J PHYCOL, V30, P147, DOI 10.1111/j.0022-3646.1994.00147.x; Miura A., 1984, JAP J PHYCOL, V32, P373; NAG DK, 1989, NATURE, V340, P318, DOI 10.1038/340318a0; Nelson WA, 1999, J APPL PHYCOL, V11, P407, DOI 10.1023/A:1008174307352; Niwa K, 2010, AQUACULTURE, V308, P6, DOI 10.1016/j.aquaculture.2010.08.007; OHME M, 1988, PLANT SCI, V57, P135, DOI 10.1016/0168-9452(88)90079-9; OHME M, 1986, Japanese Journal of Phycology, V34, P101; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Wang JF, 2010, J APPL PHYCOL, V22, P297, DOI 10.1007/s10811-009-9459-0; Wang L, 2010, THESIS OCEAN U CHINA; Wang S.J., 1986, OCEAN LIMNOL SIN, V17, P217; WANG SJ, 1984, HYDROBIOLOGIA, V116, P213; Wang SJ, 1985, SEAWEED CULTIVATION, P145; Wang SJ, 1994, J SHANGHAI FISHERIES, V3, P8; WHITE JH, 1985, NATURE, V315, P350, DOI 10.1038/315350a0; Yan XH, 2005, J APPL PHYCOL, V17, P467, DOI 10.1007/s10811-005-2752-7; Yan XH, 2000, J APPL PHYCOL, V12, P69, DOI 10.1023/A:1008129119065; Yan XH, 2007, HIGH TECH LETT, V17, P205; Yan XH, 2007, BOT MAR, V50, P257, DOI 10.1515/BOT.2007.027; Yan XH, 2010, J PHYCOL, V46, P982, DOI 10.1111/j.1529-8817.2010.00889.x; Yan XingHong, 2005, Journal of Fisheries of China, V29, P166; Zheng B.F, 1960, ACTA BOT SIN, V9, P32; Zhong CH, 2011, THESIS SHANGHAI OCEA	34	14	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73414	10.1371/journal.pone.0073414	http://dx.doi.org/10.1371/journal.pone.0073414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991194	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800104
J	Lei, BL; Schwinn, DA; Morris, DP				Lei, Beilei; Schwinn, Debra A.; Morris, Daniel P.			Stimulation of alpha(1a) Adrenergic Receptors Induces Cellular Proliferation or Antiproliferative Hypertrophy Dependent Solely on Agonist Concentration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; BETA-GAMMA-SUBUNITS; SIGNAL-TRANSDUCTION PATHWAYS; SMOOTH-MUSCLE-CELLS; HAMSTER OVARY CELLS; RAT CAROTID-ARTERY; N-TERMINAL KINASE; ALPHA(1)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS	Stimulation of alpha(1a)Adrenergic Receptors (ARs) is known to have anti-proliferative and hypertrophic effects; however, some studies also suggests this receptor can increase cell proliferation. Surprisingly, we find the alpha(1a)AR expressed in rat-1 fibroblasts can produce either phenotype, depending exclusively on agonist concentration. Stimulation of the alpha(1a)AR by high dose phenylephrine (>10(-7) M) induces an antiproliferative, hypertrophic response accompanied by robust and extended p38 activation. Inhibition of p38 with SB203580 prevented the antiproliferative response, while inhibition of Erk or Jnk had no effect. In stark contrast, stimulation of the alpha(1a)AR with low dose phenylephrine (similar to 10(-8) M) induced an Erk-dependent increase in cellular proliferation. Agonist-induced Erk phosphorylation was preceded by rapid FGFR and EGFR transactivation; however, only EGFR inhibition blocked Erk activation and proliferation. The general matrix metalloprotease inhibitor, GM6001, blocked agonist induced Erk activation within seconds, strongly suggesting EGFR activation involved extracellular triple membrane pass signaling. Erk activation required little Ca2+ release and was blocked by PLC beta or PKC inhibition but not by intracellular Ca2+ chelation, suggesting Ca2+ independent activation of novel PKC isoforms. In contrast, Ca2+ release was essential for PI3K/Akt activation, which was acutely maximal at non-proliferative doses of agonist. Remarkably, our data suggests EGFR transactivation leading to Erk induced proliferation has the lowest activation threshold of any alpha(1a)AR response. The ability of alpha(1a)ARs to induce proliferation are discussed in light of evidence suggesting antagonistic growth responses reflect native alpha(1a)AR function.	[Lei, Beilei] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Schwinn, Debra A.] Univ Iowa, Carver Coll Med, Dept Anesthesiol, Iowa City, IA USA; [Schwinn, Debra A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Schwinn, Debra A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Morris, Daniel P.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Duke University; University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Morris, DP (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	dpm9@uw.edu		Schwinn, Debra/0000-0002-9696-5231	NIH/NHLBI [R37 HL49103, 5R37HL049103-19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049103] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by 2005-2016 NIH/NHLBI R37 HL49103 (MERIT AWARD): Subcellular Distribution & Regulation of alpha 1a-Adrenoceptors to Debra A. Schwinn, Project Number: 5R37HL049103-19; $1,250,000/5 years (Years 16-20; MERIT award began in year 11). NHLBI website: http://www.nhlbi.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomeit A, 1999, MOL CELL BIOL, V19, P5289; AHLQUIST RP, 1948, AM J PHYSIOL, V153, P586, DOI 10.1152/ajplegacy.1948.153.3.586; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Albert AP, 2011, ADV EXP MED BIOL, V704, P391, DOI 10.1007/978-94-007-0265-3_22; Alexandrov A, 1998, MOL PHARMACOL, V54, P755, DOI 10.1124/mol.54.5.755; Alexandrov A, 1999, BIOCHEM BIOPH RES CO, V261, P372, DOI 10.1006/bbrc.1999.1015; [Anonymous], 1915, BODILY CHANGES PAIN; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Auge F, 2004, CRIT REV ONCOL HEMAT, V49, P277, DOI 10.1016/j.critrevonc.2003.10.006; Autelitano DJ, 1998, J MOL CELL CARDIOL, V30, P1515, DOI 10.1006/jmcc.1998.0717; Ballard-Croft C, 2002, SHOCK, V18, P38, DOI 10.1097/00024382-200207000-00008; Ballou LM, 2000, J BIOL CHEM, V275, P4803, DOI 10.1074/jbc.275.7.4803; Cabrera-Wrooman A, 2010, N-S ARCH PHARMACOL, V382, P499, DOI 10.1007/s00210-010-0569-7; Cariolato L, 2011, J BIOL CHEM, V286, P7925, DOI 10.1074/jbc.M110.185645; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chen J, 1999, J PHARMACOL EXP THER, V289, P1376; Chen NY, 2001, J BIOL CHEM, V276, P46722, DOI 10.1074/jbc.M107156200; Choi DY, 2001, J BIOL CHEM, V276, P5116, DOI 10.1074/jbc.M002959200; Clerk A, 2006, CELL SIGNAL, V18, P225, DOI 10.1016/j.cellsig.2005.04.005; Cohen MV, 2000, ANNU REV PHYSIOL, V62, P79, DOI 10.1146/annurev.physiol.62.1.79; Cotecchia S, 2010, J RECEPT SIG TRANSD, V30, P410, DOI 10.3109/10799893.2010.518152; Daly CJ, 2010, BRIT J PHARMACOL, V159, P787, DOI 10.1111/j.1476-5381.2009.00608.x; Daniels DV, 1999, EUR J PHARMACOL, V370, P337, DOI 10.1016/S0014-2999(99)00154-5; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Deighan C, 2004, BRIT J PHARMACOL, V142, P1031, DOI 10.1038/sj.bjp.0705872; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; Faber JE, 2006, AM J PHYSIOL-HEART C, V291, pH2272, DOI 10.1152/ajpheart.00404.2006; Faber JE, 2006, CLIN EXP PHARMACOL P, V33, P204, DOI 10.1111/j.1440-1681.2006.04347.x; Faber JE, 2001, J PHARMACOL EXP THER, V298, P441; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; Fernandez-Patron C, 2007, CAN J PHYSIOL PHARM, V85, P97, DOI 10.1139/Y06-097; FONSECA MI, 1995, J BIOL CHEM, V270, P8902, DOI 10.1074/jbc.270.15.8902; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gonzalez-Cabrera PJ, 2004, ENDOCRINOLOGY, V145, P5157, DOI 10.1210/en.2004-0728; Gray KT, 2008, BRIT J PHARMACOL, V155, P103, DOI 10.1038/bjp.2008.245; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; HASSELL JA, 1980, P NATL ACAD SCI-BIOL, V77, P3978, DOI 10.1073/pnas.77.7.3978; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Horinouchi T, 2007, J PHARMACOL SCI, V105, P103, DOI 10.1254/jphs.FP0070891; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kalyankrishna S, 2003, J PHARMACOL EXP THER, V304, P761, DOI 10.1124/jpet.102.040949; Keffel S, 2000, BIOCHEM BIOPH RES CO, V272, P906, DOI 10.1006/bbrc.2000.2850; Kreda SM, 2001, ENDOCRINOLOGY, V142, P4839, DOI 10.1210/en.142.11.4839; LANGER SZ, 1974, BIOCHEM PHARMACOL, V23, P1793, DOI 10.1016/0006-2952(74)90187-7; Lazou A, 1998, BIOCHEM J, V332, P459, DOI 10.1042/bj3320459; Lei B, 2005, N-S ARCH PHARMACOL, V371, P229, DOI 10.1007/s00210-005-1019-9; Lei BL, 2009, CELL SIGNAL, V21, P1532, DOI 10.1016/j.cellsig.2009.06.001; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Marti D, 2005, AM J PHYSIOL-HEART C, V289, pH1923, DOI 10.1152/ajpheart.00288.2005; Martinez-Salas S. G., 2007, Autonomic & Autacoid Pharmacology, V27, P137, DOI 10.1111/j.1474-8673.2007.00403.x; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Methven L, 2009, BRIT J PHARMACOL, V158, P209, DOI 10.1111/j.1476-5381.2009.00269.x; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; MINNEMAN KP, 1988, PHARMACOL REV, V40, P87; Mohl MC, 2011, CARDIOVASC RES; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; Morton JS, 2007, BRIT J PHARMACOL, V150, P112, DOI 10.1038/sj.bjp.0706956; Muramatsu I, 2008, BRIT J PHARMACOL, V155, P1224, DOI 10.1038/bjp.2008.360; Nagareddy PR, 2009, CARDIOVASC RES, V84, P368, DOI 10.1093/cvr/cvp230; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; Oganesian A, 2011, P NATL ACAD SCI USA, V108, P19796, DOI 10.1073/pnas.1116271108; Pediani JD, 2005, MOL PHARMACOL, V67, P992, DOI 10.1124/mol.104.008417; Pediani JD, 2000, J PHARMACOL EXP THER, V293, P887; Perez DM, 2009, MOL PHARMACOL, V76, P144, DOI 10.1124/mol.108.054320; Prakriya M, 2009, IMMUNOL REV, V231, P88, DOI 10.1111/j.1600-065X.2009.00820.x; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Price RR, 2002, J BIOL CHEM, V277, P9570, DOI 10.1074/jbc.M111762200; Raina H, 2009, J PHYSIOL-LONDON, V587, P2599, DOI 10.1113/jphysiol.2008.165258; Rengo G, 2011, J MOL CELL CARDIOL, V50, P785, DOI 10.1016/j.yjmcc.2010.08.014; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Ruan Y, 1998, J PHARMACOL EXP THER, V284, P576; Rudner XL, 1999, CIRCULATION, V100, P2336, DOI 10.1161/01.CIR.100.23.2336; Saeed AE, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-47; Salazar L, 2009, HUM MOL GENET, V18, P1951, DOI 10.1093/hmg/ddp116; Santiskulvong C, 2001, AM J PHYSIOL-CELL PH, V281, pC886, DOI 10.1152/ajpcell.2001.281.3.C886; Santiskulvong C, 2003, EXP CELL RES, V290, P437, DOI 10.1016/S0014-4827(03)00355-0; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Shah BH, 2006, J NEUROCHEM, V96, P520, DOI 10.1111/j.1471-4159.2005.03585.x; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stam WB, 1999, BRIT J PHARMACOL, V127, P661, DOI 10.1038/sj.bjp.0702598; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Steenbergen C, 2002, BASIC RES CARDIOL, V97, P276, DOI 10.1007/s00395-002-0364-9; Sterin-Borda L, 2007, BIOCHEM PHARMACOL, V74, P1401, DOI 10.1016/j.bcp.2007.06.041; Taguchi K, 1998, N-S ARCH PHARMACOL, V357, P100, DOI 10.1007/PL00005143; Takashima N, 2006, GENES CELLS, V11, P1039, DOI 10.1111/j.1365-2443.2006.00999.x; Taniguchi T, 2001, J PHYSIOL-LONDON, V535, P107, DOI 10.1111/j.1469-7793.2001.00107.x; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Teeters JC, 2003, AM J PHYSIOL-HEART C, V284, pH385, DOI 10.1152/ajpheart.00658.2002; Tomlins SA, 2005, EXP CELL RES, V308, P439, DOI 10.1016/j.yexcr.2005.04.032; Uchi J, 2008, CIRC RES, V102, P1378; VazquezPrado J, 1996, MOL PHARMACOL, V50, P17; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Xu SH, 2011, CURR BIOL, V21, P1960, DOI 10.1016/j.cub.2011.10.050; Yamauchi J, 2001, BIOCHEM BIOPH RES CO, V281, P1019, DOI 10.1006/bbrc.2001.4472; Zacharia J, 2005, BRIT J PHARMACOL, V146, P942, DOI 10.1038/sj.bjp.0706395; Zhang H, 2001, CIRC RES, V89, P815, DOI 10.1161/hh2101.098379; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zhong HY, 1999, J NEUROCHEM, V72, P2388, DOI 10.1046/j.1471-4159.1999.0722388.x	115	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72430	10.1371/journal.pone.0072430	http://dx.doi.org/10.1371/journal.pone.0072430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991110	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700039
J	Kubacka, D; Kamenska, A; Broomhead, H; Minshall, N; Darzynkiewicz, E; Standart, N				Kubacka, Dorota; Kamenska, Anastasiia; Broomhead, Helen; Minshall, Nicola; Darzynkiewicz, Edward; Standart, Nancy			Investigating the Consequences of eIF4E2 (4EHP) Interaction with 4E-Transporter on Its Cellular Distribution in HeLa Cells	PLOS ONE			English	Article							EUKARYOTIC TRANSLATION INITIATION; CAP-BINDING PROTEIN; MESSENGER-RNA TRANSLATION; P-BODIES; PHYLOGENETIC ANALYSIS; HOMOLOGOUS PROTEIN; TERMINAL DOMAIN; DROSOPHILA CUP; PROMOTES; STRESS	In addition to the canonical eIF4E cap-binding protein, eukaryotes have evolved sequence-related variants with distinct features, some of which have been shown to negatively regulate translation of particular mRNAs, but which remain poorly characterised. Mammalian eIF4E proteins have been divided into three classes, with class I representing the canonical cap-binding protein eIF4E1. eIF4E1 binds eIF4G to initiate translation, and other eIF4E-binding proteins such as 4E-BPs and 4E-T prevent this interaction by binding eIF4E1 with the same consensus sequence YX L-4 Phi. We investigate here the interaction of human eIF4E2 (4EHP), a class II eIF4E protein, which binds the cap weakly, with eIF4E-transporter protein, 4E-T. We first show that ratios of eIF4E1:4E-T range from 50:1 to 15:1 in HeLa and HEK293 cells respectively, while those of eIF4E2:4E-T vary from 6:1 to 3:1. We next provide evidence that eIF4E2 binds 4E-T in the yeast two hybrid assay, as well as in pull-down assays and by recruitment to P-bodies in mammalian cells. We also show that while both eIF4E1 and eIF4E2 bind 4E-T via the canonical YX L-4 Phi sequence, nearby downstream sequences also influence eIF4E:4E-T interactions. Indirect immunofluorescence was used to demonstrate that eIF4E2, normally homogeneously localised in the cytoplasm, does not redistribute to stress granules in arsenite-treated cells, nor to P-bodies in Actinomycin D-treated cells, in contrast to eIF4E1. Moreover, eIF4E2 shuttles through nuclei in a Crm1-dependent manner, but in an 4E-T-independent manner, also unlike eIF4E1. Altogether we conclude that while both cap-binding proteins interact with 4E-T, and can be recruited by 4E-T to P-bodies, eIF4E2 functions are likely to be distinct from those of eIF4E1, both in the cytoplasm and nucleus, further extending our understanding of mammalian class I and II cap-binding proteins.	[Kubacka, Dorota; Kamenska, Anastasiia; Broomhead, Helen; Minshall, Nicola; Standart, Nancy] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Kubacka, Dorota; Darzynkiewicz, Edward] Univ Warsaw, Inst Expt Phys, Fac Phys, Div Biophys, Warsaw, Poland	University of Cambridge; University of Warsaw	Standart, N (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	nms@mole.bio.cam.ac.uk	Kubacka, Dorota/C-2179-2017; Kamenska, Anastasiia/AHE-6374-2022	Kubacka, Dorota/0000-0003-0421-0470; 	Wellcome Trust [084885/Z/08/Z]; BBSRC [BB/J00779X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J00779X/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a project grant from the Wellcome Trust to NS and ED (084885/Z/08/Z). AK gratefully acknowledges the Gates Cambridge Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Brown CJ, 2011, J MOL BIOL, V405, P736, DOI 10.1016/j.jmb.2010.10.045; Cargnello M, 2012, MOL CELL BIOL, V32, P4572, DOI 10.1128/MCB.00544-12; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Evsikov AV, 2009, DEV GENES EVOL, V219, P111, DOI 10.1007/s00427-008-0268-2; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gkogkas CG, 2013, NATURE; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Igreja C, 2011, GENE DEV, V25, P1955, DOI 10.1101/gad.17136311; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Kinkelin K, 2012, RNA, V18, P1624, DOI 10.1261/rna.033639.112; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Kramer S, 2012, J CELL SCI, V125, P2896, DOI 10.1242/jcs.099275; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lee HC, 2008, BIOCHEM BIOPH RES CO, V369, P1160, DOI 10.1016/j.bbrc.2008.03.017; Marnef A, 2012, MOL BIOL CELL, V23, P213, DOI 10.1091/mbc.E11-05-0415; Marnef A, 2010, RNA, V16, P2094, DOI 10.1261/rna.2295410; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Paku KS, 2012, BIOCHEM J, V441, P237, DOI 10.1042/BJ20101481; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Standart N, 2008, BIOCHEM SOC T, V36, P671, DOI 10.1042/BST0360671; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; Tettweiler G, 2012, DISTRIBUTION ELF4E F; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Umenaga Y, 2011, BIOCHEM BIOPH RES CO, V414, P462, DOI 10.1016/j.bbrc.2011.09.084; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Villaescusa JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005213; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	63	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72761	10.1371/journal.pone.0072761	http://dx.doi.org/10.1371/journal.pone.0072761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991149	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100116
J	Miller, AM; Gilchrist, DS; Nijjar, J; Araldi, E; Ramirez, CM; Lavery, CA; Fernandez-Hernando, C; McInnes, IB; Kurowska-Stolarska, M				Miller, Ashley M.; Gilchrist, Derek S.; Nijjar, Jagtar; Araldi, Elisa; Ramirez, Cristina M.; Lavery, Christopher A.; Fernandez-Hernando, Carlos; McInnes, Iain B.; Kurowska-Stolarska, Mariola			MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INFLAMMATORY RESPONSE; MICRORNA-155; EXPRESSION; STEATOHEPATITIS; BIOCONDUCTOR; LXR	Hepatic steatosis is a global epidemic that is thought to contribute to the pathogenesis of type 2 diabetes. MicroRNAs (miRs) are regulators that can functionally integrate a range of metabolic and inflammatory pathways in liver. We aimed to investigate the functional role of miR-155 in hepatic steatosis. Male C57BL/6 wild-type (WT) and miR-155(-/-) mice were fed either normal chow or high fat diet (HFD) for 6 months then lipid levels, metabolic and inflammatory parameters were assessed in livers and serum of the mice. Mice lacking endogenous miR-155 that were fed HFD for 6 months developed increased hepatic steatosis compared to WT controls. This was associated with increased liver weight and serum VLDL/LDL cholesterol and alanine transaminase (ALT) levels, as well as increased hepatic expression of genes involved in glucose regulation (Pck1, Cebpa), fatty acid uptake (Cd36) and lipid metabolism (Fasn, Fabp4, Lpl, Abcd2, Pla2g7). Using miRNA target prediction algorithms and the microarray transcriptomic profile of miR-155(-/-) livers, we identified and validated that Nr1h3 (LXR alpha) as a direct miR-155 target gene that is potentially responsible for the liver phenotype of miR-155(-/-) mice. Together these data indicate that miR-155 plays a pivotal role regulating lipid metabolism in liver and that its deregulation may lead to hepatic steatosis in patients with diabetes.	[Miller, Ashley M.; Lavery, Christopher A.] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Gilchrist, Derek S.; Nijjar, Jagtar; McInnes, Iain B.; Kurowska-Stolarska, Mariola] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Araldi, Elisa; Ramirez, Cristina M.; Fernandez-Hernando, Carlos] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY USA	University of Glasgow; University of Glasgow; New York University	McInnes, IB (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Iain.McInnes@glasgow.ac.uk	Ramírez, Cristina/ABI-1568-2020; Ramírez, Cristina/A-6975-2016; Araldi, Elisa/AAZ-5946-2021; Kurowska-Stolarska, Mariola/AAD-1683-2019	Ramírez, Cristina/0000-0003-2589-0786; Ramírez, Cristina/0000-0003-2589-0786; McInnes, Iain/0000-0002-6462-4280; Araldi, Elisa/0000-0002-6596-6784	British Heart Foundation [FS/08/035/25309]; Masterswitch (EU FP7 project); Arthritis Research UK Career Development Grant; MRC; Versus Arthritis [19213] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Masterswitch (EU FP7 project); Arthritis Research UK Career Development Grant(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	A.M. Miller is supported by a British Heart Foundation Intermediate Research Fellowship (FS/08/035/25309). D. S. Gilchrist is funded by Masterswitch (EU FP7 project). M. Kurowska-Stolarska is supported by an Arthritis Research UK Career Development Grant. J. Nijjar is supported by a MRC PhD Fellowship. C. A. Lavery is supported by a British Heart Foundation PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-151; Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chang CL, 2011, ENDOCRINOLOGY, V152, P384, DOI 10.1210/en.2010-0493; Chen T, 2011, INT J CARDIOL, V147, P446, DOI 10.1016/j.ijcard.2010.10.133; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lakner AM, 2011, WORLD J GASTROENTERO, V17, P2536, DOI 10.3748/wjg.v17.i20.2536; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Sun HX, 2012, HYPERTENSION; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang P., 2010, J IMMUNOL; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	35	89	92	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72324	10.1371/journal.pone.0072324	http://dx.doi.org/10.1371/journal.pone.0072324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991091	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000324470100098
J	Wielputz, MO; Weinheimer, O; Eichinger, M; Wiebel, M; Biederer, J; Kauczor, HU; Heussel, CP; Mall, MA; Puderbach, M				Wielpuetz, Mark O.; Weinheimer, Oliver; Eichinger, Monika; Wiebel, Matthias; Biederer, Juergen; Kauczor, Hans-Ulrich; Heussel, Claus P.; Mall, Marcus A.; Puderbach, Michael			Pulmonary Emphysema in Cystic Fibrosis Detected by Densitometry on Chest Multidetector Computed Tomography	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; AIRWAY SURFACE LIQUID; LUNG-DISEASE; QUANTITATIVE ASSESSMENT; SCORING SYSTEM; PATHOGENESIS; MANAGEMENT; PHENOTYPES; DIAGNOSIS; QUANTIFICATION	Background: Histopathological studies on lung specimens from patients with cystic fibrosis (CF) and recent results from a mouse model indicate that emphysema may contribute to CF lung disease. However, little is known about the relevance of emphysema in patients with CF. In the present study, we used computationally generated density masks based on multidetector computed tomography (MDCT) of the chest for non-invasive characterization and quantification of emphysema in CF. Methods: Volumetric MDCT scans were acquired in parallel to pulmonary function testing in 41 patients with CF (median age 20.1 years; range 7-66 years) and 21 non-CF controls (median age 30.4 years; range 4-68 years), and subjected to dedicated software. The lung was segmented, low attenuation volumes below a threshold of -950 Hounsfield units were assigned to emphysema volume (EV), and the emphysema index was computed (EI). Results were correlated with forced expiratory volume in 1 s percent predicted (FEV1%), residual volume (RV), and RV/total lung capacity (RV/TLC). Results: We show that EV was increased in CF (457 +/- 530 ml) compared to non-CF controls (78 +/- 90 ml) (P<0.01). EI was also increased in CF (7.7 +/- 7.5%) compared to the control group (1.2 +/- 1.4%) (P<0.05). EI correlated inversely with FEV1% (r(s)=-0.66), and directly with RV (r(s)=0.69) and RV/TLC (r(s)=0.47) in patients with CF (P<0.007), but not in non-CF controls. Emphysema in CF was detected from early adolescence (similar to 13 years) and increased with age (r(s)=0.67, P<0.001). Conclusions: Our results indicate that early onset emphysema detected by densitometry on chest MDCT is a characteristic pathology that contributes to airflow limitation and may serve as a novel endpoint for monitoring lung disease in CF.	[Wielpuetz, Mark O.; Weinheimer, Oliver; Biederer, Juergen; Kauczor, Hans-Ulrich] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Wielpuetz, Mark O.; Weinheimer, Oliver; Eichinger, Monika; Biederer, Juergen; Kauczor, Hans-Ulrich; Heussel, Claus P.; Mall, Marcus A.; Puderbach, Michael] Translat Lung Res Ctr TLRC Heidelberg, Heidelberg, Germany; [Weinheimer, Oliver] Med Johannes Gutenberg Univ, Dept Diagnost & Intervent Radiol, Mainz, Germany; [Eichinger, Monika] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Wiebel, Matthias] Heidelberg Univ, Thoraxklin, Cyst Fibrosis Ctr, Dept Pulmonol, Heidelberg, Germany; [Heussel, Claus P.; Puderbach, Michael] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Dept Translat Pulmonol, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Div Pediat Pulmonol, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Cyst Fibrosis Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Mall, MA (corresponding author), Translat Lung Res Ctr TLRC Heidelberg, Heidelberg, Germany.	Marcus.Mall@med.uni-heidelberg.de	Kauczor, HU/AAX-6033-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Weinheimer, Oliver/AAN-3652-2021; Wielpuetz, Mark/ABE-1790-2020; Kauczor, Hans-Ulrich/AAU-5955-2021; Mall, Marcus A./AAA-1498-2022	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Mall, Marcus A./0000-0002-4057-2199	Bundesministerium fur Bildung und Forschung BMBF [82DZL00401, 82DZL00402, 82DZL00404]; Deutsche Forschungsgemeinschaft DFG [MA 2081/4-1]	Bundesministerium fur Bildung und Forschung BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This study was supported by grants from the Bundesministerium fur Bildung und Forschung BMBF (www.bmbf.de) to the German Center for Lung Research DZL (grants 82DZL00401, 82DZL00402, 82DZL00404) and the Deutsche Forschungsgemeinschaft DFG (www.dfg.de) to Marcus A. Mall (grant MA 2081/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NS, 2012, LARYNGOSCOPE, V122, P1193, DOI 10.1002/lary.23278; Barbosa EM, 2011, ACAD RADIOL, V18, P1258, DOI 10.1016/j.acra.2011.06.004; BEDROSSIAN CWM, 1976, HUM PATHOL, V7, P195, DOI 10.1016/S0046-8177(76)80023-8; BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Brody AS, 2006, J THORAC IMAG, V21, P14, DOI 10.1097/01.rti.0000203937.82276.ce; Brody AS, 2005, AM J RESP CRIT CARE, V172, P1246, DOI 10.1164/rccm.200503-401PP; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Cobos-Correa A, 2009, NAT CHEM BIOL, V5, P628, DOI 10.1038/nchembio.196; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; de Jong PA, 2006, THORAX, V61, P80, DOI 10.1136/thx.2005.045146; de Long PA, 2005, AM J RESP CRIT CARE, V172, P218, DOI 10.1164/rccm.200410-1311OC; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; ESTERLY JR, 1968, THORAX, V23, P670, DOI 10.1136/thx.23.6.670; Gaggar A, 2011, EUR RESPIR J, V38, P721, DOI 10.1183/09031936.00173210; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hall GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023932; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Helbich TH, 1999, RADIOLOGY, V213, P537, DOI 10.1148/radiology.213.2.r99nv04537; Helbich TH, 1999, AM J ROENTGENOL, V173, P81, DOI 10.2214/ajr.173.1.10397104; Heussel CP, 2009, EUR RADIOL, V19, P2391, DOI 10.1007/s00330-009-1437-z; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ley-Zaporozhan J, 2010, J MAGN RESON IMAGING, V32, P1340, DOI 10.1002/jmri.22376; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mall MA, 2009, EXP PHYSIOL, V94, P171, DOI 10.1113/expphysiol.2008.042994; Martinez CH, 2012, THORAX, V67, P399, DOI 10.1136/thoraxjnl-2011-201185; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Mets OM, 2012, EUR RADIOL, V22, P120, DOI 10.1007/s00330-011-2237-9; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robinson TE, 2004, CURR OPIN PULM MED, V10, P537, DOI 10.1097/01.mcp.0000142924.38801.45; Schubert SC, 2009, J CYST FIBROS S2, V8, pS53, DOI DOI 10.1016/S1569-1993(09)60212-5; Hoffman Eric A, 2006, Proc Am Thorac Soc, V3, P519, DOI 10.1513/pats.200603-086MS; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; Stern M, 2008, EUR RESPIR J, V31, P29, DOI 10.1183/09031936.00056507; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785; Zach JA, 2012, INVEST RADIOL, V47, P596, DOI 10.1097/RLI.0b013e318262292e; Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0	61	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73142	10.1371/journal.pone.0073142	http://dx.doi.org/10.1371/journal.pone.0073142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991177	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100127
J	Baranova, NS; Foulcer, SJ; Briggs, DC; Tilakaratna, V; Enghild, JJ; Milner, CM; Day, AJ; Richter, RP				Baranova, Natalia S.; Foulcer, Simon J.; Briggs, David C.; Tilakaratna, Viranga; Enghild, Jan J.; Milner, Caroline M.; Day, Anthony J.; Richter, Ralf P.			Inter-alpha-inhibitor Impairs TSG-6-induced Hyaluronan Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-STIMULATED GENE-6; BLOOD FOLLICLE BARRIER; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; TRYPSIN-INHIBITOR; RHEUMATOID-ARTHRITIS; PROTEIN TSG-6; HEAVY-CHAINS; GRAFTED HYALURONAN; OOCYTE COMPLEXES	Under inflammatory conditions and in the matrix of the cumulus-oocyte complex, the polysaccharide hyaluronan (HA) becomes decorated covalently with heavy chains (HCs) of the serum glycoprotein inter-alpha-inhibitor (I alpha I). This alters the functional properties of the HA as well as its structural role within extracellular matrices. The covalent transfer of HCs from I alpha I to HA is catalyzed by TSG-6 (tumor necrosis factor-stimulated gene-6), but TSG-6 is also known as a HA cross-linker that induces condensation of the HA matrix. Here, we investigate the interplay of these two distinct functions of TSG-6 by studying the ternary interactions of I alpha I and TSG-6 with well defined films of end-grafted HA chains. We demonstrate that TSG-6-mediated cross-linking of HA films is impaired in the presence of I alpha I and that this effect suppresses the TSG-6-mediated enhancement of HA binding to CD44-positive cells. Furthermore, we find that the interaction of TSG-6 and I alpha I in the presence of HA gives rise to two types of complexes that independently promote the covalent transfer of heavy chains to HA. One type of complex interacts very weakly with HA and is likely to correspond to the previously reported covalent HC.TSG-6 complexes. The other type of complex is novel and binds stably but noncovalently to HA. Prolonged incubation with TSG-6 and I alpha I leads toHA films that contain, in addition to covalently HA-bound HCs, several tightly but noncovalently bound molecular species. These findings have important implications for understanding how the biological activities of TSG-6 are regulated, such that the presence or absence of I alpha I will dictate its function.	[Baranova, Natalia S.; Richter, Ralf P.] CIC BiomaGUNE, Biosurfaces Unit, Donostia San Sebastian 20009, Spain; [Foulcer, Simon J.; Briggs, David C.; Tilakaratna, Viranga; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Milner, Caroline M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Enghild, Jan J.] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Richter, Ralf P.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Richter, Ralf P.] Univ Grenoble 1, Dept Mol Chem, F-38041 Grenoble 9, France	CIC biomaGUNE; University of Manchester; University of Manchester; Aarhus University; Max Planck Society; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Day, AJ (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk; rrichter@cicbiomagune.es	Milner, Caroline M/P-5526-2015; Richter, Ralf Peter/B-3343-2013; Day, Anthony/O-1658-2015; biomaGUNE, CIC/J-9136-2014	Milner, Caroline M/0000-0001-7355-9655; Richter, Ralf Peter/0000-0003-3071-2837; Day, Anthony/0000-0002-1415-3134; Briggs, David/0000-0002-9793-7339; Baranova, Natalia/0000-0002-3086-9124; biomaGUNE, CIC/0000-0001-7690-0660; Enghild, Jan Johannes/0000-0001-9292-9172	German Federal Ministry of Education and Research [0315157]; Spanish Ministry of Economy and Competitiveness [MAT2011-24306, RYC2009-04275]; European Research Council [306435]; Arthritis Research UK [18472, 19489]; Medical Research Council [G0701180, G0800127]; MRC [G0701180] Funding Source: UKRI; Versus Arthritis [18472, 19489] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	This work was supported by German Federal Ministry of Education and Research Grant 0315157, Spanish Ministry of Economy and Competitiveness Grants MAT2011-24306 and RYC2009-04275, and European Research Council Starting Grant 306435 (to R. P. R.). This work was also supported by Arthritis Research UK Grants 18472 and 19489 and Medical Research Council Grant G0701180 (to A. J. D. and C. M. M.).; Recipient of Medical Research Council Doctoral Training Award Grant G0800127.	Attili S, 2012, BIOMACROMOLECULES, V13, P1466, DOI 10.1021/bm3001759; Attili S, 2012, LANGMUIR, V28, P3206, DOI 10.1021/la204602n; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; CHEN L, 1992, J BIOL CHEM, V267, P12380; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; HAMERMAN D, 1963, J CLIN INVEST, V42, P1882, DOI 10.1172/JCI104873; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Hess KA, 1998, BIOL REPROD, V58, P705, DOI 10.1095/biolreprod58.3.705; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Kida D, 1999, J RHEUMATOL, V26, P1230; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; POWERS RW, 1995, AM J PHYSIOL-ENDOC M, V269, pE290, DOI 10.1152/ajpendo.1995.269.2.E290; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	64	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29642	29653		10.1074/jbc.M113.477422	http://dx.doi.org/10.1074/jbc.M113.477422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005673	Green Published, hybrid			2022-12-25	WOS:000330615300040
J	Govorunova, EG; Sineshchekov, OA; Li, H; Janz, R; Spudich, JL				Govorunova, Elena G.; Sineshchekov, Oleg A.; Li, Hai; Janz, Roger; Spudich, John L.			Characterization of a Highly Efficient Blue-shifted Channelrhodopsin from the Marine Alga Platymonas subcordiformis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN; PHOTOPHOBIC RESPONSES; OPTOGENETIC TOOLS; VOLVOX-CARTERI; SCHIFF-BASE; LIGHT; BACTERIORHODOPSIN; CHLAMYDOMONAS; PHOTOTAXIS; CHANNEL	Rhodopsin photosensors of phototactic algae act as light-gated cation channels when expressed in animal cells. These proteins (channelrhodopsins) are extensively used for millisecond scale photocontrol of cellular functions (optogenetics). We report characterization of PsChR, one of the phototaxis receptors in the alga Platymonas (Tetraselmis) subcordiformis. PsChR exhibited similar to 3-fold higher unitary conductance and greater relative permeability for Na+ ions, as compared with the most frequently used channelrhodopsin-2 from Chlamydomonas reinhardtii (CrChR2). Photocurrents generated by PsChR in HEK293 cells showed lesser inactivation and faster peak recovery than those by CrChR2. Their maximal spectral sensitivity was at 445 nm, making PsChR the most blue-shifted channel-rhodopsin so far identified. The lambda(max) of detergent-purified PsChR was 437 nm at neutral pH and exhibited red shifts (pK(a) values at 6.6 and 3.8) upon acidification. The purified pigment undergoes a photocycle with a prominent red-shifted intermediate whose formation and decay kinetics match the kinetics of channel opening and closing. The rise and decay of an M-like intermediate prior to formation of this putative conductive state were faster than in CrChR2. PsChR mediated sufficient light-induced membrane depolarization in cultured hippocampal neurons to trigger reliable repetitive spiking at the upper threshold frequency of the neurons. At low frequencies spiking probability decreases less with PsChR than with CrChR2 because of the faster recovery of the former. Its blue-shifted absorption enables optogenetics at wavelengths even below 400 nm. A combination of characteristics makes PsChR important for further research on structure-function relationships in ChRs and potentially useful for optogenetics, especially for combinatorial applications when short wavelength excitation is required.	[Govorunova, Elena G.; Sineshchekov, Oleg A.; Li, Hai; Spudich, John L.] Univ Texas Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Janz, Roger] Univ Texas Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), Univ Texas Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu	LI, HAI/G-3823-2012; LI, HAI/B-4052-2012; Li, Hai/J-5419-2014	Govorunova, Elena/0000-0003-0522-9683; Janz, Roger/0000-0002-9872-0596	National Institutes of Health [R01GM027750, R21MH098288]; Hermann Eye Fund; Endowed Chair from the Robert A. Welch Foundation [AU-0009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH098288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hermann Eye Fund; Endowed Chair from the Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM027750 and R21MH098288. This work was also supported by the Hermann Eye Fund and Endowed Chair AU-0009 from the Robert A. Welch Foundation.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Brewer GJ, 2008, J NEUROSCI METH, V170, P181, DOI 10.1016/j.jneumeth.2008.01.009; Cherny VV, 2003, J GEN PHYSIOL, V121, P615, DOI 10.1085/jgp.200308813; Collot M, 2012, J AM CHEM SOC, V134, P14923, DOI 10.1021/ja304018d; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; GERGELY C, 1995, J PHOTOCH PHOTOBIO B, V27, P27, DOI 10.1016/1011-1344(94)07057-U; Govorunova EG, 2004, BIOPHYS J, V86, P2342, DOI 10.1016/S0006-3495(04)74291-5; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gray PT, 1994, PLYMOUTH WORKSHOP HD, P189; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HALLDAL, 1958, PHYSIOL PLANTARUM, V11, P118; Han X, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.012.2009; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; Hegemann P, 2013, EMBO MOL MED, V5, P173, DOI 10.1002/emmm.201202387; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kianianmomeni A, 2009, PLANT PHYSIOL, V151, P347, DOI 10.1104/pp.109.143297; Kleinlogel S, 2011, NAT METHODS, V8, P1083, DOI [10.1038/NMETH.1766, 10.1038/nmeth.1766]; KREIMER G, 1994, INT REV CYTOL, V148, P229, DOI 10.1016/S0074-7696(08)62409-2; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LITVIN FF, 1978, NATURE, V271, P476, DOI 10.1038/271476a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARTI T, 1991, J BIOL CHEM, V266, P18674; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MCLACHLAN J, 1960, CAN J MICROBIOL, V6, P367, DOI 10.1139/m60-041; Mei Y, 2012, BIOL PSYCHIAT, V71, P1033, DOI 10.1016/j.biopsych.2012.02.019; Nack M, 2009, FEBS LETT, V583, P3676, DOI 10.1016/j.febslet.2009.10.052; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OHNO K, 1977, BIOCHIM BIOPHYS ACTA, V462, P575, DOI 10.1016/0005-2728(77)90102-5; PETTEI MJ, 1977, BIOCHEMISTRY-US, V16, P1955, DOI 10.1021/bi00628a031; Plazzo AP, 2012, J BIOL CHEM, V287, P4818, DOI 10.1074/jbc.M111.326207; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Richards R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050018; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; SAUVE R, 1985, J THEOR BIOL, V113, P501, DOI 10.1016/S0022-5193(85)80035-7; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SINESHCHEKOV OA, 1992, J PHOTOCH PHOTOBIO B, V13, P119, DOI 10.1016/1011-1344(92)85051-U; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sineshchekov OA, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P25, DOI 10.1002/352760510X.ch2; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; Sineshchevkov OA, 2005, J BIOL CHEM, V280, P14663, DOI 10.1074/jbc.m501416200; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; SUBRAMANIAM S, 1990, P NATL ACAD SCI USA, V87, P1013, DOI 10.1073/pnas.87.3.1013; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tsuda S, 2013, NEUROSCI RES, V75, P76, DOI 10.1016/j.neures.2012.11.006; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Ullrich S, 2013, BIOL CHEM, V394, P271, DOI 10.1515/hsz-2012-0256; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wang JH, 2012, J BIOL CHEM, V287, P21316, DOI 10.1074/jbc.M112.344622; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yawo H, 2013, DEV GROWTH DIFFER, V55, P474, DOI 10.1111/dgd.12053; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	70	59	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29911	29922		10.1074/jbc.M113.505495	http://dx.doi.org/10.1074/jbc.M113.505495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995841	Green Published, hybrid			2022-12-25	WOS:000330615300064
J	Luque-Almagro, VM; Lyall, VJ; Ferguson, SJ; Roldan, MD; Richardson, DJ; Gates, AJ				Luque-Almagro, Victor M.; Lyall, Verity J.; Ferguson, Stuart J.; Dolores Roldan, M.; Richardson, David J.; Gates, Andrew J.			Nitrogen Oxyanion-dependent Dissociation of a Two-component Complex That Regulates Bacterial Nitrate Assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ANTITERMINATION; OPERON EXPRESSION; REDUCTASE OPERON; BINDING PROTEIN; NITRITE; GENE; NASR; INDUCTION; CRYSTAL; SYSTEM	Nitrogen is an essential nutrient for growth and is readily available to microbes in many environments in the form of ammonium and nitrate. Both ions are of environmental significance due to sustained use of inorganic fertilizers on agricultural soils. Diverse species of bacteria that have an assimilatory nitrate/nitrite reductase system (NAS) can use nitrate or nitrite as the sole nitrogen source for growth when ammonium is limited. In Paracoccus denitrificans, the pathway-specific two-component regulator for NAS expression is encoded by the nasT and nasS genes. Here, we show that the putative RNA-binding protein NasT is a positive regulator essential for expression of the nas gene cluster (i.e. nasABGHC). By contrast, a nitrogen oxyanion-binding sensor (NasS) is required for nitrate/nitrite-responsive control of nas gene expression. The NasS and NasT proteins co-purify as a stable heterotetrameric regulatory complex, NasS-NasT. This protein-protein interaction is sensitive to nitrate and nitrite, which cause dissociation of the NasS-NasT complex into monomeric NasS and an oligomeric form of NasT. NasT has been shown to bind the leader RNA for nasA. Thus, upon liberation from the complex, the positive regulator NasT is free to up-regulate nas gene expression.	[Luque-Almagro, Victor M.; Lyall, Verity J.; Richardson, David J.; Gates, Andrew J.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Luque-Almagro, Victor M.; Lyall, Verity J.; Richardson, David J.; Gates, Andrew J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Dolores Roldan, M.] Univ Cordoba, Dept Bioquim & Biol Mol, E-14071 Cordoba, Spain; [Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of East Anglia; University of East Anglia; Universidad de Cordoba; University of Oxford	Gates, AJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.gates@uea.ac.uk	Gates, Andrew J/F-8218-2011; Luque-Almagro, Victor M./A-3516-2011; Roldán Ruiz, María Dolores/K-4370-2014	Gates, Andrew J/0000-0002-4594-5038; Roldán Ruiz, María Dolores/0000-0001-7173-8641; Luque-Almagro, Victor M./0000-0003-1447-4795	United Kingdom Biotechnology and Biological Science Research Council [BB/E021999/1]; Spanish Ministerio de Ciencia y Tecnologia [BIO2008-04542-C02-01, BIO2011-30026-C02-01]; Junta de Andalucia [CVI-7560]; Ministerio de Ciencia y Tecnologia; Royal Society Wolfson Foundation; Biotechnology and Biological Sciences Research Council [BB/D523019/1, BB/E021999/1] Funding Source: researchfish; BBSRC [BB/D523019/1, BB/E021999/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Royal Society Wolfson Foundation(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by United Kingdom Biotechnology and Biological Science Research Council Grant BB/E021999/1, Spanish Ministerio de Ciencia y Tecnologia Grants BIO2008-04542-C02-01 and BIO2011-30026-C02-01, and Junta de Andalucia Grant CVI-7560.; Recipient of a postdoctoral fellowship from the Ministerio de Ciencia y Tecnologia.; Royal Society Wolfson Foundation Research Merit Award Fellow.	Boudes M, 2012, MOL MICROBIOL, V85, P431, DOI 10.1111/j.1365-2958.2012.08111.x; Caballero A, 2005, J BACTERIOL, V187, P396, DOI 10.1128/JB.187.1.396-399.2005; Chai WH, 1998, J MOL BIOL, V283, P339, DOI 10.1006/jmbi.1998.2105; Demeler B., 2010, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864.PS0713S60; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Frigaard NU, 2004, J BACTERIOL, V186, P646, DOI 10.1128/JB.186.3.646-653.2004; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gates AJ, 2011, BIOCHEM J, V435, P743, DOI 10.1042/BJ20101920; GOLDMAN BS, 1994, J BACTERIOL, V176, P5077, DOI 10.1128/jb.176.16.5077-5085.1994; GUTIERREZ JC, 1995, MOL MICROBIOL, V18, P579, DOI 10.1111/j.1365-2958.1995.mmi_18030579.x; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Koropatkin NM, 2006, P NATL ACAD SCI USA, V103, P9820, DOI 10.1073/pnas.0602517103; LIN JT, 1993, J BACTERIOL, V175, P2370, DOI 10.1128/JB.175.8.2370-2378.1993; Lin JT, 1996, J MOL BIOL, V256, P423, DOI 10.1006/jmbi.1996.0098; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P1838, DOI 10.1042/BST20110688; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Morth JP, 2004, STRUCTURE, V12, P1595, DOI 10.1016/j.str.2004.06.018; O'Hara BP, 1999, EMBO J, V18, P5175, DOI 10.1093/emboj/18.19.5175; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Pino C, 2006, BIOCHEM SOC T, V34, P127, DOI 10.1042/BST0340127; Ramesh A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002666; Romeo A, 2012, MICROBIOL-SGM, V158, P1543, DOI 10.1099/mic.0.053850-0; Sambrook J, 2001, MOL CLONING LAB MANU; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shu CYJ, 2002, TRENDS BIOCHEM SCI, V27, P3, DOI 10.1016/S0968-0004(01)02036-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stewart V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002773; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang BM, 2012, APPL ENVIRON MICROB, V78, P6558, DOI 10.1128/AEM.01720-12; Wilson SA, 1996, EMBO J, V15, P5907, DOI 10.1002/j.1460-2075.1996.tb00977.x; Wu SQT, 1999, J BACTERIOL, V181, P7274, DOI 10.1128/JB.181.23.7274-7284.1999	31	20	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29692	29702		10.1074/jbc.M113.459032	http://dx.doi.org/10.1074/jbc.M113.459032			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005668	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000330615300044
J	Coverdale, TC; Axelman, EE; Brisson, CP; Young, EW; Altieri, AH; Bertness, MD				Coverdale, Tyler C.; Axelman, Eric E.; Brisson, Caitlin P.; Young, Eric W.; Altieri, Andrew H.; Bertness, Mark D.			New England Salt Marsh Recovery: Opportunistic Colonization of an Invasive Species and Its Non-Consumptive Effects	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; POTENTIAL CONSERVATION VALUE; DIE-OFF; ECOSYSTEM; SHIFTS; VULNERABILITY; BIODIVERSITY; RESILIENCE; HERBIVORY; PREDATION	Predator depletion on Cape Cod (USA) has released the herbivorous crab Sesarma reticulatum from predator control leading to the loss of cordgrass from salt marsh creek banks. After more than three decades of die-off, cordgrass is recovering at heavily damaged sites coincident with the invasion of green crabs (Carcinus maenas) into intertidal Sesarma burrows. We hypothesized that Carcinus is dependent on Sesarma burrows for refuge from physical and biotic stress in the salt marsh intertidal and reduces Sesarma functional density and herbivory through consumptive and non-consumptive effects, mediated by both visual and olfactory cues. Our results reveal that in the intertidal zone of New England salt marshes, Carcinus are burrow dependent, Carcinus reduce Sesarma functional density and herbivory in die-off areas and Sesarma exhibit a generic avoidance response to large, predatory crustaceans. These results support recent suggestions that invasive Carcinus are playing a role in the recovery of New England salt marshes and assertions that invasive species can play positive roles outside of their native ranges.	[Coverdale, Tyler C.; Axelman, Eric E.; Brisson, Caitlin P.; Young, Eric W.; Bertness, Mark D.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Altieri, Andrew H.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Brown University; Smithsonian Institution; Smithsonian Tropical Research Institute	Coverdale, TC (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Tyler_Coverdale@Brown.edu	Altieri, Andrew H/P-1738-2017	Coverdale, Tyler/0000-0003-0910-9187; Brisson, Caitlin/0000-0001-8567-1863; Altieri, Andrew/0000-0001-7439-8742	NSF BIO [OCE-0927090]	NSF BIO(National Science Foundation (NSF))	This work was funded by NSF BIO OCE-0927090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2013, ECOLOGY IN PRESS; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Bertness MD, 2013, ECOLOGY IN PRESS; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Broadbent EN, 2006, ECOL APPL, V16, P1148, DOI 10.1890/1051-0761(2006)016[1148:ROFSAS]2.0.CO;2; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carpenter SR, 2009, ECOL SOC, V14; Carroll SP, 2011, EVOL APPL, V4, P184, DOI 10.1111/j.1752-4571.2010.00180.x; Coverdale TC, 2013, CONSERV BIOL, DOI [10.1111/cobi.12052, DOI 10.1111/C0BI.12052.PUBMED:23566036]; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Higgins JJ, 2011, ALIGNED RANK TRANSFO, P143; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; MacDonald JA, 2007, BIOL INVASIONS, V9, P837, DOI 10.1007/s10530-006-9085-6; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nunez MA, 2005, ECOL SOC, V10, DOI 10.5751/ES-01342-1001r04; ODUM E P, 1971, P574; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Say T., 1817, J ACAD NATURAL SCI P, P57; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Schlaepfer MA, 2012, CONSERV BIOL, V26, P1156, DOI 10.1111/j.1523-1739.2012.01948.x; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Simberloff D, 2011, SCIENCE, V332, P419, DOI 10.1126/science.332.6028.419-a; Vitule JRS, 2012, CONSERV BIOL, V26, P1153, DOI 10.1111/j.1523-1739.2012.01950.x; Smith SM, 2009, NORTHEAST NAT, V16, P183, DOI 10.1656/045.016.0203; Trussell GC, 2002, ECOL LETT, V5, P241, DOI 10.1046/j.1461-0248.2002.00304.x; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Walker B. H., 1995, CONSERV BIOL, V9, P1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	42	19	19	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73823	10.1371/journal.pone.0073823	http://dx.doi.org/10.1371/journal.pone.0073823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009763	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600077
J	Huang, LT; Wong, AMK; Chen, CPC; Chang, WH; Cheng, JW; Lin, YR; Pei, YC				Huang, Li-Ting; Wong, Alice M. K.; Chen, Carl P. C.; Chang, Wei-Han; Cheng, Ju-Wen; Lin, Yu-Ru; Pei, Yu-Cheng			Global Motion Percept Mediated through Integration of Barber Poles Presented in Bilateral Visual Hemifields	PLOS ONE			English	Article							RECEPTIVE-FIELD PROPERTIES; APERTURE PROBLEM; AREA MT; PERCEIVED DIRECTION; SURROUND MODULATION; ILLUSION; NEURONS; MECHANISMS; OCCLUSION; FIGURE	How is motion information that has been obtained through multiple viewing apertures integrated to form a global motion percept? We investigated the mechanisms of motion integration across apertures in two hemifields by presenting gratings through two rectangles (that form the dual barber poles) and recording the perceived direction of motion by human observers. To this end, we presented dual barber poles in conditions with various inter-component distances between the apertures and evaluated the degree to which the hemifield information was integrated by measuring the magnitude of the perceived barber pole illusion. Surprisingly, when the inter-component distance between the two apertures was short, the perceived direction of motion of the dual barber poles was similar to that of a single barber pole formed by the concatenation of the two component barber poles, indicating motion integration is achieved through a simple concatenation mechanism. We then presented dual barber poles in which the motion and contour properties of the two component barber poles differed to characterize the constraints underlying cross-hemifield integration. We found that integration is achieved only when phase, speed, wavelength, temporal frequency, and duty cycle are identical in the two barber poles, but can remain robust when the contrast of the two component barber poles differs substantially. We concluded that a motion stimulus presented in bilateral hemifields tends to be integrated to yield a global percept with a substantial tolerance for spatial distance and contrast difference.	[Huang, Li-Ting; Wong, Alice M. K.; Chen, Carl P. C.; Chang, Wei-Han; Cheng, Ju-Wen; Lin, Yu-Ru; Pei, Yu-Cheng] Chang Gung Mem Hosp Linkou, Dept Phys Med & Rehabil, Taoyuan, Taiwan; [Chen, Carl P. C.; Pei, Yu-Cheng] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Pei, Yu-Cheng] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Pei, YC (corresponding author), Chang Gung Mem Hosp Linkou, Dept Phys Med & Rehabil, Taoyuan, Taiwan.	yspeii@adm.cgmh.org.tw	Wong, Alice M. K./ABI-1000-2020	Wong, Alice M. K./0000-0003-3586-1292; Pei, Yu-Cheng/0000-0001-5986-0046	Chang Gung Memorial Hospital [CMRPG100-0536C]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The funding is Chang Gung Memorial Hospital grant CMRPG100-0536C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Anderson BL, 1999, VISION RES, V39, P1273, DOI 10.1016/S0042-6989(98)00240-5; Bertamini M, 2006, ACTA PSYCHOL, V123, P55, DOI 10.1016/j.actpsy.2006.04.006; Beutter BR, 1996, VISION RES, V36, P3061, DOI 10.1016/0042-6989(96)00064-8; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A. S., 1981, PERCEPTUAL ORG, P99; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; Caplovitz GP, 2006, VISION RES, V46, P2877, DOI 10.1016/j.visres.2006.02.026; Caplovitz GP, 2006, PERCEPTION, V35, P993, DOI 10.1068/p5568; CASTET E, 1993, VISION RES, V33, P1921, DOI 10.1016/0042-6989(93)90019-S; Castet E, 1999, VISION RES, V39, P915, DOI 10.1016/S0042-6989(98)00146-1; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FENNEMA CL, 1979, COMPUT VISION GRAPH, V9, P301, DOI 10.1016/0146-664X(79)90097-2; Fisher N, 2001, PERCEPTION, V30, P1321, DOI 10.1068/p3156; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Gori S, 2008, PERCEPTION, V37, P631, DOI 10.1068/p5770; Gori S, 2006, PERCEPTION, V35, P853, DOI 10.1068/p5531; Gori S, 2011, NEURAL NETWORKS, V24, P1082, DOI 10.1016/j.neunet.2011.06.017; Gori S, 2010, PERCEPTION, V39, P863, DOI 10.1068/p6678; Gori S, 2010, VISION RES, V50, P1194, DOI 10.1016/j.visres.2010.03.022; Gori S, 2008, ACTA PSYCHOL, V129, P399, DOI 10.1016/j.actpsy.2008.09.004; Guilford JP, 1929, AM J PSYCHOL, V44, P686; Gurnsey R, 2002, PERCEPTION, V31, P1275, DOI 10.1068/p3446; Gurnsey R, 2006, VISION RES, V46, P1823, DOI 10.1016/j.visres.2005.09.011; HILDRETH EC, 1987, ANNU REV NEUROSCI, V10, P477, DOI 10.1146/annurev.ne.10.030187.002401; Huang X, 2007, NEURON, V53, P761, DOI 10.1016/j.neuron.2007.01.032; Huang X, 2008, J NEUROSCI, V28, P13889, DOI 10.1523/JNEUROSCI.1946-08.2008; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; Kim SH, 2011, I-PERCEPTION, V2, P154, DOI 10.1068/i0434; KOOI FL, 1993, VISION RES, V33, P2347, DOI 10.1016/0042-6989(93)90112-A; KOVACS G, 1995, J NEUROSCI, V15, P1984, DOI 10.1523/JNEUROSCI.15-03-01984.1995; Kuriki I, 2008, J VISION, V8, DOI 10.1167/8.10.16; Liden L, 1998, VISION RES, V38, P3883, DOI 10.1016/S0042-6989(98)00083-2; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Michotte A., 1964, STUDIA PSYCHOL; NAKAYAMA K, 1988, VISION RES, V28, P739, DOI 10.1016/0042-6989(88)90052-1; NAKAYAMA K, 1988, VISION RES, V28, P747, DOI 10.1016/0042-6989(88)90053-3; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P818, DOI 10.1152/jn.1979.42.3.818; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Pinna B, 2000, VISION RES, V40, P2091, DOI 10.1016/S0042-6989(00)00072-9; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; ROSE D, 1979, VISION RES, V19, P533, DOI 10.1016/0042-6989(79)90138-X; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Ruzzoli M, 2011, NEUROPSYCHOLOGIA, V49, P3648, DOI 10.1016/j.neuropsychologia.2011.09.020; Sajda P, 2004, NEURAL NETWORKS, V17, P809, DOI 10.1016/j.neunet.2004.03.013; SHIFFRAR M, 1995, VISION RES, V35, P2137, DOI 10.1016/0042-6989(94)00299-1; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Singh M, 2005, P NATL ACAD SCI USA, V102, P939, DOI 10.1073/pnas.0408444102; Spillmann L, 2009, VISION RES, V49, P1507, DOI 10.1016/j.visres.2009.02.022; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Tommasi L, 1999, VISION RES, V39, P777, DOI 10.1016/S0042-6989(98)00132-1; Tse PU, 2007, BIOL CYBERN, V96, P1, DOI 10.1007/s00422-006-0135-z; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; Wertheimer M., 2012, PERCEIVED MOTION FIG, DOI 10.7551/mitpress/9222.003.0005; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; Yazdanbakhsh A, 2006, NAT NEUROSCI, V9, P697, DOI 10.1038/nn1693; Yazdanbakhsh A, 2008, NEUROSCI LETT, V438, P246, DOI 10.1016/j.neulet.2008.04.040; Yazdanbakhsh A, 2011, NEURAL NETWORKS, V24, P1093, DOI 10.1016/j.neunet.2011.06.016; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; Zhang NR, 2010, J NEUROSCI, V30, P6482, DOI 10.1523/JNEUROSCI.5168-09.2010	70	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74032	10.1371/journal.pone.0074032	http://dx.doi.org/10.1371/journal.pone.0074032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009764	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600078
J	Pogribna, U; Yu, XT; Burson, K; Zhou, YX; Lasky, RE; Narayana, PA; Parikh, NA				Pogribna, Ulana; Yu, Xintian; Burson, Katrina; Zhou, Yuxiang; Lasky, Robert E.; Narayana, Ponnada A.; Parikh, Nehal A.			Perinatal Clinical Antecedents of White Matter Microstructural Abnormalities on Diffusion Tensor Imaging in Extremely Preterm Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NEURODEVELOPMENTAL OUTCOMES; BREAST-MILK; BRAIN; BORN; CAFFEINE; COMMON; AGE	Objective: To identify perinatal clinical antecedents of white matter microstructural abnormalities in extremely preterm infants. Methods: A prospective cohort of extremely preterm infants (N = 86) and healthy term controls (N = 16) underwent diffusion tensor imaging (DTI) at term equivalent age. Region of interest-based measures of white matter microstructure - fractional anisotropy and mean diffusivity - were quantified in seven vulnerable cerebral regions and group differences assessed. In the preterm cohort, multivariable linear regression analyses were conducted to identify independent clinical factors associated with microstructural abnormalities. Results: Preterm infants had a mean (standard deviation) gestational age of 26.1 (1.7) weeks and birth weight of 824 (182) grams. Compared to term controls, the preterm cohort exhibited widespread microstructural abnormalities in 9 of 14 regional measures. Chorioamnionitis, necrotizing enterocolitis, white matter injury on cranial ultrasound, and increasing duration of mechanical ventilation were adversely correlated with regional microstructure. Conversely, antenatal steroids, female sex, longer duration of caffeine therapy, and greater duration of human milk use were independent favorable factors. White matter injury on cranial ultrasound was associated with a five weeks or greater delayed maturation of the corpus callosum; every additional 10 days of human milk use were associated with a three weeks or greater advanced maturation of the corpus callosum. Conclusions: Diffusion tensor imaging is sensitive in detecting the widespread cerebral delayed maturation and/or damage increasingly observed in extremely preterm infants. In our cohort, it also aided identification of several previously known or suspected perinatal clinical antecedents of brain injury, aberrant development, and neurodevelopmental impairments.	[Pogribna, Ulana; Yu, Xintian; Burson, Katrina; Lasky, Robert E.; Parikh, Nehal A.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Neonatol, Houston, TX 77030 USA; [Zhou, Yuxiang; Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Parikh, NA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Neonatol, Houston, TX 77030 USA.	Nehal.Parikh@NationwideChildrens.org	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	National Center for Research Resources (NCRR) (University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences) [UL1 RR024148]; NCRR/Eunice Shriver National Institute of Child Health & Human Development (Best Pharmaceutical for Children Act) [UL1 RR024148-04S3]; NCRR/NIH [S10 RR19186]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019186, UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR) (University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences); NCRR/Eunice Shriver National Institute of Child Health & Human Development (Best Pharmaceutical for Children Act); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Financial Support came from: 1. National Center for Research Resources (NCRR) grant UL1 RR024148 (University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences) 2. NCRR/Eunice Shriver National Institute of Child Health & Human Development grant UL1 RR024148-04S3 (Best Pharmaceutical for Children Act) to Nehal A. Parikh. 3. The 3T Scanner was partially funded by NCRR/NIH through a grant to Ponnada A. Narayana (Grant #S10 RR19186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Anjari M, 2009, PEDIATRICS, V124, P268, DOI 10.1542/peds.2008-1294; Arzoumanian Y, 2003, AM J NEURORADIOL, V24, P1646; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; de Vries LS, 2009, ANN NEUROL, V66, P127, DOI 10.1002/ana.21761; Doyle LW, 2010, ANN NEUROL, V68, P734, DOI 10.1002/ana.22098; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Hart AR, 2010, PEDIATR RADIOL, V40, P1390, DOI 10.1007/s00247-010-1633-7; Himpens E, 2010, EUR J PEDIATR, V169, P1213, DOI 10.1007/s00431-010-1207-6; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Iwata S, 2007, INT J DEV NEUROSCI, V25, P523, DOI 10.1016/j.ijdevneu.2007.09.009; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Leviton A, 2010, ACTA PAEDIATR, V99, P1795, DOI 10.1111/j.1651-2227.2010.01973.x; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Rees CM, 2007, ARCH DIS CHILD-FETAL, V92, pF193, DOI 10.1136/adc.2006.099929; Rose J, 2007, DEV MED CHILD NEUROL, V49, P745, DOI 10.1111/j.1469-8749.2007.00745.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Thompson DK, 2012, NEUROIMAGE, V59, P3571, DOI 10.1016/j.neuroimage.2011.11.057; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176	34	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72974	10.1371/journal.pone.0072974	http://dx.doi.org/10.1371/journal.pone.0072974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009724	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600049
J	Silva, TLAE; Vasconcellos, LRC; Lopes, AH; Souto-Padron, T				Silva, Thiago L. Alves e; Vasconcellos, Luiz R. C.; Lopes, Angela H.; Souto-Padron, Thais			The Immune Response of Hemocytes of the Insect Oncopeltus fasciatus against the Flagellate Phytomonas serpens	PLOS ONE			English	Article							TRYPANOSOMA-RANGELI; RHODNIUS-PROLIXUS; SALIVARY-GLANDS; CELL; PHAGOCYTOSIS; INFECTIONS; TOMATO; PLANTS; HOSTS	The genus Phytomonas includes parasites that are etiological agents of important plant diseases, especially in Central and South America. These parasites are transmitted to plants via the bite of an infected phytophagous hemipteran. Despite the economic impact of these parasites, many basic questions regarding the genus Phytomonas remain unanswered, such as the mechanism by which the parasites cope with the immune response of the insect vector. In this report, using a model of systemic infection, we describe the function of Oncopeltus fasciatus hemocytes in the immune response towards the tomato parasite Phytomonas serpens. Hemocytes respond to infection by trapping parasites in nodular structures and phagocytizing the parasites. In electron microscopy of hemocytes, parasites were located inside vacuoles, which appear fused with lysosomes. The parasites reached the O. fasciatus salivary glands at least six hours post-infection. After 72 hours post-infection, many parasites were attached to the salivary gland outer surface. Thus, the cellular responses did not kill all the parasites.	[Silva, Thiago L. Alves e; Vasconcellos, Luiz R. C.; Lopes, Angela H.; Souto-Padron, Thais] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Lopes, AH (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Bloco 1, Rio De Janeiro, RJ, Brazil.	angela.lopes@micro.ufrj.br; souto.padron@micro.ufrj.br	LA Silva, Thiago/L-7699-2016; Lopes, Angela/AAX-2501-2021	LA Silva, Thiago/0000-0002-8520-5405; Hampshire Lopes, Angela/0000-0003-0660-4596; /0000-0002-3877-7013	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	This work was supported by grants from the Brazilian Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Groberg SM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.016014; Blandin SA, 2007, IMMUNOL REV, V219, P8, DOI 10.1111/j.1600-065X.2007.00553.x; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; de Oliveira MA, 2003, PARASITOL INT, V52, P299, DOI 10.1016/j.parint.2003.08.002; Dias FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048170; DORN A, 1978, CELL TISSUE RES, V187, P479; Dushay MS, 2009, CELL MOL LIFE SCI, V66, P2643, DOI 10.1007/s00018-009-0036-0; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Elias CGR, 2008, EXP PARASITOL, V120, P343, DOI 10.1016/j.exppara.2008.08.011; Eslin P, 2009, ADV PARASIT, V70, P189, DOI 10.1016/S0065-308X(09)70007-7; FEIR D, 1964, NATURE, V202, P1136, DOI 10.1038/2021136a0; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Ferreira LL, 2010, J INVERTEBR PATHOL, V105, P91, DOI 10.1016/j.jip.2010.05.013; FREYMULLER E, 1990, J PROTOZOOL, V37, P225, DOI 10.1111/j.1550-7408.1990.tb01132.x; Gazos-Lopes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047285; GIBBS AJ, 1957, PARASITOLOGY, V47, P297, DOI 10.1017/S0031182000021983; HANSON WL, 1963, J PROTOZOOL, V10, P233, DOI 10.1111/j.1550-7408.1963.tb01668.x; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ishii K, 2012, J BIOL CHEM, V287, P36582, DOI 10.1074/jbc.M112.399667; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lopes Angela H., 2010, Open Parasitology Journal, V4, P30; Marois E, 2011, CURR OPIN MICROBIOL, V14, P429, DOI 10.1016/j.mib.2011.07.016; MCGHEE RB, 1964, J PROTOZOOL, V11, P555, DOI 10.1111/j.1550-7408.1964.tb01798.x; Meirelles RMS, 2005, PARASITOL RES, V97, P259, DOI 10.1007/s00436-005-1433-4; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Schmidt O, 2001, BIOESSAYS, V23, P344, DOI 10.1002/bies.1049; Scully LR, 2006, FEMS MICROBIOL LETT, V263, P1, DOI 10.1111/j.1574-6968.2006.00388.x; TAKLE GB, 1988, J INVERTEBR PATHOL, V51, P64, DOI 10.1016/0022-2011(88)90089-4; Tobie EJ, 1970, J INVERTEBR PATHOL, V16, P118; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711	35	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72076	10.1371/journal.pone.0072076	http://dx.doi.org/10.1371/journal.pone.0072076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015207	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800027
J	Conrad, V; Kleiner, M; Bartels, A; O'Brien, JH; Bulthoff, HH; Noppeney, U				Conrad, Verena; Kleiner, Mario; Bartels, Andreas; O'Brien, Jessica Hartcher; Buelthoff, Heinrich H.; Noppeney, Uta			Naturalistic Stimulus Structure Determines the Integration of Audiovisual Looming Signals in Binocular Rivalry	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; STATISTICS; PERCEPTION; BIAS; PRINCIPLES; COHERENCE; RESPONSES; FEATURES; SOUNDS; IMAGES	Rapid integration of biologically relevant information is crucial for the survival of an organism. Most prominently, humans should be biased to attend and respond to looming stimuli that signal approaching danger (e. g. predator) and hence require rapid action. This psychophysics study used binocular rivalry to investigate the perceptual advantage of looming (relative to receding) visual signals (i.e. looming bias) and how this bias can be influenced by concurrent auditory looming/receding stimuli and the statistical structure of the auditory and visual signals. Subjects were dichoptically presented with looming/receding visual stimuli that were paired with looming or receding sounds. The visual signals conformed to two different statistical structures: (1) a 'simple' random-dot kinematogram showing a starfield and (2) a "naturalistic" visual Shepard stimulus. Likewise, the looming/receding sound was (1) a simple amplitude-and frequency-modulated (AM-FM) tone or (2) a complex Shepard tone. Our results show that the perceptual looming bias (i.e. the increase in dominance times for looming versus receding percepts) is amplified by looming sounds, yet reduced and even converted into a receding bias by receding sounds. Moreover, the influence of looming/receding sounds on the visual looming bias depends on the statistical structure of both the visual and auditory signals. It is enhanced when audiovisual signals are Shepard stimuli. In conclusion, visual perception prioritizes processing of biologically significant looming stimuli especially when paired with looming auditory signals. Critically, these audiovisual interactions are amplified for statistically complex signals that are more naturalistic and known to engage neural processing at multiple levels of the cortical hierarchy.	[Conrad, Verena; Kleiner, Mario; Bartels, Andreas; O'Brien, Jessica Hartcher; Buelthoff, Heinrich H.; Noppeney, Uta] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Bartels, Andreas] Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Noppeney, Uta] Univ Birmingham, Computat Neurosci & Cognit Robot Ctr, Birmingham, W Midlands, England	Max Planck Society; Eberhard Karls University of Tubingen; Korea University; University of Birmingham	Conrad, V (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	verena.conrad@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019; Bartels, Andreas/A-9446-2014	Bülthoff, Heinrich H/0000-0003-2568-0607; Bartels, Andreas/0000-0002-4939-7817; Noppeney, Uta/0000-0002-7697-2290	Max Planck Society	Max Planck Society(Max Planck Society)	This project was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Bach DR, 2009, INT J PSYCHOPHYSIOL, V74, P28, DOI 10.1016/j.ijpsycho.2009.06.004; Baker DH, 2009, P NATL ACAD SCI USA, V106, P5436, DOI 10.1073/pnas.0812860106; Berger D, 2007, SENSOR FUSION PERCEP, P273; Berger DR, 2003, SKETCHES APPL SIGGRA, P1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Guski R., 1992, ECOL PSYCHOL, V4, P189, DOI DOI 10.1207/S15326969EC00403_4; Kayser C, 2012, NEURON, V73, P627, DOI 10.1016/j.neuron.2012.02.001; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; Kleiner M, 2007, PERCEPTION, V36, P14; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Lee H, 2011, J NEUROSCI, V31, P11338, DOI 10.1523/JNEUROSCI.6510-10.2011; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Lewkowicz DJ, 2008, CHILD DEV, V79, P1538, DOI 10.1111/j.1467-8624.2008.01204.x; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Munhall KG, 2009, CURR BIOL, V19, P735, DOI 10.1016/j.cub.2009.03.019; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Noppeney U, 2010, J NEUROSCI, V30, P7434, DOI 10.1523/JNEUROSCI.0455-10.2010; Parise CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005664; Parker AL., 2006, J VISION, V6, P855, DOI [DOI 10.1167/6.6.855, 10.1167/6.6.855]; Parker A, 2007, VISION RES, V47, P2661, DOI 10.1016/j.visres.2007.06.019; ROSENBLUM LD, 1987, PERCEPTION, V16, P175, DOI 10.1068/p160175; Sadaghiani S, 2009, J NEUROSCI, V29, P6490, DOI 10.1523/JNEUROSCI.5437-08.2009; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Tolhurst DJ, 1992, OPHTHAL PHYSL OPT, P12229; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Tuomainen J, 2005, COGNITION, V96, pB13, DOI 10.1016/j.cognition.2004.10.004; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Watson TL, 2004, CURR BIOL, V14, P1670, DOI 10.1016/j.cub.2004.08.064; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010	52	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70710	10.1371/journal.pone.0070710	http://dx.doi.org/10.1371/journal.pone.0070710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24015176	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200007
J	Guo, YF; Guo, F; Wei, CY; Qiu, JX; Liu, Y; Fang, Y; Gao, JW				Guo, Yifeng; Guo, Fang; Wei, Chongyang; Qiu, Jianxin; Liu, Yong; Fang, Yu; Gao, Junwei			CTLA4 Gene Polymorphisms Influence the Incidence of Infection after Renal Transplantation in Chinese Recipients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; URINARY-TRACT-INFECTION; KIDNEY-TRANSPLANTATION; ACUTE REJECTION; LIVER-TRANSPLANTATION; ANTIGEN-4 INFLUENCE; PROMOTER REGION; ASSOCIATION; AUTOIMMUNE	Background: Immunosuppressive therapy is usually administered following renal transplantation to protect the graft from rejection. However, this often causes complications such as infections to occur. Single nucleotide polymorphisms (SNPs) within the CTLA4 gene, such as -1772T/C (rs733618), + 49A/G (rs231775) and + 6230 G/A (rs3087243), can affect graft rejection and the long-term clinical outcome of organ transplantation. The role of CTLA4 SNPs in T cell-mediated immunity in renal transplantation and association with infection after transplantation is unknown. Methods: In this study, the risk of infection according to CTLA4 SNPs was investigated in 304 patients who received kidney graft transplants between 2008 and 2012. Results: The frequency of the rs4553808 GG genotype was significantly higher in recipients with viral infection (14.89%) than in those without infections (3.50%) (Bonferroni-adjusted p = 0.005). A significant difference (p = 0.001) in patients with the rs4553808 GG genotype from those with the AA+AG genotypes was found in the viral cohort using the log-rank test. A significant association was found between the rs4553808 genotype and onset of viral infection in transplant recipients (p = 0.001). The frequencies of the CGTAG and CGCAG haplotypes were significantly higher in the viral infection group (9.6% and 5.3%) than in the non-viral infection group (3.8% and 1.4%) (p = 0.0149 and p = 0.0111). No association between any CTLA4 SNP and bacterial infection was found. Multivariate analyses revealed that one risk factor, the use of antibody induction therapy (p = 0.007), was associated with bacterial infection, and two risk factors, antibody use (p = 0.015) and recipient rs4553808 genotype (p = 0.001), were associated with viral infection. Conclusions: The rs4553808 GG genotype may be a risk factor for viral infection in kidney transplantation. The CTLA4 haplotypes CGTAG and CGCAG were partially associated with the development of viral infection in Chinese kidney transplant recipients.	[Guo, Yifeng; Qiu, Jianxin; Liu, Yong; Fang, Yu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Urol Ctr, Shanghai 200030, Peoples R China; [Guo, Yifeng; Qiu, Jianxin; Liu, Yong; Fang, Yu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Organ Transplantat Ctr, Shanghai 200030, Peoples R China; [Guo, Fang; Wei, Chongyang] Chinese Acad Sci, Key Lab Syst Biol, Lab Tumor Targeted Therapy, Shanghai, Peoples R China; [Gao, Junwei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Guo, YF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Urol Ctr, Shanghai 200030, Peoples R China.	gyfslm@gmail.com; guof@sari.ac.cn	Qiu, Jason/B-3502-2012	Qiu, Jason/0000-0003-1067-3199	National Natural Science Foundation of China [30971137, 31171308]; Chinese Postdoctoral Science Foundation [2003033271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The project was supported by the National Natural Science Foundation of China (30971137 and 31171308) and grants from the Chinese Postdoctoral Science Foundation (2003033271). The funder had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Baek CH, 2012, NEPHRON EXTRA, V2, P66, DOI 10.1159/000337339; Baniasadi V, 2006, TISSUE ANTIGENS, V67, P383, DOI 10.1111/j.1399-0039.2006.00595.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouqbis L, 2003, GENES IMMUN, V4, P132, DOI 10.1038/sj.gene.6363933; Chistiakov DA, 2006, CLIN IMMUNOL, V118, P233, DOI 10.1016/j.clim.2005.09.017; de Reuver P, 2003, AM J TRANSPLANT, V3, P1587, DOI 10.1046/j.1600-6135.2003.00261.x; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Duan SQ, 2011, MOL BIOL REP, V38, P5125, DOI 10.1007/s11033-010-0660-7; Erfani N, 2006, CANCER GENET CYTOGEN, V165, P114, DOI 10.1016/j.cancergencyto.2005.07.020; Fernandez-Mestre M, 2009, HUM IMMUNOL, V70, P532, DOI 10.1016/j.humimm.2009.03.016; Gao JW, 2012, TRANSPL IMMUNOL, V26, P207, DOI 10.1016/j.trim.2012.02.005; Gorgi Y, 2006, TRANSPLANT P, V38, P2303, DOI 10.1016/j.transproceed.2006.06.132; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hoffmann TW, 2010, J MED GENET, V47, P54, DOI 10.1136/jmg.2009.068841; Hudson LL, 2002, HUM GENET, V111, P452, DOI 10.1007/s00439-002-0807-2; Khalaf AT, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/167395; Kim HJ, 2010, TRANSPL IMMUNOL, V24, P40, DOI 10.1016/j.trim.2010.10.001; Kimkong I, 2011, ASIAN PAC J ALLERGY, V29, P229; Kupeli E, 2011, TRANSPL P, V43, P551, DOI 10.1016/j.transproceed.2011.01.063; Kusztal M, 2010, TRANSPL IMMUNOL, V23, P121, DOI 10.1016/j.trim.2010.05.002; Lee CS, 2003, CLIN RHEUMATOL, V22, P221, DOI 10.1007/s10067-003-0720-7; Mourad G, 2012, TRANSPL P, V44, P2821, DOI 10.1016/j.transproceed.2012.09.088; Nishi SPE, 2010, INFECT DIS CLIN N AM, V24, P541, DOI 10.1016/j.idc.2010.04.005; Ohmann EL, 2010, J HEART LUNG TRANSPL, V29, P1342, DOI 10.1016/j.healun.2010.07.013; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Saemann M, 2008, EUR J CLIN INVEST, V38, P58, DOI 10.1111/j.1365-2362.2008.02014.x; Schott E, 2007, EUR J GASTROEN HEPAT, V19, P947, DOI 10.1097/MEG.0b013e3282efa240; Tapirdamaz O, 2006, GUT, V55, P863, DOI 10.1136/gut.2005.080937; Tse KC, 2008, TRANSPL INFECT DIS, V10, P44, DOI 10.1111/j.1399-3062.2007.00231.x; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wallden J, 2008, SCAND J IMMUNOL, V68, P345, DOI 10.1111/j.1365-3083.2008.02144.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu J, 2009, CLIN CHIM ACTA, V403, P229, DOI 10.1016/j.cca.2009.03.037	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70824	10.1371/journal.pone.0070824	http://dx.doi.org/10.1371/journal.pone.0070824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015180	gold, Green Published, Green Submitted			2022-12-25	WOS:000323815200010
J	Chu, WC; Lee, YM; Sun, YH				Chu, Wei-Chen; Lee, Yuan-Ming; Sun, Yi Henry			FGF /FGFR Signal Induces Trachea Extension in the Drosophila Visual System	PLOS ONE			English	Article							CELL-MIGRATION; BRANCHING MORPHOGENESIS; RECEPTOR HOMOLOG; COMPOUND EYE; PROTEIN; INSIGHTS; PHOTORECEPTORS; SPECIFICATION; LOCALIZATION; LEPIDOPTERA	The Drosophila compound eye is a large sensory organ that places a high demand on oxygen supplied by the tracheal system. Although the development and function of the Drosophila visual system has been extensively studied, the development and contribution of its tracheal system has not been systematically examined. To address this issue, we studied the tracheal patterns and developmental process in the Drosophila visual system. We found that the retinal tracheae are derived from air sacs in the head, and the ingrowth of retinal trachea begin at mid-pupal stage. The tracheal development has three stages. First, the air sacs form near the optic lobe in 42-47% of pupal development (pd). Second, in 47-52% pd, air sacs extend branches along the base of the retina following a posterior-to-anterior direction and further form the tracheal network under the fenestrated membrane (TNUFM). Third, the TNUFM extend fine branches into the retina following a proximal-to-distal direction after 60% pd. Furthermore, we found that the trachea extension in both retina and TNUFM are dependent on the FGF(Bnl)/FGFR(Btl) signaling. Our results also provided strong evidence that the photoreceptors are the source of the Bnl ligand to guide the trachea ingrowth. Our work is the first systematic study of the tracheal development in the visual system, and also the first study demonstrating the interactions of two well-studied systems: the eye and trachea.	[Chu, Wei-Chen; Sun, Yi Henry] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chu, Wei-Chen; Lee, Yuan-Ming; Sun, Yi Henry] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lee, Yuan-Ming; Sun, Yi Henry] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lee, Yuan-Ming; Sun, Yi Henry] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Sun, YH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	mbyhsun@gate.sinica.edu.tw	Sun, Y. Henry/ABC-4614-2021; Sun, Y. Henry/AAZ-7966-2021; Chu, Wei-Chen/D-1392-2017	Sun, Y. Henry/0000-0001-8279-5270; Chu, Wei-Chen/0000-0002-3447-9043	National Science Council of the Republic of China [NSC 96-2321-B-001-002, 97-2321-B-001-002, 98-2321-B-001-034, 99-2321-B-001-016, 100-2321-B-001-012]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by grants to Y.H.S. [NSC 96-2321-B-001-002, 97-2321-B-001-002, 98-2321-B-001-034, 99-2321-B-001-016, 100-2321-B-001-012] from the National Science Council of the Republic of China (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; BAUMANN F, 1973, NATURE-NEW BIOL, V244, P146, DOI 10.1038/newbio244146b0; Baumann O, 2004, DEV BIOL, V269, P519, DOI 10.1016/j.ydbio.2004.01.047; CARLSON SD, 1979, ANNU REV ENTOMOL, V24, P379, DOI 10.1146/annurev.en.24.010179.002115; Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; CHI C, 1975, CELL TISSUE RES, V159, P379, DOI 10.1007/BF00221784; COLES JA, 1981, J EXP BIOL, V95, P75; Cordero JB, 2010, DEV DYNAM, V239, P875, DOI 10.1002/dvdy.22235; DEMEREC M, 1994, BIOL DROSOPHILA, P467, DOI DOI 10.1002/BIES.10041.PUBMED:11835274; Dossenbach C, 2001, DEVELOPMENT, V128, P4563; Fahl E, 2008, ADV EXP MED BIOL, V613, P171, DOI 10.1007/978-0-387-74904-4_19; Fan SS, 2004, J BIOMED SCI, V11, P362, DOI 10.1159/000077105; Frankfort BJ, 2004, GENESIS, V38, P182, DOI 10.1002/gene.20018; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Guha A, 2009, DEV BIOL, V335, P317, DOI 10.1016/j.ydbio.2009.09.005; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; Kim JY, 2012, GENES BRAIN BEHAV, V11, P177, DOI 10.1111/j.1601-183X.2011.00743.x; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Lau TF, 2007, EUR J ENTOMOL, V104, P459, DOI 10.14411/eje.2007.066; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lehmann FO, 2005, J EXP BIOL, V208, P3645, DOI 10.1242/jeb.01788; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Maruyama R, 2012, DEV DYNAM, V241, P119, DOI 10.1002/dvdy.22775; McFarland RA, 1940, J GEN PHYSIOL, V24, P69, DOI 10.1085/jgp.24.1.69; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Mukherjee T, 2012, G3-GENES GENOM GENET, V2, P23, DOI 10.1534/g3.111.001495; Nagaraj R, 2007, DEVELOPMENT, V134, P825, DOI 10.1242/dev.02788; NARDI JB, 1984, ROUX ARCH DEV BIOL, V194, P1, DOI 10.1007/BF00848947; PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309; REED CT, 1975, ROUX ARCH DEV BIOL, V178, P285, DOI 10.1007/BF00848064; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; RIBI WA, 1979, J COMP PHYSIOL, V132, P1, DOI 10.1007/BF00617727; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schmitz A, 2001, J EXP BIOL, V204, P4321; Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Stavenga DG, 1995, PROG RETIN EYE RES, V15, P231, DOI 10.1016/1350-9462(95)00011-9; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; Wakakuwa M, 2004, J EXP BIOL, V207, P1479, DOI 10.1242/jeb.00913; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Yack JE, 2007, ARTHROPOD STRUCT DEV, V36, P11, DOI 10.1016/j.asd.2006.07.001; Yan D, 2007, DEV BIOL, V312, P203, DOI 10.1016/j.ydbio.2007.09.015; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73878	10.1371/journal.pone.0073878	http://dx.doi.org/10.1371/journal.pone.0073878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991208	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800111
J	Spalinger, MR; Lang, S; Vavricka, SR; Fried, M; Rogler, G; Scharl, M				Spalinger, Marianne R.; Lang, Silvia; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael			Protein Tyrosine Phosphatase Non-Receptor Type 22 Modulates NOD2-Induced Cytokine Release and Autophagy	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; NOD2; DISEASE; SUSCEPTIBILITY; ASSOCIATION; PROLIFERATION; MACROPHAGES; EXPRESSION; INDUCTION	Background: Variations within the gene locus encoding protein tyrosine phosphatase non-receptor type 22 (PTPN22) are associated with the risk to develop inflammatory bowel disease (IBD). PTPN22 is involved in the regulation of T- and B-cell receptor signaling, but although it is highly expressed in innate immune cells, its function in other signaling pathways is less clear. Here, we study whether loss of PTPN22 controls muramyl-dipeptide (MDP)-induced signaling and effects in immune cells. Material & Methods: Stable knockdown of PTPN22 was induced in THP-1 cells by shRNA transduction prior to stimulation with the NOD2 ligand MDP. Cells were analyzed for signaling protein activation and mRNA expression by Western blot and quantitative PCR; cytokine secretion was assessed by ELISA, autophagosome induction by Western blot and immunofluorescence staining. Bone marrow derived dendritic cells (BMDC) were obtained from PTPN22 knockout mice or wild-type animals. Results: MDP-treatment induced PTPN22 expression and activity in human and mouse cells. Knockdown of PTPN22 enhanced MDP-induced activation of mitogen-activated protein kinase (MAPK)-isoforms p38 and c-Jun N-terminal kinase as well as canonical NF-kappa B signaling molecules in THP-1 cells and BMDC derived from PTPN22 knockout mice. Loss of PTPN22 enhanced mRNA levels and secretion of interleukin (IL)-6, IL-8 and TNF in THP-1 cells and PTPN22 knockout BMDC. Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells. Conclusions: Our data demonstrate that PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products, what might explain the association of PTPN22 variants with IBD pathogenesis.	[Spalinger, Marianne R.; Lang, Silvia; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Vavricka, Stephan R.] Stadtspital Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Triemli Hospital	Scharl, M (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	michael.scharl@usz.ch	Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Scharl, Michael/0000-0002-6729-1469	Fonds zur Forderung des akademischen Nachwuchses of the Zurcher Universitatsverein; Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation [314730-146204, 310030-120312, 320000-114009/1]; Swiss IBD Cohort [3347CO-108792]; Zurich Center for Integrative Human Physiology of the University of Zurich	Fonds zur Forderung des akademischen Nachwuchses of the Zurcher Universitatsverein; Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort; Zurich Center for Integrative Human Physiology of the University of Zurich	This research was supported by a grant from the Fonds zur Forderung des akademischen Nachwuchses of the Zurcher Universitatsverein to MS, a research grant from the Swiss Philanthropy Foundation to MS and GR, a research credit from the University of Zurich to MS, research grants from the Swiss National Science Foundation to MS (Grant No. 314730-146204), GR (Grant No. 310030-120312), SRV (Grant No. 320000-114009/1) and the Swiss IBD Cohort (Grant No. 3347CO-108792) and by the Zurich Center for Integrative Human Physiology of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Cao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042783; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Diaz-Gallo LM, 2011, INFLAMM BOWEL DIS, V17, P2287, DOI 10.1002/ibd.21630; Douroudis K, 2010, TISSUE ANTIGENS, V76, P315, DOI 10.1111/j.1399-0039.2010.01512.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jin Y, 2012, J INTERFERON CYTOKIN; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; MAHIDA YR, 1991, GUT, V32, P1531, DOI 10.1136/gut.32.12.1531; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olsen T, 2011, CYTOKINE, V56, P633, DOI 10.1016/j.cyto.2011.08.036; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Ren S, 2013, INT J BIOCHEM CELL B, V45, P335, DOI 10.1016/j.biocel.2012.11.012; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; Scharl M, 2011, INFLAMM BOWEL DIS; Spalinger MR, 2013, GASTROENTEROLOGY, V144, P978, DOI 10.1053/j.gastro.2013.01.048; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383	39	31	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72384	10.1371/journal.pone.0072384	http://dx.doi.org/10.1371/journal.pone.0072384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991106	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000324228800070
J	Sylvester, A; MacEachern, L; Booth, V; Morrow, MR				Sylvester, Alexander; MacEachern, Lauren; Booth, Valerie; Morrow, Michael R.			Interaction of the C-Terminal Peptide of Pulmonary Surfactant Protein B (SP-B) with a Bicellar Lipid Mixture Containing Anionic Lipid	PLOS ONE			English	Article							FAST-TUMBLING BICELLES; SOLID-STATE H-2; MAGNETIC-RESONANCE; PHOSPHOLIPID BICELLES; SYNTHETIC PEPTIDES; PHOSPHORUS NMR; MINI-B; LUNG; MEMBRANES; DYNAMICS	The hydrophobic lung surfactant SP-B is essential for respiration. SP-B promotes spreading and adsorption of surfactant at the alveolar air-water interface and may facilitate connections between the surface layer and underlying lamellar reservoirs of surfactant material. SP-B63-78 is a cationic and amphipathic helical peptide containing the C-terminal helix of SP-B. H-2 NMR has been used to examine the effect of SP-B63-78 on the phase behavior and dynamics of bicellar lipid dispersions containing the longer chain phospholipids DMPC-d(54) and DMPG and the shorter chain lipid DHPC mixed with a 3:1:1 molar ratio. Below the gel-to-liquid crystal phase transition temperature of the longer chain components, bicellar mixtures form small, rapidly reorienting disk-like particles with shorter chain lipid components predominantly found around the highly curved particle edges. With increasing temperature, the particles coalesce into larger magnetically-oriented structures and then into more extended lamellar phases. The susceptibility of bicellar particles to coalescence and large scale reorganization makes them an interesting platform in which to study peptide-induced interactions between lipid assemblies. SP-B63-78 is found to lower the temperature at which the orientable phase transforms to the more extended lamellar phase. The peptide also changes the spectrum of motions contributing to quadrupole echo decay in the lamellar phase. The way in which the peptide alters interactions between bilayered micelle structures may provide some insight into some aspects of the role of full-length SP-B in maintaining a functional surfactant layer in lungs.	[Sylvester, Alexander; MacEachern, Lauren; Booth, Valerie; Morrow, Michael R.] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Sylvester, Alexander; Booth, Valerie] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Morrow, MR (corresponding author), Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada.	mmorrow@mun.ca	Booth, Valerie/AAH-5932-2019	Booth, Valerie/0000-0001-9342-9217	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) Operating Grant to Valerie Booth and a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) Discovery Grant to Michael Morrow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2006, LANGMUIR, V22, P2447, DOI 10.1021/la053177l; Andersson A, 2005, LANGMUIR, V21, P7702, DOI 10.1021/la0513003; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; BLOOM M, 1987, BIOCHEMISTRY-US, V26, P2101, DOI 10.1021/bi00382a007; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; Booth V, 2004, BIOCHEMISTRY-US, V43, P15187, DOI 10.1021/bi0481895; Chavarha M, 2012, LANGMUIR, V28, P16596, DOI 10.1021/la3025364; Chavarha M, 2010, BIOPHYS J, V98, P1549, DOI 10.1016/j.bpj.2009.12.4302; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; CLEMENTS JA, 1957, P SOC EXP BIOL MED, V95, P170; Crouch EC, 1998, BBA-MOL BASIS DIS, V1408, P278, DOI 10.1016/S0925-4439(98)00073-8; Crowell KJ, 1999, BBA-BIOMEMBRANES, V1416, P21, DOI 10.1016/S0005-2736(98)00206-5; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Eaton J.W., 2002, GNU OCTAVE MANUAL; Flynn A, 2012, LANGMUIR, V28, P2782, DOI 10.1021/la204111z; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Harroun TA, 2005, LANGMUIR, V21, P5356, DOI 10.1021/la050018t; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Hayley M, 2006, BIOPHYS J, V91, P4555, DOI 10.1529/biophysj.106.089979; HILDEBRAN JN, 1979, J APPL PHYSIOL, V47, P604, DOI 10.1152/jappl.1979.47.3.604; JOHANSSON J, 1991, BIOCHEMISTRY-US, V30, P6917, DOI 10.1021/bi00242a015; Johansson J, 1998, BBA-MOL BASIS DIS, V1408, P161, DOI 10.1016/S0925-4439(98)00065-9; Kang JH, 1996, BIOCHEM MOL BIOL INT, V40, P617; Katsaras J, 2005, NATURWISSENSCHAFTEN, V92, P355, DOI 10.1007/s00114-005-0641-1; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kurutz JW, 2002, BIOCHEMISTRY-US, V41, P9627, DOI 10.1021/bi016077x; LAFLEUR M, 1989, BIOPHYS J, V56, P1037, DOI 10.1016/S0006-3495(89)82749-3; Lang CJ, 2005, AM J PHYSIOL-REG I, V289, pR1426, DOI 10.1152/ajpregu.00496.2004; Liu SY, 2008, RAPID COMMUN MASS SP, V22, P197, DOI 10.1002/rcm.3345; Luchette PA, 2001, BBA-BIOMEMBRANES, V1513, P83, DOI 10.1016/S0005-2736(01)00358-3; MacEachern L, 2013, LANGMUIR, V29, P3688, DOI 10.1021/la305136q; Marcotte I, 2003, BIOPHYS J, V85, P328, DOI 10.1016/S0006-3495(03)74477-4; Marinov R, 1996, EUR BIOPHYS J BIOPHY, V24, P423, DOI 10.1007/BF00576714; McCormack FX, 1998, BBA-MOL BASIS DIS, V1408, P109, DOI 10.1016/S0925-4439(98)00062-3; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Nieh MP, 2004, MACROMOL SYMP, V219, P135, DOI 10.1002/masy.200550112; Nieh MP, 2004, LANGMUIR, V20, P7893, DOI 10.1021/la048641l; Nieh MP, 2003, LANGMUIR, V19, P6936, DOI 10.1021/la034549y; Nieh MP, 2002, BIOPHYS J, V82, P2487, DOI 10.1016/S0006-3495(02)75591-4; Nieh MP, 2001, LANGMUIR, V17, P2629, DOI 10.1021/la001567w; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Palleboina D, 2012, EUR BIOPHYS J BIOPHY, V41, P755, DOI 10.1007/s00249-012-0850-4; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Perez-Gil J, 2002, BIOL NEONATE, V81, P6, DOI 10.1159/000056765; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Possmayer F, 2010, RESP PHYSIOL NEUROBI, V173, pS55, DOI 10.1016/j.resp.2010.02.014; Postle AD, 2001, COMP BIOCHEM PHYS A, V129, P65, DOI 10.1016/S1095-6433(01)00306-3; PROSSER RS, 1991, BIOCHEMISTRY-US, V30, P4687, DOI 10.1021/bi00233a008; REVAK SD, 1991, PEDIATR RES, V29, P460, DOI 10.1203/00006450-199105010-00010; Rugonyi S, 2008, RESP PHYSIOL NEUROBI, V163, P244, DOI 10.1016/j.resp.2008.05.018; Sarker M, 2007, BIOCHEMISTRY-US, V46, P11047, DOI 10.1021/bi7011756; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; Soong R, 2008, LANGMUIR, V24, P518, DOI 10.1021/la7022264; Soong R, 2009, BIOPHYS J, V97, P796, DOI 10.1016/j.bpj.2009.05.034; Sternin E, 2001, LANGMUIR, V17, P2610, DOI 10.1021/la001199w; Struppe J, 1998, BIOCHEMISTRY-US, V37, P15523, DOI 10.1021/bi981326b; Struppe J, 2000, BIOPHYS J, V78, P281, DOI 10.1016/S0006-3495(00)76591-X; Triba MN, 2005, BIOPHYS J, V88, P1887, DOI 10.1529/biophysj.104.055061; Triba MN, 2006, BIOPHYS J, V91, P1357, DOI 10.1529/biophysj.106.085118; Uddin MN, 2010, LANGMUIR, V26, P12104, DOI 10.1021/la1014362; URBINA JA, 1995, BBA-BIOMEMBRANES, V1238, P163, DOI 10.1016/0005-2736(95)00117-L; van Dam L, 2004, BBA-BIOMEMBRANES, V1664, P241, DOI 10.1016/j.bbamem.2004.06.005; Veldhuizen EJA, 2000, BIOPHYS J, V79, P377, DOI 10.1016/S0006-3495(00)76299-0; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; Walther FJ, 2002, EXP LUNG RES, V28, P623, DOI 10.1080/01902140260426733; Walther FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008672; Wang H, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.060902; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Yang TC, 2009, BIOPHYS J, V96, P3762, DOI 10.1016/j.bpj.2009.02.027; Yue BH, 2005, J PHYS CHEM B, V109, P609, DOI 10.1021/jp047510q; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	79	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72248	10.1371/journal.pone.0072248	http://dx.doi.org/10.1371/journal.pone.0072248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991073	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000324228800054
J	Nielsen, MT; Nielsen, JB; Anyaogu, DC; Holm, DK; Nielsen, KF; Larsen, TO; Mortensen, UH				Nielsen, Morten Thrane; Nielsen, Jakob Blaesbjerg; Anyaogu, Dianna Chinyere; Holm, Dorte Koefoed; Nielsen, Kristian Fog; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro			Heterologous Reconstitution of the Intact Geodin Gene Cluster in Aspergillus nidulans through a Simple and Versatile PCR Based Approach	PLOS ONE			English	Article							POLYKETIDE SYNTHASE; FILAMENTOUS FUNGI; NATURAL-PRODUCTS; BIOSYNTHESIS; TERREUS; METABOLITES; EXPRESSION; CLONING; ENZYME; CYTOCHROME-P450	Fungal natural products are a rich resource for bioactive molecules. To fully exploit this potential it is necessary to link genes to metabolites. Genetic information for numerous putative biosynthetic pathways has become available in recent years through genome sequencing. However, the lack of solid methodology for genetic manipulation of most species severely hampers pathway characterization. Here we present a simple PCR based approach for heterologous reconstitution of intact gene clusters. Specifically, the putative gene cluster responsible for geodin production from Aspergillus terreus was transferred in a two step procedure to an expression platform in A. nidulans. The individual cluster fragments were generated by PCR and assembled via efficient USER fusion prior to transformation and integration via re-iterative gene targeting. A total of 13 open reading frames contained in 25 kb of DNA were successfully transferred between the two species enabling geodin synthesis in A. nidulans. Subsequently, functions of three genes in the cluster were validated by genetic and chemical analyses. Specifically, ATEG_08451 (gedC) encodes a polyketide synthase, ATEG_08453 (gedR) encodes a transcription factor responsible for activation of the geodin gene cluster and ATEG_08460 (gedL) encodes a halogenase that catalyzes conversion of sulochrin to dihydrogeodin. We expect that our approach for transferring intact biosynthetic pathways to a fungus with a well developed genetic toolbox will be instrumental in characterizing the many exciting pathways for secondary metabolite production that are currently being uncovered by the fungal genome sequencing projects.	[Nielsen, Morten Thrane; Nielsen, Jakob Blaesbjerg; Anyaogu, Dianna Chinyere; Holm, Dorte Koefoed; Nielsen, Kristian Fog; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Anyaogu, DC (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	tol@bio.dtu.dk; um@bio.dtu.dk	Mortensen, Uffe/AAQ-1150-2021; Nielsen, Kristian Fog/C-7233-2011; Hoof, Jakob Blæsbjerg/L-6019-2015	Nielsen, Kristian Fog/0000-0002-5848-0911; Hoof, Jakob Blæsbjerg/0000-0002-7650-9300; Larsen, Thomas Ostenfeld/0000-0002-3362-5707	Danish Research Agency for Technology and Production [09-064967]; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	Danish Research Agency for Technology and Production; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	This work was supported by the Danish Research Agency for Technology and Production, grant 09-064967. The PhD studies of which this work was part of was funded by the Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZAL M, 1969, J CHEM SOC C, P1721, DOI 10.1039/j39690001721; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Askenazi M, 2003, NAT BIOTECHNOL, V21, P150, DOI 10.1038/nbt781; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; CHEN ZG, 1992, ARCH MICROBIOL, V158, P29, DOI 10.1007/BF00249062; CHEN ZG, 1995, PHYTOCHEMISTRY, V38, P299, DOI 10.1016/0031-9422(94)00543-3; Chiang YM, 2010, APPL ENVIRON MICROB, V76, P2067, DOI 10.1128/AEM.02187-09; Couch RD, 2004, J BIOTECHNOL, V108, P171, DOI 10.1016/j.jbiotec.2003.10.021; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Ehrlich KC, 2010, APPL ENVIRON MICROB, V76, P3374, DOI 10.1128/AEM.02495-09; FRANCK B, 1966, ANGEW CHEM INT EDIT, V5, P728, DOI 10.1002/anie.196607282; FUJII I, 1988, J BIOCHEM-TOKYO, V103, P878, DOI 10.1093/oxfordjournals.jbchem.a122365; GATENBECK S, 1969, Acta Chemica Scandinavica, V23, P3493, DOI 10.3891/acta.chem.scand.23-3493; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Hansen BG, 2012, APPL ENVIRON MICROB, V78, P4908, DOI 10.1128/AEM.07955-11; Heneghan MN, 2010, CHEMBIOCHEM, V11, P1508, DOI 10.1002/cbic.201000259; Henry KM, 2005, J AM CHEM SOC, V127, P3300, DOI 10.1021/ja045520z; Henry KM, 2005, J AM CHEM SOC, V127, P3724, DOI 10.1021/ja0455188; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; HUANG KX, 1995, J BIOL CHEM, V270, P21495, DOI 10.1074/jbc.270.37.21495; Itoh T, 2010, NAT CHEM, V2, P858, DOI [10.1038/NCHEM.764, 10.1038/nchem.764]; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Larsen TO, 2007, MED MYCOL, V45, P225, DOI 10.1080/13693780601185939; Nielsen JB, 2008, FUNGAL GENET BIOL, V45, P165, DOI 10.1016/j.fgb.2007.07.003; Nielsen KF, 2011, J NAT PROD, V74, P2338, DOI 10.1021/np200254t; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Nielsen MT, 2013, PLOS ONE, DOI [10.1317/journal.pone.0073369, DOI 10.1317/J0URNAL.P0NE.0073369]; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Sakai K, 2008, J BIOSCI BIOENG, V106, P466, DOI 10.1263/jbb.106.466; SANKAWA U, 1973, TETRAHEDRON LETT, P2125; Simpson TJ, 2012, CHEMBIOCHEM, V13, P1680, DOI 10.1002/cbic.201200014; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; STEGLICH W, 1972, J CHEM SOC CHEM COMM, P102, DOI 10.1039/c39720000102; Wilson RA, 2009, MICROBIOL-SGM, V155, P3810, DOI 10.1099/mic.0.035436-0; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108	40	71	88	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72871	10.1371/journal.pone.0072871	http://dx.doi.org/10.1371/journal.pone.0072871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009710	Green Submitted, Green Published, gold			2022-12-25	WOS:000324403200034
J	Cho, U; Zimmerman, SM; Chen, LC; Owen, E; Kim, JV; Kim, SK; Wandless, TJ				Cho, Ukrae; Zimmerman, Stephanie M.; Chen, Ling-chun; Owen, Elliot; Kim, Jesse V.; Kim, Stuart K.; Wandless, Thomas J.			Rapid and Tunable Control of Protein Stability in Caenorhabditis elegans Using a Small Molecule	PLOS ONE			English	Article							EXPRESSION	Destabilizing domains are conditionally unstable protein domains that can be fused to a protein of interest resulting in degradation of the fusion protein in the absence of stabilizing ligand. These engineered protein domains enable rapid, reversible and dose-dependent control of protein expression levels in cultured cells and in vivo. To broaden the scope of this technology, we have engineered new destabilizing domains that perform well at temperatures of 20-25 degrees C. This raises the possibility that our technology could be adapted for use at any temperature. We further show that these new destabilizing domains can be used to regulate protein concentrations in C. elegans. These data reinforce that DD can function in virtually any organism and temperature.	[Cho, Ukrae; Chen, Ling-chun; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Zimmerman, Stephanie M.; Owen, Elliot; Kim, Jesse V.; Kim, Stuart K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Owen, Elliot; Kim, Jesse V.; Kim, Stuart K.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wandless, TJ (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu		Cho, Ukrae/0000-0001-8796-810X	National Institute of General Medical Sciences of the National Institutes of Health [GM073046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health (GM073046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bacaj T, 2007, GENETICS, V176, P2651, DOI 10.1534/genetics.107.074369; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BRENNER S, 1974, GENETICS, V77, P71; Davis MW, 2008, GENE, V4; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hoier EF, 2000, GENE DEV, V14, P874; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Leong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030177; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Wei X, 2012, NAT METHODS, V9, P391, DOI [10.1038/NMETH.1929, 10.1038/nmeth.1929]	16	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72393	10.1371/journal.pone.0072393	http://dx.doi.org/10.1371/journal.pone.0072393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991108	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700038
J	Flageng, MH; Knappskog, S; Haynes, B; Lonning, PE; Mellgren, G				Flageng, Marianne Hauglid; Knappskog, Stian; Haynes, Ben P.; Lonning, Per Eystein; Mellgren, Gunnar			Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ACTIVATED PROTEIN-KINASE; CANCER CELL-LINES; ESTROGEN-RECEPTOR; ENDOCRINE THERAPY; CLINICAL-IMPLICATIONS; TAMOXIFEN-RESISTANT; GENE AMPLIFICATION; RANDOMIZED-TRIAL; ERBB2 EXPRESSION	Cross-talk between the estrogen and the EGFR/HER signalling pathways has been suggested as a potential cause of resistance to endocrine therapy in breast cancer. Here, we determined HER1-4 receptor and neuregulin-1 (NRG1) ligand mRNA expression levels in breast cancers and corresponding normal breast tissue from patients previously characterized for plasma and tissue estrogen levels. In tumours from postmenopausal women harbouring normal HER2 gene copy numbers, we found HER2 and HER4, but HER3 levels in particular, to be elevated (2.48, 1.30 and 22.27 -fold respectively; P<0.01 for each) compared to normal tissue. Interestingly, HER3 as well as HER4 were higher among ER+ as compared to ER-tumours (P=0.004 and P=0.024, respectively). HER2 and HER3 expression levels correlated positively with ER mRNA (ESR1) expression levels (r=0.525, P=0.044; r=0.707, P=0.003, respectively). In contrast, EGFR/HER1 was downregulated in tumour compared to normal tissue (0.13-fold, P<0.001). In addition, EGFR/HER1 correlated negatively to intra-tumour (r=-0.633, P=0.001) as well as normal tissue (r=-0.556, P=0.006) and plasma estradiol levels (r=-0.625, P=0.002), suggesting an inverse regulation between estradiol and EGFR/HER1 levels. In ER+ tumours from postmenopausal women, NRG1 levels correlated positively with EGFR/HER1 (r=0.606, P=0.002) and negatively to ESR1 (r=-0.769, P=0.003) and E2 levels (r=-0.542, P=0.020). Our results indicate influence of estradiol on the expression of multiple components of the HER system in tumours not amplified for HER2, adding further support to the hypothesis that cross-talk between these systems may be of importance to breast cancer growth in vivo.	[Flageng, Marianne Hauglid; Knappskog, Stian; Lonning, Per Eystein; Mellgren, Gunnar] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Flageng, Marianne Hauglid; Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Knappskog, Stian; Lonning, Per Eystein] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Haynes, Ben P.] Royal Marsden Hosp, London SW3 6JJ, England	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Royal Marsden NHS Foundation Trust	Mellgren, G (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	gunnar.mellgren@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Lonning, Per Eystein/0000-0002-8890-6303; Knappskog, Stian/0000-0002-4153-1655	Norwegian Cancer Society; Samarbeidsorganet Helse Vest RHF; Inger R. Haldorsens legat; Michael Irgens Flocks legat; Odd Fellow Medisinsk Vitenskapelig Forskningsfond	Norwegian Cancer Society(Norwegian Cancer Society); Samarbeidsorganet Helse Vest RHF; Inger R. Haldorsens legat; Michael Irgens Flocks legat; Odd Fellow Medisinsk Vitenskapelig Forskningsfond	Funding for this project was provided by the Norwegian Cancer Society (kreftforeningen.no), Samarbeidsorganet Helse Vest RHF (www.helsebergen.no/forskning/samarbeidsorganet), Inger R. Haldorsens legat (irhaldorsen.no/haldorsen.html), Michael Irgens Flocks legat (www.stiegler.no) and Odd Fellow Medisinsk Vitenskapelig Forskningsfond (oddfellow.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis IL, 1998, J CLIN ONCOL, V16, P1340, DOI 10.1200/JCO.1998.16.4.1340; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bates NP, 1997, ONCOGENE, V15, P473, DOI 10.1038/sj.onc.1201368; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Chiu CG, 2010, ANN SURG, V251, P1107, DOI 10.1097/SLA.0b013e3181dbb77e; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cristofanilli M, 2010, CLIN CANCER RES, V16, P1904, DOI 10.1158/1078-0432.CCR-09-2282; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; De Placido S, 2003, CLIN CANCER RES, V9, P1039; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Dowsett M, 2012, PREDICTION ANTIPROLI; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Flageng MH, 2009, BRIT J CANCER, V101, P1253, DOI 10.1038/sj.bjc.6605324; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Gee JMW, 2006, ENDOCR-RELAT CANCER, V13, pS77, DOI 10.1677/erc.1.01274; Geisler J, 2000, J STEROID BIOCHEM, V72, P259, DOI 10.1016/S0960-0760(00)00036-4; Geisler J, 2008, J STEROID BIOCHEM, V109, P90, DOI 10.1016/j.jsbmb.2007.12.011; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Haynes BP, 2010, CLIN CANCER RES, V16, P1790, DOI 10.1158/1078-0432.CCR-09-2481; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Hutcheson IR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2848; Jelovac D, 2005, CANCER RES, V65, P5380, DOI 10.1158/0008-5472.CAN-04-4502; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Johnston SRD, 2007, J STEROID BIOCHEM, V106, P180, DOI 10.1016/j.jsbmb.2007.05.019; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; KOENDERS PG, 1991, CANCER RES, V51, P4544; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Koutras AK, 2010, CRIT REV ONCOL HEMAT, V74, P73, DOI 10.1016/j.critrevonc.2009.04.011; Larsen MS, 2012, BREAST, V21, P662, DOI 10.1016/j.breast.2012.07.005; Leary AF, 2010, CLIN CANCER RES, V16, P1486, DOI 10.1158/1078-0432.CCR-09-1764; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu BL, 2009, MOL CANCER RES, V7, P1882, DOI 10.1158/1541-7786.MCR-08-0509; Lonning PE, 2009, J STEROID BIOCHEM, V117, P31, DOI 10.1016/j.jsbmb.2009.06.005; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Masri S, 2010, J STEROID BIOCHEM, V118, P277, DOI 10.1016/j.jsbmb.2009.10.011; Newman SP, 2000, ONCOGENE, V19, P490, DOI 10.1038/sj.onc.1203416; Pinhel I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3145; Press MF, 2008, CLIN CANCER RES, V14, P7861, DOI 10.1158/1078-0432.CCR-08-1056; Purdie CA, 2010, BRIT J CANCER, V103, P475, DOI 10.1038/sj.bjc.6605799; QUENEL N, 1995, BREAST CANCER RES TR, V35, P283, DOI 10.1007/BF00665980; Revillion F, 2003, ANTICANCER RES, V23, P1455; RUSSELL KS, 1992, CANCER RES, V52, P6624; Salvatori L, 2000, ENDOCRINOLOGY, V141, P2266, DOI 10.1210/en.141.6.2266; Salvatori L, 2009, J CELL PHYSIOL, V220, P35, DOI 10.1002/jcp.21724; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Sommer A, 2003, J STEROID BIOCHEM, V85, P33, DOI 10.1016/S0960-0760(03)00139-0; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Tagliabue E, 1999, INT J BIOL MARKER, V14, P16, DOI 10.1177/172460089901400104; Wilson MA, 2002, J CELL BIOCHEM, V85, P601, DOI 10.1002/jcb.10168; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Yarden RI, 2001, J CELL BIOCHEM, P232; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	61	17	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e74618	10.1371/journal.pone.0074618	http://dx.doi.org/10.1371/journal.pone.0074618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991224	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470700069
J	Goldklang, MP; Perez-Zoghbi, JF; Trischler, J; Nkyimbeng, T; Zakharov, SI; Shiomi, T; Zelonina, T; Marks, AR; D'Armiento, JM; Marx, SO				Goldklang, Monica P.; Perez-Zoghbi, Jose F.; Trischler, Jordis; Nkyimbeng, Takwi; Zakharov, Sergey I.; Shiomi, Takayuki; Zelonina, Tina; Marks, Andrew R.; D'Armiento, Jeanine M.; Marx, Steven O.			Treatment of experimental asthma using a single small molecule with anti-inflammatory and BK channel-activating properties	FASEB JOURNAL			English	Article						airway smooth muscle; airway contractility; MAP kinases; ERK	AIRWAY SMOOTH-MUSCLE; KINASE-C-DELTA; HOUSE-DUST MITE; N-TERMINAL KINASE; PROTEIN-KINASES; MOUSE MODEL; INTRACELLULAR CA2+; POTASSIUM CHANNELS; T-CELLS; INFLAMMATION	Large conductance voltage- and calcium-activated potassium (BK) channels are highly expressed in airway smooth muscle (ASM). Utilizing the ovalbumin (OVA) and house dust mite (HDM) models of asthma in C57BL/6 mice, we demonstrate that systemic administration of the BK channel agonist rottlerin (5 mu g/g) during the challenge period reduced methacholine-induced airway hyperreactivity (AHR) in OVA-and HDM-sensitized mice (47% decrease in peak airway resistance in OVA-asthma animals, P<0.01; 54% decrease in HDM-asthma animals, P<0.01) with a 35-40% reduction in inflammatory cells and 20-35% reduction in Th2 cytokines in bronchoalveolar lavage fluid. Intravenous rottlerin (5 mu g/g) reduced AHR within 5 min in the OVA-asthma mice by 45% (P<0.01). With the use of an ex vivo lung slice technique, rottlerin relaxed acetylcholine-stimulated murine airway lumen area to 87 +/- 4% of the precontracted area (P<0.01 vs. DMSO control). Rottlerin increased BK channel activity in human ASM cells (V-50 shifted by 73.5 +/- 13.5 and 71.8 +/- 14.6 mV in control and asthmatic cells, respectively, both P<0.05 as compared with pretreatment) and reduced the frequency of acetylcholine-induced Ca2+ oscillations in murine ex vivo lung slices. These findings suggest that rottlerin, with both anti-inflammatory and ASM relaxation properties, may have benefit in treating asthma.	[Goldklang, Monica P.; Shiomi, Takayuki; Zelonina, Tina; D'Armiento, Jeanine M.] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10032 USA; [Goldklang, Monica P.; D'Armiento, Jeanine M.] Columbia Univ, Coll Phys & Surg, Div Pulm Allergy & Crit Care, New York, NY 10032 USA; [Zakharov, Sergey I.; Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Div Cardiol, Dept Med, New York, NY 10032 USA; [Trischler, Jordis; Nkyimbeng, Takwi; Marks, Andrew R.; D'Armiento, Jeanine M.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Zakharov, Sergey I.; Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Perez-Zoghbi, Jose F.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Marx, SO (corresponding author), Columbia Univ, 630 West 168th St,P&S 9-420, New York, NY 10032 USA.	arm42@columbia.edu; jmd12@columbia.edu; sm460@columbia.edu	Shiomi, Takayuki/A-2228-2014; Zakharov, Sergey/L-8511-2014; Zakharov, Sergey/O-2896-2019	Shiomi, Takayuki/0000-0002-4250-1204; Zakharov, Sergey/0000-0001-9864-8304; Zakharov, Sergey/0000-0001-9864-8304; Goldklang, Monica/0000-0002-7019-3130; Perez-Zoghbi, Jose Francisco/0000-0002-7554-6468	U.S. National Institutes of Health [UL1 TR000040]; American Asthma Foundation; U.S. National Institute of Heart, Lung, and Blood [P01-HL-081172, R01-HL-086936, T32-HL-007854, T32-HL-007343]; American Heart Association [11SDG5670050]; American Lung Association [RG-196192-N]; Flight Attendant Medical Research Institute Young Clinical Scientist Award [103236]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086936, T32HL007854, P01HL081172, T32HL007343] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; U.S. National Institute of Heart, Lung, and Blood; American Heart Association(American Heart Association); American Lung Association; Flight Attendant Medical Research Institute Young Clinical Scientist Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Yong-Xiao Wang and members of the Wang laboratory at Albany Medical College (Albany, NY, USA) for help with the isolation of murine ASM cells. The authors thank Drs. Charles Emala and Elizabeth Townsend for providing human ASM cells and for thoughtful critiques of this work. The authors thank Jacquelyn Trice for assistance with the lung slice experiments, Sarah Marks for assistance with cell culture and histology, and Dr. Amy Simon for advice about the HDM model. The authors thank Drs. Tiffany Thomas and Serge Cremers (Columbia University Biomarkers Core Lab, Irving Institute for Clinical and Translational Research; U.S. National Institutes of Health grant UL1 TR000040) for assistance with the liquid chromatography-mass spectrometry work. This study was supported by funds from an American Asthma Foundation grant (to A. R. M.); U.S. National Institute of Heart, Lung, and Blood grants P01-HL-081172 (to S.O.M., A. R. M., and J.M.D.), R01-HL-086936 (to J.M.D.), T32-HL-007854 (to M. P. G.), and T32-HL-007343 (to M. P. G.); American Heart Association grant 11SDG5670050 (to J.F.P.-Z.); American Lung Association grant RG-196192-N (to J.F.P.-.Z); and Flight Attendant Medical Research Institute Young Clinical Scientist Award 103236 (to J.M.D. and M. P. G.). Columbia University, on behalf of S.O.M., S.I.Z., A. R. M., and J.M.D., has filed a patent for the use of rottlerin in activating BK channels and treating asthma.	Alrashdan YA, 2012, AM J PHYSIOL-LUNG C, V302, pL1118, DOI 10.1152/ajplung.00232.2011; BARNES PJ, 1985, BRIT J CLIN PHARMACO, V20, pS289, DOI 10.1111/j.1365-2125.1985.tb02815.x; Bates ME, 2000, J BIOL CHEM, V275, P10968, DOI 10.1074/jbc.275.15.10968; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cho SH, 2004, J ALLERGY CLIN IMMUN, V114, P1085, DOI 10.1016/j.jaci.2004.07.035; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Eynott PR, 2003, BRIT J PHARMACOL, V140, P1373, DOI 10.1038/sj.bjp.0705569; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Goplen N, 2012, FASEB J, V26, P1934, DOI 10.1096/fj.11-196477; Grunstein MM, 2005, J ALLERGY CLIN IMMUN, V116, P94, DOI 10.1016/j.jaci.2005.03.046; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; GUJRAL M. L., 1960, INDIAN JOUR MED RES, V48, P52; Hallsworth MP, 2001, AM J RESP CRIT CARE, V164, P688, DOI 10.1164/ajrccm.164.4.2011004; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Janssen LJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1757, DOI 10.1152/ajpcell.1997.272.6.C1757; Janssen LJ, 2004, AM J PHYSIOL-LUNG C, V287, pL852, DOI 10.1152/ajplung.00130.2004; Janssen LJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-123; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; KUME H, 1995, AM J PHYSIOL-LUNG C, V268, pL221, DOI 10.1152/ajplung.1995.268.2.L221; Langlois A, 2009, J LEUKOCYTE BIOL, V85, P656, DOI 10.1189/jlb.0808492; Lee JH, 2001, AM J PHYSIOL-LUNG C, V280, pL1019, DOI 10.1152/ajplung.2001.280.5.L1019; Lee JS, 2008, CYTOKINE, V42, P365, DOI 10.1016/j.cyto.2008.03.010; Liu CQ, 2005, AM J PHYSIOL-LUNG C, V289, pL574, DOI 10.1152/ajplung.00134.2005; Liu QH, 2009, P NATL ACAD SCI USA, V106, P11418, DOI 10.1073/pnas.0813307106; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Mehra D, 2010, AM J PHYSIOL-LUNG C, V298, pL189, DOI 10.1152/ajplung.00042.2009; Miura K, 1999, J IMMUNOL, V162, P4198; Moore PE, 2002, AM J PHYSIOL-LUNG C, V282, pL847, DOI 10.1152/ajplung.00245.2001; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Neuhaus-Steinmetz U, 2000, INT ARCH ALLERGY IMM, V121, P57, DOI 10.1159/000024298; Perez JF, 2005, J GEN PHYSIOL, V125, P535, DOI 10.1085/jgp.200409216; Perez-Zoghbi JF, 2010, J GEN PHYSIOL, V135, P247, DOI 10.1085/jgp.200910365; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Sanderson MJ, 2003, METHOD ENZYMOL, V360, P447; Schubl S, 2009, J SURG RES, V153, P181, DOI 10.1016/j.jss.2008.04.032; Seibold MA, 2008, HUM MOL GENET, V17, P2681, DOI 10.1093/hmg/ddn168; Semenov I, 2006, AM J PHYSIOL-LUNG C, V291, pL802, DOI 10.1152/ajplung.00104.2006; Semenov I, 2011, J PHYSIOL-LONDON, V589, P1803, DOI 10.1113/jphysiol.2010.204347; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; Tan X, 2013, AM J PHYSIOL-LUNG C, V304, pL790, DOI 10.1152/ajplung.00356.2012; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Townsend EA, 2010, AM J PHYSIOL-LUNG C, V298, pL521, DOI 10.1152/ajplung.00287.2009; Wang JM, 2000, J IMMUNOL, V165, P4051, DOI 10.4049/jimmunol.165.7.4051; Zakharov SI, 2005, J BIOL CHEM, V280, P30882, DOI 10.1074/jbc.M505302200; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200	56	25	26	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4975	4986		10.1096/fj.13-235176	http://dx.doi.org/10.1096/fj.13-235176			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23995289	Green Published			2022-12-25	WOS:000329999000031
J	Ahonen, SJ; Arumilli, M; Lohi, H				Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes			A CNGB1 Frameshift Mutation in Papillon and Phalene Dogs with Progressive Retinal Atrophy	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; CONE-ROD DYSTROPHY; RECESSIVE RETINITIS-PIGMENTOSA; BETA-SUBUNIT; CATION CHANNEL; ION CHANNELS; SEQUENCING DATA; DEGENERATION; PHOTORECEPTOR; GENE	Progressive retinal degenerations are the most common causes of complete blindness both in human and in dogs. Canine progressive retinal atrophy (PRA) or degeneration resembles human retinitis pigmentosa (RP) and is characterized by a progressive loss of rod photoreceptor cells followed by a loss of cone function. The primary clinical signs are detected as vision impairment in a dim light. Although several genes have been associated with PRAs, there are still PRAs of unknown genetic cause in many breeds, including Papillons and Phalenes. We have performed a genome wide association and linkage studies in cohort of 6 affected Papillons and Phalenes and 14 healthy control dogs to map a novel PRA locus on canine chromosome 2, with a 1.9 Mb shared homozygous region in the affected dogs. Parallel exome sequencing of a trio identified an indel mutation, including a 1-bp deletion, followed by a 6-bp insertion in the CNGB1 gene. This mutation causes a frameshift and premature stop codon leading to probable nonsense mediated decay (NMD) of the CNGB1 mRNA. The mutation segregated with the disease and was confirmed in a larger cohort of 145 Papillons and Phalenes (P-Fisher = 1.4x10(-8)) with a carrier frequency of 17.2 %. This breed specific mutation was not present in 334 healthy dogs from 10 other breeds or 121 PRA affected dogs from 44 other breeds. CNGB1 is important for the photoreceptor cell function its defects have been previously associated with retinal degeneration in both human and mouse. Our study indicates that a frameshift mutation in CNGB1 is a cause of PRA in Papillons and Phalenes and establishes the breed as a large functional animal model for further characterization of retinal CNGB1 biology and possible retinal gene therapy trials. This study enables also the development of a genetic test for breeding purposes.	[Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland	University of Helsinki; University of Helsinki	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Ahonen, Saija/0000-0003-3313-784X; Arumilli, Meharji/0000-0003-4072-0996	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Jane and Aatos Erkko Foundation	This study was supported partly by the Academy of Finland, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation. SA is a student in Helsinki Graduate Program in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguirre G D, 1998, Mol Vis, V4, P23; Ardell MD, 2000, GENE, V245, P311, DOI 10.1016/S0378-1119(00)00023-8; Ardell MD, 1996, FEBS LETT, V389, P213, DOI 10.1016/0014-5793(96)00588-1; Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Dekomien G, 2000, CYTOGENET CELL GENET, V90, P261, DOI 10.1159/000056785; Downs LM, 2013, ANIM GENET, V44, P169, DOI 10.1111/j.1365-2052.2012.02379.x; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Goldstein O, 2010, MOL VIS, V16, P1549; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hakanson Nils, 1995, Veterinary and Comparative Ophthalmology, V5, P83; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hiekkalinna T, 2011, HUM HERED, V71, P256, DOI 10.1159/000329467; Hofmann F, 2003, PHARMACOL REV, V55, P587, DOI 10.1124/pr.55.4.10; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Narfstrom K, 1998, AM J VET RES, V59, P221; Narfstrom Kristina, 1999, Veterinary Ophthalmology, V2, P67; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; PARRY HB, 1953, BRIT J OPHTHALMOL, V37, P487, DOI 10.1136/bjo.37.8.487; Petersen-Jones SM, 1998, EYE, V12, P566, DOI 10.1038/eye.1998.146; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2009, R FDN STAT COMP; Rozen S, 2000, Methods Mol Biol, V132, P365; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Vilboux T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-10; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	46	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72122	10.1371/journal.pone.0072122	http://dx.doi.org/10.1371/journal.pone.0072122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015210	Green Submitted, Green Published, gold			2022-12-25	WOS:000323733800029
J	Camerino, GM; Pierno, S; Liantonio, A; De Bellis, M; Cannone, M; Sblendorio, V; Conte, E; Mele, A; Tricarico, D; Tavella, S; Ruggiu, A; Cancedda, R; Ohira, Y; Danieli-Betto, D; Ciciliot, S; Germinario, E; Sandona, D; Betto, R; Camerino, DC; Desaphy, JF				Camerino, Giulia Maria; Pierno, Sabata; Liantonio, Antonella; De Bellis, Michela; Cannone, Maria; Sblendorio, Valeriana; Conte, Elena; Mele, Antonietta; Tricarico, Domenico; Tavella, Sara; Ruggiu, Alessandra; Cancedda, Ranieri; Ohira, Yoshinobu; Danieli-Betto, Daniela; Ciciliot, Stefano; Germinario, Elena; Sandona, Dorianna; Betto, Romeo; Camerino, Diana Conte; Desaphy, Jean-Francois			Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; AFFIN REGULATORY PEPTIDE; K-ATP CHANNEL; SOLEUS MUSCLE; INDUCED ANGIOGENESIS; DIVERSE FUNCTIONS; EXPRESSION; DISUSE; MICE	Pleiotrophin (PTN) is a widespread cytokine involved in bone formation, neurite outgrowth, and angiogenesis. In skeletal muscle, PTN is upregulated during myogenesis, post-synaptic induction, and regeneration after crushing, but little is known regarding its effects on muscle function. Here, we describe the effects of PTN on the slow-twitch soleus and fast-twitch extensor digitorum longus (EDL) muscles in mice over-expressing PTN under the control of a bone promoter. The mice were maintained in normal loading or disuse condition, induced by hindlimb unloading (HU) for 14 days. Effects of exposition to near-zero gravity during a 3-months spaceflight (SF) into the Mice Drawer System are also reported. In normal loading, PTN overexpression had no effect on muscle fiber cross-sectional area, but shifted soleus muscle toward a slower phenotype, as shown by an increased number of oxidative type 1 fibers, and increased gene expression of cytochrome c oxidase subunit IV and citrate synthase. The cytokine increased soleus and EDL capillary-to-fiber ratio. PTN overexpression did not prevent soleus muscle atrophy, slow-to-fast transition, and capillary regression induced by SF and HU. Nevertheless, PTN exerted various effects on sarcolemma ion channel expression/function and resting cytosolic Ca2+ concentration in soleus and EDL muscles, in normal loading and after HU. In conclusion, the results show very similar effects of HU and SF on mouse soleus muscle, including activation of specific gene programs. The EDL muscle is able to counterbalance this latter, probably by activating compensatory mechanisms. The numerous effects of PTN on muscle gene expression and functional parameters demonstrate the sensitivity of muscle fibers to the cytokine. Although little benefit was found in HU muscle disuse, PTN may emerge useful in various muscle diseases, because it exerts synergetic actions on muscle fibers and vessels, which could enforce oxidative metabolism and ameliorate muscle performance.	[Camerino, Giulia Maria; Pierno, Sabata; Liantonio, Antonella; De Bellis, Michela; Cannone, Maria; Sblendorio, Valeriana; Conte, Elena; Mele, Antonietta; Tricarico, Domenico; Camerino, Diana Conte; Desaphy, Jean-Francois] Univ Bari Aldo Moro, Pharmacol Sect, Dept Pharm & Drug Sci, Bari, Italy; [Tavella, Sara; Ruggiu, Alessandra; Cancedda, Ranieri] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; [Ohira, Yoshinobu] Osaka Univ, Grad Sch Med & Frontier Biosci, Osaka, Japan; [Danieli-Betto, Daniela; Ciciliot, Stefano; Germinario, Elena; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, Padua, Italy; [Betto, Romeo] CNR, Inst Neurosci, Padua, Italy	Universita degli Studi di Bari Aldo Moro; University of Genoa; Osaka University; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Desaphy, JF (corresponding author), Univ Bari Aldo Moro, Pharmacol Sect, Dept Pharm & Drug Sci, Bari, Italy.	jfdesaphy@farmbiol.uniba.it	Camerino, Giulia Maria/I-6896-2013; sandona, dorianna/AAB-9480-2020; Conte, Elena/AAV-3153-2020; De Bellis, Michela/ABE-2595-2020; Ciciliot, Stefano/L-3887-2019; Conte, Elena/AAF-4055-2019; Desaphy, Jean-Francois/T-6191-2019; Tavella, Sara/D-3011-2017	Ciciliot, Stefano/0000-0002-5833-6581; Conte, Elena/0000-0001-8571-5125; Desaphy, Jean-Francois/0000-0001-8816-9369; Tavella, Sara/0000-0003-1478-4910; DANIELI, DANIELA/0000-0002-6186-8327; Mele, Antonietta/0000-0002-9278-7183; Camerino, Giulia Maria/0000-0003-1410-6327; Pierno, Sabata/0000-0003-3121-2666; Liantonio, Antonella/0000-0002-4103-7577	Italian Space Agency (ASI)	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI))	This study was supported by the Italian Space Agency (ASI, grant OSMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Banas K, 2011, AM J PHYSIOL-REG I, V301, pR916, DOI 10.1152/ajpregu.00663.2010; Brocca L, 2010, EXP PHYSIOL, V95, P331, DOI 10.1113/expphysiol.2009.050245; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; Caruelle D, 2004, J MUSCLE RES CELL M, V25, P45, DOI 10.1023/B:JURE.0000021387.92378.2e; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; de Paoli FV, 2013, J PHYSIOL-LONDON, V591, P531, DOI 10.1113/jphysiol.2012.243246; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; DESPLANCHES D, 1990, J APPL PHYSIOL, V69, P504, DOI 10.1152/jappl.1990.69.2.504; DESPLANCHES D, 1991, EUR J APPL PHYSIOL O, V63, P288, DOI 10.1007/BF00233864; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Fujino H, 2005, J APPL PHYSIOL, V98, P1407, DOI 10.1152/japplphysiol.00961.2004; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Heroult M, 2004, ONCOGENE, V23, P1745, DOI 10.1038/sj.onc.1206879; Hilber K, 2008, CURR OPIN PHARMACOL, V8, P327, DOI 10.1016/j.coph.2008.01.007; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Kishlyansky M, 2010, BIOCHEM BIOPH RES CO, V399, P359, DOI 10.1016/j.bbrc.2010.07.076; LAAROUBI K, 1994, GROWTH FACTORS, V10, P89, DOI 10.3109/08977199409010982; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Li G, 2005, CALCIFIED TISSUE INT, V76, P299, DOI 10.1007/s00223-004-0145-6; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; PENG HB, 1995, J NEUROSCI, V15, P3027; Pierno S, 2002, BRAIN, V125, P1510, DOI 10.1093/brain/awf162; Pierno S, 2007, J PHYSIOL-LONDON, V584, P983, DOI 10.1113/jphysiol.2007.141358; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Talmadge AJ, 1993, J APPL PHYSIOL, V75, P2337; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Tricarico D, 2006, P NATL ACAD SCI USA, V103, P1118, DOI 10.1073/pnas.0505974103; Tricarico D, 2010, J PHYSIOL-LONDON, V588, P773, DOI 10.1113/jphysiol.2009.185835; Wagatsuma A, 2008, PHYSIOL RES, V57, P613, DOI 10.33549/physiolres.931288; Wang YJ, 2008, LIFE SCI, V82, P11, DOI 10.1016/j.lfs.2007.10.015; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152	44	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72028	10.1371/journal.pone.0072028	http://dx.doi.org/10.1371/journal.pone.0072028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015201	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800023
J	Hu, Y; Bai, L; Geiger, T; Goldberger, N; Walker, RC; Green, JE; Wakefield, LM; Hunter, KW				Hu, Ying; Bai, Ling; Geiger, Thomas; Goldberger, Natalie; Walker, Renard C.; Green, Jeffery E.; Wakefield, Lalage M.; Hunter, Kent W.			Genetic Background May Contribute to PAM50 Gene Expression Breast Cancer Subtype Assignments	PLOS ONE			English	Article							INDUCED MAMMARY-TUMOR; TRANSCRIPTIONAL NETWORK; MOLECULAR PORTRAITS; CELL-LINES; MOUSE; METASTASIS; SUSCEPTIBILITY; PROGRESSION; POPULATION; PREDICTOR	Recent advances in genome wide transcriptional analysis have provided greater insights into the etiology and heterogeneity of breast cancer. Molecular signatures have been developed that stratify the conventional estrogen receptor positive or negative categories into subtypes that are associated with differing clinical outcomes. It is thought that the expression patterns of the molecular subtypes primarily reflect cell-of-origin or tumor driver mutations. In this study however, using a genetically engineered mouse mammary tumor model we demonstrate that the PAM50 subtype signature of tumors driven by a common oncogenic event can be significantly influenced by the genetic background on which the tumor arises. These results have important implications for interpretation of "snapshot" expression profiles, as well as suggesting that incorporation of genetic background effects may allow investigation into phenotypes not initially anticipated in individual mouse models of cancer.	[Hu, Ying] Ctr Biomed Informat & Informat Technol, Bethesda, MD USA; [Bai, Ling; Geiger, Thomas; Goldberger, Natalie; Walker, Renard C.; Green, Jeffery E.; Wakefield, Lalage M.; Hunter, Kent W.] NCI, Lab Canc Biol & Genet, CCR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Canc Biol & Genet, CCR, NIH, Bethesda, MD 20892 USA.	hunterk@mail.nih.gov			National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010881, ZIABC011255, ZIABC005740] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Faraji F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002926; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haibe-Kains B., 2012, GENEFU RELEVANT FUNC; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hsieh SM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2412; Hu Y, 2012, P NATL ACAD SCI USA, V109, P3184, DOI 10.1073/pnas.1117872109; Hunter KW, 2001, CANCER RES, V61, P8866; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kunz G, 2011, ARCH GYNECOL OBSTET, V283, P597, DOI 10.1007/s00404-010-1454-9; Le Voyer T, 2000, MAMM GENOME, V11, P883, DOI 10.1007/s003350010163; Le Voyer T, 2001, GENOMICS, V74, P253, DOI 10.1006/geno.2001.6562; Montagna C, 2003, CANCER RES, V63, P2179; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walesiak M, 2012, SEARCHING OPTIMAL CL; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zbytek B, 2013, APPL IMMUNOHISTO M M, V21, P48, DOI 10.1097/PAI.0b013e3182427cda	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72287	10.1371/journal.pone.0072287	http://dx.doi.org/10.1371/journal.pone.0072287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015230	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800044
J	Miklas, JW; Dallabrida, SM; Reis, LA; Ismail, N; Rupnick, M; Radisic, M				Miklas, Jason W.; Dallabrida, Susan M.; Reis, Lewis A.; Ismail, Nesreen; Rupnick, Maria; Radisic, Milica			QHREDGS Enhances Tube Formation, Metabolism and Survival of Endothelial Cells in Collagen-Chitosan Hydrogels	PLOS ONE			English	Article							DESIGNED ANGIOPOIETIN-1 VARIANT; BIOMIMETIC SURFACTANT POLYMERS; IN-VIVO; LUMEN FORMATION; BLOOD-FLOW; PEPTIDE; ADHESION; MORPHOGENESIS; BIOMATERIALS; MIGRATION	Cell survival in complex, vascularized tissues, has been implicated as a major bottleneck in advancement of therapies based on cardiac tissue engineering. This limitation motivates the search for small, inexpensive molecules that would simultaneously be cardio-protective and vasculogenic. Here, we present peptide sequence QHREDGS, based upon the fibrinogen-like domain of angiopoietin-1, as a prime candidate molecule. We demonstrated previously that QHREDGS improved cardiomyocyte metabolism and mitigated serum starved apoptosis. In this paper we further demonstrate the potency of QHREDGS in its ability to enhance endothelial cell survival, metabolism and tube formation. When endothelial cells were exposed to the soluble form of QHREDGS, improvements in endothelial cell barrier functionality, nitric oxide production and cell metabolism (ATP levels) in serum starved conditions were found. The functionality of the peptide was then examined when conjugated to collagen-chitosan hydrogel, a potential carrier for in vivo application. The presence of the peptide in the hydrogel mitigated paclitaxel induced apoptosis of endothelial cells in a dose dependent manner. Furthermore, the peptide modified hydrogels stimulated tube-like structure formation of encapsulated endothelial cells. When integrin alpha v beta 3 or alpha 5 beta 1were antibody blocked during cell encapsulation in peptide modified hydrogels, tube formation was abolished. Therefore, the dual protective nature of the novel peptide QHREDGS may position this peptide as an appealing augmentation for collagen-chitosan hydrogels that could be used for biomaterial delivered cell therapies in the settings of myocardial infarction.	[Miklas, Jason W.; Reis, Lewis A.; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Dallabrida, Susan M.; Ismail, Nesreen] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Rupnick, Maria] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Rupnick, Maria] Harvard Univ, Sch Med, Boston, MA USA; [Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada	University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto	Radisic, M (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	m.radisic@utoronto.ca		Miklas, Jason/0000-0002-9002-0667	NSERC [STPGP 381002-09, RGPIN 326982-10]; NSERC-CIHR [CHRPJ 385981-10]; Discovery Accelerator Supplement [RGPAS 396125-10]; ORF GL2 grant; McLean Award	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-CIHR(Natural Sciences and Engineering Research Council of Canada (NSERC)Canadian Institutes of Health Research (CIHR)); Discovery Accelerator Supplement; ORF GL2 grant; McLean Award	The authors wish to acknowledge the following funding sources: NSERC Strategic Grant (STPGP 381002-09), NSERC-CIHR Collaborative Health Research Grant (CHRPJ 385981-10), NSERC Discovery Grant (RGPIN 326982-10) and Discovery Accelerator Supplement (RGPAS 396125-10), ORF GL2 grant and McLean Award (to MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chiu LLY, 2010, MACROMOL BIOSCI, V10, P1286, DOI 10.1002/mabi.201000202; Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039; Cho CH, 2005, CIRC RES, V97, P86, DOI 10.1161/01.RES.0000174093.64855.a6; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dallabrida Susan M, 2005, Circ Res, V96, pe8, DOI 10.1161/01.RES.0000158285.57191.60; David S, 2011, ARTERIOSCL THROM VAS, V31, P2643, DOI 10.1161/ATVBAHA.111.233189; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Ismail NS, 2010, J INVEST DERMATOL, V130, P1307, DOI 10.1038/jid.2009.431; Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Noll G, 1998, EUR HEART J, V19, pC30; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Rask F, 2010, SOFT MATTER, V6, P5089, DOI 10.1039/c0sm00362j; Rask F, 2010, J BIOMED MATER RES A, V95A, P105, DOI 10.1002/jbm.a.32808; Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030; Rustad KC, 2010, ORGANOGENESIS, V6, P151, DOI 10.4161/org.6.3.12139; Sagnella S, 2005, TISSUE ENG, V11, P226, DOI 10.1089/ten.2005.11.226; Sagnella SM, 2004, BIOMATERIALS, V25, P1249, DOI 10.1016/S0142-9612(03)00634-3; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; van der Heijden M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023448; Van Slyke P, 2009, TISSUE ENG PT A, V15, P1269, DOI 10.1089/ten.tea.2007.0400; Wang X, 2012, J BIOMED MATER RES A, V100A, P794, DOI 10.1002/jbm.a.34026; Zhang C, 2013, J BIOMEDICAL MAT R A	55	30	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72956	10.1371/journal.pone.0072956	http://dx.doi.org/10.1371/journal.pone.0072956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013716	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200061
J	Xu, W; Lacerda, L; Debeb, BG; Atkinson, RL; Solley, TN; Li, L; Orton, D; McMurray, JS; Hang, BI; Lee, E; Klopp, AH; Ueno, NT; Reuben, JM; Krishnamurthy, S; Woodward, WA				Xu, Wei; Lacerda, Lara; Debeb, Bisrat G.; Atkinson, Rachel L.; Solley, Travis N.; Li, Li; Orton, Darren; McMurray, John S.; Hang, Brian I.; Lee, Ethan; Klopp, Ann H.; Ueno, Naoto T.; Reuben, James M.; Krishnamurthy, Savitri; Woodward, Wendy A.			The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MAMMARY STEM-CELLS; BETA-CATENIN; SELF-RENEWAL; IN-VITRO; SIGNAL-TRANSDUCTION; ANTITUMOR-ACTIVITY; WNT PROTEINS; ACTIVATION; INHIBITION	WNT signaling plays a key role in the self-renewal of tumor initiation cells (TICs). In this study, we used pyrvinium pamoate (PP), an FDA-approved antihelmintic drug that inhibits WNT signaling, to test whether pharmacologic inhibition of WNT signaling can specifically target TICs of aggressive breast cancer cells. SUM-149, an inflammatory breast cancer cell line, and SUM-159, a metaplastic basal-type breast cancer cell line, were used in these studies. We found that PP inhibited primary and secondary mammosphere formation of cancer cells at nanomolar concentrations, at least 10 times less than the dose needed to have a toxic effect on cancer cells. A comparable mammosphere formation IC50 dose to that observed in cancer cell lines was obtained using malignant pleural effusion samples from patients with IBC. A decrease in activity of the TIC surrogate aldehyde dehydrogenase was observed in PP-treated cells, and inhibition of WNT signaling by PP was associated with down-regulation of a panel of markers associated with epithelial-mesenchymal transition. In vivo, intratumoral injection was associated with tumor necrosis, and intraperitoneal injection into mice with tumor xenografts caused significant tumor growth delay and a trend toward decreased lung metastasis. In in vitro mammosphere-based and monolayer-based clonogenic assays, we found that PP radiosensitized cells in monolayer culture but not mammosphere culture. These findings suggest WNT signaling inhibition may be a feasible strategy for targeting aggressive breast cancer. Investigation and modification of the bioavailability and toxicity profile of systemic PP are warranted.	[Xu, Wei; Lacerda, Lara; Debeb, Bisrat G.; Atkinson, Rachel L.; Solley, Travis N.; Li, Li; Klopp, Ann H.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Orton, Darren] StemSynergy Therapeut Inc, Lauderdale By The Sea, FL USA; [McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Hang, Brian I.; Lee, Ethan] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Div Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Woodward, Wendy/AAX-6593-2020; Lacerda, Lara/E-2639-2015	Woodward, Wendy/0000-0002-7935-739X	National Institutes of Health [R01CA138239-01]; State of Texas; University of Texas Health Sciences Center [KL2 RR024149]; NCI GI Spore [P50 CA 95103]; NIGMS [R01 GM081635-05]; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA138239, P50CA095103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas; University of Texas Health Sciences Center; NCI GI Spore(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health R01CA138239-01, the State of Texas Grant for Rare and Aggressive Cancers, the University of Texas Health Sciences Center KL2 RR024149, NCI GI Spore P50 CA 95103, NIGMS R01 GM081635-05 and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BECK JW, 1959, AM J TROP MED HYG, V8, P349, DOI 10.4269/ajtmh.1959.8.349; BONNIER P, 1995, INT J CANCER, V62, P382, DOI 10.1002/ijc.2910620404; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Debeb BG, 2010, INT J RADIAT ONCOL, V76, P889, DOI 10.1016/j.ijrobp.2009.09.052; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Du Z, CANC SCI, V101, P2417; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; Herschkowitz JI, 2010, DIS MODEL MECH, V3, P257, DOI 10.1242/dmm.005207; HILL RP, 1989, INT J RADIAT ONCOL, V16, P513, DOI 10.1016/0360-3016(89)90353-2; Iwamoto T, 2011, BREAST CANCER RES TR, V125, P785, DOI 10.1007/s10549-010-1280-6; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu CC, 2012, P NATL ACAD SCI USA, V107, P5136; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PERRIMON N, 1989, GENETICS, V121, P333; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tomitsuka E, 2010, ANN NY ACAD SCI, V1201, P44, DOI 10.1111/j.1749-6632.2010.05620.x; Van Laere S, 2010, CANCER-AM CANCER SOC, V116, P2794, DOI 10.1002/cncr.25180; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Woodward WA, 2009, INT J RADIAT ONCOL, V74, P1580, DOI 10.1016/j.ijrobp.2009.03.047; Xiao Y, 2008, AM J PATHOL, V173, P561, DOI 10.2353/ajpath.2008.071214; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	61	40	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71508	10.1371/journal.pone.0071508	http://dx.doi.org/10.1371/journal.pone.0071508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013655	gold, Green Submitted, Green Published			2022-12-25	WOS:000323815200013
J	Arfanakis, K; Fleischman, DA; Grisot, G; Barth, CM; Varentsova, A; Morris, MC; Barnes, LL; Bennett, DA				Arfanakis, Konstantinos; Fleischman, Debra A.; Grisot, Giorgia; Barth, Christopher M.; Varentsova, Anna; Morris, Martha C.; Barnes, Lisa L.; Bennett, David A.			Systemic Inflammation in Non-Demented Elderly Human Subjects: Brain Microstructure and Cognition	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SMALL-VESSEL DISEASE; GENE-EXPRESSION; OLDER PERSONS; WHITE-MATTER; DIFFUSION; INTERLEUKIN-6; DECLINE; MARKERS; MRI	The purpose of this study was to test the hypothesis that higher levels of systemic inflammation in a community sample of non-demented subjects older than seventy years of age are associated with reduced diffusion anisotropy in brain white matter and lower cognition. Ninety-five older persons without dementia underwent detailed clinical and cognitive evaluation and magnetic resonance imaging, including diffusion tensor imaging. Systemic inflammation was assessed with a composite measure of commonly used circulating inflammatory markers (C-reactive protein and tumor necrosis factor-alpha). Tract-based spatial statistics analyses demonstrated that diffusion anisotropy in the body and isthmus of the corpus callosum was negatively correlated with the composite measure of systemic inflammation, controlling for demographic, clinical and radiologic factors. Visuospatial ability was negatively correlated with systemic inflammation, and diffusion anisotropy in the body and isthmus of the corpus callosum was shown to mediate this association. The findings of the present study suggest that higher levels of systemic inflammation may be associated with lower microstructural integrity in the corpus callosum of non-demented elderly individuals, and this may partially explain the finding of reduced higher-order visual cognition in aging.	[Arfanakis, Konstantinos; Grisot, Giorgia; Barth, Christopher M.; Varentsova, Anna] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Arfanakis, Konstantinos; Fleischman, Debra A.; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Arfanakis, Konstantinos] Rush Univ, Med Ctr, Dept Diagnost Radiol & Nucl Med, Chicago, IL 60612 USA; [Fleischman, Debra A.; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Fleischman, Debra A.; Barnes, Lisa L.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Morris, Martha C.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA	Illinois Institute of Technology; Rush University; Rush University; Rush University; Rush University; Rush University	Arfanakis, K (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	arfanakis@iit.edu	Arfanakis, Konstantinos/AAN-3148-2021	Arfanakis, Konstantinos/0000-0001-9705-597X	National Institute on Aging (NIA) [R01AG17917, R01AG2448]; National Institute of Minority Health and Health Disparities (NHMHD) [P20MD6886]; Alzheimer's Association grant [IIRG-07-59818]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R21EB005273, R21EB006525]; National Institute of Neurological Disorders and Stroke [R21NS076827]; Rush Translational Science Consortium; Pritzker Institute of Biomedical Science and Engineering; Marsha K. Dowd Philanthropic Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006525, R21EB005273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017917] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006886] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Minority Health and Health Disparities (NHMHD); Alzheimer's Association grant(Alzheimer's Association); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rush Translational Science Consortium; Pritzker Institute of Biomedical Science and Engineering; Marsha K. Dowd Philanthropic Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support provided by: National Institute on Aging (NIA) grants R01AG17917, R01AG2448; National Institute of Minority Health and Health Disparities (NHMHD) P20MD6886; Alzheimer's Association grant IIRG-07-59818; National Institute of Biomedical Imaging and Bioengineering (NIBIB) grants R21EB005273, R21EB006525; National Institute of Neurological Disorders and Stroke grant R21NS076827; Rush Translational Science Consortium; Pritzker Institute of Biomedical Science and Engineering; Marsha K. Dowd Philanthropic Fund. The fun ders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P23, DOI 10.1177/0891988708328216; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bettcher BM, 2013, NEUROCASE, V19, P182, DOI 10.1080/13554794.2011.654227; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Dik MG, 2005, NEUROLOGY, V64, P1371, DOI 10.1212/01.WNL.0000158281.08946.68; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Fleischman DA, 2010, J AM GERIATR SOC, V58, P1823, DOI 10.1111/j.1532-5415.2010.03049.x; Fornage M, 2008, STROKE, V39, P1952, DOI 10.1161/STROKEAHA.107.508135; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Glisky Elizabeth L., 2007, P3; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; Jefferson AL, 2007, NEUROLOGY, V68, P1032, DOI 10.1212/01.wnl.0000257815.20548.df; Kesler SR, 2004, CEREB CORTEX, V14, P174, DOI 10.1093/cercor/bhg116; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lezak MD, 2004, NEUROPSYCHOLOGICAL A; Luders E, 2009, INTELLIGENCE, V37, P156, DOI 10.1016/j.intell.2008.07.002; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miralbell J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.020; Mooijaart SP, 2013, J INTERN MED, V274, P77, DOI 10.1111/joim.12052; Noble JM, 2010, ARCH NEUROL-CHICAGO, V67, P87, DOI 10.1001/archneurol.2009.308; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Pierpaoli C, 2010, ISMRM P, P1597; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; Satizabal CL, 2012, NEUROLOGY, V78, P720, DOI 10.1212/WNL.0b013e318248e50f; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Schneider B.A., 2000, HDB AGING COGNITION, P155; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sullivan GW, 2000, J LEUKOCYTE BIOL, V67, P591, DOI 10.1002/jlb.67.5.591; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Trollor JN, 2012, AGE, V34, P1295, DOI 10.1007/s11357-011-9301-x; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Weindruch R, 2002, MECH AGEING DEV, V123, P177, DOI 10.1016/S0047-6374(01)00344-X; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; Zacharaki EI, 2008, LECT NOTES COMPUT SC, V5241, P620, DOI 10.1007/978-3-540-85988-8_74; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zhang S, 2013, P 21 ANN M ISMRM SAL; Zhang SW, 2011, NEUROIMAGE, V54, P974, DOI 10.1016/j.neuroimage.2010.09.008	69	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73107	10.1371/journal.pone.0073107	http://dx.doi.org/10.1371/journal.pone.0073107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991174	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800093
J	Senju, A; Vernetti, A; Kikuchi, Y; Akechi, H; Hasegawa, T				Senju, Atsushi; Vernetti, Angelina; Kikuchi, Yukiko; Akechi, Hironori; Hasegawa, Toshikazu			Cultural Modulation of Face and Gaze Scanning in Young Children	PLOS ONE			English	Article							STIMULI; INFANTS; EXPRESSIONS; TRACKING; THINKING; DISPLAY	Previous research has demonstrated that the way human adults look at others' faces is modulated by their cultural background, but very little is known about how such a culture-specific pattern of face gaze develops. The current study investigated the role of cultural background on the development of face scanning in young children between the ages of 1 and 7 years, and its modulation by the eye gaze direction of the face. British and Japanese participants' eye movements were recorded while they observed faces moving their eyes towards or away from the participants. British children fixated more on the mouth whereas Japanese children fixated more on the eyes, replicating the results with adult participants. No cultural differences were observed in the differential responses to direct and averted gaze. The results suggest that different patterns of face scanning exist between different cultures from the first years of life, but differential scanning of direct and averted gaze associated with different cultural norms develop later in life.	[Senju, Atsushi; Vernetti, Angelina] Univ London, Ctr Brain & Cognit Dev, London, England; [Kikuchi, Yukiko; Akechi, Hironori] Japan Soc Promot Sci, Tokyo, Japan; [Kikuchi, Yukiko] Ibaraki Univ, Coll Educ, Ibaraki, Japan; [Akechi, Hironori] Tokyo Denki Univ, Div Informat Syst Design, Saitama, Japan; [Hasegawa, Toshikazu] Univ Tokyo, Dept Cognit & Behav Sci, Tokyo 1538902, Japan	University of London; Birkbeck University London; Japan Society for the Promotion of Science; Ibaraki University; Tokyo Denki University; University of Tokyo	Senju, A (corresponding author), Univ London, Ctr Brain & Cognit Dev, London, England.	a.senju@bbk.ac.uk	Senju, Atsushi/C-4097-2008	Senju, Atsushi/0000-0002-8081-7170; Akechi, Hironori/0000-0003-4673-095X; Vernetti, Angelina/0000-0003-1256-1414	UK Medical Research Council [G1100252, G0701484]; Great Britain Sasakawa Foundation [3495]; Japan Society for the Promotion of Science [B16330192]; Grants-in-Aid for Scientific Research [25118003] Funding Source: KAKEN; Medical Research Council [G0701484, G1100252] Funding Source: researchfish; MRC [G1100252, G0701484] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Britain Sasakawa Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by the UK Medical Research Council [grant number G1100252; G0701484], the Great Britain Sasakawa Foundation [grant number #3495] and the Japan Society for the Promotion of Science [grant number B16330192]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akechi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059312; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; Fu GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037688; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; Hunnius S, 2004, INFANCY, V6, P231, DOI 10.1207/s15327078in0602_5; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kelly DJ, 2011, DEVELOPMENTAL SCI, V14, P1176, DOI 10.1111/j.1467-7687.2011.01067.x; Kelly DJ, 2011, FRONT PSYCH, P2; Liu SY, 2011, J EXP CHILD PSYCHOL, V108, P180, DOI 10.1016/j.jecp.2010.06.008; McCarthy A, 2008, J CROSS CULT PSYCHOL, V39, P716, DOI 10.1177/0022022108323807; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Rigato S, 2010, SOC COGN AFFECT NEUR, V5, P88, DOI 10.1093/scan/nsp037; Senju A, 2013, INT J BEHAV DEV, V37, P131, DOI 10.1177/0165025412465360; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Todorovic D, 2006, VISION RES, V46, P3549, DOI 10.1016/j.visres.2006.04.011; Wheeler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018621; Yarbus A.L., 1967, EYE MOVEMENT VISION	23	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74017	10.1371/journal.pone.0074017	http://dx.doi.org/10.1371/journal.pone.0074017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215RU	23991212	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000324228800113
J	Liu, X; Nie, H; Zhang, YB; Yao, YF; Maitikabili, A; Qu, YP; Shi, SL; Chen, CY; Li, Y				Liu, Xia; Nie, Huan; Zhang, Yubao; Yao, Yuanfei; Maitikabili, Alaiyi; Qu, Youpeng; Shi, Shuliang; Chen, Cuiying; Li, Yu			Cell Surface-Specific N-Glycan Profiling in Breast Cancer	PLOS ONE			English	Article							INDUCED HEPATOCELLULAR-CARCINOMA; GLYCOMIC CHANGES; GLYCOSYLATION; DIAGNOSIS; BIOMARKER; IDENTIFICATION; INHIBITION; EXPRESSION; DISEASE; MICE	Aberrant changes in specific glycans have been shown to be associated with immunosurveillance, tumorigenesis, tumor progression and metastasis. In this study, the N-glycan profiling of membrane proteins from human breast cancer cell lines and tissues was detected using modified DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE). The N-glycan profiles of membrane proteins were analyzed from 7 breast cancer cell lines and MCF 10A, as well as from 100 pairs of breast cancer and corresponding adjacent tissues. The results showed that, compared with the matched adjacent normal tissue samples, two biantennary N-glycans (NA2 and NA2FB) were significantly decreased (p <0.0001) in the breast cancer tissue samples, while the triantennary glycan (NA3FB) and a high-mannose glycan (M8) were dramatically increased (p = 0.001 and p <0.0001, respectively). Moreover, the alterations in these specific N-glycans occurred through the oncogenesis and progression of breast cancer. These results suggested that the modified method based on DSA-FACE is a high-throughput detection technology that is suited for analyzing cell surface N-glycans. These cell surface-specific N-glycans may be helpful in recognizing the mechanisms of tumor cell immunologic escape and could be potential targets for new breast cancer drugs.	[Liu, Xia; Nie, Huan; Yao, Yuanfei; Maitikabili, Alaiyi; Qu, Youpeng; Shi, Shuliang; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Zhang, Yubao] Harbin Med Univ, Tumor Hosp, Harbin, Heilongjiang, Peoples R China; [Chen, Cuiying] Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium; [Chen, Cuiying] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Harbin Institute of Technology; Harbin Medical University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Chen, CY (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium.	chittychen@ymail.com; liyugene@hit.edu.cn			National Natural Science Foundation of China [30700987, 81171945]; China Postdoctoral Science Foundation [20090451003]; Harbin Institute of Technology [HITQNJS.2007.026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Harbin Institute of Technology(Harbin Institute of Technology)	This work was supported by a grant from The National Natural Science Foundation of China (30700987 and 81171945), China Postdoctoral Science Foundation funded project (20090451003) and Project Supported by Development Program for Outstanding Young Teachers in Harbin Institute of Technology (HITQNJS.2007.026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Blomme B, 2010, AM J PHYSIOL-GASTR L, V298, pG615, DOI 10.1152/ajpgi.00414.2009; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chen CY, 2009, J PROTEOME RES, V8, P463, DOI 10.1021/pr800656e; Chen CC, 2010, REJUV RES, V13, P439, DOI 10.1089/rej.2009.0992; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Cormier JN, 1999, INT J CANCER, V80, P781, DOI 10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; Debruyne EN, 2010, CLIN CHEM, V56, P823, DOI 10.1373/clinchem.2009.139295; DICKERSON HW, 1989, J PROTOZOOL, V36, P159, DOI 10.1111/j.1550-7408.1989.tb01065.x; Ding N, 2011, AGE AGEING, V40, P568, DOI 10.1093/ageing/afr084; Fang M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-215; Fang M, 2010, INT J CANCER, V127, P148, DOI 10.1002/ijc.25030; Geyer H, 2006, BBA-PROTEINS PROTEOM, V1764, P1853, DOI 10.1016/j.bbapap.2006.10.007; Goldman R, 2009, CLIN CANCER RES, V15, P1808, DOI 10.1158/1078-0432.CCR-07-5261; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; Gui HL, 2010, LIVER INT, V30, P259, DOI 10.1111/j.1478-3231.2009.02170.x; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hudelist G, 2006, PROTEOMICS, V6, P1989, DOI 10.1002/pmic.200500129; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Lee KJ, 2009, BIOCHEM BIOPH RES CO, V380, P223, DOI 10.1016/j.bbrc.2009.01.070; Lisowska E, 2002, CELL MOL LIFE SCI, V59, P445, DOI 10.1007/s00018-002-8437-3; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Liu XE, 2010, LIVER INT, V30, P1221, DOI 10.1111/j.1478-3231.2010.02279.x; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; PAWELEK J, 2005, CLIN CANCER RES, V11, P2969, DOI DOI 10.1158/1078-0432.CCR-04-2211.PUBMED:15837749; PIERCE M, 2010, P NATL ACAD SCI USA, V107, P21116, DOI DOI 10.1073/PNAS.1013405107.PUBMED:21078982; Qu Y, 2012, ANN HEPATOL, V11, P202, DOI 10.1016/S1665-2681(19)31025-7; RIES LAG, 2005, SEER CANC STAT REV; Sobin, 2009, UICC TNM CLASSIFICAT; Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200; Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; Vlad Anda M, 2004, Breast Dis, V20, P73; WANG L, 2012, OJGAS, V2; Waterborg J H, 1984, Methods Mol Biol, V1, P1, DOI 10.1385/0-89603-062-8:1; Zhao YP, 2012, CANCER-AM CANCER SOC, V118, P639, DOI 10.1002/cncr.26342	43	38	38	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72704	10.1371/journal.pone.0072704	http://dx.doi.org/10.1371/journal.pone.0072704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009699	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200029
J	Wyce, A; Ganji, G; Smitheman, KN; Chung, CW; Korenchuk, S; Bai, YC; Barbash, O; Le, BC; Craggs, PD; McCabe, MT; Kennedy-Wilson, KM; Sanchez, LV; Gosmini, RL; Parr, N; McHugh, CF; Dhanak, D; Prinjha, RK; Auger, KR; Tummino, PJ				Wyce, Anastasia; Ganji, Gopinath; Smitheman, Kimberly N.; Chung, Chun-wa; Korenchuk, Susan; Bai, Yuchen; Barbash, Olena; Le, BaoChau; Craggs, Peter D.; McCabe, Michael T.; Kennedy-Wilson, Karen M.; Sanchez, Lydia V.; Gosmini, Romain L.; Parr, Nigel; McHugh, Charles F.; Dhanak, Dashyant; Prinjha, Rab K.; Auger, Kurt R.; Tummino, Peter J.			BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models	PLOS ONE			English	Article							N-MYC; C-MYC; BROMODOMAIN INHIBITION; THERAPEUTIC STRATEGY; GENE-EXPRESSION; CELL-LINES; IDENTIFICATION; APOPTOSIS; TARGETS; GROWTH	BET family proteins are epigenetic regulators known to control expression of genes involved in cell growth and oncogenesis. Selective inhibitors of BET proteins exhibit potent anti-proliferative activity in a number of hematologic cancer models, in part through suppression of the MYC oncogene and downstream Myc-driven pathways. However, little is currently known about the activity of BET inhibitors in solid tumor models, and whether down-regulation of MYC family genes contributes to sensitivity. Here we provide evidence for potent BET inhibitor activity in neuroblastoma, a pediatric solid tumor associated with a high frequency of MYCN amplifications. We treated a panel of neuroblastoma cell lines with a novel small molecule inhibitor of BET proteins, GSK1324726A (I-BET726), and observed potent growth inhibition and cytotoxicity in most cell lines irrespective of MYCN copy number or expression level. Gene expression analyses in neuroblastoma cell lines suggest a role of BET inhibition in apoptosis, signaling, and N-Myc-driven pathways, including the direct suppression of BCL2 and MYCN. Reversal of MYCN or BCL2 suppression reduces the potency of I-BET726-induced cytotoxicity in a cell line-specific manner; however, neither factor fully accounts for I-BET726 sensitivity. Oral administration of I-BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down-regulation MYCN and BCL2 expression, suggesting a potential role for these genes in tumor growth. Taken together, our data highlight the potential of BET inhibitors as novel therapeutics for neuroblastoma, and suggest that sensitivity is driven by pleiotropic effects on cell growth and apoptotic pathways in a context-specific manner.	[Wyce, Anastasia; Smitheman, Kimberly N.; Korenchuk, Susan; Barbash, Olena; Le, BaoChau; McCabe, Michael T.; McHugh, Charles F.; Dhanak, Dashyant; Auger, Kurt R.; Tummino, Peter J.] GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Collegeville, PA USA; [Ganji, Gopinath; Bai, Yuchen] GlaxoSmithKline, Mol Med Unit, Collegeville, PA USA; [Chung, Chun-wa; Craggs, Peter D.] GlaxoSmithKline, Platform Technol & Sci, Stevenage, Herts, England; [Kennedy-Wilson, Karen M.; Sanchez, Lydia V.] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA; [Gosmini, Romain L.] GlaxoSmithKline, Lipid Metab Discovery Performance Unit, Les Ulis, France; [Parr, Nigel; Prinjha, Rab K.] GlaxoSmithKline, Epinova Discovery Performance Unit, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Tummino, PJ (corresponding author), GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Collegeville, PA USA.	Peter.J.Tummino@gsk.com		Craggs, Pete/0000-0002-9546-6617				Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brambilla E, 1996, AM J PATHOL, V149, P1941; CASTLE VP, 1993, AM J PATHOL, V143, P1543; Chen QR, 2010, J PROTEOME RES, V9, P373, DOI 10.1021/pr900701v; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; DOLE M, 1994, CANCER RES, V54, P3253; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Galderisi U, 1999, J CELL BIOCHEM, V73, P97, DOI 10.1002/(SICI)1097-4644(19990401)73:1<97::AID-JCB11>3.0.CO;2-M; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; Jasty R, 2001, NEOPLASIA, V3, P304, DOI 10.1038/sj.neo.7900171; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang RC, 2011, BIOCHEM BIOPH RES CO, V410, P364, DOI 10.1016/j.bbrc.2011.06.020; Jones MH, 1997, GENOMICS, V45, P529, DOI 10.1006/geno.1997.5000; Lamers F, 2012, EUR J CANCER, V48, P3093, DOI 10.1016/j.ejca.2012.01.037; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Malynn BA, 2000, GENE DEV, V14, P1390; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; PUISSANT A, 2013, CANC DISCOV; Raetz EA, 2003, CANCER, V98, P841, DOI 10.1002/cncr.11584; REED JC, 1991, CANCER RES, V51, P6529; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Strieder V, 2003, J BIOL CHEM, V278, P2983, DOI 10.1074/jbc.M207596200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Golen CM, 2000, CELL DEATH DIFFER, V7, P654, DOI 10.1038/sj.cdd.4400693; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; WANG YS, 1992, ONCOGENE, V7, P1241; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	138	148	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72967	10.1371/journal.pone.0072967	http://dx.doi.org/10.1371/journal.pone.0072967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009722	Green Submitted, Green Published, gold			2022-12-25	WOS:000324403200038
J	Costin, BN; Dever, SM; Miles, MF				Costin, Blair N.; Dever, Seth M.; Miles, Michael F.			Ethanol Regulation of Serum Glucocorticoid Kinase 1 Expression in DBA2/J Mouse Prefrontal Cortex	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; PROTEIN-KINASE; SGK; ALCOHOL; STRESS; ACTIVATION; FAMILY; GENE; WITHDRAWAL; RECEPTORS	Background: We previously identified a group of glucocorticoid-responsive genes, including Serum Glucocorticoid kinase 1 (Sgk1), regulated by acute ethanol in prefrontal cortex of DBA2/J mice. Acute ethanol activates the hypothalamic pituitary adrenal axis (HPA) causing release of glucocorticoids. Chronic ethanol dysregulates the HPA response in both humans and rodents, possibly contributing to important interactions between stress and alcoholism. Because Sgk1 regulates ion channels and learning and memory, we hypothesized that Sgk1 contributes to HPA-dependent acute and adaptive neuronal responses to ethanol. These studies characterized acute and chronic ethanol regulation of Sgk1 mRNA and protein and their relationship with ethanol actions on the HPA axis. Results: Acute ethanol increased Sgk1 mRNA expression in a dose and time dependent manner. Three separate results suggested that ethanol regulated Sgk1 via circulating glucocorticoids: acute ethanol increased glucocorticoid receptor binding to the Sgk1 promoter; adrenalectomy blocked ethanol induction of Sgk1 mRNA; and chronic ethanol exposure during locomotor sensitization down-regulated HPA axis activation and Sgk1 induction by acute ethanol. SGK1 protein had complex temporal responses to acute ethanol with rapid and transient increases in Ser422 phosphorylation at 15 min. following ethanol administration. This activating phosphorylation had functional consequences, as suggested by increased phosphorylation of the known SGK1 target, N-myc downstream-regulated gene 1 (NDRG1). After repeated ethanol administration during locomotor sensitization, basal SGK1 protein phosphorylation increased despite blunting of Sgk1 mRNA induction by ethanol. Conclusions: These results suggest that HPA axis and glucocorticoid receptor signaling mediate acute ethanol induction of Sgk1 transcription in mouse prefrontal cortex. However, acute ethanol also causes complex changes in SGK1 protein expression and activity. Chronic ethanol modifies both SGK1 protein and HPA-mediated induction of Sgk1 mRNA. These adaptive molecular responses of glucocorticoid-responsive gene expression and SGK1 in prefrontal cortex may contribute to mechanisms underlying behavioral responses to chronic ethanol exposure.	[Costin, Blair N.; Miles, Michael F.] Virginia Commonwealth Univ, Alcohol Res Ctr, Richmond, VA 23284 USA; [Costin, Blair N.; Dever, Seth M.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Miles, MF (corresponding author), Virginia Commonwealth Univ, Alcohol Res Ctr, Richmond, VA 23284 USA.	mfmiles@vcu.edu			National Institute on Alcohol Abuse and Alcoholism [P20AA017828, U01AA016662, U01AA016667, F31AA020141]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017828, F31AA020141, R01AA020634, U01AA016662, U01AA016667] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism grants P20AA017828, U01AA016662 and U01AA016667 to MFM, and F31AA020141 to BNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Costa A, 1996, PSYCHONEUROENDOCRINO, V21, P263, DOI 10.1016/0306-4530(96)00001-7; Costin BN, 2013, ALCOHOL CLIN EXP RES, V37, P57, DOI 10.1111/j.1530-0277.2012.01841.x; Dai X, 2002, NEUROPSYCHOPHARMACOL, V27, P442, DOI 10.1016/S0893-133X(02)00308-1; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; ELLIS FW, 1966, J PHARMACOL EXP THER, V153, P121; Gamper N, 2002, PFLUG ARCH EUR J PHY, V443, P625, DOI 10.1007/s00424-001-0741-5; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kiefer Markus, 2011, Adv Cogn Psychol, V7, P55, DOI 10.2478/v10053-008-0090-4; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lee CT, 2006, EUR J NEUROSCI, V23, P1311, DOI 10.1111/j.1460-9568.2006.04650.x; Lee S, 1997, J NEUROSCI, V17, P8856; Lovallo WR, 2000, ALCOHOL CLIN EXP RES, V24, P651, DOI 10.1097/00000374-200005000-00009; Ma YL, 2006, LEARN MEMORY, V13, P114, DOI 10.1101/lm.179206; Marinelli M, 1997, J PHARMACOL EXP THER, V281, P1392; Metten P, 1998, MAMM GENOME, V9, P983, DOI 10.1007/s003359900911; Miranda P, 2013, J NEUROSCI, V33, P2684, DOI 10.1523/JNEUROSCI.3442-12.2013; Miyata S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019859; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1097/00000374-200012000-00013; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; ROBERTS AJ, 1995, J PHARMACOL EXP THER, V275, P790; Sahin P, 2013, NEUROPATHOL APPL NEU; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schutz-Geschwender A, 2004, UANTITATIVE TWOCOLOR; Sorocco KH, 2006, INT J PSYCHOPHYSIOL, V59, P210, DOI 10.1016/j.ijpsycho.2005.10.009; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632; Treadwell JA, 2004, NEUROCHEM RES, V29, P357, DOI 10.1023/B:NERE.0000013738.06437.a6; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Uhart M, 2009, ADDICT BIOL, V14, P43, DOI 10.1111/j.1369-1600.2008.00131.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vendruscolo LF, 2012, J NEUROSCI, V32, P7563, DOI 10.1523/JNEUROSCI.0069-12.2012; WAND GS, 1991, J CLIN ENDOCR METAB, V72, P1290, DOI 10.1210/jcem-72-6-1290; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Warntges S, 2002, PFLUG ARCH EUR J PHY, V443, P617, DOI 10.1007/s00424-001-0737-1; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; Wesch D, 2010, AM J PHYSIOL-CELL PH, V299, pC779, DOI 10.1152/ajpcell.00184.2010; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021100	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72979	10.1371/journal.pone.0072979	http://dx.doi.org/10.1371/journal.pone.0072979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991167	gold, Green Published			2022-12-25	WOS:000324470700054
J	Deng, MZ; He, WX; Tan, Y; Han, HL; Hu, XY; Xia, K; Zhang, ZH; Yan, RQ				Deng, Minzi; He, Wanxia; Tan, Ya; Han, Hailong; Hu, Xiangyou; Xia, Kun; Zhang, Zhuohua; Yan, Riqiang			Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of beta Site Amyloid Precursor Protein-cleaving Enzyme 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid Precursor Protein; Confocal Microscopy; Secretases; Synapses; BACE1; RTN3; Axonal Transport; Kymograph; Synaptic Localization	ALZHEIMERS-DISEASE; A-BETA; ASPARTYL PROTEASE; GAMMA-SECRETASE; BACE1; APP; TRAFFICKING; DEFICITS; FAMILY; RTN3	Background: Axonal transport of BACE1 and the regulation of BACE1 synaptic localization remain to be fully characterized. Results: Colocalization of BACE1 with synaptophysin was reduced by overexpression of RTN3. This reduction was due to reduced BACE1 axonal transport. Conclusion: Increased interaction of RTN3 with BACE1 in the soma impacts axonal transport of BACE1. Significance: Changes of BACE1 synaptic localization potentially alter synaptic A generation and amyloid deposition. BACE1 is the sole enzyme responsible for cleaving amyloid precursor protein at the -secretase site, and this cleavage initiates the generation of -amyloid peptide (A). Because amyloid precursor protein is predominantly expressed by neurons and deposition of A aggregates in the human brain is highly correlated with the A released at axonal terminals, we focused our investigation of BACE1 localization on the neuritic region. We show that BACE1 was not only enriched in the late Golgi, trans-Golgi network, and early endosomes but also in both axons and dendrites. BACE1 was colocalized with the presynaptic vesicle marker synaptophysin, indicating the presence of BACE1 in synapses. Because the excessive release of A from synapses is attributable to an increase in amyloid deposition, we further explored whether the presence of BACE1 in synapses was regulated by reticulon 3 (RTN3), a protein identified previously as a negative regulator of BACE1. We found that RTN3 is not only localized in the endoplasmic reticulum but also in neuritic regions where no endoplasmic reticulum-shaping proteins are detected, implicating additional functions of RTN3 in neurons. Coexpression of RTN3 with BACE1 in cultured neurons was sufficient to reduce colocalization of BACE1 with synaptophysin. This reduction correlated with decreased anterograde transport of BACE1 in axons in response to overexpressed RTN3. Our results in this study suggest that altered RTN3 levels can impact the axonal transport of BACE1 and demonstrate that reducing axonal transport of BACE1 in axons is a viable strategy for decreasing BACE1 in axonal terminals and, perhaps, reducing amyloid deposition.	[Deng, Minzi; Tan, Ya; Han, Hailong; Xia, Kun; Zhang, Zhuohua] Cent S Univ, State Key Lab Med Genet, Xiangya Med Sch, Changsha 410078, Hunan, Peoples R China; [He, Wanxia; Hu, Xiangyou; Yan, Riqiang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Central South University; Cleveland Clinic Foundation	Zhang, ZH (corresponding author), Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn; yanr@ccf.org	XIA, KUN/AAO-3525-2020	Yan, Riqiang/0000-0001-7195-7617	National Institutes of Health [AG025493, NS074256]; Chinese Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund Grant [81028008]; Chinese 973 Program Project Grant [2011CB510002]; Alzheimer's Association [NPSPAD-10-174543]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund Grant; Chinese 973 Program Project Grant(National Basic Research Program of China); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG025493 and NS074256 (to R. Y.). This work was also supported by Chinese Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund Grant 81028008 (to R. Y. and Z. Z.), by Chinese 973 Program Project Grant 2011CB510002 (to Z. Z.), and by Alzheimer's Association Grant NPSPAD-10-174543 (to R. Y.).	Araki W, 2013, CURR ALZHEIMER RES, V10, P135, DOI 10.2174/1567205011310020003; Cumming JN, 2004, CURR OPIN DRUG DISC, V7, P536; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Ghosh AK, 2012, J NEUROCHEM, V120, P71, DOI 10.1111/j.1471-4159.2011.07476.x; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hampel H, 2009, SCAND J CLIN LAB INV, V69, P8, DOI 10.1080/00365510701864610; He WX, 2007, J BIOL CHEM, V282, P29144, DOI 10.1074/jbc.M704181200; He WX, 2006, J MOL BIOL, V363, P625, DOI 10.1016/j.jmb.2006.07.094; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iwahashi J, 2007, BIOCHEM BIOPH RES CO, V355, P508, DOI 10.1016/j.bbrc.2007.02.001; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kasa P, 2001, BRAIN RES, V909, P159, DOI 10.1016/S0006-8993(01)02679-8; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kume H, 2009, J NEUROSCI RES, V87, P2963, DOI 10.1002/jnr.22112; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo XY, 2010, INT J CLIN EXP PATHO, V3, P618; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Prior M, 2010, NEUROSCI BIOBEHAV R, V34, P1201, DOI 10.1016/j.neubiorev.2010.01.017; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Schroeder BE, 2005, NEURON, V48, P873, DOI 10.1016/j.neuron.2005.12.005; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shi Q, 2013, J NEUROSCI, V33, P3059, DOI 10.1523/JNEUROSCI.2445-12.2013; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Shi Q, 2009, J NEUROSCI, V29, P5108, DOI 10.1523/JNEUROSCI.5887-08.2009; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Siegenthaler BM, 2012, NEURODEGENER DIS, V10, P116, DOI 10.1159/000335910; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tan JG, 2012, J NEUROCHEM, V120, P869, DOI 10.1111/j.1471-4159.2011.07623.x; Teng FYH, 2005, J NEUROSCI RES, V79, P273, DOI 10.1002/jnr.20361; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wang CL, 2012, BIOL OPEN, V1, P1248, DOI 10.1242/bio.20122451; Wang ZL, 2012, CURR ALZHEIMER RES, V9, P217, DOI 10.2174/156720512799361691; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Wojcik S, 2007, ACTA NEUROPATHOL, V114, P517, DOI 10.1007/s00401-007-0281-y; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Zhao B, 2013, J BIOL CHEM, V288, P15590, DOI 10.1074/jbc.M112.440784	64	38	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30236	30245		10.1074/jbc.M113.480079	http://dx.doi.org/10.1074/jbc.M113.480079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005676	Green Published, hybrid			2022-12-25	WOS:000329868100022
J	Liu, F; Gamez, G; Myers, DR; Clemmons, W; Lam, WA; Jobe, SM				Liu, Fang; Gamez, Graciela; Myers, David R.; Clemmons, Wayne; Lam, Wilbur A.; Jobe, Shawn M.			Mitochondrially Mediated Integrin alpha(IIb)beta(3) Protein Inactivation Limits Thrombus Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Integrin; Mitochondria; Platelets; Thrombosis	PERMEABILITY TRANSITION PORE; COATED-PLATELET FORMATION; VON-WILLEBRAND-FACTOR; PHOSPHATIDYLSERINE EXPOSURE; PROCOAGULANT ACTIVITY; CYTOPLASMIC DOMAIN; CALPAIN CLEAVAGE; ADHERENT PLATELETS; BLEEDING DISORDER; NA+/H+ EXCHANGER	When platelets are strongly stimulated, a procoagulant platelet subpopulation is formed that is characterized by phosphatidylserine (PS) exposure and epitope modulation of integrin (IIb3) or a loss of binding of activation-dependent antibodies. Mitochondrial permeability transition pore (mPTP) formation, which is essential for the formation of procoagulant platelets, is impaired in the absence of cyclophilin D (CypD). Here we investigate the mechanisms responsible for these procoagulant platelet-associated changes in integrin (IIb3) and the physiologic role of procoagulant platelet formation in the regulation of platelet aggregation. Among strongly stimulated adherent platelets, integrin (IIb3) epitope changes, mPTP formation, PS exposure, and platelet rounding were closely associated. Furthermore, platelet mPTP formation resulted in a decreased ability to recruit additional platelets. In the absence of CypD, integrin (IIb3) function was accentuated in both static and flow conditions, and, in vivo, a prothrombotic phenotype occurred in mice with a platelet-specific deficiency of CypD. CypD-dependent proteolytic events, including cleavage of the integrin (3) cytoplasmic domain, coincided closely with integrin (IIb3) inactivation. Calpain inhibition blocked integrin (3) cleavage and inactivation but not mPTP formation or PS exposure, indicating that integrin inactivation and PS exposure are mediated by distinct pathways subsequent to mPTP formation. mPTP-dependent alkalinization occurred in procoagulant platelets, suggesting a possible alternative mechanism for enhancement of calpain activity in procoagulant platelets. Together, these results indicate that, in strongly stimulated platelets, mPTP formation initiates the calpain-dependent cleavage of integrin (3) and associated regulatory proteins, resulting in integrin (IIb3) inactivation, and demonstrate a novel CypD-dependent negative feedback mechanism that limits platelet aggregation and thrombotic occlusion.	[Liu, Fang; Gamez, Graciela; Myers, David R.; Clemmons, Wayne; Lam, Wilbur A.; Jobe, Shawn M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Myers, David R.; Lam, Wilbur A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Lam, Wilbur A.; Jobe, Shawn M.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Children's Healthcare of Atlanta (CHOA)	Jobe, SM (corresponding author), BloodCtr Wisconsin, POB 2178, Milwaukee, WI 53201 USA.	shawn.jobe@bcw.edu	Myers, David Richard/G-7542-2017	Myers, David Richard/0000-0001-9659-3274	National Institutes of Health [HL095858]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health grant HL095858. This work was also supported by American Heart Association Fellow-to-Faculty Transition Award 2006-2011.	Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Briede JJ, 2003, J THROMB HAEMOST, V1, P559, DOI 10.1046/j.1538-7836.2003.00077.x; Brooks MB, 2007, J THROMB HAEMOST, V5, P1972, DOI 10.1111/j.1538-7836.2007.02683.x; Brooks MB, 2002, BLOOD, V99, P2434, DOI 10.1182/blood.V99.7.2434; Bucki R, 2006, BBA-MOL CELL BIOL L, V1761, P195, DOI 10.1016/j.bbalip.2005.12.008; Choo HJ, 2012, ARTERIOSCL THROM VAS, V32, P2946, DOI 10.1161/ATVBAHA.112.300433; Cosemans JMEM, 2011, BLOOD, V117, P651, DOI 10.1182/blood-2010-01-262683; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; GAFFET P, 1995, EUR J CELL BIOL, V67, P336; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Hess MW, 2001, HISTOCHEM CELL BIOL, V115, P439; HORNE WC, 1981, EUR J BIOCHEM, V120, P295, DOI 10.1111/j.1432-1033.1981.tb05703.x; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Kamocka MM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3322676; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Leo L, 2002, BLOOD, V100, P2839, DOI 10.1182/blood-2002-04-1234; Leytin V, 2004, BIOCHEM BIOPH RES CO, V320, P303, DOI 10.1016/j.bbrc.2004.05.166; Lishko VK, 2010, J THROMB HAEMOST, V8, P799, DOI 10.1111/j.1538-7836.2010.03778.x; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lopez E, 2011, CURR MED CHEM, V18, P5414, DOI 10.2174/092986711798194405; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; MURER EH, 1969, BIOCHIM BIOPHYS ACTA, V172, P266, DOI 10.1016/0005-2728(69)90069-3; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Remenyi G, 2005, ARTERIOSCL THROM VAS, V25, P467, DOI 10.1161/01.ATV.0000152726.49229.bf; Samson J, 2001, PLATELETS, V12, P436, DOI 10.1080/09537100120078395; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; van Kruchten R, 2013, BLOOD, V121, P1850, DOI 10.1182/blood-2012-09-454314; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Yakimenko AO, 2012, BIOPHYS J, V102, P2261, DOI 10.1016/j.bpj.2012.04.004; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhao X, 1998, NEUROSCI LETT, V247, P53, DOI 10.1016/S0304-3940(98)00219-5; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	47	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30672	30681		10.1074/jbc.M113.472688	http://dx.doi.org/10.1074/jbc.M113.472688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014035	hybrid, Green Published			2022-12-25	WOS:000329868100067
J	Stewart, DS; Hotta, M; Li, GD; Desai, R; Chiara, DC; Olsen, RW; Forman, SA				Stewart, Deirdre S.; Hotta, Mayo; Li, Guo-dong; Desai, Rooma; Chiara, David C.; Olsen, Richard W.; Forman, Stuart A.			Cysteine Substitutions Define Etomidate Binding and Gating Linkages in the alpha-M1 Domain of gamma-Aminobutyric Acid Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Anesthetics; GABA Receptors; Ion Channels; Nicotinic Acetylcholine Receptors; Sulfhydryl	GENERAL ANESTHETIC ETOMIDATE; GATED ION-CHANNEL; TRANSMEMBRANE DOMAIN; SUBUNIT INTERFACE; PROPOFOL BINDING; SITES; MUTATIONS; STATE; MODULATION; ACTIVATION	Etomidate is a potent general anesthetic that acts as an allosteric co-agonist at GABA(A) receptors. Photoreactive etomidate derivatives labeled Met-236 in transmembrane domain M1, which structural models locate in the +/- subunit interface. Other nearby residues may also contribute to etomidate binding and/or transduction through rearrangement of the site. In human 122L GABA(A) receptors, we applied the substituted cysteine accessibility method to 1-M1 domain residues extending from 1Gln-229 to 1Gln-242. We used electrophysiology to characterize each mutant's sensitivity to GABA and etomidate. We also measured rates of sulfhydryl modification by p-chloromercuribenzenesulfonate (pCMBS) with and without GABA and tested if etomidate blocks modification of pCMBS-accessible cysteines. Cys substitutions in the outer 1-M1 domain impaired GABA activation and variably affected etomidate sensitivity. In seven of eight residues where pCMBS modification was evident, rates of modification were accelerated by GABA co-application, indicating that channel activation increases water and/or pCMBS access. Etomidate reduced the rate of modification for cysteine substitutions at 1Met-236, 1Leu-232 and 1Thr-237. We infer that these residues, predicted to face 2-M3 or M2 domains, contribute to etomidate binding. Thus, etomidate interacts with a short segment of the outer 1-M1 helix within a subdomain that undergoes significant structural rearrangement during channel gating. Our results are consistent with in silico docking calculations in a homology model that orient the long axis of etomidate approximately orthogonal to the transmembrane axis.	[Stewart, Deirdre S.; Hotta, Mayo; Desai, Rooma; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Stewart, Deirdre S.; Chiara, David C.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Li, Guo-dong; Olsen, Richard W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Li, Guo-dong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Forman, SA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Jackson 444, Boston, MA 02114 USA.	saforman@partners.org	Forman, Stuart/Q-6590-2019	Forman, Stuart/0000-0001-6340-2478	National Institutes of Health [R01GM089745, P01GM58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448, R01GM089745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM089745 and P01GM58448.	Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2012, J BIOL CHEM, V287, P27762, DOI 10.1074/jbc.M112.363341; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Burkat PM, 2001, J NEUROSCI, V21, P7026, DOI 10.1523/JNEUROSCI.21-18-07026.2001; Carlson BX, 2000, MOL PHARMACOL, V57, P474, DOI 10.1124/mol.57.3.474; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Desai R, 2009, ANESTHESIOLOGY, V111, P774, DOI 10.1097/ALN.0b013e3181b55fae; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Ghosh B, 2013, J BIOL CHEM, V288, P17420, DOI 10.1074/jbc.M113.464040; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Krasowski MD, 1998, J PHARMACOL EXP THER, V284, P934; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Rusch D, 2005, ANESTHESIOLOGY, V102, P783; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Scheller M, 2002, J NEUROSCI, V22, P8411; Siegwart Roberta, 2003, BMC Pharmacol, V3, P13, DOI 10.1186/1471-2210-3-13; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Stewart DS, 2013, MOL PHARMACOL, V83, P1200, DOI 10.1124/mol.112.084558; Tomlin SL, 1998, ANESTHESIOLOGY, V88, P708, DOI 10.1097/00000542-199803000-00022; Yang J, 1996, NEUROSCIENCE, V73, P69, DOI 10.1016/0306-4522(96)00018-8	50	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30373	30386		10.1074/jbc.M113.494583	http://dx.doi.org/10.1074/jbc.M113.494583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24009076	Green Published, hybrid			2022-12-25	WOS:000329868100034
J	Gourapura, RJ; Khan, MA; Gallo, RM; Shaji, D; Liu, JY; Brutkiewicz, RR				Gourapura, Renukaradhya J.; Khan, Masood A.; Gallo, Richard M.; Shaji, Daniel; Liu, Jianyun; Brutkiewicz, Randy R.			Forming a Complex with MHC Class I Molecules Interferes with Mouse CD1d Functional Expression	PLOS ONE			English	Article							CD1D-MEDIATED ANTIGEN PRESENTATION; T-CELL RECOGNITION; SURFACE; INHIBITION; RECEPTORS; BINDING; MICE; LY49; GLYCOLIPIDS; TRAFFICKING	CD1d molecules are structurally similar to MHC class I, but present lipid antigens as opposed to peptides. Here, we show that MHC class I molecules physically associate with (and regulate the functional expression of) mouse CD1d on the surface of cells. Low pH (3.0) acid stripping of MHC class I molecules resulted in increased surface expression of murine CD1d on antigen presenting cells as well as augmented CD1d-mediated antigen presentation to NKT cells. Consistent with the above results, TAP1-/- mice were found to have a higher percentage of type I NKT cells as compared to wild type mice. Moreover, bone marrow-derived dendritic cells from TAP1-/- mice showed increased antigen presentation by CD1d compared to wild type mice. Together, these results suggest that MHC class I molecules can regulate NKT cell function, in part, by masking CD1d.	[Gourapura, Renukaradhya J.; Khan, Masood A.; Gallo, Richard M.; Shaji, Daniel; Liu, Jianyun; Brutkiewicz, Randy R.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Brutkiewicz, RR (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	rbrutkie@iupui.edu	Gourapura, Renukaradhya/E-3143-2011; Khan, Masood A./G-9693-2011	Khan, Masood A./0000-0003-4031-4189; Brutkiewicz, Randy/0000-0002-7396-480X; Gourapura, Renukaradhya/0000-0003-2861-180X	NIH [R01 AI46455, P01 AI056097, T32 DK007519, T32 HL07910]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056097, R01AI046455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01 AI46455 and P01 AI056097 to R.R.B.R.M.G. was the recipient of a NIH T32 postdoctoral fellowship (T32 HL07910) and G.J.R. was supported by an NIH training grant (T32 DK007519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; BLUMBERG RS, 1995, IMMUNOL REV, V147, P5, DOI 10.1111/j.1600-065X.1995.tb00085.x; BRADBURY A, 1990, EUR J IMMUNOL, V20, P1831, DOI 10.1002/eji.1830200830; Brossay L, 1997, J IMMUNOL, V159, P1216; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Brutkiewicz RR, 2003, CRIT REV IMMUNOL, V23, P403, DOI 10.1615/CritRevImmunol.v23.i56.30; Burdin N, 1998, J IMMUNOL, V161, P3271; CANCHIS PW, 1993, IMMUNOLOGY, V80, P561; Chen HJ, 1997, J IMMUNOL, V158, P5112; Chen HJ, 1997, J IMMUNOL, V159, P2240; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Gui M, 2001, J IMMUNOL, V167, P6239, DOI 10.4049/jimmunol.167.11.6239; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Joyce S, 1996, J EXP MED, V184, P1579, DOI 10.1084/jem.184.4.1579; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Khan MA, 2009, J IMMUNOL, V182, P4744, DOI 10.4049/jimmunol.0804311; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lin YL, 2005, J LEUKOCYTE BIOL, V77, P151, DOI 10.1189/jlb.0704399; Maeda M, 2001, J IMMUNOL, V167, P4180, DOI 10.4049/jimmunol.167.8.4180; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Renukaradhya GJ, 2005, J IMMUNOL, V175, P4301, DOI 10.4049/jimmunol.175.7.4301; Renukaradhya JG, 2004, HYBRIDOMA HYBRIDOM, V23, P373; Roark JH, 1998, J IMMUNOL, V160, P3121; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Schell TD, 2002, INT IMMUNOL, V14, P775, DOI 10.1093/intimm/dxf041; Shimizu I, 2001, IMMUNOBIOLOGY, V204, P466, DOI 10.1078/0171-2985-00056; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Skold M, 2003, IMMUNOLOGY, V110, P313, DOI 10.1046/j.1365-2567.2003.01741.x; Sriram V, 2002, P NATL ACAD SCI USA, V99, P8197, DOI 10.1073/pnas.122636199; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; SZOLLOSI J, 1989, J IMMUNOL, V143, P208; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Young DC, 2006, GLYCOBIOLOGY, V16, p103R, DOI 10.1093/glycob/cwj111; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72867	10.1371/journal.pone.0072867	http://dx.doi.org/10.1371/journal.pone.0072867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009709	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600039
J	Iizumi, Y; Oishi, M; Taniguchi, T; Goi, W; Sowa, Y; Sakai, T				Iizumi, Yosuke; Oishi, Masakatsu; Taniguchi, Tomoyuki; Goi, Wakana; Sowa, Yoshihiro; Sakai, Toshiyuki			The Flavonoid Apigenin Downregulates CDK1 by Directly Targeting Ribosomal Protein S9	PLOS ONE			English	Article							CELL-CYCLE ARREST; INHIBITION; INDUCTION; P21/WAF1; GROWTH; P53; PROGRESSION; APOPTOSIS; SUBUNIT; GENE	Flavonoids have been reported to inhibit tumor growth by causing cell cycle arrest. However, little is known about the direct targets of flavonoids in tumor growth inhibition. In the present study, we developed a novel method using magnetic FG beads to purify flavonoid-binding proteins, and identified ribosomal protein S9 (RPS9) as a binding partner of the flavonoid apigenin. Similar to treatment with apigenin, knockdown of RPS9 inhibited the growth of human colon cancer cells at the G2/M phase by downregulating cyclin-dependent kinase 1 (CDK1) expression at the promoter level. Furthermore, knockdown of RPS9 suppressed G2/M arrest caused by apigenin. These results suggest that apigenin induces G2/M arrest at least partially by directly binding and inhibiting RPS9 which enhances CDK1 expression. We therefore raise the possibility that identification of the direct targets of flavonoids may contribute to the discovery of novel molecular mechanisms governing tumor growth.	[Iizumi, Yosuke; Oishi, Masakatsu; Taniguchi, Tomoyuki; Goi, Wakana; Sowa, Yoshihiro; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan; [Oishi, Masakatsu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kamigyo Ku, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Sakai, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan.	tsakai@koto.kpu-m.ac.jp			JSPS [21890223, 23689036]; Grants-in-Aid for Scientific Research [13J10279] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 21890223 and 23689036. KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; Bai FL, 1998, FEBS LETT, V437, P61, DOI 10.1016/S0014-5793(98)01198-3; Birt DF, 1997, ANTICANCER RES, V17, P85; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Hsu SL, 2001, EUR J PHARMACOL, V425, P165, DOI 10.1016/S0014-2999(01)01144-X; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Kim DI, 2008, CARCINOGENESIS, V29, P1701, DOI 10.1093/carcin/bgn055; Lepley DM, 1997, MOL CARCINOGEN, V19, P74, DOI 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L; Lepley DM, 1996, CARCINOGENESIS, V17, P2367, DOI 10.1093/carcin/17.11.2367; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MATSUKAWA Y, 1993, CANCER RES, V53, P1328; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; NISHINO H, 1983, CANCER LETT, V21, P1, DOI 10.1016/0304-3835(83)90075-7; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Plaumann B, 1996, ONCOGENE, V13, P1605; SATO F, 1994, BIOCHEM BIOPH RES CO, V204, P578, DOI 10.1006/bbrc.1994.2498; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Takagaki N, 2005, INT J ONCOL, V26, P185; Torkin R, 2005, MOL CANCER THER, V4, P1; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Ujiki MB, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-76; Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wang WQ, 2000, MOL CARCINOGEN, V28, P102; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WEI HC, 1990, CANCER RES, V50, P499; YOSHIDA M, 1990, FEBS LETT, V260, P10, DOI 10.1016/0014-5793(90)80053-L; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhong Y, 2010, EUR J CANCER, V46, P3365, DOI 10.1016/j.ejca.2010.07.007; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	39	27	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73219	10.1371/journal.pone.0073219	http://dx.doi.org/10.1371/journal.pone.0073219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009741	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600061
J	Reinders, J; Sonntag, R; Heisel, C; Reiner, T; Vot, L; Kretzer, JP				Reinders, Joern; Sonntag, Robert; Heisel, Christian; Reiner, Tobias; Vot, Leo; Kretzer, Jan Philippe			Wear Performance of Ceramic-On-Metal Hip Bearings	PLOS ONE			English	Article							IN-VITRO; DIFFERENTIAL-HARDNESS; FILM FORMATION; ARTHROPLASTY; REPLACEMENT; LUBRICATION; JOINTS; SQUEAKING; SIMULATOR; RATES	Ceramic-on-metal (CoM) bearings are considered to be a promising alternative to polyethylene-based bearings or hard-on-hard bearings (Ceramic-on-Ceramic (CoC) and Metal-on-Metal (MoM)). Although, CoM shows lower wear rates than MoM, in-vitro wear testing of CoM shows widely varying results. This may be related to limitations of wear-measuring methods. Therefore, the aim of this study was to improve the gravimetric measurement technique and to test wear behaviour of CoM bearings compared to CoC bearings. Level walking according to ISO-14242 was simulated for four CoM and four CoC bearings. Prior to simulation, errors in measurement of gravimetric wear were detected and improvements in measurement technique incorporated. The results showed no differences in mean wear rates between CoM and CoC bearings. However, the CoM bearings showed wear results over a wide range of wear performance. High reliability of wear results was recorded for the CoC bearings. Material transfer was observed on the ceramic heads of the CoM bearings. Therefore, for level walking a partial mixed or boundary lubrication has to be assumed for this type of bearing. CoM is a highly sensitive wear-couple. The reasons for the observed behaviour cannot be clarified from this study. Simulator studies have to be considered as an ideal loading condition. Therefore, high variations in wear rates as seen in this study, even at low levels, may have an adverse effect on the in-vivo wear behavior. Careful clinical use may be advisable until the reasons for the variation are fully clarified and understood.	[Reinders, Joern; Sonntag, Robert; Heisel, Christian; Reiner, Tobias; Vot, Leo; Kretzer, Jan Philippe] Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Lab Biomechan & Implant Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Reinders, J (corresponding author), Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Lab Biomechan & Implant Res, Heidelberg, Germany.	joern.reinders@med.uni-heidelberg.de		Reinders, Jorn/0000-0002-8258-7735				Affatato S, 2010, ARTIF ORGANS, V34, P319, DOI 10.1111/j.1525-1594.2009.00854.x; Affatato S, 2009, J BIOMECH, V42, P2439, DOI 10.1016/j.jbiomech.2009.07.031; Barnes CL, 2008, J ARTHROPLASTY, V23, P56, DOI 10.1016/j.arth.2008.05.021; Cigada A, 2011, J APPL BIOMATER BIOM, V9, P2, DOI 10.5301/JABB.2011.7730; D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39; Fan JY, 2012, FARADAY DISCUSS, V156, P69, DOI 10.1039/c2fd00129b; Firkins PJ, 2001, J BIOMECH, V34, P1291, DOI 10.1016/S0021-9290(01)00096-3; Fisher J, 1991, Proc Inst Mech Eng H, V205, P73, DOI 10.1243/PIME_PROC_1991_205_271_02; Fisher J, 2006, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000238871.07604.49; Garellick G, 2009, ANN REPORT GOTEBORG; Hannouche D, 2003, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000096806.78689.50; Heisel C, 2008, J BONE JOINT SURG AM, V90A, P125, DOI 10.2106/JBJS.H.00437; Isaac GH, 2009, J BONE JOINT SURG BR, V91B, P1134, DOI 10.1302/0301-620X.91B9.22306; Ishida T, 2009, J BIOMED MATER RES B, V91B, P887, DOI 10.1002/jbm.b.31471; Jin ZM, 2003, TRIBOLOGICAL RESEARCH AND DESIGN FOR ENGINEERING SYSTEMS, P237; Kamali A, 2010, J BONE JOINT SURG BR, V92B, P717, DOI 10.1302/0301-620X.92B5.23320; Keurentjes JC, 2008, CLIN ORTHOP RELAT R, V466, P1438, DOI 10.1007/s11999-008-0177-8; Kinkel S, 2009, CLIN ORTHOP RELAT R, V467, P2053, DOI 10.1007/s11999-009-0756-3; Kretzer JP, 2010, TRIBOL LETT, V37, P23, DOI 10.1007/s11249-009-9486-7; Kretzer JP, 2009, J ORTHOP RES, V27, P1473, DOI 10.1002/jor.20921; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Meng QE, 2013, TRIBOL INT, V63, P51, DOI 10.1016/j.triboint.2012.02.012; Myant C, 2012, J MECH BEHAV BIOMED, V6, P30, DOI 10.1016/j.jmbbm.2011.09.008; Nevelos J, 2000, J ARTHROPLASTY, V15, P793, DOI 10.1054/arth.2000.8100; Pozivil M, 2006, MICROCHIM ACTA, V154, P55, DOI 10.1007/s00604-005-0479-4; Valenti JR, 2007, J ARTHROPLASTY, V22, P920, DOI 10.1016/j.arth.2006.06.008; Schouten R, 2012, J BONE JOINT SURG BR, V94B, P1462, DOI 10.1302/0301-620X.94B11.29343; Steens W, 2006, ORTHOPADE, V35, P860, DOI 10.1007/s00132-006-0973-3; Tower SS, 2010, J BONE JOINT SURG AM, V92A, P2847, DOI 10.2106/JBJS.J.00125; Walter WL, 2007, J ARTHROPLASTY, V22, P496, DOI 10.1016/j.arth.2006.06.018; Williams DH, 2011, J BONE JOINT SURG AM, V93A, P2164, DOI 10.2106/JBJS.J.01884; Williams S, 2013, J BIOMED MATER RES B, V101, P770; Williams SR, 2011, P I MECH ENG H, V225, P783, DOI 10.1177/0954411911404773; Williams S, 2007, CLIN ORTHOP RELAT R, P23, DOI 10.1097/BLO.0b013e31814da946; Willmann G, 2000, CLIN ORTHOP RELAT R, P22; Wimmer MA, 2010, J ORTHOP RES, V28, P436, DOI 10.1002/jor.21020; Zywiel MG, 2011, CLIN ORTHOP RELAT R, V469, P1536, DOI 10.1007/s11999-010-1658-0	39	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73252	10.1371/journal.pone.0073252	http://dx.doi.org/10.1371/journal.pone.0073252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009743	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600062
J	Fukamachi, H; Seol, HS; Shimada, S; Funasaka, C; Baba, K; Kim, JH; Park, YS; Kim, MJ; Kato, K; Inokuchi, M; Kawachi, H; Yook, JH; Eishi, Y; Kojima, K; Kim, WH; Jang, SJ; Yuasa, Y				Fukamachi, Hiroshi; Seol, Hyang Sook; Shimada, Shu; Funasaka, Chikako; Baba, Kanako; Kim, Ji Hun; Park, Young Soo; Kim, Mi Jeung; Kato, Keiji; Inokuchi, Mikito; Kawachi, Hiroshi; Yook, Jeong Hwan; Eishi, Yoshinobu; Kojima, Kazuyuki; Kim, Woo Ho; Jang, Se Jin; Yuasa, Yasuhito			CD49f(high) Cells Retain Sphere-Forming and Tumor-Initiating Activities in Human Gastric Tumors	PLOS ONE			English	Article							CANCER STEM-CELLS; GASTROINTESTINAL EPITHELIAL-CELLS; PROSPECTIVE IDENTIFICATION; ALPHA(6)BETA(4) INTEGRIN; SELF-RENEWAL; CARCINOMA; PROLIFERATION; EXPRESSION; GROWTH; MECHANISM	Identification of gastric tumor-initiating cells (TICs) is essential to explore new therapies for gastric cancer patients. There are reports that gastric TICs can be identified using the cell surface marker CD44 and that they form floating spheres in culture, but we could not obtain consistent results with our patient-derived tumor xenograft (PDTX) cells. We thus searched for another marker for gastric TICs, and found that CD49f(high) cells from newly-dissected gastric cancers formed tumors with histological features of parental ones while CD49f(low) cells did not when subcutaneously injected into immunodeficient mice. These results indicate that CD49f, a subunit of laminin receptors, is a promising marker for human gastric TICs. We established a primary culture system for PDTX cells where only CD49f(high) cells could grow on extracellular matrix (ECM) to form ECM-attaching spheres. When injected into immunodeficient mice, these CD49f(high) sphere cells formed tumors with histological features of parental ones, indicating that only TICs could grow in the culture system. Using this system, we found that some sphere-forming TICs were more resistant than gastric tumor cell lines to chemotherapeutic agents, including doxorubicin, 5-fluorouracil and doxifluridine. There was a patient-dependent difference in the tumorigenicity of sphere-forming TICs and their response to anti-tumor drugs. These results suggest that ECM plays an essential role for the growth of TICs, and that this culture system will be useful to find new drugs targeting gastric TICs.	[Fukamachi, Hiroshi; Shimada, Shu; Funasaka, Chikako; Baba, Kanako; Yuasa, Yasuhito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan; [Seol, Hyang Sook; Kim, Ji Hun; Park, Young Soo; Kim, Mi Jeung; Jang, Se Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Kato, Keiji; Inokuchi, Mikito; Kojima, Kazuyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Surg Oncol, Tokyo, Japan; [Kawachi, Hiroshi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Tokyo, Japan; [Yook, Jeong Hwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Tokyo Medical & Dental University (TMDU); University of Ulsan; Asan Medical Center; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Ulsan; Asan Medical Center; Seoul National University (SNU)	Fukamachi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	hfukama.monc@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670; Inokuchi, Mikito/0000-0001-7321-848X	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science (JSPS) [20390169, 22501005]; Ministry of Health & Welfare, Republic of Korea [A062254]; JSPS; National Research Foundation of Korea; Grants-in-Aid for Scientific Research [25830074] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation of Korea(National Research Foundation of Korea); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science (JSPS) (20390169 to YY and 22501005 to HF, respectively), by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A062254, SJJ), and by A3 Foresight Programs from the JSPS and National Research Foundation of Korea (YY and WHK, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adikrisna R, 2012, GASTROENTEROLOGY, V143, P234, DOI 10.1053/j.gastro.2012.03.054; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen T, 2012, CELL RES, V22, P248, DOI 10.1038/cr.2011.109; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; da Cunha CB, 2010, LAB INVEST, V90, P1604, DOI 10.1038/labinvest.2010.155; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; FUKAMACHI H, 1992, J CELL SCI, V103, P511; FUKAMACHI H, 1995, DEV GROWTH DIFFER, V37, P11; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Han ME, 2011, CELL MOL LIFE SCI, V68, P3589, DOI 10.1007/s00018-011-0672-z; Haraguchi N, 2013, INT J ONCOL, V43, P425, DOI 10.3892/ijo.2013.1955; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu WY, 2011, ENDOCRINOLOGY, V152, P2150, DOI 10.1210/en.2010-1377; Ichinose M, 1997, BIOCHEM BIOPH RES CO, V230, P537, DOI 10.1006/bbrc.1996.5977; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; JUN SH, 1994, INT J ONCOL, V4, P55; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; Kim WH, 1999, ANTICANCER RES, V19, P3067; Koike N, 1997, J CANCER RES CLIN, V123, P310, DOI 10.1007/s004320050063; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rocco A, 2012, J CELL PHYSIOL, V227, P2686, DOI 10.1002/jcp.23013; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Singh SK, 2003, CANCER RES, V63, P5821; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tani T, 1996, AM J PATHOL, V149, P781; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WEINEL RJ, 1995, GASTROENTEROLOGY, V108, P523, DOI 10.1016/0016-5085(95)90082-9; Yamamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046979; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5	52	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72438	10.1371/journal.pone.0072438	http://dx.doi.org/10.1371/journal.pone.0072438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015244	gold, Green Published, Green Submitted			2022-12-25	WOS:000323733800052
J	Lommerse, K; Stewart, RC; Chilimba, Q; van den Akker, T; Lund, C				Lommerse, Kinke; Stewart, Robert C.; Chilimba, Queen; van den Akker, Thomas; Lund, Crick			A Descriptive Analysis of HIV Prevalence, HIV Service Uptake, and HIV-Related Risk Behaviour among Patients Attending a Mental Health Clinic in Rural Malawi	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SUBSTANCE-ABUSE; HIV/AIDS CARE; ILLNESS; ADULTS; OUTPATIENTS; COUNTRIES; PEOPLE; IMPACT	Background: Human immunodeficiency virus (HIV) and mental illness are interlinked health problems; mental illness may pose a risk for contracting HIV and HIV-positive individuals are at higher risk of mental illness. However, in countries with high HIV prevalence, the main focus of HIV-related health programmes is usually on prevention and treatment of somatic complications of HIV, and mental illness is not given high priority. We examined HIV prevalence, uptake of HIV services, and HIV-related risk behaviour among people attending a mental health clinic in rural Malawi. Methodology: Semi-structured interviews were performed with patients capable to consent (94%), and with those accompanied by a capable caregiver who consented. HIV counselling and testing was offered to participants. Findings: Among 174 participants, we collected 162 HIV test results (91%). HIV prevalence was 14.8%. Women were three times as likely to be HIV-positive compared to men. Two-thirds of participants reported having been tested for HIV prior to this study. The uptake of HIV-services among HIV-positive patients was low: 35% did not use recommended prophylactic therapy and 44% of patients not receiving antiretroviral treatment (ART) had never been assessed for ART eligibility. The reported rate of sexual activity was 61%, and 9% of sexually active participants had multiple partners. Inconsistent condom use with stable (89%) and occasional (79%) sexual partners, and absence of knowledge of the HIV status of those partners (53%, 63%) indicate high levels of sexual risk behaviour. Conclusions: HIV-prevalence among persons attending the clinic, particularly men, was lower than among the general population in a population survey. The rate of HIV testing was high, but there was low uptake of preventive measures and ART. This illustrates that HIV-positive individuals with mental illness or epilepsy constitute a vulnerable population. HIV programmes should include those with neuropsychiatric illness.	[Lommerse, Kinke; Chilimba, Queen; van den Akker, Thomas] Minist Hlth, Thyolo Dist Hlth Off, Thyolo, Malawi; [Lommerse, Kinke] GGZinGeest, Dept Psychiat, Amsterdam, Netherlands; [Stewart, Robert C.] Univ Malawi, Coll Med, Dept Mental Hlth, Blantyre, Malawi; [Lund, Crick] Univ Cape Town, Dept Psychiat & Mental Hlth, Ctr Publ Mental Hlth, ZA-7925 Cape Town, South Africa	University of Malawi; University of Cape Town	Lommerse, K (corresponding author), Minist Hlth, Thyolo Dist Hlth Off, Thyolo, Malawi.	k.lommerse@ggzingeest.nl		Lund, Crick/0000-0002-5159-8220	Department for International Development (DFID), United Kingdom	Department for International Development (DFID), United Kingdom	Crick Lund is funded by the Department for International Development (DFID), United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other external funding received for this study.	Acuda S. W., 1996, Central African Journal of Medicine, V42, P254; AyusoMateos JL, 1997, BRIT J PSYCHIAT, V170, P181, DOI 10.1192/bjp.170.2.181; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Birbeck G, 2007, LANCET NEUROL, V6, P39, DOI 10.1016/S1474-4422(06)70629-9; Campos Michael D, 2008, J Ethn Subst Abuse, V7, P268, DOI 10.1080/15332640802313262; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Chandra PS, 2003, INT J STD AIDS, V14, P532, DOI 10.1258/095646203767869147; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Collins PY, 2009, AIDS CARE, V21, P863, DOI 10.1080/09540120802626188; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Cournos F, 1997, CLIN PSYCHOL REV, V17, P259, DOI 10.1016/S0272-7358(97)00018-4; Desai MM, 2007, J NERV MENT DIS, V195, P776, DOI 10.1097/NMD.0b013e31814514ad; Desai MM, 2004, AM J PSYCHIAT, V161, P2287, DOI 10.1176/appi.ajp.161.12.2287; Gottesman II, 1997, SCHIZOPHRENIA BULL, V23, P675, DOI 10.1093/schbul/23.4.675; Government of Malawi Ministry of Health, 2008, GUID US ANT THER MAL; Government of Malawi Ministry of Health, 2009, GUID HIV TEST COUNS; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Meade CS, 2007, COMMUNITY MENT HLT J, V43, P153, DOI 10.1007/s10597-006-9071-6; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; *NAT STAT OFF, 2005, MAL DEM HLTH SURV 20; Parrott FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027917; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rosenberg SD, 2001, AM J PUBLIC HEALTH, V91, P31, DOI 10.2105/AJPH.91.1.31; Senn TE, 2009, PSYCHOL MED, V39, P355, DOI 10.1017/S0033291708003930; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Tucker JS, 2003, AIDS BEHAV, V7, P29, DOI 10.1023/A:1022557222690; Wainberg ML, 2008, WORLD PSYCHIATRY, V7, P166; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; World Health Organization, 2011, WORLD HLTH STAT GEN	30	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72171	10.1371/journal.pone.0072171	http://dx.doi.org/10.1371/journal.pone.0072171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015216	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800035
J	Fisher, KD; Scheffler, TL; Kasten, SC; Reinholt, BM; van Eyk, GR; Escobar, J; Scheffler, JM; Gerrard, DE				Fisher, Kimberly D.; Scheffler, Tracy L.; Kasten, Steven C.; Reinholt, Brad M.; van Eyk, Gregory R.; Escobar, Jeffery; Scheffler, Jason M.; Gerrard, David E.			Energy Dense, Protein Restricted Diet Increases Adiposity and Perturbs Metabolism in Young, Genetically Lean Pigs	PLOS ONE			English	Article							REACTIVE DICARBONYL-COMPOUNDS; GAMMA-GLUTAMYL-TRANSFERASE; CORONARY-ARTERY-DISEASE; OSSABAW MINIATURE SWINE; FRUCTOSE CORN SYRUP; INSULIN-RESISTANCE; LIPID-METABOLISM; SKELETAL-MUSCLE; GROWTH-PERFORMANCE; ATHEROGENIC DIET	Animal models of obesity and metabolic dysregulation during growth (or childhood) are lacking. Our objective was to increase adiposity and induce metabolic syndrome in young, genetically lean pigs. Pre-pubertal female pigs, age 35 d, were fed a high-energy diet (HED; n = 12), containing 15% tallow, 35% refined sugars and 9.1-12.9% crude protein, or a control corn-based diet (n = 11) with 12.2-19.2% crude protein for 16 wk. Initially, HED pigs self-regulated energy intake similar to controls, but by wk 5, consumed more (P<0.001) energy per kg body weight. At wk 15, pigs were subjected to an oral glucose tolerance test (OGTT); blood glucose increased (P<0.05) in control pigs and returned to baseline levels within 60 min. HED pigs were hyperglycemic at time 0, and blood glucose did not return to baseline (P = 0.01), even 4 h post-challenge. During OGTT, glucose area under the curve (AUC) was higher and insulin AUC was lower in HED pigs compared to controls (P = 0.001). Chronic HED intake increased (P<0.05) subcutaneous, intramuscular, and perirenal fat deposition, and induced hyperglycemia, hypoinsulinemia, and low-density lipoprotein hypercholesterolemia. A subset of HED pigs (n = 7) was transitioned back to a control diet for an additional six weeks. These pigs were subjected to an additional OGTT at 22 wk. Glucose AUC and insulin AUC did not improve, supporting that dietary intervention was not sufficient to recover glucose tolerance or insulin production. These data suggest a HED may be used to increase adiposity and disrupt glucose homeostasis in young, growing pigs.	[Fisher, Kimberly D.; Scheffler, Tracy L.; Kasten, Steven C.; Reinholt, Brad M.; van Eyk, Gregory R.; Escobar, Jeffery; Scheffler, Jason M.; Gerrard, David E.] Virginia Tech Univ, Dept Anim & Poultry Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Scheffler, JM (corresponding author), Virginia Tech Univ, Dept Anim & Poultry Sci, Blacksburg, VA USA.	jmscheff@vt.edu	gerrard, david/AAG-7507-2019; Scheffler, Tracy/AAU-5232-2021	Scheffler, Jason/0000-0001-6360-8820; gerrard, david/0000-0002-3482-1400	Fralin Life Science Institute, Virginia Tech	Fralin Life Science Institute, Virginia Tech	This project was funded by an Obesity Seed Grant from Fralin Life Science Institute, Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATINMO T, 1976, J NUTR, V106, P1654, DOI 10.1093/jn/106.11.1654; ATINMO T, 1976, J ANIM SCI, V43, P606, DOI 10.2527/jas1976.433606x; BELL FP, 1992, ARTERIOSCLER THROMB, V12, P155, DOI 10.1161/01.ATV.12.2.155; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Bray GA, 2004, AM J CLIN NUTR, V80, P1090; Carey GB, 1997, MED SCI SPORT EXER, V29, P1437, DOI 10.1097/00005768-199711000-00008; CDC, 2013, AD SCH HLTH CHILDH O; Christoffersen B, 2012, OBESITY SILVER SPRIN; Clark BA, 2011, AM J PHYSIOL-ENDOC M, V300, pE848, DOI 10.1152/ajpendo.00534.2010; Coope A, 2008, FEBS LETT, V582, P1471, DOI 10.1016/j.febslet.2008.03.037; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cowgill GR, 1928, AM J PHYSIOL, V85, P45, DOI 10.1152/ajplegacy.1928.85.1.45; DAVEY RJ, 1977, J ANIM SCI, V45, P59, DOI 10.2527/jas1977.45159x; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Dyson MC, 2004, FASEB J, V18, pA1224; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; EZEKWE MO, 1975, GROWTH, V39, P95; Faris RJ, 2012, COMPARATIVE MED, V62, P495; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Guillerm-Regost C, 2006, OBESITY, V14, P1700, DOI 10.1038/oby.2006.195; HAUSMAN GJ, 1986, GROWTH DEVELOP AGING, V50, P287; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; HENRY Y, 1987, J ANIM SCI, V65, P1257, DOI 10.2527/jas1987.6551257x; HETZER HO, 1967, J ANIM SCI, V26, P1244, DOI 10.2527/jas1967.2661244x; Jonsson T, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-39; Kaps M., 2004, BIOSTATISTICS ANIMAL; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kleber M, 2011, J PEDIATR ENDOCR MET, V24, P125, DOI 10.1515/JPEM.2011.089; Knauf C, 2005, J CLIN INVEST, V115, P3554, DOI 10.1172/JCI25764; Kruyt ND, 2012, DIABETES TECHNOL THE, V14, P311, DOI 10.1089/dia.2011.0171; KUAN KK, 1986, AUST J EXP AGR, V26, P285, DOI 10.1071/EA9860285; Larsen MO, 2002, ANN NY ACAD SCI, V967, P414; Lawlor DA, 2005, AM J EPIDEMIOL, V161, P1081, DOI 10.1093/aje/kwi125; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lin X, 2010, AM J PHYSIOL-REG I, V298, pR1435, DOI 10.1152/ajpregu.00634.2009; Lo CY, 2008, FOOD CHEM, V107, P1099, DOI 10.1016/j.foodchem.2007.09.028; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; MARTIN RJ, 1973, P SOC EXP BIOL MED, V143, P198, DOI 10.3181/00379727-143-37285; McNeel RL, 2005, OBES RES, V13, P1651, DOI 10.1038/oby.2005.203; Mendoza OF, 2010, J ANIM SCI, V88, P3887, DOI 10.2527/jas.2010-2873; MERSMANN HJ, 1982, GROWTH, V46, P189; MERSMANN HJ, 1973, AM J PHYSIOL, V224, P1123, DOI 10.1152/ajplegacy.1973.224.5.1123; MERSMANN HJ, 1984, J ANIM SCI, V58, P324, DOI 10.2527/jas1984.582324x; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; NOVAKOFSKI J, 1989, J FOOD SCI, V54, P15, DOI 10.1111/j.1365-2621.1989.tb08556.x; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; PETERSON AD, 1971, J NUTR, V101, P1057, DOI 10.1093/jn/101.8.1057; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Pond W. G., 2001, BIOL DOMESTIC PIG; Price KL, 2010, J ANIM SCI, V88, P3896, DOI 10.2527/jas.2009-2728; Radcliffe JS, 1998, J ANIM SCI, V76, P1880; Schinckel AP, 1999, EVALUATION COMMONLY; Sebert SP, 2005, INT J OBESITY, V29, P324, DOI 10.1038/sj.ijo.0802823; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Sturek M, 2007, SWINE LAB SURG ANEST, P297; Thomas TR, 2002, METABOLISM, V51, P1587, DOI 10.1053/meta.2002.36313; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Velloso LA, 2008, NEUROIMMUNOMODULAT, V15, P189, DOI 10.1159/000153423; Waget A, 2011, ENDOCRINOLOGY, V152, P3018, DOI 10.1210/en.2011-0286; Wagner JR, 1999, J ANIM SCI, V77, P1442; WANGSNESS PJ, 1977, AM J PHYSIOL, V233, pE104, DOI 10.1152/ajpendo.1977.233.2.E104; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; White JS, 2009, J NUTR, V139, pS1219, DOI 10.3945/jn.108.097998; Xi SM, 2004, INT J EXP PATHOL, V85, P223, DOI 10.1111/j.0959-9673.2004.00394.x	67	12	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72320	10.1371/journal.pone.0072320	http://dx.doi.org/10.1371/journal.pone.0072320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991090	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800059
J	Klepeis, NE; Hughes, SC; Edwards, RD; Allen, T; Johnson, M; Chowdhury, Z; Smith, KR; Boman-Davis, M; Bellettiere, J; Hovell, MF				Klepeis, Neil E.; Hughes, Suzanne C.; Edwards, Rufus D.; Allen, Tracy; Johnson, Michael; Chowdhury, Zohir; Smith, Kirk R.; Boman-Davis, Marie; Bellettiere, John; Hovell, Melbourne F.			Promoting Smoke-Free Homes: A Novel Behavioral Intervention Using Real-Time Audio-Visual Feedback on Airborne Particle Levels	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; INDOOR AIR-QUALITY; SECONDHAND SMOKE; RESIDENTIAL EXPOSURE; RANDOMIZED-TRIAL; CHILDREN; INSTRUMENTS; HOUSEHOLDS; MONITORS; REDUCE	Interventions are needed to protect the health of children who live with smokers. We pilot-tested a real-time intervention for promoting behavior change in homes that reduces second hand tobacco smoke (SHS) levels. The intervention uses a monitor and feedback system to provide immediate auditory and visual signals triggered at defined thresholds of fine particle concentration. Dynamic graphs of real-time particle levels are also shown on a computer screen. We experimentally evaluated the system, field-tested it in homes with smokers, and conducted focus groups to obtain general opinions. Laboratory tests of the monitor demonstrated SHS sensitivity, stability, precision equivalent to at least 1 mu g/m(3), and low noise. A linear relationship (R-2 = 0.98) was observed between the monitor and average SHS mass concentrations up to 150 mu g/m(3). Focus groups and interviews with intervention participants showed in-home use to be acceptable and feasible. The intervention was evaluated in 3 homes with combined baseline and intervention periods lasting 9 to 15 full days. Two families modified their behavior by opening windows or doors, smoking outdoors, or smoking less. We observed evidence of lower SHS levels in these homes. The remaining household voiced reluctance to changing their smoking activity and did not exhibit lower SHS levels in main smoking areas or clear behavior change; however, family members expressed receptivity to smoking outdoors. This study established the feasibility of the real-time intervention, laying the groundwork for controlled trials with larger sample sizes. Visual and auditory cues may prompt family members to take immediate action to reduce SHS levels. Dynamic graphs of SHS levels may help families make decisions about specific mitigation approaches.	[Klepeis, Neil E.; Hughes, Suzanne C.; Boman-Davis, Marie; Bellettiere, John; Hovell, Melbourne F.] San Diego State Univ, Grad Sch Publ Hlth, SDSU Res Fdn, Ctr Behav Epidemiol & Community Hlth C BEACH, San Diego, CA 92182 USA; [Edwards, Rufus D.; Johnson, Michael] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Allen, Tracy] Elect Monitored Ecosyst LLC, Berkeley, CA USA; [Chowdhury, Zohir] San Diego State Univ, Grad Sch Publ Hlth, Div Environm Hlth, San Diego, CA 92182 USA; [Smith, Kirk R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Klepeis, Neil E.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Klepeis, Neil E.] Educ Training & Res Inc, Scotts Valley, CA USA	California State University System; San Diego State University; University of California System; University of California Irvine; California State University System; San Diego State University; University of California System; University of California Berkeley; Stanford University	Klepeis, NE (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, SDSU Res Fdn, Ctr Behav Epidemiol & Community Hlth C BEACH, San Diego, CA 92182 USA.	nklepeis@projects.sdsu.edu	Bellettiere, John/AAC-6092-2020; Boman-Davis, Marie/L-9385-2019	Bellettiere, John/0000-0002-7167-3048; Klepeis, Neil/0000-0002-6934-3242; , Rufus/0000-0002-6051-6936; Hughes, Suzanne/0000-0001-8279-1544; Johnson, Michael/0000-0002-4886-1534	Tobacco Related Disease Research Program of California (TRDRP) [17IT-0008]; U.S. National Cancer Institute (NCI) [R01 CA138192-04]; U.S. National Heart, Lung, and Blood Institute (NHLBI) [R01 HL103684-02]; NATIONAL CANCER INSTITUTE [R01CA138192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103684] Funding Source: NIH RePORTER	Tobacco Related Disease Research Program of California (TRDRP)(University of California System); U.S. National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported primarily with funds provided by the Tobacco Related Disease Research Program of California (TRDRP), Grant Number 17IT-0008, awarded in July 2008 (http://trdrp.org). Support for this work was also provided by the U.S. National Cancer Institute (NCI; http://www.cancer.gov/), Grant Number R01 CA138192-04, and the U.S. National Heart, Lung, and Blood Institute (NHLBI; http://www.nhlbi.nih.gov/), Grant Number, R01 HL103684-02. The content is solely the responsibility of the authors and does not represent the official views of the TRDRP or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 2009, THESIS U CALIFORNIA; Binns HJ, 2009, PATIENT EDUC COUNS, V74, P272, DOI 10.1016/j.pec.2008.09.001; Chung A, 2001, J AIR WASTE MANAGE, V51, P109, DOI 10.1080/10473289.2001.10464254; Dacunto PJ, 2014, INDOOR AIR, V24, P59, DOI 10.1111/ina.12049; Dacunto PJ, 2013, ATMOS ENVIRON, V71, P399, DOI 10.1016/j.atmosenv.2013.02.018; Dockery DW, 2001, ENVIRON HEALTH PERSP, V109, P483, DOI 10.2307/3454657; Emmons KM, 2001, PEDIATRICS, V108, P18, DOI 10.1542/peds.108.1.18; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Gehrman CA, 2003, NICOTINE TOB RES, V5, P289, DOI 10.1080/1462220031000094231; GOETZ T, 2011, WIRED            JUN, P19; Gonzales M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-265; Hovell ME, 2009, NICOTINE TOB RES, V11, P1254, DOI 10.1093/ntr/ntp133; Hovell MF, 2011, CHEST, V140, P681, DOI 10.1378/chest.10-2609; HOVELL MF, 2009, EMERGING THEORIES MO; Jaakkola MS, 1997, EUR RESPIR J, V10, P2384, DOI 10.1183/09031936.97.10102384; Jenkins RA, 2004, J AIR WASTE MANAGE, V54, P229, DOI 10.1080/10473289.2004.10470892; Jiang RT, 2011, J ENVIRON MONITOR, V13, P1695, DOI 10.1039/c0em00732c; Junker MH, 2001, ENVIRON HEALTH PERSP, V109, P1045, DOI 10.2307/3454960; Kim S, 2009, N KOREAN REV, V5, P3, DOI 10.3172/NKR.5.1.3; Kingham S, 2006, ATMOS ENVIRON, V40, P338, DOI 10.1016/j.atmosenv.2005.09.042; Klepeis NE, 1996, ENVIRON SCI TECHNOL, V30, P2813, DOI 10.1021/es960067f; Klepeis NE, 2003, AEROSOL SCI TECH, V37, P780, DOI 10.1080/02786820300914; Klepeis NE, 2006, ATMOS ENVIRON, V40, P4393, DOI 10.1016/j.atmosenv.2006.03.018; Klepeis NE, 2006, ATMOS ENVIRON, V40, P4408, DOI 10.1016/j.atmosenv.2006.03.017; Moosmuller H, 2001, ENVIRON SCI TECHNOL, V35, P781, DOI 10.1021/es0013935; Northcross AL, 2013, ENVIRON SCI-PROC IMP, V15, P433, DOI 10.1039/c2em30568b; Ott WR, 2003, J AIR WASTE MANAGE, V53, P918, DOI 10.1080/10473289.2003.10466248; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2001, ENVIRON HEALTH PERSP, V109, P711, DOI 10.2307/3454788; Priest N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001746.pub2; Pyle SA, 2005, FAMILIES SYSTEMS HLT, V23, P3, DOI DOI 10.1037/1091-7527.23.1.3; R Development Core Team, 2012, R LANG ENV STAT COMP; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Semple S, 2013, TOB CONTROL, V22, P295, DOI 10.1136/tobaccocontrol-2011-050401; Shaw A., 2012, REDUCING CHILDRENS E; USDHHS, 2006, HLTH CONS INV EXP TO; WILSON I, 2012, TOB CONTR, DOI DOI 10.1136/T0BACC0C0NTR0L-2011-050212; Wilson SR, 2011, CHEST, V139, P581, DOI 10.1378/chest.10-0772; Wipfli H, 2008, AM J PUBLIC HEALTH, V98, P672, DOI 10.2105/AJPH.2007.126631; Zhang X, 2012, TOB CONTROL, V21, P330, DOI 10.1136/tc.2011.043802	40	44	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73251	10.1371/journal.pone.0073251	http://dx.doi.org/10.1371/journal.pone.0073251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009742	Green Published, gold			2022-12-25	WOS:000324403200045
J	Lee, J; Moghadam, ME; Kung, E; Cao, H; Beebe, T; Miller, Y; Roman, BL; Lien, CL; Chi, NC; Marsden, AL; Hsiai, TK				Lee, Juhyun; Moghadam, Mahdi Esmaily; Kung, Ethan; Cao, Hung; Beebe, Tyler; Miller, Yury; Roman, Beth L.; Lien, Ching-Ling; Chi, Neil C.; Marsden, Alison L.; Hsiai, Tzung K.			Moving Domain Computational Fluid Dynamics to Interface with an Embryonic Model of Cardiac Morphogenesis	PLOS ONE			English	Article							NAVIER-STOKES EQUATIONS; SHEAR-STRESS; ELEMENT; FLOW; OPTIMIZATION; EXPRESSION; ALGORITHM; GMRES; KLF2	Peristaltic contraction of the embryonic heart tube produces time- and spatial-varying wall shear stress (WSS) and pressure gradients (del P) across the atrioventricular (AV) canal. Zebrafish (Danio rerio) are a genetically tractable system to investigate cardiac morphogenesis. The use of Tg(fli1a:EGFP)(y1) transgenic embryos allowed for delineation and two-dimensional reconstruction of the endocardium. This time-varying wall motion was then prescribed in a two-dimensional moving domain computational fluid dynamics (CFD) model, providing new insights into spatial and temporal variations in WSS and del P during cardiac development. The CFD simulations were validated with particle image velocimetry (PIV) across the atrioventricular (AV) canal, revealing an increase in both velocities and heart rates, but a decrease in the duration of atrial systole from early to later stages. At 20-30 hours post fertilization (hpf), simulation results revealed bidirectional WSS across the AV canal in the heart tube in response to peristaltic motion of the wall. At 40-50 hpf, the tube structure undergoes cardiac looping, accompanied by a nearly 3-fold increase in WSS magnitude. At 110-120 hpf, distinct AV valve, atrium, ventricle, and bulbus arteriosus form, accompanied by incremental increases in both WSS magnitude and del P, but a decrease in bi-directional flow. Laminar flow develops across the AV canal at 20-30 hpf, and persists at 110-120 hpf. Reynolds numbers at the AV canal increase from 0.07 +/- 0.03 at 20-30 hpf to 0.23 +/- 0.07 at 110-120 hpf (p<0.05, n=6), whereas Womersley numbers remain relatively unchanged from 0.11 to 0.13. Our moving domain simulations highlights hemodynamic changes in relation to cardiac morphogenesis; thereby, providing a 2-D quantitative approach to complement imaging analysis.	[Lee, Juhyun; Cao, Hung; Beebe, Tyler; Hsiai, Tzung K.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Lee, Juhyun; Cao, Hung; Hsiai, Tzung K.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Moghadam, Mahdi Esmaily; Kung, Ethan; Marsden, Alison L.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Miller, Yury; Chi, Neil C.] Univ Calif San Diego, Sch Med, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Roman, Beth L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Lien, Ching-Ling] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Lien, Ching-Ling] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Hsiai, Tzung K.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA	University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hsiai, TK (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	thsiai@mednet.ucla.edu	Esmaily/X-8575-2018; Marsden, A/C-4037-2011	Esmaily/0000-0002-6795-6010; Marsden, A/0000-0003-1902-171X; Roman, Beth/0000-0002-1250-1705; Kung, Ethan/0000-0002-2532-2458; Cao, Hung/0000-0003-4197-7208	National Institutes of Health [HL-068689, HL-083015, HD069305-01, 1R01HL111437-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083015, R01HL111437, K08HL068689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by National Institutes of Health (http://www.nih.gov) HL-068689 (TKH) HL-083015 (TKH), HD069305-01 (NCC, TKH), and 1R01HL111437-01 (TKH, NCC). The authors simply observed the fish heart with fluorescent microscope. Before observing, fish was sedated by 0.003% Tricaine and fixed by low temperature agarose gel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazilevs Y, 2008, COMPUT MECH, V43, P3, DOI 10.1007/s00466-008-0315-x; Bazilevs Y, 2007, COMPUT METHOD APPL M, V197, P173, DOI 10.1016/j.cma.2007.07.016; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bonow RO, 2011, BRAUNWALDS HEART DIS; BROOKS AN, 1982, COMPUT METHOD APPL M, V32, P199, DOI 10.1016/0045-7825(82)90071-8; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen CY, 2011, BIORHEOLOGY, V48, P305, DOI 10.3233/BIR-2012-0600; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Cozma D, 2004, Rom J Intern Med, V42, P129; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Detrich H.W., 2011, ZEBRAFISH GENETICS G; Ethier CR, 2007, INTRO BIOMECHANICS C, Vxiii, p[511, 516]; Farrell J, 2010, USING VISIBLE SNR VS; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; FRANCA LP, 1992, COMPUT METHOD APPL M, V99, P209, DOI 10.1016/0045-7825(92)90041-H; Fung YC, 1990, BIOMECHANICS MOTION, P569; Godinho Leanne, 2011, Cold Spring Harb Protoc, V2011, P879, DOI 10.1101/pdb.prot5647; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Jansen KE, 2000, COMPUT METHOD APPL M, V190, P305, DOI 10.1016/S0045-7825(00)00203-6; Ji JW, 2006, J THEOR BIOL, V241, P94, DOI 10.1016/j.jtbi.2005.11.019; Kim DH, 2012, ECHOCARDIOGRAPHY; Kowalski WJ, 2012, BIOMECH MODEL MECHAN, V11, P1057, DOI 10.1007/s10237-012-0373-z; Liebling M, 2006, DEV DYNAM, V235, P2940, DOI 10.1002/dvdy.20926; Lim WL, 2001, J BIOMECH, V34, P1417, DOI 10.1016/S0021-9290(01)00132-4; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Mankad R, 2001, J CARDIOVASC MAGN R, V3, P257, DOI 10.1081/JCMR-100107474; Marsden AL, 2008, COMPUT METHOD APPL M, V197, P1890, DOI 10.1016/j.cma.2007.12.009; Melling A, 1997, MEAS SCI TECHNOL, V8, P1406, DOI 10.1088/0957-0233/8/12/005; MERCIER JC, 1982, CIRCULATION, V65, P962, DOI 10.1161/01.CIR.65.5.962; Moghadam ME, 2011, COMPUT MECH, V48, P277, DOI 10.1007/s00466-011-0599-0; Moore KL, 2003, DEV HUMAN CLIN ORIEN, Vxv, P560; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Rahimtoola SH, 2002, CIRCULATION, V106, P1183, DOI 10.1161/01.CIR.0000029210.14716.01; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Salmon WC, 2011, COLD SPRING HARBOR P; Santhanakrishnan A, 2011, CELL BIOCHEM BIOPHYS, V61, P1, DOI 10.1007/s12013-011-9158-8; Scarano F, 1999, EXP FLUIDS, V26, P513, DOI 10.1007/s003480050318; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; SHAKIB F, 1989, COMPUT METHOD APPL M, V75, P415, DOI 10.1016/0045-7825(89)90040-6; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Szczerba D, 2005, J THEOR BIOL, V234, P87, DOI 10.1016/j.jtbi.2004.11.014; Taylor JM, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003043; TEZDUYAR T, 1993, COMPUTER, V26, P27, DOI 10.1109/2.237441; Tezduyar TE, 2006, COMPUT METHOD APPL M, V195, P2002, DOI 10.1016/j.cma.2004.09.014; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Wang YJ, 2009, ANN BIOMED ENG, V37, P1069, DOI 10.1007/s10439-009-9682-5; Whiting CH, 2001, INT J NUMER METH FL, V35, P93, DOI 10.1002/1097-0363(20010115)35:1<93::AID-FLD85>3.0.CO;2-G; Wu YT, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-70	53	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72924	10.1371/journal.pone.0072924	http://dx.doi.org/10.1371/journal.pone.0072924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009714	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000324403200035
J	Larsson, M; Uvell, H; Sandstrom, J; Ryden, P; Selth, LA; Bjorklund, S				Larsson, Miriam; Uvell, Hanna; Sandstrom, Jenny; Ryden, Patrik; Selth, Luke A.; Bjorklund, Stefan			Functional Studies of the Yeast Med5, Med15 and Med16 Mediator Tail Subunits	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; HOLOENZYME; COMPLEX; PATHWAY; KINASE	The yeast Mediator complex can be divided into three modules, designated Head, Middle and Tail. Tail comprises the Med2, Med3, Med5, Med15 and Med16 protein subunits, which are all encoded by genes that are individually non-essential for viability. In cells lacking Med16, Tail is displaced from Head and Middle. However, inactivation of MED5/MED15 and MED15/MED16 are synthetically lethal, indicating that Tail performs essential functions as a separate complex even when it is not bound to Middle and Head. We have used the N-Degron method to create temperature-sensitive (ts) mutants in the Mediator tail subunits Med5, Med15 and Med16 to study the immediate effects on global gene expression when each subunit is individually inactivated, and when Med5/15 or Med15/16 are inactivated together. We identify 25 genes in each double mutant that show a significant change in expression when compared to the corresponding single mutants and to the wild type strain. Importantly, 13 of the 25 identified genes are common for both double mutants. We also find that all strains in which MED15 is inactivated show down-regulation of genes that have been identified as targets for the Ace2 transcriptional activator protein, which is important for progression through the G1 phase of the cell cycle. Supporting this observation, we demonstrate that loss of Med15 leads to a G1 arrest phenotype. Collectively, these findings provide insight into the function of the Mediator Tail module.	[Larsson, Miriam; Uvell, Hanna; Sandstrom, Jenny; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Ryden, Patrik] Umea Univ, Dept Stat, S-90187 Umea, Sweden; [Selth, Luke A.] Canc Res UK London Res Inst, Mech Transcript Lab, Clare Hall Labs, S Mimms, Herts, England	Umea University; Umea University; Cancer Research UK	Bjorklund, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	stefan.bjorklund@medchem.umu.se	Selth, Luke/AAH-4823-2021; Rydén, Patrik/I-4201-2016	Selth, Luke/0000-0002-4686-1418; Rydén, Patrik/0000-0002-0577-123X; Sandstrom, Jenny/0000-0003-0117-6975	Swedish Cancer Society; Swedish Research Council; Kempe Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council; the Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Balciunas D, 2003, J BIOL CHEM, V278, P3831, DOI 10.1074/jbc.M206946200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chang YW, 2001, GENETICS, V157, P17; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Conaway RC, 2012, BIOCHIM BIOPHYS ACTA, V1829, P69; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Enyenihi AH, 2003, GENETICS, V163, P47; Frydlova I, 2009, EUKARYOT CELL, V8, P586, DOI 10.1128/EC.00376-08; Goldstein AL, 2001, GENETICS, V159, P499; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hallberg M, 2004, P NATL ACAD SCI USA, V101, P3370, DOI 10.1073/pnas.0400221101; Han SJ, 1999, MOL CELL BIOL, V19, P979; Hoose SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002590; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kwon JY, 1999, P NATL ACAD SCI USA, V96, P14990, DOI 10.1073/pnas.96.26.14990; Laabs TL, 2003, P NATL ACAD SCI USA, V100, P10275, DOI 10.1073/pnas.1833999100; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lee JH, 2010, MOL CELL BIOL, V30, P5502, DOI 10.1128/MCB.00966-10; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Linder T, 2008, NUCLEIC ACIDS RES, V36, P2489, DOI 10.1093/nar/gkn070; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ramne A, 2000, MOL GEN GENET, V263, P253, DOI 10.1007/s004380051166; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sanchez-Diaz Alberto, 2004, Sci STKE, V2004, pPL8, DOI 10.1126/stke.2232004pl8; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang YC, 2003, CELL, V112, P697, DOI 10.1016/S0092-8674(03)00121-1; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	55	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73137	10.1371/journal.pone.0073137	http://dx.doi.org/10.1371/journal.pone.0073137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991176	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700057
J	Song, XH; Lopez-Campistrous, A; Sun, L; Dower, NA; Kedei, N; Yang, J; Kelsey, JS; Lewin, NE; Esch, TE; Blumberg, PM; Stone, JC				Song, Xiaohua; Lopez-Campistrous, Ana; Sun, Lucy; Dower, Nancy A.; Kedei, Noemi; Yang, Jing; Kelsey, Jessica S.; Lewin, Nancy E.; Esch, Tim E.; Blumberg, Peter M.; Stone, James C.			RasGRPs Are Targets of the Anti-Cancer Agent Ingenol-3-Angelate	PLOS ONE			English	Article							PROTEIN-KINASE-C; NUCLEOTIDE-RELEASING PROTEIN; DIACYLGLYCEROL-BINDING MOTIFS; PHORBOL ESTERS; SIGNALING PATHWAY; INDUCED APOPTOSIS; CELL DEVELOPMENT; RAS ACTIVATION; B-CELLS; DELTA	Ingenol-3-angelate (I3A) is a non-tumor promoting phorbol ester-like compound identified in the sap of Euphoria peplus. Similar to tumor promoting phorbol esters, I3A is a diacylglycerol (DAG) analogue that binds with high affinity to the C1 domains of PKCs, recruits PKCs to cellular membranes and promotes enzyme activation. Numerous anti-cancer activities have been attributed to I3A and ascribed to I3A's effects on PKCs. We show here that I3A also binds to and activates members of the RasGRP family of Ras activators leading to robust elevation of Ras-GTP and engagement of the Raf-Mek-Erk kinase cascade. In response to I3A, recombinant proteins consisting of GFP fused separately to full-length RasGRP1 and RasGRP3 were rapidly recruited to cell membranes, consistent with direct binding of the compound to RasGRP's C1 domain. In the case of RasGRP3, IA3 treatment led to positive regulatory phosphorylation on T133 and activation of the candidate regulatory kinase PKCd. I3A treatment of select B non-Hodgkin's lymphoma cell lines resulted in quantitative and qualitative changes in Bcl-2 family member proteins and induction of apoptosis, as previously demonstrated with the DAG analogue bryostatin 1 and its synthetic analogue pico. Our results offer further insights into the anticancer properties of I3A, support the idea that RasGRPs represent potential cancer therapeutic targets along with PKC, and expand the known range of ligands for RasGRP regulation.	[Song, Xiaohua; Lopez-Campistrous, Ana; Sun, Lucy; Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Dower, Nancy A.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Kedei, Noemi; Yang, Jing; Kelsey, Jessica S.; Lewin, Nancy E.; Esch, Tim E.; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Alberta; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stone, JC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	jim.stone@ualberta.ca			Canadian Institutes of Health Research (CIHR) [MOP14630]; Canadian Cancer Society Research Institute (CCSRI) [018453]; Alberta Cancer Foundation (ACF) [26050]; Alberta Ingenuity-Health Solutions [200100408]; Center for Cancer Research, National Cancer Institute, National Institutes of Health [Z1A BC 005270]; NATIONAL CANCER INSTITUTE [ZIABC005270] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Alberta Cancer Foundation (ACF); Alberta Ingenuity-Health Solutions; Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by grants to JCS from the Canadian Institutes of Health Research (CIHR grant MOP14630, http://www.cihr-irsc.gc.ca), Canadian Cancer Society Research Institute (CCSRI grant 018453, http://www.cancer.ca/Research.aspx), Alberta Cancer Foundation (ACF grant 26050, http://albertacancer.ca), and Alberta Ingenuity-Health Solutions (200100408 http://www.aihealthsolutions.ca). Research was also supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (Project Z1A BC 005270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Braun DC, 2005, MOL CANCER THER, V4, P141; Brodie C, 2004, MOL PHARMACOL, V66, P76, DOI 10.1124/mol.66.1.76; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Cozzi SJ, 2006, CANCER RES, V66, P10083, DOI 10.1158/0008-5472.CAN-06-0348; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Durgan J, 2007, FEBS LETT, V581, P3377, DOI 10.1016/j.febslet.2007.06.035; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; Hampson P, 2010, APOPTOSIS, V15, P946, DOI 10.1007/s10495-010-0507-7; Hashimoto T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3470; Kazanietz MG, 2005, BBA-PROTEINS PROTEOM, V1754, P296, DOI 10.1016/j.bbapap.2005.07.034; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kedei N, 2011, CHEMBIOCHEM, V12, P1242, DOI 10.1002/cbic.201100064; Kronfeld I, 2002, EUR J IMMUNOL, V32, P136, DOI 10.1002/1521-4141(200201)32:1<136::AID-IMMU136>3.0.CO;2-T; Le TTT, 2009, VACCINE, V27, P3053, DOI 10.1016/j.vaccine.2009.03.025; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Lopez-Campistrous A, 2012, EXP HEMATOL, V40, P646, DOI 10.1016/j.exphem.2012.03.002; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Mason SA, 2010, INVEST NEW DRUG, V28, P575, DOI 10.1007/s10637-009-9292-y; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Ogbourne Steven M, 2007, Anticancer Drugs, V18, P357, DOI 10.1097/CAD.0b013e3280149ec5; Pak Y, 2001, J MED CHEM, V44, P1690, DOI 10.1021/jm000488e; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Ramsay JR, 2011, BRIT J DERMATOL, V164, P633, DOI 10.1111/j.1365-2133.2010.10184.x; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Stang SL, 2009, EXP HEMATOL, V37, P122, DOI 10.1016/j.exphem.2008.09.008; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Stone JC, 2004, J MED CHEM, V47, P6638, DOI 10.1021/jm0495069; Tuthill MC, 2006, MOL CANCER THER, V5, P602, DOI 10.1158/1535-7163.MCT-05-0317; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Yang D, 2011, ONCOGENE, V30, P4590, DOI [10.1038/onc.2011.541, 10.1038/onc.2011.166]; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	42	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72331	10.1371/journal.pone.0072331	http://dx.doi.org/10.1371/journal.pone.0072331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991094	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100100
J	Towne, C; Montgomery, KL; Iyer, SM; Deisseroth, K; Delp, SL				Towne, Chris; Montgomery, Kate L.; Iyer, Shrivats M.; Deisseroth, Karl; Delp, Scott L.			Optogenetic Control of Targeted Peripheral Axons in Freely Moving Animals	PLOS ONE			English	Article							CATWALK GAIT ANALYSIS; NOCICEPTIVE NEURONS; IN-VIVO; NERVE STIMULATION; NEURAL CIRCUITRY; DIFFERENT ROUTES; SEROTYPE 6; DELIVERY; VIRUS; CHANNELRHODOPSIN-2	Optogenetic control of the peripheral nervous system (PNS) would enable novel studies of motor control, somatosensory transduction, and pain processing. Such control requires the development of methods to deliver opsins and light to targeted sub-populations of neurons within peripheral nerves. We report here methods to deliver opsins and light to targeted peripheral neurons and robust optogenetic modulation of motor neuron activity in freely moving, non-transgenic mammals. We show that intramuscular injection of adeno-associated virus serotype 6 enables expression of channelrhodopsin (ChR2) in motor neurons innervating the injected muscle. Illumination of nerves containing mixed populations of axons from these targeted neurons and from neurons innervating other muscles produces ChR2-mediated optogenetic activation restricted to the injected muscle. We demonstrate that an implanted optical nerve cuff is welltolerated, delivers light to the sciatic nerve, and optically stimulates muscle in freely moving rats. These methods can be broadly applied to study PNS disorders and lay the groundwork for future therapeutic application of optogenetics.	[Towne, Chris; Montgomery, Kate L.; Iyer, Shrivats M.; Deisseroth, Karl; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Delp, SL (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	delp@stanford.edu	Core, Vector/CAF-4832-2022	Delp, Scott/0000-0002-9643-7551; Iyer, Shrivats/0000-0003-4648-3637	Stanford Bio-X Program; Swiss National Science Foundation Fellowship; Office of Technology Licensing Stanford Graduate Fellowship; Bio-X Bioengineering Graduate Fellowship	Stanford Bio-X Program; Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); Office of Technology Licensing Stanford Graduate Fellowship; Bio-X Bioengineering Graduate Fellowship	This study was supported by the Stanford Bio-X Program (SLD and KD). CT was supported by a Swiss National Science Foundation Fellowship. SMI was supported by an Office of Technology Licensing Stanford Graduate Fellowship. KLM was supported by a Bio-X Bioengineering Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Erbguth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046827; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Ji ZG, 2010, PLOS ONE, V7; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liske H, 2013, MUSCLE NERVE, V47, P916, DOI 10.1002/mus.23696; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NAPLES GG, 1988, IEEE T BIO-MED ENG, V35, P905, DOI 10.1109/10.8670; Sharp AA, 2011, J NEUROPHYSIOL, V106, P2776, DOI 10.1152/jn.00712.2011; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Wilson SP, 1999, P NATL ACAD SCI USA, V96, P3211, DOI 10.1073/pnas.96.6.3211; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Xu Y, 2003, HUM GENE THER, V14, P897, DOI 10.1089/104303403765701187; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	30	114	144	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72691	10.1371/journal.pone.0072691	http://dx.doi.org/10.1371/journal.pone.0072691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991144	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470100113
J	Zhou, ZN; Sharma, VP; Beaty, BT; Roh-Johnson, M; Peterson, EA; Van Rooijen, N; Kenny, PA; Wiley, HS; Condeelis, JS; Segall, JE				Zhou, Z. N.; Sharma, V. P.; Beaty, B. T.; Roh-Johnson, M.; Peterson, E. A.; Van Rooijen, N.; Kenny, P. A.; Wiley, H. S.; Condeelis, J. S.; Segall, J. E.			Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo	ONCOGENE			English	Article						HBEGF; breast cancer invasion; EGFR; metastasis	LIPOSOME-MEDIATED DEPLETION; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR; HB-EGF; RECEPTOR; PARACRINE; CORTACTIN; INVADOPODIA; MIGRATION; MOTILITY	Increased expression of HBEGF in estrogen receptor-negative breast tumors is correlated with enhanced metastasis to distant organ sites and more rapid disease recurrence upon removal of the primary tumor. Our previous work has demonstrated a paracrine loop between breast cancer cells and macrophages in which the tumor cells are capable of stimulating macrophages through the secretion of colony-stimulating factor-1 while the tumor-associated macrophages (TAMs), in turn, aid in tumor cell invasion by secreting epidermal growth factor. To determine how the autocrine expression of epidermal growth factor receptor (EGFR) ligands by carcinoma cells would affect this paracrine loop mechanism, and in particular whether tumor cell invasion depends on spatial ligand gradients generated by TAMs, we generated cell lines with increased HBEGF expression. We found that autocrine HBEGF expression enhanced in vivo intravasation and metastasis and resulted in a novel phenomenon in which macrophages were no longer required for in vivo invasion of breast cancer cells. In vitro studies revealed that expression of HBEGF enhanced invadopodium formation, thus providing a mechanism for cell autonomous invasion. The increased invadopodium formation was directly dependent on EGFR signaling, as demonstrated by a rapid decrease in invadopodia upon inhibition of autocrine HBEGF/EGFR signaling as well as inhibition of signaling downstream of EGFR activation. HBEGF expression also resulted in enhanced invadopodium function via upregulation of matrix metalloprotease 2 (MMP2) and MMP9 expression levels. We conclude that high levels of HBEGF expression can short-circuit the tumor cell/macrophage paracrine invasion loop, resulting in enhanced tumor invasion that is independent of macrophage signaling.	[Zhou, Z. N.; Sharma, V. P.; Beaty, B. T.; Roh-Johnson, M.; Condeelis, J. S.; Segall, J. E.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Peterson, E. A.; Kenny, P. A.] Albert Einstein Coll Med, Dev & Mol Biol, Bronx, NY 10461 USA; [Van Rooijen, N.] Free Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Wiley, H. S.] Pacific NW Natl Lab, Syst Biol Program, Richland, WA 99352 USA; [Wiley, H. S.] Pacific NW Natl Lab, Environ Mol Sci Lab, Richland, WA 99352 USA; [Condeelis, J. S.; Segall, J. E.] Albert Einstein Coll Med, Gruss Lipper Ctr Biophoton, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Vrije Universiteit Amsterdam; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Yeshiva University; Albert Einstein College of Medicine	Segall, JE (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	jeffrey.segall@einstein.yu.edu	Van Rooijen, Nico/Z-1578-2019	Sharma, Ved P/0000-0001-9998-5070; Wiley, Steven/0000-0003-0232-6867	Susan G. Komen for the Cure [KG111405]; NIH F32 postdoctoral fellowship [F32-CA159663-01]; NIH [1K12GM102779-01];  [CA100324];  [CA77522];  [T32-GM007288]; NATIONAL CANCER INSTITUTE [R01CA077522, P30CA013330, F32CA159663, P01CA100324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, K12GM102779] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIH F32 postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Condeelis, Cox, Hodgson and Segall labs for their comments and suggestions. We thank Carl Manthey and Johnson and Johnson for providing the JnJ compound. JES is the Betty and Sheldon Feinberg Senior Faculty Scholar in Cancer Research. Funding was provided by CA100324 (ERS, ARB, DC, JWP, JC and JES), CA77522 (JES), T32-GM007288 (ZNZ), a postdoctoral fellowship from the Susan G. Komen for the Cure, KG111405 (VPS), an NIH F32 postdoctoral fellowship F32-CA159663-01 (MRJ) and an NIH 1K12GM102779-01 (EAP).	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Artacho-Cordon A, 2012, CANCER BIOL THER, V13, P14, DOI 10.4161/cbt.13.1.18869; Artym VV, 2011, EUR J CELL BIOL, V90, P172, DOI 10.1016/j.ejcb.2010.06.006; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Garton KJ, 2002, BIOTECHNIQUES, V32, P830, DOI 10.2144/02324rr01; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hayes KE, 2013, ONCOGENE, V32, P4766, DOI 10.1038/onc.2012.513; Hernandez L, 2009, METHODS MOL BIOL, V571, P227, DOI 10.1007/978-1-60761-198-1_15; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; Joslin EJ, 2010, MOL BIOSYST, V6, P1293, DOI 10.1039/c003921g; Kedrin D, 2007, CURR PROTOC CELL BIO, P1; Kedrin D, 2009, CLIN CANCER RES, V15, P3733, DOI 10.1158/1078-0432.CCR-08-2163; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nishi E, 2004, GROWTH FACTORS, V22, P253, DOI 10.1080/08977190400008448; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Roussos ET, 2011, CLIN EXP METASTAS, V28, P515, DOI 10.1007/s10585-011-9388-6; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; SCOTT J, 1985, J CELL SCI, P19; Sharma VP, 2013, METHODS MOL BIOL, V1046, P343, DOI 10.1007/978-1-62703-538-5_21; Shimura T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-205; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Smirnova T, 2012, ONCOGENE, V31, P706, DOI 10.1038/onc.2011.275; Smirnova T, 2011, AM J PATHOL, V178, P2857, DOI 10.1016/j.ajpath.2011.02.030; Tolino MA, 2011, BBA-GEN SUBJECTS, V1810, P875, DOI 10.1016/j.bbagen.2011.05.011; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yotsumoto F, 2010, INT J CANCER, V127, P2707, DOI 10.1002/ijc.25472; Zaynagetdinov R, 2011, J IMMUNOL, V187, P5703, DOI 10.4049/jimmunol.1100558; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	52	72	72	0	26	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3784	3793		10.1038/onc.2013.363	http://dx.doi.org/10.1038/onc.2013.363			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	24013225	Green Accepted			2022-12-25	WOS:000339394100004
J	Sung, YH; Jin, Y; Kang, Y; Devkota, S; Lee, J; Roh, JI; Lee, HW				Sung, Young Hoon; Jin, Young; Kang, Yunhwa; Devkota, Sushil; Lee, Jaehoon; Roh, Jae-Il; Lee, Han-Woong			Ei24, a Novel E2F Target Gene, Affects p53-independent Cell Death upon Ultraviolet C Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; S-PHASE; TRANSCRIPTION FACTORS; AUTOPHAGY GENES; BREAST-CANCER; P53 RESPONSE; APOPTOSIS; CYCLE; MICE; CARCINOGENESIS	The deficiency of retinoblastoma (Rb) gene deregulates E2F transcription factors and thus induces E2F target genes directly or p53 target genes indirectly via mouse p19(Arf) (or p14(ARF) in humans), an E2F target gene. Here, we identified that etoposide-induced 2.4 mRNA (Ei24)/p53-induced gene 8 (Pig8), a p53 target gene involved in apoptosis and autophagy, was up-regulated in Rb-/- mouse embryonic fibroblasts (MEFs). The Ei24 promoter was activated by E2F1 via multiple E2F-responsive elements, independently of the previously reported p53-responsive element. Chromatin immunoprecipitation assays revealed that E2F1 directly acts on the mouse Ei24 promoter. We observed that Ei24 expression was suppressed in p53(-/-) MEFs upon UVC irradiation, which was exacerbated in p53(-/-) E2f1(-/-) MEFs, supporting the positive role of E2F1 on Ei24 transcription. Furthermore, Ei24 knockdown sensitized p53(-/-) MEFs against UVC irradiation. Together, our data indicate that Ei24 is a novel E2F target gene contributing to the survival of p53-deficient cells upon UVC irradiation and thus may have a potential significance as a therapeutic target of certain chemotherapy for treating p53-deficient tumors.	[Sung, Young Hoon; Jin, Young; Kang, Yunhwa; Devkota, Sushil; Lee, Jaehoon; Roh, Jae-Il; Lee, Han-Woong] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Sung, Young Hoon; Jin, Young; Kang, Yunhwa; Devkota, Sushil; Lee, Jaehoon; Roh, Jae-Il; Lee, Han-Woong] Yonsei Univ, Lab Anim Res Ctr, Seoul 120749, South Korea; [Lee, Jaehoon] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea	Yonsei University; Yonsei University; Sungkyunkwan University (SKKU)	Sung, YH (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	sungyh@yonsei.ac.kr; hwl@yonsei.ac.kr			National Research Foundation of Korea [2009-0081177, 2010-0020878]; Ministry of Education, Science, and Technology (MEST) of the Korean government; Ministry for Health and Welfare Affairs [A085136]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST) of the Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare Affairs	This work was supported by National Research Foundation of Korea Grants 2009-0081177 and 2010-0020878 funded by the Ministry of Education, Science, and Technology (MEST) of the Korean government and Korea Healthcare Technology R&D Project A085136 from the Ministry for Health and Welfare Affairs.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; Devkota S, 2012, INT J BIOCHEM CELL B, V44, P1887, DOI 10.1016/j.biocel.2012.06.034; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; GOODRICH DW, 1993, BIOCHIM BIOPHYS ACTA, V1155, P43, DOI 10.1016/0304-419X(93)90021-4; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Lehar SM, 1996, ONCOGENE, V12, P1181; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lin WC, 2001, GENE DEV, V15, P1833; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mork CN, 2007, FEBS LETT, V581, P5440, DOI 10.1016/j.febslet.2007.10.046; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Polager S, 2003, J BIOL CHEM, V278, P1443, DOI 10.1074/jbc.M210327200; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; QIN XQ, 1995, MOL CELL BIOL, V15, P742; QUELLE DE, 1995, CELL, V83, P993; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sung YH, 2007, MOL CELLS, V24, P409; Sung YH, 2010, CANCER RES, V70, P10454, DOI 10.1158/0008-5472.CAN-10-0031; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31261	31267		10.1074/jbc.M113.477570	http://dx.doi.org/10.1074/jbc.M113.477570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014029	hybrid, Green Published			2022-12-25	WOS:000330778900042
J	Alsteens, D; Martinez, N; Jamin, M; Jacob-Dubuisson, F				Alsteens, David; Martinez, Nicolas; Jamin, Marc; Jacob-Dubuisson, Francois			Sequential Unfolding of Beta Helical Protein by Single-Molecule Atomic Force Microscopy	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; BORDETELLA-PERTUSSIS; CRYSTAL-STRUCTURE; BACTERIAL ADHESIN; DOMAIN; SECRETION; REVEALS; MOTIF; AUTOTRANSPORTER; SPECTROSCOPY	The parallel beta helix is a common fold among extracellular proteins, however its mechanical properties remain unexplored. In Gram-negative bacteria, extracellular proteins of diverse functions of the large 'TpsA' family all fold into long beta helices. Here, single-molecule atomic force microscopy and steered molecular dynamics simulations were combined to investigate the mechanical properties of a prototypic TpsA protein, FHA, the major adhesin of Bordetella pertussis. Strong extension forces were required to fully unfold this highly repetitive protein, and unfolding occurred along a stepwise, hierarchical process. Our analyses showed that the extremities of the beta helix unfold early, while central regions of the helix are more resistant to mechanical unfolding. In particular, a mechanically resistant subdomain conserved among TpsA proteins and critical for secretion was identified. This nucleus harbors structural elements packed against the beta helix that might contribute to stabilizing the N-terminal region of FHA. Hierarchical unfolding of the beta helix in response to a mechanical stress may maintain beta-helical portions that can serve as templates for regaining the native structure after stress. The mechanical properties uncovered here might apply to many proteins with beta-helical or related folds, both in prokaryotes and in eukaryotes, and play key roles in their structural integrity and functions.	[Alsteens, David] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium; [Martinez, Nicolas; Jamin, Marc] UJF EMBL CNRS, Unit Virus Host Cell Interact, UMI3265, Grenoble, France; [Martinez, Nicolas] Inst Laue Langevin, Grenoble, France; [Jacob-Dubuisson, Francois] Univ Lille, Ctr Infect & Immun Lille, INSERM 1019, CNRS 8204, Lille, France	Universite Catholique Louvain; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut Laue-Langevin (ILL); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Alsteens, D (corresponding author), Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium.	david.alsteens@uclouvain.be; jamin@embl.fr; francoise.jacob@ibl.fr	Alsteens, David/AAU-5475-2020; Jacob-Dubuisson, Françoise/F-1610-2018; Alsteens, David A/F-2669-2014	Alsteens, David/0000-0001-9229-113X; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; Alsteens, David A/0000-0001-9229-113X; Martinez, Nicolas/0000-0002-3973-3864; Jamin, Marc/0000-0002-8677-2110	Agence Nationale de la Recherche, ANR DYN FHAC (France); Fonds National de la Recherche Scientifique (Belgium) INSERM; CNRS; Universite Lille Nord de France (France); Region Rhone-Alpes (France)	Agence Nationale de la Recherche, ANR DYN FHAC (France)(French National Research Agency (ANR)); Fonds National de la Recherche Scientifique (Belgium) INSERM(Fonds de la Recherche Scientifique - FNRS); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Lille Nord de France (France); Region Rhone-Alpes (France)(Region Auvergne-Rhone-Alpes)	This work was supported by the Agence Nationale de la Recherche, ANR DYN FHAC 2010-2014 (France), Fonds National de la Recherche Scientifique (Belgium) INSERM, CNRS, Universite Lille Nord de France (France), Region Rhone-Alpes (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Bryan AW, 2011, P NATL ACAD SCI USA, V108, P11099, DOI 10.1073/pnas.1017504108; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Guedin S, 1998, MOL MICROBIOL, V29, P763, DOI 10.1046/j.1365-2958.1998.00970.x; HANNAH JH, 1994, INFECT IMMUN, V62, P5010, DOI 10.1128/IAI.62.11.5010-5019.1994; Hertadi R, 2003, J MOL BIOL, V333, P993, DOI 10.1016/j.jmb.2003.09.010; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jacob-Dubuisson F, 2007, BORDETELLA MOL MICRO, P69; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/j.jsb.2006.01.015; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lambert-Buisine C, 1998, MOL MICROBIOL, V28, P1283, DOI 10.1046/j.1365-2958.1998.00892.x; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; Liu DF, 1997, INFECT IMMUN, V65, P3465, DOI 10.1128/IAI.65.8.3465-3468.1997; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; MAKHOV AM, 1994, J MOL BIOL, V241, P110, DOI 10.1006/jmbi.1994.1478; Marszalek PE, 1998, NATURE, V396, P661, DOI 10.1038/25322; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Serra DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028811; Weaver TM, 2009, J BIOL CHEM, V284, P22297, DOI 10.1074/jbc.M109.014431; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	42	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73572	10.1371/journal.pone.0073572	http://dx.doi.org/10.1371/journal.pone.0073572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009757	gold, Green Submitted, Green Published			2022-12-25	WOS:000323734600072
J	Kasuga, S; Hirashima, M; Nozaki, D				Kasuga, Shoko; Hirashima, Masaya; Nozaki, Daichi			Simultaneous Processing of Information on Multiple Errors in Visuomotor Learning	PLOS ONE			English	Article							INTERNAL-MODELS; ADAPTATION; PREMOTOR; NORMALIZATION; ATTENTION; SELECTION; DIRECTION; DECISION; STIMULI; CORTEX	The proper association between planned and executed movements is crucial for motor learning because the discrepancies between them drive such learning. Our study explored how this association was determined when a single action caused the movements of multiple visual objects. Participants reached toward a target by moving a cursor, which represented the right hand's position. Once every five to six normal trials, we interleaved either of two kinds of visual perturbation trials: rotation of the cursor by a certain amount (+/- 15 degrees,+/- 30 degrees, and +/- 45 degrees) around the starting position (single-cursor condition) or rotation of two cursors by different angles (+ 15 degrees and -45 degrees, 0 degrees and 30 degrees, etc.) that were presented simultaneously (double-cursor condition). We evaluated the aftereffects of each condition in the subsequent trial. The error sensitivity (ratio of the aftereffect to the imposed visual rotation) in the single-cursor trials decayed with the amount of rotation, indicating that the motor learning system relied to a greater extent on smaller errors. In the double-cursor trials, we obtained a coefficient that represented the degree to which each of the visual rotations contributed to the aftereffects based on the assumption that the observed aftereffects were a result of the weighted summation of the influences of the imposed visual rotations. The decaying pattern according to the amount of rotation was maintained in the coefficient of each imposed visual rotation in the double-cursor trials, but the value was reduced to approximately 40% of the corresponding error sensitivity in the single-cursor trials. We also found a further reduction of the coefficients when three distinct cursors were presented (e.g., -15 degrees, 15 degrees, and 30 degrees). These results indicated that the motor learning system utilized multiple sources of visual error information simultaneously to correct subsequent movement and that a certain averaging mechanism might be at work in the utilization process.	[Kasuga, Shoko] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 223, Japan; [Kasuga, Shoko; Hirashima, Masaya; Nozaki, Daichi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Kasuga, Shoko] Japan Soc Promot Sci, Tokyo, Japan	Keio University; University of Tokyo; Japan Society for the Promotion of Science	Nozaki, D (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	nozaki@p.u-tokyo.ac.jp	Kasuga, Shoko/C-3663-2012	Kasuga, Shoko/0000-0002-5721-5817; Nozaki, Daichi/0000-0002-1338-8337	NEXT Program [LS034];  [2110411];  [20670008]	NEXT Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by Grants-in-Aid for JSPS Fellows (#2110411) to SK, and KAKENHI (#20670008) and the NEXT Program (#LS034) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Andersen Richard A, 2003, Adv Neurol, V93, P159; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 1997, J NEUROSCI, V17, P8621; Castro LNG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002052; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; Gluck MA, 2001, NEUROBIOL LEARN MEM, V76, P314, DOI 10.1006/nlme.2001.4031; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; Kasuga S, 2011, J NEUROPHYSIOL, V106, P1218, DOI 10.1152/jn.00278.2011; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McSorley E, 2006, J NEUROPHYSIOL, V96, P1420, DOI 10.1152/jn.00315.2006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Ptak R, 2010, J NEUROSCI, V30, P12557, DOI 10.1523/JNEUROSCI.2722-10.2010; Sailer U, 2002, PROG BRAIN RES, V140, P341; Schmitz G, 2010, EXP BRAIN RES, V203, P479, DOI 10.1007/s00221-010-2245-z; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Tipper SP, 2001, EXP BRAIN RES, V136, P241, DOI 10.1007/s002210000577; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; White O, 2010, CURR BIOL, V20, P1290, DOI 10.1016/j.cub.2010.05.069; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	40	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72741	10.1371/journal.pone.0072741	http://dx.doi.org/10.1371/journal.pone.0072741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009702	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600036
J	Kirby, A; Herbert, A				Kirby, Andrew; Herbert, Annie			Correlations between Income Inequality and Antimicrobial Resistance	PLOS ONE			English	Article							OUTPATIENT ANTIBIOTIC USE; STREPTOCOCCUS-PNEUMONIAE; EUROPEAN SURVEILLANCE; CONSUMPTION; IMPACT; EPIDEMIOLOGY; HEALTH	Objectives: The aim of this study is to investigate if correlations exist between income inequality and antimicrobial resistance. This study's hypothesis is that income inequality at the national level is positively correlated with antimicrobial resistance within developed countries. Data collection and analysis: Income inequality data were obtained from the Standardized World Income Inequality Database. Antimicrobial resistance data were obtained from the European antimicrobial Resistance Surveillance Network and outpatient antimicrobial consumption data, measured by Defined daily Doses per 1000 inhabitants per day, from the European Surveillance of antimicrobial Consumption group. Spearman's correlation coefficient (r) defined strengths of correlations of: > 0.8 as strong, > 0.5 as moderate and > 0.2 as weak. Confidence intervals and p values were defined for all r values. Correlations were calculated for the time period 2003-10, for 15 European countries. Results: Income inequality and antimicrobial resistance correlations which were moderate or strong, with 95% confidence intervals > 0, included the following. Enterococcus faecalis resistance to aminopenicillins, vancomycin and high level gentamicin was moderately associated with income inequality (r= >= 0.54 for all three antimicrobials). Escherichia coli resistance to aminoglycosides, aminopenicillins, third generation cephalosporins and fluoroquinolones was moderately-strongly associated with income inequality (r= >= 0.7 for all four antimicrobials). Klebsiella pneumoniae resistance to third generation cephalosporins, aminoglycosides and fluoroquinolones was moderately associated with income inequality (r= >= 0.5 for all three antimicrobials). Staphylococcus aureus methicillin resistance and income inequality were strongly associated (r=0.87). Conclusion: As income inequality increases in European countries so do the rates of antimicrobial resistance for bacteria including E. faecalis, E. coli, K. pneumoniae and S. aureus. Further studies are needed to confirm these findings outside Europe and investigate the processes that could causally link income inequality and antimicrobial resistance.	[Kirby, Andrew] Leeds Teaching Hosp Natl Hlth Serv Trust, Dept Microbiol, Leeds, W Yorkshire, England; [Herbert, Annie] Pennine Acute Natl Hlth Serv Trust, Dept Res & Dev, Manchester, Lancs, England		Kirby, A (corresponding author), Leeds Teaching Hosp Natl Hlth Serv Trust, Dept Microbiol, Leeds, W Yorkshire, England.	kirbyandrew@doctors.org.uk	Herbert, Annie/AAA-4635-2019; Herbert, Annie/I-2337-2014	Herbert, Annie/0000-0002-5570-1408; Kirby, Andrew/0000-0002-2440-9316				Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P71, DOI 10.1093/jac/dkr459; [Anonymous], 2010, LIB NHS LEG FRAM NEX; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; ECDC/EMEA, 2009, BACT CHALL TIM REACT; European Antimicrobial Resistance Surveillance System, 2009, EARSS ANN REP 2008; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Harada K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/180682; Hulscher MEJL, 2010, LANCET INFECT DIS, V10, P167, DOI 10.1016/S1473-3099(10)70027-X; Hunter J.E., 1990, METHODS META ANAL CO; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Marothi Y A, 2005, Indian J Med Microbiol, V23, P214; Murphy M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593820; Nilsson P, 2005, SCAND J INFECT DIS, V37, P436, DOI 10.1080/00365540510037795; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Raphael D, 2011, MATURITAS, V69, P22, DOI 10.1016/j.maturitas.2011.02.011; Rea RS, 2008, THER DRUG MONIT, V30, P674, DOI 10.1097/FTD.0b013e31818b6b2f; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Roberts AD, 2012, SEMIN VASC SURG, V25, P75, DOI 10.1053/j.semvascsurg.2012.04.010; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Semins MJ, 2012, UROLOGY, V79, P266, DOI 10.1016/j.urology.2011.09.040; Singh R, 2011, CURR OPIN PHARMACOL, V11, P453, DOI 10.1016/j.coph.2011.07.009; Solt F, 2009, SOC SCI QUART, V90, P231, DOI 10.1111/j.1540-6237.2009.00614.x; Subramanian SV, 2006, HEALTH PLACE, V12, P141, DOI 10.1016/j.healthplace.2004.11.001; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; *WHO (, 2004, AN THER CHEM CLASS S; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	33	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73115	10.1371/journal.pone.0073115	http://dx.doi.org/10.1371/journal.pone.0073115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009734	Green Published, gold			2022-12-25	WOS:000323734600056
J	Paulus, P; Holfeld, J; Urbschat, A; Mutlak, H; Ockelmann, PA; Tacke, S; Zacharowski, K; Reissig, C; Stay, D; Scheller, B				Paulus, Patrick; Holfeld, Johannes; Urbschat, Anja; Mutlak, Haitham; Ockelmann, Pia Alexandra; Tacke, Sabine; Zacharowski, Kai; Reissig, Christin; Stay, David; Scheller, Bertram			Prednisolone as Preservation Additive Prevents from Ischemia Reperfusion Injury in a Rat Model of Orthotopic Lung Transplantation	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; CORTICOSTEROIDS INHIBIT; NEUTROPHIL RECRUITMENT; MACROPHAGE PLASTICITY; ALVEOLAR MACROPHAGES; DUAL ROLE; MECHANISM; HYPOXIA; INDUCE; INTERVENTIONS	The lung is, more than other solid organs, susceptible for ischemia reperfusion injury after orthotopic transplantation. Corticosteroids are known to potently suppress pro-inflammatory processes when given in the post-operative setting or during rejection episodes. Whereas their use has been approved for these clinical indications, there is no study investigating its potential as a preservation additive in preventing vascular damage already in the phase of ischemia. To investigate these effects we performed orthotopic lung transplantations (LTX) in the rat. Prednisolone was either added to the perfusion solution for lung preservation or omitted and rats were followed for 48 hours after LTX. Prednisolone preconditioning significantly increased survival and diminished reperfusion edema. Hypoxia induced vasoactive cytokines such as VEGF were reduced. Markers of leukocyte invasiveness like matrix metalloprotease (MMP)-2, or common pro-inflammatory molecules like the CXCR4 receptor or the chemokine (C-C motif) ligand (CCL)-2 were downregulated by prednisolone. Neutrophil recruitment to the grafts was only increased in Perfadex treated lungs. Together with this, prednisolone treated animals displayed significantly reduced lung protein levels of neutrophil chemoattractants like CINC-1, CINC-2 alpha/beta and LIX and upregulated tissue inhibitor of matrix metalloproteinase (TIMP)-1. Interestingly, lung macrophage invasion was increased in both, Perfadex and prednisolone treated grafts, as measured by MMP-12 or RM4. Markers of anti-inflammatory macrophage transdifferentiation like MRC-1, IL-13, IL-4 and CD163, significantly correlated with prednisolone treatment. These observations lead to the conclusion that prednisolone as an additive to the perfusion solution protects from hypoxia triggered danger signals already in the phase of ischemia and thus reduces graft edema in the phase of reperfusion. Additionally, prednisolone preconditioning might also lead to macrophage polarization as a beneficial long-term effect.	[Paulus, Patrick; Mutlak, Haitham; Ockelmann, Pia Alexandra; Zacharowski, Kai; Reissig, Christin; Stay, David; Scheller, Bertram] Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain The, Frankfurt, Germany; [Holfeld, Johannes] Med Univ Innsbruck, Clin Cardiac Surg, A-6020 Innsbruck, Austria; [Urbschat, Anja] Goethe Univ Hosp, Frankfurt, Germany; [Tacke, Sabine] Univ Giessen, Dept Vet Clin Sci, Clin Small Anim Surg, D-35390 Giessen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Medical University of Innsbruck; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Justus Liebig University Giessen	Paulus, P (corresponding author), Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain The, Frankfurt, Germany.	Patrick.Paulus@kgu.de	Tacke, Sabine/A-3213-2019		 [F13/09-R 88/2009]		This work has been funded by a junior investigator research grant (F13/09-R 88/2009) to P. Paulus by the faculty of medicine of the Goethe-University Frankfurt, Germany. The funders of this study had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abraham D, 2004, ANN THORAC SURG, V77, P1751, DOI 10.1016/j.athoracsur.2003.10.050; Abraham D, 2002, TRANSPLANTATION, V73, P1703, DOI 10.1097/00007890-200206150-00003; Aharinejad S, 2007, AM J TRANSPLANT, V7, P2012, DOI 10.1111/j.1600-6143.2007.01875.x; Barbulescu K, 1998, ANN NY ACAD SCI, V859, P319, DOI 10.1111/j.1749-6632.1998.tb11155.x; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Belvisi Maria G, 2004, Proc Am Thorac Soc, V1, P207, DOI 10.1513/pats.200402-002MS; Bhorade Sangeeta M, 2009, Proc Am Thorac Soc, V6, P47, DOI 10.1513/pats.200808-096GO; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blotta MH, 1997, J IMMUNOL, V158, P5589; Boucek MM, 2007, J HEART LUNG TRANSPL, V26, P796, DOI 10.1016/j.healun.2007.06.006; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chung KF, 2005, EUR RESPIR J, V26, P762, DOI 10.1183/09031936.05.00093305; Corbel M, 2002, CELL BIOL TOXICOL, V18, P51, DOI 10.1023/A:1014471213371; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2011, ANESTHESIOLOGY, V114, P239, DOI 10.1097/ALN.0b013e3182070c66; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Ferrero V, 2007, AM J CARDIOL, V99, P1082, DOI 10.1016/j.amjcard.2006.11.064; Fiser SM, 2001, ANN THORAC SURG, V71, P1134, DOI 10.1016/S0003-4975(01)02407-9; Follette DM, 1998, J HEART LUNG TRANSPL, V17, P423; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Iwata T, 2008, TRANSPLANTATION, V85, P417, DOI [10.1097/TP.0b013e318e91b6, 10.1097/TP.0b013e31815e91b6]; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Lee JC, 2011, CLIN CHEST MED, V32, P279, DOI 10.1016/j.ccm.2011.02.007; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McAdams HP, 2001, RADIOLOGY, V218, P233, DOI 10.1148/radiology.218.1.r01ja45233; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Moldobaeva A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026716; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ng CSH, 2006, SURG TODAY, V36, P205, DOI 10.1007/s00595-005-3124-2; NOVICK RJ, 1991, ANN THORAC SURG, V51, P642, DOI 10.1016/0003-4975(91)90325-K; PARRILLO JE, 1979, ANNU REV PHARMACOL, V19, P179, DOI 10.1146/annurev.pa.19.040179.001143; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Paulus P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039265; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peeters P, 2008, TRANSPLANTATION, V85, pS31, DOI 10.1097/TP.0b013e318169c548; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Rogatsky I, 2006, TISSUE ANTIGENS, V68, P1, DOI 10.1111/j.1399-0039.2006.00599.x; Ross SD, 1999, ANN THORAC SURG, V67, P1428, DOI 10.1016/S0003-4975(99)00248-9; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SLEIMAN C, 1995, EUR RESPIR J, V8, P5, DOI 10.1183/09031936.95.08010005; Song J, 2013, J IMMUNOL, V190, P401, DOI 10.4049/jimmunol.1202286; Sun L, 2013, CLIN EXP IMMUNOL, V172, P263, DOI 10.1111/cei.12059; THOMPSON EB, 1974, METABOLISM, V23, P159, DOI 10.1016/0026-0495(74)90113-9; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Wissink S, 1998, MOL ENDOCRINOL, V12, P355, DOI 10.1210/me.12.3.355; Wohlschlager J, 2011, PATHOLOGE, V32, P104, DOI 10.1007/s00292-010-1403-1; Zhao MQ, 2006, AM J PHYSIOL-LUNG C, V291, pL1018, DOI 10.1152/ajplung.00086.2006	54	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73298	10.1371/journal.pone.0073298	http://dx.doi.org/10.1371/journal.pone.0073298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009745	Green Submitted, gold, Green Published			2022-12-25	WOS:000323734600064
J	Gao, HGL; Fisher, PW; Lambi, AG; Wade, CK; Barr-Gillespie, AE; Popoff, SN; Barbe, MF				Gao, Helen G. L.; Fisher, Paul W.; Lambi, Alex G.; Wade, Christine K.; Barr-Gillespie, Ann E.; Popoff, Steven N.; Barbe, Mary F.			Increased Serum and Musculotendinous Fibrogenic Proteins following Persistent Low-Grade Inflammation in a Rat Model of Long-Term Upper Extremity Overuse	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TISSUE GROWTH-FACTOR; CARPAL-TUNNEL-SYNDROME; CONNECTIVE-TISSUE; MUSCULOSKELETAL DISORDERS; FACTOR-BETA; SKELETAL-MUSCLE; TNF-ALPHA; TGF-BETA; COLLAGEN-METABOLISM	We examined the relationship between grip strength declines and muscle-tendon responses induced by long-term performance of a high-repetition, low-force (HRLF) reaching task in rats. We hypothesized that grip strength declines would correlate with inflammation, fibrosis and degradation in flexor digitorum muscles and tendons. Grip strength declined after training, and further in weeks 18 and 24, in reach limbs of HRLF rats. Flexor digitorum tissues of reach limbs showed low-grade increases in inflammatory cytokines: IL-1 beta after training and in week 18, IL-1 alpha in week 18, TNF-alpha and IL-6 after training and in week 24, and IL-10 in week 24, with greater increases in tendons than muscles. Similar cytokine increases were detected in serum with HRLF: IL-1 alpha and IL-10 in week 18, and TNF-alpha and IL-6 in week 24. Grip strength correlated inversely with IL-6 in muscles, tendons and serum, and TNF-alpha in muscles and serum. Four fibrogenic proteins, TGFB1, CTGF, PDGFab and PDGFbb, and hydroxyproline, a marker of collagen synthesis, increased in serum in HRLF weeks 18 or 24, concomitant with epitendon thickening, increased muscle and tendon TGFB1 and CTGF. A collagenolytic gelatinase, MMP2, increased by week 18 in serum, tendons and muscles of HRLF rats. Grip strength correlated inversely with TGFB1 in muscles, tendons and serum; with CTGF-immunoreactive fibroblasts in tendons; and with MMP2 in tendons and serum. Thus, motor declines correlated with low-grade systemic and musculotendinous inflammation throughout task performance, and increased fibrogenic and degradative proteins with prolonged task performance. Serum TNF-alpha, IL-6, TGFB1, CTGF and MMP2 may serve as serum biomarkers of work-related musculoskeletal disorders, although further studies in humans are needed.	[Gao, Helen G. L.; Fisher, Paul W.; Lambi, Alex G.; Popoff, Steven N.; Barbe, Mary F.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Wade, Christine K.] Thomas Jefferson Univ, Dept Phys Therapy, Philadelphia, PA 19107 USA; [Barr-Gillespie, Ann E.] Univ Pacific, Coll Hlth Profess, Hillsboro, OR USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; University of the Pacific	Barbe, MF (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA.	mary.barbe@temple.edu		Barbe, Mary/0000-0002-5235-9803	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR056019]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056019] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number AR056019 to MFB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038359; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P199, DOI 10.1080/15321810701454649; Baker BA, 2007, MED SCI SPORT EXER, V39, P1275, DOI 10.1249/mss.0b013e3180686dc7; Barbe MF, 2008, J ORTHOP RES, V26, P1320, DOI 10.1002/jor.20674; Barbe MF, 2006, BRAIN BEHAV IMMUN, V20, P423, DOI 10.1016/j.bbi.2006.03.001; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Barr AE, 2002, PHYS THER, V82, P173, DOI 10.1093/ptj/82.2.173; Barr AE, 2004, J ORTHOP SPORT PHYS, V34, P610, DOI 10.2519/jospt.2004.34.10.610; Barr AE, 2004, EXERC SPORT SCI REV, V32, P135; Barr AE, 2004, J ELECTROMYOGR KINES, V14, P77, DOI 10.1016/j.jelekin.2003.09.008; Barr AE, 2003, J BONE MINER RES, V18, P2023, DOI 10.1359/jbmr.2003.18.11.2023; Beddy D, 2006, BRIT J SURG, V93, P1290, DOI 10.1002/bjs.5431; Bureau of Labor Statistics, 2012, NONF OC INJ ILLN REQ; Carp S, 2008, BIOMARK MED, V2, P67, DOI 10.2217/17520363.2.1.67; Carp SJ, 2007, CLIN SCI, V112, P305, DOI 10.1042/CS20060050; Clark BD, 2004, J ORTHOP SPORT PHYS, V34, P244, DOI 10.2519/jospt.2004.34.5.244; Clark BD, 2003, J NEUROTRAUM, V20, P681, DOI 10.1089/089771503322144590; Cook JL, 2004, BRIT J SPORT MED, V38, P206, DOI 10.1136/bjsm.2003.004747; Coq JO, 2009, EXP NEUROL, V220, P234, DOI 10.1016/j.expneurol.2009.08.008; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Malheiro OCD, 2009, ANAT REC, V292, P1656, DOI 10.1002/ar.20953; DENNETT X, 1988, LANCET, V1, P905; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Elliott MB, 2008, BRAIN RES, V1218, P103, DOI 10.1016/j.brainres.2008.04.029; Ettema AM, 2004, J BONE JOINT SURG AM, V86A, P1458, DOI 10.2106/00004623-200407000-00014; Ettema Anke M, 2006, Hand (N Y), V1, P78, DOI 10.1007/s11552-006-9009-z; Fedorczyk JM, 2010, J ORTHOP RES, V28, P298, DOI 10.1002/jor.20984; Freeland AE, 2002, MICROSURG, V22, P378, DOI 10.1002/micr.10065; Gallagher S, 2013, HUM FACTORS, V55, P108, DOI 10.1177/0018720812449648; Garner Bridget C, 2011, J Knee Surg, V24, P251; George J, 2000, CLIN BIOCHEM, V33, P563, DOI 10.1016/S0009-9120(00)00170-3; Gerr F, 2002, AM J IND MED, V41, P221, DOI 10.1002/ajim.10066; Graham KM, 2010, J NEUROL SCI, V294, P43, DOI 10.1016/j.jns.2010.04.007; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hirata H, 2005, J PATHOL, V205, P443, DOI 10.1002/path.1709; Hirata H, 2004, J PATHOL, V204, P605, DOI 10.1002/path.1673; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jana M, 2003, J NEUROCHEM, V86, P519, DOI 10.1046/j.1471-4159.2003.01864.x; JARVINEN MJ, 1993, SPORTS MED, V15, P78; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kehl LJ, 2003, EXERC SPORT SCI REV, V31, P188, DOI 10.1097/00003677-200310000-00006; Kelly M, 2003, CURR PHARM DESIGN, V9, P39, DOI 10.2174/1381612033392341; Kietrys DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046954; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kuiper JI, 2005, OCCUP ENVIRON MED, V62, P363, DOI 10.1136/oem.2004.016998; Kuiper JI, 2004, CLIN BIOMECH, V19, P209, DOI 10.1016/j.clinbiomech.2003.10.004; Kuiper JI, 2002, SCAND J WORK ENV HEA, V28, P168, DOI 10.5271/sjweh.661; Larsson B, 2001, EUR J APPL PHYSIOL, V84, P492, DOI 10.1007/s004210100409; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Liu JY, 2001, AM J RESP CELL MOL, V25, P3, DOI 10.1165/ajrcmb.25.1.4481; Manns JM, 2006, ARTHRITIS RHEUM, V54, P2415, DOI 10.1002/art.22021; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Neuman MG, 2012, INT J HEPATOL, V2012, DOI DOI 10.1155/2012/231210; Pap G, 1998, PATHOL RES PRACT, V194, P41, DOI 10.1016/S0344-0338(98)80010-1; Pasternak B, 2010, BRIT J SPORT MED, V44, P669, DOI 10.1136/bjsm.2008.049411; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen SJ, 2011, ANN RHEUM DIS, V70, P1375, DOI 10.1136/ard.2010.138883; PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649; PHAN SH, 1992, J IMMUNOL, V149, P103; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Rani S, 2010, J CELL PHYSIOL, V225, P152, DOI 10.1002/jcp.22208; Rani S, 2009, J HISTOCHEM CYTOCHEM, V57, P1061, DOI 10.1369/jhc.2009.954081; Rechardt M, 2011, CYTOKINE, V54, P149, DOI 10.1016/j.cyto.2011.02.003; Rempel DM, 2004, J ELECTROMYOGR KINES, V14, P71, DOI 10.1016/j.jelekin.2003.09.009; Riondino S, 2011, INT ARCH OCC ENV HEA, V84, P745, DOI 10.1007/s00420-010-0605-4; Rohde T, 1997, AM J PHYSIOL-ENDOC M, V273, pE85, DOI 10.1152/ajpendo.1997.273.1.E85; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; Saxton JM, 2000, OCCUP MED-OXFORD, V50, P121, DOI 10.1093/occmed/50.2.121; Seher A, 2011, MOL VIS, V17, P53; Smith CA, 2007, J APPL PHYSIOL, V102, P755, DOI 10.1152/japplphysiol.01503.2005; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Stauber WT, 2000, MUSCLE NERVE, V23, P1819, DOI 10.1002/1097-4598(200012)23:12<1819::AID-MUS4>3.0.CO;2-2; Steinman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048560; Thrall RS, 1997, AM J PATHOL, V151, P1303; Tucci M A, 1997, Biomed Sci Instrum, V33, P246; Uchio Y, 2002, J SHOULDER ELB SURG, V11, P570, DOI 10.1067/mse.2002.126769; van Nieuwenhoven FA, 2005, NEPHROL DIAL TRANSPL, V20, P6, DOI 10.1093/ndt/gfh570; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; WORRELL TW, 1994, SPORTS MED, V17, P338, DOI 10.2165/00007256-199417050-00006; Xin DL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-63; Yu F, 2009, CELL SIGNAL, V21, P867, DOI 10.1016/j.cellsig.2009.01.030; Yu Q, 2000, GENE DEV, V14, P163	91	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71875	10.1371/journal.pone.0071875	http://dx.doi.org/10.1371/journal.pone.0071875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015193	Green Published, gold			2022-12-25	WOS:000323733800015
J	Gui, D; Jia, KT; Xia, J; Yang, LL; Chen, JL; Wu, YP; Yi, MS				Gui, Duan; Jia, Kuntong; Xia, Jia; Yang, Lili; Chen, Jialin; Wu, Yuping; Yi, Meisheng			De novo Assembly of the Indo-Pacific Humpback Dolphin Leucocyte Transcriptome to Identify Putative Genes Involved in the Aquatic Adaptation and Immune Response	PLOS ONE			English	Article							BOTTLE-NOSED-DOLPHIN; SOUSA-CHINENSIS; POPULATION; CETACEANS; MARKERS; IDENTIFICATION; LOCALIZATION; DIVERSITY; MOLECULES; EVOLUTION	Background: The Indo-Pacific humpback dolphin (Sousa chinensis), a marine mammal species inhabited in the waters of Southeast Asia, South Africa and Australia, has attracted much attention because of the dramatic decline in population size in the past decades, which raises the concern of extinction. So far, this species is poorly characterized at molecular level due to little sequence information available in public databases. Recent advances in large-scale RNA sequencing provide an efficient approach to generate abundant sequences for functional genomic analyses in the species with un-sequenced genomes. Principal Findings: We performed a de novo assembly of the Indo-Pacific humpback dolphin leucocyte transcriptome by Illumina sequencing. 108,751 high quality sequences from 47,840,388 paired-end reads were generated, and 48,868 and 46,587 unigenes were functionally annotated by BLAST search against the NCBI non-redundant and Swiss-Prot protein databases (E-value<10(-5)), respectively. In total, 16,467 unigenes were clustered into 25 functional categories by searching against the COG database, and BLAST2GO search assigned 37,976 unigenes to 61 GO terms. In addition, 36,345 unigenes were grouped into 258 KEGG pathways. We also identified 9,906 simple sequence repeats and 3,681 putative single nucleotide polymorphisms as potential molecular markers in our assembled sequences. A large number of unigenes were predicted to be involved in immune response, and many genes were predicted to be relevant to adaptive evolution and cetacean-specific traits. Conclusion: This study represented the first transcriptome analysis of the Indo-Pacific humpback dolphin, an endangered species. The de novo transcriptome analysis of the unique transcripts will provide valuable sequence information for discovery of new genes, characterization of gene expression, investigation of various pathways and adaptive evolution, as well as identification of genetic markers.	[Gui, Duan; Xia, Jia; Wu, Yuping] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Gui, Duan; Jia, Kuntong; Yang, Lili; Wu, Yuping; Yi, Meisheng] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jialin] Guang Dong Pearl River Estuary Chinese White Dolp, Zhuhai, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wu, YP (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	exwyp@mail.sysu.edu.cn; yimsh@mail.sysu.edu.cn	kuntong, jia/GYQ-7618-2022	Gui, Duan/0000-0002-0236-6837	National Natural Science Foundation of China [31271576, 41276147]; Ph.D. Programs Foundation of Ministry of Education of China [20120171110033]; Administration of Ocean and Fisheries of Guangdong Province, China; Priming Scientific Research Foundation for Junior Teachers in the Sun Yat-sen University [42000-1188140]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Administration of Ocean and Fisheries of Guangdong Province, China; Priming Scientific Research Foundation for Junior Teachers in the Sun Yat-sen University	The work was supported by the National Natural Science Foundation of China (Grant Nos. 31271576, 41276147), the Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20120171110033), the Sousa chinensis Conservation Action Project from the Administration of Ocean and Fisheries of Guangdong Province, China, and the Priming Scientific Research Foundation for Junior Teachers in the Sun Yat-sen University (Grant No. 42000-1188140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akfirat FS, 2013, BIOCHEM GENET, V51, P223, DOI 10.1007/s10528-012-9557-6; Amaral AR, 2012, MOL ECOL, V21, P4854, DOI 10.1111/j.1365-294X.2012.05728.x; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Au WWL, 2006, J EXP BIOL, V209, P2726, DOI 10.1242/jeb.02306; Barbosa S, 2013, MOL ECOL RESOUR, V13, P43, DOI 10.1111/1755-0998.12024; Bathoorn Erik, 2008, Int J Chron Obstruct Pulmon Dis, V3, P217; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Beuchat CA, 1996, AM J PHYSIOL-REG I, V271, pR157, DOI 10.1152/ajpregu.1996.271.1.R157; Bowater RO, 2003, AUST VET J, V81, P627, DOI 10.1111/j.1751-0813.2003.tb12509.x; Chen BY, 2009, INTEGR ZOOL, V4, P240, DOI 10.1111/j.1749-4877.2009.00160.x; Clark AG, 2006, TRENDS ECOL EVOL, V21, P316, DOI 10.1016/j.tree.2006.04.004; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-77; Fair PA, 2013, ENVIRON TOXICOL CHEM, V32, P736, DOI 10.1002/etc.2122; Fish FE, 2007, ANAT REC, V290, P614, DOI 10.1002/ar.20546; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gravena W, 2009, MOL ECOL RESOUR, V9, P600, DOI 10.1111/j.1755-0998.2008.02458.x; Harrison R.J., 1974, P45; HICKS BD, 1985, J INVEST DERMATOL, V85, P60, DOI 10.1111/1523-1747.ep12275348; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LaMere SA, 2009, J VIROL, V83, P12956, DOI 10.1128/JVI.01354-09; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Magni F, 2006, PROTEOMICS, V6, P5637, DOI 10.1002/pmic.200600212; MALVIN RL, 1978, P SOC EXP BIOL MED, V157, P665; MORRIS DJ, 1981, ENDOCR REV, V2, P234, DOI 10.1210/edrv-2-2-234; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natale DA, 2000, GENOME BIOL, V1; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Parsons ECM, 1998, SCI TOTAL ENVIRON, V214, P175, DOI 10.1016/S0048-9697(98)00063-1; Parsons ECM, 2001, VET REC, V148, P776, DOI 10.1136/vr.148.25.776; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pinheiro A, 2011, IMMUNOGENETICS, V63, P397, DOI 10.1007/s00251-011-0533-9; Pritchard VL, 2013, MOL ECOL RESOUR, V13, P276, DOI 10.1111/1755-0998.12040; Reidenerg JS, 2007, ANAT REC, V290, P507, DOI 10.1002/ar.20541; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Seavey MM, 2012, BIOCHEM PHARMACOL, V83, P1136, DOI 10.1016/j.bcp.2011.12.024; Shen T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-39; Stone BM, 2012, J WILDLIFE DIS, V48, P47, DOI 10.7589/0090-3558-48.1.47; Suzuki M, 2008, J COMP PHYSIOL B, V178, P149, DOI 10.1007/s00360-007-0204-1; Suzuki M, 2010, J COMP PHYSIOL B, V180, P229, DOI 10.1007/s00360-009-0397-6; Tomo I, 2010, J WILDLIFE DIS, V46, P488, DOI 10.7589/0090-3558-46.2.488; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu YL, 2013, SCI TOTAL ENVIRON, V444, P423, DOI 10.1016/j.scitotenv.2012.11.110; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yordy JE, 2010, ENVIRON TOXICOL CHEM, V29, P2143, DOI 10.1002/etc.279	55	29	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72417	10.1371/journal.pone.0072417	http://dx.doi.org/10.1371/journal.pone.0072417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015242	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800051
J	Zhang, YM; Zhu, HX; Zhang, XL; Gu, DY; Zhou, XC; Wang, ML; Cao, CX; Zhang, XJ; Wu, XM; Gong, WD; Tang, YF; Zhou, JW; Tang, CJ; Zhang, ZD; Chen, JF				Zhang, Yangmei; Zhu, Haixia; Zhang, Xunlei; Gu, Dongying; Zhou, Xichang; Wang, Meilin; Cao, Chunxiang; Zhang, Xiaojing; Wu, Xiaomin; Gong, Weida; Tang, Yongfei; Zhou, Jianwei; Tang, Cuiju; Zhang, Zhengdong; Chen, Jinfei			Clinical Significance of MYT1L Gene Polymorphisms in Chinese Patients with Gastric Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; ZINC FINGERS; ASSOCIATION; PROGNOSIS; CARDIA; SCHIZOPHRENIA; APOPTOSIS; ARREST	Background: Myelin transcription factor 1 (MYT1) and its homologue MYT1-like (MYT1L) are the two main members of MYT/NZF family transcription factors, which are highly related, share a high degree of identity and show similar regulatory functions in neural development. There are evidences from several cytology experiments showing that MYT1 is associated with carcinoma. Methodology/Principal Findings: In the present study, we genotyped 944 surgically resected gastric cancer patients by the SNaPshot method to explore the association of MYT1L rs17039396 polymorphism with survival of gastric cancer in a Chinese population. We found that cardia cancer patients carrying MYT1L rs17039396 GG genotype survived for a significantly shorter time than those carrying the GA genotype. This significance was enhanced in the dominant model (GG vs. GA/AA, log-rank P = 0.001), suggesting a potential protect role of the variant A allele. Multivariate Cox regression analyses showed that the AG/GG genotypes were associated with a significantly decreased risk of death from gastric cancer (adjusted hazard ratio (HR) = 0.57, 95% confidence interval (CI) = 0.40-0.81). Stratification analyses further showed that such protective effect was statistically significant in subgroups of patients with tumor size <= 5 cm (adjusted HR = 0.34, 95% CI = 0.19-0.64), well-moderate gastric cancer (adjusted HR = 0.59, 95% CI = 0.35-0.98), no lymph-node metastasis (adjusted HR = 0.49, 95% CI = 0.31-0.76), no distant metastasis (adjusted HR = 0.59, 95% CI = 0.41-0.84). Conclusions/Significance: In conclusion, these data represents the first demonstration that MYT1L rs17039396 variants could indentified as a favorable prognostic indicator for gastric cancer, particularly among the cardia gastric cancer. Further validation in other larger studies with different ethnic populations and functional evaluations are needed.	[Zhang, Yangmei; Zhang, Xunlei; Gu, Dongying; Cao, Chunxiang; Zhang, Xiaojing; Wu, Xiaomin; Tang, Cuiju; Chen, Jinfei] Nanjing Med Univ, Dept Oncol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Yangmei] Southeast Univ, Coll Med, Affiliated Xuzhou Hosp, Xuzhou Cent Hosp,Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Haixia; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Zhu, Haixia; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhou, Xichang] Qinghai Univ, Coll Med, Dept Imaging & Nucl Med, Affiliated Hosp Qinghai Univ, Xining, Peoples R China; [Gong, Weida] Yixing Canc Hosp, Dept Surg, Yixing, Peoples R China; [Tang, Yongfei] Yixing Peoples Hosp, Dept Surg, Yixing, Peoples R China; [Zhou, Jianwei] Nanjing Med Univ, Ctr Canc, Sch Publ Hlth, Dept Mol Cell Biol & Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nanjing Medical University; Nanjing Medical University; Qinghai University; Nanjing Medical University	Tang, CJ (corresponding author), Nanjing Med Univ, Dept Oncol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	cuijutang@sina.com; drzhengdongzhang@sina.com; njjinfeichen@sina.com	Zhang, Xun/HHM-9059-2022; zhang, zheng/HCH-9684-2022	Zhang, Xun/0000-0001-5411-2727; 	National Natural Science Foundation of China [81230068, 81000880, 81071641, 81202268, 81201570, 81102089]; Natural Science Foundation of Jiangsu Province [BK2011773, BK2011775, BK2011194]; Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002, 12KJA330002]; Jiangsu Provincial Graduates Innovative Project [CXZZ12_0594]; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Basic Research of Jiangsu Provincial Department of Education; Jiangsu Provincial Graduates Innovative Project; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by the National Natural Science Foundation of China (81230068, 81000880, 81071641, 81202268, 81201570 and 81102089), Natural Science Foundation of Jiangsu Province (BK2011773, BK2011775 and BK2011194), the Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002, and 12KJA330002), Jiangsu Provincial Graduates Innovative Project (CXZZ12_0594), Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project, the Qing Lan Project of Jiangsu Provincial Department of Education, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Choi HS, 2009, MOL CELL BIOL, V29, P2168, DOI 10.1128/MCB.01508-08; Chow JPH, 2013, ONCOGENE, V32, P4778, DOI 10.1038/onc.2012.504; Dai X, 2004, J INVEST DERMATOL, V122, P1356, DOI 10.1111/j.0022-202X.2004.22522.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Kim MA, 2005, CANCER-AM CANCER SOC, V103, P1439, DOI 10.1002/cncr.20966; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Li W, 2012, GENES BRAIN BEHAV, V11, P87, DOI 10.1111/j.1601-183X.2011.00734.x; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Resende C, 2010, HELICOBACTER, V15, P34, DOI 10.1111/j.1523-5378.2010.00782.x; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Santoro R, 2007, BRIT J SURG, V94, P737, DOI 10.1002/bjs.5600; Seidl C, 2007, MOL CANCER THER, V6, P2346, DOI 10.1158/1535-7163.MCT-07-0132; Sjakste T, 2011, DNA CELL BIOL, V30, P433, DOI 10.1089/dna.2010.1153; Stevens SJC, 2011, AM J MED GENET A, V155A, P2739, DOI 10.1002/ajmg.a.34274; Tajima Y, 2007, BRIT J CANCER, V96, P631, DOI 10.1038/sj.bjc.6603583; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Zhang YM, 2013, DNA CELL BIOL, V32, P111, DOI 10.1089/dna.2012.1840	32	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71979	10.1371/journal.pone.0071979	http://dx.doi.org/10.1371/journal.pone.0071979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015200	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800022
J	Lamari, N; Ruggiero, MV; d'Ippolito, G; Kooistra, WHCF; Fontana, A; Montresor, M				Lamari, Nadia; Ruggiero, Maria Valeria; d'Ippolito, Giuliana; Kooistra, Wiebe H. C. F.; Fontana, Angelo; Montresor, Marina			Specificity of Lipoxygenase Pathways Supports Species Delineation in the Marine Diatom Genus Pseudo-nitzschia	PLOS ONE			English	Article							OXYLIPIN METABOLISM; INNATE IMMUNITY; DIVERSITY; EICOSANOIDS; DEFENSE; COMPATIBILITY; REPRODUCTION; CONVERSION; PHYLOGENY; ALDEHYDES	Oxylipins are low-molecular weight secondary metabolites derived from the incorporation of oxygen into the carbon chains of polyunsaturated fatty acids (PUFAs). Oxylipins are produced in many prokaryotic and eukaryotic lineages where they are involved in a broad spectrum of actions spanning from stress and defense responses, regulation of growth and development, signaling, and innate immunity. We explored the diversity in oxylipin patterns in the marine planktonic diatom Pseudo-nitzschia. This genus includes several species only distinguishable with the aid of molecular markers. Oxylipin profiles of cultured strains were obtained by reverse phase column on a liquid chromatograph equipped with UV photodiode detector and q-ToF mass spectrometer. Lipoxygenase compounds were mapped on phylogenies of the genus Pseudo-nitzschia inferred from the nuclear encoded hyper-variable region of the LSU rDNA and the plastid encoded rbcL. Results showed that the genus Pseudo-nitzschia exhibits a rich and varied lipoxygenase metabolism of eicosapentaenoic acid (EPA), with a high level of specificity for oxylipin markers that generally corroborated the genotypic delineation, even among genetically closely related cryptic species. These results suggest that oxylipin profiles constitute additional identification tools for Pseudo-nitzschia species providing a functional support to species delineation obtained with molecular markers and morphological traits. The exploration of the diversity, patterns and plasticity of oxylipin production across diatom species and genera will also provide insights on the ecological functions of these secondary metabolites and on the selective pressures driving their diversification.	[Lamari, Nadia; d'Ippolito, Giuliana; Fontana, Angelo] CNR, Ist Chim Biomol, Pozzuoli, Italy; [Ruggiero, Maria Valeria; Kooistra, Wiebe H. C. F.; Montresor, Marina] Stn Zool A Dohrn, Lab Ecol & Evolut Plankton, I-80121 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Stazione Zoologica Anton Dohrn di Napoli	Ruggiero, MV (corresponding author), Stn Zool A Dohrn, Lab Ecol & Evolut Plankton, I-80121 Naples, Italy.	mariavaleria.ruggiero@szn.it	Ruggiero, Maria Valeria/AFO-6987-2022; Fontana, Angelo/C-3354-2012; Lamari, Nadia/D-9140-2013; d'Ippolito, Giuliana/AAW-8651-2020; Fontana, Angelo/AAO-2741-2021	Ruggiero, Maria Valeria/0000-0002-1661-0466; Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Montresor, Marina/0000-0002-2475-1787; Kooistra, Wiebe/0000-0002-8641-9739; d'Ippolito, Giuliana/0000-0002-6821-6962	Ministerodell'Istruzione, Universita e Ricerca project "Energia da FontiRinnovabili"; StazioneZoologica Anton Dohrn (Naples, Italy); EC project MIDTAL [201724]	Ministerodell'Istruzione, Universita e Ricerca project "Energia da FontiRinnovabili"; StazioneZoologica Anton Dohrn (Naples, Italy); EC project MIDTAL	This work was supported by: the Ministerodell'Istruzione, Universita e Ricerca project "Energia da FontiRinnovabili"; StazioneZoologica Anton Dohrn (Naples, Italy). MVR fellowship was supported by the EC project MIDTAL (FP7, Contract number 201724, www.midtal.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu LM, 2012, FUNGAL BIOL-UK, V116, P249, DOI 10.1016/j.funbio.2011.11.008; Ahmed P., 2009, BOT RES INT, V2, P11, DOI DOI 10.3109/07388550903524243; Alverson AJ, 2008, PROTIST, V159, P339, DOI 10.1016/j.protis.2008.04.001; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Barreiro A, 2011, J EXP MAR BIOL ECOL, V401, P13, DOI 10.1016/j.jembe.2011.03.007; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Cutignano A, 2006, CHEMBIOCHEM, V7, P450, DOI 10.1002/cbic.200500343; Cutignano A, 2011, J PHYCOL, V47, P233, DOI 10.1111/j.1529-8817.2011.00972.x; d'Ippolito G, 2005, ORG BIOMOL CHEM, V3, P4065, DOI 10.1039/b510640k; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; d'Ippolito G, 2003, ORG LETT, V5, P885, DOI 10.1021/ol034057c; d'Ippolito G, 2009, NEW PHYTOL, V183, P1064, DOI 10.1111/j.1469-8137.2009.02887.x; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Evans KM, 2008, J PHYCOL, V44, P215, DOI 10.1111/j.1529-8817.2007.00454.x; Fink P, 2006, ARCH HYDROBIOL, V167, P561, DOI 10.1127/0003-9136/2006/0167-0561; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Fontana A, 2007, PURE APPL CHEM, V79, P481, DOI 10.1351/pac200779040481; Frisvad JC, 2008, MYCOL RES, V112, P231, DOI 10.1016/j.mycres.2007.08.018; Gerecht A, 2011, J PHYCOL, V47, P1050, DOI 10.1111/j.1529-8817.2011.01030.x; Gerwick WH, 1999, ADV EXP MED BIOL, V447, P211; GERWICK WH, 1993, MARINE NATURAL PRODU, P117; Guella G, 2010, MAR DRUGS, V8, P2080, DOI 10.3390/md8072080; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Huseby S, 2012, EUR J PHYCOL, V47, P480, DOI 10.1080/09670262.2012.741714; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; Quijano-Scheggia SI, 2009, PHYCOLOGIA, V48, P492, DOI 10.2216/08-21.1; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jenke-Kodama H, 2008, PROG DRUG RES, P121; Kooistra WHCF, 2003, J PHYCOL, V39, P185, DOI 10.1046/j.1529-8817.2003.02083.x; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; LENAERS G, 1989, J MOL EVOL, V29, P40, DOI 10.1007/BF02106180; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; Lundholm N, 2012, J PHYCOL, V48, P436, DOI 10.1111/j.1529-8817.2012.01132.x; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Montillet JL, 2002, PLANT PHYSIOL BIOCH, V40, P633, DOI 10.1016/S0981-9428(02)01402-X; Nigam S, 2007, FEBS J, V274, P3503, DOI 10.1111/j.1742-4658.2007.05910.x; O'Donnell Valerie B., 2009, V462, P5, DOI 10.1007/978-1-60327-115-8_1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Ribalet F, 2007, PHYTOCHEMISTRY, V68, P2059, DOI 10.1016/j.phytochem.2007.05.012; Ribalet F, 2009, PROTIST, V160, P444, DOI 10.1016/j.protis.2009.01.003; Scholin C. A., 1994, Natural Toxins, V2, P152, DOI 10.1002/nt.2620020403; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; Shearer GC, 2009, CURR ATHEROSCLER REP, V11, P403, DOI 10.1007/s11883-009-0061-3; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; SLOANE DL, 1995, PROTEIN ENG, V8, P275, DOI 10.1093/protein/8.3.275; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Vanelslander B, 2009, J PHYCOL, V45, P1278, DOI 10.1111/j.1529-8817.2009.00762.x; Vanormelingen P, 2008, PROTIST, V159, P73, DOI 10.1016/j.protis.2007.08.004; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; WANG RH, 1990, J CHEM SOC CHEM COMM, P413, DOI 10.1039/c39900000413; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Wichard T, 2005, J CHEM ECOL, V31, P949, DOI 10.1007/s10886-005-3615-z; Zheng NY, 1997, CHEM COMMUN, P399, DOI 10.1039/a608369b	70	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73281	10.1371/journal.pone.0073281	http://dx.doi.org/10.1371/journal.pone.0073281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014077	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200077
J	Xiao, X; Min, JL; Wang, P; Chou, KC				Xiao, Xuan; Min, Jian-Liang; Wang, Pu; Chou, Kuo-Chen			iGPCR-Drug: A Web Server for Predicting Interaction between GPCRs and Drugs in Cellular Networking	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; TARGET INTERACTION NETWORKS; SUPPORT VECTOR MACHINE; GENERAL-FORM; CHOUS PSEAAC; PHYSICOCHEMICAL PROPERTIES; SUBCELLULAR-LOCALIZATION; COUPLED RECEPTORS; TERTIARY STRUCTURE	Involved in many diseases such as cancer, diabetes, neurodegenerative, inflammatory and respiratory disorders, G-protein-coupled receptors (GPCRs) are among the most frequent targets of therapeutic drugs. It is time-consuming and expensive to determine whether a drug and a GPCR are to interact with each other in a cellular network purely by means of experimental techniques. Although some computational methods were developed in this regard based on the knowledge of the 3D (dimensional) structure of protein, unfortunately their usage is quite limited because the 3D structures for most GPCRs are still unknown. To overcome the situation, a sequence-based classifier, called "iGPCR-drug", was developed to predict the interactions between GPCRs and drugs in cellular networking. In the predictor, the drug compound is formulated by a 2D (dimensional) fingerprint via a 256D vector, GPCR by the PseAAC (pseudo amino acid composition) generated with the grey model theory, and the prediction engine is operated by the fuzzy K-nearest neighbour algorithm. Moreover, a user-friendly web-server for iGPCR-drug was established at http://www.jci-bioinfo.cn/iGPCR-Drug/. For the convenience of most experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated math equations presented in this paper just for its integrity. The overall success rate achieved by iGPCR-drug via the jackknife test was 85.5%, which is remarkably higher than the rate by the existing peer method developed in 2010 although no web server was ever established for it. It is anticipated that iGPCR-Drug may become a useful high throughput tool for both basic research and drug development, and that the approach presented here can also be extended to study other drug - target interaction networks.	[Xiao, Xuan; Min, Jian-Liang; Wang, Pu] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan] ZheJiang Text & Fash Coll, Informat Sch, Ningbo, Zhejiang, Peoples R China; [Chou, Kuo-Chen] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, Belmont, MA USA	Jingdezhen Ceramic Institute; King Abdulaziz University; Gordon Life Science Institute	Xiao, X (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xxiao@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009; Min, liang jian/HHZ-1665-2022	Min, liang jian/0000-0002-3375-1148	National Natural Science Foundation of China [60961003, 31260273]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2010GZS0122, 20114BAB211013, 20122BAB201020]; Department of Education of JiangXi Province [GJJ12490]; Jiangxi Provincial Foreign Scientific and Technological Cooperation Project [20120BDH80023]; JiangXi Provincial Foundation for Leaders of Disciplines in Science [20113BCB22008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; Department of Education of JiangXi Province; Jiangxi Provincial Foreign Scientific and Technological Cooperation Project; JiangXi Provincial Foundation for Leaders of Disciplines in Science	This work was supported by the grants from the National Natural Science Foundation of China (60961003 and 31260273), the Key Project of Chinese Ministry of Education (210116), the Province National Natural Science Foundation of JiangXi (2010GZS0122, 20114BAB211013 and 20122BAB201020), the Department of Education of JiangXi Province (GJJ12490), the Jiangxi Provincial Foreign Scientific and Technological Cooperation Project (20120BDH80023), and the JiangXi Provincial Foundation for Leaders of Disciplines in Science (20113BCB22008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chang TH, 2013, J COMPUT AID MOL DES, V27, P91, DOI 10.1007/s10822-012-9628-0; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; Chou KC, 2005, J PROTEOME RES, V4, P1681, DOI 10.1021/pr050145a; Chou KC, 2005, J PROTEOME RES, V4, P1657, DOI 10.1021/pr050135+; Chou KC, 2005, J PROTEOME RES, V4, P1413, DOI 10.1021/pr050087t; Chou KC, 2005, BIOCHEM BIOPH RES CO, V331, P56, DOI 10.1016/j.bbrc.2005.03.123; Chou KC, 2004, J PROTEOME RES, V3, P856, DOI 10.1021/pr049931q; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, FEBS LETT, V363, P127, DOI 10.1016/0014-5793(95)00245-5; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; Chou KC, 2002, BIOCHEM BIOPH RES CO, V292, P702, DOI 10.1006/bbrc.2002.6686; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Deng Julong, 1989, Journal of Grey Systems, V1, P1; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Finn P, 1998, MACH LEARN, V30, P241, DOI 10.1023/A:1007460424845; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gillet VJ, 2003, J CHEM INF COMP SCI, V43, P338, DOI 10.1021/ci025592e; Gregori-Puigjane E, 2011, J COMPUT CHEM, V32, P2638, DOI 10.1002/jcc.21843; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang C, 2013, J MEMBRANE BIOL, V246, P327, DOI 10.1007/s00232-013-9536-9; Jiang Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/287019; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Khosravian M, 2013, PROTEIN PEPTIDE LETT, V20, P180, DOI 10.2174/092986613804725307; Knowles J, 2003, NAT REV DRUG DISCOV, V2, P63, DOI 10.1038/nrd986; Laurent S, 2006, CONTRAST MEDIA MOL I, V1, P128, DOI 10.1002/cmmi.100; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; LIN SX, 2013, J BIOMED SCI JBISE, V6, P435, DOI DOI 10.4236/JBISE.2013.64054; Lin WZ, 2013, MOL BIOSYST, V9, P634, DOI 10.1039/c3mb25466f; Lin WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049040; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Lin WZ, 2009, PROTEIN ENG DES SEL, V22, P699, DOI 10.1093/protein/gzp057; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Maggiora GM, 1996, NEURAL NETWORKS QSAR, P255; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Milligan G, 2001, TRENDS PHARMACOL SCI, V22, P513, DOI 10.1016/S0165-6147(00)01801-0; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ren BY, 2002, COMPUT CHEM, V26, P357, DOI 10.1016/S0097-8485(01)00128-0; Roterman I, 2011, J THEOR BIOL, V283, P60, DOI 10.1016/j.jtbi.2011.05.027; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P577, DOI 10.1016/j.bbrc.2005.06.128; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016; Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Voet D., 1995, BIOCHEMISTRY; Vogt I, 2007, CHEM BIOL DRUG DES, V70, P195, DOI 10.1111/j.1747-0285.2007.00555.x; Wan SB, 2013, J THEOR BIOL, V323, P40, DOI 10.1016/j.jtbi.2013.01.012; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao XA, 2011, MOL DIVERS, V15, P149, DOI 10.1007/s11030-010-9227-8; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; ZHANG CT, 1995, PROTEIN ENG, V8, P425, DOI 10.1093/protein/8.5.425; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141; Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	103	101	103	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72234	10.1371/journal.pone.0072234	http://dx.doi.org/10.1371/journal.pone.0072234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015221	gold, Green Published, Green Submitted			2022-12-25	WOS:000323815200031
J	Marchitelli, C; Crisa, A; Mostarda, E; Napolitano, F; Moioli, B				Marchitelli, Cinzia; Crisa, Alessandra; Mostarda, Elisa; Napolitano, Francesco; Moioli, Bianca			Splicing Variants of SERPINA1 Gene in Ovine Milk: Characterization of cDNA and Identification of Polymorphisms	PLOS ONE			English	Article							ALPHA-1-ANTITRYPSIN GENE; PRODUCTION TRAITS; INHIBITOR; ALPHA(1)-ANTITRYPSIN; ASSOCIATION; SUPERFAMILY; MECHANISMS; PROTEINS; DISEASE	The serine protease inhibitor, clade A, member 1 (SERPINA1) is the gene for a protein called alpha-1-antitrypsin (AAT), which is a member of the serine protease inhibitor (serpin) superfamily of proteins. By conformational change, serpins control several chemical reactions inhibiting the activity of proteases. AAT is the most abundant endogenous serpin in blood circulation and it is present in relatively high concentration in human milk as well as in bovine and porcine colostrum. Here we report for the first time the molecular characterization and sequence variability of the ovine SERPINA1 cDNA and gene. cDNAs from mammary gland and from milk were PCR amplified, and three different transcripts (1437, 1166 and 521bp) of the SERPINA1 gene were identified. We amplified and sequenced different regions of the gene (5' UTR, from exon 2 to exon 5 and 3' UTR), and we found that the exon-intron structure of the gene is similar to that of human and bovine. We detected a total of 97 SNPs in cDNAs and gene sequences from 10 sheep of three different breeds. In adult sheep tissues a SERPINA1 gene expression analysis indicated a differential expression of the three different transcripts. The finding reported in this paper will aid further studies on possible involvement of the SERPINA1 gene in different physiological states and its possible association with production traits.	[Marchitelli, Cinzia; Crisa, Alessandra; Mostarda, Elisa; Napolitano, Francesco; Moioli, Bianca] Consiglio Ric & Sperimentaz Agr CRA, PCM, Anim Prod Res Ctr, Monterotondo, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Marchitelli, C (corresponding author), Consiglio Ric & Sperimentaz Agr CRA, PCM, Anim Prod Res Ctr, Monterotondo, Italy.	cinzia.marchitelli@entecra.it	Crisà, Alessandra/AAL-1469-2021	Crisà, Alessandra/0000-0003-4218-2407; Napolitano, Francesco/0000-0002-6877-2192; Marchitelli, Cinzia/0000-0001-5160-0717; Moioli, Bianca/0000-0001-7222-0991	research programme "Improvement of Italian livestock through the use of innovative biotechnologies: functional genomics, transcriptomics and proteomics (GENZOOT)"; Italian Ministry of Agriculture	research programme "Improvement of Italian livestock through the use of innovative biotechnologies: functional genomics, transcriptomics and proteomics (GENZOOT)"; Italian Ministry of Agriculture	This study was supported by the research programme "Improvement of Italian livestock through the use of innovative biotechnologies: functional genomics, transcriptomics and proteomics (GENZOOT)" funded by the Italian Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton-Rickardt, 2012, ISRN IMMUNOLOGY, V2012, DOI [10.5402/2012/354365, DOI 10.5402/2012/354365]; Beecher C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-99; Chowanadisai W, 2002, AM J CLIN NUTR, V76, P828, DOI 10.1093/ajcn/76.4.828; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Farshchian M, 2011, AM J PATHOL, V179, P1110, DOI 10.1016/j.ajpath.2011.05.012; Gupta VK, 2008, PROTEIN EXPRES PURIF, V57, P290, DOI 10.1016/j.pep.2007.09.013; Hashemi Mohammad, 2010, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V9, P279; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Khan MS, 2011, AMINO ACIDS, V2011, DOI [10.4061/2011/606797, DOI 10.4061/2011/606797.PUBMED:22312466]; Khatib H, 2005, J DAIRY SCI, V88, P1208, DOI 10.3168/jds.S0022-0302(05)72787-9; Kok KF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-22; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Li QL, 2010, S AFR J ANIM SCI, V40, P113; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lonnerdal B, 2010, J PEDIATR-US, V156, pS26, DOI 10.1016/j.jpeds.2009.11.017; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Signorelli F., 2010, P 9 WORLD C GEN APPL; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Tuder Rubin M, 2010, Proc Am Thorac Soc, V7, P381, DOI 10.1513/pats.201002-020AW; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273	30	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73020	10.1371/journal.pone.0073020	http://dx.doi.org/10.1371/journal.pone.0073020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009725	Green Submitted, gold, Green Published			2022-12-25	WOS:000324403200039
J	Chung, SD; Liu, SP; Lin, CC; Li, HC; Lin, HC				Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Ching-Chun; Li, Hsien-Chang; Lin, Herng-Ching			Bladder Pain Syndrome/Interstitial Cystitis Is Associated with Hyperthyroidism	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; INTERSTITIAL CYSTITIS; GRAVES-DISEASE; PANIC DISORDER; POPULATION; SYMPTOMS; DEPRESSION; PREVALENCE; WOMEN; EPIDEMIOLOGY	Background: Although the etiology of bladder pain syndrome/interstitial cystitis (BPS/IC) is still unclear, a common theme with BPS/IC patients is comorbid disorders which are related to the autonomic nervous system that connects the nervous system to end-organs. Nevertheless, no study to date has reported the association between hyperthyroidism and BPS/IC. In this study, we examined the association of IC/BPS with having previously been diagnosed with hyperthyroidism in Taiwan. Design: Data in this study were retrieved from the Longitudinal Health Insurance Database. Our study consisted of 736 female cases with BPS/IC and 2208 randomly selected female controls. We performed a conditional logistic regression to calculate the odds ratio (OR) for having previously been diagnosed with hyperthyroidism between cases and controls. Results: Of the 2944 sampled subjects, there was a significant difference in the prevalence of prior hyperthyroidism between cases and controls (3.3% vs. 1.5%, p<0.001). The conditional logistic regression analysis revealed that compared to controls, the OR for prior hyperthyroidism among cases was 2.16 (95% confidence interval (CI): 1.27 similar to 3.66). Furthermore, the OR for prior hyperthyroidism among cases was 2.01 (95% CI: 1.15 similar to 3.53) compared to controls after adjusting for diabetes, coronary heart disease, obesity, hyperlipidemia, chronic pelvic pain, irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, panic disorder, migraines, sicca syndrome, allergies, endometriosis, and asthma. Conclusions: Our study results indicated an association between hyperthyroidism and BPS/IC. We suggest that clinicians treating female subjects with hyperthyroidism be alert to urinary complaints in this population.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Div Urol, Dept Surg, Taipei, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Lin, Ching-Chun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Li, Hsien-Chang] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Bielecka-Dabrowa A, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-4; Carle A, 2011, EUR J ENDOCRINOL, V164, P801, DOI 10.1530/EJE-10-1155; Chelimsky G, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00114; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chung SD, 2011, CLIN ENDOCRINOL, V75, P704, DOI 10.1111/j.1365-2265.2011.04126.x; Clemens JQ, 2005, J UROLOGY, V173, P98, DOI 10.1097/01.ju.0000146114.53828.82; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Demet MM, 2002, ARCH MED RES, V33, P552, DOI 10.1016/S0188-4409(02)00410-1; EVERED DC, 1972, METABOLISM, V21, P393, DOI 10.1016/0026-0495(72)90052-2; Hendrick VC, 2000, COMPREHENSIVE TXB PS, P1808; Ho CH, 2011, UROLOGY, V77, P50, DOI 10.1016/j.urology.2010.07.479; Kang JH, 2012, NEUROUROL U IN PRESS; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; KATHOL RG, 1986, GEN HOSP PSYCHIAT, V8, P23, DOI 10.1016/0163-8343(86)90060-5; Keller JJ, 2012, NEUROUROL U IN PRESS; Leppilahti M, 2002, J UROLOGY, V168, P139, DOI 10.1016/S0022-5347(05)64847-1; Maher CF, 2001, J UROLOGY, V165, P884, DOI 10.1016/S0022-5347(05)66551-2; Michael YL, 2000, J UROLOGY, V164, P423, DOI 10.1016/S0022-5347(05)67376-4; Nickel JC, 2009, J UROLOGY, V181, P2555, DOI 10.1016/j.juro.2009.02.030; RODEWIG K, 1993, PSYCHOTHER PSYCH MED, V43, P271; Rosenberg MT, 2005, J UROLOGY, V174, P2231, DOI 10.1097/01.ju.0000181203.82693.95; TRZEPACZ PT, 1988, BIOL PSYCHIAT, V23, P678, DOI 10.1016/0006-3223(88)90051-0; Vadiveloo T, 2011, J CLIN ENDOCR METAB, V96, P1344, DOI 10.1210/jc.2010-2693; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; VARGAS F, 1994, CLIN SCI, V87, P323, DOI 10.1042/cs0870323; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474; Watkins KE, 2011, GEN HOSP PSYCHIAT, V33, P143, DOI 10.1016/j.genhosppsych.2011.01.004; Weissman MM, 2004, ARCH GEN PSYCHIAT, V61, P273, DOI 10.1001/archpsyc.61.3.273; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E; Wu EL, 2013, J PSYCHOSOM RES, V74, P233, DOI 10.1016/j.jpsychores.2012.12.016	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72284	10.1371/journal.pone.0072284	http://dx.doi.org/10.1371/journal.pone.0072284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991081	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100095
J	Taniguchi, Y; Matsuda, H; Yamada, T; Sugiyama, T; Homma, K; Kaneko, Y; Yamagishi, S; Iwaisaki, H				Taniguchi, Yukio; Matsuda, Hirokazu; Yamada, Takahisa; Sugiyama, Toshie; Homma, Kosuke; Kaneko, Yoshinori; Yamagishi, Satoshi; Iwaisaki, Hiroaki			Genome-Wide SNP and STR Discovery in the Japanese Crested Ibis and Genetic Diversity among Founders of the Japanese Population	PLOS ONE			English	Article							NIPPONIA-NIPPON; POLYMORPHISM DISCOVERY; REDUCED REPRESENTATION; SEQUENCING TECHNOLOGY; MICROSATELLITE LOCI; CONSERVATION	The Japanese crested ibis is an internationally conserved, critically threatened bird. Captive-breeding programs have been established to conserve this species in Japan. Since the current Japanese population of crested ibis originates only from 5 founders donated by the Chinese government, understanding the genetic diversity between them is critical for an effective population management. To discover genome-wide single nucleotide polymorphisms (SNPs) and short tandem repeats (STRs) while obtaining genotype data of these polymorphic markers in each founder, reduced representation libraries were independently prepared from each of the founder genomes and sequenced on an Illumina HiSeq2000. This yielded 316 million 101-bp reads. Consensus sequences were created by clustering sequence reads, and then sequence reads from each founder were mapped to the consensus sequences, resulting in the detection of 52,512 putative SNPs and 162 putative STRs. The numbers of haplotypes and STR alleles and the investigation of genetic similarities suggested that the total genetic diversity between the founders was lower, although we could not identify a pair with closely related genome sequences. This study provided important insight into protocols for genetic management of the captive breeding population of Japanese crested ibis in Japan and towards the national project for reintroduction of captive-bred individuals into the wild. We proposed a simple, efficient, and cost-effective approach for simultaneous detection of genome-wide polymorphic markers and their genotypes for species currently lacking a reference genome sequence.	[Taniguchi, Yukio; Matsuda, Hirokazu; Iwaisaki, Hiroaki] Kyoto Univ, Grad Sch Agr, Lab Anim Breeding & Genet, Kyoto, Japan; [Yamada, Takahisa; Sugiyama, Toshie] Niigata Univ, Fac Agr, Dept Agrobiol, Niigata 95021, Japan; [Homma, Kosuke] Niigata Univ, Field Ctr Sustainable Agr & Forestry, Niigata, Japan; [Kaneko, Yoshinori] Sado Japanese Crested Ibis Conservat Ctr, Sado, Japan; [Yamagishi, Satoshi] Yamashina Inst Ornithol, Abiko, Chiba, Japan	Kyoto University; Niigata University; Niigata University	Taniguchi, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Anim Breeding & Genet, Kyoto, Japan.	tyukio@kais.kyoto-u.ac.jp			Ministry of the Environment of Japan	Ministry of the Environment of Japan(Ministry of the Environment, Japan)	This work was funded by the Ministry of the Environment of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SCIENCE, V336, P524; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Durrell L, 1987, J JERSEY WILDLIFE PR, V24, P6; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; He LP, 2006, CONSERV GENET, V7, P157, DOI 10.1007/s10592-005-6790-0; Ji YJ, 2004, MOL ECOL NOTES, V4, P615, DOI 10.1111/j.1471-8286.2004.00754.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu Yin Zeng, 1981, Acta Zoologica Sinica, V27, P273; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Urano K, 2013, ZOOL SCI; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Zhang B, 2004, BIRD CONSERV INT, V14, P183, DOI 10.1017/S0959270904000231	21	5	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72781	10.1371/journal.pone.0072781	http://dx.doi.org/10.1371/journal.pone.0072781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991150	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100117
J	Kai, F; Duncan, R				Kai, FuiBoon; Duncan, Roy			Prostate cancer cell migration induced by myopodin isoforms is associated with formation of morphologically and biochemically distinct actin networks	FASEB JOURNAL			English	Article						PC3 cells; actin bundles; stress fibers; actomyosin; synaptopodin 2	BINDING PROTEIN; FILAMENT BUNDLES; STRESS FIBERS; ALPHA-ACTININ; SYNAPTOPODIN; FESSELIN; SUPPRESSION; EXPRESSION; MOTILITY; MYOSIN	Myopodin is an actin-binding protein that promotes cancer cell migration in response to serum stimulation and is associated with invasive tumor development. To determine whether enhanced migration reflects changes in actin cytoskeleton remodeling, fluorescence confocal microscopy was used to examine the composition and morphology of filamentous actin structures in mock-transduced cells vs. stably transduced PC3 cells expressing human myopodin isoforms, and the chemokinetic response of cells was quantified using transwell assays. The same approaches were used to analyze the effects of external migration stimuli, actin polymerization inhibitors or deletion of the isoform-specific amino- and/or carboxy termini on cell migration and actin bundle formation. Results indicate that the termini of the myopodin isoforms differentially alter the formation of morphologically distinct F-actin networks that also differ in their myosin and myopodin staining patterns. Furthermore, enhanced cell migration was reduced by >50% when actin bundle formation was impaired by myopodin-truncation, low concentrations of an actin polymerization inhibitor, or in the absence of an external migration stimulus. Human myopodin isoforms are therefore potent regulators of stress fiber formation, inducing the formation of biochemically and morphologically distinct F-actin networks in the cell body whose presence directly correlates with increased cell migration.	[Kai, FuiBoon; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada; [Duncan, Roy] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Tupper Med Bldg,5850 Coll St,POB 15000, Halifax, NS B3H 4R2, Canada.	roy.duncan@dal.ca		Duncan, Roy/0000-0002-5162-5081	Dalhousie Medical Research Foundation (DMRF); Prostate Cancer Fight Foundation of Canada; Canadian Institutes of Health Research (CIHR); Beatrice Hunter Cancer Research Institute; Canadian Imperial Bank of Commerce as part of the Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR	Dalhousie Medical Research Foundation (DMRF); Prostate Cancer Fight Foundation of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute; Canadian Imperial Bank of Commerce as part of the Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR	The authors thank Jan Gettemans (Ghent University, Belgium) for kindly providing the cDNAs for MYO1, MYO2, and MYO3. This work was funded by a grant from the Dalhousie Medical Research Foundation (DMRF) with support from the Prostate Cancer Fight Foundation of Canada, and by a grant from the Canadian Institutes of Health Research (CIHR). F. K. was supported by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by the Canadian Imperial Bank of Commerce as part of the Terry Fox Strategic Health Research Training Program in Cancer Research at CIHR.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Beall B, 2001, BIOCHEMISTRY-US, V40, P14252, DOI 10.1021/bi011806u; Beqqali A, 2010, J CELL SCI, V123, P1141, DOI 10.1242/jcs.063859; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Claeys KG, 2009, ACTA NEUROPATHOL, V117, P293, DOI 10.1007/s00401-008-0479-7; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; De Ganck A, 2005, FEBS LETT, V579, P6673, DOI 10.1016/j.febslet.2005.10.054; De Ganck A, 2008, BIOCHEM BIOPH RES CO, V370, P269, DOI 10.1016/j.bbrc.2008.03.086; De Ganck A, 2009, INT J ONCOL, V34, P1403, DOI 10.3892/ijo_00000268; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jing L, 2004, AM J PATHOL, V164, P1799, DOI 10.1016/S0002-9440(10)63738-8; Kai FB, 2012, CARCINOGENESIS, V33, P2100, DOI 10.1093/carcin/bgs268; Khaymina SS, 2007, J PROTEOME RES, V6, P3648, DOI 10.1021/pr070237v; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Leinweber BD, 1999, J MUSCLE RES CELL M, V20, P539, DOI 10.1023/A:1005597306671; Lin F, 2001, AM J PATHOL, V159, P1603, DOI 10.1016/S0002-9440(10)63006-4; Linnemann A, 2013, J MUSCLE RES CELL M, V34, P61, DOI 10.1007/s10974-012-9334-5; Linnemann A, 2010, EUR J CELL BIOL, V89, P681, DOI 10.1016/j.ejcb.2010.04.004; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pham M, 2006, J MUSCLE RES CELL M, V27, P45, DOI 10.1007/s10974-005-9053-2; Schmoller KM, 2009, BIOPHYS J, V97, P83, DOI 10.1016/j.bpj.2009.04.040; Schroeter M, 2004, BIOCHEMISTRY-US, V43, P13875, DOI 10.1021/bi0487490; Schroeter MM, 2008, BIOSCIENCE REP, V28, P195, DOI 10.1042/BSR20080079; Schroeter MM, 2008, BIOCHEM BIOPH RES CO, V371, P582, DOI 10.1016/j.bbrc.2008.04.134; Schroeter MM, 2005, J MUSCLE RES CELL M, V26, P183, DOI 10.1007/s10974-005-9009-6; Shah V, 2001, ONCOGENE, V20, P2112, DOI 10.1038/sj.onc.1204291; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tkatchenko AV, 2001, NEUROMUSCULAR DISORD, V11, P269, DOI 10.1016/S0960-8966(00)00198-X; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Trudeau T, 2013, STRUCTURE, V21, P332, DOI 10.1016/j.str.2012.12.013; Ulbricht A, 2013, CURR BIOL, V23, P430, DOI 10.1016/j.cub.2013.01.064; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039; Wong JS, 2012, EMBO J, V31, P1028, DOI 10.1038/emboj.2011.464; Yu YP, 2011, ONCOGENE, V30, P4855, DOI 10.1038/onc.2011.200; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227	42	10	11	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					5046	5058		10.1096/fj.13-231571	http://dx.doi.org/10.1096/fj.13-231571			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24005909				2022-12-25	WOS:000329999000037
J	Palmer, LD; Downs, DM				Palmer, Lauren D.; Downs, Diana M.			The Thiamine Biosynthetic Enzyme ThiC Catalyzes Multiple Turnovers and Is Inhibited by S-Adenosylmethionine (AdoMet) Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Iron-Sulfur Protein; Radicals; S-adenosylmethionine (AdoMet); Thiamine; Thiamine Biosynthesis	ANAEROBIC RIBONUCLEOTIDE REDUCTASE; ESCHERICHIA-COLI; RADICAL SAM; 5-AMINOIMIDAZOLE RIBOTIDE; LYSINE 2,3-AMINOMUTASE; BIOTIN SYNTHASE; LIPOYL SYNTHASE; PYRIMIDINE; PROTEIN; CLUSTER	ThiC (4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate synthase; EC 4.1.99.17) is a radical S-adenosylmethionine (AdoMet) enzyme that uses a [4Fe-4S](+) cluster to reductively cleave AdoMet to methionine and a 5-deoxyadenosyl radical that initiates catalysis. In plants and bacteria, ThiC converts the purine intermediate 5-aminoimidazole ribotide to 4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate, an intermediate of thiamine pyrophosphate (coenzyme B1) biosynthesis. In this study, assay conditions were implemented that consistently generated 5-fold molar excess of HMP, demonstrating that ThiC undergoes multiple turnovers. ThiC activity was improved by in situ removal of product 5-deoxyadenosine. The activity was inhibited by AdoMet metabolites S-adenosylhomocysteine, adenosine, 5-deoxyadenosine, S-methyl-5-thioadenosine, methionine, and homocysteine. Neither adenosine nor S-methyl-5-thioadenosine had been shown to inhibit radical AdoMet enzymes, suggesting that ThiC is distinct from other family members. The parameters for improved ThiC activity and turnover described here will facilitate kinetic and mechanistic analyses of ThiC.	[Palmer, Lauren D.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, 527 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	dmdowns@uga.edu			National Institutes of Health [GM47296]; National Science Foundation [DGE-0718123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47296 (to D. M. D.). This work was also supported by National Science Foundation Graduate Research Fellowship grant DGE-0718123 (to L. D. P.).	Allen S, 2002, J BACTERIOL, V184, P6130, DOI 10.1128/JB.184.22.6130-6137.2002; Begley TP, 2008, CURR OPIN CHEM BIOL, V12, P118, DOI 10.1016/j.cbpa.2008.02.006; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BOCK RM, 1956, ARCH BIOCHEM BIOPHYS, V62, P253, DOI 10.1016/0003-9861(56)90123-0; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Challand MR, 2010, J BIOL CHEM, V285, P5240, DOI 10.1074/jbc.M109.056606; Challand MR, 2009, FEBS LETT, V583, P1358, DOI 10.1016/j.febslet.2009.03.044; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee A, 2010, ANGEW CHEM INT EDIT, V49, P8653, DOI 10.1002/anie.201003419; Cheek J, 2002, J AM CHEM SOC, V124, P2860, DOI 10.1021/ja017784g; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Dougherty MJ, 2006, MICROBIOL-SGM, V152, P2345, DOI 10.1099/mic.0.28926-0; ESTRAMAREIX B, 1969, BIOCHIM BIOPHYS ACTA, V192, P375, DOI 10.1016/0304-4165(69)90384-5; ESTRAMAREIX B, 1984, J AM CHEM SOC, V106, P3857, DOI 10.1021/ja00325a025; ESTRAMAREIX B, 1990, BIOCHIM BIOPHYS ACTA, V1035, P154, DOI 10.1016/0304-4165(90)90110-I; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; Frey PA, 1999, ADV FR RAD, V2, P1; Frodyma M, 2000, J BACTERIOL, V182, P236, DOI 10.1128/JB.182.1.236-240.2000; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Halliday NM, 2010, ANAL BIOCHEM, V403, P20, DOI 10.1016/j.ab.2010.04.021; HARDER J, 1992, J BIOL CHEM, V267, P25548; Hiscox MJ, 2012, BBA-PROTEINS PROTEOM, V1824, P1165, DOI 10.1016/j.bbapap.2012.03.013; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; KURAMITSU HK, 1964, J BIOL CHEM, V239, P3425; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Martinez-Gomez NC, 2009, BIOCHEMISTRY-US, V48, P217, DOI 10.1021/bi802154j; Mehl RA, 2002, J LABELLED COMPD RAD, V45, P1097, DOI 10.1002/jlcr.627; MEYER E, 1992, BIOCHEMISTRY-US, V31, P5022, DOI 10.1021/bi00136a016; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; MOSS ML, 1990, J BIOL CHEM, V265, P18112; MOYED HS, 1964, J BACTERIOL, V88, P1024, DOI 10.1128/JB.88.4.1024-1029.1964; Ollagnier-de-Choudens S, 2002, FEBS LETT, V532, P465, DOI 10.1016/S0014-5793(02)03733-X; Palmer LD, 2012, J BACTERIOL, V194, P6088, DOI 10.1128/JB.01361-12; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; Segel I.H., 1975, ENZYME KINETICS; Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Tamarit J, 1999, J BIOL CHEM, V274, P31291, DOI 10.1074/jbc.274.44.31291; Tranchimand S, 2011, BIOCHEMISTRY-US, V50, P4623, DOI 10.1021/bi102033a; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; WALKER RD, 1975, CAN J BIOCHEM CELL B, V53, P312, DOI 10.1139/o75-044; Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t	47	31	32	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30693	30699		10.1074/jbc.M113.500280	http://dx.doi.org/10.1074/jbc.M113.500280			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014032	hybrid, Green Published			2022-12-25	WOS:000329868100069
J	Yan, XS; Weng, HR				Yan, Xisheng; Weng, Han-Rong			Endogenous Interleukin-1 beta in Neuropathic Rats Enhances Glutamate Release from the Primary Afferents in the Spinal Dorsal Horn through Coupling with Presynaptic N-Methyl-D-aspartic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Glia; Glutamate Receptors Ionotropic (AMPA; NMDA); Pain; Patch Clamp	LONG-TERM POTENTIATION; SUBSTANTIA-GELATINOSA NEURONS; SCIATIC-NERVE LIGATION; SYNAPTIC-TRANSMISSION; NMDA RECEPTORS; TRANSMITTER RELEASE; INFLAMMATORY PAIN; SENSORY NEURONS; ROOT GANGLION; GROWTH-FACTOR	Excessive activation of glutamate receptors and overproduction of proinflammatory cytokines, including interleukin-1 (IL-1) in the spinal dorsal horn, are key mechanisms underlying the development and maintenance of neuropathic pain. In this study, we investigated the mechanisms by which endogenous IL-1 alters glutamatergic synaptic transmission in the spinal dorsal horn in rats with neuropathic pain induced by ligation of the L5 spinal nerve. We demonstrated that endogenous IL-1 in neuropathic rats enhances glutamate release from the primary afferent terminals and non-NMDA glutamate receptor activities in postsynaptic neurons in the spinal dorsal horn. Myeloid differentiation primary response protein 88 (MyD88) is a mediator used by IL-1 to enhance non-NMDA glutamate receptor activities in postsynaptic neurons in the spinal dorsal horn. Presynaptic NMDA receptors are effector receptors used by the endogenous IL-1 to enhance glutamate release from the primary afferents in neuropathic rats. This is further supported by the fact that NMDA currents recorded from small neurons in the dorsal root ganglion of normal rats are potentiated by exogenous IL-1. Furthermore, we provided evidence that functional coupling between IL-1 receptors and presynaptic NMDA receptors at the primary afferent terminals is mediated by the neutral sphingomyelinase/ceramide signaling pathway. Hence, functional coupling between IL-1 receptors and presynaptic NMDA receptors at the primary afferent terminals is a crucial mechanism leading to enhanced glutamate release and activation of non-NMDA receptors in the spinal dorsal horn neurons in neuropathic pain conditions. Interruption of such functional coupling could be an effective approach for the treatment of neuropathic pain.	[Yan, Xisheng; Weng, Han-Rong] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Weng, HR (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, 240 West Green St, Athens, GA 30602 USA.	hrweng@uga.edu			National Institutes of Health from NINDS [RO1 NS-064289]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064289] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS-064289 from NINDS (to H. R. W.).	Ataka T, 2000, PAIN, V86, P273, DOI 10.1016/S0304-3959(00)00255-4; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; BINDONI M, 1988, BRAIN RES, V462, P10, DOI 10.1016/0006-8993(88)90578-1; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Chen BC, 2009, J BIOL CHEM, V284, P20562, DOI 10.1074/jbc.M109.028084; Chen TJ, 2012, EUR J PHARMACOL, V685, P24, DOI 10.1016/j.ejphar.2012.04.002; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; DeLeo JA, 1997, BRAIN RES, V759, P50, DOI 10.1016/S0006-8993(97)00209-6; Doyle T, 2011, FASEB J, V25, P2782, DOI 10.1096/fj.10-178095; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Falchi M, 2001, DRUG EXP CLIN RES, V27, P97; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; Gerber G, 2000, NEUROSCIENCE, V100, P393, DOI 10.1016/S0306-4522(00)00269-4; Glitsch M, 1999, J NEUROSCI, V19, P511; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Kawasaki Y, 2003, ANESTHESIOLOGY, V98, P682, DOI 10.1097/00000542-200303000-00016; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kleibeuker W, 2008, BRAIN BEHAV IMMUN, V22, P200, DOI 10.1016/j.bbi.2007.07.009; Kobayashi Y, 2012, BIOCHEM BIOPH RES CO, V421, P318, DOI 10.1016/j.bbrc.2012.03.153; Kohno T, 2003, J PHYSIOL-LONDON, V548, P131, DOI 10.1113/jphysiol.2002.036186; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kwon MS, 2005, ARCH PHARM RES, V28, P582, DOI 10.1007/BF02977762; Lee HL, 2004, NEUROREPORT, V15, P2807; Lever IJ, 2002, BRIT J PHARMACOL, V135, P21, DOI 10.1038/sj.bjp.0704506; Lissin DV, 1999, J NEUROSCI, V19, P1263; Ma C, 2005, PAIN, V113, P106, DOI 10.1016/j.pain.2004.10.001; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Mao JR, 2002, J NEUROSCI, V22, P8312; McGuinness L, 2010, NEURON, V68, P1109, DOI 10.1016/j.neuron.2010.11.023; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakabo Y, 1997, IMMUNOLOGY, V90, P477, DOI 10.1046/j.1365-2567.1997.d01-2189.x; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Nie H, 2010, J NEUROPHYSIOL, V103, P2570, DOI 10.1152/jn.00013.2010; Nie H, 2009, J NEUROPHYSIOL, V101, P2041, DOI 10.1152/jn.91138.2008; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Song JH, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-50; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Sung BK, 2003, J NEUROSCI, V23, P2899; Tsakiri N, 2008, MOL CELL NEUROSCI, V38, P259, DOI 10.1016/j.mcn.2008.02.015; Wang W, 2012, PAIN PHYSICIAN, V15, pE995; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weng HR, 2007, NEUROSCIENCE, V149, P898, DOI 10.1016/j.neuroscience.2007.07.063; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; Weng HR, 2005, NEUROSCI LETT, V386, P18, DOI 10.1016/j.neulet.2005.05.049; Willis WD, 2002, BRAIN RES REV, V40, P202, DOI 10.1016/S0165-0173(02)00202-3; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Wu LJ, 2005, J NEUROSCI, V25, P11107, DOI 10.1523/JNEUROSCI.1678-05.2005; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Yan XS, 2013, J PHYSIOL-LONDON, V591, P2001, DOI 10.1113/jphysiol.2012.250522; YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3; YOSHIMURA M, 1989, J NEUROPHYSIOL, V62, P96, DOI 10.1152/jn.1989.62.1.96; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang YH, 2002, J PHYSIOL-LONDON, V544, P385, DOI 10.1113/jphysiol.2002.024265; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	81	68	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30544	30557		10.1074/jbc.M113.495465	http://dx.doi.org/10.1074/jbc.M113.495465			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003233	Green Published, hybrid			2022-12-25	WOS:000329868100056
J	Demina, IV; Persson, T; Santos, P; Plaszczyca, M; Pawlowski, K				Demina, Irina V.; Persson, Tomas; Santos, Patricia; Plaszczyca, Marian; Pawlowski, Katharina			Comparison of the Nodule vs. Root Transcriptome of the Actinorhizal Plant Datisca glomerata: Actinorhizal Nodules Contain a Specific Class of Defensins	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; SUBTILISIN-LIKE PROTEASE; ANTIFUNGAL PROTEINS; CASUARINA-GLAUCA; GENE-EXPRESSION; INFECTION; SEQUENCE; FUNGAL; FAMILY; INTERACTS	Actinorhizal root nodule symbioses are very diverse, and the symbiosis of Datisca glomerata has previously been shown to have many unusual aspects. In order to gain molecular information on the infection mechanism, nodule development and nodule metabolism, we compared the transcriptomes of D. glomerata roots and nodules. Root and nodule libraries representing the 3'-ends of cDNAs were subjected to high-throughput parallel 454 sequencing. To identify the corresponding genes and to improve the assembly, Illumina sequencing of the nodule transcriptome was performed as well. The evaluation revealed 406 differentially regulated genes, 295 of which (72.7%) could be assigned a function based on homology. Analysis of the nodule transcriptome showed that genes encoding components of the common symbiosis signaling pathway were present in nodules of D. glomerata, which in combination with the previously established function of SymRK in D. glomerata nodulation suggests that this pathway is also active in actinorhizal Cucurbitales. Furthermore, comparison of the D. glomerata nodule transcriptome with nodule transcriptomes from actinorhizal Fagales revealed a new subgroup of nodule-specific defensins that might play a role specific to actinorhizal symbioses. The D. glomerata members of this defensin subgroup contain an acidic C-terminal domain that was never found in plant defensins before.	[Demina, Irina V.; Persson, Tomas; Plaszczyca, Marian; Pawlowski, Katharina] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Santos, Patricia] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA	Stockholm University; Michigan State University	Pawlowski, K (corresponding author), Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden.	katharina.pawlowski@su.se	Pawlowski, Katharina/U-9955-2017	Pawlowski, Katharina/0000-0003-2693-885X	Forskningsradet Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning) [2005-2773-3234-80]; Vetenskapsradet (Swedish Research Council) [2007-17840-52674-16]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/43228/2008]	Forskningsradet Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); Vetenskapsradet (Swedish Research Council)(Swedish Research Council); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was funded by a grant from Forskningsradet Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, grant 2005-2773-3234-80) and a grant from Vetenskapsradet (Swedish Research Council, grant 2007-17840-52674-16) to KP. PS acknowledges support by Fundacao para a Ciencia e Tecnologia (FCT; grant SFRH/BPD/43228/2008). Web site of Formas: www.formas.se. Web site of VR: www.vr.se. Web site of FCT: www.fct.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Alloisio N, 2010, MOL PLANT MICROBE IN, V23, P593, DOI 10.1094/MPMI-23-5-0593; Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENSON DR, 1993, MICROBIOL REV, V57, P293, DOI 10.1128/MMBR.57.2.293-319.1993; Berg RH, 1999, CAN J BOT, V77, P1351, DOI 10.1139/cjb-77-9-1351; Berg RH, 1999, CAN J BOT, V77, P1334, DOI 10.1139/cjb-77-9-1334; Berry AM, 2004, PLANT PHYSIOL, V135, P1849, DOI 10.1104/pp.103.031534; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; BRUIX M, 1993, BIOCHEMISTRY-US, V32, P715, DOI 10.1021/bi00053a041; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Crespi M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.149re11; Dresselhaus T, 2009, CURR OPIN PLANT BIOL, V12, P773, DOI 10.1016/j.pbi.2009.09.015; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; EZAKI B, 1995, PHYSIOL PLANTARUM, V93, P11, DOI 10.1034/j.1399-3054.1995.930103.x; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; Fant F, 1999, PROTEINS, V37, P388, DOI 10.1002/(SICI)1097-0134(19991115)37:3<388::AID-PROT7>3.0.CO;2-F; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Giacomelli L, 2012, MOL PLANT MICROBE IN, V25, P1118, DOI 10.1094/MPMI-12-11-0323; GOETTINGMINESKY MP, 1994, P NATL ACAD SCI USA, V91, P9891, DOI 10.1073/pnas.91.21.9891; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAFEEZ F, 1984, PLANT SOIL, V79, P383, DOI 10.1007/BF02184330; HOAGLAND DR, 1938, 347 U CAL CAL AGR EX; Hocher V, 2006, NEW PHYTOL, V169, P681, DOI 10.1111/j.1469-8137.2006.01644.x; Hocher V, 2011, PLANT PHYSIOL, V156, P700, DOI 10.1104/pp.111.174151; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Jacobsen KR, 2002, PLANT BIOLOGY, V4, P46, DOI 10.1055/s-2002-20435; Journet EP, 2002, NUCLEIC ACIDS RES, V30, P5579, DOI 10.1093/nar/gkf685; Kevei Z, 2007, PLANT CELL, V19, P3974, DOI 10.1105/tpc.107.053975; Kim HB, 2002, MOL PLANT MICROBE IN, V15, P209, DOI 10.1094/MPMI.2002.15.3.209; Kiss E, 2009, PLANT PHYSIOL, V151, P1239, DOI 10.1104/pp.109.143933; Laplaze L, 2000, MOL PLANT MICROBE IN, V13, P113, DOI 10.1094/MPMI.2000.13.1.113; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Li W, 2009, J INTEGR PLANT BIOL, V51, P279, DOI 10.1111/j.1744-7909.2008.00790.x; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Murakami Y, 2006, DNA RES, V13, P255, DOI 10.1093/dnares/dsl017; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Murray JD, 2011, PLANT J, V65, P244, DOI 10.1111/j.1365-313X.2010.04415.x; NEWCOMB W, 1982, NEW ZEAL J BOT, V20, P93, DOI 10.1080/0028825X.1982.10426409; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Oelkers K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-1; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W; Pawlowski K, 2003, MOL PLANT MICROBE IN, V16, P796, DOI 10.1094/MPMI.2003.16.9.796; Pawlowski K, 2012, PROTOPLASMA, V249, P967, DOI 10.1007/s00709-012-0388-4; Persson T, 2011, J BACTERIOL, V193, P7017, DOI 10.1128/JB.06208-11; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; RIBEIRO A, 1995, PLANT CELL, V7, P785, DOI 10.1105/tpc.7.6.785; Ribeiro A, 1996, PLANT J, V10, P361, DOI 10.1046/j.1365-313X.1996.10020361.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schubert M, 2011, PLANTA, V233, P139, DOI 10.1007/s00425-010-1285-8; Schubert M, 2010, PLANTA, V231, P507, DOI 10.1007/s00425-009-1049-5; Silverstein KAT, 2006, CURR OPIN PLANT BIOL, V9, P142, DOI 10.1016/j.pbi.2006.01.002; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Silvester WB, 1999, CAN J BOT, V77, P1358, DOI 10.1139/cjb-77-9-1358; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Svistoonoff S, 2003, MOL PLANT MICROBE IN, V16, P600, DOI 10.1094/MPMI.2003.16.7.600; Svistoonoff S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064515; Swensen SM, 1997, PHYSIOL PLANTARUM, V99, P565, DOI 10.1034/j.1399-3054.1997.990407.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TJEPKEMA JD, 1988, PLANT PHYSIOL, V86, P581, DOI 10.1104/pp.86.2.581; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VANBRUSSEL AAN, 1992, SCIENCE, V257, P70, DOI 10.1126/science.257.5066.70; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Yano K, 2009, PLANT J, V60, P168, DOI 10.1111/j.1365-313X.2009.03943.x; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105; Yokota K, 2009, PLANT CELL, V21, P267, DOI 10.1105/tpc.108.063693	91	29	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72442	10.1371/journal.pone.0072442	http://dx.doi.org/10.1371/journal.pone.0072442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009681	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600020
J	Johnston, MW; Purkis, SJ				Johnston, Matthew W.; Purkis, Sam J.			Modeling the Potential Spread of the Recently Identified Non-Native Panther Grouper (Chromileptes altivelis) in the Atlantic Using a Cellular Automaton Approach	PLOS ONE			English	Article							INVASIVE LIONFISH; PTEROIS-VOLITANS; LARVAL DURATION; PATTERNS; OCEAN	The Indo-pacific panther grouper (Chromileptes altiveli) is a predatory fish species and popular imported aquarium fish in the United States which has been recently documented residing in western Atlantic waters. To date, the most successful marine invasive species in the Atlantic is the lionfish (Pterois volitans/miles), which, as for the panther grouper, is assumed to have been introduced to the wild through aquarium releases. However, unlike lionfish, the panther grouper is not yet thought to have an established breeding population in the Atlantic. Using a proven modeling technique developed to track the lionfish invasion, presented is the first known estimation of the potential spread of panther grouper in the Atlantic. The employed cellular automaton-based computer model examines the life history of the subject species including fecundity, mortality, and reproductive potential and combines this with habitat preferences and physical oceanic parameters to forecast the distribution and periodicity of spread of this potential new invasive species. Simulations were examined for origination points within one degree of capture locations of panther grouper from the United States Geological Survey Nonindigenous Aquatic Species Database to eliminate introduction location bias, and two detailed case studies were scrutinized. The model indicates three primary locations where settlement is likely given the inputs and limits of the model; Jupiter Florida/Vero Beach, the Cape Hatteras Tropical Limit/Myrtle Beach South Carolina, and Florida Keys/Ten Thousand Islands locations. Of these locations, Jupiter Florida/Vero Beach has the highest settlement rate in the model and is indicated as the area in which the panther grouper is most likely to become established. This insight is valuable if attempts are to be made to halt this potential marine invasive species.	[Johnston, Matthew W.; Purkis, Sam J.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA	Nova Southeastern University	Johnston, MW (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	johnmatt@nova.edu			National Coral Reef Institute	National Coral Reef Institute	This study was supported in part by the National Coral Reef Institute. This is NCRI contribution #XXX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Carpenter KE, 1999, FAO SPECIES IDENTI 4, V4; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Crooks J. A., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P103; Hare JA, 2003, NOAA TECH MEMO NOS N, V2, P21; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Johnston MW, 2011, MAR POLLUT BULL, V62, P1218, DOI 10.1016/j.marpolbul.2011.03.028; Johnston MW, 2012, AQUAT INVASIONS, V7, P405, DOI 10.3391/ai.2012.7.3.011; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Kool JT, 2010, ECOGRAPHY, V33, P597, DOI 10.1111/j.1600-0587.2009.06012.x; Morris J.A., 2009, NOAA TECH MEMO NOS N, V99, P1; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Rimmer MA, 1999, APEC NACA COOP GROUP, P91; Sadovy Y, 2008, IUCN 2012 IUCN RED L; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Sugama K, 1999, APEC NACA COOP GROUP, P91; Sugama K, 2002, REG WORKSH SUST SEAF, P55; Sugama K, 2003, AQUACULTURE ASIA, V8, P34; USGS NAS, 2013, US GEOL SURV NON AQ; Williams Ashley J., 2009, Endangered Species Research, V9, P67, DOI 10.3354/esr00237; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441	31	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73023	10.1371/journal.pone.0073023	http://dx.doi.org/10.1371/journal.pone.0073023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009726	gold, Green Submitted, Green Published			2022-12-25	WOS:000323734600050
J	Li, X; Li, TT; Zhang, XH; Hou, LF; Yang, XQ; Zhu, FH; Tang, W; Zuo, JP				Li, Xin; Li, Tian-Tian; Zhang, Xiao-Hui; Hou, Li-Fei; Yang, Xiao-Qian; Zhu, Feng-Hua; Tang, Wei; Zuo, Jian-Ping			Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CUTTING EDGE; INDUCTION; MICE; CNS; INFLAMMATION; IL-12; ACTIVATION; MECHANISMS; RESPONSES	Background: Artemisinin analogue SM934 was previously reported to possess immunosuppressive properties. The aim of this study was to determine the effects and the underlying mechanisms of SM934 in murine experimental autoimmune encephalomyelitis (EAE). Methods: Female C57BL/6 mice immunized with MOG(35-55) were treated with or without SM934, then the clinical scores and other relevant parameters were assessed. Th1, Th17 and regulatory T (Treg) cell profiles were determined through ELISA, qRT-PCR, flow cytometry and BrdU incorporation assay. The effects of SM934 on Th1, Th17 and Treg cells differentiation were explored through intracellular staining and flow cytometry examination. Results: In vivo, administration of SM934 significantly inhibited the development of EAE and suppressed the elevation of serum IL-17. Ex vivo, upon antigen-recall stimulation, IL-2, IFN-gamma, IL-17 and IL-6 production were decreased, whereas IL-10 and TGF-beta production were increased from the splenocytes isolated from SM934-treated mice. Consistently, both flow cytometry and qRT-PCR results showed that SM934 treatment significantly increased the Treg, while strongly suppressed the Th17 and Th1, responses in the peripheral. Furthermore, in the spinal lesion, SM934 treatment dramatically decreased the infiltration of CD4(+) T cells, within which the Treg cells percentage was enlarged, whereas the Th17, but not Th1 percentage, was significantly decreased comparing with the vehicle-treated groups. Finally, both BrdU incorporation and in vitro Treg differentiation assays revealed that SM934 treatment could directly promote the expansion of Treg cells in vivo and in vitro. Conclusion: Taken together, this study demonstrated that SM934 treatment could ameliorate the murine EAE disease, which might be mediated by inducing Treg differentiation and expansion.	[Li, Xin; Li, Tian-Tian; Hou, Li-Fei; Yang, Xiao-Qian; Zhu, Feng-Hua; Tang, Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Lab Immunopharmacol, Shanghai 200031, Peoples R China; [Zhang, Xiao-Hui; Zuo, Jian-Ping] Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai University of Traditional Chinese Medicine	Tang, W (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Lab Immunopharmacol, Shanghai 200031, Peoples R China.	tangwei@mail.shcnc.ac.cn; jpzuo@mail.shcnc.ac.cn			National Science Fair Committee (NSFC), China [81072652, 81273524, 81273525]; National Science & Technology Major Project "New Drug Creation and Manufacturing Program'', China [2012ZX09102-101-006]; Science 1/4dagger Technology Commission of Shanghai Municipality, China [11431921102]	National Science Fair Committee (NSFC), China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "New Drug Creation and Manufacturing Program'', China; Science 1/4dagger Technology Commission of Shanghai Municipality, China	This work was supported by the grants of National Science Fair Committee (NSFC), China (No. 81072652, 81273524, 81273525), National Science & Technology Major Project "New Drug Creation and Manufacturing Program'', China (2012ZX09102-101-006) and Science 1/4 dagger Technology Commission of Shanghai Municipality, China (11431921102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Donia M, 2009, J AUTOIMMUN, V33, P135, DOI 10.1016/j.jaut.2009.06.003; El-Behi M, 2010, J NEUROIMMUNE PHARM; Elhofy A, 2002, IMMUNOL RES, V25, P167, DOI 10.1385/IR:25:2:167; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Ferber IA, 1996, J IMMUNOL, V156, P5; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Handel AE, 2011, EUR J CLIN INVEST, V41, P1254, DOI 10.1111/j.1365-2362.2011.02519.x; Hou LF, 2011, ARTHRITIS RHEUM; Hou LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032424; Hou LF, 2009, INT IMMUNOPHARMACOL, V9, P1509, DOI 10.1016/j.intimp.2009.09.003; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Konkimalla VB, 2008, NITRIC OXIDE-BIOL CH, V19, P184, DOI 10.1016/j.niox.2008.04.008; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Li Y, 2012, ACTA PHARMACOL SIN, V33, P1141, DOI 10.1038/aps.2012.104; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lowther DE, 2012, IMMUNOL REV, V248, P156, DOI 10.1111/j.1600-065X.2012.01130.x; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Murdoch C, 2000, BLOOD, V95, P3032; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Ni J, 2009, BRIT J PHARMACOL, V158, P2046, DOI 10.1111/j.1476-5381.2009.00528.x; O'Connor RA, 2008, CELL IMMUNOL, V251, P8, DOI 10.1016/j.cellimm.2008.02.001; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; O'Connor RA, 2012, EUR J IMMUNOL, V42, P1174, DOI 10.1002/eji.201142216; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Pierson E, 2012, IMMUNOL REV, V248, P205, DOI 10.1111/j.1600-065X.2012.01126.x; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Segal BM, 1996, J EXP MED, V184, P771, DOI 10.1084/jem.184.2.771; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Shin T, 2012, ANAT CELL BIOL, V45, P141, DOI 10.5115/acb.2012.45.3.141; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Wang JX, 2007, BRIT J PHARMACOL, V150, P652, DOI 10.1038/sj.bjp.0707137; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zhang J, 2009, ACTA PHARMACOL SIN, V30, P1144, DOI 10.1038/aps.2009.101; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919	58	36	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74108	10.1371/journal.pone.0074108	http://dx.doi.org/10.1371/journal.pone.0074108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009768	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600081
J	Du, GJ; Zhao, B; Zhang, YP; Sun, T; Liu, WJ; Li, JH; Liu, YH; Wang, YY; Li, H; Hou, XD				Du, Gangjun; Zhao, Bei; Zhang, Yaping; Sun, Ting; Liu, Weijie; Li, Jiahuan; Liu, Yinghui; Wang, Yingying; Li, Hong; Hou, Xidong			Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer Progression	PLOS ONE			English	Article							METHYL-N-NITROSOUREA; RNA-BINDING PROTEIN; TUMOR; CELLS; EXPRESSION; CARCINOMA; APOPTOSIS; OBESITY; MODEL; CARCINOGENESIS	Microenvironment has been increasingly recognized as a critical regulator of cancer progression. In this study, we identified early changes in the microenvironment that contribute to malignant progression. Exposure of human bronchial epithelial cells (BEAS-2B) to methylnitrosourea (MNU) caused a reduction in cell toxicity and an increase in clonogenic capacity when the temperature was lowered from 37 degrees C to 28 degrees C. Hypothermia-incubated adipocyte media promoted proliferation in A549 cells. Although a hypothermic environment could increase urethane-induced tumor counts and Lewis lung cancer (LLC) metastasis in lungs of three breeds of mice, an increase in tumor size could be discerned only in obese mice housed in hypothermia. Similarly, coinjections using differentiated adipocytes and A549 cells promoted tumor development in athymic nude mice when adipocytes were cultured at 28 degrees C. Conversely, fat removal suppressed tumor growth in obese C57BL/6 mice inoculated with LLC cells. Further studies show hypothermia promotes a MNU-induced epithelial-mesenchymal transition (EMT) and protects the tumor cell against immune control by TGF-beta 1 upregulation. We also found that activated adipocytes trigger tumor cell proliferation by increasing either TNF-alpha or VEGF levels. These results suggest that hypothermia activates adipocytes to stimulate tumor boost and play critical determinant roles in malignant progression.	[Du, Gangjun; Zhao, Bei; Zhang, Yaping; Sun, Ting; Liu, Weijie; Li, Jiahuan; Liu, Yinghui; Wang, Yingying; Li, Hong; Hou, Xidong] Henan Univ, Pharmaceut Coll, Inst Pharm, Kaifeng, Henan, Peoples R China	Henan University	Du, GJ (corresponding author), Henan Univ, Pharmaceut Coll, Inst Pharm, Kaifeng, Henan, Peoples R China.	724200@henu.edu.cn	wang, yingying/GRS-3058-2022		National Natural Science Foundation of China [81173094]; joint construction fund for Henan University from Henan Province; Ministry of Education of China [SBGJ090704]; Young Core Instructor of Henan Province, China [2010GGJS-025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); joint construction fund for Henan University from Henan Province; Ministry of Education of China(Ministry of Education, China); Young Core Instructor of Henan Province, China	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by grants from the National Natural Science Foundation of China (No. 81173094), the joint construction fund for Henan University from Henan Province and the Ministry of Education of China (No. SBGJ090704) and the Young Core Instructor of Henan Province, China (No. 2010GGJS-025).	Amatangelo MD, 2012, CARCINOGENESIS, V33, P1965, DOI 10.1093/carcin/bgs227; Bateman A, 2011, J CLIN INVEST, V121, P516, DOI 10.1172/JCI46088; Benjamin DI, 2012, CELL METAB, V16, P565, DOI 10.1016/j.cmet.2012.09.013; Bragado Paloma, 2012, Recent Results Cancer Res, V195, P25, DOI 10.1007/978-3-642-28160-0_3; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Castano Z, 2011, INT J DEV BIOL, V55, P889, DOI 10.1387/ijdb.113366zc; Choi JW, 2012, PROTEOMICS, V12, P1999, DOI 10.1002/pmic.201100582; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Du GJ, 2010, CANCER CHEMOTH PHARM, V65, P277, DOI 10.1007/s00280-009-1032-7; Enderling H, 2012, CANCER RES, V72, P2172, DOI 10.1158/0008-5472.CAN-11-3269; Fakir H, 2010, RADIAT ENVIRON BIOPH, V49, P169, DOI 10.1007/s00411-009-0264-6; Foster R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045061; Giugale LE, 2012, GYNECOL ONCOL, V127, P326, DOI 10.1016/j.ygyno.2012.08.014; Goetz JG, 2012, CELL ADHES MIGR, V6, P190, DOI 10.4161/cam.20782; Guzman A, 2008, MUTAT RES-GEN TOX EN, V656, P8, DOI 10.1016/j.mrgentox.2008.06.016; Hiscox S, 2011, EXPERT OPIN THER TAR, V15, P609, DOI 10.1517/14728222.2011.561201; Hobohm U, 2005, BRIT J CANCER, V92, P421, DOI 10.1038/sj.bjc.6602386; Hong JK, 2007, METAB ENG, V9, P208, DOI 10.1016/j.ymben.2006.11.003; Hursting SD, 2012, CANCER PREV RES, V5, P1260, DOI 10.1158/1940-6207.CAPR-12-0140; Jiang WL, 2009, NEUROCHEM INT, V55, P124, DOI 10.1016/j.neuint.2009.02.007; Langdon SP, 2012, CURR DRUG TARGETS, V13, P1535; LEDOUX SP, 1991, CANCER RES, V51, P775; LEE K, 1990, UROL RES, V18, P197, DOI 10.1007/BF00295847; Li HT, 2007, CANCER RES, V67, P7850, DOI 10.1158/0008-5472.CAN-07-1087; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lindquist JM, 1998, J BIOL CHEM, V273, P30147, DOI 10.1074/jbc.273.46.30147; Lu YP, 2012, P NATL ACAD SCI USA, V109, P9065, DOI 10.1073/pnas.1205810109; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Paez D, 2012, CLIN CANCER RES, V18, P645, DOI 10.1158/1078-0432.CCR-11-2186; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; RAINEY JB, 1987, BRIT J CANCER, V55, P265, DOI 10.1038/bjc.1987.51; Sakurai T, 2005, EXP CELL RES, V309, P264, DOI 10.1016/j.yexcr.2005.06.002; Shahparaki A, 2002, METABOLISM, V51, P1211, DOI 10.1053/meta.2002.34037; Sheets PL, 2004, J BIOCHEM MOL TOXIC, V18, P92, DOI 10.1002/jbt.20010; Sonna LA, 2010, CELL STRESS CHAPERON, V15, P687, DOI 10.1007/s12192-010-0181-2; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Sumitomo Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-72; SWANN PF, 1968, BIOCHEM J, V110, P49, DOI 10.1042/bj1100049; Tabuchi Y, 2012, INT J MOL MED, V29, P380, DOI 10.3892/ijmm.2011.862; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Tiwari AK, 2012, J INTERN MED, V271, P392, DOI 10.1111/j.1365-2796.2011.02462.x; Trumble SJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00184; Tsubura A, 2011, IN VIVO, V25, P11; Vazzana N, 2012, CURR MED CHEM, V19, P5837, DOI 10.2174/092986712804143349; Vessella Robert L, 2007, Cancer Biol Ther, V6, P1496; Wagner M, 2012, ANGIOGENESIS, V15, P481, DOI 10.1007/s10456-012-9276-y; Waldner Maximilian J., 2008, Inflammation & Allergy Drug Targets, V7, P187, DOI 10.2174/187152808785748137; Wang C, 2012, INT J BIOCHEM CELL B, V44, P2308, DOI 10.1016/j.biocel.2012.09.012; Yu HJ, 2013, HISTOPATHOLOGY, V62, P788, DOI 10.1111/his.12087	52	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72044	10.1371/journal.pone.0072044	http://dx.doi.org/10.1371/journal.pone.0072044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015203	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200024
J	Kurisaki, H; Nagao, Y; Nagafuchi, S; Mitsuyama, M				Kurisaki, Hironori; Nagao, Yukihiro; Nagafuchi, Seiho; Mitsuyama, Masao			Autoimmune Gastro-Pancreatitis with Anti-Protein Disulfide Isomerase-Associated 2 Autoantibody in Aire-Deficient BALB/cAnN Mice	PLOS ONE			English	Article							GENE; MUTATIONS; TYPE-1; THYMUS; COMMON; TRANSCRIPTION; LOCALIZATION; TOLERANCE; PHENOTYPE; DOMAINS	Although the autoimmune regulator (Aire) knockout (KO) mouse model has been reported to present various organ-specific autoimmune diseases depending on genetic background, autoimmune pancreatitis in mice of BALB/c background has not yet been reported. Here, we report that Aire KO mice with BALB/cAnN background showed significant lymphoid cell infiltration in the pancreas and stomach. To examine whether the phenotype in the pancreas and stomach is due to autoimmune reaction associated with autoantibody production, indirect immunofluorescence staining followed by Western blot analysis was performed. Consequently, the autoantibody against pancreas and stomach was detected in the sera of Aire KO mice, and the target antigen of the autoantibody was identified as protein disulfide isomerase-associated 2 (Pdia2), which was reported to be expressed preferentially in the pancreas and stomach. Thus, Aire KO mice of BALB/cAnN background can serve as a useful animal model for autoimmune gastro-pancreatitis with anti-Pdia2 autoantibody production.	[Kurisaki, Hironori; Mitsuyama, Masao] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan; [Kurisaki, Hironori; Nagao, Yukihiro; Nagafuchi, Seiho] Kyushu Univ, Dept Med Sci & Technol, Grad Sch Med Sci, Fukuoka 812, Japan	Kyoto University; Kyushu University	Kurisaki, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan.	kurisaki@med.kyushu-u.ac.jp		Nagafuchi, Seiho/0000-0002-8790-8358	JSPS KAKENHI [21790423, 24790555]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 21790423, 24790555 and URL: http://www.jsps.go.jp/english/index.html. The funders had no role in study designm data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Desilva MG, 1996, DNA CELL BIOL, V15, P9, DOI 10.1089/dna.1996.15.9; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Horiuchi A, 1998, AM J GASTROENTEROL, V93, P260, DOI 10.1016/S0002-9270(97)00067-1; Inaba K, 1992, J EXP MED, V176, P0693; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kogawa K, 2002, CLIN IMMUNOL, V103, P277, DOI 10.1006/clim.2002.5208; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; Pearce SHS, 1998, AM J HUM GENET, V63, P1675, DOI 10.1086/302145; Peterson P, 2005, J AUTOIMMUN, V25, P49, DOI 10.1016/j.jaut.2005.09.022; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Scott HS, 1998, MOL ENDOCRINOL, V12, P1112, DOI 10.1210/me.12.8.1112; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105	24	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73862	10.1371/journal.pone.0073862	http://dx.doi.org/10.1371/journal.pone.0073862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991207	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800110
J	Moore, AR; Ghiretti, AE; Paradis, S				Moore, Anna R.; Ghiretti, Amy E.; Paradis, Suzanne			A Loss-Of-Function Analysis Reveals That Endogenous Rem2 Promotes Functional Glutamatergic Synapse Formation and Restricts Dendritic Complexity	PLOS ONE			English	Article							DEPENDENT CALCIUM-CHANNELS; RGK FAMILY; CELL-SHAPE; GTPASE; BINDING; MEMBER; RAD; GEM; LOCALIZATION; INHIBITION	Rem2 is a member of the RGK family of small Ras-like GTPases whose expression and function is regulated by neuronal activity in the brain. A number of questions still remain as to the endogenous functions of Rem2 in neurons. RNAi-mediated Rem2 knockdown leads to an increase in dendritic complexity and a decrease in functional excitatory synapses, though a recent report challenged the specificity of Rem2-targeted RNAi reagents. In addition, overexpression in a number of cell types has shown that Rem2 can inhibit voltage-gated calcium channel (VGCC) function, while studies employing RNAi-mediated knockdown of Rem2 have failed to observe a corresponding enhancement of VGCC function. To further investigate these discrepancies and determine the endogenous function of Rem2, we took a comprehensive, loss-of-function approach utilizing two independent, validated Rem2-targeted shRNAs to analyze Rem2 function. We sought to investigate the consequence of endogenous Rem2 knockdown by focusing on the three reported functions of Rem2 in neurons: regulation of synapse formation, dendritic morphology, and voltage-gated calcium channels. We conclude that endogenous Rem2 is a positive regulator of functional, excitatory synapse development and a negative regulator of dendritic complexity. In addition, while we are unable to reach a definitive conclusion as to whether the regulation of VGCCs is an endogenous function of Rem2, our study reports important data regarding RNAi reagents for use in future investigation of this issue.	[Paradis, Suzanne] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Paradis, S (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	paradis@brandeis.edu		Moore, Anna/0000-0001-6183-906X	NIH [R01NS065856, F31DA032181, T32NS07292, P30NS45713]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292, P30NS045713, R01NS065856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA032181] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH Grant R01NS065856 (SP), NIH Grant F31DA032181 (AEG), NIH Grant T32NS07292 (ARM), and NIH Grant P30NS45713 (for Core Facilities for Neurobiology at Brandeis University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Edel MJ, 2010, CELL CYCLE, V9, P3414, DOI 10.4161/cc.9.17.12719; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2008, BIOCHEM BIOPH RES CO, V368, P827, DOI 10.1016/j.bbrc.2008.02.020; Fu MG, 2005, CIRCULATION, V111, P1071, DOI 10.1161/01.CIR.0000156439.55349.AD; Ghiretti AE, 2013, J NEUROSCI, V33, P6504, DOI 10.1523/JNEUROSCI.3861-12.2013; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Mahalakshmi RN, 2007, TRAFFIC, V8, P1164, DOI 10.1111/j.1600-0854.2007.00599.x; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Pang CY, 2010, CHANNELS, V4, P192, DOI 10.4161/chan.4.3.11867; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Queenan BN, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/718203; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; SHOLL DA, 1953, J ANAT, V87, P387; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Wang HY, 2011, PROC SPIE, V7917, DOI 10.1117/12.873592; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Yang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037079; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203; 2003, NAT CELL BIOL, V5, P489, DOI DOI 10.1038/NCB0603-490.PUBMED:12776118	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74751	10.1371/journal.pone.0074751	http://dx.doi.org/10.1371/journal.pone.0074751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991227	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800123
J	Albrecht, K; Volz, KG; Sutter, M; von Cramon, DY				Albrecht, Konstanze; Volz, Kirsten G.; Sutter, Matthias; von Cramon, D. Yves			What Do I Want and When Do I Want It: Brain Correlates of Decisions Made for Self and Other	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; REWARD; FMRI; TIME; EMOTION; SYSTEM; RATIONALITY; PREFERENCE; IMMEDIATE; DOPAMINE	A number of recent functional Magnetic Resonance Imaging (fMRI) studies on intertemporal choice behavior have demonstrated that so-called emotion- and reward-related brain areas are preferentially activated by decisions involving immediately available (but smaller) rewards as compared to (larger) delayed rewards. This pattern of activation was not seen, however, when intertemporal choices were made for another (unknown) individual, which speaks to that activation having been triggered by self-relatedness. In the present fMRI study, we investigated the brain correlates of individuals who passively observed intertemporal choices being made either for themselves or for an unknown person. We found higher activation within the ventral striatum, medial prefrontal and orbitofrontal cortex, pregenual anterior cingulate cortex, and posterior cingulate cortex when an immediate reward was possible for the observer herself, which is in line with findings from studies in which individuals actively chose immediately available rewards. Additionally, activation in the dorsal anterior cingulate cortex, posterior cingulate cortex, and precuneus was higher for choices that included immediate options than for choices that offered only delayed options, irrespective of who was to be the beneficiary. These results indicate that (1) the activations found in active intertemporal decision making are also present when the same decisions are merely observed, thus supporting the assumption that a robust brain network is engaged in immediate gratification; and (2) with immediate rewards, certain brain areas are activated irrespective of whether the observer or another person is the beneficiary of a decision, suggesting that immediacy plays a more general role for neural activation. An explorative analysis of participants' brain activation corresponding to chosen rewards, further indicates that activation in the aforementioned brain areas depends on the mere presence, availability, or actual reception of immediate rewards.	[Albrecht, Konstanze] Rhein Westfal TH Aachen, Inst Psychol, Aachen, Germany; [Volz, Kirsten G.] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Sutter, Matthias] Univ Innsbruck, Dept Publ Finance, A-6020 Innsbruck, Austria; [Sutter, Matthias] Univ Cologne, Dept Econ, D-50931 Cologne, Germany; [von Cramon, D. Yves] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [von Cramon, D. Yves] Max Planck Inst Human Cognit & Brain Sci, Dept Cognit Neurol, Leipzig, Germany	RWTH Aachen University; Eberhard Karls University of Tubingen; University of Innsbruck; University of Cologne; Max Planck Society; Max Planck Society	Albrecht, K (corresponding author), Rhein Westfal TH Aachen, Inst Psychol, Aachen, Germany.	albrecht@psych.rwth-aachen.de	Sutter, Matthias/R-2018-2018	Sutter, Matthias/0000-0002-6143-8706				AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Albrecht K, 2011, SOC COGN AFFECT NEUR, V6, P218, DOI 10.1093/scan/nsq046; Bellebaum C, 2012, BEHAV BRAIN RES, V227, P241, DOI 10.1016/j.bbr.2011.10.042; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; GREEN L, 1994, PSYCHON B REV, V1, P383, DOI 10.3758/BF03213979; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Hershfield H, 2009, SOC COGN AFFECT NEUR, V4, P85; Jager T, 2005, TECHNICAL REPORT; Jamison J, 2010, J ECON PSYCHOL, V31, P832, DOI 10.1016/j.joep.2010.03.004; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Keren G, 2009, PERSPECT PSYCHOL SCI, V4, P533, DOI 10.1111/j.1745-6924.2009.01164.x; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lazar NA, 2008, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-78191-4_1; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Mischel W., 2003, TIME DECISION EC PSY, P175; Neumann J, 2003, NEUROIMAGE, V20, P1346, DOI 10.1016/S1053-8119(03)00443-9; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Parfit Derek., 1984, REASONS PERSONS; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Rohde K, 2005, HYPERBOLIC FACTOR ME; Rustichini A, 2008, COGN AFFECT BEHAV NE, V8, P355, DOI 10.3758/CABN.8.4.355; Samuelson PA, 1936, REV ECON STUD, V4, P155; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Talairach J., 1988, COPLANAR STEREOTAXIC; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	55	15	15	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73531	10.1371/journal.pone.0073531	http://dx.doi.org/10.1371/journal.pone.0073531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23991196	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700064
J	Bastani, A; Jaberzadeh, S				Bastani, Andisheh; Jaberzadeh, Shapour			Differential Modulation of Corticospinal Excitability by Different Current Densities of Anodal Transcranial Direct Current Stimulation	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; NONINVASIVE CORTICAL STIMULATION; LONG-TERM POTENTIATION; MAGNETIC STIMULATION; HORIZONTAL CONNECTIONS; ELECTRICAL-STIMULATION; SYNAPTIC PLASTICITY; BRAIN-STIMULATION; TDCS; DESENSITIZATION	Background: Novel non-invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) have been developed in recent years. TDCS-induced corticospinal excitability changes depend on two important factors current intensity and stimulation duration. Despite clinical success with existing tDCS parameters, optimal protocols are still not entirely set. Objective/hypothesis: The current study aimed to investigate the effects of four different anodal tDCS (a-tDCS) current densities on corticospinal excitability. Methods: Four current intensities of 0.3, 0.7, 1.4 and 2 mA resulting in current densities (CDs) of 0.013, 0.029, 0.058 and 0.083 mA/cm(2) were applied on twelve right-handed (mean age 34.5 +/- 10.32 yrs) healthy individuals in different sessions at least 48 hours apart. a-tDCS was applied continuously for 10 minute, with constant active and reference electrode sizes of 24 and 35 cm(2) respectively. The corticospinal excitability of the extensor carpi radialis muscle (ECR) was measured before and immediately after the intervention and at 10, 20 and 30 minutes thereafter. Results: Post hoc comparisons showed significant differences in corticospinal excitability changes for CDs of 0.013 mA/cm(2) and 0.029 mA/cm(2) (P = 0.003). There were no significant differences between excitability changes for the 0.013 mA/cm(2) and 0.058 mA/cm(2) (P = 0.080) or 0.013 mA/cm(2) and 0.083 mA/cm(2) (P = 0.484) conditions. Conclusion: This study found that a-tDCS with a current density of 0.013 mA/cm(2) induces significantly larger corticospinal excitability changes than CDs of 0.029 mA/cm(2). The implication is that might help to avoid applying unwanted amount of current to the cortical areas.	[Bastani, Andisheh; Jaberzadeh, Shapour] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary Hlth Care, Dept Physiotherapy, Melbourne, Vic 3004, Australia	Monash University	Bastani, A (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary Hlth Care, Dept Physiotherapy, Melbourne, Vic 3004, Australia.	andisheh.bastanijahromi@monash.edu		jaberzadeh, shapour/0000-0003-2957-4510				[Anonymous], 2005, APPL MULTIVARIATE RE; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; ARONIADOU VA, 1995, CEREB CORTEX, V5, P353, DOI 10.1093/cercor/5.4.353; Basmajian JV, 1985, MUSCLES ALIVE WILLIA; Bastani A, 2012, CLIN NEUROPHYSIOL, V123, P644, DOI 10.1016/j.clinph.2011.08.029; Bastani A, 2013, BRAIN STIMUL; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Gilmore K L, 1983, Aust J Physiother, V29, P3, DOI 10.1016/S0004-9514(14)60659-0; Gulledge AT, 2005, J NEUROSCI, V25, P10308, DOI 10.1523/JNEUROSCI.2697-05.2005; Hallett M, 1996, ANN NEUROL, V40, P344, DOI 10.1002/ana.410400303; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P397; HESS G, 1994, NEUROSCIENCE, V61, P225, DOI 10.1016/0306-4522(94)90226-7; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Hesse S, 2007, RESTOR NEUROL NEUROS, V25, P9; Hummel F, 2005, NEUROREHAB NEURAL RE, V19, P14, DOI 10.1177/1545968304272698; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kendall F., 2010, MUSCLES TESTING FUNC, V5th ed; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; Mellor JR, 1998, J PHYSIOL-LONDON, V506, P377, DOI 10.1111/j.1469-7793.1998.377bw.x; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Perotto A, 2005, ANATOMICAL GUIDE ELE; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Robertson V, 2006, ELECTROTHERAPY EXPLA, V4th; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Samii A, 1996, NEUROLOGY, V46, P1376, DOI 10.1212/WNL.46.5.1376; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Xue JG, 2011, J NEUROPHYSIOL, V105, P2897, DOI 10.1152/jn.00287.2010; YOON KW, 1994, J NEUROPHYSIOL, V71, P2151, DOI 10.1152/jn.1994.71.6.2151; YUEN TGH, 1981, NEUROSURGERY, V9, P292, DOI 10.1227/00006123-198109000-00013	56	75	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72254	10.1371/journal.pone.0072254	http://dx.doi.org/10.1371/journal.pone.0072254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991076	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700033
J	Masaki, K; Suzuki, SO; Matsushita, T; Matsuoka, T; Imamura, S; Yamasaki, R; Suzuki, M; Suenaga, T; Iwaki, T; Kira, JI				Masaki, Katsuhisa; Suzuki, Satoshi O.; Matsushita, Takuya; Matsuoka, Takeshi; Imamura, Shihoko; Yamasaki, Ryo; Suzuki, Makiko; Suenaga, Toshihiko; Iwaki, Toru; Kira, Jun-Ichi			Connexin 43 Astrocytopathy Linked to Rapidly Progressive Multiple Sclerosis and Neuromyelitis Optica	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GAP-JUNCTIONS; ANTI-AQUAPORIN-4 ANTIBODY; DIAGNOSTIC-CRITERIA; DEVICS-SYNDROME; WHITE-MATTER; AQUAPORIN-4; LESIONS; DELETION	Background: Multiple sclerosis (MS) and neuromyelitis optica (NMO) occasionally have an extremely aggressive and debilitating disease course; however, its molecular basis is unknown. This study aimed to determine a relationship between connexin (Cx) pathology and disease aggressiveness in Asian patients with MS and NMO. Methods/Principal Findings: Samples included 11 autopsied cases with NMO and NMO spectrum disorder (NMOSD), six with MS, and 20 with other neurological diseases (OND). Methods of analysis included immunohistochemical expression of astrocytic Cx43/Cx30, oligodendrocytic Cx47/Cx32 relative to AQP4 and other astrocytic and oligodendrocytic proteins, extent of demyelination, the vasculocentric deposition of complement and immunoglobulin, and lesion staging by CD68 staining for macrophages. Lesions were classified as actively demyelinating (n=59), chronic active (n=58) and chronic inactive (n=23). Sera from 120 subjects including 30 MS, 30 NMO, 40 OND and 20 healthy controls were examined for anti-Cx43 antibody by cell-based assay. Six NMO/NMOSD and three MS cases showed preferential loss of astrocytic Cx43 beyond the demyelinated areas in actively demyelinating and chronic active lesions, where heterotypic Cx43/Cx47 astrocyte oligodendrocyte gap junctions were extensively lost. Cx43 loss was significantly associated with a rapidly progressive disease course as six of nine cases with Cx43 loss, but none of eight cases without Cx43 loss regardless of disease phenotype, died within two years after disease onset (66.7% vs. 0%, P=0.0090). Overall, five of nine cases with Cx43 loss and none of eight cases without Cx43 loss had distal oligodendrogliopathy characterized by selective myelin associated glycoprotein loss (55.6% vs. 0.0%, P=0.0296). Loss of oligodendrocytic Cx32 and Cx47 expression was observed in most active and chronic lesions from all MS and NMO/NMOSD cases. Cx43-specific antibodies were absent in NMO/NMOSD and MS patients. Conclusions: These findings suggest that autoantibody-independent astrocytic Cx43 loss may relate to disease aggressiveness and distal oligodendrogliopathy in both MS and NMO.	[Masaki, Katsuhisa; Matsushita, Takuya; Matsuoka, Takeshi; Imamura, Shihoko; Kira, Jun-Ichi] Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan; [Suzuki, Satoshi O.; Iwaki, Toru] Kyushu Univ, Dept Neuropathol, Grad Sch Med Sci, Neurol Inst, Fukuoka 812, Japan; [Yamasaki, Ryo] Kyushu Univ, Dept Neurol Therapeut, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan; [Suzuki, Makiko] Hamamatsu Univ Sch Med, Dept Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Suenaga, Toshihiko] Tenri Hosp, Dept Neurol, Tenri, Nara 632, Japan	Kyushu University; Kyushu University; Kyushu University; Hamamatsu University School of Medicine; Tenri Hospital	Kira, JI (corresponding author), Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan.	kira@neuro.med.kyushu-u.ac.jp	Suzuki, Satoshi O/H-8367-2019; Yamasaki, Ryo/AAQ-6245-2021	Suzuki, Satoshi O/0000-0002-0742-5680; Yamasaki, Ryo/0000-0003-2071-7861	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour, and Welfare, Japan [H22-Nanchi-Ippan-130, H23-Nanchi-Ippan-017]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [22390178, 23659459, 24790889]; Kaibara Morikazu Medical Science Promotion Foundation, Japan; Japanese Multiple Sclerosis Society	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kaibara Morikazu Medical Science Promotion Foundation, Japan; Japanese Multiple Sclerosis Society	This work was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases (H22-Nanchi-Ippan-130 and H23-Nanchi-Ippan-017) from the Ministry of Health, Labour, and Welfare, Japan, by a Scientific Research B Grant (No. 22390178), a Challenging Exploratory Research Grant (No. 23659459) and a Young Scientists B Grant (No. 24790889) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by the Kaibara Morikazu Medical Science Promotion Foundation, Japan, and by the Japanese Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bergamaschi R, 2009, J NEUROL, V256, P2097, DOI 10.1007/s00415-009-5288-y; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Bruck W, 2012, ANN NEUROL, V72, P385, DOI 10.1002/ana.23621; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Kawajiri M, 2009, MULT SCLER J, V15, P262, DOI 10.1177/1352458508097923; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Kinoshita M, 2009, NEUROREPORT, V20, P508, DOI 10.1097/WNR.0b013e32832776f4; Kira J, 2011, J NEUROL SCI, V311, P69, DOI 10.1016/j.jns.2011.08.043; Koller H, 2006, J NEUROL, V253, P819, DOI 10.1007/s00415-006-0116-0; Kowajiri M, 2008, MULT SCLER J, V14, P557, DOI 10.1177/1352458507085760; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lalmohamed A, 2012, EUR J NEUROL, V19, P1007, DOI 10.1111/j.1468-1331.2012.03668.x; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Lassmann H, 1998, J NEUROIMMUNOL, V86, P213, DOI 10.1016/S0165-5728(98)00031-9; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li LH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-94; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lucchinetti CF, 2007, IMMUNE REGULATION IM, P214; Lutz SE, 2009, J NEUROSCI, V29, P7743, DOI 10.1523/JNEUROSCI.0341-09.2009; Magnotti LM, 2011, GLIA, V59, P1064, DOI 10.1002/glia.21179; Markoullis K, 2012, ACTA NEUROPATHOL, V123, P873, DOI 10.1007/s00401-012-0978-4; Markoullis K, 2012, GLIA, V60, P1053, DOI 10.1002/glia.22334; Masaki K, 2012, ACTA NEUROPATHOL, V123, P887, DOI 10.1007/s00401-012-0972-x; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Matsuoka T, 2010, ACTA NEUROPATHOL, V120, P651, DOI 10.1007/s00401-010-0733-7; Matsushita T, 2010, J NEUROL SCI, V295, P41, DOI 10.1016/j.jns.2010.05.014; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nishiyama S, 2009, NEUROLOGY, V72, P1960, DOI 10.1212/WNL.0b013e3181a82621; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI [10.1016/j.pbiomolbio.2007.03.003, DOI 10.1016/J.PBI0M0LBI0.2007.03.003.PUBMED:17462722]; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Sumelahti ML, 2010, MULT SCLER J, V16, P1437, DOI 10.1177/1352458510379244; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	58	60	61	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72919	10.1371/journal.pone.0072919	http://dx.doi.org/10.1371/journal.pone.0072919			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991165	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470700053
J	Zhang, C; Zhu, N; Xie, ZD; Lu, RJ; He, B; Liu, CY; Ma, XJ; Tan, WJ				Zhang, Chen; Zhu, Na; Xie, Zhengde; Lu, Roujian; He, Bin; Liu, Chunyan; Ma, Xuejun; Tan, Wenjie			Viral Etiology and Clinical Profiles of Children with Severe Acute Respiratory Infections in China	PLOS ONE			English	Article							PARAINFLUENZA VIRUS-INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; PANEL FAST ASSAY; HOSPITALIZED CHILDREN; SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; TRANSPLANT RECIPIENTS; MULTIPLEX PCR; ILLNESS; EPIDEMIOLOGY	Background: No comprehensive analysis is available on the viral etiology and clinical characterization among children with severe acute respiratory infection (SARI) in China during 2009 H1N1 pandemic and post-pandemic period. Methods: Cohort of 370 hospitalized children (1 to 72 months) with SARI from May 2008 to March 2010 was enrolled in this study. Nasopharyngeal aspirate (NPA) specimens were tested by a commercial assay for 18 respiratory viral targets. The viral distribution and its association with clinical character were statistically analyzed. Results: Viral pathogen was detected in 350 (94.29%) of children with SARI. Overall, the most popular viruses were: enterovirus/rhinovirus (EV/RV) (54.05%), respiratory syncytial virus (RSV) (51.08%), human bocavirus (BoCA) (33.78%), human parainfluenzaviruse type 3 (PIV3) (15.41%), and adenovirus (ADV) (12.97%). Pandemic H1N1 was the dominant influenza virus (IFV) but was only detected in 20 (5.41%) of children. Moreover, detection rate of RSV and human metapneumovirus (hMPV) among suburb participants were significantly higher than that of urban area (P<0.05). Incidence of VSARI among suburb participants was also significant higher, especially among those of 24 to 59 months group (P<0.05). Conclusion: Piconaviruses (EV/RV) and paramyxoviruses are the most popular viral pathogens among children with SARI in this study. RSV and hMPV significantly increase the risk of SARI, especially in children younger than 24 months. Higher incidence of VSARI and more susceptibilities to RSV and hMPV infections were found in suburban patients.	[Zhang, Chen; Zhu, Na; Lu, Roujian; He, Bin; Ma, Xuejun; Tan, Wenjie] China Ctr Dis Control & Prevent CDC, Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xie, Zhengde; Liu, Chunyan] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Child, Beijing, Peoples R China; [Xie, Zhengde; Liu, Chunyan] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat, Beijing, Peoples R China; [He, Bin] Huainan Ctr Dis Control & Prevent CDC, Huainan, Anhui, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Capital Medical University	Ma, XJ (corresponding author), China Ctr Dis Control & Prevent CDC, Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	maxj2004@yahoo.com.cn; tanwj28@yahoo.cn		Tripp, Ralph/0000-0002-2924-9956	State Megaproject for Infectious Disease Research of China [2011ZX10004-0012013ZX1004601]; National 863 Project of China [2007AA02Z464]	State Megaproject for Infectious Disease Research of China; National 863 Project of China	The study was funded by grants from the State Megaproject for Infectious Disease Research of China (2011ZX10004-0012013ZX1004601) and National 863 Project of China (2007AA02Z464). The Sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APALSCH AM, 1995, CLIN INFECT DIS, V20, P394, DOI 10.1093/clinids/20.2.394; Babady NE, 2012, J CLIN MICROBIOL, V50, P2282, DOI 10.1128/JCM.06186-11; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Chen DH, 2012, ZHONGHUA ER KE ZA ZH, V50, P98; Chen Hui-zhong, 2011, Zhonghua Er Ke Za Zhi, V49, P734; Chen YW, 2012, J MICROBIOL IMMUNOL; Dabisch-Ruthe M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-163; Diallo AH, 2010, LANCET, V376, P1223, DOI 10.1016/S0140-6736(10)61880-6; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Fujitsuka A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-168; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Grondahl B, 2005, CLIN MICROBIOL INFEC, V11, P848, DOI 10.1111/j.1469-0691.2005.01223.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Jokela P, 2012, J VIROL METHODS, V182, P82, DOI 10.1016/j.jviromet.2012.03.015; JOSEPHS S, 1988, PEDIATR INFECT DIS J, V7, P207, DOI 10.1097/00006454-198803000-00017; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kim CK, 2010, J KOREAN MED SCI, V25, P342, DOI 10.3346/jkms.2010.25.3.342; Lazar I, 2004, EMERG INFECT DIS, V10, P1318, DOI 10.3201/eid1007.030983; Maeng SH, 2012, PEDIATR BLOOD CANCER, V59, P708, DOI 10.1002/pbc.23390; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Mammas IN, 2011, MOL MED REP, V4, P267, DOI 10.3892/mmr.2011.416; Mansuy JM, 2012, SCAND J INFECT DIS; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Peng JS, 2012, J MED VIROL, V84, P672, DOI 10.1002/jmv.22247; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Vilchez RA, 2003, AM J TRANSPLANT, V3, P116, DOI 10.1034/j.1600-6143.2003.00024.x; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Wong S, 2009, J CLIN MICROBIOL, V47, P3839, DOI 10.1128/JCM.01469-09; Wright PF, 2007, J CLIN MICROBIOL, V45, P2126, DOI 10.1128/JCM.02553-06; Xiao Ni-Guang, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P28; Xie Zheng-de, 2011, Zhonghua Er Ke Za Zhi, V49, P745; Zhang HY, 2009, JPN J INFECT DIS, V62, P458	37	32	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72606	10.1371/journal.pone.0072606	http://dx.doi.org/10.1371/journal.pone.0072606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991128	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700043
J	Chausson, P; Leresche, N; Lambert, RC				Chausson, Patrick; Leresche, Nathalie; Lambert, Regis C.			Dynamics of Intrinsic Dendritic Calcium Signaling during Tonic Firing of Thalamic Reticular Neurons	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; IN-VITRO; PERIGENICULATE NUCLEUS; ELECTRICAL SYNAPSES; GABAERGIC NEURONS; OLFACTORY-BULB; ADULT-RAT; CAT; INHIBITION; MECHANISMS	The GABAergic neurons of the nucleus reticularis thalami that control the communication between thalamus and cortex are interconnected not only through axo-dendritic synapses but also through gap junctions and dendro-dendritic synapses. It is still unknown whether these dendritic communication processes may be triggered both by the tonic and the T-type Ca2+ channel-dependent high frequency burst firing of action potentials displayed by nucleus reticularis neurons during wakefulness and sleep, respectively. Indeed, while it is known that activation of T-type Ca2+ channels actively propagates throughout the dendritic tree, it is still unclear whether tonic action potential firing can also invade the dendritic arborization. Here, using two-photon microscopy, we demonstrated that dendritic Ca2+ responses following somatically evoked action potentials that mimic wake-related tonic firing are detected throughout the dendritic arborization. Calcium influx temporally summates to produce dendritic Ca2+ accumulations that are linearly related to the duration of the action potential trains. Increasing the firing frequency facilitates Ca2+ influx in the proximal but not in the distal dendritic compartments suggesting that the dendritic arborization acts as a low-pass filter in respect to the back-propagating action potentials. In the more distal compartment of the dendritic tree, T-type Ca2+ channels play a crucial role in the action potential triggered Ca2+ influx suggesting that this Ca2+ influx may be controlled by slight changes in the local dendritic membrane potential that determine the T-type channels' availability. We conclude that by mediating Ca2+ dynamic in the whole dendritic arborization, both tonic and burst firing of the nucleus reticularis thalami neurons might control their dendro-dendritic and electrical communications.	[Chausson, Patrick; Leresche, Nathalie; Lambert, Regis C.] UMR 7102 CNRS, Paris, France; [Chausson, Patrick; Leresche, Nathalie; Lambert, Regis C.] Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lambert, RC (corresponding author), UMR 7102 CNRS, Paris, France.	regis.lambert@snv.jussieu.fr		Leresche, Nathalie/0000-0001-6705-9769	ANR-MNMP	ANR-MNMP(French National Research Agency (ANR))	Supported by ANR-MNMP-2009 (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; AMZICA F, 1992, NEUROSCIENCE, V51, P285, DOI 10.1016/0306-4522(92)90315-S; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; BARRIONUEVO G, 1981, EXP NEUROL, V72, P486, DOI 10.1016/0014-4886(81)90238-7; Batista BHB, 2007, EPILEPSY BEHAV, V11, P60, DOI 10.1016/j.yebeh.2007.03.016; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Brunton J, 1997, NEUROSCIENCE, V78, P303; Casale AE, 2011, J NEUROSCI, V31, P18289, DOI 10.1523/JNEUROSCI.4417-11.2011; CONTRERAS D, 1992, J NEUROPHYSIOL, V68, P973, DOI 10.1152/jn.1992.68.3.973; Crandall SR, 2012, J NEUROSCI, V32, P2513, DOI 10.1523/JNEUROSCI.4402-11.2012; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; DEBIASI S, 1986, BRAIN RES, V399, P143, DOI 10.1016/0006-8993(86)90608-6; Deleuze C, 2012, J NEUROSCI, V32, P12228, DOI 10.1523/JNEUROSCI.1362-12.2012; Destexhe A, 1996, J NEUROSCI, V16, P169; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Egger V, 2003, J NEUROSCI, V23, P7551; FAMIGLIETTI EV, 1970, BRAIN RES, V20, P181, DOI 10.1016/0006-8993(70)90287-8; Haas JS, 2011, SCIENCE, V334, P389, DOI 10.1126/science.1207502; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Iftinca M, 2006, NEUROSCIENCE, V142, P1031, DOI 10.1016/j.neuroscience.2006.07.010; Joksovic PM, 2007, ANN NY ACAD SCI, V1122, P83, DOI 10.1196/annals.1403.006; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Lagier S, 2007, P NATL ACAD SCI USA, V104, P7259, DOI 10.1073/pnas.0701846104; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Liu XB, 1999, J COMP NEUROL, V414, P67; Liu XB, 2011, J COMP NEUROL, V519, P1181, DOI 10.1002/cne.22567; MONTERO VM, 1984, EXP BRAIN RES, V56, P115; MONTERO VM, 1989, EXP BRAIN RES, V75, P65; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; MUKHAMETOV LM, 1970, J PHYSIOL-LONDON, V210, P651, DOI 10.1113/jphysiol.1970.sp009233; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; OHARA PT, 1985, J NEUROCYTOL, V14, P365, DOI 10.1007/BF01217752; OHARA PT, 1988, J ELECTRON MICR TECH, V10, P283, DOI 10.1002/jemt.1060100306; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Pinault D, 1997, J NEUROSCI, V17, P3215; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shipe WD, 2008, J MED CHEM, V51, P3692, DOI 10.1021/jm800419w; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Williams SR, 2000, J NEUROSCI, V20, P1307	41	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72275	10.1371/journal.pone.0072275	http://dx.doi.org/10.1371/journal.pone.0072275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991078	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100093
J	Iwasa, H; Kudo, T; Maimaiti, S; Ikeda, M; Maruyama, J; Nakagawa, K; Hata, Y				Iwasa, Hiroaki; Kudo, Takumi; Maimaiti, Sainawaer; Ikeda, Mitsunobu; Maruyama, Junichi; Nakagawa, Kentaro; Hata, Yutaka			The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and the Cell Cycle via MDM2 Protein and p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Checkpoint Control; DNA Damage; p53; Tumor Suppressor Gene; Hippo Pathway; RASSF	HIPPO PATHWAY; MST2 PATHWAY; FAMILY; ACTIVATION; COMPLEX; KINASE; CANCER	Ras association domain family (RASSF) 6 is a member of the C-terminal RASSF proteins such as RASSF1A and RASSF3. RASSF6 is involved in apoptosis in various cells under miscellaneous conditions, but it remains to be clarified how RASSF6 exerts tumor-suppressive roles. We reported previously that RASSF3 facilitates the degradation of MDM2, a major E3 ligase of p53, and stabilizes p53 to function as a tumor suppressor. In this study, we demonstrate that RASSF6 overexpression induces G(1)/S arrest in p53-positive cells. Its depletion prevents UV- and VP-16-induced apoptosis and G(1)/S arrest in HCT116 and U2OS cells. RASSF6-induced apoptosis partially depends on p53. RASSF6 binds MDM2 and facilitates its ubiquitination. RASSF6 depletion blocks the increase of p53 in response to UV exposure and up-regulation of p53 target genes. RASSF6 depletion delays DNA repair in UV- and VP-16-treated cells and increases polyploid cells after VP-16 treatment. These findings indicate that RASSF6 stabilizes p53, regulates apoptosis and the cell cycle, and functions as a tumor suppressor. Together with the previous reports regarding RASSF1A and RASSF3, the stabilization of p53 may be the common function of the C-terminal RASSF proteins.	[Iwasa, Hiroaki; Kudo, Takumi; Maimaiti, Sainawaer; Ikeda, Mitsunobu; Maruyama, Junichi; Nakagawa, Kentaro; Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Tokyo 1138519, Japan; [Kudo, Takumi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurosurg, Tokyo 1138519, Japan; [Maimaiti, Sainawaer] Fourth Peoples Hosp Urumqi, Dept Psychotherapy, Urumqi 830000, Peoples R China	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Hata, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yuhammch@tmd.ac.jp	Iwasa, Hiroaki/ABG-9082-2021	MARUYAMA, Junichi/0000-0002-3665-2700	Ministry of Education, Sports, Science, and Technology [17081008]; Japan Society for the Promotion of Science (JSPS) [22790275, 22590267]	Ministry of Education, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Ministry of Education, Sports, Science, and Technology Grant 17081008 and by Japan Society for the Promotion of Science (JSPS) Grants 22790275 and 22590267.	Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Chan Jia Jia, 2013, Advances in Biological Regulation, V53, P258, DOI [10.1016/j.jbior.2013.07.008, 10.1016/j.jbior.2012.12.001]; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Song H, 2010, BIOCHEM BIOPH RES CO, V391, P969, DOI 10.1016/j.bbrc.2009.11.175; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Tommasi S, 2011, ONCOGENE, V30, P690, DOI 10.1038/onc.2010.440; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; Wen YG, 2011, ANN SURG ONCOL, V18, P3858, DOI 10.1245/s10434-011-1668-5; Withanage K, 2012, J BIOCHEM, V152, P111, DOI 10.1093/jb/mvs056; Yee KS, 2012, CANCER RES, V72, P2206, DOI 10.1158/0008-5472.CAN-11-2906; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	28	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30320	30329		10.1074/jbc.M113.507384	http://dx.doi.org/10.1074/jbc.M113.507384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003224	Green Published, hybrid			2022-12-25	WOS:000329868100029
J	Moon, HJ; Finney, J; Xu, L; Moore, D; Welch, DR; Mure, M				Moon, Hee-Jung; Finney, Joel; Xu, Li; Moore, David; Welch, Danny R.; Mure, Minae			MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasive in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Invasion; Epithelial-to-mesenchymal Transition; Lysyl Oxidase; Post-translational Modification; Site-directed Mutagenesis; Lysyl Oxidase-Like 2	TRANSCRIPTION FACTOR SNAIL; POSTTRANSLATIONAL MODIFICATIONS; LINKED GLYCOSYLATION; MOLECULAR ROLE; AMINE OXIDASE; MIGRATION; COFACTOR; ENZYME; PROGRESSION; MMP	Background: LOXL2 induces metastasis/invasion of breast cancer cells. Results: MCF-7 cells expressing nuclear associated LOXL2 have an invasive EMT phenotype. Conclusion: Nuclear associated catalytically competent LOXL2 contributes to stabilization of Snail1 transcription factor. Significance: This is the first study to directly compare the potencies of nuclear associated and secreted LOXL2s in breast cancer metastasis/invasion in vitro. LOXL2 is a copper- and lysine tyrosylquinone-dependent amine oxidase that has been proposed to function both extracellularly and intracellularly to activate oncogenic signaling pathways leading to EMT and invasion of breast cancer cells. In this study, we selected MCF-7 cells that stably express forms of recombinant LOXL2 differing in their subcellular localizations and catalytic competencies. This enabled us to dissect the molecular functions of intracellular and extracellular LOXL2s and examine their contributions to breast cancer metastasis/invasion. We discovered that secreted LOXL2 (approximate to 100-kDa) is N-glycosylated at Asn-455 and Asn-644, whereas intracellular LOXL2 (approximate to 75-kDa) is nonglycosylated and N-terminally processed, and is primarily associated with the nucleus. Both forms of LOXL2 can oxidize lysine in solution. However, we found that expression of intracellular LOXL2 is more strongly associated with EMT and invasiveness than secreted LOXL2 in vitro. The results indicate that nuclear associated LOXL2 contributes to the stabilization of Snail1 transcription factor at the protein level to induce EMT and promote invasion in vitro, through repression of E-cadherin, occludin, and estrogen receptor-, and up-regulation of vimentin, fibronectin, and MT1-MMP.	[Moon, Hee-Jung; Finney, Joel; Xu, Li; Mure, Minae] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Moore, David] Univ Kansas, KU Microscopy & Analyt Imaging Lab, Lawrence, KS 66045 USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Mure, M (corresponding author), Univ Kansas, Dept Chem, 1251 Wescoe Hall Dr,2054 Malott Hall, Lawrence, KS 66045 USA.	mmure@ku.edu	Welch, Danny R/B-7310-2009; Finney, Joel/AAD-3773-2021	Welch, Danny R/0000-0002-1951-4947; Finney, Joel/0000-0002-3755-8425	National Institutes of Health [P20 RR015563, GM079446-02, P30-CA168524]; American Heart Association [AHA0765445Z]; National Science Foundation [CAREER MCB-0747377]; National Foundation for Cancer Research; Div Of Molecular and Cellular Bioscience [0747377] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Foundation for Cancer Research; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015563 (to M. M., Center of Biomedical Research Excellence for Cancer Experimental Therapeutics), GM079446-02 (to M. M.), and P30-CA168524 (to D. R. W.). This work was also supported by American Heart Association Grant AHA0765445Z (to M. M.) and National Science Foundation Grant CAREER MCB-0747377 (to M. M.).; A Kansas Bioscience Authority Eminent Scholar. Supported, in part, by funding from the National Foundation for Cancer Research.	Akiri G, 2003, CANCER RES, V63, P1657; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bence M, 2011, FEBS J, V278, P4338, DOI 10.1111/j.1742-4658.2011.08351.x; Bollinger JA, 2005, BIOCHEMISTRY-US, V44, P11708, DOI 10.1021/bi0504310; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Herranz N, 2012, MOL CELL, V46, P369, DOI 10.1016/j.molcel.2012.03.002; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kirschmann DA, 2002, CANCER RES, V62, P4478; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin CY, 2011, CANCER SCI, V102, P815, DOI 10.1111/j.1349-7006.2011.01861.x; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Miyazawa Y, 2013, MOL CANCER RES, V11, P628, DOI 10.1158/1541-7786.MCR-12-0544; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Moore RH, 2007, J AM CHEM SOC, V129, P11524, DOI 10.1021/ja0731165; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mure M, 2003, J AM CHEM SOC, V125, P6113, DOI 10.1021/ja0214274; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Rebecchi KR, 2011, ANAL CHEM, V83, P8484, DOI 10.1021/ac2017037; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Saad S, 2002, CANCER RES, V62, P283; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Sodek KL, 2007, BRIT J CANCER, V97, P358, DOI 10.1038/sj.bjc.6603863; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Tang CL, 2001, J BIOL CHEM, V276, P30575, DOI 10.1074/jbc.C100138200; TANG SS, 1983, J BIOL CHEM, V258, P4331; Terry SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050188; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Welm B, 2002, CURR BIOL, V12, pR209, DOI 10.1016/S0960-9822(02)00752-2; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Xu L, 2013, J BIOL CHEM, V288, P5357, DOI 10.1074/jbc.C112.421768	55	62	64	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30000	30008		10.1074/jbc.C113.502310	http://dx.doi.org/10.1074/jbc.C113.502310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014025	hybrid, Green Published			2022-12-25	WOS:000329868100001
J	Guo, SX; Mahillon, J				Guo, Suxia; Mahillon, Jacques			pGIAK1, a Heavy Metal Resistant Plasmid from an Obligate Alkaliphilic and Halotolerant Bacterium Isolated from the Antarctic Concordia Station Confined Environment	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; THURINGIENSIS SUBSP ISRAELENSIS; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; SP-NOV.; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; SODA LAKES; GEN. NOV.; STRAIN	pGIAK1 is a 38-kb plasmid originating from the obligate alkaliphilic and halotolerant Bacillaceae strain JMAK1. The strain was originally isolated from the confined environments of the Antarctic Concordia station. Analysis of the pGIAK1 38,362-bp sequence revealed that, in addition to its replication region, this plasmid contains the genetic determinants for cadmium and arsenic resistances, putative methyltransferase, tyrosine recombinase, spore coat protein and potassium transport protein, as well as several hypothetical proteins. Cloning the pGIAK1 cad operon in Bacillus cereus H3081.97 and its ars operon in Bacillus subtilis 1A280 conferred to these hosts cadmium and arsenic resistances, respectively, therefore confirming their bona fide activities. The pGIAK1 replicon region was also shown to be functional in Bacillus thuringiensis, Bacillus subtilis and Staphylococcus aureus, but was only stably maintained in B. subtilis. Finally, using an Escherichia coli - B. thuringiensis shuttle BAC vector, pGIAK1 was shown to display conjugative properties since it was able to transfer the BAC plasmid among B. thuringiensis strains.	[Guo, Suxia; Mahillon, Jacques] Catholic Univ Louvain, Lab Food & Environm Microbiol, B-1348 Louvain, Belgium	KU Leuven; Universite Catholique Louvain	Mahillon, J (corresponding author), Catholic Univ Louvain, Lab Food & Environm Microbiol, B-1348 Louvain, Belgium.	jacques.mahillon@uclouvain.be			European Space Agency (ESA-PRODEX) through the MISSEX [AO-2004, PRODEX C90255]; COMICS [ESA-AO-07-Concordia: PRODEX C90355]; National Fund for Scientific Research (FNRS); Universite Catholique de Louvain	European Space Agency (ESA-PRODEX) through the MISSEX; COMICS; National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Catholique de Louvain	This study was financially supported by the European Space Agency (ESA-PRODEX) through the MISSEX (AO-2004, PRODEX C90255) and COMICS (ESA-AO-07-Concordia: PRODEX C90355) projects, the National Fund for Scientific Research (FNRS), and the Universite Catholique de Louvain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1972, MOL GEN GENET, V118, P295, DOI 10.1007/BF00333565; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRUP L, 1993, J BACTERIOL, V175, P6530, DOI 10.1128/jb.175.20.6530-6536.1993; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Asao M, 2006, EXTREMOPHILES, V10, P403, DOI 10.1007/s00792-006-0513-4; Bauer T, 2011, J BACTERIOL, V193, P6244, DOI 10.1128/JB.00175-11; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Branco R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-95; Brown SD, 2011, J BACTERIOL, V193, P3682, DOI 10.1128/JB.05209-11; Clewell Don B, 2011, Mob Genet Elements, V1, P38; Crupper SS, 1999, J BACTERIOL, V181, P4071, DOI 10.1128/JB.181.13.4071-4075.1999; Delgado O, 2006, INT J SYST EVOL MICR, V56, P1229, DOI 10.1099/ijs.0.63633-0; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Echigo A, 2010, INT J SYST EVOL MICR, V60, P990, DOI 10.1099/ijs.0.013268-0; ENDO G, 1995, J BACTERIOL, V177, P4437, DOI 10.1128/jb.177.15.4437-4441.1995; Fish SA, 1999, PLASMID, V41, P268, DOI 10.1006/plas.1999.1400; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; GUFFANTI AA, 1986, J BACTERIOL, V167, P766, DOI 10.1128/jb.167.3.766-773.1986; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Hemmerich C, 2010, BIOINFORMATICS, V26, P1122, DOI 10.1093/bioinformatics/btq090; Hoffmaster AR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-191; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Horikoshi K, 1996, FEMS MICROBIOL REV, V18, P259, DOI 10.1016/0168-6445(96)00017-4; Huang J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-270; ITAYA M, 1993, MOL GEN GENET, V241, P287, DOI 10.1007/BF00284680; Jangir PK, 2012, J BACTERIOL, V194, P5688, DOI 10.1128/JB.01302-12; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; JENSEN GB, 1995, J BACTERIOL, V177, P2914, DOI 10.1128/jb.177.10.2914-2917.1995; Jensen GB, 1996, CURR MICROBIOL, V33, P228, DOI 10.1007/s002849900105; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; Liu XY, 2009, APPL MICROBIOL BIOT, V82, P765, DOI 10.1007/s00253-008-1854-y; Luo MZ, 2003, METH MOL B, V236, P3; Ma YH, 2004, EXTREMOPHILES, V8, P193, DOI 10.1007/s00792-004-0377-4; Nunez B, 2001, MOL MICROBIOL, V39, P1088, DOI 10.1046/j.1365-2958.2001.02308.x; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Hidalgo M, 2003, APPL ENVIRON MICROB, V69, P1633, DOI 10.1128/AEM.69.3.1633-1641.2003; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sturr MG, 1998, EXTREMOPHILES, V2, P447, DOI 10.1007/s007920050091; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; [孙莹 SUN Ying], 2011, [微生物学通报, Microbiology], V38, P1473; Takami H, 2000, EXTREMOPHILES, V4, P99, DOI 10.1007/s007920050143; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Takami H, 2001, J BACTERIOL, V183, P4345, DOI 10.1128/JB.183.14.4345-4356.2001; Timmery S, 2011, ASTROBIOLOGY, V11, P323, DOI 10.1089/ast.2010.0573; Uraji M, 2002, GENES GENET SYST, V77, P1, DOI 10.1266/ggs.77.1; Usami R, 2007, INT J SYST EVOL MICR, V57, P770, DOI 10.1099/ijs.0.64713-0; Van Houdt R, 2009, MICROB ECOL, V57, P640, DOI 10.1007/s00248-008-9462-z; van Kranenburg R, 2005, APPL ENVIRON MICROB, V71, P1223, DOI 10.1128/AEM.71.3.1223-1230.2005; Vargas VA, 2005, INT J SYST EVOL MICR, V55, P899, DOI 10.1099/ijs.0.63318-0; Vedder A., 1934, ANTON LEEUW INT J G, V1, P143; WEAVER KE, 1993, J BACTERIOL, V175, P1900, DOI 10.1128/JB.175.7.1900-1909.1993; Xue GP, 1999, J MICROBIOL METH, V34, P183, DOI 10.1016/S0167-7012(98)00087-6; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Yoshimune IYKHK, 2011, EXTREMOPHILES HDB, P56; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhilina TN, 1996, INT J SYST BACTERIOL, V46, P305, DOI 10.1099/00207713-46-1-305; Zhou XH, 2001, PLASMID, V46, P77, DOI 10.1006/plas.2001.1539	69	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72461	10.1371/journal.pone.0072461	http://dx.doi.org/10.1371/journal.pone.0072461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009682	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600021
J	Luan, B; Soros, P; Sejdic, E				Luan, Bo; Soeroes, Peter; Sejdic, Ervin			A Study of Brain Networks Associated with Swallowing Using Graph-Theoretical Approaches	PLOS ONE			English	Article							CEREBRAL CORTICAL REPRESENTATION; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; ORGANIZATION; STIMULATION; ACTIVATION; PATTERNS	Functional connectivity between brain regions during swallowing tasks is still not well understood. Understanding these complex interactions is of great interest from both a scientific and a clinical perspective. In this study, functional magnetic resonance imaging (fMRI) was utilized to study brain functional networks during voluntary saliva swallowing in twenty-two adult healthy subjects (all females, 23:1 +/- 1:52 years of age). To construct these functional connections, we computed mean partial correlation matrices over ninety brain regions for each participant. Two regions were determined to be functionally connected if their correlation was above a certain threshold. These correlation matrices were then analyzed using graph-theoretical approaches. In particular, we considered several network measures for the whole brain and for swallowing-related brain regions. The results have shown that significant pairwise functional connections were, mostly, either local and intra-hemispheric or symmetrically inter-hemispheric. Furthermore, we showed that all human brain functional network, although varying in some degree, had typical small-world properties as compared to regular networks and random networks. These properties allow information transfer within the network at a relatively high efficiency. Swallowing-related brain regions also had higher values for some of the network measures in comparison to when these measures were calculated for the whole brain. The current results warrant further investigation of graph-theoretical approaches as a potential tool for understanding the neural basis of dysphagia.	[Soeroes, Peter] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Soeroes, Peter] Univ Western Ontario, Sch Commun Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Sejdic, E (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA.	esejdic@ieee.org	Sörös, Peter/B-3429-2008	Sörös, Peter/0000-0002-8848-5158; Sejdic, Ervin/0000-0003-4987-8298				Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUTATIONAL B, V3; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Dziewas R, 2003, NEUROIMAGE, V20, P135, DOI 10.1016/S1053-8119(03)00285-4; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hamdy S, 1999, AM J PHYSIOL-GASTR L, V277, pG219, DOI 10.1152/ajpgi.1999.277.1.G219; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kern MK, 2001, AM J PHYSIOL-GASTR L, V280, pG354, DOI 10.1152/ajpgi.2001.280.3.G354; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lowell SY, 2008, NEUROIMAGE, V42, P285, DOI 10.1016/j.neuroimage.2008.04.234; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin RE, 2004, J NEUROPHYSIOL, V92, P2428, DOI 10.1152/jn.01144.2003; Martin RE, 2001, J NEUROPHYSIOL, V85, P938, DOI 10.1152/jn.2001.85.2.938; Martin R, 2007, EXP BRAIN RES, V176, P12, DOI 10.1007/s00221-006-0592-6; MBONDA E, 1995, J PEDIATR-US, V126, P923, DOI 10.1016/S0022-3476(95)70209-1; Mosier KM, 1999, AM J NEURORADIOL, V20, P1520; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sejdic E, 2009, IEEE T BIO-MED ENG, V56, P1090, DOI 10.1109/TBME.2008.2010504; Soros P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-20; Soros P, 2009, HUM BRAIN MAPP, V30, P2426, DOI 10.1002/hbm.20680; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whittaker J, 1992, J CLASSIF, V9, P159; Zald DH, 1999, ANN NEUROL, V46, P281, DOI 10.1002/1531-8249(199909)46:3<281::AID-ANA2>3.0.CO;2-L; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	44	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73577	10.1371/journal.pone.0073577	http://dx.doi.org/10.1371/journal.pone.0073577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009758	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000323734600073
J	Soltoff, SP; Lannon, WA				Soltoff, Stephen P.; Lannon, William A.			Activation of ERK1/2 by Store-Operated Calcium Entry in Rat Parotid Acinar Cells	PLOS ONE			English	Article							INTERACTION MOLECULE-1 STIM1; NITRIC-OXIDE SYNTHASE; SALIVARY-GLAND FLUID; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; PROTEIN-KINASE; ION-TRANSPORT; RECEPTOR; PHOSPHORYLATION; CHANNELS	The regulation of intracellular Ca2+ concentration ([Ca2+](i)) plays a critical role in a variety of cellular processes, including transcription, protein activation, vesicle trafficking, and ion movement across epithelial cells. In many cells, the activation of phospholipase C-coupled receptors hydrolyzes membrane phosphoinositides and produces the depletion of endoplasmic reticulum Ca2+ stores, followed by the sustained elevation of [Ca2+](i) from Ca2+ entry across the plasma membrane via storeoperated Ca2+ entry (SOCE). Ca2+ entry is also increased in a store-independent manner by arachidonate-regulated Ca2+ (ARC) channels. Using rat parotid salivary gland cells, we examined multiple pathways of Ca2+ entry/elevation to determine if they activated cell signaling proteins and whether this occurred in a pathway-dependent manner. We observed that SOCE activates extracellular signal-related kinases 1 and 2 (ERK1/2) to similar to 3-times basal levels via a receptor-independent mechanism when SOCE was initiated by depleting Ca2+ stores using the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (TG). TG-initiated ERK1/2 phosphorylation increased as rapidly as that initiated by the muscarinic receptor agonist carbachol, which promoted an increase to similar to 5-times basal levels. Notably, ERK1/2 phosphorylation was not increased by the global elevation of [Ca2+](i) by Ca2+ ionophore or by Ca2+ entry via ARC channels in native cells, although ERK1/2 phosphorylation was increased by Ca2+ ionophore in Par-C10 and HSY salivary cell lines. Agents and conditions that blocked SOCE in native cells, including 2-aminoethyldiphenyl borate (2-APB), SKF96363, and removal of extracellular Ca2+, also reduced TG- and carbachol-stimulated ERK1/2 phosphorylation. TG-promoted ERK1/2 phosphorylation was blocked when SRC and Protein Kinases C (PKC) were inhibited, and it was blocked in cells pretreated with beta-adrenergic agonist isoproterenol. These observations demonstrate that ERK1/2 is activated by a selective mechanism of Ca2+ entry (SOCE) in these cells, and suggest that ERK1/2 may contribute to events downstream of SOCE.	[Soltoff, Stephen P.; Lannon, William A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Soltoff, SP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Signal Transduct, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu			National Institutes of Health [DE10877]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding came from a National Institutes of Health grant (to SPS): DE10877, Website: http://www.nidcr.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chaib N, 1998, CELL CALCIUM, V23, P395, DOI 10.1016/S0143-4160(98)90096-3; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Chuang TY, 2012, J CELL PHYSIOL, V227, P1610, DOI 10.1002/jcp.22878; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Diver JM, 2001, CELL CALCIUM, V30, P323, DOI 10.1054/ceca.2001.0239; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Hamamura K, 2008, J BONE MINER METAB, V26, P231, DOI 10.1007/s00774-007-0825-1; Henke N, 2012, J BIOL CHEM, V287, P42042, DOI 10.1074/jbc.M112.417212; Hong JH, 2011, TRAFFIC, V12, P232, DOI 10.1111/j.1600-0854.2010.01138.x; Kamiya T, 2011, FREE RADICAL RES, V45, P692, DOI 10.3109/10715762.2011.567985; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Liu XB, 2010, CELL CALCIUM, V47, P491, DOI 10.1016/j.ceca.2010.04.002; Lopez E, 2012, CELL SIGNAL, V24, P1315, DOI 10.1016/j.cellsig.2012.02.012; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Mignen O, 2003, J BIOL CHEM, V278, P10174, DOI 10.1074/jbc.M212536200; Nakamoto T, 2007, AM J PHYSIOL-REG I, V292, pR2380, DOI 10.1152/ajpregu.00591.2006; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Novak I, 2010, J PHYSIOL-LONDON, V588, P3615, DOI 10.1113/jphysiol.2010.190017; Ong HL, 2011, CHANNELS, V5, P422, DOI 10.4161/chan.5.5.16471; Palk L, 2010, J THEOR BIOL, V266, P625, DOI 10.1016/j.jtbi.2010.06.027; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Pulver-Kaste RA, 2006, AM J PHYSIOL-HEART C, V291, pH97, DOI 10.1152/ajpheart.00753.2005; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Rosado JA, 2001, J BIOL CHEM, V276, P15659, DOI 10.1074/jbc.M009218200; Rosado JA, 2002, TRENDS CARDIOVAS MED, V12, P229, DOI 10.1016/S1050-1738(02)00161-5; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Shuttleworth TJ, 2004, PHYSIOLOGY, V19, P355, DOI 10.1152/physiol.00018.2004; Shuttleworth TJ, 2012, FRONT BIOSCI-LANDMRK, V17, P847, DOI 10.2741/3960; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Socodato R, 2012, J BIOL CHEM, V287, P38680, DOI 10.1074/jbc.M112.353961; SOLTOFF SP, 1990, J GEN PHYSIOL, V95, P319, DOI 10.1085/jgp.95.2.319; Soltoff SP, 1998, J BIOL CHEM, V273, P23110, DOI 10.1074/jbc.273.36.23110; SOLTOFF SP, 1992, AM J PHYSIOL, V262, pC934, DOI 10.1152/ajpcell.1992.262.4.C934; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Soltoff SP, 2010, J BIOL CHEM, V285, P36330, DOI 10.1074/jbc.M110.136465; Soltoff SP, 2010, J BIOL CHEM, V285, P13337, DOI 10.1074/jbc.M110.112094; Thompson JL, 2010, CHANNELS, V4, P398, DOI 10.4161/chan.4.5.13226; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; Walsh CM, 2010, BIOCHEM J, V430, P453, DOI 10.1042/BJ20100650; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yang LH, 2006, BIOCHEM BIOPH RES CO, V349, P1339, DOI 10.1016/j.bbrc.2006.08.185; Yao J, 2004, J BIOL CHEM, V279, P21511, DOI 10.1074/jbc.M314028200; Yoshida J, 2012, BIOCHEM PHARMACOL, V84, P1592, DOI 10.1016/j.bcp.2012.09.021; Zhang H, 2011, ANAL BIOCHEM, V417, P292, DOI 10.1016/j.ab.2011.06.025; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	63	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72881	10.1371/journal.pone.0072881	http://dx.doi.org/10.1371/journal.pone.0072881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009711	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600040
J	Sun, Y; Mukai, Y; Tanaka, M; Saito, T; Sato, S; Kurasaki, M				Sun, Yongkun; Mukai, Yuuka; Tanaka, Masato; Saito, Takeshi; Sato, Shin; Kurasaki, Masaaki			Green Tea Extract Increases mRNA Expression of Enzymes Which Influence Epigenetic Marks in Newborn Female Offspring from Undernourished Pregnant Mother	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MATERNAL UNDERNUTRITION; OXIDATIVE STRESS; SIRT1; FETAL; RESTRICTION; AMPK; MALNUTRITION; POLYPHENOLS; PREVENTION	Biochemical and toxicological properties of catechin remain unclear, e.g.; how catechin affects female offspring from undernourished pregnant dams. Here, to elucidate effects of low prenatal protein on female offspring health status, changes of enzymes which modify epigenetic marks related with metabolism in kidneys from newborns were investigated after continuously administering catechin extracted from green tea to lactating maternal rats after pregnant undernourishment. We found that green tea extract intake during lactation up-regulated the activation of AMP-activated protein kinase in young female offspring from protein-restricted dams and modulated the AMP-activated protein kinase pathway in the kidney. This pathway was indicated to be stimulated by SIRT1 gene expression. The feeding of green tea extract to protein-restricted dams during lactation is likely to up-regulate AMP-activated protein kinase activation and may partly lead to alterations of the AMP-activated protein kinase pathway in female offspring kidneys. In addition, energy metabolism in fetal and offspring period with green tea extract administration might be related to enzymes which modify epigenetic marks such as DNA methyltransferase 1 and 3a.	[Sun, Yongkun; Kurasaki, Masaaki] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Mukai, Yuuka; Sato, Shin] Aomori Univ Hlth & Welf, Dept Nutr, Aomori, Japan; [Tanaka, Masato; Saito, Takeshi] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Saito, Takeshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Kurasaki, Masaaki] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Aomori University of Health & Welfare; Hokkaido University; Hokkaido University; Hokkaido University	Kurasaki, M (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	kura@ees.hokudai.ac.jp	SAITO, TAKESHI/E-5950-2012; Kurasaki, Masaaki/B-8207-2012	Kurasaki, Masaaki/0000-0003-2125-095X	Japan Society for the Promotion of Science [23655139, 24350077, 20500710]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (No. 23655139 and No. 24350077 for Kurasaki, and No. 20500710 for Sato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Arts ICW, 2000, J AGR FOOD CHEM, V48, P1752, DOI 10.1021/jf000026+; Begum G, 2012, FASEB J, V26, P1694, DOI 10.1096/fj.11-198762; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Chmurzynska A, 2010, NUTR REV, V68, P87, DOI 10.1111/j.1753-4887.2009.00265.x; Chu KO, 2006, J PHARM SCI-US, V95, P1372, DOI 10.1002/jps.20594; Drake AJ, 2012, CLIN ENDOCRINOL, V77, P808, DOI 10.1111/j.1365-2265.2012.04453.x; Fullerton MD, 2010, DIABETES, V59, P551, DOI 10.2337/db09-1732; Garcia-Souza EP, 2008, AM J PHYSIOL-ENDOC M, V295, pE626, DOI 10.1152/ajpendo.00439.2007; Gramza Anna, 2005, Polish Journal of Food and Nutrition Sciences, V14, P219; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P17; Holness MJ, 2010, NUTRITION, V26, P491, DOI 10.1016/j.nut.2009.09.012; Ikeda M, 2007, MED SCI MONITOR, V13, pBR40; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P651, DOI 10.1016/j.fct.2005.11.002; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kang LS, 2012, AM J PHYSIOL-HEART C, V302, pH560, DOI 10.1152/ajpheart.00277.2011; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Li SF, 2003, GYNECOL ONCOL, V90, P123, DOI 10.1016/S0090-8258(03)00194-X; Li Y, 2010, CURR MED CHEM, V17, P2141, DOI 10.2174/092986710791299966; Lloyd LJ, 2012, J PHYSIOL-LONDON, V590, P377, DOI 10.1113/jphysiol.2011.220186; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Morita O, 2009, FOOD CHEM TOXICOL, V47, P1296, DOI 10.1016/j.fct.2009.03.005; Mukai Y, 2013, NUTRITION, V29, P291, DOI 10.1016/j.nut.2012.06.005; Mukai Y, 2011, J NUTR BIOCHEM, V22, P16, DOI 10.1016/j.jnutbio.2009.11.004; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Sato S, 2008, CLIN EXP PHARMACOL P, V35, P43, DOI 10.1111/j.1440-1681.2007.04743.x; Sato S, 2013, J NUTR BIOCHEM, V24, P118, DOI 10.1016/j.jnutbio.2012.03.007; SUN Y, 2012, J APPL TOXICOL, DOI DOI 10.1002/JAT.2816.PUBMED:22968747.IN; THORS B, 2009, BIOCHIM BIOPHYS ACTA, V1813, P322; Tiwari V, 2010, INT J NEUROPSYCHOPH, V13, P1053, DOI 10.1017/S146114571000060X; Tu HC, 2010, TAIWAN J OBSTET GYNE, V49, P174, DOI 10.1016/S1028-4559(10)60037-X; Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98	41	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74559	10.1371/journal.pone.0074559	http://dx.doi.org/10.1371/journal.pone.0074559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009774	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600084
J	Coloma, PM; Schuemie, MJ; Trifiro, G; Furlong, L; van Mulligen, E; Bauer-Mehren, A; Avillach, P; Kors, J; Sanz, F; Mestres, J; Oliveira, JL; Boyer, S; Helgee, EA; Molokhia, M; Matthews, J; Prieto-Merino, D; Gini, R; Herings, R; Mazzaglia, G; Picelli, G; Scotti, L; Pedersen, L; van der Lei, J; Sturkenboom, M				Coloma, Preciosa M.; Schuemie, Martijn J.; Trifiro, Gianluca; Furlong, Laura; van Mulligen, Erik; Bauer-Mehren, Anna; Avillach, Paul; Kors, Jan; Sanz, Ferran; Mestres, Jordi; Oliveira, Jose Luis; Boyer, Scott; Helgee, Ernst Ahlberg; Molokhia, Mariam; Matthews, Justin; Prieto-Merino, David; Gini, Rosa; Herings, Ron; Mazzaglia, Giampiero; Picelli, Gino; Scotti, Lorenza; Pedersen, Lars; van der Lei, Johan; Sturkenboom, Miriam		EU-ADR Consortium	Drug-Induced Acute Myocardial Infarction: Identifying 'Prime Suspects' from Electronic Healthcare Records-Based Surveillance System	PLOS ONE			English	Article							TORSADES-DE-POINTES; DIABETES-MELLITUS; MEGESTROL-ACETATE; SIGNAL-DETECTION; KOUNIS SYNDROME; IMPACT ANALYSIS; PHARMACOVIGILANCE; DISEASE; PATIENT; HYPERGLYCEMIA	Background: Drug-related adverse events remain an important cause of morbidity and mortality and impose huge burden on healthcare costs. Routinely collected electronic healthcare data give a good snapshot of how drugs are being used in 'real-world' settings. Objective: To describe a strategy that identifies potentially drug-induced acute myocardial infarction (AMI) from a large international healthcare data network. Methods: Post-marketing safety surveillance was conducted in seven population-based healthcare databases in three countries (Denmark, Italy, and the Netherlands) using anonymised demographic, clinical, and prescription/dispensing data representing 21,171,291 individuals with 154,474,063 person-years of follow-up in the period 1996-2010. Primary care physicians' medical records and administrative claims containing reimbursements for filled prescriptions, laboratory tests, and hospitalisations were evaluated using a three-tier triage system of detection, filtering, and substantiation that generated a list of drugs potentially associated with AMI. Outcome of interest was statistically significant increased risk of AMI during drug exposure that has not been previously described in current literature and is biologically plausible. Results: Overall, 163 drugs were identified to be associated with increased risk of AMI during preliminary screening. Of these, 124 drugs were eliminated after adjustment for possible bias and confounding. With subsequent application of criteria for novelty and biological plausibility, association with AMI remained for nine drugs ('prime suspects'): azithromycin; erythromycin; roxithromycin; metoclopramide; cisapride; domperidone; betamethasone; fluconazole; and megestrol acetate. Limitations: Although global health status, co-morbidities, and time-invariant factors were adjusted for, residual confounding cannot be ruled out. Conclusion: A strategy to identify potentially drug-induced AMI from electronic healthcare data has been proposed that takes into account not only statistical association, but also public health relevance, novelty, and biological plausibility. Although this strategy needs to be further evaluated using other healthcare data sources, the list of 'prime suspects' makes a good starting point for further clinical, laboratory, and epidemiologic investigation.	[Coloma, Preciosa M.; Schuemie, Martijn J.; Trifiro, Gianluca; van Mulligen, Erik; Kors, Jan; van der Lei, Johan; Sturkenboom, Miriam] Erasmus MC Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Trifiro, Gianluca] Univ Messina, Dept Clin & Expt Med & Pharmacol, Pharmacol Sect, Messina, Italy; [Furlong, Laura; Bauer-Mehren, Anna; Sanz, Ferran; Mestres, Jordi] Univ Pompeu Fabra, Hosp Mar, IMIM, Res Programme Biomed Informat GRIB, Barcelona, Spain; [Avillach, Paul] Univ Bordeaux Segalen, Inst Sante Publ Epidemiol & Dev, Lab Epidemiol Stat & Informat Med, Bordeaux, France; [Avillach, Paul] Univ Aix Marseille 2, Fac Med, Lab Enseignement & Rech Traitement Informat Med, F-13284 Marseille 07, France; [Oliveira, Jose Luis] Univ Aveiro, Inst Engn Elect & Telemat Aveiro, P-3800 Aveiro, Portugal; [Boyer, Scott; Helgee, Ernst Ahlberg] AstraZeneca Res & Dev, Safety Assessment, Molndal, Sweden; [Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Matthews, Justin; Prieto-Merino, David] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Gini, Rosa] Agenzia Reg Sanita Toscana, Florence, Italy; [Herings, Ron] PHARMO Inst, Utrecht, Netherlands; [Mazzaglia, Giampiero] Soc Italiana Med Gen, Florence, Italy; [Picelli, Gino] Pedianet Soc Serv Telemat SRL, Padua, Italy; [Scotti, Lorenza] Univ Milano Bicocca, Dept Stat, Milan, Italy; [Pedersen, Lars] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Sturkenboom, Miriam] Erasmus MC Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Messina; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Universidade de Aveiro; AstraZeneca; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of Milano-Bicocca; Aarhus University; Erasmus University Rotterdam; Erasmus MC	Coloma, PM (corresponding author), Erasmus MC Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands.	p.coloma@erasmusmc.nl	Herings, Ron/AAE-4096-2021; Oliveira, José Luis/A-2223-2012; Mestres, Jordi/B-3673-2009; Sanz, Ferran/B-3852-2009; Gasull, Martina/J-4076-2019; Scotti, Lorenza/AAB-9544-2019; Trifiro, Gianluca/K-9744-2016; Furlong, Laura I./AAX-1376-2020	Herings, Ron/0000-0002-2561-8734; Oliveira, José Luis/0000-0002-6672-6176; Mestres, Jordi/0000-0002-5202-4501; Sanz, Ferran/0000-0002-7534-7661; Scotti, Lorenza/0000-0002-3861-9058; Trifiro, Gianluca/0000-0003-1147-7296; Furlong, Laura I./0000-0002-9383-528X; Schuemie, Martijn/0000-0002-0817-5361; Prieto-Merino, David/0000-0001-5001-0061; Mazzaglia, Giampiero/0000-0003-4933-2148; van Mulligen, Erik/0000-0003-1377-9386; Gini, Rosa/0000-0002-6250-877X	European Commission [215847]; National Institute for Health Research [PDA/02/06/056] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR))	This research has been funded by the European Commission's Seventh Framework Programme (FP7/2007-2013) under grant no. 215847-The EU-ADR Project. The funding agency had no role in the design and conduct of the study; or in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Ahmad SR, 2001, LANCET, V357, P1766, DOI 10.1016/S0140-6736(00)04891-1; Keller GA, 2010, CURR DRUG SAF, V5, P73, DOI 10.2174/157488610789869166; Araujo L, 2008, CURR PHARM DESIGN, V14, P2840, DOI 10.2174/138161208786369812; Avillach P, 2013, J AM MED INFORM ASSN, V20, P184, DOI 10.1136/amiajnl-2012-000933; Avillach P, 2010, STUD HEALTH TECHNOL, V160, P1085, DOI 10.3233/978-1-60750-588-4-1085; Barchielli A, 2007, INT J CARDIOL, V114, P57, DOI 10.1016/j.ijcard.2006.01.006; Bauer-Mehren A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002457; Biteker M, 2010, EXPERT REV CLIN IMMU, V6, P777, DOI 10.1586/ECI.10.47; Black N, 1996, BRIT MED J, V312, P1215; Bruggemann RJM, 2009, CLIN INFECT DIS, V48, P1441, DOI 10.1086/598327; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Caster O, 2010, DRUG SAFETY, V33, P805, DOI 10.2165/11532460-000000000-00000; Chen JP, 2009, JACC-CARDIOVASC INTE, V2, P583, DOI 10.1016/j.jcin.2009.04.017; Christensen S, 2007, ALIMENT PHARM THER, V25, P907, DOI 10.1111/j.1365-2036.2007.03274.x; Collins KK, 2008, J PEDIATR, V153, P596, DOI 10.1016/j.jpeds.2008.06.009; Coloma PM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002862; Coloma PM, 2012, PHARMACOEPIDEM DR S, V21, P611, DOI 10.1002/pds.3197; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Corrao G, 2008, ANN ONCOL, V19, P150, DOI 10.1093/annonc/mdm404; Demoly P, 2005, Eur Ann Allergy Clin Immunol, V37, P202; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Evans M, 2002, DRUG SAFETY, V25, P649, DOI 10.2165/00002018-200225090-00004; Gisondi P, 2009, SEMIN THROMB HEMOST, V35, P313, DOI 10.1055/s-0029-1222610; Goettsch WG, 2007, PHARMACOEPIDEM DR S, V16, P166, DOI 10.1002/pds.1245; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Gurwitz D, 2007, PHARMACOGENOMICS, V8, P1479, DOI 10.2217/14622416.8.11.1479; Hauben M, 2009, DRUG SAFETY, V32, P99, DOI 10.2165/00002018-200932020-00003; Heeley E, 2005, DRUG SAFETY, V28, P901, DOI 10.2165/00002018-200528100-00006; Hennessy S, 2008, BRIT J CLIN PHARMACO, V66, P375, DOI 10.1111/j.1365-2125.2008.03249.x; HENRY K, 1992, ANN INTERN MED, V116, P53, DOI 10.7326/0003-4819-116-1-53; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hug BL, 2012, JT COMM J QUAL PATIE, V38, P120, DOI 10.1016/S1553-7250(12)38016-1; Khazan M, 2002, PHARMACOTHERAPY, V22, P1632, DOI 10.1592/phco.22.17.1632.34129; Kilby JM, 1998, J ACQ IMMUN DEF SYND, V17, P46, DOI 10.1097/00042560-199801010-00007; KOUNIS NG, 1991, BRIT J CLIN PRACT, V45, P121; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Levitan B, 2008, DRUG SAFETY, V31, P727, DOI 10.2165/00002018-200831090-00001; Lindquist M, 2007, DRUG SAFETY, V30, P635, DOI 10.2165/00002018-200730070-00014; Mazzaglia G, 2005, J HYPERTENS, V23, P2093, DOI 10.1097/01.hjh.0000186832.41125.8a; McMahon JH, 2008, AM J HEALTH-SYST PH, V65, P619, DOI 10.2146/ajhp070203; Meyboom RHB, 2002, DRUG SAFETY, V25, P459, DOI 10.2165/00002018-200225060-00011; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Oliveira JL, 2013, PHARMACOEPIDEM DR S, V22, P459, DOI 10.1002/pds.3375; PANWALKER AP, 1992, ANN INTERN MED, V116, P878, DOI 10.7326/0003-4819-116-10-878_1; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Park BK, 2000, TOXICOLOGY, V153, P39, DOI 10.1016/S0300-483X(00)00303-6; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Quigley EMM, 2011, J DIGEST DIS, V12, P147, DOI 10.1111/j.1751-2980.2011.00491.x; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; Ridella Maricel, 2009, Inflammation & Allergy Drug Targets, V8, P11; Rubin JB, 2012, CURR ATHEROSCLER REP, V14, P140, DOI 10.1007/s11883-012-0226-3; Sarnes E, 2011, CLIN THER, V33, P1413, DOI 10.1016/j.clinthera.2011.09.009; Schuemie MJ, 2011, PHARMACOEPIDEM DR S, V20, P292, DOI 10.1002/pds.2051; Schuemie MJ, 2012, MED CARE; SHARKEY PK, 1991, ANTIMICROB AGENTS CH, V35, P707, DOI 10.1128/AAC.35.4.707; Stang PE, 2010, ANN INTERN MED, V153, P600, DOI 10.7326/0003-4819-153-9-201011020-00010; STONE NJ, 1994, MED CLIN N AM, V78, P117, DOI 10.1016/S0025-7125(16)30179-1; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; Sturkenboom M, 2005, PEDIATRICS, V116, pE26, DOI 10.1542/peds.2004-0040; Szekanecz Z, 2007, ANN NY ACAD SCI, V1108, P349, DOI 10.1196/annals.1422.036; The Uppsala Monitoring Centre, WHO GLOB DAT REACH 7; Thong BYH, 2010, ALLERGY ASTHMA IMMUN, V2, P77, DOI 10.4168/aair.2010.2.2.77; Tonini M, 1999, ALIMENT PHARM THERAP, V13, P1585; US Food and Drug Administration, REP REC ENT AERS YEA; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Waller P, 2005, DRUG SAFETY, V28, P843, DOI 10.2165/00002018-200528100-00002; Weeke P, 2010, RESUSCITATION, V81, P1657, DOI 10.1016/j.resuscitation.2010.06.025	67	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72148	10.1371/journal.pone.0072148	http://dx.doi.org/10.1371/journal.pone.0072148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015213	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000323733800032
J	Wullschleger, A; Kapina, V; Molnarfi, N; Courvoisier, DS; Seebach, JD; Santiago-Raber, ML; Hochstrasser, DF; Lalive, PH				Wullschleger, Alexandre; Kapina, Viktoria; Molnarfi, Nicolas; Courvoisier, Delphine S.; Seebach, Joerg D.; Santiago-Raber, Marie-Laure; Hochstrasser, Denis F.; Lalive, Patrice H.			Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; TRANSVERSE MYELITIS; IL-6; CSF; BIOMARKERS; CYTOKINE; DIAGNOSIS; SERUM	Background: Interleukin (IL)-6 is recognised as an important cytokine involved in inflammatory diseases of the central nervous system (CNS). Objective: To perform a large retrospective study designed to test cerebrospinal fluid (CSF) IL-6 levels in the context of neurological diseases, and evaluate its usefulness as a biomarker to help discriminate multiple sclerosis (MS) from other inflammatory neurological diseases (OIND). Patients and Methods: We analyzed 374 CSF samples for IL-6 using a quantitative enzyme-linked immunosorbent assay. Groups tested were composed of demyelinating diseases of the CNS (DD, n = 117), including relapsing-remitting MS (RRMS, n = 65), primary progressive MS (PPMS, n = 11), clinically isolated syndrome (CIS, n = 11), optic neuritis (ON, n = 30); idiopathic transverse myelitis (ITM, n = 10); other inflammatory neurological diseases (OIND, n = 35); and non-inflammatory neurological diseases (NIND, n = 212). Differences between groups were analysed using Kruskal-Wallis test and Mann-Whitney U-test. Results: CSF IL-6 levels exceeded the positivity cut-off of 10 pg/ml in 18 (51.4%) of the 35 OIND samples, but in only three (3.9%) of the 76 MS samples collected. CSF IL-6 was negative for all NIND samples tested (0/212). IL-6 cut-off of 10 pg/ml offers 96% sensitivity to exclude MS. Conclusion: CSF IL-6 may help to differentiate MS from its major differential diagnosis group, OIND.	[Wullschleger, Alexandre; Kapina, Viktoria; Molnarfi, Nicolas; Lalive, Patrice H.] Univ Hosp Geneva, Div Neurol, Dept Clin Neurosci, Geneva, Switzerland; [Molnarfi, Nicolas; Santiago-Raber, Marie-Laure; Lalive, Patrice H.] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Courvoisier, Delphine S.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Courvoisier, Delphine S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Seebach, Joerg D.] Univ Hosp, Div Clin Immunol & Allergol, Dept Internal Med, Geneva, Switzerland; [Seebach, Joerg D.] Fac Med, Geneva, Switzerland; [Hochstrasser, Denis F.; Lalive, Patrice H.] Univ Hosp Geneva, Lab Med Serv, Dept Genet & Lab Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; Harvard University; Harvard T.H. Chan School of Public Health; University of Geneva; University of Geneva; University of Geneva	Lalive, PH (corresponding author), Univ Hosp Geneva, Div Neurol, Dept Clin Neurosci, Geneva, Switzerland.	patrice.lalive@hcuge.ch	Lalive, Patrice/AAM-5861-2020; Wullschleger, Alexandre/GYV-3769-2022; Seebach, Jörg/AAA-3746-2020	Seebach, Jorg/0000-0001-5748-4577	Swiss National Foundation [310030_132705]; Swiss Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) fellowship exchange program	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) fellowship exchange program	This study was supported by the Swiss National Foundation (PHL, #310030_132705) and the Swiss Multiple Sclerosis Society (PHL and NM). NM is a recipient of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) fellowship exchange program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; FREI K, 1991, J NEUROIMMUNOL, V31, P147; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Harris VK, 2009, MOL DIAGN THER, V13, P225, DOI 10.2165/11313470-000000000-00000; HAUSER SL, 1990, NEUROLOGY, V40, P1735, DOI 10.1212/WNL.40.11.1735; HOUSSIAU FA, 1988, CLIN EXP IMMUNOL, V71, P320; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Ishizu T, 2006, J NEUROIMMUNOL, V175, P52, DOI 10.1016/j.jneuroim.2006.03.020; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Krishnan C, 2004, FRONT BIOSCI-LANDMRK, V9, P1483, DOI 10.2741/1351; Maimone D, 1997, J NEUROL SCI, V146, P59, DOI 10.1016/S0022-510X(96)00283-3; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Pilcher H, 2005, LANCET NEUROL, V4, P702, DOI 10.1016/S1474-4422(05)70214-3; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; SWAAK AJG, 1989, RHEUMATOL INT, V8, P263, DOI 10.1007/BF00270982; Uzawa A, 2009, J NEUROL, V256, P2082, DOI 10.1007/s00415-009-5274-4; Yuan XL, 2005, J CHROMATOGR B, V815, P179, DOI 10.1016/j.jchromb.2004.06.044	26	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72399	10.1371/journal.pone.0072399	http://dx.doi.org/10.1371/journal.pone.0072399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015240	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200040
J	Zhou, X; Zhang, X; Xie, Y; Tanaka, K; Wang, B; Zhang, H				Zhou, Xin; Zhang, Xin; Xie, Yi; Tanaka, Kaoru; Wang, Bing; Zhang, Hong			DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation via Telomere Capping Disruption	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; REPAIR; STRESS	Heavy-ion irradiation induces a higher frequency of DNA double strand breaks (DSBs) which must be properly repaired. Critical shortening of telomeres can trigger DNA damage responses such as DSBs. Telomeres are very sensitive to oxidative stress such as ionizing radiation. The DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the central component in the non-homologous end joining (NHEJ) repair complex and participates in telomere maintenance. Therefore, it is expected to enhance the cell killing effect of heavy-ion irradiation via DNA-PKcs inhibition. To test this hypothesis, cellular radiosensitivity was measured by the clonal genetic assay. DNA damage repair was relatively quantified by long PCR. Apoptosis was quantified by flow-cytometric analysis of annexin V/PI double staining, and senescence was analyzed by galactosidase activity. Telomere length was semi-quantified by real-time PCR. P53 and p21 expression was determined by western blotting. Our data demonstrated that MCF-7 and HeLa cells with DNA-PKcs inhibition were more susceptible to carbon-ion irradiation than Those without DNA-PKcs inhibition. Even though NHEJ was inhibited by the DNA-PKcs specific inhibitor, NU7026, most DNA damage induced by carbon-ion irradiation was repaired within 24 hours after irradiation in both cell lines. However, potential lethal damage repair (PLDR) could not restore cellular inactivation in DNA-PKcs inhibited cells. MCF-7 cells showed extensive senescence and accelerated telomere length reduction, while HeLa cells underwent significant apoptosis after irradiation with NU7026 incubation. In addition, both cell lines with shorter telomere were more susceptible to carbon-ion radiation. Our current data suggested that DNA-PKcs inhibition could enhance cellular sensitivity to carbon-ion radiation via disturbing its functional role in telomere end protection. The combination of DNA-PKcs inhibition and carbon-ion irradiation may be an efficient method of heavy-ion therapy.	[Zhou, Xin; Zhang, Xin; Xie, Yi; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou, Peoples R China; [Zhou, Xin; Zhang, Xin; Xie, Yi; Zhang, Hong] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China; [Zhou, Xin; Zhang, Xin; Xie, Yi; Zhang, Hong] Key Lab Heavy Ion Radiat Med Gansu Prov, Lanzhou, Peoples R China; [Tanaka, Kaoru; Wang, Bing] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Radiat Risk Reduct Res Program, Inage Ku, Chiba 260, Japan	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; National Institutes for Quantum Science & Technology	Zhang, H (corresponding author), Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou, Peoples R China.	zhangh@impcas.ac.cn	zhang, jin/GXV-9154-2022		National Basic Research Program of China [2010CB834202]; National Natural Science Foundation of China [10835011]; Scientific Technology Research Projects of Gansu Province [0702NKDA045, 0806RJYA020]; National Institute of Radiological Sciences [11J364]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Research Projects of Gansu Province; National Institute of Radiological Sciences	This work was supported by grants from the National Basic Research Program of China (2010CB834202), the National Natural Science Foundation of China (10835011), and the Scientific Technology Research Projects of Gansu Province (0702NKDA045, 0806RJYA020) and HIMAC project 11J364 which is supported by National Institute of Radiological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Daubenmier J, 2012, PSYCHONEUROENDOCRINO, V37, P917, DOI 10.1016/j.psyneuen.2011.10.008; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Dewar JM, 2012, CHROMOSOMA, V121, P117, DOI 10.1007/s00412-011-0357-2; Drissi R, 2011, CANCER PREV RES, V4, P1973, DOI 10.1158/1940-6207.CAPR-11-0069; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Hou YY, 2012, CELL BIOCHEM FUNCT, V30, P233, DOI 10.1002/cbf.1840; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; KANTOR AF, 1989, J CLIN ONCOL, V7, P912, DOI 10.1200/JCO.1989.7.7.912; Kiecolt-Glaser JK, 2010, BRAIN BEHAV IMMUN, V24, P529, DOI 10.1016/j.bbi.2010.02.002; Kusumoto-Matsuo R, 2010, AGING-US, V2, P274, DOI 10.18632/aging.100141; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Pang DL, 2011, J RADIAT RES, V52, P309, DOI 10.1269/jrr.10147; Sabatino L, 2012, INT J RADIAT BIOL, V88, P830, DOI 10.3109/09553002.2012.709307; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251; WARD JF, 1981, RADIAT RES, V86, P185, DOI 10.2307/3575500; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Zaal A, 2012, BJOG; Zhang Y, 2006, CELL RES, V16, P45, DOI 10.1038/sj.cr.7310007	26	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72641	10.1371/journal.pone.0072641	http://dx.doi.org/10.1371/journal.pone.0072641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013362	gold, Green Published, Green Submitted			2022-12-25	WOS:000323815200051
J	Ni, S; Yu, YB; Zhang, YD; Wu, W; Lai, KR; Yao, K				Ni, Shuang; Yu, Yibo; Zhang, Yidong; Wu, Wei; Lai, Kairan; Yao, Ke			Study of Oxidative Stress in Human Lens Epithelial Cells Exposed to 1.8 GHz Radiofrequency Fields	PLOS ONE			English	Article							POWER MICROWAVE-RADIATION; OXYGEN SPECIES PRODUCTION; STATIC MAGNETIC-FIELD; ACID PHENETHYL ESTER; DNA-DAMAGE; ELECTROMAGNETIC-FIELD; REDOX REGULATION; VITAMIN-E; EXPRESSION; PROLIFERATION	Objectives: The aims of the present study were to determine oxidative stress and to explore possible reasons of reactive oxygen species (ROS) increase in human lens epithelial (HLE) B3 cells exposed to low intensity 1.8 GHz radiofrequency fields (RF). Methods: The HLE B3 cells were divided into RF exposure and RF sham-exposure groups. The RF exposure intensity was at specific absorption rate (SAR) of 2, 3, or 4 W/kg. The ROS levels were measured by a fluorescent probe 2'7'-dichlorofluorescin diacetate (DCFH-DA) assay in the HLE B3 cells exposed to 1.8 GHz RF for 0.5, 1, and 1.5 h. Lipid peroxidation and cellular viability were detected by an MDA test and Cell Counting Kit-8 (CCK-8) assays, respectively, in the HLE B3 cells exposed to 1.8 GHz RF for 6, 12, and 24 h, respectively. The mRNA expression of SOD1, SOD2, CAT, and GPx1 genes and the expression of SOD1, SOD2, CAT, and GPx1 proteins was measured by qRT-PCR and Western blot assays in the HLE B3 cells exposed to 1.8 GHz RF for 1 h. Results: The ROS and MDA levels significantly increased (P<0.05) in the RF exposure group and that the cellular viability, mRNA expression of four genes, and expression of four proteins significantly decreased (P<0.05) compared with the RF sham-exposure group. Conclusions: Oxidative stress is present in HLE B3 cells exposed to 1.8 GHz low-intensity RF and that the increased production of ROS may be related to down-regulation of four antioxidant enzyme genes induced by RF exposure.	[Ni, Shuang; Yu, Yibo; Zhang, Yidong; Wu, Wei; Lai, Kairan; Yao, Ke] Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2 2, Hangzhou 310003, Zhejiang, Peoples R China; [Ni, Shuang; Yu, Yibo; Zhang, Yidong; Wu, Wei; Lai, Kairan; Yao, Ke] Zhejiang Prov Key Lab Ophthalmol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2 2, Hangzhou 310003, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	Zhejiang Key Laboratory Fund of China [2011E10006]; Zhejiang Key Innovation Team Project of China [2009R50039]; Program for the Platform Health Talents of the Health Bureau of Zhejiang Province [2011RCA023]; Qianjiang Talent Program of Zhejiang Province [2012R10023]; National Nature Science Foundation of China [30900273]	Zhejiang Key Laboratory Fund of China; Zhejiang Key Innovation Team Project of China; Program for the Platform Health Talents of the Health Bureau of Zhejiang Province; Qianjiang Talent Program of Zhejiang Province; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the Zhejiang Key Laboratory Fund of China (2011E10006), the Zhejiang Key Innovation Team Project of China (2009R50039), the Program for the Platform Health Talents of the Health Bureau of Zhejiang Province (2011RCA023), the Qianjiang Talent Program of Zhejiang Province (2012R10023), and the National Nature Science Foundation of China (30900273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara S, 2011, TOXICOL IND HEALTH, V27, P99, DOI 10.1177/0748233710381887; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P3094; Braicu C, 2011, INT J MOL SCI, V12, P9342, DOI 10.3390/ijms12129342; Brescia F, 2009, BIOELECTROMAGNETICS, V30, P525, DOI 10.1002/bem.20502; Bucioli SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-133; Chater S, 2006, ARCH MED RES, V37, P941, DOI 10.1016/j.arcmed.2006.05.010; Chen YB, 2011, INT J RADIAT BIOL, V87, P1147, DOI 10.3109/09553002.2011.584937; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gao SS, 2011, MOL VIS, V17, P3180; Guney M, 2007, TOXICOL IND HEALTH, V23, P411, DOI 10.1177/0748233707080906; Hong MN, 2012, BIOELECTROMAGNETICS, V33, P604, DOI 10.1002/bem.21731; Huang L, 2006, FREE RADICAL BIO MED, V41, P1425, DOI 10.1016/j.freeradbiomed.2006.07.022; Huang L, 2006, FREE RADICAL BIO MED, V41, P926, DOI 10.1016/j.freeradbiomed.2006.05.023; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Koyu A, 2009, TOXICOL IND HEALTH, V25, P429, DOI 10.1177/0748233709106821; Lantow M, 2006, RADIAT ENVIRON BIOPH, V45, P55, DOI 10.1007/s00411-006-0038-3; Lee JC, 2012, FREE RADICAL BIO MED, V53, P742, DOI 10.1016/j.freeradbiomed.2012.06.002; Li HW, 2007, JPN J OPHTHALMOL, V51, P412, DOI 10.1007/s10384-007-0483-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Lu YS, 2012, OXID MED CELL LONGEV, V2012, DOI [10.1155/2012/740280, 10.1155/2012/489690]; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Luukkonen J, 2010, BIOELECTROMAGNETICS, V31, P417, DOI 10.1002/bem.20580; Luukkonen J, 2009, MUTAT RES-FUND MOL M, V662, P54, DOI 10.1016/j.mrfmmm.2008.12.005; Martinez-Samano J, 2010, INT J RADIAT BIOL, V86, P1088, DOI 10.3109/09553002.2010.501841; Meral I, 2007, BRAIN RES, V1169, P120, DOI 10.1016/j.brainres.2007.07.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ozguner F, 2005, TOXICOL IND HEALTH, V21, P223, DOI 10.1191/0748233705th228oa; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reilly JP, 1999, HEALTH PHYS, V76, P314; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Sokolovic D, 2008, J RADIAT RES, V49, P579, DOI 10.1269/jrr.07077; Stefek M, 2011, REJUV RES, V14, P525, DOI 10.1089/rej.2011.1170; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Sun LX, 2006, MUTAT RES-FUND MOL M, V602, P135, DOI 10.1016/j.mrfmmm.2006.08.010; Tang XJ, 2011, EUR J PHARMACOL, V650, P72, DOI 10.1016/j.ejphar.2010.09.076; Verschaeve L, 2009, MUTAT RES-REV MUTAT, V681, P259, DOI 10.1016/j.mrrev.2008.11.002; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Wang Y, 2009, INVEST OPHTH VIS SCI, V50, P2291, DOI 10.1167/iovs.08-2568; Xu L, 2012, ASIAN PAC J CANCER P, V13, P3203, DOI 10.7314/APJCP.2012.13.7.3203; Xu SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054906; Yao K, 2004, MOL VIS, V10, P138; Yao K, 2008, MOL VIS, V14, P964; Yu Y, 2010, J INT MED RES, V38, P729, DOI 10.1177/147323001003800301; Yu YB, 2008, CELL RES, V18, P1233, DOI 10.1038/cr.2008.306; Zhang MB, 2010, CHEM-BIOL INTERACT, V183, P390, DOI 10.1016/j.cbi.2009.11.023; Zhang Y, 2013, HUM EXP TOXICOL; Zhang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026102; Zhou BR, 2012, FREE RADICAL RES, V46, P1458, DOI 10.3109/10715762.2012.726355	52	19	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72370	10.1371/journal.pone.0072370	http://dx.doi.org/10.1371/journal.pone.0072370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991100	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800064
J	Wang, J; Li, BZ; Yang, Q; Yu, W; Wang, H; Norback, D; Sundell, J				Wang, Juan; Li, Baizhan; Yang, Qin; Yu, Wei; Wang, Han; Norback, Dan; Sundell, Jan			Odors and Sensations of Humidity and Dryness in Relation to Sick Building Syndrome and Home Environment in Chongqing, China	PLOS ONE			English	Article							INDOOR AIR-QUALITY; OLFACTORY SENSITIVITY; PSYCHOSOCIAL FACTORS; HUMAN RESPONSE; SYMPTOMS; DAMPNESS; VENTILATION; HEALTH; EXPOSURE; ASSOCIATIONS	The prevalence of perceptions of odors and sensations of air humidity and sick building syndrome symptoms in domestic environments were studied using responses to a questionnaire on the home environment. Parents of 4530 1-8 year old children from randomly selected kindergartens in Chongqing, China participated. Stuffy odor, unpleasant odor, pungent odor, mold odor, tobacco smoke odor, humid air and dry air in the last three month (weekly or sometimes) was reported by 31.4%, 26.5%, 16.1%, 10.6%, 33.0%, 32.1% and 37.2% of the parents, respectively. The prevalence of parents' SBS symptoms (weekly or sometimes) were: 78.7% for general symptoms, 74.3% for mucosal symptoms and 47.5% for skin symptoms. Multi-nominal regression analyses for associations between odors/sensations of air humidity and SBS symptoms showed that the odds ratio for "weekly" SBS symptoms were consistently higher than for "sometimes" SBS symptoms. Living near a main road or highway, redecoration, and new furniture were risk factors for perceptions of odors and sensations of humid air and dry air. Dampness related problems (mold spots, damp stains, water damage and condensation) were all risk factors for perceptions of odors and sensations of humid air and dry air, as was the presence of cockroaches, rats, and mosquitoes/flies, use of mosquito-repellent incense and incense. Protective factors included cleaning the child's bedroom every day and frequently exposing bedding to sunshine. In conclusion, adults' perceptions of odors and sensations of humid air and dry air are related to factors of the home environment and SBS symptoms are related to odor perceptions.	[Wang, Juan; Li, Baizhan; Yang, Qin; Yu, Wei; Wang, Han; Sundell, Jan] Chongqing Univ, Minist Educ, Key Lab Three Gorges Reservoirs Reg Ecoenvironm, Chongqing 630044, Peoples R China; [Wang, Juan; Norback, Dan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Wang, Juan; Norback, Dan] Univ Uppsala Hosp, Uppsala, Sweden; [Sundell, Jan] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China	Chongqing University; Uppsala University; Uppsala University; Uppsala University Hospital; Tsinghua University	Li, BZ (corresponding author), Chongqing Univ, Minist Educ, Key Lab Three Gorges Reservoirs Reg Ecoenvironm, Chongqing 630044, Peoples R China.	baizhanli@cqu.edu.cn	li, bing/GWQ-9617-2022; li, bz/GVR-7133-2022	Norback, Dan/0000-0002-5174-6668; Li, Baizhan/0000-0001-7526-1748	Key National Project of Physical Science [50838009]; National Technology Support Project [2012BAJ02B06]; Fundamental Research Funds for the Central Universities [CDJXS12211107]	Key National Project of Physical Science; National Technology Support Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Key National Project of Physical Science (50838009), the National Technology Support Project (2012BAJ02B06) and the Fundamental Research Funds for the Central Universities (CDJXS12211107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN I, 1974, ARCH ENVIRON HEALTH, V29, P319, DOI 10.1080/00039896.1974.10666606; [Anonymous], 1993, INDOOR AIR, DOI DOI 10.1111/j.1600-0668.1993.00024.x; Apter AJ, 1999, ARCH OTOLARYNGOL, V125, P1005, DOI 10.1001/archotol.125.9.1005; ARUNDEL AV, 1986, ENVIRON HEALTH PERSP, V65, P351, DOI 10.2307/3430203; Bakke JV, 2012, ARCH ENVIRON OCCUP H, V67, P15, DOI 10.1080/19338244.2011.564236; BERGLUND B, 1986, Environment International, V12, P147, DOI 10.1016/0160-4120(86)90025-5; Bjornsson E, 1998, INT J TUBERC LUNG D, V2, P1023; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2001, INDOOR AIR, V11, P72; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Brasche S, 2001, INDOOR AIR, V11, P217, DOI 10.1034/j.1600-0668.2001.110402.x; Brauer C, 2006, INT ARCH OCC ENV HEA, V79, P465, DOI 10.1007/s00420-005-0075-2; Brauer C, 2006, INT ARCH OCC ENV HEA, V79, P453, DOI 10.1007/s00420-005-0074-3; CAIN WS, 1995, OCCUP MED, V10, P133; Chen Ke-jun, 2007, Huanjing Kexue, V28, P1847; Cometto-Muniz JE, 1998, INT ARCH OCC ENV HEA, V71, P105, DOI 10.1007/s004200050256; Cometto-Muniz JE, 2004, INDOOR AIR, V14, P108, DOI 10.1111/j.1600-0668.2004.00297.x; COMETTOMUNIZ JE, 1990, PHYSIOL BEHAV, V48, P719, DOI 10.1016/0031-9384(90)90217-R; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; De Palo G, 2012, BIOPHYS J, V102, P2677, DOI 10.1016/j.bpj.2012.04.040; Doty RL, 2004, CRIT REV TOXICOL, V34, P85, DOI 10.1080/10408440490269586; Engvall K, 2005, INDOOR AIR, V15, P120, DOI 10.1111/j.1600-0668.2004.00325.x; Engvall K, 2002, ARCH ENVIRON HEALTH, V57, P304, DOI 10.1080/00039890209601413; Engvall K, 2001, INT J TUBERC LUNG D, V5, P468; Engvall K, 2001, INT ARCH OCC ENV HEA, V74, P270, DOI 10.1007/s004200000218; Eriksson N, 1996, INDOOR AIR, V6, P101, DOI 10.1111/j.1600-0668.1996.t01-2-00006.x; ERIKSSON NE, 1987, ALLERGY, V42, P374, DOI 10.1111/j.1398-9995.1987.tb02224.x; FANGER PO, 1988, ENERG BUILDINGS, V12, P7, DOI 10.1016/0378-7788(88)90052-7; Golden R, 2011, CRIT REV TOXICOL, V41, P672, DOI 10.3109/10408444.2011.573467; Green G, 1979, P IND CLIM 1979 COP, P207; Guilemany JM, 2009, LARYNGOSCOPE, V119, P233, DOI 10.1002/lary.20075; Hagerhed-Engman L, 2009, INDOOR AIR, V19, P184, DOI 10.1111/j.1600-0668.2008.00573.x; Ihrig A, 2006, INT ARCH OCC ENV HEA, V79, P332, DOI 10.1007/s00420-005-0042-y; Kishi R, 2009, INDOOR AIR, V19, P243, DOI 10.1111/j.1600-0668.2009.00589.x; Kolarik B, 2009, INDOOR AIR, V19, P145, DOI 10.1111/j.1600-0668.2008.00572.x; LERCHER P, 1995, SCI TOTAL ENVIRON, V169, P71, DOI 10.1016/0048-9697(95)04634-D; Lin Ta-Chang, 2008, Clin Mol Allergy, V6, P3, DOI 10.1186/1476-7961-6-3; Liu WL, 2003, ENVIRON HEALTH PERSP, V111, P1454, DOI 10.1289/ehp.6286; Lovreglio P, 2009, J ENVIRON MONITOR, V11, P955, DOI 10.1039/b819843h; Mahooti-Brooks N, 2004, J OCCUP ENVIRON HYG, V1, P826, DOI 10.1080/15459620490890332; Mizoue T, 2004, J OCCUP HEALTH, V46, P303, DOI 10.1539/joh.46.303; MOLHAVE L, 1992, ANN NY ACAD SCI, V641, P46, DOI 10.1111/j.1749-6632.1992.tb16531.x; Molhave L., 1993, INDOOR AIR, V3, P155; MOREY PR, 1989, OCCUP MED, V4, P625; NEVALAINEN A, 1991, ENVIRON INT, V17, P299, DOI 10.1016/0160-4120(91)90015-I; NIELSEN GD, 1991, CRIT REV TOXICOL, V21, P183, DOI 10.3109/10408449109089879; Nielsen GD, 2007, REGUL TOXICOL PHARM, V48, P6, DOI 10.1016/j.yrtph.2006.11.005; Norback D, 1999, INT J TUBERC LUNG D, V3, P368; Norback D, 1995, INDOOR AIR, V5, P237, DOI 10.1111/j.1600-0668.1995.00003.x; NORBACK D, 1991, BRIT J IND MED, V48, P451; Organization WHO, 1983, 198378 WHO, P78; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Runeson R, 2006, INDOOR AIR, V16, P445, DOI 10.1111/j.1600-0668.2006.00438.x; Sahlberg B, 2012, INDOOR AIR, V22, P331, DOI 10.1111/j.1600-0668.2012.00766.x; Saijo Yasuaki, 2009, Environmental Health and Preventive Medicine, V14, P26, DOI 10.1007/s12199-008-0052-y; Saijo Yasuaki, 2010, Environmental Health and Preventive Medicine, V15, P276, DOI 10.1007/s12199-010-0139-0; Sun Y, 2011, INDOOR AIR, V21, P277, DOI 10.1111/j.1600-0668.2010.00699.x; Sun YX, 2007, SCI TOTAL ENVIRON, V387, P276, DOI 10.1016/j.scitotenv.2007.07.001; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; SUNDELL J, 1994, INDOOR AIR, V4, P83, DOI 10.1111/j.1600-0668.1994.t01-2-00003.x; Wallace L. A., 1993, INDOOR AIR, V3, P193, DOI [10.1111/j.1600-0668.1993.t01-1-00005.x, DOI 10.1111/J.1600-0668.1993.T01-1-00005.X]; Wolkoff P., 1991, INDOOR AIR, V1, P478, DOI [10.1111/j.1600-0668.1991.00012.x, DOI 10.1111/J.1600-0668.1991.00012.X]; Wolkoff P, 2007, ENVIRON INT, V33, P850, DOI 10.1016/j.envint.2007.04.004	63	38	38	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72385	10.1371/journal.pone.0072385	http://dx.doi.org/10.1371/journal.pone.0072385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991107	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800071
J	Yin, T; Lindley, TE; Albert, GW; Ahmed, R; Schmeiser, PB; Grady, MS; Howard, MA; Welsh, MJ				Yin, Terry; Lindley, Timothy E.; Albert, Gregory W.; Ahmed, Raheel; Schmeiser, Peter B.; Grady, M. Sean; Howard, Matthew A.; Welsh, Michael J.			Loss of Acid Sensing Ion Channel-1a and Bicarbonate Administration Attenuate the Severity of Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; NEURONAL DEGENERATION; HIPPOCAMPAL-NEURONS; MYOCARDIAL-ISCHEMIA; ACTIVATED CURRENTS; FLUID PERCUSSION; OXIDATIVE STRESS; LACTIC-ACIDOSIS; CLINICAL-TRIAL; ASICS	Traumatic brain injury (TBI) is a common cause of morbidity and mortality in people of all ages. Following the acute mechanical insult, TBI evolves over the ensuing minutes and days. Understanding the secondary factors that contribute to TBI might suggest therapeutic strategies to reduce the long-term consequences of brain trauma. To assess secondary factors that contribute to TBI, we studied a lateral fluid percussion injury (FPI) model in mice. Following FPI, the brain cortex became acidic, consistent with data from humans following brain trauma. Administering HCO3- after FPI prevented the acidosis and reduced the extent of neurodegeneration. Because acidosis can activate acid sensing ion channels (ASICs), we also studied ASIC1a(-/-) mice and found reduced neurodegeneration after FPI. Both HCO3- administration and loss of ASIC1a also reduced functional deficits caused by FPI. These results suggest that FPI induces cerebral acidosis that activates ASIC channels and contributes to secondary injury in TBI. They also suggest a therapeutic strategy to attenuate the adverse consequences of TBI.	[Yin, Terry; Schmeiser, Peter B.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Lindley, Timothy E.; Albert, Gregory W.; Ahmed, Raheel; Howard, Matthew A.; Welsh, Michael J.] Univ Iowa, Dept Neurosurg, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Grady, M. Sean] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Pennsylvania	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu		Welsh, Michael/0000-0002-1646-6206; Howard, Matthew/0000-0003-3935-8889	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Benson CJ, 2001, ANN NY ACAD SCI, V940, P96; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bourdeaux C, 2010, NEUROCRIT CARE, V13, P24, DOI 10.1007/s12028-010-9368-8; Bourdeaux CP, 2011, NEUROCRIT CARE, V15, P42, DOI 10.1007/s12028-011-9512-0; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonell WS, 1999, ANN NY ACAD SCI, V890, P287, DOI 10.1111/j.1749-6632.1999.tb08005.x; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Gu L, 2010, NEUROSCI LETT, V479, P63, DOI 10.1016/j.neulet.2010.05.029; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Koseki H, 2009, SYNAPSE, V63, P805, DOI 10.1002/syn.20657; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lehmann H, 2012, NEUROBIOL LEARN MEM; Marion DW, 1998, NEUROL CLIN, V16, P485, DOI 10.1016/S0733-8619(05)70073-6; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; Sarkar S, 2011, FUNDAMENTAL NEUROPATHOLOGY FOR PATHOLOGISTS AND TOXICOLOGISTS: PRINCIPLES AND TECHNIQUES, P171; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sherwood TW, 2012, AM J PHYSL CELL PHYS; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sun X, 2011, BRAIN RES, V1396, P77, DOI 10.1016/j.brainres.2011.04.011; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tsai YD, 2013, BRAIN INJURY, V27, P361, DOI 10.3109/02699052.2012.750738; Turner RJ, 2004, J AM COLL NUTR, V23, p534S, DOI 10.1080/07315724.2004.10719397; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	80	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72379	10.1371/journal.pone.0072379	http://dx.doi.org/10.1371/journal.pone.0072379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991103	Green Published, gold			2022-12-25	WOS:000324228800067
J	Benfield, T; Skovgaard, M; Schonheyder, HC; Knudsen, JD; Bangsborg, J; Ostergaard, C; Slotved, HC; Konradsen, HB; Thomsen, RW; Lambertsen, L				Benfield, Thomas; Skovgaard, Marlene; Schonheyder, Henrik Carl; Knudsen, Jenny Dahl; Bangsborg, Jette; Ostergaard, Christian; Slotved, Hans-Christian; Konradsen, Helle Bossen; Thomsen, Reimar Wernich; Lambertsen, Lotte			Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; VACCINATION; MORTALITY; CARRIAGE; EFFICACY; ADULTS	Background: There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here we report serotypes, their associated disease potential and coverage of pneumococcal conjugate vaccines (PCV) in adults with NBP and compare these to bacteremic pneumonia (BP). Methods: Adults with pneumonia and Streptococcus pneumoniae isolated from the lower respiratory tract or blood were included 1 year in a population-based design in Denmark. Pneumonia was defined as a new infiltrate on chest radiograph in combination with clinical symptoms or elevated white blood count or plasma C-reactive protein. All isolates were serotyped using type-specific pneumococcal rabbit antisera. All values are medians with interquartile ranges. Results: There were 272 cases of NBP and 192 cases of BP. Ninety-nine percent were hospitalized. NBP and BP cases were of comparable age and sex but NBP cases had more respiratory symptoms and less severe disease compared to BP cases. In total, 46 different serotypes were identified. Among NBP cases, 5 serotypes accounted for nearly a third of isolates. PCV10 and -13 types covered 17% (95% confidence interval (CI): 11-23%) and 34% (95% CI: 25-43%) of NBP isolates, respectively. In contrast, the five most frequent serotypes accounted for two-thirds of BP isolates. PCV10 and -13 types covered 39% (95% CI: 30-48%) and 64% (95% CI: 48-79) of BP isolates, respectively. More severe NBP disease was associated with infection with invasive serotypes while there was an inverse relationship for BP. Conclusions: Only a third of cases of adult non-bacteremic pneumococcal pneumonia would potentially be preventable with the use of PCV13 and just one sixth of cases with the use of PCV10 indicating that PCVs with increased valency are needed to increase vaccine coverage for NBP in adults. PCV13 could potentially prevent two-thirds of adult bacteremic pneumococcal pneumonia.	[Benfield, Thomas] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Benfield, Thomas] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Benfield, Thomas] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark; [Skovgaard, Marlene; Thomsen, Reimar Wernich] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Schonheyder, Henrik Carl] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Knudsen, Jenny Dahl; Ostergaard, Christian] Copenhagen Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark; [Bangsborg, Jette] Copenhagen Univ Hosp, Dept Clin Microbiol, Herlev, Denmark; [Slotved, Hans-Christian; Konradsen, Helle Bossen; Lambertsen, Lotte] Statens Serum Inst, DK-2300 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen; Statens Serum Institut	Benfield, T (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark.	tlb@dadlnet.dk	Slotved, Hans-Christian/H-7476-2019	Slotved, Hans-Christian/0000-0002-7294-4911; Benfield, Thomas/0000-0003-0698-9385; Skovgaard, Marlene/0000-0001-5661-1968; Lambertsen, Lotte/0000-0001-6409-6337; Thomsen, Reimar/0000-0001-9135-3474	Pfizer	Pfizer(Pfizer)	This work was supported by an unrestricted, investigator-initiated grant from Pfizer. The authors conceived the study and the study design was developed and agreed to by the authors without any input from the funding body. The study concept and design was peer reviewed prior to award of the grant from the funding body. The funding body was not involved in and, had no influence over, study design, data collection, data analyses, interpretation of results, report writing or in the decision to submit the paper for publication. All study data are held solely by the authors.	Bewick T, 2012, THORAX, V67, P540, DOI 10.1136/thoraxjnl-2011-201092; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHOW AW, 1992, CLIN INFECT DIS, V15, pS62, DOI 10.1093/clind/15.Supplement_1.S62; DANMAP, 2011, US ANT AG OCC ANT RE; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hak E, 2008, NETH J MED, V66, P378; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Ingels H, 2012, VACCINE, V30, P3944, DOI 10.1016/j.vaccine.2012.03.060; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Lambertsen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-282; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mangtani P, 2003, LANCET INFECT DIS, V3, P71, DOI 10.1016/S1473-3099(03)00514-0; Rhee JY, 2009, SHOCK, V31, P146, DOI 10.1097/SHK.0b013e318182f98f; Schonheyder H C, 1994, Ugeskr Laeger, V156, P5703; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	30	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72743	10.1371/journal.pone.0072743	http://dx.doi.org/10.1371/journal.pone.0072743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009703	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200030
J	Guy, R; El-Hayek, C; Fairley, CK; Wand, H; Carr, A; McNulty, A; Hoy, J; Bourne, C; McAllister, J; Tee, BK; Baker, D; Roth, N; Stoove, M; Chen, M				Guy, Rebecca; El-Hayek, Carol; Fairley, Christopher K.; Wand, Handan; Carr, Andrew; McNulty, Anna; Hoy, Jenny; Bourne, Christopher; McAllister, John; Tee, B. K.; Baker, David; Roth, Norman; Stoove, Mark; Chen, Marcus			Opt-Out and Opt-In Testing Increases Syphilis Screening of HIV-Positive Men Who Have Sex with Men in Australia	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; GAY MEN; ASYMPTOMATIC SYPHILIS; HOMOSEXUAL-MEN; RATES; EFFICACY; INTERVENTIONS; BEHAVIOR; SYDNEY	Background: Since 2005, Australian clinicians were advised to undertake quarterly syphilis testing for all sexually active HIV-positive men who have sex with men (MSM). We describe differences in syphilis testing frequency among HIV-positive MSM by clinic testing policies since this recommendation. Methods: Three general practices, two sexual health clinics and two hospital HIV outpatient clinics provided data on HIV viral load and syphilis testing from 2006-2010. Men having >= 1 viral load test per year were included; >95% were MSM. We used Chi-2 tests to assess changes in syphilis testing frequency over time, and differences by clinic testing policy (opt-out, opt-in and risk-based). Results: The proportion of men having HIV viral loads with same-day syphilis tests increased from 37% in 2006 to 63% in 2007 (p<0.01) and 68-69% thereafter. In 2010, same-day syphilis testing was highest in four clinics with opt-out strategies (87%, range: 84-91%) compared with one clinic with opt-in (74%, p = 0.121) and two clinics with risk-based strategies (22%, range: 20-24%, p<0.01). The proportion of men having >= 3 syphilis tests per year increased from 15% in 2006 to 36% in 2007 (p<0.01) and 36-38% thereafter. In 2010, the proportion of men having >= 3 syphilis tests in a year was highest in clinics with opt-out strategies (48%, range: 35-59%), compared with opt-in (39%, p = 0.121) and risk-based strategies (8.4%, range:5.4-12%, p<0.01). Conclusion: Over five years the proportion of HIV-positive men undergoing syphilis testing at recommended frequencies more than doubled, and was 5-6 times higher in clinics with opt-out and opt-in strategies compared with risk-based policies.	[Guy, Rebecca; Wand, Handan] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [El-Hayek, Carol; Stoove, Mark] Ctr Populat Hlth, Burnet Inst, Melbourne, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Carr, Andrew; McAllister, John] St Vincents Hosp, HIV Immunol & Infect Dis Unit, Sydney, NSW 2010, Australia; [Carr, Andrew; McAllister, John] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [McNulty, Anna; Bourne, Christopher] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNulty, Anna; Bourne, Christopher] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Hoy, Jenny] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Hoy, Jenny; Stoove, Mark] Monash Univ, Melbourne, Vic 3004, Australia; [Tee, B. K.] Ctr Clin, Melbourne, Vic, Australia; [Baker, David] East Sydney Doctors, Sydney, NSW, Australia; [Roth, Norman] Prahran Market Clin, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Burnet Institute; University of Melbourne; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Florey Institute of Neuroscience & Mental Health; Monash University	Guy, R (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	Rguy@kirby.unsw.edu.au	Hoy, Jennifer/AAK-7968-2020; El-Hayek, Carol/AAA-8666-2019	El-Hayek, Carol/0000-0001-5743-5994; Guy, Rebecca/0000-0002-2929-4634; Christopher, Fairley/0000-0001-9081-1664; Stoove, Mark/0000-0003-2887-1409; Hoy, Jennifer/0000-0002-6948-7086; Bourne, Christopher/0000-0001-7391-3941				[Anonymous], 2010, SEX TRANSM INF TEST; Bissessor M, 2010, JAIDS-J ACQ IMM DEF, V55, P211, DOI 10.1097/QAI.0b013e3181e583bf; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Cohen CE, 2005, SEX TRANSM INFECT, V81, P217, DOI 10.1136/sti.2004.012187; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, DHHS PAN ANT GUID AD; Donovan B, 2010, OXFORD TXB MED, P885; Dukers-Muijrers NHTM, 2009, SEX TRANSM INFECT, V85, P226, DOI 10.1136/sti.2008.033191; Fogarty A., 2006, HLTH MEN POSITIVE HL; Gray RT, 2011, SEX TRANSM DIS, V38, P1151, DOI 10.1097/OLQ.0b013e318238b85d; Guy R, 2012, SEX TRANSM DIS, V39, P268, DOI 10.1097/OLQ.0b013e3182471ff0; Guy RJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-211; Guy RJ, 2011, SEX HEALTH, V8, P319, DOI 10.1071/SH10095; Guy RJ, 2005, MED J AUSTRALIA, V183, P218, DOI 10.5694/j.1326-5377.2005.tb07004.x; Jin FY, 2007, SEX TRANSM INFECT, V83, P397, DOI 10.1136/sti.2007.025684; Jin FY, 2005, MED J AUSTRALIA, V183, P179, DOI 10.5694/j.1326-5377.2005.tb06989.x; Koekenbier RH, 2008, SEX TRANSM DIS, V35, P764, DOI 10.1097/OLQ.0b013e31816fcb0a; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; McCann PD, 2011, SEX TRANSM DIS, V38, P1145, DOI 10.1097/OLQ.0b013e318238b846; National Centre in HIV Epidemiology and Clinical Research, 2009, FIN TECHN REP PHAS N; Peterman TA, 2005, SEX TRANSM DIS, V32, pS4, DOI 10.1097/01.olq.0000180455.79024.e9; STD Control Section, 2009, STD SCREEN DIAGN TES; Stoove M, 2012, 19 INT AIDS C WASH U; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Zetola NM, 2007, MAYO CLIN PROC, V82, P1091, DOI 10.4065/82.9.1091; Zou HC, 2012, SEX TRANSM DIS, V39, P382, DOI 10.1097/OLQ.0b013e318248e3ff	25	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71436	10.1371/journal.pone.0071436	http://dx.doi.org/10.1371/journal.pone.0071436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009661	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200009
J	Toda, M; Shao, ZF; Yamaguchi, KD; Takagi, T; D'Alessandro-Gabazza, CN; Taguchi, O; Salamon, H; Leung, LLK; Gabazza, EC; Morser, J				Toda, Masaaki; Shao, Zhifei; Yamaguchi, Ken D.; Takagi, Takehiro; D'Alessandro-Gabazza, Corina N.; Taguchi, Osamu; Salamon, Hugh; Leung, Lawrence L. K.; Gabazza, Esteban C.; Morser, John			Differential Gene Expression in Thrombomodulin (TM; CD141)(+) and TM- Dendritic Cell Subsets	PLOS ONE			English	Article							LECTIN-LIKE DOMAIN; ACUTE-INFLAMMATION; THROMBIN; COAGULATION; MICRORNAS; ACTIVATION; PROTECTS; COFACTOR; LIPOXINS; ASPIRIN	Previously we have shown in a mouse model of bronchial asthma that thrombomodulin can convert immunogenic conventional dendritic cells into tolerogenic dendritic cells while inducing its own expression on their cell surface. Thrombomodulin(+) dendritic cells are tolerogenic while thrombomodulin(-) dendritic cells are pro-inflammatory and immunogenic. Here we hypothesized that thrombomodulin treatment of dendritic cells would modulate inflammatory gene expression. Murine bone marrow-derived dendritic cells were treated with soluble thrombomodulin and expression of surface markers was determined. Treatment with thrombomodulin reduces the expression of maturation markers and increases the expression of TM on the DC surface. Thrombomodulin treated and control dendritic cells were sorted into thrombomodulin(+) and thrombomodulin(-) dendritic cells before their mRNA was analyzed by microarray. mRNAs encoding pro-inflammatory genes and dendritic cells maturation markers were reduced while expression of cell cycle genes were increased in thrombomodulin-treated and thrombomodulin(+) dendritic cells compared to control dendritic cells and thrombomodulin(-) dendritic cells. Thrombomodulin-treated and thrombomodulin(+) dendritic cells had higher expression of 15-lipoxygenase suggesting increased synthesis of lipoxins. Thrombomodulin(+) dendritic cells produced more lipoxins than thrombomodulin(-) dendritic cells, as measured by ELISA, confirming that this pathway was upregulated. There was more phosphorylation of several cell cycle kinases in thrombomodulin(+) dendritic cells while phosphorylation of kinases involved with pro-inflammatory cytokine signaling was reduced. Cultures of thrombomodulin(+) dendritic cells contained more cells actively dividing than those of thrombomodulin(-) dendritic cells. Production of IL-10 is increased in thrombomodulin+ dendritic cells. Antagonism of IL-10 with a neutralizing antibody inhibited the effects of thrombomodulin treatment of dendritic cells suggesting a mechanistic role for IL-10. The surface of thrombomodulin(+) dendritic cells supported activation of protein C and procarboxypeptidase B2 in a thrombomodulin-dependent manner. Thus thrombomodulin treatment increases the number of thrombomodulin(+) dendritic cells, which have significantly altered gene expression compared to thrombomodulin(-) dendritic cells in key immune function pathways.	[Toda, Masaaki; Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan; [Shao, Zhifei; Leung, Lawrence L. K.; Morser, John] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Shao, Zhifei; Leung, Lawrence L. K.; Morser, John] Vet Adm Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Yamaguchi, Ken D.; Salamon, Hugh] Knowledge Synth Inc, Berkeley, CA USA; [Takagi, Takehiro; D'Alessandro-Gabazza, Corina N.; Taguchi, Osamu] Mie Univ, Grad Sch Med, Dept Pulm & Crit Med, Tsu, Mie 514, Japan	Mie University; Stanford University; Mie University	Morser, J (corresponding author), Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA.	jmorser@stanford.edu		Salamon, Hugh/0000-0003-1472-5785; Gabazza, Esteban/0000-0001-5748-1499	Maureen Lyles D'Ambrogio Endowed Professorship fund; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER	Maureen Lyles D'Ambrogio Endowed Professorship fund; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Maureen Lyles D'Ambrogio Endowed Professorship fund (to LLKL) and by Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen T, 2011, FEBS LETT, V585, P567, DOI 10.1016/j.febslet.2011.01.010; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; ESMON NL, 1982, J BIOL CHEM, V257, P859; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Geudens N, 2008, EUR RESPIR J, V32, P862, DOI 10.1183/09031936.00157107; Habib GM, 2003, FASEB J, V17, P1313, DOI 10.1096/fj.02-0899fje; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim TD, 2011, BLOOD, V118, P5476, DOI 10.1182/blood-2011-04-347526; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Morser J, 2010, J THROMB HAEMOST, V8, P868, DOI 10.1111/j.1538-7836.2010.03787.x; Morser J, 2012, CURR DRUG TARGETS, V13, P421, DOI 10.2174/138945012799424606; Nesheim M, 1997, THROMB HAEMOSTASIS, V78, P386; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; Takagi T, 2011, AM J RESP CRIT CARE, V183, P31, DOI 10.1164/rccm.201001-0107OC; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Van de Wouwer M, 2006, J THROMB HAEMOST, V4, P1813, DOI 10.1111/j.1538-7836.2006.02033.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Yamaguchi KD, 2008, J NEUROIMMUNOL, V195, P116, DOI 10.1016/j.jneuroim.2007.12.007; Zhao KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028267	39	5	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72392	10.1371/journal.pone.0072392	http://dx.doi.org/10.1371/journal.pone.0072392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009678	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200023
J	Gray, C; Al-Dujaili, EA; Sparrow, AJ; Gardiner, SM; Craigon, J; Welham, SJM; Gardner, DS				Gray, Clint; Al-Dujaili, Emad A.; Sparrow, Alexander J.; Gardiner, Sheila M.; Craigon, Jim; Welham, Simon J. M.; Gardner, David S.			Excess Maternal Salt Intake Produces Sex-Specific Hypertension in Offspring: Putative Roles for Kidney and Gastrointestinal Sodium Handling	PLOS ONE			English	Article							BLOOD-PRESSURE; VASOPRESSIN SECRETION; PROTEIN RESTRICTION; ADULT RATS; GROWTH; PREGNANCY; BRAIN; OSMOLALITY; ABSORPTION; EXPRESSION	Hypertension is common and contributes, via cardiovascular disease, towards a large proportion of adult deaths in the Western World. High salt intake leads to high blood pressure, even when occurring prior to birth - a mechanism purported to reside in altered kidney development and later function. Using a combination of in vitro and in vivo approaches we tested whether increased maternal salt intake influences fetal kidney development to render the adult individual more susceptible to salt retention and hypertension. We found that salt-loaded pregnant rat dams were hypernatraemic at day 20 gestation (147 +/- 5 vs. 128 +/- 5 mmoles/L). Increased extracellular salt impeded murine kidney development in vitro, but had little effect in vivo. Kidneys of the adult offspring had few structural or functional abnormalities, but male and female offspring were hypernatraemic (16 +/- 64 vs. 149 +/- 2 mmoles/L), with a marked increase in plasma corticosterone (e. g. male offspring; 11.9 [9.3-14.8] vs. 2.8 [2.0-8.3] nmol/L median [IQR]). Furthermore, adult male, but not female, offspring had higher mean arterial blood pressure (effect size, +16 [9-21] mm Hg; mean [95% C.I.]. With no clear indication that the kidneys of salt-exposed offspring retained more sodium per se, we conducted a preliminary investigation of their gastrointestinal electrolyte handling and found increased expression of proximal colon solute carrier family 9 (sodium/hydrogen exchanger), member 3 (SLC9A3) together with altered faecal characteristics and electrolyte handling, relative to control offspring. On the basis of these data we suggest that excess salt exposure, via maternal diet, at a vulnerable period of brain and gut development in the rat neonate lays the foundation for sustained increases in blood pressure later in life. Hence, our evidence further supports the argument that excess dietary salt should be avoided per se, particularly in the range of foods consumed by physiologically immature young.	[Gray, Clint; Gardner, David S.] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England; [Al-Dujaili, Emad A.] Queen Margaret Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gardiner, Sheila M.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [Sparrow, Alexander J.; Craigon, Jim; Welham, Simon J. M.] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England	University of Nottingham; Queen Margaret University; University of Nottingham; University of Nottingham	Gray, C (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England.	clint.gray@nottingham.ac.uk; simon.welham@nottingham.ac.uk; david.gardner@nottingham.ac.uk	Gardner, David S/A-7484-2010	Gardner, David S/0000-0002-6490-2412; Welham, Simon/0000-0002-9409-1032; Sparrow, Alexander/0000-0002-3354-3314; Craigon, Jim/0000-0003-4570-5138	Biotechnology and Biological Sciences Research Council; University of Nottingham (Institute of Clinical Research); Nutricia Research Foundation; School of Veterinary Medicine and Science; Research Councils UK fellowship in molecular nutrition	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham (Institute of Clinical Research); Nutricia Research Foundation(Danone Nutricia); School of Veterinary Medicine and Science; Research Councils UK fellowship in molecular nutrition	CG was supported 50:50 by a Biotechnology and Biological Sciences Research Council doctoral training grant and The University of Nottingham (Institute of Clinical Research). Grant support from The Nutricia Research Foundation and The School of Veterinary Medicine and Science is gratefully acknowledged. SJMW was in receipt of a Research Councils UK fellowship in molecular nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Al-Dujaili EAS, 2009, STEROIDS, V74, P456, DOI 10.1016/j.steroids.2008.12.012; Al-Dujaili EAS, 2009, STEROIDS, V74, P938, DOI 10.1016/j.steroids.2009.06.009; [Anonymous], 1988, BMJ, V297, P319; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brunton PJ, 2008, J PHYSIOL PHARMACOL, V59, P27; Cardoso HD, 2009, PEDIATR NEPHROL, V24, P1959, DOI 10.1007/s00467-009-1247-1; CHO JH, 1994, AM J PHYSIOL, V267, pC796, DOI 10.1152/ajpcell.1994.267.3.C796; Cho JH, 1998, AM J PHYSIOL-CELL PH, V274, pC586, DOI 10.1152/ajpcell.1998.274.3.C586; Coffman TM, 2011, NAT MED, V17, P1402, DOI 10.1038/nm.2541; Contreras RJ, 2000, PHYSIOL BEHAV, V71, P173, DOI 10.1016/S0031-9384(00)00331-0; CONTRERAS RJ, 1989, AM J PHYSIOL, V256, pR70, DOI 10.1152/ajpregu.1989.256.1.R70; da Silva AA, 2003, NUTR METAB CARDIOVAS, V13, P133, DOI 10.1016/S0939-4753(03)80172-2; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; DURR JA, 1981, J CLIN INVEST, V68, P337, DOI 10.1172/JCI110261; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ford ES, 2011, CIRCULATION, V123, P1737, DOI 10.1161/CIRCULATIONAHA.110.005645; Frindt G, 2012, AM J PHYSIOL-RENAL, V302, pF20, DOI 10.1152/ajprenal.00480.2011; Fujiwara TM, 2005, J AM SOC NEPHROL, V16, P2836, DOI 10.1681/ASN.2005040371; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; GUYTON AC, 1980, ANNU REV MED, V31, P15, DOI 10.1146/annurev.me.31.020180.000311; HAZON N, 1988, J HYPERTENS, V6, P517, DOI 10.1097/00004872-198807000-00002; He FJ, 2010, KIDNEY INT, V78, P745, DOI 10.1038/ki.2010.280; He PJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/238080; Koleganova N, 2011, AM J PHYSIOL-RENAL, V301, pF344, DOI 10.1152/ajprenal.00626.2010; Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002; Langley-Evans SC, 2011, EXP PHYSIOL, V96, P203, DOI 10.1113/expphysiol.2010.054460; Leenen FHH, 2010, BBA-MOL BASIS DIS, V1802, P1132, DOI 10.1016/j.bbadis.2010.03.004; Linz D, 2012, HYPERTENSION, V60, P1560, DOI 10.1161/HYPERTENSIONAHA.112.201590; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Mao CP, 2007, PEPTIDES, V28, P1178, DOI 10.1016/j.peptides.2007.03.018; Mccance RA., 1986, GLIMPSES COMP GROWTH; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; Ojeda NB, 2008, ADV CHRONIC KIDNEY D, V15, P101, DOI 10.1053/j.ackd.2008.01.001; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Porter JP, 2007, AM J PHYSIOL-REG I, V293, pR334, DOI 10.1152/ajpregu.00887.2006; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Ritz E, 2011, NAT REV NEPHROL, V7, P137, DOI 10.1038/nrneph.2011.1; Ross MG, 2005, AM J PHYSIOL-REG I, V288, pR97, DOI 10.1152/ajpregu.00315.2004; Sanders PW, 2009, HYPERTENSION, V53, P442, DOI 10.1161/HYPERTENSIONAHA.108.120303; Schreuder MF, 2007, KIDNEY INT, V72, P265, DOI 10.1038/sj.ki.5002307; Schwarz JM, 2010, ENDOCRINOLOGY, V151, P4871, DOI 10.1210/en.2010-0142; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x	50	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72682	10.1371/journal.pone.0072682	http://dx.doi.org/10.1371/journal.pone.0072682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991143	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700048
J	Naddafi, R; Rudstam, LG				Naddafi, Rahmat; Rudstam, Lars G.			Predator Diversity Effects in an Exotic Freshwater Food Web	PLOS ONE			English	Article							MUSSELS DREISSENA-POLYMORPHA; ZEBRA MUSSELS; TROPHIC CASCADES; INDUCED DEFENSES; PREY; RISK; BIODIVERSITY; SELECTION; IMPACTS; COMPETITION	Cascading trophic interactions are often defined as the indirect effects of a predator on primary producers through the effect of the predator on herbivores. These effects can be both direct through removal of herbivores [density-mediated indirect interactions (DMIIs)] or indirect through changes in the behavior of the herbivores [trait-mediated indirect interactions (TMIIs)]. How the relative importance of these two indirect interactions varies with predator diversity remains poorly understood. We tested the effect of predator diversity on both TMIIs and DMIIs on phytoplankton using two competitive invasive dreissenid mussel species (zebra mussel and quagga mussel) as the herbivores and combinations of one, two or all three species of the predators pumpkinseed sunfish, round goby, and rusty crayfish. Predators had either direct access to mussels and induced both TMII and DMII, or no direct access and induced only TMII through the presence of risk cues. In both sets of treatments, the predators induced a trophic cascade which resulted in more phytoplankton remaining with predators present than with only mussels present. The trophic cascade was weaker in three-predator and two-predator treatments than in one-predator treatments when predators had direct access to dreissenids (DMIIs and TMIIs). Crayfish had higher cascading effects on phytoplankton than both pumpkinseed and round goby. Increased predator diversity decreased the strength of DMIIs but had no effect on the strength of TMIIs. The strength of TMIIs was higher with zebra than quagga mussels. Our study suggests that inter-specific interference among predators in multi-species treatments weakens the consumptive cascading effects of predation on lower trophic levels whereas the importance of predator diversity on trait mediated effects depends on predator identity.	[Naddafi, Rahmat] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Rudstam, Lars G.] Cornell Univ, Dept Nat Resources, Cornell Biol Field Stn, Bridgeport, NY USA	Swedish University of Agricultural Sciences; Cornell University	Naddafi, R (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	Rahmat.Naddafi@slu.se		Rudstam, Lars/0000-0002-3732-6368	Swedish Research Council [623-2008-486]; Cornell Agricultural Experiment Station; Swedish University of Agricultural Science	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cornell Agricultural Experiment Station; Swedish University of Agricultural Science	This study was supported by the Swedish Research Council (http://vr.se/) (registration number: 623-2008-486) to RN and by a grant from the Cornell Agricultural Experiment Station (http://cuaes.cornell.edu/) to LGR and by the Swedish University of Agricultural Science (http://www.slu.se/viltfiskmiljo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Czarnoleski M, 2011, ANIM BEHAV, V82, P543, DOI 10.1016/j.anbehav.2011.06.008; DeVanna KM, 2011, FRESHWATER BIOL, V56, P2448, DOI 10.1111/j.1365-2427.2011.02668.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eklov P, 2001, ECOLOGY, V82, P2486, DOI 10.1890/0012-9658(2001)082[2486:FAPPEO]2.0.CO;2; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Freeman AS, 2007, MAR ECOL PROG SER, V334, P145; Freeman AS, 2009, OIKOS, V118, P758, DOI 10.1111/j.1600-0706.2008.17176.x; Geraldi NR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055100, 10.1371/journal.pone.0069244]; Green NS, 2008, J FRESHWATER ECOL, V23, P91, DOI 10.1080/02705060.2008.9664560; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; Heath RT, 1995, J GREAT LAKES RES, V21, P501, DOI 10.1016/S0380-1330(95)71062-0; Hettyey A, 2010, OIKOS, V119, P1814, DOI 10.1111/j.1600-0706.2010.18563.x; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Hirsch P, 2011, THESIS UPPSALA U UPP, P853; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044839; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Jude DJ, 1995, ECOVIS WORLD MG SER, P447; Karatayev AY, 2011, J SHELLFISH RES, V30, P923, DOI 10.2983/035.030.0334; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mills Ed, 2013, ONEIDA LAKE LONG TER; Mowles SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023068; Naddafi R, 2008, LIMNOL OCEANOGR, V53, P1973, DOI 10.4319/lo.2008.53.5.1973; Naddafi R, 2007, OIKOS, V116, P1289, DOI 10.1111/j.2007.0030-1299.15695.x; Naddafi R, 2007, FRESHWATER BIOL, V52, P823, DOI 10.1111/j.1365-2427.2007.01732.x; Naddafi R, 2012, BIOL INVASIONS, V14, P2117, DOI 10.1007/s10530-012-0218-9; Naddafi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005345; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; PECKARSKY BL, 1991, OECOLOGIA, V85, P521, DOI 10.1007/BF00323764; Pires LMD, 2004, FRESHWATER BIOL, V49, P116; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Rudstam LG, 2010, FISHERIES LIMNOLOGY; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Steffan SA, 2010, ECOLOGY, V91, P2242, DOI 10.1890/09-0787.1; TENWINKEL EH, 1982, FRESHWATER BIOL, V12, P553; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Turner AM, 2000, OIKOS, V88, P148, DOI 10.1034/j.1600-0706.2000.880117.x; Turner AM, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P140; Vance-Chalcraft HD, 2005, OECOLOGIA, V144, P472, DOI 10.1007/s00442-005-0077-5; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Walters C, 2000, MAR ECOL PROG SER, V208, P309; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Werner EE, 2006, ECOLOGY, V87, P347, DOI 10.1890/05-0091; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WISSINGER S, 1993, ECOLOGY, V74, P207, DOI 10.2307/1939515; Wojdak JM, 2005, OIKOS, V111, P592, DOI 10.1111/j.0030-1299.2005.13869.x	56	5	5	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72599	10.1371/journal.pone.0072599	http://dx.doi.org/10.1371/journal.pone.0072599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991126	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100107
J	van Oers, JMM; Edwards, Y; Chahwan, R; Zhang, W; Smith, C; Pechuan, X; Schaetzlein, S; Jin, B; Wang, Y; Bergman, A; Scharff, MD; Edelmann, W				van Oers, J. M. M.; Edwards, Y.; Chahwan, R.; Zhang, W.; Smith, C.; Pechuan, X.; Schaetzlein, S.; Jin, B.; Wang, Y.; Bergman, A.; Scharff, M. D.; Edelmann, W.			The MutS beta complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair	ONCOGENE			English	Article						DNA mismatch repair; MSH2-MSH3; DNA double-strand break repair; chromosomal instability; p53; sarcomagenesis	SACCHAROMYCES-CEREVISIAE MSH2; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; SOMATIC HYPERMUTATION; PROTEIN EXPRESSION; HOMOLOGOUS RECOMBINATION; TUMOR SUPPRESSION; DEFICIENT MICE; APC MUTATIONS; COLON-CANCER	Loss of the DNA mismatch repair (MMR) protein MSH3 leads to the development of a variety of tumors in mice without significantly affecting survival rates, suggesting a modulating role for the MutS beta (MSH2-MSH3) complex in late-onset tumorigenesis. To better study the role of MSH3 in tumor progression, we crossed Msh3(-/-) mice onto a tumor predisposing p53-deficient background. Survival of Msh3/p53 mice was not reduced compared with p53 single mutant mice; however, the tumor spectrum changed significantly from lymphoma to sarcoma, indicating MSH3 as a potent modulator of p53-driven tumorigenesis. Interestingly, Msh3(-/-) mouse embryonic fibroblasts displayed increased chromatid breaks and persistence of gamma H2AX foci following ionizing radiation, indicating a defect in DNA double-strand break repair (DSBR). Msh3/p53 tumors showed increased loss of heterozygosity, elevated genome-wide copy-number variation and a moderate microsatellite instability phenotype compared with Msh2/p53 tumors, revealing that MSH2-MSH3 suppresses tumorigenesis by maintaining chromosomal stability. Our results show that the MSH2-MSH3 complex is important for the suppression of late-onset tumors due to its roles in DNA DSBR as well as in DNA MMR. Further, they demonstrate that MSH2-MSH3 suppresses chromosomal instability and modulates the tumor spectrum in p53-deficient tumorigenesis and possibly has a role in other chromosomally unstable tumors as well.	[van Oers, J. M. M.; Edwards, Y.; Chahwan, R.; Schaetzlein, S.; Jin, B.; Wang, Y.; Scharff, M. D.; Edelmann, W.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Zhang, W.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Smith, C.; Pechuan, X.; Bergman, A.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Edelmann, W (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	winfried.edelmann@einstein.yu.edu	Pechuan, Ximo/AAD-7775-2019; Pechuan, Joaquin/H-7327-2015; Chahwan, Richard/AAQ-9381-2021; Smith, Cameron/B-7683-2011	Pechuan, Ximo/0000-0001-8938-7931; Pechuan, Joaquin/0000-0001-8938-7931; Chahwan, Richard/0000-0002-8672-7790; Smith, Cameron/0000-0002-6347-7506; Wang, Yuxun/0000-0002-4252-6102	National Institutes of Health [CA76329, CA93484, CA72649, CA102705]; National Women's Division of the Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE [R01CA072649, P30CA013330, R01CA093484, R01CA102705, R01CA076329, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Women's Division of the Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rani Sellers from the Einstein Histotechnology and Comparative Pathology facility for mouse pathology and for reviewing the manuscript. This study was supported by National Institutes of Health grants CA76329 and CA93484 (WE), and CA72649 and CA102705 (MDS). MDS is supported by the Harry Eagle Chair provided by the National Women's Division of the Albert Einstein College of Medicine.	Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Benachenhou N, 1998, INT J CANCER, V77, P173, DOI 10.1002/(SICI)1097-0215(19980717)77:2<173::AID-IJC1>3.0.CO;2-N; Benachenhou N, 1999, BRIT J CANCER, V79, P1012, DOI 10.1038/sj.bjc.6690162; Berndt SI, 2007, INT J CANCER, V120, P1548, DOI 10.1002/ijc.22510; Chen PC, 2005, CANCER RES, V65, P8662, DOI 10.1158/0008-5472.CAN-05-0742; Cranston A, 1997, NAT GENET, V17, P114, DOI 10.1038/ng0997-114; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Edelmann W, 2000, CANCER RES, V60, P803; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hirata H, 2008, J UROLOGY, V179, P2020, DOI 10.1016/j.juro.2008.01.009; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacks T, 1996, J CANCER RES CLIN, V122, P319, DOI 10.1007/BF01220798; Kawakami T, 2004, BIOCHEM BIOPH RES CO, V325, P934, DOI 10.1016/j.bbrc.2004.10.114; Kumar C, 2013, J MOL BIOL, V425, P1881, DOI 10.1016/j.jmb.2013.02.024; Kuraguchi M, 2001, CANCER RES, V61, P7934; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Li ZQ, 2006, DNA REPAIR, V5, P675, DOI 10.1016/j.dnarep.2006.02.003; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Michiels S, 2007, CARCINOGENESIS, V28, P1731, DOI 10.1093/carcin/bgm111; Miura T, 2012, GENETICS, V191, P65, DOI 10.1534/genetics.112.139105; Orimo H, 2000, J HUM GENET, V45, P228, DOI 10.1007/s100380070031; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Peled JU, 2010, AM J PATHOL, V177, P2597, DOI 10.2353/ajpath.2010.100234; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; Plaschke J, 2012, INT J COLORECTAL DIS, V27, P911, DOI 10.1007/s00384-011-1408-0; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Svetlanov A, 2008, GENETICS, V178, P1937, DOI 10.1534/genetics.107.084798; Toft NJ, 2002, ONCOGENE, V21, P6299, DOI 10.1038/sj.onc.1205727; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Tome S, 2013, DNA REPAIR, V12, P46, DOI 10.1016/j.dnarep.2012.10.006; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Varela I, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r100; Wang YX, 2010, P NATL ACAD SCI USA, V107, P5511, DOI 10.1073/pnas.1001223107; Wu XP, 2006, J IMMUNOL, V176, P5426, DOI 10.4049/jimmunol.176.9.5426	52	27	27	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3939	3946		10.1038/onc.2013.365	http://dx.doi.org/10.1038/onc.2013.365			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24013230	Green Accepted, Green Submitted			2022-12-25	WOS:000339394700006
J	Bhat, A; Hoch, AI; Decaris, ML; Leach, JK				Bhat, Archana; Hoch, Allison I.; Decaris, Martin L.; Leach, J. Kent			Alginate hydrogels containing cell-interactive beads for bone formation	FASEB JOURNAL			English	Article						extracellular matrix; osteogenesis; adhesion ligands; mesenchymal stem cell	MESENCHYMAL STEM-CELLS; TROPHIC FACTOR SECRETION; OSTEOBLAST-LIKE CELLS; EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION; ADHESION PEPTIDES; SCAFFOLDS; GROWTH; MICROCARRIERS; CULTURE	Alginate hydrogels containing cell-instructive cues are the subject of intense interest for their use as cell carriers in bone tissue engineering. Peptides and proteins are chemically grafted onto these hydrophilic materials to facilitate adhesion and direct phenotype of entrapped cells. However, the presentation of a single or small number of peptides does not represent the complexity of the native extracellular matrix (ECM) of bony tissues. Mesenchymal stem cells (MSCs) secrete ECM that can be harvested and deposited on various substrata to promote osteogenic differentiation. In this study, we hypothesized that the presentation of engineered cell-secreted ECM on microbeads suspended in alginate hydrogels would promote cell adhesion and enhance osteogenic differentiation of undifferentiated MSCs without chemical incorporation of cell-adhesive peptides. Human MSCs entrapped in alginate hydrogels loaded with ECM-coated beads showed increased interaction with beads, when compared with cells suspended in hydrogels containing uncoated blank (BLK) beads. MSCs entrapped in ECM gels exhibited increased alkaline phosphatase (ALP) activity and expression of osteogenic genes in vitro compared with hydrogels modified with arginine-glycine-aspartic acid (RGD)-containing peptides. Transplantation of MSCs into an ectopic site resulted in significant increases in blood vessel density for ECM hydrogels when compared with the BLK or RGD gels. Furthermore, we observed comparable levels of bone formation at 6 wk with ECM and RGD hydrogels. These findings demonstrate that engineered ECM can be deployed in a minimally invasive manner to direct the formation of bony tissue. This strategy may provide an alternative to the engraftment of proteins or peptides onto the polymer backbone of hydrogels for directing cellular behavior.	[Bhat, Archana; Hoch, Allison I.; Decaris, Martin L.; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Leach, J. Kent] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Leach, JK (corresponding author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr,GBSF 3321, Davis, CA 95616 USA.	jkleach@ucdavis.edu		Hoch, Allison/0000-0002-2418-8736	Hartwell Foundation; Department of the Army [W81XWH-10-1-0984]	Hartwell Foundation; Department of the Army	The authors are grateful for financial support from The Hartwell Foundation and the Department of the Army (W81XWH-10-1-0984). The authors thank Marissa Hugh-banks and Nandor Laszik for their contributions to the work.	Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501; Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; Davis HE, 2011, ACTA BIOMATER, V7, P691, DOI 10.1016/j.actbio.2010.09.007; Decaris ML, 2012, TISSUE ENG PT A, V18, P2148, DOI [10.1089/ten.tea.2011.0677, 10.1089/ten.TEA.2011.0677]; Decaris ML, 2012, ACTA BIOMATER, V8, P744, DOI 10.1016/j.actbio.2011.10.035; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103; Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827; Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200; He JW, 2010, TISSUE ENG PT A, V16, P127, DOI [10.1089/ten.tea.2009.0255, 10.1089/ten.TEA.2009.0255]; He JW, 2012, TISSUE ENG PT A, V18, P1520, DOI [10.1089/ten.tea.2011.0127, 10.1089/ten.TEA.2011.0127]; He JW, 2010, J CELL BIOCHEM, V110, P87, DOI 10.1002/jcb.22514; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015; Kim J, 2010, J BIOMED MATER RES A, V95A, P673, DOI 10.1002/jbm.a.32884; Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r; Kozawa O, 2001, J CELL BIOCHEM, V81, P430, DOI 10.1002/1097-4644(20010601)81:3<430::AID-JCB1056>3.0.CO;2-G; Lao LH, 2008, COLLOID SURFACE B, V66, P218, DOI 10.1016/j.colsurfb.2008.06.014; Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110; Liao JH, 2010, ACTA BIOMATER, V6, P2386, DOI 10.1016/j.actbio.2010.01.011; Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012; Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009; Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684; Mountziaris PM, 2012, J BIOMED MATER RES A, V100A, P1097, DOI 10.1002/jbm.a.34058; Paek HJ, 2006, TISSUE ENG, V12, P1733, DOI 10.1089/ten.2006.12.1733; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; Subramani K, 2006, BIOMED MATER, V1, P144, DOI 10.1088/1748-6041/1/3/009; Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]; Wu YN, 2007, BIOMATERIALS, V28, P4056, DOI 10.1016/j.biomaterials.2007.05.039	47	28	29	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4844	4852		10.1096/fj.12-213611	http://dx.doi.org/10.1096/fj.12-213611			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24005905				2022-12-25	WOS:000329999000019
J	Shymanets, A; Prajwal; Bucher, K; Beer-Hammer, S; Harteneck, C; Nurnberg, B				Shymanets, Aliaksei; Prajwal; Bucher, Kirsten; Beer-Hammer, Sandra; Harteneck, Christian; Nuernberg, Bernd			p87 and p101 Subunits Are Distinct Regulators Determining Class I-B Phosphoinositide 3-Kinase (PI3K) Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; PROTEIN-COUPLED RECEPTORS; CATALYTIC SUBUNIT; ACTIVATION; PI3K-GAMMA; P110-BETA; ISOFORM; KINASE; ROLES; INHIBITION	Class IB phosphoinositide 3-kinase gamma (PI3K gamma) comprises a single catalytic p110 gamma subunit, which binds to two non-catalytic subunits, p87 or p101, and controls a plethora of fundamental cellular responses. The non-catalytic subunits are assumed to be redundant adaptors for G beta gamma enabling G-protein-coupled receptor-mediated regulation of PI3K gamma. Growing experimental data provide contradictory evidence. To elucidate the roles of the non-catalytic subunits in determining the specificity of PI3K gamma, we tested the impact of p87 and p101 in heterodimeric p87-p110 gamma and p101-p110 gamma complexes on the modulation of PI3K gamma activity in vitro and in living cells. RT-PCR, biochemical, and imaging data provide four lines of evidence: (i) specific expression patterns of p87 and p101, (ii) up-regulation of p101, providing the basis to consider p87 as a protein forming a constitutively and p101 as a protein forming an inducibly expressed PI3K gamma, (iii) differences in basal and stimulated enzymatic activities, and (iv) differences in complex stability, all indicating apparent diversity within class IB PI3K gamma. In conclusion, expression and activities of PI3K gamma are modified differently by p87 and p101 in vitro and in living cells, arguing for specific regulatory roles of the non-catalytic subunits in the differentiation of PI3K gamma signaling pathways.	[Nuernberg, Bernd] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany; Univ Tubingen, Interfac Ctr Pharmacogen & Pharmaceut Res, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Nurnberg, B (corresponding author), Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, Wilhelmstr 56, D-72074 Tubingen, Germany.	bernd.nuernberg@uni-tuebingen.de	Beer-Hammer, Sandra/C-7442-2014; Beer-Hammer, Sandra/AAK-4516-2020	Beer-Hammer, Sandra/0000-0001-6049-0257; Nurnberg, Bernd/0000-0002-5995-6555; , Prajwal/0000-0002-2621-3886; Bucher, Kirsten/0000-0003-4746-6337	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft.	Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Brazzatti JA, 2012, ONCOGENE, V31, P2350, DOI 10.1038/onc.2011.414; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Czupalla C, 2003, J BIOL CHEM, V278, P11536, DOI 10.1074/jbc.M210351200; Damilano F, 2010, ANN NY ACAD SCI, V1188, P39, DOI 10.1111/j.1749-6632.2009.05081.x; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Dbouk HA, 2010, P NATL ACAD SCI USA, V107, P19897, DOI 10.1073/pnas.1008739107; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kirsch C, 2001, BIOCHEM BIOPH RES CO, V282, P691, DOI 10.1006/bbrc.2001.4623; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leopoldt D, 1997, N-S ARCH PHARMACOL, V356, P216, DOI 10.1007/PL00005044; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Luk SK, 2012, EUR J CANCER, V48, P149, DOI 10.1016/j.ejca.2011.09.006; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Preuss I, 2009, CELL SIGNAL, V21, P551, DOI 10.1016/j.cellsig.2008.12.007; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Shymanets A, 2012, BIOCHEM J, V441, P851, DOI 10.1042/BJ20111664; Shymanets A, 2009, PROTEIN PEPTIDE LETT, V16, P1053, DOI 10.2174/092986609789055340; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Voigt P, 2005, J BIOL CHEM, V280, P5121, DOI 10.1074/jbc.M413104200; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walser R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001587; Williams R, 2009, BIOCHEM SOC T, V37, P615, DOI 10.1042/BST0370615; Wu H, 2007, BIOCHEM SOC T, V35, P242, DOI 10.1042/BST0350242; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	50	32	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31059	31068		10.1074/jbc.M113.508234	http://dx.doi.org/10.1074/jbc.M113.508234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014027	Green Published, hybrid			2022-12-25	WOS:000330778900025
J	Simpson, AJR; Reiss, JD; McAlpine, D				Simpson, Andrew J. R.; Reiss, Joshua D.; McAlpine, David			Tuning of Human Modulation Filters Is Carrier-Frequency Dependent	PLOS ONE			English	Article							INTENSITY DISCRIMINATION; AMPLITUDE-MODULATION; SPEECH; INCREMENT; REPRESENTATION; SENSITIVITY; DECREMENTS; SENSATION; MECHANISM; LOUDNESS	Recent studies employing speech stimuli to investigate 'cocktail-party' listening have focused on entrainment of cortical activity to modulations at syllabic (5 Hz) and phonemic (20 Hz) rates. The data suggest that cortical modulation filters (CMFs) are dependent on the sound-frequency channel in which modulations are conveyed, potentially underpinning a strategy for separating speech from background noise. Here, we characterize modulation filters in human listeners using a novel behavioral method. Within an 'inverted' adaptive forced-choice increment detection task, listening level was varied whilst contrast was held constant for ramped increments with effective modulation rates between 0.5 and 33 Hz. Our data suggest that modulation filters are tonotopically organized (i.e., vary along the primary, frequency-organized, dimension). This suggests that the human auditory system is optimized to track rapid (phonemic) modulations at high sound-frequencies and slow (prosodic/syllabic) modulations at low frequencies.	[Simpson, Andrew J. R.; Reiss, Joshua D.] Queen Mary Univ London, Ctr Digital Mus, London, England; [Simpson, Andrew J. R.; McAlpine, David] Univ Cent, Ear Inst, London, England	University of London; Queen Mary University London	Simpson, AJR (corresponding author), Queen Mary Univ London, Ctr Digital Mus, London, England.	andy.simpson@eecs.qmul.ac.uk		McAlpine, David/0000-0001-5467-6725	EPSRC	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The first author was supported by an EPSRC (http://www.epsrc.ac.uk/) DTA studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour DL, 2011, NEUROSCI BIOBEHAV R, V35, P2064, DOI 10.1016/j.neubiorev.2011.04.009; Brungart DS, 2006, J ACOUST SOC AM, V120, P4007, DOI 10.1121/1.2363929; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Ding N, 2013, J NEUROSCI, V33, P5728, DOI 10.1523/JNEUROSCI.5297-12.2013; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Gallun FJ, 2006, J ACOUST SOC AM, V119, P3919, DOI 10.1121/1.2200136; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Garcia-Lazaro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022584; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; Jepsen ML, 2008, J ACOUST SOC AM, V124, P422, DOI 10.1121/1.2924135; JESTEADT W, 1977, J ACOUST SOC AM, V61, P169, DOI 10.1121/1.381278; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LONG GR, 1985, J ACOUST SOC AM, V78, P507, DOI 10.1121/1.392472; MCGILL WJ, 1968, PERCEPT PSYCHOPHYS, V4, P105, DOI 10.3758/BF03209518; MILLER GA, 1947, J ACOUST SOC AM, V19, P609, DOI 10.1121/1.1916528; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Oxenham AJ, 1997, J ACOUST SOC AM, V102, P1779, DOI 10.1121/1.420086; Ozimek E, 1996, J ACOUST SOC AM, V100, P3304, DOI 10.1121/1.416993; PETERS RW, 1995, J ACOUST SOC AM, V97, P3791, DOI 10.1121/1.412394; Plack CJ, 2006, J ACOUST SOC AM, V119, P3950, DOI 10.1121/1.2198184; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Simpson AJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057497; VIEMEISTER NF, 1988, J ACOUST SOC AM, V84, P172, DOI 10.1121/1.396961; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wang YD, 2012, J NEUROPHYSIOL, V107, P2033, DOI 10.1152/jn.00310.2011; WATSON CS, 1969, J ACOUST SOC AM, V46, P989, DOI 10.1121/1.1911819; Weber E. H., 1846, HANDWORTERBUCH PHYSL, VIII/2, P481; Xiang JJ, 2013, J ACOUST SOC AM, V133, pEL7, DOI 10.1121/1.4769400; Zatorre RJ, 2012, SPRINGER HANDB AUDIT, V43, P261, DOI 10.1007/978-1-4614-2314-0_10	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73590	10.1371/journal.pone.0073590	http://dx.doi.org/10.1371/journal.pone.0073590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009759	gold, Green Submitted, Green Published			2022-12-25	WOS:000323734600074
J	Sletner, L; Nakstad, B; Yajnik, CS; Morkrid, K; Vangen, S; Vardal, MH; Holme, IM; Birkeland, KI; Jenum, AK				Sletner, Line; Nakstad, Britt; Yajnik, Chittaranjan S.; Morkrid, Kjersti; Vangen, Siri; Vardal, Mari H.; Holme, Ingar M.; Birkeland, Kare I.; Jenum, Anne Karen			Ethnic Differences in Neonatal Body Composition in a Multi-Ethnic Population and the Impact of Parental Factors: A Population-Based Cohort Study	PLOS ONE			English	Article							BIRTH-WEIGHT; GEOGRAPHICAL VARIATION; DEVELOPMENTAL ORIGINS; MINORITY GROUPS; INFANTS; ANTHROPOMETRY; ASSOCIATION; PREGNANCY; DISEASE; BLACK	Background: Neonates from low and middle income countries (LAMIC) tend to have lower birth weight compared with Western European (WE) neonates. Parental height, BMI and maternal parity, age and educational level often differ according to ethnic background, and are associated with offspring birth weight. Less is known about how these factors affect ethnic differences in neonatal body composition. Objectives: To explore differences in neonatal body composition in a multi-ethnic population, and the impact of key parental factors on these differences. Methods: A population-based cohort study of pregnant mothers, fathers and their offspring, living in Oslo, Norway. Gender- and gestational-specific z-scores were calculated for several anthropometric measurements, with the neonates of WE ethnic origin as reference. Mean z-scores for neonates with LAMIC origin, and their parents, are presented as outcome variables. Results: 537 singleton, term neonates and their parents were included. All anthropometric measurements were smaller in neonates with LAMIC origin. Abdominal circumference and ponderal index differed the most from WE (mean z-score: -0.57 (95% CI: -0.69 to -0.44) and -0.54 (-0.66 to -0.44), and remained so after adjusting for parental size. Head circumference and skin folds differed less, and length the least (-0.21 (-0.35 to -0.07)). These measures became comparable to WEs when adjusted for parental factors. Conclusions: LAMIC origin neonates were relatively "thin-fat'', as indicated by reduced AC and ponderal index and relatively preserved length and skin folds, compared with neonates with WE origin. This phenotype may predispose to type 2 diabetes.	[Sletner, Line; Nakstad, Britt; Morkrid, Kjersti; Birkeland, Kare I.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sletner, Line; Nakstad, Britt] Akershus Univ Hosp, Dept Child & Adolescents Med, Lorenskog, Norway; [Sletner, Line; Vangen, Siri] Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway; [Yajnik, Chittaranjan S.] King Edward Mem Hosp, Diabet Unit, Pune, Maharashtra, India; [Morkrid, Kjersti; Birkeland, Kare I.] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Vardal, Mari H.; Holme, Ingar M.] Oslo Univ Hosp, Unit Biostat & Epidemiol, Oslo, Norway; [Jenum, Anne Karen] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, Oslo, Norway; [Jenum, Anne Karen] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet)	Sletner, L (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	line.sletner@medisin.uio.no	Birkeland, Kåre I/E-9750-2010		Research Council of Norway; South-Eastern Norway Regional Health Authority; Norwegian Directorate of Health	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority; Norwegian Directorate of Health	The Research Council of Norway has funded PhD fellowships for LS and KM, and the data collection was also supported by the South-Eastern Norway Regional Health Authority, The Norwegian Directorate of Health and collaborative partners in the city of Oslo, Stovner, Grorud and Bjerke administrative districts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; Deurenberg P, 2003, ACTA DIABETOL, V40, pS246, DOI 10.1007/s00592-003-0077-z; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Goedhart G, 2008, PAEDIATR PERINAT EP, V22, P360, DOI 10.1111/j.1365-3016.2008.00945.x; GOLDENBERG RL, 1991, OBSTET GYNECOL, V78, P782; Green AS, 2010, J ENDOCRINOL, V205, P211, DOI 10.1677/JOE-09-0399; Hanson MA, 2011, INT J GYNECOL OBSTET, V115, pS3, DOI 10.1016/S0020-7292(11)60003-9; Hanson MA, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000328033; Harding S, 2004, INT J EPIDEMIOL, V33, P1279, DOI 10.1093/ije/dyh186; Harrington TAM, 2004, PEDIATR RES, V55, P437, DOI 10.1203/01.PDR.0000111202.29433.2D; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jenum AK, 2010, SCAND J PUBLIC HEALT, V38, P60, DOI 10.1177/1403494810378921; Jenum AK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-150; JOHNSTON FE, 1976, AM J CLIN NUTR, V29, P61, DOI 10.1093/ajcn/29.1.61; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1080, DOI 10.1080/00016340600697447; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1066, DOI 10.1080/00016340600697306; Lewis RM, 2012, PLACENTA, V33, pS28, DOI 10.1016/j.placenta.2011.12.003; Modi N, 2009, PEDIATR RES, V65, P584, DOI [10.1203/PDR.0b013e31819d98be, 10.1203/01.pdr.0000350364.10602.33]; Moser K, 2008, HLTH STAT Q, V39, P34; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Shields Beverley M, 2006, BMC Pediatr, V6, P24, DOI 10.1186/1471-2431-6-24; Singh KA, 2010, OBSTET GYNECOL, V115, P998, DOI 10.1097/AOG.0b013e3181da901a; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stanfield KM, 2012, INT J EPIDEMIOL, V41, P1409, DOI 10.1093/ije/dys139; Stein CR, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.047; Tran AT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-554; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; van Steijn L, 2009, INT J OBESITY, V33, P1326, DOI 10.1038/ijo.2009.154; Vangen S, 2002, INT J EPIDEMIOL, V31, P654, DOI 10.1093/ije/31.3.654; Veena SR, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-16; West J, 2013, J EPIDEMIOL COMMUN H, V67, P544, DOI 10.1136/jech-2012-201891; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	43	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73058	10.1371/journal.pone.0073058	http://dx.doi.org/10.1371/journal.pone.0073058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009731	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600053
J	Taylor, AW				Taylor, Andrew W.			Alpha-Melanocyte Stimulating Hormone (alpha-MSH) Is a Post-Caspase Suppressor of Apoptosis in RAW 264.7 Macrophages	PLOS ONE			English	Article							DEPRIVATION-INDUCED APOPTOSIS; SIGNALING PATHWAY; ACTIVATION; KINASE; LIPOPOLYSACCHARIDE; TOLERANCE; CELLS; GAMMA	The neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is an important regulator of immune cell activity within the immunosuppressive ocular microenvironment. Its constitutive presence not only suppresses macrophage inflammatory activity, it also participates in retinal pigment epithelial cell (RPE) mediated activation of macrophages to function similar to myeloid suppressor cells. In addition, alpha-MSH promotes survival of the alternatively activated macrophages where without alpha-MSH RPE induce apoptosis in the macrophages, which is seen as increased TUNEL stained cells. Since there is little know about alpha-MSH as an anti-apoptotic factor, the effects of alpha-MSH on caspase activity, mitochondrial membrane potential, Bcl2 to BAX expression, along with TUNEL staining, and Annexin V binding were examined in RAW 264.7 macrophages under serum-starved conditions that trigger apoptosis. There was no effect of alpha-MSH on activated Caspase 9 and Caspase 3 while there was suppression of Caspase 8 activity. In addition, alpha-MSH did not improve mitochondrial membrane potential, change the ratio between Bcl-2 and BAX, nor reduce Annexin V binding. These results demonstrate that the diminution in TUNEL staining by alpha-MSH is through alpha-MSH mediating suppression of the apoptotic pathway that is post-Caspase 3, but before DNA fragmentation. Therefore, as alpha-MSH promotes the alternative activation of macrophages it also provides a survival signal, and the potential for the caspases to participate in non-apoptotic activities that can contribute to an immunosuppressive microenvironment.	Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University	Taylor, AW (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	awtaylor@bu.edu	Taylor, Andrew/I-1665-2013	Taylor, Andrew/0000-0002-0330-8591	NIH [NEI EY010752]; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R29EY010752, R01EY010752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the following: NIH grant through NEI EY010752 and Massachusetts Lions Eye Research Fund http://www.masslionseyeresearch.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200; Caruso C, 2007, ENDOCRINOLOGY, V148, P4918, DOI 10.1210/en.2007-0366; Chai BX, 2006, PEPTIDES, V27, P2846, DOI 10.1016/j.peptides.2006.05.005; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; D'Agostino G, 2010, J MOL MED, V88, P1195, DOI 10.1007/s00109-010-0651-0; Grabbe S, 1996, J IMMUNOL, V156, P473; Gumireddy K, 2003, J CELL BIOCHEM, V90, P87, DOI 10.1002/jcb.10615; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Iida KT, 2002, ARTERIOSCL THROM VAS, V22, P380, DOI 10.1161/hq0302.105272; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Kawanaka N, 2011, J NEUROIMMUNOL, V232, P17, DOI 10.1016/j.jneuroim.2010.09.025; Lam CW, 2006, PEPTIDES, V27, P404, DOI 10.1016/j.peptides.2005.01.031; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lau CH, 2009, OCUL IMMUNOL INFLAMM, V17, P380, DOI 10.3109/09273940903118642; Lee SY, 2004, TRANSPLANTATION, V78, P1756, DOI 10.1097/01.TP.0000144332.44435.AB; Li DY, 2008, J LEUKOCYTE BIOL, V84, P191, DOI 10.1189/jlb.0707463; Lopez S, 2013, J NUTR, V143, P620, DOI 10.3945/jn.113.174656; Luger TA, 1999, PATHOBIOLOGY, V67, P318, DOI 10.1159/000028089; Nishida T, 1999, INVEST OPHTH VIS SCI, V40, P2268; Rajora N, 1996, J LEUKOCYTE BIOL, V59, P248, DOI 10.1002/jlb.59.2.248; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Taylor Andrew W, 2007, Chem Immunol Allergy, V92, P71, DOI 10.1159/000099255; Taylor Andrew W., 1994, Neuroimmunomodulation, V1, P188, DOI 10.1159/000097167; Taylor A, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/246856; TAYLOR AW, 1992, CURR EYE RES, V11, P1199, DOI 10.3109/02713689208999545; Taylor AW, 2005, J NEUROIMMUNOL, V162, P43, DOI 10.1016/j.jneuroim.2005.01.008; Taylor AW, 2011, INVEST OPHTHALMOL VI; TUNG YC, 2006, ENDOCRINOLOGY; Wei J, 2006, APOPTOSIS, V11, P545, DOI 10.1007/s10495-006-5146-7; Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74488	10.1371/journal.pone.0074488	http://dx.doi.org/10.1371/journal.pone.0074488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009773	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600083
J	Lennartsson, AK; Theorell, T; Rockwood, AL; Kushnir, MM; Jonsdottir, IH				Lennartsson, Anna-Karin; Theorell, Tores; Rockwood, Alan L.; Kushnir, Mark M.; Jonsdottir, Ingibjorg H.			Perceived Stress at Work Is Associated with Lower Levels of DHEA-S	PLOS ONE			English	Article							ACUTE PSYCHOSOCIAL STRESS; DEHYDROEPIANDROSTERONE-SULFATE; NECK/SHOULDER SYMPTOMS; SALIVARY CORTISOL; MEDIA WORKERS; MANAGEMENT; DEPRESSION; SECRETION; ZONATION; RHYTHMS	Background: It is known that long-term psychosocial stress may cause or contribute to different diseases and symptoms and accelerate aging. One of the consequences of prolonged psychosocial stress may be a negative effect on the levels of dehydroepiandrosterone (DHEA) and its sulphated metabolite dehydroepiandrosterone sulphate (DHEA-S). The aim of this study is to investigate whether levels of DHEA and DHEA-S differ in individuals who report perceived stress at work compared to individuals who report no perceived stress at work. Methods: Morning fasting DHEA-S and DHEA levels were measured in serum in a non-stressed group (n = 40) and a stressed group (n = 41). DHEA and DHEA-S levels were compared between the groups using ANCOVA, controlling for age. Results: The mean DHEA-S levels were 23% lower in the subjects who reported stress at work compared to the non-stressed group. Statistical analysis (ANCOVA) showed a significant difference in DHEA-S levels between the groups (p = 0.010). There was no difference in DHEA level between the groups. Conclusions: This study indicates that stressed individual have markedly lower levels of DHEA-S. Given the important and beneficial functions of DHEA and DHEA-S, lower levels of DHEA-S may constitute one link between psychosocial stress, ill health and accelerated ageing.	[Lennartsson, Anna-Karin; Jonsdottir, Ingibjorg H.] Inst Stress Med, Gothenburg, Sweden; [Lennartsson, Anna-Karin; Jonsdottir, Ingibjorg H.] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden; [Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Rockwood, Alan L.; Kushnir, Mark M.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Rockwood, Alan L.; Kushnir, Mark M.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	University of Gothenburg; Stockholm University; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Lennartsson, AK (corresponding author), Inst Stress Med, Gothenburg, Sweden.	anna-karin.lennartsson@vgregion.se		Kushnir, Mark/0000-0003-4480-0854; Theorell, Tores/0000-0003-1956-7931	Swedish government	Swedish government	This study was supported by a grant from the Swedish government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RS, 2007, YONSEI MED J, V48, P379, DOI 10.3349/ymj.2007.48.3.379; Altman R, 2008, VASC PHARMACOL, V48, P76, DOI 10.1016/j.vph.2007.12.002; Antoni MH, 2003, STRESS, V6, P173, DOI 10.1080/1025389031000156727; Brzoza Z, 2008, PSYCHOSOM MED, V70, P723, DOI 10.1097/PSY.0b013e31817bcc8d; Carlson LE, 2004, PSYCHONEUROENDOCRINO, V29, P448, DOI 10.1016/S0306-4530(03)00054-4; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; de Gonzalo-Calvo D, 2012, AGE, V34, P761, DOI 10.1007/s11357-011-9266-9; Du CL, 2011, SAF HEALTH WORK, V2, P169, DOI 10.5491/SHAW.2011.2.2.169; Elo AL, 2003, SCAND J WORK ENV HEA, V29, P444, DOI 10.5271/sjweh.752; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gadinger MC, 2011, PSYCHOSOM MED, V73, P44, DOI 10.1097/PSY.0b013e3181fc6fe8; GLASER JL, 1992, J BEHAV MED, V15, P327, DOI 10.1007/BF00844726; Goodyer IM, 1996, PSYCHOL MED, V26, P245, DOI 10.1017/S0033291700034644; Hansen AM, 2010, INT ARCH OCC ENV HEA, V83, P143, DOI 10.1007/s00420-009-0440-7; Hasselhorn H M, 2001, Spine (Phila Pa 1976), V26, pE24; Hasson D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-78; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Izawa S, 2011, PSYCHONEUROENDOCRINO; Izawa S, 2008, BIOL PSYCHOL, V79, P294, DOI 10.1016/j.biopsycho.2008.07.003; Kellner M, 2010, J PSYCHIATR RES, V44, P215, DOI 10.1016/j.jpsychires.2009.08.009; Khalil A, 1998, ATHEROSCLEROSIS, V136, P99, DOI 10.1016/S0021-9150(97)00194-9; Kim MS, 2010, YONSEI MED J, V51, P212, DOI 10.3349/ymj.2010.51.2.212; Kivimaki M., 2012, LANCET; Kjellberg AaWC, 2002, ARBETE HALSA; Kjellberg A, 2010, WORK, V36, P9, DOI 10.3233/WOR-2010-1003; Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Kushnir MM, 2010, CLIN CHEM, V56, P1138, DOI 10.1373/clinchem.2010.143222; Kushnir MM, 2010, MASS SPECTROM REV, V29, P480, DOI 10.1002/mas.20264; Kushnir MM, 2009, CLIN CHEM, V55, P519, DOI 10.1373/clinchem.2008.110262; Lac G, 2012, BRAIN COGNITION, V80, P277, DOI 10.1016/j.bandc.2012.07.007; Larsman P, 2006, EUR J APPL PHYSIOL, V96, P127, DOI 10.1007/s00421-004-1263-6; Larsman P, 2013, INT ARCH OCC ENV HEA, V86, P57, DOI 10.1007/s00420-012-0744-x; Lennartsson AK, 2012, BIOL PSYCHOL, V90, P143, DOI 10.1016/j.biopsycho.2012.03.003; LIU CH, 1990, J CLIN ENDOCR METAB, V71, P900, DOI 10.1210/jcem-71-4-900; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; MASON JW, 1968, PSYCHOSOM MED, V30, P710, DOI 10.1097/00006842-196809000-00027; McCraty R, 1998, INTEGR PHYS BEH SCI, V33, P151, DOI 10.1007/BF02688660; Morgan CA, 2004, ARCH GEN PSYCHIAT, V61, P819, DOI 10.1001/archpsyc.61.8.819; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; Nguyen Ann D., 2008, V13, P33, DOI 10.1159/000134765; NIESCHLAG E, 1973, J ENDOCRINOL, V57, P123, DOI 10.1677/joe.0.0570123; Ohlsson C, 2010, J CLIN ENDOCR METAB, V95, P4406, DOI 10.1210/jc.2010-0760; Parker CR, 1997, J CLIN ENDOCR METAB, V82, P3898, DOI 10.1210/jc.82.11.3898; Ramirez JA, 2007, BIOORGAN MED CHEM, V15, P7538, DOI 10.1016/j.bmc.2007.09.012; Romanowska J, 2011, PSYCHOTHER PSYCHOSOM, V80, P78, DOI 10.1159/000321557; ROSENFELD RS, 1975, J CLIN ENDOCR METAB, V40, P850, DOI 10.1210/jcem-40-5-850; ROTTER JI, 1985, METABOLISM, V34, P731, DOI 10.1016/0026-0495(85)90023-X; Schell E, 2008, EUR SPINE J, V17, P393, DOI 10.1007/s00586-007-0554-0; Siegrist J, 2008, EUR ARCH PSY CLIN N, V258, P115, DOI 10.1007/s00406-008-5024-0; Sondergaard HP, 2002, PSYCHOTHER PSYCHOSOM, V71, P298, DOI 10.1159/000064806; Theorell T, 1997, ACTA PHYSIOL SCAND, V161, P107; Theorell T, 2008, SCAND J WORK ENV HEA, P136; Theorell T, 2009, RES OCCUP STRESS WEL, V7, P249, DOI 10.1108/S1479-3555(2009)0000007010; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; Walton K G, 1995, J Altern Complement Med, V1, P263, DOI 10.1089/acm.1995.1.263; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Yehuda R, 2006, ACTA PSYCHIAT SCAND, V114, P187, DOI 10.1111/j.1600-0447.2006.00801.x	58	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72460	10.1371/journal.pone.0072460	http://dx.doi.org/10.1371/journal.pone.0072460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015247	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800055
J	Vandendriessche, B; Rogge, E; Goossens, V; Vandenabeele, P; Stasch, JP; Brouckaert, P; Cauwels, A				Vandendriessche, Benjamin; Rogge, Elke; Goossens, Vera; Vandenabeele, Peter; Stasch, Johannes-Peter; Brouckaert, Peter; Cauwels, Anje			The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems	PLOS ONE			English	Article							SEPTIC SHOCK; NO; DYSFUNCTION; SEPSIS	Sepsis and septic shock are associated with high mortality rates and the majority of sepsis patients die due to complications of multiple organ failure (MOF). The cyclic GMP (cGMP) producing enzyme soluble guanylate cyclase (sGC) is crucially involved in the regulation of (micro) vascular homeostasis, cardiac function and, consequently, organ function. However, it can become inactivated when exposed to reactive oxygen species (ROS). The resulting heme-free sGC can be reactivated by the heme-and nitric oxide (NO)-independent sGC activator BAY 58-2667 (Cinaciguat). We report that late (+8 h) post-treatment with BAY 58-2667 in a mouse model can protect against lethal endotoxic shock. Protection was associated with reduced hypothermia, circulating IL-6 levels, cardiomyocyte apoptosis, and mortality. In contrast to BAY 58-2667, the sGC stimulator BAY 41-2272 and the phosphodiesterase 5 inhibitor Sildenafil did not have any beneficial effect on survival, emphasizing the importance of the selectivity of BAY 58-2667 for diseased vessels and tissues. Hemodynamic parameters (blood pressure and heart rate) were decreased, and linear and nonlinear indices of blood pressure variability, reflective for (un)coupling of the communication between the autonomic nervous system and the heart, were improved after late protective treatment with BAY 58-2667. In conclusion, our results demonstrate the pivotal role of the NO/sGC axis in endotoxic shock. Stabilization of sGC function with BAY 58-2667 can prevent mortality when given in the correct treatment window, which probably depends on the dynamics of the heme-free sGC pool, in turn influenced by oxidative stress. We speculate that, considering the central role of sGC signaling in many pathways required for maintenance of (micro) circulatory homeostasis, BAY 58-2667 supports organ function by recoupling inter-organ communication pathways.	[Vandendriessche, Benjamin; Rogge, Elke; Goossens, Vera; Vandenabeele, Peter; Brouckaert, Peter; Cauwels, Anje] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Vandendriessche, Benjamin; Rogge, Elke; Goossens, Vera; Vandenabeele, Peter; Brouckaert, Peter; Cauwels, Anje] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Stasch, Johannes-Peter] Bayer HealthCare, Inst Cardiovasc Res, Wuppertal, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; Bayer AG; Bayer Healthcare Pharmaceuticals	Cauwels, A (corresponding author), VIB, Dept Mol Biomed Res, Ghent, Belgium.	anje.cauwels@dmbr.ugent.be	Vandendriessche, Benjamin/N-2415-2013; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Vandendriessche, Benjamin/0000-0003-0672-0327; Vandenabeele, Peter/0000-0002-6669-8822; 	agency for Innovation by Science and Technology (IWT); Research Foundation Flanders (FWO); Ghent University: Concerted Research Actions (GOA); European grants (Euregional PACT II); Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, G.0787.13N]; Flemish grants (Methusalem grant) [BOF09/01M00709]; Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer [F94]; VIB; Methusalem grant	agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); Ghent University: Concerted Research Actions (GOA); European grants (Euregional PACT II); Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grants (Research Foundation Flanders)(FWO); Flemish grants (Methusalem grant); Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer; VIB; Methusalem grant	This research was supported by the agency for Innovation by Science and Technology (IWT); Research Foundation Flanders (FWO); and Ghent University: Concerted Research Actions (GOA). The BD Pathway 855 is supported by European grants (Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 7/32), Flemish grants (Research Foundation Flanders - FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, G.0787.13N, Methusalem grant - BOF09/01M00709), Ghent University grants (MRP, GROUP-ID consortium), a grant from the Foundation against Cancer, F94) and grants from VIB. P.V. is holder of a Methusalem grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROUCKAERT PG, 1989, LYMPHOKINE RES, V8, P269; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Buys ES, 2009, AM J PHYSIOL-HEART C, V297, pH654, DOI 10.1152/ajpheart.00367.2009; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cauwels A, 2007, ARCH BIOCHEM BIOPHYS, V462, P132, DOI 10.1016/j.abb.2007.01.021; Cauwels A, 2010, J MOL MED, V88, P921, DOI 10.1007/s00109-010-0633-2; Cauwels A, 2009, J EXP MED, V206, P2915, DOI 10.1084/jem.20091236; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Dellinger RP, 2004, CRIT CARE MED, V32, P282, DOI 10.1097/01.CCM.0000105423.06091.8E; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Frey R, 2008, J CLIN PHARMACOL, V48, P1400, DOI 10.1177/0091270008322906; Fukutani T, 2009, ARCH HISTOL CYTOL, V72, P117, DOI 10.1679/aohc.72.117; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Groneberg D, 2010, CIRCULATION, V121, P401, DOI 10.1161/CIRCULATIONAHA.109.890962; Just A, 2000, AM J PHYSIOL-REG I, V279, pR2214, DOI 10.1152/ajpregu.2000.279.6.R2214; Kaplan D, HRV SOFTWARE; Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1; Kumar A, 2001, J CARDIOTHOR VASC AN, V15, P364, DOI 10.1053/jcan.2001.22317; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lucas KA, 2000, PHARMACOL REV, V52, P375; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Meyer M, 2006, J MATH BIOL, V52, P830, DOI 10.1007/s00285-006-0375-5; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Nguyen HB, 2006, ANN EMERG MED, V48, P28, DOI 10.1016/j.annemergmed.2006.02.015; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Radaelli A, 2012, SHOCK; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Schmidt H B, 2001, Curr Opin Crit Care, V7, P314, DOI 10.1097/00075198-200110000-00002; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611	38	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72155	10.1371/journal.pone.0072155	http://dx.doi.org/10.1371/journal.pone.0072155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015214	Green Published, gold			2022-12-25	WOS:000323733800033
J	Afriat, R; Horowitz, S; Priel, E				Afriat, Reuven; Horowitz, Shulamith; Priel, Esther			Mycoplasma fermentans Inhibits the Activity of Cellular DNA Topoisomerase I by Activation of PARP1 and Alters the Efficacy of Its Anti-Cancer Inhibitor	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INDUCED APOPTOSIS; CANCER; DEGRADATION; GLCNACYLATION; TRANSCRIPTION; CAMPTOTHECIN; FIBROBLASTS; POLYMERASE	To understand the effects of the interaction between Mycoplasma and cells on the host cellular function, it is important to elucidate the influences of infection of cells with Mycoplasma on nuclear enzymes such as DNA Topoisomerase type I (Topo I). Human Topo I participates in DNA transaction processes and is the target of anti-cancer drugs, the camptothecins (CPTs). Here we investigated the mechanism by which infection of human tumor cells with Mycoplasma fermentans affects the activity and expression of cellular Topo I, and the anti-cancer efficacy of CPT. Human cancer cells were infected or treated with live or sonicated M. fermentans and the activity and expression of Topo I was determined. M. fermentans significantly reduced (by 80%) Topo I activity in the infected/treated tumor cells without affecting the level of Topo I protein. We demonstrate that this reduction in enzyme activity resulted from ADP-ribosylation of the Topo I protein by Poly-ADP-ribose polymerase (PARP-1). In addition, pERK was activated as a result of the induction of the MAPK signal transduction pathway by M. fermentans. Since PARP-1 was shown to be activated by pERK, we concluded that M. fermentans modified the cellular Topo I activity by activation of PARP-I via the induction of the MAPK signal transduction pathway. Moreover, the infection of tumor cells with M. fermentans diminished the inhibitory effect of CPT. The results of this study suggest that modification of Topo I activity by M. fermentans may alter cellular gene expression and the response of tumor cells to Topo I inhibitors, influencing the anti-cancer capacity of Topo I antagonists.	[Priel, Esther] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center	Priel, E (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	priel@bgu.ac.il			Seed Research fund, Ben-Gurion University	Seed Research fund, Ben-Gurion University	Funding was provided by the Seed Research fund, Ben-Gurion University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUER B, 1982, HUM GENET, V61, P369; BASEMAN JB, 1995, MICROB PATHOGENESIS, V19, P105, DOI 10.1006/mpat.1995.0050; Bendetz-Nezer S, 2004, MOL PHARMACOL, V66, P627; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Cretaio Erica, 2007, Ital J Biochem, V56, P91; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 2001, CANCER RES, V61, P5926; Dong L, 1999, INFECT IMMUN, V67, P3061, DOI 10.1128/IAI.67.6.3061-3065.1999; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Feng SH, 1999, INFECT IMMUN, V67, P2951, DOI 10.1128/IAI.67.6.2951-2956.1999; Gerlic M, 2004, CELL DEATH DIFFER, V11, P1204, DOI 10.1038/sj.cdd.4401482; Gerlic M, 2007, CELL MICROBIOL, V9, P142, DOI 10.1111/j.1462-5822.2006.00774.x; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Horowitz S, 2000, J RHEUMATOL, V27, P2747; Jiang S, 2008, J CELL BIOCHEM, V104, P580, DOI 10.1002/jcb.21647; Johnston M D, 1981, Methods Enzymol, V78, P394; Kaufmann S, 1999, IMMUNOBLOT ANAL BAND; Lennette EH, 1980, MYCOPLASMA MANUAL CL, P365; Levi I, 2012, GLYCOBIOLOGY, V22, P704, DOI 10.1093/glycob/cws008; Marie C, 1999, INFECT IMMUN, V67, P688, DOI 10.1128/IAI.67.2.688-693.1999; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Noach N, 2007, GLYCOBIOLOGY, V17, P1357, DOI 10.1093/glycob/cwm105; Park SY, 2005, CANCER RES, V65, P3894, DOI 10.1158/0008-5472.CAN-04-4014; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Rawadi G, 1999, J BIOL CHEM; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 1983, GEN CULTIVATION TECH, P99; Rogers MB, 2011, ONCOTARGET, V2, P271; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHERO JH, 1986, SCIENCE, V231, P737, DOI 10.1126/science.3003910; Shibata K, 1997, FEMS IMMUNOL MED MIC, V17, P103, DOI 10.1111/j.1574-695X.1997.tb01002.x; Stewart L, 2001, Methods Mol Biol, V95, P1; SUGAMA K, 1990, INFECT IMMUN, V58, P3564, DOI 10.1128/IAI.58.11.3564-3567.1990; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG RYH, 1992, J CLIN MICROBIOL, V30, P245, DOI 10.1128/JCM.30.1.245-248.1992; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; You XX, 2008, FEMS IMMUNOL MED MIC, V52, P228, DOI 10.1111/j.1574-695X.2007.00366.x	44	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72377	10.1371/journal.pone.0072377	http://dx.doi.org/10.1371/journal.pone.0072377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013388	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200036
J	Chen, SJ; Asakawa, T; Ding, SS; Liao, LH; Zhang, LY; Shen, JY; Yu, J; Sugiyama, K; Namba, H; Li, CD				Chen, Shujiao; Asakawa, Tetsuya; Ding, Shanshan; Liao, Linghong; Zhang, Lingyuan; Shen, Jianying; Yu, Jie; Sugiyama, Kenji; Namba, Hiroki; Li, Candong			Chaihu-Shugan-San Administration Ameliorates Perimenopausal Anxiety and Depression in Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR MODULATORS; MENOPAUSAL STATUS; HORMONE-THERAPY; WOMEN; MODEL; EXPRESSION; SYMPTOMS; BEHAVIOR; STRESS; GENE	Chaihu-Shugan-San (CSS) is a traditional Chinese herbal formula that is widely used for treating perimenopausal symptoms in China; however, its mechanisms remain unknown. The present study was designed to investigate potential CSS mechanisms in rats with unpredicted chronic mild stress (UCMS) and normally aging rats (52 weeks of age). We performed the sucrose consumption test along with the forced swimming test to confirm depression like behaviour and the open field test (OFT) to confirm anxiety-like behavior in the animals. In addition, we used an enzyme-linked immunosorbent assay to measure serum and hippocampal estradiol (E-2) levels and a quantitative real-time polymerase chain reaction to assess hippocampal mRNA levels of estrogen receptors (ERs) alpha and beta as well as G protein-coupled receptor 30 (GPR30). We found that CSS administration resulted in a significant increase in the ratio of hippocampal ER alpha and ER beta mRNA (ER alpha/ER beta ratio) in expression. In contrast, changes in ER alpha/ER beta mRNA ratio were sensitively associated with changes in mood states in the animal models. These findings suggest that enhancement of ER alpha/ER beta ratio may play a role in the pharmacological mechanisms of CSS. Furthermore, this ratio can be employed as a potential index for evaluating mood states in animal models and can be considered as a therapeutic target for perimenopausal anxiety and depression in the furture.	[Chen, Shujiao; Ding, Shanshan; Liao, Linghong; Zhang, Lingyuan; Shen, Jianying; Yu, Jie; Li, Candong] Fujian Univ Tradit Chinese Med, Res Base TCM Syndrome, Minhou Fuzhou City, Peoples R China; [Asakawa, Tetsuya; Sugiyama, Kenji; Namba, Hiroki] Hamamatsu Univ, Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4312102, Japan	Fujian University of Traditional Chinese Medicine; Hamamatsu University School of Medicine	Asakawa, T (corresponding author), Hamamatsu Univ, Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4312102, Japan.	asakawat1971@gmail.com; cdli@fjtcm.edu.cn	Asakawa, Tetsuya/ABE-5307-2020	Asakawa, Tetsuya/0000-0002-2300-3509	National Sciences Foundation of China [81173203]; Grants-in-Aid for Scientific Research [24592157] Funding Source: KAKEN	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Sciences Foundation of China (No: 81173203) http://www.nsfc.gov.cn/Portal0/default166htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts G, 2010, J CHROMATOGR A, V1217, P7706, DOI 10.1016/j.chroma.2010.10.010; Anderson G, 2013, PROG NEURO-PSYCHOPH, V42, P101, DOI 10.1016/j.pnpbp.2012.07.016; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Asakawa T, 2012, CURRENT RES ACUPUNCT, P215; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Bosworth HB, 2001, PSYCHOSOM MED, V63, P603, DOI 10.1097/00006842-200107000-00013; Calmarza-Font I, 2012, BEHAV BRAIN RES, V227, P287, DOI 10.1016/j.bbr.2011.10.036; Chim H, 2002, MATURITAS, V41, P275, DOI 10.1016/S0378-5122(01)00299-7; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Freeman EW, 2004, ARCH GEN PSYCHIAT, V61, P62, DOI 10.1001/archpsyc.61.1.62; Gyllstrom ME, 2007, BEST PRACT RES CL OB, V21, P275, DOI 10.1016/j.bpobgyn.2006.11.002; Harlow BL, 2003, ARCH GEN PSYCHIAT, V60, P29, DOI 10.1001/archpsyc.60.1.29; Henderson VW, 2005, J NEUROL NEUROSUR PS, V76, P103, DOI 10.1136/jnnp.2003.024927; Huang W, 2011, J GASTROINTEST SURG, V15, P87, DOI 10.1007/s11605-010-1374-9; Jansson C, 2003, MATURITAS, V45, P129, DOI 10.1016/S0378-5122(03)00127-0; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kim SH, 2005, LIFE SCI, V76, P1297, DOI 10.1016/j.lfs.2004.10.022; Li SL, 2009, J PHARMACEUT BIOMED, V49, P253, DOI 10.1016/j.jpba.2008.11.007; Liang W, 2010, CHINA J TRADITIONAL, V2, P201; Maki PM, 2006, NEUROSCIENCE, V138, P1027, DOI 10.1016/j.neuroscience.2006.01.001; Montoro P, 2011, J PHARMACEUT BIOMED, V54, P535, DOI 10.1016/j.jpba.2010.10.004; Moretti M, 2013, J MOL NEUROSCI, V49, P68, DOI 10.1007/s12031-012-9892-4; Nadal-Serrano M, 2012, J CELL BIOCHEM, V113, P3178, DOI 10.1002/jcb.24192; Owens JF, 1998, MATURITAS, V30, P41, DOI 10.1016/S0378-5122(98)00039-5; Pandya CD, 2012, PROG NEUROP IN PRESS; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Russo E, 2013, NEUROPHARMACOLOGY, V64, P371, DOI 10.1016/j.neuropharm.2012.06.039; Ryan J, 2012, DRUGS, V72, P1725, DOI 10.2165/11635960-000000000-00000; Sarkisova KY, 2010, EPILEPSIA, V51, P146, DOI 10.1111/j.1528-1167.2009.02260.x; Suzuki H, 2013, MOL PSYCHIATR, V18, P674, DOI 10.1038/mp.2012.62; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Thomas C, 2012, J CLIN INVEST, V122, P2771, DOI 10.1172/JCI65133; Tian RT, 2009, J CHROMATOGR A, V1216, P2150, DOI 10.1016/j.chroma.2008.10.127; Usall J, 2011, ACTAS ESP PSIQUIATRI, V39, P334; Versini A, 2010, NEUROPSYCHOPHARMACOL, V35, P1818, DOI 10.1038/npp.2010.49; Walf AA, 2007, PHARMACOL BIOCHEM BE, V86, P407, DOI 10.1016/j.pbb.2006.07.003; Wang L, 2012, SHAANXI J TRADITIONA, V33, P105; Wang Y, 2012, J ETHNOPHARMACOL, V141, P571, DOI 10.1016/j.jep.2011.08.079; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zhang YJ, 2011, BRAIN RES BULL, V86, P222, DOI 10.1016/j.brainresbull.2011.07.002; Zhao T, 2010, J HUM GENET, V55, P50, DOI 10.1038/jhg.2009.122	43	29	33	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72428	10.1371/journal.pone.0072428	http://dx.doi.org/10.1371/journal.pone.0072428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015243	gold, Green Published, Green Submitted			2022-12-25	WOS:000323815200042
J	Gao, G; Xuan, C; Yang, Q; Liu, XC; Liu, ZG; He, GW				Gao, Ge; Xuan, Chao; Yang, Qin; Liu, Xiao-Cheng; Liu, Zhi-Gang; He, Guo-Wei			Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN AORTIC-STENOSIS; CARBONIC-ANHYDRASE; GEL-ELECTROPHORESIS; ATRIAL APPENDAGES; VALVE; TRANSFERRINS; COMPLEMENT; FIBRONECTIN; VITRONECTIN	Background: Little is known about genetic basis and proteomics in valvular heart disease (VHD) including rheumatic (RVD) and degenerative (DVD) valvular disease. The present proteomic study examined the hypothesis that certain proteins may be associated with the pathological changes in the plasma of VHD patients. Methods and Results: Differential protein analysis in the plasma identified 18 differentially expressed protein spots and 14 corresponding proteins or polypeptides by two-dimensional electrophoresis and mass spectrometry in 120 subjects. Two up-regulated (complement C4A and carbonic anhydrase 1) and three down-regulated proteins (serotransferrin, alpha-1-antichymotrypsin, and vitronectin) were validated by ELISA in enlarging samples. The plasma levels (n = 40 for each) of complement C4A in RVD (715.8 +/- 35.6 vs. 594.7 +/- 28.2 ng/ml, P = 0.009) and carbonic anhydrase 1 (237.70 +/- 15.7 vs. 184.7 +/- 10.8 U/L, P = 0.007) in DVD patients were significantly higher and that of serotransferrin (2.36 +/- 0.20 vs. 2.93 +/- 0.16 mg/ml, P = 0.025) and alpha-1-antichymotrypsin (370.0 +/- 13.7 vs. 413.0 +/- 11.6 mu g/ml, P = 0.019) in RVD patients were significantly lower than those in controls. The plasma vitronectin level in both RVD (281.3 +/- 11.0 vs. 323.2 +/- 10.0 mg/ml, P = 0.006) and DVD (283.6 +/- 11.4 vs. 323.2 +/- 10.0 mu g/ml, P = 0.011) was significantly lower than those in normal controls. Conclusions: We have for the first time identified alterations of 14 differential proteins or polypeptides in the plasma of patients with various VHD. The elevation of plasma complement C4A in RVD and carbonic anhydrase 1 in DVD and the decrease of serotransferrin and alpha-1-antichymotrypsin in RVD patients may be useful biomarkers for these valvular diseases. The decreased plasma level of vitronectin - a protein related to the formation of valvular structure - in both RVD and DVD patients might indicate the possible genetic deficiency in these patients.	[Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China; [Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, Affiliated Hosp, Tianjin, Peoples R China; [Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Hangzhou, Zhejiang, Peoples R China; [Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Xuan, Chao; Liu, Xiao-Cheng; Liu, Zhi-Gang] TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China; [Yang, Qin] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [He, Guo-Wei] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA	Hangzhou Normal University; Hangzhou Normal University; Hangzhou Normal University; Hangzhou Normal University; Chinese University of Hong Kong; Oregon Health & Science University	He, GW (corresponding author), Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China.	gwhezj@163.com	He, Guo-Wei/GPC-6168-2022; Yang, Heroine/GRY-2630-2022; Xuan, Chao/U-4565-2019	He, Guo-Wei/0000-0001-6497-876X; Xuan, Chao/0000-0001-8273-0178	National Natural Science Foundation of China [81170148]; National Basic Research Program of China [2010CB529500]; International S & T Cooperation Program of China [2009DFB30560]; Tianjin Municipal Science and Technology Commission [09ZCZDSF04200, 10JCYBJC26400]; Tianjin Municipal Research Grant for Applied Basic and Frontier Technology, China; Binhai Key Platform for Creative Research Program [2012-BH110004]; Tianjin Binhai New Area Health Bureau [2011BHKZ001, 2012BWKZ 008, 2011BHKY002, 2012 BWKY024]; Tianjin Health Bureau [2012KZ009, 2012KZ010]; Hong Kong Research Grants Council [CUHK4789/09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International S & T Cooperation Program of China; Tianjin Municipal Science and Technology Commission; Tianjin Municipal Research Grant for Applied Basic and Frontier Technology, China; Binhai Key Platform for Creative Research Program; Tianjin Binhai New Area Health Bureau; Tianjin Health Bureau; Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The work described in this paper was fully supported by grants from the National Natural Science Foundation of China (No. 81170148), the National Basic Research Program of China (No. 2010CB529500), International S & T Cooperation Program of China (No. 2009DFB30560) and Tianjin Municipal Science and Technology Commission 09ZCZDSF04200 and 10JCYBJC26400, Tianjin Municipal Research Grant for Applied Basic and Frontier Technology, China, Binhai Key Platform for Creative Research Program (2012-BH110004), Tianjin Binhai New Area Health Bureau (2011BHKZ001 and 2012BWKZ 008) and (2011BHKY002 and 2012 BWKY024) Tianjin Health Bureau (2012KZ009 and 2012KZ010), and Hong Kong Research Grants Council Grants (CUHK4789/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2003, FEBS LETT, V548, P5, DOI 10.1016/S0014-5793(03)00719-1; Aitken A, 2005, PROTEOMICS PROTOCOLS, P319, DOI DOI 10.1385/1-59259-890-0:319; Akhtar S, 1999, CARDIOVASC PATHOL, V8, P203, DOI 10.1016/S1054-8807(99)00003-4; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Andres MT, 2010, ANTIMICROB AGENTS CH, V54, P4335, DOI 10.1128/AAC.01620-09; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Bouchey D, 1996, ANAT RECORD, V244, P540; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carter ND, 1991, CARBONIC ANHYDRASES, P197; Chambers G, 2000, J PATHOL, V192, P280, DOI 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L; Chang XT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3929; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; CHOPRA P, 1992, INT J CARDIOL, V34, P199, DOI 10.1016/0167-5273(92)90156-W; DEMESSIAS IJT, 1995, SCAND J RHEUMATOL, V24, P164, DOI 10.3109/03009749509099307; Fae KC, 2008, J AUTOIMMUN, V31, P136, DOI 10.1016/j.jaut.2008.04.023; Gil-Dones F, 2012, J PROTEOMICS, V75, P1639, DOI 10.1016/j.jprot.2011.11.036; Gozal D, 2009, AM J RESP CRIT CARE, V180, P1253, DOI 10.1164/rccm.200905-0765OC; HARTUNG K, 1992, J CLIN INVEST, V90, P1346, DOI 10.1172/JCI116000; HE GW, 1994, ANN THORAC SURG, V57, P1140, DOI 10.1016/0003-4975(94)91344-7; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hu S.S., 2009, REPORT CARDIOVASCULA; Issaq HJ, 2008, BIOTECHNIQUES, V44, P697, DOI 10.2144/000112823; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; LEGRAND D, 1988, BIOCHIMIE, V70, P1185, DOI 10.1016/0300-9084(88)90184-8; Li LN, 2010, J PROTEOME RES, V9, P2460, DOI 10.1021/pr901151k; Li ZX, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-30; Ma Q, 2010, J PROTEOME RES, V9, P40, DOI 10.1021/pr9001367; Maganti K, 2010, MAYO CLIN PROC, V85, P483, DOI 10.4065/mcp.2009.0706; Man XY, 2003, ANN RHEUM DIS, V62, P71, DOI 10.1136/ard.62.1.71; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Marko-Varga G, 2005, J PROTEOME RES, V4, P1200, DOI 10.1021/pr050122w; Martin-Rojas T, 2012, J PROTEOME RES, V11, P1537, DOI 10.1021/pr2005692; Matt P, 2007, J MOL CELL CARDIOL, V43, P792, DOI 10.1016/j.yjmcc.2007.08.011; Mirjafari P, 2007, IND ENG CHEM RES, V46, P921, DOI 10.1021/ie060287u; Modrego J, 2010, J CARDIOVASC ELECTR, V21, P859, DOI 10.1111/j.1540-8167.2010.01718.x; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Ramanan R, 2009, WORLD J MICROB BIOT, V25, P981, DOI 10.1007/s11274-009-9975-8; SCULLY LJ, 1993, GASTROENTEROLOGY, V104, P1478, DOI 10.1016/0016-5085(93)90359-K; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Tannu NS, 2010, MOL PSYCHIATR, V15, P185, DOI 10.1038/mp.2008.53; Wittmann-Liebold B, 2006, PROTEOMICS, V6, P4688, DOI 10.1002/pmic.200500874; Xuan C, 2012, CIRCULATION, V126; Zhao L, 2011, J COMP PATHOL, V144, P187, DOI 10.1016/j.jcpa.2010.09.001	49	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72111	10.1371/journal.pone.0072111	http://dx.doi.org/10.1371/journal.pone.0072111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015209	Green Published, gold			2022-12-25	WOS:000323815200027
J	Adamu, H; Wegayehu, T; Petros, B				Adamu, Haileeyesus; Wegayehu, Teklu; Petros, Beyene			High Prevalence of Diarrhoegenic Intestinal Parasite Infections among Non-ART HIV Patients in Fitche Hospital, Ethiopia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DIARRHEA; ADULTS; CRYPTOSPORIDIOSIS; EPIDEMIOLOGY; INDIVIDUALS; IMMUNOLOGY; HIV/AIDS; COUNT	Background: HIV infection has been modifying both the epidemiology and outcome of parasite infections. Hence, this study was undertaken to determine the prevalence of Cryptosporidium and other intestinal parasite infections among HIV positives with and without Antiretroviral Treatment(ART) and its association with CD4+ T-cell count. Methods: A cross-sectional study was conducted at Fitche hospital focusing on HIV positives who came to hospital for follow-ups. A total of 378 HIV positive persons with and without ART participated in the study. Data on socio-demographic factors and diarrhoea status were obtained by interviewing all 214 with ART and 164 without ART. Stool samples were collected from all patients and examined for intestinal parasites using direct, formol-ether and modified acid-fast staining techniques. Results: The prevalence of intestinal parasite infections in this study was significantly higher among HIV positive persons not on ART. Specifically, the rate of infection with Cryptosporidium species, Blastocystis spp., Giardia lamblia, and Entamoeba histolytica/E. dispar were higher, particularly in those with CD4+ T-cell counts less than 200 cells/mu L. Fifty seven percent of the study participants were on ART. Out of these 164/378 (43%) of the non-ART study participants were infected with at least one intestinal parasite species. Significant association was observed between lower CD4+ T-cell count (<200 cells/mu L) and the prevalence of Cryptosporidium spp. and Blastocystis spp. The two parasites were significantly more prevalent in HIV positive non-ART patients. Conclusion: HIV infection increased the risk of having Cryptosporidium and other intestinal parasites and diarrhoea. Therefore, raising HIV positive's immune status and screening for intestinal parasites is important. This study showed that patients who are taking ART had a lower prevalence of diarrhoea causing parasites and Cryptosporidium suggesting that ART through improvement of immune status of the patients may have contributed to controlling diarrhoea-causing parasites in HIV positive patients.	[Adamu, Haileeyesus] Univ Addis Ababa, Dept Biol, Addis Ababa, Ethiopia; [Wegayehu, Teklu] Univ Addis Ababa, Coll Hlth Sci, Addis Ababa, Ethiopia; [Petros, Beyene] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; Addis Ababa University	Adamu, H (corresponding author), Univ Addis Ababa, Dept Biol, Addis Ababa, Ethiopia.	haile27@gmail.com		Adamu, Haileeyesus/0000-0003-2998-5977	School of Graduate Studies, Addis Ababa University	School of Graduate Studies, Addis Ababa University	This work was supported by the School of Graduate Studies, Addis Ababa University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu H, 2010, ACTA TROP, V115, P77, DOI 10.1016/j.actatropica.2010.02.003; Adamu H, 2009, ETHIOP J HEALTH DEV, V23, P133; ADEGBOLA RA, 1994, J TROP MED HYG, V97, P103; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Awole M., 2003, ETHIOP J HEALTH DEV, V17, P71; Borkow G, 2004, CLIN MICROBIOL REV, V17, P1012, DOI 10.1128/CMR.17.4.1012-1030.2004; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Cimerman S, 1999, Int J Infect Dis, V3, P203, DOI 10.1016/S1201-9712(99)90025-5; Endeshaw T, 2004, ETHIOPIAN MED J, V42, P195; Endeshaw T, 2006, ETHIOP J HLTH DEV, V21, P61; Foudraine NA, 1998, AIDS, V12, P35, DOI 10.1097/00002030-199801000-00005; Habtamu B, 2006, EPIDEMIOLOGY ECOLOGY, P519; Haileeyesus Adamu, 2006, Ethiopian Journal of Health Development, V20, P39; Hailemariam G, 2004, JPN J INFECT DIS, V57, P41; Kelly P, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-7; Lew EA, 1997, GASTROENTEROL CLIN N, V26, P259, DOI 10.1016/S0889-8553(05)70295-8; Lindo JF, 1998, AM J TROP MED HYG, V59, P717, DOI 10.4269/ajtmh.1998.59.717; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; McGowan I, 1997, GASTROENTEROL CLIN N, V26, P145, DOI 10.1016/S0889-8553(05)70291-0; Mekonnen G, 2007, THESIS ADDIS ABABA U; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Nissapatorn V, 2011, INDIAN J MED RES, V134, P878, DOI 10.4103/0971-5916.92633; Sarfati C, 2006, AM J TROP MED HYG, V74, P162, DOI 10.4269/ajtmh.2006.74.162; Sorvillo FJ, 1995, AM J TROP MED HYG, V53, P656, DOI 10.4269/ajtmh.1995.53.656; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Walson JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000644; WHO, 1998, CONTR TROP DIS; WHO, 2002, PREVENTION CONTROL S	28	38	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72634	10.1371/journal.pone.0072634	http://dx.doi.org/10.1371/journal.pone.0072634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991132	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800080
J	Chen, XH; Zeng, DG; Chen, XL; Xie, DX; Zhao, YZ; Yang, CL; Li, YM; Ma, N; Li, M; Yang, Q; Liao, ZP; Wang, H				Chen, Xiaohan; Zeng, Digang; Chen, Xiuli; Xie, Daxiang; Zhao, Yongzhen; Yang, Chunling; Li, Yongmei; Ma, Ning; Li, Ming; Yang, Qiong; Liao, Zhenping; Wang, Hui			Transcriptome Analysis of Litopenaeus vannamei in Response to White Spot Syndrome Virus Infection	PLOS ONE			English	Article							ANTIGEN PRESENTATION; EXPRESSION ANALYSIS; SIGNALING PATHWAY; MOLECULAR-CLONING; PENAEUS-MONODON; WEB TOOL; SHRIMP; GENES	Pacific white shrimp (Litopenaeus vannamei) is the most extensively farmed crustacean species in the world. White spot syndrome virus (WSSV) is one of the major pathogens in the cultured shrimp. However, the molecular mechanisms of the host-virus interaction remain largely unknown. In this study, the impact of WSSV infection on host gene expression in the hepatopancreas of L. vannamei was investigated through the use of 454 pyrosequencing-based RNA-Seq of cDNA libraries developed from WSSV-challenged shrimp or normal controls. By comparing the two cDNA libraries, we show that 767 host genes are significantly up-regulated and 729 genes are significantly down-regulated by WSSV infection. KEGG analysis of the differentially expressed genes indicated that the distribution of gene pathways between the up-and down-regulated genes is quite different. Among the differentially expressed genes, several are found to be involved in various processes of animal defense against pathogens such as apoptosis, mitogen-activated protein kinase (MAPK) signaling, toll-like receptor (TLR) signaling, Wnt signaling and antigen processing and presentation pathways. The present study provides valuable information on differential expression of L. vannamei genes following WSSV infection and improves our current understanding of this host-virus interaction. In addition, the large number of transcripts obtained in this study provides a strong basis for future genomic research on shrimp.	[Chen, Xiaohan; Zeng, Digang; Chen, Xiuli; Xie, Daxiang; Zhao, Yongzhen; Yang, Chunling; Li, Yongmei; Ma, Ning; Li, Ming; Yang, Qiong; Liao, Zhenping; Wang, Hui] Guangxi Inst Fisheries, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Peoples R China		Zeng, DG (corresponding author), Guangxi Inst Fisheries, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Peoples R China.	swjssys@126.com	zhao, YZ/GXH-6401-2022; li, yong/HDN-3885-2022; ZHAO, YUAN/HCI-5831-2022		National Natural Science Foundation of China [31160531]; "Twelfth Five-Year" National Science and Technology Project in Rural Areas [2012AA10A404-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Twelfth Five-Year" National Science and Technology Project in Rural Areas	This work was supported by the National Natural Science Foundation of China (31160531) and the "Twelfth Five-Year" National Science and Technology Project in Rural Areas (#2012AA10A404-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bonnichon V, 2006, DIS AQUAT ORGAN, V72, P179, DOI 10.3354/dao072179; Brodsky F M, 1992, Trends Cell Biol, V2, P109, DOI 10.1016/0962-8924(92)90015-F; Bruce Alberts AJ, 2002, MOL BIOL CELL; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P297, DOI 10.1016/j.fsi.2004.08.002; COHEN JJ, 1993, HOSP PRACT, V28, P35, DOI 10.1080/21548331.1993.11442887; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Flegel TW, 2011, MAR BIOTECHNOL, V13, P587, DOI 10.1007/s10126-010-9287-x; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gomez-Anduro GA, 2012, COMP BIOCHEM PHYS B, V162, P120, DOI 10.1016/j.cbpb.2012.03.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; James R, 2010, FISH SHELLFISH IMMUN, V29, P884, DOI 10.1016/j.fsi.2010.07.029; Kiatpathomchai W, 2001, DIS AQUAT ORGAN, V47, P235, DOI 10.3354/dao047235; Lee JA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-237; Lightner DV, 1997, REV SCI TECH OIE, V16, P146, DOI 10.20506/rst.16.1.1010; LINZEN B, 1989, NATURWISSENSCHAFTEN, V76, P206, DOI 10.1007/BF00627687; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Liu YC, 2007, MOL IMMUNOL, V44, P598, DOI 10.1016/j.molimm.2006.01.015; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Purdie AC, 2012, COMP IMMUNOL MICROB, V35, P151, DOI 10.1016/j.cimid.2011.12.007; Robalino J, 2007, PHYSIOL GENOMICS, V29, P44, DOI 10.1152/physiolgenomics.00165.2006; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Scherbaum S, 2010, J COMP PHYSIOL B, V180, P1235, DOI 10.1007/s00360-010-0495-5; Song KK, 2010, FISH SHELLFISH IMMUN, V28, P596, DOI 10.1016/j.fsi.2009.12.015; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tan Yan-wei, 2011, Virologica Sinica, V26, P123, DOI 10.1007/s12250-011-3181-1; Tassanakajon A, 2010, MAR BIOTECHNOL, V12, P487, DOI [10.1007/s10126-010-9288-9, 10.1007/s10126-011-9381-8]; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tey SK, 2012, AUTOPHAGY, V8, P1839, DOI 10.4161/auto.21860; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Valles-Jimenez R, 2004, MAR BIOTECHNOL, V6, P475, DOI 10.1007/s10126-004-3138-6; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wang YG, 2000, DIS AQUAT ORGAN, V41, P9, DOI 10.3354/dao041009; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhou JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029961	50	80	83	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73218	10.1371/journal.pone.0073218	http://dx.doi.org/10.1371/journal.pone.0073218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991181	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800096
J	Waknine-Grinberg, JH; Even-Chen, S; Avichzer, J; Turjeman, K; Bentura-Marciano, A; Haynes, RK; Weiss, L; Allon, N; Ovadia, H; Golenser, J; Barenholz, Y				Waknine-Grinberg, Judith H.; Even-Chen, Simcha; Avichzer, Jasmine; Turjeman, Keren; Bentura-Marciano, Annael; Haynes, Richard K.; Weiss, Lola; Allon, Nahum; Ovadia, Haim; Golenser, Jacob; Barenholz, Yechezkel			Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CHEMOKINE RECEPTOR CXCR3; T-CELL RESPONSES; ADHESION MOLECULES; MULTIPLE-SCLEROSIS; LIGANDS CXCL9; DOUBLE-BLIND; IFN-GAMMA; DEXAMETHASONE; ARTEMISONE	Cerebral malaria is the most severe complication of Plasmodium falciparum infection, and a leading cause of death in children under the age of five in malaria-endemic areas. We report high therapeutic efficacy of a novel formulation of liposome-encapsulated water-soluble glucocorticoid prodrugs, and in particular beta-methasone hemisuccinate (BMS), for treatment of experimental cerebral malaria (ECM), using the murine P. berghei ANKA model. BMS is a novel derivative of the potent steroid beta-methasone, and was specially synthesized to enable remote loading into nano-sterically stabilized liposomes (nSSL), to form nSSL-BMS. The novel nano-drug, composed of nSSL remote loaded with BMS, dramatically improves drug efficacy and abolishes the high toxicity seen upon administration of free BMS. nSSL-BMS reduces ECM rates in a dose-dependent manner and creates a survival time-window, enabling administration of an antiplasmodial drug, such as artemisone. Administration of artemisone after treatment with the nSSL-BMS results in complete cure. Treatment with BMS leads to lower levels of cerebral inflammation, demonstrated by changes in cytokines, chemokines, and cell markers, as well as diminished hemorrhage and edema, correlating with reduced clinical score. Administration of the liposomal formulation results in accumulation of BMS in the brains of sick mice but not of healthy mice. This steroidal nano-drug effectively eliminates the adverse effects of the cerebral syndrome even when the treatment is started at late stages of disease, in which disruption of the blood-brain barrier has occurred and mice show clear signs of neurological impairment. Overall, sequential treatment with nSSL-BMS and artemisone may be an efficacious and well-tolerated therapy for prevention of CM, elimination of parasites, and prevention of long-term cognitive damage.	[Waknine-Grinberg, Judith H.; Even-Chen, Simcha; Turjeman, Keren; Allon, Nahum; Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Membrane & Liposome Res, Dept Biochem,IMRIC, IL-91010 Jerusalem, Israel; [Waknine-Grinberg, Judith H.; Bentura-Marciano, Annael; Golenser, Jacob] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Avichzer, Jasmine; Ovadia, Haim] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel; [Haynes, Richard K.] Hong Kong Univ Sci & Technol, Inst Mol Technol Drug Discovery & Synth, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Weiss, Lola] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hong Kong University of Science & Technology; Hebrew University of Jerusalem	Barenholz, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Membrane & Liposome Res, Dept Biochem,IMRIC, IL-91010 Jerusalem, Israel.	jacobg@ekmd.huji.ac.il; yb@ekmd.huji.ac.il	Haynes, Richard/AAB-5820-2022	Haynes, Richard/0000-0001-8554-1823	Barenholz Fund; Gretel B. Bloch Charitable Trust; Sir Zelman Cowen Universities Fund; Israel Science Foundation	Barenholz Fund; Gretel B. Bloch Charitable Trust; Sir Zelman Cowen Universities Fund; Israel Science Foundation(Israel Science Foundation)	This study was supported in part by the Barenholz Fund. The Barenholz Fund is a fund established by Professor Barenholz from royalties that the Hebrew University and Professor Barenholz get from various patents which are dedicated to support research in his lab. There are no connections between the patents for which he gets the royalties and this research, so it is basically a research fund. This work was also supported by grants from The Gretel B. Bloch Charitable Trust, The Sir Zelman Cowen Universities Fund, and the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003515; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Ampawong S, 2011, INT J CLIN EXP PATHO, V4, P566; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Avnir Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025721; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Bonkowski D, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-8; Breman JG, 2012, LANCET INFECT DIS, V12, P820, DOI 10.1016/S1473-3099(12)70226-8; BurkeGaffney A, 1996, AM J PHYSIOL-CELL PH, V270, pC552, DOI 10.1152/ajpcell.1996.270.2.C552; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Cern A, 2012, J CONTROL RELEASE, V160, P147, DOI 10.1016/j.jconrel.2011.11.029; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; Clark CJ, 2011, PARASITE IMMUNOL, V33, P637, DOI 10.1111/j.1365-3024.2011.01329.x; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; Clemmer L, 2011, ANTIMICROB AGENTS CH, V55, P1383, DOI 10.1128/AAC.01277-10; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; de Miranda Aline Silva, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P285; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dubois EFL, 2005, CURR RESPIR MED REV, V1, P103, DOI 10.2174/1573398052953604; Efferth T, 2010, CRIT REV TOXICOL, V40, P405, DOI 10.3109/10408441003610571; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Enwere G, 2005, TROP MED INT HEALTH, V10, P1171, DOI 10.1111/j.1365-3156.2005.01505.x; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Fu Y, 2012, J PARASITOL, V98, P310, DOI 10.1645/GE-2825.1; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; Gelati M, 2000, CAN J NEUROL SCI, V27, P241, DOI 10.1017/S0317167100000883; Ghosh S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-330; Grab DJ, 2011, CELL MICROBIOL, V13, P1470, DOI 10.1111/j.1462-5822.2011.01661.x; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; Haynes RK, 2006, ANGEW CHEM INT EDIT, V45, P2082, DOI 10.1002/anie.200503071; HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Kizelsztein P, 2009, J NEUROIMMUNOL, V213, P20, DOI 10.1016/j.jneuroim.2009.05.019; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Lowenberg M, 2008, STEROIDS, V73, P1025, DOI 10.1016/j.steroids.2007.12.002; Luhder F, 2009, CRIT REV IMMUNOL, V29, P255, DOI 10.1615/CritRevImmunol.v29.i3.50; Martins YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032048; Medana IM, 1996, GLIA, V16, P51, DOI 10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.3.CO;2-2; Medana IM, 2000, AM J PATHOL, V156, P1055, DOI 10.1016/S0002-9440(10)64973-5; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Peng JN, 2010, J MED CHEM, V53, P61, DOI 10.1021/jm900672t; Platten M, 2005, NAT MED, V11, P252, DOI 10.1038/nm0305-252; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Prasad K, 2000, COCHRANE DB SYST REV, V2; Ramharter M, 2006, AM J TROP MED HYG, V75, P637, DOI 10.4269/ajtmh.2006.75.637; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; Sadowska AM, 2007, STEROIDS, V72, P1, DOI 10.1016/j.steroids.2006.10.007; Sarto BY, 2004, ANN TROP MED PARASIT, V98, P297, DOI 10.1179/000349804225003271; Schleimer RP, 2003, MIDDLETONS ALLERGY P, P870; Schmuck G, 2009, BIRTH DEFECTS RES B, V86, P131, DOI 10.1002/bdrb.20192; SMITH MD, 1979, J CHROMATOGR, V164, P129, DOI 10.1016/S0378-4347(00)81182-2; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Villegas-Mendez A, 2011, J IMMUNOL, V187, P2885, DOI 10.4049/jimmunol.1100241; Waknine-Grinberg JH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-227; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wilson NO, 2011, DIS MARKERS, V30, P39, DOI [10.1155/2011/828256, 10.3233/DMA-2011-0763]; World Health Organization, 2007, MAL CHILDR; Zucker D, 2010, J CONTROL RELEASE, V146, P326, DOI 10.1016/j.jconrel.2010.05.024	70	37	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72722	10.1371/journal.pone.0072722	http://dx.doi.org/10.1371/journal.pone.0072722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991146	Green Submitted, gold, Green Published			2022-12-25	WOS:000324228800085
J	Ward, CL; Corona, BT; Yoo, JJ; Harrison, BS; Christ, GJ				Ward, Catherine L.; Corona, Benjamin T.; Yoo, James J.; Harrison, Benjamin S.; Christ, George J.			Oxygen Generating Biomaterials Preserve Skeletal Muscle Homeostasis under Hypoxic and Ischemic Conditions	PLOS ONE			English	Article							SATURATED LIFOR SOLUTION; PIG ISOLATED HEARTS; HYPERBARIC-OXYGEN; COMPARTMENT SYNDROME; CRUSH INJURIES; RAT DIAPHRAGM; LIMB ISCHEMIA; LOW-FLOW; CONTRACTILE; PERFUSION	Provision of supplemental oxygen to maintain soft tissue viability acutely following trauma in which vascularization has been compromised would be beneficial for limb and tissue salvage. For this application, an oxygen generating biomaterial that may be injected directly into the soft tissue could provide an unprecedented treatment in the acute trauma setting. The purpose of the current investigation was to determine if sodium percarbonate (SPO), an oxygen generating biomaterial, is capable of maintaining resting skeletal muscle homeostasis under otherwise hypoxic conditions. In the current studies, a biologically and physiologically compatible range of SPO (1-2 mg/mL) was shown to: 1) improve the maintenance of contractility and attenuate the accumulation of HIF1 alpha, depletion of intramuscular glycogen, and oxidative stress (lipid peroxidation) that occurred following similar to 30 minutes of hypoxia in primarily resting (duty cycle = 0.2 s train/120 s contraction interval <0.002) rat extensor digitorum longus (EDL) muscles in vitro (95% N-2-5% CO2, 37 degrees C); 2) attenuate elevations of rat EDL muscle resting tension that occurred during contractile fatigue testing (3 bouts of 25 100 Hz tetanic contractions; duty cycle = 0.2 s/2 s = 0.1) under oxygenated conditions in vitro (95% O-2-5% CO2, 37 degrees C); and 3) improve the maintenance of contractility (in vivo) and prevent glycogen depletion in rat tibialis anterior (TA) muscle in a hindlimb ischemia model (i.e., ligation of the iliac artery). Additionally, injection of a commercially available lipid oxygen-carrying compound or the components (sodium bicarbonate and hydrogen peroxide) of 1 mg/mL SPO did not improve EDL muscle contractility under hypoxic conditions in vitro. Collectively, these findings demonstrate that a biological and physiological concentration of SPO (1-2 mg/mL) injected directly into rat skeletal muscle (EDL or TA muscles) can partially preserve resting skeletal muscle homeostasis under hypoxic conditions.	[Ward, Catherine L.; Corona, Benjamin T.; Yoo, James J.; Harrison, Benjamin S.; Christ, George J.] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Wake Forest University	Christ, GJ (corresponding author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	gchrist@wakehealth.edu	Yoo, James J./L-4850-2017		Armed Forces Institute for Regenerative Medicine (AFIRM) [W81XWH-08-2-0032]; Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command [W81XWH-07-1-0718]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health [R01AR063808]	Armed Forces Institute for Regenerative Medicine (AFIRM); Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported, in part, by the Armed Forces Institute for Regenerative Medicine (AFIRM) (W81XWH-08-2-0032) and Telemedicine and Advanced Technology Research Center (TATRC) (W81XWH-07-1-0718) at the U.S. Army Medical Research and Materiel Command, as well as the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (R01AR063808) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Bouachour G, 1996, J TRAUMA, V41, P333, DOI 10.1097/00005373-199608000-00023; Bowersox J.C., 1986, J HYPERBARIC MED, V1, P141; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Centis V, 2009, FRONT BIOSCI-LANDMRK, V14, P665, DOI 10.2741/3272; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Clausen T, 2011, EXP PHYSIOL, V96, P356, DOI 10.1113/expphysiol.2010.054999; Corona BT, 2010, AM J PHYSIOL-CELL PH, V298, pC365, DOI 10.1152/ajpcell.00365.2009; Corona BT, 2010, MUSCLE NERVE, V42, P270, DOI 10.1002/mus.21715; Corona BT, 2013, BIOMATERIALS; Criswell TL, 2012, AM J PATHOL, V180, P787, DOI 10.1016/j.ajpath.2011.10.012; CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147; Dragas M, 2009, INJURY, V40, P815, DOI 10.1016/j.injury.2008.08.012; Dutka TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035226; Fernandez MR, 2010, INT ENDOD J, V43, P102, DOI 10.1111/j.1365-2591.2009.01648.x; Gage F, 2009, TRANSPL P, V41, P3571, DOI 10.1016/j.transproceed.2009.06.228; Gifford Shaun M, 2011, Perspect Vasc Surg Endovasc Ther, V23, P81, DOI 10.1177/1531003511410356; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Haapaniemi T, 1996, PLAST RECONSTR SURG, V97, P602, DOI 10.1097/00006534-199603000-00017; Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003; Henke PK, 2009, SEMIN VASC SURG, V22, P34, DOI 10.1053/j.semvascsurg.2009.01.002; Heunks LMA, 2001, AM J PHYSIOL-LUNG C, V281, pL1402, DOI 10.1152/ajplung.2001.281.6.L1402; Hill AV, 1928, P R SOC LOND B-CONTA, V109, P39; HOFMANN WW, 1976, AM J PHYSIOL, V230, P34, DOI 10.1152/ajplegacy.1976.230.1.34; HOOD DA, 1986, AM J PHYSIOL, V250, pE449, DOI 10.1152/ajpendo.1986.250.4.E449; Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513; HUDLICKA O, 1994, J APPL PHYSIOL, V77, P1317, DOI 10.1152/jappl.1994.77.3.1317; IDSTROM JP, 1985, AM J PHYSIOL, V248, pH40, DOI 10.1152/ajpheart.1985.248.1.H40; Kaneko J, 2000, J ENDODONT, V26, P25, DOI 10.1097/00004770-200001000-00006; MATSUDA T, 1987, J TRAUMA, V27, P115, DOI 10.1097/00005373-198702000-00002; MENDEZ J, 1960, METABOLISM, V9, P184; MOHAN C, 1992, AM J SURG, V164, P194, DOI 10.1016/S0002-9610(05)81069-4; Mohanraj P, 1998, J APPL PHYSIOL, V84, P1960, DOI 10.1152/jappl.1998.84.6.1960; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Myers RAM, 2000, INT ANESTHESIOL CLIN, V38, P139, DOI 10.1097/00004311-200001000-00009; Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065; Olschewski P, 2010, CRYOBIOLOGY, V60, P337, DOI 10.1016/j.cryobiol.2010.03.005; Ottenheijm CAC, 2006, AM J PHYSIOL-LUNG C, V290, pL127, DOI 10.1152/ajplung.00073.2005; Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109; Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077; Regner KR, 2010, J SURG RES, V164, pE291, DOI 10.1016/j.jss.2010.08.033; REN JM, 1992, AM J PHYSIOL, V263, pE1086; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; Satterfield CN, 1961, J CHEM ENG DATA, V6, P504; SEGAL SS, 1985, AM J PHYSIOL, V248, pC265, DOI 10.1152/ajpcell.1985.248.3.C265; SINENSKY MC, 1995, TOXICOL LETT, V75, P101; Skuk D, 2013, CELL TRANSP IN PRESS; Skuk D, 2007, NEUROMUSCULAR DISORD, V17, P38, DOI 10.1016/j.nmd.2006.10.003; Smith MA, 2006, RESP PHYSIOL NEUROBI, V151, P229, DOI 10.1016/j.resp.2005.12.011; Stowe DF, 2008, J HEART LUNG TRANSPL, V27, P1008, DOI 10.1016/j.healun.2008.05.028; Stowe DF, 2007, AM J PHYSIOL-HEART C, V293, pH895, DOI 10.1152/ajpheart.00149.2007; Strauss MB, 2012, UNDERSEA HYPERBAR M, V39, P847; TAKAHASHI F, 1987, PLAST RECONSTR SURG, V80, P582, DOI 10.1097/00006534-198710000-00018; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; VESPER SJ, 1994, J HAZARD MATER, V36, P265, DOI 10.1016/0304-3894(94)85019-4; Vidigal J, 2007, MICROSURG, V27, P252, DOI 10.1002/micr.20350; Vinnakota KC, 2010, J PHYSIOL-LONDON, V588, P1961, DOI 10.1113/jphysiol.2009.185934; Wattel F, 1998, ANAESTHESIA, V53, P63; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Wright VP, 2005, J APPL PHYSIOL, V98, P1753, DOI 10.1152/japplphysiol.01022.2004; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu XP, 2005, AM J PHYSIOL-LUNG C, V288, pL16, DOI 10.1152/ajplung.00412.2003	64	46	48	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72485	10.1371/journal.pone.0072485	http://dx.doi.org/10.1371/journal.pone.0072485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991116	Green Submitted, gold, Green Published			2022-12-25	WOS:000324228800075
J	Oue, N; Naito, Y; Hayashi, T; Takigahira, M; Kawano-Nagatsuma, A; Sentani, K; Sakamoto, N; Oo, HZ; Uraoka, N; Yanagihara, K; Ochiai, A; Sasaki, H; Yasui, W				Oue, N.; Naito, Y.; Hayashi, T.; Takigahira, M.; Kawano-Nagatsuma, A.; Sentani, K.; Sakamoto, N.; Oo, H. Zarni; Uraoka, N.; Yanagihara, K.; Ochiai, A.; Sasaki, H.; Yasui, W.			Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-alpha secretion in gastric cancer	ONCOGENE			English	Article						SPC18; SEC11A; signal peptidase complex; prognosis; gastric cancer	GROWTH-FACTOR-ALPHA; GENE-EXPRESSION PROFILES; CDNA MICROARRAY; REG-IV; PROTEIN; CARCINOGENESIS; TUMORIGENESIS; CARCINOMA; BIOMARKER; INVASION	We built an in-house oligonucleotide array on which 394 genes were selected based on our Serial Analysis of Gene Expression (SAGE) data and previously reported array data and listed several genes related to cancer progression. Among these, we focused on SEC11A, which encodes the SPC18 protein. SEC11A mRNA expression was measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) in gastric cancer (GC) tissue samples. Expression and distribution of SPC18 protein were investigated by immunohistochemical analysis in two independent GC cohorts (Hiroshima cohort, n = 99 and Chiba cohort, n 989). To determine the effect of SPC18 on cell viability and invasiveness in vitro, MTT and Boyden chamber invasion assays were performed. To evaluate the influence of SPC18 on cell growth in vivo, GC cells were injected into severe combined immunodeficiency mice. Levels of TGF-alpha and EGF in media from the GC cells were measured by enzyme-linked immunosorbent assay (ELISA). Studies in human tissue revealed overexpression of SEC11A mRNA in 40% of 42 GC samples by qRT-PCR. Immunohistochemical analysis of SPC18 revealed that 26 and 20% of GC cases were SPC18-positive in the Hiroshima and Chiba cohorts, respectively. In both cohorts, the Kaplan-Meier analysis showed poorer survival in SPC18-positive GC cases than in SPC18-negative GC cases. Forced expression of SPC18 activates GC cell growth in vitro and in vivo. The levels of TGF-alpha in culture media from GC cells were reduced by knockdown of SPC18. These results indicate that SPC18 contributes to malignant progression through promotion of TGF-alpha secretion in GC.	[Oue, N.; Naito, Y.; Hayashi, T.; Sentani, K.; Sakamoto, N.; Oo, H. Zarni; Uraoka, N.; Yasui, W.] Hiroshima Univ Inst Biomed & Hlth Sci, Dept Mol Pathol, Minami Ku, Hiroshima 7348551, Japan; [Takigahira, M.] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Investigat Treatment Div, Kashiwa, Chiba, Japan; [Kawano-Nagatsuma, A.; Ochiai, A.] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba, Japan; [Yanagihara, K.] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Translat Res, Kashiwa, Chiba, Japan; [Sasaki, H.] Natl Canc Ctr, Div Genet, Tokyo, Japan	Hiroshima University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Yasui, W (corresponding author), Hiroshima Univ Inst Biomed & Hlth Sci, Dept Mol Pathol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	wyasui@hiroshima-u.ac.jp			Grants-in-Aid for Scientific Research [13J01171] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; de Castro NP, 2010, FUTURE ONCOL, V6, P1127, DOI [10.2217/fon.10.68, 10.2217/FON.10.68]; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; GREENBURG G, 1989, J BIOL CHEM, V264, P15762; Hasegawa S, 2002, CANCER RES, V62, P7012; Hippo Y, 2001, CANCER RES, V61, P889; Hippo Y, 2002, CANCER RES, V62, P233; Ii M, 2006, EXP BIOL MED, V231, P20; Inoue H, 2002, CLIN CANCER RES, V8, P3475; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nitadori JI, 2006, AM J CLIN PATHOL, V125, P682, DOI 10.1309/DT6BJ698LDX2NGGX; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Oue N, 2009, INT J CANCER, V125, P2383, DOI 10.1002/ijc.24624; Regalo G, 2010, LAB INVEST, V90, P1132, DOI 10.1038/labinvest.2010.79; SHELNESS GS, 1990, J BIOL CHEM, V265, P9512; TEIXIDO J, 1987, NATURE, V326, P883, DOI 10.1038/326883a0; Ueda Masatsugu, 1998, Invasion and Metastasis, V18, P176, DOI 10.1159/000024510; Yasui W, 1999, JPN J CANCER RES, V90, P589, DOI 10.1111/j.1349-7006.1999.tb00787.x; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006; Zembutsu H, 2002, CANCER RES, V62, P518	25	30	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3918	3926		10.1038/onc.2013.364	http://dx.doi.org/10.1038/onc.2013.364			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	23995782				2022-12-25	WOS:000339394700004
J	Cowling, VH; Turner, SA; Cole, MD				Cowling, V. H.; Turner, S. A.; Cole, M. D.			Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis	ONCOGENE			English	Article						Myc; lymphoma; mutations; Burkitt's; transcription	N-TERMINAL DOMAIN; RNA-POLYMERASE-I; TRANSACTIVATION DOMAIN; RIBOSOME BIOGENESIS; PROTEIN-SYNTHESIS; CODING REGION; DNA-BINDING; PHOSPHORYLATION; TRANSCRIPTION; EXPRESSION	Burkitt's lymphomas (BLs) acquire consistent point mutations in a conserved domain of Myc, Myc Box I. We report that the enhanced transforming activity of BL-associated Myc mutants can be uncoupled from loss of phosphorylation and increased protein stability. Furthermore, two different BL-associated Myc mutations induced similar gene expression profiles independently of T58 phosphorylation, and these profiles are dramatically different from MycWT. Nol5a/Nop56, which is required for ribosomal RNA methylation, was identified as a gene hyperactivated by the BL-associated Myc mutants. We show that Nol5a is necessary for Myc-induced cell transformation, enhances MycWT-induced cell transformation and increases the size of MycWT-induced tumors. Thus, Nol5a expands the link between Myc-induced regulation of nucleolar target genes, which are rate limiting for cell transformation and tumor growth.	[Cowling, V. H.; Cole, M. D.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dept Pharmacol, Lebanon, NH 03756 USA; [Turner, S. A.; Cole, M. D.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dept Genet, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center	Cole, MD (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dept Pharmacol, One Med Ctr Dr,Rubin 633, Lebanon, NH 03756 USA.	Michael.D.Cole@dartmouth.edu		Cowling, Victoria/0000-0001-7638-4870	National Cancer Institute [CA055248]; National Institute of General Medical Sciences [T32GM008704]; NATIONAL CANCER INSTITUTE [R01CA080320, R01CA055248, P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER; MRC [MR/K024213/1, G0700240] Funding Source: UKRI; Medical Research Council [MR/K024213/1, G0700240] Funding Source: researchfish	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Steve Hann and Chi Dang for providing cell lines. This project was supported by a grant from the National Cancer Institute (CA055248; MDC) and by Award Number T32GM008704 from the National Institute of General Medical Sciences (SAT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Alawi F, 2007, BIOCHEM BIOPH RES CO, V362, P893, DOI 10.1016/j.bbrc.2007.08.071; ALBERT T, 1994, ONCOGENE, V9, P759; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bogomolnaya LM, 2004, CURR GENET, V45, P350, DOI 10.1007/s00294-004-0497-5; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; BRENNSCHEIDT U, 1994, LEUKEMIA, V8, P897; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; CLARK HM, 1994, CANCER RES, V54, P3383; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Goy A, 2006, CANCER CYTOPATHOL, V108, P10, DOI 10.1002/cncr.21500; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hayano T, 2003, J BIOL CHEM, V278, P34309, DOI 10.1074/jbc.M304304200; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; JOHNSTON JM, 1991, BLOOD, V78, P2419; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Li Z, 2013, ONCOGENE, V32, P1988, DOI 10.1038/onc.2012.227; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Machida YJ, 2006, MOL BIOL CELL, V17, P4837, DOI 10.1091/mbc.E06-04-0340; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pandolfi PP, 2004, ONCOGENE, V23, P3134, DOI 10.1038/sj.onc.1207618; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; PULVERER BJ, 1994, ONCOGENE, V9, P59; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vallat LD, 2007, BLOOD, V109, P3989, DOI 10.1182/blood-2006-09-045377; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; YANO T, 1993, ONCOGENE, V8, P2741; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yustein JT, 2007, CURR OPIN HEMATOL, V14, P375, DOI 10.1097/MOH.0b013e3281bccdee	60	32	34	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2014	33	27					3519	3527		10.1038/onc.2013.338	http://dx.doi.org/10.1038/onc.2013.338			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2FK	24013231	Green Accepted			2022-12-25	WOS:000338941100004
J	Kasar, S; Underbayev, C; Yuan, Y; Hanlon, M; Aly, S; Khan, H; Chang, V; Batish, M; Gavrilova, T; Badiane, F; Degheidy, H; Marti, G; Raveche, E				Kasar, S.; Underbayev, C.; Yuan, Y.; Hanlon, M.; Aly, S.; Khan, H.; Chang, V.; Batish, M.; Gavrilova, T.; Badiane, F.; Degheidy, H.; Marti, G.; Raveche, E.			Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia	ONCOGENE			English	Article						miR-15a/16-1; BSAP; HDAC inhibitor; CLL; NZB	HISTONE DEACETYLASE INHIBITOR; ZEALAND BLACK MOUSE; MALIGNANT B-1 CELLS; TRANSCRIPTION FACTOR; MULTIPLE-MYELOMA; MANTLE CELL; B-CELLS; PAX5; 13Q14; EXPRESSION	Genetic lesions and other regulatory events lead to silencing of the 13q14 locus in a majority of chronic lymphocytic leukemia (CLL) patients. This locus encodes a pair of critical proapoptotic microRNAs, miR-15a/16-1. Decreased levels of miR-15a/16-1 are critical for the increased survival exhibited by CLL cells. Similarly, in a de novo murine model of CLL, the NZB strain, germline-encoded regulation of the syntenic region resulted in decreased miR-15a/16-1. In this paper, we have identified additional molecular mechanisms regulating miR-15a/16-1 levels and have shown that the transcription factor BSAP (B-cell-specific activator protein) directly interacts with Dleu2, the host gene containing the miR-15a/16-1 loci, and by negative regulation of the Dleu2 promoter, results in repression of miR-15a/16-1 expression. CLL patient B-cell expression levels of BSAP were increased compared with control sources of B cells. With the use of small interfering RNA-mediated repression, the levels of BSAP were decreased in vitro in the NZB-derived malignant B-1 cell line, LNC, and in ex vivo CLL patient peripheral blood mononuclear cells (PBMCs). BSAP knockdown led to an increase in the expression of miR-15a/16-1 and an increase in apoptosis, and a cell cycle arrest in both the cell line and patient PBMCs. Moreover, using Dleu2 promoter analysis by chromatin immunoprecipitation assay, we have shown that BSAP directly interacts with the Dleu2 promoter. Derepression of the Dleu2 promoter via inhibition of histone deacetylation combined with BSAP knockdown increased miR-15a/16-1 expression, and also increased malignant B-cell death. In summary, therapy targeting enhanced host gene Dleu2 transcription may augment CLL therapy.	[Kasar, S.; Underbayev, C.; Hanlon, M.; Aly, S.; Khan, H.; Chang, V.; Batish, M.; Gavrilova, T.; Badiane, F.; Raveche, E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Yuan, Y.] NIH, Bethesda, MD 20892 USA; [Chang, V.] Vet Affairs New Jersey Hlth Care Syst, E Orange, NJ USA; [Degheidy, H.; Marti, G.] OSEL CDRH FDA, White Oak, MD USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Raveche, E (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, 185S Orange Ave,MSB C-512, Newark, NJ 07103 USA.	batishmo@njms.rutgers.edu; raveches@njms.rutgers.edu	Underbayev, Chingiz/J-2970-2019; Batish, Mona/AAG-8296-2019	Batish, Mona/0000-0001-9039-6149; Chang, Victor/0000-0003-3640-7235	NSF/FDA/SIR [1238375]; NIH [R01CA12926]; Early Independence Award [1DP5OD012160-01]; UMDNJ-NJMS Flow Cytometry Core; NATIONAL CANCER INSTITUTE [R01CA129826] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012160] Funding Source: NIH RePORTER	NSF/FDA/SIR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Independence Award; UMDNJ-NJMS Flow Cytometry Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NSF/FDA/SIR No. 1238375 and NIH R01CA12926 (ESR). Early Independence Award # 1DP5OD012160-01 (MB). We thank the UMDNJ-NJMS Flow Cytometry Core for their support.	Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Batish M, 2011, METHODS MOL BIOL, V714, P3, DOI 10.1007/978-1-61779-005-8_1; Bottcher S, 2012, J CLIN ONCOL, V30, P980, DOI 10.1200/JCO.2011.36.9348; Bougel S, 2010, J PATHOL, V220, P87, DOI 10.1002/path.2620; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Chang H, 2004, LEUKEMIA LYMPHOMA, V45, P965, DOI 10.1080/10428190310001638832; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen L.-J., 2007, Experimental Oncology, V29, P116; Chong SY, 2001, CANCER IMMUNOL IMMUN, V50, P41, DOI 10.1007/s002620000165; Chung EY, 2012, J CLIN INVEST, V122, P2257, DOI 10.1172/JCI45851; Chung EY, 2008, CANCER BIOL THER, V7, P1758, DOI 10.4161/cbt.7.11.6722; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Corcoran MM, 1998, BLOOD, V91, P1382, DOI 10.1182/blood.V91.4.1382; Crapoulet N, 2011, ANTI-CANCER AGENT ME, V11, P643, DOI 10.2174/187152011796817637; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dubovsky JA, 2011, LEUKEMIA RES, V35, P394, DOI 10.1016/j.leukres.2010.08.001; El-Khoury V, 2010, MOL CANCER THER, V9, P1349, DOI 10.1158/1535-7163.MCT-09-1000; Firtina S, 2012, LEUKEMIA RES, V36, P87, DOI 10.1016/j.leukres.2011.07.017; Hamada T, 1998, BRIT J HAEMATOL, V102, P691; Hanlon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007169; Humphrey RW, 2011, JNCI-J NATL CANCER I, V103, P1222, DOI 10.1093/jnci/djr246; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; Kasar S, 2012, GENES IMMUN, V13, P109, DOI 10.1038/gene.2011.58; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Krenacs L, 1998, BLOOD, V92, P1308, DOI 10.1182/blood.V92.4.1308.416k32_1308_1316; Kubetzko FBB, 2004, CARCINOGENESIS, V25, P1839, DOI 10.1093/carcin/bgh190; Lanasa MC, 2011, LEUKEMIA, V25, P1459, DOI 10.1038/leu.2011.117; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lucas DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010941; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mertens D, 2009, LEUKEMIA LYMPHOMA, V50, P502, DOI 10.1080/10428190902763509; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Montserrat E, 2008, BLOOD, V112, P924, DOI 10.1182/blood-2008-05-155721; O'Brien P, 2011, CANCER RES, V71, P7345, DOI 10.1158/0008-5472.CAN-11-1874; Palamarchuk A, 2010, BLOOD, V115, P3916, DOI 10.1182/blood-2009-10-249367; PENG BH, 1994, J IMMUNOL, V153, P1869; Perez-Perarnau A, 2011, EPIGENETICS-US, V6, P1228, DOI 10.4161/epi.6.10.17200; Piller GJ, 2001, BRIT J HAEMATOL, V112, P282, DOI 10.1046/j.1365-2141.2001.02411.x; Poppe B, 2005, GENE CHROMOSOME CANC, V44, P218, DOI 10.1002/gcc.20214; Proulx M, 2010, INT J HEMATOL, V92, P451, DOI 10.1007/s12185-010-0691-9; Ramalingam SS, 2009, J THORAC ONCOL, V4, P97, DOI 10.1097/JTO.0b013e318191520c; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; ROBERTSON LE, 1992, BLOOD, V80, P29; Robichaud GA, 2008, NUCLEIC ACIDS RES, V36, P4609, DOI 10.1093/nar/gkn432; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Salerno E, 2010, CYTOM PART B-CLIN CY, V78B, pS98, DOI 10.1002/cyto.b.20544; Salerno E, 2009, MOL CANCER THER, V8, P2684, DOI 10.1158/1535-7163.MCT-09-0127; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Scaglione BJ, 2007, BRIT J HAEMATOL, V139, P645, DOI 10.1111/j.1365-2141.2007.06851.x; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Stathis A, 2011, CLIN CANCER RES, V17, P1582, DOI 10.1158/1078-0432.CCR-10-1893; Thelander EF, 2007, LEUKEMIA RES, V31, P1219, DOI 10.1016/j.leukres.2006.10.022; Van Damme M, 2012, EPIGENETICS-US, V7, P1403, DOI 10.4161/epi.22674; Wang JC, 2011, ONCOLOGY-BASEL, V81, P325, DOI 10.1159/000334577; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Zhang M, 1998, ONCOL REP, V5, P23; Zhang M, 2001, EXP CELL RES, V264, P233, DOI 10.1006/excr.2000.5122; Zhang X, 2012, ONCOGENE, V31, P3002, DOI 10.1038/onc.2011.470; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	66	31	32	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 19	2014	33	25					3307	3315		10.1038/onc.2013.291	http://dx.doi.org/10.1038/onc.2013.291			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK5DA	23995789	Green Accepted			2022-12-25	WOS:000338443400010
J	Mangione, PP; Esposito, G; Relini, A; Raimondi, S; Porcari, R; Giorgetti, S; Corazza, A; Fogolari, F; Penco, A; Goto, Y; Lee, YH; Yagi, H; Cecconi, C; Naqvi, MM; Gillmore, JD; Hawkins, PN; Chiti, F; Rolandi, R; Taylor, GW; Pepys, MB; Stoppini, M; Bellotti, V				Mangione, P. Patrizia; Esposito, Gennaro; Relini, Annalisa; Raimondi, Sara; Porcari, Riccardo; Giorgetti, Sofia; Corazza, Alessandra; Fogolari, Federico; Penco, Amanda; Goto, Yuji; Lee, Young-Ho; Yagi, Hisashi; Cecconi, Ciro; Naqvi, Mohsin M.; Gillmore, Julian D.; Hawkins, Philip N.; Chiti, Fabrizio; Rolandi, Ranieri; Taylor, Graham W.; Pepys, Mark B.; Stoppini, Monica; Bellotti, Vittorio			Structure, Folding Dynamics, and Amyloidogenesis of D76N beta(2)-Microglobulin ROLES OF SHEAR FLOW, HYDROPHOBIC SURFACES, AND alpha-CRYSTALLIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID PEPTIDE; GLOBULAR-PROTEINS; ELECTROSTATIC PROPERTIES; PHYSIOLOGICAL CONDITIONS; ENERGY LANDSCAPE; ADSORPTION; FORCE; AGGREGATION; INTERFACE; CONFORMATION	Systemic amyloidosis is a fatal disease caused by misfolding of native globular proteins, which then aggregate extracellularly as insoluble fibrils, damaging the structure and function of affected organs. The formation of amyloid fibrils in vivo is poorly understood. We recently identified the first naturally occurring structural variant, D76N, of human beta(2)-microglobulin (beta(2)m), the ubiquitous light chain of class I major histocompatibility antigens, as the amyloid fibril protein in a family with a new phenotype of late onset fatal hereditary systemic amyloidosis. Here we show that, uniquely, D76N beta(2)m readily forms amyloid fibrils in vitro under physiological extracellular conditions. The globular native fold transition to the fibrillar state is primed by exposure to a hydrophobic-hydrophilic interface under physiological intensity shear flow. Wild type beta(2)m is recruited by the variant into amyloid fibrils in vitro but is absent from amyloid deposited in vivo. This may be because, as we show here, such recruitment is inhibited by chaperone activity. Our results suggest general mechanistic principles of in vivo amyloid fibrillogenesis by globular proteins, a previously obscure process. Elucidation of this crucial causative event in clinical amyloidosis should also help to explain the hitherto mysterious timing and location of amyloid deposition.	[Gillmore, Julian D.; Hawkins, Philip N.; Taylor, Graham W.; Pepys, Mark B.; Bellotti, Vittorio] UCL, Wolfson Drug Discovery Unit, Ctr Amyloidosis & Acute Phase Prot, Div Med, London NW3 2PF, England; [Mangione, P. Patrizia; Raimondi, Sara; Giorgetti, Sofia; Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Dept Mol Med, Inst Biochem, I-27100 Pavia, Italy; [Esposito, Gennaro; Corazza, Alessandra; Fogolari, Federico] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Relini, Annalisa; Penco, Amanda; Rolandi, Ranieri] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Goto, Yuji; Lee, Young-Ho; Yagi, Hisashi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Cecconi, Ciro] CNR, Nanosci Inst, I-41125 Modena, Italy; [Naqvi, Mohsin M.] Univ Modena & Reggio Emilia, Dept Phys, I-41125 Modena, Italy; [Chiti, Fabrizio] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy	University of London; University College London; University of Pavia; University of Udine; University of Genoa; Osaka University; Consiglio Nazionale delle Ricerche (CNR); Universita di Modena e Reggio Emilia; University of Florence	Bellotti, V (corresponding author), UCL, Wolfson Drug Discovery Unit, Ctr Amyloidosis & Acute Phase Prot, Div Med, Rowland Hill St, London NW3 2PF, England.	v.bellotti@ucl.ac.uk	Rolandi, Ranieri/C-4765-2012; Giorgetti, Sofia/AAD-4341-2019; Corazza, Alessandra/AGB-1457-2022; Relini, Annalisa/AHC-3105-2022; Cecconi, Ciro/K-5028-2016; Bellotti, Vittorio/A-6201-2014	Rolandi, Ranieri/0000-0002-0580-1611; Giorgetti, Sofia/0000-0001-9438-6511; Corazza, Alessandra/0000-0003-2272-1928; Cecconi, Ciro/0000-0002-6101-2609; Fogolari, Federico/0000-0001-9862-250X; RELINI, ANNALISA/0000-0002-4040-9279; Taylor, Graham/0000-0002-9672-8463; Bellotti, Vittorio/0000-0001-8678-662X; Mangione, Palma/0000-0003-0260-1400	United Kingdom Medical Research Council [MR/K000187/1]; University College London (UCL) Amyloidosis Research Fund; UCL Wolfson Drug Discovery Unit Funds; Cariplo Foundation [2009-2543, 2011-2096]; Italian Ministry of University; Research Project FIRB RBFR109EOS; Regione Lombardia; International Collaborative Research Program of the Institute for Protein Research, Osaka University; MRC [MR/K000187/1, G7900510] Funding Source: UKRI; Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN; Medical Research Council [MR/K000187/1, G7900510] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London (UCL) Amyloidosis Research Fund; UCL Wolfson Drug Discovery Unit Funds; Cariplo Foundation(Fondazione Cariplo); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Research Project FIRB RBFR109EOS; Regione Lombardia(Regione Lombardia); International Collaborative Research Program of the Institute for Protein Research, Osaka University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by United Kingdom Medical Research Council Grant MR/K000187/1 (to V. B.), the University College London (UCL) Amyloidosis Research Fund and UCL Wolfson Drug Discovery Unit Funds, Cariplo Foundation Projects 2009-2543 and 2011-2096 (to V. B.), Italian Ministry of University and Research Project FIRB RBFR109EOS (to S. G.), Regione Lombardia (to V. B.), and the International Collaborative Research Program of the Institute for Protein Research, Osaka University (to R. P.). Core support for the Wolfson Drug Discovery Unit is provided by the United Kingdom National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme.	Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bekard IB, 2011, BIOPOLYMERS, V95, P733, DOI 10.1002/bip.21646; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Donaldson SH, 2011, P NATL ACAD SCI USA, V108, P15699, DOI 10.1073/pnas.1112411108; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; FARMER BT, 1992, J BIOMOL NMR, V2, P195, DOI 10.1007/BF01875530; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fogolari F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S18; Garvey M, 2011, BIOPOLYMERS, V95, P376, DOI 10.1002/bip.21584; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hammer MU, 2010, FARADAY DISCUSS, V146, P299, DOI 10.1039/b926184b; Hoernke M, 2011, LANGMUIR, V27, P14218, DOI 10.1021/la203016z; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P291, DOI 10.1016/B978-0-12-375182-9.10014-4; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; KEELER J, 1994, METHOD ENZYMOL, V239, P145; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Krasowska M, 2009, ADV COLLOID INTERFAC, V147-48, P155, DOI 10.1016/j.cis.2008.10.003; Lad MD, 2006, PHYS CHEM CHEM PHYS, V8, P2179, DOI 10.1039/b515934b; Lapidus S, 2008, P NATL ACAD SCI USA, V105, P6039, DOI 10.1073/pnas.0708708105; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Munson B.R., 2009, FUNDAMENTALS FLUID M, V6th; NARSIMHAN G, 1992, BIOTECHNOL PROGR, V8, P187, DOI 10.1021/bp00015a003; Ozawa D, 2011, J BIOL CHEM, V286, P9668, DOI 10.1074/jbc.M110.167965; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Rennella E, 2012, BBA-PROTEINS PROTEOM, V1824, P842, DOI 10.1016/j.bbapap.2012.04.002; Rennella E, 2012, J AM CHEM SOC, V134, P4457, DOI 10.1021/ja209004q; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Sethuraman A, 2004, PROTEINS, V56, P669, DOI 10.1002/prot.20183; Shankaran H, 2004, BIOPHYS J, V86, P576, DOI 10.1016/S0006-3495(04)74136-3; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Szymczak P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033102; Teoh CL, 2011, BIOCHEMISTRY-US, V50, P4046, DOI 10.1021/bi2002482; TRIPP BC, 1995, J COLLOID INTERF SCI, V173, P16, DOI 10.1006/jcis.1995.1291; Urry DW, 2002, J MUSCLE RES CELL M, V23, P543, DOI 10.1023/A:1023422925910; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Walsh I, 2012, BIOINFORMATICS, V28, P2189, DOI 10.1093/bioinformatics/bts343; Wang QM, 2011, PHYS CHEM CHEM PHYS, V13, P15200, DOI 10.1039/c1cp21156k; Webster GT, 2011, J PHYS CHEM B, V115, P2617, DOI 10.1021/jp110367t; Wierenga PA, 2003, LANGMUIR, V19, P8964, DOI 10.1021/la034868p; Wierenga PA, 2006, J COLLOID INTERF SCI, V299, P850, DOI 10.1016/j.jcis.2006.03.016; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688; Yu X, 2012, LANGMUIR, V28, P6595, DOI 10.1021/la3002306	74	67	68	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30917	30930		10.1074/jbc.M113.498857	http://dx.doi.org/10.1074/jbc.M113.498857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014031	Green Published, hybrid			2022-12-25	WOS:000330778900012
J	De La Mota-Peynado, A; Lee, SYC; Pierce, BM; Wani, P; Singh, CR; Roelofs, J				De La Mota-Peynado, Alina; Lee, Stella Yu-Chien; Pierce, Brianne Marie; Wani, Prashant; Singh, Chingakham Ranjit; Roelofs, Jeroen			The Proteasome-associated Protein Ecm29 Inhibits Proteasomal ATPase Activity and in Vivo Protein Degradation by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; REGULATORY PARTICLE; CORE PARTICLE; ORNITHINE DECARBOXYLASE; MOLECULAR ARCHITECTURE; STRESS-RESPONSE; CANCER-THERAPY; SUBUNITS; TERMINI; BINDING	Several proteasome-associated proteins regulate degradation by the 26 S proteasome using the ubiquitin chains that mark most substrates for degradation. The proteasome-associated protein Ecm29, however, has no ubiquitin-binding or modifying activity, and its direct effect on substrate degradation is unclear. Here, we show that Ecm29 acts as a proteasome inhibitor. Besides inhibiting the proteolytic cleavage of peptide substrates in vitro, it inhibits the degradation of ubiquitin-dependent and -independent substrates in vivo. Binding of Ecm29 to the proteasome induces a closed conformation of the substrate entry channel of the core particle. Furthermore, Ecm29 inhibits proteasomal ATPase activity, suggesting that the mechanism of inhibition and gate regulation by Ecm29 is through regulation of the proteasomal ATPases. Consistent with this, we identified through chemical cross-linking that Ecm29 binds to, or in close proximity to, the proteasomal ATPase subunit Rpt5. Additionally, we show that Ecm29 preferentially associates with both mutant and nucleotide depleted proteasomes. We propose that the inhibitory ability of Ecm29 is important for its function as a proteasome quality control factor by ensuring that aberrant proteasomes recognized by Ecm29 are inactive.	[De La Mota-Peynado, Alina; Lee, Stella Yu-Chien; Pierce, Brianne Marie; Singh, Chingakham Ranjit; Roelofs, Jeroen] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Wani, Prashant; Roelofs, Jeroen] Kansas State Univ, Grad Biochem Grp, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Roelofs, J (corresponding author), Kansas State Univ, Div Biol, 338 Ackert Hall, Manhattan, KS 66506 USA.	jroelofs@ksu.edu	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465; Dentel, Brianne/0000-0003-4384-3529	National Institutes of Health from the National Center for Research Resources [5P20 RR017708, P20 RR016475]; National Institutes of Health from NIGMS [8 P20 GM103420, P20 GM103418]; Johnson Cancer Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Johnson Cancer Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20 RR017708 and P20 RR016475 (from the National Center for Research Resources) and 8 P20 GM103420 and P20 GM103418 (from NIGMS). This work was also supported by the Johnson Cancer Research Center.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lander GC, 2013, CURR OPIN STRUC BIOL, V23, P243, DOI 10.1016/j.sbi.2013.02.004; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee SH, 2012, J BIOL CHEM, V287, P9269, DOI 10.1074/jbc.M111.316208; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Liu CW, 2013, TRENDS BIOCHEM SCI, V38, P103, DOI 10.1016/j.tibs.2012.11.009; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shim SM, 2012, CELL REP, V2, P603, DOI 10.1016/j.celrep.2012.07.013; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Um JW, 2010, J BIOL CHEM, V285, P36434, DOI 10.1074/jbc.M110.133777; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232	61	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29467	29481		10.1074/jbc.M113.491662	http://dx.doi.org/10.1074/jbc.M113.491662			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995839	hybrid, Green Published			2022-12-25	WOS:000330615300024
J	Krumm, SA; Takeda, M; Plemper, RK				Krumm, Stefanie A.; Takeda, Makoto; Plemper, Richard K.			The Measles Virus Nucleocapsid Protein Tail Domain Is Dispensable for Viral Polymerase Recruitment and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; RESPIRATORY SYNCYTIAL VIRUS; RNA-SYNTHESIS; P PROTEIN; CRYSTAL-STRUCTURE; PHOSPHOPROTEIN; NUCLEOPROTEIN; BINDING; COMPLEX; GENOME	Paramyxovirus genomes are ribonucleoprotein (RNP) complexes consisting of nucleoprotein (N)-encapsidated viral RNA. Measles virus (MeV) N features an amino-terminal RNA-binding core and a 125-residue tail domain, of which only the last 75 residues are considered fully mobile on the nucleocapsid surface. A molecular recognition element (MoRE) domain mediates binding of the viral phosphoprotein (P). This P N-tail interaction is considered instrumental for recruiting the polymerase complex to the template. We have engineered MeV N variants with tail truncations progressively eliminating the MoRE domain and upstream tail sections. Confirming previous reports, RNPs with N truncations lacking the carboxyl-terminal 43-residues harboring the MoRE domain cannot serve as polymerase template. Remarkably, further removal of all tail residues predicted to be surface-exposed significantly restores RNP bioactivity. Insertion of structurally dominant tags into the central N-tail section reduces bioactivity, but the negative regulatory effect of exposed N-tail stems is sequence-independent. Bioactive nucleocapsids lacking exposed N-tail sections are unable to sustain virus replication, because of weakened interaction of the advancing polymerase complex with the template. Deletion of the N-MoRE-binding domain in P abrogates polymerase recruitment to standard nucleocapsids, but polymerase activity is partially restored when N-tail truncated RNPs serve as template. Revising central elements of the current replication model, these data reveal that MeV polymerase is capable of productively docking directly to the nucleocapsid core. Dispensable for polymerase recruitment, N-MoRE binding to P-tail stabilizes the advancing polymerase-RNP complex and may rearrange unstructured central tail sections to facilitate polymerase access to the template.	[Krumm, Stefanie A.; Plemper, Richard K.] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Takeda, Makoto] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Musashimurayama 2080011, Japan	University System of Georgia; Georgia State University; National Institute of Infectious Diseases (NIID)	Plemper, RK (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Petit Sci Ctr Ste 712,100 Piedmont Ave, Atlanta, GA 30303 USA.	rplemper@gsu.edu	Takeda, Makoto/J-2550-2018	Takeda, Makoto/0000-0002-8194-7727	National Institutes of Health [AI071002, AI085328, AI083402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071002, R56AI083402, R01AI083402, R21AI085328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071002, AI085328, and AI083402 (to R.K.P.).	Bankamp B, 1996, VIROLOGY, V216, P272, DOI 10.1006/viro.1996.0060; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; BUCHHOLZ CJ, 1993, J VIROL, V67, P5803, DOI 10.1128/JVI.67.10.5803-5812.1993; BUCHHOLZ CJ, 1994, VIROLOGY, V204, P770, DOI 10.1006/viro.1994.1592; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; Cevik B, 2004, VIROLOGY, V325, P216, DOI 10.1016/j.virol.2004.05.012; COLLINS PL, 1983, P NATL ACAD SCI-BIOL, V80, P3208, DOI 10.1073/pnas.80.11.3208; Communie G, 2013, J VIROL, V87, P7166, DOI 10.1128/JVI.00487-13; Couturier M, 2010, J MOL RECOGNIT, V23, P301, DOI 10.1002/jmr.982; Cox R, 2013, J VIROL, V87, P7558, DOI 10.1128/JVI.00653-13; CURRAN J, 1993, J VIROL, V67, P4358, DOI 10.1128/JVI.67.7.4358-4364.1993; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; Curran J, 1998, J VIROL, V72, P4274, DOI 10.1128/JVI.72.5.4274-4280.1998; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; Desfosses A, 2011, J VIROL, V85, P1391, DOI 10.1128/JVI.01459-10; DIALLO A, 1994, J GEN VIROL, V75, P233, DOI 10.1099/0022-1317-75-1-233; Dochow M, 2012, J BIOL CHEM, V287, P6878, DOI 10.1074/jbc.M111.325258; Doyle J, 2006, J VIROL, V80, P1524, DOI 10.1128/JVI.80.3.1524-1536.2006; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Houben K, 2007, BIOPHYS J, V93, P2830, DOI 10.1529/biophysj.107.108829; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Kingston RL, 2004, J VIROL, V78, P8630, DOI 10.1128/JVI.78.16.8630-8640.2004; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Laine D, 2003, J VIROL, V77, P11332, DOI 10.1128/JVI.77.21.11332-11346.2003; Laine D, 2005, J GEN VIROL, V86, P1771, DOI 10.1099/vir.0.80791-0; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Longhi S., 2011, NEGATIVE STRAND RNA, P95; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Madani F, 2009, J AM CHEM SOC, V131, P4613, DOI 10.1021/ja809315x; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Rennick LJ, 2007, J GEN VIROL, V88, P2710, DOI 10.1099/vir.0.83106-0; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Seki F, 2011, J VIROL, V85, P11871, DOI 10.1128/JVI.05067-11; Shu YL, 2012, J BIOL CHEM, V287, P11951, DOI 10.1074/jbc.M111.333088; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	49	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29943	29953		10.1074/jbc.M113.503862	http://dx.doi.org/10.1074/jbc.M113.503862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003217	Green Published, hybrid			2022-12-25	WOS:000330615300067
J	Patel, PC; Lee, HSW; Ming, AYK; Rath, A; Deber, CM; Yip, CM; Rocheleau, JV; Gray-Owen, SD				Patel, Prerna C.; Lee, Hannah S. W.; Ming, Aaron Y. K.; Rath, Arianna; Deber, Charles M.; Yip, Christopher M.; Rocheleau, Jonathan V.; Gray-Owen, Scott D.			Inside-out Signaling Promotes Dynamic Changes in the Carcinoembryonic Antigen-related Cellular Adhesion Molecule 1 (CEACAM1) Oligomeric State to Control Its Cell Adhesion Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY GLYCOPROTEIN; C-CAM; NEISSERIA-GONORRHOEAE; CYTOPLASMIC DOMAIN; TRANSMEMBRANE DOMAIN; HOMOPHILIC ADHESION; CALMODULIN-BINDING; EPITHELIAL-CELLS; FAMILY; PROTEIN	Cell-cell contacts are fundamental to multicellular organisms and are subject to exquisite levels of control. The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) can engage in both cis-homophilic (parallel) oligomerization and trans-homophilic(anti-parallel) binding. In this study, we establish that the CEACAM1 transmembrane domain has a propensity to form cis-dimers via the transmembrane-embedded (432)GXXXG(436) motif and that this basal state is overcome when activated calmodulin binds to the CEACAM1 cytoplasmic domain. Although mutation of the (432)GXXXG(436) motif reduced CEACAM1 oligomerization, it did not affect surface localization of the receptor or influence CEACAM1-dependent cellular invasion by the pathogenic Neisseria. The mutation did, however, have a striking effect on CEACAM1-dependent cellular aggregation, increasing both the kinetics of cell-cell association and the size of cellular aggregates formed. CEACAM1 association with tyrosine kinase c-Src and tyrosine phosphatases SHP-1 and SHP-2 was not affected by the (432)GXXXG(436) mutation, consistent with their association with the monomeric form of wild type CEACAM1. Collectively, our results establish that a dynamic oligomer-to-monomer shift in surface-expressed CEACAM1 facilitates trans-homophilic binding and downstream effector signaling.	[Patel, Prerna C.; Lee, Hannah S. W.; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Ming, Aaron Y. K.; Yip, Christopher M.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Rath, Arianna; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gray-Owen, SD (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616; Yip, Christopher/0000-0003-4507-556X; Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics; Canadian Institutes of Health Research [FRN-5810]; Canada Research Chairs Program; Natural Sciences and Engineering Research Council of Canada/Canadian Institutes of Health Research Collaborative Health Research Program [365861-09]; Canadian Foundation for Innovation [JVR-NMD106997]; Banting and Best Diabetes Centre, University of Toronto	Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada/Canadian Institutes of Health Research Collaborative Health Research Program(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Banting and Best Diabetes Centre, University of Toronto(University of Toronto)	This work was supported in part by the Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics (to P. C. P.), Canadian Institutes of Health Research Grant FRN-5810 (to C. M. D.), the Canada Research Chairs Program (to C. M. Y.), Natural Sciences and Engineering Research Council of Canada/Canadian Institutes of Health Research Collaborative Health Research Program Grant 365861-09 (to C. M. Y. and S. D. G.), and Canadian Foundation for Innovation Grant JVR-NMD106997.; Recipient of stipend support from the Banting and Best Diabetes Centre, University of Toronto.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; BARNETT TR, 1989, J CELL BIOL, V108, P267, DOI 10.1083/jcb.108.2.267; Beauchemin N, 1999, EXP CELL RES, V252, P243; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; BLIKSTAD I, 1992, FEBS LETT, V302, P26, DOI 10.1016/0014-5793(92)80276-M; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BRUMMER J, 1995, ONCOGENE, V11, P1649; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; EDLUND M, 1993, FEBS LETT, V327, P90, DOI 10.1016/0014-5793(93)81046-3; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; HINODA Y, 1988, P NATL ACAD SCI USA, V85, P6959, DOI 10.1073/pnas.85.18.6959; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Hunter I, 1996, BIOCHEM J, V320, P847, DOI 10.1042/bj3200847; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; KUROKI M, 1991, J BIOL CHEM, V266, P11810; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Lawson EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029606; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; LIN SH, 1995, BIOCHEM J, V311, P239, DOI 10.1042/bj3110239; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; Morales VM, 1999, J IMMUNOL, V163, P1363; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; N'Guessan PD, 2007, J INFECT DIS, V195, P1651, DOI 10.1086/514820; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Obrink B, 2002, ANN NY ACAD SCI, V971, P597; OIKAWA S, 1992, BIOCHEM BIOPH RES CO, V186, P881, DOI 10.1016/0006-291X(92)90828-9; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Rocheleau JV, 2003, BIOPHYS J, V84, P4078, DOI 10.1016/S0006-3495(03)75133-9; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; Rowe HA, 2007, CELL MICROBIOL, V9, P154, DOI 10.1111/j.1462-5822.2006.00775.x; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schumann D, 2004, BIOCHEM BIOPH RES CO, V318, P227, DOI 10.1016/j.bbrc.2004.04.024; Singer BB, 2000, CANCER RES, V60, P1236; SKUBITZ KM, 1995, J IMMUNOL, V155, P5382; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; Sundberg U, 2004, J CELL SCI, V117, P1091, DOI 10.1242/jcs.00944; Tamamizu S, 1999, J MEMBRANE BIOL, V170, P157, DOI 10.1007/s002329900545; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; TINGSTROM A, 1990, J CELL SCI, V96, P17; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7; Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038; WATT SM, 1991, BLOOD, V78, P63; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Wikstrom K, 1996, EXP CELL RES, V227, P360, DOI 10.1006/excr.1996.0285	74	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29654	29669		10.1074/jbc.M113.504639	http://dx.doi.org/10.1074/jbc.M113.504639			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005674	Green Published, hybrid			2022-12-25	WOS:000330615300041
J	Reschke, S; Sigfridsson, KGV; Kaufmann, P; Leidel, N; Horn, S; Gast, K; Schulzke, C; Haumann, M; Leimkuhler, S				Reschke, Stefan; Sigfridsson, Kajsa G. V.; Kaufmann, Paul; Leidel, Nils; Horn, Sebastian; Gast, Klaus; Schulzke, Carola; Haumann, Michael; Leimkuehler, Silke			Identification of a Bis-molybdopterin Intermediate in Molybdenum Cofactor Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GUANINE DINUCLEOTIDE; SULFITE OXIDASE; GENE-PRODUCTS; MOLYBDOENZYME; REDUCTASE; BINDING; STEP; DEFICIENCY; MATURATION	The molybdenum cofactor is an important cofactor, and its biosynthesis is essential for many organisms, including humans. Its basic form comprises a single molybdopterin (MPT) unit, which binds a molybdenum ion bearing three oxygen ligands via a dithiolene function, thus forming Mo-MPT. In bacteria, this form is modified to form the bis-MPT guanine dinucleotide cofactor with two MPT units coordinated at one molybdenum atom, which additionally contains GMPs bound to the terminal phosphate group of the MPTs (bis-MGD). The MobA protein catalyzes the nucleotide addition to MPT, but the mechanism of the biosynthesis of the bis-MGD cofactor has remained enigmatic. We have established an in vitro system for studying bis-MGD assembly using purified compounds. Quantification of the MPT/molybdenum and molybdenum/phosphorus ratios, time-dependent assays for MPT and MGD detection, and determination of the numbers and lengths of Mo-S and Mo-O bonds by X-ray absorption spectroscopy enabled identification of a novel bis-Mo-MPT intermediate on MobA prior to nucleotide attachment. The addition of Mg-GTP to MobA loaded with bis-Mo-MPT resulted in formation and release of the final bis-MGD product. This cofactor was fully functional and reconstituted the catalytic activity of apo-TMAO reductase (TorA). We propose a reaction sequence for bis-MGD formation, which involves 1) the formation of bis-Mo-MPT, 2) the addition of two GMP units to form bis-MGD on MobA, and 3) the release and transfer of the mature cofactor to the target protein TorA, in a reaction that is supported by the specific chaperone TorD, resulting in an active molybdoenzyme.	[Reschke, Stefan; Kaufmann, Paul; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany; [Gast, Klaus] Univ Potsdam, Dept Phys Biochem, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Sigfridsson, Kajsa G. V.; Leidel, Nils; Horn, Sebastian; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Schulzke, Carola] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, D-17487 Greifswald, Germany	University of Potsdam; University of Potsdam; Free University of Berlin; Ernst Moritz Arndt Universitat Greifswald	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochemie & Biol, Karl Lieknecht Str 24-25, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	MIchael, Haumann/A-7087-2013; Schulzke, Carola/AAT-8055-2021	Schulzke, Carola/0000-0002-7530-539X; Leimkuhler, Silke/0000-0003-3238-2122; Horn, Sebastian/0000-0001-7812-5813; Sigfridsson Clauss, Kajsa/0000-0002-7604-251X	Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Unifying Concepts in Catalysis"; DFG [LE1171/6-1, Ha3265/3-1, Ha3265/6-1]; Heisenberg Fellowship; European Cooperation in Science and Technology (COST) Action [CM1003]; Stiftelsen Bengt Lundqvist minne; Wenner-Gren Foundation; European Research Council (ERC)	Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Heisenberg Fellowship(German Research Foundation (DFG)); European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); Stiftelsen Bengt Lundqvist minne; Wenner-Gren Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Unifying Concepts in Catalysis" (to S. L.), by DFG Grant LE1171/6-1 (to S. L.), and by a Heisenberg Fellowship and Grants Ha3265/3-1 and Ha3265/6-1 from the DFG (to M. H.). This work was also supported by European Cooperation in Science and Technology (COST) Action CM1003 (to S. L. and C. S.).; Recipient of fellowships from "Stiftelsen Bengt Lundqvist minne" and the Wenner-Gren Foundation. Present address: MAX IV Laboratory, Lund University, 22100 Lund, Sweden.; Supported by the European Research Council (ERC).	Chen MD, 2002, CHINESE SCI BULL, V47, P978; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Genes O, 2005, J BIOL CHEM, V280, P15644, DOI 10.1074/jbc.M501119200; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Genest O, 2006, FEMS MICROBIOL LETT, V265, P51, DOI 10.1111/j.1574-6968.2006.00468.x; Genest O, 2009, FEMS MICROBIOL LETT, V297, P1, DOI 10.1111/j.1574-6968.2009.01660.x; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Havelius KGV, 2011, INORG CHEM, V50, P741, DOI 10.1021/ic101291j; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; Hover BM, 2013, J AM CHEM SOC, V135, P7019, DOI 10.1021/ja401781t; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Kuper J, 2003, ARCH BIOCHEM BIOPHYS, V411, P36, DOI 10.1016/S0003-9861(02)00714-2; Lake MW, 2000, J BIOL CHEM, V275, P40211, DOI 10.1074/jbc.M007406200; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Liu MTW, 2000, J BIOL CHEM, V275, P1814, DOI 10.1074/jbc.275.3.1814; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Magalon A, 2002, J BIOL CHEM, V277, P48199, DOI 10.1074/jbc.M205806200; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; Neumann M, 2008, FEBS J, V275, P5678, DOI 10.1111/j.1742-4658.2008.06694.x; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/850924; Neumann M, 2011, J BIOL CHEM, V286, P1400, DOI 10.1074/jbc.M110.155671; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Nichols J, 2002, J BIOL CHEM, V277, P24995, DOI 10.1074/jbc.M203238200; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PALMER T, 1994, EUR J BIOCHEM, V222, P687, DOI 10.1111/j.1432-1033.1994.tb18913.x; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Qiu JA, 2010, BIOCHEMISTRY-US, V49, P3989, DOI 10.1021/bi1001954; Rajagopalan K. V., 1996, ESCHERICHIA COLI SAL, VI, P674; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Rudolph MJ, 2003, J BIOL CHEM, V278, P14514, DOI 10.1074/jbc.M300449200; Samuel PP, 2011, EUR J INORG CHEM, P4387, DOI 10.1002/ejic.201100331; Stevenson CEM, 2000, STRUCTURE, V8, P1115, DOI 10.1016/S0969-2126(00)00518-9; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995	49	39	41	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29736	29745		10.1074/jbc.M113.497453	http://dx.doi.org/10.1074/jbc.M113.497453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003231	hybrid, Green Published			2022-12-25	WOS:000330615300049
J	Garcia, ML; Reynolds, TD; Mothes, W; Robek, MD				Garcia, Mayra L.; Reynolds, Tracy D.; Mothes, Walther; Robek, Michael D.			Functional Characterization of the Putative Hepatitis B Virus Core Protein Late Domain Using Retrovirus Chimeras	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; LATE-BUDDING DOMAINS; ROUS-SARCOMA-VIRUS; UBIQUITIN LIGASE; SORTING PATHWAY; ENVELOPED VIRUS; MATRIX PROTEIN; TSG101; INTERACTS; RELEASE	The hepatitis B virus (HBV) Core protein encodes a late (L)-domain like motif ((129)PPAYRPPNAP(138)) that has been purported to serve as a docking site for recruitment of host factors such as Nedd4 that can mediate viral particle release from infected cells. However, mutation of this region of Core typically disrupts nucleocapsid formation in the cytoplasm, making it difficult to ascertain if the Core PPAY motif constitutes a functional L-domain that mediates HBV release in the context of replicating virus. Since many viral L-domains are functionally interchangeable between different virus families, and such swapping experiments have been used as a tool to identify other viral sequences with L-domain activity, we generated chimeric constructs between murine leukemia virus (MLV) Gag and HBV Core to determine if the potential HBV L-domain motif is sufficient to stimulate virus release. We found that the HBV Core PPAY motif, but not the PNAP motif, demonstrates L-domain activity in the context of MLV replication to direct virus release and infectious virion production. Additionally, we found that overexpression of the cellular Nedd4 or WWP1 ubiquitin ligases stimulates release of a partially defective PPAY domain mutant, providing further evidence supporting a role for the Nedd4 ubiquitin ligase in promoting HBV release. These studies lend further insight into the mechanisms used by HBV to mediate its release from infected cells.	[Garcia, Mayra L.; Reynolds, Tracy D.; Robek, Michael D.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University	Robek, MD (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	michael.robek@yale.edu			Ford Foundation; National Institutes of Health Research Supplement to Promote Diversity in Health-Related Research [R01 CA131133]; NIH [T32 AI055403]; NATIONAL CANCER INSTITUTE [R01CA131133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055403] Funding Source: NIH RePORTER	Ford Foundation; National Institutes of Health Research Supplement to Promote Diversity in Health-Related Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.L.G. was supported by a predoctoral fellowship from the Ford Foundation and an National Institutes of Health Research Supplement to Promote Diversity in Health-Related Research (R01 CA131133). T.D.R. was supported by NIH training grant T32 AI055403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barsov EV, 2001, J VIROL, V75, P4973, DOI 10.1128/JVI.75.11.4973-4983.2001; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Chain BM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-33; Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107; Chua PK, 2006, VIROLOGY, V354, P1, DOI 10.1016/j.virol.2006.07.018; Craven RC, 1999, J VIROL, V73, P3359, DOI 10.1128/JVI.73.4.3359-3365.1999; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Dhason MS, 2012, VIROLOGY, V430, P20, DOI 10.1016/j.virol.2012.04.012; Dorjbal B, 2011, J BIOL CHEM, V286, P31092, DOI 10.1074/jbc.M111.259945; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Falcon V, 2008, AM J INFECT DIS, V4, P96, DOI 10.3844/ajidsp.2008.96.103; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garcia ML, 2009, J VIROL, V83, P4923, DOI 10.1128/JVI.02644-08; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Honeychurch KM, 2007, J VIROL, V81, P7310, DOI 10.1128/JVI.00034-07; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Ponsel D, 2003, J VIROL, V77, P416, DOI 10.1128/JVI.77.1.416-422.2003; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Roingeard P, 1998, HEPATOLOGY, V28, P1128, DOI 10.1002/hep.510280431; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; Rost M, 2008, J BIOL CHEM, V283, P32119, DOI 10.1074/jbc.M802632200; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132; Yuan B, 1999, EMBO J, V18, P4700, DOI 10.1093/emboj/18.17.4700; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Zhadina M, 2007, P NATL ACAD SCI USA, V104, P20031, DOI 10.1073/pnas.0708002104	54	11	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72845	10.1371/journal.pone.0072845	http://dx.doi.org/10.1371/journal.pone.0072845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009707	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600037
J	Zhao, SS; Xiong, ZL; Mao, X; Meng, DD; Lei, Q; Li, Y; Deng, PY; Chen, MJ; Tu, M; Lu, XP; Yang, GX; He, GY				Zhao, Shasha; Xiong, Zilan; Mao, Xiang; Meng, Dandan; Lei, Qian; Li, Yin; Deng, Pengyi; Chen, Mingjie; Tu, Min; Lu, Xinpei; Yang, Guangxiao; He, Guangyuan			Atmospheric Pressure Room Temperature Plasma Jets Facilitate Oxidative and Nitrative Stress and Lead to Endoplasmic Reticulum Stress Dependent Apoptosis in HepG2 Cells	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; PROTEIN-TYROSINE NITRATION; REACTIVE OXYGEN; NITRIC-OXIDE; BLOOD-COAGULATION; FREE-RADICALS; ANTIOXIDANTS; GLUTATHIONE; MECHANISMS; CANCER	Atmospheric pressure room temperature plasma jets (APRTP-Js) that can emit a mixture of different active species have recently found entry in various medical applications. Apoptosis is a key event in APRTP-Js-induced cellular toxicity, but the exact biological mechanisms underlying remain elusive. Here, we explored the role of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in APRTP-Js-induced apoptosis using in vitro model of HepG2 cells. We found that APRTP-Js facilitated the accumulation of ROS and RNS in cells, which resulted in the compromised cellular antioxidant defense system, as evidenced by the inactivation of cellular antioxidants including glutathione (GSH), superoxide dismutase (SOD) and catalase. Nitrotyrosine and protein carbonyl content analysis indicated that APRTP-Js treatment caused nitrative and oxidative injury of cells. Meanwhile, intracellular calcium homeostasis was disturbed along with the alteration in the expressions of GRP78, CHOP and pro-caspase12. These effects accumulated and eventually culminated into the cellular dysfunction and endoplasmic reticulum stress (ER stress)-mediated apoptosis. The apoptosis could be markedly attenuated by N-acetylcysteine (NAC, a free radical scavenger), which confirmed the involvement of oxidative and nitrative stress in the process leading to HepG2 cell apoptosis by APRTP-Js treatment.	[Zhao, Shasha; Mao, Xiang; Meng, Dandan; Lei, Qian; Li, Yin; Deng, Pengyi; Chen, Mingjie; Tu, Min; Yang, Guangxiao; He, Guangyuan] HUST, Coll Life Sci & Technol, Genet Engn Int Cooperat Base, Key Lab Mol Biophys,Chinese Minist Educ,Chinese M, Wuhan, Peoples R China; [Xiong, Zilan; Lu, Xinpei] HUST, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Lu, XP (corresponding author), HUST, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China.	luxinpei@hotmail.com; ygx@hust.edu.cn; hegy@hust.edu.cn	Lu, Xinpei/D-9540-2015; Tu, Min/I-3340-2019; Lu, XinPei/M-5570-2013	Lu, XinPei/0000-0003-0676-9585; Tu, Min/0000-0001-6193-7524; Tu, Min/0000-0003-3061-8592	National Science and Technology Major Project of China [2013ZX08002-004, 2013ZX08010-004]; National Natural Science Foundation [51077063, 51277087]; National Natural Science Foundation of Hubei, China [2011CDB370]; Wuhan Science and Technology Project [201260523185]; Research Fund for the Doctoral Program of Higher Education of China [20100142110005]	National Science and Technology Major Project of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei, China; Wuhan Science and Technology Project; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Science and Technology Major Project of China (2013ZX08002-004; 2013ZX08010-004) (http://www.nmp.gov.cn/), the National Natural Science Foundation (Grant No. 51077063, 51277087) (http://isisn.nsfc.gov.cn/egrantweb/), the National Natural Science Foundation of Hubei, China (2011CDB370) (http://www.hbstd.gov.cn/) and the Wuhan Science and Technology Project (201260523185) (http://www.whst.gov.cn/default.html), Research Fund for the Doctoral Program of Higher Education of China (20100142110005) (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Aslan M, 2003, J BIOL CHEM, V278, P4194, DOI 10.1074/jbc.M208916200; Cao L, 2013, ANAL BIOANAL CHEM, V405, P2635, DOI 10.1007/s00216-012-6661-8; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x; Han C, 2008, J MICROBIOL BIOTECHN, V18, P1197; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hohn A, 2013, J PROTEOMICS, DOI [10.1016/j.jprot.2013.01.004, DOI 10.1016/J.JPR0T.2013.01.004.PUBMED:23333925.(EPUB]; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim GC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/032005; Kim JY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431392; Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Lu XP, 2009, IEEE T PLASMA SCI, V37, P668, DOI 10.1109/TPS.2009.2015454; Lu XP, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912524; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Monostori P, 2009, J CHROMATOGR B, V877, P3331, DOI 10.1016/j.jchromb.2009.06.016; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakamura T, 2007, CELL MOL LIFE SCI, V64, P1609, DOI 10.1007/s00018-007-6525-0; Nakamura T, 2009, APOPTOSIS, V14, P455, DOI 10.1007/s10495-008-0301-y; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ostrikov K, 2013, ADV PHYS, V62, P113, DOI 10.1080/00018732.2013.808047; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Salvi A, 2001, BIOCHEM PHARMACOL, V61, P1237, DOI 10.1016/S0006-2952(01)00607-4; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Sladek REJ, 2004, IEEE T PLASMA SCI, V32, P1540, DOI 10.1109/TPS.2004.832636; Xu XC, 2012, INFECT IMMUN, V80, P2121, DOI 10.1128/IAI.06295-11; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Yan X, 2010, IEEE T PLASMA SCI, V38, P2451, DOI 10.1109/TPS.2010.2056393; Yousfi M, 2013, FUND CLIN PHARM, DOI [10.1111/fcp.12018, DOI 10.1111/FCP.12018.PUBMED:23432667.(EPUB]; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735	61	74	75	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73665	10.1371/journal.pone.0073665	http://dx.doi.org/10.1371/journal.pone.0073665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013954	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200086
J	Ishigaki, Y; Tanaka, H; Akama, H; Ogara, T; Uwai, K; Tokuraku, K				Ishigaki, Yukako; Tanaka, Hiroyuki; Akama, Hiroaki; Ogara, Toshiki; Uwai, Koji; Tokuraku, Kiyotaka			A Microliter-Scale High-throughput Screening System with Quantum-Dot Nanoprobes for Amyloid-beta Aggregation Inhibitors	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; ATOMIC-FORCE MICROSCOPY; FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; THIOFLAVINE-T; PROTEIN; THERAPEUTICS; INVITRO; BINDING; MEMORY	The aggregation of amyloid beta protein (A beta) is a key step in the pathogenesis of Alzheimer's disease (AD), and therefore inhibitory substances for A beta aggregation may have preventive and/or therapeutic potential for AD. Here we report a novel microliter-scale high-throughput screening system for A beta aggregation inhibitors based on fluorescence microscopy-imaging technology with quantum-dot Nanoprobes. This screening system could be analyzed with a 5-mu l sample volume when a 1536-well plate was used, and the inhibitory activity could be estimated as half-maximal effective concentrations (EC50). We attempted to comprehensively screen A beta aggregation inhibitors from 52 spices using this system to assess whether this novel screening system is actually useful for screening inhibitors. Screening results indicate that approximately 90% of the ethanolic extracts from the spices showed inhibitory activity for A beta aggregation. Interestingly, spices belonging to the Lamiaceae, the mint family, showed significantly higher activity than the average of tested spices. Furthermore, we tried to isolate the main inhibitory compound from Satureja hortensis, summer savory, a member of the Lamiaceae, using this system, and revealed that the main active compound was rosmarinic acid. These results demonstrate that this novel microliter-scale high-throughput screening system could be applied to the actual screening of A beta aggregation inhibitors. Since this system can analyze at a microscopic scale, it is likely that further minimization of the system would easily be possible such as protein microarray technology.	[Ishigaki, Yukako; Tanaka, Hiroyuki; Akama, Hiroaki; Ogara, Toshiki; Uwai, Koji; Tokuraku, Kiyotaka] Muroran Inst Technol, Div Appl Sci, Muroran, Hokkaido 050, Japan	Muroran Institute of Technology	Tokuraku, K (corresponding author), Muroran Inst Technol, Div Appl Sci, Muroran, Hokkaido 050, Japan.	tokuraku@mmm.muroran-it.ac.jp	Tokuraku, Kiyotaka/D-4542-2014	Tokuraku, Kiyotaka/0000-0002-7747-4808	Yamazaki Spice Promotion Foundation; MuIT Grant for Selective Research; JSPS KAKENHI [25350974]	Yamazaki Spice Promotion Foundation; MuIT Grant for Selective Research; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by the Yamazaki Spice Promotion Foundation (K.T.), MuIT Grant for Selective Research (K.T.), and JSPS KAKENHI Grant Numbers 25350974 (K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jameson LP, 2012, ACS CHEM NEUROSCI, V3, P807, DOI 10.1021/cn300076x; JANCIAUSKIENE S, 1995, J BIOL CHEM, V270, P26041, DOI 10.1074/jbc.270.44.26041; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kapoor S, 2001, BIOPHYS CHEM, V92, P119, DOI 10.1016/S0301-4622(01)00188-0; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; LAMAISON J L, 1990, Annales Pharmaceutiques Francaises, V48, P103; Legleiter J, 2004, J MOL BIOL, V335, P997, DOI 10.1016/j.jmb.2003.11.019; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Perry EK, 1999, J PHARM PHARMACOL, V51, P527, DOI 10.1211/0022357991772808; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; THE-ANGIOSPERM-PHYLOGENY-GROUP, 2009, APG BOT 3 J LINN SOC, V161, P105; Tokuraku K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008492	25	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72992	10.1371/journal.pone.0072992	http://dx.doi.org/10.1371/journal.pone.0072992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991168	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800091
J	Xiao, WW; Graham, PH; Hao, JL; Chang, L; Ni, J; Power, CA; Dong, QH; Kearsley, JH; Li, Y				Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Power, Carl A.; Dong, Qihan; Kearsley, John H.; Li, Yong			Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells	PLOS ONE			English	Article							DNA-DAMAGE REPAIR; DRUG-RESISTANCE; HDAC INHIBITORS; RADIOTHERAPY; COEXPRESSION; PROGRESSION; ACID; MDR1	Radiation therapy (RT) continues to be one of the most popular treatment options for localized prostate cancer (CaP). The purpose of the study was to investigate the in vitro effect of LBH589 alone and in combination with RT on the growth and survival of CaP cell lines and the possible mechanisms of radiosensitization of this combination therapy. The effect of LBH589 alone or in combination with RT on two CaP cell lines (PC-3 and LNCaP) and a normal prostatic epithelial cell line (RWPE-1) was studied by MTT and clonogenic assays, cell cycle analysis, western blotting of apoptosis-related and cell check point proteins, and DNA double strand break (DSB) repair markers. The immunofluorescence staining was used to further confirm DSB expression in treated CaP cells. Our results indicate that LBH589 inhibited proliferation in both CaP and normal prostatic epithelial cells in a time-and-dose-dependent manner; low-dose of LBH589 (IC20) combined with RT greatly improved efficiency of cell killing in CaP cells; compared to RT alone, the combination treatment with LBH589 and RT induced more apoptosis and led to a steady increase of sub-G1 population and abolishment of RT-induced G2/M arrest, increased and persistent DSB, less activation of non-homologous end joining (NHEJ)/homologous recombination (HR) repair pathways and a panel of cell cycle related proteins. These results suggest that LBH589 is a potential agent to increase radiosensitivity of human CaP cells. LBH589 used either alone, or in combination with RT is an attractive strategy for treating human CaP.	[Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Kearsley, John H.; Li, Yong] St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia; [Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Kearsley, John H.; Li, Yong] St George Hosp, Prostate Canc Inst, Kogarah, NSW, Australia; [Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Power, Carl A.; Kearsley, John H.; Li, Yong] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Xiao, Weiwei] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Weiwei] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Power, Carl A.] Univ New S Wales, Biol Resources Imaging Lab, Kensington, NSW 2033, Australia; [Dong, Qihan] Univ Western Sydney, Sch Sci & Hlth Sci, Penrith, NSW 1797, Australia; [Dong, Qihan] Univ Sydney, Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW 2006, Australia; [Dong, Qihan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	St George Hospital; St George Hospital; University of New South Wales Sydney; Sun Yat Sen University; State Key Lab Oncology South China; University of New South Wales Sydney; Western Sydney University; University of Sydney; University of Sydney	Li, Y (corresponding author), St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia.	y.li@unsw.edu.au		Ni, Jie/0000-0002-8844-6132; Xiao, WeiWei/0000-0002-9922-640X; Li, Yong/0000-0002-8910-9787	Career Development Fellowship from National Health Medical Research Council, Australia; St George Hospital Cancer Research Trust Fund, Sydney, Australia; China Scholarship Council, China	Career Development Fellowship from National Health Medical Research Council, Australia; St George Hospital Cancer Research Trust Fund, Sydney, Australia; China Scholarship Council, China(China Scholarship Council)	This study was in part supported by a Career Development Fellowship from National Health Medical Research Council (YL), Australia; St George Hospital Cancer Research Trust Fund (PHG), Sydney, Australia; and China Scholarship Council (WWX), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2012, DNA CELL BIOL, V31, pS62, DOI 10.1089/dna.2011.1575; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen H, 2009, BRIT J CANCER, V101, P432, DOI 10.1038/sj.bjc.6605185; Chen XF, 2011, MOL CANCER RES, V9, P448, DOI 10.1158/1541-7786.MCR-10-0471; Chinnaiyan P, 2008, CLIN CANCER RES, V14, P5410, DOI 10.1158/1078-0432.CCR-08-0643; Dearnaley DP, 2005, BRIT J CANCER, V92, P488, DOI 10.1038/sj.bjc.6602301; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Groselj B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/bjc.2013.21; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kal HB, 2003, INT J RADIAT ONCOL, V57, P1116, DOI 10.1016/S0360-3016(03)01455-X; Kozakai N, 2012, BRIT J CANCER, V107, P652, DOI 10.1038/bjc.2012.321; Lattal KM, 2013, NAT NEUROSCI, V16, P124, DOI 10.1038/nn.3302; Li Y, 2002, PROSTATE CANCER P D, V5, P36, DOI 10.1038/sj/pcan/4500543; Margueron R, 2004, BIOCHEM PHARMACOL, V68, P1239, DOI 10.1016/j.bcp.2004.04.031; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Martinez-Lopez W, 2001, CHROMOSOME RES, V9, P69, DOI 10.1023/A:1026747801728; Munshi A, 2006, MOL CANCER THER, V5, P1967, DOI 10.1158/1535-7163.MCT-06-0022; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Prince HM, 2009, FUTURE ONCOL, V5, P601, DOI [10.2217/fon.09.36, 10.2217/FON.09.36]; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Rathkopf D, 2010, CANCER CHEMOTH PHARM, V66, P181, DOI 10.1007/s00280-010-1289-x; Shankar S, 2008, ADV EXP MED BIOL, V615, P261, DOI 10.1007/978-1-4020-6554-5_13; Sharma NL, 2013, BJU INT, V111, P537, DOI 10.1111/j.1464-410X.2012.11647.x; Venugopal B, 2011, CURR MED CHEM, V18, P1658, DOI 10.2174/092986711795471284; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Wang L, 2011, CANCER LETT, V300, P122, DOI 10.1016/j.canlet.2010.09.013; Wouters A, 2011, INT J RADIAT ONCOL, V80, P558, DOI 10.1016/j.ijrobp.2010.12.051; Zelefsky MJ, 2006, J UROLOGY, V176, P1415, DOI 10.1016/j.juro.2006.06.002; Zhang Y, 2007, RADIAT RES, V168, P115, DOI 10.1667/RR0811.1	35	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74253	10.1371/journal.pone.0074253	http://dx.doi.org/10.1371/journal.pone.0074253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991216	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800116
J	Snedecor, SJ; Khachatryan, A; Nedrow, K; Chambers, R; Li, CY; Haider, S; Stephens, J				Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Chambers, Richard; Li, Congyu; Haider, Seema; Stephens, Jennifer			The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; GENOTYPIC RESISTANCE; HEALTH-CARE; MUTATIONS; THERAPY; NEVIRAPINE; FAILURE; COST; FREQUENCY; VARIANTS	Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART) including efavirenz is recommended as a 1st-line treatment choice in international HIV guidelines, and it is one of the most common components of initial therapy. Resistance to 1st-generation NNRTIs is found among treated and untreated HIV-infected individuals creating a subpopulation of HIV-infected individuals in whom efavirenz is not fully effective. This analysis reviewed published articles and conference abstracts to examine the prevalence of 1st-generation NNRTI resistance in Europe, the United States (US), and Canada and to identify published evidence of the economic consequences of resistance. The reported prevalence of NNRTI resistance was generally higher in US/Canada than in Europe and increased in both regions from their introduction in the late 1990s until the early 2000s. The most recent time-based trends suggest that NNRTI-resistance prevalence may be stable or decreasing. These estimates of resistance may be understated as resistance estimates using ultra-sensitive genotypic testing methods, which identify low-frequency mutations undetected by standard testing methods, showed increased prevalence of resistance by more than two-fold. No studies were identified that explicitly investigated the costs of drug resistance. Rather, most studies reported costs of treatment change, failure, or disease progression. Among those studies, annual HIV medical costs of those infected with HIV increased 1) as CD4 cells decreased, driven in part by hospitalization at lower CD4 cell counts; 2) for treatment changes, and 3) for each virologic failure. The possible erosion of efficacy or of therapy choices through resistance transmission or selection, even when present with low frequency, may become a barrier to the use of 1st-generation NNRTIs and the increased costs associated with regimen failure and disease progression underlie the importance of identification of treatment resistance to ensure optimal initial therapy choice and regimen succession.	[Snedecor, Sonya J.; Khachatryan, Alexandra; Li, Congyu; Stephens, Jennifer] Pharmerit Int, Bethesda, MD USA; [Nedrow, Katherine; Haider, Seema] Pfizer Inc, Groton, CT 06340 USA; [Chambers, Richard] Pfizer Inc, Collegeville, PA USA	Pfizer; Pfizer	Snedecor, SJ (corresponding author), Pharmerit Int, Bethesda, MD USA.	ssnedecor@pharmerit.com			Pfizer, Inc.; Pfizer	Pfizer, Inc.(Pfizer); Pfizer(Pfizer)	This study was funded by Pfizer, Inc. SJS, AK, CL and JS are employees of Pharmerit International and were paid consultants to Pfizer in connection with execution of this research study. KN, RC and SH were employees and/or shareholders of Pfizer Inc. at the time the study was conducted. All authors participated in study design, data collection and analysis, decision to publish, and preparation and review of manuscript.	Adams J, 2010, ANN PHARMACOTHER, V44, P157, DOI 10.1345/aph.1M359; [Anonymous], 2012, EUR AIDS CLIN SOC EA; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Beck EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027830; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brenner B, 2012, C RETR OPP INF; Brumme CJ, 2012, INT WORKSH HIV HEP V; Ceccherini-Silberstein F, 2010, CLIN MICROBIOL INFEC, V16, P1511, DOI 10.1111/j.1469-0691.2010.03353.x; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Corbau R, 2010, ANTIMICROB AGENTS CH, V54, P4451, DOI 10.1128/AAC.01455-09; Craig C, 2011, 161 IAS MOPE; de Mendoza C, 2005, CLIN INFECT DIS, V41, P1350, DOI 10.1086/496982; DHHS, 2011, UID US ANT AG HIV 1; Di Giambenedetto S, 2009, ANTIVIR THER, V14, P359; Dunn DT, 2011, CURR OPIN HIV AIDS, V6, P251, DOI 10.1097/COH.0b013e32834732e8; Frentz D, 2012, AIDS REV, V14, P17; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Ghosn J, 2009, AIDS REV, V11, P165; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hellinger FJ, 2010, PHARMACOECONOMICS, V28, P23, DOI 10.2165/11313810-000000000-00000; Hernandez-Novoa B, 2009, WEPEB208 IAS; Holodniy M, 2004, INT J STD AIDS, V15, P543, DOI 10.1258/0956462041558212; Jain V, 2009, C RETR OPP INF; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Joly V, 2004, ANTIMICROB AGENTS CH, V48, P172, DOI 10.1128/AAC.48.1.172-175.2004; Kagan R, 2004, AIDS RES HUM RETROV, V20, P1, DOI 10.1089/088922204322749440; Karmon S, 2012, AIDS TUPE, P258; Kim D, 2013, 20 C RETR OPP INF; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Martin S, 2007, 4 IAS C HIV PATH TRE; Meenan RT, 2010, CLIN MED RES, V8, P52, DOI [DOI 10.3121/CMR.8.1.52-A, 10.3121/cmr.8.1.52-a]; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Metzner KJ, 2011, ANTIVIR THER, V16, pA107; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mostardt S, 2012, EUR J HLTH EC; Napravnik S, 2007, AIDS, V21, P825, DOI 10.1097/QAD.0b013e32805e8764; Oette M, 2012, INTERVIROLOGY, V55, P154, DOI 10.1159/000332015; Papathanosopoulos MA, 2012, INT WORKSH HIV HEP V, pA33; Rahim S, 2009, HIV CLIN TRIALS, V10, P94, DOI 10.1310/hct1002-94; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Richman D, 2001, 41 INT C ANT AG CHEM, P17; Rizzardini G, 2011, JAIDS-J ACQ IMM DEF, V57, P211, DOI 10.1097/QAI.0b013e31821fdee2; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shet A, 2006, CURR OPIN INVESTIG D, V7, P709; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Stansell J, 2000, 17 C RETR OPP INF; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Van Eygen V, 2012, INT WORKSH HIV HEP V, pA35; Vandenhende MA, 2010, ANTIVIR THER, V15, pA127; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wagner T, 2009, ANTIVIR THER, V14, pA46; Yang Q, 2011, CAN J INF DIS, V22, p86B; Yang W, 2012, C RETR OPP INF; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; Youmans E, 2011, SOUTH MED J, V104, P95, DOI 10.1097/SMJ.0b013e3181fcd75b	67	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72784	10.1371/journal.pone.0072784	http://dx.doi.org/10.1371/journal.pone.0072784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991151	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700050
J	Nakamura, Y; Morioka, N; Abe, H; Zhang, FF; Hisaoka-Nakashima, K; Liu, KY; Nishibori, M; Nakata, Y				Nakamura, Yoki; Morioka, Norimitsu; Abe, Hiromi; Zhang, Fang Fang; Hisaoka-Nakashima, Kazue; Liu, Keyue; Nishibori, Masahiro; Nakata, Yoshihiro			Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1	PLOS ONE			English	Article							SPINAL-CORD; MOUSE MODEL; HMGB1; EXPRESSION; MICROGLIA; MEDIATOR; RELEASE; INJURY; CONTRIBUTES; ASTROCYTES	High mobility group box-1 (HMGB1) is associated with the pathogenesis of inflammatory diseases. A previous study reported that intravenous injection of anti-HMGB1 monoclonal antibody significantly attenuated brain edema in a rat model of stroke, possibly by attenuating glial activation. Peripheral nerve injury leads to increased activity of glia in the spinal cord dorsal horn. Thus, it is possible that the anti-HMGB1 antibody could also be efficacious in attenuating peripheral nerve injury-induced pain. Following partial sciatic nerve ligation (PSNL), rats were treated with either anti-HMGB1 or control IgG. Intravenous treatment with anti-HMGB1 monoclonal antibody (2 mg/kg) significantly ameliorated PSNL-induced hind paw tactile hypersensitivity at 7, 14 and 21 days, but not 3 days, after ligation, whereas control IgG had no effect on tactile hypersensitivity. The expression of HMGB1 protein in the spinal dorsal horn was significantly increased 7, 14 and 21 days after PSNL; the efficacy of the anti-HMGB1 antibody is likely related to the presence of HMGB1 protein. Also, the injury-induced translocation of HMGB1 from the nucleus to the cytosol occurred mainly in dorsal horn neurons and not in astrocytes and microglia, indicating a neuronal source of HMGB1. Markers of astrocyte (glial fibrillary acidic protein (GFAP)), microglia (ionized calcium binding adaptor molecule 1 (Iba1)) and spinal neuron (cFos) activity were greatly increased in the ipsilateral dorsal horn side compared to the sham-operated side 21 days after PSNL. Anti-HMGB1 monoclonal antibody treatment significantly decreased the injury-induced expression of cFos and Iba1, but not GFAP. The results demonstrate that nerve injury evokes the synthesis and release of HMGB1 from spinal neurons, facilitating the activity of both microglia and neurons, which in turn leads to symptoms of neuropathic pain. Thus, the targeting of HMGB1 could be a useful therapeutic strategy in the treatment of chronic pain.	[Nakamura, Yoki; Morioka, Norimitsu; Abe, Hiromi; Zhang, Fang Fang; Hisaoka-Nakashima, Kazue; Nakata, Yoshihiro] Hiroshima Univ, Dept Pharmacol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Liu, Keyue; Nishibori, Masahiro] Okayama Univ, Dept Pharmacol, Grad Sch Med Dent & Pharmacol Sci, Okayama 7008530, Japan	Hiroshima University; Okayama University	Nakata, Y (corresponding author), Hiroshima Univ, Dept Pharmacol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	ynakata@hiroshima-u.ac.jp	Zhang, Fang/HHN-2153-2022; Nakamura, Yoki/P-7785-2016; Morioka, Norimitsu/J-3165-2019	Nakamura, Yoki/0000-0001-9226-676X; Morioka, Norimitsu/0000-0001-9148-4167	Japan Society for the Promotion of Science (JSPS) [24390061, 23659687]; Grants-in-Aid for Scientific Research [24390061] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) and Exploratory Research from the Japan Society for the Promotion of Science to MN (JSPS No. 24390061 and 23659687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Andersson U, 2003, SCAND J INFECT DIS, V35, P577, DOI 10.1080/00365540310016286; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Beggs S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-74; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Feldman P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-180; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Jha Mithilesh Kumar, 2012, Immune Netw, V12, P41, DOI 10.4110/in.2012.12.2.41; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim S, 2013, MOL MED; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Leclerc P, 2013, SCAND J IMMUNOL; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lo Coco D, 2007, NEUROSCI LETT, V412, P73, DOI 10.1016/j.neulet.2006.10.063; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mika J, 2013, EUR J PHARM; Nakagawa T, 2010, J PHARMACOL SCI, V114, P347, DOI 10.1254/jphs.10R04CP; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Ren PC, 2012, BRAIN RES BULL, V88, P332, DOI 10.1016/j.brainresbull.2012.03.002; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Shibasaki M, 2010, PAIN, V149, P514, DOI 10.1016/j.pain.2010.03.023; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Tong W, 2010, BIOCHEM BIOPH RES CO, V395, P572, DOI 10.1016/j.bbrc.2010.04.086; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2013, J PHARMACOL SCI, V121, P89, DOI 10.1254/jphs.12R14CP; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Wang Haichao, 2007, Novartis Found Symp, V280, P73; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang RK, 2013, EXP THER MED, V5, P581, DOI 10.3892/etm.2012.810; Xia MS, 2011, GLIA, V59, P664, DOI 10.1002/glia.21138; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334	39	74	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73640	10.1371/journal.pone.0073640	http://dx.doi.org/10.1371/journal.pone.0073640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991202	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100131
J	Nie, J; Liu, L; Xing, G; Zhang, M; Wei, R; Guo, M; Li, X; Xie, P; Li, L; He, F; Han, W; Zhang, L				Nie, J.; Liu, L.; Xing, G.; Zhang, M.; Wei, R.; Guo, M.; Li, X.; Xie, P.; Li, L.; He, F.; Han, W.; Zhang, L.			CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation	ONCOGENE			English	Article						colon cancer; CKIP-1; Smurf1; PI3K/Akt/mTOR signaling; tumor suppression	DOMAIN-CONTAINING PROTEIN; UBIQUITIN LIGASE SMURF1; BETA-CATENIN; CANCER; IDENTIFICATION; DEGRADATION; ACTIVATION; MUTATIONS; POLARITY	Dysregulation of cellular signaling pathways can lead to colon cancer. However, research on the key signaling effectors or regulators in colon carcinogenesis is limited. Casein kinase-2 interacting protein-1 (CKIP-1; also known as PLEKHO1) is crucial during adult bone formation and is a promising drug target for osteoporosis therapy. In this study, we observed that CKIP-1 was downregulated in human colon cancer tissues and colon cancer cell lines, and this result was correlated with colon cancer progression. CKIP-1 silencing in colon cancers involved promoter methylation. In colon cancer HCT116 and SW480 cells, CKIP-1 overexpression inhibited cell growth and migration. CKIP-1 also suppressed in-vivo tumor formation. Notably, the growth-suppressive role of CKIP-1 was dependent on the downregulation of the cell cycle-regulated oncogene Smad ubiquitylation regulatory factor-1 (Smurf1). During cell cycle progression, phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling increased Smurf1 production by an mTOR-dependent translational control mechanism. Rapamycin, the mTOR inhibitor, significantly reduced Smurf1 protein levels, and Smurf1 was degraded in mitosis. In colon cancer, CKIP-1 controlled Smurf1 expression by suppressing PI3K/Akt/mTOR signaling and enhancing Smurf1 autodegradation, and CKIP-1 downregulation was correlated with Smurf1 upregulation in colon carcinogenesis. These findings provide novel insight into the mechanisms of the candidate tumor suppressor CKIP-1.	[Nie, J.; Li, X.; Han, W.] Peoples Liberat Army Gen Hosp, Inst Basic Med, Dept Mol Biol, Beijing, Peoples R China; [Nie, J.; Xing, G.; Zhang, M.; Wei, R.; Xie, P.; Li, L.; He, F.; Zhang, L.] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Liu, L.] Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Wei, R.; He, F.] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Guo, M.] Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China; [Zhang, L.] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China	Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital; Tsinghua University; Chinese People's Liberation Army General Hospital; Dalian Medical University	Han, W (corresponding author), Gen Hosp PLA, Dept Mol Biol, Beijing 100853, Peoples R China.	hanwdrsw69@yahoo.com; zhanglq@nic.bmi.ac.cn	Zhang, Minghua/AAC-4782-2020	Li, Li/0000-0003-2342-3658; Zhang, Lingqiang/0000-0002-9795-2141	National Basic Research Programs [2012CB910702, 2011CB910602, 2012CB518103]; National Natural Science Foundation Projects [31125010, 31100554, 31270820, 31230061, 81221004]; Beijing Nova Program [Z121107002512121]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation Projects(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	The excellent technical assistance of Qian Mei and Zhiqiang Wu is gratefully acknowledged. The study was supported by the National Basic Research Programs (2012CB910702, 2011CB910602 and 2012CB518103) and National Natural Science Foundation Projects (31125010, 31100554, 31270820, 31230061 and 81221004) and Beijing Nova Program (Z121107002512121).	Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kannan M, 2012, DEVELOPMENT, V139, P3600, DOI 10.1242/dev.081786; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Li H, 2002, CANCER BIOL THER, V1, P621, DOI 10.4161/cbt.309; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nie J, 2011, CHINESE SCI BULL, V56, P3155, DOI 10.1007/s11434-011-4703-9; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Nie J, 2010, FEBS LETT, V584, P3005, DOI 10.1016/j.febslet.2010.05.033; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Osmundson EC, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-14; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; Tokuda E, 2007, CANCER RES, V67, P9666, DOI 10.1158/0008-5472.CAN-07-1050; Wang YF, 2012, EMBO REP, V13, P1004, DOI 10.1038/embor.2012.144; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532	27	33	36	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3677	3687		10.1038/onc.2013.340	http://dx.doi.org/10.1038/onc.2013.340			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	23995790				2022-12-25	WOS:000338942900007
J	Fu, P; Yang, ZY; Bach, LA				Fu, Ping; Yang, Zhiyong; Bach, Leon A.			Prohibitin-2 Binding Modulates Insulin-like Growth Factor-binding Protein-6 (IGFBP-6)-induced Rhabdomyosarcoma Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-BINDING; MUSCLE DIFFERENTIATION; CRISTAE MORPHOGENESIS; TERMINAL DOMAINS; PROSTATE-CANCER; FAMILY-MEMBERS; T-CELLS; EXPRESSION; RECEPTOR; PHOSPHORYLATION	Insulin-like growth factor (IGF)-binding protein (IGFBP)-6 decreases cancer cell proliferation and survival by inhibiting the effects of IGF-II. More recently, IGFBP-6 was found to promote the migration of rhabdomyosarcoma (RMS) cells in an IGF-independent manner, and MAPK pathways were involved in this process. However, the precise molecular mechanisms of these IGF-independent migratory actions of IGFBP-6 are largely unknown. Here, we report that prohibitin-2 (PHB2), a single-span membrane protein, is a key regulator of IGFBP-6-induced RMS cell migration. PHB2 and IGFBP-6 co-localize on the RMS cell surface, and they specifically interact, as demonstrated by affinity chromatography, co-immunoprecipitation, biosensor analysis, and confocal microscopy. Binding affinities for PHB2 are 9.0 +/- 1.0 nM for IGFBP-6 and 10.2 +/- 0.5 nM for mIGFBP-6, a non-IGF-binding mutant of IGFBP-6. The C-domain but not the N-domain of IGFBP-6 is involved in PHB2 binding. In addition, IGFBP-6 indirectly increases PHB2 tyrosine phosphorylation on RMS membranes. Importantly, PHB2 knockdown completely abolished IGFBP-6-mediated RMS cell migration. In contrast, IGFBP-6-induced MAPK pathway activation was not affected, suggesting that PHB2 may act as a downstream effector of these pathways. These results indicate that PHB2 plays a key role in this IGF-independent action of IGFBP-6 and suggest a possible therapeutic target for RMS.	[Fu, Ping; Yang, Zhiyong; Bach, Leon A.] Monash Univ, Dept Med, Cent Clin Sch, Alfred Med Res & Educ Precinct, Prahran, Vic 3181, Australia; [Bach, Leon A.] Alfred Hosp, Dept Endocrinol & Diabet, Melbourne, Vic 3004, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Bach, LA (corresponding author), Alfred Hosp, Dept Endocrinol & Diabet, Commercial Rd, Melbourne, Vic 3004, Australia.	leon.bach@monash.edu		Bach, Leon/0000-0002-9062-1518	National Health and Medical Research Council of Australia; Cancer Council Victoria; Alfred Research Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Alfred Research Trust	This work was supported by grants from the National Health and Medical Research Council of Australia, Cancer Council Victoria, and the Alfred Research Trust.	Ande SR, 2012, INT J OBESITY, V36, P1236, DOI 10.1038/ijo.2011.227; Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Ande SR, 2009, BBA-MOL CELL RES, V1793, P1372, DOI 10.1016/j.bbamcr.2009.05.008; Ande SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004586; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Bach LA, 1999, HORM METAB RES, V31, P226, DOI 10.1055/s-2007-978723; Bach LA, 2005, GROWTH HORM IGF RES, V15, P185, DOI 10.1016/j.ghir.2005.04.001; Bacher S, 2002, BIOCHIMIE, V84, P1207; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Chiu CF, 2013, ONCOGENE, V32, P777, DOI 10.1038/onc.2012.86; Chiu CF, 2012, CANCER LETT, V320, P205, DOI 10.1016/j.canlet.2012.02.027; Emerson V, 2010, J VIROL, V84, P1355, DOI 10.1128/JVI.01641-09; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fu P, 2007, J BIOL CHEM, V282, P22298, DOI 10.1074/jbc.M703066200; Fu P, 2010, J CELL PHYSIOL, V224, P636, DOI 10.1002/jcp.22156; Fukasawa H, 2011, AM J PATHOL, V179, P2254, DOI 10.1016/j.ajpath.2011.07.046; Gallicchio MA, 2001, INT J CANCER, V94, P645, DOI 10.1002/ijc.1519; Headey SJ, 2004, J MOL ENDOCRINOL, V33, P377, DOI 10.1677/jme.1.01547; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Iosef C, 2008, ENDOCRINOLOGY, V149, P1214, DOI 10.1210/en.2007-0959; Iosef C, 2010, CELL SIGNAL, V22, P1033, DOI 10.1016/j.cellsig.2010.02.006; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Kokkinakis DM, 2004, J NEUROPATH EXP NEUR, V63, P1182, DOI 10.1093/jnen/63.11.1182; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Martins Ana Sofia, 2011, Sarcoma, V2011, P209736, DOI 10.1155/2011/209736; McRobert EA, 2003, J BIOL CHEM, V278, P25783, DOI 10.1074/jbc.M210433200; Mengwasser J, 2004, ONCOGENE, V23, P7430, DOI 10.1038/sj.onc.1207987; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Nordqvist ACS, 2002, J NEURO-ONCOL, V57, P19; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Ponce J, 2010, PROTEOMICS, V10, P1954, DOI 10.1002/pmic.200900055; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Scholl FA, 2000, BRIT J CANCER, V82, P1239; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Visser M, 1997, ONCOGENE, V15, P1309, DOI 10.1038/sj.onc.1201302; Wang Sheng, 2008, Transl Oncogenomics, V3, P23; Xu Xuan-Fu, 2009, J Carcinog, V8, P13, DOI 10.4103/1477-3163.55429; Yurugi H, 2012, BIOCHEM BIOPH RES CO, V420, P275, DOI 10.1016/j.bbrc.2012.02.149; Zhang CY, 2012, INT J CANCER, V130, P2003, DOI 10.1002/ijc.26201; Zhu BB, 2006, CANCER RES, V66, P8640, DOI 10.1158/0008-5472.CAN-06-1443; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	59	34	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29890	29900		10.1074/jbc.M113.510826	http://dx.doi.org/10.1074/jbc.M113.510826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003225	Green Published, hybrid			2022-12-25	WOS:000330615300062
J	Herr, DR; Lee, CW; Wang, W; Ware, A; Rivera, R; Chun, J				Herr, Deron R.; Lee, Chang-Wook; Wang, Wei; Ware, Adam; Rivera, Richard; Chun, Jerold			Sphingosine 1-Phosphate Receptors Are Essential Mediators of Eyelid Closure during Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CELL-MIGRATION; LYSOPHOSPHATIDIC ACID; EGF RECEPTOR; LYSOPHOSPHOLIPID RECEPTORS; FINGOLIMOD FTY720; ENDOTHELIAL-CELLS; MICE LACKING; WAVY HAIR; KAPPA-B	The fetal development of the mammalian eyelid involves the expansion of the epithelium over the developing cornea, fusion into a continuous sheet covering the eye, and a splitting event several weeks later that results in the formation of the upper and lower eyelids. Recent studies have revealed a significant number of molecular signaling components that are essential mediators of eyelid development. Receptor-mediated sphingosine 1-phosphate (S1P) signaling is known to influence diverse biological processes, but its involvement in eyelid development has not been reported. Here, we show that two S1P receptors, S1P(2) and S1P(3), are collectively essential mediators of eyelid closure during murine development. Homozygous deletion of the gene encoding either receptor has no apparent effect on eyelid development, but double-null embryos are born with an "eyes open at birth" defect due to a delay in epithelial sheet extension. Both receptors are expressed in the advancing epithelial sheet during the critical period of extension. Fibroblasts derived from double-null embryos have a deficient response to epidermal growth factor, suggesting that S1P(2) and S1P(3) modulate this essential signaling pathway during eyelid closure.	[Herr, Deron R.; Lee, Chang-Wook; Ware, Adam; Rivera, Richard; Chun, Jerold] Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Herr, Deron R.; Wang, Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore	Scripps Research Institute; National University of Singapore	Chun, J (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, 10550 North Torrey Pines Rd,DNC 118, La Jolla, CA 92037 USA.	jchun@scripps.edu	Herr, Deron/AAB-7380-2020; Chun, Jerold/Y-4670-2019	Herr, Deron/0000-0001-5755-0896; Lee, Chang-Wook/0000-0002-0907-8475	National Institutes of Health [MH051699, NS048478, DC009505, DA019674]; Capita Foundation; National University of Singapore; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051699, R01MH051699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Capita Foundation; National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants MH051699, NS048478, DC009505, and DA019674 (to J. C.). This work was also supported by the Capita Foundation and the National University of Singapore (to D.R.H.).	Abrahan CE, 2010, INVEST OPHTH VIS SCI, V51, P1171, DOI 10.1167/iovs.09-3909; Addison WHF, 1921, AM J ANAT, V29, P1, DOI 10.1002/aja.1000290103; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; Byun TH, 2011, ANAT REC, V294, P789, DOI 10.1002/ar.21366; Caballero S, 2009, EXP EYE RES, V88, P367, DOI 10.1016/j.exer.2008.07.012; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Copland DA, 2012, AM J PATHOL, V180, P672, DOI 10.1016/j.ajpath.2011.10.008; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Du X, 2004, GENETICS, V166, P331, DOI 10.1534/genetics.166.1.331; Esche M, 2010, NEUROSCI LETT, V480, P101, DOI 10.1016/j.neulet.2010.06.014; FINDLATER GS, 1993, J ANAT, V183, P121; French KJ, 2003, CANCER RES, V63, P5962; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Herr DR, 2007, J NEUROSCI, V27, P1474, DOI 10.1523/JNEUROSCI.4245-06.2007; Herr KJ, 2011, P NATL ACAD SCI USA, V108, P15444, DOI 10.1073/pnas.1106129108; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hsieh HL, 2008, J CELL BIOCHEM, V103, P1732, DOI 10.1002/jcb.21563; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Kamada K, 2009, PATHOL INT, V59, P382, DOI 10.1111/j.1440-1827.2009.02381.x; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kurose S, 2000, EXP EYE RES, V70, P7, DOI 10.1006/exer.1999.0777; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Maines LW, 2006, INVEST OPHTH VIS SCI, V47, P5022, DOI 10.1167/iovs.05-1236; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGuire PG, 2011, ARTERIOSCL THROM VAS, V31, pE107, DOI 10.1161/ATVBAHA.111.235408; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Raveney BJE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1390, DOI 10.1001/archopht.126.10.1390; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Salomone S, 2003, EUR J PHARMACOL, V469, P125, DOI 10.1016/S0014-2999(03)01731-X; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Sumida GM, 2011, AM J PHYSIOL-CELL PH, V300, pC1164, DOI 10.1152/ajpcell.00437.2010; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; Tao H, 2005, DEVELOPMENT, V132, P3217, DOI 10.1242/dev.01892; Tateossian Hilda, 2009, Pathogenetics, V2, P5, DOI 10.1186/1755-8417-2-5; Usui S, 2004, J BIOL CHEM, V279, P12300, DOI 10.1074/jbc.M305025200; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Xia Y, 2004, BIOCHEM PHARMACOL, V68, P997, DOI 10.1016/j.bcp.2004.05.028; Xie B, 2009, J CELL PHYSIOL, V218, P192, DOI 10.1002/jcp.21588; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang L, 2003, MOL VIS, V9, P584; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhu DH, 2010, VISION RES, V50, P643, DOI 10.1016/j.visres.2009.09.002	64	20	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29882	29889		10.1074/jbc.M113.510099	http://dx.doi.org/10.1074/jbc.M113.510099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003216	hybrid, Green Published			2022-12-25	WOS:000330615300061
J	Hills, CE; Jin, TR; Siamantouras, E; Liu, IKK; Jefferson, KP; Squires, PE				Hills, Claire E.; Jin, Tianrong; Siamantouras, Eleftherios; Liu, Issac K-K; Jefferson, Kieran P.; Squires, Paul E.			'Special K' and a Loss of Cell-To-Cell Adhesion in Proximal Tubule-Derived Epithelial Cells: Modulation of the Adherens Junction Complex by Ketamine	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; TGF-BETA; UP-REGULATION; COMMUNICATION; TGF-BETA-1; DISEASE	Ketamine, a mild hallucinogenic class C drug, is the fastest growing 'party drug' used by 16-24 year olds in the UK. As the recreational use of Ketamine increases we are beginning to see the signs of major renal and bladder complications. To date however, we know nothing of a role for Ketamine in modulating both structure and function of the human renal proximal tubule. In the current study we have used an established model cell line for human epithelial cells of the proximal tubule (HK2) to demonstrate that Ketamine evokes early changes in expression of proteins central to the adherens junction complex. Furthermore we use AFM single-cell force spectroscopy to assess if these changes functionally uncouple cells of the proximal tubule ahead of any overt loss in epithelial cell function. Our data suggests that Ketamine (24-48 hrs) produces gross changes in cell morphology and cytoskeletal architecture towards a fibrotic phenotype. These physical changes matched the concentration-dependent (0.1-1 mg/mL) cytotoxic effect of Ketamine and reflect a loss in expression of the key adherens junction proteins epithelial (E)- and neural (N)-cadherin and beta-catenin. Down-regulation of protein expression does not involve the pro-fibrotic cytokine TGF beta, nor is it regulated by the usual increase in expression of Slug or Snail, the transcriptional regulators for E-cadherin. However, the loss in E-cadherin can be partially rescued pharmacologically by blocking p38 MAPK using SB203580. These data provide compelling evidence that Ketamine alters epithelial cell-to-cell adhesion and cell-coupling in the proximal kidney via a non-classical pro-fibrotic mechanism and the data provides the first indication that this illicit substance can have major implications on renal function. Understanding Ketamine-induced renal pathology may identify targets for future therapeutic intervention.	[Hills, Claire E.; Squires, Paul E.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Jin, Tianrong; Siamantouras, Eleftherios; Liu, Issac K-K] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England; [Jefferson, Kieran P.] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Hills, CE (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	C.Hills@warwick.ac.uk	Hills, Claire CE/J-6726-2015	Hills, Claire CE/0000-0001-8917-2666; Squires, Paul/0000-0003-4547-6777	Diabetes UK [BDA: 12/0004546]; Diabetes UK [12/0004546] Funding Source: researchfish; Rosetrees Trust [M297] Funding Source: researchfish	Diabetes UK(Diabetes UK); Diabetes UK(Diabetes UK); Rosetrees Trust(Rosetrees Trust)	This work was supported by the generous support of The Teresa Rosenbaum Golden Charitable Trust (Rosetree Trust). AFM-SCFS was made possible by the support of an equipment grant from Diabetes UK (BDA: 12/0004546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chu PSK, 2008, BJU INT, V102, P1616, DOI 10.1111/j.1464-410X.2008.07920.x; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; Hills CE, 2006, AM J PHYSIOL-RENAL, V291, pF1045, DOI 10.1152/ajprenal.00344.2005; Hills CE, 2012, CELL PHYSIOL BIOCHEM, V30, P575, DOI 10.1159/000341439; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hills CE, 2010, MOL ENDOCRINOL, V24, P822, DOI 10.1210/me.2009-0391; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Hills CE, 2009, CELL PHYSIOL BIOCHEM, V24, P177, DOI 10.1159/000233244; Hills CE, 2009, AM J PHYSIOL-RENAL, V296, pF614, DOI 10.1152/ajprenal.90500.2008; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KANNO Y, 1984, EXP CELL RES, V152, P270, DOI 10.1016/0014-4827(84)90253-2; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Morgan CJA, 2010, ADDICTION, V105, P121, DOI 10.1111/j.1360-0443.2009.02761.x; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; Selby NM, 2008, CLIN KIDNEY J, V1, P310, DOI 10.1093/ndtplus/sfn054; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Srirangam Shalom, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-006447; Tsai TH, 2009, INT J UROL, V16, P826, DOI 10.1111/j.1442-2042.2009.02361.x; Wood D, 2011, BJU INT, V107, P1881, DOI 10.1111/j.1464-410X.2010.10031.x; WRIGHT M, 1982, J AM VET MED ASSOC, V180, P1462; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	30	23	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71819	10.1371/journal.pone.0071819	http://dx.doi.org/10.1371/journal.pone.0071819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009666	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000323734600008
J	Kolleck, J; Yang, M; Zinner, D; Roos, C				Kolleck, Jakob; Yang, Mouyu; Zinner, Dietmar; Roos, Christian			Genetic Diversity in Endangered Guizhou Snub-Nosed Monkeys (Rhinopithecus brelichi): Contrasting Results from Microsatellite and Mitochondrial DNA Data	PLOS ONE			English	Article							POPULATION-SIZE; EXTINCTION RISK; CONSERVATION; BOTTLENECKS; INFERENCE; SOFTWARE; CHINA; TESTS; FLOW	To evaluate the conservation status of a species or population it is necessary to gain insight into its ecological requirements, reproduction, genetic population structure, and overall genetic diversity. In our study we examined the genetic diversity of Rhinopithecus brelichi by analyzing microsatellite data and compared them with already existing data derived from mitochondrial DNA, which revealed that R. brelichi exhibits the lowest mitochondrial diversity of all so far studied Rhinopithecus species. In contrast, the genetic diversity of nuclear DNA is high and comparable to other Rhinopithecus species, i.e. the examined microsatellite loci are similarly highly polymorphic as in other species of the genus. An explanation for these differences in mitochondrial and nuclear genetic diversity could be a male biased dispersal. Females most likely stay within their natal band and males migrate between bands, thus mitochondrial DNA will not be exchanged between bands but nuclear DNA via males. A Bayesian Skyline Plot based on mitochondrial DNA sequences shows a strong decrease of the female effective population size (N-ef) starting about 3,500 to 4,000 years ago, which concurs with the increasing human population in the area and respective expansion of agriculture. Given that we found no indication for a loss of nuclear DNA diversity in R. brelichi it seems that this factor does not represent the most prominent conservation threat for the long-term survival of the species. Conservation efforts should therefore focus more on immediate threats such as development of tourism and habitat destruction.	[Kolleck, Jakob; Yang, Mouyu; Roos, Christian] German Primate Ctr, Leibniz Inst Primate Res, Primate Genet Lab, Gottingen, Germany; [Yang, Mouyu] Fanjingshan Natl Nat Reserve, Jiangkou, Peoples R China; [Zinner, Dietmar] German Primate Ctr, Leibniz Inst Primate Res, Cognit Ethol Lab, Gottingen, Germany; [Roos, Christian] Gene Bank Primates, German Primate Ctr, Leibniz Inst Primate Res, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Roos, C (corresponding author), German Primate Ctr, Leibniz Inst Primate Res, Primate Genet Lab, Gottingen, Germany.	croos@dpz.eu			Margot Marsh Biodiversity Foundation; German Primate Center	Margot Marsh Biodiversity Foundation; German Primate Center	The Margot Marsh Biodiversity Foundation and the German Primate Center financially supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JD, 2011, CONSERV GENET, V12, P981, DOI 10.1007/s10592-011-0201-5; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Bleisch W, 2008, IUCN 2012 IUCN RED L; Bleisch W, 1992, ASIAN PRIMATES, V1, P4; Chang ZF, 2012, CHINESE SCI BULL, V57, P1135, DOI 10.1007/s11434-011-4872-6; Chaves PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020722; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ebenau A., 2011, VIETNAM J PRIMATOL, V1, P1; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R., 2002, INTRO CONSERVATION G; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton M.B., 2009, POPULATION GENETICS; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; IUCN, 2022, IUCN RED LIST THREAT; Jablonski N. G., 1998, NATURAL HIST DOUCS S; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; KIMURA M, 1964, GENETICS, V49, P725; KIRKPATRICK RC, 1995, BIOL CONSERV, V72, P363, DOI 10.1016/0006-3207(94)00039-S; Lande R., 1987, VIABLE POPULATIONS C, P87, DOI DOI 10.1017/CBO9780511623400.007; Li BG, 2002, INT J PRIMATOL, V23, P1227, DOI 10.1023/A:1021122819845; Li MH, 2010, HEREDITY, V104, P600, DOI 10.1038/hdy.2009.150; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Luo MF, 2012, AM J PRIMATOL, V74, P91, DOI 10.1002/ajp.21006; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Mbora DNM, 2010, CONSERV GENET, V11, P1725, DOI 10.1007/s10592-010-0065-0; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Pan D, 2005, CHINESE SCI BULL, V50, P2850, DOI 10.1007/BF02899655; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Plesnar-Bielak A, 2012, P ROY SOC B-BIOL SCI, V279, P4661, DOI 10.1098/rspb.2012.1867; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vonholdt BM, 2010, MOL ECOL, V19, P4412, DOI 10.1111/j.1365-294X.2010.04769.x; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Xiang ZF, 2009, BIOL CONSERV, V142, P469, DOI 10.1016/j.biocon.2008.11.019; Yang MY, 2012, AM J PHYS ANTHROPOL, V147, P1, DOI 10.1002/ajpa.21618; Yang MY, 2009, AM J PRIMATOL, V71, P266, DOI 10.1002/ajp.20645; Yang YQ., 2002, FANJINGSHAN RES ECOL; Zhou WJ, 2004, QUATERNARY RES, V62, P39, DOI 10.1016/j.yqres.2004.05.004; Zhou ZH, 1990, RES FANJING MOUNTAIN, P442; Zhu ZQ, 2003, HUBEI FOR SCI TECH Z, VZ1, P46	56	16	16	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73647	10.1371/journal.pone.0073647	http://dx.doi.org/10.1371/journal.pone.0073647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009761	Green Published, gold			2022-12-25	WOS:000323734600076
J	van Cleef, BAGL; van Benthem, BHB; Haenen, APJ; Bosch, T; Monen, J; Kluytmans, JAJW				van Cleef, Brigitte A. G. L.; van Benthem, Birgit H. B.; Haenen, Anja P. J.; Bosch, Thijs; Monen, Jos; Kluytmans, Jan A. J. W.			Low Incidence of Livestock-Associated Methicillin-Resistant Staphylococcus aureus Bacteraemia in The Netherlands in 2009	PLOS ONE			English	Article							PREVALENCE; ST398; CARRIAGE; OUTBREAK; MRSA	Methicillin-resistant Staphylococcus aureus (MRSA) is a worldwide problem in both hospitals and communities all over the world. In 2003, a new MRSA clade emerged with a reservoir in pigs and veal calves: livestock-associated MRSA (LA-MRSA). We wanted to estimate the incidence of bacteraemias due to LA-MRSA using national surveillance data from 2009 in the Netherlands. We found a low incidence of LA-MRSA and MRSA bacteraemia episodes, compared to bacteraemias caused by all S. aureus (0.04, 0.18 and 19.3 episodes of bacteraemia per 100,000 inhabitants per year, respectively). LA-MRSA and MRSA were uncommon compared to numbers from other countries as well. MRSA in general and LA-MRSA in specific does not appear to be a public health problem in the Netherlands now. The low incidence of LA-MRSA bacteraemia episodes may best be explained by differences in the populations affected by LA-MRSA versus other MRSA. However, reduced virulence of the strain involved, and the effectiveness of the search and destroy policy might play a role as well.	[van Cleef, Brigitte A. G. L.; van Benthem, Birgit H. B.; Haenen, Anja P. J.; Bosch, Thijs; Monen, Jos] RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [van Cleef, Brigitte A. G. L.; Kluytmans, Jan A. J. W.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [van Cleef, Brigitte A. G. L.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Med Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; Vrije Universiteit Amsterdam	van Cleef, BAGL (corresponding author), RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands.	brivancleef@gmail.com	Haenen, Anja/E-1621-2016					Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Fanoy E, 2009, EUROSURVEILLANCE, V14; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Haenen APJ, 2010, INFECTIEZIEKTEN B, V21, P7; Huijsdens XW, 2009, EUROSURVEILLANCE, V14, P12; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kaiser AM, 2010, INFECT CONT HOSP EP, V31, P1188, DOI 10.1086/656744; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Kluytmans J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b364; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Verkade E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041855; Verkade E, 2012, INFECT CONT HOSP EP, V33, P624, DOI 10.1086/665726; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf M W, 2008, Euro Surveill, V13; Zarfel G, 2013, EPIDEMIOL INFECT, V141, P888, DOI 10.1017/S0950268812001343	25	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73096	10.1371/journal.pone.0073096	http://dx.doi.org/10.1371/journal.pone.0073096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009733	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600055
J	Vanska, S; Auranen, K; Leino, T; Salo, H; Nieminen, P; Kilpi, T; Tiihonen, P; Apter, D; Lehtinen, M				Vanska, Simopekka; Auranen, Kari; Leino, Tuija; Salo, Heini; Nieminen, Pekka; Kilpi, Terhi; Tiihonen, Petri; Apter, Dan; Lehtinen, Matti			Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; HUMAN-PAPILLOMAVIRUS VACCINATION; CROSS-PROTECTIVE EFFICACY; POPULATION-LEVEL IMPACT; BLIND PATRICIA TRIAL; OF-STUDY ANALYSIS; INTRAEPITHELIAL NEOPLASIA; QUADRIVALENT; PREVALENCE; FINLAND	The development of high-risk human papillomavirus (hrHPV) infection to cervical cancer is a complicated process. We considered solely hrHPV infections, thus avoiding the confounding effects of disease progression, screening, and treatments. To analyse hrHPV epidemiology and to estimate the overall impact of vaccination against infections with hrHPVs, we developed a dynamic compartmental transmission model for single and multiple infections with 14 hrHPV types. The infection-related parameters were estimated using population-based sexual behaviour and hrHPV prevalence data from Finland. The analysis disclosed the important role of persistent infections in hrHPV epidemiology, provided further evidence for a significant natural immunity, and demonstrated the dependence of transmission probability estimates on the model structure. The model predicted that vaccinating girls at 80% coverage will result in a 55% reduction in the overall hrHPV prevalence and a higher 65% reduction in the prevalence of persistent hrHPV infections in females. In males, the reduction will be 42% in the hrHPV prevalence solely by the herd effect from the 80% coverage in girls. If such high coverage among girls is not reached, it is still possible to reduce the female hrHPV prevalence indirectly by the herd effect if also boys are included in the vaccination program. On the other hand, any herd effects in older unvaccinated cohorts were minor. Limiting the epidemiological model to infection yielded improved understanding of the hrHPV epidemiology and of mechanisms with which vaccination impacts on hrHPV infections.	[Vanska, Simopekka; Auranen, Kari; Leino, Tuija; Salo, Heini; Kilpi, Terhi; Tiihonen, Petri] Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Vanska, Simopekka; Lehtinen, Matti] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; [Nieminen, Pekka] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Apter, Dan] Family Federat Finland, Sexual Hlth Clin, Helsinki, Finland	Finland National Institute for Health & Welfare; Tampere University; University of Helsinki; Helsinki University Central Hospital; Family Federation of Finland	Vanska, S (corresponding author), Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Helsinki, Finland.	simopekka.vanska@thl.fi	Nieminen, Pekka/W-8570-2019; Apter, Dan/D-6269-2017	Apter, Dan/0000-0002-5175-8845; lehtinen, matti/0000-0002-9481-0535	European Community's Seventh Framework programme (FP7) [242061EU]	European Community's Seventh Framework programme (FP7)	The work was supported by the European Community's Seventh Framework programme (FP7/2007 2013) under grant agreement No. 242061EU (PreHdict). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Choi YH, 2012, VACCINE, V30, P3383, DOI 10.1016/j.vaccine.2012.03.065; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Coupe VMH, 2012, VACCINE, V30, P1813, DOI 10.1016/j.vaccine.2012.01.001; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Elbasha EH, 2008, B MATH BIOL, V70, P2126, DOI 10.1007/s11538-008-9338-x; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Johnson HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049614; Kontula O., 2009, SEXUAL DESIRE REALIT; Kretzschmar M, 2000, SEX TRANSM DIS, V27, P627, DOI 10.1097/00007435-200011000-00011; Laukkanen P, 2003, J GEN VIROL, V84, P2105, DOI 10.1099/vir.0.18995-0; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Leinonen M, 2008, INT J CANCER, V123, P1344, DOI 10.1002/ijc.23670; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Merikukka M, 2011, INT J CANCER, V128, P1114, DOI 10.1002/ijc.25675; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; National Institute for Health and Welfare (THL), 2008, SCH HLTH PROM STUD F; Official Statistics of Finland, 2008, CHANG MAR STAT NEWL; Palmroth J, 2012, INT J CANC; Trottier H, 2010, CANCER RES, V70, P8569, DOI 10.1158/0008-5472.CAN-10-0621; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	31	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72088	10.1371/journal.pone.0072088	http://dx.doi.org/10.1371/journal.pone.0072088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009669	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600010
J	Borja, MS; Zhao, L; Hammerson, B; Tang, CR; Yang, R; Carson, N; Fernando, G; Liu, XQ; Budamagunta, MS; Genest, J; Shearer, GC; Duclos, F; Oda, MN				Borja, Mark S.; Zhao, Lei; Hammerson, Bradley; Tang, Chongren; Yang, Richard; Carson, Nancy; Fernando, Gayani; Liu, Xiaoqin; Budamagunta, Madhu S.; Genest, Jacques; Shearer, Gregory C.; Duclos, Franck; Oda, Michael N.			HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; PARAMAGNETIC-RESONANCE SPECTROSCOPY; RANDOMIZED CONTROLLED-TRIAL; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; MYELOPEROXIDASE IMPAIRS	High density lipoprotein (HDL) cholesterol levels are associated with decreased risk of cardiovascular disease, but not all HDL are functionally equivalent. A primary determinant of HDL functional status is the conformational adaptability of its main protein component, apoA-I, an exchangeable apolipoprotein. Chemical modification of apoA-I, as may occur under conditions of inflammation or diabetes, can severely impair HDL function and is associated with the presence of cardiovascular disease. Chemical modification of apoA-I also impairs its ability to exchange on and off HDL, a critical process in reverse cholesterol transport. In this study, we developed a method using electron paramagnetic resonance spectroscopy (EPR) to quantify HDL-apoA-I exchange. Using this approach, we measured the degree of HDL-apoA-I exchange for HDL isolated from rabbits fed a high fat, high cholesterol diet, as well as human subjects with acute coronary syndrome and metabolic syndrome. We observed that HDL-apoA-I exchange was markedly reduced when atherosclerosis was present, or when the subject carries at least one risk factor of cardiovascular disease. These results show that HDL-apoA-I exchange is a clinically relevant measure of HDL function pertinent to cardiovascular disease.	[Borja, Mark S.; Oda, Michael N.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Zhao, Lei; Yang, Richard; Fernando, Gayani; Liu, Xiaoqin; Duclos, Franck] Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ USA; [Hammerson, Bradley] Accent Assays Inc, Sacramento, CA USA; [Hammerson, Bradley] Accent Assays Inc, Sacramento, CA USA; [Budamagunta, Madhu S.] Univ Washington, Dept Med, Washington, DC USA; Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Genest, Jacques] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; Univ S Dakota, Sanford Res USD, Cardiovasc Hlth Res Ctr, Sioux Falls, SD USA; [Shearer, Gregory C.] Univ S Dakota, Sanford Sch Med, Dept Basic Biomed Sci, Sioux Falls, SD USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Bristol-Myers Squibb; University of Washington; University of California System; University of California Davis; McGill University; Royal Victoria Hospital; Sanford Health; University of South Dakota; University of South Dakota	Oda, MN (corresponding author), Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA.	moda@chori.org	Shearer, Gregory/B-7309-2014; Budamagunta, Madhu S/C-4628-2011		Canadian Institutes of Health Research (CIHR) [MOP 67088]; National Science Foundation [1248683]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Canadian Institutes of Health Research (CIHR) MOP 67088 to MNO and a National Science Foundation Small Business Innovation Research (SBIR) grant 1248683 to Accent Assays, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bittner V, 2000, AM HEART J, V139, P288, DOI 10.1067/mhj.2000.101224; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Eren Esin, 2012, Open Biochem J, V6, P78, DOI 10.2174/1874091X01206010078; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; Hazen SL, 2000, BIOCHEM J, V352, P693, DOI 10.1042/0264-6021:3520693; Heinecke JW, 2003, AM J CARDIOL, V91, p12A; Hoofnagle AN, 2010, ARTERIOSCL THROM VAS, V30, P2528, DOI 10.1161/ATVBAHA.110.212894; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Lagerstedt JO, 2012, BBA-MOL CELL BIOL L, V1821, P448, DOI 10.1016/j.bbalip.2011.12.010; Lagerstedt JO, 2011, J BIOL CHEM, V286, P2966, DOI 10.1074/jbc.M110.163097; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; Liang HQ, 1996, J LIPID RES, V37, P1962; Lusa S, 1996, BIOCHEM J, V313, P275, DOI 10.1042/bj3130275; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Mikkola TS, 2003, ATHEROSCLEROSIS, V170, P31, DOI 10.1016/S0021-9150(03)00247-8; Mulya A, 2008, J LIPID RES, V49, P2390, DOI 10.1194/jlr.M800241-JLR200; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Nijstad N, 2009, J BIOL CHEM, V284, P6093, DOI 10.1074/jbc.M807683200; Nobecourt E, 2010, ARTERIOSCL THROM VAS, V30, P766, DOI 10.1161/ATVBAHA.109.201715; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Okuhira K, 2004, J LIPID RES, V45, P645, DOI 10.1194/jlr.M300257-JLR200; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pownall HJ, 2007, BIOCHEMISTRY-US, V46, P7449, DOI 10.1021/bi700496w; Pownall HJ, 2006, CURR OPIN LIPIDOL, V17, P209, DOI 10.1097/01.mol.0000226110.66942.e8; Pu LJ, 2012, DIABETES CARE; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; RYAN RO, 1992, BIOCHEMISTRY-US, V31, P4509, DOI 10.1021/bi00133a018; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 1997, J BIOL CHEM, V272, P3953, DOI 10.1074/jbc.272.7.3953; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2010, J LIPID RES, V51, P1849, DOI 10.1194/jlr.M004085; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shearer GC, 2012, J LIPID RES, V53, P2429, DOI 10.1194/jlr.P022392; Smith JD, 2010, ARTERIOSCL THROM VAS, V30, P151, DOI 10.1161/ATVBAHA.108.179226; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Tsai MY, 2008, ATHEROSCLEROSIS, V200, P359, DOI 10.1016/j.atherosclerosis.2007.12.038; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Yasuda T, 2010, CIRC J, V74, P2263, DOI 10.1253/circj.CJ-10-0934; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	81	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71541	10.1371/journal.pone.0071541	http://dx.doi.org/10.1371/journal.pone.0071541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015188	gold, Green Submitted, Green Published			2022-12-25	WOS:000323733800010
J	Chan, SCW; Walser, J; Kappeli, P; Shamsollahi, MJ; Ferguson, SJ; Gantenbein-Ritter, B				Chan, Samantha C. W.; Walser, Jochen; Kaeppeli, Patrick; Shamsollahi, Mohammad Javad; Ferguson, Stephen J.; Gantenbein-Ritter, Benjamin			Region Specific Response of Intervertebral Disc Cells to Complex Dynamic Loading: An Organ Culture Study Using a Dynamic Torsion-Compression Bioreactor	PLOS ONE			English	Article							LOW-BACK-PAIN; IN-VITRO; LUMBAR SPINE; MICROMECHANICAL ENVIRONMENT; NUCLEUS PULPOSUS; GENE-EXPRESSION; PORCINE MODEL; DEGENERATION; MECHANICS; INJURY	The spine is routinely subjected to repetitive complex loading consisting of axial compression, torsion, flexion and extension. Mechanical loading is one of the important causes of spinal diseases, including disc herniation and disc degeneration. It is known that static and dynamic compression can lead to progressive disc degeneration, but little is known about the mechanobiology of the disc subjected to combined dynamic compression and torsion. Therefore, the purpose of this study was to compare the mechanobiology of the intervertebral disc when subjected to combined dynamic compression and axial torsion or pure dynamic compression or axial torsion using organ culture. We applied four different loading modalities [1. control: no loading (NL), 2. cyclic compression (CC), 3. cyclic torsion (CT), and 4. combined cyclic compression and torsion (CCT)] on bovine caudal disc explants using our custom made dynamic loading bioreactor for disc organ culture. Loads were applied for 8 h/day and continued for 14 days, all at a physiological magnitude and frequency. Our results provided strong evidence that complex loading induced a stronger degree of disc degeneration compared to one degree of freedom loading. In the CCT group, less than 10% nucleus pulposus (NP) cells survived the 14 days of loading, while cell viabilities were maintained above 70% in the NP of all the other three groups and in the annulus fibrosus (AF) of all the groups. Gene expression analysis revealed a strong up-regulation in matrix genes and matrix remodeling genes in the AF of the CCT group. Cell apoptotic activity and glycosaminoglycan content were also quantified but there were no statistically significant differences found. Cell morphology in the NP of the CCT was changed, as shown by histological evaluation. Our results stress the importance of complex loading on the initiation and progression of disc degeneration.	[Chan, Samantha C. W.; Shamsollahi, Mohammad Javad; Gantenbein-Ritter, Benjamin] Univ Bern, Inst Surg Technol & Biomech, Tissue & Organ Mech Grp, Bern, Switzerland; [Walser, Jochen; Kaeppeli, Patrick; Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Chan, SCW (corresponding author), Univ Bern, Inst Surg Technol & Biomech, Tissue & Organ Mech Grp, Bern, Switzerland.	Samantha.chan@istb.unibe.ch	Gantenbein, Benjamin/H-9302-2019; Ferguson, Stephen J./A-4118-2012	Gantenbein, Benjamin/0000-0002-9005-0655; Ferguson, Stephen J./0000-0003-0650-5889	Swiss National Science Foundation [310030_127586/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation 310030_127586/1 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1981, SPINE, V6, P241, DOI 10.1097/00007632-198105000-00006; ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002; Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Au G, 2001, ERGONOMICS, V44, P373, DOI 10.1080/00140130010008129; Aultman CD, 2004, SPINE, V29, pE304, DOI 10.1097/01.BRS.0000132515.21703.38; Baer AE, 2003, J BIOMECH ENG-T ASME, V125, P1, DOI 10.1115/1.1532790; Barbir A, 2010, SPINE, V36, P607, DOI DOI 10.1097/BRS.0B013E3181D9B58B; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROBERG KB, 1983, SPINE, V8, P151, DOI 10.1097/00007632-198303000-00006; Callaghan JP, 2001, CLIN BIOMECH, V16, P28, DOI 10.1016/S0268-0033(00)00063-2; Chan Samantha C W, 2012, J Vis Exp, DOI 10.3791/3490; Chan SCW, 2013, SPINE J, V13, P273, DOI 10.1016/j.spinee.2012.12.007; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008; Cloyd JM, 2007, SPINE, V32, P1826, DOI 10.1097/BRS.0b013e3181132a9d; Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0; Drake JDM, 2008, CLIN BIOMECH, V23, P510, DOI 10.1016/j.clinbiomech.2007.12.005; Drake JDM, 2009, CLIN BIOMECH, V24, P1, DOI 10.1016/j.clinbiomech.2008.09.010; Drake JDM, 2005, CLIN BIOMECH, V20, P1038, DOI 10.1016/j.clinbiomech.2005.06.007; Duncan NA, 2006, J BONE JOINT SURG AM, V88A, P47, DOI 10.2106/JBJS.F.00035; Elliott B, 2002, MED SCI SPORT EXER, V34, P1714, DOI 10.1249/01.MSS.0000036863.74140.90; FARFAN HF, 1970, J BONE JOINT SURG AM, VA 52, P468, DOI 10.2106/00004623-197052030-00006; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Gantenbein-Ritter B, 2008, TISSUE ENG PART C-ME, V14, P353, DOI 10.1089/ten.tec.2008.0313; Gawri R, 2011, SPINE, V36, P1835, DOI 10.1097/BRS.0b013e3181f81314; Gluck GS, 2008, SPINE J, V8, P778, DOI 10.1016/j.spinee.2007.07.388; Gregory DE, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003327; Grimshaw P, 2002, SPORTS MED, V32, P655, DOI 10.2165/00007256-200232100-00004; Hadjipavlou AG, 1998, J SPINAL DISORD, V11, P318; Hadjipavlou AG, 1998, J SPINAL DISORD, V11, P312; Haglund L, 2011, TISSUE ENG PART C-ME, V17, P1011, DOI [10.1089/ten.tec.2011.0025, 10.1089/ten.TEC.2011.0025]; Hangai M, 2009, AM J SPORT MED, V37, P149, DOI 10.1177/0363546508323252; Hartman RA, 2011, J BIOMECH, V45, P382; Jim B, 2011, EUR SPINE J, V20, P1244, DOI 10.1007/s00586-011-1721-x; Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d; KELSEY J L, 1984, Journal of Orthopaedic Research, V2, P61, DOI 10.1002/jor.1100020110; Kim J, 2012, ANN BIOMED ENG, V40, P1996, DOI 10.1007/s10439-012-0570-z; Kingsley MI, 2012, MED SCI SPORT EXER, V44, P2199, DOI 10.1249/MSS.0b013e318260dbc1; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean JL, 2004, J ORTHOP RES, V22, P1193, DOI 10.1016/j.orthres.2004.04.004; Malonzo C, 2013, J TISSUE ENG REGEN M; Michalek AJ, 2009, J BIOMECH, V42, P2279, DOI 10.1016/j.jbiomech.2009.06.047; NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107; Nachemson A, 1970, SCAND J REHABIL ME S, V1, P1; Norman R, 1998, CLIN BIOMECH, V13, P561, DOI 10.1016/S0268-0033(98)00020-5; Paul CPL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062411; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; PEARCY MJ, 1984, SPINE, V9, P582, DOI 10.1097/00007632-198409000-00008; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Setton LA, 2004, SPINE, V29, P2710, DOI 10.1097/01.brs.0000146050.57722.2a; Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c; Smith CK, 2006, J BIOMECH ENG-T ASME, V128, P437, DOI 10.1115/1.2187038; van Deursen DL, 2001, SPINE, V26, P2582, DOI 10.1097/00007632-200112010-00011; Veres SP, 2010, EUR SPINE J, V19, P1468, DOI 10.1007/s00586-010-1383-0; Walser J., 2012, REPLACING ANIMAL MOD, P89; Walsh AJL, 2004, J BIOMECH, V37, P329, DOI 10.1016/S0021-9290(03)00290-2; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; White A.A., 1990, CLIN BIOMECH; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilke HJ, 1996, J BIOMECH, V29, P549, DOI 10.1016/0021-9290(95)00037-2; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867; Yantzer BK, 2007, SPINE, V32, P881, DOI 10.1097/01.brs.0000259838.40738.1f; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001	69	46	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72489	10.1371/journal.pone.0072489	http://dx.doi.org/10.1371/journal.pone.0072489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24013824	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800060
J	Vogelweith, F; Moret, Y; Thiery, D; Moreau, J				Vogelweith, Fanny; Moret, Yannick; Thiery, Denis; Moreau, Jerome			Lobesia botrana Larvae Develop Faster in the Presence of Parasitoids	PLOS ONE			English	Article							FECUNDITY	To combat parasitism hosts often rely on their immune system, which is the last line of defense. However, the immune system may not always be effective, and other non-immunological defenses might be favored to reduce the cost of parasite infection. Here we report that larvae of the moth Lobesia botrana can rapidly accelerate their development and reach maturity earlier in response to cues perceived at a distance from parasitoids. Such a phenotypically plastic life history shift, induced by the perception of deadly enemies in the environment, is likely to be an adaptive defensive strategy to prevent parasitoid attack, and has important implications in host-parasite dynamics.	[Vogelweith, Fanny; Moret, Yannick; Moreau, Jerome] Univ Bourgogne, Equipe Ecol Evolut, UMR Biogeosci 6282, Dijon, France; [Thiery, Denis] INRA, UMR Sante & Agroecol Vignoble 1065, Inst Sci Vigne & du Vin, Villenave Dornon, France; [Thiery, Denis] Univ Bordeaux, INRA, UMR 1065, Bordeaux Sci Agro, Villenave Dornon, France	Universite de Bourgogne; INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Vogelweith, F (corresponding author), Univ Bourgogne, Equipe Ecol Evolut, UMR Biogeosci 6282, Dijon, France.	fanny.vogelweith@u-bourgogne.fr	Vogelweith, Fanny/H-7765-2019; Moret, Yannick/I-9282-2012; moreau, jerome/A-3496-2013	Vogelweith, Fanny/0000-0002-3595-6702; 	CNRS; ANR [ANR07-JCJC-0134, ANR08-JCJC-0006]; ANR (Conseil Regional de Bourgogne)	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); ANR (Conseil Regional de Bourgogne)(French National Research Agency (ANR)Region Bourgogne-Franche-Comte)	Funding was provided by the CNRS and the ANR (ANR07-JCJC-0134 and ANR08-JCJC-0006 and the Conseil Regional de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Fred MS, 2010, ANIM BEHAV, V79, P313, DOI 10.1016/j.anbehav.2009.11.001; Guedes RNC, 2012, J COMP PHYSIOL A, V198, P325, DOI 10.1007/s00359-012-0711-8; Hawkins BA, 1997, ECOLOGY, V78, P2145, DOI 10.1890/0012-9658(1997)078[2145:PPAPAM]2.0.CO;2; Kraaijeveld AR, 2002, PARASITOLOGY, V125, pS71, DOI 10.1017/S0031182002001750; MINCHELLA DJ, 1985, PARASITOLOGY, V90, P205, DOI 10.1017/S0031182000049143; MINCHELLA DJ, 1981, AM NAT, V118, P876, DOI 10.1086/283879; Moreau J, 2010, BIOL CONTROL, V54, P300, DOI 10.1016/j.biocontrol.2010.05.019; Moret Y, 2004, ECOL LETT, V7, P146, DOI 10.1046/j.1461-0248.2003.00561.x; Nespolo RF, 2009, ECOL RES, V24, P997, DOI 10.1007/s11284-008-0570-5; Roff Derek A., 1992; Roth O, 2008, J EVOLUTION BIOL, V21, P1703, DOI 10.1111/j.1420-9101.2008.01584.x; Stearns S.C., 1992, pi; Thiery D, 2005, OECOLOGIA, V143, P548, DOI 10.1007/s00442-005-0022-7; Thiery D., 2008, RAVAGEURS VIGNE; Togashi K, 2009, APPL ENTOMOL ZOOL, V44, P249, DOI 10.1303/aez.2009.249; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	19	7	7	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72568	10.1371/journal.pone.0072568	http://dx.doi.org/10.1371/journal.pone.0072568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015260	Green Published, gold			2022-12-25	WOS:000323733800065
J	Jacob-Ferreira, AL; Kondo, MY; Baral, PK; James, MNG; Holt, A; Fan, XH; Schulz, R				Jacob-Ferreira, Anna Laura; Kondo, Marcia Yuri; Baral, Pravas Kumar; James, Michael N. G.; Holt, Andrew; Fan, Xiaohu; Schulz, Richard			Phosphorylation Status of 72 kDa MMP-2 Determines Its Structure and Activity in Response to Peroxynitrite	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE 2; PROTEIN-PHOSPHORYLATION; OXIDATIVE STRESS; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; ACTIVATION; MODULATION; SUBSTRATE; CLEAVAGE; DISEASE	Matrix metalloproteinase-2 (MMP-2) is a key intra-and extra-cellular protease which contributes to several oxidative stress related pathologies. A molecular understanding of 72 kDa MMP-2 activity, directly mediated by S-glutathiolation of its cysteine residues in the presence of peroxynitrite (ONOO-) and by phosphorylation of its serine and threonine residues, is essential to develop new generation inhibitors of intracellular MMP-2. Within its propeptide and collagen binding domains there is an interesting juxtaposition of predicted phosphorylation sites with nearby cysteine residues which form disulfide bonds. However, the combined effect of these two post-translational modifications on MMP-2 activity has not been studied. The activity of human recombinant 72 kDa MMP-2 (hrMMP-2) following in vitro treatments was measured by troponin I proteolysis assay and a kinetic activity assay using a fluorogenic peptide substrate. ONOO- treatment in the presence of 30 mu M glutathione resulted in concentration-dependent changes in MMP-2 activity, with 0.1-1 mu M increasing up to twofold and 100 mu M attenuating its activity. Dephosphorylation of MMP-2 with alkaline phosphatase markedly increased its activity by sevenfold, either with or without ONOO-. Dephosphorylation of MMP-2 also affected the conformational structure of the enzyme as revealed by circular dichroism studies, suggesting an increase in the proportion of alpha-helices and a decrease in beta-strands compared to the phosphorylated form of MMP-2. These results suggest that ONOO- activation (at low mu M) and inactivation (at high mu M) of 72 kDa MMP-2, in the presence or absence of glutathione, is also influenced by its phosphorylation status. These insights into the role of post-translational modifications in the structure and activity of 72 kDa MMP-2 will aid in the development of inhibitors specifically targeting intracellular MMP-2.	[Jacob-Ferreira, Anna Laura; Kondo, Marcia Yuri; Holt, Andrew; Fan, Xiaohu; Schulz, Richard] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Pediat, Edmonton, AB, Canada; [Jacob-Ferreira, Anna Laura; Kondo, Marcia Yuri; Fan, Xiaohu; Schulz, Richard] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Pharmacol, Edmonton, AB, Canada; [Baral, Pravas Kumar; James, Michael N. G.] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Biochem, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Schulz, R (corresponding author), Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Pediat, Edmonton, AB, Canada.	richard.schulz@ualberta.ca	Schulz, Richard/A-8739-2012; Schulz, Richard/M-3518-2019	Schulz, Richard/0000-0002-5045-3193; Schulz, Richard/0000-0002-5045-3193; James, Michael/0000-0002-5978-4562	Canadian Institutes of Health Research [MOD 77526]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research grant (MOD 77526). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Aureli L, 2008, CURR MED CHEM, V15, P2192, DOI 10.2174/092986708785747490; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Broncel M, 2010, ORG BIOMOL CHEM, V8, P2575, DOI 10.1039/c001458c; Cadete VJJ, 2012, FEBS J, V279, P2444, DOI 10.1111/j.1742-4658.2012.08622.x; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Jiang ZHG, 2006, STRUCTURE, V14, P379, DOI 10.1016/j.str.2005.11.007; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; PONTREMOLI S, 1987, P NATL ACAD SCI USA, V84, P3604, DOI 10.1073/pnas.84.11.3604; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; Rao GN, 2000, J BIOL CHEM, V275, P16993, DOI 10.1074/jbc.275.22.16993; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Sariahmetoglu M, 2012, HEART, V98, P656, DOI 10.1136/heartjnl-2011-301250; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vepa S, 1997, FREE RADICAL BIO MED, V22, P25, DOI 10.1016/S0891-5849(96)00241-9; Viappiani S, 2006, AM J PHYSIOL-HEART C, V290, pH2167, DOI 10.1152/ajpheart.00128.2006; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; VILLA LM, 1994, P NATL ACAD SCI USA, V91, P12383, DOI 10.1073/pnas.91.26.12383; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wright VP, 2009, J PHYSIOL-LONDON, V587, P5767, DOI 10.1113/jphysiol.2009.178285	33	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71794	10.1371/journal.pone.0071794	http://dx.doi.org/10.1371/journal.pone.0071794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013357	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200019
J	Lopez, DH; Fiol-deRoque, MA; Noguera-Salva, MA; Teres, S; Campana, F; Piotto, S; Castro, JA; Mohaibes, RJ; Escriba, PV; Busquets, X				Lopez, Daniel H.; Fiol-deRoque, Maria A.; Noguera-Salva, Maria A.; Teres, Silvia; Campana, Federica; Piotto, Stefano; Castro, Jose A.; Mohaibes, Raheem J.; Escriba, Pablo V.; Busquets, Xavier			2-Hydroxy Arachidonic Acid: A New Non-Steroidal Anti-Inflammatory Drug	PLOS ONE			English	Article							NITRIC-OXIDE; MOLECULAR-DYNAMICS; FORCE-FIELD; INFLAMMATION; PROTEIN; PARAMETERIZATION; SIMULATIONS; MODEL	Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are a family of COX1 and COX2 inhibitors used to reduce the synthesis of pro-inflammatory mediators. In addition, inflammation often leads to a harmful generation of nitric oxide. Efforts are being done in discovering safer NSAIDs molecules capable of inhibiting the synthesis of pro-inflammatory lipid mediators and nitric oxide to reduce the side effects associated with long term therapies. Methodology/Principal Findings: The analogue of arachidonic acid (AA), 2-hydroxy-arachidonic acid (2OAA), was designed to inhibit the activities of COX1 and COX2 and it was predicted to have similar binding energies as AA for the catalytic sites of COX1 and COX2. The interaction of AA and 2OAA with COX1 and COX2 was investigated calculating the free energy of binding and the Fukui function. Toxicity was determined in mouse microglial BV-2 cells. COX1 and COX2 (PGH2 production) activities were measured in vitro. COX1 and COX2 expression in human macrophage-like U937 cells were carried out by Western blot, immunocytochemistry and RT-PCR analysis. NO production (Griess method) and iNOS (Western blot) were determined in mouse microglial BV-2 cells. The comparative efficacy of 2OAA, ibuprofen and cortisone in lowering TNF-alpha serum levels was determined in C57BL6/J mice challenged with LPS. We show that the presence of the -OH group reduces the likelihood of 2OAA being subjected to H* abstraction in COX, without altering significantly the free energy of binding. The 2OAA inhibited COX1 and COX2 activities and the expression of COX2 in human U937 derived macrophages challenged with LPS. In addition, 2OAA inhibited iNOS expression and the production of NO in BV-2 microglial cells. Finally, oral administration of 2OAA decreased the plasma TNF-alpha levels in vivo. Conclusion/Significance: These findings demonstrate the potential of 2OAA as a NSAID.	[Lopez, Daniel H.; Teres, Silvia] Lipopharma Therapeut, Palma de Mallorca, Balearic Island, Spain; [Fiol-deRoque, Maria A.; Noguera-Salva, Maria A.; Mohaibes, Raheem J.; Busquets, Xavier] Univ Balearic Isl, IUNICS, Dept Biol, Cell Biol Lab, Palma de Mallorca, Balearic Island, Spain; [Campana, Federica; Piotto, Stefano] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy; [Castro, Jose A.] Univ Balearic Isl, IUNICS, Dept Biol, Genet Lab, Palma de Mallorca, Balearic Island, Spain; [Escriba, Pablo V.] Univ Balearic Isl, IUNICS, Dept Biol, Lab Mol & Cellular Biomed, Palma de Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; University of Salerno; Universitat de les Illes Balears; Universitat de les Illes Balears	Escriba, PV (corresponding author), Univ Balearic Isl, IUNICS, Dept Biol, Lab Mol & Cellular Biomed, Palma de Mallorca, Balearic Island, Spain.	pablo.escriba@uib.es	Busquets, Xavier/M-5574-2018; Piotto, Stefano/AAZ-4641-2021; Piotto, Stefano/AAE-4031-2020; Piotto, Stefano P/A-8210-2011; Fiol-deRoque, Maria Antonia/AAZ-5888-2020; Castro, Jose A./J-9192-2014	Busquets, Xavier/0000-0003-1157-5590; Piotto, Stefano/0000-0002-3102-1918; Piotto, Stefano/0000-0002-3102-1918; Fiol-deRoque, Maria Antonia/0000-0001-8566-0929; Castro, Jose A./0000-0001-8262-560X; Lopez, Daniel Horacio/0000-0002-2912-4061; Escriba, Pablo/0000-0001-9795-182X	Ministerio de Economia y Competitividad, Spain [BIO2010-21132, IPT-010000-2010-016]; Ajuts a Grups Competitius (Govern de les Illes Balears); Marathon Foundation; Government of the Balearic Islands (Conselleria d'Educacio, Cultura i Universitat); European Social Fund	Ministerio de Economia y Competitividad, Spain; Ajuts a Grups Competitius (Govern de les Illes Balears); Marathon Foundation; Government of the Balearic Islands (Conselleria d'Educacio, Cultura i Universitat); European Social Fund(European Social Fund (ESF))	This work was supported by grants BIO2010-21132 (PVE) and IPT-010000-2010-016 (XB) (Ministerio de Economia y Competitividad, Spain), by Ajuts a Grups Competitius (Govern de les Illes Balears), and the Marathon Foundation. MAF-DR is supported by a fellowship from the Government of the Balearic Islands (Conselleria d'Educacio, Cultura i Universitat) and the European Social Fund. DHL and ST were supported by Torres Quevedo Contracts (Ministerio de Economia y Competitividad, Spain, and the European Social Fund). RJM is supported by a Marathon Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 1999, J IMMUNOL, V163, P963; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; De Rse V, 2002, EUR RESPIR J, V19, P333, DOI 10.1183/09031936.02.00229202; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eads D, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-2; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Food & Drug Administration, 2013, GUID IND EST MAX SAF; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3189, DOI 10.1021/bi052337p; Gomes A, 2009, BIOCHEM PHARMACOL, V78, P171, DOI 10.1016/j.bcp.2009.03.028; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE JM, 1991, NATURE, V351, P248, DOI 10.1038/351248a0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohata T, 1997, JPN J CANCER RES, V88, P234, DOI 10.1111/j.1349-7006.1997.tb00372.x; Parr RG, 1989, INT SERIES MONOGRAPH, V10; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; Tran TA, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-14; Tronstad KJ, 2003, EXPERT OPIN THER TAR, V7, P663; Uozumi N, 2008, J IMMUNOL, V181, P3558, DOI 10.4049/jimmunol.181.5.3558; Wen J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-38; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200	39	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72052	10.1371/journal.pone.0072052	http://dx.doi.org/10.1371/journal.pone.0072052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015204	Green Published, gold			2022-12-25	WOS:000323815200025
J	Zhi, F; Zhou, GX; Shao, NY; Xia, XW; Shi, YM; Wang, Q; Zhang, Y; Wang, R; Xue, L; Wang, SN; Wu, SJ; Peng, Y; Yang, YL				Zhi, Feng; Zhou, Guangxin; Shao, Naiyuan; Xia, Xiwei; Shi, Yimin; Wang, Qiang; Zhang, Yi; Wang, Rong; Xue, Lian; Wang, Suinuan; Wu, Sujia; Peng, Ya; Yang, Yilin			miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK	PLOS ONE			English	Article							HUMAN GASTRIC-CANCER; MALIGNANT GLIOMAS; MICRORNA; EXPRESSION; SURVIVAL; PROTEIN; TUMOR; NEUROPATHOLOGY; IDENTIFICATION; CARCINOMA	Astrocytomas are common malignant intracranial tumors that comprise the majority of adult primary central nervous system tumors. MicroRNAs (miRNAs) are small, non-coding RNAs (20-24 nucleotides) that post-transcriptionally modulate gene expression by negatively regulating the stability or translational efficiency of their target mRNAs. In our previous studies, we found that the downregulation of miR-106a-5p in astrocytomas is associated with poor prognosis. However, its specific gene target(s) and underlying functional mechanism(s) in astrocytomas remain unclear. In this study, we used mRNA microarray experiments to measure global mRNA expression in the presence of increased or decreased miR-106a-5p levels. We then performed bioinformatics analysis based on multiple target prediction algorithms to obtain candidate target genes that were further validated by computational predictions, western blot analysis, quantitative real-time PCR, and the luciferase reporter assay. Fas-activated serine/threonine kinase (FASTK) was identified as a direct target of miR-106a-5p. In human astrocytomas, miR-106a-5p is downregulated and negatively associated with clinical staging, whereas FASTK is upregulated and positively associated with advanced clinical stages, at both the protein and mRNA levels. Furthermore, Kaplan-Meier analysis revealed that the reduced expression of miR-106a-5p or the increased expression of FASTK is significantly associated with poor survival outcome. These results further supported the finding that FASTK is a direct target gene of miR-106a-5p. Next, we explored the function of miR-106a-5p and FASTK during astrocytoma progression. Through gain-of-function and loss-of-function studies, we demonstrated that miR-106a-5p can significantly inhibit cell proliferation and migration and can promote cell apoptosis in vitro. The knockdown of FASTK induced similar effects on astrocytoma cells as those induced by the overexpression of miR-106a-5p. These observations suggest that miR-106a-5p functions as a tumor suppressor during the development of astrocytomas by targeting FASTK.	[Zhi, Feng; Wang, Rong; Xue, Lian; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China; [Shao, Naiyuan; Xia, Xiwei; Shi, Yimin; Wang, Qiang; Zhang, Yi; Wang, Suinuan; Peng, Ya] Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China; [Zhou, Guangxin; Wu, Sujia] Nanjing Univ, Sch Med, Jinling Hosp, Dept Orthoped, Nanjing 210008, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Nanjing University	Wu, SJ (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Orthoped, Nanjing 210008, Jiangsu, Peoples R China.	sujiawu1957@yahoo.cn; yapeng997@163.com; yilinyang.czfph@gmail.com		Shao, Naiyuan/0000-0001-5523-7142	National Natural Science Foundation of China [31071046, 81102039]; Changzhou Social Development Project [CS20092015, CS20102010]; Changzhou Health Bureau Project [ZD200903, ZD201007]; Changzhou Science Technology Bureau Guiding Project [CY20119004]; China Postdoctoral Science Foundation [2012M512178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Social Development Project; Changzhou Health Bureau Project; Changzhou Science Technology Bureau Guiding Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China: 31071046, 81102039; Changzhou Social Development Project: CS20092015, CS20102010; Changzhou Health Bureau Project: ZD200903, ZD201007; Changzhou Science Technology Bureau Guiding Project: CY20119004; and China Postdoctoral Science Foundation: 2012M512178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brint E, 2013, CELL MOL LIFE SCI; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Donnem T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029671; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043452; Gabayan AJ, 2006, NEUROSURGERY, V58, P701, DOI 10.1227/01.NEU.0000194836.07848.69; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Hummel R, 2011, ANN SURG ONCOL, V18, P253, DOI 10.1245/s10434-010-1213-y; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim B H, 2012, J SURG ONCOL; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li W, 2004, MOL CELL BIOL, V24, P10718, DOI 10.1128/MCB.24.24.10718-10732.2004; Li W, 2004, BIOCHEM BIOPH RES CO, V318, P95, DOI 10.1016/j.bbrc.2004.03.188; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Simarro M, 2007, P NATL ACAD SCI USA, V104, P11370, DOI 10.1073/pnas.0704964104; TIAN QS, 1995, J EXP MED, V182, P865, DOI 10.1084/jem.182.3.865; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang KH, 2011, J BIOL CHEM, V286, P9468, DOI 10.1074/jbc.M110.178335; Wang Z., 2012, MOL CARCINOG; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xiao BX, 2009, CLIN CHIM ACTA, V400, P97, DOI 10.1016/j.cca.2008.10.021; Yang G, 2011, J MOL MED; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhi F, 2012, INT J BIOL SCI, V8, P289, DOI 10.7150/ijbs.3520; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	43	57	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72390	10.1371/journal.pone.0072390	http://dx.doi.org/10.1371/journal.pone.0072390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013584	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200038
J	Huang, SS; Chan, WL; Leu, HB; Huang, PH; Chen, JW; Lin, SJ				Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang; Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong			Association between CHADS(2) Score and the Preventive Effect of Statin Therapy on New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CATHETER ABLATION; DRUG-THERAPY; STROKE; RISK	Objectives: New-onset atrial fibrillation (AF) commonly occurs in patients with acute myocardial infarction (AMI). Data regarding the value of the CHADS(2) score in patients hospitalized for AMI is limited. This study aimed to determine whether the CHADS(2) score is associated with new-onset AF and if it can help identify the patients who will benefit most from statin use for the prevention of arrhythmia after AMI. Methods: A total of 724 consecutive AMI patients were enrolled in this study. The patients were divided into 3 groups according to their CHADS(2) scores: group 1, score 0; group 2, score 1-2; and group 3, score 3-6. The study endpoint was an episode of new-onset AF that lasted more than 30 seconds during hospitalization at the coronary care unit. Results: Seventy-eight (10.8%) patients developed new-onset AF, and 273 (37.7%) were on a statin upon admission. The incidence of new-onset AF increased significantly from 5.8% in group 1 to 11.3% in group 2 and 14.3% in group 3 (chi(2) for linear trend, P = 0.017). Statin use (odds ratio [OR], 0.22; 95% CI, 0.06-0.85) and CHADS(2) score (OR, 1.53; 95% CI, 1.02-2.28) were independent predictors of new-onset AF in AMI patients. Patients with CHADS(2) score <= 2 had significantly reduced C-reactive protein level and lower risk of developing new-onset AF if they were taking statins (P < 0.05). Multivariate logistic regression analysis demonstrated the benefit of statin use for preventing new-onset AF in patients with CHADS(2) scores <= 2 (OR, 0.34; 95% CI, 0.14-0.81). Conclusions: The CHADS(2) score is a convenient scoring system for predicting the incidence of new-onset AF and may help in identifying the patients who will benefit most from statin use for the prevention of arrhythmia after AMI.	[Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang; Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	sjlin@vghtpe.gov.tw						Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; Chao TF, 2012, INT J CARDIOL; Chao TF, 2012, HEART RHYTHM, V9, P1185, DOI 10.1016/j.hrthm.2012.03.007; Chao TF, 2011, HEART RHYTHM, V8, P1155, DOI 10.1016/j.hrthm.2011.03.016; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Goldberg RJ, 2002, AM HEART J, V143, P519, DOI 10.1067/mhj.2002.120410; Korantzopoulos P, 2007, INT J CARDIOL, V115, P135, DOI 10.1016/j.ijcard.2006.04.026; Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225; Liu T, 2006, AM J CARDIOL, V97, P1266, DOI 10.1016/j.amjcard.2005.11.016; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Maehama T, 2010, AM J CARDIOL, V106, P535, DOI 10.1016/j.amjcard.2010.03.067; Mehta RH, 2003, AM J CARDIOL, V92, P1031, DOI 10.1016/j.amjcard.2003.06.001; Murray KT, 2007, HEART RHYTHM, V4, pS88, DOI 10.1016/j.hrthm.2006.12.027; Ozaydin M, 2010, INT J CARDIOL, V141, P147, DOI 10.1016/j.ijcard.2008.11.172; Page RL, 2005, NAT REV DRUG DISCOV, V4, P899, DOI 10.1038/nrd1876; Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161/01.CIR.0000029743.68247.31; Rathore SS, 2000, CIRCULATION, V101, P969, DOI 10.1161/01.CIR.101.9.969; Ray KK, 2006, AM J CARDIOL, V98, p18P, DOI 10.1016/j.amjcard.2006.09.016; Rosenson RS, 2004, ATHEROSCLEROSIS, V173, P1, DOI 10.1016/S0021-9150(03)00239-9; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579; Shiroshita-Takeshita A, 2005, J INTERV CARD ELECTR, V13, P181, DOI 10.1007/s10840-005-2362-y; Strandberg TE, 1999, LANCET, V353, P118, DOI 10.1016/S0140-6736(05)76154-7; Wann LS, 2011, CIRCULATION, V123, P104, DOI 10.1161/CIR.0b013e3181fa3cf4	26	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74709	10.1371/journal.pone.0074709	http://dx.doi.org/10.1371/journal.pone.0074709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991226	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800122
J	Naber, M; Stoll, J; Einhauser, W; Carter, O				Naber, Marnix; Stoll, Josef; Einhaeuser, Wolfgang; Carter, Olivia			How to Become a Mentalist: Reading Decisions from a Competitor's Pupil Can Be Achieved without Training but Requires Instruction	PLOS ONE			English	Article							BRAIN ACTIVITY; SIZE; DILATION; DIAMETER; AMYGDALA; SADNESS; SIGNALS	Pupil dilation is implicated as a marker of decision-making as well as of cognitive and emotional processes. Here we tested whether individuals can exploit another's pupil to their advantage. We first recorded the eyes of 3 "opponents", while they were playing a modified version of the "rock-paper-scissors" childhood game. The recorded videos served as stimuli to a second set of participants. These "players" played rock-paper-scissors against the pre-recorded opponents in a variety of conditions. When players just observed the opponents' eyes without specific instruction their probability of winning was at chance. When informed that the time of maximum pupil dilation was indicative of the opponents' choice, however, players raised their winning probability significantly above chance. When just watching the reconstructed area of the pupil against a gray background, players achieved similar performance, showing that players indeed exploited the pupil, rather than other facial cues. Since maximum pupil dilation was correct about the opponents' decision only in 60% of trials (chance 33%), we finally tested whether increasing this validity to 100% would allow spontaneous learning. Indeed, when players were given no information, but the pupil was informative about the opponent's response in all trials, players performed significantly above chance on average and half (5/10) reached significance at an individual level. Together these results suggest that people can in principle use the pupil to detect cognitive decisions in another individual, but that most people have neither explicit knowledge of the pupil's utility nor have they learnt to use it despite a lifetime of exposure.	[Naber, Marnix; Stoll, Josef; Einhaeuser, Wolfgang] Univ Marburg, Marburg, Germany; [Naber, Marnix; Carter, Olivia] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia; [Naber, Marnix] Harvard Univ, Vis Sci Lab, Cambridge, MA 02138 USA; [Naber, Marnix] Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands; [Einhaeuser, Wolfgang] Ctr Interdisciplinary Res ZiF, Bielefeld, Germany	Philipps University Marburg; University of Melbourne; Harvard University; Leiden University; Leiden University - Excl LUMC	Naber, M (corresponding author), Univ Marburg, Marburg, Germany.	marnixnaber@gmail.com	Einhäuser, Wolfgang/A-3041-2012	Einhäuser, Wolfgang/0000-0001-7516-9589; Naber, Marnix/0000-0003-4208-8437; Carter, Olivia/0000-0001-7708-6154	German Research Foundation (DFG) through Research Training Group 885 "NeuroAct"; Netherlands Organisation for Scientific Research; Australian National Health and Medical Research Council [628590];  [EI852/1]	German Research Foundation (DFG) through Research Training Group 885 "NeuroAct"(German Research Foundation (DFG)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); 	This work was supported by the German Research Foundation (DFG) through Research Training Group 885 "NeuroAct" (MN), grant EI852/1 (JS & WE), Netherlands Organisation for Scientific Research (MN), and by an Australian National Health and Medical Research Council fellowship # 628590 (OC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya S, 2012, SOC COGN AFFECT NEUR, V7, P332, DOI 10.1093/scan/nsr013; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BEATTY J, 1978, SCIENCE, V199, P1216, DOI 10.1126/science.628837; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; BULL R, 1979, PERCEPT MOTOR SKILL, V49, P27, DOI 10.2466/pms.1979.49.1.27; Demos KE, 2008, CEREB CORTEX, V18, P2729, DOI 10.1093/cercor/bhn034; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Hall E.T., 1959, SILENT LANGUAGE; HAMEL RF, 1974, J PSYCHOL, V87, P171, DOI 10.1080/00223980.1974.9915687; Harrison NA, 2007, EMOTION, V7, P724, DOI 10.1037/1528-3542.7.4.724; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Harrison NA, 2009, SOC NEUROSCI-UK, V4, P233, DOI 10.1080/17470910802553508; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D., 1973, ATTENTION EFFORT; Naber M, 2013, J VIS, V13; Naber M, 2013, J VISION, V13, DOI 10.1167/13.2.11; Naber M, 2012, J VISION, V12, DOI 10.1167/12.1.25; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; POOCK GK, 1973, PERCEPT MOTOR SKILL, V37, P1000, DOI 10.2466/pms.1973.37.3.1000; SIMMS TM, 1967, PERCEPT PSYCHOPHYS, V2, P553, DOI 10.3758/BF03210265; SIMPSON HM, 1969, PERCEPT MOTOR SKILL, V29, P495, DOI 10.2466/pms.1969.29.2.495; SIMPSON HM, 1971, PSYCHOPHYSIOLOGY, V8, P491, DOI 10.1111/j.1469-8986.1971.tb00481.x; Stass J, 1967, PSYCHON SCI, V7, P375, DOI DOI 10.3758/BF03331131; STEINHAUER SR, 1983, PSYCHOPHYSIOLOGY, V20, P472; Stoll J, 2013, CURR BIOL; Tombs S, 2004, EVOL HUM BEHAV, V25, P221, DOI 10.1016/j.evolhumbehav.2004.05.001; TOMLINSON N, 1978, B PSYCHONOMIC SOC, V12, P477; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; WAGENAAR WA, 1972, PSYCHOL BULL, V77, P65, DOI 10.1037/h0032060; Wang JT, 2006, AM ECON REV, V100, P984; YOSS RE, 1970, NEUROLOGY, V20, P545, DOI 10.1212/WNL.20.6.545	37	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73302	10.1371/journal.pone.0073302	http://dx.doi.org/10.1371/journal.pone.0073302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215RU	23991185	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800098
J	Liu, Y; Kach, A; Ziegler, U; Ong, ACM; Wallace, DP; Arcaro, A; Serra, AL				Liu, Yang; Kaech, Andres; Ziegler, Urs; Ong, Albert C. M.; Wallace, Darren P.; Arcaro, Alexandre; Serra, Andreas L.			The Role of Phospholipase D in Modulating the MTOR Signaling Pathway in Polycystic Kidney Disease	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; MORPHOPROTEOMIC ANALYSIS; THERAPEUTIC IMPLICATIONS; MAMMALIAN TARGET; CANCER-CELLS; CYST GROWTH; AUTOPHAGY; ACTIVATION; SIROLIMUS; MACROAUTOPHAGY	The mammalian target of rapamycin (mTOR) signaling pathway is aberrantly activated in polycystic kidney disease (PKD). Emerging evidence suggests that phospholipase D (PLD) and its product phosphatidic acid (PA) regulate mTOR activity. In this study, we assessed in vitro the regulatory function of PLD and PA on the mTOR signaling pathway in PKD. We found that the basal level of PLD activity was elevated in PKD cells. Targeting PLD by small molecule inhibitors reduced cell proliferation and blocked mTOR signaling, whereas exogenous PA stimulated mTOR signaling and abolished the inhibitory effect of PLD on PKD cell proliferation. We also show that blocking PLD activity enhanced the sensitivity of PKD cells to rapamycin and that combining PLD inhibitors and rapamycin synergistically inhibited PKD cell proliferation. Furthermore, we demonstrate that targeting mTOR did not induce autophagy, whereas targeting PLD induced autophagosome formation. Taken together, our findings suggest that deregulated mTOR pathway activation is mediated partly by increased PLD signaling in PKD cells. Targeting PLD isoforms with pharmacological inhibitors may represent a new therapeutic strategy in PKD.	[Liu, Yang; Serra, Andreas L.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Kaech, Andres; Ziegler, Urs] Univ Zurich, Ctr Microscopy & Image Anal, Zurich, Switzerland; [Ong, Albert C. M.] Univ Sheffield, Dept Infect & Immun, Acad Unit Nephrol, Sheffield, S Yorkshire, England; [Wallace, Darren P.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Arcaro, Alexandre] Univ Bern, Dept Clin Res, Bern, Switzerland	University of Zurich; University of Zurich; University of Sheffield; University of Kansas; University of Kansas Medical Center; University of Bern	Serra, AL (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	andreas.serra@uzh.ch	Ong, Albert/AAN-9430-2021; Arcaro, Alexandre/G-1711-2010	Ong, Albert/0000-0002-7211-5400; Arcaro, Alexandre/0000-0001-9107-2947; Wallace, Darren/0000-0003-4616-7669	Swiss National Science Foundation [310030-132597]; Chinese Academy of Sciences; PKD Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Chinese Academy of Sciences(Chinese Academy of Sciences); PKD Foundation	This work was supported by grants from the Swiss National Science Foundation (310030-132597 to AS) and the Chinese Academy of Sciences (YL). We thank Prof. H. Alex Brown and Prof. Craig W. Lindsley for providing PLD1 and PLD2 inhibitors. The PKD Biomaterials and Cellular Models Core that was funded by the PKD Foundation generated primary cell cultures. We thank PD Dr. M.P. Tschan for helpful discussions and the staff of the Image Center of the University of Zurich for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Belibi F, 2011, AM J PHYSIOL-RENAL, V300, pF1235, DOI 10.1152/ajprenal.00348.2010; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Chen CH, 2011, J BIOL CHEM, V286, P40386, DOI 10.1074/jbc.M111.282590; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Dhingra S, 2011, INT J CLIN EXP PATHO, V4, P134; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Gomez-Cambronero J, 2010, THESCIENTIFICWORLDJO, V10, P1356, DOI 10.1100/tsw.2010.116; Gretz N, 1996, NEPHROL DIAL TRANSPL, V11, P46; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Novalic Z, 2012, J AM SOC NEPHROL, V23, P842, DOI 10.1681/ASN.2011040340; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Parker E, 2007, KIDNEY INT, V72, P157, DOI 10.1038/sj.ki.5002229; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; Reif GA, 2011, AM J PHYSIOL-RENAL, V301, pF1005, DOI 10.1152/ajprenal.00243.2011; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen Q, 2011, INT J CLIN EXP PATHO, V4, P13; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2012, J AM SOC NEPHROL, V23, P1674, DOI 10.1681/ASN.2012040367; Takita T, 2011, ARCH BIOCHEM BIOPHYS, V509, P197, DOI 10.1016/j.abb.2011.02.007; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wallace DP, 1996, KIDNEY INT, V50, P1327, DOI 10.1038/ki.1996.445; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yu ASL, 2008, J PATHOL, V216, P120, DOI 10.1002/path.2392; Zafar I, 2010, KIDNEY INT, V78, P754, DOI 10.1038/ki.2010.250; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	46	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73173	10.1371/journal.pone.0073173	http://dx.doi.org/10.1371/journal.pone.0073173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009738	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000324403200044
J	Clementz, AG; Mutolo, MJ; Leir, SH; Morris, KJ; Kucybala, K; Harris, H; Harris, A				Clementz, Anthony G.; Mutolo, Michael J.; Leir, Shih-Hsing; Morris, Kirsten J.; Kucybala, Karolina; Harris, Henry; Harris, Ann			Collagen XV Inhibits Epithelial to Mesenchymal Transition in Pancreatic Adenocarcinoma Cells	PLOS ONE			English	Article							ALPHA(2)BETA(1) INTEGRIN; EXTRACELLULAR-MATRIX; TYROSINE KINASE; E-CADHERIN; DOMAIN; MEMBRANE; ACTIVATION; CARCINOMA; GROWTH; CHAIN	Collagen XV (COLXV) is a secreted non-fibrillar collagen found within basement membrane (BM) zones of the extracellular matrix (ECM). Its ability to alter cellular growth in vitro and to reduce tumor burden and increase survival in vivo support a role as a tumor suppressor. Loss of COLXV during the progression of several aggressive cancers precedes basement membrane invasion and metastasis. The resultant lack of COLXV subjacent to the basement membrane and subsequent loss of its interactions with other proteins in this zone may directly impact tumor progression. Here we show that COLXV significantly reduces invasion of pancreatic adenocarcinoma cells through a collagen I (COLI) matrix. Moreover, we demonstrate that epithelial to mesenchymal transition (EMT) in these cells, which is recapitulated in vitro by cell scattering on a COLI substrate, is inhibited by over-expression of COLXV. We identify critical collagen-binding surface receptors on the tumor cells, including the discoidin domain receptor 1 (DDR1) and E-Cadherin (E-Cad), which interact with COLXV and appear to mediate its function. In the presence of COLXV, the intracellular redistribution of E-Cad from the cell periphery, which is associated with COLI-activated EMT, is inhibited and concurrently, DDR1 signaling is suppressed. Furthermore, continuous exposure of the pancreatic adenocarcinoma cells to high levels of COLXV suppresses endogenous levels of N-Cadherin (N-Cad). These data reveal a novel mechanism whereby COLXV can function as a tumor suppressor in the basement membrane zone.	[Clementz, Anthony G.; Mutolo, Michael J.; Leir, Shih-Hsing; Morris, Kirsten J.; Kucybala, Karolina; Harris, Ann] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL USA; [Clementz, Anthony G.; Mutolo, Michael J.; Leir, Shih-Hsing; Morris, Kirsten J.; Kucybala, Karolina; Harris, Ann] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Harris, Ann] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Harris, Henry] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Oxford	Harris, A (corresponding author), Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL USA.	ann-harris@northwestern.edu	Leir, Shih-Hsing/O-6739-2019; Leir, Shih-Hsing/AAG-1086-2019	Leir, Shih-Hsing/0000-0001-9524-3379; 	National Institutes of Health [CA129258]; Children's Memorial Research Center; H Foundation, through the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE [R21CA129258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Memorial Research Center; H Foundation, through the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded in part by National Institutes of Health CA129258 (PI:AH), Children's Memorial Research Center (http://www.luriechildrensresearch.org) and the H Foundation, through the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (http://cancer.northwestern.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta PS, 2000, HUM PATHOL, V31, P359, DOI 10.1016/S0046-8177(00)80251-8; Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Amenta PS, 2003, J PATHOL, V199, P298, DOI 10.1002/path.1303; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; BOYER B, 1989, INT J CANCER, P69; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Curat CA, 2002, J AM SOC NEPHROL, V13, P2648, DOI 10.1097/01.ASN.0000032419.13208.0C; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Fukushige T, 2005, J DERMATOL, V32, P74; FUKUYAMA R, 1991, JPN J CANCER RES, V82, P8, DOI 10.1111/j.1349-7006.1991.tb01737.x; Grzesiak JJ, 2011, INT J CANC; Hagg PM, 1997, GENOMICS, V45, P31, DOI 10.1006/geno.1997.4884; Harris A, 2007, MOL CANCER RES, V5, P1241, DOI 10.1158/1541-7786.MCR-07-0200; Harris H, 2003, DNA CELL BIOL, V22, P225, DOI 10.1089/104454903321908601; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hendrix M, 2002, METASTASIS RES PROTO, V2; HUEBNER K, 1992, GENOMICS, V14, P220, DOI 10.1016/S0888-7543(05)80209-5; KIVIRIKKO S, 1994, J BIOL CHEM, V269, P4773; KIVIRIKKO S, 1995, AM J PATHOL, V147, P1500; MURAGAKI Y, 1994, J BIOL CHEM, V269, P4042; Mutolo MJ, 2012, MATRIX BIOL, V31, P285, DOI 10.1016/j.matbio.2012.03.003; MYERS JC, 1992, P NATL ACAD SCI USA, V89, P10144, DOI 10.1073/pnas.89.21.10144; PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rasi K, 2010, CIRC RES, V107, P1241, DOI 10.1161/CIRCRESAHA.110.222133; Rasi K, 2010, J NEUROSCI, V30, P14490, DOI 10.1523/JNEUROSCI.2644-10.2010; Ruiz PA, 2011, J BIOL CHEM, V286, P12912, DOI 10.1074/jbc.M110.143693; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vogel WF, 2002, FEBS LETT, V514, P175, DOI 10.1016/S0014-5793(02)02360-8; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wang CZ, 2005, J CELL PHYSIOL, V203, P295, DOI 10.1002/jcp.20227; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Yeh YC, 2009, J CELL PHYSIOL, V218, P146, DOI 10.1002/jcp.21578; ZUTTER MM, 1990, AM J PATHOL, V137, P863	45	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72250	10.1371/journal.pone.0072250	http://dx.doi.org/10.1371/journal.pone.0072250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991074	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470700031
J	Huang, JY; Cui, SY; Chen, YT; Song, HZ; Huang, GC; Feng, B; Sun, M; De, W; Wang, R; Chen, LB				Huang, Jia-Yuan; Cui, Shi-Yun; Chen, Yi-Tian; Song, Hai-Zhu; Huang, Gui-Chun; Feng, Bing; Sun, Ming; De, Wei; Wang, Rui; Chen, Long-Bang			MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; HUMAN CANCER; ING4; IDENTIFICATION; PREDICTION; INHIBITOR	Increasing evidence shows that dysregulation of microRNAs (miRNAs) is involved in malignant transformation. We investigated the clinical significance of miR-650 and its involvement in chemoresistance to docetaxel. Our results showed that the relative expression level of miR-650 was significantly higher in LAD tissues than in corresponding nontumor tissues and high level of miR-650 expression was found to be significantly associated with high incidence of lymph node metastasis, advanced clinical stage and poor prognosis of LAD patients. Univariate and multivariate analyses indicated that high miR-650 expression was an independent prognostic factor for survival. Also, we found that the level of miR-650 in LAD tissues was correlated with the response of patients to docetaxel-based chemotherapy. Silencing of miR-650 could increase the in vitro sensitivity of docetaxel-resistant LAD cells to docetaxel, while upregulation of miR-650 decreased the sensitivity of parental LAD cells to docetaxel both in vitro and in vivo. Additionally, silencing of miR-650 could enhance the caspase-3-dependent apoptosis, which might be correlated with the decreased ratio of Bcl-2/Bax. Further researches suggested that inhibitor of growth 4 (ING4) was a direct target of miR-650. Downregulated or upregulated ING4 expression could partially rescue the effects of miR-650 inhibitor or mimics in docetaxel-resistant or parental LAD cells. Furthermore, we found that ING4 was upregulated in docetaxel-responding LAD tissues, and its expression was inversely correlated with miR-650. Thus, miR-650 is a novel prognostic marker in LAD and its expression is a potential indicator of chemosensitivity to docetaxel-based chemotherapy regimen.	[Huang, Jia-Yuan; Cui, Shi-Yun; Chen, Yi-Tian; Song, Hai-Zhu; Huang, Gui-Chun; Feng, Bing; Wang, Rui; Chen, Long-Bang] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Ming; De, Wei] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Wang, R (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China.	wangrui1977218@163.com; chenlongbang@yeah.net			National Natural Science Foundation of China [81172335, 30901440, 81071806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172335, 30901440, and 81071806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen PS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-90; Cui SY, 2013, MOL CANC RES; Dumortier O, 2012, DIABETES OBES METAB, V14, P22, DOI 10.1111/j.1463-1326.2012.01656.x; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Feng B, 2012, CANCER LETT, V317, P184, DOI 10.1016/j.canlet.2011.11.024; Feng L, 2011, BIOCHEM BIOPH RES CO, V406, P534, DOI 10.1016/j.bbrc.2011.02.081; Houwen Li, 2003, Ann Thorac Cardiovasc Surg, V9, P147; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Li M, 2009, J PATHOL, V219, P87, DOI 10.1002/path.2571; Li XH, 2011, ORAL ONCOL, V47, P217, DOI 10.1016/j.oraloncology.2011.01.004; Liu YL, 2012, J CANCER RES CLIN, V138, P647, DOI 10.1007/s00432-011-1099-5; Mallory AC, 2004, CURR OPIN PLANT BIOL, V7, P120, DOI 10.1016/j.pbi.2004.01.006; Mathema VB, 2012, TUMOR BIOL, V33, P1, DOI 10.1007/s13277-011-0249-3; Miller YE, 2005, AM J RESP CELL MOL, V33, P216, DOI 10.1165/rcmb.2005-0158OE; Mraz M, 2012, BLOOD, V119, P2110, DOI 10.1182/blood-2011-11-394874; Nikitina E. G., 2012, Experimental Oncology, V34, P2; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Qi Ji, 2012, Front Med, V6, P134, DOI 10.1007/s11684-012-0188-4; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Wang QM, 2012, EXP BIOL MED, V237, P227, DOI 10.1258/ebm.2011.011192; Wang QS, 2010, HISTOPATHOLOGY, V57, P271, DOI 10.1111/j.1365-2559.2010.03623.x; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang R, 2012, MOL MED, V18, P874, DOI 10.2119/molmed.2011.00230; Wang R, 2010, J CELL MOL MED, V14, P206, DOI 10.1111/j.1582-4934.2009.00964.x; Xia W, 2009, SCI CHINA SER C, V52, P1123, DOI 10.1007/s11427-009-0159-4; Xu JZ, 2012, AUTOPHAGY, V8, P873, DOI 10.4161/auto.19629; Zhang XL, 2010, BIOCHEM BIOPH RES CO, V395, P275, DOI 10.1016/j.bbrc.2010.04.005	33	55	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72615	10.1371/journal.pone.0072615	http://dx.doi.org/10.1371/journal.pone.0072615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991130	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100109
J	Berk, JM; Maitra, S; Dawdy, AW; Shabanowitz, J; Hunt, DF; Wilson, KL				Berk, Jason M.; Maitra, Sushmit; Dawdy, Andrew W.; Shabanowitz, Jeffrey; Hunt, Donald F.; Wilson, Katherine L.			O-Linked beta-N-Acetylglucosamine (O-GlcNAc) Regulates Emerin Binding to Barrier to Autointegration Factor (BAF) in a Chromatin- and Lamin B-enriched "Niche"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiomyopathy; Chromosomes; Non-histone Chromosomal Proteins; Lamin; Muscular Dystrophy; Nuclear Matrix; Nuclear Membrane; O-GlcNAc; Emerin; Laminopathy; Nucleoskeleton	INNER NUCLEAR-MEMBRANE; DREIFUSS MUSCULAR-DYSTROPHY; DISTINCT FUNCTIONAL DOMAINS; TRANSCRIPTIONAL REPRESSOR; MODIFIED PROTEINS; ENVELOPE PROTEIN; PHOSPHORYLATION; TRANSFERASE; ROLES; DNA	Background: Nuclear membrane protein emerin binding to nuclear intermediate filaments (lamins) and BAF contributes to forming a nuclear lamina structure. Results: Emerin is O-GlcNAc-modified at eight sites: two (Ser-53 and Ser-54) influence further O-GlcNAcylation, and one (Ser-173) regulates association with BAF in the chromatin/lamin B niche. Conclusion:O-GlcNAc transferase, a nutrient-responsive enzyme, regulates emerin. Significance: Emerin hyper-O-GlcNAcylation may contribute to cardiomyopathy and other conditions. Emerin, a membrane component of nuclear lamina networks with lamins and barrier to autointegration factor (BAF), is highly O-GlcNAc-modified (O-GlcNAcylated) in mammalian cells. Mass spectrometry analysis revealed eight sites of O-GlcNAcylation, including Ser-53, Ser-54, Ser-87, Ser-171, and Ser-173. Emerin O-GlcNAcylation was reduced approximate to 50% by S53A or S54A mutation in vitro and in vivo. O-GlcNAcylation was reduced approximate to 66% by the triple S52A/S53A/S54A mutant, and S173A reduced O-GlcNAcylation of the S52A/S53A/S54A mutant by approximate to 30%, in vivo. We separated two populations of emerin, A-type lamins and BAF; one population solubilized easily, and the other required sonication and included histones and B-type lamins. Emerin and BAF associated only in histone- and lamin-B-containing fractions. The S173D mutation specifically and selectively reduced GFP-emerin association with BAF by 58% and also increased GFP-emerin hyper-phosphorylation. We conclude that -N-acetylglucosaminyltransferase, an essential enzyme, controls two regions in emerin. The first region, defined by residues Ser-53 and Ser-54, flanks the LEM domain. O-GlcNAc modification at Ser-173, in the second region, is proposed to promote emerin association with BAF in the chromatin/lamin B niche. These results reveal direct control of a conserved LEM domain nuclear lamina component by -N-acetylglucosaminyltransferase, a nutrient sensor that regulates cell stress responses, mitosis, and epigenetics.	[Berk, Jason M.; Wilson, Katherine L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Maitra, Sushmit; Dawdy, Andrew W.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA	Johns Hopkins University; University of Virginia	Wilson, KL (corresponding author), Johns Hopkins Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	klwilson@jhmi.edu	Wilson, Katherine/HII-8144-2022	Dawdy, Andrew/0000-0003-1932-012X	National Institutes of Health [RO1 GM37537, RO1 GM048646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM048646, R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM37537 (to D. F. H.) and RO1 GM048646 (to K. L. W.).	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Barkan R, 2012, MOL BIOL CELL, V23, P543, DOI 10.1091/mbc.E11-06-0505; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Berk JM, 2013, NUCLEUS-PHILA, V4, P298, DOI 10.4161/nucl.25751; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bonne G, 2010, EMERY DREIFUSS MUSCU; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; BRIDGER JM, 1993, J CELL SCI, V104, P297; Broers JLV, 1999, J CELL SCI, V112, P3463; Cabanillas R, 2011, AM J MED GENET A, V155A, P2617, DOI 10.1002/ajmg.a.34249; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Cheng XG, 2000, J STEROID BIOCHEM, V75, P147, DOI 10.1016/S0960-0760(00)00167-9; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; de Oca RM, 2011, NUCLEUS-PHILA, V2, P580, DOI 10.4161/nucl.2.6.17960; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; Dedeic Z, 2011, J CELL SCI, V124, P1691, DOI 10.1242/jcs.080259; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Dittrich CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024555; Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fairley EAL, 2002, J CELL SCI, V115, P341; Gloster TM, 2010, CURR SIGNAL TRANSD T, V5, P74, DOI 10.2174/157436210790226537; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Hahne H, 2012, MOL CELL PROTEOMICS, V11, P843, DOI 10.1074/mcp.M112.019463; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hirano Y, 2005, J BIOL CHEM, V280, P39925, DOI 10.1074/jbc.M503214200; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Ibrahim N, 2011, J VIROL, V85, P11588, DOI 10.1128/JVI.00641-11; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Leach N, 2007, J VIROL, V81, P10792, DOI 10.1128/JVI.00196-07; Leach NR, 2010, VIROLOGY, V406, P127, DOI 10.1016/j.virol.2010.07.002; Lee KK, 2001, J CELL SCI, V114, P4567; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, J CELL BIOL, V178, P661, DOI 10.1083/jcb.200704049; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Meister P, 2011, CURR OPIN GENET DEV, V21, P167, DOI 10.1016/j.gde.2011.01.023; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Morris JB, 2007, J VIROL, V81, P4429, DOI 10.1128/JVI.02354-06; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Simon DN, 2013, CHROMOSOMA, V122, P13, DOI 10.1007/s00412-013-0399-8; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Sui C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-539; Tifft KE, 2009, J CELL SCI, V122, P3780, DOI 10.1242/jcs.048397; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tsuchiya Y, 1999, EUR J BIOCHEM, V259, P859, DOI 10.1046/j.1432-1327.1999.00112.x; Tunnah D, 2005, J MOL HISTOL, V36, P337, DOI 10.1007/s10735-005-9004-7; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wheeler MA, 2010, CELL MOL LIFE SCI, V67, P781, DOI 10.1007/s00018-009-0219-8; Wilson K. L., 2010, COLD SPRING HARB PER, V2; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; Wozniak MA, 2013, PEERJ, V1, DOI 10.7717/peerj.134; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yip SC, 2012, J CELL SCI, V125, P310, DOI 10.1242/jcs.086256; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035; Zwerger M, 2011, ANNU REV BIOMED ENG, V13, P397, DOI 10.1146/annurev-bioeng-071910-124736	111	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30192	30209		10.1074/jbc.M113.503060	http://dx.doi.org/10.1074/jbc.M113.503060			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014020	hybrid, Green Published			2022-12-25	WOS:000329868100019
J	Banerjee, V; Kar, RK; Datta, A; Parthasarathi, K; Chatterjee, S; Das, KP; Bhunia, A				Banerjee, Victor; Kar, Rajiv K.; Datta, Aritreyee; Parthasarathi, Krupakar; Chatterjee, Subhrangsu; Das, Kali P.; Bhunia, Anirban			Use of a Small Peptide Fragment as an Inhibitor of Insulin Fibrillation Process: A Study by High and Low Resolution Spectroscopy	PLOS ONE			English	Article							TRANSFER DIFFERENCE NMR; AMYLOID FIBRILLATION; COMMON MECHANISM; PROTEIN; MODEL; AGGREGATION; FIBRILS; PROINSULIN; TOXICITY; STRATEGY	A non-toxic, nine residue peptide, NIVNVSLVK is shown to interfere with insulin fibrillation by various biophysical methods. Insulin undergoes conformational changes under certain stress conditions leading to amyloid fibrils. Fibrillation of insulin poses a problem in its long-term storage, reducing its efficacy in treating type II diabetes. The dissociation of insulin oligomer to monomer is the key step for the onset of fibrillation. The time course of insulin fibrillation at 62 degrees C using Thioflavin T fluorescence shows an increase in the lag time from 120 min without peptide to 236 min with peptide. Transmission electron micrographs show branched insulin fibrils in its absence and less inter-fibril association in its presence. Upon incubation at 62 degrees C and pH 2.6, insulin lost some alpha-helical structure as seen by Fourier transformed infra-red spectroscopy (FT-IR), but if the peptide is added, secondary structure is almost fully maintained for 3 h, though lost partially at 4 h. FT-IR spectroscopy also shows that insulin forms the cross beta structure indicative of fibrils beyond 2 h, but in the presence of the peptide, a-helix retention is seen till 4 h. Both size exclusion chromatography and dynamic light scattering show that insulin primarily exists as trimer, whose conversion to a monomer is resisted by the peptide. Saturation transfer difference nuclear magnetic resonance confirms that the hydrophobic residues in the peptide are in close contact with an insulin hydrophobic groove. Molecular dynamics simulations in conjunction with principal component analyses reveal how the peptide interrupts insulin fibrillation. In vitro hemolytic activity of the peptide showed insignificant cytotoxicity against HT1080 cells. The insulin aggregation is probed due to the inter play of two key residues, Phe(B24) and Tyr(B26) monitored from molecular dynamics simulations studies. Further new peptide based leads may be developed from this nine residue peptide.	[Banerjee, Victor; Das, Kali P.] Bose Inst, Dept Chem, Kolkata, India; [Kar, Rajiv K.; Datta, Aritreyee; Chatterjee, Subhrangsu; Bhunia, Anirban] Bose Inst, Biomol NMR & Drug Design Lab, Dept Biophys, Kolkata, India; [Parthasarathi, Krupakar] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; National University of Singapore	Das, KP (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	kalipada@jcbose.ac.in; bhunia@jcbose.ac.in	Banerjee, Victor/N-8427-2014; BANERJEE, VICTOR/J-9581-2019; Kar, Rajiv Kumar/O-5939-2018	Banerjee, Victor/0000-0002-3906-3362; BANERJEE, VICTOR/0000-0002-3906-3362; Kar, Rajiv Kumar/0000-0003-4629-5863; Datta, Aritreyee/0000-0001-7757-8415; Bhunia, Anirban/0000-0002-8752-2842; Das, Kali/0000-0001-7686-9077	CSIR [09015(0358)/2008-EMR-I]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported partially by CSIR (fellowship No. 09015(0358)/2008-EMR-I to VB) and partially funded by Institutional fund (to KP and AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; [Anonymous], 2009, DESM MOL INT TOOLS V; [Anonymous], 2012, BIOLUMINATE VERS 1 0; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Banerjee V, 2013, COLLOID SURFACE B, V111, P71, DOI 10.1016/j.colsurfb.2013.04.052; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; BLACKSHEAR PJ, 1983, DIABETES CARE, V6, P387, DOI 10.2337/diacare.6.4.387; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; BRANGE J, 1992, PHARMACEUT RES, V9, P715, DOI 10.1023/A:1015835017916; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, PROTEINS, V27, P507, DOI 10.1002/(SICI)1097-0134(199704)27:4<507::AID-PROT4>3.3.CO;2-H; BRANGE J, 1986, DIABETIC MED, V3, P532, DOI 10.1111/j.1464-5491.1986.tb00809.x; BREWSTER ME, 1991, PHARMACEUT RES, V8, P792, DOI 10.1023/A:1015870521744; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dong A, 1996, BIOCHEMISTRY-US, V35, P1450, DOI 10.1021/bi9518104; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; GRAU U, 1987, DIABETES, V36, P1453, DOI 10.2337/diabetes.36.12.1453; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katakam M, 1995, PDA J Pharm Sci Technol, V49, P160; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Landreh M, 2012, BIOCHEM BIOPH RES CO, V418, P489, DOI 10.1016/j.bbrc.2012.01.051; Viet MH, 2011, J PHYS CHEM B, V115, P7433, DOI 10.1021/jp1116728; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pastor MT, 2005, CURR OPIN STRUC BIOL, V15, P57, DOI 10.1016/j.sbi.2005.01.004; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Permanne B, 2002, FASEB J, V16, P860, DOI 10.1096/fj.01-0841fje; Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; Rabiee A, 2011, CHEM BIOL DRUG DES, V78, P659, DOI 10.1111/j.1747-0285.2011.01197.x; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shikama Y, 2010, INTERNAL MED, V49, P397, DOI 10.2169/internalmedicine.49.2633; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Tan ZP, 2011, P NATL ACAD SCI USA, V108, P4297, DOI 10.1073/pnas.1100195108; THUROW H, 1984, DIABETOLOGIA, V27, P212; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; Wang JB, 2011, BIOCHEM BIOPH RES CO, V415, P675, DOI 10.1016/j.bbrc.2011.10.135; Wang S, 2007, J BIOL CHEM, V282, P2765, DOI 10.1074/jbc.M607531200; Wi S, 1998, BIOSPECTROSCOPY, V4, P93, DOI 10.1002/(SICI)1520-6343(1998)4:2<93::AID-BSPY2>3.0.CO;2-T; Yumlu S, 2009, HUM PATHOL, V40, P1655, DOI 10.1016/j.humpath.2009.02.019; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078	65	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72318	10.1371/journal.pone.0072318	http://dx.doi.org/10.1371/journal.pone.0072318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009675	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600015
J	Despars, G; Carbonneau, CL; Bardeau, P; Coutu, DL; Beausejour, CM				Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Coutu, Daniel L.; Beausejour, Christian M.			Loss of the Osteogenic Differentiation Potential during Senescence Is Limited to Bone Progenitor Cells and Is Dependent on p53	PLOS ONE			English	Article							CELLULAR SENESCENCE; EXPRESSION; MICE; IRRADIATION; REGULATOR; INK4A/ARF; SURVIVORS; DAMAGE	DNA damage can lead to the induction of cellular senescence. In particular, we showed that exposure to ionizing radiation (IR) leads to the senescence of bone marrow-derived multipotent stromal cells (MSC) and osteoblast-like stromal cells (OB-SC), a phenotype associated with bone loss. The mechanism by which IR leads to bone dysfunction is not fully understood. One possibility involves that DNA damage-induced senescence limits the regeneration of bone progenitor cells. Another possibility entails that bone dysfunction arises from the inability of accumulating senescent cells to fulfill their physiological function. Indeed, we show here that exposure to IR prevented the differentiation and mineralization functions of MSC, an effect we found was limited to this population as more differentiated OB-SC could still form mineralize nodules. This is in contrast to adipogenesis, which was inhibited in both IR-induced senescent MSC and 3T3-L1 pre-adipocytes. Furthermore, we demonstrate that IR-induced loss of osteogenic potential in MSC was p53-dependent, a phenotype that correlates with the inability to upregulate key osteogenic transcription factors. These results are the first to demonstrate that senescence impacts osteogenesis in a cell type dependent manner and suggest that the accumulation of senescent osteoblasts is unlikely to significantly contribute to bone dysfunction in a cell autonomous manner.	[Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Beausejour, Christian M.] CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Beausejour, Christian M.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Coutu, Daniel L.] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Stem Cell Dynam Res Unit, Munich, Germany	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Beausejour, CM (corresponding author), CHU St Justine, Ctr Rech, Montreal, PQ, Canada.	christian.beausejour@recherche-ste-justine.qc.ca	Coutu, Daniel/AAD-5292-2022	Coutu, Daniel/0000-0002-4641-0115	Canadian Institute of Health Research [MOP-102709]; Fonds de la Recherche en Sante du Qubec (FRSQ); CIHR; FRQS	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Qubec (FRSQ); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	This work was supported by a grant from the Canadian Institute of Health Research (MOP-102709) (C.M.B.). G.D. has been supported by a student fellowship from the Fonds de la Recherche en Sante du Qubec (FRSQ.) C.L.C. and C.M.B. have been supported, respectively, by a student fellowship from the CIHR and a scientist award by the FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082; Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626; Chen Q, 2012, J BONE MINER RES OFF; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; Kondo H, 2009, RADIAT RES, V171, P283, DOI 10.1667/RR1463.1; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Landry Y, 2010, J CELL MOL MED, V14, P1594, DOI 10.1111/j.1582-4934.2009.00887.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehrara BJ, 2010, FASEB J, V24, P4877, DOI 10.1096/fj.10-155762; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Mostoufi-Moab S, 2012, J BONE MINER RES, V27, P760, DOI 10.1002/jbmr.1499; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Saeed H, 2011, J BONE MINER RES, V26, P1494, DOI 10.1002/jbmr.349; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	38	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73206	10.1371/journal.pone.0073206	http://dx.doi.org/10.1371/journal.pone.0073206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009740	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600060
J	Ohsumi, A; Chen, FS; Sakamoto, J; Nakajima, D; Kobayashi, M; Bando, T; Date, H				Ohsumi, Akihiro; Chen, Fengshi; Sakamoto, Jin; Nakajima, Daisuke; Kobayashi, Masashi; Bando, Toru; Date, Hiroshi			Protective Effect of Surfactant Inhalation against Warm Ischemic Injury in an Isolated Rat Lung Ventilation Model	PLOS ONE			English	Article							REPERFUSION INJURY; NITRIC-OXIDE; CARDIAC DEATH; TRANSPLANTATION MODEL; EXOGENOUS SURFACTANT; ISCHEMIA/REPERFUSION INJURY; SINGLE-CENTER; CYTOCHROME-C; DONOR LUNGS; CELL-DEATH	Warm ischemia-reperfusion injury remains a crucial issue in transplantation following the cardiac death of donors. Previously, we showed that surfactant inhalation during warm ischemia mitigated ischemia-reperfusion injury. This study investigated the mechanisms of surfactant inhalation protection of the warm ischemic lung after reoxygenation with ventilation alone. In an isolated rat lung ventilation model, cardiac arrest was induced in the CTRL (control) and SURF (surfactant treatment) groups by ventricular fibrillation. Ventilation was restarted 110 min later; the lungs were flushed, and a heart and lung block was procured. In the SURF group, a natural bovine surfactant (Surfacten (R)) was inhaled for 3 min at the end of warm ischemia. In the Sham (no ischemia) group, lungs were flushed, procured, and ventilated in the same way. Afterwards, the lungs were ventilated with room air without reperfusion for 60 min. Surfactant inhalation significantly improved dynamic compliance and airway resistance. Moreover, surfactant inhalation significantly decreased inducible nitric oxide synthase and caspase-3 transcript levels, and increased those of Bcl-2 and surfactant protein-C. Immunohistochemically, lungs in the SURF group showed weaker staining for 8-hydroxy-2'-deoxyguanosine, inducible nitric oxide synthase, and apoptosis, and stronger staining for Bcl-2 and surfactant protein-C. Our results indicate that surfactant inhalation in the last phase of warm ischemia mitigated the injury resulting from reoxygenation after warm ischemia. The reduction in oxidative damage and the inhibition of apoptosis might contribute to the protection of the warm ischemic lungs.	[Ohsumi, Akihiro; Chen, Fengshi; Sakamoto, Jin; Nakajima, Daisuke; Kobayashi, Masashi; Bando, Toru; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan	Kyoto University	Date, H (corresponding author), Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan.	hdate@kuhp.kyoto-u.ac.jp		Ohsumi, Akihiro/0000-0002-2847-9653	Grants-in-Aid for Scientific Research [23390333] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		AKASHI A, 1993, TRANSPLANTATION, V55, P24, DOI 10.1097/00007890-199301000-00006; Brackenbury AM, 2001, AM J RESP CRIT CARE, V163, P1135, DOI 10.1164/ajrccm.163.5.2004049; Chen FS, 2006, ANN THORAC SURG, V82, P465, DOI 10.1016/j.athoracsur.2006.01.010; Cooke DT, 2005, TRANSPLANTATION, V79, P762, DOI 10.1097/01.TP.0000153368.08861.15; De Oliveira NC, 2010, J THORAC CARDIOV SUR, V139, P1306, DOI 10.1016/j.jtcvs.2010.02.004; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Erasmus ME, 2010, TRANSPLANTATION, V89, P452, DOI 10.1097/TP.0b013e3181c46a74; Fujinaga T, 2006, TRANSPLANTATION, V82, P1168, DOI 10.1097/01.tp.0000237207.73439.2e; Gewaltig MT, 2002, CARDIOVASC RES, V55, P250, DOI 10.1016/S0008-6363(02)00327-9; Grunenfelder J, 2001, CIRCULATION, V104, pI202; Inci I, 2011, TRANSPL INT, V24, P78, DOI 10.1111/j.1432-2277.2010.01154.x; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2127, DOI 10.1093/nar/12.4.2127; Kawamura T, 2010, TRANSPLANTATION, V90, P1344, DOI 10.1097/TP.0b013e3181fe1357; Kermeen FD, 2007, J HEART LUNG TRANSPL, V26, P850, DOI 10.1016/j.healun.2007.05.016; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kuang JQ, 1998, J HEART LUNG TRANSPL, V17, P406; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Miles PR, 1999, AM J PHYSIOL-LUNG C, V276, pL186, DOI 10.1152/ajplung.1999.276.1.L186; Nakajima D, 2011, TRANSPLANTATION, V92, P858, DOI 10.1097/TP.0b013e31822d8778; Ohsumi A, 2012, J HEART LUNG TRANSPL, V31, P1136, DOI 10.1016/j.healun.2012.07.006; Ohsumi A, 2012, TRANSPL INT, V25, P1096, DOI 10.1111/j.1432-2277.2012.01532.x; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Sakamoto J, 2012, J HEART LUNG TRANSPL, V31, P773, DOI 10.1016/j.healun.2012.03.012; Sakamoto J, 2011, TRANSPLANTATION, V92, P864, DOI 10.1097/TP.0b013e31822d87c6; SHAUL PW, 1994, J CLIN INVEST, V94, P2231, DOI 10.1172/JCI117585; Shaw MJ, 2001, ANN THORAC SURG, V72, P386, DOI 10.1016/S0003-4975(01)02792-8; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Struber M, 1999, INTENS CARE MED, V25, P862, DOI 10.1007/s001340050967; Struber M, 2007, J THORAC CARDIOV SUR, V133, P1620, DOI 10.1016/j.jtcvs.2006.12.057; Szabo C, 1996, SHOCK, V6, P79, DOI 10.1097/00024382-199608000-00001; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; ULICNY KS, 1993, ANN THORAC SURG, V55, P1185, DOI 10.1016/0003-4975(93)90031-C; van Putte BP, 2009, J THORAC CARDIOV SUR, V137, P824, DOI 10.1016/j.jtcvs.2008.08.046; Willet K, 2000, BBA-BIOENERGETICS, V1460, P346, DOI 10.1016/S0005-2728(00)00201-2; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576	37	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72574	10.1371/journal.pone.0072574	http://dx.doi.org/10.1371/journal.pone.0072574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009692	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600030
J	Zeilstra, J; Joosten, SPJ; Vermeulen, L; Koster, J; Medema, JP; Versteeg, R; Spaargaren, M; Pals, ST				Zeilstra, Jurrit; Joosten, Sander P. J.; Vermeulen, Louis; Koster, Jan; Medema, Jan Paul; Versteeg, Rogier; Spaargaren, Marcel; Pals, Steven T.			CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status	PLOS ONE			English	Article							STEM-CELLS; TUMOR-GROWTH; ENDOTHELIAL-CELLS; TP53 MUTATION; WNT TARGET; C-MET; APC; PHOSPHORYLATION; METASTASIS; APOPTOSIS	CD44 marks stem cell-like cells in a number of tumour types, including colorectal cancer (CRC), while aberrant CD44 expression conveys increased tumourigenic, invasive, and metastatic potential. Previous data indicate that CD44 is a direct target of p53-mediated transcriptional repression in breast cancer. Since inactivating p53 mutations are frequent genetic events in CRC these could unleash expression of CD44. In the present study, we therefore explored the relation between p53 mutational status and CD44 expression in a cohort of 90 localized primary CRCs and studied the effect of radiation-induced p53 activation on CD44 expression. Interestingly, we observed that, in contrast to breast cancer, loss of function p53 mutations were not associated with elevated CD44 expression in colon cancer. Moreover, DNA-damage induced p53 activation did not result in repression of CD44 expression, neither in colon cancer cells nor in normal intestinal epithelial cells. Our data demonstrate that CD44 expression in normal and malignant intestinal epithelial cells is not regulated by p53, implying that regulation of this potentially important therapeutic target is tissue and cancer-type specific.	[Zeilstra, Jurrit; Joosten, Sander P. J.; Spaargaren, Marcel; Pals, Steven T.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Vermeulen, Louis; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol LEXOR, NL-1105 AZ Amsterdam, Netherlands; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Pals, ST (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	s.t.pals@amc.uva.nl	Versteeg, Rogier/AAQ-1765-2020; Spaargaren, Marcel/AAU-1298-2021; Vermeulen, Louis/B-7488-2008; Koster, Jan/C-5934-2008	Spaargaren, Marcel/0000-0002-3135-5109; Vermeulen, Louis/0000-0002-6066-789X; Koster, Jan/0000-0002-0890-7585; Medema, Jan Paul/0000-0003-3045-2924; Versteeg, Rogier/0000-0001-7172-0388; Pals, Steven/0000-0002-1419-0939; Joosten, Sander/0000-0002-6699-3717	Dutch Cancer Foundation	Dutch Cancer Foundation(KWF Kankerbestrijding)	This work has been funded by the Dutch Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fujisaki T, 1999, CANCER RES, V59, P4427; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harada N, 2001, INT J CANCER, V91, P67, DOI 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Iacopetta B, 2006, ANN ONCOL, V17, P842, DOI 10.1093/annonc/mdl035; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Reeder JA, 1998, CANCER RES, V58, P3719; Russo P, 2002, INT J CANCER, V100, P266, DOI 10.1002/ijc.10461; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zeilstra J, 2011, BIOCHEM BIOPH RES CO, V406, P1, DOI 10.1016/j.bbrc.2010.12.070; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	37	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72849	10.1371/journal.pone.0072849	http://dx.doi.org/10.1371/journal.pone.0072849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009708	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600038
J	Zhao, K; Yan, WJ; Chen, YH; Zuo, XN; Fu, XL				Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin; Zuo, Xi-Nian; Fu, Xiaolan			Amygdala Volume Predicts Inter-Individual Differences in Fearful Face Recognition	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTIONAL STIMULI; SOCIAL-BEHAVIOR; RESPONSES; DAMAGE; SEGMENTATION; ANXIETY; MRI; CHILDREN; CORTEX	The present study investigates the relationship between inter-individual differences in fearful face recognition and amygdala volume. Thirty normal adults were recruited and each completed two identical facial expression recognition tests offline and two magnetic resonance imaging (MRI) scans. Linear regression indicated that the left amygdala volume negatively correlated with the accuracy of recognizing fearful facial expressions and positively correlated with the probability of misrecognizing fear as surprise. Further exploratory analyses revealed that this relationship did not exist for any other subcortical or cortical regions. Nor did such a relationship exist between the left amygdala volume and performance recognizing the other five facial expressions. These mind-brain associations highlight the importance of the amygdala in recognizing fearful faces and provide insights regarding inter-individual differences in sensitivity toward fear-relevant stimuli.	[Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin; Fu, Xiaolan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Fu, XL (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	fuxl@psych.ac.cn	Zuo, Xi-Nian/A-7273-2009	Zuo, Xi-Nian/0000-0001-9110-585X	973 Program [2011CB302201]; National Natural Science Foundation of China [61075042, 81171409, 81220108014]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by grants from 973 Program (No. 2011CB302201) and the National Natural Science Foundation of China (Nos. 61075042, 81171409, 81220108014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Anderson AK, 2003, J NEUROSCI, V23, P5627; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Bickart KC, 2012, J NEUROSCI, V32, P14729, DOI 10.1523/JNEUROSCI.1599-12.2012; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Calder AJ, 2003, NEUROPSYCHOLOGIA, V41, P195, DOI 10.1016/S0028-3932(02)00149-5; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Cremers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028421; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Darwin C., 2002, EXPRESSION EMOTIONS; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DICKS D, 1969, SCIENCE, V165, P69, DOI 10.1126/science.165.3888.69; Du S, 2011, J VIS, V11, P1425; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006; EKMAN P, 1986, MOTIV EMOTION, V10, P159, DOI 10.1007/BF00992253; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisler MS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-70; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Gosselin P, 1999, J GENET PSYCHOL, V160, P181, DOI 10.1080/00221329909595391; Hadj-Bouziane F, 2012, P NAT ACAD SCI, V109, P3640; Hadj-Bouziane F, 2008, P NATL ACAD SCI USA, V105, P5591, DOI 10.1073/pnas.0800489105; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Hooker CI, 2008, NEUROPSYCHOLOGIA, V46, P2709, DOI 10.1016/j.neuropsychologia.2008.05.005; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kling AS, 1992, AMYGDALA NEUROBIOLOG; Kohavi R., 1998, MACH LEARN, V30-2, P271, DOI [DOI 10.1023/A:1017181826899, 10.1023/A:1017181826899]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lissek S, 2008, AM J PSYCHIAT, V165, P124, DOI 10.1176/appi.ajp.2007.06091513; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Mueller SC, 2013, J AM ACAD CHILD PSY, V52, P184, DOI 10.1016/j.jaac.2012.11.016; Park HJ, 2012, PSYCHIAT RES, V197, P237, DOI 10.1016/j.psychres.2011.11.001; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; ROLLS ET, 1999, BRAIN EMOTION; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sprengelmeyer R, 1999, P ROY SOC B-BIOL SCI, V266, P2451, DOI 10.1098/rspb.1999.0945; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Tsuchiya N, 2009, NAT NEUROSCI, V12, P1224, DOI 10.1038/nn.2380; van der Zwaag W, 2012, BRAIN TOPOGR, V25, P125, DOI 10.1007/s10548-012-0219-0; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Williams MA, 2008, EUR J NEUROSCI, V27, P3074, DOI 10.1111/j.1460-9568.2008.06264.x; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007; Yan CG, 2013, NEUROIMAGE IN PRESS; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	69	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74096	10.1371/journal.pone.0074096	http://dx.doi.org/10.1371/journal.pone.0074096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009767	gold, Green Published			2022-12-25	WOS:000323734600080
J	de Timary, P; Uva, MCD; Denoel, C; Hebborn, L; Derely, M; Desseilles, M; Luminet, O				de Timary, Philippe; Uva, Mariana Cordovil de Sousa; Denoel, Catherine; Hebborn, Ludger; Derely, Marc; Desseilles, Martin; Luminet, Olivier			The Associations between Self-Consciousness, Depressive State and Craving to Drink among Alcohol Dependent Patients Undergoing Protracted Withdrawal	PLOS ONE			English	Article							AWARENESS MODEL; ALEXITHYMIA; MOTIVATION; STIGMA; SCALE; MINDFULNESS; CONSUMPTION; ABSTINENCE; NALTREXONE; SEVERITY	Context: In order to understand how certain personality traits influence the relation between depression symptoms and craving for alcohol, trait self-consciousness (trait SC) was examined during a withdrawal and detoxification program. Methods: Craving (Obsessive and Compulsive Drinking Scale), depressive state (Beck Depression Inventory) and trait SC (Revised Self-Consciousness Scale) were assessed in alcohol-dependent inpatients (DSM-IV, N = 30) both at the beginning (T1: day 1 or 2) and at the end (T2: day 14 to 18) of protracted withdrawal during rehabilitation. Results: A significant decrease in craving and depressive symptoms was observed from T1 to T2, while SC scores remained stable. At both times, strong positive correlations were observed between craving and depression. Moreover, regression analyses indicated that trait SC significantly moderated the impact of depression on cravings for alcohol. Limitations: This study was performed on a relatively small sample size. Administration of medications during detoxification treatment can also be a confounding factor. Finally, craving could have been evaluated through other types of measurements. Conclusions: During protracted withdrawal, alcohol craving decreased with the same magnitude as depressive mood. Depressive symptoms were related to alcohol craving but only among patients with high trait SC scores. Our results suggest that metacognitive approaches targeting SC could decrease craving and, in turn, prevent future relapses.	[de Timary, Philippe] Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain, Belgium; [Uva, Mariana Cordovil de Sousa; Denoel, Catherine; Luminet, Olivier] Catholic Univ Louvain, Res Inst Psychol Sci, B-1348 Louvain, Belgium; [de Timary, Philippe; Desseilles, Martin; Luminet, Olivier] Belgian Natl Fund Sci Res FRS FNRS, Brussels, Belgium; [Desseilles, Martin] Harvard Univ, Sch Med, Dept Psychiat, Depress Clin & Res Program,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Desseilles, Martin] Univ Namur, Dept Psychol, Namur, Belgium; [de Timary, Philippe; Uva, Mariana Cordovil de Sousa] Catholic Univ Louvain, Unite Hepatol Integree, Dept Adult Psychiat, B-1348 Louvain, Belgium; [de Timary, Philippe; Uva, Mariana Cordovil de Sousa] Catholic Univ Louvain, Inst Neurosci, Acad Hosp St Luc, B-1348 Louvain, Belgium; [Hebborn, Ludger] Clin Europe St Michel, Psychiat Ward, Brussels, Belgium; [Derely, Marc] Clin La Ramee, Alcohol Dependence Unit, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Fonds de la Recherche Scientifique - FNRS; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Namur; Universite Catholique Louvain; Universite Catholique Louvain	de Timary, P (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain, Belgium.	Philippe.detimary@uclouvain.be		Desseilles, Martin/0000-0003-4748-3401	Belgian National Fund for Scientific Research (FNRS-FRS) [3.4585.07]	Belgian National Fund for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Belgian National Fund for Scientific Research (FNRS-FRS; grant 3.4585.07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; Andersohn F., 2004, GER J PSYCHIAT, V7, P6; Ansseau M, 2000, EUR ADDICT RES, V6, P51, DOI 10.1159/000019010; Anton RF, 1999, ALCOHOL RES HEALTH, V23, P165; ANTON RF, 1995, ALCOHOL CLIN EXP RES, V19, P92, DOI 10.1111/j.1530-0277.1995.tb01475.x; APA, 1994, DIAGN STAT MAN MENT; Armeli S, 2003, PSYCHOL ADDICT BEHAV, V17, P266, DOI 10.1037/0893-164X.17.4.266; Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BOURQUE P, 1982, CAN J BEHAV SCI, V14, P211, DOI 10.1037/h0081254; Bowen S, 2009, SUBST ABUS, V30, P295, DOI 10.1080/08897070903250084; Brandon TH, 1996, EXP CLIN PSYCHOPHARM, V4, P29, DOI 10.1037/1064-1297.4.1.29; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carney MA, 2000, J CONSULT CLIN PSYCH, V68, P788, DOI 10.1037/0022-006X.68.5.788; CLARK DC, 1985, J NERV MENT DIS, V173, P482, DOI 10.1097/00005053-198508000-00005; CLARK DC, 1993, J STUD ALCOHOL, V54, P107, DOI 10.15288/jsa.1993.54.107; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; de Timary P, 2008, PSYCHIAT RES, V157, P105, DOI 10.1016/j.psychres.2006.12.008; Deyo M, 2009, EXPLORE-NY, V5, P265, DOI 10.1016/j.explore.2009.06.005; DiClemente CC, 1998, COMPREHENSIVE TRANST; Frischknecht U, 2011, EUR ADDICT RES, V17, P241, DOI 10.1159/000328637; HAVILAND MG, 1988, PSYCHOTHER PSYCHOSOM, V49, P37, DOI 10.1159/000288065; HULL JG, 1983, J ABNORM PSYCHOL, V92, P514, DOI 10.1037/0021-843X.92.4.514; HULL JG, 1986, J PERS SOC PSYCHOL, V51, P790, DOI 10.1037/0022-3514.51.4.790; HULL JG, 1981, J ABNORM PSYCHOL, V90, P586, DOI 10.1037/0021-843X.90.6.586; Judd C. M., 2011, DATA ANAL MODEL COMP; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Littlefield AK, 2010, SOC PERSONAL PSYCHOL, V4, P767, DOI 10.1111/j.1751-9004.2010.00296.x; Luoma JB, 2007, ADDICT BEHAV, V32, P1331, DOI 10.1016/j.addbeh.2006.09.008; Maurage P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058928; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oslin DW, 2009, DRUG ALCOHOL DEPEN, V103, P131, DOI 10.1016/j.drugalcdep.2009.03.009; PAILLE FM, 1995, ALCOHOL ALCOHOLISM, V30, P239; Pinard L, 1996, AM J ADDICTION, V5, P32; Saunders SM, 2006, J SUBST ABUSE TREAT, V30, P261, DOI 10.1016/j.jsat.2006.01.003; SCHEIER MF, 1985, J APPL SOC PSYCHOL, V15, P687, DOI 10.1111/j.1559-1816.1985.tb02268.x; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; SCHUCKIT MA, 1994, ACTA PSYCHIAT SCAND, V89, P28, DOI 10.1111/j.1600-0447.1994.tb05798.x; Schuckit MA, 1997, AM J PSYCHIAT, V154, P948; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Toussaint A, 2006, J Pharm Belg, V61, P37; Uva MCD, 2010, ALCOHOL ALCOHOLISM, V45, P241, DOI 10.1093/alcalc/agq012; Uva MCD, 2010, PERS INDIV DIFFER, V48, P16, DOI 10.1016/j.paid.2009.08.004; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Wahl OF, 1999, SCHIZOPHRENIA BULL, V25, P467, DOI 10.1093/oxfordjournals.schbul.a033394; Weinstein A, 1998, ALCOHOL CLIN EXP RES, V22, P1376, DOI 10.1111/j.1530-0277.1998.tb03922.x; Witkiewitz K, 2010, J CONSULT CLIN PSYCH, V78, P362, DOI 10.1037/a0019172	47	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71560	10.1371/journal.pone.0071560	http://dx.doi.org/10.1371/journal.pone.0071560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24013131	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200016
J	Keshavarz-Motamed, Z; Garcia, J; Kadem, L				Keshavarz-Motamed, Zahra; Garcia, Julio; Kadem, Lyes			Fluid Dynamics of Coarctation of the Aorta and Effect of Bicuspid Aortic Valve	PLOS ONE			English	Article							WALL SHEAR-STRESS; BLOOD-FLOW; ELASTIC PROPERTIES; ASCENDING AORTA; MODEL; STENOSIS; STEADY; REPAIR; ARCH; ASYMMETRY	Up to 80% of patients with coarctation of the aorta (COA) have a bicuspid aortic valve (BAV). Patients with COA and BAV have elevated risks of aortic complications despite successful surgical repair. The development of such complications involves the interplay between the mechanical forces applied on the artery and the biological processes occurring at the cellular level. The focus of this study is on hemodynamic modifications induced in the aorta in the presence of a COA and a BAV. For this purpose, numerical investigations and magnetic resonance imaging measurements were conducted with different configurations: (1) normal: normal aorta and normal aortic valve; (2) isolated COA: aorta with COA (75% reduction by area) and normal aortic valve; (3) complex COA: aorta with the same severity of COA (75% reduction by area) and BAV. The results show that the coexistence of COA and BAV significantly alters blood flow in the aorta with a significant increase in the maximal velocity, secondary flow, pressure loss, time-averaged wall shear stress and oscillatory shear index downstream of the COA. These findings can contribute to a better understanding of why patients with complex COA have adverse outcome even following a successful surgery.	[Keshavarz-Motamed, Zahra] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Keshavarz-Motamed, Zahra] Univ Montreal, Dept Biomed Engn, Montreal, PQ, Canada; [Keshavarz-Motamed, Zahra; Garcia, Julio; Kadem, Lyes] Concordia Univ, Dept Mech & Ind Engn, Lab Cardiovasc Fluid Dynam, Montreal, PQ, Canada; [Garcia, Julio] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Garcia, Julio] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA	Universite de Montreal; Universite de Montreal; Concordia University - Canada; Laval University; Quebec Heart & Lung Institute; Northwestern University	Keshavarz-Motamed, Z (corresponding author), Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.	zahra.keshavarz@crchum.qc.ca	Garcia, Julio/AAF-7659-2020; Flores, Julio Garcia/AAI-3938-2020; Garcia, Julio/F-6305-2014	Flores, Julio Garcia/0000-0001-9528-8155; Garcia, Julio/0000-0001-9528-8155				27Thubrikar M., 1990, AORTIC VALVE; Abbott ME, 1928, AM HEART J, V3, P574, DOI 10.1016/S0002-8703(28)90281-1; AHMED SA, 1983, J BIOMECH, V16, P505, DOI 10.1016/0021-9290(83)90065-9; Barker AJ, 2010, ANN BIOMED ENG, V38, P788, DOI 10.1007/s10439-009-9854-3; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; Brili S, 1998, AM J CARDIOL, V82, P1140, DOI 10.1016/S0002-9149(98)00575-X; CASSANOVA RA, 1978, J BIOMECH, V11, P441, DOI 10.1016/0021-9290(78)90056-8; Celik IB, 2008, J FLUID ENG-T ASME, V130, DOI 10.1115/1.2960953; Chandran KB, 2013, J BIOMECH, V46, P208, DOI 10.1016/j.jbiomech.2012.10.038; Chemla D, 1998, AM J PHYSIOL-HEART C, V274, pH500, DOI 10.1152/ajpheart.1998.274.2.H500; CLARK C, 1976, J BIOMECH, V9, P677, DOI 10.1016/0021-9290(76)90169-X; Conti CA, 2010, J THORAC CARDIOV SUR, V140, P890, DOI 10.1016/j.jtcvs.2010.01.016; DeGroff CG, 2003, J AM SOC ECHOCARDIOG, V16, P162, DOI 10.1067/mje.2003.20; Faggiano E, 2013, BIOMECH MODEL MECHAN, V12, P801, DOI 10.1007/s10237-012-0444-1; Feng Y, 2005, P ANN INT IEEE EMBS, P607; Frydrychowicz A, 2009, J MAGN RESON IMAGING, V30, P77, DOI 10.1002/jmri.21790; Fung Y.C, 1981, MECH PROPERTIES LIVI; Gao F, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-25; Garcia J, 2012, J BIOMECH ENG; Ghalichi F, 1998, BIORHEOLOGY, V35, P281, DOI 10.1016/S0006-355X(99)80011-0; Hope MD, 2010, RADIOLOGY, V255, P53, DOI 10.1148/radiol.09091437; Jin S, 2003, J BIOMECH ENG-T ASME, V125, P347, DOI 10.1115/1.1574332; Keshavarz-Motamed Z, 2012, J BIOMECH, V45, P1239, DOI 10.1016/j.jbiomech.2012.01.039; Keshavarz-Motamed Z, 2011, J BIOMECH, V44, P2817, DOI 10.1016/j.jbiomech.2011.08.001; Keshavarz-Motamed Z, 2010, J MED ENG PHYS, V3, P315; Kim HJ, 2009, ANN BIOMED ENG, V37, P2153, DOI 10.1007/s10439-009-9760-8; KIRSH MM, 1977, J THORAC CARDIOV SUR, V74, P636; KU DN, 1990, J BIOMECH ENG-T ASME, V112, P444, DOI 10.1115/1.2891209; LaDisa JF, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004996; LaDisa JFJ, 2011, CONGENIT HEART DIS, V6, P432, DOI 10.1111/j.1747-0803.2011.00553.x; Liu SQ, 2003, AM J PHYSIOL-HEART C, V285, pH1072, DOI 10.1152/ajpheart.01009.2002; Meierhofer C, 2013, EUR HEART J-CARD IMG, V14, P797, DOI 10.1093/ehjci/jes273; Morris L, 2005, J BIOMECH ENG-T ASME, V127, P767, DOI 10.1115/1.1992521; Murakami T, 2005, ANN THORAC SURG, V80, P995, DOI 10.1016/j.athoracsur.2005.03.055; NEREM RM, 1992, J BIOMECH ENG-T ASME, V114, P274, DOI 10.1115/1.2891384; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; O'Rourke M, 2008, JACC-CARDIOVASC IMAG, V1, P749, DOI 10.1016/j.jcmg.2008.08.002; Oliver JM, 2004, J AM COLL CARDIOL, V44, P1641, DOI 10.1016/j.jacc.2004.07.037; OROURKE MF, 1971, CIRCULATION, V44, P281, DOI 10.1161/01.CIR.44.2.281; PARIKH SR, 1991, J AM COLL CARDIOL, V17, P1367, DOI 10.1016/S0735-1097(10)80149-4; PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L; Richter Y, 2006, CIRCULATION, V113, P2679, DOI 10.1161/CIRCULATIONAHA.106.632687; Roos-Hesselink JW, 2003, HEART, V89, P1074, DOI 10.1136/heart.89.9.1074; Ryval J, 2004, J BIOMECH ENG-T ASME, V126, P625, DOI 10.1115/1.1798055; Saikrishnan N, 2012, ANN BIOMED ENG, V40, P1760, DOI 10.1007/s10439-012-0527-2; Secchi F, 2009, RADIOL MED, V114, P524, DOI 10.1007/s11547-009-0386-6; Seifert BL, 1999, J AM SOC ECHOCARDIOG, V12, P744, DOI 10.1016/S0894-7317(99)70025-8; Senzaki H, 2008, CIRCULATION, V118, pS191, DOI 10.1161/CIRCULATIONAHA.107.757096; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Sturm C, 1992, ASAIO J, V38, pM225, DOI 10.1097/00002480-199207000-00025; Tang DL, 2003, ANN BIOMED ENG, V31, P1182, DOI 10.1114/1.1615577; Taylor C A, 1999, Comput Aided Surg, V4, P231, DOI 10.3109/10929089909148176; UNGER EL, 1977, AM J ROENTGENOL, V129, P329, DOI 10.2214/ajr.129.2.329; Viscardi F, 2010, ARTIF ORGANS, V34, P1114, DOI 10.1111/j.1525-1594.2009.00989.x; Vitarelli A, 2008, J AM SOC ECHOCARDIOG, V21, P729, DOI 10.1016/j.echo.2007.10.007; Vogt M, 2005, CIRCULATION, V111, P3269, DOI 10.1161/CIRCULATIONAHA.104.529792; von Kodolitsch Y, 2002, J AM COLL CARDIOL, V39, P617, DOI 10.1016/S0735-1097(01)01784-3; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Watton PN, 2004, BIOMECH MODEL MECHAN, V3, P98, DOI 10.1007/s10237-004-0052-9; Wentzel JJ, 2005, J AM COLL CARDIOL, V45, P846, DOI 10.1016/j.jacc.2004.12.026; Wilcox D.C., 2006, TURBULENCE MODELING, V3; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Wong KKL, 2007, J MED ENG PHYS, V32, P174; Xu JP, 1997, AM HEART J, V134, P93, DOI 10.1016/S0002-8703(97)70111-X; Xu XY, 2010, EUR J VASC ENDOVASC, V39, P295, DOI 10.1016/j.ejvs.2009.10.016; YEARWOOD TL, 1980, J BIOMECH, V13, P1075, DOI 10.1016/0021-9290(80)90051-2; YEARWOOD TL, 1982, J BIOMECH, V15, P683, DOI 10.1016/0021-9290(82)90023-9	69	26	26	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72394	10.1371/journal.pone.0072394	http://dx.doi.org/10.1371/journal.pone.0072394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015239	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200039
J	Song, XX; Kim, SY; Lee, YJ				Song, Xinxin; Kim, Seog-Young; Lee, Yong J.			Evidence for Two Modes of Synergistic Induction of Apoptosis by Mapatumumab and Oxaliplatin in Combination with Hyperthermia in Human Colon Cancer Cells	PLOS ONE			English	Article							AGONISTIC MONOCLONAL-ANTIBODY; ISOLATED HEPATIC PERFUSION; TUMOR-NECROSIS-FACTOR; C-FLIP; COLORECTAL-CANCER; LIVER METASTASES; BCL-XL; DOWN-REGULATION; TRAIL; DEATH	Colorectal cancer is the third leading cause of cancer-related mortality in the world- the main cause of death from colorectal cancer is hepatic metastases, which can be treated with isolated hepatic perfusion (IHP). Searching for the most clinically relevant approaches for treating colorectal metastatic disease by isolated hepatic perfusion (IHP), we developed the application of oxaliplatin concomitantly with hyperthermia and humanized death receptor 4 (DR4) antibody mapatumumab (Mapa), and investigated the molecular mechanisms of this multimodality treatment in human colon cancer cell lines CX-1 and HCT116 as well as human colon cancer stem cells Tu-12, Tu-21 and Tu-22. We showed here, in this study, that the synergistic effect of the multimodality treatment-induced apoptosis was caspase dependent and activated death signaling via both the extrinsic apoptotic pathway and the intrinsic pathway. Death signaling was activated by c-Jun N-terminal kinase (JNK) signaling which led to Bcl-xL phosphorylation at serine 62, decreasing the anti-apoptotic activity of Bcl-xL, which contributed to the intrinsic pathway. The downregulation of cellular FLICE inhibitory protein long isoform (c-FLIPL) in the extrinsic pathway was accomplished through ubiquitination at lysine residue (K) 195 and protein synthesis inhibition. Overexpression of c-FLIPL mutant (K195R) and Bcl-xL mutant (S62A) completely abrogated the synergistic effect. The successful outcome of this study supports the application of multimodality strategy to patients with colorectal hepatic metastases who fail to respond to standard chemoradiotherapy that predominantly targets the mitochondrial apoptotic pathway.	[Song, Xinxin; Kim, Seog-Young; Lee, Yong J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Lee, Yong J.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, YJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	leeyj@upmc.edu		Song, Xinxin/0000-0003-3868-2644	NCI [CA140554];  [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA140554] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grant: NCI grant fund (CA140554). This project used the UPCI Core Facility and was supported in part by award P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala MA, 2010, J CELL BIOCHEM, V110, P1073, DOI 10.1002/jcb.22619; Alexander HR, 2005, ANN SURG ONCOL, V12, P138, DOI 10.1245/ASO.2005.05.003; Atallah D, 2004, INT J HYPERTHER, V20, P405, DOI 10.1080/02656730310001637325; Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; Cummins Jordan M., 2004, Cancer Research, V64, P3006; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; El Fajoui Z, 2011, GASTROENTEROLOGY, V141, P663, DOI 10.1053/j.gastro.2011.04.055; Gao W, 2013, GASTROENTEROLOGY; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; HAFSTROM LR, 1994, SURG ONCOL, V3, P103, DOI 10.1016/0960-7404(94)90005-1; Hegewisch-Becker S, 2002, ANN ONCOL, V13, P1197, DOI 10.1093/annonc/mdf216; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Korkolopoulou P, 2007, HISTOPATHOLOGY, V51, P150, DOI 10.1111/j.1365-2559.2007.02723.x; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lee YJ, 2001, CANCER GENE THER, V8, P397, DOI 10.1038/sj.cgt.7700310; Libutti SK, 2000, J AM COLL SURGEONS, V191, P519, DOI 10.1016/S1072-7515(00)00733-X; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu C, 2012, MOL BIOL REP, V39, P8717, DOI 10.1007/s11033-012-1731-8; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Mahalingam D, 2011, CURR DRUG TARGETS, V12, P2079, DOI 10.2174/138945011798829357; Mawji IA, 2007, CANCER RES, V67, P8307, DOI 10.1158/0008-5472.CAN-07-1687; Mom CH, 2009, CLIN CANCER RES, V15, P5584, DOI 10.1158/1078-0432.CCR-09-0996; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Raymond E, 2002, MOL CANCER THER, V1, P227; Ruers T, 2002, EUR J CANCER, V38, P1023, DOI 10.1016/S0959-8049(02)00059-X; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Seo BR, 2013, BIOCHIMIE, V95, P858, DOI 10.1016/j.biochi.2012.12.002; Song X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.104; Song XX, 2012, MOL CANCER RES, V10, P1567, DOI 10.1158/1541-7786.MCR-12-0209-T; Song XX, 2012, J CELL BIOCHEM, V113, P1547, DOI 10.1002/jcb.24023; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Ullenhag GJ, 2007, CLIN CANCER RES, V13, P5070, DOI 10.1158/1078-0432.CCR-06-2547; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Varghese S, 2010, ANN SURG ONCOL, V17, P1870, DOI 10.1245/s10434-010-0998-z; Vulfovich M, 2005, CURR OPIN MOL THER, V7, P502; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Yoo JS, 2008, J CELL BIOCHEM, V103, P98, DOI 10.1002/jcb.21389; Younes A, 2010, BRIT J CANCER, V103, P1783, DOI 10.1038/sj.bjc.6605987; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zeh HJ, 2009, ANN SURG ONCOL, V16, P385, DOI 10.1245/s10434-008-0179-5; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang YL, 2008, WORLD J GASTROENTERO, V14, P3069, DOI 10.3748/wjg.14.3069; Zhao LQ, 2011, MOL CANCER THER, V10, P2415, DOI 10.1158/1535-7163.MCT-11-0401	49	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73654	10.1371/journal.pone.0073654	http://dx.doi.org/10.1371/journal.pone.0073654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013390	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200085
J	Cheng, SX; Tu, Y; Zhang, S				Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai			FoxM1 Promotes Glioma Cells Progression by Up-Regulating Anxa1 Expression	PLOS ONE			English	Article							METASTASIS-ASSOCIATED PROTEINS; TRANSCRIPTION FACTOR; GROWTH; IDENTIFICATION; ANNEXIN-1; PROFILES; TUMORS; PROLIFERATION; ANGIOGENESIS; INHIBITION	Forkhead box M1 (FoxM1) is a member of the forkhead transcription factor family and is overexpression in malignant gliomas. However, the molecular mechanisms by which FoxM1lead to glioma carcinogenesis and progression are still not well known. In the present study, we show that Anxa1 was overexpression in gliomas and predicted the poor outcome. Furthermore, Anxa1 closely related to the FoxM1 expression and was a direct transcriptional target of FoxM1. Overexpression of FoxM1 up-regulated Anxa1 expression, whereas suppression of FoxM1 expression down-regulated Anxa1 expression in glioma cells. Finally, FoxM1 enhanced the proliferation, migration, and angiogenesis in Anxa1-dependent manner both in vitro and in vivo. Our findings provide both clinical and mechanistic evidences that FoxM1 contributes to glioma development by directly up-regulating Anxa1 expression.	[Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai] CPAPF, Inst Traumat Brain Injury & Nervous Dis, Ctr Neurol & Neurosurg, Affiliated Hosp,Logist Coll, Tianjin, Peoples R China		Tu, Y (corresponding author), CPAPF, Inst Traumat Brain Injury & Nervous Dis, Ctr Neurol & Neurosurg, Affiliated Hosp,Logist Coll, Tianjin, Peoples R China.	ytumail@gmail.com; zhangsai718@yahoo.com		cheng, shixiang/0000-0002-6777-1892	National Natural Science Foundation of China [31200809]; Logistics College of CPAPF [FYZ201201, WYM201109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Logistics College of CPAPF	This work was supported by the National Natural Science Foundation of China (31200809) and intramural research programs from Logistics College of CPAPF (FYZ201201 and WYM201109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, INT J CANCER, V129, P1781, DOI 10.1002/ijc.25839; Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Balli D, 2011, ONCOGENE; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Rickman DS, 2001, CANCER RES, V61, P6885; Ruano Y, 2008, CANCER-AM CANCER SOC, V112, P1575, DOI 10.1002/cncr.23338; Schittenhelm J, 2009, MODERN PATHOL, V22, P1600, DOI 10.1038/modpathol.2009.132; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	32	25	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72376	10.1371/journal.pone.0072376	http://dx.doi.org/10.1371/journal.pone.0072376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991102	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800066
J	Ravoet, J; Maharramov, J; Meeus, I; De Smet, L; Wenseleers, T; Smagghe, G; de Graaf, DC				Ravoet, Jorgen; Maharramov, Jafar; Meeus, Ivan; De Smet, Lina; Wenseleers, Tom; Smagghe, Guy; de Graaf, Dirk C.			Comprehensive Bee Pathogen Screening in Belgium Reveals Crithidia mellificae as a New Contributory Factor to Winter Mortality	PLOS ONE			English	Article							DEFORMED WING VIRUS; HONEYBEES APIS-MELLIFERA; COLONY COLLAPSE DISORDER; MITE VARROA-DESTRUCTOR; ACUTE PARALYSIS VIRUS; NOSEMA-CERANAE; SPIROPLASMA-MELLIFERUM; PROTOZOAN PARASITES; MOLECULAR-DETECTION; UNITED-STATES	Since the last decade, unusually high honey bee colony losses have been reported mainly in North-America and Europe. Here, we report on a comprehensive bee pathogen screening in Belgium covering 363 bee colonies that were screened for 18 known disease-causing pathogens and correlate their incidence in summer with subsequent winter mortality. Our analyses demonstrate that, in addition to Varroa destructor, the presence of the trypanosomatid parasite Crithidia mellificae and the microsporidian parasite Nosema ceranae in summer are also predictive markers of winter mortality, with a negative synergy being observed between the two in terms of their effects on colony mortality. Furthermore, we document the first occurrence of a parasitizing phorid fly in Europe, identify a new fourth strain of Lake Sinai Virus (LSV), and confirm the presence of other little reported pathogens such as Apicystis bombi, Aphid Lethal Paralysis Virus (ALPV), Spiroplasma apis, Spiroplasma melliferum and Varroa destructor Macula-like Virus (VdMLV). Finally, we provide evidence that ALPV and VdMLV replicate in honey bees and show that viruses of the LSV complex and Black Queen Cell Virus tend to non-randomly co-occur together. We also noticed a significant correlation between the number of pathogen species and colony losses. Overall, our results contribute significantly to our understanding of honey bee diseases and the likely causes of their current decline in Europe.	[Ravoet, Jorgen; De Smet, Lina; de Graaf, Dirk C.] Univ Ghent, Fac Sci, Lab Zoophysiol, B-9000 Ghent, Belgium; [Maharramov, Jafar; Meeus, Ivan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [Wenseleers, Tom] Katholieke Univ Leuven, Lab Socioecol & Social Evolut, Louvain, Belgium	Ghent University; Ghent University; KU Leuven	Ravoet, J (corresponding author), Univ Ghent, Fac Sci, Lab Zoophysiol, B-9000 Ghent, Belgium.	Jorgen.Ravoet@UGent.be	Wenseleers, Tom/J-3960-2013; Smagghe, Guy/AAE-8914-2019; de Graaf, Dirk C./HGD-4017-2022	Wenseleers, Tom/0000-0002-1434-861X; Smagghe, Guy/0000-0001-8334-3313; ravoet, Jorgen/0000-0002-2904-7342	Research Foundation of Flanders (FWO-Vlaanderen) [G.0628.11]; European Union [BEEDOC: FP7-KBBE-2009-3 244956 CP-FP]	Research Foundation of Flanders (FWO-Vlaanderen)(FWO); European Union(European Commission)	Research Foundation of Flanders (FWO-Vlaanderen G.0628.11), European Union (7th Framework Program BEEDOC: FP7-KBBE-2009-3 244956 CP-FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; Nguyen BK, 2011, J APICULT RES, V50, P195, DOI 10.3896/IBRA.1.50.3.03; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Cantwell G. E., 1970, AM BEE J, V110, P222; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2007, AM BEE J, V147, P1027; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; CLARK TB, 1985, INT J SYST BACTERIOL, V35, P296, DOI 10.1099/00207713-35-3-296; Core A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029639; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; Dainat B, 2012, 5 EUR C AP; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2012, CONTEMP TOP ENTOMOL, P71; De Smet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047953; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Garedew A, 2004, APIDOLOGIE, V35, P419, DOI 10.1051/apido:2004032; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Invernizzi C, 2009, J INVERTEBR PATHOL, V101, P150, DOI 10.1016/j.jip.2009.03.006; JANOVY J, 1995, ECOL MODEL, V77, P189, DOI 10.1016/0304-3800(93)E0087-J; LANGRIDGE DF, 1967, J PROTOZOOL, V14, P485, DOI 10.1111/j.1550-7408.1967.tb02033.x; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Lipa JJ, 1996, APIDOLOGIE, V27, P29, DOI 10.1051/apido:19960104; Fernandez JM, 2012, J INVERTEBR PATHOL, V111, P106, DOI 10.1016/j.jip.2012.06.008; Meeus I, 2012, J INVERTEBR PATHOL, V109, P172, DOI 10.1016/j.jip.2011.11.006; Morimoto T, 2013, ENV MICROBIOL REP, V5, P74, DOI 10.1111/j.1758-2229.2012.00385.x; MOUCHES C, 1983, ANN INST PASTEUR MIC, VA134, P383, DOI 10.1016/S0769-2609(83)80063-5; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Plischuk S, 2011, ENV MICROBIOL REP, V3, P565, DOI 10.1111/j.1758-2229.2011.00261.x; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Rutrecht ST, 2008, INT J PARASITOL, V38, P799, DOI 10.1016/j.ijpara.2007.11.004; Schafer MO, 2010, J ECON ENTOMOL, V103, P10, DOI 10.1603/EC09233; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; UNEP (United Nations Environment Program), 2010, GLOB HON BEE COL DIS; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Yang B, 2013, ECOL EVOL, V3, P298, DOI 10.1002/ece3.464; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	62	162	171	3	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72443	10.1371/journal.pone.0072443	http://dx.doi.org/10.1371/journal.pone.0072443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991113	Green Published, gold			2022-12-25	WOS:000324228800073
J	Rodrigues, CR; Lenicov, FR; Jancic, C; Sabatte, J; Cabrini, M; Ceballos, A; Merlotti, A; Gonzalez, H; Ostrowski, M; Geffner, J				Rodriguez Rodrigues, Christian; Remes Lenicov, Federico; Jancic, Carolina; Sabatte, Juan; Cabrini, Mercedes; Ceballos, Ana; Merlotti, Antonela; Gonzalez, Heidi; Ostrowski, Matas; Geffner, Jorge			Candida albicans Delays HIV-1 Replication in Macrophages	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCYTE-DERIVED MACROPHAGES; IN-VITRO; INFECTION; PROTEIN; CELLS; PHAGOCYTOSIS; MECHANISMS; LATENCY; LIPOPOLYSACCHARIDE	Macrophages are one of the most important HIV-1 target cells. Unlike CD4(+) T cells, macrophages are resistant to the cytophatic effect of HIV-1. They are able to produce and harbor the virus for long periods acting as a viral reservoir. Candida albicans (CA) is a commensal fungus that colonizes the portals of HIV-1 entry, such as the vagina and the rectum, and becomes an aggressive pathogen in AIDS patients. In this study, we analyzed the ability of CA to modulate the course of HIV-1 infection in human monocyte-derived macrophages. We found that CA abrogated HIV-1 replication in macrophages when it was evaluated 7 days after virus inoculation. A similar inhibitory effect was observed in monocyte-derived dendritic cells. The analysis of the mechanisms responsible for the inhibition of HIV-1 production in macrophages revealed that CA efficiently sequesters HIV-1 particles avoiding its infectivity. Moreover, by acting on macrophages themselves, CA diminishes their permissibility to HIV-1 infection by reducing the expression of CD4, enhancing the production of the CCR5-interacting chemokines CCL3/MIP-1a, CCL4/MIP-1 beta, and CCL5/RANTES, and stimulating the production of interferon-a and the restriction factors APOBEC3G, APOBEC3F, and tetherin. Interestingly, abrogation of HIV-1 replication was overcome when the infection of macrophages was evaluated 2-3 weeks after virus inoculation. However, this reactivation of HIV-1 infection could be silenced by CA when added periodically to HIV-1-challenged macrophages. The induction of a silent HIV-1 infection in macrophages at the periphery, where cells are continuously confronted with CA, might help HIV-1 to evade the immune response and to promote resistance to antiretroviral therapy.	[Rodriguez Rodrigues, Christian; Remes Lenicov, Federico; Sabatte, Juan; Cabrini, Mercedes; Ceballos, Ana; Merlotti, Antonela; Gonzalez, Heidi; Ostrowski, Matas; Geffner, Jorge] Univ Buenos Aires, Fac Med, Inst Invest Med Retrovirus & SIDA INBIRS, Buenos Aires, Argentina; [Jancic, Carolina; Geffner, Jorge] Univ Buenos Aires, Hosp Clin Jose de San Martin, Inst Inmunol Genet & Metab INIGEM, Buenos Aires, Argentina	University of Buenos Aires; University of Buenos Aires	Geffner, J (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Med Retrovirus & SIDA INBIRS, Buenos Aires, Argentina.	larageffner@yahoo.com.ar		Rodriguez Rodrigues, Christian/0000-0001-8720-2083; Ostrowski, Matias/0000-0002-3982-1338	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires University School of Medicine; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Fogarty International Center/NIH grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program [D43 TW 001037]; FOGARTY INTERNATIONAL CENTER [D43TW001037] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Buenos Aires University School of Medicine(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Fogarty International Center/NIH grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Buenos Aires University School of Medicine, and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina). This research has been also funded by a Fogarty International Center/NIH grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program (Grant # D43 TW 001037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa KS, 2002, INT J HEMATOL, V76, P27, DOI 10.1007/BF02982715; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Bagnarelli P, 1996, J VIROL, V70, P7603, DOI 10.1128/JVI.70.11.7603-7613.1996; BECK Z, 2009, PLOS ONE, V4, DOI DOI 10.1371/J0URNAL.P0NE.0008297.PUBMED:20011536; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; CASSETTA L, 2013, AIDS, P12004; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; CROWE SM, 1994, J LEUKOCYTE BIOL, V56, P318, DOI 10.1002/jlb.56.3.318; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Devadas K, 2010, J LEUKOCYTE BIOL, V87, P915, DOI 10.1189/jlb.0307172; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Gruber A, 1998, J INFECT DIS, V177, P1057, DOI 10.1086/515231; Gruber A, 2003, FEMS IMMUNOL MED MIC, V37, P77, DOI 10.1016/S0928-8244(03)00110-X; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Heinsbroek SEM, 2005, TRENDS IMMUNOL, V26, P352, DOI 10.1016/j.it.2005.05.005; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; HOXIE JA, 1986, SCIENCE, V234, P1123, DOI 10.1126/science.3095925; Huang CFB, 2011, IMMUNOLOGY, V132, P401, DOI 10.1111/j.1365-2567.2010.03375.x; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Konopka K, 2002, AIDS RES HUM RETROV, V18, P123, DOI 10.1089/08892220252779665; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412; Mikulak J, 2009, VIROLOGY, V390, P37, DOI 10.1016/j.virol.2009.04.005; Naif HM, 1997, J IMMUNOL, V158, P501; POMERANTZ RJ, 1990, J EXP MED, V172, P253, DOI 10.1084/jem.172.1.253; Qin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027609; Ramos-e-Silva M, 2010, CLIN DERMATOL, V28, P217, DOI 10.1016/j.clindermatol.2009.12.008; Redel L, 2010, J LEUKOCYTE BIOL, V87, P575, DOI 10.1189/jlb.0409264; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; SHATTOCK RJ, 1994, J GEN VIROL, V75, P849, DOI 10.1099/0022-1317-75-4-849; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Swords WE, 2006, MICROB PATHOGENESIS, V40, P41, DOI 10.1016/j.micpath.2005.10.006; Vachot L, 2008, JAIDS-J ACQ IMM DEF, V48, P398, DOI 10.1097/QAI.0b013e3181776bc7; Wahl SM, 2000, J LEUKOCYTE BIOL, V68, P303; Walsh GM, 1998, J IMMUNOL METHODS, V217, P153, DOI 10.1016/S0022-1759(98)00103-3; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024193; Wang X, 2011, BIOCHEM BIOPH RES CO, V414, P20, DOI 10.1016/j.bbrc.2011.09.007; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248	48	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72814	10.1371/journal.pone.0072814	http://dx.doi.org/10.1371/journal.pone.0072814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009706	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200033
J	Lawrence, EJ; Mandato, CA				Lawrence, Elizabeth J.; Mandato, Craig A.			Mitochondria Localize to the Cleavage Furrow in Mammalian Cytokinesis	PLOS ONE			English	Article							MITOTIC SPINDLE; ENDOPLASMIC-RETICULUM; AXONAL-TRANSPORT; CELL-DIVISION; SACCHAROMYCES-CEREVISIAE; DYNAMIC MICROTUBULES; CONTRACTILE RING; DIVIDING CELLS; CITRON-KINASE; HEAVY-CHAIN	Mitochondria are dynamic organelles with multiple cellular functions, including ATP production, calcium buffering, and lipid biosynthesis. Several studies have shown that mitochondrial positioning is regulated by the cytoskeleton during cell division in several eukaryotic systems. However, the distribution of mitochondria during mammalian cytokinesis and whether the distribution is regulated by the cytoskeleton has not been examined. Using live spinning disk confocal microscopy and quantitative analysis of mitochondrial fluorescence intensity, we demonstrate that mitochondria are recruited to the cleavage furrow during cytokinesis in HeLa cells. After anaphase onset, the mitochondria are recruited towards the site of cleavage furrow formation, where they remain enriched as the furrow ingresses and until cytokinesis completion. Furthermore, we show that recruitment of mitochondria to the furrow occurs in multiple mammalian cells lines as well as in monopolar, bipolar, and multipolar divisions, suggesting that the mechanism of recruitment is conserved and robust. Using inhibitors of cytoskeleton dynamics, we show that the microtubule cytoskeleton, but not actin, is required to transport mitochondria to the cleavage furrow. Thus, mitochondria are specifically recruited to the cleavage furrow in a microtubule-dependent manner during mammalian cytokinesis. Two possible reasons for this could be to localize mitochondrial function to the furrow to facilitate cytokinesis and / or ensure accurate mitochondrial inheritance.	[Lawrence, Elizabeth J.; Mandato, Craig A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University	Mandato, CA (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.	craig.mandato@mcgill.ca		Lawrence, Elizabeth/0000-0001-9543-8678	NSERC [298314]; CIHR [mops 68970]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by NSERC (298314; http://www.nserc-crsng.gc.ca/) and CIHR (mops 68970; http://www.cihr-irsc.gc.ca/) grants awarded to CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Alsop GB, 2004, J CELL SCI, V117, P1591, DOI 10.1242/jcs.01007; AMINHANJANI S, 1991, CELL MOTIL CYTOSKEL, V20, P136, DOI 10.1002/cm.970200206; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; CHRISTIANSEN EG, 1949, NATURE, V163, P361, DOI 10.1038/163361a0; Contento RL, 2010, EMBO J, V29, P4035, DOI 10.1038/emboj.2010.258; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dunster K, 2002, EUR J CELL BIOL, V81, P117, DOI 10.1078/0171-9335-00232; Eda M, 2001, J CELL SCI, V114, P3273; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2001, CELL STRUCT FUNCT, V26, P659, DOI 10.1247/csf.26.659; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; FLUCK RA, 1991, J CELL BIOL, V115, P1259, DOI 10.1083/jcb.115.5.1259; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Gandhi R, 2004, MOL BIOL CELL, V15, P121, DOI 10.1091/mbc.E03-05-0342; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hehnly H, 2012, MOL BIOL CELL, V23, P7, DOI 10.1091/mbc.E11-06-0512; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Inoue YH, 2004, J CELL BIOL, V166, P49, DOI 10.1083/jcb.200402052; Kondo T, 2012, EXP CELL RES, V318, P915, DOI 10.1016/j.yexcr.2012.02.009; Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; MacAskill AF, 2010, EUR J NEUROSCI, V32, P231, DOI 10.1111/j.1460-9568.2010.07345.x; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Matsumura F, 2011, ARCH BIOCHEM BIOPHYS, V510, P76, DOI 10.1016/j.abb.2011.03.002; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MILLER AL, 1993, J CELL SCI, V106, P523; Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981; MORRIS RL, 1993, J CELL SCI, V104, P917; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Murphy MP, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003386; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Murthy K, 2008, J CELL SCI, V121, P2350, DOI 10.1242/jcs.027052; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Peraza-Reyes L, 2010, BIOESSAYS, V32, P1040, DOI 10.1002/bies.201000083; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; POVLISHOCK JT, 1976, BRAIN RES, V114, P379, DOI 10.1016/0006-8993(76)90961-6; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Shannon KB, 2005, MOL BIOL CELL, V16, P4423, DOI 10.1091/mbc.E04-11-0974; Sheahan MB, 2004, PLANT J, V37, P379, DOI 10.1046/j.1365-313X.2003.01967.x; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Staiber W, 2007, CELL TISSUE RES, V329, P197, DOI 10.1007/s00441-007-0400-z; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Sung JY, 2008, P NATL ACAD SCI USA, V105, P3112, DOI 10.1073/pnas.0712180105; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanaka K, 2011, J CELL SCI, V124, P2457, DOI 10.1242/jcs.086470; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; TOMBES RM, 1989, J CELL BIOL, V109, P627, DOI 10.1083/jcb.109.2.627; VANCE JE, 1990, J BIOL CHEM, V265, P7248; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Webb SE, 1997, DEV BIOL, V192, P78, DOI 10.1006/dbio.1997.8724; Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090; Wilson EB, 1916, P NATL ACAD SCI USA, V2, P321, DOI 10.1073/pnas.2.6.321; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100; Yamaoka S, 2011, PLANT CELL REP, V30, P239, DOI 10.1007/s00299-010-0926-5; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zanelli SA, 2006, J NEUROCHEM, V97, P724, DOI 10.1111/j.1471-4159.2006.03767.x; Zhai XY, 2003, J AM SOC NEPHROL, V14, P611, DOI 10.1097/01.ASN.0000051725.00406.0C	95	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72886	10.1371/journal.pone.0072886	http://dx.doi.org/10.1371/journal.pone.0072886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991162	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100123
J	Pawlus, MR; Wang, LY; Murakami, A; Dai, GH; Hu, CJ				Pawlus, Matthew R.; Wang, Liyi; Murakami, Aya; Dai, Guanhai; Hu, Cheng-Jun			STAT3 or USF2 Contributes to HIF Target Gene Specificity	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; TRANSCRIPTIONAL ACTIVITY; FACTOR (HIF)-1-ALPHA; UP-REGULATION; FACTOR-ALPHA; DNA-BINDING; HYPOXIA; HIF-2-ALPHA; HIF-1-ALPHA; FACTOR-2	The HIF1- and HIF2-mediated transcriptional responses play critical roles in solid tumor progression. Despite significant similarities, including their binding to promoters of both HIF1 and HIF2 target genes, HIF1 and HIF2 proteins activate unique subsets of target genes under hypoxia. The mechanism for HIF target gene specificity has remained unclear. Using siRNA or inhibitor, we previously reported that STAT3 or USF2 is specifically required for activation of endogenous HIF1 or HIF2 target genes. In this study, using reporter gene assays and chromatin immuno-precipitation, we find that STAT3 or USF2 exhibits specific binding to the promoters of HIF1 or HIF2 target genes respectively even when over-expressed. Functionally, HIF1 alpha interacts with STAT3 to activate HIF1 target gene promoters in a HIF1 alpha HLH/PAS and N-TAD dependent manner while HIF2 alpha interacts with USF2 to activate HIF2 target gene promoters in a HIF2 alpha N-TAD dependent manner. Physically, HIF1 alpha HLH and PAS domains are required for its interaction with STAT3 while both N- and C-TADs of HIF2 alpha are involved in physical interaction with USF2. Importantly, addition of functional USF2 binding sites into a HIF1 target gene promoter increases the basal activity of the promoter as well as its response to HIF2+ USF2 activation while replacing HIF binding site with HBS from a HIF2 target gene does not change the specificity of the reporter gene. Importantly, RNA Pol II on HIF1 or HIF2 target genes is primarily associated with HIF1 alpha or HIF2 alpha in a STAT3 or USF2 dependent manner. Thus, we demonstrate here for the first time that HIF target gene specificity is achieved by HIF transcription partners that are required for HIF target gene activation, exhibit specific binding to the promoters of HIF1 or HIF2 target genes and selectively interact with HIF1 alpha or HIF2 alpha protein.	[Pawlus, Matthew R.; Murakami, Aya; Hu, Cheng-Jun] Univ Colorado, Sch Dent Med, Mol Biol Grad Program, Aurora, CO 80045 USA; [Wang, Liyi; Hu, Cheng-Jun] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO USA; [Dai, Guanhai] Zhejiang Acad Tradit Chinese Med, Inst Basic Res, Hangzhou, Zhejiang, Peoples R China	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hu, CJ (corresponding author), Univ Colorado, Sch Dent Med, Mol Biol Grad Program, Anschutz Med Campus, Aurora, CO 80045 USA.	Cheng-jun.hu@ucdenver.edu		Hu, Cheng-Jun/0000-0003-0985-1285; Pawlus, Matthew/0000-0001-6007-7198	National Cancer Institute [RO1CA134687]; NATIONAL CANCER INSTITUTE [R01CA134687] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant from the National Cancer Institute (RO1CA134687, Hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfranca A, 2002, MOL CELL BIOL, V22, P12, DOI 10.1128/MCB.22.1.12-22.2002; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Dimova EY, 2006, J BIOL CHEM, V281, P2999, DOI 10.1074/jbc.M512078200; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Figueroa YG, 2002, EXP HEMATOL, V30, P1419, DOI 10.1016/S0301-472X(02)00934-7; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Hu JM, 2011, MOL CANCER RES, V9, P1520, DOI 10.1158/1541-7786.MCR-11-0090; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Levy DE, 2006, P NATL ACAD SCI USA, V103, P10151, DOI 10.1073/pnas.0604042103; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Maxwell P, 1998, Curr Opin Hematol, V5, P166, DOI 10.1097/00062752-199805000-00003; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Pawlus MR, 2012, MOL CELL BIOL, V32, P4595, DOI 10.1128/MCB.00724-12; Pawlus MR, 2013, ONCOGENE IN PRESS; Pawlus MR, 2013, ONCOGENE; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje	48	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72358	10.1371/journal.pone.0072358	http://dx.doi.org/10.1371/journal.pone.0072358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991099	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100101
J	Riffell, JA; Alarcon, R				Riffell, Jeffrey A.; Alarcon, Ruben			Multimodal Floral Signals and Moth Foraging Decisions	PLOS ONE			English	Article							HAWKMOTH MANDUCA-SEXTA; HONEYBEE APIS-MELLIFERA; COLOR PREFERENCES; BUMBLE-BEES; NOCTURNAL HAWKMOTH; INNATE PREFERENCES; DATURA-WRIGHTII; CHOICE BEHAVIOR; SENSORY CONTROL; OLFACTORY CUES	Background: Combinations of floral traits - which operate as attractive signals to pollinators - act on multiple sensory modalities. For Manduca sexta hawkmoths, how learning modifies foraging decisions in response to those traits remains untested, and the contribution of visual and olfactory floral displays on behavior remains unclear. Methodology/Principal Findings: Using M. sexta and the floral traits of two important nectar resources in southwestern USA, Datura wrightii and Agave palmeri, we examined the relative importance of olfactory and visual signals. Natural visual and olfactory cues from D. wrightii and A. palmeri flowers permits testing the cues at their native intensities and composition - a contrast to many studies that have used artificial stimuli (essential oils, single odorants) that are less ecologically relevant. Results from a series of two-choice assays where the olfactory and visual floral displays were manipulated showed that naive hawkmoths preferred flowers displaying both olfactory and visual cues. Furthermore, experiments using A. palmeri flowers - a species that is not very attractive to hawkmoths - showed that the visual and olfactory displays did not have synergistic effects. The combination of olfactory and visual display of D. wrightii, however - a flower that is highly attractive to naive hawkmoths - did influence the time moths spent feeding from the flowers. The importance of the olfactory and visual signals were further demonstrated in learning experiments in which experienced moths, when exposed to uncoupled floral displays, ultimately chose flowers based on the previously experienced olfactory, and not visual, signals. These moths, however, had significantly longer decision times than moths exposed to coupled floral displays. Conclusions/Significance: These results highlight the importance of specific sensory modalities for foraging hawkmoths while also suggesting that they learn the floral displays as combinatorial signals and use the integrated floral traits from their memory traces to mediate future foraging decisions.	[Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Alarcon, Ruben] Calif State Univ Channel Isl, Biol Program, Camarillo, CA USA	University of Washington; University of Washington Seattle; California State University System; California State University Channel Islands	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu			National Science Foundation [IOS 01-082270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant IOS 01-082270 (to JAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Balkenius A, 2008, ADAPT BEHAV, V16, P349, DOI 10.1177/1059712308092955; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Balkenius A, 2006, NATURWISSENSCHAFTEN, V93, P255, DOI 10.1007/s00114-006-0099-9; Balkenius A, 2010, J EXP BIOL, V213, P3741, DOI 10.1242/jeb.043760; Balkenius A, 2009, J EXP BIOL, V212, P535, DOI 10.1242/jeb.021220; Ben Zvi MM, 2008, PLANT BIOTECHNOL J, V6, P403, DOI 10.1111/j.1467-7652.2008.00329.x; Bronstein JL, 2009, ANN BOT-LONDON, V103, P1435, DOI 10.1093/aob/mcp053; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Cross FR, 2009, J EXP BIOL, V212, P1869, DOI 10.1242/jeb.028126; de Jager ML, 2012, FUNCT ECOL, V26, P1197, DOI 10.1111/j.1365-2435.2012.02028.x; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dukas R, 2008, ETHOLOGY, V114, P1195, DOI 10.1111/j.1439-0310.2008.01565.x; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Elle E, 2002, FUNCT ECOL, V16, P79, DOI 10.1046/j.0269-8463.2001.00599.x; Faegri K., 1979, PRINCIPLES POLLINATI; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; GIURFA M, 1994, J COMP PHYSIOL A, V175, P773, DOI 10.1007/BF00191849; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; Goyret J, 2011, BEHAV ECOL, V22, P976, DOI 10.1093/beheco/arr078; Goyret J, 2010, J EXP BIOL, V213, P3676, DOI 10.1242/jeb.045831; GRANT V, 1983, BOT GAZ, V144, P439, DOI 10.1086/337395; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; HARDER LD, 1987, ECOLOGY, V68, P1104, DOI 10.2307/1938384; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Kaczorowski RL, 2012, ANIM BEHAV, V83, P905, DOI 10.1016/j.anbehav.2012.01.007; Kelber A, 2010, BEHAV ECOL, V21, P1093, DOI 10.1093/beheco/arq115; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; Leonard Anne S., 2012, Systematics Association Special Volume Series, V81, P279; Leonard AS, 2011, CURR ZOOL, V57, P215, DOI 10.1093/czoolo/57.2.215; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Proctor M., 1996, NATURAL HIST POLLINA; Raguso RA, 2004, CURR OPIN PLANT BIOL, V7, P434, DOI 10.1016/j.pbi.2004.05.010; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Reinhard J, 2004, J EXP BIOL, V207, P4371, DOI 10.1242/jeb.01306; Reinhard J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009110; Riffell J. A., 2008, COMMUN INTEGR BIOL, V1, P1; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Roberts JA, 2007, BEHAV ECOL, V18, P236, DOI 10.1093/beheco/arl079; Roy BA, 1997, OECOLOGIA, V109, P414, DOI 10.1007/s004420050101; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Scott PE, 2004, SOUTHWEST NAT, V49, P425, DOI 10.1894/0038-4909(2004)049<0425:TOAPFA>2.0.CO;2; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Slauson LA, 2000, AM J BOT, V87, P825, DOI 10.2307/2656890; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Taylor RC, 2007, ANIM BEHAV, V74, P1753, DOI 10.1016/j.anbehav.2007.03.010; Vereecken NJ, 2008, P NATL ACAD SCI USA, V105, P7484, DOI 10.1073/pnas.0800194105; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357	63	17	17	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72809	10.1371/journal.pone.0072809	http://dx.doi.org/10.1371/journal.pone.0072809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991154	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100118
J	Park, JW; Shin, MK; Lambert, PF				Park, J. W.; Shin, M-K; Lambert, P. F.			High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins	ONCOGENE			English	Article						HPV16 E7; HPV-positive cancer; Fanconi anemia	HUMAN-PAPILLOMAVIRUS TYPE-16; FANCONI-ANEMIA PATHWAY; FANCD2 KNOCKOUT MICE; CERVICAL-CANCER; MOUSE MODEL; NECK-CANCER; CELL-CYCLE; S-PHASE; GENOMIC INSTABILITY; LIFE-CYCLE	Fanconi anemia (FA) is a rare genetic disorder caused by defects in a DNA damage repair system, the FA pathway. FA patients frequently develop squamous cell carcinoma (SCC) at sites that are associated with human papillomavirus (HPV)-driven cancer including the female reproductive tract. To assess experimentally whether FA deficiency increases susceptibility to HPV-associated cervical/vaginal cancer, we monitored cancer incidence in the female lower reproductive tract of FA-deficient mice expressing HPV16 oncogenes, E6 and/or E7. FA deficiency specifically increased the incidence of cancers in mice expressing E7; but this effect was not observed in mice just expressing E6. We also observed that E7, but not E6, induced DNA damage as scored by induction of g-H2AX and 53BP1 (p53 binding protein 1) nuclear foci, and this induction was heightened in FA-deficient tissue. Finally, we discovered that this induction of DNA damage responses was recapitulated in mice deficient in expression of `pocket' proteins, pRb, p107 and p130, which are established targets of E7. Our findings support the hypothesis that E7 induces cancer by causing DNA damage at least in part through the inactivation of pocket proteins. This hypothesis explains why a deficiency in DNA damage repair would increase susceptibility to E7-driven cancer.	[Park, J. W.; Shin, M-K; Lambert, P. F.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Dept Oncol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lambert, PF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	lambert@oncology.wisc.edu		Park, Jung Wook/0000-0003-4798-9621	NIH [CA098428, CA022443]; NATIONAL CANCER INSTITUTE [R01CA098428, P01CA022443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Norman Drinkwater for advice on statistical analysis of the data reported in this study and Markus Grompe for the fancD2-null mouse strain. This study was supported by grants from the NIH (CA098428 and CA022443).	Alter BP, 2003, BLOOD, V101, P2072, DOI 10.1182/blood-2002-11-3597; Balsitis SJ, 2003, MOL CELL BIOL, V23, P9094, DOI 10.1128/MCB.23.24.9094-9103.2003; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Brake T, 2003, CANCER RES, V63, P8173; Chung SH, 2008, CANCER RES, V68, P9928, DOI 10.1158/0008-5472.CAN-08-2051; Collins AS, 2005, J VIROL, V79, P14769, DOI 10.1128/JVI.79.23.14769-14780.2005; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; de Araujo MR, 2011, ORAL DIS, V17, P572, DOI 10.1111/j.1601-0825.2011.01803.x; Duensing S, 2002, CANCER RES, V62, P7075; Duensing S, 2002, ONCOGENE, V21, P6241, DOI 10.1038/sj.onc.1205709; Duensing S, 2001, J VIROL, V75, P7712, DOI 10.1128/JVI.75.16.7712-7716.2001; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Genther SM, 2003, J VIROL, V77, P2832, DOI 10.1128/JVI.77.5.2832-2842.2003; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hoskins EE, 2009, ONCOGENE, V28, P674, DOI 10.1038/onc.2008.416; Hoskins EE, 2012, J VIROL, V86, P8131, DOI 10.1128/JVI.00408-12; Houghtaling S, 2005, CANCER RES, V65, P85; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Juko-Pecirep I, 2011, GYNECOL ONCOL, V122, P377, DOI 10.1016/j.ygyno.2011.04.014; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; MAYOL X, 1993, ONCOGENE, V8, P2561; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Park JW, 2010, CANCER RES, V70, P9959, DOI 10.1158/0008-5472.CAN-10-1291; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Riley RR, 2003, CANCER RES, V63, P4862; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Shai A, 2008, CANCER RES, V68, P2622, DOI 10.1158/0008-5472.CAN-07-5266; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Shin MK, 2012, CANCER RES, V72, P5418, DOI 10.1158/0008-5472.CAN-12-2083; Shin MK, 2012, CANCER RES, V72, P1280, DOI 10.1158/0008-5472.CAN-11-2833; Shin MK, 2009, CANCER RES, V69, P5656, DOI 10.1158/0008-5472.CAN-08-3711; Simpson DS, 2009, CANCER RES, V69, P8733, DOI 10.1158/0008-5472.CAN-09-1359; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Spardy N, 2007, J VIROL, V81, P13265, DOI 10.1128/JVI.01121-07; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; Zhang QS, 2010, BLOOD, V116, P5140, DOI 10.1182/blood-2010-04-278226	59	22	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 26	2014	33	26					3383	3391		10.1038/onc.2013.327	http://dx.doi.org/10.1038/onc.2013.327			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AK9WM	24013229	Green Accepted			2022-12-25	WOS:000338779300005
J	Kitamura, H; Kimura, S; Shimamoto, Y; Okabe, J; Ito, M; Miyamoto, T; Naoe, Y; Kikuguchi, C; Meek, B; Toda, C; Okamoto, S; Kanehira, K; Hase, K; Watarai, H; Ishizuka, M; El-Osta, A; Ohara, O; Miyoshi, I				Kitamura, Hiroshi; Kimura, Shunsuke; Shimamoto, Yoshinori; Okabe, Jun; Ito, Masatoshi; Miyamoto, Tomomi; Naoe, Yoshinori; Kikuguchi, Chisato; Meek, Bob; Toda, Chitoku; Okamoto, Shiki; Kanehira, Katsushi; Hase, Koji; Watarai, Hiroshi; Ishizuka, Mayumi; El-Osta, Assam; Ohara, Osamu; Miyoshi, Ichiro			Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammation	FASEB JOURNAL			English	Article						diabetes; epigenetic control; aP2	N-TERMINAL SEQUENCES; DEUBIQUITINATING ENZYME; INSULIN-RESISTANCE; BACTERIAL LIPOPOLYSACCHARIDE; ATHEROSCLEROTIC PLAQUE; CELLULAR-LOCALIZATION; SIGNALING PATHWAYS; 3T3-L1 ADIPOCYTES; MMP-1 EXPRESSION; PROSTATE-CANCER	Macrophages play a critical role in chronic inflammation and metabolic diseases. We identified a longer splice variant of ubiquitin specific protease (USP) 2-69 as a novel molecule that modulates pathways implicated in metabolic disorders. Expression levels of aP2/FABP4 and PAI-1/SERPINE1 genes were increased by 4- and 1.8-fold, respectively, after short hairpin RNA-mediated knockdown (KD) of the USP2 gene, and such expression was alleviated by overexpression of USP2-69 in human myeloid cell lines. Supernatants derived from USP2-KD cells induced IL6 (similar to 6-fold) and SAA3 (similar to 15-fold) in 3T3-L1 adipocytes to suggest the anti-inflammatory properties of USP2. In addition, we observed a 30% decrease in the number of macrophages in mesenteric adipose tissue derived from USP2-69 transgenic mice fed a high-fat diet for 14 wk compared with that in their C57BL/6 littermates (P<0.01), which was consistent with a similar to 40% decrease in transcription of aP2 and PAI-1. The aP2 locus exhibited elevated chromatin accessibility (>2.1-fold), methylation of histone H3 lysine 4 (>4.5-fold), and acetylation of histone H4 (>2.5-fold) in USP2-KD cells. Transfection of isopeptidase-mutated USP2-69 did not alter chromatin conformation on the aP2 locus in USP2-KD cells. Our results suggest that USP2-69 suppresses meta-inflammatory molecules involved in the development of type-2 diabetes.	[Kitamura, Hiroshi; Miyamoto, Tomomi; Miyoshi, Ichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Nagoya, Aichi 4678601, Japan; [Kimura, Shunsuke; Naoe, Yoshinori] Hokkaido Univ, Grad Sch Med Sci, Dept Funct Morphol, Lab Histol & Cytol, Sapporo, Hokkaido, Japan; [Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Toxicol Lab, Sapporo, Hokkaido, Japan; [Shimamoto, Yoshinori] Kitasato Univ, Sch Vet Med, Dept Vet Teaching Hosp, Towada, Aomori, Japan; [Okabe, Jun; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic, Australia; [Okabe, Jun; El-Osta, Assam] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Ito, Masatoshi; Kikuguchi, Chisato; Ohara, Osamu] RIKEN Res Ctr Allergy & Immunol, Lab Immunogen, Yokohama, Kanagawa, Japan; [Watarai, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Immune Regulat, Yokohama, Kanagawa, Japan; Natl Inst Longev Sci, Natl Ctr Geriatr & Gerontol, Immunol Sect, Dept Mech Aging, Obu, Japan; [Meek, Bob] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands; [Toda, Chitoku; Okamoto, Shiki] Natl Inst Physiol Sci, Div Endocrinol & Metab, Okazaki, Aichi 444, Japan; [Kanehira, Katsushi] Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 305, Japan; [Hase, Koji; Watarai, Hiroshi] Japanese Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Hase, Koji] Univ Tokyo, Inst Med Sci, Div Mucosal Barriol, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan	Nagoya City University; Hokkaido University; Hokkaido University; Kitasato University; Baker Heart and Diabetes Institute; Monash University; RIKEN; RIKEN; National Center for Geriatrics & Gerontology; St. Antonius Hospital Utrecht; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Japan Science & Technology Agency (JST); University of Tokyo	Kitamura, H (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ktmr@med.nagoya-cu.ac.jp	Kimura, Shunsuke/D-7093-2012; Okamoto, Shiki/X-7274-2018; Meek, Bob/C-5042-2015; Ohara, Osamu/G-5448-2015	Kimura, Shunsuke/0000-0001-9408-2884; Okamoto, Shiki/0000-0002-2802-0527; Ohara, Osamu/0000-0002-3328-9571; El-Osta, Assam/0000-0003-2969-9137; El-Osta, Assam/0000-0001-7968-7375; Toda, Chitoku/0000-0002-1641-6217; Okabe, Jun/0000-0002-7196-0522	Japan Society for the Promotion of Science Kakenhi [21790334, 80312403]; Takeda Science Foundation; Ono Medical Research Foundation; Mochida Memorial Foundation; Suzuken Memorial Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Novartis Foundation; Nitto Foundation; AstraZeneca; Grants-in-Aid for Scientific Research [24117723] Funding Source: KAKEN	Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Medical Research Foundation; Mochida Memorial Foundation; Suzuken Memorial Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Novartis Foundation(Novartis); Nitto Foundation; AstraZeneca(AstraZeneca); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Atsuo Kobayashi, Tomoko Yuasa, Tomoko Hasegawa, Saori Hayashi, Ryosuke Yashi, Dr. Mai Yamagishi, and Dr. Fumihiko Ishikawa at RIKEN, Prof. Toshihiko Iwanaga at Hokkaido University, and Satoshi Tanaka at Nippon Becton Dickinson Company for technical assistance. This study was supported by the Japan Society for the Promotion of Science Kakenhi (21790334 and 80312403), Takeda Science Foundation, Ono Medical Research Foundation, Mochida Memorial Foundation, Suzuken Memorial Foundation, Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, Novartis Foundation, Nitto Foundation, and AstraZeneca.	Ashar HR, 2010, BBA-GENE REGUL MECH, V1799, P55, DOI 10.1016/j.bbagrm.2009.11.013; Bedard N, 2011, BIOL REPROD, V85, P594, DOI 10.1095/biolreprod.110.088542; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; De Taeye BM, 2006, J BIOL CHEM, V281, P32796, DOI 10.1074/jbc.M606214200; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Fasshauer M, 2004, J ENDOCRINOL, V181, P129, DOI 10.1677/joe.0.1810129; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gewies A, 2003, CANCER RES, V63, P682; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Jacobi D, 2012, ADIPOCYTE, V1, P4, DOI 10.4161/adip.19036; Kitamura H, 2004, FEBS LETT, V578, P180, DOI 10.1016/j.febslet.2004.11.008; Kitamura H, 2002, J HISTOCHEM CYTOCHEM, V50, P245, DOI 10.1177/002215540205000212; Kitamura H., 2013, ADIPOCYTE IN PRESS; Kitamura H, 2008, PHYSIOL GENOMICS, V33, P121, DOI 10.1152/physiolgenomics.00095.2007; Lin HJ, 2000, MOL CELL BIOL, V20, P6568, DOI 10.1128/MCB.20.17.6568-6578.2000; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Lin SK, 2004, ARTHRITIS RHEUM-US, V50, P785, DOI 10.1002/art.20058; Mansilla S, 2008, ARTERIOSCL THROM VAS, V28, P1844, DOI 10.1161/ATVBAHA.108.171389; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mastaitis JW, 2005, DIABETES, V54, P952, DOI 10.2337/diabetes.54.4.952; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Ng MCY, 2013, DIABETES, V62, P965, DOI 10.2337/db12-0266; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Nio-Kobayashi J, 2010, J HISTOCHEM CYTOCHEM, V58, P741, DOI 10.1369/jhc.2010.956227; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ress C, 2010, EUR CYTOKINE NETW, V21, P65, DOI 10.1684/ecn.2009.0177; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Samuvel DJ, 2011, ENDOCRINOLOGY, V152, P4662, DOI 10.1210/en.2011-1026; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Treeck O, 2008, BRIT J CANCER, V99, P1246, DOI 10.1038/sj.bjc.6604692; Villanueva CJ, 2010, IMMUNITY, V33, P647, DOI 10.1016/j.immuni.2010.11.017; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; Xu YZ, 2011, J BIOL CHEM, V286, P12839, DOI 10.1074/jbc.M110.185637	50	21	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4940	4953		10.1096/fj.13-233528	http://dx.doi.org/10.1096/fj.13-233528			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24005904				2022-12-25	WOS:000329999000028
J	Rengachari, S; Aschauer, P; Schittmayer, M; Mayer, N; Gruber, K; Breinbauer, R; Birner-Gruenberger, R; Dreveny, I; Oberer, M				Rengachari, Srinivasan; Aschauer, Philipp; Schittmayer, Matthias; Mayer, Nicole; Gruber, Karl; Breinbauer, Rolf; Birner-Gruenberger, Ruth; Dreveny, Ingrid; Oberer, Monika			Conformational Plasticity and Ligand Binding of Bacterial Monoacylglycerol Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOGLYCERIDE LIPASE; MACROMOLECULAR STRUCTURES; DIACYLGLYCEROL LIPASE; MALASSEZIA-GLOBOSA; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PURIFICATION; MODEL; 2-ARACHIDONOYLGLYCEROL; PHOSPHONATE	Monoacylglycerol lipases (MGLs) play an important role in lipid catabolism across all kingdoms of life by catalyzing the release of free fatty acids from monoacylglycerols. The three-dimensional structures of human and a bacterial MGL were determined only recently as the first members of this lipase family. In addition to the alpha/beta-hydrolase core, they showed unexpected structural similarities even in the cap region. Nevertheless, the structural basis for substrate binding and conformational changes of MGLs is poorly understood. Here, we present a comprehensive study of five crystal structures of MGL from Bacillus sp. H257 in its free form and in complex with different substrate analogs and the natural substrate 1-lauroylglycerol. The occurrence of different conformations reveals a high degree of conformational plasticity of the cap region. We identify a specific residue, Ile-145, that might act as a gatekeeper restricting access to the binding site. Site-directed mutagenesis of Ile-145 leads to significantly reduced hydrolase activity. Bacterial MGLs in complex with 1-lauroylglycerol, myristoyl, palmitoyl, and stearoyl substrate analogs enable identification of the binding sites for the alkyl chain and the glycerol moiety of the natural ligand. They also provide snapshots of the hydrolytic reaction of a bacterial MGL at different stages. The alkyl chains are buried in a hydrophobic tunnel in an extended conformation. Binding of the glycerol moiety is mediated via Glu-156 and water molecules. Analysis of the structural features responsible for cap plasticity and the binding modes of the ligands suggests conservation of these features also in human MGL.	[Rengachari, Srinivasan; Aschauer, Philipp; Gruber, Karl; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Schittmayer, Matthias; Birner-Gruenberger, Ruth] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Schittmayer, Matthias; Birner-Gruenberger, Ruth] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Mayer, Nicole; Breinbauer, Rolf] Graz Univ Technol, Inst Organ Chem, A-8010 Graz, Austria; [Dreveny, Ingrid] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England	University of Graz; Medical University of Graz; Medical University of Graz; Graz University of Technology; University of Nottingham	Dreveny, I (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England.	ingrid.dreveny@nottingham.ac.uk; m.oberer@uni-graz.at	Birner-Gruenberger, Ruth/E-8623-2010; Schittmayer, Matthias/AAW-1020-2021; Gruber, Karl/GPP-6706-2022; Dreveny, Ingrid/E-8939-2017; Breinbauer, Rolf/AAK-1750-2020; Birner-Gruenberger, Ruth/X-9433-2019	Birner-Gruenberger, Ruth/0000-0003-3950-0312; Schittmayer, Matthias/0000-0003-3249-655X; Gruber, Karl/0000-0002-3485-9740; Dreveny, Ingrid/0000-0003-2256-642X; Breinbauer, Rolf/0000-0001-6009-7359; Birner-Gruenberger, Ruth/0000-0003-3950-0312; Rengachari, Srinivasan/0000-0003-4237-8258; Oberer, Monika/0000-0003-2525-9513	Doctoral School "DK Molecular Enzymology" Grant [W901-B12]; Austrian Science Fund;  [FWF P24857]; Austrian Science Fund (FWF) [W 901, P 24857] Funding Source: researchfish	Doctoral School "DK Molecular Enzymology" Grant; Austrian Science Fund(Austrian Science Fund (FWF)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Doctoral School "DK Molecular Enzymology" Grant W901-B12 and by Project FWF P24857 funded by the Austrian Science Fund.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colton IJ, 2011, ADV SYNTH CATAL, V353, P2529, DOI 10.1002/adsc.201100459; CONLEY AJ, 1973, ANTIMICROB AGENTS CH, V4, P501, DOI 10.1128/AAC.4.5.501; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; DeLano WL, 2010, PYMOL MOL GRAPH SYST; DEREWENDA U, 1992, BIOCHEMISTRY-US, V31, P1532, DOI 10.1021/bi00120a034; Dhouib R, 2010, J BACTERIOL, V192, P4776, DOI 10.1128/JB.00261-10; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; EGLOFF MP, 1995, BIOCHEMISTRY-US, V34, P2751, DOI 10.1021/bi00009a003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Imamura S, 2000, J BIOCHEM-TOKYO, V127, P419, DOI 10.1093/oxfordjournals.jbchem.a022623; Kabara J.J., 1978, PHARM EFFECT LIPIDS, P25; KABARA JJ, 1977, LIPIDS, V12, P753, DOI 10.1007/BF02570908; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlsson M, 2000, PROTEIN EXPRES PURIF, V18, P286, DOI 10.1006/prep.1999.1194; Kitaura S, 2001, J BIOCHEM-TOKYO, V129, P397, DOI 10.1093/oxfordjournals.jbchem.a002870; Labar G, 2010, CURR MED CHEM, V17, P2588, DOI 10.2174/092986710791859414; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liu L, 2012, BIOCHEM BIOPH RES CO, V424, P285, DOI 10.1016/j.bbrc.2012.06.108; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; MANNESSE MLM, 1995, BBA-LIPID LIPID MET, V1259, P56, DOI 10.1016/0005-2760(95)00145-3; MARGUET F, 1994, BBA-LIPID LIPID MET, V1210, P157, DOI 10.1016/0005-2760(94)90116-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POPE JL, 1962, FED PROC, V21, P259; Rengachari S, 2012, BBA-MOL CELL BIOL L, V1821, P1012, DOI 10.1016/j.bbalip.2012.04.006; Sakiyama T, 2001, J BIOSCI BIOENG, V91, P88, DOI 10.1263/jbb.91.88; Schalk-Hihi C, 2011, PROTEIN SCI, V20, P670, DOI 10.1002/pro.596; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Susani-Etzerodt H, 2006, CHEM PHYS LIPIDS, V144, P60, DOI 10.1016/j.chemphyslip.2006.06.018; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; WHITTLE PJ, 1994, ANNU REV BIOPH BIOM, V23, P349, DOI 10.1146/annurev.bb.23.060194.002025; Xu TT, 2012, J STRUCT BIOL, V178, P363, DOI 10.1016/j.jsb.2012.03.006	46	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31093	31104		10.1074/jbc.M113.491415	http://dx.doi.org/10.1074/jbc.M113.491415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014019	Green Published, hybrid			2022-12-25	WOS:000330778900028
J	Kaymak, E; Ryder, SP				Kaymak, Ebru; Ryder, Sean P.			RNA Recognition by the Caenorhabditis elegans Oocyte Maturation Determinant OMA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; RNA; RNA-binding Protein; RNA-binding Proteins; RNA-Protein Interaction; Caenorhabditis elegans; OMA-1; RNA-binding Protein; glp-1; Post-transcriptional Regulation	ZINC-FINGER PROTEINS; CELL FATE DETERMINANT; MESSENGER-RNA; TRANSLATIONAL REPRESSION; TARGET SPECIFICITY; MEIOTIC MATURATION; MATERNAL PROTEINS; BINDING PROTEINS; GENE-EXPRESSION; GERM-LINE	Maternally supplied mRNAs encode proteins that pattern early embryos in many species. In the nematode Caenorhabditis elegans, a suite of RNA-binding proteins regulates expression of maternal mRNAs during oogenesis, the oocyte to embryo transition, and early embryogenesis. To understand how these RNA-binding proteins contribute to development, it is necessary to determine how they select specific mRNA targets for regulation. OMA-1 and OMA-2 are redundant proteins required for oocyte maturationan essential part of meiosis that prepares oocytes for fertilization. Both proteins have CCCH type tandem zinc finger RNA-binding domains. Here, we define the RNA binding specificity of OMA-1 and demonstrate that OMA-1/2 are required to repress the expression of a glp-1 3-UTR reporter in developing oocytes. OMA-1 binds with high affinity to a conserved region of the glp-1 3-UTR previously shown to interact with POS-1 and GLD-1, RNA-binding proteins required for glp-1 reporter repression in the posterior of fertilized embryos. Our results reveal that OMA-1 is a sequence-specific RNA-binding protein required to repress expression of maternal transcripts during oogenesis and suggest that interplay between OMA-1 and other factors for overlapping binding sites helps to coordinate the transition from oocyte to embryo.	[Kaymak, Ebru; Ryder, Sean P.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ryder, SP (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Sean.Ryder@umassmed.edu			National Institutes of Health [GM081422, GM098643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081422, R01GM098643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081422 and GM098643 (to S. P. R.).	Berry LW, 1997, DEVELOPMENT, V124, P925; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, MOL B INT U, P80; BRENNER S, 1974, GENETICS, V77, P71; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; EVANS TC, 1994, CELL, V77, P183, DOI 10.1016/0092-8674(94)90311-5; Farley BM, 2008, CRIT REV BIOCHEM MOL, V43, P135, DOI [10.1080/10409230801921338, 10.1080/10409230801921338 ]; Farley BM, 2012, MOL BIOL CELL, V23, P4473, DOI 10.1091/mbc.E12-03-0216; Farley BM, 2008, RNA, V14, P2685, DOI 10.1261/rna.1256708; Greenstein David, 2005, WormBook, P1, DOI 10.1895/wormbook.1.53.1; Guedes S, 1997, DEVELOPMENT, V124, P731; Guven-Ozkan T, 2010, DEVELOPMENT, V137, P3373, DOI 10.1242/dev.055327; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaymak E, 2010, CURR OPIN STRUC BIOL, V20, P305, DOI 10.1016/j.sbi.2010.03.010; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee Min-Ho, 2006, WormBook, P1; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Lublin AL, 2007, DEV BIOL, V303, P635, DOI 10.1016/j.ydbio.2006.12.004; Marin VA, 2003, DEVELOPMENT, V130, P2623, DOI 10.1242/dev.00486; Masui Y, 1979, Int Rev Cytol, V57, P185, DOI 10.1016/S0074-7696(08)61464-3; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Pagano JM, 2009, P NATL ACAD SCI USA, V106, P20252, DOI 10.1073/pnas.0907916106; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Shimada M, 2002, GENES CELLS, V7, P933, DOI 10.1046/j.1365-2443.2002.00570.x; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; Standart Nancy, 1992, Seminars in Developmental Biology, V3, P367; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Tabara H, 1999, DEVELOPMENT, V126, P1; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334; Yamamoto I, 2006, DEV DYNAM, V235, P571, DOI 10.1002/dvdy.20662	52	17	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30463	30472		10.1074/jbc.M113.496547	http://dx.doi.org/10.1074/jbc.M113.496547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014033	hybrid, Green Published			2022-12-25	WOS:000329868100042
J	Kumar, R; Moure, CM; Khan, SH; Callaway, C; Grimm, SL; Goswami, D; Griffin, PR; Edwards, DP				Kumar, Raj; Moure, Carmen M.; Khan, Shagufta H.; Callaway, Celetta; Grimm, Sandra L.; Goswami, Devrishi; Griffin, Patrick R.; Edwards, Dean P.			Regulation of the Structurally Dynamic N-terminal Domain of Progesterone Receptor by Protein-induced Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intrinsically Disordered Proteins; Mass Spectrometry (MS); Progesterone; Protein Folding; Steroid Hormone Receptor; TATA-binding Protein; N-terminal Transcription Activation domain AF1; Hydrogen Deuterium Exchange Mass; Progesterone Receptor	NUCLEAR HORMONE-RECEPTORS; GLUCOCORTICOID-RECEPTOR; INTRINSIC DISORDER; COREPRESSOR BINDING; ANDROGEN RECEPTOR; LIGAND-BINDING; IN-VITRO; COACTIVATOR; TRANSCRIPTION; ACTIVATION	The N-terminal domain (NTD) of steroid receptors harbors a transcriptional activation function (AF1) that is composed of an intrinsically disordered polypeptide. We examined the interaction of the TATA-binding protein (TBP) with the NTD of the progesterone receptor (PR) and its ability to regulate AF1 activity through coupled folding and binding. As assessed by solution phase biophysical methods, the isolated NTD of PR contains a large content of random coil, and it is capable of adopting secondary -helical structure and more stable tertiary folding either in the presence of the natural osmolyte trimethylamine-N-oxide or through a direct interaction with TBP. Hydrogen-deuterium exchange coupled with mass spectrometry confirmed the highly dynamic intrinsically disordered property of the NTD within the context of full-length PR. Deletion mapping and point mutagenesis defined a region of the NTD (amino acids 350-428) required for structural folding in response to TBP interaction. Overexpression of TBP in cells enhanced transcriptional activity mediated by the PR NTD, and deletion mutations showed that a region (amino acids 327-428), similar to that required for TBP-induced folding, was required for functional response. TBP also increased steroid receptor co-activator 1 (SRC-1) interaction with the PR NTD and cooperated with SRC-1 to stimulate NTD-dependent transcriptional activity. These data suggest that TBP can mediate structural reorganization of the NTD to facilitate the binding of co-activators required for maximal transcriptional activation.	[Moure, Carmen M.; Callaway, Celetta; Grimm, Sandra L.; Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Kumar, Raj; Khan, Shagufta H.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA	Baylor College of Medicine; Baylor College of Medicine; Scripps Research Institute; Geisinger Commonwealth School of Medicine	Edwards, DP (corresponding author), Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA.	deane@bcm.edu	Goswami, Devrishi/A-8891-2014		National Institutes of Health from USPHS [RO1CA046938];  [GM084041];  [P30 NCI-CA125123]; NATIONAL CANCER INSTITUTE [R01CA046938, P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA046938 from USPHS (to D. P. E.), GM084041 to NIGMS (to P. R. G.), and Grant P30 NCI-CA125123 (to Monoclonal Antibody/Baculovirus Shared Resource of the Dan L. Duncan Cancer Center, and Kurt Christensen, Director of the Shared Resource).	Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Bain DL, 2001, J BIOL CHEM, V276, P23825, DOI 10.1074/jbc.M102611200; Billas I, 2013, J MOL BIOL, V425, P2317, DOI 10.1016/j.jmb.2013.03.017; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Busby SA, 2007, INT J MASS SPECTROM, V259, P130, DOI 10.1016/j.ijms.2006.08.006; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Clemm DL, 2000, MOL ENDOCRINOL, V14, P52, DOI 10.1210/me.14.1.52; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fischer K, 2010, MOL ENDOCRINOL, V24, P1935, DOI 10.1210/me.2010-0005; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Garza AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025875; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Goswami D., 2013, J AM SOC MASS SPECTR, V110, P11475; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Hovland AR, 1998, J BIOL CHEM, V273, P5455, DOI 10.1074/jbc.273.10.5455; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Khan S. H., 2011, PLOS ONE, V6; Khan SH, 2012, J BIOL CHEM, V287, P44546, DOI 10.1074/jbc.M112.411330; Krasowski MD, 2008, J PROTEOME RES, V7, P4359, DOI 10.1021/pr8003024; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Kumar R, 2012, MOL CELL ENDOCRINOL, V348, P450, DOI 10.1016/j.mce.2011.03.024; Kumar R, 2012, ENDOCR REV, V33, P271, DOI 10.1210/er.2011-1033; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; McEwan IJ, 2012, MOL CELL ENDOCRINOL, V348, P345, DOI 10.1016/j.mce.2011.08.035; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Press M, 2002, STEROIDS, V67, P799, DOI 10.1016/S0039-128X(02)00039-9; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Takimoto GS, 2003, J STEROID BIOCHEM, V85, P209, DOI 10.1016/S0960-0760(03)00197-3; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; Wang DQ, 2007, BIOCHEMISTRY-US, V46, P8036, DOI 10.1021/bi7004575; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2005, SEMIN REPROD MED, V23, P9, DOI 10.1055/s-2005-864030; Wardell SE, 2010, MOL ENDOCRINOL, V24, P335, DOI 10.1210/me.2008-0081; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; WEIGEL NL, 1992, MOL ENDOCRINOL, V6, P1585, DOI 10.1210/me.6.10.1585; West GM, 2013, STRUCTURE, V21, P229, DOI 10.1016/j.str.2012.12.001; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046	66	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30285	30299		10.1074/jbc.M113.491787	http://dx.doi.org/10.1074/jbc.M113.491787			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23995840	Green Published, hybrid			2022-12-25	WOS:000329868100026
J	Shen, CX; Jo, SY; Liao, CZ; Hess, JL; Nikolovska-Coleska, Z				Shen, Chenxi; Jo, Stephanie Y.; Liao, Chenzhong; Hess, Jay L.; Nikolovska-Coleska, Zaneta			Targeting Recruitment of Disruptor of Telomeric Silencing 1-like (DOT1L) CHARACTERIZING THE INTERACTIONS BETWEEN DOT1L AND MIXED LINEAGE LEUKEMIA (MLL) FUSION PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fusion Protein; Histone Methylation; Peptides; Protein-Protein Interactions; Surface Plasmon Resonance (SPR); AF9; DOT1L; ENL; Mixed Lineage Leukemia	TRANSCRIPTIONAL ELONGATION; H3K79 METHYLATION; LEUKEMIA; GENE; ENL; METHYLTRANSFERASE; REPRESSION; PARTNERS; REQUIRES; COMPLEX	The MLL fusion proteins, AF9 and ENL, activate target genes in part via recruitment of the histone methyltransferase DOT1L (disruptor of telomeric silencing 1-like). Here we report biochemical, biophysical, and functional characterization of the interaction between DOT1L and MLL fusion proteins, AF9/ENL. The AF9/ENL-binding site in human DOT1L was mapped, and the interaction site was identified to a 10-amino acid region (DOT1L(865-874)). This region is highly conserved in DOT1L from a variety of species. Alanine scanning mutagenesis analysis shows that four conserved hydrophobic residues from the identified binding motif are essential for the interactions with AF9/ENL. Binding studies demonstrate that the entire intact C-terminal domain of AF9/ENL is required for optimal interaction with DOT1L. Functional studies show that the mapped AF9/ENL interacting site is essential for immortalization by MLL-AF9, indicating that DOT1L interaction with MLL-AF9 and its recruitment are required for transformation by MLL-AF9. These results strongly suggest that disruption of interaction between DOT1L and AF9/ENL is a promising therapeutic strategy with potentially fewer adverse effects than enzymatic inhibition of DOT1L for MLL fusion protein-associated leukemia.	[Shen, Chenxi; Jo, Stephanie Y.; Hess, Jay L.; Nikolovska-Coleska, Zaneta] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Shen, Chenxi; Hess, Jay L.; Nikolovska-Coleska, Zaneta] Univ Michigan, Sch Med, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Liao, Chenzhong] Hefei Univ Technol, Sch Med Engn, Hefei 230009, Anhui, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hefei University of Technology	Nikolovska-Coleska, Z (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	zanetan@med.umich.edu		Liao, Chenzhong/0000-0001-7080-1768; Shen, Chenxi/0000-0002-0045-8850	National Institutes of Health; Ruth Kirschstein Award; Cancer Research Committee Fund of the University of Michigan Comprehensive Cancer Center; Lymphoma and Leukemia Society; NATIONAL CANCER INSTITUTE [R01CA151425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Committee Fund of the University of Michigan Comprehensive Cancer Center; Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant (to J. L. H.) and the Ruth Kirschstein Award (to S. Y. J.). This work was also supported by funds from the Cancer Research Committee Fund of the University of Michigan Comprehensive Cancer Center (to Z. N. C.) and the Lymphoma and Leukemia Society (to J. L. H.).	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bernt KM, 2011, EPIGENOMICS-UK, V3, P667, DOI [10.2217/EPI.11.98, 10.2217/epi.11.98]; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; Huret JL, 2001, LEUKEMIA, V15, P987, DOI 10.1038/sj.leu.2402135; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; Slany RK, 1998, MOL CELL BIOL, V18, P122, DOI 10.1128/MCB.18.1.122; Srinivasan RS, 2004, LEUKEMIA, V18, P1364, DOI 10.1038/sj.leu.2403415; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	34	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30585	30596		10.1074/jbc.M113.457135	http://dx.doi.org/10.1074/jbc.M113.457135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23996074	Green Published, hybrid			2022-12-25	WOS:000329868100059
J	Abaeva, AA; Canault, M; Kotova, YN; Obydennyy, SI; Yakimenko, AO; Podoplelova, NA; Kolyadko, VN; Chambost, H; Mazurov, AV; Ataullakhanov, FI; Nurden, AT; Alessi, MC; Panteleev, MA				Abaeva, Anastasia A.; Canault, Matthias; Kotova, Yana N.; Obydennyy, Sergey I.; Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Kolyadko, Vladimir N.; Chambost, Herve; Mazurov, Aleksei V.; Ataullakhanov, Fazoil I.; Nurden, Alan T.; Alessi, Marie-Christine; Panteleev, Mikhail A.			Procoagulant Platelets Form an alpha-Granule Protein-covered "Cap" on Their Surface That Promotes Their Attachment to Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; INTEGRIN ALPHA(IIB)BETA(3); THROMBUS FORMATION; GLANZMANN THROMBASTHENIA; STIMULATED PLATELETS; ADHERENT PLATELETS; COATED-PLATELETS; FACTOR-XIIIA; FIBRINOGEN; SUBPOPULATIONS	Strongly activated "coated" platelets are characterized by increased phosphatidylserine (PS) surface expression, alpha-granule protein retention, and lack of active integrin alpha(IIb)beta(3). To study how they are incorporated into thrombi despite a lack of free activated integrin, we investigated the structure, function, and formation of the alpha-granule protein "coat." Confocal microscopy revealed that fibrin(ogen) and thrombospondin colocalized as "cap," a single patch on the PS-positive platelet surface. In aggregates, the cap was located at the point of attachment of the PS-positive platelets. Without fibrin(ogen) retention, their ability to be incorporated in aggregates was drastically reduced. The surface fibrin(ogen) was strongly decreased in the presence of a fibrin polymerization inhibitor GPRP and also in platelets from a patient with dysfibrinogenemia and a fibrinogen polymerization defect. In contrast, a fibrinogen-clotting protease ancistron increased the amount of fibrin(ogen) and thrombospondin on the surface of the PS-positive platelets stimulated with collagen-related peptide. Transglutaminases are also involved in fibrin( ogen) retention. However, platelets from patients with factor XIII deficiency had normal retention, and a pan-transglutaminase inhibitor T101 had only a modest inhibitory effect. Fibrin( ogen) retention was normal in Bernard-Soulier syndrome and kindlin-3 deficiency, but not in Glanzmann thrombasthenia lacking the platelet pool of fibrinogen and alpha(IIb)beta(3). These data show that the fibrin(ogen)-covered cap, predominantly formed as a result of fibrin polymerization, is a critical mechanism that allows coated (or rather "capped") platelets to become incorporated into thrombi despite their lack of active integrins.	[Abaeva, Anastasia A.; Kotova, Yana N.; Obydennyy, Sergey I.; Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Kolyadko, Vladimir N.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Ctr Theoret Problems Physicochem Pharmacol, Moscow 119991, Russia; [Canault, Matthias; Chambost, Herve; Alessi, Marie-Christine] Univ Aix Marseille 2, F-13284 Marseille 07, France; [Canault, Matthias; Alessi, Marie-Christine] Hop Enfants La Timone, INSERM, UMR 1062, INRA 1260, F-13385 Marseille 05, France; [Kotova, Yana N.; Obydennyy, Sergey I.; Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow 117198, Russia; [Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] HemaCore LLC, Moscow 125319, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Natl Res Ctr Hematol, Moscow 125167, Russia; [Mazurov, Aleksei V.] Russian Cardiol Res & Prod Complex, Moscow 121552, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow MV Lomonosov State Univ, Fac Phys, Moscow 119899, Russia; [Nurden, Alan T.] Hop Xavier Arnozan, F-33604 Pessac, France	Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; National Medical Research Center of Cardiology; Lomonosov Moscow State University; CHU Bordeaux	Alessi, MC (corresponding author), Hop Enfants La Timone, INSERM, UMR 1062, 27 Bd Jean Moulin, F-13385 Marseille 05, France.	marie-christine.alessi@univ-amu.fr; mapanteleev@yandex.ru	Podoplelova, Nadezhda/AAT-3654-2020; Podoplelova, Nadezhda/A-7482-2014; Ataullakhanov, Fazoil/J-8076-2012; Alexey, Mazurov/AAB-4104-2020; Ataullakhanov, Fazoil/O-3458-2019; Panteleev, Mikhail A/H-5491-2012; Obydennyy, Sergey I/B-1051-2014; Kotova, Yana/A-7935-2014; Canault, Matthias/H-5128-2013; ALESSI, Marie-christine/AAK-3582-2020	Podoplelova, Nadezhda/0000-0001-8013-1112; Podoplelova, Nadezhda/0000-0001-8013-1112; Panteleev, Mikhail A/0000-0002-8128-7757; Obydennyy, Sergey I/0000-0002-2930-8768; Kotova, Yana/0000-0003-4769-8162; Canault, Matthias/0000-0002-7880-5250; ALESSI, Marie-christine/0000-0003-3927-5792; CHAMBOST, HERVE/0000-0002-5319-1969; Kolyadko, Vladimir/0000-0003-4008-2461	Russian Foundation for Basic Research [11-04-00303, 12-04-00438, 12-04-31401, 12-04-31788, 12-04-32246, 12-04-31873, 12-04-33055, 13-04-00401]; Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Russian Academy of Sciences Presidium Basic Research Program "Basic Science for Medicine"; Russian Academy of Sciences Presidium Basic Research Program "Molecular Mechanisms of Physiologic Functions"; Russian Federation [SP-2274.2012.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Russian Academy of Sciences Presidium Basic Research Program "Basic Science for Medicine"; Russian Academy of Sciences Presidium Basic Research Program "Molecular Mechanisms of Physiologic Functions"; Russian Federation(Russian Federation)	This work was supported by Russian Foundation for Basic Research Grants 11-04-00303, 12-04-00438, 12-04-31401, 12-04-31788, 12-04-32246, 12-04-31873, 12-04-33055, and 13-04-00401; by the Russian Academy of Sciences Presidium Basic Research Programs "Molecular and Cellular Biology," "Basic Science for Medicine," and "Molecular Mechanisms of Physiologic Functions"; and by Russian Federation President Fellowship for Young Scientists SP-2274.2012.4.	Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; BALE MD, 1985, J BIOL CHEM, V260, P7502; BALE MD, 1986, J BIOL CHEM, V261, P862; Berny MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010415; Briede JJ, 1999, BBA-MOL CELL RES, V1451, P163, DOI 10.1016/S0167-4889(99)00085-3; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; DISDIER M, 1989, THROMB RES, V53, P521, DOI 10.1016/0049-3848(89)90142-4; Fager AM, 2010, ARTERIOSCL THROM VAS, V30, P2400, DOI 10.1161/ATVBAHA.110.216531; HANDAGAMA P, 1993, BLOOD, V82, P135, DOI 10.1182/blood.V82.1.135.bloodjournal821135; HANTGAN RR, 1990, BLOOD, V76, P345; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; HOURDILLE P, 1985, BLOOD, V65, P912; Jackson SP, 2010, BLOOD, V116, P2011, DOI 10.1182/blood-2010-01-261669; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Kempton CL, 2005, ARTERIOSCL THROM VAS, V25, P861, DOI 10.1161/01.ATV.0000155987.26583.9b; Kotova YN, 2008, J THROMB HAEMOST, V6, P1603, DOI 10.1111/j.1538-7836.2008.03052.x; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Mattheij NJA, 2013, J BIOL CHEM, V288, P13325, DOI 10.1074/jbc.M112.428359; Mazurov AV, 2002, PLATELETS, V13, P465, DOI 10.1080/0953710021000057839; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; PEERSCHKE EIB, 1995, AM J PATHOL, V147, P678; Robert P, 2011, J IMMUNOL, V186, P5273, DOI 10.4049/jimmunol.1003141; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Topalov NN, 2012, BRIT J HAEMATOL, V157, P105, DOI 10.1111/j.1365-2141.2011.09021.x; Topalov NN, 2012, ARTERIOSCL THROM VAS, V32, P2475, DOI 10.1161/ATVBAHA.112.253765; Yakimenko AO, 2012, BIOPHYS J, V102, P2261, DOI 10.1016/j.bpj.2012.04.004; Yamauchi Y, 2002, MATRIX BIOL, V21, P441, DOI 10.1016/S0945-053X(02)00036-7	34	59	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29621	29632		10.1074/jbc.M113.474163	http://dx.doi.org/10.1074/jbc.M113.474163			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995838	Green Published, hybrid			2022-12-25	WOS:000330615300038
J	Bao, FJ; Chen, H; Yu, Y; Yu, JG; Zhou, S; Wang, J; Wang, QM; Elsheikh, A				Bao, Fangjun; Chen, Hao; Yu, Ye; Yu, Jiguo; Zhou, Shi; Wang, Jing; Wang, QinMei; Elsheikh, Ahmed			Evaluation of the Shape Symmetry of Bilateral Normal Corneas in a Chinese Population	PLOS ONE			English	Article							ZERNIKE POLYNOMIALS; MEASUREMENT ERROR; TOPOGRAPHY; ASTIGMATISM; KERATOCONUS; PACHYMETRY; THICKNESS; EYES	Purpose: To investigate the bilateral symmetry of the global corneal topography in normal corneas with a wide range of curvature, astigmatism and thickness values Design: Cross-Sectional Study Methods: Topography images were recorded for the anterior and posterior surfaces of 342 participants using a Pentacam. Elevation data were fitted to a general quadratic model that considered both translational and rotational displacements. Comparisons between fellow corneas of estimates of corneal shape parameters (elevation, radius in two main directions, R-x and R-y, and corresponding shape factors, Q(x) and Q(y)) and corneal position parameters (translational displacements: x(0), y(0) and z(0), and rotational displacements: alpha, beta and gamma) were statistically analyzed. Results: The general quadratic model provided average RMS of fit errors with the topography data of 1.7 +/- 0.6 mu m and 5.7 +/- 1.3 mm in anterior and posterior corneal surfaces. The comparisons showed highly significant bilateral correlations with the differences between fellow corneas in R-x, R-y, Q(x) and Q(y) of anterior and posterior surfaces remaining insignificantly different from zero. Bilateral differences in elevation measurements at randomly-selected points in both corneal central and peripheral areas indicated strong mirror symmetry between fellow corneas. The mean geometric center (x(0), y(0), z(0)) of both right and left corneas was located on the temporal side and inferior-temporal side of the apex in anterior and posterior topography map, respectively. Rotational displacement angle alpha along X axis had similar distributions in bilateral corneas, while rotation angle beta along Upsilon axis showed both eyes tilting towards the nasal side. Further, rotation angle gamma along Z axis, which is related to corneal astigmatism, showed clear mirror symmetry. Conclusions: Analysis of corneal topography demonstrated strong and statistically-significant mirror symmetry between bilateral corneas. This characteristic could help in detection of pathological abnormalities, disease diagnosis, measurement validation and surgery planning.	[Bao, Fangjun; Chen, Hao; Yu, Ye; Yu, Jiguo; Zhou, Shi; Wang, Jing; Wang, QinMei] Affiliated Eye Hosp, WenZhou Med Coll, Wenzhou, Peoples R China; [Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool L69 3BX, Merseyside, England; [Elsheikh, Ahmed] Moorfields Eye Hosp, NHS Fdn Trust, Biomed Res Ctr, Inst Hlth Res, London, England; [Elsheikh, Ahmed] UCL Inst Ophthalmol, London, England	Wenzhou Medical University; University of Liverpool; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Wang, QM (corresponding author), Affiliated Eye Hosp, WenZhou Med Coll, Wenzhou, Peoples R China.	wangqm55@126.com	Yu, Jiguo Albert/I-5242-2014; Elsheikh, Ahmed/AAT-1476-2020	Yu, Jiguo Albert/0000-0001-6451-1158; Elsheikh, Ahmed/0000-0001-7456-1749	Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College [YNCX201107]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Engineering and Physical Sciences Research Council [1125849, EP/H052046/1] Funding Source: researchfish; National Institute for Health Research [HTD 539] Funding Source: researchfish; EPSRC [EP/H052046/1] Funding Source: UKRI	Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College (YNCX201107). The research was also partially supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology (AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio G, 2001, OPHTHALMOLOGY, V108, P1695, DOI 10.1016/S0161-6420(01)00706-0; Alterson R, 2003, PHYS MED BIOL, V48, P3431, DOI 10.1088/0031-9155/48/20/011; Bhatoa NS, 2010, CONTACT LENS ANTERIO, V33, P128, DOI 10.1016/j.clae.2009.11.004; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Guggenheim JA, 2008, OPHTHAL PHYSL OPT, V28, P327, DOI 10.1111/j.1475-1313.2008.00576.x; GUILLON M, 1986, OPHTHAL PHYSL OPT, V6, P47, DOI 10.1111/j.1475-1313.1986.tb00699.x; Iskander DR, 2001, IEEE T BIO-MED ENG, V48, P87, DOI 10.1109/10.900255; Karabatsas CH, 1998, OPHTHALMOLOGY, V105, P1999, DOI 10.1016/S0161-6420(98)91115-0; Keech A, 2010, OPTOMETRY VISION SCI, V87, P736, DOI 10.1097/OPX.0b013e3181f321aa; Khoramnia R, 2007, J CATARACT REFR SURG, V33, P830, DOI 10.1016/j.jcrs.2006.12.025; KLYCE SD, 1984, INVEST OPHTH VIS SCI, V25, P1426; Levy D, 2004, OPHTHALMOLOGY, V111, P867, DOI 10.1016/j.ophtha.2003.12.024; Mach E, 1897, CONTRIBUTION ANAL SE; MAEDA N, 1995, ARCH OPHTHALMOL-CHIC, V113, P870, DOI 10.1001/archopht.1995.01100070044023; MANDELL RB, 1996, INT CONTACT LENS CLI, V23, P205; Myrowitz EH, 2005, OPTOMETRY VISION SCI, V82, P428, DOI 10.1097/01.OPX.0000162666.83092.E4; Navalho M, 2012, RADIOLOGY, V264, P823, DOI 10.1148/radiol.12112513; Navarro R, 2006, J OPT SOC AM A, V23, P219, DOI 10.1364/JOSAA.23.000219; Novak J, 2005, OPT LASER ENG, V43, P776, DOI 10.1016/j.optlaseng.2004.08.002; Prakash G, 2010, J CATARACT REFR SURG, V36, P1365, DOI 10.1016/j.jcrs.2010.02.023; Schneider M, 2009, IEEE T BIO-MED ENG, V56, P493, DOI 10.1109/TBME.2008.2006019; SCHWIEGERLING J, 1995, J OPT SOC AM A, V12, P2105, DOI 10.1364/JOSAA.12.002105; Szczotka LB, 1997, OPTOMETRY VISION SCI, V74, P14, DOI 10.1097/00006324-199701000-00015; Tejedor J, 2012, ASTIGMATISM OPTICS P, P75; Volkau I, 2006, ACAD RADIOL, V13, P752, DOI 10.1016/j.acra.2006.01.043; Wang L, 2003, J CATARACT REFR SURG, V29, P1514, DOI 10.1016/S0886-3350(03)00467-X; Webb RH, 1992, TECHNICAL DIGEST SER, V3, P28; Xu JJ, 2012, OPHTHAL PHYSL OPT, V32, P125, DOI 10.1111/j.1475-1313.2011.00880.x; Zha Y, 2013, GRAEF ARCH CLIN EXP, V251, P537, DOI 10.1007/s00417-012-2069-6	31	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73412	10.1371/journal.pone.0073412	http://dx.doi.org/10.1371/journal.pone.0073412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009752	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600067
J	Belnoue, L; Grosjean, N; Ladeveze, E; Abrous, DN; Koehl, M				Belnoue, Laure; Grosjean, Noelle; Ladeveze, Elodie; Abrous, Djoher Nora; Koehl, Muriel			Prenatal Stress Inhibits Hippocampal Neurogenesis but Spares Olfactory Bulb Neurogenesis	PLOS ONE			English	Article							ADULT NEUROGENESIS; CELL-PROLIFERATION; PATTERN SEPARATION; FEMALE RATS; SUBVENTRICULAR ZONE; RESTRAINT STRESS; NEWBORN NEURONS; MAMMALIAN BRAIN; DENTATE GYRUS; GRANULE CELLS	The dentate gyrus (DG) and the olfactory bulb (OB) are two regions of the adult brain in which new neurons are integrated daily in the existing networks. It is clearly established that these newborn neurons are implicated in specific functions sustained by these regions and that different factors can influence neurogenesis in both structures. Among these, life events, particularly occurring during early life, were shown to profoundly affect adult hippocampal neurogenesis and its associated functions like spatial learning, but data regarding their impact on adult bulbar neurogenesis are lacking. We hypothesized that prenatal stress could interfere with the development of the olfactory system, which takes place during the prenatal period, leading to alterations in adult bulbar neurogenesis and in olfactory capacities. To test this hypothesis we exposed pregnant C57BI/6J mice to gestational restraint stress and evaluated behavioral and anatomic consequences in adult male offspring. We report that prenatal stress has no impact on adult bulbar neurogenesis, and does not alter olfactory functions in adult male mice. However, it decreases cell proliferation and neurogenesis in the DG of the hippocampus, thus confirming previous reports on rats. Altogether our data support a selective and cross-species long-term impact of prenatal stress on neurogenesis.	[Belnoue, Laure; Grosjean, Noelle; Ladeveze, Elodie; Abrous, Djoher Nora; Koehl, Muriel] INSERM, U862, Bordeaux, France; [Belnoue, Laure; Grosjean, Noelle; Ladeveze, Elodie; Abrous, Djoher Nora; Koehl, Muriel] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Koehl, M (corresponding author), INSERM, U862, Bordeaux, France.	muriel.koehl@inserm.fr	Koehl, Muriel/ABI-2043-2020; Koehl, Muriel/C-3698-2011; Abrous, Nora-Djoher/N-6977-2017	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; abrous, nora/0000-0002-8589-305X	Institut National de la Sante et de la Recherche Medicale; University of Bordeaux 2; Region Aquitaine; Agence Nationale pour la Recherche; La Fondation pour la Recherche Medicale Aquitaine	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Bordeaux 2; Region Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale pour la Recherche(French National Research Agency (ANR)); La Fondation pour la Recherche Medicale Aquitaine	This work was supported by Institut National de la Sante et de la Recherche Medicale, University of Bordeaux 2, Region Aquitaine, and Agence Nationale pour la Recherche (to D.N.A.). L.B. was a recipient of a "La Fondation pour la Recherche Medicale Aquitaine'' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Akers KG, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-29; Alonso M, 2012, NAT NEUROSCI, V15, P897, DOI 10.1038/nn.3108; Bayer LE, 2002, BEHAV BRAIN RES, V133, P185, DOI 10.1016/S0166-4328(02)00002-5; Belnoue L, 2011, J NEUROSCI, V31, P1010, DOI 10.1523/JNEUROSCI.3941-10.2011; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bustamante C, 2013, INT J DEV NEUROSCI, V31, P267, DOI 10.1016/j.ijdevneu.2013.02.007; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Darnaudery M, 2006, NEUROBIOL AGING, V27, P119, DOI 10.1016/j.neurobiolaging.2005.01.008; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Fumagalli F, 2007, PROG NEUROBIOL, V81, P197, DOI 10.1016/j.pneurobio.2007.01.002; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hitoshi S, 2007, J NEUROSCI RES, V85, P3574, DOI 10.1002/jnr.21455; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kippin TE, 2004, J NEUROSCI, V24, P2832, DOI 10.1523/JNEUROSCI.0110-04.2004; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Koehl M, 2012, BIOL PSYCHIAT, V72, P282, DOI 10.1016/j.biopsych.2012.03.001; Koehl M, 2011, NEUROGENESIS IN THE ADULT BRAIN II: CLINICAL IMPLICATIONS, P53, DOI 10.1007/978-4-431-53945-2_4; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Koehl M, 2009, EUR J NEUROSCI, V29, P635, DOI 10.1111/j.1460-9568.2009.06608.x; Korosi A, 2012, BEHAV BRAIN RES, V227, P400, DOI 10.1016/j.bbr.2011.07.037; Lau WM, 2007, RESTOR NEUROL NEUROS, V25, P17; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lucassen PJ, 2009, EUR J NEUROSCI, V29, P97, DOI 10.1111/j.1460-9568.2008.06543.x; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Mandyam CD, 2008, DEV NEUROBIOL, V68, P575, DOI 10.1002/dneu.20600; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Montaron MF, 1999, EUR J NEUROSCI, V11, P1479, DOI 10.1046/j.1460-9568.1999.00579.x; Moreno MM, 2009, P NATL ACAD SCI US; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Petreanu L, 2002, J NEUROSCI, V22, P6106; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Racekova E, 2009, CELL MOL NEUROBIOL, V29, P811, DOI 10.1007/s10571-009-9362-x; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Salomon S, 2011, J NEUROENDOCRINOL, V23, P118, DOI 10.1111/j.1365-2826.2010.02097.x; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Schulz KM, 2011, PHYSIOL BEHAV, V104, P340, DOI 10.1016/j.physbeh.2011.02.021; Son GH, 2006, J NEUROSCI, V26, P3309, DOI 10.1523/JNEUROSCI.3850-05.2006; Tronel S, 2010, HIPPOCAMPUS; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Van Waes V, 2009, ALCOHOL CLIN EXP RES, V33, P1346, DOI 10.1111/j.1530-0277.2009.00964.x; Veyrac A, 2009, NEUROPSYCHOPHARMACOL, V34, P786, DOI 10.1038/npp.2008.191; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170	58	41	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72972	10.1371/journal.pone.0072972	http://dx.doi.org/10.1371/journal.pone.0072972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009723	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600048
J	Gao, B; Fan, LS; Li, XX; Yang, HF; Liu, FL; Wang, L; Xi, L; Ma, N; Zhao, LJ				Gao, Bin; Fan, Lusheng; Li, Xingxing; Yang, Huifang; Liu, Fengluan; Wang, Ling; Xi, Lin; Ma, Nan; Zhao, Liangjun			RcRR1, a Rosa canina Type-A Response Regulator Gene, Is Involved in Cytokinin-Modulated Rhizoid Organogenesis	PLOS ONE			English	Article							IN-VITRO PROPAGATION; SIGNAL-TRANSDUCTION; PLANT-REGENERATION; LEAF EXPLANTS; ARABIDOPSIS; BIOSYNTHESIS; EXPRESSION; PROTEINS; GROWTH; SIZE	In vitro, a new protocol of plant regeneration in rose was achieved via protocorm-like bodies (PLBs) induced from the rootlike organs named rhizoids that developed from leaf explants. The development of rhizoids is a critical stage for efficient regeneration, which is triggered by exogenous auxin. However, the role of cytokinin in the control of organogenesis in rose is as yet uncharacterized. The aim of this study was to elucidate the molecular mechanism of cytokinin-modulated rhizoid formation in Rosa canina. Here, we found that cytokinin is a key regulator in the formation of rhizoids. Treatment with cytokinin reduced callus activity and significantly inhibited rhizoid formation in Rosa canina. We further isolated the full-length cDNA of a type-A response regulator gene of cytokinin signaling, RcRR1, from which the deduced amino acid sequence contained the conserved DDK motif. Gene expression analysis revealed that RcRR1 was differentially expressed during rhizoid formation and its expression level was rapidly up-regulated by cytokinin. In addition, the functionality of RcRR1 was tested in Arabidopsis. RcRR1 was found to be localized to the nucleus in GFP-RcRR1 transgenic plants and overexpression of RcRR1 resulted in increased primary root length and lateral root density. More importantly, RcRR1 overexpression transgenic plants also showed reduced sensitivity to cytokinin during root growth; auxin distribution and the expression of auxin efflux carriers PIN genes were altered in RcRR1 overexpression plants. Taken together, these results demonstrate that RcRR1 is a functional type-A response regulator which is involved in cytokinin-regulated rhizoid formation in Rosa canina.	[Gao, Bin; Li, Xingxing; Yang, Huifang; Liu, Fengluan; Wang, Ling; Xi, Lin; Ma, Nan; Zhao, Liangjun] China Agr Univ, Dept Ornamental Hort & Landscape Architecture, Beijing 100094, Peoples R China; [Fan, Lusheng] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS	Zhao, LJ (corresponding author), China Agr Univ, Dept Ornamental Hort & Landscape Architecture, Beijing 100094, Peoples R China.	zhaolj5073@sina.com			National Natural Science Foundation of China [31171993]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Surface Project from National Natural Science Foundation of China (Grant No. 31171993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; BARWALE UB, 1986, PLANTA, V167, P473, DOI 10.1007/BF00391223; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Camacho Y, 2008, PHYSIOL PLANTARUM, V132, P272, DOI 10.1111/j.1399-3054.2007.01005.x; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Choi J, 2007, J PLANT BIOL, V50, P98, DOI 10.1007/BF03030617; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Desikan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002491; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; El-Showk S, 2013, DEVELOPMENT, V140, P1373, DOI 10.1242/dev.086371; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ibrahim R, 2001, SCI HORTIC-AMSTERDAM, V88, P41, DOI 10.1016/S0304-4238(00)00189-8; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kuppu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064190; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; Mizuno T, 2004, CURR OPIN PLANT BIOL, V7, P499, DOI 10.1016/j.pbi.2004.07.015; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; Pati PK, 2006, BIOTECHNOL ADV, V24, P94, DOI 10.1016/j.biotechadv.2005.07.001; Pati PK, 2010, METHODS MOL BIOL, V589, P163, DOI 10.1007/978-1-60327-114-1_16; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; Pernisova M, 2009, P NATL ACAD SCI USA, V106, P3609, DOI 10.1073/pnas.0811539106; Sakakibara H, 2005, VITAM HORM, V72, P271, DOI 10.1016/S0083-6729(05)72008-2; Sakakibara H, 2002, J PLANT GROWTH REGUL, V21, P17, DOI 10.1007/s003440010043; Sakakibara H, 2006, TRENDS PLANT SCI, V11, P440, DOI 10.1016/j.tplants.2006.07.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sugiyama M, 1999, CURR OPIN PLANT BIOL, V2, P61, DOI 10.1016/S1369-5266(99)80012-0; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Tian CW, 2008, PLANT CELL REP, V27, P823, DOI 10.1007/s00299-007-0504-7; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Zhang SB, 2004, CRIT REV PLANT SCI, V23, P325, DOI 10.1080/07352680490484569; Zhao XY, 2008, J INTEGR PLANT BIOL, V50, P816, DOI 10.1111/j.1744-7909.2008.00701.x	51	5	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72914	10.1371/journal.pone.0072914	http://dx.doi.org/10.1371/journal.pone.0072914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009713	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600042
J	Leung, YY; Lee, TCP; Ho, SMY; Cheung, LK				Leung, Yiu Yan; Lee, Terence Chak Pui; Ho, Samuel Mun Yin; Cheung, Lim Kwong			Trigeminal Neurosensory Deficit and Patient Reported Outcome Measures: The Effect on Life Satisfaction and Depression Symptoms	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SCALE; SURGERY	Objectives: To investigate the effect of persistent neurosensory disturbance of the lingual nerve (LN) or inferior alveolar nerve (IAN) on life satisfaction and depression symptoms. Methods: This study recruited patients with persistent LN or IAN deficit as a consequence of lower third molar surgery for 12 months or more to form the study group. A control group was formed by matching age and gender of recruited subjects in the study group with patients without the neurosensory complications. Life satisfaction was assessed with Satisfaction With Life Scale (SWLS) and depression symptoms were assessed with 20-item Center for Epidemiological Studies Depression scale (CESD-20). Results: Fourty-eight participants (24 cases and 24 controls) were recruited. Patients with LN or IAN deficits after lower third molar surgery were less satisfied with their lives when compared to the control group (p<0.001). They were presenting with more depression symptoms (p = 0.001). 45.8% of the study group subjects had a CESD-20 score of 16 or above. Older patients presented with more depression symptoms among the subjects with neurosensory disturbance after lower third molar surgery (p = 0.02). Conclusions: Individuals with permanent trigeminal neurosensory deficit after lower third molar surgery have worse life satisfaction and more depressive symptoms when compared to those who did not suffer from the surgical complication.	[Leung, Yiu Yan; Cheung, Lim Kwong] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Lee, Terence Chak Pui] Hong Kong Baptist Univ, Fac Social Sci, Psychol Unit, Hong Kong, Hong Kong, Peoples R China; [Ho, Samuel Mun Yin] City Univ Hong Kong, Dept Appl Social Studies, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Hong Kong Baptist University; City University of Hong Kong	Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk	Ho, Samuel M.Y. M.Y./D-2454-2014	Ho, Samuel M.Y. M.Y./0000-0001-7803-1657; Cheung, Lim Kwong/0000-0002-2248-286X; /0000-0001-7038-3279				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arrindell WA, 1999, PERS INDIV DIFFER, V26, P815, DOI 10.1016/S0191-8869(98)00180-9; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P775, DOI 10.1016/j.apmr.2011.12.020; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314; Cheung LK, 2010, INT J ORAL MAX SURG, V39, P320, DOI 10.1016/j.ijom.2009.11.010; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Ferrus-Torres E, 2011, J ORAL MAXIL SURG, V69, P54, DOI 10.1016/j.joms.2010.05.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Khanna D, 2011, ARTHRIT CARE RES, V63, pS486, DOI 10.1002/acr.20581; Latoo J, 2012, BRIT J HOSP MED, V73, P331, DOI 10.12968/hmed.2012.73.6.331; Leung YY, PLOS ONE UNPUB; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; PAVOT W, 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; Tonack M, 2008, SPINAL CORD, V46, P380, DOI 10.1038/sj.sc.3102088	21	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72891	10.1371/journal.pone.0072891	http://dx.doi.org/10.1371/journal.pone.0072891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009712	Green Published, gold			2022-12-25	WOS:000323734600041
J	Bevelander, KE; Anschutz, DJ; Creemers, DHM; Kleinjan, M; Engels, RCME				Bevelander, Kirsten E.; Anschutz, Doeschka J.; Creemers, Daan H. M.; Kleinjan, Marloes; Engels, Rutger C. M. E.			The Role of Explicit and Implicit Self-Esteem in Peer Modeling of Palatable Food Intake: A Study on Social Media Interaction among Youngsters	PLOS ONE			English	Article							BODY-MASS INDEX; ASSOCIATION TEST; CHILDREN; IMAGE; OTHERS; GIRLS; DISCREPANCIES; ACCEPTANCE; ADOLESCENT; ATTITUDES	Objective: This experimental study investigated the impact of peers on palatable food intake of youngsters within a social media setting. To determine whether this effect was moderated by self-esteem, the present study examined the roles of global explicit self-esteem (ESE), body esteem (BE) and implicit self-esteem (ISE). Methods: Participants (N = 118; 38.1% boys; M age 11.14 +/-.79) were asked to play a computer game while they believed to interact online with a same-sex normal-weight remote confederate (i.e., instructed peer) who ate either nothing, a small or large amount of candy. Results: Participants modeled the candy intake of peers via a social media interaction, but this was qualified by their self-esteem. Participants with higher ISE adjusted their candy intake to that of a peer more closely than those with lower ISE when the confederate ate nothing compared to when eating a modest (beta = .26, p = .05) or considerable amount of candy (kcal) (beta = .32, p = .001). In contrast, participants with lower BE modeled peer intake more than those with higher BE when eating nothing compared to a considerable amount of candy (kcal) (beta = .21, p = .02); ESE did not moderate social modeling behavior. In addition, participants with higher discrepant or "damaged" self-esteem (i.e., high ISE and low ESE) modeled peer intake more when the peer ate nothing or a modest amount compared to a substantial amount of candy (kcal) (beta = -.24, p = .004; beta= -.26, p < .0001, respectively). Conclusion: Youngsters conform to the amount of palatable food eaten by peers through social media interaction. Those with lower body esteem or damaged self-esteem may be more at risk to peer influences on food intake.	[Bevelander, Kirsten E.; Anschutz, Doeschka J.; Creemers, Daan H. M.; Kleinjan, Marloes; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bevelander, KE (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	Kris.Bevelander@gmail.com	Bevelander, Kirsten E/E-7878-2012; Kleinjan, Marloes/AAF-1128-2019	Engels, Rutger/0000-0003-1944-9126; Kleinjan, Marloes/0000-0002-4545-5549; , Kirsten/0000-0003-1011-7862	Behavioural Science Institute of the Radboud University Nijmegen, The Netherlands	Behavioural Science Institute of the Radboud University Nijmegen, The Netherlands	The present study was supported by a grant of the Behavioural Science Institute of the Radboud University Nijmegen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anschutz DJ, 2008, INT J EATING DISORDE, V42; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bevelander K. E., 2012, BRIT J NUTR, V1, P1; Bevelander KE, 2012, APPETITE, V58, P864, DOI 10.1016/j.appet.2012.02.003; Bevelander KE, 2011, APPETITE, V57, P99, DOI 10.1016/j.appet.2011.04.005; BOHRNSTEDT GW, 1983, J PERS SOC PSYCHOL, V45, P43, DOI 10.1037/0022-3514.45.1.43; Bosson JK, 2003, SELF IDENTITY, V2, P169, DOI 10.1080/15298860309029; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Cockerham E, 2009, J BEHAV THER EXP PSY, V40, P265, DOI 10.1016/j.jbtep.2008.12.003; Creemers DHM, 2012, J BEHAV THER EXP PSY, V43, P638, DOI 10.1016/j.jbtep.2011.09.006; CROSS AT, 1994, J AM DIET ASSOC, V94, P1398, DOI 10.1016/0002-8223(94)92542-9; DeHart T, 2006, J EXP SOC PSYCHOL, V42, P1, DOI 10.1016/j.jesp.2004.12.005; Dehart T, 2011, SELF IDENTITY, V10, P127, DOI 10.1080/15298861003687880; Dorsselaer S, 2007, HBSC 2005 GEZ WELZ J; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feeney JR, 2011, EAT BEHAV, V12, P75, DOI 10.1016/j.eatbeh.2010.09.007; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Furnham A, 2002, J PSYCHOL, V136, P581, DOI 10.1080/00223980209604820; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Heatherton TF, 2000, J PERS SOC PSYCHOL, V78, P725, DOI 10.1037/0022-3514.78.4.725; Heatherton TF, 2003, POSITIVE PSYCHOLOGICAL ASSESSMENT: HANDBOOK OF MODELS AND MEASURES, P219, DOI 10.1037/10612-014; Hendy HM, 2002, APPETITE, V39, P217, DOI 10.1006/appe.2002.0510; Herman CP, 2005, PHYSIOL BEHAV, V86, P762, DOI 10.1016/j.physbeh.2005.08.064; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Hermans RCJ, 2008, APPETITE, V51, P512, DOI 10.1016/j.appet.2008.03.016; Hermans RCJ, 2012, EAT BEHAV, V13, P246, DOI 10.1016/j.eatbeh.2012.03.008; Hermans RCJ, 2009, APPETITE, V53, P135, DOI 10.1016/j.appet.2009.05.004; Hermans RCJ, 2009, APPETITE, V52, P801, DOI 10.1016/j.appet.2009.03.008; KENNY DA, 1993, PSYCHOL BULL, V114, P145, DOI 10.1037/0033-2909.114.1.145; Kuntsche E, 2006, DRUG ALCOHOL DEPEN, V84, P167, DOI 10.1016/j.drugalcdep.2006.01.014; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Leary, 2005, EUROPEAN REV SOCIAL, V16, P75, DOI [10.1080/10463280540000007, DOI 10.1080/10463280540000007]; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leone T, 2007, APPETITE, V49, P58, DOI 10.1016/j.appet.2006.11.005; Livingstone S., 2009, EU KIDS ONLINE FINAL; MENDELSON BK, 1982, PERCEPT MOTOR SKILL, V54, P899, DOI 10.2466/pms.1982.54.3.899; MUTHEN BO, 1994, SOCIOL METHOD RES, V22, P376, DOI 10.1177/0049124194022003006; Nederland SV, 2011, BODY MASS INDEX JONG; Nowak M, 1998, J ADOLESCENT HEALTH, V23, P389, DOI 10.1016/S1054-139X(97)00263-2; Peterson JL, 2013, J EXP SOC PSYCHOL, V49, P99, DOI 10.1016/j.jesp.2012.07.013; Phillips RG, 1998, INT J OBESITY, V22, P287, DOI 10.1038/sj.ijo.0800582; Pliner P, 2004, APPETITE, V42, P227, DOI 10.1016/j.appet.2003.12.001; Ricciardelli LA, 2001, CLIN PSYCHOL REV, V21, P325, DOI 10.1016/S0272-7358(99)00051-3; Robins RW, 2002, PSYCHOL AGING, V17, P423, DOI 10.1037//0882-7974.17.3.423; Robinson E, 2011, APPETITE, V56, P747, DOI 10.1016/j.appet.2011.03.001; Romero ND, 2009, J AM DIET ASSOC, V109, P133, DOI 10.1016/j.jada.2008.10.005; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Rudman LA, 2007, J PERS SOC PSYCHOL, V93, P798, DOI 10.1037/0022-3514.93.5.798; Salvy SJ, 2008, APPETITE, V50, P514, DOI 10.1016/j.appet.2007.10.009; Schroder-Abe M, 2007, EUR J PERSONALITY, V21, P319, DOI 10.1002/per.626; THOMPSON JK, 1991, INT J EAT DISORDER, V10, P615, DOI 10.1002/1098-108X(199109)10:5<615::AID-EAT2260100514>3.0.CO;2-K; Tiggemann M, 1998, INT J EAT DISORDER, V23, P83, DOI 10.1002/(SICI)1098-108X(199801)23:1&lt;83::AID-EAT10&gt;3.0.CO;2-O; Tiggemann Marika, 2005, Body Image, V2, P129, DOI 10.1016/j.bodyim.2005.03.006; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Utter J, 2003, J AM DIET ASSOC, V103, P1298, DOI 10.1016/S0002-8223(03)01079-4; WARDLE J, 1986, APPETITE, V7, P209, DOI 10.1016/S0195-6663(86)80026-5; Zeigler-Hill V, 2006, J PERS, V74, P119, DOI 10.1111/j.1467-6494.2005.00371.x	62	27	27	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72481	10.1371/journal.pone.0072481	http://dx.doi.org/10.1371/journal.pone.0072481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015251	gold, Green Published, Green Submitted			2022-12-25	WOS:000323733800059
J	Bryant, C; Giovanello, KS; Ibrahim, JG; Chang, J; Shen, DG; Peterson, BS; Zhu, HT				Bryant, Christopher; Giovanello, Kelly S.; Ibrahim, Joseph G.; Chang, Jing; Shen, Dinggang; Peterson, Bradley S.; Zhu, Hongtu		Alzheimer's Dis Neuroimaging Initi	Mapping the Genetic Variation of Regional Brain Volumes as Explained by All Common SNPs from the ADNI Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; CORTEX; HERITABILITY; RELEVANCE; VARIANTS; DEMENTIA	Typically twin studies are used to investigate the aggregate effects of genetic and environmental influences on brain phenotypic measures. Although some phenotypic measures are highly heritable in twin studies, SNPs (single nucleotide polymorphisms) identified by genome-wide association studies (GWAS) account for only a small fraction of the heritability of these measures. We mapped the genetic variation (the proportion of phenotypic variance explained by variation among SNPs) of volumes of pre-defined regions across the whole brain, as explained by 512,905 SNPs genotyped on 747 adult participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We found that 85% of the variance of intracranial volume (ICV) (p = 0.04) was explained by considering all SNPs simultaneously, and after adjusting for ICV, total grey matter (GM) and white matter (WM) volumes had genetic variation estimates near zero (p = 0.5). We found varying estimates of genetic variation across 93 non-overlapping regions, with asymmetry in estimates between the left and right cerebral hemispheres. Several regions reported in previous studies to be related to Alzheimer's disease progression were estimated to have a large proportion of volumetric variance explained by the SNPs.	[Bryant, Christopher; Ibrahim, Joseph G.; Chang, Jing; Zhu, Hongtu] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Giovanello, Kelly S.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Shen, Dinggang; Zhu, Hongtu] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Peterson, Bradley S.] New York State Psychiat Inst & Hosp, Div Child & Adolescent Psychiat, New York, NY 10032 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; New York State Psychiatry Institute	Zhu, HT (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	hzhu@bios.unc.edu	Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013; Shen, Dinggang/ABF-6812-2020; Levey, Allan/F-2104-2011; Saykin, Andrew/A-1318-2007	Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Shen, Dinggang/0000-0002-7934-5698; Levey, Allan/0000-0002-3153-502X; Ponto, Laura/0000-0003-1197-6714; Saykin, Andrew/0000-0002-1376-8532	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health (NIH)) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; NATIONAL CANCER INSTITUTE [T32CA106209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P30AG008051, P50AG005138, P50AG008702, U01AG024904, K01AG030514, P30AG010129, P30AG013846] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health (NIH) grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2003, DEMENT GERIATR COGN, V16, P57, DOI 10.1159/000070676; [Anonymous], RAPID REV NEUROSCIEN; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Carmelli D, 1998, STROKE, V29, P1177, DOI 10.1161/01.STR.29.6.1177; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; Erten-Lyons D, 2010, ALZHEIMERS DEMENT, V6, P118, DOI 10.1016/j.jalz.2009.05.663; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gilmore JH, 2010, HUM BRAIN MAPP, V31, P1174, DOI 10.1002/hbm.20926; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hibar DP, 2011, NEUROIMAGE, V56, P1875, DOI 10.1016/j.neuroimage.2011.03.077; Pol HEH, 2006, NEUROIMAGE, V31, P482, DOI 10.1016/j.neuroimage.2005.12.056; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Inkster B, 2013, NEUROBIOL AGING, V34, P238, DOI 10.1016/j.neurobiolaging.2012.07.007; Kremen WS, 2012, NEUROBIOL AGING, V33, P1, DOI 10.1016/j.neurobiolaging.2010.02.007; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; MacDonald D.J., 1998, NEUROIMAGE, V7, pS717, DOI [10.1016/S1053-8119(18)31550-7, DOI 10.1016/S1053-8119(18)31550-7]; Madsen SK, 2010, NEUROBIOL AGING, V31, P1312, DOI 10.1016/j.neurobiolaging.2010.05.002; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Niskanen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026113; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Pfefferbaum A, 2000, NEUROBIOL AGING, V21, P63, DOI 10.1016/S0197-4580(00)00086-5; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Shen DG, 2004, NEUROIMAGE, V21, P1508, DOI 10.1016/j.neuroimage.2003.12.015; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Strijbis EM, 2012, MULT SCLER, V31; TRAMO MJ, 1995, J COGNITIVE NEUROSCI, V7, P292, DOI 10.1162/jocn.1995.7.2.292; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wright IC, 2002, NEUROIMAGE, V17, P256, DOI 10.1006/nimg.2002.1163; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoon U, 2011, NEUROSCI LETT, V493, P8, DOI 10.1016/j.neulet.2011.01.070	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71723	10.1371/journal.pone.0071723	http://dx.doi.org/10.1371/journal.pone.0071723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015190	Green Published, gold			2022-12-25	WOS:000323733800012
J	Ugalde, JA; Gallardo, MJ; Belmar, C; Munoz, P; Ruiz-Tagle, N; Ferrada-Fuentes, S; Espinoza, C; Allen, EE; Gallardo, VA				Ugalde, Juan A.; Gallardo, Maria J.; Belmar, Camila; Munoz, Praxedes; Ruiz-Tagle, Nathaly; Ferrada-Fuentes, Sandra; Espinoza, Carola; Allen, Eric E.; Gallardo, Victor A.			Microbial Life in a Fjord: Metagenomic Analysis of a Microbial Mat in Chilean Patagonia	PLOS ONE			English	Article							GENOME SEQUENCE; SULFUR; BACTERIA; DATABASE; ECOLOGY; VIRUSES; SERVER; GENES; NOV.	The current study describes the taxonomic and functional composition of metagenomic sequences obtained from a filamentous microbial mat isolated from the Comau fjord, located in the northernmost part of the Chilean Patagonia. The taxonomic composition of the microbial community showed a high proportion of members of the Gammaproteobacteria, including a high number of sequences that were recruited to the genomes of Moritella marina MP-1 and Colwellia psycherythraea 34H, suggesting the presence of populations related to these two psychrophilic bacterial species. Functional analysis of the community indicated a high proportion of genes coding for the transport and metabolism of amino acids, as well as in energy production. Among the energy production functions, we found protein-coding genes for sulfate and nitrate reduction, both processes associated with Gammaproteobacteria-related sequences. This report provides the first examination of the taxonomic composition and genetic diversity associated with these conspicuous microbial mat communities and provides a framework for future microbial studies in the Comau fjord.	[Ugalde, Juan A.; Allen, Eric E.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Gallardo, Maria J.] Univ Concepcion, Ctr Opt & Photon, Concepcion, Chile; [Belmar, Camila] Univ Catolica Norte, Fac Ciencias Mar, Programa Magister Ciencias Mar, Coquimbo, Chile; [Munoz, Praxedes] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile; [Munoz, Praxedes] Ctr Estudios Avanzados Zonas Aridas, La Serena, Chile; [Ruiz-Tagle, Nathaly] Univ Concepcion, Ctr Biotechnol, Concepcion, Chile; [Ferrada-Fuentes, Sandra] Univ Concepcion, Lab Genet & Acuicultura, Dept Oceanog, Concepcion, Chile; [Espinoza, Carola] Univ Concepcion, Lab Bentos, Dept Oceanog, Concepcion, Chile; [Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidad de Concepcion; Universidad Catolica del Norte; Universidad Catolica del Norte; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; University of California System; University of California San Diego	Ugalde, JA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	jugalde@ucsd.edu	Ugalde, Juan/E-7070-2010; Gallardo, María José/ABH-2726-2021; Ugalde, Juan Antonio/GLV-2034-2022; RUIZ-TAGLE, NATHALY M/K-7781-2017	Ugalde, Juan/0000-0001-6638-0817; Ugalde, Juan Antonio/0000-0001-6638-0817; RUIZ-TAGLE, NATHALY M/0000-0002-8595-5206; belmar, camila/0000-0002-9288-4805; Gallardo-Nelson, Maria Jose/0000-0003-2963-8692	Fondecyt [1070552, 1110786, 1120469]; PIA-Conicyt [PFB08-24]; Universidad de Concepcion DIUC [210.112-103-1.0]; National Science Foundation [MCB-1149552]; Omics Solutions, Chile; Fulbright-Conicyt fellowship	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PIA-Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad de Concepcion DIUC; National Science Foundation(National Science Foundation (NSF)); Omics Solutions, Chile; Fulbright-Conicyt fellowship	This work was partially supported by Fondecyt grants 1070552, 1110786 (VAG) and 1120469 (PM), PIA-Conicyt PFB08-24 (MJG), Universidad de Concepcion DIUC 210.112-103-1.0 (VAG) and National Science Foundation award MCB-1149552 (EEA). Sequencing was possible thanks to an award from Omics Solutions, Chile. JAU was partially supported by a Fulbright-Conicyt fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa S, 2006, EXTREMOPHILES, V10, P311, DOI 10.1007/s00792-005-0501-0; Bienhold C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053590; Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1171, DOI 10.1099/00207713-48-4-1171; Choi FJ, 2010, INT J SYST EVOL MICR, V60, P1952, DOI 10.1099/ijs.0.016055-0; Clark MS, 2004, COMP FUNCT GENOM, V5, P230, DOI 10.1002/cfg.398; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dos Santos JP, 1998, J MOL BIOL, V284, P421, DOI 10.1006/jmbi.1998.2155; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glud RN, 2004, MAR BIOL, V145, P51, DOI 10.1007/s00227-004-1296-8; HAUSER A, 1989, ANDEAN GEOL, V16, P229; HAUSSERMANN V, 2010, MARINE BENTHIC FAUNA; Jimenez DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052069; Jung SY, 2006, INT J SYST EVOL MICR, V56, P33, DOI 10.1099/ijs.0.63920-0; Kalanetra KM, 2004, APPL ENVIRON MICROB, V70, P7487, DOI 10.1128/AEM.70.12.7487-7496.2004; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAUTHARAPU KB, 2012, APPL MICROBIOL BIOT, V97, P1, DOI DOI 10.1007/S00253-012-4529-7.PUBMED:23111600; Kautharapu KB, 2012, J BACTERIOL, V194, P6296, DOI 10.1128/JB.01382-12; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang AS, 2009, FEMS MICROBIOL REV, V33, P295, DOI 10.1111/j.1574-6976.2008.00132.x; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Munn CB, 2006, J MAR BIOL ASSOC UK, V86, P453, DOI 10.1017/S002531540601335X; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Sanchez N, 2011, J PLANKTON RES, V33, P1212, DOI 10.1093/plankt/fbr022; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Silva N, 2006, OXIGENO DISUELTO PH; SOBARZO M, 2009, REGION FIORDOS ZONA, P6; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Team RDC, R LANG ENV STAT COMP; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Zabala B, 2009, J VIROL, V83, P9313, DOI 10.1128/JVI.00672-09; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819	50	15	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71952	10.1371/journal.pone.0071952	http://dx.doi.org/10.1371/journal.pone.0071952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015199	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800021
J	Liao, XL; Lu, SY; Wu, YQ; Xu, WF; Zhuo, Y; Peng, Q; Li, B; Zhang, L; Wang, YX				Liao, Xiaoling; Lu, Shaoying; Wu, Yiqian; Xu, Wenfeng; Zhuo, Yue; Peng, Qin; Li, Bo; Zhang, Ling; Wang, Yingxiao			The Effect of Differentiation Induction on FAK and Src Activity in Live HMSCs Visualized by FRET	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MESENCHYMAL STEM-CELLS; STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; NEURONAL DIFFERENTIATION; BETA-CATENIN; TYROSINE PHOSPHORYLATION; BONE; ACTIVATION; EXPRESSION	FAK and Src signaling play important roles in cell differentiation, survival and migration. However, it remains unclear how FAK and Src activities are regulated at the initial stage of stem cell differentiation. We utilized fluorescence resonance energy transfer (FRET)-based FAK and Src biosensors to visualize these kinase activities at the plasma membrane of human mesenchymal stem cells (HMSCs) under the stimulation of osteogenic, myoblastic, or neural induction reagents. Our results indicate that the membrane FAK and Src activities are distinctively regulated by these differentiation induction reagents. FAK and Src activities were both up-regulated with positive feedback upon osteogenic induction, while myoblastic induction only activated Src, but not FAK. Neural induction, however, transiently activated FAK and subsequently Src, which triggered a negative feedback to partially inhibit FAK activity. These results unravel distinct regulation mechanisms of FAK and Src activities during HMSC fate decision, which should advance our understanding of stem cell differentiation in tissue engineering.	[Liao, Xiaoling; Xu, Wenfeng; Li, Bo; Zhang, Ling] Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Chongqing, Peoples R China; [Lu, Shaoying; Zhuo, Yue; Wang, Yingxiao] Univ Illinois, Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA; [Liao, Xiaoling; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Ctr Biophys & Computat Biol, Dept Integrat & Mol Physiol,Inst Genom Biol, Urbana, IL 61801 USA; [Wu, Yiqian] Chinese Univ Hong Kong, Dept Elect Engn, Biomed Engn Programme, Shatin, Hong Kong, Peoples R China; [Lu, Shaoying; Peng, Qin; Wang, Yingxiao] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA	Chongqing University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chinese University of Hong Kong; University of California System; University of California San Diego	Wang, YX (corresponding author), Univ Illinois, Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA.	yingxiao@illinois.edu	Zhuo, Yue/I-5526-2017	Zhuo, Yue/0000-0002-5739-1896	National Institutes of Health (NIH) [HL098472, NS063405]; National Science Foundation [CBET0846429]; Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China [CSTC2012JJB0097]; National Natural Foundation of China [31271014, 81101154]; Research Foundation of Chongqing University of Science Technology [CK2010B18, CK2011Z03]; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China; National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Chongqing University of Science Technology; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Institutes of Health (NIH) HL098472, NS063405, National Science Foundation CBET0846429 (YW, SL and CW), Research Foundation of University of Illinois (SL), the Natural Science Key Foundation Project of CQ in China CSTC2012JJB0097, the National Natural Foundation of China 31271014, 81101154 (XL, WX, BL), and Research Foundation of Chongqing University of Science & Technology CK2010B18, CK2011Z03 (XL, WX). YZ was supported by the Beckman Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher WK, 2011, ADV DRUG DELIVER REV, V63, P342, DOI 10.1016/j.addr.2010.12.004; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Clemente CFMZ, 2005, AM J PHYSIOL-REG I, V289, pR862, DOI 10.1152/ajpregu.00348.2004; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FINCHAM VJ, 1995, ONCOGENE, V10, P2247; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Koukouritaki SB, 1999, MOL MED, V5, P731, DOI 10.1007/BF03402097; Lee JH, 2011, J R SOC INTERFACE, V8, P998, DOI 10.1098/rsif.2010.0613; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Lim MJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P197, DOI 10.1016/j.abb.2007.06.004; Liu LY, 2010, BIOMECH MODEL MECHAN, V9, P659, DOI 10.1007/s10237-010-0206-x; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mareschi K, 2006, EXP HEMATOL, V34, P1563, DOI 10.1016/j.exphem.2006.06.020; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Papp S, 2009, STEM CELLS, V27, P1507, DOI 10.1002/stem.85; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Ridgway RA, 2012, CARCINOGENESIS, V33, P2369, DOI 10.1093/carcin/bgs284; Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003; Theus MH, 2006, EXP CELL RES, V312, P3096, DOI 10.1016/j.yexcr.2006.06.022; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	57	5	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72233	10.1371/journal.pone.0072233	http://dx.doi.org/10.1371/journal.pone.0072233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015220	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200030
J	Feng, SJ; Liang, XW; Cruz, MA; Vu, H; Zhou, Z; Pemmaraju, N; Dong, JF; Kroll, MH; Afshar-Kharghan, V				Feng, Shuju; Liang, Xiaowen; Cruz, Miguel A.; Hangoc Vu; Zhou, Zhou; Pemmaraju, Naresh; Dong, Jing-Fei; Kroll, Michael H.; Afshar-Kharghan, Vahid			The Interaction between Factor H and Von Willebrand Factor	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; COMPLEMENT FACTOR-H; THROMBOTIC THROMBOCYTOPENIC PURPURA; GLYCOPROTEIN IB-BINDING; COFACTOR ACTIVITY; ADAMTS13; DEFICIENCY; DISEASE; SURFACE; DOMAIN	Complement factor H (fH) is a plasma protein that regulates activation of the alternative pathway, and mutations in fH are associated with a rare form of thrombotic microangiopathy (TMA), known as atypical hemolytic uremic syndrome (aHUS). A more common TMA is thrombotic thrombocytopenic purpura, which is caused by the lack of normal ADAMTS-13-mediated cleavage of von Willebrand factor (VWF). We investigated whether fH interacts with VWF and affects cleavage of VWF. We found that factor H binds to VWF in plasma, to plasma-purified VWF, and to recombinant A1 and A2 domains of VWF as detected by co-immunoprecipitation (co-IP) and surface plasmon resonance assays. Factor H enhanced ADAMTS-13-mediated cleavage of recombinant VWF-A2 as determined by quantifying the cleavage products using Western-blotting, enhanced cleavage of a commercially available fragment of VWF-A2 (FRETS-VWF73) as determined by fluorometric assay, and enhanced cleavage of ultralarge (UL) VWF under flow conditions as determined by cleavage of VWF-platelet strings attached to histamine stimulated endothelial cells. Using recombinant full-length and truncated fH molecules, we found that the presence of the C-terminal half of fH molecule is important for binding to VWF-A2 and for enhancing cleavage of the A2 domain by ADAMTS-13. We conclude that factor H binds to VWF and may modulate cleavage of VWF by ADAMTS-13.	[Feng, Shuju; Hangoc Vu; Pemmaraju, Naresh; Kroll, Michael H.; Afshar-Kharghan, Vahid] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Houston, TX 77030 USA; [Liang, Xiaowen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Cruz, Miguel A.] Baylor Coll Med, Cardiovasc Res Sect, Houston, TX 77030 USA; [Zhou, Zhou; Dong, Jing-Fei] Puget Sound Blood Ctr, Seattle, WA 98104 USA	University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Puget Sound Blood Center	Afshar-Kharghan, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Internal Med, Houston, TX 77030 USA.	vakharghan@mdanderson.org						ALSENZ J, 1984, BIOCHEM J, V224, P389, DOI 10.1042/bj2240389; Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Chen JM, 2012, ARTERIOSCL THROM VAS, V32, P2625, DOI 10.1161/ATVBAHA.112.254144; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; Davin JC, 2010, AM J KIDNEY DIS, V55, P708, DOI 10.1053/j.ajkd.2009.08.011; de Jorge EG, 2011, J AM SOC NEPHROL, V22, P137, DOI 10.1681/ASN.2010050451; DERODRIGUEZ CS, 2010, BLOOD, V115, P158; DiScipio RG, 1998, J IMMUNOL, V160, P4057; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; GORDON DL, 1995, J IMMUNOL, V155, P348; Hulstein JJJ, 2005, BLOOD, V106, P3035, DOI 10.1182/blood-2005-03-1153; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Kavanagh D, 2008, ANNU REV MED, V59, P293, DOI 10.1146/annurev.med.59.060106.185110; Kavanagh D, 2010, CURR OPIN HEMATOL, V17, P432, DOI 10.1097/MOH.0b013e32833cae86; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Mache CJ, 2009, CLIN J AM SOC NEPHRO, V4, P1312, DOI 10.2215/CJN.01090209; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Mnjoyan Z, 2008, PLATELETS, V19, P512, DOI 10.1080/09537100802238494; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Noris M, 2005, J AM SOC NEPHROL, V16, P1177, DOI 10.1681/ASN.2005010086; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Remuzzi G, 2002, BLOOD, V100, P778, DOI 10.1182/blood-2001-12-0166; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; Turner NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059372; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; Veyradier A, 2003, J PEDIATR-US, V142, P310, DOI 10.1067/mpd.2003.79; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	39	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73715	10.1371/journal.pone.0073715	http://dx.doi.org/10.1371/journal.pone.0073715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991205	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800108
J	Tomita, M; Asada, M; Asada, N; Nakamura, J; Oguchi, A; Higashi, AY; Endo, S; Robertson, E; Kimura, T; Kita, T; Economides, AN; Kreidberg, J; Yanagita, M				Tomita, Mayumi; Asada, Misako; Asada, Nariaki; Nakamura, Jin; Oguchi, Akiko; Higashi, Atsuko Y.; Endo, Shuichiro; Robertson, Elizabeth; Kimura, Takeshi; Kita, Toru; Economides, Aris N.; Kreidberg, Jordan; Yanagita, Motoko			Bmp7 Maintains Undifferentiated Kidney Progenitor Population and Determines Nephron Numbers at Birth	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; MESANGIAL CELL-PROLIFERATION; STEM-CELLS; METANEPHRIC MESENCHYME; MAMMALIAN KIDNEY; RENAL-FUNCTION; MICE; EXPRESSION; MAINTENANCE; BRAIN	The number of nephrons, the functional units of the kidney, varies among individuals. A low nephron number at birth is associated with a risk of hypertension and the progression of renal insufficiency. The molecular mechanisms determining nephron number during embryogenesis have not yet been clarified. Germline knockout of bone morphogenetic protein 7 (Bmp7) results in massive apoptosis of the kidney progenitor cells and defects in early stages of nephrogenesis. This phenotype has precluded analysis of Bmp7 function in the later stage of nephrogenesis. In this study, utilization of conditional null allele of Bmp7 in combination with systemic inducible Cre deleter mice enabled us to analyze Bmp7 function at desired time points during kidney development, and to discover the novel function of Bmp7 to inhibit the precocious differentiation of the progenitor cells to nephron. Systemic knockout of Bmp7 in vivo after the initiation of kidney development results in the precocious differentiation of the kidney progenitor cells to nephron, in addition to the prominent apoptosis of progenitor cells. We also confirmed that in vitro knockout of Bmp7 in kidney explant culture results in the accelerated differentiation of progenitor population. Finally we utilized colony-forming assays and demonstrated that Bmp7 inhibits epithelialization and differentiation of the kidney progenitor cells. These results indicate that the function of Bmp7 to inhibit the precocious differentiation of the progenitor cells together with its anti-apoptotic effect on progenitor cells coordinately maintains renal progenitor pool in undifferentiated status, and determines the nephron number at birth.	[Tomita, Mayumi; Asada, Misako; Asada, Nariaki; Nakamura, Jin; Oguchi, Akiko; Endo, Shuichiro; Yanagita, Motoko] Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan; [Higashi, Atsuko Y.] Kansai Med Univ, Dept Pharmacol, Moriguchi, Osaka 570, Japan; [Robertson, Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Kita, Toru] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan; [Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Kreidberg, Jordan] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	Kyoto University; Kansai Medical University; University of Oxford; Kyoto University; Kobe City Medical Center General Hospital; Regeneron; Harvard University; Boston Children's Hospital; Harvard Medical School	Yanagita, M (corresponding author), Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan.	motoy@kuhp.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021	Tomita, Mayumi/0000-0001-9673-468X; Yanagita, Motoko/0000-0002-0339-9008; Economides, Aris/0000-0002-6508-8942	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT program)"; Council for Science and Technology Policy (CSTP)	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT program)"; Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This research was granted by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT program)", initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol CL, 2009, SEMIN NEPHROL, V29, P445, DOI 10.1016/j.semnephrol.2009.03.019; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Borovecki F, 2004, NEPHRON EXP NEPHROL, V97, P26, DOI 10.1159/000077595; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Dotsch J, 2009, J MOL MED, V87, P841, DOI 10.1007/s00109-009-0507-7; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Godin RE, 1999, INT J DEV BIOL, V43, P405; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Kazama I, 2008, J AM SOC NEPHROL, V19, P2181, DOI 10.1681/ASN.2007111212; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Krizhanovsky V, 2006, MECH DEVELOP, V123, P67, DOI 10.1016/j.mod.2005.09.005; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nishinakamura R, 2008, KIDNEY INT, V73, P913, DOI 10.1038/sj.ki.5002784; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Puddu M, 2009, AM J NEPHROL, V30, P162, DOI 10.1159/000211324; Ross A, 2007, SEX DEV, V1, P127, DOI 10.1159/000100034; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Schreuder MF, 2007, KIDNEY INT, V72, P265, DOI 10.1038/sj.ki.5002307; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Sutherland MR, 2011, J AM SOC NEPHROL, V22, P1365, DOI 10.1681/ASN.2010121266; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; THONY HC, 1995, EUR J PEDIATR, V154, pS65, DOI 10.1007/BF02191509; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vukicevic S, 1996, P NATL ACAD SCI USA, V93, P9021, DOI 10.1073/pnas.93.17.9021; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz	38	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73554	10.1371/journal.pone.0073554	http://dx.doi.org/10.1371/journal.pone.0073554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991197	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800106
J	Leino, MS; Loxham, M; Blume, C; Swindle, EJ; Jayasekera, NP; Dennison, PW; Shamji, BWH; Edwards, MJ; Holgate, ST; Howarth, PH; Davies, DE				Leino, Marina S.; Loxham, Matthew; Blume, Cornelia; Swindle, Emily J.; Jayasekera, Nivenka P.; Dennison, Patrick W.; Shamji, Betty W. H.; Edwards, Matthew J.; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.			Barrier Disrupting Effects of Alternaria Alternata Extract on Bronchial Epithelium from Asthmatic Donors	PLOS ONE			English	Article							PROTEASE-DEPENDENT ACTIVATION; PROINFLAMMATORY CYTOKINES; FUNGAL ALLERGENS; DENDRITIC CELLS; MITE ALLERGENS; RISK-FACTOR; LUNG; SENSITIZATION; INTERLEUKIN-8; EXPRESSION	Sensitization and exposure to the allergenic fungus Alternaria alternata has been associated with increased risk of asthma and asthma exacerbations. The first cells to encounter inhaled allergens are epithelial cells at the airway mucosal surface. Epithelial barrier function has previously been reported to be defective in asthma. This study investigated the contribution of proteases from Alternaria alternata on epithelial barrier function and inflammatory responses and compared responses of in vitro cultures of differentiated bronchial epithelial cells derived from severely asthmatic donors with those from non-asthmatic controls. Polarised 16HBE cells or air-liquid interface (ALI) bronchial epithelial cultures from non-asthmatic or severe asthmatic donors were challenged apically with extracts of Alternaria and changes in inflammatory cytokine release and transepithelial electrical resistance (TER) were measured. Protease activity in Alternaria extracts was characterised and the effect of selectively inhibiting protease activity on epithelial responses was examined using protease inhibitors and heat-treatment. In 16HBE cells, Alternaria extracts stimulated release of IL-8 and TNF alpha, with concomitant reduction in TER; these effects were prevented by heat-treatment of the extracts. Examination of the effects of protease inhibitors suggested that serine proteases were the predominant class of proteases mediating these effects. ALI cultures from asthmatic donors exhibited a reduced IL-8 response to Alternaria relative to those from healthy controls, while neither responded with increased thymic stromal lymphopoietin (TSLP) release. Only cultures from asthmatic donors were susceptible to the barrier-weakening effects of Alternaria. Therefore, the bronchial epithelium of severely asthmatic individuals may be more susceptible to the deleterious effects of Alternaria.	[Leino, Marina S.; Loxham, Matthew; Blume, Cornelia; Swindle, Emily J.; Jayasekera, Nivenka P.; Dennison, Patrick W.; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.] Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci,Sir Henry Wellcome Labs, Southampton SO9 5NH, Hants, England; [Leino, Marina S.; Loxham, Matthew; Blume, Cornelia; Swindle, Emily J.; Jayasekera, Nivenka P.; Dennison, Patrick W.; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.] Univ Southampton, Fac Med, Sir Henry Wellcome Labs,Univ Hosp Southampton, Southampton NIHR Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England; [Shamji, Betty W. H.; Edwards, Matthew J.] Novartis Horsham Res Ctr, Novartis Inst Biomed Res, Horsham, W Sussex, England	University of Southampton; University of Southampton; Novartis	Loxham, M (corresponding author), Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci,Sir Henry Wellcome Labs, South Block, Southampton SO9 5NH, Hants, England.	m.loxham@soton.ac.uk	Davies, Donna E/H-2993-2012	Davies, Donna/0000-0002-5117-2991; Howarth, Peter/0000-0003-0619-7927; Swindle, Emily/0000-0003-3644-7747; Loxham, Matthew/0000-0001-6459-538X; Blume, Cornelia/0000-0001-6133-7318	European Respiratory Society; Medical Research Council, UK; MRC [G0900453] Funding Source: UKRI; Medical Research Council [G0900453] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; National Centre for the Replacement [G1001598/1] Funding Source: researchfish	European Respiratory Society; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement	This project was funded by a European Respiratory Society Long Term Fellowship to MSL, and also by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bhat RK, 2003, CLIN EXP ALLERGY, V33, P35, DOI 10.1046/j.1365-2222.2002.01481.x; Black PN, 2000, ALLERGY, V55, P501, DOI 10.1034/j.1398-9995.2000.00293.x; Blume C, 2013, EUR RESPIR J, V42, P87, DOI 10.1183/09031936.00075612; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; Carmona EM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-95; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.2307/3433608; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Doherty TA, 2012, J IMMUNOL, V188, P2622, DOI 10.4049/jimmunol.1101632; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Esch RE, 2004, J ALLERGY CLIN IMMUN, V113, P210, DOI 10.1016/j.jaci.2003.11.024; Fekkar A, 2012, J INFECT DIS, V205, P1163, DOI 10.1093/infdis/jis031; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kauffman HF, 2003, CURR ALLERGY ASTHM R, V3, P430, DOI 10.1007/s11882-003-0080-z; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Matsuwaki Y, 2007, J ALLERGY CLIN IMMUN, V119, pS137, DOI 10.1016/j.jaci.2006.11.666; Matsuwaki Y, 2009, J IMMUNOL, V183, P6708, DOI 10.4049/jimmunol.0901220; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Murai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030280; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Neukirch C, 1999, J ALLERGY CLIN IMMUN, V103, P709, DOI 10.1016/S0091-6749(99)70247-2; Neveu WA, 2011, AM J RESP CELL MOL, V45, P1133, DOI 10.1165/rcmb.2011-0054OC; O'Driscoll B Ronan, 2005, BMC Pulm Med, V5, P4, DOI 10.1186/1471-2466-5-4; OHOLLAREN MT, 1991, NEW ENGL J MED, V324, P359, DOI 10.1056/NEJM199102073240602; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Runswick S, 2007, RESPIROLOGY, V12, P834, DOI 10.1111/j.1440-1843.2007.01175.x; Shen HD, 1999, INT ARCH ALLERGY IMM, V119, P259, DOI 10.1159/000024202; Shin SH, 2006, ACTA OTO-LARYNGOL, V126, P1286, DOI 10.1080/00016480500395179; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Tai HY, 2006, ALLERGY, V61, P382, DOI 10.1111/j.1398-9995.2005.00958.x; Tomee JFC, 1997, J INFECT DIS, V176, P300, DOI 10.1086/517272; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wan H, 2001, CLIN EXP ALLERGY, V31, P279, DOI 10.1046/j.1365-2222.2001.00970.x; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zureik M, 2002, BMJ-BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411	59	54	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71278	10.1371/journal.pone.0071278	http://dx.doi.org/10.1371/journal.pone.0071278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009658	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200005
J	Leitner, J; Westerholz, S; Heinke, B; Forsthuber, L; Wunderbaldinger, G; Jager, T; Gruber-Schoffnegger, D; Braun, K; Sandkuhler, J				Leitner, Joerg; Westerholz, Soeren; Heinke, Bernhard; Forsthuber, Liesbeth; Wunderbaldinger, Gabriele; Jaeger, Tino; Gruber-Schoffnegger, Doris; Braun, Katharina; Sandkuehler, Juergen			Impaired Excitatory Drive to Spinal Gabaergic Neurons of Neuropathic Mice	PLOS ONE			English	Article							CHRONIC CONSTRICTION INJURY; GREEN FLUORESCENT PROTEIN; PERIPHERAL-NERVE INJURY; SUPERFICIAL DORSAL-HORN; SUBSTANTIA-GELATINOSA NEURONS; LAMINA-I NEURONS; GLUTAMATERGIC SYNAPSES; TERM PLASTICITY; FOS EXPRESSION; SELECTIVE LOSS	Adequate pain sensitivity requires a delicate balance between excitation and inhibition in the dorsal horn of the spinal cord. This balance is severely impaired in neuropathy leading to enhanced pain sensations (hyperalgesia). The underlying mechanisms remain elusive. Here we explored the hypothesis that the excitatory drive to spinal GABAergic neurons might be impaired in neuropathic animals. Transgenic adult mice expressing EGFP under the promoter for GAD67 underwent either chronic constriction injury of the sciatic nerve or sham surgery. In transverse slices from lumbar spinal cord we performed whole-cell patch-clamp recordings from identified GABAergic neurons in lamina II. In neuropathic animals rates of mEPSC were reduced indicating diminished global excitatory input. This downregulation of excitatory drive required a rise in postsynaptic Ca2+. Neither the density and morphology of dendritic spines on GABAergic neurons nor the number of excitatory synapses contacting GABAergic neurons were affected by neuropathy. In contrast, paired-pulse ratio of A delta- or C-fiber-evoked monosynaptic EPSCs following dorsal root stimulation was increased in neuropathic animals suggesting reduced neurotransmitter release from primary afferents. Our data indicate that peripheral neuropathy triggers Ca2+-dependent signaling pathways in spinal GABAergic neurons. This leads to a global downregulation of the excitatory drive to GABAergic neurons. The downregulation involves a presynaptic mechanism and also applies to the excitation of GABAergic neurons by presumably nociceptive A delta- and C-fibers. This then leads to an inadequately low recruitment of inhibitory interneurons during nociception. We suggest that this previously unrecognized mechanism of impaired spinal inhibition contributes to hyperalgesia in neuropathy.	[Leitner, Joerg; Heinke, Bernhard; Forsthuber, Liesbeth; Wunderbaldinger, Gabriele; Jaeger, Tino; Gruber-Schoffnegger, Doris; Sandkuehler, Juergen] Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria; [Westerholz, Soeren] Univ Magdeburg, Fac Med, Inst Physiol, D-39106 Magdeburg, Germany; [Braun, Katharina] Univ Magdeburg, Fac Nat Sci, Inst Biol, D-39106 Magdeburg, Germany	Medical University of Vienna; Otto von Guericke University; Otto von Guericke University	Sandkuhler, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X	Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung [FWF] [P19367]; Medical University of Vienna (Forderstipendium an der Medizinischen Universitat Wien)	Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung [FWF](Austrian Science Fund (FWF)); Medical University of Vienna (Forderstipendium an der Medizinischen Universitat Wien)	This project was supported by the Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung [FWF] grant P19367; www.fwf.ac.at) to JS and a scholarship from the Medical University of Vienna (Forderstipendium an der Medizinischen Universitat Wien; www.meduniwien.ac.at) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyan S, 2006, J NEUROPHYSIOL, V96, P579, DOI 10.1152/jn.00087.2006; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CARLTON SM, 1991, NEUROSCI LETT, V121, P40, DOI 10.1016/0304-3940(91)90644-9; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Dahlhaus A, 2005, J PHYSIOL-LONDON, V566, P355, DOI 10.1113/jphysiol.2005.088567; Dai Y, 2001, PAIN, V90, P287, DOI 10.1016/S0304-3959(00)00411-5; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Dougherty KJ, 2009, NEUROSCIENCE, V163, P909, DOI 10.1016/j.neuroscience.2009.06.055; Fenselau H, 2011, J NEUROSCI, V31, P17383, DOI 10.1523/JNEUROSCI.3076-11.2011; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Hantman AW, 2004, J NEUROSCI, V24, P836, DOI 10.1523/JNEUROSCI.4221-03.2004; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hegyi Z, 2009, EUR J NEUROSCI, V30, P251, DOI 10.1111/j.1460-9568.2009.06816.x; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; Herzog A, 2006, INT C MED INF VIS ME, P34; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jergova S, 2005, EUR J PAIN, V9, P345, DOI 10.1016/j.ejpain.2004.09.002; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016/S0304-3959(96)03222-8; Kobe F, 2012, J NEUROSCI, V32, P2915, DOI 10.1523/JNEUROSCI.2765-11.2012; Lee KFH, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/704103; Lind G, 2008, EUR J PAIN, V12, P132, DOI 10.1016/j.ejpain.2007.03.011; Lu VB, 2009, J PHYSIOL-LONDON, V587, P1013, DOI 10.1113/jphysiol.2008.166306; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Nagy GG, 2004, J NEUROSCI, V24, P5766, DOI 10.1523/JNEUROSCI.1237-04.2004; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Polgar E, 2003, PAIN, V104, P229, DOI 10.1016/S0304-3959(03)00011-3; Polgar E, 2004, PAIN, V111, P144, DOI 10.1016/j.pain.2004.06.011; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Ruscheweyh R, 2002, J PHYSIOL-LONDON, V541, P231, DOI 10.1113/jphysiol.2002.017756; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Schoffnegger D, 2006, J PHYSIOL-LONDON, V577, P869, DOI 10.1113/jphysiol.2006.118034; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; SPIKE RC, 1992, J COMP NEUROL, V323, P359, DOI 10.1002/cne.903230305; Tan AM, 2012, EXP NEUROL, V235, P142, DOI 10.1016/j.expneurol.2011.08.026; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; TODD AJ, 1989, NEUROSCIENCE, V31, P799, DOI 10.1016/0306-4522(89)90442-9; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yamazaki Y, 2001, BRAIN RES, V914, P106, DOI 10.1016/S0006-8993(01)02783-4; Yasaka T, 2009, J NEUROSCI, V29, P13401, DOI 10.1523/JNEUROSCI.2628-09.2009; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	56	44	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73370	10.1371/journal.pone.0073370	http://dx.doi.org/10.1371/journal.pone.0073370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009748	gold, Green Published			2022-12-25	WOS:000324403200047
J	Chenery, A; Burrows, K; Antignano, F; Underhill, TM; Petkovich, M; Zaph, C				Chenery, Alistair; Burrows, Kyle; Antignano, Frann; Underhill, T. Michael; Petkovich, Martin; Zaph, Colby			The Retinoic Acid-Metabolizing Enzyme Cyp26b1 Regulates CD4 T Cell Differentiation and Function	PLOS ONE			English	Article							TGF-BETA; EXPRESSION; RECEPTORS	The vitamin A metabolite retinoic acid (RA) has potent immunomodulatory properties that affect T cell differentiation, migration and function. However, the precise role of RA metabolism in T cells remains unclear. Catabolism of RA is mediated by the Cyp26 family of cytochrome P450 oxidases. We examined the role of Cyp26b1, the T cell-specific family member, in CD4(+) T cells. Mice with a conditional knockout of Cyp26b1 in T cells (Cyp26b1(-/-) mice) displayed normal lymphoid development but showed an increased sensitivity to serum retinoids, which led to increased differentiation under both inducible regulatory T (iT(reg)) cell- and T(H)17 cell-polarizing conditions in vitro. Further, Cyp26b1 expression was differentially regulated in iT(reg) and T(H)17 cells. Transfer of naive Cyp26b1(-/-) CD4(+) T cells into Rag1(-/-) mice resulted in significantly reduced disease in a model of T cell-dependent colitis. Our results show that T cell-specific expression of Cyp26b1 is required for the development of T cell-mediated colitis and may be applicable to the development of therapeutics that target Cyp26b1 for the treatment of inflammatory bowel disease.	[Chenery, Alistair; Burrows, Kyle; Antignano, Frann; Underhill, T. Michael; Zaph, Colby] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Chenery, Alistair; Burrows, Kyle; Zaph, Colby] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Underhill, T. Michael] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Petkovich, Martin] Queens Univ, Dept Biomol & Med Sci, Canc Res Inst, Kingston, ON, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Queens University - Canada	Zaph, C (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	colby@brc.ubc.ca		Antignano, Frann/0000-0003-0502-5330; Burrows, Kyle/0000-0001-5371-3512; Chenery, Alistair/0000-0001-8755-461X; Zaph, Colby/0000-0002-9889-9848	Canadian Institutes of Health Research [MSH-95368, MOP-89773, MOP-106623]; Canada Foundation for Innovation grant; CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation grant(Canada Foundation for Innovation); CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research grants (www.cihr.ca) (MSH-95368, MOP-89773, MOP-106623 to C.Z.) and a Canada Foundation for Innovation grant (to C.Z.). F.A. is the recipient of a CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada postdoctoral fellowship. C.Z. is a CIHR New Investigator and an MSFHR Career Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Chang SY, 2010, GASTROENTEROLOGY, V138, P1468, DOI 10.1053/j.gastro.2009.11.006; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; Dranse HJ, 2011, J CELL SCI, V124, P2723, DOI 10.1242/jcs.084699; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; HUMPHREY JH, 1992, B WORLD HEALTH ORGAN, V70, P225; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Kiss I, 2008, EUR J IMMUNOL, V38, P147, DOI 10.1002/eji.200737342; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Lu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024590; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016089; Wang CW, 2013, J EXP MED, V210, P475, DOI 10.1084/jem.20121088; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	28	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72308	10.1371/journal.pone.0072308	http://dx.doi.org/10.1371/journal.pone.0072308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991089	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700036
J	Werner, J; Griebeler, EM				Werner, Jan; Griebeler, Eva Maria			New Insights into Non-Avian Dinosaur Reproduction and Their Evolutionary and Ecological Implications: Linking Fossil Evidence to Allometries of Extant Close Relatives	PLOS ONE			English	Article							CLUTCH SIZE; ORNITHISCHIAN DINOSAURS; PHYLOGENETIC ANALYSIS; TROODON-FORMOSUS; EGG CLUTCHES; SISTER GROUP; BODY-SIZE; NEST; TURTLES; BIOLOGY	It has been hypothesized that a high reproductive output contributes to the unique gigantism in large dinosaur taxa. In order to infer more information on dinosaur reproduction, we established allometries between body mass and different reproductive traits (egg mass, clutch mass, annual clutch mass) for extant phylogenetic brackets (birds, crocodiles and tortoises) of extinct non-avian dinosaurs. Allometries were applied to nine non-avian dinosaur taxa (theropods, hadrosaurs, and sauropodomorphs) for which fossil estimates on relevant traits are currently available. We found that the reproductive traits of most dinosaurs conformed to similar-sized or scaled-up extant reptiles or birds. The reproductive traits of theropods, which are considered more bird-like, were indeed consistent with birds, while the traits of sauropodomorphs conformed better to reptiles. Reproductive traits of hadrosaurs corresponded to both reptiles and birds. Excluding Massospondylus carinatus, all dinosaurs studied had an intermediary egg to body mass relationship to reptiles and birds. In contrast, dinosaur clutch masses fitted with either the masses predicted from allometries of birds (theropods) or to the masses of reptiles (all other taxa). Theropods studied had probably one clutch per year. For sauropodomorphs and hadrosaurs, more than one clutch per year was predicted. Contrary to current hypotheses, large dinosaurs did not have exceptionally high annual egg numbers (AEN). Independent of the extant model, the estimated dinosaur AEN did not exceed 850 eggs (75,000 kg sauropod) for any of the taxa studied. This estimated maximum is probably an overestimation due to unrealistic assumptions. According to most AEN estimations, the dinosaurs studied laid less than 200 eggs per year. Only some AEN estimates obtained for medium to large sized sauropods were higher (200-400 eggs). Our results provide new (testable) hypotheses, especially for reproductive traits that are insufficiently documented or lacking from the fossil record. This contributes to the understanding of their evolution.	[Werner, Jan; Griebeler, Eva Maria] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, Mainz, Germany	Johannes Gutenberg University of Mainz	Werner, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, Saarstr 21, Mainz, Germany.	wernerja@uni-mainz.de			German Research Foundation [2625/2-1]	German Research Foundation(German Research Foundation (DFG))	The project was financed by the German Research Foundation (grant GR 2625/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1977, RESP PHYSIOL, V31, P19, DOI 10.1016/0034-5687(77)90062-7; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Birchard GF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0036; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Booth DT, 1998, AUST J ZOOL, V46, P183, DOI 10.1071/ZO98003; Booth DT, 1991, EGG INCUBATION ITS E, P117; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Carpenter K., 1999, EGGS NESTS BABY DINO; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Dol'nik VR, 2000, IZV AKAD NAUK BIOL+, P702; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferguson MWJ., 1985, BIOL REPTILIA, P451; Figuerola J, 2006, J ORNITHOL, V147, P57, DOI 10.1007/s10336-005-0017-5; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Griebeler EM, 2010, J EVOLUTION BIOL, V23, P888, DOI 10.1111/j.1420-9101.2010.01958.x; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Griebeler Eva Maria, 2011, P263; Hendriks AJ, 2008, OECOLOGIA, V155, P705, DOI 10.1007/s00442-007-0952-3; HIRTH HF, 1980, AM ZOOL, V20, P507; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 1996, NATURE, V383, P103, DOI 10.1038/383103b0; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; HOYT DF, 1979, AUK, V96, P73; Iverson J.B., 1992, HERPETOL MONOGR, V6, P25, DOI [10.2307/1466960, DOI 10.2307/1466960]; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; JANIS CM, 1991, ANN ZOOL FENN, V28, P201; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; MARTIN TE, 1992, ECOLOGY, V73, P579, DOI 10.2307/1940764; Martins EP, 2002, EVOLUTION, V56, P1; Mateus Isabel, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P101; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Olofsson H, 2009, P ROY SOC B-BIOL SCI, V276, P2963, DOI 10.1098/rspb.2009.0500; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Paul Gregory S., 1994, P244; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2012, R LANG ENV STAT COMP; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; RAHN H, 1989, J ORNITHOL, V130, P207, DOI 10.1007/BF01649755; REISS MJ, 1985, J THEOR BIOL, V113, P529, DOI 10.1016/S0022-5193(85)80037-0; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; ROHWER FC, 1988, AUK, V105, P161, DOI 10.1093/auk/105.1.161; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEYMOUR RS, 1980, AM ZOOL, V20, P437; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; SWOT, 2012, STAT WORLDS SEA TURT; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Vila B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010362; Weishampel DB., 2004, DINOSAURIA; Werner J, 2012, EVOL ECOL, V26, P1391, DOI 10.1007/s10682-011-9552-0; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zelenitsky DK, 2008, PALAEONTOLOGY, V51, P807, DOI 10.1111/j.1475-4983.2008.00770.x	73	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72862	10.1371/journal.pone.0072862	http://dx.doi.org/10.1371/journal.pone.0072862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991160	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100122
J	Zhang, JP; Zeng, C; Xu, L; Gong, J; Fang, JH; Zhuang, SM				Zhang, J-P; Zeng, C.; Xu, L.; Gong, J.; Fang, J-H; Zhuang, S-M			MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling	ONCOGENE			English	Article						miR-148a; epithelial-mesenchymal transition; metastasis; met; hepatocellular carcinoma	HEPATOCELLULAR-CARCINOMA; E-CADHERIN; PROMOTES APOPTOSIS; GASTRIC-CANCER; EXPRESSION; SNAIL; CONTRIBUTES; INVASION; BETA; MET	Metastasis is responsible for the rapid recurrence and poor survival of malignancies. Epithelial-mesenchymal transition (EMT) has a critical role in metastasis. Increasing evidence indicates that EMT can be regulated by microRNAs (miRNAs). miR-148a is a liver-abundant miRNA. However, the role of miR-148a in the development of liver cancer remains largely unknown. In this study, we found that, compared with normal livers, miR-148a was significantly decreased in hepatocellular carcinoma (HCC) tissues, especially in those with the portal vein tumor thrombus. An in vitro transwell assay and an in vivo orthotopic liver xenograft model showed that the restoration of miR-148a expression significantly repressed the migration and pulmonary metastasis of hepatoma cells. Linear regression analysis revealed a positive correlation between the expression of miR-148a and the mRNA level of E-cadherin gene in human HCC tissues. Both gain-and loss-of-function studies disclosed that miR-148a promoted the expression of epithelial marker (E-cadherin) and reduced the levels of mesenchymal markers (N-cadherin, fibronectin or vimentin) in hepatoma cells. These data suggest that miR-148a may suppress EMT and cancer metastasis. Further mechanistic investigations showed that miR-148a directly inhibited Met expression by binding to its 3'-UTR. Moreover, the reintroduction of miR-148a attenuated the downstream signaling of Met, like activated phosphorylation of AKT-Ser473 and inhibitory phosphorylation of GSK-3b-Ser9, and consequently reduced the nuclear accumulation of Snail, a transcription factor that promotes EMT. Taken together, miR-148a may negatively regulate Met/Snail signaling and therefore inhibit the EMT and metastasis of hepatoma cells. These findings highlight the significance of miR-148a downregulation in tumor progression and implicate miR-148a as an attractive candidate for cancer therapy.	[Zhang, J-P; Zeng, C.; Gong, J.; Fang, J-H; Zhuang, S-M] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, J-P; Xu, L.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Zhuang, SM (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Xin Gang Xi Rd 135, Guangzhou 510275, Guangdong, Peoples R China.	zhuangshimei@163.com	Fang, Jian-hong/HCH-6747-2022; ZHANG, JINGPING/AAT-8229-2021; zhang, jingping/AAM-2751-2021	zhang, jingping/0000-0003-0090-6710; Fang, Jian-hong/0000-0002-7723-5348; Zhuang, Shi-Mei/0000-0002-2512-3942	Ministry of Science and Technology of China [2010CB912803, 2011CB811305]; Ministry of Health of China [2012ZX10002011]; National Natural Science Foundation of China [81101593, 30925036]; Ministry of Education of China [20110171120043]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Health of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This study was supported by grants from Ministry of Science and Technology of China (2010CB912803, 2011CB811305), Ministry of Health of China (2012ZX10002011), National Natural Science Foundation of China (81101593, 30925036), Ministry of Education of China (20110171120043).	Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Gailhouste L, 2013, HEPATOLOGY, V58, P1153, DOI 10.1002/hep.26422; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Papadimitriou E, 2012, ONCOGENE, V31, P2862, DOI 10.1038/onc.2011.457; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Wei Y, 2002, HEPATOLOGY, V36, P692, DOI 10.1053/jhep.2002.35342; Xu Q, 2013, CARCINOGENESIS, V34, P539, DOI 10.1093/carcin/bgs374; Xu Q, 2013, J MOL CELL BIOL, V5, P3, DOI 10.1093/jmcb/mjs049; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Yu J, 2011, J BIOMED RES, V25, P170, DOI 10.1016/S1674-8301(11)60022-5; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	34	112	119	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 31	2014	33	31					4069	4076		10.1038/onc.2013.369	http://dx.doi.org/10.1038/onc.2013.369			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YG	24013226				2022-12-25	WOS:000340595300006
J	Cheung, GYC; Kretschmer, D; Queck, SY; Joo, HS; Wang, R; Duong, AC; Nguyen, TH; Bach, THL; Porter, AR; DeLeo, FR; Peschel, A; Otto, M				Cheung, Gordon Y. C.; Kretschmer, Dorothee; Queck, Shu Y.; Joo, Hwang-Soo; Wang, Rong; Duong, Anthony C.; Nguyen, Thuan H.; Bach, Thanh-Huy L.; Porter, Adeline R.; DeLeo, Frank R.; Peschel, Andreas; Otto, Michael			Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin ( PSM) alpha 3 peptide	FASEB JOURNAL			English	Article						Staphylococcus aureus; toxins; neutrophils; hemolysis; inflammation; biofilm	STAPHYLOCOCCUS-AUREUS; VIRULENCE DETERMINANTS; ACTIVATES NEUTROPHILS; BIOFILM MATURATION; EPIDERMIDIS; INFECTIONS; MECHANISMS; SKIN	Phenol-soluble modulins (PSMs) are a family of peptides with multiple functions in staphylococcal pathogenesis. To gain insight into the structural features affecting PSM functions, we analyzed an alanine substitution library of PSM3, a strongly cytolytic and proinflammatory PSM of Staphylococcus aureus with a significant contribution to S. aureus virulence. Lysine residues were essential for both receptor-dependent proinflammatory and receptor-independent cytolytic activities. Both phenotypes also required additional structural features, with the C terminus being crucial for receptor activation. Biofilm formation was affected mostly by hydrophobic amino acid positions, suggesting that the capacity to disrupt hydrophobic interactions is responsible for the effect of PSMs on biofilm structure. Antimicrobial activity, absent from natural PSM3, could be created by the exchange of large hydrophobic side chains, indicating that PSM3 has evolved to exhibit cytolytic rather than antimicrobial activity. In addition to gaining insight into the structure-function relationship in PSMs, our study identifies nontoxic PSM3 derivatives for active vaccination strategies and lays the foundation for future efforts aimed to understand the biological role of PSM recognition by innate host defense.Cheung, G. Y., Kretschmer, D., Queck, S. Y., Joo, H.-S., Wang, R., Duong, A. C., Nguyen, T. H., Bach, T.-H., Porter, A. R., DeLeo, F. R., Peschel, A., Otto, M. Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin (PSM) 3 peptide.	[Cheung, Gordon Y. C.; Queck, Shu Y.; Joo, Hwang-Soo; Wang, Rong; Duong, Anthony C.; Nguyen, Thuan H.; Bach, Thanh-Huy L.; Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Kretschmer, Dorothee; Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Cellular & Mol Microbiol Div, Tubingen, Germany; [Porter, Adeline R.; DeLeo, Frank R.] NIAID, Pathogen Host Cell Biol Sect, Lab Human Bacterial Pathogenesis, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Eberhard Karls University of Tubingen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), NIAID, 9000 Rockville Pike,Bldg 33 1W10, Bethesda, MD 20892 USA.	motto@niaid.nih.gov		DeLeo, Frank/0000-0003-3150-2516; JOO, HWANG-SOO/0000-0003-4668-3225; Otto, Michael/0000-0002-2222-4115	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH); German Research Foundation [SFB685, TRR34]; German Ministry of Education and Research; Interdisziplin res Zentrum fur Klinische Forschung (IZKF) Program of the Medical Faculty, University of Tubingen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001079, ZIAAI000904] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH); German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Interdisziplin res Zentrum fur Klinische Forschung (IZKF) Program of the Medical Faculty, University of Tubingen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Nele Nikola, Kevin Holmes, and David Stephany for technical help; Michael Dolan for PSM alpha 3 modeling; Francois Boulay (Commissariat a l'Energie Atomique, Grenoble, France) for FPR1 and FPR2-transfected cell lines; and Bas Surewaard for advice on the in vivo studies. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH) (to M.O. and F. D.), and grants from the German Research Foundation (SFB685, TRR34), the German Ministry of Education and Research (SkinStaph, Menage), and the Interdisziplin res Zentrum fur Klinische Forschung (IZKF) Program of the Medical Faculty, University of Tubingen (to A.P.).	Cassat JE, 2013, CELL HOST MICROBE, V13, P759, DOI 10.1016/j.chom.2013.05.003; Chatterjee SS, 2013, NAT MED, V19, P364, DOI 10.1038/nm.3047; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; GLADSTONE GP, 1967, BRIT J EXP PATHOL, V48, P11; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Otto M, 2008, BIODRUGS, V22, P27, DOI 10.2165/00063030-200822010-00003; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Periasamy Saravanan, 2012, Commun Integr Biol, V5, P275, DOI 10.4161/cib.19420; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Pokorny A, 2002, BIOCHEMISTRY-US, V41, P11044, DOI 10.1021/bi020244r; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Rasigade J. P., 2013, PLOS ONE, V8; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; WATSON DC, 1988, BIOCHEM J, V252, P87, DOI 10.1042/bj2520087; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	39	47	49	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					153	161		10.1096/fj.13-232041	http://dx.doi.org/10.1096/fj.13-232041			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24008753	Green Published			2022-12-25	WOS:000333526100017
J	Li, XZ; Yu, Y; Funk, CD				Li, Xinzhi; Yu, Ying; Funk, Colin D.			Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4)	FASEB JOURNAL			English	Article						omega 3 polyunsaturated fatty acids; prostaglandin; inflammation; GPR120	PROLIFERATOR-ACTIVATED RECEPTORS; SIGNALING PATHWAYS; RESOLVIN D1; EICOSAPENTAENOIC ACID; GENE-TRANSCRIPTION; INSULIN-SECRETION; GPR120; INFLAMMATION; CELLS; EXPRESSION	Cyclooxygenase-2 (COX-2)-derived prostaglandins are implicated in numerous inflammatory disorders. The purpose of these studies was to examine previously unexplored interactions between COX-2 induction and docosahexaenoic acid (DHA) via the free fatty acid receptor 4 (FFA4) signaling pathway in murine RAW 264.7 cells and peritoneal macrophages challenged with lipopolysaccharide (LPS). DHA dose (IC50 = 18 mu M)- and time-dependently reduced COX-2 expression, without affecting COX-1. DHA (25 mu M for 24 h) decreased LPS-induced prostaglandin E-2 (PGE(2)) synthesis by 81%, primarily through reducing COX-2 (60%), as well as down-regulating microsomal prostaglandin E synthase-1 (46%), but independently of peroxisome proliferator-activated receptors. FFA4 knockdown abrogated DHA effects on COX-2 induction, PGE2 production, and interleukin 6 (IL-6) gene expression. In the presence of inhibitors of eicosanoid metabolism via COX-2, 12/15-lipoxygenase and CYP450s (rofecoxib (1 mu M), PD146176 (2 mu M), or MS-PPOH (20 mu M)), DHA was still effective in attenuating COX-2 induction. Moreover, Toll-like receptor 4 signaling via Akt/JNK phosphorylation and p65 nuclear translocation was repressed by DHA-activated FFA4 coupling with beta-arrestin 2, which was reversed by FFA4 knockdown. These data support DHA modulation of COX-2 expression and activity, in part, via FFA4, which provides a new mechanistic explanation for some of the anti-inflammatory effects of DHA.	[Li, Xinzhi; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Yu, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China	Queens University - Canada; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,Rm 433,18 Stuart St, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca	Li, Xinzhi/X-2650-2019	Funk, Colin/0000-0001-7029-4233	Heart and Stroke Foundation of Ontario; Canadian Institutes for Health Research [CCI 117951]; National Natural Science Foundation of China [NSFC 81161120538]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. A. Craig (Cancer Research Institute, Queen's University, Kingston, ON, Canada) for supplying RAW 264.7 cells. This work was supported by the Joint Health Research Initiative between the Canadian Institutes for Health Research and the National Natural Science Foundation of China (CCI 117951 and NSFC 81161120538). C. D. F. holds a Tier I Canada Research Chair in Molecular, Cellular, and Physiological Medicine and is the recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Bezugla Y, 2006, PROSTAG OTH LIPID M, V79, P93, DOI 10.1016/j.prostaglandins.2005.11.001; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burns RN, 2010, BIOCHEM BIOPH RES CO, V396, P1030, DOI 10.1016/j.bbrc.2010.05.057; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; DEWITT DL, 1993, ARCH BIOCHEM BIOPHYS, V306, P94, DOI 10.1006/abbi.1993.1485; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hui YQ, 2010, CIRCULATION, V121, P2654, DOI 10.1161/CIRCULATIONAHA.109.910687; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Katsuma S, 2005, J BIOL CHEM, V280, P19507, DOI 10.1074/jbc.M412385200; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Massaro M, 2006, P NATL ACAD SCI USA, V103, P15184, DOI 10.1073/pnas.0510086103; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Matsumura S, 2007, BIOMED RES-TOKYO, V28, P49, DOI 10.2220/biomedres.28.49; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; Nguyen CA, 2012, CURR MED CHEM, V19, P28; Ni NC, 2011, J PHARMACOL EXP THER, V339, P768, DOI 10.1124/jpet.111.186031; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; RIESE J, 1994, J LEUKOCYTE BIOL, V55, P476, DOI 10.1002/jlb.55.4.476; Ringbom T, 2001, J NAT PROD, V64, P745, DOI 10.1021/np000620d; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; SHERRY B, 1988, J EXP MED, V168, P2251, DOI 10.1084/jem.168.6.2251; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Smith WL, 2005, CURR OPIN CELL BIOL, V17, P174, DOI 10.1016/j.ceb.2005.02.005; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spite M, 2009, BRIT J PHARMACOL, V158, P1062, DOI 10.1111/j.1476-5381.2009.00234.x; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yu Y., 2012, SCI TRANSL MED, V4; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027; ZHANG CL, 1992, THROMB RES, V65, P65	52	66	70	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4987	4997		10.1096/fj.13-235333	http://dx.doi.org/10.1096/fj.13-235333			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24005906				2022-12-25	WOS:000329999000032
J	Schulte, B; John, I; Simon, B; Brockmann, C; Oelmeier, SA; Jahraus, B; Kirchgessner, H; Riplinger, S; Carlomagno, T; Wabnitz, GH; Samstag, Y				Schulte, Bianca; John, Isabel; Simon, Bernd; Brockmann, Christoph; Oelmeier, Stefan A.; Jahraus, Beate; Kirchgessner, Henning; Riplinger, Selina; Carlomagno, Teresa; Wabnitz, Guido H.; Samstag, Yvonne			A Reducing Milieu Renders Cofilin Insensitive to Phosphatidylinositol 4,5-Bisphosphate (PIP2) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; ACTIN-DEPOLYMERIZING FACTOR; DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; CARCINOMA-CELLS; FORCE-FIELD; DEPHOSPHORYLATION; CYTOSKELETON	Oxidative stress can lead to T cell hyporesponsiveness. A reducing micromilieu (e. g. provided by dendritic cells) can rescue T cells from such oxidant-induced dysfunction. However, the reducing effects on proteins leading to restored T cell activation remained unknown. One key molecule of T cell activation is the actin-remodeling protein cofilin, which is dephosphorylated on serine 3 upon T cell costimulation and has an essential role in formation of mature immune synapses between T cells and antigen-presenting cells. Cofilin is spatiotemporally regulated; at the plasma membrane, it can be inhibited by phosphatidylinositol 4,5-bisphosphate (PIP2). Here, we show by NMR spectroscopy that a reducing milieu led to structural changes in the cofilin molecule predominantly located on the protein surface. They overlapped with the PIP2-but not actin-binding sites. Accordingly, reduction of cofilin had no effect on F-actin binding and depolymerization and did not influence the cofilin phosphorylation state. However, it did prevent inhibition of cofilin activity through PIP2. Therefore, a reducing milieu may generate an additional pool of active cofilin at the plasma membrane. Consistently, in-flow microscopy revealed increased actin dynamics in the immune synapse of untransformed human T cells under reducing conditions. Altogether, we introduce a novel mechanism of redox regulation: reduction of the actin-remodeling protein cofilin renders it insensitive to PIP2 inhibition, resulting in enhanced actin dynamics.	[Schulte, Bianca; John, Isabel; Jahraus, Beate; Kirchgessner, Henning; Riplinger, Selina; Wabnitz, Guido H.; Samstag, Yvonne] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany; [Simon, Bernd; Brockmann, Christoph; Carlomagno, Teresa] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Oelmeier, Stefan A.] Karlsruhe Inst Technol, Inst Proc Engn Life Sci, Sect Biomol Separat Engn 4, D-76131 Karlsruhe, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Karlsruhe Institute of Technology	Samstag, Y (corresponding author), Heidelberg Univ, Inst Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	yvonne.samstag@urz.uni-heidelberg.de		Carlomagno, Teresa/0000-0002-2437-2760; Oelmeier, Stefan/0000-0001-6863-8375; Wabnitz, Guido/0000-0001-5101-9885; Schulte, Bianca/0000-0003-1096-3751; Simon, Bernd/0000-0003-0164-5516	German Research Foundation [SFB 938, DFG Sa393/3-4]	German Research Foundation(German Research Foundation (DFG))	This work was supported in part by German Research Foundation Grants SFB 938 and DFG Sa393/3-4.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Allen PG, 1997, FEBS LETT, V401, P89, DOI 10.1016/S0014-5793(96)01439-1; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Goddard T., 2007, SPARKY 3 VERSION 3 1; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Goyal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071769; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; Martner A, 2011, J IMMUNOL, V187, P6243, DOI 10.4049/jimmunol.1102138; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Pfannstiel J, 2001, J BIOL CHEM, V276, P49476, DOI 10.1074/jbc.M104760200; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; SAMSTAG Y, 1992, INT IMMUNOL, V4, P1255, DOI 10.1093/intimm/4.11.1255; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027227; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wabnitz GH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.36; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; Zhao HX, 2010, BIOPHYS J, V98, P2327, DOI 10.1016/j.bpj.2010.01.046	36	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29430	29439		10.1074/jbc.M113.479766	http://dx.doi.org/10.1074/jbc.M113.479766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003227	hybrid, Green Published			2022-12-25	WOS:000330615300021
J	Hirose, S; Kimura, HM; Jimura, K; Kunimatsu, A; Abe, O; Ohtomo, K; Miyashita, Y; Konishi, S				Hirose, Satoshi; Kimura, Hiroko M.; Jimura, Koji; Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni; Miyashita, Yasushi; Konishi, Seiki			Dissociable Temporo-Parietal Memory Networks Revealed by Functional Connectivity during Episodic Retrieval	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; AGE-RELATED DIFFERENCES; DEFAULT-MODE NETWORK; EVENT-RELATED FMRI; HUMAN BRAIN; RECOGNITION MEMORY; NEURAL BASIS; LOBE CONTRIBUTIONS; RECENCY JUDGMENTS; EXECUTIVE CONTROL	Episodic memory retrieval most often recruits multiple separate processes that are thought to involve different temporal regions. Previous studies suggest dissociable regions in the left lateral parietal cortex that are associated with the retrieval processes. Moreover, studies using resting-state functional connectivity (RSFC) have provided evidence for the temporoparietal memory networks that may support the retrieval processes. In this functional MRI study, we tested functional significance of the memory networks by examining functional connectivity of brain activity during episodic retrieval in the temporal and parietal regions of the memory networks. Recency judgments, judgments of the temporal order of past events, can be achieved by at least two retrieval processes, relational and item-based. Neuroimaging results revealed several temporal and parietal activations associated with relational/item-based recency judgments. Significant RSFC was observed between one parahippocampal region and one left lateral parietal region associated with relational recency judgments, and between four lateral temporal regions and another left lateral parietal region associated with item-based recency judgments. Functional connectivity during task was found to be significant between the parahippocampal region and the parietal region in the RSFC network associated with relational recency judgments. However, out of the four tempo-parietal RSFC networks associated with item-based recency judgments, only one of them (between the left posterior lateral temporal region and the left lateral parietal region) showed significant functional connectivity during task. These results highlight the contrasting roles of the parahippocampal and the lateral temporal regions in recency judgments, and suggest that only a part of the tempo-parietal RSFC networks are recruited to support particular retrieval processes.	[Hirose, Satoshi; Kimura, Hiroko M.; Jimura, Koji; Miyashita, Yasushi; Konishi, Seiki] Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; [Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni] Univ Tokyo, Sch Med, Dept Radiol, Tokyo 113, Japan; [Hirose, Satoshi; Konishi, Seiki] Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan; [Jimura, Koji] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan	University of Tokyo; University of Tokyo; Juntendo University; Tokyo Institute of Technology	Hirose, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	sahirose@m.u-tokyo.ac.jp; konishi@m.u-tokyo.ac.jp	Kunimatsu, Akira/AAC-8617-2019; Miyashita, Yasushi/B-7171-2019	Kunimatsu, Akira/0000-0002-7141-2585; Miyashita, Yasushi/0000-0003-3496-8637; Abe, Osamu/0000-0002-1180-2629	Ministry of Education, Culture, Sports, Science and Technology, Japan [19002010, 22300134, 12601-A03]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Specially Promoted Research (19002010) to Y. M. and a Grant-in-Aid for Scientific Research B (22300134) to S. K., Global COE Program "Integrative Life Science Based on the Study of Biosignaling Mechanisms" (12601-A03) to Y. M. from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2012, J NEUROSCI, V32, P8254, DOI 10.1523/JNEUROSCI.0305-12.2012; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dudukovic NM, 2007, NEUROPSYCHOLOGIA, V45, P2608, DOI 10.1016/j.neuropsychologia.2007.02.025; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Evans LH, 2012, J NEUROSCI, V32, P7253, DOI 10.1523/JNEUROSCI.6396-11.2012; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fujii T, 2004, NEUROIMAGE, V21, P1596, DOI 10.1016/j.neuroimage.2004.01.005; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greve A, 2010, J NEUROSCI, V30, P7099, DOI 10.1523/JNEUROSCI.0345-10.2010; Grove KL, 2009, J COGNITIVE NEUROSCI, V21, P461, DOI 10.1162/jocn.2009.21040; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Hintzman DL, 2001, J EXP PSYCHOL LEARN, V27, P1347, DOI 10.1037//0278-7393.27.6.1347; Hirose S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036496; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Iidaka T, 2006, CEREB CORTEX, V16, P1349, DOI 10.1093/cercor/bhl040; Jimura K, 2009, EUR J NEUROSCI, V29, P1915, DOI 10.1111/j.1460-9568.2009.06731.x; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Kimura HM, 2010, NEUROIMAGE, V49, P3474, DOI 10.1016/j.neuroimage.2009.11.003; Konishi S, 2006, CEREB CORTEX, V16, P469, DOI 10.1093/cercor/bhi126; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Konishi S, 2002, J NEUROSCI, V22, P9549; Konishi S, 1999, CEREB CORTEX, V9, P745, DOI 10.1093/cercor/9.7.745; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Mennes M, 2013, CEREB CORTEX, V23, P223, DOI 10.1093/cercor/bhs010; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rajah MN, 2008, BRAIN RES, V1199, P111, DOI 10.1016/j.brainres.2007.12.051; Rajah MN, 2008, NEUROPSYCHOLOGIA, V46, P1088, DOI 10.1016/j.neuropsychologia.2007.10.023; Rajah MN, 2006, NEUROPSYCHOLOGIA, V44, P350, DOI 10.1016/j.neuropsychologia.2005.06.003; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Seghier ML, 2008, NEUROIMAGE, V42, P1226, DOI 10.1016/j.neuroimage.2008.05.029; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Suzuki M, 2002, NEUROIMAGE, V17, P1790, DOI 10.1006/nimg.2002.1303; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Tsukiura T, 2006, NEUROIMAGE, V30, P617, DOI 10.1016/j.neuroimage.2005.09.043; Tsukiura T, 2002, J COGNITIVE NEUROSCI, V14, P922, DOI 10.1162/089892902760191144; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vilberg KL, 2007, NEUROPSYCHOLOGIA, V45, P2216, DOI 10.1016/j.neuropsychologia.2007.02.027; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2010, J NEUROPHYSIOL, V103, P793, DOI 10.1152/jn.00546.2009; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Watanabe T, 2012, J NEUROSCI, V32, P9659, DOI 10.1523/JNEUROSCI.5553-11.2012; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088; Zorrilla LTE, 1996, NEUROREPORT, V7, P2803	89	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71210	10.1371/journal.pone.0071210	http://dx.doi.org/10.1371/journal.pone.0071210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009657	gold, Green Submitted, Green Published			2022-12-25	WOS:000323734600003
J	Stolk, A; Hunnius, S; Bekkering, H; Toni, I				Stolk, Arjen; Hunnius, Sabine; Bekkering, Harold; Toni, Ivan			Early Social Experience Predicts Referential Communicative Adjustments in Five-Year-Old Children	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; YOUNG-CHILDREN; MIND; LANGUAGE; SIBLINGS; SPEECH; SKILLS; LEARN; OLDER; TASK	A large body of work has focused on children's ability to attribute mental states to other people, and whether these abilities are influenced by the extent and nature of children's social interactions. However, it remains largely unknown which developmental factors shape children's ability to influence the mental states of others. Building on the suggestion that collaborative experiences early in life might be crucial for the emergence of mental coordination abilities, here we assess the relative contribution of social exposure to familial and non-familial agents on children's communicative adjustments to their mental model of an addressee ('audience design'). During an online interactive game, five-year-olds spontaneously organized their non-verbal communicative behaviors according to their beliefs about an interlocutor. The magnitude of these communicative adjustments was predicted by the time spent at daycare, from birth until four years of age, over and above effects of familial social environment. These results suggest that the degree of non-familial social interaction early in life modulates the influence that children's beliefs have on their referential communicative behavior.	[Stolk, Arjen; Hunnius, Sabine; Bekkering, Harold; Toni, Ivan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Stolk, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.stolk@donders.ru.nl	Hunnius, Sabine/D-5834-2012; Toni, Ivan/D-1980-2009; Stolk, Arjen/F-5964-2013; Bekkering, Harold/A-6357-2009	Toni, Ivan/0000-0003-0936-3601; Stolk, Arjen/0000-0003-3798-4923	Netherlands Organisation for Scientific Research [453-08-002]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by a VICI grant #453-08-002 from The Netherlands Organisation for Scientific Research to I. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Clark H.H., 1996, USING LANGUAGE; Cole K, 2000, BRIT J DEV PSYCHOL, V18, P279, DOI 10.1348/026151000165698; Cutting AL, 1999, CHILD DEV, V70, P853, DOI 10.1111/1467-8624.00061; de Rosnay M, 2006, BRIT J DEV PSYCHOL, V24, P7, DOI 10.1348/02615005X82901; de Ruiter JP, 2010, INTERACT STUD, V11, P51, DOI 10.1075/is.11.1.05rui; DUNN J, 1989, CHILD DEV, V60, P399, DOI 10.2307/1130985; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Holmes HA, 1996, J EXP CHILD PSYCHOL, V63, P263, DOI 10.1006/jecp.1996.0050; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Lewis C, 1996, CHILD DEV, V67, P2930, DOI 10.2307/1131760; MARATSOS MP, 1973, CHILD DEV, V44, P697; Marshall PJ, 2010, NEURAL NETWORKS, V23, P1017, DOI 10.1016/j.neunet.2010.07.007; Newman-Norlund SE, 2009, COGNITION, V111, P46, DOI 10.1016/j.cognition.2008.12.004; Nilsen ES, 2008, DEVELOPMENTAL SCI, V11, P556, DOI 10.1111/j.1467-7687.2008.00701.x; Nilsen ES, 2012, CHILD DEV, V83, P1400, DOI 10.1111/j.1467-8624.2012.01762.x; Nilsen ES, 2009, COGNITIVE PSYCHOL, V58, P220, DOI 10.1016/j.cogpsych.2008.07.002; OshimaTakane Y, 1996, CHILD DEV, V67, P621; OSHIMATAKANE Y, 1988, J CHILD LANG, V15, P95, DOI 10.1017/S0305000900012071; PERNER J, 1994, CHILD DEV, V65, P1228, DOI 10.1111/j.1467-8624.1994.tb00814.x; Peterson CC, 2000, MIND LANG, V15, P123, DOI 10.1111/1468-0017.00126; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ronald A, 2006, SOC NEUROSCI-UK, V1, P412, DOI 10.1080/17470910601068088; Rubio-Fernandez P, 2013, PSYCHOL SCI, V24, P27, DOI 10.1177/0956797612447819; Ruffman T, 1998, DEV PSYCHOL, V34, P161, DOI 10.1037/0012-1649.34.1.161; SHATZ M, 1973, MONOGR SOC RES CHILD, V38, P1, DOI 10.2307/1165783; Tomasello M, 2008, JEAN NICOD LECT, P1; van IJzendoorn M. H., 1992, PARENT ROLE OTHER AD, V1992, P5, DOI DOI 10.1002/CD.23219925703; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304	35	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72667	10.1371/journal.pone.0072667	http://dx.doi.org/10.1371/journal.pone.0072667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009696	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600032
J	Li, B; Li, JB; Xiao, XF; Ma, YF; Wang, J; Liang, XX; Zhao, HX; Jiang, F; Yao, YQ; Wang, XH				Li, Bo; Li, Jian-Bo; Xiao, Xi-feng; Ma, Ye-fei; Wang, Jun; Liang, Xin-xin; Zhao, Hong-xi; Jiang, Feng; Yao, Yuan-qing; Wang, Xiao-hong			Altered DNA Methylation Patterns of the H19 Differentially Methylated Region and the DAZL Gene Promoter Are Associated with Defective Human Sperm	PLOS ONE			English	Article							MALE-INFERTILITY; SPERMATOGENIC FAILURE; EXPRESSION; MOUSE; IGF2; TRANSCRIPT; BINDING; ARREST; CANCER; COMMON	DNA methylation disturbance is associated with defective human sperm. However, oligozoospermia (OZ) and asthenozoospermia (AZ) usually present together, and the relationship between the single-phenotype defects in human sperm and DNA methylation is poorly understood. In this study, 20 infertile OZ patients and 20 infertile AZ patients were compared with 20 fertile normozoospermic men. Bisulfate-specific PCR was used to analyze DNA methylation of the H19-DMR and the DAZL promoter in these subjects. A similar DNA methylation pattern of the H19-DMR was detected in AZ and NZ(control), with only complete methylation and mild hypomethylation(<50% unmethylated CpGs) identified, and there was no significant difference in the occurrence of these two methylation patterns between AZ and NZ (P>0.05). However, the methylation pattern of severe hypomethylation (>50% unmethylated CpGs) and complete unmethylation was only detected in 5 OZ patients, and the occurrence of these two methylation patterns was 8.54 +/- 10.86% and 9 +/- 6.06%, respectively. Loss of DNA methylation of the H19-DMR in the OZ patients was found to mainly occur in CTCF-binding site 6, with occurrence of 18.15 +/- 14.71%, which was much higher than that in patients with NZ (0.84 +/- 2.05%) and AZ (0.58 +/- 1.77%) (P<0.001). Additional, our data indicated the occurrence of >20% methylated clones in the DAZL promoter only in infertile patients, there was no significant difference between the AZ and OZ patients in the proportion of moderately-to-severely hypermethylated clones (p>0.05). In all cases, global sperm genome methylation analyses, using LINE1 transposon as the indicator, showed that dysregulation of DNA methylation is specifically associated with the H19-DMR and DAZL promoter. Therefore, abnormal DNA methylation status of H19-DMR, especially at the CTCF-binding site 6, is closely associated with OZ. Abnormal DNA methylation of the DAZL promoter might represent an epigenetic marker of male infertility.	[Li, Bo; Li, Jian-Bo; Xiao, Xi-feng; Ma, Ye-fei; Wang, Jun; Liang, Xin-xin; Zhao, Hong-xi; Jiang, Feng; Wang, Xiao-hong] Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China; [Yao, Yuan-qing] Gen Hosp Chinese Peoples Liberat Army, Dept Obstet & Gynecol, Beijing, Peoples R China	Air Force Military Medical University	Wang, XH (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China.	yqyao@126.com; xhwang_1968@126.com		YAO, YUANQING/0000-0001-5942-4121; Li, Bo/0000-0001-7818-0070	National Natural Science Foundation of China [81300531]; National Science and Technology Support program (the 12th Five-year Plan) of China [2012BAI32B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support program (the 12th Five-year Plan) of China	The National Natural Science Foundation of China (Grant No. 81300531) and the National Science and Technology Support program (the 12th Five-year Plan) of China (Grant No. 2012BAI32B01) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khtib M, 2011, FERTIL STERIL, V95, P1955, DOI 10.1016/j.fertnstert.2011.02.029; Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; Arney KL, 2003, TRENDS GENET, V19, P17, DOI 10.1016/S0168-9525(02)00004-5; Banerjee S, 2000, MECH DEVELOP, V90, P217, DOI 10.1016/S0925-4773(99)00254-3; Bartholdi D, 2009, J MED GENET, V46, P192, DOI 10.1136/jmg.2008.061820; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Bjornsson HT, 2004, COLD SPRING HARB SYM, V69, P447, DOI 10.1101/sqb.2004.69.447; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Chai NN, 1997, MOL HUM REPROD, V3, P705, DOI 10.1093/molehr/3.8.705; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gianotten J, 2004, HUM REPROD UPDATE, V10, P533, DOI 10.1093/humupd/dmh045; Gronskov K, 2011, J MED GENET, V48, P308, DOI 10.1136/jmg.2010.086504; HARGREAVE TB, 1986, BRIT J UROL, V58, P188, DOI 10.1111/j.1464-410X.1986.tb09024.x; Houston DW, 2000, DEVELOPMENT, V127, P447; Hwang K, 2011, NAT REV UROL, V8, P86, DOI 10.1038/nrurol.2010.230; Karashima T, 2000, DEVELOPMENT, V127, P1069; Le Bouc Y, 2010, ANN ENDOCRINOL-PARIS, V71, P237, DOI 10.1016/j.ando.2010.02.004; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Lin YM, 2002, FERTIL STERIL, V77, P626, DOI 10.1016/S0015-0282(01)03226-5; Lin YM, 2001, MOL HUM REPROD, V7, P1015, DOI 10.1093/molehr/7.11.1015; Liu DY, 2007, HUM REPROD, V22, P1878, DOI 10.1093/humrep/dem087; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Netchine I, 2007, J CLIN ENDOCR METAB, V92, P3148, DOI 10.1210/jc.2007-0354; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Raheem AA, 2012, J CLIN UROL, V5, P254, DOI 10.1016/j.bjmsu.2012.06.003; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Suzuki J, 2011, BIOL REPROD, V84, P947, DOI 10.1095/biolreprod.110.087833; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Teng YN, 2006, FERTIL STERIL, V86, P129, DOI 10.1016/j.fertnstert.2005.12.027; Teng YN, 2012, HUM REPROD, V27, P2857, DOI 10.1093/humrep/des227; VANGURP RJHLM, 1994, JNCI-J NATL CANCER I, V86, P1070, DOI 10.1093/jnci/86.14.1070; Vogel T, 2002, MOL HUM REPROD, V8, P797, DOI 10.1093/molehr/8.9.797; Woodcock DM, 1997, J BIOL CHEM, V272, P7810, DOI 10.1074/jbc.272.12.7810; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	43	32	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71215	10.1371/journal.pone.0071215	http://dx.doi.org/10.1371/journal.pone.0071215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015185	gold, Green Published, Green Submitted			2022-12-25	WOS:000323733800007
J	Pigozzo, SR; Da Re, L; Romualdi, C; Mazzara, PG; Galletta, E; Fletcher, S; Wilton, SD; Vitiello, L				Pigozzo, Sarah R.; Da Re, Lorena; Romualdi, Chiara; Mazzara, Pietro G.; Galletta, Eva; Fletcher, Sue; Wilton, Stephen D.; Vitiello, Libero			Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal	PLOS ONE			English	Article							SOMATIC REVERSION SUPPRESSION; POSITIVE FIBERS; GENE TRANSCRIPTS; CELL-POPULATION; REGENERATION; PHENOTYPE; EXPANSION; DELETIONS; MUTATION; FRAME	Muscles in Duchenne dystrophy patients are characterized by the absence of dystrophin, yet transverse sections show a small percentage of fibers (termed "revertant fibers") positive for dystrophin expression. This phenomenon, whose biological bases have not been fully elucidated, is present also in the murine and canine models of DMD and can confound the evaluation of therapeutic approaches. We analyzed 11 different muscles in a cohort of 40 mdx mice, the most commonly model used in pre-clinical studies, belonging to four age groups; such number of animals allowed us to perform solid ANOVA statistical analysis. We assessed the average number of dystrophin-positive fibers, both absolute and normalized for muscle size, and the correlation between their formation and the ageing process. Our results indicate that various muscles develop different numbers of revertant fibers, with different time trends; besides, they suggest that the biological mechanism(s) behind dystrophin re-expression might not be limited to the early development phases but could actually continue during adulthood. Importantly, such finding was seen also in cardiac muscle, a fact that does not fit into the current hypothesis of the clonal origin of "revertant" myonuclei from satellite cells. This work represents the largest, statistically significant analysis of revertant fibers in mdx mice so far, which can now be used as a reference point for improving the evaluation of therapeutic approaches for DMD. At the same time, it provides new clues about the formation of revertant fibers/cardiomyocytes in dystrophic skeletal and cardiac muscle.	[Pigozzo, Sarah R.; Fletcher, Sue; Wilton, Stephen D.] Univ Western Australia, Queen Elizabeth II Med Ctr, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; [Pigozzo, Sarah R.; Da Re, Lorena; Romualdi, Chiara; Mazzara, Pietro G.; Galletta, Eva; Vitiello, Libero] Univ Padua, Dept Biol, Padua, Italy	University of Western Australia; University of Padua	Wilton, SD (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia.	steve.wilton@uwa.edu.au; libero.vitiello@bio.unipd.it	Romualdi, Chiara/K-1132-2016; Vitiello, Libero/AAJ-6962-2021	Romualdi, Chiara/0000-0003-4792-9047; Vitiello, Libero/0000-0003-0017-0838; Fletcher, Sue/0000-0002-8632-641X; Wilton, Steve/0000-0002-9400-893X	Italian Ministry of University and Research	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	Italian Ministry of University and Research (funds ex60% to LV); Donation from Royal Bank of Canada Investor Services to LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; BURROW KL, 1991, NEUROLOGY, V41, P661, DOI 10.1212/WNL.41.5.661; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; FANIN M, 1995, MUSCLE NERVE, V18, P1115, DOI 10.1002/mus.880181007; FANIN M, 1992, NEUROMUSCULAR DISORD, V2, P41, DOI 10.1016/0960-8966(92)90025-2; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; NICHOLSON LVB, 1993, NEUROMUSCULAR DISORD, V3, P525, DOI 10.1016/0960-8966(93)90109-W; NICHOLSON LVB, 1992, J MED GENET, V29, P892, DOI 10.1136/jmg.29.12.892; PARTRIDGE T, 2008, RECENT ADV SKELETAL, P93; Publishing S, 2009, SAS STAT 9 2 US GUID; Schatzberg SJ, 1998, MUSCLE NERVE, V21, P991, DOI 10.1002/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.3.CO;2-S; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; THANH LT, 1995, AM J HUM GENET, V56, P725; UCHINO M, 1995, J NEUROL SCI, V129, P44, DOI 10.1016/0022-510X(94)00245-J; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; Wertz K, 1998, DEV DYNAM, V212, P229, DOI 10.1002/(SICI)1097-0177(199806)212:2<229::AID-AJA7>3.0.CO;2-J; Wilton SD, 1997, MUSCLE NERVE, V20, P728; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Yokota T, 2006, J CELL SCI, V119, P2679, DOI 10.1242/jcs.03000	27	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72147	10.1371/journal.pone.0072147	http://dx.doi.org/10.1371/journal.pone.0072147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015212	Green Published, gold			2022-12-25	WOS:000323733800031
J	Jellema, RK; Wolfs, TGAM; Passos, VL; Zwanenburg, A; Ophelders, DRMG; Kuypers, E; Hopman, AHN; Dudink, J; Steinbusch, HW; Andriessen, P; Germeraad, WTV; Vanderlocht, J; Kramer, BW				Jellema, Reint K.; Wolfs, Tim G. A. M.; Passos, Valeria Lima; Zwanenburg, Alex; Ophelders, Daan R. M. G.; Kuypers, Elke; Hopman, Anton H. N.; Dudink, Jeroen; Steinbusch, Harry W.; Andriessen, Peter; Germeraad, Wilfred T. V.; Vanderlocht, Joris; Kramer, Boris W.			Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-Ischemia	PLOS ONE			English	Article							WHITE-MATTER; EXPERIMENTAL STROKE; PROGENITOR CELLS; INJURY; TRANSPLANTATION; VULNERABILITY; INFLAMMATION; CONTRIBUTES; HYPOTHERMIA; LYMPHOCYTE	Hypoxic-ischemic encephalopathy (HIE) in preterm infants is a severe disease for which no curative treatment is available. Cerebral inflammation and invasion of activated peripheral immune cells have been shown to play a pivotal role in the etiology of white matter injury, which is the clinical hallmark of HIE in preterm infants. The objective of this study was to assess the neuroprotective and anti-inflammatory effects of intravenously delivered mesenchymal stem cells (MSC) in an ovine model of HIE. In this translational animal model, global hypoxia-ischemia (HI) was induced in instrumented preterm sheep by transient umbilical cord occlusion, which closely mimics the clinical insult. Intravenous administration of 2 x 10(6) MSC/kg reduced microglial proliferation, diminished loss of oligodendrocytes and reduced demyelination, as determined by histology and Diffusion Tensor Imaging (DTI), in the preterm brain after global HI. These anti-inflammatory and neuroprotective effects of MSC were paralleled by reduced electrographic seizure activity in the ischemic preterm brain. Furthermore, we showed that MSC induced persistent peripheral T-cell tolerance in vivo and reduced invasion of T-cells into the preterm brain following global HI. These findings show in a preclinical animal model that intravenously administered MSC reduced cerebral inflammation, protected against white matter injury and established functional improvement in the preterm brain following global HI. Moreover, we provide evidence that induction of T-cell tolerance by MSC might play an important role in the neuroprotective effects of MSC in HIE. This is the first study to describe a marked neuroprotective effect of MSC in a translational animal model of HIE.	[Jellema, Reint K.; Ophelders, Daan R. M. G.; Kuypers, Elke; Steinbusch, Harry W.; Kramer, Boris W.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Jellema, Reint K.; Wolfs, Tim G. A. M.; Zwanenburg, Alex; Ophelders, Daan R. M. G.; Kuypers, Elke; Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Wolfs, Tim G. A. M.; Hopman, Anton H. N.; Germeraad, Wilfred T. V.; Vanderlocht, Joris; Kramer, Boris W.] Maastricht Univ, Sch Oncol & Dev Biol, Maastricht, Netherlands; [Passos, Valeria Lima] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands; [Zwanenburg, Alex] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands; [Hopman, Anton H. N.] Maastricht Univ, Dept Mol Cell Biol, Maastricht, Netherlands; [Germeraad, Wilfred T. V.] Maastricht Univ, Med Ctr, Div Haematol, Dept Internal Med, Maastricht, Netherlands; [Vanderlocht, Joris] Maastricht Univ, Med Ctr, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands; [Dudink, Jeroen] Sophia Childrens Univ Hosp, Dept Neonatol & Neurosci, Rotterdam, Netherlands; [Andriessen, Peter] Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Maxima Medical Center	Kramer, BW (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	b.kramer@maastrichtuniversity.nl	Jellema, Reint/AAW-1214-2020; Lima Passos, Valeria/AFT-1000-2022; Zwanenburg, Alex/AAF-6476-2020; Steinbusch, Heinrich/L-6950-2017; Kramer, Boris/AAO-3183-2021	Jellema, Reint/0000-0002-6918-0930; Zwanenburg, Alex/0000-0002-0342-9545; Dudink, Jeroen/0000-0003-0446-3646; Lima Passos, Valeria/0000-0003-0580-6639; Wolfs, Tim/0000-0003-4417-4144; Andriessen, Peter/0000-0002-5159-6874; Ophelders, Daan/0000-0001-7410-5102	Rotationsstelle grant of The European Graduate School of Neuroscience (EURON)	Rotationsstelle grant of The European Graduate School of Neuroscience (EURON)	Financial support for the study was provided by the Rotationsstelle grant of The European Graduate School of Neuroscience (EURON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Alderliesten T, 2013, ARCH DIS CHILD-FETAL, V98, pF304, DOI 10.1136/archdischild-2012-301768; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2006, J CHILD NEUROL, V21, P582, DOI 10.1177/08830738060210070101; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Bennet L, 2006, J PHYSIOL-LONDON, V572, P141, DOI 10.1113/jphysiol.2006.105197; Bennet L, 2012, ANN NEUROL, V71, P589, DOI 10.1002/ana.22670; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Davidson JO, 2011, J PHYSIOL-LONDON, V589, P3823, DOI 10.1113/jphysiol.2011.212043; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gortner L, 2012, KLIN PADIATR, V224, P233, DOI 10.1055/s-0032-1316296; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Jansen MPHM, 1999, J PATHOL, V189, P527; Jellema RK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-13; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leemans, 2009, P INT SOC MAG RESON, V245, P3537, DOI DOI 10.1093/occmed/kqr069; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lynch NE, 2012, EPILEPSIA, V53, P549, DOI 10.1111/j.1528-1167.2011.03401.x; MAYNARD D, 1969, ELECTROEN CLIN NEURO, V27, P672; Miller SP, 2002, NEUROLOGY, V58, P542, DOI 10.1212/WNL.58.4.542; Niemarkt HJ, 2012, EARLY HUM DEV, V88, P209, DOI 10.1016/j.earlhumdev.2011.08.008; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Perasso L, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/534925; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Rosen I, 2006, CLIN PERINATOL, V33, P593, DOI 10.1016/j.clp.2006.06.013; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Steffenhagen C, 2012, STEM CELLS DEV, V21, P1838, DOI 10.1089/scd.2011.0137; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van Velthoven CTJ, 2012, ANN NEUROL, V71, P785, DOI 10.1002/ana.23543; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; VANVELTHOVEN CT, 2011, BRAIN BEHAV IMMUN; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Ward P, 2006, PEDIATRICS, V117, pE619, DOI 10.1542/peds.2005-0545; Winerdal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036422; Wolfs TGAM, 2012, J MATERN-FETAL NEO M, V25, P8, DOI 10.3109/14767058.2012.664447; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yasuhara T, 2006, CELL TRANSPLANT, V15, P231, DOI 10.3727/000000006783982034; ZANJANI ED, 1992, J CLIN INVEST, V89, P1178, DOI 10.1172/JCI115701	54	63	66	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73031	10.1371/journal.pone.0073031	http://dx.doi.org/10.1371/journal.pone.0073031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991170	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800092
J	Ma, YM; Bao-Han, WY; Lv, X; Su, YT; Zhao, XH; Yin, YM; Zhang, XM; Zhou, ZX; MacNaughton, WK; Wang, HY				Ma, Yiming; Bao-Han, Wuyun; Lv, Xue; Su, Yuntao; Zhao, Xinhua; Yin, Yongmei; Zhang, Xingmao; Zhou, Zhixiang; MacNaughton, Wallace K.; Wang, Hongying			MicroRNA-34a Mediates the Autocrine Signaling of PAR(2)-Activating Proteinase and Its Role in Colonic Cancer Cell Proliferation	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-2; EXPRESSION; TRYPSIN; GROWTH; FIBRONECTIN; STIMULATION; ASSOCIATION; CARCINOMA; PROMOTES; ADHESION	The tumor microenvironment is replete with proteinases. As a sensor of proteinases, proteinase activated receptor 2 (PAR(2)) plays critical roles in tumorigenesis. We showed that PAR(2) and its activating proteinase were coexpressed in different colon cancer cell lines, including HT29. Inactivating proteinase or knockdown of PAR(2) significantly not only reduced cell proliferation in vitro but also inhibited tumorigenicity of HT29 in vivo. In addition, activation of PAR(2) promoted DNA synthesis and upregulated Cyclin D1 activity at both transcriptional and post-transcriptional levels. Further studies showed that miRNA-34a mediated PAR(2)-induced Cyclin D1 upregulation. Inhibition of miR-34a partially abolished the suppression of Cyclin D1 induced by PAR(2) deficiency. In addition, we showed that TGF-beta contributed to the regulation of miR-34a by PAR(2). Finally, in colorectal carcinoma samples, upregulation of PAR(2) and downregulation of miR-34a were significantly correlated with grade and lymphomatic metastasis. Our findings provide the first evidence that miRNA mediates autocrine proteinase signaling-mediated cancer cell proliferation.	[Ma, Yiming; Bao-Han, Wuyun; Lv, Xue; Zhao, Xinhua; Wang, Hongying] Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Xingmao; Zhou, Zhixiang] Chinese Acad Med Sci, Dept Gastrointestinal Canc Surg, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100730, Peoples R China; [Su, Yuntao; Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [MacNaughton, Wallace K.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Nanjing Medical University; University of Calgary; University of Calgary	Wang, HY (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100730, Peoples R China.	hongyingwang@cicams.ac.cn			973 National Key Fundamental Research Program of China [2012CB967003]; National Nature Science Foundation of China [81172034, 91129717, 81201966]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the 973 National Key Fundamental Research Program of China (http://www.973.gov.cn/AreaAppl.aspx) (2012CB967003) and the National Nature Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm)(81172034, 91129717 and 81201966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bohm SK, 1996, BIOCHEM J, V314, P1009; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Ducroc R, 2002, LIFE SCI, V70, P1359, DOI 10.1016/S0024-3205(01)01519-3; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gratio V, 2011, AM J PATHOL, V179, P2625, DOI 10.1016/j.ajpath.2011.07.016; Green D, 2010, CELL CYCLE, V9, P656, DOI 10.4161/cc.9.4.10729; Ikeda O, 2003, INT J ONCOL, V22, P295; Jiang Q, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-194; Jikuhara A, 2003, LIFE SCI, V73, P2817, DOI 10.1016/S0024-3205(03)00702-1; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma Y, 2012, CURR PHARM DES; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McKerrow JH, 2000, MOL MED, V6, P450, DOI 10.1007/BF03401787; Miyata S, 1998, CLIN EXP METASTAS, V16, P613, DOI 10.1023/A:1006576313979; Miyata S, 2000, J BIOL CHEM, V275, P4592, DOI 10.1074/jbc.275.7.4592; Ohta T, 2003, INT J ONCOL, V23, P61; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ribeiro FS, 2009, ONCOL REP, V21, P1599, DOI 10.3892/or_00000393; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Yamamoto H, 2003, J PATHOL, V199, P176, DOI 10.1002/path.1277; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	40	39	42	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72383	10.1371/journal.pone.0072383	http://dx.doi.org/10.1371/journal.pone.0072383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991105	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800069
J	Javed, S; Mejias-Luque, R; Kalali, B; Bolz, C; Gerhard, M				Javed, Sundus; Mejias-Luque, Raquel; Kalali, Behnam; Bolz, Christian; Gerhard, Markus			Helicobacter bilis Gamma-Glutamyltranspeptidase Enhances Inflammatory Stress Response via Oxidative Stress in Colon Epithelial Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; GENE-TRANSCRIPTION; GLUTATHIONE LEVELS; NITRIC-OXIDE; IN-VIVO; PYLORI; EXPRESSION; ACTIVATION	Helicobacter bilis (H. bilis) infection is associated with cases of inflammatory bowel Disease, thyphlocolitis, hepatitis and cholecystitis. However, little is known about the bacterial virulence determinants or the molecular mechanisms involved. Recently, H. bilis gamma-glutamyltranspeptidase (HBgGT) was shown to be a virulence factor decreasing host cell viability. Bacterial gGTs play a key role in synthesis and degradation of glutathione and enables the bacteria to utilize extracellular glutamine and glutathione as sources of glutamate. gGT-mediated loss of cell viability has so far been linked to DNA damage via oxidative stress, but the signaling cascades involved herein have not been described. In this study, we identified enhanced ROS production induced by HBgGT as a central factor involved in the activation of the oxidative stress response cascades, which finally activate CREB, AP-1 and NF-kappa B in H. bilis infected colon cancer cells. IL-8, an important pro-inflammatory chemokine that is a common downstream target of these transcription factors, was up-regulated upon H. bilis infection in an HBgGT dependent manner. Moreover, the induction of these signaling responses and inflammatory cytokine production in host cells could be linked to HBgGT-mediated glutamine deprivation. This study implicates for the first time HBgGT as an important regulator of signaling cascades regulating inflammation in H. bilis infected host epithelial cells that could be responsible for induction of inflammatory disorders by the bacterium.	[Javed, Sundus; Mejias-Luque, Raquel; Kalali, Behnam; Bolz, Christian; Gerhard, Markus] Tech Univ Munich, Dept Med Microbiol Immunol & Hyg, D-80290 Munich, Germany	Technical University of Munich	Gerhard, M (corresponding author), Tech Univ Munich, Dept Med Microbiol Immunol & Hyg, D-80290 Munich, Germany.	markus.gerhard@mikrobio.med.tum.de	Javed, Sundus/AAY-2257-2020; Javed, Sundus/AAS-1576-2020; Gerhard, Markus/N-3387-2014; Gerhard, Markus/P-8996-2019	Javed, Sundus/0000-0001-8352-8078; Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Mejias-Luque, Raquel/0000-0002-4602-4927	Higher Education Commission, HRD Division, H-8, Islamabad; DZIF German Centre for Infection Research, Munich	Higher Education Commission, HRD Division, H-8, Islamabad; DZIF German Centre for Infection Research, Munich	SJ was supported by a scholarship from the Higher Education Commission, HRD Division, H-8, Islamabad. MG received finding from the DZIF German Centre for Infection Research, Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Bobrovnikova-Marjon EV, 2004, CANCER RES, V64, P4858, DOI 10.1158/0008-5472.CAN-04-0682; Boelens PG, 2001, J NUTR, V131, p2569S, DOI 10.1093/jn/131.9.2569S; Boonyanugomol W, 2012, DIGEST DIS SCI, V57, P2615, DOI 10.1007/s10620-012-2216-2; Carneiro BA, 2006, INFECT IMMUN, V74, P81, DOI 10.1128/IAI.74.1.81-87.2006; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Chaouche-Drider N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005396; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Chien CC, 2000, J MED MICROBIOL, V49, P525, DOI 10.1099/0022-1317-49-6-525; Coeffier M, 2002, CYTOKINE, V18, P92, DOI 10.1006/cyto.2002.1027; Coeffier M, 2001, CYTOKINE, V13, P148, DOI 10.1006/cyto.2000.0813; DeMarco VG, 2003, J NUTR, V133, P2176, DOI 10.1093/jn/133.7.2176; Ding SZ, 2008, J GASTROEN HEPATOL, V23, pE67, DOI 10.1111/j.1440-1746.2007.04912.x; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Felty Quentin, 2005, J Carcinog, V4, P1, DOI 10.1186/1477-3163-4-1; Flahou B, 2011, CELL MICROBIOL, V13, P1933, DOI 10.1111/j.1462-5822.2011.01682.x; Fox JG, 2007, GUT, V56, P898, DOI 10.1136/gut.2006.115428; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Fox JG, 2004, COMPARATIVE MED, V54, P571; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Gillberg L, 2012, SCAND J GASTROENTERO, V47, P1283, DOI 10.3109/00365521.2012.706830; Gologan S, 2013, J CROHNS COLITIS, V7, P622, DOI 10.1016/j.crohns.2012.08.015; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; HARWARD TRS, 1994, J SURG RES, V56, P351, DOI 10.1006/jsre.1994.1054; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Lesueur C, 2012, BIOCHIMIE, V94, P806, DOI 10.1016/j.biochi.2011.11.012; Li N, 2004, AM J PHYSIOL-GASTR L, V286, pG914, DOI 10.1152/ajpgi.00493.2003; Liu ZP, 2011, DIGEST DIS SCI, V56, P2838, DOI 10.1007/s10620-011-1701-3; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P902; Matsukura N, 2002, JPN J CANCER RES, V93, P842, DOI 10.1111/j.1349-7006.2002.tb01327.x; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; MODI WS, 1990, HUM GENET, V84, P185; Murata H, 2004, ALIMENT PHARM THER, V20, P90, DOI 10.1111/j.1365-2036.2004.01972.x; Murray PR, 2010, ARCH DERMATOL, V146, P523, DOI 10.1001/archdermatol.2010.86; Panigrahi P, 1997, JPEN-PARENTER ENTER, V21, P75, DOI 10.1177/014860719702100275; Pearl DS, 2013, J CROHNS COLITIS, V7, P481, DOI 10.1016/j.crohns.2012.07.022; Plauth M, 1999, INT J COLORECTAL DIS, V14, P86, DOI 10.1007/s003840050191; Potsic B, 2002, PEDIATR RES, V52, P430, DOI [10.1203/00006450-200209000-00021, 10.1203/01.PDR.0000025347.92120.02]; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rahman I, 2000, FREE RADICAL BIO MED, V28, P1405, DOI 10.1016/S0891-5849(00)00215-X; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Rokutan K, 1998, J GASTROENTEROL, V33, P646, DOI 10.1007/s005350050151; ROMERO S, 1988, J CLIN MICROBIOL, V26, P142, DOI 10.1128/JCM.26.1.142-143.1988; Rossi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030543; Rossi M, 2010, INT J SYST EVOL MICR, V60, P2392, DOI 10.1099/ijs.0.016287-0; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Shomer NH, 1997, INFECT IMMUN, V65, P4858, DOI 10.1128/IAI.65.11.4858-4864.1997; Solnick J.V., 2001, HELICOBACTER PYLORI; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; Takayama S, 2010, DIGEST DIS SCI, V55, P1905, DOI 10.1007/s10620-009-0946-6; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Vorobjova T, 2006, DIGEST LIVER DIS, V38, P171, DOI 10.1016/j.dld.2005.12.008; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407	65	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73160	10.1371/journal.pone.0073160	http://dx.doi.org/10.1371/journal.pone.0073160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009737	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200042
J	Kopsida, E; Lynn, PM; Humby, T; Wilkinson, LS; Davies, W				Kopsida, Eleni; Lynn, Phoebe M.; Humby, Trevor; Wilkinson, Lawrence S.; Davies, William			Dissociable Effects of Sry and Sex Chromosome Complement on Activity, Feeding and Anxiety-Related Behaviours in Mice	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; GENDER-DIFFERENCES; FOOD-INTAKE; DEFICIENT MICE; ACTIVITY LEVEL; MOTOR-ACTIVITY; ANIMAL-MODELS; Y-CHROMOSOME; BODY-WEIGHT; TESTOSTERONE	Whilst gonadal hormones can substantially influence sexual differentiation of the brain, recent findings have suggested that sex-linked genes may also directly influence neurodevelopment. Here we used the well-established murine 'four core genotype' (FCG) model on a gonadally-intact, outbred genetic background to characterise the contribution of Sry-dependent effects (i.e. those arising from the expression of the Y-linked Sry gene in the brain, or from hormonal sequelae of gonadal Sry expression) and direct effects of sex-linked genes other than Sry ('sex chromosome complement' effects) to sexually dimorphic mouse behavioural phenotypes. Over a 24 hour period, XX and XY gonadally female mice (lacking Sry) exhibited greater horizontal locomotor activity and reduced food consumption per unit bodyweight than XX and XY gonadally male mice (possessing Sry); in two behavioural tests (the elevated plus and zero mazes) XX and XY gonadally female mice showed evidence for increased anxiety-related behaviours relative to XX and XY gonadally male mice. Exploratory correlational analyses indicated that these Sry-dependent effects could not be simply explained by brain expression of the gene, nor by circulating testosterone levels. We also noted a sex chromosome complement effect on food (but not water) consumption whereby XY mice consumed more over a 24hr period than XX mice, and a sex chromosome complement effect in a third test of anxiety-related behaviour, the light-dark box. The present data suggest that: i) the male-specific factor Sry may influence activity and feeding behaviours in mice, and ii) dissociable feeding and anxiety-related murine phenotypes may be differentially modulated by Sry and by other sex-linked genes. Our results may have relevance for understanding the molecular underpinnings of sexually dimorphic behavioural phenotypes in healthy men and women, and in individuals with abnormal sex chromosome constitutions.	[Kopsida, Eleni; Lynn, Phoebe M.; Humby, Trevor; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales; [Kopsida, Eleni; Lynn, Phoebe M.; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Kopsida, Eleni; Lynn, Phoebe M.; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Kopsida, Eleni; Lynn, Phoebe M.; Humby, Trevor; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University	Davies, W (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales.	daviesw4@cardiff.ac.uk		Davies, William/0000-0002-7714-2440; HUMBY, trevor/0000-0002-1840-1799	Medical Research Council United Kingdom (MRC, UK); Cardiff University Endowment Award; Biotechnology and Biological Sciences Research Council United Kingdom (BBSRC, UK); Research Councils UK Fellowship; Cardiff University LINK award; Medical Research Council [G0801418B] Funding Source: researchfish	Medical Research Council United Kingdom (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cardiff University Endowment Award; Biotechnology and Biological Sciences Research Council United Kingdom (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Councils UK Fellowship(UK Research & Innovation (UKRI)); Cardiff University LINK award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council United Kingdom (MRC, UK http://www.mrc.ac.uk/index.htm) Studentship and a Cardiff University Endowment Award to EK, by a Biotechnology and Biological Sciences Research Council United Kingdom (BBSRC, UK http://www.bbsrc.ac.uk/home/home.aspx) Studentship to PML, by a Research Councils UK Fellowship to WD, and by a Cardiff University LINK award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; ANISHCHENKO TG, 1992, B EXP BIOL MED+, V113, P35, DOI 10.1007/BF00787739; Arndt SS, 2009, PHYSIOL BEHAV, V97, P385, DOI 10.1016/j.physbeh.2009.03.008; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; BELL DD, 1971, PHYSIOL BEHAV, V7, P27, DOI 10.1016/0031-9384(71)90231-9; Bonthuis PJ, 2010, FRONT NEUROENDOCRIN, V31, P341, DOI 10.1016/j.yfrne.2010.05.001; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Buchanan FF, 2011, BRIT J ANAESTH, V106, P832, DOI 10.1093/bja/aer094; Chen XQ, 2013, ENDOCRINOLOGY, V154, P1092, DOI 10.1210/en.2012-2098; Chen XQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002709; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Chiba S, 2009, J REPROD DEVELOP, V55, P518, DOI 10.1262/jrd.20239; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cui R, 2012, EXP GERONTOL, V47, P67, DOI 10.1016/j.exger.2011.10.009; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; EATON WO, 1986, PSYCHOL BULL, V100, P19, DOI 10.1037/0033-2909.100.1.19; Espejo EF, 1997, BEHAV BRAIN RES, V86, P105, DOI 10.1016/S0166-4328(96)02245-0; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kalinichev M, 2008, BEHAV PHARMACOL, V19, P71, DOI 10.1097/FBP.0b013e3282f3cf48; Kas MJH, 2008, BEHAV NEUROSCI, V122, P769, DOI 10.1037/0735-7044.122.4.769; Kempenaers B, 2008, PHILOS T R SOC B, V363, P1711, DOI 10.1098/rstb.2007.0001; Kopsida Eleni, 2009, Open Neuroendocrinol J, V2, P20; Leach LS, 2008, SOC PSYCH PSYCH EPID, V43, P983, DOI 10.1007/s00127-008-0388-z; Lettiero T, 2008, AM J MED GENET A, V146A, P397, DOI 10.1002/ajmg.a.32123; Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Lynn PMY, 2010, THESIS CARDIFF U CAR; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; McPhie-Lalmansingh AA, 2008, HORM BEHAV, V54, P565, DOI 10.1016/j.yhbeh.2008.05.016; Milsted A, 2004, NEUROSCI LETT, V369, P203, DOI 10.1016/j.neulet.2004.07.052; NUNEZ AA, 1980, PHYSIOL BEHAV, V24, P469, DOI 10.1016/0031-9384(80)90238-3; Ogli K., 1994, Annals Academy of Medicine Singapore, V23, P536; de la Mora MP, 2010, PROG NEUROBIOL, V90, P198, DOI 10.1016/j.pneurobio.2009.10.010; Pigott TA, 2003, PSYCHIAT CLIN N AM, V26, P621, DOI 10.1016/S0193-953X(03)00040-6; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; Preston BT, 2012, J ANIM ECOL, V81, P296, DOI 10.1111/j.1365-2656.2011.01907.x; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; Schmaus BJ, 2008, INT J PSYCHOPHYSIOL, V69, P101, DOI 10.1016/j.ijpsycho.2008.03.006; Schmitteckert EM, 1999, LAB ANIM, V33, P385, DOI 10.1258/002367799780487922; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; SLOB AK, 1975, PHYSIOL BEHAV, V14, P353, DOI 10.1016/0031-9384(75)90044-X; Sotak BN, 2005, BRAIN RES, V1061, P88, DOI 10.1016/j.brainres.2005.08.053; STERNBERG WF, 1995, EUR J ANAESTH, V12, P14; Suto J, 2011, MAMM GENOME, V22, P648, DOI 10.1007/s00335-011-9353-3; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; TOKUYAMA K, 1982, PHYSIOL BEHAV, V28, P899, DOI 10.1016/0031-9384(82)90211-6; Trent S, 2012, PSYCHONEUROENDOCRINO, V37, P221, DOI 10.1016/j.psyneuen.2011.06.006; Varma M, 2001, NUTR RES, V21, P395, DOI 10.1016/S0271-5317(00)00284-0; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Waters PD, 2007, SEMIN CELL DEV BIOL, V18, P389, DOI 10.1016/j.semcdb.2007.02.007; Wilson CA, 2007, REPRODUCTION, V133, P331, DOI 10.1530/REP-06-0078; Woods SC, 2003, EXP BIOL MED, V228, P1175; Wu JB, 2009, FASEB J, V23, P4029, DOI 10.1096/fj.09-139097	66	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73699	10.1371/journal.pone.0073699	http://dx.doi.org/10.1371/journal.pone.0073699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009762	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000324403200051
J	de Almeida, H; Bastos, IMD; Ribeiro, BM; Maigret, B; Santana, JM				de Almeida, Hugo; Bastos, Izabela M. D.; Ribeiro, Bergmann M.; Maigret, Bernard; Santana, Jaime M.			New Binding Site Conformations of the Dengue Virus NS3 Protease Accessed by Molecular Dynamics Simulation	PLOS ONE			English	Article							STRUCTURE-BASED DISCOVERY; ANTIVIRAL INHIBITORS; SERINE-PROTEASE; WEST; IDENTIFICATION; FLEXIBILITY; HELICASE; NS2B; SPECIFICITY; ACTIVATION	Dengue fever is caused by four distinct serotypes of the dengue virus (DENV1-4), and is estimated to affect over 500 million people every year. Presently, there are no vaccines or antiviral treatments for this disease. Among the possible targets to fight dengue fever is the viral NS3 protease (NS3(PRO)), which is in part responsible for viral processing and replication. It is now widely recognized that virtual screening campaigns should consider the flexibility of target protein by using multiple active conformational states. The flexibility of the DENV NS3(PRO) could explain the relatively low success of previous virtual screening studies. In this first work, we explore the DENV NS3(PRO) conformational states obtained from molecular dynamics (MD) simulations to take into account protease flexibility during the virtual screening/docking process. To do so, we built a full NS3(PRO) model by multiple template homology modeling. The model comprised the NS2B cofactor (essential to the NS3(PRO) activation), a glycine flexible link and the proteolytic domain. MD simulations had the purpose to sample, as closely as possible, the ligand binding site conformational landscape prior to inhibitor binding. The obtained conformational MD sample was clustered into four families that, together with principal component analysis of the trajectory, demonstrated protein flexibility. These results allowed the description of multiple binding modes for the Bz-Nle-Lys-Arg-Arg-H inhibitor, as verified by binding plots and pair interaction analysis. This study allowed us to tackle protein flexibility in our virtual screening campaign against the dengue virus NS3 protease.	[de Almeida, Hugo; Bastos, Izabela M. D.; Santana, Jaime M.] Univ Brasilia, Dept Biol Celular, Lab Interacao Patogeno Hospedeiro, Brasilia, DF, Brazil; [Ribeiro, Bergmann M.] Univ Brasilia, Dept Biol Celular, Lab Microscopia Eletron & Virol, Brasilia, DF, Brazil; [Maigret, Bernard] Nancy Univ, LORIA, Equipe Projet Orpailleur, UMR 7503, Vandoeuvre Les Nancy, France	Universidade de Brasilia; Universidade de Brasilia; Universite de Lorraine	Santana, JM (corresponding author), Univ Brasilia, Dept Biol Celular, Lab Interacao Patogeno Hospedeiro, Brasilia, DF, Brazil.	jsantana@unb.br	Santana, Jaime/H-5319-2013; Ribeiro, Bergmann Morais/C-7114-2015	Ribeiro, Bergmann Morais/0000-0002-1061-196X; Bastos, Izabela/0000-0002-2785-4255; de Almeida Silva, Hugo/0000-0003-3773-3251	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Comite Francais d'Evaluation de la Cooperation Universitaire avec le Bresil (COFECUB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP); Decanato de Pesquisa e Pos-Graduacao da Universidade de Brasilia (DPP-UnB)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Comite Francais d'Evaluation de la Cooperation Universitaire avec le Bresil (COFECUB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Decanato de Pesquisa e Pos-Graduacao da Universidade de Brasilia (DPP-UnB)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Comite Francais d'Evaluation de la Cooperation Universitaire avec le Bresil (COFECUB), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX), Financiadora de Estudos e Projetos (FINEP), Decanato de Pesquisa e Pos-Graduacao da Universidade de Brasilia (DPP-UnB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Amaro RE, 2010, CURR TOP MED CHEM, V10, P3, DOI 10.2174/156802610790232279; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Brinkworth RI, 1999, J GEN VIROL, V80, P1167, DOI 10.1099/0022-1317-80-5-1167; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09; Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Cregar-Hernandez Lynne, 2011, Antiviral Chemistry & Chemotherapy, V21, P209, DOI 10.3851/IMP1767; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Ekonomiuk D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000356; Ekonomiuk D, 2009, J MED CHEM, V52, P4860, DOI 10.1021/jm900448m; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; Franco C, 2010, BIOSECUR BIOTERROR, V8, P273, DOI 10.1089/bsp.2010.0032; Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8; Frimayanti Neni, 2011, In Silico Biology, V11, P29, DOI 10.3233/ISB-2012-0442; Frimayanti N, 2011, INT J MOL SCI, V12, P1089, DOI 10.3390/ijms12021089; Ganesh VK, 2005, BIOORGAN MED CHEM, V13, P257, DOI 10.1016/j.bmc.2004.09.036; Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05; HALSTEAD SB, 1967, JPN J MED SCI BIOL, VS 20, P96; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0; Konishi Eiji, 2011, Trop Med Health, V39, P63, DOI 10.2149/tmh.2011-S01; Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee Y.K., 2007, ASIA PAC J MOL BIOL, V15, P53; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Liu SQ, 2010, J MOL MODEL, V16, P17, DOI 10.1007/s00894-009-0518-x; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Martin JR, 1997, STRUCTURE, V5, P521, DOI 10.1016/S0969-2126(97)00208-6; Miller DW, 1999, J MOL BIOL, V286, P267, DOI 10.1006/jmbi.1998.2445; Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002; Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008; Nitsche C, 2011, BIOORGAN MED CHEM, V19, P7318, DOI 10.1016/j.bmc.2011.10.061; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Osguthorpe DJ, 2012, J PHYS CHEM B, V116, P6952, DOI 10.1021/jp3003992; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Rosales-Leon L, 2007, J MOL GRAPH MODEL, V25, P585, DOI 10.1016/j.jmgm.2006.04.001; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salaemae W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-68; Schmidt A, 2005, ACTA CRYSTALLOGR D, V61, P1132, DOI 10.1107/S0907444905016732; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309; Sinko W, 2013, CHEM BIOL DRUG DES, V81, P41, DOI 10.1111/cbdd.12051; Spyrakis F, 2011, CURR TOP MED CHEM, V11, P192, DOI 10.2174/156802611794863571; Steuber H, 2010, CURR TOP MED CHEM, V10, P323, DOI 10.2174/156802610790725470; Tiew KC, 2012, BIOORGAN MED CHEM, V20, P1213, DOI 10.1016/j.bmc.2011.12.047; Tomlinson S. M., 2009, Infectious Disorders - Drug Targets, V9, P327; Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003; Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006; Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Yan YW, 1998, PROTEIN SCI, V7, P837; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	69	10	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72402	10.1371/journal.pone.0072402	http://dx.doi.org/10.1371/journal.pone.0072402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991109	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100102
J	Gamell, C; Schofield, AV; Suryadinata, R; Sarcevic, B; Bernard, O				Gamell, Cristina; Schofield, Alice V.; Suryadinata, Randy; Sarcevic, Boris; Bernard, Ora			LIMK2 Mediates Resistance to Chemotherapeutic Drugs in Neuroblastoma Cells through Regulation of Drug-Induced Cell Cycle Arrest	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ACTIN DYNAMICS; COFILIN PHOSPHORYLATION; GENE-EXPRESSION; TUBULIN; KINASE; MICROTUBULES; P53; INCREASES; PROTEIN	Drug resistance is a major obstacle for the successful treatment of many malignancies, including neuroblastoma, the most common extracranial solid tumor in childhood. Therefore, current attempts to improve the survival of neuroblastoma patients, as well as those with other cancers, largely depend on strategies to counter cancer cell drug resistance; hence, it is critical to understand the molecular mechanisms that mediate resistance to chemotherapeutics. The levels of LIM-kinase 2 (LIMK2) are increased in neuroblastoma cells selected for their resistance to microtubule-targeted drugs, suggesting that LIMK2 might be a possible target to overcome drug resistance. Here, we report that depletion of LIMK2 sensitizes SHEP neuroblastoma cells to several microtubule-targeted drugs, and that this increased sensitivity correlates with enhanced cell cycle arrest and apoptosis. Furthermore, we show that LIMK2 modulates microtubule acetylation and the levels of tubulin Polymerization Promoting Protein 1 (TPPP1), suggesting that LIMK2 may participate in the mitotic block induced by microtubule-targeted drugs through regulation of the microtubule network. Moreover, LIMK2-depleted cells also show an increased sensitivity to certain DNA-damage agents, suggesting that LIMK2 might act as a general pro-survival factor. Our results highlight the exciting possibility of combining specific LIMK2 inhibitors with anticancer drugs in the treatment of multi-drug resistant cancers.	[Gamell, Cristina; Schofield, Alice V.; Bernard, Ora] St Vincents Inst Med Res, Cytoskeleton & Canc Unit, Melbourne, Vic, Australia; [Schofield, Alice V.; Sarcevic, Boris; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Suryadinata, Randy; Sarcevic, Boris] St Vincents Inst Med Res, Cell Cycle & Canc Unit, Melbourne, Vic, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Bernard, O (corresponding author), St Vincents Inst Med Res, Cytoskeleton & Canc Unit, Melbourne, Vic, Australia.	obernard@svi.edu.au	Suryadinata, Randy/C-2819-2013	Sarcevic, Boris/0000-0002-8063-1050; Gamell, Cristina/0000-0003-0720-2652	Kids' Cancer Project; Victorian Government's Operational Infrastructure support Program; Australian National Health and Medical Research Council (NHMRC)	Kids' Cancer Project; Victorian Government's Operational Infrastructure support Program; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by The Kids' Cancer Project and in part by the Victorian Government's Operational Infrastructure support Program. OB was supported by a Fellowship from the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo K, 2006, J HISTOCHEM CYTOCHEM, V54, P487, DOI 10.1369/jhc.5C6813.2006; Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Berthold F, 2000, DRUGS, V59, P1261, DOI 10.2165/00003495-200059060-00006; Blanc E, 2003, AM J PATHOL, V163, P321, DOI 10.1016/S0002-9440(10)63656-5; CHAN HSL, 1991, NEW ENGL J MED, V325, P1608, DOI 10.1056/NEJM199112053252304; Croft DR, 2011, CELL RES, V21, P666, DOI 10.1038/cr.2010.154; Dan S, 2002, CANCER RES, V62, P1139; De Bernardi B, 2003, J CLIN ONCOL, V21, P1592, DOI 10.1200/JCO.2003.05.191; Don S, 2004, MOL CANCER THER, V3, P1137; Foletta VC, 2004, EXP CELL RES, V294, P392, DOI 10.1016/j.yexcr.2003.11.024; Friedman GK, 2007, PEDIATR BLOOD CANCER, V49, P1060, DOI 10.1002/pbc.21354; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; George RE, 2010, EXPERT OPIN PHARMACO, V11, P1467, DOI 10.1517/14656566.2010.482100; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599; GOLDSTEIN LJ, 1990, J CLIN ONCOL, V8, P128, DOI 10.1200/JCO.1990.8.1.128; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2001, CANCER RES, V61, P5803; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Keshelava N, 2001, CANCER RES, V61, P6185; LAQUAGLIA MP, 1991, J PEDIATR SURG, V26, P1107, DOI 10.1016/0022-3468(91)90684-L; Li R, 2006, FASEB J, V20, P1218, DOI 10.1096/fj.05-5258fje; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Nomoto S, 1999, GENE, V236, P259, DOI 10.1016/S0378-1119(99)00280-2; Norris MD, 1996, NEW ENGL J MED, V334, P231, DOI 10.1056/NEJM199601253340405; Panno ML, 2006, FEBS LETT, V580, P2371, DOI 10.1016/j.febslet.2006.03.055; Po'uha ST, 2010, ONCOGENE, V29, P597, DOI 10.1038/onc.2009.367; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; SCHOFIELD AV, 2012, J BIOL CHEM; SCHOFIELD AV, 2013, J BIOL CHEM; Smolich B, 1997, J BIOCHEM-TOKYO, V121, P382; Sumi T, 2006, EXP CELL RES, V312, P1021, DOI 10.1016/j.yexcr.2005.12.030; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72850	10.1371/journal.pone.0072850	http://dx.doi.org/10.1371/journal.pone.0072850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991158	gold, Green Published			2022-12-25	WOS:000324470100120
J	Tsai, LH; Chen, PM; Cheng, YW; Chen, CY; Sheu, GT; Wu, TC; Lee, H				Tsai, L-H; Chen, P-M; Cheng, Y-W; Chen, C-Y; Sheu, G-T; Wu, T-C; Lee, H.			LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas	ONCOGENE			English	Article						LKB1; NKX2-1; p53; lung adenocarcinoma	GENE-EXPRESSION; CANCER; MUTATIONS; P53; TRANSCRIPTION; SUPPRESSOR; LKB1/STK11; GENOME	LKB1 loss is a frequent homozygous deletion and/or gene mutation found in lung adenocarcinomas. However, few cases of LKB1 loss by either deletion or mutation are seen in Asian patients. Our preliminary data showed that LKB1 loss was associated with p53 mutation in lung tumors from Taiwanese adenocarcinoma patients and p53 transcription is directly regulated by NKX2-1. Therefore, we hypothesized that LKB1 loss could occur due to aberration of p53 regulation mediated by NKX2-1. In the present study, 16 lung adenocarcinoma cell lines were investigated to determine if LKB1 transcription could be deregulated by NKX2-1-mediated p53 aberration. Mechanistic studies indicated that LKB1 was directly upregulated by p53 and that NKX2-1-mediated p53 expression may positively regulate LKB1 expression in p53 wild-type cells. However, in p53-mutated cells, LKB1 transcription was deregulated by NKX2-1 via suppression of SP1 binding onto the LKB1 promoter. Therefore, the action of the NKX2-1/p53 pathway on LKB1 loss differed in p53 wild-type versus p53-mutated cells. As expected, soft-agar growth and invasion capability was significantly reduced by ectopic expression of NKX2-1 in p53 wild-type cells, but it was markedly elevated by silencing NKX2-1 in p53-mutated cells. Similar reciprocal observations were also seen in lung tumors from lung adenocarcinoma patients with either wild-type or mutated p53 tumors. Cox regression analysis showed that patients with low-LKB1 tumors had poorer overall survival (OS) and relapse-free survival (RFS) when compared with patients with high-LKB1 tumors. In p53 wild-type patients, shorter OS and RFS periods were predicted for low-NKX2-1/low-LKB1 tumors than for high-NKX2-1/high-LKB1 tumors. In patients with p53-mutated tumors, poorer OS and RFS were predicted for high-NKX2-1/low-LKB1 tumors than for low-NKX2-1/high-LKB1 tumors. In summary, losses of LKB1 at the transcriptional level by altered activity of the NKX2-1/p53 pathway may promote tumor malignancy and poor patient outcome.	[Tsai, L-H; Chen, P-M; Lee, H.] Inst Med & Mol Toxicol, Taichung, Taiwan; [Tsai, L-H; Chen, P-M; Sheu, G-T; Lee, H.] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Cheng, Y-W; Lee, H.] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chen, C-Y] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Wu, T-C] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan	Chung Shan Medical University; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Lee, H (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, 250 Wu Hsing St, Taipei 110, Taiwan.	hl@tmu.edu.tw	Sheu, Gwo-Tarng/H-8855-2019	Sheu, Gwo-Tarng/0000-0002-1299-3375	National Science Council of Taiwan, ROC [NSC99-2628-B-038-016-MY3, NSC1-100-2314-B-038-043-MY3]	National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was jointly supported by Grants from the National Science Council (NSC99-2628-B-038-016-MY3 and NSC1-100-2314-B-038-043-MY3) of Taiwan, ROC.	Au NHC, 2004, J PATHOL, V204, P101, DOI 10.1002/path.1612; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Charloux A, 1997, INT J EPIDEMIOL, V26, P14, DOI 10.1093/ije/26.1.14; Chen F, 2007, CANCER EPIDEM BIOMAR, V16, P2724, DOI 10.1158/1055-9965.EPI-07-0455; Chen JJW, 2001, CANCER RES, V61, P5223; Cheng YW, 2007, CANCER RES, V67, P10686, DOI 10.1158/0008-5472.CAN-07-1461; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fernandez P, 2004, ONCOGENE, V23, P5084, DOI 10.1038/sj.onc.1207665; Gill RK, 2011, ONCOGENE, V30, P3784, DOI 10.1038/onc.2011.98; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kim MJ, 2010, CANCER GENET CYTOGEN, V196, P204, DOI 10.1016/j.cancergencyto.2009.09.020; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Onozato R, 2007, CANCER SCI, V98, P1747, DOI 10.1111/j.1349-7006.2007.00585.x; Saad RS, 2004, HUM PATHOL, V35, P3, DOI 10.1016/j.humpath.2003.08.011; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Scott KD, 2007, CANCER RES, V67, P5622, DOI 10.1158/0008-5472.CAN-07-0762; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Takeda H, 2006, ONCOGENE, V25, P1816, DOI 10.1038/sj.onc.1209207; Tang XM, 2011, CLIN CANCER RES, V17, P2434, DOI 10.1158/1078-0432.CCR-10-1412; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Wei CJ, 2005, CANCER RES, V65, P11297, DOI 10.1158/0008-5472.CAN-05-0716; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu DW, 2011, CLIN CANCER RES, V17, P1895, DOI 10.1158/1078-0432.CCR-10-2316; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Wu HH, 2010, ONCOGENE, V29, P4330, DOI 10.1038/onc.2010.178; Wu YH, 2010, CANCER RES, V70, P10422, DOI 10.1158/0008-5472.CAN-10-2615; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999	38	29	30	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3851	3860		10.1038/onc.2013.353	http://dx.doi.org/10.1038/onc.2013.353			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23995788				2022-12-25	WOS:000339394100011
J	Gao, Q; Mechin, I; Kothari, N; Guo, ZY; Deng, GJ; Haas, K; McManus, J; Hoffmann, D; Wang, AL; Wiederschain, D; Rocnik, J; Czechtizky, W; Chen, X; McLean, L; Arlt, H; Harper, D; Liu, F; Majid, T; Patel, V; Lengauer, C; Garcia-Echeverria, C; Zhang, BL; Cheng, H; Dorsch, M; Huang, SMA				Gao, Qiang; Mechin, Ingrid; Kothari, Nayantara; Guo, Zhuyan; Deng, Gejing; Haas, Kimberly; McManus, Jessica; Hoffmann, Dietmar; Wang, Anlai; Wiederschain, Dmitri; Rocnik, Jennifer; Czechtizky, Werngard; Chen, Xin; McLean, Larry; Arlt, Heike; Harper, David; Liu, Feng; Majid, Tahir; Patel, Vinod; Lengauer, Christoph; Garcia-Echeverria, Carlos; Zhang, Bailin; Cheng, Hong; Dorsch, Marion; Huang, Shih-Min A.			Evaluation of Cancer Dependence and Druggability of PRP4 Kinase Using Cellular, Biochemical, and Structural Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Crystallography; Drug Discovery; Proteomics; Structural Biology	PROTEIN; PHOSPHORYLATION; DISCOVERY; LOCALIZATION; INTERACTS; REVEALS; SCREEN; GENES; SNRNP; SUITE	Background: Little is known about the cancer dependence and druggability of PRP4. Results: Significance of PRP4 catalytic activity is demonstrated, novel substrates are identified, and features of kinase domain structure are revealed. Conclusion: PRP4 is required for cancer cell survival, displays substrate specificity, and is amenable to pharmacological inhibition. Significance: Our results indicate that PRP4 is a potential drug target to pursue in cancer. PRP4 kinase is known for its roles in regulating pre-mRNA splicing and beyond. Therefore, a wider spectrum of PRP4 kinase substrates could be expected. The role of PRP4 kinase in cancer is also yet to be fully elucidated. Attaining specific and potent PRP4 inhibitors would greatly facilitate the study of PRP4 biological function and its validation as a credible cancer target. In this report, we verified the requirement of enzymatic activity of PRP4 in regulating cancer cell growth and identified an array of potential novel substrates through orthogonal proteomics approaches. The ensuing effort in structural biology unveiled for the first time unique features of PRP4 kinase domain and its potential mode of interaction with a low molecular weight inhibitor. These results provide new and important information for further exploration of PRP4 kinase function in cancer.	[Gao, Qiang; Kothari, Nayantara; Guo, Zhuyan; Deng, Gejing; McManus, Jessica; Hoffmann, Dietmar; Wang, Anlai; Wiederschain, Dmitri; Rocnik, Jennifer; Arlt, Heike; Harper, David; Liu, Feng; Lengauer, Christoph; Garcia-Echeverria, Carlos; Zhang, Bailin; Cheng, Hong; Dorsch, Marion; Huang, Shih-Min A.] Sanofi Oncol, Discovery & Early Dev, Cambridge, MA 02139 USA; [Gao, Qiang; Kothari, Nayantara; Guo, Zhuyan; Deng, Gejing; McManus, Jessica; Hoffmann, Dietmar; Wang, Anlai; Wiederschain, Dmitri; Rocnik, Jennifer; Arlt, Heike; Harper, David; Liu, Feng; Lengauer, Christoph; Garcia-Echeverria, Carlos; Zhang, Bailin; Cheng, Hong; Dorsch, Marion; Huang, Shih-Min A.] Sanofi Oncol, Discovery & Early Dev, F-94400 Vitry Sur Seine, France; [Majid, Tahir; Patel, Vinod] Sanofi, Lead Generat & Candidate Realizat, Waltham, MA 02451 USA; [Czechtizky, Werngard] Sanofi, Lead Generat & Candidate Realizat, D-65926 Frankfurt, Germany; [Haas, Kimberly; Chen, Xin; McLean, Larry] Sanofi, Lead Generat & Candidate Realizat, Bridgewater, NJ 08807 USA; [Mechin, Ingrid] Sanofi, Tucson Res Ctr, Tucson, AZ 85755 USA	Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis	Huang, SMA (corresponding author), Sanofi Oncol, 640 Mem Dr, Cambridge, MA 02139 USA.	alex.huang@sanofi.com						Ackermann BL, 2007, EXPERT REV PROTEOMIC, V4, P175, DOI 10.1586/14789450.4.2.175; ALAHARI SK, 1993, NUCLEIC ACIDS RES, V21, P4079, DOI 10.1093/nar/21.17.4079; Baldassa S, 2010, J CELL PHYSIOL, V224, P722, DOI 10.1002/jcp.22172; Bauer JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2595; Bennett EM, 2004, J VIROL, V78, P11303, DOI 10.1128/JVI.78.20.11303-11312.2004; BRICOGNE G, 2011, BUSTER VERSION 2 9 1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Duan ZF, 2008, MOL CANCER THER, V7, P2377, DOI 10.1158/1535-7163.MCT-08-0316; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giroux V, 2006, FASEB J, V20, P1982, DOI 10.1096/fj.06-6239com; *GROUP CC, 2011, MOL OP ENV; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Huang BL, 2007, J IMMUNOL, V178, P7081, DOI 10.4049/jimmunol.178.11.7081; Huang Y, 2000, BIOCHEM BIOPH RES CO, V271, P456, DOI 10.1006/bbrc.2000.2651; Jaffe JD, 2008, MOL CELL PROTEOMICS, V7, P1952, DOI 10.1074/mcp.M800218-MCP200; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kojima T, 2001, J BIOL CHEM, V276, P32247, DOI 10.1074/jbc.M103790200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Schwelnus W, 2001, EMBO REP, V2, P35, DOI 10.1093/embo-reports/kve009; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu RH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009654	40	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30125	30138		10.1074/jbc.M113.473348	http://dx.doi.org/10.1074/jbc.M113.473348			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003220	Green Published, hybrid			2022-12-25	WOS:000329868100013
J	Ginnan, R; Zou, XJ; Pfleiderer, PJ; Mercure, MZ; Barroso, M; Singer, HA				Ginnan, Roman; Zou, Xiaojing; Pfleiderer, Paul J.; Mercure, Melissa Z.; Barroso, Margarida; Singer, Harold A.			Vascular Smooth Muscle Cell Motility Is Mediated by a Physical and Functional Interaction of Ca2+/Calmodulin-dependent Protein Kinase II delta(2) and Fyn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASE; FIBROBLAST-GROWTH-FACTOR; DEPENDENT ACTIVATION; RPTP-ALPHA; MIGRATION; INTEGRIN; DELTA; PHOSPHORYLATION; TRAFFICKING; CAMKII	In vascular smooth muscle (VSM) cells, Ca2+/calmodulin-dependent protein kinase II delta(2) (CaMKII delta(2)) activates non-receptor tyrosine kinases and EGF receptor, with a Src family kinase as a required intermediate. siRNA-mediated suppression of Fyn, a Src family kinase, inhibited VSM cell motility. Simultaneous suppression of both Fyn and CaMKII delta(2) was non-additive, suggesting coordinated regulation of cell motility. Confocal immunofluorescence microscopy indicated that CaMKII delta(2) and Fyn selectively (compared with Src) co-localized with the Golgi in quiescent cultured VSM cells. Stimulation with PDGF resulted in a rapid (<5 min) partial redistribution and co-localization of both kinases in peripheral membrane regions. Furthermore, CaMKII delta(2) and Fyn selectively (compared with Src) co-immunoprecipitated, suggesting a physical interaction in a signaling complex. Stimulation of VSM cells with ionomycin, a calcium ionophore, resulted in activation of CaMKII delta(2) and Fyn and disruption of the complex. Pretreatment with KN-93, a pharmacological inhibitor of CaMKII, prevented activation-dependent disruption of CaMKII delta(2) and Fyn, implicating CaMKII delta(2) as an upstream mediator of Fyn. Overexpression of constitutively active CaMKII resulted in the dephosphorylation of Fyn at Tyr-527, which is required for Fyn activation. Taken together, these data demonstrate a dynamic interaction between CaMKII delta(2) and Fyn in VSM cells and indicate a mechanism by which CaMKII delta(2) and Fyn may coordinately regulate VSM cell motility.	[Ginnan, Roman; Zou, Xiaojing; Barroso, Margarida; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Zou, Xiaojing] Huazhong Univ Sci & Technol, Union Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Pfleiderer, Paul J.] CAHG, New York, NY 10017 USA; [Mercure, Melissa Z.] Virginia Tech Carilion Sch Med, Dept Basic Sci, Roanoke, VA 24016 USA	Albany Medical College; Huazhong University of Science & Technology	Singer, HA (corresponding author), Albany Med Coll MC8, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	singerh@mail.amc.edu		Barroso, Margarida/0000-0002-0407-3181	National Institutes of Health from NHLBI [T32 HL07194, R01 HL49426, R01 HL092510]; American Heart Association Northeast Affiliate Predoctoral Training Grant [0215300T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092510, R01HL049426, T32HL007194] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Northeast Affiliate Predoctoral Training Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Training Grant T32 HL07194 and Grants R01 HL49426 and R01 HL092510 (to H. A. S.) from NHLBI. This work was also supported by American Heart Association Northeast Affiliate Predoctoral Training Grant 0215300T (to P. J. P.).	Abraham ST, 1996, J BIOL CHEM, V271, P2506, DOI 10.1074/jbc.271.5.2506; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; BILATO C, 1995, J CLIN INVEST, V96, P1905, DOI 10.1172/JCI118236; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Easley CA, 2008, CELL MOTIL CYTOSKEL, V65, P662, DOI 10.1002/cm.20294; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Ginnan R, 2004, AM J PHYSIOL-CELL PH, V286, pC1281, DOI 10.1152/ajpcell.00202.2003; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Govindarajan G, 2000, CIRC RES, V87, P710, DOI 10.1161/01.RES.87.8.710; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lavoie JN, 2010, CELL SIGNAL, V22, P1604, DOI 10.1016/j.cellsig.2010.04.007; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lu KK, 2005, AM J PHYSIOL-CELL PH, V289, pC1343, DOI 10.1152/ajpcell.00064.2005; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mayer BJ, 2001, J CELL SCI, V114, P1253; McGinnis LK, 2011, MOL REPROD DEV, V78, P831, DOI 10.1002/mrd.21326; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Rosenfeldt HM, 2001, BIOCHEM SOC T, V29, P836, DOI 10.1042/0300-5127:0290836; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154	47	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29703	29712		10.1074/jbc.M113.477257	http://dx.doi.org/10.1074/jbc.M113.477257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003228	hybrid, Green Published			2022-12-25	WOS:000330615300045
J	Gleichmann, T; Diensthuber, RP; Moglich, A				Gleichmann, Tobias; Diensthuber, Ralph P.; Moeglich, Andreas			Charting the Signal Trajectory in a Light-Oxygen-Voltage Photoreceptor by Random Mutagenesis and Covariance Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOV DOMAIN; STRUCTURAL BASIS; PAS DOMAIN; AEROTAXIS RECEPTOR; MEGAPRIMER PCR; REDOX SENSOR; TRANSDUCTION; MECHANISM; PHOTOTROPIN; LIBRARIES	Modular signal receptors empower organisms to process environmental stimuli into adequate physiological responses. At the molecular level, a sensor module receives signals and processes the inherent information into changes of biological activity of an effector module. To better understand the molecular bases underpinning these processes, we analyzed signal reception and processing in the dimeric light-oxygen-voltage (LOV) blue light receptor YF1 that serves as a paradigm for the widespread Per-ARNT-Sim (PAS) signal receptors. Random mutagenesis identifies numerous YF1 variants in which biological activity is retained but where light regulation is abolished or inverted. One group of variants carries mutations within the LOV photosensor that disrupt proper coupling of the flavin-nucleotide chromophore to the protein scaffold. Another larger group bears mutations that cluster at the dyad interface and disrupt signal transmission to two coaxial coiled-coils that connect to the effector. Sequence covariation implies wide conservation of structural and mechanistic motifs, as also borne out by comparison to several PAS domains in which mutations leading to disruption of signal transduction consistently map to confined regions broadly equivalent to those identified in YF1. Not only do these data provide insight into general mechanisms of signal transduction, but also they establish concrete means for customized reprogramming of signal receptors.	[Gleichmann, Tobias; Diensthuber, Ralph P.; Moeglich, Andreas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Humboldt University of Berlin	Diensthuber, RP (corresponding author), Humboldt Univ, Inst Biol, Invalidenstr 42, D-10115 Berlin, Germany.	ralph.diensthuber@hu-berlin.de; andreas.moeglich@hu-berlin.de		Moglich, Andreas/0000-0002-7382-2772	Alexander-von-Humboldt Foundation; Deutsche Forschungsgemeinschaft within research group FOR 1279 [MO 2192/3-1]	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft within research group FOR 1279	This work was supported by a Sofja-Kovalevskaya Award from the Alexander-von-Humboldt Foundation (to A. M.) and Deutsche Forschungsgemeinschaft Grant MO 2192/3-1 within research group FOR 1279.	Aravind L, 2010, SENSORY MECHANISMS IN BACTERIA: MOLECULAR ASPECTS OF SIGNAL RECOGNITION, P1; Ayers RA, 2008, BIOCHEMISTRY-US, V47, P12078, DOI 10.1021/bi801254c; Campbell AJ, 2010, MOL MICROBIOL, V77, P575, DOI 10.1111/j.1365-2958.2010.07231.x; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; Little R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046651; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Repik A, 2000, MOL MICROBIOL, V36, P806, DOI 10.1046/j.1365-2958.2000.01910.x; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Slavny P, 2010, MOL MICROBIOL, V75, P61, DOI 10.1111/j.1365-2958.2009.06956.x; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Szurmant H, 2013, MOL MICROBIOL, V87, P707, DOI 10.1111/mmi.12128; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Watts KJ, 2006, J BACTERIOL, V188, P2154, DOI 10.1128/JB.188.6.2154-2162.2006; Winkler K, 2012, J BIOL CHEM, V287, P15479, DOI 10.1074/jbc.M112.348409; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	52	26	26	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29345	29355		10.1074/jbc.M113.506139	http://dx.doi.org/10.1074/jbc.M113.506139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003219	Green Published, hybrid			2022-12-25	WOS:000330615300014
J	Kim, Y; Ha, CM; Chang, S				Kim, Yoonju; Ha, Chang Man; Chang, Sunghoe			SNX26, a GTPase-activating Protein for Cdc42, Interacts with PSD-95 Protein and Is Involved in Activity-dependent Dendritic Spine Formation in Mature Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYN TYROSINE KINASE; LONG-TERM POTENTIATION; RHO GTPASES; PLASTICITY; RECEPTOR; MATURATION; MORPHOLOGY; RICS; FAMILY; CORTEX	SNX26, a brain-enriched RhoGAP, plays a key role in dendritic arborization during early neuronal development in the neocortex. In mature neurons, it is localized to dendritic spines, but little is known about its role in later stages of development. Our results show that SNX26 interacts with PSD-95 in dendritic spines of cultured hippocampal neurons, and as a GTPase-activating protein for Cdc42, it decreased the F-actin content in COS-7 cells and in dendritic spines of neurons. Overexpression of SNX26 resulted in a GTPase-activating protein activity-dependent decrease in total protrusions and spine density together with dramatic inhibition of filopodia-to-spine transformations. Such effects of SNX26 were largely rescued by a constitutively active mutant of Cdc42. Consistently, an shRNA-mediated knockdown of SNX26 significantly increased total protrusions and spine density, resulting in an increase in thin or stubby type spines at the expense of the mushroom spine type. Moreover, endogenous expression of SNX26 was shown to be bi-directionally modulated by neuronal activity. Therefore, we propose that in addition to its key role in neuronal development, SNX26 also has a role in the activity-dependent structural change of dendritic spines in mature neurons.	[Kim, Yoonju; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Physiol & Biomed Sci, Seoul 110799, South Korea; [Kim, Yoonju; Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Med Res Ctr, Neurosci Res Inst, Seoul 110799, South Korea; [Kim, Yoonju; Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chang, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol, 309 Biomed Sci Bldg,28 Yeongeon Dong, Seoul 110799, South Korea.	sunghoe@snu.ac.kr		chang, sunghoe/0000-0002-3446-7288; Kim, Yoonju/0000-0003-2657-2923	Basic Research Promotion Fund [313-2008-2-C00690]; Brain Research Center of the 21st Century Frontier Research Program [M103KV010009-06K2201-00910]; Basic Science Research Program [NRF-2011-355-C00121]; Ministry of Education and Science and Technology, Republic of Korea; National Research Foundation of Korea	Basic Research Promotion Fund(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program; Ministry of Education and Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from Basic Research Promotion Fund Grant 313-2008-2-C00690 (to S. C.) funded by the National Research Foundation of Korea, Brain Research Center of the 21st Century Frontier Research Program Grant M103KV010009-06K2201-00910 (to S. C.), and Basic Science Research Program Grant NRF-2011-355-C00121 (to Y.K.) funded by the Ministry of Education and Science and Technology, Republic of Korea.	Arellano JI, 2007, NEUROSCIENCE, V145, P464, DOI 10.1016/j.neuroscience.2006.12.015; Babus LW, 2011, BRAIN RES, V1415, P96, DOI 10.1016/j.brainres.2011.07.059; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Chiang SH, 2003, EMBO J, V22, P2679, DOI 10.1093/emboj/cdg262; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fiala JC, 1998, J NEUROSCI, V18, P8900; GRANT SGN, 1994, TRENDS NEUROSCI, V17, P71, DOI 10.1016/0166-2236(94)90077-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huerta PT, 1996, NEUROREPORT, V7, P1685, DOI 10.1097/00001756-199607080-00032; Isosaka T, 2008, EUR J NEUROSCI, V28, P973, DOI 10.1111/j.1460-9568.2008.06405.x; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kitazawa H, 1998, J NEUROPHYSIOL, V79, P137, DOI 10.1152/jn.1998.79.1.137; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lim SH, 2009, EMBO J, V28, P3564, DOI 10.1038/emboj.2009.289; Liu H, 2006, J BIOL CHEM, V281, P23611, DOI 10.1074/jbc.M511205200; Long H, 2013, CEREB CORTEX, V23, P71, DOI 10.1093/cercor/bhr378; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANESS PF, 1992, DEV NEUROSCI-BASEL, V14, P257, DOI 10.1159/000111670; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Nasu-Nishimura Y, 2006, GENES CELLS, V11, P607, DOI 10.1111/j.1365-2443.2006.00966.x; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Rosario M, 2012, GENE DEV, V26, P1743, DOI 10.1101/gad.191593.112; Shen PC, 2011, NEUROSCIENCE, V199, P589, DOI 10.1016/j.neuroscience.2011.08.053; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Yuste R, 2001, NEUROSCIENTIST, V7, P387, DOI 10.1177/107385840100700508; Zhao CM, 2003, J BIOL CHEM, V278, P34641, DOI 10.1074/jbc.M304594200; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	47	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29453	29466		10.1074/jbc.M113.468801	http://dx.doi.org/10.1074/jbc.M113.468801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003235	Green Published, hybrid			2022-12-25	WOS:000330615300023
J	Wang, LH; Lee, HH; Fang, LS; Mayfield, AB; Chen, CS				Wang, Li-Hsueh; Lee, Hsieh-He; Fang, Lee-Shing; Mayfield, Anderson B.; Chen, Chii-Shiarng			Fatty Acid and Phospholipid Syntheses Are Prerequisites for the Cell Cycle of Symbiodinium and Their Endosymbiosis within Sea Anemones	PLOS ONE			English	Article							MEMBRANE BIOGENESIS; LIPID BIOSYNTHESIS; CORAL; ZOOXANTHELLAE	Lipids are a source of metabolic energy, as well as essential components of cellular membranes. Although they have been shown to be key players in the regulation of cell proliferation in various eukaryotes, including microalgae, their role in the cell cycle of cnidarian-dinoflagellate (genus Symbiodinium) endosymbioses remains to be elucidated. The present study examined the effects of a lipid synthesis inhibitor, cerulenin, on the cell cycle of both cultured Symbiodinium (clade B) and those engaged in an endosymbiotic association with the sea anemone Aiptasia pulchella. In the former, cerulenin exposure was found to inhibit free fatty acid (FFA) synthesis, as it does in other organisms. Additionally, while it also significantly inhibited the synthesis of phosphatidylethanolamine (PE), it did not affect the production of sterol ester (SE) or phosphatidylcholine (PC). Interestingly, cerulenin also significantly retarded cell division by arresting the cell cycles at the G(0)/G(1) phase. Cerulenin-treated Symbiodinium were found to be taken up by anemone hosts at a significantly depressed quantity in comparison with control Symbiodinium. Furthermore, the uptake of cerulenin-treated Symbiodinium in host tentacles occurred much more slowly than in untreated controls. These results indicate that FFA and PE may play critical roles in the recognition, proliferation, and ultimately the success of endosymbiosis with anemones.	[Wang, Li-Hsueh; Mayfield, Anderson B.; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Wang, Li-Hsueh; Lee, Hsieh-He; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Hualien, Taiwan; [Fang, Lee-Shing] Cheng Shiu Univ, Dept Sport Hlth & Leisure Studies, Kaohsiung, Taiwan; [Mayfield, Anderson B.] Living Oceans Fdn, Landover, MD USA; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Cheng Shiu University; National Sun Yat Sen University	Chen, CS (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	cchen@nmmba.gov.tw		Mayfield, Anderson/0000-0003-0138-7844	National Museum of Marine Biology and Aquarium [981001092, 99200312]; National Science Council [NSC 101-2311-B-291-002-MY3]; Living Oceans Foundation	National Museum of Marine Biology and Aquarium; National Science Council(Ministry of Science and Technology, Taiwan); Living Oceans Foundation	This study was supported by grants from the National Museum of Marine Biology and Aquarium (981001092 and 99200312) and National Science Council (NSC 101-2311-B-291-002-MY3). ABM was supported by a postdoctoral research fellowship from the Living Oceans Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Christie WW, 1998, PHYTOCHEM ANALYSIS, V9, P53, DOI 10.1002/(SICI)1099-1565(199803/04)9:2&lt;53::AID-PCA391&gt;3.0.CO;2-U; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046801; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; FISHMAN Y, 1978, J BACTERIOL, V134, P434, DOI 10.1128/JB.134.2.434-439.1978; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Garrett TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057975; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hata T, 1960, JAPAN J BACTERIOL, V15, P1075; HOEGHGULDBERG O, 1987, CORAL REEFS, V5, P201, DOI 10.1007/BF00300964; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; JANERO DR, 1981, J CELL BIOL, V91, P126, DOI 10.1083/jcb.91.1.126; JANERO DR, 1982, EXP CELL RES, V138, P451, DOI 10.1016/0014-4827(82)90197-5; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KNACKER T, 1985, BIOCHEM J, V229, P701, DOI 10.1042/bj2290701; Kwok ACM, 2005, PLANT CELL PHYSIOL, V46, P1973, DOI 10.1093/pcp/pci213; Lin KL, 2000, ZOOL STUD, V39, P172; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Mascarelli PE, 1999, B MAR SCI, V65, P577; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MEESTERS EH, 1993, MAR ECOL PROG SER, V96, P189, DOI 10.3354/meps096189; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; Peng SE, 2010, PROTEOMICS, V10, P1002, DOI 10.1002/pmic.200900595; REIMER A A, 1971, Journal of Experimental Marine Biology and Ecology, V7, P207, DOI 10.1016/0022-0981(71)90032-3; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Smith GJ, 1999, MAR BIOL, V134, P405, DOI 10.1007/s002270050557; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Wang LH, 2008, CORAL REEFS, V27, P823, DOI 10.1007/s00338-008-0434-z; Whitehead LF, 2003, J EXP BIOL, V206, P3149, DOI 10.1242/jeb.00539; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Zhukova NV, 2006, BOT MAR, V49, P339, DOI 10.1515/BOT.2006.041	33	18	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72486	10.1371/journal.pone.0072486	http://dx.doi.org/10.1371/journal.pone.0072486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009685	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600023
J	Barnes, JC; Beaver, KM; Boutwell, BB				Barnes, J. C.; Beaver, Kevin M.; Boutwell, Brian B.			A Functional Polymorphism in a Serotonin Transporter Gene (5-HTTLPR) Interacts with 9/11 to Predict Gun-Carrying Behavior	PLOS ONE			English	Article							ENVIRONMENT INTERACTION; RISK; DEPRESSION; CHILDHOOD; EVENTS; STRESS; REGION; SAMPLE	On September 11, 2001, one of the deadliest terrorist attacks in US history took place on American soil and people around the world were impacted in myriad ways. Building on prior literature which suggests individuals are more likely to purchase a gun for self-protection if they are fearful of being victimized, the authors hypothesized that the terrorist attacks of 9/11 would lead to an increase in gun carrying among US residents. At the same time, a line of research has shown that a polymorphism in the 5-HTT gene (i.e., 5-HTTLPR) interacts with environmental stressors to predict a range of psychopathologies and behaviors. Thus, it was hypothesized that 9/11 and 5-HTTLPR would interact to predict gun carrying. The results supported both hypotheses by revealing a positive association between 9/11 and gun carrying (b = .426, odds ratio = 1.531, standard error for b = .194, z = 2.196, p = .028) in the full sample of respondents (n = 15,052) and a statistically significant interaction between 9/11 and 5-HTTLPR in the prediction of gun carrying (b = -1.519, odds ratio = .219, standard error for b = .703, z = -2.161, p = .031) in the genetic subsample of respondents (n = 2,350). This is one of the first studies to find an association between 9/11 and gun carrying and, more importantly, is the first study to report a gene-environment interaction (GxE) between a measured gene and a terrorist attack.	[Barnes, J. C.] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX 75230 USA; [Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA; [Beaver, Kevin M.] King Abdulaziz Univ, Ctr Social & Human Res, Jeddah 21413, Saudi Arabia; [Boutwell, Brian B.] Sam Houston State Univ, Coll Criminal Justice, Huntsville, TX USA	University of Texas System; University of Texas Dallas; State University System of Florida; Florida State University; King Abdulaziz University; Texas State University System; Sam Houston State University	Barnes, JC (corresponding author), Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX 75230 USA.	jcbarnes@utdallas.edu	Beaver, Kevin M./B-4631-2013	Barnes, J.C./0000-0001-6932-5397	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Beaver KM, 2012, AM J ORTHOPSYCHIAT, V82, P260, DOI 10.1111/j.1939-0025.2012.01148.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Charney E, 2012, AM POLIT SCI REV, V106, P1, DOI 10.1017/S0003055411000554; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Cohen M, BIOMARKERS WAVE 3 AD; De Neve JE, 2011, J HUM GENET, V56, P456, DOI 10.1038/jhg.2011.39; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Goenjian AK, 2012, J AFFECT DISORDERS, V140, P244, DOI 10.1016/j.jad.2012.02.015; Haberstick BC, 2005, AM J MED GENET B, V135B, P59, DOI 10.1002/ajmg.b.30176; Harris K. M., 2009, NATL LONGITUDINAL ST; He QH, 2010, NEUROPHARMACOLOGY, V59, P518, DOI 10.1016/j.neuropharm.2010.07.008; Jones JM, 2001, AM NOW LESS CONCERNE; Kelley M. S., 1997, NATL LONGITUDINAL ST; King G, 2001, INT ORGAN, V55, P693, DOI 10.1162/00208180152507597; Kleck G, 2011, J CRIM JUST, V39, P312, DOI 10.1016/j.jcrimjus.2011.03.002; Lotrich Francis E, 2003, Am J Pharmacogenomics, V3, P145, DOI 10.2165/00129785-200303020-00007; Marshall RD, 2007, AM PSYCHOL, V62, P304, DOI 10.1037/0003-066X.62.4.304; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Sinclair S.J., 2012, PSYCHOL TERRORISM FE; Tuvblad C, 2006, J CHILD PSYCHOL PSYC, V47, P734, DOI 10.1111/j.1469-7610.2005.01552.x; Uecker JE, 2008, SOCIOL SPECTRUM, V28, P477, DOI 10.1080/02732170802206047; Vaske J, 2012, DEV PSYCHOPATHOL, V24, P181, DOI 10.1017/S0954579411000769	24	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e70807	10.1371/journal.pone.0070807	http://dx.doi.org/10.1371/journal.pone.0070807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015179	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800003
J	Fung, J; Poon, RTP; Yu, WC; Chan, SC; Chan, ACY; Chok, KSH; Cheung, TT; Seto, WK; Lo, CM; Lai, CL; Yuen, MF				Fung, James; Poon, Ronnie T. P.; Yu, Wan-Ching; Chan, See-Ching; Chan, Albert C. Y.; Chok, Kenneth S. H.; Cheung, Tan-To; Seto, Wai-Kay; Lo, Chung-Mau; Lai, Ching-Lung; Yuen, Man-Fung			Use of Liver Stiffness Measurement for Liver Resection Surgery: Correlation with Indocyanine Green Clearance Testing and Post-Operative Outcome	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; MAJOR HEPATECTOMY; FIBROSCAN; CIRRHOSIS; PREDICTION; MODEL	Background: Liver stiffness measurement (LSM) using transient elastography has recently become available for the assessment of liver fibrosis. Whether LSM can predict the functional liver reserve in patients undergoing liver resection is not certain. Aim: To correlate liver stiffness measurement (LSM) with indocyanine green (ICG) clearance test and liver biochemistry, and to determine its usefulness in predicting postoperative outcomes in patients undergoing liver resection. Patients and Methods: Transient elastography and ICG clearance test were performed pre-operatively in 44 patients with hepatocellular carcinoma. The LSM and ICG retention rate at 15 minutes (R15) were correlated with pre-operative factors and post-operative outcomes. Results: There was significant correlation between ICG R15 and LSM. In patients with LSM >= 11 kPa vs,11 kPa, there was significantly higher ICG R15 (17.1% vs 10.0% respectively, p = 0.025). For patients with ICG R15 >= 10% compared to those <10%, there was significantly higher LSM (12.0 vs 7.6 kPa respectively, p = 0.015). Twenty-eight patients proceeded to resection. There was a significant correlation between LSM and the peak INR after liver resection (r = 0.426, p = 0.024). There was a significant correlation between ICG R15 and the post-operative peak AST level (r = -0.414, p = 0.029) and peak ALT level (r = -0.568, p = 0.002). The operative time was a significant independent factor associated with post-operative complications and peak INR. Conclusion: LSM correlated well with ICG R15 in patients undergoing liver resection, and predicted early post-operative complications. Addition of LSM to ICG R15 testing may provide better prognostic information for patients undergoing resection.	[Fung, James; Seto, Wai-Kay; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Poon, Ronnie T. P.; Yu, Wan-Ching; Chan, See-Ching; Chan, Albert C. Y.; Chok, Kenneth S. H.; Cheung, Tan-To; Lo, Chung-Mau] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Chok, Kenneth Siu Ho/C-9606-2012; Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012; Chan, Albert/AAC-1642-2022	Chok, Kenneth Siu Ho/0000-0001-7921-3807; SETO, Wai-Kay/0000-0002-9012-313X; Chan, Albert/0000-0002-1383-2952; Lai, Ching-Lung/0000-0002-5927-2436; Fung, James/0000-0002-1286-8902				Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; CAESAR J, 1961, CLIN SCI, V21, P43; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Cescon M, 2012, ANN SURG, V256, P706, DOI 10.1097/SLA.0b013e3182724ce8; Cescon M, 2009, ARCH SURG-CHICAGO, V144, P57, DOI 10.1001/archsurg.2008.522; FAN ST, 1995, ARCH SURG-CHICAGO, V130, P198; Fung J, 2010, J VIRAL HEPAT; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2010, AM J GASTROENTEROL, V105, P1116, DOI 10.1038/ajg.2009.665; Hsieh CB, 2004, WORLD J GASTROENTERO, V10, P2394; Ichikawa T, 2009, J HEPATO-BILIARY-PAN, V16, P42, DOI 10.1007/s00534-008-0003-4; Kim SU, 2008, HEPATOL INT, V2, P471, DOI 10.1007/s12072-008-9091-0; Lam CM, 1999, BRIT J SURG, V86, P1012, DOI 10.1046/j.1365-2168.1999.01204.x; Lau H, 1997, BRIT J SURG, V84, P1255; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Ohwada S, 2006, BRIT J SURG, V93, P339, DOI 10.1002/bjs.5258; Purcell R, 2006, ANZ J SURG, V76, P75, DOI 10.1111/j.1445-2197.2006.03643.x; Watanabe Y, 1999, J CARDIOTHOR VASC AN, V13, P299, DOI 10.1016/S1053-0770(99)90267-7; Wong JSW, 2013, ANN SURG, V257, P922, DOI 10.1097/SLA.0b013e318269d2ec	21	23	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72306	10.1371/journal.pone.0072306	http://dx.doi.org/10.1371/journal.pone.0072306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015232	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800045
J	Kellermann, V; Overgaard, J; Loeschcke, V; Kristensen, TN; Hoffmann, AA				Kellermann, Vanessa; Overgaard, Johannes; Loeschcke, Volker; Kristensen, Torsten Nygaard; Hoffmann, Ary A.			Trait Associations across Evolutionary Time within a Drosophila Phylogeny: Correlated Selection or Genetic Constraint?	PLOS ONE			English	Article							CHILL-COMA RECOVERY; STARVATION RESISTANCE; NATURAL-POPULATIONS; THERMAL TOLERANCE; STRESS RESISTANCE; DESICCATION; ADAPTATION; PATTERNS; LIMITS; COLD	Traits do not evolve independently. To understand how trait changes under selection might constrain adaptive changes, phenotypic and genetic correlations are typically considered within species, but these capture constraints across a few generations rather than evolutionary time. For longer-term constraints, comparisons are needed across species but associations may arise because of correlated selection pressures rather than genetic interactions. Implementing a unique approach, we use known patterns of selection to separate likely trait correlations arising due to correlated selection from those reflecting genetic constraints. We examined the evolution of stress resistance in >90 Drosophila species adapted to a range of environments, while controlling for phylogeny. Initially we examined the role of climate and phylogeny in shaping the evolution of starvation and body size, two traits previously not examined in this context. Following correction for phylogeny only a weak relationship between climate and starvation resistance was detected, while all of the variation in the relationship between body size and climate could be attributed to phylogeny. Species were divided into three environmental groups (hot and dry, hot and wet, cold) with the expectation that, if genetic correlations underpin trait correlations, these would persist irrespective of the environment, whereas selection-driven evolution should produce correlations dependent on the environment. We found positive associations between most traits in hot and dry environments coupled with high trait means. In contrast few trait correlations were observed in hot/wet and cold environments. These results suggest trait associations are primarily driven by correlated selection rather than genetic interactions, highlighting that such interactions are unlikely to limit evolution of stress resistance.	[Kellermann, Vanessa; Overgaard, Johannes; Loeschcke, Volker; Kristensen, Torsten Nygaard] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Kellermann, Vanessa] Monash Univ, Dept Biol Sci, Clayton, Vic 3800, Australia; [Kristensen, Torsten Nygaard] Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark; [Kristensen, Torsten Nygaard] NordGen Nordic Genet Resource Ctr, As, Norway; [Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Dept Genet, Melbourne, Vic 3010, Australia	Aarhus University; Monash University; Aarhus University; University of Melbourne	Kellermann, V (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	Vanessa.kellermann@monash.edu	Loeschcke, Volker/J-2527-2013; Overgaard, Johannes/I-7493-2013; Overgaard, Johannes/AAA-3922-2022; Kristensen, Torsten N/C-5031-2015; Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019	Loeschcke, Volker/0000-0003-1450-0754; Overgaard, Johannes/0000-0002-2851-4551; Kristensen, Torsten N/0000-0001-6204-8753; Hoffmann, Ary/0000-0001-9497-7645; Kellermann, Vanessa/0000-0002-9859-9642	Danish Natural Sciences Research Council (FNU); Danish Natural Sciences Research Council (DFF); Science Industry Endowment Fund; Australian Research Council	Danish Natural Sciences Research Council (FNU)(Danish Natural Science Research Council); Danish Natural Sciences Research Council (DFF); Science Industry Endowment Fund; Australian Research Council(Australian Research Council)	The Danish Natural Sciences Research Council (FNU and DFF) provided financial support to VL, TNK, and JO. The Science Industry Endowment Fund and the Australian Research Council provided financial support to AAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; Anderson AR, 2003, HEREDITY, V90, P195, DOI 10.1038/sj.hdy.6800220; Andrewartha H. G., 1954, ECOLOGICAL WEB MORE; Bertoli CI, 2010, ENTOMOL EXP APPL, V134, P154, DOI 10.1111/j.1570-7458.2009.00948.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Duputie A, 2012, ECOL LETT, V15, P251, DOI 10.1111/j.1461-0248.2011.01734.x; Edney E.B., 1977, WATER BALANCE LAND A, P17; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Gibbs AG, 2003, J THERM BIOL, V28, P353, DOI 10.1016/S0306-4565(03)00011-1; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Greve M, 2011, GLOBAL ECOL BIOGEOGR, V20, P661, DOI 10.1111/j.1466-8238.2011.00666.x; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hine E, 2004, EVOLUTION, V58, P2754, DOI 10.1111/j.0014-3820.2004.tb01627.x; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 2005, J EVOLUTION BIOL, V18, P804, DOI 10.1111/j.1420-9101.2004.00871.x; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Hutley LB, 2011, AGR FOREST METEOROL, V151, P1417, DOI 10.1016/j.agrformet.2011.03.002; JAMES AC, 1995, GENETICS, V140, P659; Karan D, 1998, EVOLUTION, V52, P825, DOI [10.1111/j.1558-5646.1998.tb03706.x, 10.2307/2411276]; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kingsolver JG, 2011, AM NAT, V177, P346, DOI 10.1086/658341; Lyons CL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-226; MacMillan HA, 2009, INSECT SCI, V16, P263, DOI 10.1111/j.1744-7917.2009.01251.x; Matzkin LM, 2009, FUNCT ECOL, V23, P521, DOI 10.1111/j.1365-2435.2008.01533.x; Orme C. D. L., METHODS ECO IN PRESS; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parkash R, 1999, J ZOOL SYST EVOL RES, V37, P195; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Scriber JM, 2012, INSECT SCI, V19, P277, DOI 10.1111/j.1744-7917.2011.01477.x; Sinclair BJ, 2012, PHYSIOL BIOCHEM ZOOL, V85, P594, DOI 10.1086/665388; Team RDC, 2011, R ENV STAT COMP GRAP; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; vanHerrewege J, 1997, ECOSCIENCE, V4, P151, DOI 10.1080/11956860.1997.11682389	51	14	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72072	10.1371/journal.pone.0072072	http://dx.doi.org/10.1371/journal.pone.0072072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015206	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800026
J	Pazos, P; Lima, L; Casanueva, FF; Dieguez, C; Garcia, MC				Pazos, Patricia; Lima, Luis; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.			Interleukin 6 Deficiency Modulates the Hypothalamic Expression of Energy Balance Regulating Peptides during Pregnancy in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; BODY-WEIGHT; FOOD-INTAKE; PROINFLAMMATORY CYTOKINE; LIPID-METABOLISM; MESSENGER-RNA; RAT-BRAIN; TNF-ALPHA; RECEPTOR; HORMONE	Pregnancy is associated with hyperphagia, increased adiposity and multiple neuroendocrine adaptations. Maternal adipose tissue secretes rising amounts of interleukin 6 (IL6), which acts peripherally modulating metabolic function and centrally increasing energy expenditure and reducing body fat. To explore the role of IL6 in the central mechanisms governing dam's energy homeostasis, early, mid and late pregnant (gestational days 7, 13 and 18) wild-type (WT) and Il6 knockout mice (Il6-KO) were compared with virgin controls at diestrus. Food intake, body weight and composition as well as indirect calorimetry measurements were performed in vivo. Anabolic and orexigenic peptides: neuropeptide Y (Npy) and agouti-related peptide (Agrp); and catabolic and anorectic neuropeptides: proopiomelanocortin (Pomc), corticotrophin and thyrotropin-releasing hormone (Crh and Trh) mRNA levels were determined by in situ hybridization. Real time-PCR and western-blot were used for additional tissue gene expression and protein studies. Non-pregnant Il6-KO mice were leaner than WT mice due to a decrease in fat but not in lean body mass. Pregnant Il6-KO mice had higher fat accretion despite similar body weight gain than WT controls. A decreased fat utilization in absence of Il6 might explain this effect, as shown by increased respiratory exchange ratio (RER) in virgin Il6-KO mice. Il6 mRNA levels were markedly enhanced in adipose tissue but reduced in hypothalamus of mid and late pregnant WT mice. Trh expression was also stimulated at gestational day 13 and lack of Il6 blunted this effect. Conversely, in late pregnant mice lessened hypothalamic Il6 receptor alpha (Il6ra), Pomc and Crh mRNA were observed. Il6 deficiency during this stage up-regulated Npy and Agrp expression, while restoring Pomc mRNA levels to virgin values. Together these results demonstrate that IL6/IL6Ra system modulates Npy/Agrp, Pomc and Trh expression during mouse pregnancy, supporting a role of IL6 in the central regulation of body fat in this physiological state.	[Pazos, Patricia; Lima, Luis; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.] Univ Santiago de Compostela, Dept Physiol, Res Ctr Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Pazos, Patricia; Lima, Luis; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.] Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain; [Pazos, Patricia; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.] Minist Econ & Competitividad MINECO, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Casanueva, Felipe F.] CHUS, Lab Endocrinol Mol & Celular, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Spanish Ministry of Economy & Competitiveness; Complexo Hospitalario Universitario de Santiago de Compostela	Garcia, MC (corresponding author), Univ Santiago de Compostela, Dept Physiol, Res Ctr Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain.	maria.garcia.garcia@usc.es	García, María C/A-7565-2014	García, María C/0000-0001-5672-1366; Lima Rodriguez, Luis/0000-0002-9516-5865; dieguez, carlos/0000-0002-0919-4337	European Community; Ministerio de Economia y Competitividad; Xunta de Galicia [ERG-516456, BFU2007-62683/BFI, PGIDIT06PXIB208067PR]; European Community [Health-F2-2008-223713, 245009]	European Community(European Commission); Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Community(European Commission)	This work was funded by European Community, Ministerio de Economia y Competitividad and Xunta de Galicia grants (MCGG and CD: ERG-516456; MCGG and PP: BFU2007-62683/BFI; MCGG and LL:PGIDIT06PXIB208067PR). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of ISCIII. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under grant agreements (CD: Health-F2-2008-223713: "Reprobesity"; FP7/2007-2013: no 245009: "NeuroFAST"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2000, HORM METAB RES, V32, P164, DOI 10.1055/s-2007-978615; Benrick A, 2009, J NEUROENDOCRINOL, V21, P620, DOI 10.1111/j.1365-2826.2009.01879.x; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Betz MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038997; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Caja S, 2008, HORM METAB RES, V40, P375, DOI 10.1055/s-2008-1062701; Cao CY, 2001, EUR J NEUROSCI, V13, P1781, DOI 10.1046/j.0953-816x.2001.01551.x; DE M, 1992, ENDOCRINOLOGY, V131, P14, DOI 10.1210/en.131.1.14; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Garcia MC, 2003, FASEB J, V17, P1392, DOI 10.1096/fj.02-0933com; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Garcia MD, 2000, BIOL REPROD, V62, P698, DOI 10.1095/biolreprod62.3.698; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Good DJ, 2005, LAB ANIMAL, V34, P30, DOI 10.1038/laban0205-30; Harris RBS, 2010, NEUROENDOCRINOLOGY, V92, P198, DOI 10.1159/000319793; HERRERA E, 1991, DIABETES, V40, P83, DOI 10.2337/diab.40.2.S83; Hidalgo J, 2010, BRAIN BEHAV IMMUN, V24, P119, DOI 10.1016/j.bbi.2009.09.002; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Johnson MS, 2001, J EXP BIOL, V204, P1925; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; Kamath J, 2009, PHARMACOL THERAPEUT, V121, P20, DOI 10.1016/j.pharmthera.2008.09.004; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kronfeld-Schor N, 2000, BIOL REPROD, V63, P274, DOI 10.1095/biolreprod63.1.274; Ladyman SR, 2011, J NEUROENDOCRINOL, V23, P1091, DOI 10.1111/j.1365-2826.2011.02191.x; Ladyman SR, 2010, J NEUROENDOCRINOL, V22, P805, DOI 10.1111/j.1365-2826.2010.02017.x; Ladyman SR, 2012, REPRODUCTIO IN PRESS; Lage M, 1999, CLIN ENDOCRINOL, V50, P211, DOI 10.1046/j.1365-2265.1999.00637.x; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Li G, 2002, NEUROSCIENCE, V115, P879, DOI 10.1016/S0306-4522(02)00447-5; Liu L., 2008, J VIS EXP; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Makarova E N, 2010, Neurosci Behav Physiol, V40, P263, DOI 10.1007/s11055-010-9253-0; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mistry AM, 2002, EXP BIOL MED, V227, P616, DOI 10.1177/153537020222700809; Nogueiras R, 2003, OBES RES, V11, P408, DOI 10.1038/oby.2003.55; Oberto A, 2003, ENDOCRINOLOGY, V144, P4826, DOI 10.1210/en.2003-0197; Orsi NM, 2006, ANIM REPROD SCI, V96, P54, DOI 10.1016/j.anireprosci.2005.11.010; Pedersen BK, 2011, BRAIN BEHAV IMMUN, V25, P811, DOI 10.1016/j.bbi.2011.02.010; Pekary AE, 2007, J MOL NEUROSCI, V31, P245, DOI 10.1385/JMN/31:03:245; Perez-Sieira S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053836; Phillips CT, 2008, ENDOCRINOLOGY, V149, P544, DOI 10.1210/en.2007-1153; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Ramos MP, 2003, AM J PHYSIOL-ENDOC M, V285, pE318, DOI 10.1152/ajpendo.00456.2002; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Schele E, 2013, J NEUROENDOCRINOL; Senaris RM, 2011, J NEUROENDOCRINOL, V23, P675, DOI 10.1111/j.1365-2826.2011.02158.x; Shin AC, 2009, PHYSIOL BEHAV, V97, P572, DOI 10.1016/j.physbeh.2009.02.010; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Steensberg A, 2006, BRAIN BEHAV IMMUN, V20, P585, DOI 10.1016/j.bbi.2006.03.002; Stenlof K, 2003, J CLIN ENDOCR METAB, V88, P4379, DOI 10.1210/jc.2002-021733; Trujillo ML, 2011, ENDOCRINOLOGY, V152, P1355, DOI 10.1210/en.2010-0975; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Vallieres L, 1999, ENDOCRINOLOGY, V140, P3890, DOI 10.1210/en.140.9.3890; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wernstedt I, 2006, ENDOCRINOLOGY, V147, P2690, DOI 10.1210/en.2005-1133; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211	69	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72339	10.1371/journal.pone.0072339	http://dx.doi.org/10.1371/journal.pone.0072339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015235	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800047
J	Smidt, W				Smidt, Werner			Potential Elucidation of a Novel CTL Epitope in HIV-1 Protease by the Protease Inhibitor Resistance Mutation L90M	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; VIRUS-REPLICATION; PREDICTIONS; INFECTION; RESPONSES; BINDING; POL; IMMUNOGENICITY; PRESSURE; THERAPY	The combination of host immune responses and use of antiretrovirals facilitate partial control of human immunodeficiency virus type 1 (HIV-1) infection and result in delayed progression to Acquired Immunodeficiency Syndrome (AIDS). Both treatment and host immunity impose selection pressures on the highly mutable HIV-1 genome resulting in antiretroviral resistance and immune escape. Researchers have shown that antiretroviral resistance mutations can shape cytotoxic T-lymphocyte immunity by altering the epitope repertoire of HIV infected cells. Here it was discovered that an important antiretroviral resistance mutation, L90M in HIV protease, occurs at lower frequencies in hosts that harbor the B*15, B*48 or A*32 human leukocyte antigen subtypes. A likely reason is the elucidation of novel epitopes by L90M. NetMHCPan predictions reveal increased affinity of the peptide spanning the HIV protease region, PR 89-97 and PR 90-99 to HLA-B*15/B*48 and HLA-A*32 respectively due to the L90M substitution. The higher affinity could increase the chance of the epitope being presented and recognized by Cytotoxic T-lymphocytes and perhaps provide additional immunological pressures in the presence of antiretroviral attenuating mutations. This evidence supports the notion that knowledge of HLA allotypes in HIV infected individuals could augment antiretroviral treatment by the elucidation of epitopes due to antiretroviral resistance mutations in HIV protease.	Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa	University of Pretoria	Smidt, W (corresponding author), Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa.	werner.smidt@student.up.ac.za			National Research Foundation South Africa [71262:2011]	National Research Foundation South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	This work was supported by the National Research Foundation South Africa under the grant number 71262:2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Cardinaud S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002049; De Groot AS, 2006, DRUG DISCOV TODAY, V11, P203, DOI 10.1016/S1359-6446(05)03720-7; Di Giambenedetto S, 2011, CLIN MICROBIOL INFEC, V17, P1352, DOI 10.1111/j.1469-0691.2011.03563.x; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Johnson VA, 2013, TOP ANTIVIR MED, V21, P4; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Karlsson AC, 2007, J VIROL, V81, P11543, DOI 10.1128/JVI.00779-07; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Layrisse Z, 2000, HUM IMMUNOL, V61, P925, DOI 10.1016/S0198-8859(00)00161-0; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Mason RA, 2004, J IMMUNOL, V172, P7212, DOI 10.4049/jimmunol.172.11.7212; Menendez-Arias L, 2002, TRENDS PHARMACOL SCI, V23, P381, DOI 10.1016/S0165-6147(02)02054-0; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mueller SM, 2007, J VIROL, V81, P2887, DOI 10.1128/JVI.01547-06; Mueller SM, 2011, JAIDS-J ACQ IMM DEF, V56, P109, DOI 10.1097/QAI.0b013e3181fe946e; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Petrovsky N, 2002, IMMUNOL CELL BIOL, V80, P248, DOI 10.1046/j.1440-1711.2002.01093.x; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; R Core Team, 2012, R LANG ENV STAT COMP; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SETTE A, 1994, J IMMUNOL, V153, P5586; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Stratov I, 2005, J VIROL, V79, P7728, DOI 10.1128/JVI.79.12.7728-7737.2005; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Vollbrecht T, 2012, MED MICROBIOL IMMUN, V201, P201, DOI 10.1007/s00430-011-0222-1; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71888	10.1371/journal.pone.0071888	http://dx.doi.org/10.1371/journal.pone.0071888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015196	gold, Green Published, Green Submitted			2022-12-25	WOS:000323733800018
J	Guellouz, A; Valerio-Lepiniec, M; Urvoas, A; Chevrel, A; Graille, M; Fourati-Kammoun, Z; Desmadril, M; van Tilbeurgh, H; Minard, P				Guellouz, Asma; Valerio-Lepiniec, Marie; Urvoas, Agathe; Chevrel, Anne; Graille, Marc; Fourati-Kammoun, Zaineb; Desmadril, Michel; van Tilbeurgh, Herman; Minard, Philippe			Selection of Specific Protein Binders for Pre-Defined Targets from an Optimized Library of Artificial Helicoidal Repeat Proteins (alphaRep)	PLOS ONE			English	Article							NON-ANTIBODY SCAFFOLDS; BINDING-PROTEINS; LIGAND-BINDING; SACCHAROMYCES-CEREVISIAE; FAB FRAGMENTS; NEOCARZINOSTATIN; DESIGN; EVOLUTION; DARPINS; DISPLAY	We previously designed a new family of artificial proteins named alpha Rep based on a subgroup of thermostable helicoidal HEAT-like repeats. We have now assembled a large optimized alpha Rep library. In this library, the side chains at each variable position are not fully randomized but instead encoded by a distribution of codons based on the natural frequency of side chains of the natural repeats family. The library construction is based on a polymerization of micro-genes and therefore results in a distribution of proteins with a variable number of repeats. We improved the library construction process using a "filtration" procedure to retain only fully coding modules that were recombined to recreate sequence diversity. The final library named Lib2.1 contains 1.7x10(9) independent clones. Here, we used phage display to select, from the previously described library or from the new library, new specific alpha Rep proteins binding to four different non-related predefined protein targets. Specific binders were selected in each case. The results show that binders with various sizes are selected including relatively long sequences, with up to 7 repeats. ITC-measured affinities vary with K-d values ranging from micromolar to nanomolar ranges. The formation of complexes is associated with a significant thermal stabilization of the bound target protein. The crystal structures of two complexes between alpha Rep and their cognate targets were solved and show that the new interfaces are established by the variable surfaces of the repeated modules, as well by the variable N-cap residues. These results suggest that alpha Rep library is a new and versatile source of tight and specific binding proteins with favorable biophysical properties.	[Guellouz, Asma; Valerio-Lepiniec, Marie; Urvoas, Agathe; Chevrel, Anne; Graille, Marc; Fourati-Kammoun, Zaineb; Desmadril, Michel; van Tilbeurgh, Herman; Minard, Philippe] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France; [Guellouz, Asma; Valerio-Lepiniec, Marie; Urvoas, Agathe; Chevrel, Anne; Graille, Marc; Fourati-Kammoun, Zaineb; Desmadril, Michel; van Tilbeurgh, Herman; Minard, Philippe] CNRS, Unite Mixte Rech 8619, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Minard, P (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France.	philippe.minard@u-psud.fr	ARTEMIS, Project/K-9256-2013; Minard, Philippe/GRS-4797-2022; GRAILLE, Marc/D-3242-2014; Desmadril, Michel/AAC-8174-2020	Minard, Philippe/0000-0002-3256-528X; GRAILLE, Marc/0000-0002-7853-5852; Fourati, Zaineb/0000-0002-2316-4142	University of Paris-Sud; Centre National de la Recherche Scientifique (CNRS)	University of Paris-Sud; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the University of Paris-Sud and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behar G, 2013, PROTEIN ENG DES SEL; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Cansizoglu AE, 2007, STRUCTURE, V15, P1431, DOI 10.1016/j.str.2007.09.009; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cortajarena AL, 2011, PROTEIN SCI, V20, P336, DOI 10.1002/pro.564; Cortajarena AL, 2010, ACS CHEM BIOL, V5, P545, DOI 10.1021/cb9002464; Cyranka-Czaja A, 2012, ACTA BIOCHIM POL, V59, P383; Drevelle A, 2006, J MOL BIOL, V358, P455, DOI 10.1016/j.jmb.2006.02.002; Drevelle A, 2009, CHEMBIOCHEM, V10, P1349, DOI 10.1002/cbic.200800745; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford AS, 2006, EUKARYOT CELL, V5, P301, DOI 10.1128/EC.5.2.301-312.2006; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Gunnarsson LC, 2006, BIOMOL ENG, V23, P111, DOI 10.1016/j.bioeng.2005.12.002; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Heyd B, 2000, J BACTERIOL, V182, P1812, DOI 10.1128/JB.182.7.1812-1818.2000; Heyd B, 2003, BIOCHEMISTRY-US, V42, P5674, DOI 10.1021/bi0273664; Hoffmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031298; Huber T, 2007, J STRUCT BIOL, V159, P206, DOI 10.1016/j.jsb.2007.01.013; Jackrei ME, 2009, PROTEIN SCI, V18, P762, DOI 10.1002/pro.75; Javadi Y, 2009, P NATL ACAD SCI USA, V106, P17383, DOI 10.1073/pnas.0907455106; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kajander T, 2005, J AM CHEM SOC, V127, P10188, DOI 10.1021/ja0524494; Kajava AV, 2011, J STRUCT BIOL; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kloss E, 2008, J MOL BIOL, V383, P1195, DOI 10.1016/j.jmb.2008.08.069; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Koide S, 2009, CURR OPIN BIOTECH, V20, P398, DOI 10.1016/j.copbio.2009.07.007; Kramer MA, 2010, J MOL BIOL, V404, P381, DOI 10.1016/j.jmb.2010.09.023; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Luke B, 2007, NUCLEIC ACIDS RES, V35, P7688, DOI 10.1093/nar/gkm912; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; Patel S, 2013, PROTEIN ENG DES SEL; Piotukh K, 2012, PROTEIN ENG DES SEL, V25, P649, DOI 10.1093/protein/gzs062; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Scholle MD, 2004, PROTEIN EXPRES PURIF, V37, P243, DOI 10.1016/j.pep.2004.05.012; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Soltes G, 2003, J IMMUNOL METHODS, V274, P233, DOI 10.1016/S0022-1759(02)00294-6; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; Urvoas A, 2012, TRENDS BIOTECHNOL, V30, P512, DOI 10.1016/j.tibtech.2012.06.001; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valerio-Lepiniec M, 2002, PROTEIN ENG, V15, P861, DOI 10.1093/protein/15.11.861; Varadamsetty G, 2012, J MOL BIOL, V424, P68, DOI 10.1016/j.jmb.2012.08.029; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046	63	36	36	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71512	10.1371/journal.pone.0071512	http://dx.doi.org/10.1371/journal.pone.0071512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014183	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200014
J	Hoffman, WH; Passmore, GG; Hannon, DW; Talor, MV; Fox, P; Brailer, C; Haislip, D; Keel, C; Harris, G; Rose, NR; Fiordalisi, I; Cihakova, D				Hoffman, William H.; Passmore, Gregory G.; Hannon, David W.; Talor, Monica V.; Fox, Pam; Brailer, Catherine; Haislip, Dynita; Keel, Cynthia; Harris, Glenn; Rose, Noel R.; Fiordalisi, Irma; Cihakova, Daniela			Increased Systemic Th17 Cytokines Are Associated with Diastolic Dysfunction in Children and Adolescents with Diabetic Ketoacidosis	PLOS ONE			English	Article							OXIDATIVE STRESS; AUTOIMMUNE MYOCARDITIS; DILATED CARDIOMYOPATHY; T-LYMPHOCYTES; ECHOCARDIOGRAPHIC EVALUATION; DOPPLER ECHOCARDIOGRAPHY; THERAPEUTIC IMPLICATIONS; CARDIAC INFLAMMATION; ENDOTHELIAL-CELLS; EJECTION FRACTION	Diastolic dysfunction suggestive of diabetic cardiomyopathy is established in children with T1DM, but its pathogenesis is not well understood. We studied the relationships of systemic inflammatory cytokines/chemokines and cardiac function in 17 children with T1DM during and after correction of diabetic ketoacidosis (DKA). Twenty seven of the 39 measured cytokines/chemokines were elevated at 6-12 hours into treatment of DKA compared to values after DKA resolution. Eight patients displayed at least one parameter of diastolic abnormality (DA) during acute DKA. Significant associations were present between nine of the cytokine/chemokine levels and the DA over time. Interestingly, four of these nine interactive cytokines (GM-CSF, G-CSF, IL-12p40, IL-17) are associated with a Th17 mediated cell response. Both the DA and CCL7 and IL-12p40, had independent associations with African American patients. Thus, we report occurrence of a systemic inflammatory response and the presence of cardiac diastolic dysfunction in a subset of young T1DM patients during acute DKA.	[Hoffman, William H.] Georgia Regents Univ, Sect Pediat Endocrinol, Augusta, GA USA; [Passmore, Gregory G.] Georgia Regents Univ, Augusta, GA USA; [Hannon, David W.] E Carolina Univ, Brody Sch Med, Pediat Cardiol Sect, Greenville, NC USA; [Talor, Monica V.; Rose, Noel R.; Cihakova, Daniela] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fox, Pam; Brailer, Catherine; Haislip, Dynita; Keel, Cynthia; Fiordalisi, Irma] E Carolina Univ, Brody Sch Med, Pediat Crit Care Sect, Greenville, NC USA; [Harris, Glenn] E Carolina Univ, Brody Sch Med, Sect Pediat Endocrinol, Greenville, NC USA; [Rose, Noel R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of North Carolina; East Carolina University; Johns Hopkins University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hoffman, WH (corresponding author), Georgia Regents Univ, Sect Pediat Endocrinol, Augusta, GA USA.	Whoffman@GRU.edu	Cihakova, Daniela/A-9821-2017	Cihakova, Daniela/0000-0002-8713-2860	Johns Hopkins Center for Autoimmune Disease Research	Johns Hopkins Center for Autoimmune Disease Research	The study was funded by Johns Hopkins Center for Autoimmune Disease Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adal E, 2006, J PEDIATR ENDOCR MET, V19, P713; AIRAKSINEN KEJ, 1989, DIABETES CARE, V12, P159, DOI 10.2337/diacare.12.2.159; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Barin JG, 2012, IMMUNOBIOLOGY, V217, P468, DOI 10.1016/j.imbio.2011.06.009; Barin JG, 2010, EXP MOL PATHOL, V89, P83, DOI 10.1016/j.yexmp.2010.06.005; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; BREIDBART S, 1987, J PEDIATR-US, V111, P736, DOI 10.1016/S0022-3476(87)80256-1; Carl GF, 2003, ENDOCR RES, V29, P73, DOI 10.1081/ERC-120018678; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Cerielo A, 1997, J DIABETES COMPLICAT, V11, P250, DOI 10.1016/S1056-8727(97)00021-4; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Chen TJ, 2003, BURNS, V29, P343, DOI 10.1016/S0305-4179(03)00007-X; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499; Dalton RR, 2003, ANN CLIN LAB SCI, V33, P435; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; De Marco M, 2011, DIABETES CARE, V34, P2300, DOI 10.2337/dc11-0191; Deeter KH, 2011, PEDIATR DIABETES, V12, P295, DOI 10.1111/j.1399-5448.2010.00695.x; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Douglas SA, 2010, CELL MOL NEUROBIOL, V30, P1467, DOI 10.1007/s10571-010-9593-x; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Escher F, 2011, HEART, V97, P733, DOI 10.1136/hrt.2010.205716; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fiordalisi I, 2007, PEDIATR DIABETES, V8, P142, DOI 10.1111/j.1399-5448.2007.00253.x; Fisman EZ, 2008, ADV CARDIOL, V45, P44, DOI 10.1159/000115187; Florys B, 2000, Med Sci Monit, V6, P342; Furukawa A, 2001, AUTOIMMUNITY, V34, P165, DOI 10.3109/08916930109007380; Ghanim H, 2010, DIABETES CARE, V33, P1103, DOI 10.2337/dc09-2193; Gunczler P, 2002, J PEDIATR ENDOCR MET, V15, P181; Haddad JJ, 2003, J NEUROIMMUNOL, V145, P154, DOI 10.1016/j.jneuroim.2003.09.002; Haelens A, 1996, IMMUNOBIOLOGY, V195, P499, DOI 10.1016/S0171-2985(96)80019-2; Haga T, 2009, J MOL CELL CARDIOL, V46, P719, DOI 10.1016/j.yjmcc.2009.02.003; HARRIS GD, 1994, ARCH PEDIAT ADOL MED, V148, P1046, DOI 10.1001/archpedi.1994.02170100044009; Hoffman WH, 2001, J DIABETES COMPLICAT, V15, P144, DOI 10.1016/S1056-8727(00)00142-2; Hoffman WH, 2003, CLIN IMMUNOL, V108, P175, DOI 10.1016/S1521-6616(03)00144-X; Hoffman WH, 1998, J DIABETES COMPLICAT, V12, P314, DOI 10.1016/S1056-8727(98)00012-9; Holsclaw DS, 1997, PEDIATR PULM, V24, P438, DOI 10.1002/(SICI)1099-0496(199712)24:6<438::AID-PPUL9>3.0.CO;2-C; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; ILLAN F, 1992, CLIN INVESTIGATOR, V70, P403; Isales CM, 1999, J DIABETES COMPLICAT, V13, P91, DOI 10.1016/S1056-8727(99)00030-6; Jain SK, 2001, ADV EXP MED BIOL, V498, P221; Jerath RS, 2005, CLIN IMMUNOL, V116, P11, DOI 10.1016/j.clim.2005.03.004; Jeschke MG, 2004, ANN SURG, V239, P553, DOI 10.1097/01.sla.0000118569.10289.ad; Joseph J, 2012, J IMMUNOL, V188, P216, DOI 10.4049/jimmunol.1101215; Kakkar R, 1996, CLIN SCI, V91, P441, DOI 10.1042/cs0910441; Karavanaki K, 2011, ENDOCR J, V58, P1045, DOI 10.1507/endocrj.EJ11-0024; Khullar M, 2010, CAN J PHYSIOL PHARM, V88, P233, DOI 10.1139/Y10-016; Kitabchi AE, 2004, BIOCHEM BIOPH RES CO, V315, P404, DOI 10.1016/j.bbrc.2004.01.065; Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lappe JM, 2008, J CARD FAIL, V14, P521, DOI 10.1016/j.cardfail.2008.02.016; Lavine SJ, 2006, J AM SOC ECHOCARDIOG, V19, P1350, DOI 10.1016/j.echo.2006.05.008; Lee DM, 2002, J DIABETES COMPLICAT, V16, P294, DOI 10.1016/S1056-8727(01)00215-X; Li Y, 2005, AM J PATHOL, V167, P5, DOI 10.1016/S0002-9440(10)62948-3; Lind M, 2011, LANCET, V378, P140, DOI 10.1016/S0140-6736(11)60471-6; Liu XH, 2011, MED HYPOTHESES, V76, P593, DOI 10.1016/j.mehy.2011.01.008; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; MACGILLIVRAY MH, 1981, PEDIATR RES, V15, P99, DOI 10.1203/00006450-198102000-00002; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Marfella R, 2001, J CLIN INVEST, V108, P635, DOI 10.1172/JCI13727; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; MATSUMORI A, 1994, BRIT HEART J, V72, P561; MERCIER JC, 1982, CIRCULATION, V65, P962, DOI 10.1161/01.CIR.65.5.962; Mihm MJ, 2001, LIFE SCI, V69, P527, DOI 10.1016/S0024-3205(01)01141-9; Miki T, 2012, HEART FAIL REV; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Mohagheghie A, 2011, NUKLEARMED-NUCL MED, V50, P3, DOI 10.3413/nukmed-0318-10-05; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ness RB, 2004, AM J EPIDEMIOL, V160, P1033, DOI 10.1093/aje/kwh325; Oglesbee MJ, 2005, CLIN BIOCHEM, V38, P900, DOI 10.1016/j.clinbiochem.2005.05.011; ONIKI T, 1992, BRIT HEART J, V68, P425; Oppeltz RF, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-38; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; PAILLOLE C, 1989, AM J CARDIOL, V64, P1010, DOI 10.1016/0002-9149(89)90799-6; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Raby AC, 2011, EUR J IMMUNOL, V41, P2741, DOI 10.1002/eji.201041350; RAEV DC, 1994, HEART VESSELS, V9, P121, DOI 10.1007/BF01745237; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; RIGGS TW, 1990, AM J CARDIOL, V65, P899, DOI 10.1016/0002-9149(90)91433-7; Rose NR, 2011, J INTERF CYTOK RES, V31, P705, DOI 10.1089/jir.2011.0057; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Salem M, 2009, PEDIATR DIABETES, V10, P513, DOI 10.1111/j.1399-5448.2009.00517.x; Schram MT, 2005, DIABETOLOGIA, V48, P370, DOI 10.1007/s00125-004-1628-8; Schwacha MG, 2012, INT J CLIN EXP MED, V5, P136; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Spinale FG, 2011, CIRCULATION, V124, P2052, DOI 10.1161/CIRCULATIONAHA.111.064071; Suys BE, 2004, DIABETES CARE, V27, P1947, DOI 10.2337/diacare.27.8.1947; Tardif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE1205, DOI 10.1152/ajpendo.2001.281.6.E1205; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Van Sickle BJ, 2009, CYTOKINE, V48, P290, DOI 10.1016/j.cyto.2009.08.011; VANDAM I, 1988, EUR HEART J, V9, P165, DOI 10.1093/oxfordjournals.eurheartj.a062470; Vazeou A, 2008, EUR J PEDIATR, V167, P877, DOI 10.1007/s00431-007-0603-z; Westermann D, 2011, CIRCULATION, V124, P2082, DOI 10.1161/CIRCULATIONAHA.111.035964; Wojcik M, 2010, J PEDIATR ENDOCR MET, V23, P1055, DOI 10.1515/jpem.2010.167; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yoshida T, 2005, CARDIOVASC RES, V68, P278, DOI 10.1016/j.cardiores.2005.06.006; Yue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018186; Zhang YW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-133; Zhao H, 2012, CELL PHYSIOL BIOCHEM, V30, P1383, DOI 10.1159/000343327	110	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71905	10.1371/journal.pone.0071905	http://dx.doi.org/10.1371/journal.pone.0071905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013901	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200021
J	Lawson, LP; Vernesi, C; Ricci, S; Rovero, F				Lawson, Lucinda P.; Vernesi, Cristiano; Ricci, Silvia; Rovero, Francesco			Evolutionary History of the Grey-Faced Sengi, Rhynchocyon udzungwensis, from Tanzania: A Molecular and Species Distribution Modelling Approach	PLOS ONE			English	Article							BAYESIAN-ESTIMATION; MITOCHONDRIAL DATA; AFRICAN MONKEY; GENE TREES; INFERENCE; NUCLEAR; HYBRIDIZATION; CONSEQUENCES; MOUNTAINS; MAMMALIA	Rhynchocyon udzungwensis is a recently described and poorly understood sengi (giant elephant-shrew) endemic to two small montane forests in Southern Tanzania, and surrounded in lower forests by R. cirnei reichardi. In this study, we investigate the molecular genetic relationship between R. udzungwensis and R. c. reichardi, and the possible role that shifting species distributions in response to climate fluctuations may have played in shaping their evolutionary history. Rhynchocyon udzungwensis and R. c. reichardi individuals were sampled from five localities for genetic analyses. Three mitochondrial and two nuclear loci were used to construct species trees for delimitation and to determine whether introgression was detectable either from ancient or ongoing hybridization. All species-tree results show R. udzungwensis and R. c. reichardi as distinct lineages, though mtDNA shows evidence of introgression in some populations. Nuclear loci of each species were monophyletic, implying introgression is exclusively historical. Because we found evidence of introgression, we used distribution data and species distribution modelling for present, glacial, and interglacial climate cycles to predict how shifting species distributions may have facilitated hybridization in some populations. Though interpretations are affected by the limited range of these species, a likely scenario is that the mtDNA introgression found in eastern mid-elevation populations was facilitated by low numbers of R. udzungwensis that expanded into lowland heavily occupied R. c. reichardi areas during interglacial climate cycles. These results imply that relationships within the genus Rhynchocyon may be confounded by porous species boundaries and introgression, even if species are not currently sympatric.	[Lawson, Lucinda P.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Vernesi, Cristiano] Ctr Res & Innovat, Dept Biodivers & Mol Ecol, Michele Alladige, Italy; [Ricci, Silvia; Rovero, Francesco] Museo Sci, Trop Biodivers Sect, Trento, Italy	University System of Ohio; University of Cincinnati	Lawson, LP (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	lucinda.lawson@uc.edu	Rovero, Francesco/AAI-3157-2020	Rovero, Francesco/0000-0001-6688-1494; Lawson, Lucinda/0000-0003-3939-7829; Vernesi, Cristiano/0000-0001-7534-5669	National Geographic's Committee for Research and Exploration [8497-08]; Trento Autonomous Province; Trento Science Museum; Critical Ecosystem Partnership Fund	National Geographic's Committee for Research and Exploration(National Geographic Society); Trento Autonomous Province; Trento Science Museum; Critical Ecosystem Partnership Fund	This research was supported by grants from National Geographic's Committee for Research and Exploration (grant 8497-08 to F.R.), Trento Autonomous Province, Trento Science Museum and the Critical Ecosystem Partnership Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Andanje Samuel, 2010, Journal of East African Natural History, V99, P1, DOI 10.2982/028.099.0101; Ane C, 2007, MOL BIOL EVOL, V24, P412; AVMA, 2000, AVMA GUID EUTH; Bowie Rauri C.K., 2005, Journal of East African Natural History, V94, P191, DOI 10.2982/0012-8317(2005)94[191:GAMEFT]2.0.CO;2; Chan KMA, 2005, EVOLUTION, V59, P720; Chung YJ, 2011, SYST BIOL, V60, P261, DOI 10.1093/sysbio/syr003; Coals PGR, JE AFR NAT IN PRESS; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; CORBET GB, 1968, B BRIT MUS NAT HIST, V16, P47; Davenport TRB, 2006, SCIENCE, V312, P1378, DOI 10.1126/science.1125631; Degnan JH, 2009, SYST BIOL, V58, P35, DOI 10.1093/sysbio/syp008; DINESEN L, 1994, IBIS, V136, P3, DOI 10.1111/j.1474-919X.1994.tb08125.x; Dinesen Lars, 1993, Scopus, V17, P48; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Douzery E, 1997, MOL BIOL EVOL, V14, P1154, DOI 10.1093/oxfordjournals.molbev.a025725; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumbacher JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032410; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fjeldsa Jon, 2003, Bulletin of the British Ornithologists' Club, V123, P52; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huchon D, 1999, MOL ECOL, V8, P1743, DOI 10.1046/j.1365-294x.1999.00768.x; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Kingdon J., 1974, E AFRICAN MAMMALS AT, V2, P341; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lawson LP, 2010, MOL ECOL, V19, P4046, DOI 10.1111/j.1365-294X.2010.04788.x; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Lee JY, 2012, SYST BIOL, V61, P253, DOI 10.1093/sysbio/syr101; Linnen CR, 2008, SYST BIOL, V57, P876, DOI 10.1080/10635150802580949; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Marshall AR, 2005, INT J PRIMATOL, V26, P127, DOI 10.1007/s10764-005-0011-z; McPeek MA, 2006, EVOLUTION, V60, P1967, DOI 10.1111/j.0014-3820.2006.tb01835.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nyari AS, 2010, AFR ZOOL, V45, P330, DOI 10.3377/004.045.0212; Olson LE, 2004, BIOL J LINN SOC, V83, P1, DOI 10.1111/j.1095-8312.2004.00366.x; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rannala B, 2003, GENETICS, V164, P1645; Rathbun GB, 2009, AFR J ECOL, V47, P1, DOI 10.1111/j.1365-2028.2009.01102.x; Roberts TE, 2010, BIOL LETTERS, V6, P233, DOI 10.1098/rsbl.2009.0741; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rovero F, 2008, J ZOOL, V274, P126, DOI 10.1111/j.1469-7998.2007.00363.x; Rovero F, J MAMMAL IN PRESS; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smit HA, 2007, MOL ECOL, V16, P2680, DOI 10.1111/j.1365-294X.2007.03334.x; Smit HA, 2011, J ZOOL, V284, P133, DOI 10.1111/j.1469-7998.2011.00790.x; Spinks PQ, 2009, SYST BIOL, V58, P1, DOI 10.1093/sysbio/syp005; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	74	8	9	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72506	10.1371/journal.pone.0072506	http://dx.doi.org/10.1371/journal.pone.0072506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015252	gold, Green Submitted, Green Published			2022-12-25	WOS:000323815200043
J	Wedderhoff, I; Kursula, I; Groves, MR; Lucana, DOD				Wedderhoff, Ina; Kursula, Inari; Groves, Matthew R.; Lucana, Dario Ortiz de Orue			Iron Binding at Specific Sites within the Octameric HbpS Protects Streptomycetes from Iron-Mediated Oxidative Stress	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; CATALASE-PEROXIDASE; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; LIPID PEROXIDATION; PLANT FERRITIN; ION-BINDING; METAL; REVEALS; PROTEINS	The soil bacterium Streptomyces reticuli secretes the octameric protein HbpS that acts as a sensory component of the redox-signalling pathway HbpS-SenS-SenR. This system modulates a genetic response on iron-and haem-mediated oxidative stress. Moreover, HbpS alone provides this bacterium with a defence mechanism to the presence of high concentrations of iron ions and haem. While the protection against haem has been related to its haem-binding and haem-degrading activity, the interaction with iron has not been studied in detail. In this work, we biochemically analyzed the iron-binding activity of a set of generated HbpS mutant proteins and present evidence showing the involvement of one internal and two exposed D/EXXE motifs in binding of high quantities of ferrous iron, with the internal E78XXE81 displaying the tightest binding. We additionally show that HbpS is able to oxidize ferrous to ferric iron ions. Based on the crystal structure of both the wild-type and the mutant HbpS-D78XXD81, we conclude that the local arrangement of the side chains from the glutamates in E78XXE81 within the octameric assembly is a pre-requisite for interaction with iron. The data obtained led us to propose that the exposed and the internal motif build a highly specific route that is involved in the transport of high quantities of iron ions into the core of the HbpS octamer. Furthermore, physiological studies using Streptomyces transformants secreting either wild-type or HbpS mutant proteins and different redox-cycling compounds led us to conclude that the iron-sequestering activity of HbpS protects these soil bacteria from the hazardous side effects of peroxide-and iron-based oxidative stress.	[Wedderhoff, Ina; Lucana, Dario Ortiz de Orue] Univ Osnabruck, Dept Biol Chem, Osnabruck, Germany; [Kursula, Inari] Helmholtz Ctr Infect Res, German Electron Synchrotron, Ctr Struct Syst Biol, Hamburg, Germany; [Kursula, Inari] Univ Oulu, Dept Biochem, Oulu, Finland; [Groves, Matthew R.] Univ Groningen, Dept Pharm, Groningen, Netherlands	University Osnabruck; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz-Center for Infection Research; Finland National Institute for Health & Welfare; University of Oulu; University of Groningen	Lucana, DOD (corresponding author), Univ Osnabruck, Dept Biol Chem, Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de	Kursula, Inari/AHB-9980-2022	Kursula, Inari/0000-0001-5236-7056; Groves, Matthew/0000-0001-9859-5177	Deutsche Forschungsgemeinschaft (DFG) [OR 224/1-3, OR 224/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding for this study from the Deutsche Forschungsgemeinschaft (DFG) grants OR 224/1-3 and OR 224/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Bogel G, 2007, FEBS J, V274, P3900, DOI 10.1111/j.1742-4658.2007.05923.x; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; CHUNG MCM, 1985, ANAL BIOCHEM, V148, P498, DOI 10.1016/0003-2697(85)90258-1; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; Crichton R., 2001, INORGANIC BIOCH IRON; Cuypers MG, 2007, J MOL BIOL, V371, P787, DOI 10.1016/j.jmb.2006.11.032; Doyle CK, 2005, INFECT IMMUN, V73, P62, DOI 10.1128/IAI.73.1.62-69.2005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang HM, 2002, BIOCHEM J, V368, P641, DOI 10.1042/BJ20021005; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Groves MR, 2010, CURRENT RES TECHNOLO, P33; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; Hong R, 2012, APPL ENVIRON MICROB, V78, P1776, DOI 10.1128/AEM.07068-11; Hopwood D. A., 1985, GENETIC MANIPULATION; Hotopp JCD, 2003, J INORG BIOCHEM, V93, P66, DOI 10.1016/S0162-0134(02)00436-1; James NG, 2010, PROTEIN SCI, V19, P99, DOI 10.1002/pro.287; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klare JP, 2012, ANTIOXID REDOX SIGN, V16, P639, DOI 10.1089/ars.2011.4080; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson TL, 2009, BIOCHEMISTRY-US, V48, P9031, DOI 10.1021/bi900869x; LEHRER SS, 1969, J BIOL CHEM, V244, P3613; Li YM, 2003, J BIOL CHEM, V278, P6651, DOI 10.1074/jbc.M211249200; Lucana DOD, 2010, J BIOL CHEM, V285, P28086, DOI 10.1074/jbc.M110.127506; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Lucana DOD, 2003, MOL GENET GENOMICS, V268, P618, DOI 10.1007/s00438-002-0776-0; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meschke H, 2010, MICROB BIOTECHNOL, V3, P428, DOI 10.1111/j.1751-7915.2010.00165.x; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Niki E, 2012, FEBS LETT, V586, P3767, DOI 10.1016/j.febslet.2012.09.025; Ortiz de Orue Lucana D, 2012, J SIGNAL TRANSDUCT, DOI DOI 10.1155/2012/605905.EPUB; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Romao CV, 2006, J BIOL INORG CHEM, V11, P891, DOI 10.1007/s00775-006-0142-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Siedenburg G, 2012, ANTIOXID REDOX SIGN, V16, P668, DOI 10.1089/ars.2011.4290; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Torda AE, 2013, FEMS MICROBIOL LETT, V342, P106, DOI 10.1111/1574-6968.12093; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034; Yuan Q, 2007, CHEM RES TOXICOL, V20, P129, DOI 10.1021/tx600270f; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zou P, 2008, ACTA CRYSTALLOGR F, V64, P386, DOI 10.1107/S1744309108008348; Zou PJ, 1999, MICROBIOL-SGM, V145, P549, DOI 10.1099/13500872-145-3-549	73	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71579	10.1371/journal.pone.0071579	http://dx.doi.org/10.1371/journal.pone.0071579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013686	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200017
J	Boyas, S; Remaud, A; Rivers, E; Bilodeau, M				Boyas, Sebastien; Remaud, Anthony; Rivers, Erin; Bilodeau, Martin			Fatiguing Exercise Intensity Influences the Relationship between Parameters Reflecting Neuromuscular Function and Postural Control Variables	PLOS ONE			English	Article							MUSCLE FATIGUE; ISOMETRIC CONTRACTIONS; POSITION SENSE; ANKLE FATIGUE; SURFACES; BALANCE; HUMANS; FLEXOR; TRUNK; KNEE	The purpose of this study was to investigate the influence of fatiguing exercise intensity on the nature and extent of fatigue-induced changes in neuromuscular function and postural stability in quiet standing. We also explored the contribution of selected neuromuscular mechanisms involved in force production to postural stability impairment observed following fatigue using an approach based on multivariate regressions. Eighteen young subjects performed 30-s postural trials on one leg with their eyes closed. Postural trials were performed before and after fatiguing exercises of different intensities: 25, 50 and 75% of maximal isometric plantarflexor torque. Fatiguing exercises consisted of sustaining a plantarflexor isometric contraction at the target intensity until task failure. Maximal isometric plantarflexor torque, electromyographic activity of plantarflexor and dorsiflexor muscles, activation level (twitch interpolation technique) and twitch contractile properties of plantarflexors were used to characterize neuromuscular function. The 25% exercise was associated with greater central fatigue whereas the 50 and 75% exercises involved mostly peripheral fatigue. However, all fatiguing exercises induced similar alterations in postural stability, which was unexpected considering previous literature. Stepwise multiple regression analyses showed that fatigue-related changes in selected parameters related to neuromuscular function could explain more than half (0.51 <= R-2 <= 0.82) of the changes in postural variables for the 25% exercise. On the other hand, regression models were less predictive (0.17 <= R-2 <= 0.73) for the 50 and 75% exercises. This study suggests that fatiguing exercise intensity does not influence the extent of postural stability impairment, but does influence the type of fatigue induced and the neuromuscular function predictors explaining changes in postural variables.	[Boyas, Sebastien; Remaud, Anthony; Bilodeau, Martin] Bruyere Res Inst, Aging & Movement Res Lab, Ottawa, ON, Canada; [Boyas, Sebastien; Rivers, Erin; Bilodeau, Martin] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada; [Bilodeau, Martin] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Boyas, S (corresponding author), Bruyere Res Inst, Aging & Movement Res Lab, Ottawa, ON, Canada.	sebastien.boyas@hotmail.com	Remaud, Anthony/H-3120-2019	Remaud, Anthony/0000-0001-6946-3407	Natural Sciences and Engineering Research Council of Canada [312041-2008]; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was funded in part by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant # 312041-2008 to M. Bilodeau) and the Canada Foundation for Innovation (Leaders Opportunity Fund Award to M. Bilodeau). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; BELANGER AY, 1983, EUR J APPL PHYSIOL O, V51, P381, DOI 10.1007/BF00429075; Bisson EJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-39; Boyas S., 2011, Annals of Physical and Rehabilitation Medicine, V54, P88, DOI 10.1016/j.rehab.2011.01.001; Boyas S, 2009, J ELECTROMYOGR KINES, V19, P259, DOI 10.1016/j.jelekin.2007.09.002; Boyas S, 2011, GAIT POSTURE, V34, P254, DOI 10.1016/j.gaitpost.2011.05.009; Boyas S, 2011, EUR J APPL PHYSIOL, V111, P1187, DOI 10.1007/s00421-010-1731-0; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Harkins KM, 2005, J ATHL TRAINING, V40, P191; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; JOHANSSON R, 1991, CRIT REV BIOMED ENG, V18, P413; Kawakami Y, 2000, J APPL PHYSIOL, V88, P1969, DOI 10.1152/jappl.2000.88.6.1969; Kennedy A, 2011, J ELECTROMYOGR KINES, V21, P471, DOI 10.1016/j.jelekin.2011.02.001; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; KUO AD, 1993, PROG BRAIN RES, V97, P349; Lephart SM, 1998, SPORTS MED, V25, P149, DOI 10.2165/00007256-199825030-00002; Loscher WN, 1996, J PHYSIOL-LONDON, V491, P271; LUNDIN TM, 1993, J APPL BIOMECH, V9, P191, DOI 10.1123/jab.9.3.191; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Paschalis V, 2007, MUSCLE NERVE, V35, P496, DOI 10.1002/mus.20723; Remaud A, 2007, NEUROPHYSIOL CLIN, V37, P1, DOI 10.1016/j.neucli.2007.01.002; Riemann BL, 2003, ARCH PHYS MED REHAB, V84, P90, DOI 10.1053/apmr.2003.50004; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Smith JL, 2007, J APPL PHYSIOL, V103, P560, DOI 10.1152/japplphysiol.00220.2007; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	31	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72482	10.1371/journal.pone.0072482	http://dx.doi.org/10.1371/journal.pone.0072482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991115	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800074
J	Muranaka, LS; Giorgiano, TE; Takita, MA; Forim, MR; Silva, LFC; Coletta, HD; Machado, MA; de Souza, AA				Muranaka, Ligia S.; Giorgiano, Thais E.; Takita, Marco A.; Forim, Moacir R.; Silva, Luis F. C.; Coletta-Filho, Helvecio D.; Machado, Marcos A.; de Souza, Alessandra A.			N-Acetylcysteine in Agriculture, a Novel Use for an Old Molecule: Focus on Controlling the Plant-Pathogen Xylella fastidiosa	PLOS ONE			English	Article							BIOFILM FORMATION; PIERCES-DISEASE; GENE-EXPRESSION; GROWTH; ADHESION; MUCOLYTICS; ADHERENCE; GENOMICS; CITRUS	Xylella fastidiosa is a plant pathogen bacterium that causes diseases in many different crops. In citrus, it causes Citrus Variegated Chlorosis (CVC). The mechanism of pathogenicity of this bacterium is associated with its capacity to colonize and form a biofilm in the xylem vessels of host plants, and there is not yet any method to directly reduce populations of this pathogen in the field. In this study, we investigated the inhibitory effect of N-Acetylcysteine (NAC), a cysteine analogue used mainly to treat human diseases, on X. fastidiosa in different experimental conditions. Concentrations of NAC over 1 mg/mL reduced bacterial adhesion to glass surfaces, biofilm formation and the amount of exopolysaccharides (EPS). The minimal inhibitory concentration of NAC was 6 mg/mL. NAC was supplied to X. fastidiosa-infected plants in hydroponics, fertigation, and adsorbed to organic fertilizer (NAC-Fertilizer). HPLC analysis indicated that plants absorbed NAC at concentrations of 0.48 and 2.4 mg/mL but not at 6 mg/mL. Sweet orange plants with CVC symptoms treated with NAC (0.48 and 2.4 mg/mL) in hydroponics showed clear symptom remission and reduction in bacterial population, as analyzed by quantitative PCR and bacterial isolation. Experiments using fertigation and NAC-Fertilizer were done to simulate a condition closer to that normally is used in the field. For both, significant symptom remission and a reduced bacterial growth rate were observed. Using NAC-Fertilizer the lag for resurgence of symptoms on leaves after interruption of the treatment increased to around eight months. This is the first report of the anti-bacterial effect of NAC against a phytopathogenic bacterium. The results obtained in this work together with the characteristics of this molecule indicate that the use of NAC in agriculture might be a new and sustainable strategy for controlling plant pathogenic bacteria.	[Muranaka, Ligia S.; Giorgiano, Thais E.; Takita, Marco A.; Silva, Luis F. C.; Coletta-Filho, Helvecio D.; Machado, Marcos A.; de Souza, Alessandra A.] Ctr Citricultura Sylvio Moreira, Inst Agron, Sao Paulo, Brazil; [Muranaka, Ligia S.] Univ Estadual Campinas, Dept Genet & Biol Mol, Sao Paulo, Brazil; [Forim, Moacir R.] Univ Fed Sao Carlos, Dept Quim, Sao Paulo, Brazil	Instituto Agronomico de Campinas (IAC); Universidade Estadual de Campinas; Universidade Federal de Sao Carlos	de Souza, AA (corresponding author), Ctr Citricultura Sylvio Moreira, Inst Agron, Sao Paulo, Brazil.	alessandra@centrodecitricultura.br	De Souza, Alessandra/C-3458-2012; Takita, Marco A/C-3430-2013; Coletta-Filho, Helvecio D./K-8235-2012; Citros, Inct/I-2442-2013; de Souza, Alessandra Alves/GLR-7357-2022; Forim, Moacir R/E-2563-2012; Machado, Marcos Antonio/G-3582-2012	Takita, Marco A/0000-0003-3935-1361; de Souza, Alessandra Alves/0000-0003-4589-8355; Forim, Moacir/0000-0001-8798-2921; Machado, Marcos Antonio/0000-0001-9780-3990; Coletta-Filho, Helvecio/0000-0002-1382-4629	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2008/51274-5, 471448/2011-7, INCT-Citros 08/57909-2, 573848/08-4]; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grants 2008/51274-5, 471448/2011-7 and INCT-Citros 08/57909-2, 573848/08-4). MAT, HDCF, MAM and AADS are recipients of research fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2012, MOL PLANT MICROBE IN, V25, P453, DOI 10.1094/MPMI-03-11-0074; Amorim Lilian, 1993, Fitopatologia Brasileira, V18, P174; Aslam S, 2011, INT J ARTIF ORGANS, V34, P752, DOI 10.5301/ijao.5000024; Balsamo R, 2010, EUR RESPIR REV, V19, P127, DOI 10.1183/09059180.00003510; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; Caserta R, 2010, APPL ENVIRON MICROB, V76, P4250, DOI 10.1128/AEM.02114-09; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Choi HK, 2013, MOL PLANT MICROBE IN, V26, P643, DOI 10.1094/MPMI-09-12-0217-R; Coletta-Filho HD, 2013, J PLANT PAT IN PRESS; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; de Souza AA, 2003, MOL PLANT MICROBE IN, V16, P867, DOI 10.1094/MPMI.2003.16.10.867; De Souza AA, 2009, TREE FORESTRY SCI BI, V3, P73; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Hafez MM, 2009, APPL BIOCHEM BIOTECH, V158, P97, DOI 10.1007/s12010-008-8312-2; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Huynh HQ, 2004, DIGEST DIS SCI, V49, P1853, DOI 10.1007/s10620-004-9583-2; Ionescu M, 2009, APPL ENVIRON MICROB, V75, P483, DOI 10.1128/AEM.01616-08; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; Kumar GNM, 2011, PACIFIC NW EXTENSION; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Lemos EGD, 2003, FEMS MICROBIOL LETT, V219, P39, DOI 10.1016/S0378-1097(02)01189-8; Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Noszal B, 2000, J MED CHEM, V43, P2176, DOI 10.1021/jm9909600; Oliveira AC, 2002, PHYTOPATHOLOGY, V92, P1048, DOI 10.1094/PHYTO.2002.92.10.1048; Olofsson AC, 2003, APPL ENVIRON MICROB, V69, P4814, DOI 10.1128/AEM.69.8.4814-4822.2003; Osiro D, 2004, FEMS MICROBIOL LETT, V236, P313, DOI [10.1111/j.1574-6968.2004.tb09663.x, 10.1016/j.femsle.2004.06.003]; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643; Pintucci JP, 2010, EUR REV MED PHARMACO, V14, P683; Quah SY, 2012, J ENDODONT, V38, P81, DOI 10.1016/j.joen.2011.10.004; Rashed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055326; Riise GC, 2000, RESPIRATION, V67, P552, DOI 10.1159/000067473; Rubin BK, 2007, RESP CARE, V52, P859; Schwandt LQ, 2004, ACTA OTO-LARYNGOL, V124, P726, DOI 10.1080/00016480410022516; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Wang N, 2012, PHYTOPATHOLOGY, V102, P1045, DOI 10.1094/PHYTO-07-12-0146-R; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140	43	45	47	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72937	10.1371/journal.pone.0072937	http://dx.doi.org/10.1371/journal.pone.0072937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009716	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200036
J	Wang, Q; Wei, F; Li, CS; Lv, GY; Wang, GY; Liu, TJ; Bellail, AC; Hao, CH				Wang, Quan; Wei, Feng; Li, Chunsheng; Lv, Guoyue; Wang, Guangyi; Liu, Tongjun; Bellail, Anita C.; Hao, Chunhai			Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; MAMMALIAN TARGET; PHASE-II; MOTIF PHOSPHORYLATION; SIGNALING PATHWAYS; INDUCED APOPTOSIS; BINDING PARTNER; CANCER-THERAPY; CELL-GROWTH; ACTIVATION	Mammalian target of rapamycin complex 1 and 2 (mTORC1/2) are overactive in colorectal carcinomas; however, the first generation of mTOR inhibitors such as rapamycin have failed to show clinical benefits in treating colorectal carcinoma in part due to their effects only on mTORC1. The second generation of mTOR inhibitors such as PP242 targets mTOR kinase; thus, they are capable of inhibiting both mTORC1 and mTORC2. To examine the therapeutic potential of the mTOR kinase inhibitors, we treated a panel of colorectal carcinoma cell lines with PP242. Western blotting showed that the PP242 inhibition of mTORC2-mediated AKT phosphorylation at Ser 473 (AKT(S473)) was transient only in the first few hours of the PP242 treatment. Receptor tyrosine kinase arrays further revealed that PP242 treatment increased the phosphorylated epidermal growth factor receptor (EGFR) at Tyr 1068 (EGFR(T1068)). The parallel increase of AKT(S473) and EGFR(T1068) in the cells following PP242 treatment raised the possibility that EGFR phosphorylation might contribute to the PP242 incomplete inhibition of mTORC2. To test this notion, we showed that the combination of PP242 with erlotinib, an EGFR small molecule inhibitor, blocked both mTORC1 and mTORC2 kinase activity. In addition, we showed that the combination treatment inhibited colony formation, blocked cell growth and induced apoptotic cell death. A systemic administration of PP242 and erlotinib resulted in the progression suppression of colorectal carcinoma xenografts in mice. This study suggests that the combination of mTOR kinase and EGFR inhibitors may provide an effective treatment of colorectal carcinoma.	[Wang, Quan] Jilin Univ, Dept Gastrointestinal Surg, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Wei, Feng; Lv, Guoyue; Wang, Guangyi] Jilin Univ, Dept Hepatopancreatobiliary Surg, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Li, Chunsheng; Liu, Tongjun] Jilin Univ, Dept Colorectal Surg, Hosp 3, Changchun 130023, Jilin, Peoples R China; [Bellail, Anita C.; Hao, Chunhai] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Jilin University; Jilin University; Jilin University; Emory University	Wang, Q (corresponding author), Jilin Univ, Dept Gastrointestinal Surg, Hosp 1, Changchun 130023, Jilin, Peoples R China.	wangquan-jlcc@hotmail.com; chao@emory.edu		, Anita/0000-0002-6982-5882	National Institutes of Health [CA129687]; NATIONAL CANCER INSTITUTE [R01CA129687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health grant CA129687 (CH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare I, 2013, EXPERT OPIN PHARMACO, V14, P505, DOI 10.1517/14656566.2013.770473; Bajetta E, 2009, CANCER CHEMOTH PHARM, V64, P67, DOI 10.1007/s00280-008-0852-1; Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Blaser B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-86; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Don ASA, 2011, REV RECENT CLIN TRIA, V6, P24, DOI 10.2174/157488711793980147; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foster DA, 2009, CELL CYCLE, V8, P1026, DOI 10.4161/cc.8.7.8044; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hezel AF, 2007, EXPERT OPIN INV DRUG, V16, P867, DOI 10.1517/13543784.16.6.867; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kim DD, 2012, EXPERT OPIN INV DRUG, V21, P1775, DOI 10.1517/13543784.2012.721353; Kozuch P, 2009, CLIN COLORECTAL CANC, V8, P38, DOI 10.3816/CCC.2009.n.006; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li B, 2012, ONCOL REP, V28, P15, DOI 10.3892/or.2012.1786; Li HY, 2012, BREAST CANCER RES TR, V134, P1057, DOI 10.1007/s10549-012-2036-2; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyerhardt JA, 2007, ANN ONCOL, V18, P1185, DOI 10.1093/annonc/mdm124; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P1892, DOI 10.1200/JCO.2005.05.3728; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Thimmaiah KN, 2003, CANCER RES, V63, P364; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Townsley CA, 2006, BRIT J CANCER, V94, P1136, DOI 10.1038/sj.bjc.6603055; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wei F, 2012, CANCER LETT, V322, P58, DOI 10.1016/j.canlet.2012.02.005; Weickhardt AJ, 2012, J CLIN ONCOL, V30, P1505, DOI 10.1200/JCO.2011.38.6599; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zeng ZH, 2012, BLOOD, V120, P2679, DOI 10.1182/blood-2011-11-393934; Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008; Zhang YJ, 2009, ANN SURG ONCOL, V16, P2617, DOI 10.1245/s10434-009-0555-9; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73175	10.1371/journal.pone.0073175	http://dx.doi.org/10.1371/journal.pone.0073175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991179	Green Submitted, gold, Green Published			2022-12-25	WOS:000324470700058
J	Lin, CS; Guo, XG; Lange, S; Liu, J; Ouyang, KF; Yin, X; Jiang, LJ; Cai, YB; Mu, YX; Sheikh, F; Ye, S; Chen, J; Ke, YH; Cheng, HQ				Lin, Changsong; Guo, Xiaogang; Lange, Stephan; Liu, Jie; Ouyang, Kunfu; Yin, Xiang; Jiang, Liujun; Cai, Yibo; Mu, Yongxin; Sheikh, Farah; Ye, Sheng; Chen, Ju; Ke, Yuehai; Cheng, Hongqiang			Cypher/ZASP Is a Novel A-kinase Anchoring Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; CALCIUM-CHANNELS; CA2+ CHANNEL; SEVERE FORM; CALCINEURIN; PHOSPHORYLATION; DOMAIN; PDZ; HEART	PKA signaling is important for the post-translational modification of proteins, especially those in cardiomyocytes involved in cardiac excitation-contraction coupling. PKA activity is spatially and temporally regulated through compartmentalization by protein kinase A anchoring proteins. Cypher/ZASP, a member of PDZ-LIM domain protein family, is a cytoskeletal protein that forms multiprotein complexes at sarcomeric Z-lines. It has been demonstrated that Cypher/ZASP plays a pivotal structural role in the structural integrity of sarcomeres, and several of its mutations are associated with myopathies including dilated cardiomyopathy. Here we show that Cypher/ZASP, interacting specifically with the type II regulatory subunit RII alpha of PKA, acted as a typical protein kinase A anchoring protein in cardiomyocytes. In addition, we show that Cypher/ZASP itself was phosphorylated at Ser(265) and Ser(296) by PKA. Furthermore, the PDZ domain of Cypher/ZASP interacted with the L-type calcium channel through its C-terminal PDZ binding motif. Expression of Cypher/ZASP facilitated PKA-mediated phosphorylation of the L-type calcium channel in vitro. Additionally, the phosphorylation of the L-type calcium channel at Ser(1928) induced by isoproterenol was impaired in neonatal Cypher/ZASP-null cardiomyocytes. Moreover, Cypher/ZASP interacted with the Ser/Thr phosphatase calcineurin, which is a phosphatase for the L-type calcium channel. Taken together, our data strongly suggest that Cypher/ZASP not only plays a structural role for the sarcomeric integrity, but is also an important sarcomeric signaling scaffold in regulating the phosphorylation of channels or contractile proteins.	[Ke, Yuehai; Cheng, Hongqiang] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Xiaogang; Yin, Xiang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiovasc Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lange, Stephan; Ouyang, Kunfu; Mu, Yongxin; Sheikh, Farah; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Liu, Jie; Ye, Sheng] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; University of California System; University of California San Diego; Zhejiang University	Ke, YH (corresponding author), Zhejiang Univ, Sch Med, Program Mol Cell Biol, Dept Pathol & Pathophysiol, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	yke@zju.edu.cn; hqcheng11@zju.edu.cn	ouyang, kunfu/B-3073-2011; Chen, Ju/E-5579-2011; mu, yongxin/G-1882-2014; Lange, Stephan/A-1422-2010	ouyang, kunfu/0000-0003-0292-375X; mu, yongxin/0000-0002-5569-5255; Lange, Stephan/0000-0001-9361-6602; lin, changsong/0000-0001-6328-2381; Cheng, Hongqiang/0000-0001-9662-1570	National Natural Science Foundation of China [81170117]; Zhejiang Provincial Natural Science Foundation of China [LY12H02006]; Major Research Program from the state Ministry of Science and Technology of China [2010CB912004]; National Institutes of Health [HL107744]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112388, R00HL107744, K99HL107744, R01HL066100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Major Research Program from the state Ministry of Science and Technology of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Natural Science Foundation of China Grant 81170117 (to H. C.), Zhejiang Provincial Natural Science Foundation of China Grant LY12H02006 (to X. G.), Major Research Program from the state Ministry of Science and Technology of China Grant 2010CB912004 (to Y.K.), and by National Institutes of Health K99/R00 Grant HL107744 (to S.L.).	Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blant A, 2012, CAN J PHYSIOL PHARM, V90, P1161, DOI [10.1139/y2012-032, 10.1139/Y2012-032]; Cheng HQ, 2011, HUM MOL GENET, V20, P1751, DOI 10.1093/hmg/ddr050; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dong XT, 2012, J BIOL CHEM, V287, P848, DOI 10.1074/jbc.M111.293258; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Harvey RD, 2013, J MOL CELL CARDIOL, V58, P143, DOI 10.1016/j.yjmcc.2012.12.006; Heineke J, 2012, J MOL CELL CARDIOL, V52, P62, DOI 10.1016/j.yjmcc.2011.10.018; Hojayev B, 2012, MOL CELL BIOL, V32, P4025, DOI 10.1128/MCB.05948-11; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kielbasa OM, 2011, FASEB J, V25, P2276, DOI 10.1096/fj.10-169219; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Maturana AD, 2008, CARDIOVASC RES, V78, P458, DOI 10.1093/cvr/cvn052; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Pang X, 2009, ACTA PHARMACOL SIN, V30, P537, DOI 10.1038/aps.2009.28; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Sumandea CA, 2011, J BIOL CHEM, V286, P530, DOI 10.1074/jbc.M110.148684; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Uys GM, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-18; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Velthuis AJWT, 2007, THESCIENTIFICWORLDJO, V7, P1470, DOI 10.1100/tsw.2007.232; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Woo AYH, 2012, ACTA PHARMACOL SIN, V33, P335, DOI 10.1038/aps.2011.201; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang QL, 2001, CARDIOVASC RES, V51, P80, DOI 10.1016/S0008-6363(01)00273-5; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	51	32	33	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29403	29413		10.1074/jbc.M113.470708	http://dx.doi.org/10.1074/jbc.M113.470708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23996002	Green Published, hybrid			2022-12-25	WOS:000330615300019
J	ter Braak, B; Laughton, AM; Altincicek, B; Parker, BJ; Gerardo, NM				ter Braak, Bas; Laughton, Alice M.; Altincicek, Boran; Parker, Benjamin J.; Gerardo, Nicole M.			Exposure to Bacterial Signals Does Not Alter Pea Aphids' Survival upon a Second Challenge or Investment in Production of Winged Offspring	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM; IMMUNITY; INSECT; SPECIFICITY; INFECTION; SYMBIONTS; DEFENSE	Pea aphids have an obligate nutritional symbiosis with the bacteria Buchnera aphidicola and frequently also harbor one or more facultative symbionts. Aphids are also susceptible to bacterial pathogen infections, and it has been suggested that aphids have a limited immune response towards such pathogen infections compared to other, more well-studied insects. However, aphids do possess at least some of the genes known to be involved in bacterial immune responses in other insects, and immune-competent hemocytes. One possibility is that immune priming with microbial elicitors could stimulate immune protection against subsequent bacterial infections, as has been observed in several other insect systems. To address this hypothesis we challenged aphids with bacterial immune elicitors twenty-four hours prior to live bacterial pathogen infections and then compared their survival rates to aphids that were not pre-exposed to bacterial signals. Using two aphid genotypes, we found no evidence for immune protection conferred by immune priming during infections with either Serratia marcescens or with Escherichia coli. Immune priming was not altered by the presence of facultative, beneficial symbionts in the aphids. In the absence of inducible immune protection, aphids may allocate energy towards other defense traits, including production of offspring with wings that could escape deteriorating conditions. To test this, we monitored the ratio of winged to unwinged offspring produced by adult mothers of a single clone that had been exposed to bacterial immune elicitors, to live E. coli infections or to no challenge. We found no correlation between immune challenge and winged offspring production, suggesting that this mechanism of defense, which functions upon exposure to fungal pathogens, is not central to aphid responses to bacterial infections.	[ter Braak, Bas; Laughton, Alice M.; Altincicek, Boran; Parker, Benjamin J.; Gerardo, Nicole M.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [ter Braak, Bas] Leiden Univ, Div Toxicol, Leiden, Netherlands; [Laughton, Alice M.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Altincicek, Boran] Univ Bonn, Bonn, Germany	Emory University; Leiden University; Leiden University - Excl LUMC; University of London; Queen Mary University London; University of Bonn	Gerardo, NM (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	nicole.gerardo@emory.edu		Altincicek, Boran/0000-0003-2019-452X	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [AL902/4-1]; National Science Foundation [IOS-1025853]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	Research was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) (AL902/4-1) (BA) and National Science Foundation grant IOS-1025853 (NMG & AML). BJP was funded through a National Science Foundation graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Barribeau SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-251; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cong M, 2009, J INVERTEBR PATHOL, V100, P120, DOI 10.1016/j.jip.2008.10.004; Costechareyre D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054118; CRAWLEY M, 2005, STAT INTRO USING R W; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gonzalez-Tokman DM, 2010, PHYSIOL ENTOMOL, V35, P364, DOI 10.1111/j.1365-3032.2010.00752.x; Hatano E, 2012, ECOL ENTOMOL, V37, P75, DOI 10.1111/j.1365-2311.2011.01336.x; Hatano E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011188; Kunert G, 2005, ECOL LETT, V8, P596, DOI 10.1111/j.1461-0248.2005.00754.x; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Little TJ, 2004, TRENDS ECOL EVOL, V19, P58, DOI 10.1016/j.tree.2003.11.011; MACKAUER M, 1973, J INVERTEBR PATHOL, V22, P418, DOI 10.1016/0022-2011(73)90172-9; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pope EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020960; Reber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035372; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Schmitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042114; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Therneau T., 2013, PACKAGE SURVIVAL ANA, P37; Therneau TM, 2000, MODELING SURVIVAL DA; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517	37	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73600	10.1371/journal.pone.0073600	http://dx.doi.org/10.1371/journal.pone.0073600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009760	gold, Green Published			2022-12-25	WOS:000323734600075
J	Wang, J; Li, Z; Li, SC; Qi, W; Liu, P; Liu, FQ; Ye, YL; Wu, LS; Wang, L; Wu, WS				Wang, Jing; Li, Zhan; Li, Shicheng; Qi, Wei; Liu, Peng; Liu, Fuqiang; Ye, Yuanlv; Wu, Liansheng; Wang, Lei; Wu, Wangsuo			Adsorption of Cu(II) on Oxidized Multi-Walled Carbon Nanotubes in the Presence of Hydroxylated and Carboxylated Fullerenes	PLOS ONE			English	Article							AQUEOUS-SOLUTION; SPHERICAL AROMATICITY; ACTIVATED CARBONS; METAL-IONS; REMOVAL; SORPTION; COPPER; RAMAN; ACID; PRECONCENTRATION	The adsorption of Cu(II) on oxidized multi-walled carbon nanotubes (oMWCNTs) as a function of contact time, pH, ionic strength, temperature, and hydroxylated fullerene (C-60(OH)(n)) and carboxylated fullerene (C-60(C(COOH)(2))(n)) were studied under ambient conditions using batch techniques. The results showed that the adsorption of Cu(II) had rapidly reached equilibrium and the kinetic process was well described by a pseudo-second-order rate model. Cu(II) adsorption on oMWCNTs was dependent on pH but independent of ionic strength. Compared with the Freundlich model, the Langmuir model was more suitable for analyzing the adsorption isotherms. The thermodynamic parameters calculated from temperature-dependent adsorption isotherms suggested that Cu(II) adsorption on oMWCNTs was spontaneous and endothermic. The effect of C-60(OH)(n) on Cu(II) adsorption of oMWCNTs was not significant at low C-60(OH)(n) concentration, whereas a negative effect was observed at higher concentration. The adsorption of Cu(II) on oMWCNTs was enhanced with increasing pH values at pH < 5, but decreased at pH >= 5. The presence of C-60(C(COOH)(2))(n) inhibited the adsorption of Cu(II) onto oMWCNTs at pH 4-6. The double sorption site model was applied to simulate the adsorption isotherms of Cu(II) in the presence of C-60(OH)(n) and fitted the experimental data well.	[Wang, Jing; Qi, Wei; Liu, Peng; Liu, Fuqiang; Ye, Yuanlv; Wu, Liansheng; Wang, Lei; Wu, Wangsuo] Lanzhou Univ, Radiochem Lab, Sch Nucl Sci & Technol, Lanzhou 730000, Peoples R China; [Li, Zhan] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China; [Li, Shicheng] China Acad Engn Phys, Inst Nucl Phys & Chem, Mianyang, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Engineering Physics	Wu, WS (corresponding author), Lanzhou Univ, Radiochem Lab, Sch Nucl Sci & Technol, Lanzhou 730000, Peoples R China.	wuws@lzu.edu.cn	LI, Zhan/AAX-7886-2021		National Natural Science Foundation of China [J1030932]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The author would like to thank the financial support from National Natural Science Foundation of China (J1030932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour A, 2007, TALANTA, V71, P887, DOI 10.1016/j.talanta.2006.05.085; Alkan M, 2001, J COLLOID INTERF SCI, V243, P280, DOI 10.1006/jcis.2001.7796; Aviles F, 2009, CARBON, V47, P2970, DOI 10.1016/j.carbon.2009.06.044; Balasubramanian K, 2005, SMALL, V1, P180, DOI 10.1002/smll.200400118; Buhl M, 2001, CHEM REV, V101, P1153, DOI 10.1021/cr990332q; Bystrzejewski M, 2011, COLLOID SURFACE A, V377, P402, DOI 10.1016/j.colsurfa.2011.01.041; Chakrapani N, 2003, J PHYS CHEM B, V107, P9308, DOI 10.1021/jp034970v; Chawla P, 2010, MINI-REV MED CHEM, V10, P662, DOI 10.2174/138955710791572497; Chen CL, 2007, COLLOID SURFACE A, V302, P449, DOI 10.1016/j.colsurfa.2007.03.007; Chen CL, 2006, IND ENG CHEM RES, V45, P9144, DOI 10.1021/ie060791z; Chen GC, 2008, ENVIRON SCI TECHNOL, V42, P8297, DOI 10.1021/es801376w; Cheng FY, 2000, J PHYS CHEM SOLIDS, V61, P1145, DOI 10.1016/S0022-3697(99)00353-4; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Di ZC, 2006, CHEMOSPHERE, V62, P861, DOI 10.1016/j.chemosphere.2004.06.044; Ferrari AC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075414; Gao ZM, 2009, J HAZARD MATER, V167, P357, DOI 10.1016/j.jhazmat.2009.01.050; Gauden PA, 2006, CHEM PHYS LETT, V421, P409, DOI 10.1016/j.cplett.2006.02.003; HAYES KF, 1987, J COLLOID INTERF SCI, V115, P564, DOI 10.1016/0021-9797(87)90078-6; Heath JR, 1999, ACCOUNTS CHEM RES, V32, P388, DOI 10.1021/ar990059e; Hirsch A, 2000, ANGEW CHEM INT EDIT, V39, P3915, DOI 10.1002/1521-3773(20001103)39:21<3915::AID-ANIE3915>3.0.CO;2-O; HIURA H, 1993, CHEM PHYS LETT, V202, P509, DOI 10.1016/0009-2614(93)90040-8; Ho Y.-S., 1995, THESIS U BIRMINGHAM; Hu J, 2009, J HAZARD MATER, V162, P1542, DOI 10.1016/j.jhazmat.2008.06.058; Hussain CM, 2008, J CHROMATOGR A, V1185, P161, DOI 10.1016/j.chroma.2008.01.073; Hyung H, 2008, ENVIRON SCI TECHNOL, V42, P4416, DOI 10.1021/es702916h; Hyung H, 2007, ENVIRON SCI TECHNOL, V41, P179, DOI 10.1021/es061817g; Jia ZJ, 1999, MAT SCI ENG A-STRUCT, V271, P395, DOI 10.1016/S0921-5093(99)00263-4; Kuo CY, 2009, DESALINATION, V249, P781, DOI 10.1016/j.desal.2008.11.022; Lee SM, 2001, WATER RES, V35, P534, DOI 10.1016/S0043-1354(00)00284-0; Li T., 1999, J CENT SOUTH UNIV T, V6, P35; Li YH, 2010, J HAZARD MATER, V177, P876, DOI 10.1016/j.jhazmat.2009.12.114; Li YH, 2003, CARBON, V41, P2787, DOI 10.1016/S0008-6223(03)00392-0; Lin DH, 2008, ENVIRON SCI TECHNOL, V42, P7254, DOI 10.1021/es801297u; Lu CY, 2008, J HAZARD MATER, V151, P239, DOI 10.1016/j.jhazmat.2007.05.078; Lu CY, 2006, CHEM ENG SCI, V61, P1138, DOI 10.1016/j.ces.2005.08.007; Montes-Moran MA, 2004, CARBON, V42, P1219, DOI 10.1016/j.carbon.2004.01.023; Pardanaud C, 2012, DIAM RELAT MATER, V22, P92, DOI 10.1016/j.diamond.2011.12.015; Pyrzynska K, 2008, SEP PURIF REV, V37, P374, DOI 10.1080/15422110802178843; Pyrzynska K, 2010, TRAC-TREND ANAL CHEM, V29, P718, DOI 10.1016/j.trac.2010.03.013; Pyrzynska K, 2010, COLLOID SURFACE A, V362, P102, DOI 10.1016/j.colsurfa.2010.03.047; Rao GP, 2007, SEP PURIF TECHNOL, V58, P224, DOI 10.1016/j.seppur.2006.12.006; Sardenberg RB, 2011, ACS NANO, V5, P2681, DOI 10.1021/nn102913p; Sheng GD, 2010, J HAZARD MATER, V178, P333, DOI 10.1016/j.jhazmat.2010.01.084; Shi KL, 2009, COLLOID SURFACE A, V349, P90, DOI 10.1016/j.colsurfa.2009.07.057; Sitko R, 2012, TRAC-TREND ANAL CHEM, V37, P22, DOI 10.1016/j.trac.2012.03.016; Tagmatarchis N., 2001, Mini-Reviews in Medicinal Chemistry, V1, P339, DOI 10.2174/1389557013406693; Tan XL, 2008, CARBON, V46, P1741, DOI 10.1016/j.carbon.2008.07.023; Ucer A, 2006, SEP PURIF TECHNOL, V47, P113, DOI 10.1016/j.seppur.2005.06.012; Wang XK, 2005, ENVIRON SCI TECHNOL, V39, P2856, DOI 10.1021/es048287d; Wang XJ, 2011, DESALINATION, V278, P231, DOI 10.1016/j.desal.2011.05.033; Wu CH, 2007, J COLLOID INTERF SCI, V311, P338, DOI 10.1016/j.jcis.2007.02.077; Xu D, 2008, J HAZARD MATER, V154, P407, DOI 10.1016/j.jhazmat.2007.10.059; Xu JY, 2009, J APPL TOXICOL, V29, P578, DOI 10.1002/jat.1442; Yang ST, 2009, J HAZARD MATER, V166, P109, DOI 10.1016/j.jhazmat.2008.11.003; Yavuz O, 2003, WATER RES, V37, P948, DOI 10.1016/S0043-1354(02)00409-8; Ye C, 2006, CHINESE SCI BULL, V51, P1060, DOI 10.1007/s11434-006-1060-1; Zhao DL, 2010, CHEM ENG J, V164, P49, DOI 10.1016/j.cej.2010.08.014	57	38	40	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72475	10.1371/journal.pone.0072475	http://dx.doi.org/10.1371/journal.pone.0072475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009683	gold, Green Submitted, Green Published			2022-12-25	WOS:000323734600022
J	Wang, XW; Liu, J; Wang, Z; Huang, YM; Liu, WP; Zhu, X; Cai, Y; Fang, XG; Lin, SY; Yuan, L; Ouyang, GL				Wang, Xiaowei; Liu, Jia; Wang, Zhe; Huang, Yangmei; Liu, Weiping; Zhu, Xiao; Cai, Yao; Fang, Xiaoguang; Lin, Shuyong; Yuan, Li; Ouyang, Gaoliang			Periostin Contributes to the Acquisition of Multipotent Stem Cell-Like Properties in Human Mammary Epithelial Cells and Breast Cancer Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; GROWTH; PROTEIN; EXPRESSION; DIFFERENTIATION; ACTIVATION; INVASION; NICHE	Periostin (POSTN), a recently characterised matricellular protein, is frequently dysregulated in various malignant cancers and promotes tumor metastatic growth. POSTN plays a critical role in the crosstalk between murine breast cancer stem cells (CSCs) and their niche to permit metastatic colonization. However, whether pro-metastatic capability of POSTN is associated with multipotent potentials of mesenchymal stem cells (MSCs) has not been documented. Here we demonstrate that POSTN promotes a stem cell-like trait and a mesenchymal phenotype in human mammary epithelial cells and breast cancer cells. Interestingly, ectopic overexpression of POSTN or recombinant POSTN treatment can induce human mammary epithelial cells and breast cancer cells differentiation into multiple cell lineages that recapitulate part of the multilineage differentiation potentials of MSCs. Moreover, POSTN is highly expressed in bone marrow-derived MSCs and their derived adipocytes, chondrocytes, and osteoblasts in vitro. Furthermore, POSTN promotes the growth of xenograft tumors in vivo. POSTN-overexpressing human mammary epithelial cells enhance breast tumor growth and metastasis. These data thus provide evidence of a new role for POSTN in mammary epithelial neoplasia and metastasis, suggesting that epithelial cancer cells might acquire CSC-like traits and a mesenchymal phenotype, as well as the multipotent potentials of MSCs to promote tumorigenesis and metastasis. Therefore, targeting POSTN and other extracellular matrix components of tumor microenvironment may help to develop new therapeutical strategies to inhibit tumor metastasis.	[Wang, Xiaowei; Liu, Jia; Wang, Zhe; Huang, Yangmei; Liu, Weiping; Zhu, Xiao; Cai, Yao; Fang, Xiaoguang; Lin, Shuyong; Yuan, Li; Ouyang, Gaoliang] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Wang, Xiaowei; Liu, Jia; Wang, Zhe; Huang, Yangmei; Liu, Weiping; Zhu, Xiao; Cai, Yao; Fang, Xiaoguang; Ouyang, Gaoliang] Xiamen Univ, Sch Life Sci, Lab Stem Cells & Tumor Metastasis, Xiamen, Peoples R China; [Fang, Xiaoguang] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA	Xiamen University; Xiamen University; Cleveland Clinic Foundation	Ouyang, GL (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.	oygldz@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012; Fang, Xiaoguang/N-2313-2014	Lin, Shu-Yong/0000-0002-4419-1713; 	National Nature Science Foundation of China [31171339, 31071302, 30871242]; National Basic Research Program of China [2009CB941601, 2010CB732402, 2011CBA01105]; Programme of Introducing Talents of Discipline to Universities [B12001]; Project of Education of China [B06016]; Fundamental Research Funds for the Central Universities [2010121095]; Program for New Century Excellent Talents in University; Scientific Fund for Distinguished Young Investigator of Fujian Province [2010J06013]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Project of Education of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Fund for Distinguished Young Investigator of Fujian Province	This work was supported by grants from the National Nature Science Foundation of China (No. 31171339, 31071302, 30871242), the National Basic Research Program of China (No. 2009CB941601, 2010CB732402, 2011CBA01105), the Programme of Introducing Talents of Discipline to Universities (No. B12001), the 111 Project of Education of China (No. B06016), the Fundamental Research Funds for the Central Universities (No. 2010121095), the Program for New Century Excellent Talents in University, and the Scientific Fund for Distinguished Young Investigator of Fujian Province (No. 2010J06013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Casal C, 2010, CANCER RES, V70, P4676, DOI 10.1158/0008-5472.CAN-09-4197; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Contie S, 2011, INT J CANCER, V128, P352, DOI 10.1002/ijc.25591; Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng J, 2012, S1PR1 S; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Sasaki H, 2001, JPN J CANCER RES, V92, P869, DOI 10.1111/j.1349-7006.2001.tb01174.x; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang Z, 2012, CELL STEM CELL, V10, P111, DOI 10.1016/j.stem.2012.01.002; Xu D, PLOS ONE, V7; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	48	56	61	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72962	10.1371/journal.pone.0072962	http://dx.doi.org/10.1371/journal.pone.0072962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009721	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600047
J	Fan, JJ; Zeng, X; Li, YB; Wang, SF; Wang, ZY; Sun, Y; Gao, HJ; Zhang, GP; Feng, MQ; Ju, DW				Fan, Jiajun; Zeng, Xian; Li, Yubin; Wang, Shaofei; Wang, Ziyu; Sun, Yun; Gao, Hongjian; Zhang, Guoping; Feng, Meiqing; Ju, Dianwen			Autophagy Plays a Critical Role in ChLym-1-Induced Cytotoxicity of Non-Hodgkin's Lymphoma Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; ANTI-HLA-DR; ARSENIC TRIOXIDE; APOPTOSIS; PATHWAY; GROWTH; DEATH; INHIBITION; MTOR; ANTIBODIES	Autophagy is a critical mechanism in both cancer therapy resistance and tumor suppression. Monoclonal antibodies have been documented to kill tumor cells via apoptosis, antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). In this study, we report for the first time that chLym-1, a chimeric anti-human HLA-DR monoclonal antibody, induces autophagy in Raji Non-Hodgkin's Lymphoma (NHL) cells. Interestingly, inhibition of autophagy by pharmacological inhibitors (3-methyladenine and NH4Cl) or genetic approaches (siRNA targeting Atg5) suppresses chLym-1-induced growth inhibition, apoptosis, ADCC and CDC in Raji cells, while induction of autophagy could accelerate cytotoxic effects of chLym-1 on Raji cells. Furthermore, chLym-1-induced autophagy can mediate apoptosis through Caspase 9 activation, demonstrating the tumor-suppressing role of autophagy in antilymphoma effects of chLym-1. Moreover, chLym-1 can activate several upstream signaling pathways of autophagy including Akt/mTOR and extracellular signal-regulated kinase 1/2 (Erk1/2). These results elucidate the critical role of autophagy in cytotoxicity of chLym-1 antibody and suggest a potential therapeutic strategy of NHL therapy by monoclonal antibody chLym-1 in combination with autophagy inducer.	[Fan, Jiajun; Zeng, Xian; Li, Yubin; Wang, Shaofei; Wang, Ziyu; Sun, Yun; Feng, Meiqing; Ju, Dianwen] Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China; [Li, Yubin] Nanjing Agr Univ, Coll Life Sci, Minist Agr, Key Lab Microbiol Engn Agr Environm, Nanjing, Jiangsu, Peoples R China; [Gao, Hongjian] Fudan Univ, Sch Med, Shanghai 200433, Peoples R China; [Zhang, Guoping] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Fudan University; Fudan University	Feng, MQ (corresponding author), Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China.	fmq@fudan.edu.cn; dianwenju@fudan.edu.cn	Zeng, Xian/O-8750-2018; LI, YUBIN/L-4952-2017; sun, yun/C-2739-2014; Zeng, Xian/AAL-8713-2020	Zeng, Xian/0000-0002-1397-554X; LI, YUBIN/0000-0002-3377-741X; sun, yun/0000-0002-2652-3040; Zeng, Xian/0000-0002-1397-554X	Shanghai Science and Technology Funds [11431920104]; National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China [2011ZX09102-001-27]	Shanghai Science and Technology Funds; National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China	This work was supported by Shanghai Science and Technology Funds (11431920104)[http://www.stcsm.gov.cn/] and National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China (2011ZX09102-001-27) [http://www.most.gov.cn/tztg/index.htm]. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Barsouk A, 1996, J ENDOCRINOL INVEST, V19, P334, DOI 10.1007/BF03344966; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Bravo-San Pedro JM, 2013, CELL MOL LIFE SCI, V70, P121, DOI 10.1007/s00018-012-1061-y; Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Cheng J, 2012, TOXICOL MECH METHOD, V22, P512, DOI 10.3109/15376516.2012.686534; DeNardo GL, 2007, J NUCL MED, V48, P1338, DOI 10.2967/jnumed.107.041095; Gomez-Pinillos A, 2012, HEMATOL ONCOL CLIN N, V26, P483, DOI 10.1016/j.hoc.2012.02.014; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Heckmann BL, 2012, BRIT J PHARMACOL, V168, P163; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Ibanez E, 2012, CURR MED CHEM, V19, P3031; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Li YB, 2013, MOL NEUROBIOL, V47, P1000, DOI 10.1007/s12035-013-8403-0; Liang CY, 2007, AUTOPHAGY, V3, P69, DOI 10.4161/auto.3437; Liu C, 2004, CANCER BIOTHER RADIO, V19, P545, DOI 10.1089/cbr.2004.19.545; Liu CS, 2007, AQUAT TOXICOL, V82, P135, DOI 10.1016/j.aquatox.2007.02.006; Liu Y, 2007, TOXICOL IN VITRO, V21, P677, DOI 10.1016/j.tiv.2007.01.015; Nicotra G, 2010, MODERN PATHOL, V23, P937, DOI 10.1038/modpathol.2010.80; O'Brien TF, 2012, ARCH IMMUNOL THER EX, V60, P173, DOI 10.1007/s00005-012-0171-4; Ottenello L, 2000, J LEUKOCYTE BIOL, V68, P662; Park KJ, 2009, BIOCHEM BIOPH RES CO, V382, P726, DOI 10.1016/j.bbrc.2009.03.095; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Singh BN, 2012, BIOCHEM PHARMACOL, V84, P1154, DOI 10.1016/j.bcp.2012.08.007; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Tobin E, 2007, LEUKEMIA LYMPHOMA, V48, P944, DOI 10.1080/10428190701272272; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Yang YP, 2008, ACTA PHARMACOL SIN, V29, P123, DOI 10.1111/j.1745-7254.2008.00732.x; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Younes A, 2012, NAT REV CLIN ONCOL, V9, P643, DOI 10.1038/nrclinonc.2012.156; Zang LH, 2012, ARCH BIOCHEM BIOPHYS, V518, P31, DOI 10.1016/j.abb.2011.11.019; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhang N, 2007, CANCER BIOTHER RADIO, V22, P342, DOI 10.1089/cbr.2007.359.A; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	43	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72478	10.1371/journal.pone.0072478	http://dx.doi.org/10.1371/journal.pone.0072478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015249	gold, Green Published, Green Submitted			2022-12-25	WOS:000323733800057
J	Liu, C; Liu, Z; Little, JC; Zhang, YP				Liu, Cong; Liu, Zhe; Little, John C.; Zhang, Yinping			Convenient, Rapid and Accurate Measurement of SVOC Emission Characteristics in Experimental Chambers	PLOS ONE			English	Article							SEMIVOLATILE ORGANIC-COMPOUNDS; INDOOR ENVIRONMENT; PHTHALATE PLASTICIZER; EXPOSURE; AIR; SURFACE; ESTERS; ASTHMA; DUST; DEHP	Chamber tests are usually used to determine the source characteristics of semi-volatile organic compounds (SVOCs) which are critical to quantify indoor exposure to SVOCs. In contrast to volatile organic compounds (VOCs), the sorption effect of SVOCs to chamber surfaces usually needs to be considered due to the much higher surface/air partition coefficients, resulting in a long time to reach steady state, frequently on the order of months, and complicating the mathematical analysis of the resulting data. A chamber test is also complicated if the material-phase concentration is not constant. This study shows how to design a chamber to overcome these limitations. A dimensionless mass transfer analysis is used to specify conditions for (1) neglecting the SVOC sorption effect to chamber surfaces, (2) neglecting the convective mass transfer resistance at sorption surfaces if the sorption effect cannot be neglected, and (3) regarding the material-phase concentration in the source as constant. Several practical and quantifiable ways to improve chamber design are proposed. The approach is illustrated by analyzing available data from three different chambers in terms of the accuracy with which the model parameters can be determined and the time needed to conduct the chamber test. The results should greatly facilitate the design of chambers to characterize SVOC emissions and the resulting exposure.	[Liu, Cong; Zhang, Yinping] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China; [Liu, Zhe; Little, John C.] Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA USA	Tsinghua University; Virginia Polytechnic Institute & State University	Zhang, YP (corresponding author), Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China.	zhangyp@tsinghua.edu.cn	Little, John C/B-4154-2009; liu, cong/J-3848-2013; Zhang, Yinping/B-5187-2012	Zhang, Yinping/0000-0001-9175-7890	Natural Science Foundation of China [51136002, 51076079]; National High Technology Research and Development Program 863 [2010AA064903]; Tsinghua University Initiative Scientific Research Program [20121088010]; National Science Foundation of the United States [CBET-1066642]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Tsinghua University Initiative Scientific Research Program; National Science Foundation of the United States(National Science Foundation (NSF))	This work was sponsored by the Natural Science Foundation of China (Grant No. 51136002 and 51076079, http://www.nsfc.gov.cn), the National High Technology Research and Development Program 863 (No. 2010AA064903, http://www.most.gov.cn/), the Tsinghua University Initiative Scientific Research Program (Grant No. 20121088010, http://www.tsinghua.edu.cn) and by the National Science Foundation of the United States (Grant No. CBET-1066642, www.epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Cadogan DF, 1996, KIRK OTHMER ENCY CHE, V19, P258; Clausen PA, 2010, ATMOS ENVIRON, V44, P2760, DOI 10.1016/j.atmosenv.2010.04.020; Diamond ML, 2000, ENVIRON SCI TECHNOL, V34, P2900, DOI 10.1021/es9906406; Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1111/j.1600-0668.2004.00223.x; Hale RC, 2002, CHEMOSPHERE, V46, P729, DOI 10.1016/S0045-6535(01)00237-5; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Junge CE., 1977, FATE POLLUTANTS AIR, P7; LITTLE JC, 1994, ATMOS ENVIRON, V28, P227, DOI 10.1016/1352-2310(94)90097-3; Little JC, 2012, ENVIRON SCI TECHNOL, V46, P11171, DOI 10.1021/es301088a; Liu C, 2012, ATMOS ENVIRON, V55, P347, DOI 10.1016/j.atmosenv.2012.03.030; Liu C, 2010, ATMOS ENVIRON, V44, P1952, DOI 10.1016/j.atmosenv.2010.03.002; Liu Z, 2011, CHARACTERIZING EMISS; Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Uhde E, 2001, INDOOR AIR, V11, P150, DOI 10.1034/j.1600-0668.2001.011003150.x; Wang LX, 2010, CHINESE SCI BULL, V55, P1469, DOI 10.1007/s11434-010-3094-7; Wensing M, 2005, SCI TOTAL ENVIRON, V339, P19, DOI 10.1016/j.scitotenv.2004.10.028; Weschler CJ, 2010, ATMOS ENVIRON, V44, P3609, DOI 10.1016/j.atmosenv.2010.06.029; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Xu Y, 2006, ENVIRON SCI TECHNOL, V40, P456, DOI 10.1021/es051517j; Xu Y, 2003, ATMOS ENVIRON, V37, P2497, DOI 10.1016/S1352-2310(03)00160-2; Xu Y, 2010, ENV HLTH PERSPECT, V118; Xu Y, 2012, ENVIRON SCI TECHNOL, V46, P12534, DOI 10.1021/es302319m; Xu Y, 2009, ENVIRON SCI TECHNOL, V43, P2374, DOI 10.1021/es801354f	27	18	18	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72445	10.1371/journal.pone.0072445	http://dx.doi.org/10.1371/journal.pone.0072445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015246	Green Submitted, Green Published, gold			2022-12-25	WOS:000323733800054
J	Beckert, U; Aw, WY; Burhenne, H; Forsterling, L; Kaever, V; Timmons, L; Seifert, R				Beckert, Ulrike; Aw, Wen Yih; Burhenne, Heike; Foersterling, Lisa; Kaever, Volkhard; Timmons, Lisa; Seifert, Roland			The Receptor-Bound Guanylyl Cyclase DAF-11 Is the Mediator of Hydrogen Peroxide-Induced Cgmp Increase in Caenorhabditis elegans	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE RELEASE; C-ELEGANS; GUANOSINE 3',5'-MONOPHOSPHATE; SIGNALING PATHWAY; BODY-SIZE; LIFE-SPAN; TISSUES; RAT; SUPERFAMILY	Adenosine 3', 5'-cyclic monophosphate (cAMP) and guanosine 3', 5'-cyclic monophosphate (cGMP) are well-studied second messengers that transmit extracellular signals into mammalian cells, with conserved functions in various other species such as Caenorhabditis elegans (C. elegans). cAMP is generated by adenylyl cyclases, and cGMP is generated by guanylyl cyclases, respectively. Studies using C. elegans have revealed additional roles for cGMP signaling in lifespan extension. For example, mutants lacking the function of a specific receptor-bound guanylyl cyclase, DAF-11, have an increased life expectancy. While the daf-11 phenotype has been attributed to reductions in intracellular cGMP concentrations, the actual content of cyclic nucleotides has not been biochemically determined in this system. Similar assumptions were made in studies using phosphodiesterase loss-of-function mutants or using adenylyl cyclase overexpressing mutants. In the present study, cyclic nucleotide regulation in C. elegans was studied by establishing a special nematode protocol for the simultaneous detection and quantitation of cyclic nucleotides. We also examined the influence of reactive oxygen species (ROS) on cyclic nucleotide metabolism and lifespan in C. elegans using highly specific HPLC-coupled tandem mass-spectrometry and behavioral assays. Here, we show that the relation between cGMP and survival is more complex than previously appreciated.	[Beckert, Ulrike; Aw, Wen Yih; Burhenne, Heike; Foersterling, Lisa; Kaever, Volkhard; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Aw, Wen Yih; Timmons, Lisa] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Mass Spectrometry Metabol, Hannover, Germany	Hannover Medical School; University of Kansas; Hannover Medical School	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Kaever, Volkhard/G-3280-2013; Seifert, Roland/G-3189-2013; Bähre, Heike/AAL-7873-2021; Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Aw, Wen Yih/0000-0002-1724-412X	Fulbright graduate student fellowship; German Academic Exchange Service RISE fellowship	Fulbright graduate student fellowship; German Academic Exchange Service RISE fellowship	This work was supported by a Fulbright graduate student fellowship to Ulrike Beckert and a German Academic Exchange Service RISE fellowship to Wen Yih Aw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN DF, 1963, BIOCHEM BIOPH RES CO, V11, P330, DOI 10.1016/0006-291X(63)90566-7; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI [DOI 10.1126/SCIENCE.282.5396.2028, DOI 10.1126/science.282.5396.2028]; Baude EJ, 1997, J BIOL CHEM, V272, P16035, DOI 10.1074/jbc.272.25.16035; Behrends S, 2003, CURR MED CHEM, V10, P291, DOI 10.2174/0929867033368286; BERTHET J, 1957, J Biol Chem, V224, P463; BERTHET J, 1957, J BIOL CHEM, V229, P351; Birnby DA, 2000, GENETICS, V155, P85; BOHME E, 1969, N-S ARCH PHARMAKOL, V264, P220, DOI 10.1007/BF02431417; BRENNER S, 1974, GENETICS, V77, P71; Burhenne H, 2011, N-S ARCH PHARMACOL, V383, P33; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Ghosh SR, 2010, EUR J CELL BIOL, V89, P437, DOI 10.1016/j.ejcb.2009.11.027; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; HARDMAN JG, 1969, J BIOL CHEM, V244, P6363; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hope IA., 1999, C ELEGANS PRACTICAL; ISHIKAWA E, 1969, J BIOL CHEM, V244, P6371; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Seifert R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003466; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VOWELS JJ, 1994, GENETICS, V138, P303; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; WHITE AA, 1969, BIOCHIM BIOPHYS ACTA, V191, P686, DOI 10.1016/0005-2744(69)90362-3; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]	48	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72569	10.1371/journal.pone.0072569	http://dx.doi.org/10.1371/journal.pone.0072569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015261	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200048
J	Dengler, V; McCallum, N; Kiefer, P; Christen, P; Patrignani, A; Vorholt, JA; Berger-Bachi, B; Senn, MM				Dengler, Vanina; McCallum, Nadine; Kiefer, Patrick; Christen, Philipp; Patrignani, Andrea; Vorholt, Julia A.; Berger-Baechi, Brigitte; Senn, Maria M.			Mutation in the C-Di-AMP Cyclase dacA Affects Fitness and Resistance of Methicillin Resistant Staphylococcus aureus	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; CELL-WALL BIOSYNTHESIS; ANTIBIOTIC-RESISTANCE; STRESS-RESPONSE; INSERTIONAL INACTIVATION; GENE; LEVEL; EXPRESSION; VIRULENCE; SUSCEPTIBILITY	Faster growing and more virulent strains of methicillin resistant Staphylococcus aureus (MRSA) are increasingly displacing highly resistant MRSA. Elevated fitness in these MRSA is often accompanied by decreased and heterogeneous levels of methicillin resistance; however, the mechanisms for this phenomenon are not yet fully understood. Whole genome sequencing was used to investigate the genetic basis of this apparent correlation, in an isogenic MRSA strain pair that differed in methicillin resistance levels and fitness, with respect to growth rate. Sequencing revealed only one single nucleotide polymorphism (SNP) in the diadenylate cyclase gene dacA in the faster growing but less resistant strain. Diadenylate cyclases were recently discovered to synthesize the new second messenger cyclic diadenosine monophosphate (c-di-AMP). Introduction of this mutation into the highly resistant but slower growing strain reduced resistance and increased its growth rate, suggesting a direct connection between the dacA mutation and the phenotypic differences of these strains. Quantification of cellular c-di-AMP revealed that the dacA mutation decreased c-di-AMP levels resulting in reduced autolysis, increased salt tolerance and a reduction in the basal expression of the cell wall stress stimulon. These results indicate that c-di-AMP affects cell envelope-related signalling in S. aureus. The influence of c-di-AMP on growth rate and methicillin resistance in MRSA indicate that altering c-di-AMP levels could be a mechanism by which MRSA strains can increase their fitness levels by reducing their methicillin resistance levels.	[Dengler, Vanina; McCallum, Nadine; Berger-Baechi, Brigitte; Senn, Maria M.] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [McCallum, Nadine] Univ Sydney, Sydney Emerging Infect Dis & Biosecur Inst SEIB, Sydney, NSW 2006, Australia; [Kiefer, Patrick; Christen, Philipp; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Patrignani, Andrea] Univ ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; University of Sydney; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Dengler, V (corresponding author), Univ Zurich, Inst Med Microbiol, Zurich, Switzerland.	vdengler@imm.uzh.ch	Vorholt, Julia/K-3514-2016	Vorholt, Julia/0000-0002-6011-4910; Holmes, Nadine/0000-0001-7470-3786; Partigiani, Andrea/0000-0001-8019-3911; Christen, Philipp/0000-0002-3139-2874; Dengler Haunreiter, Vanina/0000-0002-0850-0363	European Union [241446]; Novartis foundation for medical-biological research; ETH Zurich	European Union(European Commission); Novartis foundation for medical-biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ETH Zurich(ETH Zurich)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no241446 (project ANTIRESDEV), the Novartis foundation for medical-biological research and the ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Balibar CJ, 2009, J BACTERIOL, V191, P851, DOI 10.1128/JB.01357-08; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; BERGERBACHI B, 1983, J BACTERIOL, V154, P479; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; Berscheid A, 2012, INT J MED MICROBIOL, V302, P84, DOI 10.1016/j.ijmm.2012.01.002; Blake KL, 2009, MOL MICROBIOL, V72, P335, DOI 10.1111/j.1365-2958.2009.06648.x; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Bruins MJ, 2007, J CLIN MICROBIOL, V45, P682, DOI 10.1128/JCM.02417-06; Campbell J, 2012, ANTIMICROB AGENTS CH, V56, P1810, DOI 10.1128/AAC.05938-11; Corrigan R. M., 2013, P NATL ACAD SCI US, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Dengler V, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-16; Duran SP, 1996, FEMS MICROBIOL LETT, V141, P255, DOI 10.1016/0378-1097(96)00231-5; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Ender M, 2008, INT J MED MICROBIOL, V298, P607, DOI 10.1016/j.ijmm.2008.01.015; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; Glanzmann P, 1999, ANTIMICROB AGENTS CH, V43, P240, DOI 10.1128/AAC.43.2.240; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Henze UU, 1996, ANTIMICROB AGENTS CH, V40, P2121, DOI 10.1128/AAC.40.9.2121; Hubscher J, 2009, FEMS MICROBIOL LETT, V295, P251, DOI 10.1111/j.1574-6968.2009.01603.x; Jarvis WR, 2012, AM J INFECT CONTROL, V40, P194, DOI 10.1016/j.ajic.2012.02.001; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Katayama Y, 2003, MICROB DRUG RESIST, V9, P329, DOI 10.1089/107662903322762752; Komatsuzawa H, 2000, J ANTIMICROB CHEMOTH, V45, P421, DOI 10.1093/jac/45.4.421; Komatsuzawa H, 2002, ANTIMICROB AGENTS CH, V46, P75, DOI 10.1128/AAC.46.1.75-81.2002; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuntze K, 2011, MOL MICROBIOL, V82, P758, DOI 10.1111/j.1365-2958.2011.07856.x; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Ling BD, 1998, ANTIMICROB AGENTS CH, V42, P936, DOI 10.1128/AAC.42.4.936; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; McCallum N, 2010, J BACTERIOL, V192, P5151, DOI 10.1128/JB.00491-10; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nakao A, 2000, RES MICROBIOL, V151, P823, DOI 10.1016/S0923-2508(00)01148-7; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; ORNELASSOARES A, 1994, J BIOL CHEM, V269, P27246; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; RYFFEL C, 1994, ANTIMICROB AGENTS CH, V38, P724, DOI 10.1128/AAC.38.4.724; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Sobral RG, 2006, J BACTERIOL, V188, P2543, DOI 10.1128/JB.188.7.2543-2553.2006; Sobral RG, 2007, J BACTERIOL, V189, P2376, DOI 10.1128/JB.01439-06; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu SW, 1999, MICROB DRUG RESIST, V5, P9, DOI 10.1089/mdr.1999.5.9; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110	68	59	62	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73512	10.1371/journal.pone.0073512	http://dx.doi.org/10.1371/journal.pone.0073512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013956	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000323815200081
J	Lee, CY; Hairi, NN; Ahmad, WAW; Ismail, O; Liew, HB; Zambahari, R; Ali, RM; Fong, AYY; Sim, KH				Lee, Chuey Yan; Hairi, Noran N.; Ahmad, Wan Azman Wan; Ismail, Omar; Liew, Houng Bang; Zambahari, Robaayah; Ali, Rosli Mohd; Fong, Alan Yean Yip; Sim, Kui Hian		NCVD-PCI Investigators	Are There Gender Differences in Coronary Artery Disease? The Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) Registry	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; MANAGEMENT; WOMEN; MORTALITY; OUTCOMES	Objectives: To assess whether gender differences exist in the clinical presentation, angiographic severity, management and outcomes in patients with coronary artery disease (CAD). Methods: The study comprised of 1,961 women and 8,593 men who underwent percutaneous coronary intervention (PCI) and were included in the Malaysian NCVD-PCI Registry from 2007-2009. Significant stenosis was defined as >= 70% stenosis in at least one of the epicardial vessels. Results: Women were significantly older and had significantly higher rates of diabetes mellitus, hypertension, chronic renal failure, new onset angina and prior history of heart failure whereas smokers and past history of myocardial infarction were higher in men. In the ST-elevation myocardial infarction (STEMI) cohort, more women were in Killip class III-IV, had longer door-to-balloon time (169.5 min. vs 127.3 min, p<0.052) and significantly longer transfer time (300.4 min vs 166.3 min, p<0.039). Overall, women had significantly more left main stem (LMS) disease (1.3% vs 0.6%, p<0.003) and smaller diameter vessels (<3.0 mm: 45.5% vs 34.8%, p<0.001). In-hospital mortality rates for all PCI, STEMI, Non-STEMI (NSTEMI) and unstable angina for women and men were 1.99% vs 0.98%, Odds ratio (OR): 2.06 (95% confidence interval (CI): 1.40 to 3.01), 6.19% vs 2.88%, OR: 2.23 (95% CI: 1.31 to 3.79), 2.90% vs 0.79%, OR: 3.75 (95% CI: 1.58 to 8.90) and 1.79% vs 0.29%, OR: 6.18 (95% CI: 0.56 to 68.83), respectively. Six-month adjusted OR for mortality for all PCI, STEMI and NSTEMI in women were 2.18 (95% CI: 0.97 to 4.90), 2.68 (95% CI: 0.37 to 19.61) and 2.66 (95% CI: 0.73 to 9.69), respectively. Conclusions: Women who underwent PCI were older with more co-morbidities. In-hospital and six-month mortality for all PCI, STEMI and NSTEMI were higher due largely to significantly more LMS disease, smaller diameter vessels, longer door-to-balloon and transfer time in women.	[Lee, Chuey Yan] Sultanah Aminah Hosp, Dept Cardiol, Johor Baharu, Johor, Malaysia; [Hairi, Noran N.] Univ Malaya, Dept Social & Prevent Med, Petaling Jaya, Malaysia; [Hairi, Noran N.] Univ Malaya, Julius Ctr, Fac Med, Petaling Jaya, Malaysia; [Ahmad, Wan Azman Wan] Univ Malaya, Med Ctr, Div Cardiol, Petaling Jaya, Malaysia; [Ismail, Omar] Hosp Pulau Pinang, Dept Cardiol, George Town, Malaysia; [Liew, Houng Bang] Queen Elizabeth Hosp, Dept Cardiol, Sabah, Malaysia; [Zambahari, Robaayah; Ali, Rosli Mohd] Natl Heart Inst, Dept Cardiol, Kuala Lumpur, Malaysia; [Fong, Alan Yean Yip] Hosp Umum Sarawak, Dept Cardiol, Sarawak, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Institute Jantung Negara	Lee, CY (corresponding author), Sultanah Aminah Hosp, Dept Cardiol, Johor Baharu, Johor, Malaysia.	chueyyanlee@gmail.com	HAIRI, NORAN/B-9339-2010	HAIRI, NORAN/0000-0002-2692-9016; LEE, CHUEY YAN/0000-0002-7706-2811	Ministry of Health Malaysia (MoH); National Heart Association of Malaysia (NHAM); (UM/MOHE) HIR Grant [E000010-20001]	Ministry of Health Malaysia (MoH); National Heart Association of Malaysia (NHAM); (UM/MOHE) HIR Grant	This study was supported by grants from the Ministry of Health Malaysia (MoH), (URL: www.moh.gov.my) and the National Heart Association of Malaysia (NHAM), (URL: www.nham.org). The NHAM contracted statistician Sharon Won Sun Chen to assist with data collection and analysis. NNH's work on this study was supported by the (UM/MOHE) HIR Grant E000010-20001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson J, 2007, HEART, V93, P1357, DOI 10.1136/hrt.2006.102012; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Coronado BE, 1997, J AM COLL CARDIOL, V29, P1490, DOI 10.1016/S0735-1097(97)00077-6; Department of Statistics, 2010, POP DISTR BAS DEM CH, P6; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Douglas PS, 1996, NEW ENGL J MED, V334, P1311, DOI 10.1056/NEJM199605163342007; Hasdai D, 2003, AM J CARDIOL, V91, P1466, DOI 10.1016/S0002-9149(03)00400-4; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Milner KA, 2002, AM HEART J, V143, P283, DOI 10.1067/mhj.2002.119759; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Wan Ahmad WA, 2013, ANN REPORT MALAYSIAN; Wan Ahmad WA, 2010, ANN REPORT MALAYSIAN; Wan Ahmad WA, 2011, ANN REPORT MALAYSIAN	19	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72382	10.1371/journal.pone.0072382	http://dx.doi.org/10.1371/journal.pone.0072382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015238	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200037
J	Lauer, AM; Connelly, CJ; Graham, H; Ryugo, DK				Lauer, Amanda M.; Connelly, Catherine J.; Graham, Heather; Ryugo, David K.			Morphological Characterization of Bushy Cells and Their Inputs in the Laboratory Mouse (Mus musculus) Anteroventral Cochlear Nucleus	PLOS ONE			English	Article							ANTERIOR VENTRAL COCHLEAR; MEDIAL SUPERIOR OLIVE; AUDITORY-NERVE; PRINCIPAL CELLS; TRAPEZOID BODY; HORSERADISH-PEROXIDASE; NEURONAL ARCHITECTURE; INFERIOR COLLICULUS; PROJECTION PATTERNS; MULTIPOLAR CELLS	Spherical and globular bushy cells of the AVCN receive huge auditory nerve endings specialized for high fidelity neural transmission in response to acoustic events. Recent studies in mice and other rodent species suggest that the distinction between bushy cell subtypes is not always straightforward. We conducted a systematic investigation of mouse bushy cells along the rostral-caudal axis in an effort to understand the morphological variation that gives rise to reported response properties in mice. We combined quantitative light and electron microscopy to investigate variations in cell morphology, immunostaining, and the distribution of primary and non-primary synaptic inputs along the rostral-caudal axis. Overall, large regional differences in bushy cell characteristics were not found; however, rostral bushy cells received a different complement of axosomatic input compared to caudal bushy cells. The percentage of primary auditory nerve terminals was larger in caudal AVCN, whereas non-primary excitatory and inhibitory inputs were more common in rostral AVCN. Other ultrastructural characteristics of primary auditory nerve inputs were similar across the rostral and caudal AVCN. Cross sectional area, postsynaptic density length and curvature, and mitochondrial volume fraction were similar for axosomatic auditory nerve terminals, although rostral auditory nerve terminals contained a greater concentration of synaptic vesicles near the postsynaptic densities. These data demonstrate regional differences in synaptic organization of inputs to mouse bushy cells rather than the morphological characteristic of the cells themselves.	[Lauer, Amanda M.; Graham, Heather; Ryugo, David K.] Johns Hopkins Univ, Dept Otolaryngol HNS, Baltimore, MD 21218 USA; [Connelly, Catherine J.; Ryugo, David K.] St Vincents Hosp, Garvan Inst Med Res, Hearing Res Unit, Darlinghurst, NSW 2010, Australia; [Connelly, Catherine J.; Ryugo, David K.] Univ New S Wales, Sch Med Sci, Kensington, NSW 2033, Australia	Johns Hopkins University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Lauer, AM (corresponding author), Johns Hopkins Univ, Dept Otolaryngol HNS, Baltimore, MD 21218 USA.	alauer2@jhmi.edu	Ryugo, David K./G-1940-2012	Ryugo, David K./0000-0002-5250-7503; Lauer, Amanda/0000-0003-4184-7374	NIH [DC012352, DC005211, DC000232, DC004395, EY001765]; American Hearing Research Foundation; NHMRC [1009482]; Garnett Passe & Rodney Williams Memorial Foundation; Vincent Fairfax Family Foundation; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000232, R01DC004395, P30DC005211, T32DC000023, R03DC012352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Garnett Passe & Rodney Williams Memorial Foundation; Vincent Fairfax Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by the following: NIH grants DC012352, DC005211, DC000232, DC004395, EY001765, www.nih.gov; American Hearing Research Foundation, http://american-hearing.org/; NHMRC grant 1009482, http://www.nhmrc.gov.au/; Garnett Passe & Rodney Williams Memorial Foundation, http://www.gprwmf.org.au/; and Vincent Fairfax Family Foundation, http://vfff.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babalian AL, 2002, NEUROREPORT, V13, P555, DOI 10.1097/00001756-200203250-00038; Bazwinsky I, 2008, J CHEM NEUROANAT, V35, P158, DOI 10.1016/j.jchemneu.2007.10.003; Bourk T. R, 1976, ELECT RESPONSES NEUR; BRAWER JR, 1975, J COMP NEUROL, V160, P491, DOI 10.1002/cne.901600406; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Cao XJ, 2007, J NEUROPHYSIOL, V97, P3961, DOI 10.1152/jn.00052.2007; Cao XJ, 2010, J NEUROPHYSIOL, V104, P2308, DOI 10.1152/jn.00451.2010; Chanda S, 2010, J NEUROPHYSIOL, V104, P2063, DOI 10.1152/jn.00474.2010; Chanda S, 2010, J NEUROPHYSIOL, V103, P1915, DOI 10.1152/jn.00751.2009; COVEY E, 1984, J COMP NEUROL, V226, P289, DOI 10.1002/cne.902260212; Darrow KN, 2012, J COMP NEUROL, V520, P1365, DOI 10.1002/cne.22797; DISTERHOFT JF, 1980, J COMP NEUROL, V192, P687, DOI 10.1002/cne.901920405; Doucet JR, 2006, ANAT REC PART A, V288A, P331, DOI 10.1002/ar.a.20294; EBERT U, 1992, NEUROSCI LETT, V145, P51, DOI 10.1016/0304-3940(92)90201-H; Fay R. R., 1988, HEARING VERTEBRATES; Fredrich M, 2009, EXP BRAIN RES, V195, P241, DOI 10.1007/s00221-009-1776-7; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; Gai Y, 2008, J NEUROPHYSIOL, V99, P1077, DOI 10.1152/jn.00708.2007; GENTSCHEV T, 1973, BRAIN RES, V62, P37, DOI 10.1016/0006-8993(73)90618-5; Gomez-Nieto R, 2011, NEUROSCIENCE, V179, P188, DOI 10.1016/j.neuroscience.2011.01.058; Gomez-Nieto R, 2009, J COMP NEUROL, V516, P241, DOI 10.1002/cne.22139; Grothe B, 2000, PROG NEUROBIOL, V61, P581, DOI 10.1016/S0301-0082(99)00068-4; HACKNEY CM, 1990, ANAT EMBRYOL, V182, P123; HARRISON JM, 1965, J COMP NEUROL, V124, P15, DOI 10.1002/cne.901240103; IBATA Y, 1976, J NEUROCYTOL, V5, P395, DOI 10.1007/BF01181647; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; KLEPPER A, 1991, BRAIN RES, V557, P190, DOI 10.1016/0006-8993(91)90134-H; KOSSL M, 1989, J NEUROSCI, V9, P4169; Lauer AM, 2011, JARO-J ASSOC RES OTO, V12, P633, DOI 10.1007/s10162-011-0279-y; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Manis PB, 2012, SPRINGER HANDB AUDIT, V41, P61, DOI 10.1007/978-1-4419-9517-9_4; MASTERTON B, 1975, J COMP PHYSIOL PSYCH, V89, P379, DOI 10.1037/h0077034; MCDONALD DM, 1971, BRAIN RES, V28, P1, DOI 10.1016/0006-8993(71)90520-8; McGinley MJ, 2006, HEARING RES, V216, P52, DOI 10.1016/j.heares.2006.02.006; Mellott JG, 2011, NEUROSCIENCE, V180, P138, DOI 10.1016/j.neuroscience.2011.02.010; NEISES GR, 1982, ANAT REC, V204, P271, DOI 10.1002/ar.1092040312; Nicol MJ, 2002, J PHYSIOL-LONDON, V539, P713, DOI 10.1113/jphysiol.2001.012972; O'Neil JN, 2010, J COMP NEUROL, V518, P2382, DOI 10.1002/cne.22339; Oertel D, 2001, AUDIOL NEURO-OTOL, V6, P161, DOI 10.1159/000046825; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; OSTAPOFF EM, 1994, J COMP NEUROL, V346, P19, DOI 10.1002/cne.903460103; OSTAPOFF EM, 1991, J COMP NEUROL, V314, P598, DOI 10.1002/cne.903140314; Radziwon KE, 2009, J COMP PHYSIOL A, V195, P961, DOI 10.1007/s00359-009-0472-1; RAMON, 1909, HISTOLOGIE SYSTEME N, P774; Redd EE, 2000, HEARING RES, V147, P160, DOI 10.1016/S0378-5955(00)00129-5; Rhode WS, 2008, NEUROSCIENCE, V154, P87, DOI 10.1016/j.neuroscience.2008.03.013; RHODE WS, 1983, J COMP NEUROL, V213, P448, DOI 10.1002/cne.902130408; ROBERTS RC, 1987, J COMP NEUROL, V258, P267, DOI 10.1002/cne.902580207; Roos MJ, 2012, HEARING RES, V289, P13, DOI 10.1016/j.heares.2012.04.019; ROUILLER EM, 1984, J COMP NEUROL, V225, P167, DOI 10.1002/cne.902250203; Rowland KC, 2000, J NEUROSCI, V20, P9135; Ryugo DK, 2006, HEARING RES, V216, P100, DOI 10.1016/j.heares.2006.01.007; Ryugo DK, 1997, J COMP NEUROL, V385, P230, DOI 10.1002/(SICI)1096-9861(19970825)385:2<230::AID-CNE4>3.0.CO;2-2; RYUGO DK, 1991, J COMP NEUROL, V305, P35, DOI 10.1002/cne.903050105; RYUGO DK, 1982, J COMP NEUROL, V210, P239, DOI 10.1002/cne.902100304; RYUGO DK, 2009, NEW ENCY NEUROSCIENC, P759; SCHOFIELD BR, 1991, J COMP NEUROL, V312, P68, DOI 10.1002/cne.903120106; SCHOFIELD BR, 1994, J COMP NEUROL, V344, P83, DOI 10.1002/cne.903440107; SHERRIFF FE, 1994, NEUROSCIENCE, V58, P627, DOI 10.1016/0306-4522(94)90086-8; SMITH PH, 1987, J COMP NEUROL, V266, P360, DOI 10.1002/cne.902660305; SNYDER RL, 1988, J COMP NEUROL, V278, P209, DOI 10.1002/cne.902780205; Spirou GA, 2005, NEUROSCIENCE, V136, P843, DOI 10.1016/j.neuroscience.2005.08.068; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; THOMPSON AM, 1995, J COMP NEUROL, V351, P104, DOI 10.1002/cne.903510110; Thompson AM, 2001, BRAIN RES, V907, P195, DOI 10.1016/S0006-8993(01)02483-0; Tirko NN, 2012, J COMP NEUROL, V520, P2202, DOI 10.1002/cne.23038; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3031, DOI 10.1016/0306-4522(82)90228-7; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3053, DOI 10.1016/0306-4522(82)90229-9; Trettel J, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P279, DOI 10.1201/9781420038736.ch19; Trussell LO, 2002, SPR HDB AUD, V15, P72; Typlt M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029965; Wang Y, 2008, J NEUROPHYSIOL, V100, P1255, DOI 10.1152/jn.90715.2008; Warr WB, 1996, HEARING RES, V93, P83, DOI 10.1016/0378-5955(95)00198-0; WEBSTER DB, 1982, AM J ANAT, V163, P103, DOI 10.1002/aja.1001630202; WENTHOLD RJ, 1987, NEUROSCIENCE, V22, P897, DOI 10.1016/0306-4522(87)92968-X; WICKESBERG RE, 1988, J COMP NEUROL, V268, P389, DOI 10.1002/cne.902680308; Willard FH, 1983, AUDITORY PSYCHOBIOLO, P201; WU SH, 1986, J NEUROSCI, V6, P2691; Yang H, 2010, J NEUROSCI, V30, P11466, DOI 10.1523/JNEUROSCI.2300-10.2010; YOUNG ED, 2010, HDB BRAIN MICROCIRCU, P215; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208	83	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73308	10.1371/journal.pone.0073308	http://dx.doi.org/10.1371/journal.pone.0073308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991186	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800099
J	Lin, WP; Wang, XJ; Wang, CR; Zhang, LQ; Li, N; Wang, FS; Lin, JH				Lin, Wen-Ping; Wang, Xue-Jin; Wang, Cong-Ren; Zhang, Li-Qun; Li, Neng; Wang, Fa-Sheng; Lin, Jian-Hua			Polymorphism in the Hypoxia-Inducible Factor 1alpha Gene May Confer Susceptibility to LDD in Chinese Cohort	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; DEGENERATIVE DISC DISEASE; ENDOTHELIAL GROWTH-FACTOR; INTERVERTEBRAL DISC; PROSTATE-CANCER; RISK-FACTORS; EXPRESSION; HIF-1-ALPHA; FACTOR-1-ALPHA; ASSOCIATION	Objective: This study aimed to investigate whether or not hypoxia-inducible factor-1 alpha (HIF-1 alpha) gene variants are associated with the susceptibility and clinical characteristics of lumbar disc degeneration (LDD). Methods: We examined 320 patients with LDD and 447 gender- and age-matched control subjects. We also determined the HIF-1 alpha gene variants, including C1772T (P582S) and G1790A (A588T) polymorphisms. Results: Significant differences were observed in allelic and genotypic distributions of 1790 A > G polymorphisms between LDD cases and control subjects. Logistic regression revealed that 1790 AA genotypes indicated a protective effect against the development of LDD. The HIF-1 alpha 1790 A > G polymorphisms also affected the severity of LDD as evaluated based on the modified Japanese Orthopedic Association (mJOA) scores. The 1790 AA genotype carriers exhibited significantly lower mJOA scores than AG and GG carriers. C1772T did not show any association with the risk and severity of LDD. Conclusion: Our study suggested that HIF-1 alpha 1790 A > G polymorphisms may be used as a molecular marker to determine the susceptibility and severity of LDD.	[Lin, Wen-Ping] Fujian Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Quanzhou, Fujian Province, Peoples R China; [Wang, Xue-Jin] Fujian Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Quanzhou, Fujian Province, Peoples R China; [Wang, Cong-Ren] Fujian Med Univ, Affiliated Quanzhou Hosp 1, Dept Oncosurg, Quanzhou, Fujian Province, Peoples R China; [Zhang, Li-Qun; Wang, Fa-Sheng; Lin, Jian-Hua] Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China; [Li, Neng] Fujian Med Univ, Coll Preclin Med, Dept Pathogeny Biol, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Lin, JH (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China.	jianhua0918@126.com		Lin, Jianhua/0000-0003-0698-0292; Zhang, Liqun/0000-0002-2937-2743	Scientific Research Project of Department of Public Health of Fujian Province, China [2012-2-56]	Scientific Research Project of Department of Public Health of Fujian Province, China	This study was supported by a grant from the Scientific Research Project of Department of Public Health of Fujian Province, China in 2012 (Grant No. 2012-2-56). The URL of the funder's website is http://www.fjphb.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Brouwer E, 2009, CLIN EXP RHEUMATOL, V27, P945; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Clifford SC, 2001, ONCOGENE, V20, P5067, DOI 10.1038/sj.onc.1204602; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Fairbank J, 2002, BIOCHEM SOC T, V30, P829, DOI 10.1042/bst0300829; Fang JM, 2001, CANCER RES, V61, P5731; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Fusaru AM, 2012, ROM J MORPHOL EMBRYO, V53, P903; Garcia-Cosamalon J, 2010, J ANAT, V217, P1, DOI 10.1111/j.1469-7580.2010.01227.x; Ha KY, 2006, SPINE, V31, P1309, DOI 10.1097/01.brs.0000219493.76081.d6; Hebert C, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-3; Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016; Jim JJT, 2005, SPINE, V30, P2735, DOI 10.1097/01.brs.0000190828.85331.ef; Kim HO, 2008, ONCOL REP, V20, P1181, DOI 10.3892/or_00000127; Kim NK, 2011, ACTA NEUROCHIR, V153, P129, DOI 10.1007/s00701-010-0831-2; Lee JH, 2011, INT J DERMATOL, V50, P956, DOI 10.1111/j.1365-4632.2010.04846.x; Li P, 2012, ASIAN J ANDROL, V14, P864, DOI 10.1038/aja.2012.101; Matsui H, 1998, SPINE, V23, P1029, DOI 10.1097/00007632-199805010-00013; Nakajima M, 2012, J ORTHOP RES, V30, P1244, DOI 10.1002/jor.22063; Nava-Salazar Sonia, 2011, BMC Res Notes, V4, P68, DOI 10.1186/1756-0500-4-68; Putra AC, 2011, CLIN RESP J; Raheja LF, 2011, CELL BIOL INT, V35, P981, DOI 10.1042/CBI20100733; Revanappa KK, 2011, EUR SPINE J, V20, P1545, DOI 10.1007/s00586-011-1773-y; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Schoenfeld AJ, 2011, MIL MED, V176, P1320, DOI 10.7205/MILMED-D-11-00061; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403; Tsukada K, 2013, MICROCIRCULATION, V20, P385, DOI 10.1111/micc.12033; Vainrib M, 2012, CANCER BIOL THER, V13, P720, DOI 10.4161/cbt.20554; Wahlstrom J, 2012, SPINE, V37, P1334, DOI 10.1097/BRS.0b013e31824b5464; Williams FMK, 2011, BEST PRACT RES CL RH, V25, P69, DOI 10.1016/j.berh.2011.01.007	36	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73158	10.1371/journal.pone.0073158	http://dx.doi.org/10.1371/journal.pone.0073158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991178	Green Published, gold			2022-12-25	WOS:000324228800095
J	Khalfaoui, T; Groulx, JF; Sabra, G; GuezGuez, A; Basora, N; Vermette, P; Beaulieu, JF				Khalfaoui, Taoufik; Groulx, Jean-Francois; Sabra, Georges; GuezGuez, Amel; Basora, Nuria; Vermette, Patrick; Beaulieu, Jean-Francois			Laminin Receptor 37/67LR Regulates Adhesion and Proliferation of Normal Human Intestinal Epithelial Cells	PLOS ONE			English	Article							CRYPT-VILLUS AXIS; BINDING PROTEIN-PRECURSOR; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; FUNCTIONAL DIVERSITY; SURFACE RECEPTOR; COLON-CANCER; RT-PCR; CARCINOMA; INTEGRINS	Interactions between the cell basal membrane domain and the basement membrane are involved in several cell functions including proliferation, migration and differentiation. Intestinal epithelial cells can interact with laminin, a major intestinal basement membrane glycoprotein, via several cell-surface laminin-binding proteins including integrin and non-integrin receptors. The 37/67kDa laminin receptor (37/67LR) is one of these but its role in normal epithelial cells is still unknown. The aim of this study was to characterise the expression pattern and determine the main function of 37/67LR in the normal human small intestinal epithelium. Immunolocalization studies revealed that 37/67LR was predominantly present in the undifferentiated/proliferative region of the human intestinal crypt in both the immature and adult intestine. Using a human intestinal epithelial crypt (HIEC) cell line as experimental model, we determined that 37/67LR was expressed in proliferative cells in both the cytoplasmic and membrane compartments. Small-interfering RNA-mediated reduction of 37/67LR expression led to HIEC cell-cycle reduction and loss of the ability to adhere to laminin-related peptides under conditions not altering ribosomal function. Taken together, these findings indicate that 37/67LR regulates proliferation and adhesion in normal intestinal epithelial cells independently of its known association with ribosomal function.	[Khalfaoui, Taoufik; Groulx, Jean-Francois; GuezGuez, Amel; Basora, Nuria; Beaulieu, Jean-Francois] Univ Sherbrooke, Lab Intestinal Physiopathol, Dept Anat & Cell Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; [Sabra, Georges; Vermette, Patrick] Univ Sherbrooke, Dept Chem & Biotechnol Engn, Lab Bioengn & Biophys, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Beaulieu, JF (corresponding author), Univ Sherbrooke, Lab Intestinal Physiopathol, Dept Anat & Cell Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Francois.Beaulieu@USherbrooke.ca			Canadian Institutes of Health Research [MOP 97836]; Canada Research Chair in Intestinal Physiopathology; FRSQ	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Intestinal Physiopathology; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research Grant MOP 97836 (http://www.cihr-irsc.gc.ca/). JFB is the recipient of the Canada Research Chair in Intestinal Physiopathology (http://www.chairs-chaires.gc.ca/) and a member of the FRSQ-funded Centre de Recherche Clinique Etienne Le Bel of the Centre Hospitalier Universitaire de Sherbrooke (http://www.crc.chus.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardini E, 1997, J BIOL CHEM, V272, P2342; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Babyatsky M.W., 1999, TXB GASTROENTEROLOGY, P547; Basora N, 1999, J BIOL CHEM, V274, P29819, DOI 10.1074/jbc.274.42.29819; Basson MD, 2003, SURGERY, V133, P263, DOI 10.1067/msy.2003.24; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; Beaulieu JF, 2012, METHODS MOL BIOL, V806, P157, DOI 10.1007/978-1-61779-367-7_11; Beaulieu Jean-Francois, 2010, World J Gastrointest Pathophysiol, V1, P3, DOI 10.4291/wjgp.v1.i1.3; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Benoit YD, 2012, J CELL SCI, V125, P3454, DOI 10.1242/jcs.102061; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Benoit YD, 2012, SIGNAL TRANSDUCT, V2012; Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152; Bouatrouss Y, 2000, AM J PATHOL, V156, P45, DOI 10.1016/S0002-9440(10)64704-9; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; CIOCE V, 1991, J NATL CANCER I, V83, P29, DOI 10.1093/jnci/83.1.29; DERRICO A, 1991, MODERN PATHOL, V4, P239; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Donaldson Elaine A., 2000, Molecular Cell Biology Research Communications, V3, P53, DOI 10.1006/mcbr.2000.0191; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Francoeur C, 2004, AM J PHYSIOL-GASTR L, V287, pG592, DOI 10.1152/ajpgi.00535.2003; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; HAND PH, 1985, CANCER RES, V45, P833; Kazmin DA, 2000, J MOL BIOL, V298, P431, DOI 10.1006/jmbi.2000.3680; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Kinoshita K, 1998, BIOCHEM BIOPH RES CO, V253, P277, DOI 10.1006/bbrc.1998.9699; Kuehn C, 2012, ACTA BIOMATER, V8, P619, DOI 10.1016/j.actbio.2011.10.036; LANDOWSKI TH, 1995, CLIN EXP METASTAS, V13, P357; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Levy E, 2000, J LIPID RES, V41, P12; Liu JM, 2012, HUM MOL GENET, V21, P1592, DOI 10.1093/hmg/ddr596; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Monchaux E, 2007, BIOMACROMOLECULES, V8, P3668, DOI 10.1021/bm7007907; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Pageot LP, 2000, MICROSC RES TECHNIQ, V49, P394; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Perreault N, 1998, BIOCHEM BIOPH RES CO, V248, P121, DOI 10.1006/bbrc.1998.8919; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quaroni A, 1997, GASTROENTEROLOGY, V113, P1198, DOI 10.1053/gast.1997.v113.pm9322515; RAO M, 1994, GASTROENTEROLOGY, V107, P764, DOI 10.1016/0016-5085(94)90125-2; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Salama RHM, 2001, EXP CELL RES, V270, P13, DOI 10.1006/excr.2001.5341; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Seltana A, 2010, WOUND REPAIR REGEN, V18, P114, DOI 10.1111/j.1524-475X.2009.00554.x; Shaw D, 2012, WORLD J GASTROENTERO, V18, P6357, DOI 10.3748/wjg.v18.i44.6357; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; SOBEL ME, 1993, SEMIN CANCER BIOL, V4, P311; STALLMACH A, 1990, DIGESTION, V46, P31, DOI 10.1159/000200364; Stitt AW, 1998, AM J PATHOL, V152, P1359; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Teller IC, 2007, DEV DYNAM, V236, P1980, DOI 10.1002/dvdy.21186; TERRANOVA VP, 1983, P NATL ACAD SCI-BIOL, V80, P444, DOI 10.1073/pnas.80.2.444; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tremblay E, 2006, J CELL BIOCHEM, V99, P1175, DOI 10.1002/jcb.21015; Umeda D, 2008, BIOCHEM BIOPH RES CO, V371, P172, DOI 10.1016/j.bbrc.2008.04.041; VACHON PH, 1995, AM J PHYSIOL-GASTR L, V268, pG857, DOI 10.1152/ajpgi.1995.268.5.G857; Weiser MM, 1997, FALK SYMP, V94, P149; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	83	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e74337	10.1371/journal.pone.0074337	http://dx.doi.org/10.1371/journal.pone.0074337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991217	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470700067
J	Wassink, G; Bennet, L; Davidson, JO; Westgate, JA; Gunn, AJ				Wassink, Guido; Bennet, Laura; Davidson, Joanne O.; Westgate, Jenny A.; Gunn, Alistair J.			Pre-Existing Hypoxia Is Associated with Greater EEG Suppression and Early Onset of Evolving Seizure Activity during Brief Repeated Asphyxia in Near-Term Fetal Sheep	PLOS ONE			English	Article							UMBILICAL-CORD OCCLUSION; CEREBRAL-BLOOD-FLOW; GESTATIONAL-AGE FETUSES; OVINE FETUS; CARDIOVASCULAR-RESPONSES; ELECTROCORTICAL ACTIVITY; ANOXIA TOLERANCE; ISCHEMIC INJURY; ACUTE HYPOXEMIA; BRAIN-INJURY	Spontaneous antenatal hypoxia is associated with high risk of adverse outcomes, however, there is little information on neural adaptation to labor-like insults. Chronically instrumented near-term sheep fetuses (125 +/- 3 days, mean +/- SEM) with baseline PaO2 < 17 mmHg (hypoxic group: n = 8) or > 17 mmHg (normoxic group: n = 8) received 1-minute umbilical cord occlusions repeated every 5 minutes for a total of 4 hours, or until mean arterial blood pressure (MAP) fell below 20 mmHg for two successive occlusions. 5/8 fetuses with pre-existing hypoxia were unable to complete the full series of occlusions (vs. 0/8 normoxic fetuses). Pre-existing hypoxia was associated with progressive metabolic acidosis (nadir: pH 7.08 +/- 0.04 vs. 7.33 +/- 0.02, p<0.01), hypotension during occlusions (nadir: 24.7 +/- 1.8 vs. 51.4 +/- 3.2 mmHg, p<0.01), lower carotid blood flow during occlusions (23.6 +/- 6.1 vs. 63.0 +/- 4.8 mL/min, p<0.01), greater suppression of EEG activity during, between, and after occlusions (p<0.01) and slower resolution of cortical impedance, an index of cytotoxic edema. No normoxic fetuses, but 4/8 hypoxic fetuses developed seizures 148 +/- 45 minutes after the start of occlusions, with a seizure burden of 26 +/- 6 sec during the inter-occlusion period, and 15.1 +/- 3.4 min/h in the first 6 hours of recovery. In conclusion, in fetuses with pre-existing hypoxia, repeated brief asphyxia at a rate consistent with early labor is associated with hypotension, cephalic hypoperfusion, greater EEG suppression, inter-occlusion seizures, and more sustained cytotoxic edema, consistent with early onset of neural injury.	[Wassink, Guido; Bennet, Laura; Davidson, Joanne O.; Gunn, Alistair J.] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Westgate, Jenny A.] Dept Obstet & Gynaecol, Auckland, New Zealand	University of Auckland	Gunn, AJ (corresponding author), Univ Auckland, Dept Physiol, Auckland, New Zealand.	aj.gunn@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021	Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Bennet, Laura/0000-0002-4336-7596	Health Research Council of New Zealand; Auckland Medical Research Foundation; Lottery Health grants board	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; Lottery Health grants board	This study was supported by the Health Research Council of New Zealand, the Auckland Medical Research Foundation and the Lottery Health grants board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; BARTELDS B, 1993, PEDIATR RES, V34, P51, DOI 10.1203/00006450-199307000-00013; Bennet L, 1998, PEDIATR RES, V44, P951, DOI 10.1203/00006450-199812000-00022; Bennet L, 2007, AM J PHYSIOL-REG I, V292, pR1569, DOI 10.1152/ajpregu.00743.2006; Blood AB, 2002, J PHYSIOL-LONDON, V543, P1015, DOI 10.1113/jphysiol.2002.023077; Caravale B, 2003, PEDIATR NEUROL, V29, P18, DOI 10.1016/S0887-8994(03)00046-8; Covert RF, 1996, REPROD FERT DEVELOP, V8, P157, DOI 10.1071/RD9960157; DeHaan HH, 1997, PEDIATR RES, V41, P96, DOI 10.1203/00006450-199701000-00015; Drury PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039273; Ebensperger G, 2005, J PHYSIOL-LONDON, V567, P963, DOI 10.1113/jphysiol.2005.094524; Frasch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022100; Gardner DS, 2002, J PHYSIOL-LONDON, V540, P351, DOI 10.1113/jphysiol.2001.013434; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Gratton R, 1996, J SOC GYNECOL INVEST, V3, P60, DOI 10.1016/1071-5576(95)00047-X; Green LR, 1996, J PHYSIOL-LONDON, V497, P271, DOI 10.1113/jphysiol.1996.sp021766; Gunn AJ, 2000, AM J OBSTET GYNECOL, V183, P1564, DOI 10.1067/mob.2000.108084; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Ilie A, 2006, J NEUROPHYSIOL, V96, P2809, DOI 10.1152/jn.00466.2006; ITSKOVITZ J, 1991, PEDIATR RES, V30, P381, DOI 10.1203/00006450-199110000-00016; Kaneko M, 2003, AM J OBSTET GYNECOL, V188, P961, DOI 10.1067/mob.2003.219; Kawagoe Y, 1999, AM J OBSTET GYNECOL, V181, P1520, DOI 10.1016/S0002-9378(99)70399-6; MALLARD EC, 1995, PEDIATR RES, V37, P707, DOI 10.1203/00006450-199506000-00006; Miller SP, 2004, AM J OBSTET GYNECOL, V190, P93, DOI 10.1016/S0002-9378(03)00908-6; Murray DM, 2009, PEDIATRICS, V124, pE459, DOI 10.1542/peds.2008-2190; Nakajima W, 1996, BRAIN RES, V740, P316, DOI 10.1016/S0006-8993(96)00875-X; Nguyen PN, 2004, J PHYSIOL-LONDON, V560, P593, DOI 10.1113/jphysiol.2004.069336; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; Pamenter ME, 2011, P NATL ACAD SCI USA, V108, P11274, DOI 10.1073/pnas.1102429108; PAPILE LA, 1985, PEDIATR RES, V19, P159, DOI 10.1203/00006450-198502000-00001; PARDI G, 1993, NEW ENGL J MED, V328, P692, DOI 10.1056/NEJM199303113281004; PerezPinzon MA, 1997, ADV EXP MED BIOL, V411, P75; Pulgar VM, 2007, BRAIN RES, V1176, P18, DOI 10.1016/j.brainres.2007.07.089; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Scher MS, 2002, EPILEPTIC DISORD, V4, P139; SHELLEY HJ, 1961, BRIT MED BULL, V17, P137, DOI 10.1093/oxfordjournals.bmb.a069888; SOOTHILL PW, 1995, EUR J OBSTET GYN R B, V59, P21, DOI 10.1016/0028-2243(94)02013-5; SZYMONOWICZ W, 1990, PEDIATR RES, V28, P361, DOI 10.1203/00006450-199010000-00012; Takahashi Naoto, 1995, Acta Paediatrica Japonica, V37, P341; Tan WKM, 1996, PEDIATR RES, V39, P791, DOI 10.1203/00006450-199605000-00008; VANBEL F, 1994, PEDIATR RES, V35, P329; Wassink G, 2007, J APPL PHYSIOL, V103, P1311, DOI 10.1152/japplphysiol.00396.2007; Watson CS, 2002, REPROD FERT DEVELOP, V14, P35, DOI 10.1071/RD01013; Westgate JA, 2005, AM J OBSTET GYNECOL, V193, P1526, DOI 10.1016/j.ajog.2005.03.024; Westgate JA, 2001, AM J OBSTET GYNECOL, V184, P743, DOI 10.1067/mob.2001.111932; WILLIAMS CE, 1990, J NEUROSCI METH, V32, P9, DOI 10.1016/0165-0270(90)90066-O; WILLIAMS CE, 1991, STROKE, V22, P516, DOI 10.1161/01.STR.22.4.516; YAFFE H, 1987, J DEV PHYSIOL, V9, P325; Yawno T, 2007, NEUROSCIENCE, V146, P1726, DOI 10.1016/j.neuroscience.2007.03.023; YONEYAMA Y, 1994, AM J OBSTET GYNECOL, V170, P684, DOI 10.1016/S0002-9378(94)70248-9	51	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73895	10.1371/journal.pone.0073895	http://dx.doi.org/10.1371/journal.pone.0073895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991209	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100133
J	Niedan, S; Kauer, M; Aryee, DNT; Kofler, R; Schwentner, R; Meier, A; Potschger, U; Kontny, U; Kovar, H				Niedan, S.; Kauer, M.; Aryee, D. N. T.; Kofler, R.; Schwentner, R.; Meier, A.; Poetschger, U.; Kontny, U.; Kovar, H.			Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma	ONCOGENE			English	Article						CDK2; Ewing sarcoma; EWS-FLI1; FOXO1	CELL-CYCLE ARREST; METHYLSELENINIC ACID; GENE-EXPRESSION; TUMOR-CELLS; IN-VITRO; CANCER; EWS/FLI-1; TRANSFORMATION; INHIBITION; PATHWAYS	The Ewing sarcoma (ES) EWS-FLI1 chimeric oncoprotein is a prototypic aberrant ETS transcription factor with activating and repressive regulatory functions. We report that EWS-FLI1-repressed promoters are enriched in forkhead box ( FOX) recognition motifs, and identify FOXO1 as a EWS-FLI1-suppressed regulator orchestrating a major subset of EWS-FLI1-repressed genes. In addition to FOXO1 regulation by direct promoter binding of EWS-FLI1, its subcellular localization and activity is regulated by cyclin-dependent kinase 2- and AKT-mediated phosphorylation downstream of EWS-FLI1. Restoration of nuclear FOXO1 expression in ES cells impaired proliferation and significantly reduced clonogenicity. Gene-expression profiling revealed a significant overlap between EWS-FLI1-repressed and FOXO1-activated genes. As a proof of principle for a potential therapeutic application of our findings, the treatment of ES cell lines with methylseleninic acid (MSA) reactivated endogenous FOXO1 in the presence of EWS-FLI1 in a dose- and time-dependent manner and induced massive cell death dependent on FOXO1. In an orthotopic xenograft mouse model, MSA increased FOXO1 expression in the tumor paralleled by a significant decrease in ES tumor growth. FOXO1 reactivation by small molecules may therefore serve as a promising strategy for a future ES-specific therapy.	[Niedan, S.; Kauer, M.; Aryee, D. N. T.; Schwentner, R.; Poetschger, U.; Kovar, H.] St Anna Kinderkrebsforschung, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Aryee, D. N. T.; Kovar, H.] Med Univ, Dept Pediat, Vienna, Austria; [Kofler, R.] Med Univ Innsbruck, Div Mol Pathophysiol Bioctr, Innsbruck, Austria; [Meier, A.; Kontny, U.] Univ Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Hematol Oncol, Freiburg, Germany	Saint Anna Children's Hospital; Medical University of Innsbruck; University of Freiburg	Kovar, H (corresponding author), St Anna Kinderkrebsforschung, Childrens Canc Res Inst, Zimmermannplatz 10, A-1090 Vienna, Austria.	heinrich.kovar@ccri.at		Kovar, Heinrich/0000-0001-6873-9109; Potschger, Ulrike/0000-0001-7024-7082; Schwentner, Raphaela/0000-0001-6839-0322	Austrian Science Fund (FWF) [22328-B09]; 7th framework program of the European Commission [259348]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 22328] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); 7th framework program of the European Commission(European Commission); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Lukas Kenner for processing tumor sections and hematoxylin and eosin stainings. This study was supported in part by the Austrian Science Fund (FWF), grant 22328-B09, and by the 7th framework program of the European Commission, grant 259348 ('ASSET'). Raphaela Schwentner is a recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Dong Y, 2003, CANCER RES, V63, P52; Duffield-Lillico AJ, 2003, JNCI-J NATL CANCER I, V95, P1477, DOI 10.1093/jnci/djg061; France KA, 2011, J BIOL CHEM, V286, P22750, DOI 10.1074/jbc.M111.225433; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Moreno O, 2007, INT J CANCER, V121, P1197, DOI 10.1002/ijc.22764; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hotfilder M, 2005, BRIT J CANCER, V92, P705, DOI 10.1038/sj.bjc.6602384; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Kovar H, 2005, SEMIN CANCER BIOL, V15, P189, DOI 10.1016/j.semcancer.2005.01.004; KOVAR H, 1993, ONCOGENE, V8, P2683; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; KOZIOL JA, 1981, BIOMETRICS, V37, P383, DOI 10.2307/2530427; Li QX, 2008, CELL DEATH DIFFER, V15, P1197, DOI 10.1038/cdd.2008.48; Maiese K, 2009, MED RES REV, V29, P395, DOI 10.1002/med.20139; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Siligan C, 2005, ONCOGENE, V24, P2512, DOI 10.1038/sj.onc.1208455; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Teixeira CC, 2010, J BIOL CHEM, V285, P31055, DOI 10.1074/jbc.M109.079962; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toretsky JA, 1999, CANCER RES, V59, P5745; Uren Aykut, 2005, Future Oncol, V1, P521, DOI 10.2217/14796694.1.4.521; Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Winter GE, 2011, MOL CANCER THER, V10, P1846, DOI 10.1158/1535-7163.MCT-11-0100; Wu Y, 2005, CANCER RES, V65, P9073, DOI 10.1158/0008-5472.CAN-05-2016; Yang L, 2010, BIOCHEM BIOPH RES CO, V402, P129, DOI 10.1016/j.bbrc.2010.09.129; Zhang Haitao, 2005, Cancer Genomics & Proteomics, V2, P97; Zhu ZJ, 2002, CANCER RES, V62, P156	50	24	27	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3927	3938		10.1038/onc.2013.361	http://dx.doi.org/10.1038/onc.2013.361			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	23995784	Green Published, hybrid			2022-12-25	WOS:000339394700005
J	Tsuchida, R; Osawa, T; Wang, F; Nishii, R; Das, B; Tsuchida, S; Muramatsu, M; Takahashi, T; Inoue, T; Wada, Y; Minami, T; Yuasa, Y; Shibuya, M				Tsuchida, R.; Osawa, T.; Wang, F.; Nishii, R.; Das, B.; Tsuchida, S.; Muramatsu, M.; Takahashi, T.; Inoue, T.; Wada, Y.; Minami, T.; Yuasa, Y.; Shibuya, M.			BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors	ONCOGENE			English	Article						Bone Morphogenetic Protein 4 (BMP4); Thrombospondin-1 (TSP1); angiogenesis; tumor microenvironment; tumor endothelial cells; vascular endothelial growth factor (VEGF)	BONE MORPHOGENETIC PROTEIN-4; SIDE-POPULATION FRACTION; EMBRYONIC STEM-CELLS; ENDOTHELIAL-CELLS; CANCER-CELLS; SIGNALING PATHWAY; DOWN-REGULATION; BMP4; APOPTOSIS; EXPRESSION	Bone morphogenetic protein 4 (BMP4) has potential as an anticancer agent. Recent studies have suggested that BMP4 inhibits the survival of cancer stem cells (CSCs) of neural and colon cancers. Here, we showed that BMP4 paracrinically inhibited tumor angiogenesis via the induction of Thrombospondin-1 (TSP1), and consequently suppressed tumor growth in vivo. Although HeLa (human cervical cancer), HCl-H460-LNM35 (highly metastatic human lung cancer) and B16 (murine melanoma) cells did not respond to the BMP4 treatment in vitro, the growth of xeno- and allografts of these cells was suppressed via reductions in tumor angiogenesis after intraperitoneal treatment with BMP4. When we assessed the mRNA expression of major angiogenesis-related factors in grafted tumors, we found that the expression of TSP1 was significantly upregulated by BMP4 administration. We then confirmed that BMP4 was less effective in suppressing the tumor growth of TSP1-knockdown cancer cells. Furthermore, we found that BMP4 reduced vascular endothelial growth factor (VEGF) expression in vivo in a TSP1-dependent manner, which indicates that BMP4 interfered with the stabilization of tumor angiogenesis. In conclusion, the BMP4/TSP1 loop paracrinically suppressed tumor angiogenesis in the tumor microenvironment, which subsequently reduced the growth of tumors. BMP4 may become an antitumor agent and open a new field of antiangiogenic therapy.	[Tsuchida, R.; Osawa, T.; Wang, F.; Nishii, R.; Tsuchida, S.; Muramatsu, M.; Yuasa, Y.; Shibuya, M.] Tokyo Med & Dent Univ, Dept Mol Oncol, Tokyo, Japan; [Tsuchida, R.; Nishii, R.] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Osawa, T.; Inoue, T.; Wada, Y.; Minami, T.] Univ Tokyo, RCAST, Lab Syst Biol & Med, Tokyo, Japan; [Wang, F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Das, B.] Stanford Univ, Sch Med, Dept Pathol & Med, Div Oncol, Stanford, CA 94305 USA; [Tsuchida, S.] Tokyo Univ Hosp, Dept Pediat, Tokyo 113, Japan; [Muramatsu, M.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Takahashi, T.] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi 4648601, Japan; [Shibuya, M.] Jobu Univ, Inst Physiol & Med, Takasaki, Gunma, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; Memorial Sloan Kettering Cancer Center; Stanford University; University of Tokyo; Roswell Park Cancer Institute; Nagoya University	Tsuchida, R (corresponding author), Tokyo Med & Dent Univ, Dept Pediat, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	rtsuped@tmd.ac.jp; shibuya@ims.u-tokyo.ac.jp	Takahashi, Takashi/I-7262-2014; Das, Bikul/ABF-9292-2020; Wang, Feng/Q-7386-2017; Nishii, Rina/AAC-4177-2022	Takahashi, Takashi/0000-0003-0615-7001; 	Japan Society for the Promotion of Science [22-400024]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [17014020];  [23701047];  [24116509]; Grants-in-Aid for Scientific Research [23701047, 24116509] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Takashi Koda and Ms Kiyomi Kaneki for assisting in analysis of microarray data, Mr Daichi Yamanaka for operating of FACS sorting and Ms Shigeko Shimizu for preparing of immunohistochemistry. RT is a Research Fellow of the Japan Society of the Promotion of Science. This work was supported by the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (22-400024), Grant-in-Aid for Young Scientist (23701047), Grant-in-Aid for Scientific Research on Innovative Areas (24116509), the Takeda Science Foundation and a Grant-in-Aid Special Project Research on Cancer-Bioscience (17014020) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Chiu CY, 2012, MOL CANCER RES, V10, P415, DOI 10.1158/1541-7786.MCR-11-0293; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5; Farnsworth RH, 2011, CANCER RES, V71, P6547, DOI 10.1158/0008-5472.CAN-11-0200; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gee MFW, 2005, ONCOGENE, V24, P8025, DOI 10.1038/sj.onc.1208939; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Guo NH, 1997, CANCER RES, V57, P1735; Guo W, 1999, CLIN ORTHOP RELAT R, P175; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Haubold M, 2010, INT J BIOL SCI, V6, P700; Hayashi S, 2008, AM J MED GENET A, V146A, P2905, DOI 10.1002/ajmg.a.32519; Heinke J, 2007, CARDIOVASC RES, V76, P390, DOI 10.1016/j.cardiores.2007.08.003; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Iantosca MR, 1999, J NEUROSCI RES, V56, P248; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kim IY, 2004, CANCER RES, V64, P7355, DOI 10.1158/0008-5472.CAN-04-0154; Kiyono M, 2006, ONCOGENE, V25, P7131, DOI 10.1038/sj.onc.1209700; Kiyono M, 2003, MOL CELL BIOL, V23, P4627, DOI 10.1128/MCB.23.13.4627-4636.2003; Komuro A, 2009, JNCI-J NATL CANCER I, V101, P592, DOI 10.1093/jnci/djp058; Kozaki K, 2000, CANCER RES, V60, P2535; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Moreno-Miralles I, 2011, ARTERIOSCL THROM VAS, V31, P2216, DOI 10.1161/ATVBAHA.111.230235; Muramatsu M, 2010, CANCER RES, V70, P8211, DOI 10.1158/0008-5472.CAN-10-0202; Nishanian TG, 2004, CANCER BIOL THER, V3, P667; Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733; Osawa T, 2011, P NATL ACAD SCI USA, V108, P20725, DOI 10.1073/pnas.1108462109; Osawa T, 2009, CANCER SCI, V100, P844, DOI 10.1111/j.1349-7006.2009.01105.x; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rothhammer T, 2008, EUR J CANCER, V44, P2526, DOI 10.1016/j.ejca.2008.07.029; Sarnat HB, 2005, J CHILD NEUROL, V20, P637, DOI 10.1177/08830738050200080101; Shepherd TG, 2008, GENE, V414, P95, DOI 10.1016/j.gene.2008.02.015; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Su DM, 2009, J BIOL CHEM, V284, P12153, DOI 10.1074/jbc.M807930200; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Tsuchida R, 2008, ONCOGENE, V27, P3923, DOI 10.1038/onc.2008.38; Wang F, 2011, CANCER SCI, V102, P2007, DOI 10.1111/j.1349-7006.2011.02065.x; Wang F, 2011, J BIOL CHEM, V286, P9097, DOI 10.1074/jbc.M110.165605; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamauchi M, 2007, CANCER SCI, V98, P1491, DOI 10.1111/j.1349-7006.2007.00534.x; Zaslavsky A, 2010, MOL CANCER RES, V8, P1198, DOI 10.1158/1541-7786.MCR-10-0047; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408; Zhou ZM, 2011, CANCER BIOTHER RADIO, V26, P77, DOI 10.1089/cbr.2010.0857	50	29	31	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3803	3811		10.1038/onc.2013.358	http://dx.doi.org/10.1038/onc.2013.358			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	24013228	Bronze			2022-12-25	WOS:000339394100006
J	Ghionzoli, M; Repele, A; Sartiani, L; Costanzi, G; Parenti, A; Spinelli, V; David, AL; Garriboli, M; Totonelli, G; Tian, J; Andreadis, ST; Cerbai, E; Mugelli, A; Messineo, A; Pierro, A; Eaton, S; De Coppi, P				Ghionzoli, Marco; Repele, Andrea; Sartiani, Laura; Costanzi, Giulia; Parenti, Astrid; Spinelli, Valentina; David, Anna L.; Garriboli, Massimo; Totonelli, Giorgia; Tian, Jun; Andreadis, Stelios T.; Cerbai, Elisabetta; Mugelli, Alessandro; Messineo, Antonio; Pierro, Agostino; Eaton, Simon; De Coppi, Paolo			Human amniotic fluid stem cell differentiation along smooth muscle lineage	FASEB JOURNAL			English	Article						tissue engineering; myogenic; regenerative medicine; fetal cells; multipotent	PROGENITOR CELLS; BONE-MARROW; ACTIN EXPRESSION; BLOOD-VESSELS; TGF-BETA; IN-VITRO; CONTRACTION; BLADDER; CHANNELS; DERIVATION	Functional smooth muscle engineering requires isolation and expansion of smooth muscle cells (SMCs), and this process is particularly challenging for visceral smooth muscle tissue where progenitor cells have not been clearly identified. Herein we showed for the first time that efficient SMCs can be obtained from human amniotic fluid stem cells (hAFSCs). Clonal lines were generated from c-kit(+) hAFSCs. Differentiation toward SM lineage (SMhAFSCs) was obtained using a medium conditioned by PDGF-BB and TGF-beta 1. Molecular assays revealed higher level of alpha smooth muscle actin (alpha-SMA), desmin, calponin, and smoothelin in SMhAFSCs when compared to hAFSCs. Ultrastructural analysis demonstrated that SMhAFSCs also presented in the cytoplasm increased intermediate filaments, dense bodies, and glycogen deposits like SMCs. SMhAFSC metabolism evaluated via mass spectrometry showed higher glucose oxidation and an enhanced response to mitogenic stimuli in comparison to hAFSCs. Patch clamp of transduced hAFSCs with lentiviral vectors encoding ZsGreen under the control of the alpha-SMA promoter was performed demonstrating that SMhAFSCs retained a smooth muscle cell-like electro-physiological fingerprint. Eventually SMhAFSCs contractility was evident both at single cell level and on a collagen gel. In conclusion, we showed here that hAFSCs under selective culture conditions are able to give rise to functional SMCs.	[Ghionzoli, Marco; Repele, Andrea; Costanzi, Giulia; Garriboli, Massimo; Totonelli, Giorgia; Pierro, Agostino; Eaton, Simon; De Coppi, Paolo] UCL, Inst Child Hlth, Surg Unit, London, England; [David, Anna L.] UCL, Inst Womens Hlth, Prenatal Cell & Gene Therapy Grp, London, England; [Ghionzoli, Marco; Repele, Andrea; Costanzi, Giulia; Garriboli, Massimo; Totonelli, Giorgia; Pierro, Agostino; Eaton, Simon; De Coppi, Paolo] Great Ormond St Hosp Sick Children, London, England; [Sartiani, Laura; Parenti, Astrid; Spinelli, Valentina; Cerbai, Elisabetta; Mugelli, Alessandro] Univ Florence, Dept Pharmacol, Florence, Italy; [Ghionzoli, Marco; Messineo, Antonio] Univ Florence, Dept Pediat Surg, Florence, Italy; [Tian, Jun; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Florence; University of Florence; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	De Coppi, P (corresponding author), UCL Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	p.decoppi@ucl.ac.uk	Cerbai, Elisabetta/J-2663-2013; Sartiani, Laura/ABF-5576-2020; Totonelli, Giorgia/AAH-9253-2019; Sartiani, Laura/M-1364-2015; Garriboli, Massimo/AFN-3851-2022	Cerbai, Elisabetta/0000-0001-7839-1361; Sartiani, Laura/0000-0002-4208-0913; Sartiani, Laura/0000-0002-4208-0913; Garriboli, Massimo/0000-0001-5377-3849; David, Anna/0000-0002-0199-6140; De Coppi, Paolo/0000-0002-1659-0207; spinelli, valentina/0000-0002-4910-0243; Parenti, Astrid/0000-0002-7980-6853; messineo, antonio/0000-0002-9789-843X; Ghionzoli, Marco/0000-0002-3128-737X; Eaton, Simon/0000-0003-0892-9204; spinelli, valentina/0000-0001-6083-6983	Fondazione Citta della Speranza; Fondazione Meyer Firenze; Ministero dell'Istruzione; dell'Universita e delle Ricerca (Rome, Italy); Great Osmond Street Hospital (GOSH) Charity (London, UK); GOSH Charity; University College London/University College London Hospitals from the UK Department of Health National Institute for Health Research Biomedical Research Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086582] Funding Source: NIH RePORTER	Fondazione Citta della Speranza; Fondazione Meyer Firenze; Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e delle Ricerca (Rome, Italy); Great Osmond Street Hospital (GOSH) Charity (London, UK); GOSH Charity; University College London/University College London Hospitals from the UK Department of Health National Institute for Health Research Biomedical Research Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Bertrand Vernay for assistance with time lapse microscopy, Ayad Eddaoudi for his valuable help in cell sorting, Dr. Sara Paccosi and Dr. Claudia Musilli for their support with cell cultures, and Dr. Pedro Lei and Dr. Waseem Qasim for their support with transduction. This work has been supported by Fondazione Citta della Speranza, Fondazione Meyer Firenze, Ministero dell'Istruzione, dell'Universita e delle Ricerca (Rome, Italy; PRIN 2010-11), and the Great Osmond Street Hospital (GOSH) Charity (London, UK). P. D. C. is supported by the GOSH Charity. A. L. D. is supported at University College London/University College London Hospitals by funding from the UK Department of Health National Institute for Health Research Biomedical Research Centre's funding scheme.	Aikawa M, 1997, CIRCULATION, V96, P82; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bollini S, 2011, STEM CELLS DEV, V20, P1985, DOI 10.1089/scd.2010.0424; Bonnet P, 2008, STEM CELLS DEV, V17, P1131, DOI 10.1089/scd.2007.0219; Coco DP, 2009, AM J SURG PATHOL, V33, P1795, DOI 10.1097/PAS.0b013e3181b76477; Crescioli C, 2005, J CLIN ENDOCR METAB, V90, P962, DOI 10.1210/jc.2004-1496; De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; DELAFOSSE B, 1994, AM J PHYSIOL-ENDOC M, V267, pE775, DOI 10.1152/ajpendo.1994.267.5.E775; Ehrlich HP, 2000, J CELL PHYSIOL, V182, P303, DOI 10.1002/(SICI)1097-4652(200002)182:2<303::AID-JCP20>3.0.CO;2-H; Gabella G, 2002, RES PRO CEL, V38, P1; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Huber A, 2012, J TISSUE ENG REGEN M, V6, P505, DOI 10.1002/term.451; Huet E, 2008, FASEB J, V22, P1144, DOI 10.1096/fj.07-8748com; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b; Liu JY, 2008, CARDIOVASC RES, V79, P24, DOI 10.1093/cvr/cvn059; Liu JY, 2007, CARDIOVASC RES, V75, P618, DOI 10.1016/j.cardiores.2007.04.018; Liu JY, 2010, TISSUE ENG PT A, V16, P2553, DOI [10.1089/ten.tea.2009.0833, 10.1089/ten.TEA.2009.0833]; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Merkulova-Rainon T, 2012, CARDIOVASC RES, V95, P205, DOI 10.1093/cvr/cvs097; Miano JM, 2002, RES PRO CEL, V38, P39; Mistry DK, 1998, BRIT J PHARMACOL, V124, P1131, DOI 10.1038/sj.bjp.0701940; Nakase Y, 2008, J THORAC CARDIOV SUR, V136, P850, DOI 10.1016/j.jtcvs.2008.05.027; Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Peng HF, 2011, TISSUE ENG PT A, V17, P981, DOI [10.1089/ten.tea.2010.0109, 10.1089/ten.TEA.2010.0109]; Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Sala FG, 2009, J SURG RES, V156, P205, DOI 10.1016/j.jss.2009.03.062; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Snetkov VA, 1998, PEDIATR RES, V43, P548, DOI 10.1203/00006450-199804000-00019; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; THYBERG J, 1995, CELL TISSUE RES, V281, P421; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; vanderLoop FTL, 1996, J CELL BIOL, V134, P401, DOI 10.1083/jcb.134.2.401; Wade GR, 1999, AM J PHYSIOL-GASTR L, V277, pG885, DOI 10.1152/ajpgi.1999.277.4.G885; Wang AJ, 2012, CELLS TISSUES ORGANS, V195, P5, DOI 10.1159/000331412; Wang C., TISSUE ENG A, V16, P1201; Wang Q, 1996, AM J PHYSIOL-CELL PH, V271, pC1725, DOI 10.1152/ajpcell.1996.271.5.C1725; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Yang Y, 1999, DEVELOPMENT, V126, P3027	59	26	27	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4853	4865		10.1096/fj.12-218578	http://dx.doi.org/10.1096/fj.12-218578			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23995291	Green Published			2022-12-25	WOS:000329999000020
J	Bloem, E; van den Biggelaar, M; Wroblewska, A; Voorberg, J; Faber, JH; Kjalke, M; Stennicke, HR; Mertens, K; Meijer, AB				Bloem, Esther; van den Biggelaar, Maartje; Wroblewska, Aleksandra; Voorberg, Jan; Faber, Johan H.; Kjalke, Marianne; Stennicke, Henning R.; Mertens, Koen; Meijer, Alexander B.			Factor VIII C1 Domain Spikes 2092-2093 and 2158-2159 Comprise Regions That Modulate Cofactor Function and Cellular Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; RECEPTOR-RELATED PROTEIN; VON-WILLEBRAND-FACTOR; HUMAN-FACTOR-V; EXCHANGE MASS-SPECTROMETRY; FACTOR-IX; CRYSTAL-STRUCTURE; HEMOPHILIA-A; C2 DOMAIN; FACTOR-X	The C1 domain of factor VIII (FVIII) has been implicated in binding to multiple constituents, including phospholipids, von Willebrand factor, and low-density lipoprotein receptor-related protein (LRP). We have previously described a human monoclonal antibody called KM33 that blocks these interactions as well as cellular uptake by LRP-expressing cells. To unambiguously identify the apparent "hot spot" on FVIII to which this antibody binds, we have employed hydrogen-deuterium exchange mass spectrometry. The results showed that KM33 protects FVIII regions 2091-2104 and 2157-2162 from hydrogen-deuterium exchange. These comprise the two C1 domain spikes 2092-2093 and 2158-2159. Spike 2092-2093 has been demonstrated recently to contribute to assembly with lipid membranes with low phosphatidylserine (PS) content. Therefore, spike 21582159 might serve a similar role. This was assessed by replacement of Arg-2159 for Asn, which introduces a motif for N-linked glycosylation. Binding studies revealed that the purified, glycosylated R2159N variant had lost its interaction with antibody KM33 but retained substantial binding to von Willebrand factor and LRP. Cellular uptake of the R2159N variant was reduced both by LRP-expressing U87-MG cells and by human monocyte derived dendritic cells. FVIII activity was virtually normal on membranes containing 15% PS but reduced at low PS content. These findings suggest that the C1 domain spikes 2092-2093 and 2158-2159 together modulate FVIII membrane assembly by a subtle, PS-dependent mechanism. These findings contribute evidence in favor of an increasingly important role of the C1 domain in FVIII biology.	[Bloem, Esther; van den Biggelaar, Maartje; Wroblewska, Aleksandra; Voorberg, Jan; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Faber, Johan H.; Kjalke, Marianne; Stennicke, Henning R.] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, NL-3584 CG Utrecht, Netherlands	Novo Nordisk; Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl		Wroblewska, Aleksandra/0000-0003-2059-6158; Voorberg, Jan/0000-0003-4585-2621				Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Andersen MD, 2011, INT J MASS SPECTROM, V302, P139, DOI 10.1016/j.ijms.2010.09.010; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fribourg C, 2006, BIOCHEMISTRY-US, V45, P10777, DOI 10.1021/bi060451h; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; HOYER LW, 1994, NEW ENGL J MED, V330, P38, DOI 10.1056/NEJM199401063300108; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; Kim SW, 1999, BIOCHEMISTRY-US, V38, P11448, DOI 10.1021/bi991275y; LENTING PJ, 1995, J BIOL CHEM, V270, P14884, DOI 10.1074/jbc.270.25.14884; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; Liu ML, 2000, BLOOD, V96, P979, DOI 10.1182/blood.V96.3.979.015k42a_979_987; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Meems H., 2011, THESIS UTRECHT U; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Scharrer I, 1999, HAEMOPHILIA, V5, P145; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Stel H. V., 1984, THESIS U AMSTERDAM; Stoilova-McPhie S, 2002, BLOOD, V99, P1215, DOI 10.1182/blood.V99.4.1215; Thim L, 2010, HAEMOPHILIA, V16, P349, DOI 10.1111/j.1365-2516.2009.02135.x; Van den Biggelaar M, 2007, J THROMB HAEMOST, V5, P2235, DOI 10.1111/j.1538-7836.2007.02737.x; van den Biggelaar M, 2011, J THROMB HAEMOST, V9, P821; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van den Brink EN, 2001, BLOOD, V97, P966, DOI 10.1182/blood.V97.4.966; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wroblewska A, 2012, BLOOD, V119, P5294, DOI 10.1182/blood-2011-11-391680	41	38	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29670	29679		10.1074/jbc.M113.473116	http://dx.doi.org/10.1074/jbc.M113.473116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24009077	hybrid, Green Published			2022-12-25	WOS:000330615300042
J	Li, HP; Zhong, M; Guo, W; Zhuang, DM; Li, L; Liu, YJ; Bao, ZY; Liu, SY; Wang, XL; Li, TY; Yang, SM; Li, JY				Li, Hanping; Zhong, Min; Guo, Wei; Zhuang, Daomin; Li, Lin; Liu, Yongjian; Bao, Zuoyi; Liu, Siyang; Wang, Xiaolin; Li, Tianyi; Yang, Shaomin; Li, Jingyun			Prevalence and Mutation Patterns of HIV Drug Resistance from 2010 to 2011 among ART-Failure Individuals in the Yunnan Province, China	PLOS ONE			English	Article							METHADONE-MAINTENANCE TREATMENT; ANTIRETROVIRAL THERAPY; BLOOD-DONORS; RISK-FACTORS; USERS; HIV/AIDS; INFECTION; TRANSMISSION; REPLICATION; COMMUNITY	Background: Assessing the prevalence of HIV-1 drug-resistance and the mutation patterns associated with resistance in the geographical regions implementing free antiretroviral therapy (ART) in China is necessary for preventing the spread of resistant strains and designing the regimens for the subsequent therapies with limited resources. Methods: Plasma samples in different cities/prefectures were collected at Yunnan Provincial Hospital of Infectious Disease from January 2010 to December 2011. Genotyping of drug-resistant individuals was conducted using an in-house assay on plasma samples. Viral load, CD4 T cell counts and demographic data were obtained from medical records and an administered questionnaire. Results: A total of 609 pol sequences (515 ART-failure and 94 therapy-naive individuals) derived from 664 samples were obtained. The prevalence of drug-resistance was 45.1% in the ART-failure individuals. Of these, 26.8% harbored HIV strains dually resistant to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors, and 14.8% harbored HIV strains resistant to only one drug category. Mutations such as M184V/I, K103N, V106A, Y181C and G190A were common among the ART-failure individuals, and the frequencies of M184V/I, K103N and V106A were 28.2%, 19.2%, and 22.1%, respectively. The percentages of individuals exhibiting intermediate or high-level resistance to 3TC, FTC, EFV and NVP drugs were 28.4%, 28.2%, 37.3%, and 37.5%, respectively. Factors such as ethnicity, transmission route, CD4 counts, viral load and the duration of ART were significantly correlated with development of drug resistance in the ART-failure individuals. Conclusions: The high prevalence of HIV drug-resistance observed among the ART-failure individuals from 2010 to 2011 in Yunnan province should be of increasing concern in regions where the implementation of ART is widespread. Education about the risk factors associated with HIV drug resistance is important for preventing and controlling the spread of HIV drug-resistant strains.	[Li, Hanping; Guo, Wei; Zhuang, Daomin; Li, Lin; Liu, Yongjian; Bao, Zuoyi; Liu, Siyang; Wang, Xiaolin; Li, Tianyi; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhong, Min; Yang, Shaomin] Yunnan Prov Hosp Infect Dis, Kunming, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn			National Natural Science Foundation [30800938, 30830088]; National Key S & T Special Projects on Major Infectious Disease [2012ZX10001-002, 2008ZX10001-004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key S & T Special Projects on Major Infectious Disease	This work was supported by The National Natural Science Foundation grant (30800938,30830088) (http://www.nsfc.gov.cn/Portal0/default152.htm) and The National Key S & T Special Projects on Major Infectious Disease grant (2012ZX10001-002,2008ZX10001-004)(http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SYP, 2007, AIDS CARE, V19, P1, DOI 10.1080/09540120600900496; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Deng R, 2007, SOC SCI MED, V64, P1560, DOI 10.1016/j.socscimed.2006.12.011; Fu ZH, 2011, AIDS BEHAV, V15, P1017, DOI 10.1007/s10461-010-9797-6; Gong Jian, 2011, Virologica Sinica, V26, P386, DOI 10.1007/s12250-011-3210-0; Imamichi T, 2000, J VIROL, V74, P10958, DOI 10.1128/JVI.74.23.10958-10964.2000; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Julias JG, 2004, VIROLOGY, V322, P13, DOI 10.1016/j.virol.2004.01.004; Li J, 2011, ADDICTION, V106, P1780, DOI 10.1111/j.1360-0443.2011.03459.x; Li JY, 2005, CELL RES, V15, P843, DOI 10.1038/sj.cr.7290356; Liao LJ, 2012, CLIN INFECT DIS, V54, pS320, DOI 10.1093/cid/cir1016; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Luo L, 2011, CHINESE MED J-PEKING, V124, P440, DOI 10.3760/cma.j.issn.0366-6999.2011.03.022; Ma WJ, 2010, BIOMED ENVIRON SCI, V23, P287, DOI 10.1016/S0895-3988(10)60065-7; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Mills EJ, 2012, AIDS, V26, P1425, DOI 10.1097/QAD.0b013e328354bf43; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; Slesak G, 2012, INT J STD AIDS, V23, P570, DOI 10.1258/ijsa.2012.011416; SUN XH, 1994, AIDS, V8, pS55; Tu YQ, 2009, TRANSFUSION, V49, P1865, DOI 10.1111/j.1537-2995.2009.02219.x; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209; Wang SY, 2005, ANN OPER RES, V135, P17, DOI 10.1007/s10479-005-6231-y; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Wu F, 2010, CHINESE MED J-PEKING, V123, P1011, DOI 10.3760/cma.j.issn.0366-6999.2010.08.007; XIA MS, 1994, AIDS, V8, P1701, DOI 10.1097/00002030-199412000-00010; Xiao L, 2010, JAIDS-J ACQ IMM DEF, V53, pS116, DOI 10.1097/QAI.0b013e3181c7dfb5; Xing Y, 2012, AIDS CARE, V24, P756, DOI 10.1080/09540121.2011.630359; Yang F, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-3; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang KL, 2011, PUBLIC HEALTH, V125, P266, DOI 10.1016/j.puhe.2011.01.008; Zhang L, 2008, TROP MED INT HEALTH, V13, P814, DOI 10.1111/j.1365-3156.2008.02071.x; Zhang ZH, 2012, SEX TRANSM DIS, V39, P930, DOI 10.1097/OLQ.0b013e318272c497; Zhao Y, 2011, JAIDS-J ACQ IMM DEF, V58, P47, DOI 10.1097/QAI.0b013e318229f2a2	35	20	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72630	10.1371/journal.pone.0072630	http://dx.doi.org/10.1371/journal.pone.0072630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009694	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600031
J	Li, JR; Schneider, KA; Li, HP				Li, Junrui; Schneider, Kristan A.; Li, Haipeng			The Hitchhiking Effect of a Strongly Selected Substitution in Male Germline on Neutral Polymorphism in a Monogamy Population	PLOS ONE			English	Article							RAPID EVOLUTION; FERTILITY; GENES; ADVANTAGE	Comparative genomic studies suggest that a huge number of genes that show the strongest evidence for positive selection in human are testis- or sperm-specific genes, which are possibly due to germline selection. We propose a novel selection model in which the germlines of heterozygous males in a monogamous population are under natural selection. Under this model, we study the dynamics of a strongly selected substitution in the male germline and its hitch-hiking effect on the preexisting linked neutral polymorphism. We show that the expected heterozygosity at the neural locus is reduced by 8c/s (alpha/4)(-8c/s) Gamma(-8c/s, 4/alpha), where c is the recombination rate between selected and neutral locus, s is selective coefficient of advantageous allele, alpha = 2Ns and N is diploid effective population size.	[Li, Haipeng] Chinese Acad Sci, CAS MPG Parter Inst Computat Biol, Lab Evolutionary Genom, CAS Key Lab Computat Biol, Shanghai, Peoples R China; [Li, Junrui] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Schneider, Kristan A.] Univ Appl Sci, Mittweida, Germany; [Schneider, Kristan A.] Univ Vienna, Dept Math, Vienna, Austria	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Vienna	Li, HP (corresponding author), Chinese Acad Sci, CAS MPG Parter Inst Computat Biol, Lab Evolutionary Genom, CAS Key Lab Computat Biol, Shanghai, Peoples R China.	lihaipeng@picb.ac.cn		Schneider, Kristan/0000-0003-4138-1180	Basic Research Program of China (973 project) [2012CB316505]; National Natural Science Foundation of China [31172073, 91131010]	Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Basic Research Program of China (973 project, No. 2012CB316505) and the National Natural Science Foundation of China (31172073 and 91131010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkhead TR, 1998, SPERM COMPETITION SE; Chevin LM, 2006, GENETICS, V173, P1829, DOI 10.1534/genetics.105.052977; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; Chow CY, 2010, GENETICS, V186, P1355, DOI 10.1534/genetics.110.123174; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; FELDMAN MW, 1983, GENETICS, V105, P1003; Franck P, 1999, INSECT MOL BIOL, V8, P419, DOI 10.1046/j.1365-2583.1999.83131.x; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; HADELER KP, 1975, J MATH BIOL, V2, P19, DOI 10.1007/BF00276013; HEISLER IL, 1990, EVOLUTION, V44, P1164, DOI 10.1111/j.1558-5646.1990.tb05223.x; KAPLAN NL, 1989, GENETICS, V123, P887; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; KURTZ TG, 1970, J APPL PROBAB, V7, P49, DOI 10.2307/3212147; Meiklejohn CD, 2010, TRENDS ECOL EVOL, V25, P215, DOI 10.1016/j.tree.2009.10.005; Metz EC, 1998, P NATL ACAD SCI USA, V95, P10676, DOI 10.1073/pnas.95.18.10676; Moller AP., 1998, SPERM COMPETITION SE; NAGYLAKI T, 1987, GENETICS, V115, P367; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; OHTA T, 1975, GENET RES, V25, P313, DOI 10.1017/S0016672300015731; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pujolar JM, 2011, MOL ECOL, V20, P4968, DOI 10.1111/j.1365-294X.2011.05336.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Teshima KM, 2006, GENETICS, V172, P713, DOI 10.1534/genetics.105.044065; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110	29	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71497	10.1371/journal.pone.0071497	http://dx.doi.org/10.1371/journal.pone.0071497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015187	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800009
J	Zorrilla, EP; Roberts, AJ; Rivier, JE; Koob, GF				Zorrilla, Eric P.; Roberts, Amanda J.; Rivier, Jean E.; Koob, George F.			Anxiolytic-Like Effects of Antisauvagine-30 in Mice Are Not Mediated by CRF2 Receptors	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DORSAL RAPHE NUCLEUS; ANXIETY-RELATED BEHAVIOR; RAT CENTRAL AMYGDALA; REDUCES FOOD-INTAKE; TYPE-2 RECEPTORS; HORMONE RECEPTOR-2; SEROTONERGIC NEURONS; FACTOR-2 RECEPTORS; MOTOR-ACTIVITY	The role of brain corticotropin-releasing factor type 2 (CRF2) receptors in behavioral stress responses remains controversial. Conflicting findings suggest pro-stress, anti-stress or no effects of impeding CRF2 signaling. Previous studies have used antisauvagine-30 as a selective CRF2 antagonist. The present study tested the hypotheses that 1) potential anxiolytic-like actions of intracerebroventricular (i.c.v.) administration of antisauvagine-30 also are present in mice lacking CRF2 receptors and 2) potential anxiolytic-like effects of antisauvagine-30 are not shared by the more selective CRF2 antagonist astressin(2)-B. Cannulated, male CRF2 receptor knockout (n = 22) and wildtype littermate mice (n = 21) backcrossed onto a C57BL/6J genetic background were tested in the marble burying, elevated plus-maze, and shock-induced freezing tests following pretreatment (i.c.v.) with vehicle, antisauvagine-30 or astressin(2)-B. Antisauvagine-30 reduced shock-induced freezing equally in wildtype and CRF2 knockout mice. In contrast, neither astressin(2)-B nor CRF2 genotype influenced shock-induced freezing. Neither CRF antagonist nor CRF2 genotype influenced anxiety-like behavior in the plus-maze or marble burying tests. A literature review showed that the typical antisauvagine-30 concentration infused in previous intracranial studies (similar to 1 mM) was 3 orders greater than its IC50 to block CRF1-mediated cAMP responses and 4 orders greater than its binding constants (K-d, K-i) for CRF1 receptors. Thus, increasing, previously used doses of antisauvagine-30 also exert non-CRF2-mediated effects, perhaps via CRF1. The results do not support the hypothesis that brain CRF2 receptors tonically promote anxiogenic-like behavior. Utilization of CRF2 antagonists, such as astressin(2)-B, at doses that are more subtype-selective, can better clarify the significance of brain CRF2 systems in stress-related behavior.	[Zorrilla, Eric P.; Koob, George F.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA; [Roberts, Amanda J.] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Rivier, Jean E.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Rivier, Jean E.] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Zorrilla, Eric P.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego	Zorrilla, EP (corresponding author), Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA.	ezorrilla@scripps.edu; gkoob@scripps.edu	fathi, mazyar/H-1722-2016		National Institutes of Health [DK026741, DK070118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070118, P01DK026741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grants DK026741 and DK070118. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2004, NEUROSCIENCE, V129, P509, DOI 10.1016/j.neuroscience.2004.07.052; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bledsoe AC, 2011, BRAIN RES BULL, V85, P117, DOI 10.1016/j.brainresbull.2011.03.003; Brauns O, 2002, PEPTIDES, V23, P881, DOI 10.1016/S0196-9781(02)00014-1; Brauns O, 2001, NEUROPHARMACOLOGY, V41, P507, DOI 10.1016/S0028-3908(01)00094-6; Chance WT, 2007, LIFE SCI, V80, P1064, DOI 10.1016/j.lfs.2006.11.047; Chen CY, 2005, GASTROENTEROLOGY, V129, P8, DOI 10.1053/j.gastro.2005.04.015; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; Cooper MA, 2007, PSYCHOPHARMACOLOGY, V194, P297, DOI 10.1007/s00213-007-0849-1; Cooper MA, 2010, PHYSIOL BEHAV, V101, P527, DOI 10.1016/j.physbeh.2010.08.003; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Cullen MJ, 2001, ENDOCRINOLOGY, V142, P992, DOI 10.1210/en.142.3.992; Della-Zuana O, 2004, INT J OBESITY, V28, P628, DOI 10.1038/sj.ijo.0802435; Dockstader CL, 2001, J NEUROSCI, V21, P9077, DOI 10.1523/JNEUROSCI.21-22-09077.2001; Fekete EM, 2007, NEUROPSYCHOPHARMACOL, V32, P1052, DOI 10.1038/sj.npp.1301214; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Forster GL, 2008, EUR J NEUROSCI, V28, P299, DOI 10.1111/j.1460-9568.2008.06333.x; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gutknecht E, 2008, J NEUROCHEM, V104, P926, DOI 10.1111/j.1471-4159.2007.05052.x; Hammack SE, 2003, J NEUROSCI, V23, P1019; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Higelin J, 2001, NEUROPHARMACOLOGY, V40, P114, DOI 10.1016/S0028-3908(00)00105-2; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; KALIN NH, 1988, BRAIN RES, V457, P130, DOI 10.1016/0006-8993(88)90064-9; Kishimoto T, 2000, NAT GENET, V24, P415, DOI 10.1038/74271; Lam MP, 2011, PSYCHOPHARMACOLOGY, V218, P229, DOI 10.1007/s00213-011-2337-x; Lam MP, 2011, ALCOHOL, V45, P621, DOI 10.1016/j.alcohol.2011.05.001; Lukkes JL, 2008, EUR J PHARMACOL, V578, P185, DOI 10.1016/j.ejphar.2007.09.024; Maruyama H, 2007, NEUROENDOCRINOLOGY, V86, P1, DOI 10.1159/000103556; Miragaya JR, 2008, AM J PHYSIOL-REG I, V295, pR404, DOI 10.1152/ajpregu.00565.2007; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ohata H, 2004, PEPTIDES, V25, P1703, DOI 10.1016/j.peptides.2004.05.023; Ohata H, 2011, NEUROREPORT, V22, P494, DOI 10.1097/WNR.0b013e3283487467; Pelleymounter MA, 2000, J PHARMACOL EXP THER, V293, P799; Pelleymounter MA, 2002, J PHARMACOL EXP THER, V302, P145, DOI 10.1124/jpet.302.1.145; Radulovic J, 1999, J NEUROSCI, V19, P5016; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Risbrough VB, 2003, PSYCHOPHARMACOLOGY, V170, P178, DOI 10.1007/s00213-003-1535-6; Risbrough VB, 2004, J NEUROSCI, V24, P6545, DOI 10.1523/JNEUROSCI.5760-03.2004; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Rodgers RJ, 2002, PHYSIOL BEHAV, V77, P301, DOI 10.1016/S0031-9384(02)00856-9; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Sahuque LL, 2006, PSYCHOPHARMACOLOGY, V186, P122, DOI 10.1007/s00213-006-0362-y; Sananbenesi F, 2003, J NEUROSCI, V23, P11436; Scholl JL, 2010, EUR J PHARMACOL, V644, P80, DOI 10.1016/j.ejphar.2010.07.008; Sekino A, 2004, PSYCHOPHARMACOLOGY, V176, P30, DOI 10.1007/s00213-004-1863-1; Staub DR, 2006, BRAIN RES, V1070, P77, DOI 10.1016/j.brainres.2005.10.096; Sutherland JE, 2011, NEUROPHARMACOLOGY, V60, P561, DOI 10.1016/j.neuropharm.2010.12.022; Takahashi C, 2011, PEPTIDES, V32, P2384, DOI 10.1016/j.peptides.2011.09.016; Takahashi LK, 2001, BRAIN RES, V902, P135, DOI 10.1016/S0006-8993(01)02405-2; Tanaka M, 2011, BRAIN RES BULL, V84, P414, DOI 10.1016/j.brainresbull.2011.01.016; Tanaka M, 2008, BRAIN RES BULL, V75, P509, DOI 10.1016/j.brainresbull.2007.08.009; Telegdy G, 2011, BEHAV BRAIN RES, V222, P295, DOI 10.1016/j.bbr.2011.03.047; Todorovic C, 2007, EUR J NEUROSCI, V25, P3385, DOI 10.1111/j.1460-9568.2007.05592.x; Turek VF, 2005, NEUROSCIENCE, V133, P1021, DOI 10.1016/j.neuroscience.2005.03.037; Valdez GR, 2002, BRAIN RES, V943, P142, DOI 10.1016/S0006-8993(02)02707-5; Valdez GR, 2003, BRAIN RES, V980, P206, DOI 10.1016/S0006-8993(03)02971-8; Venihaki M, 2004, J NEUROENDOCRINOL, V16, P411, DOI 10.1111/j.1365-2826.2004.01170.x; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Vuong SM, 2010, BEHAV BRAIN RES, V208, P278, DOI 10.1016/j.bbr.2009.11.036; Zhao Y, 2007, J PHARMACOL EXP THER, V323, P846, DOI 10.1124/jpet.107.123208; Zorrilla EP, 2004, J PHARMACOL EXP THER, V310, P1027, DOI 10.1124/jpet.104.068676; Zorrilla EP, 2010, DRUG DISCOV TODAY, V15, P371, DOI 10.1016/j.drudis.2010.02.011	67	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e63942	10.1371/journal.pone.0063942	http://dx.doi.org/10.1371/journal.pone.0063942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015170	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800001
J	Wang, CS; Du, LJ; Si, MJ; Yin, QH; Chen, L; Shu, M; Yuan, F; Fei, XC; Ding, XY				Wang, Cheng-Sheng; Du, Lian-Jun; Si, Ming-Jue; Yin, Qi-Hua; Chen, Liang; Shu, Min; Yuan, Fei; Fei, Xiao-Chun; Ding, Xiao-Yi			Noninvasive Assessment of Response to Neoadjuvant Chemotherapy in Osteosarcoma of Long Bones with Diffusion-Weighted Imaging: An Initial In Vivo Study	PLOS ONE			English	Article							TUMOR NECROSIS; SARCOMA; VOLUME	Objectives: The purpose of our study is to investigate whether diffusion-weighted imaging (DWI) is useful for monitoring the therapeutic response after neoadjuvant chemotherapy in osteosarcoma of long bones. Materials and methods: Conventional magnetic resonance imaging (MRI) and DWI were obtained from 35 patients with histologically proven osteosarcomas. MR examinations were performed in all patients before and after 4 courses of preoperative neoadjuvant chemotherapy. Apparent diffusion coefficients (ADC) were measured. The degree of tumor necrosis was assessed macroscopically and histologically by two experienced pathologists after operation. Student's t test was performed for testing changes in ADC value. Pearson's correlation coefficient was used to estimate the correlation between necrosis rate and post- neoadjuvant chemotherapy ADC values. P<0.05 was considered to denote a significant difference. Results: The difference of the whole osteosarcoma between pre- neoadjuvant chemotherapy ADC value (1.24 +/- 0.17x10(-3) mm(2)/s) and post- (1.93 +/- 0.39x10(-3) mm(2)/s) was significant difference (P<0.01). Regarding in patients with good response, the post- neoadjuvant chemotherapy values were significantly higher than the pre- neoadjuvant chemotherapy values (P<0.01). The post- neoadjuvant chemotherapy ADC value in patients with good response was higher than that of poor response (t = 8.995, P<0.01). The differences in post- neoadjuvant chemotherapy ADC between viable (1.03 +/- 0.17x10(-3) mm(2)/s) and necrotic (2.38 +/- 0.25x10(-3) mm(2)/s) tumor was highly significant (t = 23.905, P<0.01). A positive correlation between necrosis rates and the whole tumor ADC values (r = 0.769, P<0.01) was noted, but necrosis rates were not correlated with the ADC values of necrotic (r = -0.191, P = 0.272) and viable tumor areas (r = 0.292, P = 0.089). Conclusions: DWI can identify residual viable tumor tissues and tumor necrosis induced by neoadjuvant chemotherapy in osteosarcoma. The ADC value can directly reflect the degree of tumor necrosis, and it is useful to evaluate the preoperative neoadjuvant chemotherapy response in patients with osteosarcoma.	[Wang, Cheng-Sheng; Du, Lian-Jun; Si, Ming-Jue; Yin, Qi-Hua; Chen, Liang; Shu, Min; Ding, Xiao-Yi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Wang, Cheng-Sheng] Fujian Med Univ, Union Hosp, Dept Radiol, Fuzhou, Peoples R China; [Yuan, Fei; Fei, Xiao-Chun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fujian Medical University; Shanghai Jiao Tong University	Ding, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	dxyrj@hotmail.com			National Natural Science Foundation of China [81072188]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was received for this work from the National Natural Science Foundation of China (Project Number: 81072188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai J, 2011, PEDIATR RADIOL, V41, P441, DOI 10.1007/s00247-010-1876-3; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Bieling P, 1996, J CLIN ONCOL, V14, P848, DOI 10.1200/JCO.1996.14.3.848; DEBAERE T, 1992, RADIOLOGY, V185, P587, DOI 10.1148/radiology.185.2.1410378; der Woude HJ v, 1998, SKELETAL RADIOL, V27, P57; Dudeck O, 2008, J MAGN RESON IMAGING, V27, P1109, DOI 10.1002/jmri.21358; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; GOBEL V, 1987, J CANCER RES CLIN, V113, P187, DOI 10.1007/BF00391442; Hayashida Y, 2006, EUR RADIOL, V16, P2637, DOI 10.1007/s00330-006-0342-y; Kim MS, 2008, ANN SURG ONCOL, V15, P906, DOI 10.1245/s10434-007-9779-8; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Lang P, 1998, RADIOLOGY, V206, P227, DOI 10.1148/radiology.206.1.9423677; Oka K, 2010, SKELETAL RADIOL, V39, P141, DOI 10.1007/s00256-009-0830-7; Pakos EE, 2009, EUR J CANCER, V45, P2367, DOI 10.1016/j.ejca.2009.03.005; PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6; Uhl M, 2006, INVEST RADIOL, V41, P618, DOI 10.1097/01.rli.0000225398.17315.68; Uhl M, 2006, PEDIATR RADIOL, V36, P1306, DOI 10.1007/s00247-006-0324-x; Wittig JC, 2002, AM FAM PHYSICIAN, V65, P1123	18	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72679	10.1371/journal.pone.0072679	http://dx.doi.org/10.1371/journal.pone.0072679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991141	gold, Green Submitted, Green Published			2022-12-25	WOS:000324228800083
J	Gobel, M; Eisele, L; Mollmann, M; Huttmann, A; Johansson, P; Scholtysik, R; Bergmann, M; Busch, R; Dohner, H; Hallek, M; Seiler, T; Stilgenbauer, S; Klein-Hitpass, L; Duhrsen, U; Durig, J				Goebel, Maria; Eisele, Lewin; Moellmann, Michael; Huettmann, Andreas; Johansson, Patricia; Scholtysik, Rene; Bergmann, Manuela; Busch, Raymonde; Doehner, Hartmut; Hallek, Michael; Seiler, Till; Stilgenbauer, Stephan; Klein-Hitpass, Ludger; Duehrsen, Ulrich; Duerig, Jan			Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							HUMAN MULTIPLE-MYELOMA; BREAST-CANCER CELLS; GROWTH-FACTOR; EPITHELIN PRECURSOR; GENE-EXPRESSION; CD38 EXPRESSION; GRANULIN; ZAP-70; RESISTANCE; MUTATIONS	Progranulin (Pgrn) is a 88 kDa secreted protein with pleiotropic functions including regulation of cell cycle progression, cell motility, wound repair and tumorigenesis. Using microarray based gene expression profiling we have recently demonstrated that the gene for Pgrn, granulin (GRN), is significantly higher expressed in aggressive CD38(+)ZAP-70(+) as compared to indolent CD38(-)ZAP-70(-) chronic lymphocytic leukemia (CLL) cases. Here, we measured Pgrn plasma concentrations by enzyme-linked immunosorbent assay (ELISA) in the Essen CLL cohort of 131 patients and examined Pgrn for association with established prognostic markers and clinical outcome. We found that high Pgrn plasma levels were strongly associated with adverse risk factors including unmutated IGHV status, expression of CD38 and ZAP-70, poor risk cytogenetics (11q-, 17p-) as detected by flourescence in situ hybridization (FISH) and high Binet stage. Pgrn as well as the aforementioned risk factors were prognostic for time to first treatment and overall survival in this series. Importantly, these results could be confirmed in the independent multicentric CLL1 cohort of untreated Binet stage A patients (n = 163). Here, multivariate analysis of time to first treatment revealed that high risk Pgrn (HR = 2.06, 95%-CI = 1.13-3.76, p = 0.018), unmutated IGHV status (HR = 5.63, 95%-CI = 3.05-10.38, p<0.001), high risk as defined by the study protocol (HR = 2.06, 95%-CI = 1.09-3.89, p = 0.026) but not poor risk cytogenetics were independent prognostic markers. In summary our results suggest that Pgrn is a novel, robust and independent prognostic marker in CLL that can be easily measured by ELISA.	[Goebel, Maria; Moellmann, Michael; Huettmann, Andreas; Johansson, Patricia; Duehrsen, Ulrich; Duerig, Jan] Univ Duisburg Essen, Univ Hosp, Dept Hematol, Essen, Germany; [Eisele, Lewin] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Scholtysik, Rene; Duehrsen, Ulrich] Univ Duisburg Essen, Univ Hosp, Inst Cell Biol, Essen, Germany; [Bergmann, Manuela; Doehner, Hartmut; Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Busch, Raymonde] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Hallek, Michael] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Hallek, Michael] Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Seiler, Till] Univ Hosp Grosshadern, Dept Med 3, Munich, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Ulm University; Technical University of Munich; University of Cologne; University of Cologne; University of Munich	Durig, J (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Hematol, Essen, Germany.	jan.duerig@uk-essen.de	Huettmann, Andreas/AAH-6483-2019; Stilgenbauer, Stephan/ABE-6609-2020; Hallek, Michael/Y-3191-2019; Patricia, Johansson/ABF-6824-2020; Döhner, Hartmut/C-8933-2016; Hüttmann, Andreas/W-6106-2019	Hallek, Michael/0000-0002-7425-4455; Patricia, Johansson/0000-0002-3265-8689; Döhner, Hartmut/0000-0003-2116-5536; Hüttmann, Andreas/0000-0003-2230-3873	Wiedenfeld-Stiftung; intramural IFORES grant Gobel et al	Wiedenfeld-Stiftung; intramural IFORES grant Gobel et al	MG was supported by grant provided by the Wiedenfeld-Stiftung. This work represents a part of MG's MD thesis. PJ was supported by an intramural IFORES grant Gobel et al. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrhale T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-231; Antonell A, 2012, J ALZHEIMERS DIS, V31, P581, DOI 10.3233/JAD-2012-112120; Bagnoli S, 2012, CELL MOL NEUROBIOL, V32, P13, DOI 10.1007/s10571-011-9741-y; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Cuevas-Antonio R, 2010, CANCER INVEST, V28, P452, DOI 10.3109/07357900903346455; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Donald CD, 2001, ANTICANCER RES, V21, P3739; Durig J, 2003, BLOOD, V101, P2748, DOI 10.1182/blood-2002-09-2683; Eisele L, 2009, EUR J HAEMATOL, V83, P320, DOI 10.1111/j.1600-0609.2009.01287.x; Frampton G, 2012, GUT, V61, P268, DOI 10.1136/gutjnl-2011-300643; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Han JJ, 2011, GYNECOL ONCOL, V120, P5, DOI 10.1016/j.ygyno.2010.09.006; Hanoun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034347; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Huttmann A, 2006, LEUKEMIA, V20, P1774, DOI 10.1038/sj.leu.2404363; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Johansson P, 2010, LEUKEMIA RES, V34, P892, DOI 10.1016/j.leukres.2010.02.038; Koo DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039880; Li LQ, 2011, CHINESE MED J-PEKING, V124, P2045, DOI 10.3760/cma.j.issn.0366-6999.2011.13.022; Marti G, 2006, CYTOM PART B-CLIN CY, V70B, P197, DOI 10.1002/cyto.b.20137; McDade E, 2012, NEUROLOGY, V78, P1245, DOI 10.1212/WNL.0b013e318251594c; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Moreno C, 2008, BLOOD REV, V22, P211, DOI 10.1016/j.blre.2008.03.003; Nuckel H, 2006, LEUKEMIA LYMPHOMA, V47, P1053, DOI 10.1080/10428190500464161; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Schroers R, 2005, LEUKEMIA, V19, P750, DOI 10.1038/sj.leu.2403707; Sellmann L, 2010, CANCER GENET CYTOGEN, V203, P149, DOI 10.1016/j.cancergencyto.2010.09.002; Sivina M, 2011, BLOOD, V117, P1662, DOI 10.1182/blood-2010-09-307249; Swamydas M, 2011, CELL COMMUN ADHES, V18, P119, DOI 10.3109/15419061.2011.641042; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Wang MQ, 2012, MED ONCOL, V29, P2423, DOI 10.1007/s12032-011-0131-6; Wang WG, 2006, CLIN CANCER RES, V12, P49, DOI 10.1158/1078-0432.CCR-05-0929; Wang WG, 2003, CLIN CANCER RES, V9, P2221	35	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72107	10.1371/journal.pone.0072107	http://dx.doi.org/10.1371/journal.pone.0072107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009671	Green Submitted, Green Published, gold			2022-12-25	WOS:000324403200019
J	Mao, XM; Sun, N; Wang, F; Luo, S; Zhou, Z; Feng, WH; Huang, FL; Li, YQ				Mao, Xu-Ming; Sun, Ning; Wang, Feng; Luo, Shuai; Zhou, Zhan; Feng, Wei-Hong; Huang, Fang-Liang; Li, Yong-Quan			Dual Positive Feedback Regulation of Protein Degradation of an Extra-cytoplasmic Function sigma Factor for Cell Differentiation in Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; ANTIBIOTIC BIOSYNTHESIS; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSCRIPTION; PROTEOLYSIS; SYSTEM; A3(2); ACTINORHODIN	Here we report that in Streptomyces coelicolor, the protein stability of an ECF sigma factor SigT, which is involved in the negative regulation of cell differentiation, was completely dependent on its cognate anti-sigma factor RstA. The degradation of RstA caused a ClpP/SsrA-dependent degradation of SigT during cell differentiation. This was consistent with the delayed morphological development or secondary metabolism in the Delta clpP background after rstA deletion or sigT overexpression. Meanwhile, SigT negatively regulated clpP/ssrA expression by directly binding to the clpP promoter (clpPp). The SigT-clpPp interaction could be disrupted by secondary metabolites, giving rise to the stabilized SigT protein and retarded morphological development in a non-antibiotic-producing mutant. Thus a novel regulatory mechanism was revealed that the protein degradation of the ECF sigma factor was initiated by the degradation of its anti-sigma factor, and was accelerated in a dual positive feedback manner, through regulation by secondary metabolites, to promote rapid and irreversible development of the secondary metabolism. This ingenious cooperation of intracellular components can ensure economical and exquisite control of the ECF sigma factor protein level for the proper cell differentiation in Streptomyces.	[Mao, Xu-Ming; Sun, Ning; Wang, Feng; Luo, Shuai; Zhou, Zhan; Feng, Wei-Hong; Huang, Fang-Liang; Li, Yong-Quan] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Mao, Xu-Ming; Sun, Ning; Wang, Feng; Luo, Shuai; Zhou, Zhan; Feng, Wei-Hong; Huang, Fang-Liang; Li, Yong-Quan] Key Lab Microbial Biochem & Metab Engn Zhejiang P, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Li, YQ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	lyq@zju.edu.cn	Zhou, Zhan/I-2372-2013; Mao, Xu-Ming/AAI-4212-2020	Zhou, Zhan/0000-0002-2730-5483; 	National Basic Research Program of China (973 Program) [2012CB721005]; National Science Foundation of China [31070040]; National High Technology Research and Development Program of China (863 Program) [2012AA02A706]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant [2011ZX09202-101-11]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20120101110143]; Chinese Scholarship Council [201208330062]; Zhejiang University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant; Specialized Research Fund for the Doctoral Program of Higher Education Grant; Chinese Scholarship Council(China Scholarship Council); Zhejiang University	This work was supported by National Basic Research Program of China (973 Program) Grant 2012CB721005, National Science Foundation of China Grant 31070040, National High Technology Research and Development Program of China (863 Program) Grant 2012AA02A706, National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant 2011ZX09202-101-11 and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20120101110143. This work was also supported by fellowships from Chinese Scholarship Council (201208330062) and New Star Project from Zhejiang University.	Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x; Bibb MJ, 2003, J BACTERIOL, V185, P2338, DOI 10.1128/JB.185.7.2338-2345.2003; Dalton KA, 2007, MOL MICROBIOL, V64, P719, DOI 10.1111/j.1365-2958.2007.05684.x; Damron FH, 2011, J BACTERIOL, V193, P286, DOI 10.1128/JB.01132-10; de Crecy-Lagard V, 1999, MOL MICROBIOL, V32, P505, DOI 10.1046/j.1365-2958.1999.01364.x; Feng WH, 2011, APPL MICROBIOL BIOT, V92, P1009, DOI 10.1007/s00253-011-3619-2; Gehring AM, 2001, J BACTERIOL, V183, P5991, DOI 10.1128/JB.183.20.5991-5996.2001; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Gomez-Santos N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002106; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Heinrich J, 2006, MOL MICROBIOL, V62, P566, DOI 10.1111/j.1365-2958.2006.05391.x; Heinrich J, 2009, MOL MICROBIOL, V74, P1412, DOI 10.1111/j.1365-2958.2009.06940.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001; Ho TD, 2011, J BACTERIOL, V193, P6215, DOI 10.1128/JB.05467-11; Hong HJ, 2002, MOL MICROBIOL, V44, P1199, DOI 10.1046/j.1365-2958.2002.02960.x; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim MS, 2009, MOL MICROBIOL, V73, P815, DOI 10.1111/j.1365-2958.2009.06824.x; Li QL, 2013, J BACTERIOL, V195, P2232, DOI 10.1128/JB.00054-13; Liu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040885; Mao XM, 2013, J BACTERIOL, V195, P2072, DOI 10.1128/JB.00040-13; Mao XM, 2009, FEBS LETT, V583, P3145, DOI 10.1016/j.febslet.2009.09.025; Mo S, 2008, CHEM BIOL, V15, P137, DOI 10.1016/j.chembiol.2007.11.015; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sklar JG, 2010, MOL MICROBIOL, V77, P605, DOI 10.1111/j.1365-2958.2010.07232.x; Sola-Landa A, 2013, NUCLEIC ACIDS RES, V41, P1767, DOI 10.1093/nar/gks1203; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Thackray PD, 2003, J BACTERIOL, V185, P3491, DOI 10.1128/JB.185.12.3491-3498.2003; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yang CZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004459; Yeh HY, 2011, NUCLEIC ACIDS RES, V39, P913, DOI 10.1093/nar/gkq911; Zianni Michael, 2006, J Biomol Tech, V17, P103	47	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31217	31228		10.1074/jbc.M113.491498	http://dx.doi.org/10.1074/jbc.M113.491498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014034	Green Published, hybrid			2022-12-25	WOS:000330778900038
J	Gardner, L; Sarkar, S				Gardner, Lauren; Sarkar, Sahotra			A Global Airport-Based Risk Model for the Spread of Dengue Infection via the Air Transport Network	PLOS ONE			English	Article							AEDES-ALBOPICTUS; SPECIES DISTRIBUTIONS; DISEASE VECTOR; NICHE MODELS; AIRCRAFT; MALARIA; ESTABLISHMENT; DISINSECTION; INSECTS; FEVER	The number of travel-acquired dengue infections has seen a consistent global rise over the past decade. An increased volume of international passenger air traffic originating from regions with endemic dengue has contributed to a rise in the number of dengue cases in both areas of endemicity and elsewhere. This paper reports results from a network-based risk assessment model which uses international passenger travel volumes, travel routes, travel distances, regional populations, and predictive species distribution models (for the two vector species, Aedes aegypti and Aedes albopictus) to quantify the relative risk posed by each airport in importing passengers with travel-acquired dengue infections. Two risk attributes are evaluated: (i) the risk posed by through traffic at each stopover airport and (ii) the risk posed by incoming travelers to each destination airport. The model results prioritize optimal locations (i.e., airports) for targeted dengue surveillance. The model is easily extendible to other vector-borne diseases.	[Gardner, Lauren] Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW, Australia; [Gardner, Lauren] NICTA, Sydney, NSW, Australia; [Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of New South Wales Sydney; Australian National University; University of Texas System; University of Texas Austin	Gardner, L (corresponding author), Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW, Australia.	l.gardner@unsw.edu.au						Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785; [Anonymous], COMMUNICATION; Bennett JK, 2005, J AM MOSQUITO CONTR, V21, P341, DOI 10.2987/8756-971X(2006)21[341:NSRFTA]2.0.CO;2; BROOK JH, 1994, NEW ENGL J MED, V331, P22, DOI 10.1056/NEJM199407073310105; Bureau of the Census, 2012, 2010 CENS GAZ FIL NA; *CDC, 2008, DENG FEV; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P908; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P495; Centers for Disease Control Division of Vector Borne Diseases (DVBD), INF AED ALB; Codeco CT, 2004, T ROY SOC TROP MED H, V98, P702, DOI 10.1016/j.trstmh.2003.12.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engelthaler DM, 1997, EMERG INFECT DIS, V3, P241, DOI 10.3201/eid0302.970223; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; Franklin J, 2009, MAPPING SPECIES DIST; Gardner LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/103679; Gasque P, 2013, VIRAL INFECT HUMAN N, P295, DOI [10.1007/978-3-0348-0425-7_12, DOI 10.1007/978-3-0348-0425-7_]; Geonames, 2013, CIT 15000; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jelinek T, 2002, CLIN INFECT DIS, V35, P1047, DOI 10.1086/342906; MacArthur J R, 2001, Clin Infect Dis, V32, pE124, DOI 10.1086/319754; Mairuhu ATA, 2004, EUR J CLIN MICROBIOL, V23, P425, DOI 10.1007/s10096-004-1145-1; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Martins VEP, 2006, REV SAUDE PUBL, V40, P1; Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x; MaxMind Inc, 2012, WORLDC; Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Moffett A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000378; Mundy SB, 1996, SOUTHERN MED J, V89, P616, DOI 10.1097/00007611-199606000-00012; NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314; Nicolaides C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040961; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Powers NR, 2006, J AM MOSQUITO CONTR, V22, P756, DOI 10.2987/8756-971X(2006)22[756:TRAPEO]2.0.CO;2; Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2; Roiz D, 2007, J VECTOR ECOL, V32, P10, DOI 10.3376/1081-1710(2007)32[10:ASOMBI]2.0.CO;2; Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241; RUSSELL RC, 1989, B WORLD HEALTH ORGAN, V67, P543; RUSSELL RC, 1987, B WORLD HEALTH ORGAN, V65, P659; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633; SULLIVAN WN, 1962, B WORLD HEALTH ORGAN, V27, P263; Sutton PM, 2007, AM J IND MED, V50, P345, DOI 10.1002/ajim.20452; Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Usable Databases, 2012, WORLD AIRPORTS DATAB; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WHO, DENGUE; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; World Health Organization, 1997, DENG HAERM FEV DIAGN	58	41	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72129	10.1371/journal.pone.0072129	http://dx.doi.org/10.1371/journal.pone.0072129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009672	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600012
J	Guyard, C; Raffel, SJ; Schrumpf, ME; Dahlstrom, E; Sturdevant, D; Ricklefs, SM; Martens, C; Hayes, SF; Fischer, ER; Hansen, BT; Porcella, SF; Schwan, TG				Guyard, Cyril; Raffel, Sandra J.; Schrumpf, Merry E.; Dahlstrom, Eric; Sturdevant, Daniel; Ricklefs, Stacy M.; Martens, Craig; Hayes, Stanley F.; Fischer, Elizabeth R.; Hansen, Bryan T.; Porcella, Stephen F.; Schwan, Tom G.			Periplasmic Flagellar Export Apparatus Protein, FliH, Is Involved in Post-Transcriptional Regulation of FlaB, Motility and Virulence of the Relapsing Fever Spirochete Borrelia hermsii	PLOS ONE			English	Article							LYME-DISEASE; SERPULINA-HYODYSENTERIAE; MURINE MODEL; LESS MUTANT; BURGDORFERI; SALMONELLA; GENE; INACTIVATION; CHEMOTAXIS; EXPRESSION	Spirochetes are bacteria characterized in part by rotating periplasmic flagella that impart their helical or flat-wave morphology and motility. While most other bacteria rely on a transcriptional cascade to regulate the expression of motility genes, spirochetes employ post-transcriptional mechanism(s) that are only partially known. In the present study, we characterize a spontaneous non-motile mutant of the relapsing fever spirochete Borrelia hermsii that was straight, nonmotile and deficient in periplasmic flagella. We used next generation DNA sequencing of the mutant's genome, which when compared to the wild-type genome identified a 142 bp deletion in the chromosomal gene encoding the flagellar export apparatus protein FliH. Immunoblot and transcription analyses showed that the mutant phenotype was linked to the posttranscriptional deficiency in the synthesis of the major periplasmic flagellar filament core protein FlaB. Despite the lack of FlaB, the amount of FlaA produced by the fliH mutant was similar to the wild-type level. The turnover of the residual pool of FlaB produced by the fliH mutant was comparable to the wild-type spirochete. The non-motile mutant was not infectious in mice and its inoculation did not induce an antibody response. Trans-complementation of the mutant with an intact fliH gene restored the synthesis of FlaB, a normal morphology, motility and infectivity in mice. Therefore, we propose that the flagellar export apparatus protein regulates motility of B. hermsii at the post-transcriptional level by influencing the synthesis of FlaB.	[Guyard, Cyril] Publ Hlth Ontario, Toronto, ON, Canada; [Guyard, Cyril] Univ Toronto, Toronto, ON, Canada; [Guyard, Cyril] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Raffel, Sandra J.; Schrumpf, Merry E.; Schwan, Tom G.] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT USA; [Dahlstrom, Eric; Sturdevant, Daniel; Ricklefs, Stacy M.; Martens, Craig; Hayes, Stanley F.; Fischer, Elizabeth R.; Hansen, Bryan T.; Porcella, Stephen F.] NIAID, Res Technol Sect, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Guyard, C (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	cyril.guyard@gmail.com			Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), USA; Public Health Ontario; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000492, ZICAI001052] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), USA; Public Health Ontario; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), USA (http://www.niaid.nih.gov/). CG is supported by Public Health Ontario (http://www.oahpp.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Battisti James M., 2008, V431, P69; BISSETT ML, 1987, J CLIN MICROBIOL, V25, P2296, DOI 10.1128/JCM.25.12.2296-2301.1987; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CANALEPAROLA E, 1978, ANNU REV MICROBIOL, V32, P69, DOI 10.1146/annurev.mi.32.100178.000441; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Chesnokova O, 1997, MOL MICROBIOL, V23, P579, DOI 10.1046/j.1365-2958.1997.d01-1875.x; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Cutler SJ, 1997, INT J SYST BACTERIOL, V47, P958, DOI 10.1099/00207713-47-4-958; Davis G. E., 1942, Publications of the American Association for the Advancement of Science, Vno. 18, P41; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; FELSENFELD O, 1965, J IMMUNOL, V94, P805; GAGE KL, 1992, MOL CELL PROBE, V6, P333, DOI 10.1016/0890-8508(92)90010-U; Ge YG, 1998, J BACTERIOL, V180, P2418, DOI 10.1128/JB.180.9.2418-2425.1998; Ge YG, 1997, MICROBIOL-UK, V143, P1681, DOI 10.1099/00221287-143-5-1681; Ge YG, 1997, INFECT IMMUN, V65, P2992, DOI 10.1128/IAI.65.7.2992-2995.1997; GOLDSTEIN SF, 1994, P NATL ACAD SCI USA, V91, P3433, DOI 10.1073/pnas.91.8.3433; Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Kennedy MJ, 1997, FEMS MICROBIOL LETT, V153, P119, DOI 10.1016/S0378-1097(97)00244-9; Kudryashev M, 2010, J STRUCT BIOL, V169, P54, DOI 10.1016/j.jsb.2009.08.008; Kudryashev M, 2009, MOL MICROBIOL, V71, P1415, DOI 10.1111/j.1365-2958.2009.06613.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2002, P NATL ACAD SCI USA, V99, P6169, DOI 10.1073/pnas.092010499; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Macnab RM, 1996, FLAGELLA MOTILITY ES, P123; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2000, J BACTERIOL, V182, P4207, DOI 10.1128/JB.182.15.4207-4215.2000; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; Morisaki H, 1999, MICROBIOL-SGM, V145, P2797, DOI 10.1099/00221287-145-10-2797; Motaleb MA, 2011, J BACTERIOL, V193, P3324, DOI 10.1128/JB.00202-11; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2004, J BACTERIOL, V186, P3703, DOI 10.1128/JB.186.12.3703-3711.2004; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; NOPPA L, 1995, MICROBIOL-UK, V141, P85, DOI 10.1099/00221287-141-1-85; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Rosey EL, 1996, INFECT IMMUN, V64, P4154, DOI 10.1128/IAI.64.10.4154-4162.1996; Ruby JD, 1997, J BACTERIOL, V179, P1628, DOI 10.1128/jb.179.5.1628-1635.1997; Sadziene A, 1996, J INFECT DIS, V173, P1184, DOI 10.1093/infdis/173.5.1184; SADZIENE A, 1991, J CLIN INVEST, V88, P82, DOI 10.1172/JCI115308; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Sartakova ML, 2001, J BACTERIOL, V183, P6558, DOI 10.1128/JB.183.22.6558-6564.2001; SCHWAN TG, 1989, INFECT IMMUN, V57, P3445, DOI 10.1128/IAI.57.11.3445-3451.1989; Sellek RE, 2002, INFECT IMMUN, V70, P4851, DOI 10.1128/IAI.70.9.4851-4858.2002; Sohaskey CD, 1997, J BACTERIOL, V179, P6837, DOI 10.1128/jb.179.21.6837-6842.1997; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; THOMPSON RS, 1969, J AMER MED ASSOC, V210, P1045, DOI 10.1001/jama.210.6.1045; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Zambrano MC, 2004, INFECT IMMUN, V72, P3138, DOI 10.1128/IAI.72.6.3138-3146.2004	70	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72550	10.1371/journal.pone.0072550	http://dx.doi.org/10.1371/journal.pone.0072550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009690	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600028
J	Poddighe, S; Bhat, KM; Setzu, MD; Solla, P; Angioy, AM; Marotta, R; Ruffilli, R; Marrosu, F; Liscia, A				Poddighe, Simone; Bhat, Krishna Moorthi; Setzu, Maria Dolores; Solla, Paolo; Angioy, Anna Maria; Marotta, Roberto; Ruffilli, Roberta; Marrosu, Francesco; Liscia, Anna			Impaired Sense of Smell in a Drosophila Parkinson's Model	PLOS ONE			English	Article							OLFACTORY-BULB VOLUME; PISTACIA-LENTISCUS; LOCAL INTERNEURONS; DISEASE; DISCRIMINATION; DYSFUNCTION; FRUIT; SIGNS	Parkinson's disease (PD) is one of the most common neurodegenerative disease characterized by the clinical triad: tremor, akinesia and rigidity. Several studies have suggested that PD patients show disturbances in olfaction at the earliest onset of the disease. The fruit fly Drosophila melanogaster is becoming a powerful model organism to study neurodegenerative diseases. We sought to use this system to explore olfactory dysfunction, if any, in PINK1 mutants, which is a model for PD. PINK1 mutants display many important diagnostic symptoms of the disease such as akinetic motor behavior. In the present study, we describe for the first time, to the best of our knowledge, neurophysiological and neuroanatomical results concerning the olfactory function in PINK1 mutant flies. Electroantennograms were recorded in response to synthetic and natural volatiles (essential oils) from groups of PINK1 mutant adults at three different time points in their life cycle: one from 3-5 day-old flies, from 15-20 and from 27-30 days. The results obtained were compared with the same age-groups of wild type flies. We found that mutant adults showed a decrease in the olfactory response to 1-hexanol, alpha-pinene and essential oil volatiles. This olfactory response in mutant adults decreased even more as the flies aged. Immunohistological analysis of the antennal lobes in these mutants revealed structural abnormalities, especially in the expression of Bruchpilot protein, a marker for synaptic active zones. The combination of electrophysiological and morphological results suggests that the altered synaptic organization may be due to a neurodegenerative process. Our results indicate that this model can be used as a tool for understanding PD pathogensis and pathophysiology. These results help to explore the potential of using olfaction as a means of monitoring PD progression and developing new treatments.	[Poddighe, Simone; Setzu, Maria Dolores] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Bhat, Krishna Moorthi] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Solla, Paolo; Marrosu, Francesco] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Angioy, Anna Maria] Univ Cagliari, Dept Expt Biol, Cagliari, Italy; [Marotta, Roberto; Ruffilli, Roberta] Italian Inst Technol, Nanobiotech Facil, Genoa, Italy; [Liscia, Anna] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy	University of Cagliari; University of Texas System; University of Texas Medical Branch Galveston; University of Cagliari; University of Cagliari; Istituto Italiano di Tecnologia - IIT; University of Cagliari	Liscia, A (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	liscia@unica.it	Solla, Paolo/R-5366-2016; Solla, Paolo/GQZ-7556-2022; Solla, Paolo/AAL-9671-2020; Marotta, Roberto/HGV-1599-2022; Marotta, Roberto/B-5382-2014	Solla, Paolo/0000-0002-2982-0665; Poddighe, Simone/0000-0002-7244-9240; Setzu, Maria Dolores/0000-0002-6934-4042; Liscia, Anna/0000-0002-1629-2090; Marotta, Roberto/0000-0003-0634-5483	Ministero dell'Istruzione, dell'Universitae della Ricerca, Italy; Regione Autonoma della Sardegna; NIGMS-NIH [R01GM080538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080538] Funding Source: NIH RePORTER	Ministero dell'Istruzione, dell'Universitae della Ricerca, Italy(Ministry of Education, Universities and Research (MIUR)); Regione Autonoma della Sardegna(Regione Sardegna); NIGMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by fundings from the Ministero dell'Istruzione, dell'Universitae della Ricerca, Italy to AL, by fundings form Regione Autonoma della Sardegna to FM and by an R01 grant from NIGMS-NIH (R01GM080538) to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2011, J NEUROSCI, V31, P2734, DOI 10.1523/JNEUROSCI.5046-10.2011; Berendse HW, 2006, J NEURAL TRANSM-SUPP, P321; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brodoehl S, 2012, MOVEMENT DISORD, V27, P1019, DOI 10.1002/mds.25087; Celiktas O. Y., 2007, Food Chemistry, V101, P1474, DOI 10.1016/j.foodchem.2006.03.055; Congiu R, 2002, FLAVOUR FRAG J, V17, P239, DOI 10.1002/ffj.1095; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; Eggers C, 2010, NEUROLOGY, V74, P1798, DOI 10.1212/WNL.0b013e3181e0f79c; Ferraris A, 2009, MOVEMENT DISORD, V24, P2350, DOI 10.1002/mds.22816; Glasl L, 2012, EXP NEUROL, V235, P214, DOI 10.1016/j.expneurol.2012.01.002; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/450939; Hansson BS, 2010, CHEMOECOLOGY, V20, P51, DOI 10.1007/s00049-009-0033-7; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Ibba I, 2010, NATURWISSENSCHAFTEN, V97, P1059, DOI 10.1007/s00114-010-0727-2; Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Kertelge L, 2010, MOVEMENT DISORD, V25, P2665, DOI 10.1002/mds.23272; KOLLER WC, 1992, CLIN NEUROPHARMACOL, V15, P81, DOI 10.1097/00002826-199204000-00001; Laissue PP, 1999, J COMP NEUROL, V405, P543; Latourelle JC, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-32; Ljubuncic P, 2005, J ETHNOPHARMACOL, V100, P198, DOI 10.1016/j.jep.2005.03.006; Moghtader M., 2011, Journal of Ecology and the Natural Environment, V3, P210; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Poddighe S, 2010, NATURWISSENSCHAFTEN, V97, P827, DOI 10.1007/s00114-010-0700-0; Rombaux P, 2009, RHINOLOGY, V47, P3; SCHNEIDER D, 1962, J INSECT PHYSIOL, V8, P15, DOI 10.1016/0022-1910(62)90051-3; SCHWARZ K, 1992, Z LEBENSM UNTERS FOR, V195, P95, DOI 10.1007/BF01201765; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Tuberoso CIG, 2010, FOOD CHEM, V123, P1242, DOI 10.1016/j.foodchem.2010.05.094; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350; Wolters EC, 2000, J NEUROL, V247, P103; Zanetti Stefania, 2010, Interdiscip Perspect Infect Dis, V2010, DOI 10.1155/2010/931530; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	40	25	25	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73156	10.1371/journal.pone.0073156	http://dx.doi.org/10.1371/journal.pone.0073156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009736	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600058
J	Zotes, TM; Spada, R; Mulens, V; Perez-Yague, S; Sorzano, CO; Okkenhaug, K; Carrera, AC; Barber, DF				Zotes, Teresa M.; Spada, Roberto; Mulens, Vladimir; Perez-Yaguee, Sonia; Sorzano, Carlos O.; Okkenhaug, Klaus; Carrera, Ana C.; Barber, Domingo F.			PI3K p110 delta Is Expressed by gp38(-) CD31(+) and gp38(+)CD31(+) Spleen Stromal Cells and Regulates Their CCL19, CCL21, and LT beta R mRNA Levels	PLOS ONE			English	Article							SECONDARY LYMPHOID ORGANS; PHOSPHOINOSITIDE 3-KINASE P110-DELTA; FIBROBLASTIC RETICULAR CELLS; INACTIVATED CANDIDA-ALBICANS; T-CELLS; LYMPHOTOXIN-ALPHA; B-CELL; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNE-RESPONSE; DEFICIENT MICE	The role of p110 delta PI3K in lymphoid cells has been studied extensively, showing its importance in immune cell differentiation, activation and development. Altered T cell localization in p110 delta-deficient mouse spleen suggested a role for p110d in non-hematopoietic stromal cells, which maintain hematopoietic cell segregation. We tested this hypothesis using p110 delta(WT/WT) mouse bone marrow to reconstitute lethally irradiated p110dWT/WT or p110 delta(D910A/D910A) (which express catalytically inactive p110d) recipients, and studied localization, number and percentage of hematopoietic cell subsets in spleen and lymph nodes, in homeostatic conditions and after antigen stimulation. These analyses showed diffuse T cell areas in p110d (D910A/D910A) and in reconstituted p110 delta(D910A/D910A) mice in homeostatic conditions. In these mice, spleen CD4(+) and CD8(+) T cell numbers did not increase in response to antigen, suggesting that a p110 delta(D910A/D910A) stroma defect impedes correct T cell response. FACS analysis of spleen stromal cell populations showed a decrease in the percentage of gp38(-)CD31(+) cells in p110 delta(D910A/D910A) mice. qRT-PCR studies detected p110 delta mRNA expression in p110 delta(WT/WT) spleen gp38(-)CD31(+) and gp38(+)CD31(+) subsets, which was reduced in p110 delta(D910A/D910A) spleen. Lack of p110 delta activity in these cell populations correlated with lower LT beta R, CCL19 and CCL21 mRNA levels; these molecules participate in T cell localization to specific spleen areas. Our results could explain the lower T cell numbers and more diffuse T cell areas found in p110 delta(D910A/D910A) mouse spleen, as well as the lower T cell expansion after antigen stimulation in p110 delta(D910A/D910A) compared with p110 delta(WT/WT) mice.	[Zotes, Teresa M.; Spada, Roberto; Mulens, Vladimir; Perez-Yaguee, Sonia; Carrera, Ana C.; Barber, Domingo F.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Sorzano, Carlos O.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain; [Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Barber, DF (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain.	dfbarber@cnb.csic.es	Okkenhaug, Klaus/D-5149-2012; Mulens-Arias, Vladimir/G-4531-2017; Okkenhaug, Klaus/H-3154-2019; Barber, Domingo F./G-1257-2010; Sorzano, Carlos Oscar S S./F-2639-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021	Okkenhaug, Klaus/0000-0002-9432-4051; Mulens-Arias, Vladimir/0000-0003-3549-0700; Okkenhaug, Klaus/0000-0002-9432-4051; Barber, Domingo F./0000-0001-8824-5405; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Carrera, Ana/0000-0002-3999-5434	Spanish Ministry of Science and Innovation [SAF-2007-60498, SAF-2008-00471, SAF-2011-23639, AP2007-01711]; CSIC [200820I084]; Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program [RD08/0075/0015]; Spanish Ministry of Economy and Competitiveness (MINECO) [BES-2009-016547]; Fundacion La Caixa-CNB program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Fundacion La Caixa-CNB program	This work was supported by the Spanish Ministry of Science and Innovation (SAF-2007-60498, SAF-2008-00471, SAF-2011-23639 to DFB, AP2007-01711 to TMZ), CSIC (Intramural Project 200820I084 to DFB), and the Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program (RD08/0075/0015 to DFB). RS holds a FPI pre-doctoral fellowship (BES-2009-016547) from the Spanish Ministry of Economy and Competitiveness (MINECO). VM holds a predoctoral fellowship from Fundacion La Caixa-CNB program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; BANKS TA, 1995, J IMMUNOL, V155, P1685; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; den Haan JM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00201; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fu YX, 1997, P NATL ACAD SCI USA, V94, P5739, DOI 10.1073/pnas.94.11.5739; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Geng L, 2004, CANCER RES, V64, P4893, DOI 10.1158/0008-5472.CAN-03-3955; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu D, 2010, J IMMUNOL, V184, P3098, DOI 10.4049/jimmunol.0903177; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Mueller SN, 2008, IMMUNOL REV, V224, P284, DOI 10.1111/j.1600-065X.2008.00657.x; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; PELLAS TC, 1990, AM J ANAT, V187, P347, DOI 10.1002/aja.1001870404; Puri KD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00256; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; ROSATI E, 1995, CELL IMMUNOL, V162, P256, DOI 10.1006/cimm.1995.1077; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Sawyer C, 2003, CANCER RES, V63, P1667; Scaringi L, 1995, NAT IMMUN, V14, P234; Shimizu K, 2009, CELL TISSUE RES, V338, P423, DOI 10.1007/s00441-009-0888-5; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Whitehead MA, 2012, BIOCHEM J, V443, P857, DOI 10.1042/BJ20112214	48	2	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72960	10.1371/journal.pone.0072960	http://dx.doi.org/10.1371/journal.pone.0072960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009720	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600046
J	Chopera, DR; Mann, JK; Mwimanzi, P; Omarjee, S; Kuang, XT; Ndabambi, N; Goodier, S; Martin, E; Naranbhai, V; Karim, SA; Karim, QA; Brumme, ZL; Ndung'u, T; Williamson, C; Brockman, MA				Chopera, Denis R.; Mann, Jaclyn K.; Mwimanzi, Philip; Omarjee, Saleha; Kuang, Xiaomei T.; Ndabambi, Nonkululeko; Goodier, Sarah; Martin, Eric; Naranbhai, Vivek; Karim, Salim Abdool; Karim, Quarraisha Abdool; Brumme, Zabrina L.; Ndung'u, Thumbi; Williamson, Carolyn; Brockman, Mark A.		CAPRISA 004 TRAPS Team	No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial	PLOS ONE			English	Article							REPLICATION CAPACITY; TYPE-1 NEF; CONTROLLERS; PHYLOGENIES; VARIANTS; VIRUSES; GEL	Background: Use of antiretroviral-based microbicides for HIV-1 prophylaxis could introduce a transmission barrier that inadvertently facilitates the selection of fitter viral variants among incident infections. To investigate this, we assessed the in vitro function of gag-protease and nef sequences from participants who acquired HIV-1 during the CAPRISA 004 1% tenofovir microbicide gel trial. Methods and Results: We isolated the earliest available gag-protease and nef gene sequences from 83 individuals and examined their in vitro function using recombinant viral replication capacity assays and surface protein downregulation assays, respectively. No major phylogenetic clustering and no significant differences in gag-protease or nef function were observed in participants who received tenofovir gel versus placebo gel prophylaxis. Conclusion: Results indicate that the partial protective effects of 1% tenofovir gel use in the CAPRISA 004 trial were not offset by selection of transmitted/early HIV-1 variants with enhanced Gag-Protease or Nef fitness.	[Chopera, Denis R.; Mann, Jaclyn K.; Omarjee, Saleha; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Chopera, Denis R.; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Chopera, Denis R.; Ndabambi, Nonkululeko; Goodier, Sarah; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Chopera, Denis R.; Ndabambi, Nonkululeko; Goodier, Sarah; Williamson, Carolyn] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa; [Chopera, Denis R.; Ndabambi, Nonkululeko; Goodier, Sarah; Williamson, Carolyn] Natl Hlth Lab Serv, Cape Town, South Africa; [Chopera, Denis R.; Mwimanzi, Philip; Kuang, Xiaomei T.; Martin, Eric; Brumme, Zabrina L.; Brockman, Mark A.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Chopera, Denis R.; Martin, Eric; Brumme, Zabrina L.; Brockman, Mark A.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Naranbhai, Vivek; Karim, Salim Abdool; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infekt Biol, D-10117 Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; University of Cape Town; University of Cape Town; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Kwazulu Natal; Max Planck Society	Williamson, C (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	carolyn.williamson@uct.ac.za; mark_brockman@sfu.ca	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Brockman, Mark/D-1669-2016	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Naranbhai, Vivek/0000-0003-4281-8882; Brumme, Zabrina/0000-0002-8157-1037; Brockman, Mark/0000-0001-6432-1426; , Carolyn/0000-0003-0125-1226; Goodier, Sarah/0000-0002-5272-7549; Ndung'u, Thumbi/0000-0003-2962-3992	Canadian Institutes for Health Research (CIHR) [MOP-93536, HOP-115700, THA-118569]; US Department of Health and Human Services from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health [U19-A151794]; NIAID International Research in Infectious Diseases [R01-AI078936]; South African Technology Innovation Agency (TIA); Centre for the AIDS Program of Research in South Africa (CAPRISA); United States Agency for International Development and Family Health International [GPO-A-00-05-00022-00, 132119]; South African Department of Science and Technology (DST); CONRAD [GP00-08-00005-00, PPA-09-046]; CIHR; Sanofi-Aventis; Clinical Infectious Diseases Research Initiative (CIDRI) fellowship; Claude Leon Foundation fellowship; South African National Research Foundation (NRF); Canada-Sub-Saharan Africa (CANSSA) HIV/AIDS Network; Global Health Research Initiative; Canadian International Development Agency; International Development Research Centre [106355]; Canadian Association of HIV Research; DST/NRF Research Chair in Systems Biology of HIV/AIDS; Victor Daitz Chair in HIV/TB Research; Howard Hughes Medical Institute; Michael Smith Foundation for Health Research; Abbott Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078936] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US Department of Health and Human Services from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; NIAID International Research in Infectious Diseases; South African Technology Innovation Agency (TIA); Centre for the AIDS Program of Research in South Africa (CAPRISA); United States Agency for International Development and Family Health International(United States Agency for International Development (USAID)); South African Department of Science and Technology (DST); CONRAD(United States Agency for International Development (USAID)); CIHR(Canadian Institutes of Health Research (CIHR)); Sanofi-Aventis(Sanofi-Aventis); Clinical Infectious Diseases Research Initiative (CIDRI) fellowship; Claude Leon Foundation fellowship; South African National Research Foundation (NRF)(National Research Foundation - South Africa); Canada-Sub-Saharan Africa (CANSSA) HIV/AIDS Network; Global Health Research Initiative; Canadian International Development Agency; International Development Research Centre; Canadian Association of HIV Research; DST/NRF Research Chair in Systems Biology of HIV/AIDS; Victor Daitz Chair in HIV/TB Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Abbott Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants MOP-93536, HOP-115700, and THA-118569 from the Canadian Institutes for Health Research (CIHR) to ZLB and MAB; and by the US Department of Health and Human Services grant U19-A151794 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, the NIAID International Research in Infectious Diseases grant R01-AI078936, India-South Africa collaborative grant provided through the South African Technology Innovation Agency (TIA), and the Centre for the AIDS Program of Research in South Africa (CAPRISA) to CW. The CAPRISA 004/CAPRISA Tenofovir gel Research for AIDS Prevention Science (TRAPS) program was supported by the United States Agency for International Development and Family Health International [co-operative agreement #GPO-A-00-05-00022-00 contract #132119]; the South African Department of Science and Technology (DST) and CONRAD [co-operative grant #GP00-08-00005-00, subproject PPA-09-046]. DRC is a recipient of the Canada-HOPE fellowship from CIHR and Sanofi-Aventis, the Clinical Infectious Diseases Research Initiative (CIDRI) fellowship and the Claude Leon Foundation fellowship. JKM was supported by the South African National Research Foundation (NRF). JKM and PM were supported by the Canada-Sub-Saharan Africa (CANSSA) HIV/AIDS Network, funded by the Global Health Research Initiative, a collaborative partnership of the CIHR, the Canadian International Development Agency, and the International Development Research Centre (project 106355). EM was supported by a Master's Scholarship from the Canadian Association of HIV Research and Abbott Virology. This work was supported in part by the DST/NRF Research Chair in Systems Biology of HIV/AIDS, the Victor Daitz Chair in HIV/TB Research and an International Early Career Scientist Award from the Howard Hughes Medical Institute to TN. ZLB is the recipient of a CIHR New Investigator Award and a Michael Smith Foundation for Health Research Scholar Award. MAB is a Canada Research Chair, Tier 2, in Viral Pathogenesis and Immunity. The views expressed by the authors are entirely their own and do not necessarily reflect those of their funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Corro G, 2012, AIDS RES HUM RETROV, V28, P1617, DOI [10.1089/aid.2012.0020, 10.1089/AID.2012.0020]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Mureithi MW, 2012, JAIDS-J ACQ IMM DEF, V60, P124, DOI 10.1097/QAI.0b013e31824f53a9; Mwimanzi P, 2013, VIROLOGY, V439, P74, DOI 10.1016/j.virol.2013.02.005; Mwimanzi P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-1; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Tobiume M, 2002, J VIROL, V76, P5959, DOI 10.1128/JVI.76.12.5959-5965.2002; Valley-Omar Z, 2012, J INFECT DIS, V206, P35, DOI 10.1093/infdis/jis305; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Zuo J, 2012, AIDS RES HUM RETROV, V28, P486, DOI [10.1089/aid.2011.0172, 10.1089/AID.2011.0172]	17	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71758	10.1371/journal.pone.0071758	http://dx.doi.org/10.1371/journal.pone.0071758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015191	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800013
J	Csergo, AM; Demeter, L; Turkington, R				Csergo, Anna Maria; Demeter, Laszlo; Turkington, Roy			Declining Diversity in Abandoned Grasslands of the Carpathian Mountains: Do Dominant Species Matter?	PLOS ONE			English	Article							BRACHYPODIUM-PINNATUM; CHALK GRASSLAND; HAY MEADOWS; PLANT; RICHNESS; COMPETITION; EVENNESS; MANAGEMENT; VEGETATION; RADIATION	Traditional haymaking has created exceptionally high levels of plant species diversity in semi-natural grasslands of the Carpathian Mountains (Romania), the maintenance of which is jeopardized by recent abandonment and subsequent vegetation succession. We tested the hypothesis that the different life history strategies of dominant grasses cause different patterns of diversity loss after abandonment of traditional haymaking in two types of meadow. Although diversity loss rate was not significantly different, the mechanism of loss depended on the life history of dominant species. In meadows co-dominated by competitive stress-tolerant ruderals, diversity loss occurred following the suppression of dominant grasses by tall forbs, whereas in meadows dominated by a stress-tolerant competitor, diversity loss resulted from increased abundance and biomass of the dominant grass. We conclude that management for species conservation in abandoned grasslands should manipulate the functional turnover in communities where the dominant species is a weaker competitor, and abundance and biomass of dominant species in communities where the dominant species is the stronger competitor.	[Csergo, Anna Maria] Sapientia Univ, Dept Hort, Targu Mures, Romania; [Demeter, Laszlo] Sapientia Univ, Dept Environm Engn, Miercurea Ciuc, Romania; [Csergo, Anna Maria; Turkington, Roy] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Csergo, Anna Maria; Turkington, Roy] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada	Sapientia Hungarian University of Transylvania; Sapientia Hungarian University of Transylvania; University of British Columbia; University of British Columbia	Csergo, AM (corresponding author), Sapientia Univ, Dept Hort, Targu Mures, Romania.	csergo.anna.maria@gmail.com	Csergo, Anna Maria/AAB-3581-2021; Csergő, Anna Mária/J-3446-2013; Cahill, James/B-6147-2015	Csergo, Anna Maria/0000-0003-3325-2995; Csergő, Anna Mária/0000-0003-3325-2995; Cahill, James/0000-0002-4110-1516	DG Environment through the European Forum on Nature Conservation and Pastoralism; Barbara Knowles Fund; Pogany-havas Association	DG Environment through the European Forum on Nature Conservation and Pastoralism; Barbara Knowles Fund; Pogany-havas Association	The project was funded by DG Environment through the European Forum on Nature Conservation and Pastoralism and Barbara Knowles Fund, in collaboration with the Pogany-havas Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; [Anonymous], 2001, PLANT STRATEGIES VEG; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; BERENDSE F, 1992, ECOLOGY, V73, P46, DOI 10.2307/1938719; BOBBINK R, 1987, BIOL CONSERV, V40, P301, DOI 10.1016/0006-3207(87)90122-4; BOBBINK R, 1991, BIOL CONSERV, V56, P1, DOI 10.1016/0006-3207(91)90085-N; Cioaca A, 2010, LANDSCAPES AND SOCIETIES: SELECTED CASES, P257, DOI 10.1007/978-90-481-9413-1_16; Ciocirlan V, 2000, FLORA ILUSTRATA ROMA; Cogalniceanu D, 2010, BIODIVERS CONSERV, V19, P1471, DOI 10.1007/s10531-010-9777-1; Cousins SAO, 2009, BIOL CONSERV, V142, P2752, DOI 10.1016/j.biocon.2009.07.001; Gafta D, 2008, MANUAL INTERPRETARE; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gilbert B, 2009, AM NAT, V174, P850, DOI 10.1086/647903; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP., 2014, COMP PLANT ECOLOGY F; Hansson M, 2000, J VEG SCI, V11, P31, DOI 10.2307/3236772; HERBEN T, 1994, FOLIA GEOBOT PHYTOTX, V29, P459, DOI 10.1007/BF02883144; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; HOFFMAN MT, 1994, BIODIVERSITY LETT, V2, P35, DOI DOI 10.2307/2999666; Huhta AP, 1998, ANN BOT FENN, V35, P85; Hurst A, 1999, BIOL CONSERV, V88, P75, DOI 10.1016/S0006-3207(98)00089-5; Institute Inc SAS, 2010, AS STAT 9 22 US GUID; Jacquemyn H, 2011, BIOL CONSERV, V144, P416, DOI 10.1016/j.biocon.2010.09.020; Klimes L, 2001, EVOL ECOL, V15, P363, DOI 10.1023/A:1016041100087; Klimes L, 2013, APPL VEG SCI, V16, P640, DOI 10.1111/avsc.12032; Klimesova J, 2010, FOLIA GEOBOT, V45, P225, DOI 10.1007/s12224-010-9066-5; Knowles B, 2011, MOUNTAIN HAY MEADOWS; Kohler B, 2001, PLANT SOIL, V230, P323, DOI 10.1023/A:1010335825818; Losvik MH, 1999, NORD J BOT, V19, P473, DOI 10.1111/j.1756-1051.1999.tb01231.x; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; McLaren JR, 2011, J VEG SCI, V22, P503, DOI 10.1111/j.1654-1103.2011.01263.x; Medina-Roldan E, 2011, PLANT SOIL, V344, P377, DOI 10.1007/s11104-011-0756-4; MITCHLEY J, 1988, J ECOL, V76, P341, DOI 10.2307/2260597; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; NIERING W A, 1987, Conservation Biology, V1, P287, DOI 10.1111/j.1523-1739.1987.tb00049.x; Otsus M, 2004, OECOLOGIA, V138, P293, DOI 10.1007/s00442-003-1428-8; PAWLOWSKI B, 1970, Vegetatio, V21, P181; PONS TL, 1993, OECOLOGIA, V95, P416, DOI 10.1007/BF00320997; Pykala J, 2005, BASIC APPL ECOL, V6, P25, DOI 10.1016/j.baae.2004.10.002; Reitalu T, 2010, J APPL ECOL, V47, P1216, DOI 10.1111/j.1365-2664.2010.01875.x; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Taff GN, 2010, LANDSC SER, V10, P121, DOI 10.1007/978-1-4020-9656-3_6; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; TILMAN D, 1988; Van der Graaf AJ, 2005, FUNCT ECOL, V19, P961, DOI 10.1111/j.1365-2435.2005.01056.x; Viragh K., 2003, TISCIA (Szeged), V34, P47; WHITE PS, 1988, J ECOL, V76, P192, DOI 10.2307/2260463; Wilsey BJ, 2004, ECOLOGY, V85, P2693, DOI 10.1890/04-0245; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024; Zobel M, 1998, APPL VEG SCI, V1, P55, DOI 10.2307/1479085	55	23	29	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73533	10.1371/journal.pone.0073533	http://dx.doi.org/10.1371/journal.pone.0073533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014148	Green Published, gold			2022-12-25	WOS:000323815200083
J	Na, I; Redmon, D; Kopa, M; Qin, YR; Xue, B; Uversky, VN				Na, Insung; Redmon, Derek; Kopa, Markus; Qin, Yiru; Xue, Bin; Uversky, Vladimir N.			Ordered Disorder of the Astrocytic Dystrophin-Associated Protein Complex in the Norm and Pathology	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; NATIVELY UNFOLDED PROTEINS; SEQUENCE-BASED PREDICTION; STRUCTURAL DISORDER; GLYCOPROTEIN COMPLEX; FUNCTIONAL ANTHOLOGY; MOLECULAR-MECHANISMS; SYNTROPHIN BINDING; MISSENSE MUTATION; ALPHA-SYNTROPHIN	The abundance and potential functional roles of intrinsically disordered regions in aquaporin-4, Kir4.1, a dystrophin isoforms Dp71, alpha-1 syntrophin, and alpha-dystrobrevin; i.e., proteins constituting the functional core of the astrocytic dystrophin-associated protein complex (DAPC), are analyzed by a wealth of computational tools. The correlation between protein intrinsic disorder, single nucleotide polymorphisms (SNPs) and protein function is also studied together with the peculiarities of structural and functional conservation of these proteins. Our study revealed that the DAPC members are typical hybrid proteins that contain both ordered and intrinsically disordered regions. Both ordered and disordered regions are important for the stabilization of this complex. Many disordered binding regions of these five proteins are highly conserved among vertebrates. Conserved eukaryotic linear motifs and molecular recognition features found in the disordered regions of five protein constituting DAPC likely enhance protein-protein interactions that are required for the cellular functions of this complex. Curiously, the disorder-based binding regions are rarely affected by SNPs suggesting that these regions are crucial for the biological functions of their corresponding proteins.	[Na, Insung; Redmon, Derek; Kopa, Markus; Qin, Yiru; Xue, Bin; Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	State University System of Florida; University of South Florida; Russian Academy of Sciences	Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.	vuversky@health.usf.edu	Uversky, Vladimir N./F-4515-2011; xue, bin/E-5617-2011; Qin, Yiru/AAC-8894-2021	Uversky, Vladimir N./0000-0002-4037-5857; xue, bin/0000-0002-6344-0623; Qin, Yiru/0000-0001-9787-6516; Na, Insung/0000-0003-4507-5789				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Bourhis JM, 2007, CURR PROTEIN PEPT SC, V8, P135, DOI 10.2174/138920307780363451; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Daughdrill GW, 2005, HDB PROTEIN FOLDING, P271; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2007, CURR PROTEIN PEPT SC, V8, P161, DOI 10.2174/138920307780363406; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker A K, 1998, Pac Symp Biocomput, P473; Dunker A. K., 2013, INTRINSICALLY DISORD, V1; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DWYER TM, 1995, FEBS LETT, V375, P91, DOI 10.1016/0014-5793(95)01176-F; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ehmsen J, 2002, J CELL SCI, V115, P2801; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Eraslan S, 1999, EUR J HUM GENET, V7, P765, DOI 10.1038/sj.ejhg.5200370; Esnouf RM, 2006, ACTA CRYSTALLOGR D, V62, P1260, DOI 10.1107/S0907444906033580; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Filippidis AS, 2012, ACTA NEUROCHIR SUPPL, V113, P55, DOI 10.1007/978-3-7091-0923-6_12; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Gee SH, 1998, J NEUROSCI, V18, P128; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Holder E, 1996, HUM GENET, V97, P232, DOI 10.1007/BF02265272; Hsu WL, 2012, BIOCOMPUT-PAC SYM, P116; Ichida F, 2001, CIRCULATION, V103, P1256; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Kotta-Loizou I, 2013, BBA-PROTEINS PROTEOM, V1834, P798, DOI 10.1016/j.bbapap.2013.01.006; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; MADHAVAN R, 1995, BIOCHEMISTRY-US, V34, P12204, DOI 10.1021/bi00038a014; Magri F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-37; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Meszaros B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046829; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Mosca R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014969; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Newbell BJ, 1997, BIOCHEMISTRY-US, V36, P1295, DOI 10.1021/bi962452n; Newey SE, 2000, CURR BIOL, V10, P1295, DOI 10.1016/S0960-9822(00)00760-0; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Peng Z, 2013, CELLULAR MOL LIFE SC; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Ribeiro MDC, 2013, PEERJ, V1, DOI 10.7717/peerj.2; RININSLAND F, 1994, HUM GENET, V94, P111; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120; Sigalov Alexander B, 2011, Self Nonself, V2, P55; Singh GP, 2006, PROTEINS, V62, P309, DOI 10.1002/prot.20746; Stavropoulos I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044389; SUZUKI A, 1995, J CELL BIOL, V128, P373, DOI 10.1083/jcb.128.3.373; Tada Y, 1997, GENOMICS, V45, P629, DOI 10.1006/geno.1997.4957; Tadayoni R, 2012, MOL NEUROBIOL, V45, P43, DOI 10.1007/s12035-011-8218-9; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; UVERSKY VN, 2013, BIOPOLYMERS; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu GR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P193, DOI 10.1161/CIRCEP.108.769224; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; YANG B, 1994, J BIOL CHEM, V269, P6040; YANG B, 1995, J BIOL CHEM, V270, P4975, DOI 10.1074/jbc.270.10.4975	129	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73476	10.1371/journal.pone.0073476	http://dx.doi.org/10.1371/journal.pone.0073476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014171	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200080
J	Zhang, XY; Shen, DQ; Fang, ZW; Jie, ZY; Qiu, XM; Zhang, CF; Chen, YL; Ji, LN				Zhang, Xiuying; Shen, Dongqian; Fang, Zhiwei; Jie, Zhuye; Qiu, Xinmin; Zhang, Chunfang; Chen, Yingli; Ji, Linong			Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; DIET-INDUCED OBESITY; AKKERMANSIA-MUCINIPHILA; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; BODY-WEIGHT; LIFE-STYLE; SP NOV.; MICE	To explore the relationship of gut microbiota with the development of type 2 diabetes (T2DM), we analyzed 121 subjects who were divided into 3 groups based on their glucose intolerance status: normal glucose tolerance (NGT; n = 44), prediabetes (Pre-DM; n = 64), or newly diagnosed T2DM (n = 13). Gut microbiota characterizations were determined with 16S rDNA-based high-throughput sequencing. T2DM-related dysbiosis was observed, including the separation of microbial communities and a change of alpha diversity between the different glucose intolerance statuses. To assess the correlation between metabolic parameters and microbiota diversity, clinical characteristics were also measured and a significant association between metabolic parameters (FPG, CRP) and gut microbiota was found. In addition, a total of 28 operational taxonomic units (OTUs) were found to be related to T2DM status by the Kruskal-Wallis H test, most of which were enriched in the T2DM group. Butyrate-producing bacteria (e. g. Akkermansia muciniphila ATCCBAA-835, and Faecalibacterium prausnitzii L2-6) had a higher abundance in the NGT group than in the pre-DM group. At genus level, the abundance of Bacteroides in the T2DM group was only half that of the NGT and Pre-DM groups. Previously reported T2DM-related markers were also compared with the data in this study, and some inconsistencies were noted. We found that Verrucomicrobiae may be a potential marker of T2DM as it had a significantly lower abundance in both the pre-DM and T2DM groups. In conclusion, this research provides further evidence of the structural modulation of gut microbiota in the pathogenesis of diabetes.	[Zhang, Xiuying; Chen, Yingli; Ji, Linong] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China; [Shen, Dongqian; Fang, Zhiwei; Jie, Zhuye; Qiu, Xinmin] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Chunfang] Peking Univ, Dept Clin Epidemiol, Peoples Hosp, Beijing 100871, Peoples R China	Peking University; Beijing Genomics Institute (BGI); Peking University	Ji, LN (corresponding author), Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020		National High Technology Research and Development Program [2006AA02A409]	National High Technology Research and Development Program(National High Technology Research and Development Program of China)	Financial support from the National High Technology Research and Development Program (2006AA02A409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chevrot R, 2008, INT J SYST EVOL MICR, V58, P2921, DOI 10.1099/ijs.0.2008/001297-0; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Lapthorne S, 2013, GUT MICROBES, V4, P212, DOI 10.4161/gmic.24372; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Sakon H, 2008, INT J SYST EVOL MICR, V58, P970, DOI 10.1099/ijs.0.65456-0; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27	59	473	516	8	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71108	10.1371/journal.pone.0071108	http://dx.doi.org/10.1371/journal.pone.0071108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013136	Green Submitted, gold, Green Published			2022-12-25	WOS:000323815200012
J	Arte, S; Parmanen, S; Pirinen, S; Alaluusua, S; Nieminen, P				Arte, Sirpa; Parmanen, Satu; Pirinen, Sinikka; Alaluusua, Satu; Nieminen, Pekka			Candidate Gene Analysis of Tooth Agenesis Identifies Novel Mutations in Six Genes and Suggests Significant Role for WNT and EDA Signaling and Allele Combinations	PLOS ONE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; HAIR FOLLICLE INDUCTION; ECTODYSPLASIN-A; NONSENSE MUTATION; MISSENSE MUTATION; PERMANENT TEETH; DENTAL AGENESIS; PAX9 GENE; OLIGODONTIA; HYPODONTIA	Failure to develop complete dentition, tooth agenesis, is a common developmental anomaly manifested most often as isolated but also as associated with many developmental syndromes. It typically affects third molars or one or few other permanent teeth but severe agenesis is also relatively prevalent. Here we report mutational analyses of seven candidate genes in a cohort of 127 probands with non-syndromic tooth agenesis. 82 lacked more than five permanent teeth excluding third molars, called as oligodontia. We identified 28 mutations, 17 of which were novel. Together with our previous reports, we have identified two mutations in MSX1, AXIN2 and EDARADD, five in PAX9, four in EDA and EDAR, and nine in WNT10A. They were observed in 58 probands (44%), with a mean number of missing teeth of 11.7 (range 4 to 34). Almost all of these probands had severe agenesis. Only few of the probands but several relatives with heterozygous genotypes of WNT10A or EDAR conformed to the common type of nonsyndromic tooth agenesis, incisor-premolar hypodontia. Mutations in MSX1 and PAX9 affected predominantly posterior teeth, whereas both deciduous and permanent incisors were especially sensitive to mutations in EDA and EDAR. Many mutations in EDAR, EDARADD and WNT10A were present in several families. Biallelic or heterozygous genotypes of WNT10A were observed in 32 and hemizygous or heterozygous genotypes of EDA, EDAR or EDARADD in 22 probands. An EDARADD variant were in seven probands present together with variants in EDAR or WNT10A, suggesting combined phenotypic effects of alleles in distinct genes.	[Arte, Sirpa; Parmanen, Satu; Pirinen, Sinikka; Alaluusua, Satu; Nieminen, Pekka] Univ Helsinki, Inst Dent, Helsinki, Finland; [Arte, Sirpa; Alaluusua, Satu] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Nieminen, P (corresponding author), Univ Helsinki, Inst Dent, Helsinki, Finland.	pekka.nieminen@helsinki.fi			Helsinki University Central Hospital [TYH-2010301, TYH-2012201]; Finnish Dental Society Apollonia	Helsinki University Central Hospital; Finnish Dental Society Apollonia	Funding provided by Helsinki University Central Hospital EVO grants TYH-2010301 and TYH-2012201, www.hus.fi and Finnish Dental Society Apollonia, www.apollonia.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Arte S, 2001, J DENT RES, V80, P1445, DOI 10.1177/00220345010800051201; Arte S, 2001, THESIS U HELSINKI; Bal E, 2007, HUM MUTAT, V28, P703, DOI 10.1002/humu.20500; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; De Coster PJ, 2009, J ORAL PATHOL MED, V38, P1, DOI 10.1111/j.1600-0714.2008.00699.x; Grahnen H., 1956, ODONT REV, V7, P1; HAAVIKKO K, 1971, Proceedings of the Finnish Dental Society, V67, P219; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kim JW, 2006, J DENT RES, V85, P267, DOI 10.1177/154405910608500312; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Kist R, 2005, HUM MOL GENET, V14, P3605, DOI 10.1093/hmg/ddi388; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; Laurikkala J, 2001, DEV BIOL, V229, P443, DOI 10.1006/dbio.2000.9955; Lexner MO, 2007, INT J PAEDIATR DENT, V17, P10, DOI 10.1111/j.1365-263X.2006.00801.x; Li SF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002396; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mostowska A, 2006, J HUM GENET, V51, P262, DOI 10.1007/s10038-005-0353-6; Mostowska A, 2012, CLIN GENET MEDLINEPG, DOI [10.1111/cge.12061, DOI 10.1111/CGE.12061.PUBMED:23167694.PUBMED:23167694]; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; Mustonen T, 2004, DEVELOPMENT, V131, P4907, DOI 10.1242/dev.01377; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Nieminen P, 2013, DENT ANOMALIES GENET; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Peres RCR, 2005, ARCH ORAL BIOL, V50, P861, DOI 10.1016/j.archoralbio.2005.02.003; Petrof G, 2011, AUSTRALAS J DERMATOL, V52, P224, DOI 10.1111/j.1440-0960.2011.00788.x; Pirinen S, 2001, J MED GENET, V38, P551, DOI 10.1136/jmg.38.8.551; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Plaisancie J, 2013, AM J MED GENET A, V161A, P671, DOI 10.1002/ajmg.a.35747; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Rolling S, 2009, INT J PAEDIATR DENT, V19, P172, DOI 10.1111/j.1365-263X.2008.00958.x; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Schalk-van der Weide Y, 1992, THESIS RIJKSUNIVERSI; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Tarpey P, 2007, AM J MED GENET A, V143A, P390, DOI 10.1002/ajmg.a.31567; Thesleff I, 2005, TOOTH INDUCTION; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; van der Hout AH, 2008, EUR J HUM GENET, V16, P673, DOI 10.1038/sj.ejhg.5202012; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	54	76	83	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73705	10.1371/journal.pone.0073705	http://dx.doi.org/10.1371/journal.pone.0073705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991204	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470700065
J	Rieger, T; Merkler, D; Gunther, S				Rieger, Toni; Merkler, Doron; Guenther, Stephan			Infection of Type I Interferon Receptor-Deficient Mice with Various Old World Arenaviruses: A Model for Studying Virulence and Host Species Barriers	PLOS ONE			English	Article							LASSA VIRUS-INFECTION; HUMAN DENDRITIC CELLS; MASTOMYS-NATALENSIS; RHESUS-MONKEYS; WEST-AFRICA; FEVER ENCEPHALOPATHY; MOPEIA VIRUS; SIERRA-LEONE; GUINEA-PIGS; NUCLEOPROTEIN	Lassa virus causes hemorrhagic Lassa fever in humans, while the related Old World arenaviruses Mopeia, Morogoro, and Mobala are supposedly apathogenic to humans and cause only inapparent infection in non-human primates. Here, we studied whether the virulence of Old World arenaviruses in humans and non-human primates is reflected in type I interferon receptor deficient (IFNAR(-/-)) mice by testing several strains of Lassa virus vs. the apathogenic viruses Mopeia, Morogoro, and Mobala. All Lassa virus strains tested-Josiah, AV, BA366, and Nig04-10-replicated to high titers in blood, lung, kidney, heart, spleen, brain, and liver and caused disease as evidenced by weight loss and elevation of aspartate and alanine aminotransferase (AST and ALT) levels with a high AST/ALT ratio. Lassa fever-like pathology included acute hepatitis, interstitial pneumonia, and pronounced disturbance of splenic cytoarchitecture. Infiltrations of activated monocytes/macrophages expressing inducible nitric oxide synthase and T cells were found in liver and lung. In contrast, Mopeia, Morogoro, and Mobala virus replicated poorly in the animals and acute inflammatory alterations were not noted. Depletion of CD4(+) and CD8(+) T cells strongly enhanced susceptibility of IFNAR(-/-) mice to the apathogenic viruses. In conclusion, the virulence of Old World arenaviruses in IFNAR(-/-) mice correlates with their virulence in humans and non-human primates. In addition to the type I interferon system, T cells seem to regulate whether or not an arenavirus can productively infect non-host rodent species. The observation that Lassa virus overcomes the species barrier without artificial depletion of T cells suggests it is able to impair T cell functionality in a way that corresponds to depletion.	[Rieger, Toni; Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany; [Rieger, Toni; Guenther, Stephan] German Ctr Infect Res DZIF, Hamburg, Germany; [Merkler, Doron] Univ Gottingen, Dept Neuropathol, D-37073 Gottingen, Germany; [Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Merkler, Doron] Dept Pathol & Immunol, Geneva, Switzerland	Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research; University of Gottingen; University of Geneva	Gunther, S (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	guenther@bni.uni-hamburg.de	Merkler, Doron/N-9157-2016	Merkler, Doron/0000-0002-0247-2007; Rieger, Toni/0000-0002-7863-1916; Gunther, Stephan/0000-0002-6562-0230	European Community [228292]; Swiss National Science Foundation [PP00P3 128372]	European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grant 228292 (European Virus Archive) from the European Community. DM is supported by the Swiss National Science Foundation (PP00P3 128372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839; Baize S, 2004, J IMMUNOL, V172, P2861, DOI 10.4049/jimmunol.172.5.2861; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; CALLIS RT, 1982, AM J TROP MED HYG, V31, P1038, DOI 10.4269/ajtmh.1982.31.1038; Coulibaly-N'Golo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020893; CUMMINS D, 1992, J TROP MED HYG, V95, P197; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Flatz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000836; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; GONZALEZ JP, 1983, INTERVIROLOGY, V19, P105, DOI 10.1159/000149344; Grove JN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-314; Gunther S, 2009, EMERG INFECT DIS, V15, P2008, DOI 10.3201/eid1512.090864; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; Gunther S, 2001, J INFECT DIS, V184, P345, DOI 10.1086/322033; HUFERT FT, 1989, ARCH VIROL, V106, P201, DOI 10.1007/BF01313953; JAHRLING PB, 1980, J INFECT DIS, V141, P580, DOI 10.1093/infdis/141.5.580; JAHRLING PB, 1985, T ROY SOC TROP MED H, V79, P374, DOI 10.1016/0035-9203(85)90386-4; JAHRLING PB, 1982, INFECT IMMUN, V37, P771, DOI 10.1128/IAI.37.2.771-778.1982; JOHNSON KM, 1981, AM J TROP MED HYG, V30, P1291, DOI 10.4269/ajtmh.1981.30.1291; Kerber R, 2011, J VIROL, V85, P12518, DOI 10.1128/JVI.05091-11; KILEY MP, 1979, LANCET, V2, P738; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LANGE JV, 1985, AM J TROP MED HYG, V34, P999, DOI 10.4269/ajtmh.1985.34.999; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; LUKASHEVICH IS, 1992, VIROLOGY, V188, P600, DOI 10.1016/0042-6822(92)90514-P; LUKASHEVICH IS, 1983, ACTA VIROL, V27, P282; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; MCCORMICK JB, 1986, AM J TROP MED HYG, V35, P401, DOI 10.4269/ajtmh.1986.35.401; MONATH TP, 1974, SCIENCE, V185, P263, DOI 10.1126/science.185.4147.263; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Omilabu SA, 2005, EMERG INFECT DIS, V11, P1642, DOI 10.3201/eid1110.041343; Pannetier D, 2011, J VIROL, V85, P8293, DOI 10.1128/JVI.02120-10; PETERS CJ, 1987, CURR TOP MICROBIOL, V134, P5, DOI DOI 10.1007/978-3-642-71726-0_; Safronetz D, 2010, EMERG INFECT DIS, V16, P1123, DOI 10.3201/eid1607.100146; Schmitz H, 2002, MICROBES INFECT, V4, P43, DOI 10.1016/S1286-4579(01)01508-8; WALKER DH, 1975, AM J PATHOL, V80, P261; WALKER DH, 1975, B WORLD HEALTH ORGAN, V52, P523; WALKER DH, 1982, J INFECT DIS, V146, P360, DOI 10.1093/infdis/146.3.360; WALKER DH, 1982, AM J PATHOL, V107, P349; WINN WC, 1975, B WORLD HEALTH ORGAN, V52, P535; WULFF H, 1979, B WORLD HEALTH ORGAN, V57, P631; WULFF H, 1977, B WORLD HEALTH ORGAN, V55, P441; Yun NE, 2012, J VIROL, V86, P3389, DOI 10.1128/JVI.06284-11; Zhou XH, 2004, COMPARATIVE MED, V54, P176	50	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72290	10.1371/journal.pone.0072290	http://dx.doi.org/10.1371/journal.pone.0072290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991083	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700034
J	Feldman, AG; Tucker, RM; Fenner, EK; Pelanda, R; Mack, CL				Feldman, Amy G.; Tucker, Rebecca M.; Fenner, Erika K.; Pelanda, Roberta; Mack, Cara L.			B Cell Deficient Mice Are Protected from Biliary Obstruction in the Rotavirus-Induced Mouse Model of Biliary Atresia	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIGEN-PRESENTING CELLS; BILE-DUCT INJURY; PRIMING IN-VIVO; RHEUMATOID-ARTHRITIS; LUPUS NEPHRITIS; OPEN-LABEL; IG-ALPHA; LYMPHOCYTES; RITUXIMAB	A leading theory regarding the pathogenesis of biliary atresia (BA) is that bile duct injury is initiated by a virus infection, followed by an autoimmune response targeting bile ducts. In experimental models of autoimmune diseases, B cells have been shown to play an important role. The aim of this study was to determine the role of B cells in the development of biliary obstruction in the Rhesus rotavirus (RRV)-induced mouse model of BA. Wild-type (WT) and B cell-deficient (Ig-alpha(-/-)) mice received RRV shortly after birth. Ig-alpha(-/-) RRV-infected mice had significantly increased disease-free survival rate compared to WT RRV-infected BA mice (76.8% vs. 17.5%). In stark contrast to the RRV-infected BA mice, the RRV-infected Ig-alpha(-/-) mice did not have hyperbilirubinemia or bile duct obstruction. The RRV-infected Ig-alpha(-/-) mice had significantly less liver inflammation and Th1 cytokine production compared to RRV-infected WT mice. In addition, Ig-alpha(-/-) mice had significantly increased numbers of regulatory T cells (Tregs) at baseline and after RRV infection compared to WT mice. However, depletion of Tregs in Ig-alpha(-/-) mice did not induce biliary obstruction, indicating that the expanded Tregs in the Ig-alpha(-/-) mice were not the sole reason for protection from disease. Conclusion: B cell deficient Ig-alpha(-/-) mice are protected from biliary obstruction in the RRV-induced mouse model of BA, indicating a primary role of B cells in mediating disease pathology. The mechanism of protection may involve lack of B cell antigen presentation, which impairs T-cell activation and Th1 inflammation. Immune modulators that inhibit B cell function may be a new strategy for treatment of BA.	[Feldman, Amy G.; Mack, Cara L.] Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol, Aurora, CO USA; [Tucker, Rebecca M.; Fenner, Erika K.; Mack, Cara L.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Tucker, Rebecca M.; Fenner, Erika K.; Mack, Cara L.] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO USA; [Pelanda, Roberta] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Feldman, AG (corresponding author), Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol, Aurora, CO USA.	afeldman@luriechildrens.org			NIDDK [1 RO1 DK078195]; Children's Hospital Colorado Research Institute; Cystic Fibrosis Foundation [FELDMA10BO];  [R01 AI052310];  [T32-DK06700907]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078195] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Children's Hospital Colorado Research Institute; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Mack: NIDDK 1 RO1 DK078195; Children's Hospital Colorado Research Institute; Pelanda: R01 AI052310; Feldman: T32-DK06700907; Cystic Fibrosis Foundation, FELDMA10BO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Braley-Mullen H, 2000, J IMMUNOL, V165, P7262, DOI 10.4049/jimmunol.165.12.7262; Brindley SM, 2012, HEPATOLOGY, V55, P1130, DOI 10.1002/hep.24807; Chan O, 1998, J IMMUNOL, V160, P51; Chan OTM, 1999, J IMMUNOL, V163, P3592; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Falcone M, 1998, J IMMUNOL, V161, P1163; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; HADCHOUEL M, 1981, HISTOPATHOLOGY, V5, P217, DOI 10.1111/j.1365-2559.1981.tb01779.x; Hamel KM, 2011, J IMMUNOL, V187, P4900, DOI 10.4049/jimmunol.1101844; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Jevon GP, 1999, PEDIATR DEVEL PATHOL, V2, P11, DOI 10.1007/s100249900083; KURTJONES EA, 1988, J IMMUNOL, V140, P3773; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P13, DOI 10.1016/j.jaci.2007.11.030; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lu BR, 2010, GASTROENTEROLOGY, V139, P1753, DOI 10.1053/j.gastro.2010.07.042; Lykavieris P, 2005, HEPATOLOGY, V41, P366, DOI 10.1002/hep.20547; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Mack CL, 2007, SEMIN LIVER DIS, V27, P233, DOI 10.1055/s-2007-985068; Mack CL, 2006, HEPATOLOGY, V44, P1231, DOI 10.1002/hep.21366; Mack CL, 2012, SEMIN LIVER DIS, V32, P307, DOI 10.1055/s-0032-1329899; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Myers RC, 2013, EUR J IMMUNOL, V43, P348, DOI 10.1002/eji.201242471; Noorchashm H, 1999, J IMMUNOL, V163, P743; O'Neill SK, 2005, J IMMUNOL, V174, P3781, DOI 10.4049/jimmunol.174.6.3781; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Petersen C, 1998, J HEPATOL, V28, P603, DOI 10.1016/S0168-8278(98)80283-3; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; RiepenhoffTalty M, 1996, J INFECT DIS, V174, P8, DOI 10.1093/infdis/174.1.8; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Rodriguez-Pinto D, 2005, EUR J IMMUNOL, V35, P1097, DOI 10.1002/eji.200425732; RON Y, 1987, J IMMUNOL, V138, P2848; Saxena V, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002069; SCHREIBER RA, 1993, J PEDIATR GASTR NUTR, V16, P111, DOI 10.1097/00005176-199302000-00001; Serreze DV, 1998, J IMMUNOL, V161, P3912; Sfikakis PP, 2007, CLIN IMMUNOL, V123, P66, DOI 10.1016/j.clim.2006.12.006; Sfikakis PP, 2005, ARTHRITIS RHEUM-US, V52, P501, DOI 10.1002/art.20858; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Shivakumar P, 2007, GASTROENTEROLOGY, V133, P268, DOI 10.1053/j.gastro.2007.04.031; Sokol RJ, 2003, J PEDIATR GASTR NUTR, V37, P4, DOI 10.1097/00005176-200307000-00003; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Stasi R, 2008, BLOOD, V112, P1147, DOI 10.1182/blood-2007-12-129262; TAN CEL, 1994, J PEDIATR SURG, V29, P808, DOI 10.1016/0022-3468(94)90377-8; TUCKER RM, 2013, J HEPATOL; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; Vermeulen N, 2011, INFLAMM BOWEL DIS, V17, P1291, DOI 10.1002/ibd.21508; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Yu SG, 2006, J EXP MED, V203, P349, DOI 10.1084/jem.20051438	59	29	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73644	10.1371/journal.pone.0073644	http://dx.doi.org/10.1371/journal.pone.0073644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991203	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100132
J	Wang, B; Yan, TY; Wu, JL; Chen, KW; Imajyo, S; Ohno, S; Kanazawa, S				Wang, Bin; Yan, Tianyi; Wu, Jinglong; Chen, Kewei; Imajyo, Satoshi; Ohno, Seiichiro; Kanazawa, Susumu			Regional Neural Response Differences in the Determination of Faces or Houses Positioned in a Wide Visual Field	PLOS ONE			English	Article							VERTICAL MERIDIAN ASYMMETRY; SURFACE-BASED ANALYSIS; HUMAN OBJECT AREAS; RETINOTOPIC ORGANIZATION; GANGLION-CELLS; CORTEX; SENSITIVITY; STIMULI; RETINA; SPECIALIZATION	In human visual cortex, the primary visual cortex (V1) is considered to be essential for visual information processing; the fusiform face area (FFA) and parahippocampal place area (PPA) are considered as face-selective region and places-selective region, respectively. Recently, a functional magnetic resonance imaging (fMRI) study showed that the neural activity ratios between V1 and FFA were constant as eccentricities increasing in central visual field. However, in wide visual field, the neural activity relationships between V1 and FFA or V1 and PPA are still unclear. In this work, using fMRI and wide-view present system, we tried to address this issue by measuring neural activities in V1, FFA and PPA for the images of faces and houses aligning in 4 eccentricities and 4 meridians. Then, we further calculated ratio relative to V1 (RRV1) as comparing the neural responses amplitudes in FFA or PPA with those in V1. We found V1, FFA, and PPA showed significant different neural activities to faces and houses in 3 dimensions of eccentricity, meridian, and region. Most importantly, the RRV1s in FFA and PPA also exhibited significant differences in 3 dimensions. In the dimension of eccentricity, both FFA and PPA showed smaller RRV1s at central position than those at peripheral positions. In meridian dimension, both FFA and PPA showed larger RRV1s at upper vertical positions than those at lower vertical positions. In the dimension of region, FFA had larger RRV1s than PPA. We proposed that these differential RRV1s indicated FFA and PPA might have different processing strategies for encoding the wide field visual information from V1. These different processing strategies might depend on the retinal position at which faces or houses are typically observed in daily life. We posited a role of experience in shaping the information processing strategies in the ventral visual cortex.	[Wang, Bin; Yan, Tianyi; Wu, Jinglong] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [Wang, Bin; Wu, Jinglong] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Chen, Kewei] Banner Alzheimer Inst, Computat Image Anal Program, Phoenix, AZ USA; [Chen, Kewei] Banner Good Samaritan PET Ctr, Phoenix, AZ USA; [Imajyo, Satoshi; Ohno, Seiichiro] Okayama Univ, Okayama Univ Hosp, Dept Radiol, Okayama, Japan; [Kanazawa, Susumu] Okayama Univ, Grad Sch Med, Okayama, Japan	Beijing Institute of Technology; Okayama University; Banner Research; Banner Health; Banner Alzheimer's Institute; Banner Research; Banner Health; Okayama University; Okayama University	Wu, JL (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	wu@mech.okayama-u.ac.jp	Chen, kewei/P-6304-2015; 闫, 天翼/ABC-7229-2021	Chen, kewei/0000-0001-8497-3069; 	JSPS [25303013, 24686034]; VINNOVA under the Japan-Sweden Research Cooperative Program; Okayama University	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); VINNOVA under the Japan-Sweden Research Cooperative Program; Okayama University	This research was partially supported by JSPS Grant-in-Aid for Scientific Research (B), Grant number: 25303013, by JSPS Grant-in-Aid for Young Scientists (A), Grant number: 24686034, by JSPS and VINNOVA under the Japan-Sweden Research Cooperative Program, and by Grant-in-Aids for strategic research promotion by Okayama University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2012, VISION RES, V52, P70, DOI 10.1016/j.visres.2011.10.016; Ales JM, 2010, NEUROIMAGE, V52, P1401, DOI 10.1016/j.neuroimage.2010.05.016; Arcaro MJ, 2009, J NEUROSCI, V29, P10638, DOI 10.1523/JNEUROSCI.2807-09.2009; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fujimoto K, 2007, J VISION, V7, DOI 10.1167/7.8.16; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Golomb J. D., 2011, CEREB CORTEX, DOI [10.1093/cercor/bhr357, DOI 10.1093/CERC0R/BHR357]; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Kanwisher N, 2001, NAT NEUROSCI, V4, P455, DOI 10.1038/87399; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Liu TH, 2006, J VISION, V6, P1294, DOI 10.1167/6.11.12; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; MULLEN KT, 1991, VISION RES, V31, P119, DOI 10.1016/0042-6989(91)90079-K; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; NOORLANDER C, 1983, VISION RES, V23, P1, DOI 10.1016/0042-6989(83)90035-4; Norman-Haignere SV, 2012, CEREB CORTEX, V22, P391, DOI 10.1093/cercor/bhr118; Olman CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008160; Parrish T, 2006, AM J NEURORADIOL, V27, P247; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Rosenholtz R, 2012, J VISION, V12, DOI 10.1167/12.4.14; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Simmons WK, 2010, CEREB CORTEX, V20, P813, DOI 10.1093/cercor/bhp149; Stephan KE, 2007, J NEUROSCI, V27, P3512, DOI 10.1523/JNEUROSCI.4766-06.2007; Strigel RM, 2005, AM J NEURORADIOL, V26, P578; Strother L, 2010, J NEUROPHYSIOL, V104, P2075, DOI 10.1152/jn.00462.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Thibos LN, 1996, VISION RES, V36, P249, DOI 10.1016/0042-6989(95)00109-D; Thomas NA, 2011, BRAIN RES, V1387, P108, DOI 10.1016/j.brainres.2011.02.063; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Wu JL, 2013, J NEUROSCI METH, V214, P126, DOI 10.1016/j.jneumeth.2013.01.021; Wu JL, 2012, HUM BRAIN MAPP, V33, P1727, DOI 10.1002/hbm.21324; Yue XM, 2011, CEREB CORTEX, V21, P35, DOI 10.1093/cercor/bhq050	58	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72728	10.1371/journal.pone.0072728	http://dx.doi.org/10.1371/journal.pone.0072728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991147	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100114
J	Kim, IG; Kim, SY; Choi, SI; Lee, JH; Kim, KC; Cho, EW				Kim, I. G.; Kim, S. Y.; Choi, S. I.; Lee, J. H.; Kim, K. C.; Cho, E. W.			Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH plus lung cancer stem cells through IGF1R signaling	ONCOGENE			English	Article						FBLN3; lung; EMT; cancer stem cells; IGF1R/PI3K/AKT/GSK3 beta pathway	GROWTH-FACTOR RECEPTOR; GLIOMA GROWTH; BETA-CATENIN; TGF-BETA; PATHWAY; RESISTANCE; INVASION; INSULIN; TARGET; PROGRESSION	Fibulins (FBLNs), a family of extracellular matrix proteins, have recently been shown to act as tumor suppressors or activators in different cancers, and the underlying molecular mechanisms of their action in cancer remain unclear. We have previously shown that the expression of FBLN3 is suppressed by promoter hypermethylation and is associated with invasiveness in aggressive non-small cell lung cancer. In this study, we evaluated the roles and signaling mechanism of FBLN3 in lung cancer stem cells (CSCs). Forced expression of FBLN3 suppressed invasion and migration of lung adenocarcinoma cells and decreased the expression of epithelial-to-mesenchymal transition (EMT) activators, including N-cadherin and Snail. Stemness activities of lung adenocarcinoma cells were also suppressed by FBLN3 as indicated by a decrease in spheroid formation and the levels of stemness markers such as Sox2 and beta-catenin. These effects of FBLN3 were mediated by the glycogen synthase kinase-3 beta, GSK3 beta/beta-catenin pathway, and the upstream regulators of GSK3 beta, including phosphoinositide 3-kinase (PI3K)/AKT and insulin-like growth factor-1 receptor (IGF1R), were inactivated by FBLN3. Moreover, IGF1R was shown to be a direct target of FBLN3, which competitively inhibited insulin-like growth factor (IGF) action. To confirm the effect of FBLN3 on lung CSCs, aldehyde dehydrogenase-positive (ALDH +) A549 lung CSCs were sorted and treated with recombinant FBLN3 protein. FBLN3 clearly suppressed EMT, stemness activity and the over-activated IGF1R/PI3K/AKT/GSK3 beta pathway of the ALDH + CSC subpopulation. In addition, injection of recombinant FBLN3 protein around subcutaneous xenografts established with ALDH + CSCs in athymic nude mice significantly suppressed tumor growth and progression. Overall, our results show that FBLN3 suppresses both EMT and self-renewal of the lung CSCs by modulating the IGF1R/PI3K/AKT/GSK3 beta pathway and that FBLN3 would be useful as an alternative CSC therapy.	[Kim, I. G.; Kim, S. Y.; Choi, S. I.; Lee, J. H.; Kim, K. C.] KAERI, Environm Radiat Res Grp, Dept Radiat Biol, Taejon 305353, South Korea; [Kim, I. G.; Choi, S. I.; Lee, J. H.] Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Taejon, South Korea; [Cho, E. W.] Korea Res Inst Biosci & Biotechnol, Canc Biomarkers Dev Res Ctr, Taejon, South Korea	Korea Atomic Energy Research Institute (KAERI); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, IG (corresponding author), KAERI, Environm Radiat Res Grp, Dept Radiat Biol, 989-111 Daedeok daero, Taejon 305353, South Korea.	igkim@kaeri.re.kr			Ministry of Science, ICT & Future Planning (Nuclear Research and Development Program) of the Republic of Korea; Korea Atomic Energy Research Institute	Ministry of Science, ICT & Future Planning (Nuclear Research and Development Program) of the Republic of Korea; Korea Atomic Energy Research Institute	We acknowledge the financial supports from the Ministry of Science, ICT & Future Planning (Nuclear Research and Development Program) of the Republic of Korea and basic program of Korea Atomic Energy Research Institute.	Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Bill A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041179; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brognard J, 2001, CANCER RES, V61, P3986; Camaj P, 2009, BIOL CHEM, V390, P1293, DOI 10.1515/BC.2009.140; Cappuzzo F, 2010, ANN ONCOL, V21, P562, DOI 10.1093/annonc/mdp357; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Esposito L, 2010, CURR GENOMICS, V11, P513, DOI 10.2174/138920210793175903; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gorelik E, 2010, ANTI-CANCER AGENT ME, V10, P164, DOI 10.2174/187152010790909308; Heist RS, 2009, PHARMACOGENOMICS, V10, P59, DOI 10.2217/14622416.10.1.59; Hu B, 2012, CANCER RES, V72, P3873, DOI 10.1158/0008-5472.CAN-12-1060; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Ischenko I, 2008, CURR MED CHEM, V15, P3171, DOI 10.2174/092986708786848541; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Jones RA, 2009, ONCOGENE, V28, P2152, DOI 10.1038/onc.2009.79; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCubrey JA, 2012, CURR PHARM DESIGN, V18, P1784; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Rivera C, 2011, J ONCOL, V2011, DOI 10.1155/2011/549181; Rui W, 2010, LUNG CANCER, V69, P239, DOI 10.1016/j.lungcan.2009.10.009; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang JL, 2011, CLIN CANCER RES, V17, P7563, DOI 10.1158/1078-0432.CCR-11-1707; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398	53	57	61	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3908	3917		10.1038/onc.2013.373	http://dx.doi.org/10.1038/onc.2013.373			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24013232				2022-12-25	WOS:000339394700003
J	Yu, H; Liu, T; Zhao, Z; Chen, Y; Zeng, J; Liu, S; Zhu, F				Yu, H.; Liu, T.; Zhao, Z.; Chen, Y.; Zeng, J.; Liu, S.; Zhu, F.			Mutations in 3 '-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb	ONCOGENE			English	Article						urothelial cell carcinoma of the bladder; syncytin-1; human endogenous retrovirus; long terminal repeat; c-Myb	MARROW-DERIVED CELLS; HUMAN BREAST-CANCER; MOLECULAR-DYNAMICS; ENDOGENOUS RETROVIRUSES; HUMAN TISSUES; IN-VITRO; PROTEIN; FUSION; GENE; TRANSFORMATION	Human endogenous retrovirus (HERV) accounts for similar to 8% of the human genome. Recent studies have reported that multiple HERV genes and long terminal repeats (LTRs) are involved in human tumorigenesis. Here we demonstrated that HERV-W env (syncytin-1) was overexpressed in 75.6% (62/82) of urothelial cell carcinoma (UCC) tissues of the bladder compared with only 6.1% (5/82) of matched tumor-adjacent tissues (P<0.001). Syncytin-1 overexpression increased proliferation and viability of immortalized human uroepithelial cells. Colony-formation experiments and in-vivo tumor xenografts suggested that syncytin-1 overexpression had oncogenic potential. Syncytin-1 3'-LTR mutations (142T>C and 277A>G) were present in 87.8% (72/82) of UCC tissues. Normal 3'-LTR was found in 12.2% (10/82) of UCC tissues compared with 95.1% (78/82) of matched tumor-adjacent tissues (P<0.001). Interestingly, 3'-LTR mutations were significantly associated with syncytin-1 overexpression. Luciferase assay and expression analysis revealed that 3'-LTR mutations, especially the 142T>C mutation, enhanced the syncytin-1 promoter activity and expression. In-silico analysis, electrophoretic mobility shift assays and chromatin immunoprecipitation assays demonstrated the binding of c-Myb to 3'-LTRs when the mutations occurred. This alternative interaction was found to be dependent on 142T>C mutation. C-Myb activated syncytin-1 promoter activity and expression by binding to mutant 3'-LTRs. Taken together, these data indicate that syncytin-1 overexpression may be an indicator of UCC risk. The 3'-LTR mutations may upregulate syncytin-1 expression, enabling it to participate in UCC tumorigenesis and development by interacting with c-Myb.	[Yu, H.; Chen, Y.; Zeng, J.; Zhu, F.] Wuhan Univ, Sch Med, Dept Med Microbiol, Wuhan 430071, Peoples R China; [Liu, T.; Liu, S.] Beijing Inst Basic Med Sci, State Key Lab Prote, Dept Neurobiol, Beijing, Peoples R China; [Zhao, Z.] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China	Wuhan University; Academy of Military Medical Sciences - China; Wuhan University	Zhu, F (corresponding author), Wuhan Univ, Sch Med, Dept Med Microbiol, 185 Donghu Rd, Wuhan 430071, Peoples R China.	zhufan@hotmail.com	; Liu, Tao/C-7796-2011	Yu, Honglian/0000-0003-3915-056X; zhu, fan/0000-0001-7031-2956; Liu, Tao/0000-0003-1701-6618	National Natural Sciences Foundation of China [81271820, 30870789, 30300117]; Stanley Foundation from the Stanley Medical Research Institute (SMRI), USA [06R-1366]; Hubei Provincial Natural Science Foundation for Innovative Research Team [2012FFA043]; Wuhan University [274041]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Stanley Foundation from the Stanley Medical Research Institute (SMRI), USA; Hubei Provincial Natural Science Foundation for Innovative Research Team; Wuhan University	We thank Wei Jin (Fudan University, Shanghai, China) for providing the plasmid pCMV-c-Myb. We would like to thank Don Banting, Awadhesh Kumar Sah and Navin Shrestha for polishing our writing. This work was supported by grants from the National Natural Sciences Foundation of China (No. 81271820, No. 30870789 and No. 30300117), the Stanley Foundation from the Stanley Medical Research Institute (SMRI), USA (No. 06R-1366) for Dr F Zhu, Hubei Provincial Natural Science Foundation for Innovative Research Team (No. 2012FFA043) and the project of Innovative Research Team of Wuhan University (No. 274041).	Ahn K, 2009, MOL CELLS, V28, P99, DOI 10.1007/s10059-009-0107-y; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Boese A, 2000, ONCOGENE, V19, P4328, DOI 10.1038/sj.onc.1203794; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Delidaki M, 2011, MOL CELL ENDOCRINOL, V332, P213, DOI 10.1016/j.mce.2010.10.013; Doern CD, 2008, MICROBIOL-SGM, V154, P1998, DOI 10.1099/mic.0.2007/013466-0; Eble JN, 2004, PATHOLOGY GENETICS T; Edge SB, 2010, AJCC CANC STAGING MA; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Huang WJ, 2011, SCHIZOPHRENIA BULL, V37, P988, DOI 10.1093/schbul/sbp166; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KERBEL RS, 1983, MOL CELL BIOL, V3, P523, DOI 10.1128/MCB.3.4.523; Knerr I, 2007, APOPTOSIS, V12, P37, DOI 10.1007/s10495-006-0329-9; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2002, GENOMICS, V80, P499, DOI 10.1006/geno.2002.6863; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Lu X, 2011, ADV EXP MED BIOL, V714, P129, DOI 10.1007/978-94-007-0782-5_6; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; LUTY BA, 1994, MOL SIMULAT, V14, P11, DOI 10.1080/08927029408022004; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Nellaker C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-44; Okamoto M, 1996, CANCER RES, V56, P4649; Perron H, 2012, MULT SCLER J, V18, P1721, DOI 10.1177/1352458512441381; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; ROSZELL JA, 1977, CANCER RES, V37, P239; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Sin HS, 2006, ARCH VIROL, V151, P1985, DOI 10.1007/s00705-006-0764-5; Stauffer Yves, 2004, Cancer Immun, V4, P2; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Wang-Johanning F, 2003, ONCOGENE, V22, P1528, DOI 10.1038/sj.onc.1206241; Wang-Johanning F, 2001, CLIN CANCER RES, V7, P1553; Wei W, 2006, CANCER LETT, V244, P119, DOI 10.1016/j.canlet.2005.12.008; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhao Jing, 2011, Genes Cancer, V2, P914, DOI 10.1177/1947601911431841; Zhu F, 2005, BIOCHEMISTRY-MOSCOW+, V70, P920, DOI 10.1007/s10541-005-0203-3	53	43	44	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3947	3958		10.1038/onc.2013.366	http://dx.doi.org/10.1038/onc.2013.366			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24013223				2022-12-25	WOS:000339394700007
J	Huang, J; Stewart, A; Maity, B; Hagen, J; Fagan, RL; Yang, J; Quelle, DE; Brenner, C; Fisher, RA				Huang, J.; Stewart, A.; Maity, B.; Hagen, J.; Fagan, R. L.; Yang, J.; Quelle, D. E.; Brenner, C.; Fisher, R. A.			RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis	ONCOGENE			English	Article						RGS protein; Ras; cellular transformation; Dnmt1; Tip60; apoptosis	PROTEIN SIGNALING 6; HETEROTRIMERIC G-PROTEINS; DNA METHYLTRANSFERASE; PROSTATE-CANCER; P53 ACTIVATION; BREAST-CANCER; CPG ISLANDS; EXPRESSION; CELLS; METHYLATION	The RAS protooncogene has a central role in regulation of cell proliferation, and point mutations leading to oncogenic activation of Ras occur in a large number of human cancers. Silencing of tumor-suppressor genes by DNA methyltransferase 1 (Dnmt1) is essential for oncogenic cellular transformation by Ras, and Dnmt1 is overexpressed in numerous human cancers. Here we provide new evidence that the pleiotropic regulator of G protein signaling (RGS) family member RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated degradation of Dmnt1 and promoting apoptosis. Employing mouse embryonic fibroblasts from wild-type and RGS6(-/-) mice, we found that oncogenic Ras induced upregulation of RGS6, which in turn blocked Ras-induced cellular transformation. RGS6 functions to suppress cellular transformation in response to oncogenic Ras by downregulating Dnmt1 protein expression leading to inhibition of Dnmt1-mediated anti-apoptotic activity. Further experiments showed that RGS6 functions as a scaffolding protein for both Dnmt1 and Tip60 and is required for Tip60-mediated acetylation of Dnmt1 and subsequent Dnmt1 ubiquitylation and degradation. The RGS domain of RGS6, known only for its GTPase-activating protein activity toward G alpha subunits, was sufficient to mediate Tip60 association with RGS6. This work demonstrates a novel signaling action for RGS6 in negative regulation of oncogene-induced transformation and provides new insights into our understanding of the mechanisms underlying Ras-induced oncogenic transformation and regulation of Dnmt1 expression. Importantly, these findings identify RGS6 as an essential cellular defender against oncogenic stress and a potential therapeutic target for developing new cancer treatments.	[Huang, J.; Stewart, A.; Maity, B.; Hagen, J.; Yang, J.; Quelle, D. E.; Fisher, R. A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Fagan, R. L.; Brenner, C.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Fisher, RA (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, 2-512 Bowen Sci Bldg, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Quelle, Dawn/0000-0001-8776-0122; Stewart, Adele/0000-0003-4968-2471; Fisher, Rory/0000-0003-3108-4836; Switzer, Rebecca/0000-0003-0591-2538	National Cancer Institute [CA161882, HHSN261200433000C, CA075954, CA090367]; American Cancer Society [PF-11-141-01]; NATIONAL CANCER INSTITUTE [R01CA161882, P30CA086862, R01CA090367, R01CA075954] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr John Koland for his careful reading of and useful suggestions for this manuscript, and Sara Reed for identifying effective Tip60 small hairpin RNAs for our assays. This project was supported by National Cancer Institute grants and contracts CA161882 (RAF), HHSN261200433000C (CB), CA075954 (CB), CA090367 (DEQ) and American Cancer Society (PF-11-141-01 (RLF)).	Berman DM, 2004, CANCER RES, V64, P6820, DOI 10.1158/0008-5472.CAN-04-1916; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen M, 2012, MOL CANCER THER, V11, P370, DOI 10.1158/1535-7163.MCT-11-0458; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fagan RL, 2013, J BIOL CHEM, V288, P23858, DOI 10.1074/jbc.M113.480517; Geutjes EJ, 2012, ONCOGENE, V31, P3827, DOI 10.1038/onc.2011.552; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Huang J, 2011, CANCER RES, V71, P6310, DOI 10.1158/0008-5472.CAN-10-3397; Leonhardt H, 2000, J CELL BIOCHEM, P78; Li LC, 2004, BBA-REV CANCER, V1704, P87, DOI 10.1016/j.bbcan.2004.06.001; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Liu ZY, 2002, J BIOL CHEM, V277, P37832, DOI 10.1074/jbc.M205908200; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Maity B, 2013, CARCINOGENESIS, V34, P1747, DOI 10.1093/carcin/bgt128; Maity B, 2012, J BIOL CHEM, V287, P4972, DOI 10.1074/jbc.M111.297218; Maity B, 2011, J BIOL CHEM, V286, P1409, DOI 10.1074/jbc.M110.186700; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Maslov AY, 2012, ONCOGENE, V31, P5172, DOI 10.1038/onc.2012.9; Nakagawa T, 2003, J UROLOGY, V170, P2463, DOI 10.1097/01.ju.0000095919.50869.c9; Ordway JM, 2004, ONCOGENE, V23, P3737, DOI 10.1038/sj.onc.1207483; Pakneshan P, 2005, CARCINOGENESIS, V26, P557, DOI 10.1093/carcin/bgi009; Patra SK, 2008, FEBS J, V275, P5217, DOI 10.1111/j.1742-4658.2008.06658.x; Patra SK, 2008, EXP CELL RES, V314, P1193, DOI 10.1016/j.yexcr.2008.01.012; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x; Pruitt K, 2005, J BIOL CHEM, V280, P23363, DOI 10.1074/jbc.M503083200; Reu FJ, 2006, J CLIN ONCOL, V24, P3771, DOI 10.1200/JCO.2005.03.4074; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Santourlidis S, 2001, MOL CARCINOGEN, V32, P36, DOI 10.1002/mc.1062; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Xu M, 2010, MOL MED REP, V3, P699, DOI 10.3892/mmr_00000320; Zhu YM, 2007, INT J COLORECTAL DIS, V22, P661, DOI 10.1007/s00384-006-0224-4	46	27	28	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2014	33	27					3604	3611		10.1038/onc.2013.324	http://dx.doi.org/10.1038/onc.2013.324			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2FK	23995786	Green Accepted			2022-12-25	WOS:000338941100012
J	Hu, SL; Wang, MR; Cai, GP; He, MY				Hu, Shaoliang; Wang, Mingrong; Cai, Guoping; He, Mingyue			Genetic Code-guided Protein Synthesis and Folding in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USAGE BIAS; EXPRESSION; TRANSLATION; RATES	Universal genetic codes are degenerated with 61 codons specifying 20 amino acids, thus creating synonymous codons for a single amino acid. Synonymous codons have been shown to affect protein properties in a given organism. To address this issue and explore how Escherichia coli selects its "codon-preferred" DNA template(s) for synthesis of proteins with required properties, we have designed synonymous codon libraries based on an antibody (scFv) sequence and carried out bacterial expression and screening for variants with altered properties. As a result, 342 codon variants have been identified, differing significantly in protein solubility and functionality while retaining the identical original amino acid sequence. The soluble expression level varied from completely insoluble aggregates to a soluble yield of similar to 2.5 mg/liter, whereas the antigen-binding activity changed from no binding at all to a binding affinity of > 10(-8) M. Not only does our work demonstrate the involvement of genetic codes in regulating protein synthesis and folding but it also provides a novel screening strategy for producing improved proteins without the need to substitute amino acids.	[Hu, Shaoliang; Cai, Guoping] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Hu, Shaoliang; Cai, Guoping] Tsinghua Univ, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China; [Wang, Mingrong; He, Mingyue] Chengdu Inst Biol Prod, Recombinant Prot Therapeut, Chengdu 610023, Sichuan, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen	He, MY (corresponding author), Chengdu Inst Biol Prod, Recombinant Prot Therapeut, Chengdu 610023, Sichuan, Peoples R China.	mingyuehe2001@yahoo.com			SinoPharm and national "12.5" Scheme (Beijing, China) [2011ZX09506-005]; SinoPharm, Beijing, China	SinoPharm and national "12.5" Scheme (Beijing, China); SinoPharm, Beijing, China	This work was supported by SinoPharm and national "12.5" Scheme (2011ZX09506-005) (Beijing, China) to Chengdu Institute of Biological Products. The Recombinant Protein Therapeutics Laboratory is supported by SinoPharm, Beijing, China.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Huang Y, 2009, NUCLEIC ACIDS RES, V37, P6799, DOI 10.1093/nar/gkp712; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Satapathy SS, 2012, J MOL EVOL, V75, P34, DOI 10.1007/s00239-012-9524-1; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Wang MR, 2011, MABS-AUSTIN, V3, P495, DOI 10.4161/mabs.3.5.16087; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	28	30	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30855	30861		10.1074/jbc.M113.467977	http://dx.doi.org/10.1074/jbc.M113.467977			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24003234	hybrid, Green Published			2022-12-25	WOS:000330778900006
J	Singh, BK; Sinha, RA; Zhou, J; Xie, SY; You, SH; Gauthier, K; Yen, PM				Singh, Brijesh Kumar; Sinha, Rohit Anthony; Zhou, Jin; Xie, Sherwin Ying; You, Seo-Hee; Gauthier, Karine; Yen, Paul Michael			FoxO1 Deacetylation Regulates Thyroid Hormone-induced Transcription of Key Hepatic Gluconeogenic Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FoxO; Gene Regulation; Gene Transcription; Gluconeogenesis; Phosphoenolpyruvate Carboxykinase; Sirt1; Thyroid Hormone	RESPONSE ELEMENT; IN-VIVO; TR-BETA; METABOLISM; EXPRESSION; PROMOTER; LIVER; ACETYLATION; DISEASE; SIRT1	Hepatic gluconeogenesis is a concerted process that integrates transcriptional regulation with hormonal signals. A major regulator is thyroid hormone (TH), which acts through its nuclear receptor (TR) to induce the expression of the hepatic gluconeogenic genes, phosphoenolpyruvate carboxykinase (PCK1) and glucose-6-phosphatase (G6PC). Forkhead transcription factor FoxO1 also is an important regulator of these genes; however, its functional interactions with TR are not known. Here, we report that TR-mediated transcriptional activation of PCK1 and G6PC in human hepatic cells and mouse liver was FoxO1-dependent and furthermore required FoxO1 deacetylation by the NAD(+)-dependent deacetylase, SirT1. siRNA knockdown of FoxO1 decreased, whereas overexpression of FoxO1 increased, TH-dependent transcriptional activation of PCK1 and G6PC in cultured hepatic cells. FoxO1 siRNA knockdown also decreased TH-mediated transcription in vivo. Additionally, TH was unable to induce FoxO1 deacetylation or hepatic PCK1 gene expression in TH receptor -null (TR-/-) mice. Moreover, TH stimulated FoxO1 recruitment to the PCK1 and G6PC gene promoters in a SirT1-dependent manner. In summary, our results show that TH-dependent deacetylation of a second metabolically regulated transcription factor represents a novel mechanism for transcriptional integration of nuclear hormone action with cellular energy status.	[Singh, Brijesh Kumar; Sinha, Rohit Anthony; Zhou, Jin; Xie, Sherwin Ying; Yen, Paul Michael] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, Singapore 169857, Singapore; [You, Seo-Hee] Univ Penn, Sch Med, Dept Med,Perelman Sch Med, Div Endocrinol Diabet & Metab,Inst Diabet Obes &, Philadelphia, PA 19104 USA; [Gauthier, Karine] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon, F-69364 Lyon 07, France	National University of Singapore; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Yen, PM (corresponding author), Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, 8 Coll Rd, Singapore 169857, Singapore.	paul.yen@duke-nus.edu.sg	Singh, Brijesh K/C-1093-2009; Sinha, Rohit/GXV-2427-2022; Yen, Paul M/V-9857-2019	Singh, Brijesh K/0000-0003-4615-3988; /0000-0002-6840-9502; Yen, Paul/0000-0002-3790-8114	Duke-NUS Graduate Medical School Faculty Funds; Ministry of Health; Ministry of Education and Ministry of Trade, Singapore; A*StaR Singapore; Singapore National Medical Research Council (NMRC) [(EDG)/1044/2011]; Singapore NMRC [1340/2012]; American Diabetes Association mentored research fellowship;  [NMRC/CIRG/1340/2012]	Duke-NUS Graduate Medical School Faculty Funds; Ministry of Health; Ministry of Education and Ministry of Trade, Singapore(Ministry of Education, Singapore); A*StaR Singapore(Agency for Science Technology & Research (A*STAR)); Singapore National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Singapore NMRC(National Medical Research Council, Singapore); American Diabetes Association mentored research fellowship(American Diabetes Association); 	This work was supported by Duke-NUS Graduate Medical School Faculty Funds (to P. M. Y.) sponsored by the Ministry of Health, Ministry of Education and Ministry of Trade, Singapore, and A*StaR Singapore; Singapore National Medical Research Council (NMRC) Early Development Grant (EDG)/1044/2011; Singapore NMRC Clinical Investigator Research Grant 1340/2012; and NMRC/CIRG/1340/2012 grants. This work also was supported by an American Diabetes Association mentored research fellowship (to S. H. Y. and M. A. Lazar).	Aub JC, 1929, J CLIN INVEST, V7, P97, DOI 10.1172/JCI100223; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2010, J BIOL CHEM, V285, P28156, DOI 10.1074/jbc.M110.146241; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Webb AE, 2013, NAT CELL BIOL, V15, P444, DOI 10.1038/ncb2749; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527	31	40	43	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30365	30372		10.1074/jbc.M113.504845	http://dx.doi.org/10.1074/jbc.M113.504845			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23995837	Green Published, hybrid			2022-12-25	WOS:000329868100033
J	Gur, C; Enk, J; Weitman, E; Bachar, E; Suissa, Y; Cohen, G; Schyr, RB; Sabanay, H; Horwitz, E; Glaser, B; Dor, Y; Pribluda, A; Hanna, JH; Leibowitz, G; Mandelboim, O				Gur, Chamutal; Enk, Jonatan; Weitman, Efraim; Bachar, Etty; Suissa, Yaron; Cohen, Guy; Schyr, Rachel Ben-Haroush; Sabanay, Helena; Horwitz, Elad; Glaser, Benjamin; Dor, Yuval; Pribluda, Ariel; Hanna, Jacob H.; Leibowitz, Gill; Mandelboim, Ofer			The Expression of the Beta Cell-Derived Autoimmune Ligand for the Killer Receptor Nkp46 Is Attenuated in Type 2 Diabetes	PLOS ONE			English	Article							VIRUS-INFECTED CELLS; PSAMMOMYS-OBESUS; RECOGNITION; MODEL; MECHANISMS; LYSIS	NK cells rapidly kill tumor cells, virus infected cells and even self cells. This is mediated via killer receptors, among which NKp46 (NCR1 in mice) is prominent. We have recently demonstrated that in type 1 diabetes (T1D) NK cells accumulate in the diseased pancreas and that they manifest a hyporesponsive phenotype. In addition, we found that NKp46 recognizes an unknown ligand expressed by beta cells derived from humans and mice and that blocking of NKp46 activity prevented diabetes development. Here we investigated the properties of the unknown NKp46 ligand. We show that the NKp46 ligand is mainly located in insulin granules and that it is constitutively secreted. Following glucose stimulation the NKp46 ligand translocates to the cell membrane and its secretion decreases. We further demonstrate by using several modalities that the unknown NKp46 ligand is not insulin. Finally, we studied the expression of the NKp46 ligand in type 2 diabetes (T2D) using 3 different in vivo models and 2 species; mice and gerbils. We demonstrate that the expression of the NKp46 ligand is decreased in all models of T2D studied, suggesting that NKp46 is not involved in T2D.	[Gur, Chamutal; Enk, Jonatan; Horwitz, Elad; Mandelboim, Ofer] Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, Hadassah Med Sch,Dept Immunol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Gur, Chamutal] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Jerusalem, Israel; [Weitman, Efraim] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Weitman, Efraim] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Bachar, Etty; Schyr, Rachel Ben-Haroush; Glaser, Benjamin; Leibowitz, Gill] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, Jerusalem, Israel; [Suissa, Yaron; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Cohen, Guy] Hebrew Univ Jerusalem, Dept Pharmacol, Inst Drug Res, Jerusalem, Israel; [Sabanay, Helena] Weizmann Inst Sci, Ctr Electron Microscopy, IL-76100 Rehovot, Israel; [Pribluda, Ariel; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, Hadassah Med Sch,Dept Immunol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il	Bachar-Wikström, Etty/AAJ-1147-2020; Glaser, Benjamin/F-8411-2017; Cohen, Guy/B-1363-2019; Hanna, Jacob/K-1339-2012	Glaser, Benjamin/0000-0003-4711-5000; Cohen, Guy/0000-0002-9608-1081; Hanna, Jacob/0000-0003-2042-9974; Schyr, Rachel/0000-0002-4894-7979; Bachar-Wikstrom, Etty/0000-0002-3283-6721; Mandelboim, Ofer/0000-0002-9354-1855	Israel Science Foundation; Israeli I-CORE; ICRF professorship grant; Rosetrees trust; GIF grant; JDRF-Israel grant of the Israeli Science foundation; ERC; Israeli Science Foundation (Morasha)	Israel Science Foundation(Israel Science Foundation); Israeli I-CORE; ICRF professorship grant; Rosetrees trust(Rosetrees Trust); GIF grant; JDRF-Israel grant of the Israeli Science foundation; ERC(European Research Council (ERC)European Commission); Israeli Science Foundation (Morasha)(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundation, the Israeli I-CORE, the ICRF professorship grant, by the Rosetrees trust, by the GIF grant, by the JDRF-Israel grant of the Israeli Science foundation and by the ERC advanced grant (all to O.M.) and by The Israeli Science Foundation (Morasha) to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2003, J IMMUNOL, V171, P915, DOI 10.4049/jimmunol.171.2.915; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Elias S, 2012, RNA BIOL, V9, P792, DOI 10.4161/rna.19717; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GOLD G, 1982, SCIENCE, V218, P56, DOI 10.1126/science.6181562; Grill V, 2009, DIABETES OBES METAB, V11, P143, DOI 10.1111/j.1463-1326.2009.01119.x; Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400; Gur C, 2011, J IMMUNOL, V187, P3096, DOI 10.4049/jimmunol.1101269; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Imai Y, 2013, TRENDS ENDOCRINOL ME; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Kaiser Nurit, 2012, Methods Mol Biol, V933, P89, DOI 10.1007/978-1-62703-068-7_7; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ortqvist E, 2004, DIABETES CARE, V27, P2191, DOI 10.2337/diacare.27.9.2191; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Seidel E, 2012, CELL MOL LIFE SCI; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Skak K, 2004, DIABETES, V53, P1089, DOI 10.2337/diabetes.53.4.1089; Stanietsky N, 2010, FEBS LETT, V584, P4895, DOI 10.1016/j.febslet.2010.08.047; Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74033	10.1371/journal.pone.0074033	http://dx.doi.org/10.1371/journal.pone.0074033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009765	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600079
J	Versluis, B; Tuinder, S; Boetes, C; Van der Hulst, R; Lataster, A; Van Mulken, T; Wildberger, J; de Haan, M; Leiner, T				Versluis, Bas; Tuinder, Stefania; Boetes, Carla; Van der Hulst, Rene; Lataster, Arno; Van Mulken, Tom; Wildberger, Joachim; de Haan, Michiel; Leiner, Tim			Equilibrium-Phase High Spatial Resolution Contrast-Enhanced MR Angiography at 1.5T in Preoperative Imaging for Perforator Flap Breast Reconstruction	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; CANCER-RISKS; MASTECTOMY; RADIATION	Objectives: The aim was (i) to evaluate the accuracy of equilibrium-phase high spatial resolution (EP) contrast-enhanced magnetic resonance angiography (CE-MRA) at 1.5T using a blood pool contrast agent for the preoperative evaluation of deep inferior epigastric artery perforator branches (DIEP), and (ii) to compare image quality with conventional first-pass CE-MRA. Methods: Twenty-three consecutive patients were included. All patients underwent preoperative CE-MRA to determine quality and location of DIEP. First-pass imaging after a single bolus injection of 10 mL gadofosveset trisodium was followed by EP imaging. MRA data were compared to intra-operative findings, which served as the reference standard. Results: There was 100% agreement between EP CE-MRA and surgical findings in identifying the single best perforator branch. All EP acquisitions were of diagnostic quality, whereas in 10 patients the quality of the first-pass acquisition was qualified as non-diagnostic. Both signal- and contrast-to-noise ratios were significantly higher for EP imaging in comparison with first-pass acquisitions (p < 0.01). Conclusions: EP CE-MRA of DIEP in the preoperative evaluation of patients undergoing a breast reconstruction procedure is highly accurate in identifying the single best perforator branch at 1.5Tesla (T). Besides accuracy, image quality of EP imaging proved superior to conventional first-pass CE-MRA.	[Versluis, Bas; Boetes, Carla; Wildberger, Joachim; de Haan, Michiel; Leiner, Tim] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Tuinder, Stefania; Van der Hulst, Rene; Van Mulken, Tom] Maastricht Univ, Med Ctr, Dept Plast & Reconstruct Surg, Maastricht, Netherlands; [Versluis, Bas; Wildberger, Joachim; de Haan, Michiel; Leiner, Tim] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Lataster, Arno] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [Leiner, Tim] Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Utrecht University	Tuinder, S (corresponding author), Maastricht Univ, Med Ctr, Dept Plast & Reconstruct Surg, Maastricht, Netherlands.	nervofaciale@yahoo.it		Wildberger, Joachim/0000-0002-4810-6854				Acosta R, 2010, J RECONSTR MICROSURG; Alonso-Burgos A, 2006, J PLAST RECONSTR AES, V59, P585, DOI 10.1016/j.bjps.2005.12.011; [Anonymous], 1993, MAGNETIC RESONANCE A, P56; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Chernyak V, 2009, RADIOLOGY, V250, P417, DOI 10.1148/radiol.2501080307; de Vries M, 2005, INVEST RADIOL, V40, P495, DOI 10.1097/01.rli.0000163004.65460.8b; Einstein AJ, 2009, NAT REV CARDIOL, V6, P436, DOI 10.1038/nrcardio.2009.53; Fukaya E, 2007, J RECONSTR MICROSURG, V23, P205, DOI 10.1055/s-2007-981501; Giunta RE, 2000, PLAST RECONSTR SURG, V105, P2381, DOI 10.1097/00006534-200006000-00011; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hartmann M, 2006, EUR RADIOL, V16, pB15, DOI 10.1007/s10406-006-0163-8; Lee CN, 2010, ANN PLAS SURG, V64, P563, DOI 10.1097/SAP.0b013e3181c01279; Masia J, 2006, J PLAST RECONSTR AES, V59, P594, DOI 10.1016/j.bjps.2005.10.024; Mathes DW, 2010, J RECONSTR MICROSURG, V26, P3, DOI 10.1055/s-0029-1244806; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Roje Z, 2010, COLLEGIUM ANTROPOL, V34, P113; Rozen WM, 2008, PLAST RECONSTR SURG, V121, P9, DOI 10.1097/01.prs.0000293874.71269.c9; Rozen WM, 2008, PLAST RECONSTR SURG, V122, p222E, DOI 10.1097/PRS.0b013e31818d2246; Selber JC, 2010, PLAST RECONSTR SURG, V125, P50, DOI 10.1097/PRS.0b013e3181c49770; Tuttle TM, 2010, CURR ONCOL REP, V12, P16, DOI 10.1007/s11912-009-0070-y; Wang MS, 2007, J MAGN RESON IMAGING, V26, P580, DOI 10.1002/jmri.20998	21	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71286	10.1371/journal.pone.0071286	http://dx.doi.org/10.1371/journal.pone.0071286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009659	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600004
J	Zhang, Q; Wang, B; Wei, XP; Zhou, CJ				Zhang, Qiang; Wang, Bin; Wei, Xiaopeng; Zhou, Changjun			A Novel Constraint for Thermodynamically Designing DNA Sequences	PLOS ONE			English	Article							OPTIMIZATION; SEARCH	Biotechnological and biomolecular advances have introduced novel uses for DNA such as DNA computing, storage, and encryption. For these applications, DNA sequence design requires maximal desired (and minimal undesired) hybridizations, which are the product of a single new DNA strand from 2 single DNA strands. Here, we propose a novel constraint to design DNA sequences based on thermodynamic properties. Existing constraints for DNA design are based on the Hamming distance, a constraint that does not address the thermodynamic properties of the DNA sequence. Using a unique, improved genetic algorithm, we designed DNA sequence sets which satisfy different distance constraints and employ a free energy gap based on a minimum free energy (MFE) to gauge DNA sequences based on set thermodynamic properties. When compared to the best constraints of the Hamming distance, our method yielded better thermodynamic qualities. We then used our improved genetic algorithm to obtain lower-bound DNA sequence sets. Here, we discuss the effects of novel constraint parameters on the free energy gap.	[Zhang, Qiang; Wang, Bin; Wei, Xiaopeng; Zhou, Changjun] Dalian Univ, Key Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116012, Peoples R China; [Wang, Bin; Wei, Xiaopeng] Dalian Univ Technol, Sch Mech & Engn, Dalian, Peoples R China	Dalian University; Dalian University of Technology	Zhang, Q (corresponding author), Dalian Univ, Key Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116012, Peoples R China.	zhangq@dlu.edu.cn	wang, bin/B-5533-2011	wang, bin/0000-0002-8800-000X; Zhang, Qiang/0000-0003-3776-9799	National Natural Science Foundation of China [31170797, 30870573, 61103057]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1109]; Program for Liaoning Innovative Research Team in University [LT2011018]; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for Liaoning Innovative Research Team in University; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	This work was supported by the National Natural Science Foundation of China (Nos. 31170797, 30870573, 61103057), Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1109), the Program for Liaoning Innovative Research Team in University (No. LT2011018) and by the Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Andronescu M, 2005, J MOL BIOL, V345, P987, DOI 10.1016/j.jmb.2004.10.082; Baum E. B., 1999, DNA Based Computers II. DIMACS Workshop, P235; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Deaton R, 1997, PROCEEDINGS OF 1997 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '97), P267, DOI 10.1109/ICEC.1997.592311; Garzon M., 2000, DNA Based Computers V. DIMACS Workshop (Series in Discrete Mathematics and Theoretical Computer Science Vol.54), P91; Garzon M., 1998, Genetic Programming 1998. Proceedings of the Third Annual Conference, P684; Garzon M, 2006, LECT NOTES COMPUT SC, V4287, P143; Hartemink A. J., 1999, DNA Based Computers III. DIMACS Workshop, P25; Kawashimo S, 2008, LECT NOTES COMPUT SC, V4848, P130; Kawashimo S, 2009, LECT NOTES COMPUT SC, V5347, P168, DOI 10.1007/978-3-642-03076-5_14; Penchovsky R, 2003, J COMPUT BIOL, V10, P215, DOI 10.1089/106652703321825973; ROSE JA, 1999, SPECIAL PROGRAM GECC, P1829; Shin SY, 2005, IEEE T EVOLUT COMPUT, V9, P143, DOI 10.1109/TEVC.2005.844166; Shin SY, 2002, IEEE C EVOL COMPUTAT, P79, DOI 10.1109/CEC.2002.1006213; Shortreed MR, 2005, NUCLEIC ACIDS RES, V33, P4965, DOI 10.1093/nar/gki812; Tulpan D, 2005, NUCLEIC ACIDS RES, V33, P4951, DOI 10.1093/nar/gki773; Tulpan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-105; Wang P., 2011, PLOS ONE, V6; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xiao JH, 2013, J COMPUT THEOR NANOS, V10, P1129, DOI 10.1166/jctn.2013.2818; Zhang Q, 2011, MATCH-COMMUN MATH CO, V65, P291; Zhang Q, 2010, IEEE T NANOBIOSCI, V9, P273, DOI 10.1109/TNB.2010.2069570	23	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72180	10.1371/journal.pone.0072180	http://dx.doi.org/10.1371/journal.pone.0072180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015217	Green Submitted, gold, Green Published			2022-12-25	WOS:000323733800036
J	Zhang, ZY; Mu, LX; Tang, J; Duan, ZL; Wang, FY; Wei, L; Rong, MQ; Lai, R				Zhang, Zhiye; Mu, Lixian; Tang, Jing; Duan, Zilei; Wang, Fengyu; Wei, Lin; Rong, Mingqiang; Lai, Ren			A Small Peptide with Therapeutic Potential for Inflammatory Acne Vulgaris	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; ANTIMICROBIAL PEPTIDES; GEL FORMULATION; TOPICAL TREATMENT; CLINDAMYCIN; TRYPTOPHAN; RESISTANCE; INDUCTION; RICH; KERATINOCYTES	A designed peptide named LZ1 with 15 amino acid residues containing strong antimicrobial activity against bacteria pathogens of acne vulgaris including Propionibacterium acnes, Staphylococcus epidermidis and S. aureus. Especially, it exerted strong anti-P. acnes ability. The minimal inhibitory concentration against three strains of P. acnes was only 0.6 mu g/ml, which is 4 times lower than that of clindamycin. In experimental mice skin colonization model, LZ1 significantly reduced the number of P. acnes colonized on the ear, P. acnes-induced ear swelling, and inflammatory cell infiltration. It ameliorated inflammation induced by P. acnes by inhibiting the secretion of inflammatory factors including tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1 beta. LZ1 showed little cytotoxicity on human keratinocyte and hemolytic activity on human blood red cells. Furthermore, LZ1 was very stable in human plasma. Combined with its potential bactericidal and anti-inflammatory properties, simple structure and high stability, LZ1 might be an ideal candidate for the treatment of acne.	[Zhang, Zhiye; Mu, Lixian; Tang, Jing; Duan, Zilei; Rong, Mingqiang; Lai, Ren] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Wang, Fengyu; Wei, Lin] Nanjing Agr Univ, Life Sci Coll, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhiye; Mu, Lixian; Tang, Jing; Duan, Zilei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lai, R (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn	Wei, Lin/AAE-3043-2022	Wei, Lin/0000-0003-3359-2471; Zhang, Zhiye/0000-0002-1661-2277	Ministry of Science and Technology [2010CB529800, 2013CB911300]; National Natural Science Foundation [30830021, 31025025, 31070701, 31000960, U1132601, 31200590]; Yunnan Province [2011CI139, 2012BC009]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported by Ministry of Science and Technology (2010CB529800, 2013CB911300), National Natural Science Foundation (30830021, 31025025, 31070701, 31000960, 31025025, U1132601, 31200590), and Yunnan Province (2011CI139, 2012BC009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Naser MB, 2008, EXPERT OPIN PHARMACO, V9, P2931, DOI [10.1517/14656566.9.16.2931, 10.1517/14656566.9.16.2931 ]; Asthana N, 2004, J BIOL CHEM, V279, P55042, DOI 10.1074/jbc.M408881200; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Boni R, 2003, AM J CLIN DERMATOL, V4, P273; Burkhart CG, 1999, POSTGRAD MED J, V75, P328, DOI 10.1136/pgmj.75.884.328; Castro GA, 2008, EXPERT OPIN DRUG DEL, V5, P665, DOI [10.1517/17425247.5.6.665, 10.1517/17425247.5.6.665 ]; Chronnell CMT, 2001, J INVEST DERMATOL, V117, P1120, DOI 10.1046/j.0022-202x.2001.01569.x; CRAWFORD WW, 1979, J INVEST DERMATOL, V72, P187, DOI 10.1111/1523-1747.ep12676385; Cunliffe WJ, 2002, CLIN THER, V24, P1117, DOI 10.1016/S0149-2918(02)80023-6; EADY EA, 1989, BRIT J DERMATOL, V121, P51, DOI 10.1111/j.1365-2133.1989.tb01399.x; Eady EA, 2003, DERMATOLOGY, V206, P54, DOI 10.1159/000067822; Eichenfield LF, 2009, PEDIATR DERMATOL, V26, P257, DOI 10.1111/j.1525-1470.2008.00862.x; Fimland G, 2002, BIOCHEMISTRY-US, V41, P9508, DOI 10.1021/bi025856q; Gollnick H, 1998, DERMATOLOGY, V196, P119, DOI 10.1159/000017844; Gollnick H, 2003, J AM ACAD DERMATOL, V49, pS1, DOI 10.1067/mjd.2003.618; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; HOEFFLER U, 1977, J CLIN MICROBIOL, V6, P555; HOEFFLER U, 1976, ANTIMICROB AGENTS CH, V10, P387, DOI 10.1128/AAC.10.3.387; Hwang H, 2013, CHEMMEDCHEM, V8, P59, DOI 10.1002/cmdc.201200463; Iinuma K, 2009, J INVEST DERMATOL, V129, P2113, DOI 10.1038/jid.2009.46; INGHAM E, 1980, J GEN MICROBIOL, V118, P59; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Lee DY, 2008, J INVEST DERMATOL, V128, P1863, DOI 10.1038/sj.jid.5701235; Leyden JJ, 2007, CUTIS, V79, P9; Leyden James J, 2011, J Clin Aesthet Dermatol, V4, P22; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Lu Y, 2008, MOL IMMUNOL, V45, P678, DOI 10.1016/j.molimm.2007.07.004; Mourelatos K, 2007, BRIT J DERMATOL, V156, P22, DOI 10.1111/j.1365-2133.2006.07517.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2009, J INVEST DERMATOL, V129, P2480, DOI 10.1038/jid.2009.93; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nord CE, 2006, ANAEROBE, V12, P207, DOI 10.1016/j.anaerobe.2006.08.001; Ozolins M, 2004, LANCET, V364, P2188, DOI 10.1016/S0140-6736(04)17591-0; Park Y, 2003, BBA-PROTEINS PROTEOM, V1645, P172, DOI 10.1016/S1570-9639(02)00541-1; PUHVEL SM, 1972, J INVEST DERMATOL, V58, P66, DOI 10.1111/1523-1747.ep12551495; Schaller M, 2005, BRIT J DERMATOL, V153, P66, DOI 10.1111/j.1365-2133.2005.06530.x; Schibli DJ, 2002, BIOCHEM CELL BIOL, V80, P667, DOI 10.1139/O02-147; Strom MB, 2002, J PEPT SCI, V8, P431, DOI 10.1002/psc.398; Swanson Jil K, 2003, Dermatol Nurs, V15, P359; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022120; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; WEBSTER GF, 1980, INFLAMMATION, V4, P261, DOI 10.1007/BF00915027; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Yang ST, 2003, FEBS LETT, V540, P229, DOI 10.1016/S0014-5793(03)00266-7; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602	52	32	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72923	10.1371/journal.pone.0072923	http://dx.doi.org/10.1371/journal.pone.0072923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24013774	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800086
J	Anuar, TS; Al-Mekhlafi, HM; Salleh, FM; Moktar, N				Anuar, Tengku Shahrul; Al-Mekhlafi, Hesham M.; Salleh, Fatmah Md; Moktar, Norhayati			New Insights of Microsporidial Infection among Asymptomatic Aboriginal Population in Malaysia	PLOS ONE			English	Article							ENTEROCYTOZOON-BIENEUSI; INTESTINAL MICROSPORIDIOSIS; ENCEPHALITOZOON-CUNICULI; STOOL SPECIMENS; IMMUNOCOMPETENT INDIVIDUALS; CRYPTOSPORIDIUM-PARVUM; SEPTATA-INTESTINALIS; GRAM-CHROMOTROPE; CLINICAL-SAMPLES; N-SP	Background: Studies on microsporidial infection mostly focus on immunodeficiency or immunosuppressive individuals. Therefore, this cross-sectional study describes the prevalence and risk factors of microsporidiosis among asymptomatic individuals in Malaysia. Methods/Findings: Four hundred and forty seven stool samples were collected and examined for microsporidia after staining with Gram-chromotrope Kinyoun. Demographic, socioeconomic, environmental, and behavioral information were collected by using a pre-tested questionnaire. Overall, 67 (15%) samples were positive for microsporidia. The prevalence of infection was significantly higher among individuals aged more than <15 years compared to those aged,15 years (OR = 1.97, 95% CI = 1.08, 3.62; P = 0.028). Furthermore, logistic regression analysis confirmed that the presence of other family members infected with microsporidia (OR = 8.45; 95% CI = 4.30, 16.62; P < 0.001) and being a consumer of raw vegetables (OR = 2.05; 95% CI = 1.15, 3.66; P = 0.016) were the significant risk factors of this infection. Conclusions: These findings clearly show that exposure to microsporidia is common among Aboriginal population. Further studies using molecular approach on microsporidia isolates from asymptomatic individuals is needed to determine species-specific. The risk factors associated with microsporidiosis will help in identifying more clearly the sources of the infection in the environment that pose a risk for transmission so that preventive strategies can be implemented.	[Anuar, Tengku Shahrul; Salleh, Fatmah Md; Moktar, Norhayati] Univ Kebangsaan Malaysia, Fac Med, Dept Parasitol & Med Entomol, Kuala Lumpur, Malaysia; [Al-Mekhlafi, Hesham M.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya	Moktar, N (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Parasitol & Med Entomol, Kuala Lumpur, Malaysia.	tsatab@lycos.com	Tengku, Shahrul Anuar/E-4975-2014; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016	Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410	UKMMC Fundamental Research Grant [FF-165-2011]; Special Research University Grant [UKM-GUP-2011-316]; University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia [UM-MOHE UM.C/625/1/HIR/MOHE/MED/18]	UKMMC Fundamental Research Grant; Special Research University Grant; University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia	This work was supported by UKMMC Fundamental Research Grant (FF-165-2011), Special Research University Grant (UKM-GUP-2011-316) and University of Malaya High Impact Research Grant, UM-MOHE UM.C/625/1/HIR/MOHE/MED/18 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Acosta N, 2005, T ROY SOC TROP MED H, V99, P848, DOI 10.1016/j.trstmh.2005.05.010; Ahmed A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-119; Al-Mekhlafi MA, 2011, SE ASIAN J TROP MED, V42, P19; Anane S, 2011, PATHOL BIOL, V59, P234, DOI 10.1016/j.patbio.2009.03.007; Aoun K, 1997, PARASITE, V4, P386; Ayinmode A. B., 2011, Journal of Parasitology Research, V2011, P129542, DOI 10.1155/2011/129542; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; Bryan RT, 1999, EPIDEMIOLOGY MICROSP, P502; CALI A, 1993, J EUKARYOT MICROBIOL, V40, P101, DOI 10.1111/j.1550-7408.1993.tb04889.x; Calvo M, 2004, ARCH LATINOAM NUTR, V54, P428; Cama VA, 2007, J CLIN MICROBIOL, V45, P2708, DOI 10.1128/JCM.00725-07; Canning EU, 1986, MICROSPORIDIA VERTEB, P289; Clarridge JE, 1996, J CLIN MICROBIOL, V34, P520, DOI 10.1128/JCM.34.3.520-523.1996; Coyle CM, 1996, CLIN INFECT DIS, V23, P1002, DOI 10.1093/clinids/23.5.1002; Croppo G P, 1991, Parassitologia, V33, P209; Decraene V, 2012, EPIDEMIOL INFECT, V140, P519, DOI 10.1017/S095026881100077X; Deplazes P, 2000, CONTRIB MICROBIOL, V6, P236, DOI 10.1159/000060363; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2000, MICROBES INFECT, V2, P709, DOI 10.1016/S1286-4579(00)00354-3; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Endeshaw T, 2006, JPN J INFECT DIS, V59, P306; Franzen C, 2001, MICROBES INFECT, V3, P389, DOI 10.1016/S1286-4579(01)01395-8; Franzen C, 1999, CLIN MICROBIOL REV, V12, P243, DOI 10.1128/CMR.12.2.243; Gumbo T, 1999, AIDS, V13, P819, DOI 10.1097/00002030-199905070-00011; Harcourt-Brown FM, 2003, VET REC, V152, P427, DOI 10.1136/vr.152.14.427; HOLLISTER WS, 1987, PARASITOLOGY, V94, P209, DOI 10.1017/S0031182000053890; HOLLISTER WS, 1991, PARASITOLOGY, V102, P33, DOI 10.1017/S0031182000060315; Kotler D, 1999, CLIN SYNDROMES ASS W, P258; Kotler DP, 1998, ADV PARASIT, V40, P321, DOI 10.1016/S0065-308X(08)60126-8; Leelayoova S, 2005, AM J TROP MED HYG, V73, P104, DOI 10.4269/ajtmh.2005.73.104; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Lono A, 2011, T ROY SOC TROP MED H, V105, P409, DOI 10.1016/j.trstmh.2011.03.006; Lono A, 2010, T ROY SOC TROP MED H, V104, P214, DOI 10.1016/j.trstmh.2009.07.006; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Macarisin D, 2010, APPL ENVIRON MICROB, V76, P555, DOI 10.1128/AEM.02118-09; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Moura H, 1996, J EUKARYOT MICROBIOL, V43, pS94, DOI 10.1111/j.1550-7408.1996.tb05019.x; Muller A, 1999, CLIN DIAGN LAB IMMUN, V6, P243; Muller A, 2001, J CLIN MICROBIOL, V39, P1630, DOI 10.1128/JCM.39.4.1630-1632.2001; NAGELI KW, 1857, BOT Z, V15, P760; Nicholas C, 2007, ROUT MALAYS STUD SER, P119; Nkinin SW, 2007, J CLIN MICROBIOL, V45, P2841, DOI 10.1128/JCM.00328-07; Norhayati M, 2008, T ROY SOC TROP MED H, V102, P1274, DOI 10.1016/j.trstmh.2008.05.019; Norhayati M, 2007, ANN TROP MED PARASIT, V101, P547, DOI 10.1179/136485907X193789; Orlandi PA, 2002, FOOD TECHNOL-CHICAGO, V56, P72; Rinder H, 1998, J CLIN MICROBIOL, V36, P1814, DOI 10.1128/JCM.36.6.1814-1818.1998; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Salleh FM, 2011, DIAGN MICR INFEC DIS, V69, P82, DOI 10.1016/j.diagmicrobio.2010.08.028; Samie A, 2007, T ROY SOC TROP MED H, V101, P547, DOI 10.1016/j.trstmh.2007.02.005; Shadduck JA, 1996, ASM NEWS, V62, P586; Slifko TR, 2000, INT J PARASITOL, V30, P1379, DOI 10.1016/S0020-7519(00)00128-4; Snowden Karen F., 1999, P393; SOBOTTKA I, 1995, EUR J CLIN MICROBIOL, V14, P919, DOI 10.1007/BF01691502; Svenungsson B, 1998, SCAND J INFECT DIS, V30, P314, DOI 10.1080/00365549850161043; Tumwine JK, 2002, AM J TROP MED HYG, V67, P299, DOI 10.4269/ajtmh.2002.67.299; Wanachiwanawin Darawan, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P241; Weiss LM, 1998, CURR CLIN TOP INFECT, V17, P147	61	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71870	10.1371/journal.pone.0071870	http://dx.doi.org/10.1371/journal.pone.0071870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014078	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200020
J	Belaganahalli, MN; Maan, S; Maan, NS; Nomikou, K; Guimera, M; Brownlie, J; Tesh, R; Attoui, H; Mertens, PPC				Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Guimera, Marc; Brownlie, Joe; Tesh, Robert; Attoui, Houssam; Mertens, Peter P. C.			Full Genome Sequencing of Corriparta Virus, Identifies California Mosquito Pool Virus as a Member of the Corriparta virus Species	PLOS ONE			English	Article							AFRICAN HORSESICKNESS VIRUS; BLUETONGUE-VIRUS; GENETIC RELATEDNESS; TERMINAL SEQUENCES; RAPID DETECTION; ORBIVIRUS; SEGMENTS; ARBOVIRUSES; SEROGROUP; HYBRIDIZATION	The species Corriparta virus (CORV), within the genus Orbivirus, family Reoviridae, currently contains six virus strains: corriparta virus MRM1 (CORV-MRM1); CS0109; V654; V370; Acado virus and Jacareacanga virus. However, lack of neutralization assays, or reference genome sequence data has prevented further analysis of their intra-serogroup/species relationships and identification of individual serotypes. We report whole-genome sequence data for CORV-MRM1, which was isolated in 1960 in Australia. Comparisons of the conserved, polymerase (VP1), sub-core-shell 'T2' and core-surface 'T13' proteins encoded by genome segments 1, 2 and 8 (Seg-1, Seg-2 and Seg-8) respectively, show that this virus groups with the other mosquito borne orbiviruses. However, highest levels of nt/aa sequence identity (75.9%/91.6% in Seg-2/T2: 77.6%/91.7% in Seg-8/T13, respectively) were detected between CORV-MRM1 and California mosquito pool virus (CMPV), an orbivirus isolated in the USA in 1974, showing that they belong to the same virus species. The data presented here identify CMPV as a member of the Corriparta virus species and will facilitate identification of additional CORV isolates, diagnostic assay design and epidemiological studies.	[Belaganahalli, Manjunatha N.; Maan, Sushila; Nomikou, Kyriaki; Guimera, Marc; Attoui, Houssam; Mertens, Peter P. C.] Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England; [Maan, Sushila; Maan, Narender S.] LLR Univ Vet & Anim Sci, Coll Vet Sci, Hisar, Haryana, India; [Brownlie, Joe] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Tesh, Robert] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Lala Lajpat Rai University of Veterinary & Animal Sciences; University of London; University of London Royal Veterinary College; University of Texas System; University of Texas Medical Branch Galveston	Mertens, PPC (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England.	Peter.Mertens@pirbright.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Attoui, Houssam/0000-0001-9639-9981; Mertens, Peter/0000-0002-3438-3738	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Wellcome BTV Programme grant; EMIDA grant (OrbiNet) [K1303206]; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001446, BB/I017259/1, BBS/E/I/00001144, BBS/E/I/00001876] Funding Source: researchfish; BBSRC [BB/I017259/1, BBS/E/I/00001446, BBS/E/I/00001876] Funding Source: UKRI	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome BTV Programme grant; EMIDA grant (OrbiNet); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by the Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/) awarded to MB, partly by the Department for Environment, Food and Rural Affairs (Defra) (SE2617) awarded to SM, partly by the Wellcome BTV Programme grant (http://www.wellcome.ac.uk/) awarded to KN and EMIDA grant (OrbiNet - K1303206) to fund MG. NSM, PPCM and HA were involved in this work, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the European Union (EU) (SANCO/940/2002) and Defra. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Anthony SJ, 2011, VIROLOGY, V420, P164, DOI 10.1016/j.virol.2011.09.009; Anthony SJ, 2009, VIRUS RES, V145, P187, DOI 10.1016/j.virusres.2009.07.011; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; Anthony SJ, 2009, VIRUS RES, V145, P211, DOI 10.1016/j.virusres.2009.07.019; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H., 2012, REOVIRIDAE, P497; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Bankowska K, 2013, THESIS U OXFORD; Belaganahalli MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031911; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; BORDEN EC, 1971, J GEN VIROL, V13, P261, DOI 10.1099/0022-1317-13-2-261; BOUGHTON CR, 1990, AUST NZ J MED, V20, P51, DOI 10.1111/j.1445-5994.1990.tb00371.x; Bremer CW, 1998, ONDERSTEPOORT J VET, V65, P1; BROWN SE, 1988, J GEN VIROL, V69, P135, DOI 10.1099/0022-1317-69-1-135; BROWN SE, 1992, VET MICROBIOL, V32, P241, DOI 10.1016/0378-1135(92)90147-L; CARLEY JG, 1969, AM J EPIDEMIOL, V89, P583, DOI 10.1093/oxfordjournals.aje.a120971; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; GIBBS EPJ, 1989, VET MICROBIOL, V19, P141, DOI 10.1016/0378-1135(89)90079-5; GONZALEZ HA, 1987, J GEN VIROL, V68, P661, DOI 10.1099/0022-1317-68-3-661; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Kapoor A, 2013, J GEN VIROL, V94, P1051, DOI 10.1099/vir.0.046748-0; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIEHNE PFS, 1981, AUST J EXP BIOL MED, V59, P347, DOI 10.1038/icb.1981.29; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025686; Maan NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012782; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2011, PLOS ONE, V6; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Martins LC, 2007, INT J EXP PATHOL, V88, P63, DOI 10.1111/j.1365-2613.2006.00516.x; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; MERTENS PPC, 1985, VIROLOGY, V140, P55, DOI 10.1016/0042-6822(85)90445-3; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; PEDLEY S, 1988, VIRUS RES, V10, P381, DOI 10.1016/0168-1702(88)90078-0; Potgieter AC, 2002, J GEN VIROL, V83, P2215, DOI 10.1099/0022-1317-83-9-2215; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; RAO CD, 1983, J VIROL, V46, P378, DOI 10.1128/JVI.46.2.378-383.1983; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; RONER MR, 1989, VIROLOGY, V168, P292, DOI 10.1016/0042-6822(89)90269-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAMOTO K, 1994, ARCH VIROL, V136, P87, DOI 10.1007/BF01538819; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; STANDFAST HA, 1984, AUST J BIOL SCI, V37, P351, DOI 10.1071/BI9840351; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Regenmortel MHV, 2004, EMERG INFECT DIS, V10, P8, DOI 10.3201/eid1001.030279; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; WALKER PJ, 1980, J VIROL, V34, P583, DOI 10.1128/JVI.34.3.583-591.1980; WALKER PJ, 1989, J GEN VIROL, V70, P1011, DOI 10.1099/0022-1317-70-4-1011; WHITEHEAD RH, 1968, T ROY SOC TROP MED H, V62, P439, DOI 10.1016/0035-9203(68)90096-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	65	8	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70779	10.1371/journal.pone.0070779	http://dx.doi.org/10.1371/journal.pone.0070779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015178	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000323815200009
J	Peyric, E; Moore, HA; Whitmore, D				Peyric, Elodie; Moore, Helen A.; Whitmore, David			Circadian Clock Regulation of the Cell Cycle in the Zebrafish Intestine	PLOS ONE			English	Article							PERIPHERAL-TISSUES; GENE-EXPRESSION; LIGHT ACTS; OSCILLATORS; RHYTHMS; COORDINATION; DISRUPTION; TRACT	The circadian clock controls cell proliferation in a number of healthy tissues where cell renewal and regeneration are critical for normal physiological function. The intestine is an organ that typically undergoes regular cycles of cell division, differentiation and apoptosis as part of its role in digestion and nutrient absorption. The aim of this study was to explore circadian clock regulation of cell proliferation and cell cycle gene expression in the zebrafish intestine. Here we show that the zebrafish gut contains a directly light-entrainable circadian pacemaker, which regulates the daily timing of mitosis. Furthermore, this intestinal clock controls the expression of key cell cycle regulators, such as cdc2, wee1, p21, PCNA and cdk2, but only weakly influences cyclin B1, cyclin B2 and cyclin E1 expression. Interestingly, food deprivation has little impact on circadian clock function in the gut, but dramatically reduces cell proliferation, as well as cell cycle gene expression in this tissue. Timed feeding under constant dark conditions is able to drive rhythmic expression not only of circadian clock genes, but also of several cell cycle genes, suggesting that food can entrain the clock, as well as the cell cycle in the intestine. Rather surprisingly, we found that timed feeding is critical for high amplitude rhythms in cell cycle gene expression, even when zebrafish are maintained on a light-dark cycle. Together these results suggest that the intestinal clock integrates multiple rhythmic cues, including light and food, to function optimally.	[Peyric, Elodie; Moore, Helen A.; Whitmore, David] UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England	University of London; University College London	Whitmore, D (corresponding author), UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England.	d.whitmore@ucl.ac.uk	Zebrafish, UCL/A-3125-2009	Whitmore, David/0000-0003-2420-8220	BBSRC; ERASysBio+ [BB/I004823/1]; Biotechnology and Biological Sciences Research Council [BB/I004823/1, BB/E016014/1] Funding Source: researchfish; BBSRC [BB/I004823/1, BB/E016014/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERASysBio+; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the BBSRC and ERASysBio+ (BB/I004823/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bostwick J, 2010, MOL CELL BIOCHEM, V338, P203, DOI 10.1007/s11010-009-0354-4; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Filipski E, 2006, CANCER CAUSE CONTROL, V17, P509, DOI 10.1007/s10552-005-9007-4; Filipski E, 2009, INTEGR CANCER THER, V8, P298, DOI 10.1177/1534735409352085; Gomes JR, 2005, CELL PROLIFERAT, V38, P147, DOI 10.1111/j.1365-2184.2005.00339.x; HALBERG F, 1954, AM J PHYSIOL, V177, P361, DOI 10.1152/ajplegacy.1954.177.3.361; Hoogerwerf Willemijntje A, 2006, Curr Gastroenterol Rep, V8, P353, DOI 10.1007/s11894-006-0019-3; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Laranjeiro R, 2013, P NATL ACAD SCI USA, V110, P6835, DOI 10.1073/pnas.1217912110; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Scheving LA, 2000, GASTROENTEROLOGY, V119, P536, DOI 10.1053/gast.2000.9305; SCHEVING LE, 1983, AM J ANAT, V168, P433, DOI 10.1002/aja.1001680405; Silver R, 2011, PHYSIOL BEHAV, V104, P562, DOI 10.1016/j.physbeh.2011.05.034; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2012, J BIOL RHYTHM, V27, P226, DOI 10.1177/0748730412440861; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589	28	30	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73209	10.1371/journal.pone.0073209	http://dx.doi.org/10.1371/journal.pone.0073209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013905	gold, Green Published, Green Submitted			2022-12-25	WOS:000323815200073
J	Horani, A; Brody, SL; Ferkol, TW; Shoseyov, D; Wasserman, MG; Ta-shma, A; Wilson, KS; Bayly, PV; Amirav, I; Cohen-Cymberknoh, M; Dutcher, SK; Elpeleg, O; Kerem, E				Horani, Amjad; Brody, Steven L.; Ferkol, Thomas W.; Shoseyov, David; Wasserman, Mollie G.; Ta-shma, Asaf; Wilson, Kate S.; Bayly, Philip V.; Amirav, Israel; Cohen-Cymberknoh, Malena; Dutcher, Susan K.; Elpeleg, Orly; Kerem, Eitan			CCDC65 Mutation Causes Primary Ciliary Dyskinesia with Normal Ultrastructure and Hyperkinetic Cilia	PLOS ONE			English	Article							DYNEIN REGULATORY COMPLEX; OF-FUNCTION MUTATIONS; CHLAMYDOMONAS-REINHARDTII; BEAT FREQUENCY; SITUS-INVERSUS; GENE; PROTEIN; ARMS; RANDOMIZATION; ASYMMETRY	Background: Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by impaired ciliary function, leading to chronic sinopulmonary disease. The genetic causes of PCD are still evolving, while the diagnosis is often dependent on finding a ciliary ultrastructural abnormality and immotile cilia. Here we report a novel gene associated with PCD but without ciliary ultrastructural abnormalities evident by transmission electron microscopy, but with dyskinetic cilia beating. Methods: Genetic linkage analysis was performed in a family with a PCD subject. Gene expression was studied in Chlamydomonas reinhardtii and human airway epithelial cells, using RNA assays and immunostaining. The phenotypic effects of candidate gene mutations were determined in primary culture human tracheobronchial epithelial cells transduced with gene targeted shRNA sequences. Video-microscopy was used to evaluate cilia motion. Results: A single novel mutation in CCDC65, which created a termination codon at position 293, was identified in a subject with typical clinical features of PCD. CCDC65, an orthologue of the Chlamydomonas nexin-dynein regulatory complex protein DRC2, was localized to the cilia of normal nasal epithelial cells but was absent in those from the proband. CCDC65 expression was up-regulated during ciliogenesis in cultured airway epithelial cells, as was DRC2 in C. reinhardtii following deflagellation. Nasal epithelial cells from the affected individual and CCDC65-specific shRNA transduced normal airway epithelial cells had stiff and dyskinetic cilia beating patterns compared to control cells. Moreover, Gas8, a nexin-dynein regulatory complex component previously identified to associate with CCDC65, was absent in airway cells from the PCD subject and CCDC65-silenced cells. Conclusion: Mutation in CCDC65, a nexin-dynein regulatory complex member, resulted in a frameshift mutation and PCD. The affected individual had altered cilia beating patterns, and no detectable ultrastructural defects of the ciliary axoneme, emphasizing the role of the nexin-dynein regulatory complex and the limitations of certain methods for PCD diagnosis.	[Horani, Amjad; Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Brody, Steven L.; Wasserman, Mollie G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Shoseyov, David; Cohen-Cymberknoh, Malena; Kerem, Eitan] Hadassah Hebrew Univ Med Ctr, Dept Pediat, Jerusalem, Israel; [Ta-shma, Asaf; Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel; [Wilson, Kate S.; Bayly, Philip V.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO USA; [Amirav, Israel] Bar Ilan Univ, Dept Pediat, Ziv Med Ctr, Safed, Israel; [Dutcher, Susan K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Hebrew University of Jerusalem; Hebrew University of Jerusalem; Washington University (WUSTL); Bar Ilan University; Ziv Medical Center; Washington University (WUSTL)	Horani, A (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	horani_a@kids.wustl.edu	Amirav, Israel/I-9286-2019	Amirav, Israel/0000-0002-6917-5285; Bayly, Philip/0000-0003-4303-0704	Children's Discovery Institute; National Institutes of Health (NIH) [HL082657, HL056244, GM32843]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056244, R01HL082657, R01HL056244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB014855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032843] Funding Source: NIH RePORTER	Children's Discovery Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were funded by the Children's Discovery Institute (AH, SLB, TWF, PVB, SKD) and National Institutes of Health (NIH) awards HL082657 (TWF), HL056244 (SLB), GM32843 (SKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Armengot M, 2010, AM J RHINOL ALLERGY, V24, P175, DOI 10.2500/ajra.2010.24.3448; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; Bower R, 2013, MOL BIOL CELL, V24, P1134, DOI 10.1091/mbc.E12-11-0801; Brody AS, 2006, J THORAC IMAG, V21, P14, DOI 10.1097/01.rti.0000203937.82276.ce; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Ferkol TW, 2012, J PEDIATR-US, V160, P366, DOI 10.1016/j.jpeds.2011.11.024; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Horani A, 2013, AM J RESP C IN PRESS; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059436; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Horvath J, 2005, AM J RESP CELL MOL, V33, P41, DOI 10.1165/rcmb.2004-0335OC; Jain R, 2012, AM J RESP CELL MOL, V46, P446, DOI 10.1165/rcmb.2011-0107OC; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; PIPERNO G, 1977, P NATL ACAD SCI USA, V74, P1600, DOI 10.1073/pnas.74.4.1600; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun DQ, 2010, PROC CVPR IEEE, P2432, DOI 10.1109/CVPR.2010.5539939; Walker WT, 2012, EUR RESPIR J, V40, P1024, DOI 10.1183/09031936.00176111; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zheng Y, 2006, INT J MOL MED, V18, P1119	50	76	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72299	10.1371/journal.pone.0072299	http://dx.doi.org/10.1371/journal.pone.0072299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991085	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800058
J	Alon, D; Stein, GY; Korenfeld, R; Fuchs, S				Alon, Danny; Stein, Gideon Y.; Korenfeld, Roman; Fuchs, Shmuel			Predictors and Outcomes of Infection-Related Hospital Admissions of Heart Failure Patients	PLOS ONE			English	Article							DYSFUNCTION; POPULATION	Background: Infections are one of the most common causes for hospitalization of patients with heart failure (HF). Yet, little is known regarding the prevalence and predictors of different types of acute infections as well as their impact on outcome among this growing population. Methods and Results: We identified all patients aged 50 or older with a major diagnosis of HF and at least one echocardiography examination who had been hospitalized over a 10-year period (January 2000 and December 2009). Infection-associated admissions were identified according to discharge diagnoses. Among 9,335 HF patients, 3530 (38%) were hospitalized at least once due to infections. The most frequent diagnoses were respiratory infection (52.6%) and sepsis/bacteremia (23.6%) followed by urinary (15.7%) and skin and soft tissue infections (7.8%). Hospitalizations due to infections compared to other indications were associated with increased 30-day mortality (13% vs. 8%, p<0.0001). These higher mortality rates were predominately related to respiratory infections (OR 1.28 [95% CI 1.09, 1.5]) and sepsis\bacteremia (OR 3.13 [95% CI 2.6, 3.7]). Important predictors for these serious infections included female gender, chronic obstructive pulmonary disease, past myocardial infarction and echocardiography-defined significant right (RV) but not left ventricular dysfunction. Conclusions: Major infection-related hospitalizations are frequent among patients with HF and are associated with increased mortality rates. Elderly female patients with multiple comorbidities and those with severe RV dysfunction are at higher risk for these infections.	[Fuchs, Shmuel] Rabin Med Ctr, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Fuchs, S (corresponding author), Rabin Med Ctr, Beilinson Campus, Petah Tiqwa, Israel.	shmuelf@clalit.org.il						ARMENGOL S, 1992, INT J CARDIOL, V37, P418, DOI 10.1016/0167-5273(92)90276-9; Castro P, 2004, REV MED CHILE, V132, P655; Colombo PC, 2012, HEART FAIL REV, V17, P177, DOI 10.1007/s10741-011-9261-3; Corrales-Medina VF, CIRCULATION, V125, P773; Dai SL, 2012, CAN J CARDIOL, V28, P74, DOI 10.1016/j.cjca.2011.05.002; Daneshvar D, 2010, AM HEART J, V160, P394, DOI 10.1016/j.ahj.2010.06.040; Egorova E N, 2011, Patol Fiziol Eksp Ter, P42; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Fonarow GC, 2008, AM HEART J, V155, P200, DOI 10.1016/j.ahj.2006.10.043; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Maeder M, 2006, CHEST, V129, P1349, DOI 10.1378/chest.129.5.1349; Mamas MA, 2008, INT J CARDIOL, V130, P304, DOI 10.1016/j.ijcard.2008.04.044; Mullerova H, 2012, RESP MED, V106, P1124, DOI 10.1016/j.rmed.2012.04.008; Paz A, 2002, CARDIOLOGY, V97, P83, DOI 10.1159/000057677; Sarmento Pedro Moraes, 2006, Rev Port Cardiol, V25, P13; Shafazand Masoud, 2012, BMC Res Notes, V5, P132, DOI 10.1186/1756-0500-5-132; Stein GY, 2012, J CARD FAIL, V18, P645, DOI 10.1016/j.cardfail.2012.05.007; Wang GQ, 2002, MICROBIOL-SGM, V148, P3955, DOI 10.1099/00221287-148-12-3955	18	51	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72476	10.1371/journal.pone.0072476	http://dx.doi.org/10.1371/journal.pone.0072476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009684	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200025
J	Shevade, S; Jindal, N; Dutta, S; Jarori, GK				Shevade, Saudamini; Jindal, Nitin; Dutta, Sneha; Jarori, Gotam K.			Food Vacuole Associated Enolase in Plasmodium Undergoes Multiple Post-Translational Modifications: Evidence for Atypical Ubiquitination	PLOS ONE			English	Article							ALPHA-ENOLASE; POLYUBIQUITIN CHAINS; GLYCOLYTIC-ENZYMES; DIGESTIVE VACUOLE; PROTEIN-TRANSPORT; YEAST ENOLASE; FALCIPARUM; SURFACE; LOCALIZATION; GENE	Plasmodium enolase localizes to several sub-cellular compartments viz. cytosol, nucleus, cell membrane, food vacuole (FV) and cytoskeleton, without having any organelle targeting signal sequences. This enzyme has been shown to undergo multiple post-translational modifications (PTMs) giving rise to several variants that show organelle specific localization. It is likely that these PTMs may be responsible for its diverse distribution and moonlighting functions. While most variants have a MW of similar to 50 kDa and are likely to arise due to changes in pI, food vacuole (FV) associated enolase showed three forms with MW similar to 50, 65 and 75 kDa. Evidence from immuno-precipitation and western analysis indicates that the 65 and 75 kDa forms of FV associated enolase are ubiquitinated. Using mass spectrometry (MS), definitive evidence is obtained for the nature of PTMs in FV associated variants of enolase. Results showed several modifications, viz. ubiquitination at K147, phosphorylation at Y148 and acetylation at K142 and K384. MS data also revealed the conjugation of three ubiquitin (Ub) molecules to enolase through K147. Trimeric ubiquitin has a linear peptide linkage between the NH2-terminal methionine of the first ubiquitin (Ub1) and the C-terminal G76 of the second (Ub2). Ub2 and third ubiquitin (Ub3) were linked through an atypical isopeptide linkage between K6 of Ub2 and G76 of Ub3, respectively. Further, the tri-ubiquitinated form was found to be largely associated with hemozoin while the 50 and 65 kDa forms were present in the NP-40 soluble fraction of FV. Mass spectrometry results also showed phosphorylation of S42 in the cytosolic enolase from P. falciparum and T337 in the cytoskeleton associated enolase from P. yoelii. The composition of food vacuolar proteome and likely interactors of enolase are also being reported.	[Shevade, Saudamini; Jindal, Nitin; Dutta, Sneha; Jarori, Gotam K.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Jarori, GK (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	gkj@tifr.res.in	Jarori, Gotam K/L-8908-2019		Department of Atomic energy, Govt of India	Department of Atomic energy, Govt of India(Department of Atomic Energy (DAE))	Funds were provided by Department of Atomic energy, Govt of India (http://164.100.119.21/?q=node/81). The funders have no role in study design, data collection and analysis, decion to publish, or preparation of the manuscript.	Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Barkla BJ, 2009, PLANT CELL, V21, P4044, DOI 10.1105/tpc.109.069211; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Das S, 2011, MOL BIOCHEM PARASIT, V179, P8, DOI 10.1016/j.molbiopara.2011.05.001; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Decker BL, 2006, J BIOL CHEM, V281, P14523, DOI 10.1074/jbc.M600911200; Dluzewski AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003085; Dzierszinski F, 1999, J BIOL CHEM, V274, P24888, DOI 10.1074/jbc.274.35.24888; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghosh AK, 2011, P NATL ACAD SCI USA, V108, P17153, DOI 10.1073/pnas.1103657108; Hernandez-Romano J, 2011, PARASITOLOGY, V138, P1341, DOI 10.1017/S0031182011001296; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; IIDA H, 1985, NATURE, V315, P688, DOI 10.1038/315688a0; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kleijnen MF, 2007, EMBO J, V26, P275, DOI 10.1038/sj.emboj.7601486; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kuss C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010645; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamarque M, 2008, PROTEOM CLIN APPL, V2, P1361, DOI 10.1002/prca.200700112; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Liu K.-J., 2007, J CANC MOL, V3, P45; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; Miao Wen-li, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P749; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; OLLIARO PL, 1995, PARASITOL TODAY, V11, P294, DOI 10.1016/0169-4758(95)80042-5; Pal-Bhowmick I, 2004, EUR J BIOCHEM, V271, P4845, DOI 10.1111/j.1432-1033.2004.04450.x; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Pal-Bhowmick I, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-45; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pokrzywa W, 2009, EUKARYOT CELL, V8, P278, DOI 10.1128/EC.00363-08; READ M, 1994, EUR J BIOCHEM, V220, P513, DOI 10.1111/j.1432-1033.1994.tb18650.x; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Walsh C., 2006, POSTTRANSLATIONAL MO; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WISTOW GJ, 1988, J CELL BIOL, V107, P2729, DOI 10.1083/jcb.107.6.2729	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72687	10.1371/journal.pone.0072687	http://dx.doi.org/10.1371/journal.pone.0072687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009698	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200028
J	Taylor-Robinson, DC; Smyth, R; Diggle, PJ; Whitehead, M				Taylor-Robinson, David C.; Smyth, Rosalind; Diggle, Peter J.; Whitehead, Margaret			A Longitudinal Study of the Impact of Social Deprivation and Disease Severity on Employment Status in the UK Cystic Fibrosis Population	PLOS ONE			English	Article							MACROLEVEL CONTEXTS; HEALTH INEQUALITIES; CHRONICALLY ILL; WORK DISABILITY; ADULTS; EPIDEMIOLOGY; CHALLENGES; MORTALITY; POLICIES; CHANCES	Background: People with Cystic Fibrosis (CF) in the UK and elsewhere are increasingly surviving into adulthood, yet there is little research on the employment consequences of having CF. We investigated, for the first time in a UK-wide cohort, longitudinal employment status, and its association with deprivation, disease severity, and time in hospital. Methods: We did a longitudinal registry study of adults with CF in the UK aged 20 to 40 (3458 people with 15,572 observations between 1996 and 2010), using mixed effects models. Results: Around 50% of adults with CF were in employment. Male sex, higher lung function and body mass index, and less time in hospital were associated with improved employment chances. All other things being equal, being in the most deprived quintile was associated with a reduction of employment prevalence of 17.6 percentage points compared to the prevalence in the least deprived quintile. Having poor lung function was associated with a reduced employment prevalence of 7.2 percentage points compared to the prevalence for people with relatively good lung function. Acting synergistically, deprivation modifies the effect of lung function on employment chances - poor lung function in the least deprived group was associated with a 3 percentage point reduction in employment chances, while poor lung function in the most deprived quintile was associated with a 7.7 point reduction in employment chances. Conclusions: Greater deprivation, disease severity, and time in hospital are all associated with employment chances in adults with CF. Furthermore, our analysis suggests that deprivation amplifies the harmful association of disease severity on employment. Future studies should focus on understanding and mitigating the barriers to employment faced by people with CF.	[Taylor-Robinson, David C.; Whitehead, Margaret] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Smyth, Rosalind] UCL, Inst Child Hlth, London, England; [Diggle, Peter J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of London; University College London; University of Liverpool	Taylor-Robinson, DC (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	dctr@liv.ac.uk		Diggle, Peter/0000-0003-3521-5020	MRC [G0802448]; Medical Research Council [G0802448] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DTR is supported by an MRC Population Health Scientist Fellowship (G0802448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2008, DIABETES CARE, V31, P1789, DOI 10.2337/dc08-0466; [Anonymous], 2013, LANCET RESP MED, V1, P121, DOI 10.1016/S2213-2600(13)70002-X; Bambra C., 2010, Journal of Epidemiology & Community Health, V64, P284, DOI 10.1136/jech.2008.082743; Bambra C, 2009, PREV MED, V48, P454, DOI 10.1016/j.ypmed.2008.12.018; Barr HL SA, 2011, BMJ; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; BRITTON JR, 1989, BRIT MED J, V298, P483, DOI 10.1136/bmj.298.6672.483; Burker EJ, 2004, PEDIATR PULM, V38, P413, DOI 10.1002/ppul.20090; Cumberlege J., 2010, FAIR SOC HEARLY LIVE; Cystic Fibrosis Trust, 2011, UK CF REG ANN DAT RE; Cystic Fibrosis Trust, 2011, UK CF REG; Diderichsen F, 2001, SOCIAL ORIGINS DISPA; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Edwards J, 2010, DISABIL SOC, V25, P441, DOI 10.1080/09687591003755831; Frangolias DD, 2003, AM J RESP CRIT CARE, V167, P150, DOI 10.1164/rccm.2202053; GILLEN M, 1995, AM J RESP CRIT CARE, V152, P153, DOI 10.1164/ajrccm.152.1.7599815; Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d; Hastie TJ., 1990, GEN ADDITIVE MODELS; Havermans T, 2009, J CYST FIBROS, V8, P218, DOI 10.1016/j.jcf.2009.03.002; Hogg M, 2007, J CYST FIBROS, V6, P223, DOI 10.1016/j.jcf.2006.10.004; Holland P, 2011, INT J HEALTH SERV, V41, P415, DOI 10.2190/HS.41.3.b; Holland P, 2011, INT J HEALTH SERV, V41, P395, DOI 10.2190/HS.41.3.a; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Mehta G, 2004, J ROY SOC MED, V97, P60; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; Rosenfeld M., 2005, TASK FORCE EVALUATE; Saldana PS, 2012, WORK, V42, P185, DOI 10.3233/WOR-2012-1353; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Semple MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022425; Taylor-Robinson D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4818; WALTERS S, 1993, BRIT MED J, V306, P549, DOI 10.1136/bmj.306.6877.549	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73322	10.1371/journal.pone.0073322	http://dx.doi.org/10.1371/journal.pone.0073322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009747	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000324403200046
J	Hsieh, JY; Wang, HW; Chang, SJ; Liao, KH; Lee, IH; Lin, WS; Wu, CH; Lin, WY; Cheng, SM				Hsieh, Jui-Yu; Wang, Hsei-Wei; Chang, Shing-Jyh; Liao, Ko-Hsun; Lee, I-Hui; Lin, Wei-Shiang; Wu, Chun-Hsien; Lin, Wen-Yu; Cheng, Shu-Meng			Mesenchymal Stem Cells from Human Umbilical Cord Express Preferentially Secreted Factors Related to Neuroprotection, Neurogenesis, and Angiogenesis	PLOS ONE			English	Article							MARROW STROMAL CELLS; EPIDERMAL-GROWTH-FACTOR; HUMAN BONE-MARROW; GENE-EXPRESSION; ADIPOSE-TISSUE; IN-VITRO; NEURONAL DIFFERENTIATION; MYOCARDIAL-INFARCTION; PROMOTES ANGIOGENESIS; DOPAMINERGIC-NEURONS	Mesenchymal stem cells (MSCs) are promising tools for the treatment of diseases such as infarcted myocardia and strokes because of their ability to promote endogenous angiogenesis and neurogenesis via a variety of secreted factors. MSCs found in the Wharton's jelly of the human umbilical cord are easily obtained and are capable of transplantation without rejection. We isolated MSCs from Wharton's jelly and bone marrow (WJ-MSCs and BM-MSCs, respectively) and compared their secretomes. It was found that WJ-MSCs expressed more genes, especially secreted factors, involved in angiogenesis and neurogenesis. Functional validation showed that WJ-MSCs induced better neural differentiation and neural cell migration via a paracrine mechanism. Moreover, WJ-MSCs afforded better neuroprotection efficacy because they preferentially enhanced neuronal growth and reduced cell apoptotic death of primary cortical cells in an oxygen-glucose deprivation (OGD) culture model that mimics the acute ischemic stroke situation in humans. In terms of angiogenesis, WJ-MSCs induced better microvasculature formation and cell migration on co-cultured endothelial cells. Our results suggest that WJ-MSC, because of a unique secretome, is a better MSC source to promote in vivo neurorestoration and endothelium repair. This study provides a basis for the development of cell-based therapy and carrying out of follow-up mechanistic studies related to MSC biology.	[Hsieh, Jui-Yu; Wang, Hsei-Wei; Liao, Ko-Hsun] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Chang, Shing-Jyh] Hsin Chu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Canc Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Educ, Taipei, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Res, Taipei, Taiwan; [Liao, Ko-Hsun; Lee, I-Hui] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Lee, I-Hui] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lin, Wei-Shiang; Wu, Chun-Hsien; Lin, Wen-Yu; Cheng, Shu-Meng] Natl Def Med Ctr, Div Cardiol, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Cheng, SM (corresponding author), Natl Def Med Ctr, Div Cardiol, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan.	chengsm@cm1.hinet.net	Lin, Wei-Shiang/ABA-7928-2020		National Science Council (NSC) [NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003, NSC101-2321-B- 010-011]; Mackay Memorial Hospital [MMH-HB-101-01, MMH-10192, MMH-100067]; Veterans General Hospitals University System of Taiwan Joint Research Program Tsou's Foundation [VGHUST102-G7-3-2]; National Health Research Institutes [NHRI-EX102-10254SI]; UST-University of California San Diego International Center for Excellence in Advanced Bioengineering; Taiwan NSC I-RiCE Program [NSC101-2911-I-009-101]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Veterans General Hospitals University System of Taiwan Joint Research Program Tsou's Foundation; National Health Research Institutes(National Health Research Institutes, Japan); UST-University of California San Diego International Center for Excellence in Advanced Bioengineering; Taiwan NSC I-RiCE Program; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)(Ministry of Education, Taiwan)	This work is supported by National Science Council (NSC; NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003 and NSC101-2321-B- 010-011), Mackay Memorial Hospital (MMH-HB-101-01, MMH-10192 and MMH-100067), Veterans General Hospitals University System of Taiwan Joint Research Program, Tsou's Foundation (VGHUST102-G7-3-2), National Health Research Institutes (NHRI-EX102-10254SI), UST-University of California San Diego International Center for Excellence in Advanced Bioengineering sponsored by the Taiwan NSC I-RiCE Program (NSC101-2911-I-009-101), and in part a grant from National Yang-Ming University (Ministry of Education, Aim for the Top University Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nbaheen M, 2012, STEM CELL RES; Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Bai LH, 2007, NEUROCHEM RES, V32, P353, DOI 10.1007/s11064-006-9212-x; Balasubramanian S, 2012, CYTOTHERAPY, V14, P26, DOI 10.3109/14653249.2011.605119; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Chang YJ, 2006, STEM CELLS, V24, P679, DOI 10.1634/stemcells.2004-0308; Chen HC, 2012, STEM CELLS DEV, V21, P911, DOI 10.1089/scd.2011.0186; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Choudhuri R, 1997, CANCER RES, V57, P1814; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485; Huang TS, 2008, STEM CELLS, V26, P1186, DOI 10.1634/stemcells.2007-0821; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; Jin KL, 2002, J NEUROSCI, V22, P5365; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Kern S, 2006, STEM CELLS; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Lin YC, 2011, STROKE, V42, P2045, DOI 10.1161/STROKEAHA.110.603621; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Miranda HC, 2012, PROTEOMICS, V12, P2607, DOI 10.1002/pmic.201200111; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Moller B, 2001, MOL HUM REPROD, V7, P65, DOI 10.1093/molehr/7.1.65; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ribeiro CA, 2011, J TISSUE ENG REGEN M, V5, P668, DOI 10.1002/term.365; Ribeiro CA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt109; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; Strieter Robert M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P23, DOI 10.2174/1568010053622902; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang TP, 2006, BIOINFORMATICS, V22, P2697, DOI 10.1093/bioinformatics/btl457; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; Zhang HY, 2011, J SEX MED, V8, P437, DOI 10.1111/j.1743-6109.2010.02128.x; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zou P, 2006, J NEUROCHEM, V99, P1470, DOI 10.1111/j.1471-4159.2006.04138.x	63	205	217	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72604	10.1371/journal.pone.0072604	http://dx.doi.org/10.1371/journal.pone.0072604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991127	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700042
J	Muller, I; Schnberger, T; Schneider, M; Borst, O; Ziegler, M; Seizer, P; Leder, C; Muller, K; Lang, M; Appenzeller, F; Lunov, O; Buchele, B; Fahrleitner, M; Olbrich, M; Langer, H; Geisler, T; Lang, F; Chatterjee, M; de Boer, JF; Tietge, UJF; Bernhagen, J; Simmet, T; Gawaz, M				Mueller, Iris; Schnberger, Tanja; Schneider, Martina; Borst, Oliver; Ziegler, Melanie; Seizer, Peter; Leder, Christoph; Mueller, Karin; Lang, Michael; Appenzeller, Florian; Lunov, Oleg; Buechele, Berthold; Fahrleitner, Manuela; Olbrich, Marcus; Langer, Harald; Geisler, Tobias; Lang, Florian; Chatterjee, Madhumita; de Boer, Jan Freark; Tietge, Uwe J. F.; Bernhagen, Juergen; Simmet, Thomas; Gawaz, Meinrad			Gremlin-1 Is an Inhibitor of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerotic Plaque Growth in ApoE(-/-) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; GLYCOPROTEIN-VI; I-TASSER; ANTAGONIST GREMLIN-1; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; EXPRESSION; MONOCYTE; DOCKING; GENE	Monocyte infiltration and macrophage formation are pivotal steps in atherosclerosis and plaque vulnerability. Gremlin-1/Drm is crucial in embryo-/organogenesis and has been shown to be expressed in the adult organism at sites of arterial injury and to inhibit monocyte migration. The purpose of the present study was to evaluate and characterize the role of Gremlin-1 in atherosclerosis. Here we report that Gremlin-1 is highly expressed primarily by monocytes/macrophages in aortic atherosclerotic lesions of ApoE(-/-) mice and is secreted from activated monocytes and during macrophage development in vitro. Gremlin-1 reduces macrophage formation by inhibiting macrophage migration inhibitory factor (MIF), a cytokine critically involved in atherosclerotic plaque progression and vulnerability. Gremlin-1 binds with high affinity to MIF (K-D = 54 nM), as evidenced by surface plasmon resonance analysis and co-immunoprecipitation, and reduces MIF-induced release of TNF-alpha from macrophages. Treatment of ApoE(-/-) mice with a dimeric recombinant fusion protein, (m)Gremlin1-Fc, but not with equimolar control Fc or inactivated (m)Gremlin1-Fc, reduced TNF-alpha expression, the content of monocytes/macrophages of atherosclerotic lesions, and attenuated atheroprogression. The present data disclose that Gremlin-1 is an endogenous antagonist of MIF and define a role for Gremlin-1/MIF interaction in atherosclerosis.	[Mueller, Iris; Schnberger, Tanja; Schneider, Martina; Borst, Oliver; Ziegler, Melanie; Seizer, Peter; Leder, Christoph; Mueller, Karin; Lang, Michael; Appenzeller, Florian; Fahrleitner, Manuela; Olbrich, Marcus; Langer, Harald; Geisler, Tobias; Chatterjee, Madhumita; Gawaz, Meinrad] Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, D-72076 Tubingen, Germany; [Lunov, Oleg; Buechele, Berthold; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89081 Ulm, Germany; [Lang, Florian] Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; [de Boer, Jan Freark; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9713 Groningen, Netherlands; [Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, D-52074 Aachen, Germany	Eberhard Karls University of Tubingen; Ulm University; Eberhard Karls University of Tubingen; University of Groningen; RWTH Aachen University	Gawaz, M (corresponding author), Univ Tubingen, Otfried Muller Str 10, D-72076 Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de	Chatterjee, Madhumita/AAJ-1802-2020; Sauter, Manuela/AAU-5685-2021; Lunov, Oleg/H-1387-2014; Geisler, Tobias/AAO-4472-2020; Stefanadis, Christodoulos/ABH-2232-2020	Chatterjee, Madhumita/0000-0002-3428-4107; Sauter, Manuela/0000-0002-6411-5697; Lunov, Oleg/0000-0003-2922-8896; Borst, Oliver/0000-0003-4002-4085; Ziegler, Melanie/0000-0002-6229-5698; Syrovets, Tatiana/0000-0002-6751-2233; Stefanadis, Christodoulos/0000-0001-5974-6454	Deutsche Forschungsgemeinschaft (DFG) [Transregio-SFB-19, Klinische Forschergruppe KFO-274]; DFG [MU 2928/2-1]; University of Tubingen (Iris Muller Fortune Research Program); University of Tubingen (Interdisciplinary Center for Clinical Research (IZKF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Tubingen (Iris Muller Fortune Research Program); University of Tubingen (Interdisciplinary Center for Clinical Research (IZKF)	This study was supported in part by grants from the Deutsche Forschungsgemeinschaft (DFG) (Transregio-SFB-19 and Klinische Forschergruppe KFO-274, "Platelets-Molecular Mechanisms and Translational Implications") and by DFG Grant MU 2928/2-1 to Iris Muller, the University of Tubingen (Iris Muller Fortune Research Program; H. L. Interdisciplinary Center for Clinical Research (IZKF)).	Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Chiodelli P, 2011, ARTERIOSCL THROM VAS, V31, pE116, DOI 10.1161/ATVBAHA.111.235184; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Daub K, 2010, J MOL MED, V88, P909, DOI 10.1007/s00109-010-0629-y; Diecke S, 2008, CELLS TISSUES ORGANS, V188, P52, DOI 10.1159/000121282; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Hanlon AD, 2010, BIOPHYS J, V98, P297, DOI 10.1016/j.bpj.2009.09.061; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Kane R, 2005, BRIT J OPHTHALMOL, V89, P1638, DOI 10.1136/bjo.2005.069591; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maciel TT, 2008, J MOL CELL CARDIOL, V44, P370, DOI 10.1016/j.yjmcc.2007.10.021; Massberg S, 2003, FASEB J, V17, P397, DOI 10.1096/f.03-0464.fje; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Nijstad N, 2011, BBA-MOL CELL BIOL L, V1811, P294, DOI 10.1016/j.bbalip.2011.01.008; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidt R, 2006, CIRCULATION, V113, P834, DOI 10.1161/CIRCULATIONAHA.105.568162; Schonberger T, 2008, CARDIOVASC RES, V80, P131, DOI 10.1093/cvr/cvn169; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Seizer P, 2010, SEMIN THROMB HEMOST, V36, P157, DOI 10.1055/s-0030-1251499; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stellos K, 2010, ARTERIOSCL THROM VAS, V30, P1127, DOI 10.1161/ATVBAHA.110.204370; Sugimoto H, 1996, FEBS LETT, V389, P145, DOI 10.1016/0014-5793(96)00553-4; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zeibig S, 2011, CIRC RES, V108, P695, DOI 10.1161/CIRCRESAHA.111.240515; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	57	45	46	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31635	31645		10.1074/jbc.M113.477745	http://dx.doi.org/10.1074/jbc.M113.477745			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24003215	Green Published, hybrid			2022-12-25	WOS:000330596200022
J	Shen, YY; Shi, XK; Pan, JX				Shen, Yingying; Shi, Xiaoke; Pan, Jingxuan			The Conformational Control Inhibitor of Tyrosine Kinases DCC-2036 Is Effective for Imatinib-Resistant Cells Expressing T674I FIP1L1-PDGFR alpha	PLOS ONE			English	Article							REGULATES AKT UBIQUITINATION; BCR-ABL; EOSINOPHILIC LEUKEMIA; CYTOCHROME-C; CANCER CELLS; APOPTOSIS; BIM; MUTANT; ALPHA; KIT	The cells expressing the T674I point mutant of FIP1-like-1-platelet-derived growth factor receptor alpha (FIP1L1-PDGFR alpha) in hypereosinophilics syndrome (HES) are resistant to imatinib and some second-generation tyrosine kinase inhibitors (TKIs). There is a desperate need to develop therapy to combat this acquired drug resistance. DCC-2036 has been synthesized as a third-generation TKI to combat especially the Bcr-Abl T315I mutant in chronic myeloid leukemia. This study evaluated the effect of DCC-2036 on FIP1L1-PDGFR alpha-positive cells, including the wild type (WT) and the T674I mutant. The in vitro effects of DCC-2036 on the PDGFR alpha signal pathways, proliferation, cell cycling and apoptosis of FIP1L1-PDGFR alpha-positive cells were investigated, and a nude mouse xenograft model was employed to assess the in vivo antitumor activity. We found that DCC-2036 decreased the phosphorylated levels of PDGFRa and its downstream targets without apparent effects on total protein levels. DCC-2036 inhibited proliferation, and induced apoptosis with MEK-dependent up-regulation of the pro-apoptotic protein Bim in FIP1L1-PDGFR alpha-positive cells. DCC-2036 also exhibited in vivo antineoplastic activity against cells with T674I FIP1L1-PDGFR alpha. In summary, FIP1L1-PDGFR alpha-positive cells are sensitive to DCC-2036 regardless of their sensitivity to imatinib. DCC-2036 may be a potential compound to treat imatinib-resistant HES.			Pan, JX (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510275, Guangdong, Peoples R China.	panjx2@mail.sysu.edu.cn	Shen, Yingying/GQO-9549-2022		Research Foundation of Guangzhou Bureau of Science and Technology, China; National Natural Science Fund for Distinguished Young Scholars [81025021]; Research Foundation of Education Bureau of Guangdong Province, China [cxzd1103]; National Basic Research Program of China (973 Program) [2009CB825506]; National Hi-Tech Research and Development Program of China (863 Program) [2008AA02Z420]; Fundamental Research Funds for the Central Universities	Research Foundation of Guangzhou Bureau of Science and Technology, China; National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Research Foundation of Education Bureau of Guangdong Province, China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the Research Foundation of Guangzhou Bureau of Science and Technology, China (grant to J. Pan), the National Natural Science Fund for Distinguished Young Scholars (no. 81025021 to J. Pan), the Research Foundation of Education Bureau of Guangdong Province, China (grant cxzd1103 to J. Pan), the National Basic Research Program of China (973 Program grant no. 2009CB825506 to J. Pan), the National Hi-Tech Research and Development Program of China (863 Program grant no. 2008AA02Z420 to J. Pan), and the Fundamental Research Funds for the Central Universities (to J. Pan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Buitenhuis N, 2007, CANCER RES, V67, P3759, DOI 10.1158/0008-5472.CAN-06-4183; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Cools J, 2005, DRUG RESIST UPDATE, V8, P119, DOI 10.1016/j.drup.2005.04.005; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Eide CA, 2011, CANCER RES, V71, P3189, DOI 10.1158/0008-5472.CAN-10-3224; Erben P, 2010, HAEMATOL-HEMATOL J, V95, P738, DOI 10.3324/haematol.2009.016345; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fukushima K, 2009, J BIOL CHEM, V284, P7719, DOI 10.1074/jbc.M807489200; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jin YL, 2010, MOL CANCER THER, V9, P211, DOI 10.1158/1535-7163.MCT-09-0468; Jin YL, 2009, CANCER SCI, V100, P2210, DOI 10.1111/j.1349-7006.2009.01283.x; Kole AJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2773; Lierman E, 2009, LEUKEMIA, V23, P845, DOI 10.1038/leu.2009.2; Lierman E, 2006, BLOOD, V108, P1374, DOI 10.1182/blood-2006-02-004457; Lu ZZ, 2010, CANCER LETT, V290, P182, DOI 10.1016/j.canlet.2009.09.006; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Metzgeroth G, 2012, LEUKEMIA, V26, P162, DOI 10.1038/leu.2011.181; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; Pan JX, 2005, CANCER RES, V65, P3671, DOI 10.1158/0008-5472.CAN-04-2744; Pan JX, 2001, J CLIN ENDOCR METAB, V86, P4731, DOI 10.1210/jc.86.10.4731; Radujkovic A, 2006, ANTICANCER RES, V26, P2169; Salemi S, 2009, ALLERGY, V64, P913, DOI 10.1111/j.1398-9995.2009.01943.x; Shi XP, 2009, CLIN CANCER RES, V15, P1686, DOI 10.1158/1078-0432.CCR-08-2141; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Verstovsek S, 2009, CLIN CANCER RES, V15, P368, DOI 10.1158/1078-0432.CCR-08-1302; von Bubnoff N, 2005, LEUKEMIA, V19, P286, DOI 10.1038/sj.leu.2403600; Weigel MT, 2009, CANCER LETT, V273, P70, DOI 10.1016/j.canlet.2008.07.040; Weisberg E, 2010, BLOOD, V115, P4206, DOI 10.1182/blood-2009-11-251751; Wu YB, 2012, CLIN CANCER RES, V18, P1966, DOI 10.1158/1078-0432.CCR-11-1971; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	38	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73059	10.1371/journal.pone.0073059	http://dx.doi.org/10.1371/journal.pone.0073059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009732	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600054
J	Zhang, Y; Chen, XY; Wen, G; Wu, GJ; Zhang, XL				Zhang, Yan; Chen, Xiuyu; Wen, Ge; Wu, Guijun; Zhang, Xuelin			Proton Magnetic Resonance Spectroscopy (H-1-MRS) Reveals Geniculocalcarine and Striate Area Degeneration in Primary Glaucoma	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; OPTIC-NERVE; VISUAL-CORTEX; CHOLINE; NEUROPROTECTION; ACETYLCHOLINE; CITICOLINE	Background: Glaucoma is a collection of neurodegenerative diseases that affect both the retina and the central visual pathway. We investigated whether metabolites' concentrations changed in the geniculocalcarine (GCT) and the striate area of occipital lobe by proton magnetic resonance spectroscopy (H-1-MRS), suggesting neurodegeneration of the central visual pathway in primary glaucoma. Methodology/Principal Findings: 20 patients with glaucoma in both eyes were paired with 20 healthy volunteers in same gender and an age difference less than 3 years. All the participants were examined by MR imaging including T-1 Flair, T-2 FSE and H-1-MRS. The T-1 intensity and T-2 intensity of their GCTs and striate areas were measured. The ratio of N-acetylaspartate (NAA)/Creatine (Cr), Choline (Cho)/Cr, glutamine and glutamate (Glx)/Cr were derived by multi-voxels H-1-MRS in the GCT and the striate area of each brain hemisphere. The T-1 intensity and T-2 intensity had no difference between the groups. Significant decreases in NAA/Cr and Cho/Cr but no difference in Glx/Cr was found between the groups in both the GCT and the striate area. Conclusions/Significance: Primary glaucoma affects metabolites' concentrations in the GCT and the striate area suggesting there is ongoing neurodegenerative process.	[Zhang, Yan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Xiuyu; Wen, Ge; Zhang, Xuelin] Southern Med Univ, Nan Fang Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Wu, Guijun] Southern Med Univ, Nan Fang Hosp, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Southern Medical University - China	Zhang, XL (corresponding author), Southern Med Univ, Nan Fang Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	zxlnfyy@163.com						Babb SM, 2004, PSYCHIAT RES-NEUROIM, V130, P1, DOI 10.1016/S0925-4927(03)00104-5; Babb SM, 1996, PSYCHOPHARMACOLOGY, V127, P88, DOI 10.1007/BF02805979; Boucard CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000222; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chinese Glaucoma Society, 2005, CHIN J OPHTHALMOL, V41, P1140; Chinese Ophthalmological Society, 2008, CHIN J OPHTHALMOL, V44, P862; Chiquet C, 2006, J FR OPHTALMOL, V29, P847, DOI 10.1016/S0181-5512(06)73858-X; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Fournier GN, 2004, NEUROSCIENCE, V126, P257, DOI 10.1016/j.neuroscience.2004.04.002; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Grieb P, 2002, J NEUROSCI RES, V67, P143, DOI 10.1002/jnr.10129; Gu Q, 2003, NEUROBIOL LEARN MEM, V80, P291, DOI 10.1016/S1074-7427(03)00073-X; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2003, EUR J OPHTHALMOL, V13, pS32; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; Kim YH, 1995, J KOREAN OPHTHALMOL, V36, P855; Luthra A, 2005, EXP EYE RES, V80, P43, DOI 10.1016/j.exer.2004.08.016; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P1, DOI 10.1016/j.coph.2012.10.009; OTT D, 1993, RADIOLOGY, V186, P745, DOI 10.1148/radiology.186.3.8430183; Parisi V, 2005, DOC OPHTHALMOL, V110, P91, DOI 10.1007/s10633-005-7348-7; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2163; [王怀洲 Wang Huaizhou], 2009, [眼科研究, Ophthalmic Research], V27, P558; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Yen CLE, 1999, FASEB J, V13, P135, DOI 10.1096/fasebj.13.1.135; Yenice O, 2008, PARKINSONISM RELAT D, V14, P193, DOI 10.1016/j.parkreldis.2007.07.018; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	31	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73197	10.1371/journal.pone.0073197	http://dx.doi.org/10.1371/journal.pone.0073197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009739	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600059
J	Kjaersgaard, MIS; Parner, ET; Vestergaard, M; Sorensen, MJ; Olsen, J; Christensen, J; Bech, BH; Pedersen, LH				Kjaersgaard, Maiken Ina Siegismund; Parner, Erik Thorlund; Vestergaard, Mogens; Sorensen, Merete Juul; Olsen, Jorn; Christensen, Jakob; Bech, Bodil Hammer; Pedersen, Lars Henning			Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion - A Population-Based Study	PLOS ONE			English	Article							PREGNANCY; REGISTER; COHORT	Purpose: To estimate the risk of spontaneous abortion after use of antidepressant medication during pregnancy. Methods: From the Danish Medical Birth Registry and the Danish National Hospital Registry, we identified all pregnancies leading to in- or outpatient contacts in Denmark from February 1997 to December 2008. The Danish Registry of Medicinal Product Statistics provided information on the women's prescriptions for antidepressants during pregnancy. We obtained information on women who were diagnosed with depression from the Danish Psychiatric Central Registry. Adjusted relative risks (aRR) of spontaneous abortion were estimated according to exposure to antidepressants or maternal depression using binomial regression. Results: Of the 1,005,319 pregnancies (547,300 women) identified, 114,721 (11.4%) ended in a spontaneous abortion. We identified 22,061 pregnancies exposed to antidepressants and 1,843 with a diagnosis of depression with no antidepressant use, of which 2,637 (12.0%) and 205 (11.1%) ended in a spontaneous abortion, respectively. Antidepressant exposure was associated with an aRR of 1.14 (95% confidence interval (CI) 1.10-1.18) for spontaneous abortion compared with no exposure to antidepressants. Among women with a diagnosis of depression, the aRR for spontaneous abortion after any antidepressant exposure was 1.00 (95% CI 0.80-1.24). No individual selective serotonin reuptake inhibitor (SSRI) was associated with spontaneous abortions. In unadjusted analyses, we found that mirtazapine, venlafaxine, and duloxetine were associated with spontaneous abortions among women with depression but we had no information on potential differences in disease severity and only few pregnancies were exposed in the population. Conclusion: We identified a slightly increased risk of spontaneous abortion associated with the use of antidepressants during pregnancy. However, among women with a diagnosis of depression, antidepressants in general or individual SSRI in particular were not associated with spontaneous abortions. Further studies are warranted on the newer non-SSRI antidepressants, as we had insufficient data to adjust for important confounding factors.	[Kjaersgaard, Maiken Ina Siegismund; Parner, Erik Thorlund] Aarhus Univ, Dept Publ Hlth, Biostat Sect, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Risskov, Denmark; [Olsen, Jorn; Bech, Bodil Hammer; Pedersen, Lars Henning] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ, Dept Clin Pharmacol, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Dept Obstet & Gynecol, Inst Clin Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Pedersen, LH (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	LHP@dadlnet.dk	Vestergaard, Mogens/M-9333-2014; Bech, Bodil Hammer/B-9646-2016; Parner, Erik Thorlund/F-5532-2010	Vestergaard, Mogens/0000-0001-8830-2174; Bech, Bodil Hammer/0000-0002-0287-3687; Parner, Erik Thorlund/0000-0003-3661-1922; Christensen, Jakob/0000-0002-9385-6435	Danish Council for Independent Research	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	Lars Henning Pedersen is on a Sapere Aude: DFF - Postdoc grant from the Danish Council for Independent Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Einarson A, 2009, J OBSTET GYNAECOL CA, V31, P452, DOI 10.1016/S1701-2163(16)34177-9; Einarson A, 2010, CAN MED ASSOC J, V182, P1017, DOI 10.1503/cmaj.100507; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Knudsen LB, 1998, DAN MED BULL, V45, P320; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nakano Y, 2004, ACTA PSYCHIAT SCAND, V109, P440, DOI 10.1111/j.1600-0047.2004.00273.x; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; OLSEN J, 1984, INT J EPIDEMIOL, V13, P347, DOI 10.1093/ije/13.3.347; PASTUSZAK A, 1993, JAMA-J AM MED ASSOC, V269, P2246, DOI 10.1001/jama.269.17.2246	14	64	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72095	10.1371/journal.pone.0072095	http://dx.doi.org/10.1371/journal.pone.0072095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015208	gold, Green Submitted, Green Published			2022-12-25	WOS:000323733800028
J	Kushwaha, S; Singh, PK; Rana, AK; Misra-Bhattacharya, S				Kushwaha, Susheela; Singh, Prashant Kumar; Rana, Ajay Kumar; Misra-Bhattacharya, Shailja			Immunization of Mastomys coucha with Brugia malayi Recombinant Trehalose-6-Phosphate Phosphatase Results in Significant Protection against Homologous Challenge Infection	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI; IMMUNE-RESPONSES; ANTHELMINTIC RESISTANCE; DENDRITIC CELLS; NITRIC-OXIDE; HIGH-LEVEL; NEMATODE; VACCINATION; ANTIGEN; LARVAE	Development of a vaccine to prevent or reduce parasite development in lymphatic filariasis would be a complementary approach to existing chemotherapeutic tools. Trehalose-6-phosphate phosphatase of Brugia malayi (Bm-TPP) represents an attractive vaccine target due to its absence in mammals, prevalence in the major life stages of the parasite and immunoreactivity with human bancroftian antibodies, especially from endemic normal subjects. We have recently reported on the cloning, expression, purification and biochemical characterization of this vital enzyme of B. malayi. In the present study, immunoprophylactic evaluation of Bm-TPP was carried out against B. malayi larval challenge in a susceptible host Mastomys coucha and the protective ability of the recombinant protein was evaluated by observing the adverse effects on microfilarial density and adult worm establishment. Immunization caused 78.4% decrease in microfilaremia and 71.04% reduction in the adult worm establishment along with sterilization of 70.06% of the recovered live females. The recombinant protein elicited a mixed Th1/Th2 type of protective immune response as evidenced by the generation of both pro-and anti-inflammatory cytokines IL-2, IFN-gamma, TNF-alpha, IL-4 and an increased production of antibody isotypes IgG1, IgG2a, IgG2b and IgA. Thus immunization with Bm-TPP conferred considerable protection against B. malayi establishment by engendering a long-lasting effective immune response and therefore emerges as a potential vaccine candidate against lymphatic filariasis (LF).	[Kushwaha, Susheela; Singh, Prashant Kumar; Rana, Ajay Kumar; Misra-Bhattacharya, Shailja] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Misra-Bhattacharya, S (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	Shailja_cdri@rediffmail.com		Rana, Ajay/0000-0003-3954-5887; SINGH, PRASHANT/0000-0002-6704-277X	NET fellowships by University Grants Commission, New Delhi, India; Council for Industrial and Scientific Research, New Delhi, India; CSIR network project 'SPLenDID'	NET fellowships by University Grants Commission, New Delhi, India; Council for Industrial and Scientific Research, New Delhi, India; CSIR network project 'SPLenDID'	The financial supports in the form of NET fellowships by University Grants Commission, New Delhi, India (SK) and Council for Industrial and Scientific Research, New Delhi, India (PKS) are gratefully acknowledged. The authors also acknowledge the financial assistance in the form of CSIR network project 'SPLenDID'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND NM, 1986, PARASITE IMMUNOL, V8, P391, DOI 10.1111/j.1365-3024.1986.tb00855.x; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; Babayan SA, 2006, INT J PARASITOL, V36, P903, DOI 10.1016/j.ijpara.2006.04.013; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Bottazzi ME, 2006, EXPERT REV VACCINES, V5, P189, DOI 10.1586/14760584.5.2.189; CHANDRASHEKAR R, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P15; CHANDRASHEKAR R, 1985, PARASITE IMMUNOL, V7, P633, DOI 10.1111/j.1365-3024.1985.tb00107.x; Chenthamarakshan V, 1997, J BIOSCIENCE, V22, P91, DOI 10.1007/BF02703621; Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Diemert DJ, 2008, CLIN INFECT DIS, V46, P282, DOI 10.1086/524070; Dimock KA, 1996, INFECT IMMUN, V64, P2962, DOI 10.1128/IAI.64.8.2962-2967.1996; ELSON LH, 1995, J INFECT DIS, V171, P652, DOI 10.1093/infdis/171.3.652; Gal TZ, 2001, J PARASITOL, V87, P725, DOI 10.1645/0022-3395(2001)087[0725:AITLOG]2.0.CO;2; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; GRZYCH JM, 1993, J IMMUNOL, V150, P527; Hoerauf A, 2003, CURR OPIN INFECT DIS, V16, P403, DOI 10.1097/00001432-200310000-00006; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Jenson JS, 2002, EUR J IMMUNOL, V32, P858, DOI 10.1002/1521-4141(200203)32:3<858::AID-IMMU858>3.0.CO;2-E; Johnston Kelly L, 2007, Curr Infect Dis Rep, V9, P55, DOI 10.1007/s11908-007-0023-2; Kalyanasundaram R, 2011, RES REP TROP MED, V2, P45, DOI 10.2147/RRTM.S13679; Khalil Hamed M., 1999, Journal of the Egyptian Society of Parasitology, V29, P395; Kushwaha S, 2011, PARASITE IMMUNOL; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; Kushwaha S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001770; Kushwaha S, 2011, ACTA TROP, V119, P151, DOI 10.1016/j.actatropica.2011.05.008; Le Goff L, 1997, TROP MED INT HEALTH, V2, P1170, DOI 10.1046/j.1365-3156.1997.d01-218.x; Liu LX, 1996, NEW ENGL J MED, V334, P1178, DOI 10.1056/NEJM199605023341808; LLOYD S, 1978, IMMUNOLOGY, V34, P939; Loke P, 2000, EUR J IMMUNOL; MABBOTT NA, 1995, PARASITE IMMUNOL, V17, P143, DOI 10.1111/j.1365-3024.1995.tb01016.x; MacDonald AS, 1998, J IMMUNOL, V160, P1304; Makepeace BL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000544; Molyneux DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/j.trstmh.2008.12.016; Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374; NANDURI J, 1989, CLIN MICROBIOL REV, V2, P39, DOI 10.1128/CMR.2.1.39-50.1989; Osborne J, 1996, INFECT IMMUN, V64, P3461, DOI 10.1128/IAI.64.9.3461-3466.1996; Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2; OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259; Pokharel DR, 2006, VACCINE, V24, P6208, DOI 10.1016/j.vaccine.2006.05.103; Prichard RK, 2007, EXPERT OPIN DRUG DIS, V2, pS41, DOI 10.1517/17460441.2.S1.S41; Richard-Lenoble D, 2003, FUND CLIN PHARMACOL, V17, P199, DOI 10.1046/j.1472-8206.2003.00170.x; ROM WN, 1990, AM REV RESPIR DIS, V142, P1088, DOI 10.1164/ajrccm/142.5.1088; Saeftel M, 2003, INFECT IMMUN, V71, P6978, DOI 10.1128/IAI.71.12.6978-6985.2003; Sahu BR, 2008, J INFECT DIS, V198, P434, DOI 10.1086/589881; Schwab AE, 2007, PARASITOLOGY, V134, P1025, DOI 10.1017/S0031182007002363; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Semnani RT, 2001, INFECT IMMUN, V69, P5813, DOI 10.1128/IAI.69.9.5813-5822.2001; Shakya S, 2009, PARASITOL INT, V58, P346, DOI 10.1016/j.parint.2009.07.007; SIM BKL, 1982, T ROY SOC TROP MED H, V76, P362, DOI 10.1016/0035-9203(82)90191-2; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; Townson S, 2007, EXPERT OPIN DRUG DIS, V2, pS63, DOI 10.1517/17460441.2.S1.S63; Vanam U, 2009, AM J TROP MED HYG, V80, P319, DOI 10.4269/ajtmh.2009.80.319; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; VICKERY AC, 1984, PARASITE IMMUNOL, V6, P545, DOI 10.1111/j.1365-3024.1984.tb00824.x; Volkmann L, 2001, INFECT IMMUN, V69, P2950, DOI 10.1128/IAI.69.5.2950-2956.2001; Wharton DA, 2002, CRYOLETTERS, V23, P5; Whelan M, 2000, J IMMUNOL, V164, P6453, DOI 10.4049/jimmunol.164.12.6453; YATES JA, 1985, AM J TROP MED HYG, V34, P1132, DOI 10.4269/ajtmh.1985.34.1132	63	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72585	10.1371/journal.pone.0072585	http://dx.doi.org/10.1371/journal.pone.0072585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015262	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800066
J	Villiger, M; Estevez, N; Hepp-Reymond, MC; Kiper, D; Kollias, SS; Eng, K; Hotz-Boendermaker, S				Villiger, Michael; Estevez, Natalia; Hepp-Reymond, Marie-Claude; Kiper, Daniel; Kollias, Spyros S.; Eng, Kynan; Hotz-Boendermaker, Sabina			Enhanced Activation of Motor Execution Networks Using Action Observation Combined with Imagination of Lower Limb Movements	PLOS ONE			English	Article							CORTICAL ACTIVATION; SUBCORTICAL STROKE; BRAIN ACTIVATION; VIRTUAL-REALITY; SYSTEM FUNCTION; IMAGERY; FMRI; CORTEX; PARIETAL; MODULATION	The combination of first-person observation and motor imagery, i.e. first-person observation of limbs with online motor imagination, is commonly used in interactive 3D computer gaming and in some movie scenes. These scenarios are designed to induce a cognitive process in which a subject imagines himself/herself acting as the agent in the displayed movement situation. Despite the ubiquity of this type of interaction and its therapeutic potential, its relationship to passive observation and imitation during observation has not been directly studied using an interactive paradigm. In the present study we show activation resulting from observation, coupled with online imagination and with online imitation of a goal-directed lower limb movement using functional MRI (fMRI) in a mixed block/event-related design. Healthy volunteers viewed a video (first-person perspective) of a foot kicking a ball. They were instructed to observe-only the action (O), observe and simultaneously imagine performing the action (O-MI), or imitate the action (O-IMIT). We found that when O-MI was compared to O, activation was enhanced in the ventralpremotor cortex bilaterally, left inferior parietal lobule and left insula. The O-MI and O-IMIT conditions shared many activation foci in motor relevant areas as confirmed by conjunction analysis. These results show that (i) combining observation with motor imagery (O-MI) enhances activation compared to observation-only (O) in the relevant foot motor network and in regions responsible for attention, for control of goal-directed movements and for the awareness of causing an action, and (ii) it is possible to extensively activate the motor execution network using O-MI, even in the absence of overt movement. Our results may have implications for the development of novel virtual reality interactions for neurorehabilitation interventions and other applications involving training of motor tasks.	[Villiger, Michael; Hotz-Boendermaker, Sabina] Univ Hosp Balgrist, Spinal Cord Injury Ctr, Zurich, Switzerland; [Villiger, Michael; Estevez, Natalia; Kollias, Spyros S.] Univ Zurich Hosp, Inst Neuroradiol, CH-8091 Zurich, Switzerland; [Villiger, Michael; Hepp-Reymond, Marie-Claude; Kiper, Daniel; Eng, Kynan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Villiger, Michael; Hepp-Reymond, Marie-Claude; Kiper, Daniel; Eng, Kynan] ETH, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eng, K (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	kynan@ini.phys.ethz.ch	Hotz, S/AAL-7043-2020; LUO, JINGJING/AAZ-6697-2021	Hotz, S/0000-0001-9455-6074; LUO, JINGJING/0000-0002-3222-1276; Eng, Kynan/0000-0002-1434-8767	International Foundation for Research in Paraplegia (IRP); Swiss National Science Foundation (SNF) [51NF40-144619/PMPDP3-124282]; OPO-Foundation; Neuroscience Center Zurich (ZNZ)	International Foundation for Research in Paraplegia (IRP); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); OPO-Foundation; Neuroscience Center Zurich (ZNZ)	The work was funded by the International Foundation for Research in Paraplegia (IRP), Swiss National Science Foundation (SNF) [51NF40-144619/PMPDP3-124282], OPO-Foundation, and the Neuroscience Center Zurich (ZNZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Caggiano V, 2011, CURR BIOL, V21, P144, DOI 10.1016/j.cub.2010.12.022; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chaminade T, 2005, NEUROPSYCHOLOGIA, V43, P115, DOI 10.1016/j.neuropsychologia.2004.04.026; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Grootoonk S, 2000, NEUROIMAGE, V11, P49, DOI 10.1006/nimg.1999.0515; Gustin SM, 2010, PAIN, V148, P438, DOI 10.1016/j.pain.2009.12.001; Hardwick RM, 2012, EUR J NEUROSCI, V35, P1475, DOI 10.1111/j.1460-9568.2012.08046.x; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Hotz-Boendermaker S, 2011, NEUROREHAB NEURAL RE, V25, P469, DOI 10.1177/1545968310389184; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; Iseki K, 2008, NEUROIMAGE, V41, P1021, DOI 10.1016/j.neuroimage.2008.03.010; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jastorff J, 2012, CEREB CORTEX, DOI [10.1093/cercor/bhr1382, DOI 10.1093/CERC0R/BHR1382]; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kimberley TJ, 2006, NEUROREHAB NEURAL RE, V20, P268, DOI 10.1177/1545968306286958; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Lee JH, 2009, MED IMAGE ANAL, V13, P392, DOI 10.1016/j.media.2009.01.001; Lehericy S, 2004, NEUROREPORT, V15, P1887; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Macuga KL, 2012, NEUROIMAGE, V59, P2798, DOI 10.1016/j.neuroimage.2011.09.083; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nedelko V, 2012, J NEUROL PHYS THER, V36, P182, DOI 10.1097/NPT.0b013e318272cad1; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Orr ELR, 2008, NEUROREPORT, V19, P625, DOI 10.1097/WNR.0b013e3282fbf9e0; Remaud A, 2012, J MOTOR BEHAV, V44, P329, DOI 10.1080/00222895.2012.708680; Rocca MA, 2010, J NEUROL SCI, V288, P34, DOI 10.1016/j.jns.2009.10.013; Roux FE, 2003, NEUROSURGERY, V53, P1342, DOI 10.1227/01.NEU.0000093424.71086.8F; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Sakreida K, 2005, J NEUROSCI, V25, P1335, DOI 10.1523/JNEUROSCI.4170-04.2005; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Simmons L, 2008, NEUROREHAB NEURAL RE, V22, P458, DOI 10.1177/1545968308315597; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Stippich C, 2002, NEUROSCI LETT, V331, P50, DOI 10.1016/S0304-3940(02)00826-1; Szameitat AJ, 2012, NEUROIMAGE, V62, P266, DOI 10.1016/j.neuroimage.2012.05.009; Tanaka S, 2001, NEUROREPORT, V12, P1171, DOI 10.1097/00001756-200105080-00024; Thompson WL, 2009, PSYCHOL SCI, V20, P1245, DOI 10.1111/j.1467-9280.2009.02440.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Villiger M., 2011, VIRT REH ICVR 2011 I, P1, DOI [10.1109/ICVR.2011.5971865, DOI 10.1109/ICVR.2011.5971865]; Villiger M, 2013, NEUROREHAB NEURAL RE, V27, P675, DOI 10.1177/1545968313490999; Villiger M, 2011, EXP BRAIN RES, V209, P85, DOI 10.1007/s00221-010-2522-x; Wang CH, 2008, NEUROSCI LETT, V443, P232, DOI 10.1016/j.neulet.2008.07.084; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Yu NB, 2011, INT J COMPUT ASS RAD, V6, P447, DOI 10.1007/s11548-010-0525-5; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	78	73	73	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72403	10.1371/journal.pone.0072403	http://dx.doi.org/10.1371/journal.pone.0072403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015241	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000323733800050
J	Cantinieaux, D; Quertainmont, R; Blacher, S; Rossi, L; Wanet, T; Noel, A; Brook, G; Schoenen, J; Franzen, R				Cantinieaux, Dorothee; Quertainmont, Renaud; Blacher, Silvia; Rossi, Loic; Wanet, Thomas; Noel, Agnes; Brook, Gary; Schoenen, Jean; Franzen, Rachelle			Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells Improves Recovery after Spinal Cord Injury in Rats: An Original Strategy to Avoid Cell Transplantation	PLOS ONE			English	Article							OSTEOPONTIN INDUCES ANGIOGENESIS; TRAUMATIC BRAIN-INJURY; STROMAL CELLS; FUNCTIONAL RECOVERY; ADULT RATS; NEUROTROPHIC FACTOR; GROWTH-FACTOR; MICROGLIAL PHAGOCYTOSIS; LOCOMOTOR RECOVERY; CEREBRAL-ISCHEMIA	Spinal cord injury triggers irreversible loss of motor and sensory functions. Numerous strategies aiming at repairing the injured spinal cord have been studied. Among them, the use of bone marrow-derived mesenchymal stem cells (BMSCs) is promising. Indeed, these cells possess interesting properties to modulate CNS environment and allow axon regeneration and functional recovery. Unfortunately, BMSC survival and differentiation within the host spinal cord remain poor, and these cells have been found to have various adverse effects when grafted in other pathological contexts. Moreover, paracrine-mediated actions have been proposed to explain the beneficial effects of BMSC transplantation after spinal cord injury. We thus decided to deliver BMSC-released factors to spinal cord injured rats and to study, in parallel, their properties in vitro. We show that, in vitro, BMSC-conditioned medium (BMSC-CM) protects neurons from apoptosis, activates macrophages and is pro-angiogenic. In vivo, BMSC-CM administered after spinal cord contusion improves motor recovery. Histological analysis confirms the pro-angiogenic action of BMSC-CM, as well as a tissue protection effect. Finally, the characterization of BMSC-CM by cytokine array and ELISA identified trophic factors as well as cytokines likely involved in the beneficial observed effects. In conclusion, our results support the paracrine-mediated mode of action of BMSCs and raise the possibility to develop a cell-free therapeutic approach.	[Cantinieaux, Dorothee; Quertainmont, Renaud; Rossi, Loic; Wanet, Thomas; Schoenen, Jean; Franzen, Rachelle] Univ Liege, Axonal Regenerat & Cephal Pain Unit, GIGA Neurosci, Liege, Belgium; [Blacher, Silvia; Noel, Agnes] Univ Liege, Lab Biol Tumour & Dev, GIGA Canc, Liege, Belgium; [Brook, Gary] Univ Aachen, Dept Neuropathol, Aachen, Germany	University of Liege; University of Liege; RWTH Aachen University	Franzen, R (corresponding author), Univ Liege, Axonal Regenerat & Cephal Pain Unit, GIGA Neurosci, Liege, Belgium.	rfranzen@ulg.ac.be		Noel, Agnes/0000-0002-7670-6179	Fonds leon Fredericq; FWOR; IRME; University of Liege/Fonds speciaux	Fonds leon Fredericq; FWOR; IRME; University of Liege/Fonds speciaux(University of Liege)	This work was supported by: 1) Fonds leon Fredericq (http://www.fondsleonfredericq.be/); 2) FWOR (http://home.scarlet.be/mtcbrowsers/fwor.htm); 3) IRME (http://www.irme.org/fre/); 4) University of Liege/Fonds speciaux (http://ulg.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assina R, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E3; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Boido M., 2012, WORLD NEUROSURG; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Choi JS, 2012, KOREAN J PHYSIOL PHA, V16, P405, DOI 10.4196/kjpp.2012.16.6.405; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Fan CL, 2013, INT J BIOL SCI, V9, P78, DOI 10.7150/ijbs.5626; Figueiredo C, 2008, J NEUROCHEM, V107, P73, DOI 10.1111/j.1471-4159.2008.05577.x; Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.0.CO;2-J; Fujiki M, 2004, J NEUROTRAUM, V21, P459, DOI 10.1089/089771504323004601; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Geisbusch S, 2012, J THORAC CARDIOV SUR, V144, P1471, DOI 10.1016/j.jtcvs.2012.08.062; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hans G, 2005, NEUROPHARMACOLOGY, V48, P105, DOI 10.1016/j.neuropharm.2004.09.001; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848; Kang ES, 2012, J KOREAN MED SCI, V27, P586, DOI 10.3346/jkms.2012.27.6.586; Karaoz E, 2012, TURK NEUROSURG, V22, P207, DOI 10.5137/1019-5149.JTN.5412-11.1; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kato H, 1997, EXP NEUROL, V148, P464, DOI 10.1006/exnr.1997.6707; Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Li WM, 2004, CHINESE MED J-PEKING, V117, P621; Li X, 2012, FASEB J; Li XZ, 2009, NEUROSCI RES, V65, P252, DOI 10.1016/j.neures.2009.07.007; Liu J, 2013, J NEUROL SCI; Liu Z, 2011, NEUROTOX RES, V19, P484, DOI 10.1007/s12640-010-9215-x; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nishio T, 2009, J NEUROL, V256, pS306, DOI 10.1007/s00415-009-5244-x; Oatway MA, 2005, J NEUROSCI, V25, P637, DOI 10.1523/JNEUROSCI.3960-04.2005; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; Parish CL, 2002, J NEUROSCI, V22, P8034; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Park SI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/362473; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Perrin FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015914; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Rooney GE, 2009, TISSUE ENG PT A, V15, P3049, DOI [10.1089/ten.tea.2009.0045, 10.1089/ten.TEA.2009.0045]; Samdani AF, 2009, SPINE, V34, P2605, DOI 10.1097/BRS.0b013e3181bdca87; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Song Y, 2012, NEUROCHEM RES; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sundberg LM, 2011, J NEUROTRAUM, V28, P565, DOI 10.1089/neu.2010.1533; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Tharion G, 2011, NEUROL INDIA, V59, P77, DOI 10.4103/0028-3886.84339; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Uchida K, 2012, SPINE, V37, P2125, DOI 10.1097/BRS.0b013e3182600ef7; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; WAGNER FC, 1977, PARAPLEGIA, V14, P245, DOI 10.1038/sc.1976.41; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang YF, 2007, EUR J NEUROSCI, V26, P3159, DOI 10.1111/j.1460-9568.2007.05938.x; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Warden P, 2001, EXP NEUROL, V168, P213, DOI 10.1006/exnr.2000.7622; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wong RSY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/459510; WOZNIEWICZ B, 1983, PARAPLEGIA, V21, P312, DOI 10.1038/sc.1983.52; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; You SW, 2003, RESTOR NEUROL NEUROS, V21, P39; Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181	102	158	162	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e69515	10.1371/journal.pone.0069515	http://dx.doi.org/10.1371/journal.pone.0069515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013448	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200002
J	Crowe, A; Jackaman, C; Beddoes, KM; Ricciardo, B; Nelson, DJ				Crowe, Andrew; Jackaman, Connie; Beddoes, Katie M.; Ricciardo, Belinda; Nelson, Delia J.			Rapid Copper Acquisition by Developing Murine Mesothelioma: Decreasing Bioavailable Copper Slows Tumor Growth, Normalizes Vessels and Promotes T Cell Infiltration	PLOS ONE			English	Article							PHASE-II TRIAL; CHELATING AGENT; D-PENICILLAMINE; FIBROSARCOMA CELLS; INDUCED APOPTOSIS; LOWERING THERAPY; TETRATHIOMOLYBDATE; ANGIOGENESIS; CANCER; DEFICIENCY	Copper, an essential trace element acquired through nutrition, is an important co-factor for pro-angiogenic factors including vascular endothelial growth factor (VEGF). Decreasing bioavailable copper has been used as an anti-angiogenic and anti-cancer strategy with promising results. However, the role of copper and its potential as a therapy in mesothelioma is not yet well understood. Therefore, we monitored copper levels in progressing murine mesothelioma tumors and analyzed the effects of lowering bioavailable copper. Copper levels in tumors and organs were assayed using atomic absorption spectrophotometry. Mesothelioma tumors rapidly sequestered copper at early stages of development, the copper was then dispersed throughout growing tumor tissues. These data imply that copper uptake may play an important role in early tumor development. Lowering bioavailable copper using the copper chelators, penicillamine, trientine or tetrathiomolybdate, slowed in vivo mesothelioma growth but did not provide any cures similar to using cisplatin chemotherapy or anti-VEGF receptor antibody therapy. The impact of copper lowering on tumor blood vessels and tumor infiltrating T cells was measured using flow cytometry and confocal microscopy. Copper lowering was associated with reduced tumor vessel diameter, reduced endothelial cell proliferation (reduced Ki67 expression) and lower surface ICAM/CD54 expression implying reduced endothelial cell activation, in a process similar to endothelial normalization. Copper lowering was also associated with a CD4(+) T cell infiltrate. In conclusion, these data suggest copper lowering is a potentially useful anti-mesothelioma treatment strategy that slows tumor growth to provide a window of opportunity for inclusion of other treatment modalities to improve patient outcomes.	[Jackaman, Connie; Beddoes, Katie M.; Ricciardo, Belinda; Nelson, Delia J.] Curtin Univ, Sch Biomed Sci, Immunol & Canc Grp, Perth, WA 6845, Australia; [Crowe, Andrew] Curtin Univ, CHIRI Biosci Res Precinct, Sch Pharm, Perth, WA 6845, Australia; [Jackaman, Connie; Beddoes, Katie M.; Ricciardo, Belinda; Nelson, Delia J.] Curtin Univ, CHIRI Biosci Res Precinct, Sch Biomed Sci, Perth, WA 6845, Australia	Curtin University; Curtin University; Curtin University	Nelson, DJ (corresponding author), Curtin Univ, Sch Biomed Sci, Immunol & Canc Grp, Perth, WA 6845, Australia.	Delia.Nelson@curtin.edu.au		Nelson, Delia/0000-0002-8698-5300; Jackaman, Connie/0000-0002-4583-7029	Cancer Council of WA; Dust Diseases Board of NSW	Cancer Council of WA(Cancer Council Western Australia); Dust Diseases Board of NSW	This work was supported by the Cancer Council of WA and the Dust Diseases Board of NSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Brem, 1999, Cancer Control, V6, P436; BREM SS, 1990, AM J PATHOL, V137, P1121; Brewer GJ, 2009, EXPERT OPIN INV DRUG, V18, P89, DOI [10.1517/13543780802621859, 10.1517/13543780802621859 ]; Brewer GJ, 2005, CURR CANCER DRUG TAR, V5, P195, DOI 10.2174/1568009053765807; Brewer GJ, 2005, DRUG DISCOV TODAY, V10, P1103, DOI 10.1016/S1359-6446(05)03541-5; Brewer GJ, 2000, CLIN CANCER RES, V6, P1; Brewer GJ, 2001, EXP BIOL MED, V226, P665, DOI 10.1177/153537020222600712; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cox C, 2003, ARCH OTOLARYNGOL, V129, P781, DOI 10.1001/archotol.129.7.781; Crowe A, 1996, J NUTR, V126, P183, DOI 10.1093/jn/126.1.183; DEERING TB, 1977, GASTROENTEROLOGY, V72, P1208; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gartner EM, 2009, INVEST NEW DRUG, V27, P159, DOI 10.1007/s10637-008-9165-9; Goodman VL, 2005, CURR CANCER DRUG TAR, V5, P543, DOI 10.2174/156800905774574066; Goodman VL, 2004, ENDOCR-RELAT CANCER, V11, P255, DOI 10.1677/erc.0.0110255; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hamzah J, 2008, J CLIN INVEST, V118, P1691, DOI 10.1172/JCI33201; Hassouneh B, 2007, MOL CANCER THER, V6, P1039, DOI 10.1158/1535-7163.MCT-06-0524; Hayashi M, 2007, J VET MED SCI, V69, P137, DOI 10.1292/jvms.69.137; Henry NL, 2006, ONCOLOGY-BASEL, V71, P168, DOI 10.1159/000106066; Hou GQ, 2007, TRANSL RES, V149, P260, DOI 10.1016/j.trsl.2006.12.003; Hou GQ, 2006, TRANSL RES, V148, P309, DOI 10.1016/j.trsl.2006.06.005; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kadowaki S, 2009, J VET MED SCI, V71, P1541, DOI 10.1292/jvms.001541; Khan G, 2009, EXPERT OPIN INV DRUG, V18, P541, DOI [10.1517/13543780902845622, 10.1517/13543780902845622 ]; Klein D, 2000, J HEPATOL, V32, P193, DOI 10.1016/S0168-8278(00)80063-X; Liu L, 2000, CLIN EXP IMMUNOL, V121, P94, DOI 10.1046/j.1365-2249.2000.01260.x; Lowndes SA, 2005, J MAMMARY GLAND BIOL, V10, P299, DOI 10.1007/s10911-006-9003-7; Montenegro MA, 2002, BIOCELL, V26, P339; Nasulewiez A, 2004, J TRACE ELEM MED BIO, V18, P1, DOI 10.1016/j.jtemb.2004.02.004; Omari KM, 2003, J NEUROIMMUNOL, V134, P166, DOI 10.1016/S0165-5728(02)00423-X; Pan Q, 2002, CANCER RES, V62, P4854; Pass HI, 2008, ANN THORAC SURG, V86, P383, DOI 10.1016/j.athoracsur.2008.03.016; Prewett M, 1999, CANCER RES, V59, P5209; Redman BG, 2003, CLIN CANCER RES, V9, P1666; Richards MP, 1999, BIOL TRACE ELEM RES, V69, P27, DOI 10.1007/BF02783913; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Rosen LS, 2005, ONCOLOGIST, V10, P382, DOI 10.1634/theoncologist.10-6-382; SCHUSCHKE DA, 1992, BRIT J CANCER, V66, P1059, DOI 10.1038/bjc.1992.410; SIEGEMUND R, 1991, ACTA NEUROL SCAND, V83, P364, DOI 10.1111/j.1600-0404.1991.tb03964.x; Sun S, 2007, CRIT REV ONCOL HEMAT, V62, P93, DOI 10.1016/j.critrevonc.2007.01.002; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Wei H, 2011, AM J PHYSIOL-HEART C, V301, pH712, DOI 10.1152/ajpheart.01299.2010; Yoshi J, 2001, INT J CANCER, V94, P768, DOI 10.1002/ijc.1537; Youdim MBH, 2007, J NEURAL TRANSM, V114, P205, DOI 10.1007/s00702-006-0499-1; Zowczak M, 2001, J TRACE ELEM MED BIO, V15, P193, DOI 10.1016/S0946-672X(01)80066-3	48	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73684	10.1371/journal.pone.0073684	http://dx.doi.org/10.1371/journal.pone.0073684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013775	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200088
J	Zhang, SG; Liu, CY; Li, L; Sun, TW; Luo, YG; Yun, WJ; Zhang, JY				Zhang, Shu-Guang; Liu, Chun-Yan; Li, Li; Sun, Tong-Wen; Luo, Yong-Gang; Yun, Wen-Jing; Zhang, Jin-Ying			Examination of Artificial MiRNA Mimics with Centered-Site Complementarity for Gene Targeting	PLOS ONE			English	Article							ANIMAL DEVELOPMENT; MICRORNAS; SPECIFICITY; CLEAVAGE; MIR-1; RNAS	Background: MiRNA primarily acts to repress gene expression at the post-transcriptional level through imperfect complementarity of its 5' region to the "seed site" in the 3' untranslated region of target mRNAs, with its "3'-supplementary site" and "center site" also playing important roles under certain circumstances. The aim of this study was to test if artificial miRNA mimics (miR-Mimics) that are designed to target the "centered sites" without "seed sites" complementarity are able to repress gene expression as natural miRNAs. Methods: We designed miR-Mimics carrying centered-site matches (CS-miR-Mimics) or seed-site matches (SS-miR-Mimics) and siRNA to two antiapoptotic genes BCL2 and AKT1. We tested the gene targeting of these constructs using real-time RTPCR and Western blot to quantify mRNA and protein levels of BCL2 and AKT1, respectively, luciferase reporter gene assay to investigate the interaction between miR-Mimics and their target sites, and cell survival assay to study the functional outcomes of the miR-Mimics. Results: We found that CS-miR-Mimic, SS-miR-Mimic and siRNA, all down regulated the mRNA and protein levels of their cognate target BCL2 or AKT1 in a concentration-dependent manner. Luciferase reporter gene assay further confirmed the functional interactions of CS-miR-Mimic, SS-miR-Mimic and siRNA with their target sites. We then observed that the miR-Mimics and siRNAs were all able to induce cell death, as indicated by the reduced survival rate of cells. Conclusions: We have provided evidence for the feasibility of CS-miR-Mimics for post-transcriptional repression of genes, which can be designed to have reduced numbers of seed type off-target sites compared to the number of target sites from an average endogenous seed-site miRNA. CS-miR-Mimics may be a novel approach for miRNA research requiring miRNA gain-of-function.	[Zhang, Shu-Guang; Sun, Tong-Wen; Luo, Yong-Gang; Yun, Wen-Jing] Zhengzhou Univ, Affiliated Hosp 1, Dept MICU, Zhengzhou 450052, Peoples R China; [Liu, Chun-Yan] Zhengzhou Univ, Affiliated Hosp 2, Dept Pediat, Zhengzhou 450052, Peoples R China; [Li, Li] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency, Zhengzhou 450052, Peoples R China; [Zhang, Jin-Ying] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhang, JY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Peoples R China.	jyz-zu@sohu.com	LI, LI/GVS-5344-2022; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020; Sun, Tongwen/AAQ-7741-2020; Li, Li/AEM-3636-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022		Natural Science Foundation of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; Micro RNA, 2013, BMC INFECT DIS, V13, P250, DOI [10.1186/1471-2334-13-250., DOI 10.1186/1471-2334-13-250]; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Shin C, 2008, MOL CELLS, V26, P308; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Wang YM, 2013, CELL CYCLE, V12, P32, DOI 10.4161/cc.23051; Wang Z., 2009, MICRORNA INTERFERENC, P59; Wang ZG, 2011, METHODS MOL BIOL, V676, P211, DOI 10.1007/978-1-60761-863-8_15; Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	30	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72062	10.1371/journal.pone.0072062	http://dx.doi.org/10.1371/journal.pone.0072062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013456	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200026
J	Petrik, D; Yun, S; Latchney, SE; Kamrudin, S; LeBlanc, JA; Bibb, JA; Eisch, AJ				Petrik, David; Yun, Sanghee; Latchney, Sarah E.; Kamrudin, Sohail; LeBlanc, Junie A.; Bibb, James A.; Eisch, Amelia J.			Early Postnatal In Vivo Gliogenesis From Nestin-Lineage Progenitors Requires Cdk5	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; ADULT HIPPOCAMPAL NEUROGENESIS; OLIGODENDROCYTE PRECURSOR CELLS; NEURAL STEM; SUBVENTRICULAR ZONE; MONOCLONAL-ANTIBODY; BIPOLAR TRANSITION; GLIAL-CELLS; SPINAL-CORD; MIGRATION	The early postnatal period is a unique time of brain development, as diminishing amounts of neurogenesis coexist with waves of gliogenesis. Understanding the molecular regulation of early postnatal gliogenesis may provide clues to normal and pathological embryonic brain ontogeny, particularly in regards to the development of astrocytes and oligodendrocytes. Cyclin dependent kinase 5 (Cdk5) contributes to neuronal migration and cell cycle control during embryogenesis, and to the differentiation of neurons and oligodendrocytes during adulthood. However, Cdk5's function in the postnatal period and within discrete progenitor lineages is unknown. Therefore, we selectively removed Cdk5 from nestin-expressing cells and their progeny by giving transgenic mice (nestin-CreERT2/R26R-YFP/CDK5(flox/flox) [iCdk5] and nestin-CreERT2/R26R-YFP/CDK5(wt/wt) [WT]) tamoxifen during postnatal (P) days P2-P 4 or P7-P 9, and quantified and phenotyped recombined (YFP+) cells at P14 and P21. When Cdk5 gene deletion was induced in nestin-expressing cells and their progeny during the wave of cortical and hippocampal gliogenesis (P2-P4), significantly fewer YFP+ cells were evident in the cortex, corpus callosum, and hippocampus. Phenotypic analysis revealed the cortical decrease was due to fewer YFP+ astrocytes and oligodendrocytes, with a slightly earlier influence seen in oligodendrocytes vs. astrocytes. This effect on cortical gliogenesis was accompanied by a decrease in YFP+ proliferative cells, but not increased cell death. The role of Cdk5 in gliogenesis appeared specific to the early postnatal period, as induction of recombination at a later postnatal period (P7-P9) resulted in no change YFP+ cell number in the cortex or hippocampus. Thus, glial cells that originate from nestin-expressing cells and their progeny require Cdk5 for proper development during the early postnatal period.	[Petrik, David; Yun, Sanghee; Latchney, Sarah E.; Kamrudin, Sohail; LeBlanc, Junie A.; Bibb, James A.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Eisch, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	amelia.eisch@utsouthwestern.edu	Latchney, Sarah/M-4740-2019; Yun, Sanghee/AAL-7543-2020; Latchney, Sarah/AAQ-2957-2021	Yun, Sanghee/0000-0001-7505-0836; Latchney, Sarah/0000-0002-4070-1165; Eisch, Amelia/0000-0001-6476-5385; Petrik, David/0000-0003-3026-0770	NIH [DA023701, DA023555, MH083711, DA033485, NS073855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023701, R01DA033485, K02DA023555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the following: NIH DA023701 to AJE, NIH DA023555 to AJE, NIH MH083711 to JAB, NIH DA033485 to JAB, and NIH NS073855 to JAB. http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; [Anonymous], BRAIN STRUCT FUNCT; Bankston AN, 2013, J BIOL CHEM, V288, P18047, DOI 10.1074/jbc.M113.453688; Bartzokis G, 2012, NEUROPHARMACOLOGY, V62, P2137, DOI 10.1016/j.neuropharm.2012.01.015; Battiste J, 2007, DEVELOPMENT, V134, P285, DOI 10.1242/dev.02727; Bermel C, 2009, MOL CELL NEUROSCI, V42, P427, DOI 10.1016/j.mcn.2009.09.005; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Calza L, 2002, P NATL ACAD SCI USA, V99, P3258, DOI 10.1073/pnas.052704499; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chang KH, 2012, J CELL SCI, V125, P5124, DOI 10.1242/jcs.108183; Cheng XS, 2011, ANAT HISTOL EMBRYOL, V40, P21, DOI 10.1111/j.1439-0264.2010.01033.x; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eisch AJ, 2007, CURR PHARM BIOTECHNO, V8, P147; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; GALOU M, 1994, GLIA, V12, P281, DOI 10.1002/glia.440120405; Garcia-Matas S, 2008, AGING CELL, V7, P630, DOI 10.1111/j.1474-9726.2008.00410.x; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Grove EA, 1999, CEREB CORTEX, V9, P551, DOI 10.1093/cercor/9.6.551; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; He XJ, 2011, NEUROCHEM RES, V36, P1293, DOI 10.1007/s11064-010-0391-0; He Y, 2007, GLIA, V55, P573, DOI 10.1002/glia.20485; Hirota Y, 2007, J NEUROSCI, V27, P12829, DOI 10.1523/JNEUROSCI.1014-07.2007; Honjyo Y, 1999, NEUROREPORT, V10, P3375, DOI 10.1097/00001756-199911080-00022; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; Jacobsen CT, 2003, DEV NEUROSCI-BASEL, V25, P207, DOI 10.1159/000072269; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Liu Y, 2002, GLIA, V40, P25, DOI 10.1002/glia.10111; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Navarro-Quiroga I, 2006, J COMP NEUROL, V497, P833, DOI 10.1002/cne.21037; Nishimura YV, 2010, J BIOL CHEM, V285, P5878, DOI 10.1074/jbc.M109.033761; Nolte C, 2001, GLIA, V33, P72; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Ong J, 2005, PEDIATR RES, V58, P600, DOI 10.1203/01.PDR.0000179381.86809.02; Pierozan P, 2012, EXP NEUROL, V233, P391, DOI 10.1016/j.expneurol.2011.11.005; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Razvi N, 2007, EXP TOXICOL PATHOL, V59, P177, DOI 10.1016/j.etp.2007.06.002; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Remedios R, 2007, NAT NEUROSCI, V10, P1141, DOI 10.1038/nn1955; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tang XM, 1998, J CELL BIOCHEM, V68, P128, DOI 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D; Walker AS, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/894374; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; Wennstrom M, 2003, BIOL PSYCHIAT, V54, P1015, DOI 10.1016/S0006-3223(03)00693-0; Wu YY, 2002, GLIA, V38, P65, DOI 10.1002/glia.10049; Xie MJ, 2013, CEREB CORTEX, V23, P1410, DOI 10.1093/cercor/bhs123; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yang Y, 2013, DEV BIOL, V378, P94, DOI 10.1016/j.ydbio.2013.03.023; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	81	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72819	10.1371/journal.pone.0072819	http://dx.doi.org/10.1371/journal.pone.0072819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991155	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000324228800088
J	Hausswirth, C; Schaal, K; Le Meur, Y; Bieuzen, F; Filliard, JR; Volondat, M; Louis, J				Hausswirth, Christophe; Schaal, Karine; Le Meur, Yann; Bieuzen, Francois; Filliard, Jean-Robert; Volondat, Marielle; Louis, Julien			Parasympathetic Activity and Blood Catecholamine Responses Following a Single Partial-Body Cryostimulation and a Whole-Body Cryostimulation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; COLD-WATER IMMERSION; RATE RECOVERY; CRYOTHERAPY; EXERCISE; PERFORMANCE; STIMULATION; PREDICTOR; PRESSURE; HEALTHY	The aim of this study was to compare the effects of a single whole-body cryostimulation (WBC) and a partial-body cryostimulation (PBC) (i.e., not exposing the head to cold) on indices of parasympathetic activity and blood catecholamines. Two groups of 15 participants were assigned either to a 3-min WBC or PBC session, while 10 participants constituted a control group (CON) not receiving any cryostimulation. Changes in thermal, physiological and subjective variables were recorded before and during the 20-min after each cryostimulation. According to a qualitative statistical analysis, an almost certain decrease in skin temperature was reported for all body regions immediately after the WBC (mean decrease +/- 90% CL, -13.7 +/- 0.7 degrees C) and PBC (-8.3 +/- 0.3 degrees C), which persisted up to 20-min after the session. The tympanic temperature almost certainly decreased only after the WBC session (-0.32 +/- 0.04 degrees C). Systolic and diastolic blood pressures were very likely increased after the WBC session, whereas these changes were trivial in the other groups. In addition, heart rate almost certainly decreased after PBC (-10.9%) and WBC (-15.2%) sessions, in a likely greater proportion for WBC compared to PBC. Resting vagal-related heart rate variability indices (the root-mean square difference of successive normal R-R intervals, RMSSD, and high frequency band, HF) were very likely increased after PBC (RMSSD: +54.4%, HF: +138%) and WBC (RMSSD: +85.2%, HF: +632%) sessions without any marked difference between groups. Plasma norepinephrine concentrations were likely to very likely increased after PBC (+57.4%) and WBC (+76.2%), respectively. Finally, cold and comfort sensations were almost certainly altered after WBC and PBC, sensation of discomfort being likely more pronounced after WBC than PBC. Both acute cryostimulation techniques effectively stimulated the autonomic nervous system (ANS), with a predominance of parasympathetic tone activation. The results of this study also suggest that a whole-body cold exposure induced a larger stimulation of the ANS compared to partial-body cold exposure.	[Hausswirth, Christophe; Schaal, Karine; Le Meur, Yann; Bieuzen, Francois; Louis, Julien] Natl Inst Sport Expertise & Performance INSEP, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France; [Schaal, Karine] Univ Calif Davis, Sports Performance Lab, Sports Med Program, Sacramento, CA 95817 USA; [Filliard, Jean-Robert; Volondat, Marielle] Natl Inst Sport Expertise & Performance INSEP, Dept Med, Paris, France	University of California System; University of California Davis; Sanofi-Aventis; Sanofi France	Louis, J (corresponding author), Natl Inst Sport Expertise & Performance INSEP, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France.	julien.louis@insep.fr	Louis, Julien/AAI-4392-2021; Bieuzen, Francois/F-8162-2013	Louis, Julien/0000-0002-9109-0958; Bieuzen, Francois/0000-0002-9690-9168; Schaal, Karine/0000-0001-9215-9665				Al Haddad H, 2010, EUR J APPL PHYSIOL, V108, P599, DOI 10.1007/s00421-009-1253-9; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Billman GE, 2002, J APPL PHYSIOL, V92, P446, DOI 10.1152/japplphysiol.00874.2001; Bleakley CM, 2010, PHYS THER REV, V15, P344, DOI 10.1179/174328810X12786297204873; Buch AN, 2002, EXP PHYSIOL, V87, P423, DOI 10.1111/j.1469-445X.2002.tb00055.x; Buchheit M, 2006, INT J SPORTS MED, V27, P697, DOI 10.1055/s-2005-872929; Buchheit M, 2004, AM J PHYSIOL-HEART C, V287, pH2813, DOI 10.1152/ajpheart.00490.2004; Buchheit M, 2011, SCAND J MED SCI SPOR, V21, pE477, DOI 10.1111/j.1600-0838.2011.01378.x; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Camm AJ, 1996, CIRCULATION, V93, P1043; Cholewka A, 2004, PHYS MEDICA, V1, P81; Cholewka A., 2004, THERMOL INT, V14, P57; Cholewka A, 2012, SKIN RES TECHNOL, V18, P180, DOI 10.1111/j.1600-0846.2011.00550.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Costello JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048190; ECKBERG DL, 1984, J PHYSIOL-LONDON, V347, P75, DOI 10.1113/jphysiol.1984.sp015054; FRICKE R, 1989, Z PHYS MED BALN MED, V18, P1; Goldberger JJ, 2001, CIRCULATION, V103, P1977; GOLDBERGER JJ, 1994, AM J PHYSIOL, V266, pH2152, DOI 10.1152/ajpheart.1994.266.5.H2152; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Khurana RK, 2006, CLIN AUTON RES, V16, P202, DOI 10.1007/s10286-006-0332-9; Klimek AT, 2010, INT J OCCUP MED ENV, V23, P181, DOI 10.2478/v10001-010-0019-2; Larsen PD, 2010, RESP PHYSIOL NEUROBI, V174, P111, DOI 10.1016/j.resp.2010.04.021; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; Lubkowska A, 2008, J THERM BIOL, V33, P464, DOI 10.1016/j.jtherbio.2008.08.003; Metzger D, 2000, REHABILITATION STUTT, P39; Miller E, 2011, WORLD J BIOL PSYCHIA, V12, P223, DOI 10.3109/15622975.2010.518626; Miller E, 2010, J MED INVESTIG, V57, P168, DOI 10.2152/jmi.57.168; Paddon-Jones DJ, 1997, INT J SPORTS MED, V18, P588, DOI 10.1055/s-2007-972686; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Pump B, 2001, AM J PHYSIOL-HEART C, V280, pH2607, DOI 10.1152/ajpheart.2001.280.6.H2607; Ring EFJ, 2015, INFRARED IMAGING: A CASEBOOK IN CLINICAL MEDICINE, DOI 10.1088/978-0-7503-1143-4ch1; Rymaszewska J, 2008, ARCH IMMUNOL THER EX, V56, P63, DOI 10.1007/s00005-008-0006-5; Savic M, 2013, J THERM BIOL, V38, P186, DOI 10.1016/j.jtherbio.2013.02.004; Schaal K, 2013, APPL PHYSIOL NUTR ME, V38, P126, DOI 10.1139/apnm-2012-0155; Shibahara N, 1996, J AUTONOM NERV SYST, V61, P109, DOI 10.1016/S0165-1838(96)00065-3; Smolander J, 2004, PHYSIOL BEHAV, V82, P691, DOI 10.1016/j.physbeh.2004.06.007; Sramek P, 2000, EUR J APPL PHYSIOL, V81, P436, DOI 10.1007/s004210050065; Stanley J, 2013, EUR J APPL PHYSIOL, V113, P371, DOI 10.1007/s00421-012-2445-2; Stanley J, 2012, EUR J APPL PHYSIOL, V112, P951, DOI 10.1007/s00421-011-2052-7; Swenson C, 1996, SCAND J MED SCI SPOR, V6, P193, DOI 10.1111/j.1600-0838.1996.tb00090.x; Utter AC, 2010, MED SCI SPORT EXER, V42, P361, DOI 10.1249/MSS.0b013e3181b2e8b4; Vaile J, 2011, BRIT J SPORT MED, V45, P825, DOI 10.1136/bjsm.2009.067272; Westerlund T, 2006, J THERM BIOL, V31, P342, DOI 10.1016/j.jtherbio.2006.01.004; Wilcock IM, 2006, INTJ SPORT PHYSIOL, V1, P195, DOI 10.1123/ijspp.1.3.195; Yamauchi T, 1986, Z PHYS MED BALN MED, V15, P311; ZAGROBELNY Z, 2003, LOCAL WHOLE BODY CRY	56	53	59	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72658	10.1371/journal.pone.0072658	http://dx.doi.org/10.1371/journal.pone.0072658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991134	Green Published, Green Accepted, gold			2022-12-25	WOS:000324470700044
J	Weizman, N; Krelin, Y; Shabtay-Orbach, A; Amit, M; Binenbaum, Y; Wong, RJ; Gil, Z				Weizman, N.; Krelin, Y.; Shabtay-Orbach, A.; Amit, M.; Binenbaum, Y.; Wong, R. J.; Gil, Z.			Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase	ONCOGENE			English	Article						pancreatic ductal adenocarcinoma; chemotherapy; gemcitabine; resistance; macrophages; cytidine deaminase	PHASE-III TRIAL; TUMOR MICROENVIRONMENT; CELL-MIGRATION; DUCTAL ADENOCARCINOMA; DRUG-RESISTANCE; BREAST-CANCER; MOUSE MODEL; EXPRESSION; INVASION; CHEMOTHERAPY	Resistance to pharmacologic agents used in chemotherapy is common in most human carcinomas, including pancreatic ductal adenocarcinoma (PDA), which is resistant to almost all drugs, including gemcitabine, a nucleoside analog used as a first-line treatment. Poor survival rates of PDA patients have, therefore, not changed much over 4 decades. Recent data indicated that tumor-associated macrophages (TAMs), which are abundant in the microenvironment of several tumors, including PDA, secrete pro-tumorigenic factors that contribute to cancer progression and dissemination. In this study, we show for the first time that TAMs can also induce chemoresistance of PDA by reducing gemcitabine-induced apoptosis. Macrophages co-cultured with cancer cells or TAM-conditioned medium significantly reduced apoptosis and activation of the caspase-3 pathway during gemcitabine treatment. In vivo PDA models of mice, which have reduced macrophage recruitment and activation, demonstrated improved response to gemcitabine compared with controls. Similarly, inhibition of monocytes/macrophages trafficking by a CSF1-receptor antagonist GW2580 augmented the effect of gemcitabine in a transgenic mouse PDA model that was resistant to gemcitabine alone. Analysis of multiple proteins involved in gemcitabine delivery and metabolism revealed that TAMs induced upregulation of cytidine deaminase (CDA), the enzyme that metabolizes the drug following its transport into the cell. Decreasing CDA expression by PDA cells blocked the protective effect of TAMs against gemcitabine. These results provide the first evidence of a paracrine effect of TAMs, which mediates acquired resistance of cancer cells to chemotherapy. Modulation of macrophage trafficking or inhibition of CDA may offer a new strategy for augmenting the response of PDA to chemotherapy.	[Weizman, N.; Krelin, Y.; Shabtay-Orbach, A.; Amit, M.; Binenbaum, Y.; Gil, Z.] Rambam Med Ctr, Dept Otolaryngol Head & Neck Surg, Lab Appl Canc Res, IL-31096 Haifa, Israel; [Amit, M.; Gil, Z.] Rambam Med Ctr, Technion Israel Inst Technol, Dept Otolaryngol Head & Neck Surg, IL-31096 Haifa, Israel; [Wong, R. J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Memorial Sloan Kettering Cancer Center	Gil, Z (corresponding author), Rambam Med Ctr, Technion Israel Inst Technol, Dept Otolaryngol Head & Neck Surg, 6 Haaliya St,POB 9602, IL-31096 Haifa, Israel.	ziv@baseofskull.org			Israel Science Foundation; Israel Cancer Association; Israeli Ministry of Health [3-7355]; Rambam Medical Center; ICRF Barbara S Goodman endowed research career development award in Pancreatic Cancer [2011-601-BGPC]; US-Israel Binational Science Foundation	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israeli Ministry of Health; Rambam Medical Center; ICRF Barbara S Goodman endowed research career development award in Pancreatic Cancer; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	Esther Eshkol is thanked for editorial assistance. This research was supported by the Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation, the Israel Cancer Association (grant donated by Ellen and Emanuel Kronitz in memory of Dr Leon Kronitz), the Israeli Ministry of Health (No. 3-7355), the Rambam Medical Center Intramural Grant, the ICRF Barbara S Goodman endowed research career development award in Pancreatic Cancer (2011-601-BGPC) all to ZG, and the US-Israel Binational Science Foundation to ZG and RJW.	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Akita H, 2009, ONCOGENE, V28, P2903, DOI 10.1038/onc.2009.158; Andre F, 2010, CURR OPIN ONCOL, V22, P547, DOI 10.1097/CCO.0b013e32833fb384; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cavel O, 2012, CANCER RES, V72, P5733, DOI 10.1158/0008-5472.CAN-12-0764; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Colucci G, 2010, J CLIN ONCOL, V28, P1645, DOI 10.1200/JCO.2009.25.4433; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; De Palma M, 2011, NATURE, V472, P303, DOI 10.1038/472303a; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Ferrandina G, 2008, J CLIN ONCOL, V26, P890, DOI 10.1200/JCO.2007.13.6606; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; Gilbert LA, 2011, CANCER RES, V71, P5062, DOI 10.1158/0008-5472.CAN-11-0277; Giovannetti E, 2006, MOL CANCER THER, V5, P1387, DOI 10.1158/1535-7163.MCT-06-0004; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Morgan MA, 2005, CANCER RES, V65, P6835, DOI 10.1158/0008-5472.CAN-04-2246; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Niedergethmann M, 2007, BRIT J CANCER, V97, P1432, DOI 10.1038/sj.bjc.6604031; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Riccil F, 2005, CANCER BIOL THER, V4, P302, DOI 10.4161/cbt.4.3.1501; Schafer H, 2013, ONCOGENE, V32, P180, DOI 10.1038/onc.2012.44; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; STAROSELSKY AN, 1990, CANCER RES, V50, P7775; Steube KG, 1998, INT J CANCER, V78, P120, DOI 10.1002/(SICI)1097-0215(19980925)78:1<120::AID-IJC19>3.3.CO;2-J; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Summy JM, 2005, PANCREAS, V31, P263, DOI 10.1097/01.mpa.0000178280.50534.0c; Tempero M, 2003, J CLIN ONCOL, V21, P3402, DOI 10.1200/JCO.2003.09.140; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; YAMASHINA K, 1986, CANCER RES, V46, P2396; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zheng YH, 2009, BLOOD, V114, P3625, DOI 10.1182/blood-2009-05-220285	49	179	187	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 17	2014	33	29					3812	3819		10.1038/onc.2013.357	http://dx.doi.org/10.1038/onc.2013.357			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8MU	23995783				2022-12-25	WOS:000339394100007
J	Choi, C; Helfman, DM				Choi, C.; Helfman, D. M.			The Ras-ERK pathway modulates cytoskeleton organization, cell motility and lung metastasis signature genes in MDA-MB-231 LM2	ONCOGENE			English	Article						K-Ras; ERK; stress fiber; motility; lung metastasis signature; PI3K	BREAST-CANCER METASTASIS; SIGNALING PATHWAYS; DOWN-REGULATION; CROSS-TALK; IN-VITRO; INHIBITION; ACTIVATION; EXPRESSION; FIBROBLASTS; RHOA	MDA-MB-231 LM2 (herein referred to as LM2) is a derivative of MDA-MB-231 cells that was selected for its ability to metastasize to lung tissue in vivo. We investigated cellular properties of LM2 including actin cytoskeleton organization, motility and signaling pathways that drive the expression of genes associated with the lung metastasis signature. Parental cells exhibit well-developed stress fibers, whereas LM2 had poorly organized stress fibers. LM2 exhibited higher levels of K-Ras protein and corresponding higher levels of phosphorylated ERK compared with parental cells. The Ras-ERK pathway was responsible for the disruption of stress fibers because inhibition of MEK with UO126 or small interfering RNA (siRNA) against K-Ras or ERK1/2 resulted in restoration of stress fibers and focal adhesions. We observed that the K-Ras-ERK pathway is important for the expression of genes associated with the lung metastasis signature. Paradoxically, inhibition of the Ras-ERK pathway did not result in inhibition of cell motility but was accompanied by activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Inhibition of both ERK and PI3K pathways was required to inhibit motility of LM2 cells. These results suggest that both ERK and PI3K pathways drive motile functions of metastatic LM2 cells and genes associated with the lung metastasis signature.	[Choi, C.; Helfman, D. M.] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Helfman, D. M.] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Helfman, DM (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 335 Gwahangno, Taejon 305701, South Korea.	dhelfman@kaist.ac.kr	Helfman, David M./C-2058-2011		WCU Program through the National Research Foundation of Korea - Ministry of Education Science and Technology [R31-2008-000-10071-0]; National Research Foundation of Korea [R1A-1A-2007-709]	WCU Program through the National Research Foundation of Korea - Ministry of Education Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea)	We thank Jooyoung Yi and Sunyoung Lim for technical assistance. MDA-MB-231 parental, LM2 and BrM2 cells were kindly provided by Dr Joan Massague. DMH is supported by the WCU Program through the National Research Foundation of Korea funded by the Ministry of Education Science and Technology (R31-2008-000-10071-0) and grant from the National Research Foundation of Korea (R1A-1A-2007-709).	Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Janssen RAJ, 1998, J BIOL CHEM, V273, P32182, DOI 10.1074/jbc.273.48.32182; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Ljungdahl S, 1998, CELL GROWTH DIFFER, V9, P565; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Prasad GL, 1999, ONCOGENE, V18, P2027, DOI 10.1038/sj.onc.1202264; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; Won JK, 2012, J MOL CELL BIOL, V4, P153, DOI 10.1093/jmcb/mjs021; Yamashita Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-20	33	51	51	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3668	3676		10.1038/onc.2013.341	http://dx.doi.org/10.1038/onc.2013.341			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	23995792				2022-12-25	WOS:000338942900006
J	Wolff, F; Loipetzberger, A; Gruber, W; Esterbauer, H; Aberger, F; Frischauf, AM				Wolff, F.; Loipetzberger, A.; Gruber, W.; Esterbauer, H.; Aberger, F.; Frischauf, A. M.			Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation	ONCOGENE			English	Article						Gli; imiquimod; basal cell carcinoma; Hedgehog signalling; adenosine receptor	BASAL-CELL CARCINOMAS; IMMUNE-RESPONSE; PROTEIN; PATHWAY; ACTIVATION; RECEPTORS; EXPRESSION; GENE; TRANSDUCTION; MANIPULATION	Imiquimod (IMQ), a nucleoside analogue of the imidazoquinoline family, is used in the topical treatment of basal cell carcinoma (BCC) and other skin diseases. It is reported to be a TLR7 and TLR8 agonist and, as such, initiates a Th1 immune response by activating sentinel cells in the vicinity of the tumour. BCC is a hedgehog (HH)-driven malignancy with oncogenic glioma-associated oncogene (GLI) signalling activated in a ligand-independent manner. Here we show that IMQ can also directly repress HH signalling by negatively modulating GLI activity in BCC and medulloblastoma cells. Further, we provide evidence that the repressive effect of IMQ on HH signalling is not dependent on TLR/MYD88 signalling. Our results suggest a mechanism for IMQ engaging adenosine receptors (ADORAs) to control GLI signalling. Pharmacological activation of ADORA with either an ADORA agonist or IMQ resulted in a protein kinase A (PKA)-mediated GLI phosphorylation and reduction in GLI activator levels. The activation of PKA and HH pathway target gene downregulation in response to IMQ were abrogated by ADORA inhibition. Furthermore, activated Smoothened signalling, which positively signals to GLI transcription factors, could be effectively counteracted by IMQ. These results reveal a previously unknown mode of action of IMQ in the treatment of BCC and also suggest a role for ADORAs in the regulation of oncogenic HH signalling.	[Wolff, F.; Loipetzberger, A.; Gruber, W.; Aberger, F.; Frischauf, A. M.] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Esterbauer, H.] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Salzburg University; Medical University of Vienna	Frischauf, AM (corresponding author), Salzburg Univ, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.	fritz.aberger@sbg.ac.at; annemarie.frischauf@sbg.ac.at	Aberger, Fritz/B-6357-2012; Wolff, Florian/L-4090-2015	Aberger, Fritz/0000-0003-2009-6305; Wolff, Florian/0000-0001-7271-0317; Esterbauer, Harald/0000-0001-7343-7455	international PhD programme Immunity in Cancer and Allergy (ICA) from the Austrian Science fund (FWF); FWF project [P20652]; Austrian Genome Programme GEN-AU; priority program Biosciences and Health of the University of Salzburg; Austrian Academy of Sciences (OAW)	international PhD programme Immunity in Cancer and Allergy (ICA) from the Austrian Science fund (FWF); FWF project(Austrian Science Fund (FWF)); Austrian Genome Programme GEN-AU; priority program Biosciences and Health of the University of Salzburg; Austrian Academy of Sciences (OAW)	We are especially thankful to Dr Matt Scott for providing the SMOM2 construct and to Dr Peter Hammerl for help with murine splenocytes. We are also grateful to Dr Maria Sibilia for the help with the use of IMQ treatment. Furthermore, we are grateful to Sabine Siller for excellent technical support. This work was supported by the international PhD programme Immunity in Cancer and Allergy (ICA) from the Austrian Science fund (FWF), the FWF project P20652, the Austrian Genome Programme GEN-AU and the priority program Biosciences and Health of the University of Salzburg. AL received a PhD Doc-fForte fellowship from the Austrian Academy of Sciences (OAW). We are grateful to Dr Sandra Laner-Plamberger for help with analysis of BCC and skin samples.	Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Ambach A, 2004, MOL IMMUNOL, V40, P1307, DOI 10.1016/j.molimm.2004.01.002; Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; Atwood SX, 2012, J CELL BIOL, V199, P193, DOI 10.1083/jcb.201207140; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dlugosz A, 2012, NAT REV DRUG DISCOV, V11, P437, DOI 10.1038/nrd3753; Drobits B, 2012, J CLIN INVEST, V122, P575, DOI 10.1172/JCI61034; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Gotschel F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065403; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jahnisch H, 2013, CANCER LETT, V335, P119, DOI 10.1016/j.canlet.2013.02.003; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2012, J CLIN INVEST, V122, P455, DOI 10.1172/JCI58779; Kasper Maria, 2007, V397, P67; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Lacarrubba F, 2011, J DERMATOL TREAT, V22, P353, DOI 10.3109/09546634.2010.548503; Lear JT, 2012, NEW ENGL J MED, V366, P2225, DOI 10.1056/NEJMe1202170; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schon MP, 2007, BRIT J DERMATOL, V157, P8, DOI 10.1111/j.1365-2133.2007.08265.x; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith V, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/380371; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Toriyama M, 2012, J BIOL CHEM, V287, P12691, DOI 10.1074/jbc.M111.316307; Trincavelli ML, 2010, CURR TOP MED CHEM, V10, P860, DOI 10.2174/156802610791268756; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900	68	56	56	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2013	32	50					5574	5581		10.1038/onc.2013.343	http://dx.doi.org/10.1038/onc.2013.343			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	272LF	23995793	Green Published, hybrid			2022-12-25	WOS:000328461400002
J	Gyimesi, M; Pires, RH; Billington, N; Sarlos, K; Kocsis, ZS; Modos, K; Kellermayer, MSZ; Kovacs, M				Gyimesi, Mate; Pires, Ricardo H.; Billington, Neil; Sarlos, Kata; Kocsis, Zsuzsa S.; Modos, Karoly; Kellermayer, Miklos S. Z.; Kovacs, Mihaly			Visualization of human Bloom's syndrome helicase molecules bound to homologous recombination intermediates	FASEB JOURNAL			English	Article						DNA repair; oligomerization; structure; electron microscopy; atomic force microscopy	TOPOISOMERASE-III-ALPHA; ATOMIC-FORCE MICROSCOPY; BLM HELICASE; COLI UVRD; D-LOOPS; DNA; MECHANISM; TRANSLOCATION; SUBSTRATE; MONOMERS	Homologous recombination (HR) is a key process in the repair of double-stranded DNA breaks (DSBs) that can initiate cancer or cell death. Human Bloom's syndrome RecQ-family DNA helicase (BLM) exerts complex activities to promote DSB repair while avoiding illegitimate HR. The oligomeric assembly state of BLM has been a key unresolved aspect of its activities. In this study we assessed the structure and oligomeric state of BLM, in the absence and presence of key HR-intermediate DNA structures, by using single-molecule visualization (electron microscopic and atomic force microscopic single-particle analysis) and solution biophysical (dynamic light scattering, kinetic and equilibrium binding) techniques. Besides full-length BLM, we used a previously characterized truncated construct (BLM642-1290) as a monomeric control. Contrary to previous models proposing a ring-forming oligomer, we found the majority of BLM molecules to be monomeric in all examined conditions. However, BLM showed a tendency to form dimers when bound to branched HR intermediates. Our results suggest that HR activities requiring single-stranded DNA translocation are performed by monomeric BLM, while complex DNA structures encountered and dissolved by BLM in later stages of HR induce partial oligomerization of the helicase.	[Gyimesi, Mate; Sarlos, Kata; Kocsis, Zsuzsa S.; Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, Hungarian Acad Sci, ELTE MTA,Momentum Motor Enzymol Res Grp, H-1117 Budapest, Hungary; [Pires, Ricardo H.; Modos, Karoly; Kellermayer, Miklos S. Z.] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Billington, Neil] NHLBI, Lab Mol Physiol, Bethesda, MD 20892 USA	Eotvos Lorand University; Hungarian Academy of Sciences; Semmelweis University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kovacs, M (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany P S 1-c, H-1117 Budapest, Hungary.	kovacsm@elte.hu	Kovacs, Mihaly/A-6841-2011; Gyimesi, Mate/I-2639-2017	Kellermayer, Miklos/0000-0002-5553-6553; Billington, Neil/0000-0003-2306-0228; Horvath-Sarlos, Kata/0000-0003-3813-0209; Kovacs, Mihaly/0000-0002-1200-4741; Kocsis, Zsuzsa/0000-0002-4336-3325; Gyimesi, Mate/0000-0002-7195-1925	Norway grants [NNF2-85613]; Hungarian Scientific Research Fund [K71915, NK81950]; TAMOP [4.2.1/B-09/1/KMR-2010-0003]; Human Frontier Science Program [RGY0072/2010]; Momentum Program of the Hungarian Academy of Sciences [LP2011-006/2011]; European Union; European Social Fund	Norway grants; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP; Human Frontier Science Program(Human Frontier Science Program); Momentum Program of the Hungarian Academy of Sciences; European Union(European Commission); European Social Fund(European Social Fund (ESF))	The authors thank The Electron Microscopy Core Facility of the U. S. National Heart, Lung, and Blood Institute for the use of electron microscopy facilities. This work was supported by Norway grants (NNF2-85613 to M. K.); the Hungarian Scientific Research Fund (K71915 and NK81950 to M. K.); TAMOP (4.2.1/B-09/1/KMR-2010-0003 to M. K.); the Human Frontier Science Program (RGY0072/2010 to M. K.); and the Momentum Program of the Hungarian Academy of Sciences (LP2011-006/2011 to M. K.). M. K. is a Bolyai Fellow of the Hungarian Academy of Sciences. M. G. is a Marie Curie Fellow. This research was realized in the frames of TAMOP 4.2.4. A/2-11-1-2012-0001, National Excellence Program: elaborating and operating an inland student and researcher personal support system. The project was subsidized by the European Union and cofinanced by the European Social Fund.	Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; BRYAN RK, 1990, FUND THEOR, V39, P221; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2009, J BIOL CHEM, V284, P26349, DOI 10.1074/jbc.M109.029371; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Gyimesi M, 2010, NUCLEIC ACIDS RES, V38, P4404, DOI 10.1093/nar/gkq145; Hoo CM, 2008, J NANOPART RES, V10, P89, DOI 10.1007/s11051-008-9435-7; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kim YM, 2010, NUCLEIC ACIDS RES, V38, P7764, DOI 10.1093/nar/gkq586; Lodish H., 2004, MOL BIOL CELL; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATLOCK DL, BIOCHEMISTRY, V49, P2097; Mazina OM, 2012, J BIOL CHEM, V287, P11820, DOI 10.1074/jbc.M112.341347; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Sambrook J., 2001, MOL CLONING; Shi C, 2009, BBA-GEN SUBJECTS, V1790, P1, DOI 10.1016/j.bbagen.2008.10.003; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu YN, 2012, NUCLEIC ACIDS RES, V40, P9802, DOI 10.1093/nar/gks728	40	11	11	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4954	4964		10.1096/fj.13-234088	http://dx.doi.org/10.1096/fj.13-234088			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24005907	Green Published			2022-12-25	WOS:000329999000029
J	Lofgren, M; Koutmos, M; Banerjee, R				Lofgren, Michael; Koutmos, Markos; Banerjee, Ruma			Autoinhibition and Signaling by the Switch II Motif in the G-protein Chaperone of a Radical B-12 Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; GTP HYDROLYSIS; ATP-COB(I)ALAMIN ADENOSYLTRANSFERASE; COMPLEMENTATION GROUP; STRUCTURAL BASIS; BINDING PROTEIN; COMPLEX; GENE; IDENTIFICATION; TRANSDUCTION	MeaB is an accessory GTPase protein involved in the assembly, protection, and reactivation of 5'-deoxyadenosyl cobalamin-dependent methylmalonyl-CoA mutase (MCM). Mutations in the human ortholog of MeaB result in methylmalonic aciduria, an inborn error of metabolism. G-proteins typically utilize conserved switch I and II motifs for signaling to effector proteins via conformational changes elicited by nucleotide binding and hydrolysis. Our recent discovery that MeaB utilizes an unusual switch III region for bidirectional signaling with MCM raised questions about the roles of the switch I and II motifs in MeaB. In this study, we addressed the functions of conserved switch II residues by performing alanine-scanning mutagenesis. Our results demonstrate that the GTPase activity of MeaB is autoinhibited by switch II and that this loop is important for coupling nucleotide-sensitive conformational changes in switch III to elicit the multiple chaperone functions of MeaB. Furthermore, we report the structure of MeaB center dot GDP crystallized in the presence of AlFx- to form the putative transition state analog, GDP center dot AlF4-. The resulting crystal structure and its comparison with related G-proteins support the conclusion that the catalytic site of MeaB is incomplete in the absence of the GTPase-activating protein MCM and therefore unable to stabilize the transition state analog. Favoring an inactive conformation in the absence of the client MCM protein might represent a strategy for suppressing the intrinsic GTPase activity of MeaB in which the switch II loop plays an important role.	[Lofgren, Michael; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 4320C MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776.	Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030547; Chen YB, 2001, J BIOL CHEM, V276, P45751, DOI 10.1074/jbc.M107191200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dempsey-Nunez L, 2012, MOL GENET METAB, V107, P363, DOI 10.1016/j.ymgme.2012.09.012; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Leal NA, 2003, J BIOL CHEM, V278, P9227, DOI 10.1074/jbc.M212739200; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Lofgren M, 2011, BIOCHEMISTRY-US, V50, P5790, DOI 10.1021/bi2006306; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Padovani D, 2006, BIOCHEMISTRY-US, V45, P2951, DOI 10.1021/bi051742d; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Warner DR, 1997, MOL ENDOCRINOL, V11, P1718, DOI 10.1210/me.11.11.1718; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wittinghofer F, 1998, NATURE, V394, P317, DOI 10.1038/28492; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200	52	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30980	30989		10.1074/jbc.M113.499970	http://dx.doi.org/10.1074/jbc.M113.499970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23996001	Green Published, hybrid			2022-12-25	WOS:000330778900017
J	Brune, M; Juckel, G; Enzi, B				Bruene, Martin; Juckel, Georg; Enzi, Bjoern			"An Eye for an Eye"? Neural Correlates of Retribution and Forgiveness	PLOS ONE			English	Article							SOCIAL-EXCHANGE; NEUROSCIENCE; FAIRNESS	Humans have evolved strong preferences for equity and fairness. Neuroimaging studies suggest that punishing unfairness is associated with the activation of a neural network comprising the anterior cingulate cortex, anterior insula, the ventral striatum, and the dorsolateral prefrontal cortex (DLPFC). Here, we report the neuronal correlates of retribution and "forgiveness" in a scenario, in which individuals first acted as a recipient in an Ultimatum Game, and subsequently assumed the position of a proposer in a Dictator Game played against the same opponents as in the Ultimatum Game. Most subjects responded in a tit-for-tat fashion, which was accompanied by activation of the ventral striatum, corroborating previous findings that punishing unfair behaviour has a rewarding connotation. Subjects distinguished between the human opponent and computer condition by activation of the ventromedial PFC in the human condition, indicative of mentalising. A substantial number of subjects did not retaliate. Neurally, this "forgiveness" behaviour was associated with the activation of the right (and to a lesser degree left) DLPFC, a region that serves as a cognitive control region and thus may be involved in inhibiting emotional responses against unfairness.	[Bruene, Martin; Juckel, Georg; Enzi, Bjoern] Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Dept Psychiat Psychotherapy & Prevent Med, Bochum, Germany; [Bruene, Martin; Enzi, Bjoern] Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Dept Psychiat Psychotherapy & Prevent Med, Div Cognit Neuropsychiatry & Psychiat Prevent Med, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Brune, M (corresponding author), Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Dept Psychiat Psychotherapy & Prevent Med, Univ Str 150, Bochum, Germany.	martin.bruene@rub.de	Brüne, Martin/AAX-3202-2020	Brüne, Martin/0000-0002-2507-0561				Axelrod R, 1985, EVOLUTION COOPERATIO; Baumgartner T, 2011, NAT NEUROSCI, V14, P1468, DOI 10.1038/nn.2933; Brune M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044747; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Camerer C, 2003, BEHAV GAME THEORY; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Dvash J, 2010, HUM BRAIN MAPP, V31, P1741, DOI 10.1002/hbm.20972; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; FALK A, 2004, TRENDS COGN SCI, V8, P185, DOI DOI 10.1016/J.TICS.2004.02.007.PUBMED:15050515; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fischbacher U., 2000, THEORY RECIPROCITY; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hobbes Thomas, 2008, LEVIATHAN-J MELVILLE; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knutson B, 2004, SCIENCE, V305, P1246, DOI 10.1126/science.1102822; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Scheres Anouk, 2006, Behav Brain Funct, V2, P35, DOI 10.1186/1744-9081-2-35; Smith A, 1776, THEORY MORAL SENTIME; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Urania, 2012, ENCY BRITANNICA; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wischniewski J, 2009, NEUROSCI BIOBEHAV R, V33, P305, DOI 10.1016/j.neubiorev.2008.09.008	42	24	28	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73519	10.1371/journal.pone.0073519	http://dx.doi.org/10.1371/journal.pone.0073519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009754	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600069
J	Narayan, EJ; Cockrem, JF; Hero, JM				Narayan, Edward J.; Cockrem, John F.; Hero, Jean-Marc			Sight of a Predator Induces a Corticosterone Stress Response and Generates Fear in an Amphibian	PLOS ONE			English	Article							BASE-LINE CORTICOSTERONE; SHORT-TERM CAPTURE; URINARY CORTICOSTERONE; METABOLITE RESPONSES; ANTIPREDATOR BEHAVIORS; NONINVASIVE EVALUATION; PHYSIOLOGICAL STRESS; INDIVIDUAL VARIATION; PLATYMANTIS-VITIANA; IMMOBILITY REACTION	Amphibians, like other animals, generate corticosterone or cortisol glucocorticoid responses to stimuli perceived to be threatening. It is generally assumed that the corticosterone response of animals to capture and handling reflects the corticosterone response to stimuli such as the sight of a predator that are thought to be natural stressors. Fijian ground frogs (Platymantis vitiana) are preyed upon by the introduced cane toads (Rhinella marina), and we used ground frogs to test the hypothesis that the sight of a predator will induce a corticosterone stress response in an amphibian. Urinary corticosterone metabolite concentrations increased in male ground frogs exposed to the sight of a toad for 1, 3 or 6 h, whereas corticosterone did not change in frogs exposed to another male ground frog, a ball, or when no stimulus was present in the test compartment. The frogs exposed to a toad initially moved towards the stimulus then moved away, whereas frogs exposed to another frog moved towards the test frog and remained closer to the frog than at the start of the test. Tonic immobility (TI) was measured as an index of fearfulness immediately after the test exposure of the frogs to a stimulus. The duration of TI was longer in frogs exposed to a toad than to another frog or to a ball. The results provide novel evidence that the sight of a predator can induce a corticosterone response and lead to increased fearfulness in amphibians. In addition, they show that endemic frogs can recognise an introduced predator as a threat.	[Narayan, Edward J.; Hero, Jean-Marc] Griffith Univ, Environm Futures Ctr, Sch Environm, Southport, Qld 4215, Australia; [Cockrem, John F.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	Griffith University; Massey University	Narayan, EJ (corresponding author), Griffith Univ, Environm Futures Ctr, Sch Environm, Gold Coast Campus, Southport, Qld 4215, Australia.	e.narayan@ga.griffith.edu.au	Cockrem, John/O-9859-2016; Narayan, Edward/E-8238-2016	Cockrem, John/0000-0002-5239-6591; Narayan, Edward/0000-0003-2719-0900	Griffith University; Rufford Small Grants Foundation	Griffith University(Griffith University); Rufford Small Grants Foundation	This research was supported through a Griffith University postdoctoral Research Fellowship awarded to E.J.N. and financial support was provided by the Rufford Small Grants Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belliure J, 2004, PHYSIOL BEHAV, V81, P121, DOI 10.1016/j.physbeh.2004.01.008; Berger S, 2007, HORM BEHAV, V52, P653, DOI 10.1016/j.yhbeh.2007.08.004; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cockrem JF, 2010, BRIT POULTRY SCI, V51, P453, DOI 10.1080/00071668.2010.503637; Cockrem JF, 2002, GEN COMP ENDOCR, V125, P248, DOI 10.1006/gcen.2001.7749; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Cockrem JF, 2009, GEN COMP ENDOCR, V163, P158, DOI 10.1016/j.ygcen.2009.03.029; Crossland MR, 2008, BIOL CONSERV, V141, P2387, DOI 10.1016/j.biocon.2008.07.005; DABROWSKA B, 1982, BEHAV PROCESS, V7, P179, DOI 10.1016/0376-6357(82)90026-2; Fraisse F, 2006, BRIT POULTRY SCI, V47, P110, DOI 10.1080/00071660600610534; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Heinen JT, 1997, AM MIDL NAT, V137, P136, DOI 10.2307/2426762; JONES RB, 1988, PHYSIOL BEHAV, V42, P249, DOI 10.1016/0031-9384(88)90078-9; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; Kalynchuk LE, 2004, BEHAV NEUROSCI, V118, P1365, DOI 10.1037/0735-7044.118.6.1365; Kiesecker JM, 1997, ECOLOGY, V78, P1752; Kindermann C, 2013, COMP BIOCHEM PHYS A, V165, P223, DOI 10.1016/j.cbpa.2013.03.011; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; LUPO C, 1991, BEHAV PROCESS, V24, P1, DOI 10.1016/0376-6357(91)90082-B; MORRISON C, 2006, PACIFIC ECOLOGIST, V13, P67; Munoz-Abellan C, 2009, HORM BEHAV, V56, P465, DOI 10.1016/j.yhbeh.2009.08.002; Narayan E, 2008, HERPETOL J, V18, P63; NARAYAN E, 2009, BIOL ENDANGERED FIJI, P289; NARAYAN E, 2011, FROGLOG, V99, P30; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Narayan Edward, 2012, Endangered Species Research, V18, P279, DOI 10.3354/esr00454; Narayan E, 2011, AUST J ZOOL, V59, P79, DOI 10.1071/ZO11030; Narayan E, 2010, AUST J ZOOL, V58, P189, DOI 10.1071/ZO10010; Narayan Edward, 2008, South Pacific Journal of Natural Science, V26, P28, DOI 10.1071/SP08004; Narayan EJ, 2013, J EXP ZOOL PART A, V319, P471, DOI 10.1002/jez.1810; Narayan EJ, 2013, GEN COMP ENDOCR, V191, P225, DOI 10.1016/j.ygcen.2013.06.018; Narayan EJ, 2013, GEN COMP ENDOCR, V187, P39, DOI 10.1016/j.ygcen.2013.03.021; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V165, P304, DOI 10.1016/j.cbpa.2013.03.033; Narayan EJ, 2012, GEN COMP ENDOCR, V179, P345, DOI 10.1016/j.ygcen.2012.09.017; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V164, P21, DOI 10.1016/j.cbpa.2012.10.001; Narayan EJ, 2012, GEN COMP ENDOCR, V178, P301, DOI 10.1016/j.ygcen.2012.06.014; Narayan EJ, 2012, GEN COMP ENDOCR, V177, P55, DOI 10.1016/j.ygcen.2012.02.007; Narayan EJ, 2011, AUST J ZOOL, V59, P264, DOI 10.1071/ZO11070; Narayan EJ, 2012, GEN COMP ENDOCR, V175, P284, DOI 10.1016/j.ygcen.2011.11.023; Narayan EJ, 2011, GEN COMP ENDOCR, V174, P238, DOI 10.1016/j.ygcen.2011.09.004; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Narayan Edward J., 2010, Herpetological Review, V41, P478; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Preest MR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P641, DOI 10.1086/590371; Ricciardella LF, 2010, PHYSIOL BEHAV, V101, P81, DOI 10.1016/j.physbeh.2010.04.022; Rodl T, 2007, P R SOC B, V274, P577, DOI 10.1098/rspb.2006.3755; RYAN PA, 1984, DOMODOMO, V2, P87; SHINE R, 2010, Q REV BIOL, V85, P253, DOI DOI 10.1086/655116.PUBMED:20919631; Silverin B, 1998, ANIM BEHAV, V55, P1411, DOI 10.1006/anbe.1997.0717; TAIGEN TL, 1985, AM ZOOL, V25, P987; Thaker M, 2009, HORM BEHAV, V56, P51, DOI 10.1016/j.yhbeh.2009.02.009; Thomas Nunia, 2011, Pacific Conservation Biology, V17, P68; THOMPSON RKR, 1981, ANIM LEARN BEHAV, V9, P145, DOI 10.3758/BF03212037; Young JE, 2006, COPEIA, P83, DOI 10.1643/0045-8511(2006)006[0083:ROCEWL]2.0.CO;2; ZUG G, 2004, 2008 IUCN RED LIST T	56	63	66	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73564	10.1371/journal.pone.0073564	http://dx.doi.org/10.1371/journal.pone.0073564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009756	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600071
J	Scheffer, M; van den Berg, A; Ferrari, MD				Scheffer, Marten; van den Berg, Albert; Ferrari, Michel D.			Migraine Strikes as Neuronal Excitability Reaches a Tipping Point	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; ACTIVATION; MECHANISMS; RECOVERY; HEADACHE; MODELS; AURA	Self-propagating waves of cerebral neuronal firing, known as spreading depolarisations, are believed to be at the roots of migraine attacks. We propose that the start of spreading depolarisations corresponds to a critical transition that occurs when dynamic brain networks approach a tipping point. We show that this hypothesis is consistent with current pathogenetic insights and observed dynamics. Our view implies that migraine strikes when modulating factors further raise the neuronal excitability in genetically predisposed subjects to a level where even minor perturbations can trigger spreading depolarisations. A corollary is that recently discovered generic early warning indicators for critical transitions may be used to predict the onset of migraine attacks even before patients are clinically aware. This opens up new avenues for dissecting the mechanisms for the onset of migraine attacks and for identifying novel prophylactic treatment targets for the prevention of attacks.	[Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands; [van den Berg, Albert] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Wageningen University & Research; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Scheffer, M (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands.	marten.scheffer@wur.nl	van den Berg, Albert/B-4648-2013; Ferrari, Michel D./ABE-3758-2021	van den Berg, Albert/0000-0001-9019-933X; Ferrari, Michel D./0000-0001-9691-9449	Dutch national science prize; Spinoza Award; European Research Council	Dutch national science prize; Spinoza Award; European Research Council(European Research Council (ERC)European Commission)	The research of each of the authors is supported by a Dutch national science prize, the Spinoza Award. M.S. and A.v.d.B. are also supported by a European Research Council Advanced grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; DAHLEM MA, 2010, PHYSICA D IN PRESS; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dalkara T, 2006, NEUROL SCI, V27, pS86, DOI 10.1007/s10072-006-0577-z; Eikermann-Haerter K, 2008, CURR OPIN NEUROL, V21, P294, DOI 10.1097/WCO.0b013e3282fc25de; Eikermann-Haerter K, 2011, J NEUROSCI, V31, P5755, DOI 10.1523/JNEUROSCI.5346-10.2011; Eikermann-Haerter K, 2009, ANN NEUROL, V66, P564, DOI 10.1002/ana.21779; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; KROPP P, 1993, CEPHALALGIA, V13, P37, DOI 10.1046/j.1468-2982.1993.1301037.x; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Levy D, 2012, CEPHALALGIA, V32, P581, DOI 10.1177/0333102411424621; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; Rogawski MA, 2008, ARCH NEUROL-CHICAGO, V65, P709, DOI 10.1001/archneur.65.6.709; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shibata K, 2008, J NEUROL SCI, V271, P119, DOI 10.1016/j.jns.2008.04.004; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329	25	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72514	10.1371/journal.pone.0072514	http://dx.doi.org/10.1371/journal.pone.0072514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009688	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600026
J	Wang, J; Marowsky, NC; Fan, CZ				Wang, Jun; Marowsky, Nicholas C.; Fan, Chuanzhu			Divergent Evolutionary and Expression Patterns between Lineage Specific New Duplicate Genes and Their Parental Paralogs in Arabidopsis thaliana	PLOS ONE			English	Article							BASE RESOLUTION MAPS; GENOME DUPLICATIONS; POSITIVE SELECTION; ADAPTIVE EVOLUTION; DNA METHYLATION; IDENTIFICATION; ORIGIN; SUBFUNCTIONALIZATION; WHOLE; BRASSICACEAE	Gene duplication is an important mechanism for the origination of functional novelties in organisms. We performed a comparative genome analysis to systematically estimate recent lineage specific gene duplication events in Arabidopsis thaliana and further investigate whether and how these new duplicate genes (NDGs) play a functional role in the evolution and adaption of A. thaliana. We accomplished this using syntenic relationship among four closely related species, A. thaliana, A. lyrata, Capsella rubella and Brassica rapa. We identified 100 NDGs, showing clear origination patterns, whose parental genes are located in syntenic regions and/or have clear orthologs in at least one of three outgroup species. All 100 NDGs were transcribed and under functional constraints, while 24% of the NDGs have differential expression patterns compared to their parental genes. We explored the underlying evolutionary forces of these paralogous pairs through conducting neutrality tests with sequence divergence and polymorphism data. Evolution of about 15% of NDGs appeared to be driven by natural selection. Moreover, we found that 3 NDGs not only altered their expression patterns when compared with parental genes, but also evolved under positive selection. We investigated the underlying mechanisms driving the differential expression of NDGs and their parents, and found a number of NDGs had different cis-elements and methylation patterns from their parental genes. Overall, we demonstrated that NDGs acquired divergent cis-elements and methylation patterns and may experience sub-functionalization or neo-functionalization influencing the evolution and adaption of A. thaliana.	[Wang, Jun; Marowsky, Nicholas C.; Fan, Chuanzhu] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Fan, CZ (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	cfan@wayne.edu			Wayne State University	Wayne State University	This work was supported by start-up fund from Wayne State University to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Bekaert M, 2011, PLANT CELL, V23, P1719, DOI 10.1105/tpc.110.081281; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cardoso-Moreira M, 2012, METHODS MOL BIOL, V856, P161, DOI 10.1007/978-1-61779-585-5_7; Carretero-Paulet L, 2012, MOL BIOL EVOL, V29, P3541, DOI 10.1093/molbev/mss162; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Diaz-Trivino S, 2005, NUCLEIC ACIDS RES, V33, P5404, DOI 10.1093/nar/gki854; Ding Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001255; Donoghue MTA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-47; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Fan C, 2007, J INTEGRATIVE PLANT, V49; Ferrari S, 2003, PLANT CELL, V15, P93, DOI 10.1105/tpc.005165; FERRIS SD, 1979, J MOL EVOL, V12, P267, DOI 10.1007/BF01732026; Force A, 1999, GENETICS, V151, P1531; FU YX, 1993, GENETICS, V133, P693; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Gomaa NH, 2011, MOL ECOL, V20, P3540, DOI 10.1111/j.1365-294X.2011.05193.x; Guo WJ, 2007, COMP FUNCT GENOM, DOI 10.1155/2007/21676; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Harada E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029710; He YK, 2001, PLANTA, V212, P641, DOI 10.1007/s004250000452; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Hudson CM, 2011, GENOME BIOL EVOL, V3, P1369, DOI 10.1093/gbe/evr115; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hughes AL, 2008, MOL BIOL EVOL, V25, P2199, DOI 10.1093/molbev/msn166; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2005, AM J BOT, V92, P761, DOI 10.3732/ajb.92.4.761; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laubinger S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r112; Li W. H, 1997, MOL EVOLUTION; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Lin HN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-41; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Lundemo S, 2009, MOL ECOL, V18, P2798, DOI 10.1111/j.1365-294X.2009.04236.x; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2001, GENETICS, V159, P1789; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nikiforova VJ, 2005, J EXP BOT, V56, P1887, DOI 10.1093/jxb/eri179; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Proulx SR, 2012, GENETICS, V190, P737, DOI 10.1534/genetics.111.135590; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Ranz JM, 2012, BIOESSAYS; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schmid KJ, 2001, GENETICS, V159, P589; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shiu SH, 2006, P NATL ACAD SCI USA, V103, P2232, DOI 10.1073/pnas.0510388103; Siew N, 2003, COMP FUNCT GENOM, V4, P432, DOI 10.1002/cfg.311; Slotte T, 2013, NAT GENET; Smit A, 1996, REPEATMASKER OPEN 30; TAJIMA F, 1989, GENETICS, V123, P585; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Udall JA, 2006, GENETICS, V173, P1823, DOI 10.1534/genetics.106.058271; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wang J, 2012, J MOL EVOL, V74, P113, DOI 10.1007/s00239-012-9499-y; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; Yang XH, 2009, GENOMICS, V93, P473, DOI 10.1016/j.ygeno.2009.01.002; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhang YJ, 2005, PLANT PHYSIOL, V138, P935, DOI 10.1104/pp.105.060244; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zou C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000581	103	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72362	10.1371/journal.pone.0072362	http://dx.doi.org/10.1371/journal.pone.0072362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009676	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600016
J	Chang, YT; Lin, CY; Tsai, CY; Siva, VS; Chu, CY; Tsai, HJ; Song, YL				Chang, Yun-Tsan; Lin, Cheng-Yung; Tsai, Che-Yiang; Siva, Vinu S.; Chu, Chia-Ying; Tsai, Huai-Jen; Song, Yen-Ling			The New Face of the Old Molecules: Crustin Pm4 and Transglutaminase Type I Serving as RNPs Down-Regulate Astakine-Mediated Hematopoiesis	PLOS ONE			English	Article							AU-RICH ELEMENT; RNA-BINDING PROTEINS; TRANSLATIONAL CONTROL; GENE-EXPRESSION; HEMOCYTE PRODUCTION; CLONING; MATURATION; MECHANISMS; CRUSTACEAN; TISSUE	Astakine is an important cytokine that is involved in crustacean hematopoiesis. Interestingly, the protein levels of astakine increased dramatically in plasma of LPS-injected shrimp while mRNA levels remained unchanged. Here, we investigated the involvement of astakine 3'-untranslated region (UTR) in its protein expression. The 3'-UTR of astakine down-regulated the expression of reporter protein but the mRNA stability of reporter gene was unaffected. We identified the functional regulatory elements of astakine 3'-UTR, where 3'-UTR242-483 acted as repressor. The electrophoresis mobility shift assay (EMSA), RNA pull-down assay and LC/MS/MS were performed to identify the protein association. We noted that crustin Pm4 and shrimp transglutaminase I (STG I) were associated to astakine 3'-UTR242-483, while two other proteins have yet to be revealed. Depletion of hemocytic crustin Pm4 and STG I significantly increased the protein level of astakine while astakine mRNA level remained unaffected. Lipopolysaccharide (LPS) stimulated the secretion of crustin Pm4 and STG I from hemocytes to plasma and increased the astakine level to stimulate the hemocytes proliferation. Altogether, we identified the shrimp crustin Pm4 and STG I as novel RNA binding proteins that play an important role in down-regulating astakine expression at post-transcriptional level and are crucial for the maintenance of hematopoiesis.	[Chang, Yun-Tsan; Tsai, Che-Yiang; Siva, Vinu S.; Chu, Chia-Ying; Song, Yen-Ling] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lin, Cheng-Yung; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chu, Chia-Ying; Tsai, Huai-Jen; Song, Yen-Ling] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Song, YL (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	song@ntu.edu.tw		CHU, CHIA-YING/0000-0003-1619-1975	National Science Council [NSC 100-2313-B-002 -041 -MY2]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported financially by the National Science Council (Grant no. NSC 100-2313-B-002 -041 -MY2) to Yen-Ling Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Guzman G, 2009, THAI J VET MED, V39, P205; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen MY, 2005, DEV COMP IMMUNOL, V29, P1003, DOI 10.1016/j.dci.2005.03.012; Chuang KH, 2007, GENE, V405, P10, DOI 10.1016/j.gene.2007.08.016; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Gau BH, 2011, NUCLEIC ACIDS RES, V39, P3582, DOI 10.1093/nar/gkq1295; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Grech G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/576540; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hsiao CY, 2010, FISH SHELLFISH IMMUN, V28, P77, DOI 10.1016/j.fsi.2009.10.016; Huang CC, 2004, DEV COMP IMMUNOL, V28, P279, DOI 10.1016/j.dci.2003.08.005; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Li CY, 2010, FISH SHELLFISH IMMUN, V29, P1044, DOI 10.1016/j.fsi.2010.08.020; Li CY, 2010, FISH SHELLFISH IMMUN, V28, P1, DOI 10.1016/j.fsi.2009.09.003; Lin XH, 2011, BLOOD, V117, P6417, DOI 10.1182/blood-2010-11-320614; Lin XH, 2010, J BIOL CHEM, V285, P28577, DOI 10.1074/jbc.M110.138560; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Moor CH, 2005, MECH TRANSLATIONAL C, VElsevier, P49; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Szostak E, 2013, BRIEF FUNCT GENOMICS, V12, P58, DOI 10.1093/bfgp/els056; Van De Braak CB, 2002, FISH SHELLFISH IMMUN, V13, P293, DOI 10.1006/fsim.2002.0409; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Watthanasurorot A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003361; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	43	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72793	10.1371/journal.pone.0072793	http://dx.doi.org/10.1371/journal.pone.0072793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013515	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200059
J	Gomez-Cabrero, A; Wrasidlo, W; Reisfeld, RA				Gomez-Cabrero, Azucena; Wrasidlo, Wolfgang; Reisfeld, Ralph A.			IMD-0354 Targets Breast Cancer Stem Cells: A Novel Approach for an Adjuvant to Chemotherapy to Prevent Multidrug Resistance in a Murine Model	PLOS ONE			English	Article							KINASE-BETA-INHIBITOR; KAPPA-B; DRUG-RESISTANCE; LEGUMAIN EXPRESSION; SIDE POPULATION; TUMOR-GROWTH; METASTASIS; SUPPRESSES; BIOLOGY; HYPOXIA	Although early detection of breast cancer improved in recent years, prognosis of patients with late stage breast cancer remains poor, mostly due to development of multidrug resistance (MDR) followed by tumor recurrence. Cancer stem cells (CSCs), with higher drug efflux capability and other stem cell-like properties, are concentrated in a side population (SP) of cells, which were proposed to be responsible for MDR and tumor repopulation that cause patients to succumb to breast cancer. Therefore, targeting of CSCs as an adjuvant to chemotherapy should be able to provide a more effective treatment of this disease. Here, we used IMD-0354, an inhibitor of NF-kappa B, identified for targeting CSCs, in a combination therapy with doxorubicin encapsulated in targeted nanoparticles. IMD-0354 did target CSCs, evidenced by a decrease in the SP, demonstrated by the inhibition of the following: dye/drug efflux, reduction in ABC transporters as well as in colony formation in soft agar and low attachment plates. Decrease of stem-like gene expression of Oct4, Nanog and Sox2, and apoptosis resistance related to the Survivin gene also was observed after treatment with this compound. In addition, IMD-0354 targeted non-CSCs as indicated by reducing viability and increasing apoptosis. Targeted drug delivery, achieved with a legumain inhibitor, proved to enhance drug delivery under hypoxia, a hallmark of the tumor microenvironment, but not under normoxia. Together, this allowed a safe, non-toxic delivery of both anticancer agents to the tumor microenvironment of mice bearing syngeneic metastatic breast cancer. Targeting both bulk tumor cells with a chemotherapeutic agent and CSCs with IMD-0354 should be able to reduce MDR. This could eventually result in decreasing tumor recurrences and/or improve the outcome of metastatic disease.	[Gomez-Cabrero, Azucena; Reisfeld, Ralph A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wrasidlo, Wolfgang] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	Scripps Research Institute; University of California System; University of California San Diego	Gomez-Cabrero, A (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	agomezcabrero@hotmail.com			NIH [1R01CA134364]; DOD/CDMRP [W81XWH-10-1-0764]; NATIONAL CANCER INSTITUTE [R01CA134364] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD/CDMRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH 1R01CA134364 (www.nih.gov) and DOD/CDMRP W81XWH-10-1-0764 (http://cdmrp.army.mil) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Airoldi M, 2011, TUMORI, V97, P690, DOI 10.1700/1018.11082; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bajjuri KM, 2011, CHEMMEDCHEM, V6, P54, DOI 10.1002/cmdc.201000478; Berenson JR, 2001, SEMIN ONCOL, V28, P626, DOI 10.1053/sonc.2001.29542; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ekici OD, 2004, J MED CHEM, V47, P1889, DOI 10.1021/jm049938j; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; Goodell MA, 2005, CURR PROTOC CYTOM, V9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HIGUCHI M, 1980, CLIN EXP IMMUNOL, V39, P90; Hiraga T, 2011, ONCOL REP, V25, P289, DOI 10.3892/or_00001073; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Kawanabe N, 2006, BIOCHEM BIOPH RES CO, V344, P1278, DOI 10.1016/j.bbrc.2006.03.237; Kim Ran-Ju, 2011, Lab Anim Res, V27, P147, DOI 10.5625/lar.2011.27.2.147; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Kruger JA, 2006, BLOOD, V108, P3906, DOI 10.1182/blood-2006-05-024687; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Ling J, 2012, CANCER LETT, V322, P119, DOI 10.1016/j.canlet.2012.02.033; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mak KK, 2013, MOL NUTR FOOD RES, V57, P1123, DOI 10.1002/mnfr.201200549; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; MILLER FR, 1983, INVAS METAST, V3, P22; Nagler C, 2011, ADV EXP MED BIOL, V714, P173, DOI 10.1007/978-94-007-0782-5_9; Ochiai Takanori, 2008, J Med Dent Sci, V55, P49; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Ogawa K, 2013, ANTICANCER RES, V33, P747; Ohno Y, 2013, WORLD J UROL, V31, P359, DOI 10.1007/s00345-012-0977-z; Onai Y, 2004, CARDIOVASC RES, V63, P51, DOI 10.1016/j.cardiores.2004.03.002; PRICE JE, 1990, CANCER RES, V50, P717; PRICE JE, 1990, CANCER-AM CANCER SOC, V66, P1313, DOI 10.1002/1097-0142(19900915)66:14+<1313::AID-CNCR2820661403>3.0.CO;2-4; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Pulaski BA, 1998, CANCER RES, V58, P1486; Sambrook J, 2001, MOL CLONING LAB MANU; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sugita A, 2009, INT ARCH ALLERGY IMM, V148, P186, DOI 10.1159/000161579; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Sutherland RM, 1998, ACTA ONCOL, V37, P567, DOI 10.1080/028418698430278; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; Tanaka A, 2005, BLOOD, V105, P2324, DOI 10.1182/blood-2004-08-3247; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; Uota S, 2012, CANCER SCI, V103, P100, DOI 10.1111/j.1349-7006.2011.02110.x; Vinogradov S, 2012, NANOMEDICINE-UK, V7, P597, DOI [10.2217/NNM.12.22, 10.2217/nnm.12.22]; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645; Wang LN, 2012, J CELL BIOCHEM, V113, P2679, DOI 10.1002/jcb.24143	57	42	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73607	10.1371/journal.pone.0073607	http://dx.doi.org/10.1371/journal.pone.0073607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014113	Green Submitted, gold, Green Published			2022-12-25	WOS:000323815200084
J	Xu, Y; Duan, CH; Kuang, ZZ; Hao, YH; Jeffries, JL; Lau, GW				Xu, Ying; Duan, Chaohui; Kuang, Zhizhou; Hao, Yonghua; Jeffries, Jayme L.; Lau, Gee W.			Pseudomonas aeruginosa Pyocyanin Activates NRF2-ARE-Mediated Transcriptional Response via the ROS-EGFR-PI3K-AKT/MEK-ERK MAP Kinase Signaling in Pulmonary Epithelial Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; CYSTIC-FIBROSIS; RESPIRATORY-TRACT; A549 CELLS; HYPEROXIA; INFECTION; NRF2; GLUTATHIONE; MECHANISMS; EXPRESSION	The redox-active pyocyanin (PCN) secreted by the respiratory pathogen Pseudomonas aeruginosa generates reactive oxygen species (ROS) and causes oxidative stress to pulmonary epithelial cells. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) confers protection against ROS-mediated cell death by inducing the expression of detoxifying enzymes and proteins via its binding to the cis-acting antioxidant response element (ARE). However, a clear relationship between NRF2 and PCN-mediated oxidative stress has not been established experimentally. In this study, we investigated the induction of NRF2-ARE response by PCN in the pulmonary epithelial cells. We analyzed the effect of PCN on NRF2 expression and nuclear translocation in cultured human airway epithelial cells, and in a mouse model of chronic PCN exposure. NRF2-dependent transcription of antioxidative enzymes was also assessed. Furthermore, we used inhibitors to examine the involvement of EGFR and its downstream signaling components that mediate NRF2-ARE-activation in response to PCN. PCN enhances the nuclear NRF2 accumulation and activates the transcription of ARE-mediated antioxidant genes. Furthermore, PCN activates NRF2 by inducing the EGFR-phosphoinositide-3-kinase (PI3K) signaling pathway and its main downstream effectors, AKT and MEK1/2-ERK1/2 MAP kinases. Inhibition of the EGFR-PI3K signaling markedly attenuates PCN-stimulated NRF2 accumulation in the nucleus. We demonstrate for the first time that PCN-mediated oxidative stress activates the EGFR-PI3K-AKT/MEK1/2-ERK1/2 MAP kinase signaling pathway, leading to nuclear NRF2 translocation and ARE responsiveness in pulmonary epithelial cells.	[Xu, Ying; Kuang, Zhizhou; Hao, Yonghua; Jeffries, Jayme L.; Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Xu, Ying; Duan, Chaohui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Clin Immunol Lab, Guangzhou 510275, Guangdong, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Sun Yat Sen University	Lau, GW (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA.	geelau@illinois.edu	Lau, Gee W/H-4073-2018		American Lung Association DeSouza Research Award [DS-192835-N]; NIH [HL090699]; Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health [C06 RR 16515-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090699] Funding Source: NIH RePORTER	American Lung Association DeSouza Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Lung Association DeSouza Research Award (DS-192835-N) and NIH (HL090699) to GW Lau. This investigation was conducted in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR 16515-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Deng XB, 2013, CELL BIOL TOXICOL, V29, P143, DOI 10.1007/s10565-013-9242-5; Farrell PM, 2009, RADIOLOGY, V252, P534, DOI 10.1148/radiol.2522081882; Gardner PR, 1996, ARCH BIOCHEM BIOPHYS, V333, P267, DOI 10.1006/abbi.1996.0390; Gloyne LS, 2011, TOXICOL IN VITRO, V25, P1353, DOI 10.1016/j.tiv.2011.05.004; Hao YH, 2012, CELL MICROBIOL, V14, P401, DOI 10.1111/j.1462-5822.2011.01727.x; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; Ojeniyi B, 2000, PEDIATR PULM, V29, P177, DOI 10.1002/(SICI)1099-0496(200003)29:3<177::AID-PPUL4>3.0.CO;2-U; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Reimer A, 2000, ACTA OTO-LARYNGOL, P86; Ricciardolo FLM, 2006, EUR J PHARMACOL, V533, P240, DOI 10.1016/j.ejphar.2005.12.057; Roper JM, 2004, AM J PHYSIOL-LUNG C, V286, pL1045, DOI 10.1152/ajplung.00376.2003; Tirumalai R, 2002, TOXICOL LETT, V132, P27, DOI 10.1016/S0378-4274(02)00055-3; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988	36	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72528	10.1371/journal.pone.0072528	http://dx.doi.org/10.1371/journal.pone.0072528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015256	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200047
J	Hercus, TR; Barry, EF; Dottore, M; McClure, BJ; Webb, AI; Lopez, AF; Young, IG; Murphy, JM				Hercus, Timothy R.; Barry, Emma F.; Dottore, Mara; McClure, Barbara J.; Webb, Andrew I.; Lopez, Angel F.; Young, Ian G.; Murphy, James M.			High Yield Production of a Soluble Human Interleukin-3 Variant from E. coli with Wild-Type Bioactivity and Improved Radiolabeling Properties	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; RECOMBINANT HUMAN INTERLEUKIN-3; HEMATOPOIETIC STEM-CELLS; COMMON BETA-SUBUNIT; GM-CSF; RECEPTOR ACTIVATION; MURINE IL-3; EXPRESSION; BINDING; PURIFICATION	Human interleukin-3 (hIL-3) is a polypeptide growth factor that regulates the proliferation, differentiation, survival and function of hematopoietic progenitors and many mature blood cell lineages. Although recombinant hIL-3 is a widely used laboratory reagent in hematology, standard methods for its preparation, including those employed by commercial suppliers, remain arduous owing to a reliance on refolding insoluble protein expressed in E. coli. In addition, wild-type hIL-3 is a poor substrate for radio-iodination, which has been a long-standing hindrance to its use in receptor binding assays. To overcome these problems, we developed a method for expression of hIL-3 in E. coli as a soluble protein, with typical yields of >3mg of purified hIL-3 per litre of shaking microbial culture. Additionally, we introduced a non-native tyrosine residue into our hIL-3 analog, which allowed radio-iodination to high specific activities for receptor binding studies whilst not compromising bioactivity. The method presented herein provides a cost-effective and convenient route to milligram quantities of a hIL-3 analog with wild-type bioactivity that, unlike wildtype hIL-3, can be efficiently radio-iodinated for receptor binding studies.	[Hercus, Timothy R.; Barry, Emma F.; Dottore, Mara; McClure, Barbara J.; Lopez, Angel F.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Webb, Andrew I.; Murphy, James M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Webb, Andrew I.; Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Mol Biosci, Canberra, ACT 2601, Australia	Centre for Cancer Biology; SA Pathology; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Australian National University; John Curtin School of Medical Research	Hercus, TR (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	Tim.Hercus@health.sa.gov.au; jamesm@wehi.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949; McClure, Barbara/0000-0002-5201-4127; Lopez, Angel F/0000-0001-7430-0135; Barry, Emma/0000-0003-2742-5650	National Health and Medical Research Council of Australia (NHMRC) [1033368, 565217]; Australian Research Council fellowship [FT100100100]; NHMRC IRIISS grant [361646]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council fellowship(Australian Research Council); NHMRC IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) grants (1033368 and 565217); an Australian Research Council fellowship (FT100100100) to JMM; with additional support from the Victorian State Government Operational Infrastructure Support and NHMRC IRIISS grant (361646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle DM, 1999, BIOTECHNOL APPL BIOC, V30, P163; Broughton SE, 2012, IMMUNOL REV, V250, P277, DOI 10.1111/j.1600-065X.2012.01164.x; Chen JL, 2009, J BIOL CHEM, V284, P5763, DOI 10.1074/jbc.M808197200; Clanchy FIL, 2013, CYTOKINE, V61, P33, DOI 10.1016/j.cyto.2012.09.005; Dahl C, 2004, ALLERGY, V59, P1087, DOI 10.1111/j.1398-9995.2004.00606.x; de Marco A, 2006, NAT PROTOC, V1, P1538, DOI 10.1038/nprot.2006.289; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; DELWEL R, 1987, BLOOD, V70, P333; Ding HB, 2003, PROTEIN EXPRES PURIF, V31, P34, DOI 10.1016/S1046-5928(03)00138-4; Dudley A, 2003, BIOTECHNIQUES, V35, P724, DOI 10.2144/03354st02; Feng YP, 1996, J MOL BIOL, V259, P524, DOI 10.1006/jmbi.1996.0337; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Jiang XY, 1999, P NATL ACAD SCI USA, V96, P12804, DOI 10.1073/pnas.96.22.12804; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Klein BK, 1999, EXP HEMATOL, V27, P1746, DOI 10.1016/S0301-472X(99)00118-6; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Li HB, 2011, PROTEIN EXPRES PURIF, V80, P185, DOI 10.1016/j.pep.2011.08.027; LOPEZ AF, 1990, J CELL PHYSIOL, V145, P69, DOI 10.1002/jcp.1041450111; LOPEZ AF, 1990, J ALLERGY CLIN IMMUN, V85, P99, DOI 10.1016/0091-6749(90)90229-W; Lopez AF, 2010, IUBMB LIFE, V62, P509, DOI 10.1002/iub.350; Mirza S, 2010, BIOCHEM J, V426, P307, DOI 10.1042/BJ20091745; Murphy JM, 2008, CYTOKINE, V42, P234, DOI 10.1016/j.cyto.2008.02.010; Murphy JM, 2010, GROWTH FACTORS, V28, P104, DOI 10.3109/08977190903443048; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Nowruzi K, 2008, BIOTECHNOL BIOENG, V99, P214, DOI 10.1002/bit.21566; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; OLINS PO, 1995, J BIOL CHEM, V270, P23754, DOI 10.1074/jbc.270.40.23754; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Westers L, 2006, J BIOTECHNOL, V123, P211, DOI 10.1016/j.jbiotec.2005.11.007; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Yamada T, 1998, J ALLERGY CLIN IMMUN, V101, P677, DOI 10.1016/S0091-6749(98)70177-0; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; Yao SG, 2010, BIOMOL NMR ASSIGN, V4, P73, DOI 10.1007/s12104-010-9213-1; Yao SG, 2011, J MAGN RESON, V211, P243, DOI 10.1016/j.jmr.2011.05.013; Yao SG, 2011, BIOCHEMISTRY-US, V50, P2464, DOI 10.1021/bi101810f	41	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74376	10.1371/journal.pone.0074376	http://dx.doi.org/10.1371/journal.pone.0074376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991218	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800117
J	Moghadam, GK; Wilke, R; Suaning, GJ; Lovell, NH; Dokos, S				Moghadam, Gita Khalili; Wilke, Robert; Suaning, Gregg J.; Lovell, Nigel H.; Dokos, Socrates			Quasi-Monopolar Stimulation: A Novel Electrode Design Configuration for Performance Optimization of a Retinal Neuroprosthesis	PLOS ONE			English	Article							COCHLEAR IMPLANT STIMULATION; ELECTRICAL-STIMULATION; PARTIAL TRIPOLAR; MULTIELECTRODE ARRAYS; CURRENT INJECTION; CHARGE INJECTION; NEURON INTERFACE; GANGLION-CELLS; MODEL; PROSTHESIS	In retinal neuroprostheses, spatial interaction between electric fields from various electrodes - electric crosstalk - may occur in multielectrode arrays during simultaneous stimulation of the retina. Depending on the electrode design and placement, this crosstalk can either enhance or degrade the functional characteristics of a visual prosthesis. To optimize the device performance, a balance must be satisfied between the constructive interference of crosstalk on dynamic range and power consumption and its negative effect on artificial visual acuity. In the present computational modeling study, we have examined the trade-off in these positive and negative effects using a range of currently available electrode array configurations, compared to a recently proposed stimulation strategy - the quasi monopolar (QMP) configuration - in which the return current is shared between local bipolar guards and a distant monopolar electrode. We evaluate the performance of the QMP configuration with respect to the implantation site and electrode geometry parameters. Our simulation results demonstrate that the beneficial effects of QMP are only significant at electrode-to-cell distances greater than the electrode dimensions. Possessing a relatively lower activation threshold, QMP was found to be superior to the bipolar configuration in terms of providing a relatively higher visual acuity. However, the threshold for QMP was more sensitive to the topological location of the electrode in the array, which may need to be considered when programming the manner in which electrode are simultaneously activated. This drawback can be offset with a wider dynamic range and lower power consumption of QMP. Furthermore, the ratio of monopolar return current to total return can be used to adjust the functional performance of QMP for a given implantation site and electrode parameters. We conclude that the QMP configuration can be used to improve visual information-to-stimulation mapping in a visual prosthesis, while maintaining low power consumption.	[Moghadam, Gita Khalili; Wilke, Robert; Suaning, Gregg J.; Lovell, Nigel H.; Dokos, Socrates] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia	University of New South Wales Sydney	Dokos, S (corresponding author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.	s.dokos@unsw.edu.au	Moghadam, Gita Khalili/X-3529-2019; Lovell, Nigel H/AGF-6679-2022	Lovell, Nigel H/0000-0003-1637-1079; Khalili Moghaddam, Gita/0000-0003-2099-8026; Dokos, Socrates/0000-0002-7399-2712; Suaning, Gregg/0000-0003-1918-3313	Australian Research Council Bionic Vision Australia Special Research Initiative	Australian Research Council Bionic Vision Australia Special Research Initiative(Australian Research Council)	This work was funded through the Australian Research Council Bionic Vision Australia Special Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierer JA, 2004, JARO-J ASSOC RES OTO, V5, P32, DOI 10.1007/s10162-003-3057-7; Bierer JA, 2002, J NEUROPHYSIOL, V87, P478, DOI 10.1152/jn.00212.2001; Bierer JA, 2007, J ACOUST SOC AM, V121, P1642, DOI 10.1121/1.2436712; Bierer JA, 2010, HEARING RES, V270, P134, DOI 10.1016/j.heares.2010.08.006; Bierer JA, 2010, EAR HEARING, V31, P247, DOI 10.1097/AUD.0b013e3181c7daf4; Cogan SF, 2009, J BIOMED MATER RES B, V89B, P353, DOI 10.1002/jbm.b.31223; Coulombe J, 2005, ARTIF ORGANS, V29, P233, DOI 10.1111/j.1525-1594.2005.29042.x; Dokos S, 2005, IEEE T NEUR SYS REH, V13, P137, DOI 10.1109/TNSRE.2005.847390; Dommel N, 2005, P ANN INT IEEE EMBS, P7612, DOI 10.1109/IEMBS.2005.1616274; Goldwyn JH, 2010, HEARING RES, V268, P93, DOI 10.1016/j.heares.2010.05.005; Greenberg RJ, 1999, IEEE T BIO-MED ENG, V46, P505, DOI 10.1109/10.759051; Greenwald SH, 2009, INVEST OPHTH VIS SCI, V50, P5017, DOI 10.1167/iovs.08-2897; James CJ, 2002, EAR HEARING, V23, p49S, DOI 10.1097/00003446-200202001-00006; Joarder SA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066006; Jolly CN, 1996, IEEE T BIO-MED ENG, V43, P857, DOI 10.1109/10.508549; Kendir GA, 2005, IEEE T CIRCUITS-I, V52, P857, DOI 10.1109/TCSI.2005.846208; Khalili G, 2011, I IEEE EMBS C NEUR E, P542, DOI 10.1109/NER.2011.5910605; Khalili Moghaddam G, 2011, J NEURAL ENG, V8; Lilly JC, 1961, INJURY EXCITATION EL, P60; Lovell NH, 2005, P ANN INT IEEE EMBS, P5242, DOI 10.1109/IEMBS.2005.1615661; Lovell NH, 2005, ENG MED BIOL SOC ANN, P98, DOI 10.1109/MMB.2005.1548394; Lovell NH, 2005, I IEEE EMBS C NEUR E, P458; Margalit E, 2002, SURV OPHTHALMOL, V47, P335, DOI 10.1016/S0039-6257(02)00311-9; McCreery DB, 2002, ANN BIOMED ENG, V30, P107, DOI 10.1114/1.1430748; Mens LHM, 2005, OTOL NEUROTOL, V26, P957, DOI 10.1097/01.mao.0000185060.74339.9d; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Mohd Addi M, 2008, P IEEE ENG MED BIOL, P1797; Negi S, 2010, J NEUROSCI METH, V186, P8, DOI 10.1016/j.jneumeth.2009.10.016; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Palanker D, 2005, J NEURAL ENG, V2, pS105, DOI 10.1088/1741-2560/2/1/012; Pfingst BE, 2004, JARO-J ASSOC RES OTO, V5, P11, DOI 10.1007/s10162-003-3051-0; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038; Sekirnjak C, 2006, J NEUROPHYSIOL, V95, P3311, DOI 10.1152/jn.01168.2005; Stett A, 2007, J NEURAL ENG, V4, pS7, DOI 10.1088/1741-2560/4/1/S02; Suaning GJ, Australia patent application, Patent No. [PCT2012001027 AU, PCT2012001027]; Wilke R., 2011, FADING PERCEPTION RE; Wilke RGH, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046016; Wilke R, 2011, INVEST OPHTH VIS SCI, V52, P5995, DOI 10.1167/iovs.10-6946; Wilke RGH, 2010, LECT NOTES COMPUT SC, V6443, P140, DOI 10.1007/978-3-642-17537-4_18; Yin SJ, 2010, IEEE ENG MED BIO, P2077, DOI 10.1109/IEMBS.2010.5626300; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73130	10.1371/journal.pone.0073130	http://dx.doi.org/10.1371/journal.pone.0073130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991175	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800094
J	Siebenhuhner, F; Weiss, SA; Coppola, R; Weinberger, DR; Bassett, DS				Siebenhuehner, Felix; Weiss, Shennan A.; Coppola, Richard; Weinberger, Daniel R.; Bassett, Danielle S.			Intra- and Inter-Frequency Brain Network Structure in Health and Schizophrenia	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; NEURAL MASS MODEL; FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; INTERMEDIATE PHENOTYPES; SYNAPTIC PLASTICITY; ABNORMALITIES; ORGANIZATION; EEG; DYSFUNCTION	Empirical studies over the past two decades have provided support for the hypothesis that schizophrenia is characterized by altered connectivity patterns in functional brain networks. These alterations have been proposed as genetically mediated diagnostic biomarkers and are thought to underlie altered cognitive functions such as working memory. However, the nature of this dysconnectivity remains far from understood. In this study, we perform an extensive analysis of functional connectivity patterns extracted from MEG data in 14 subjects with schizophrenia and 14 healthy controls during a 2-back working memory task. We investigate uni-, bi- and multivariate properties of sensor time series by computing wavelet entropy of and correlation between time series, and by constructing binary networks of functional connectivity both within and between classical frequency bands (gamma, beta, alpha, and theta). Networks are based on the mutual information between wavelet time series, and estimated for each trial window separately, enabling us to consider both network topology and network dynamics. We observed significant decreases in time series entropy and significant increases in functional connectivity in the schizophrenia group in comparison to the healthy controls and identified an inverse relationship between these measures across both subjects and sensors that varied over frequency bands and was more pronounced in controls than in patients. The topological organization of connectivity was altered in schizophrenia specifically in high frequency c and b band networks as well as in the gamma-beta cross-frequency networks. Network topology varied over trials to a greater extent in patients than in controls, suggesting disease-associated alterations in dynamic network properties of brain function. Our results identify signatures of aberrant neurophysiological behavior in schizophrenia across uni-, bi- and multivariate scales and lay the groundwork for further clinical studies that might lead to the discovery of new intermediate phenotypes.	[Siebenhuehner, Felix; Bassett, Danielle S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Siebenhuehner, Felix] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Weiss, Shennan A.] Columbia Univ, Dept Neurol, New York, NY USA; [Coppola, Richard] NIMH, MEG Core Facil, Bethesda, MD 20892 USA; [Weinberger, Daniel R.] NIMH, Genes Cognit & Psychosis Program, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; [Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD USA; [Bassett, Danielle S.] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Helsinki; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California Santa Barbara	Bassett, DS (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	dbassett@physics.ucsb.edu	Sharipov, Felix/B-5059-2013; Siebenhühner, Felix/A-4788-2019; Siebenhühner, Felix/V-2935-2019	Sharipov, Felix/0000-0001-9372-2915; Siebenhühner, Felix/0000-0002-2621-9145; Siebenhühner, Felix/0000-0002-2621-9145; Coppola, Richard/0000-0003-0273-0675; Weiss, Shennan/0000-0003-0825-8439	Errett Fisher Foundation; Templeton Foundation; David and Lucile Packard Foundation; Public Health Service [NS44393]; Sage Center for the Study of the Mind; Institute for Collaborative Biotechnologies from the U.S. Army Research Oce [W911NF-09-D-0001]; Center for Scientic Computing at the California NanoSystems Institute and Materials Research Laboratory: a National Science Foundation (NSF) MRSEC [DMR-1121053]; NSF [CNS-0960316]; Weinberger Lab; National Institute of Mental Health Magnetoencephalography core facility; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002890, ZICMH002889] Funding Source: NIH RePORTER	Errett Fisher Foundation; Templeton Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sage Center for the Study of the Mind; Institute for Collaborative Biotechnologies from the U.S. Army Research Oce; Center for Scientic Computing at the California NanoSystems Institute and Materials Research Laboratory: a National Science Foundation (NSF) MRSEC; NSF(National Science Foundation (NSF)); Weinberger Lab; National Institute of Mental Health Magnetoencephalography core facility; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Errett Fisher Foundation, the Templeton Foundation, the David and Lucile Packard Foundation, Public Health Service Grant NS44393, Sage Center for the Study of the Mind, and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U.S. Army Research Oce. The authors acknowledge support from the Center for Scientic Computing at the California NanoSystems Institute and Materials Research Laboratory: a National Science Foundation (NSF) MRSEC (DMR-1121053) and NSF CNS-0960316. The patients and normal controls were studied as part of the Clinical Brain Disorders Branch Sibling study (D.R. Weinberger PI), an investigation of the biological components of genetic risk for schizophrenia, with direct funding of the Weinberger Lab and the National Institute of Mental Health Magnetoencephalography core facility (R. Coppola). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Akam TE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002760; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen EA, 2011, FRONT SYST NEUROSCI, P5; Andino SLG, 2000, HUM BRAIN MAPP, V11, P46; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2013, PLOS COMP B IN PRESS; Bassett DS, 2013, CHAOS, P23; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Breakspear M, 2003, NEUROIMAGE, V20, P466, DOI 10.1016/S1053-8119(03)00332-X; Breakspear M, 2005, PHILOS T R SOC B, V360, P1051, DOI 10.1098/rstb.2005.1643; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Callicott JH, 2003, AM J PSYCHIAT, V160; Camchong J, 2011, ALTERED FUNCTIONAL A; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Cole MW, 2011, BIOL PSYCHIAT, V70, P43, DOI 10.1016/j.biopsych.2011.02.010; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Doron KW, 2012, P NATL ACAD SCI USA, V109, P18661, DOI 10.1073/pnas.1216402109; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fallani FD, 2010, BRAIN TOPOGR, V23, P214, DOI 10.1007/s10548-010-0133-2; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Ginestet CE, 2011, NEUROIMAGE, P55; Gold JM, 2004, SCHIZOPHR RES, V72, P21, DOI 10.1016/j.schres.2004.09.008; Gross J, 2013, NEUROIMAGE, P65; Haenschel C, 2011, BEHAV BRAIN RES, V216, P481, DOI 10.1016/j.bbr.2010.08.045; He H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038195; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hirvonen J, 2011, CNS NEUROSCI THER, V17, P89, DOI 10.1111/j.1755-5949.2010.00223.x; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Jeong B, 2009, HUM BRAIN MAPP, V30, P4138, DOI 10.1002/hbm.20835; John JP, 2009, J NEUROPSYCH CLIN N, V21, P160, DOI 10.1176/appi.neuropsych.21.2.160; Kikuchi M, 2011, SCHIZOPHR RES, V130, P187, DOI 10.1016/j.schres.2011.06.003; Kim D, 2008, NEUROIMAGE, V39, P1129, DOI 10.1016/j.neuroimage.2007.09.042; Kinnison J, 2012, J NEUROSCI, V32, P8361, DOI 10.1523/JNEUROSCI.0821-12.2012; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Knosche TR, 2002, BIOMED TECH, V47, P59, DOI 10.1515/bmte.2002.47.3.59; Krishnan GP, 2005, CLIN NEUROPHYSIOL, V116, P614, DOI 10.1016/j.clinph.2004.09.016; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Madden D, 2013, BRAIN CONNECT; Mantzaris AV, 2013, J COMPLEX NETWORKS; MathWorks I, 1994, MATLAB; Medvedovsky M, 2007, Neurol Neurophysiol Neurosci, P4; Meunier D, 2008, NEUROIMAGE IN PRESS; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2012, WORLD J PSYCHIATR, V2, P1, DOI 10.5498/wjp.v2.i1.1; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Moussa MN, 2011, FRONT HUM NEUROSCI, P5; Mukherjee G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036111; Muthukumaraswamy SD, 2011, CLIN NEUROPHYSIOL, V122, P2324, DOI 10.1016/j.clinph.2011.04.003; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2005, J NEUROSCI, V25; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Percival D., 2000, CA ST PR MA; Pesonen M, 2007, BRAIN RES, V1138, P171, DOI 10.1016/j.brainres.2006.12.076; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Raghavendra BS, 2009, PHYSIOL MEAS, V30, P795, DOI 10.1088/0967-3334/30/8/005; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Repovs G, 2012, FRONT HUM NEUROSCI, P6; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Rubinov M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-55; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sabeti M, 2009, ARTIF INTELL MED, V47, P263, DOI 10.1016/j.artmed.2009.03.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schoen W, 2011, CONSCIOUS COGN, V20, P1050, DOI 10.1016/j.concog.2010.05.009; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smit DJA, 2010, BEHAV GENET, V40, P167, DOI 10.1007/s10519-009-9330-8; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stephan KE, 2006, CURR MED IMAGING REV, V2, P15, DOI 10.2174/157340506775541659; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sugranyes G, 2012, SCHIZOPHR RES, V138, P136, DOI 10.1016/j.schres.2012.03.011; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Tan HY, 2012, MOL PSYCHIATR, V17, P1007, DOI 10.1038/mp.2011.91; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van den Berg D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00020; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Vicente R, 2011, FRONT HUM NEUR C 11; VOLKOW ND, 1988, SCHIZOPHR RES, V1, P47, DOI 10.1016/0920-9964(88)90039-4; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; Weiss SA, 2011, FRONT HUM NEUROSCI, P5; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Winterer G, 2006, BIOL PSYCHIAT, V60, P578, DOI 10.1016/j.biopsych.2006.03.023; Wu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00113; Xie XP, 2008, NEUROIMAGE, V40, P1672, DOI 10.1016/j.neuroimage.2008.01.007; Yu Q, 2012, FRONTIERS SYSTEMS NE, P5; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zheng H, 2010, ANOVA N REPEATED M N	140	40	40	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72351	10.1371/journal.pone.0072351	http://dx.doi.org/10.1371/journal.pone.0072351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991097	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800062
J	Martinez-Pena, RM; Hoogesteijn, AL; Rothenberg, SJ; Cervera-Montejano, MD; Pacheco-Avila, JG				Martinez-Pena, Ruth Magnolia; Hoogesteijn, Almira L.; Rothenberg, Stephen J.; Dolores Cervera-Montejano, Maria; Pacheco-Avila, Julia G.			Cleaning Products, Environmental Awareness and Risk Perception in Merida, Mexico	PLOS ONE			English	Article							WATER; POLLUTION; BELIEFS; CHINA; WASTE; VULNERABILITY; SURFACTANTS; PERFORMANCE; EXPOSURES; TRANSPORT	Cleaning products are associated with many health and environmental problems. Contamination of water resources by cleaning products is more likely to occur with septic tanks as sewage treatment systems especially in karstic terrains. We explored women's ideas about water sources and the risk cleaning products pose to health and sewage in Merida, a city in the Yucatan peninsula of Mexico. Women were unaware of the city's water management system. We found a positive and statistically significant association between risk perception and environmental awareness, education level and employment status. We suggest developing education and risk communication strategies to inform residents about the hydro-geological features in the Yucatan, the vulnerability of its karstic aquifer and the health and environmental risks associated with cleaning agents.	[Hoogesteijn, Almira L.; Dolores Cervera-Montejano, Maria] CINVESTAV, Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ecol Humana,Unidad Merida, Merida, Yucatan, Mexico; [Rothenberg, Stephen J.] INSP, Cuernavaca, Morelos, Mexico; [Pacheco-Avila, Julia G.] UADY, Fac Ingn, Merida, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Yucatan	Martinez-Pena, RM (corresponding author), 113 Woodview Terrace, Hurst, TX USA.	ruthmmp@hotmail.com	Rothenberg, Stephen J/A-1313-2008; Cervera, Maria Dolores/P-8823-2019	Cervera, Maria Dolores/0000-0002-2793-946X	Consejo Nacional de Ciencia y Tecnologia (Mexico)	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding provided by Consejo Nacional de Ciencia y Tecnologia (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACNielsen, 2006, MERC CREC ALR MUND P; ADELSON L, 1952, AM J CLIN PATHOL, V22, P656; Aiello AE, 2005, EMERG INFECT DIS, V11, P1565, DOI 10.3201/eid1110.041276; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Al-Rawi S M, 2005, Int J Environ Res Public Health, V2, P245, DOI 10.3390/ijerph2005020007; Anderson BA, 2007, POPUL ENVIRON, V28, P133, DOI 10.1007/s11111-007-0038-5; Baggett S, 2006, DESALINATION, V187, P149, DOI 10.1016/j.desal.2005.04.075; Bakalowicz M, 2005, HYDROGEOL J, V13, P148, DOI 10.1007/s10040-004-0402-9; Ballantyne R, 2008, TOURISM MANAGE, V29, P439, DOI 10.1016/j.tourman.2007.05.006; Batllori-Sampedro Eduardo, 2006, Invest. Geog, P74; Bello A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-76; Belmont MA, 2006, ENVIRON TOXICOL CHEM, V25, P29, DOI 10.1897/04-648R.1; Comision Nacional del Agua CNA, 1997, NORM OF MEX NOM 006; Crane M, 2006, PEST MANAG SCI, V62, P5, DOI 10.1002/ps.1134; Cruz M, 2009, DIAGNOSTICO RELAIDAD; de Desarrollo Secretaria Urbano y Medio Ambiente SEDUMA, 2008, AMB CULT; de Wit JBF, 2008, HEALTH PSYCHOL, V27, P110, DOI 10.1037/0278-6133.27.1.110; Drori I, 2002, SOC SCI QUART, V83, P53, DOI 10.1111/1540-6237.00070; ENGELHARD G, 1984, APPL PSYCH MEAS, V8, P21, DOI 10.1177/014662168400800104; EPA, 2009, SEPT SYST FACT SHEET; Escolero O., 2005, GEOFISC INT, V44, P301, DOI DOI 10.22201/IGEOF.00167169P.2005.44.3.201; Escolero OA, 2002, WATER RESOUR MANAG, V16, P351, DOI 10.1023/A:1021967909293; Falconer Ian R, 2006, Int J Environ Res Public Health, V3, P180, DOI 10.3390/ijerph2006030020; Febles-Patr?n, 2002, AVANCE PERSPECTIVA, V21, P67; Febles-Patron J. L., 2008, INGENIERIA, V12, P71; Ford D. C., 2007, KARST HYDROGEOLOGY G; Forrester MB, 2006, J TOXICOL ENV HEAL A, V69, P263, DOI 10.1080/15287390500227464; Franzen A, 2003, SOC SCI QUART, V84, P297, DOI 10.1111/1540-6237.8402005; Goldscheider N., 2019, AQUA MUNDI, P1, DOI [DOI 10.1007/S13146-019-00492-5, 10.4409/Am-046-12-0047]; Gorguner M, 2004, INHAL TOXICOL, V16, P87, DOI 10.1080/08958370490265004; Graniel E, 2004, ING REV ACAD, V8, P15; Habib RR, 2006, ENVIRON RES, V101, P184, DOI 10.1016/j.envres.2006.02.001; Hari AC, 2005, ENVIRON SCI TECHNOL, V39, P2592, DOI 10.1021/es048992m; Herrera-Silveira J, 2006, ECOTROPICOS, V19, P94; Huang PS, 2006, J CLEAN PROD, V14, P1635, DOI 10.1016/j.jclepro.2006.02.006; Katz BG, 2010, J ENVIRON QUAL, V39, P1181, DOI 10.2134/jeq2009.0244; Kovacs DC, 1997, J EXPO ANAL ENV EPID, V7, P505; Langford IH, 2002, RISK ANAL, V22, P101, DOI 10.1111/0272-4332.t01-1-00009; Laureano JSF, 2002, J ENVIRON QUAL, V31, P1256, DOI 10.2134/jeq2002.1256; Lemyre L, 2006, HEALTH RISK SOC, V8, P185, DOI 10.1080/13698570600677399; Leon LM, 2008, ENVIRON GEOL, V58, P275; Levett KJ, 2010, WATER SCI TECHNOL, V62, P1499, DOI 10.2166/wst.2010.434; Lim YL, 2007, CONTACT DERMATITIS, V56, P157, DOI 10.1111/j.1600-0536.2007.01032.x; Lima ML, 2005, RISK ANAL, V25, P1229, DOI 10.1111/j.1539-6924.2005.00664.x; Linacre M, 2007, WINSTEPS; Linacre M, 2012, USERS GUIDE WINSTEPS; Magana A., 2002, ING REV ACAD, V6, P61; Martinez-Pena RM, 2008, THESIS CINVESTAV UNI; McCray JE, 2005, GROUND WATER, V43, P628, DOI 10.1111/j.1745-6584.2005.0077.x; Nacional de Estadistica y Geografia Instituto INEGI, 2009, PROT INF GEOGR MUN E; Nacional de Estadistica y Geografia Instituto INEGI, 2010, INEGI CENSO POBL VIV; Ortiz J, 2000, P INT ERG ASS ANN M; Ortiz J, 2000, 14 TRIENN C INT ERG; Pacheco J., 1997, HYDROGEOL J, V5, P47, DOI [10.1007/s100400050113, DOI 10.1007/S100400050113]; Pacheco-Avila J., 2004, INGENIERIA-BOGOTA, V8, P165; Peres F, 2006, INT J OCCUP ENV HEAL, V12, P400, DOI 10.1179/oeh.2006.12.4.400; PERRY E, 1989, GEOLOGY, V17, P818, DOI 10.1130/0091-7613(1989)017<0818:GAEAOS>2.3.CO;2; Pineda-Flores G, 1999, Rev Latinoam Microbiol, V41, P251; Quintal C, 2003, EVOLUCION ESTRATEGIA, P207; Quitzau  M.-B., 2004, CHANGING IDEAS BODIL; SALGUERO CARVAJAL A, 2007, ITINERARIO POETICO M; Schmidt MR, 2006, RISK ANAL, V26, P455, DOI 10.1111/j.1539-6924.2006.00744.x; Shrikhande V., 2003, THESIS U LOUISIANA; Slimak MW, 2006, RISK ANAL, V26, P1689, DOI 10.1111/j.1539-6924.2006.00832.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; *STATACORP LP, 2007, STAT 10; Steinich B., 1996, GEOFIS INT, V35, P153; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Tilt B, 2006, HUM ORGAN, V65, P115, DOI 10.17730/humo.65.2.69dufcr1hatnpu5v; Toma L, 2007, J ENVIRON MANAGE, V83, P145, DOI 10.1016/j.jenvman.2006.02.004; Varkuti A, 2008, HYDROBIOLOGIA, V599, P249, DOI 10.1007/s10750-007-9190-2; Vaute L, 1997, J HYDROL, V199, P221, DOI 10.1016/S0022-1694(96)03245-3; Verstraeten IM, 2005, GROUND WATER MONIT R, V25, P107, DOI 10.1111/j.1745-6592.2005.0015.x; Visschers VHM, 2007, J RISK RES, V10, P371, DOI 10.1080/13669870701252463; Wakefield SEL, 2006, ENVIRON MANAGE, V37, P40, DOI 10.1007/s00267-004-0323-3; White M, 2005, EB2005003 U COL RES; Wiel-Shafran A, 2006, ECOL ENG, V26, P348, DOI 10.1016/j.ecoleng.2005.12.008; Williams A, 2007, PREV MED, V44, P520, DOI 10.1016/j.ypmed.2007.01.011; Williams H, 2012, CLIN TOXICOL, V50, P770, DOI 10.3109/15563650.2012.709936; Willis HH, 2007, RISK ANAL, V27, P1365, DOI 10.1111/j.1539-6924.2007.00958.x; Wright BD, 1999, MEASUREMENT ESSENTIA, P221; ZAHN R K, 1977, Science of the Total Environment, V8, P109, DOI 10.1016/0048-9697(77)90072-9; Zielinski-Gutierrez EC, 2006, ECOHEALTH, V3, P28, DOI 10.1007/s10393-005-0001-9; Zock JP, 2010, CURR OPIN ALLERGY CL, V10, P114, DOI 10.1097/ACI.0b013e32833733fe; Zoller U, 2006, ENVIRON INT, V32, P269, DOI 10.1016/j.envint.2005.08.023; Zota AR, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-40; Zsoka AN, 2008, J CLEAN PROD, V16, P322, DOI 10.1016/j.jclepro.2006.07.044	87	18	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74352	10.1371/journal.pone.0074352	http://dx.doi.org/10.1371/journal.pone.0074352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009770	gold, Green Published			2022-12-25	WOS:000324403200054
J	Olson, NC; Doyle, MF; Jenny, NS; Huber, SA; Psaty, BM; Kronmal, RA; Tracy, RP				Olson, Nels C.; Doyle, Margaret F.; Jenny, Nancy Swords; Huber, Sally A.; Psaty, Bruce M.; Kronmal, Richard A.; Tracy, Russell P.			Decreased Naive and Increased Memory CD4(+) T Cells Are Associated with Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE CELLS; HELICOBACTER-PYLORI; LYMPHOCYTES-T; INFLAMMATORY MARKERS; LEUKOCYTE COUNT; ARTERY PLAQUE; RISK; CALCIFICATION; STROKE	Background: Adaptive immunity has been implicated in atherosclerosis in animal models and small clinical studies. Whether chronic immune activation is associated with atherosclerosis in otherwise healthy individuals remains underexplored. We hypothesized that activation of adaptive immune responses, as reflected by higher proportions of circulating CD4(+) memory cells and lower proportions of naive cells, would be associated with subclinical atherosclerosis. Methods and Findings: We examined cross-sectional relationships of circulating CD4(+) naive and memory T cells with biomarkers of inflammation, serologies, and subclinical atherosclerosis in 912 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Circulating CD4(+) naive cells were higher in women than men and decreased with age (all p-values <0.0001). European-Americans had higher levels of naive cells and lower levels of memory cells compared with African-Americans and Hispanic-Americans (all p-values <= 0.0005). Lower naive/higher memory cells were associated with interleukin-6 levels. In multivariate models, cytomegalovirus (CMV) and H. Pylori titers were strongly associated with higher memory and lower naive cells (all p-values <0.05). Higher memory cells were associated with coronary artery calcification (CAC) level in the overall population [beta-Coefficient (95% confidence interval (CI)) =0.20 (0.03, 0.37)]. Memory and naive (inversely) cells were associated with common carotid artery intimal media thickness (CC IMT) in European-Americans [memory: beta = 0.02 (0.006, 0.04); naive: beta = -0.02 (-0.004, -0.03)]. Conclusions: These results demonstrate that the degree of chronic adaptive immune activation is associated with both CAC and CC IMT in otherwise healthy individuals, consistent with the known role of CD4(+) T cells, and with innate immunity (inflammation), in atherosclerosis. These data are also consistent with the hypothesis that immunosenescence accelerates chronic diseases by putting a greater burden on the innate immune system, and suggest the importance of prospective studies and research into strategies to modulate adaptive immune activation in chronic disease states such as atherosclerosis.	[Olson, Nels C.; Doyle, Margaret F.; Jenny, Nancy Swords; Huber, Sally A.; Tracy, Russell P.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Sci, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA; [Kronmal, Richard A.] Univ Washington, Dept Stat, Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98195 USA; [Tracy, Russell P.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Vermont	Tracy, RP (corresponding author), Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA.	Russell.Tracy@uvm.edu		Doyle, Margaret/0000-0001-6769-5386	National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95169, R01-HL-077449, R01-HL-108371]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, R01HL108371, R01HL077449] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by contracts N01-HC-95159 through N01-HC-95169 and R01-HL-077449 (to RPT) and R01-HL-108371 (to SAH) from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Ammirati E, 2010, ARTERIOSCL THROM VAS, V30, P1832, DOI 10.1161/ATVBAHA.110.206813; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Elkind MSV, 2002, STROKE, V33, P2587, DOI 10.1161/01.STR.0000034400.71491.10; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genuth S, 2003, DIABETES CARE, V26, P3160; George J, 2012, ATHEROSCLEROSIS, V222, P519, DOI 10.1016/j.atherosclerosis.2012.03.016; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; HANSSON GK, 1989, AM J PATHOL, V135, P169; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Huber SA, 2001, CIRCULATION, V103, P2610; Jenny NS, 2010, ATHEROSCLEROSIS, V209, P226, DOI 10.1016/j.atherosclerosis.2009.08.037; JONASSON L, 1985, J CLIN INVEST, V76, P125, DOI 10.1172/JCI111934; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Li CR, 2010, ATHEROSCLEROSIS, V209, P545, DOI 10.1016/j.atherosclerosis.2009.09.029; Liu ZD, 2012, ATHEROSCLEROSIS, V221, P232, DOI 10.1016/j.atherosclerosis.2011.12.026; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Mayr M, 1999, CIRCULATION, V99, P1560, DOI 10.1161/01.CIR.99.12.1560; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; Nasir K, 2005, ARTERIOSCL THROM VAS, V25, P1966, DOI 10.1161/01.ATV.0000175296.02550.e4; Nazmi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-706; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Pawelec G, 2005, AIDS, V205, p257 ; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Sakkinen PA, 1999, AM J EPIDEMIOL, V149, P261; Sasaki N, 2012, J ATHEROSCLER THROMB, V19, P503, DOI 10.5551/jat.10934; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; STEMME S, 1991, LAB INVEST, V65, P654; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tanigawa T, 2003, J CLIN IMMUNOL, V23, P469, DOI 10.1023/B:JOCI.0000010423.65719.e5; Tracy RP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000117; Usui F, 2012, BIOCHEM BIOPH RES CO, V420, P72, DOI 10.1016/j.bbrc.2012.02.117; Wigren M, 2012, ARTERIOSCL THROM VAS, V32, P2000, DOI 10.1161/ATVBAHA.112.251579; Winchester R, 2011, J IMMUNOL, V187, P1006, DOI 10.4049/jimmunol.1003521; Zhang WC, 2012, J BIOL CHEM, V287, P34157, DOI 10.1074/jbc.M112.382978; Zhou XH, 2000, CIRCULATION, V102, P2919	50	60	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71498	10.1371/journal.pone.0071498	http://dx.doi.org/10.1371/journal.pone.0071498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009662	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200010
J	Hill, SL; Phillips, T; Atkinson, A				Hill, Simeon L.; Phillips, Tony; Atkinson, Angus			Potential Climate Change Effects on the Habitat of Antarctic Krill in the Weddell Quadrant of the Southern Ocean	PLOS ONE			English	Article							EUPHAUSIA-SUPERBA; SEA-ICE; PHYTOPLANKTON COMMUNITIES; SCOTIA SEA; TEMPERATURE; GROWTH; GEORGIA; MODELS; FOOD; MARINE	Antarctic krill is a cold water species, an increasingly important fishery resource and a major prey item for many fish, birds and mammals in the Southern Ocean. The fishery and the summer foraging sites of many of these predators are concentrated between 0 degrees and 90 degrees W. Parts of this quadrant have experienced recent localised sea surface warming of up to 0.2 degrees C per decade, and projections suggest that further widespread warming of 0.27 degrees to 1.08 degrees C will occur by the late 21st century. We assessed the potential influence of this projected warming on Antarctic krill habitat with a statistical model that links growth to temperature and chlorophyll concentration. The results divide the quadrant into two zones: a band around the Antarctic Circumpolar Current in which habitat quality is particularly vulnerable to warming, and a southern area which is relatively insensitive. Our analysis suggests that the direct effects of warming could reduce the area of growth habitat by up to 20%. The reduction in growth habitat within the range of predators, such as Antarctic fur seals, that forage from breeding sites on South Georgia could be up to 55%, and the habitat's ability to support Antarctic krill biomass production within this range could be reduced by up to 68%. Sensitivity analysis suggests that the effects of a 50% change in summer chlorophyll concentration could be more significant than the direct effects of warming. A reduction in primary production could lead to further habitat degradation but, even if chlorophyll increased by 50%, projected warming would still cause some degradation of the habitat accessible to predators. While there is considerable uncertainty in these projections, they suggest that future climate change could have a significant negative effect on Antarctic krill growth habitat and, consequently, on Southern Ocean biodiversity and ecosystem services.	[Hill, Simeon L.; Phillips, Tony] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Atkinson, Angus] Plymouth Marine Lab, Plymouth, Devon, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Plymouth Marine Laboratory	Hill, SL (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	sih@bas.ac.uk	Simeon, Hill L/B-2307-2008		Natural Environment Research Council [NE/I029943/1]; Natural Environment Research Council [bas0100025, bas0100023, pml010009] Funding Source: researchfish; NERC [bas0100023, pml010009, bas0100025, NE/I029943/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SH was funded through the Natural Environment Research Council International Opportunities Fund grant NE/I029943/1. "Coordinating International Research on Southern Ocean Ecosystems: Implementation of the ICED Programme." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2006, LIMNOL OCEANOGR, V51, P973, DOI 10.4319/lo.2006.51.2.0973; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2012, CCAMLR SCI, V19, P219; Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; Atkinson A, 2001, MAR ECOL PROG SER, V216, P279, DOI 10.3354/meps216279; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Butchart S, 2012, IUCN RED LIST THREAT; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Coxeter H. S. M., 1969, INTRO GEOMETRY; DE MEESTER F., 2013, OMEGA 6 3 FATTY ACID, P267, DOI DOI 10.1007/978-1-62703-215-5_14; EVERSON I, 1992, PHILOS T ROY SOC B, V338, P311, DOI 10.1098/rstb.1992.0151; Everson I., 2000, KRILL BIOL ECOLOGY F, P194, DOI 10.1002/9780470999493; FAO (Food and Agriculture Organization), 2005, 457 FAO; Feldman GC, 2011, OCAEN COLOR WEB SEA; Feldman GC, 2012, OCEAN COLOR WEB MODI; Grant SM, 2013, ANTARCT SCI, V25, P603, DOI 10.1017/S0954102013000308; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hince Bernadette, 2000, ANTARCTIC DICT COMPL; Hofmann EE, 2003, DEEP-SEA RES PT II, V50, P3121, DOI 10.1016/j.dsr2.2003.07.012; Kawaguchi S, 2006, MAR ECOL PROG SER, V306, P1, DOI 10.3354/meps306001; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Kovacs K, 2008, IUCN RED LIST THREAT; LEE DT, 1980, INT J COMPUT INF SCI, V9, P219, DOI 10.1007/BF00977785; Mackey AP, 2012, DEEP-SEA RES PT II, V59, P130, DOI 10.1016/j.dsr2.2011.08.011; Marr J.W.S., 1962, DISCOVERY REP, VXXXII, P33; Meijers AJS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008412; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Moline MA, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001985; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; NICOL S, 1992, MAR ECOL PROG SER, V89, P175, DOI 10.3354/meps089175; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Parkinson CL, 2004, ANTARCT SCI, V16, P387, DOI 10.1017/S0954102004002214; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2012, MAR ECOL PROG SER, V470, P273, DOI 10.3354/meps10123; Press W. H., 1992, ART SCI COMPUTING; Quetin LB, 2007, ANTARCT SCI, V19, P253, DOI 10.1017/S0954102007000363; Ross RM, 2000, LIMNOL OCEANOGR, V45, P31, DOI 10.4319/lo.2000.45.1.0031; Sallee JB, 2013, J GEOPHYS RES-OCEANS, V118, P1830, DOI 10.1002/jgrc.20135; Schmidt K, 2012, DEEP-SEA RES PT II, V59, P159, DOI 10.1016/j.dsr2.2011.05.002; Siegel V, 2005, POLAR BIOL, V29, P1, DOI 10.1007/s00300-005-0058-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Staniland IJ, 2003, MAR MAMMAL SCI, V19, P331, DOI 10.1111/j.1748-7692.2003.tb01112.x; Steele M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005849; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Tarling GA, 2007, MAR ECOL PROG SER, V331, P161, DOI 10.3354/meps331161; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thorpe SE, 2007, DEEP-SEA RES PT I, V54, P792, DOI 10.1016/j.dsr.2007.01.008; Turner J, 2013, J CLIMATE, V26, P1473, DOI 10.1175/JCLI-D-12-00068.1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0152-3]; Whitehouse MJ, 1996, DEEP-SEA RES PT I, V43, P425, DOI 10.1016/0967-0637(96)00020-9; Wiedenmann J, 2008, MAR ECOL PROG SER, V358, P191, DOI 10.3354/meps07350; Xavier JC, 2003, MAR BIOL, V143, P221, DOI 10.1007/s00227-003-1049-0	60	88	90	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72246	10.1371/journal.pone.0072246	http://dx.doi.org/10.1371/journal.pone.0072246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991072	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100091
J	Sanson, M; Distel, E; Fisher, EA				Sanson, Marie; Distel, Emilie; Fisher, Edward A.			HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED CELLS; ATHEROSCLEROSIS REGRESSION; GENE-EXPRESSION; INFLAMMATORY RESPONSE; FREE-CHOLESTEROL; FOAM CELLS; STAT6; MICE; IL-4	Our lab has previously shown in a mouse model that normalization of a low HDL level achieves atherosclerotic plaque regression. This included the shift from a pro ("M1") to an anti-inflammatory ("M2") phenotypic state of plaque macrophages. Whether HDL can directly cause this phenotypic change and, if so, what the signaling mechanism is, were explored in the present studies. Murine primary macrophages treated with HDL showed increased gene expression for the M2 markers Arginase-1 (Arg-1) and Fizz-1, which are classically induced by IL-4. HDL was able to potentiate the IL-4-induced changes in Arg-1, and tended to do the same for Fizz-1, while suppressing the expression of inflammatory genes in response to IFN gamma. The effects of either IL-4 or HDL were suppressed when macrophages were from STAT6(-/-) mice, but inhibitor studies suggested differential utilization of JAK isoforms by IL-4 and HDL to activate STAT6 by phosphorylation. Overall, our results describe a new function of HDL, namely its ability to directly enrich macrophages in markers of the M2, anti-inflammatory, state in a process requiring STAT6.	[Fisher, Edward A.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA; NYU, Sch Med, Dept Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA	New York University; New York University	Fisher, EA (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA.	edward.fisher@nuymc.org	Fisher, Edward/ABE-7469-2020	Fisher, Edward/0000-0001-9802-143X	NIH [HL 098055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by NIH grant HL 098055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasanz-Puig A, 2012, BIOCHEM BIOPH RES CO, V428, P179, DOI 10.1016/j.bbrc.2012.10.037; Biswas A, 2011, EUR J IMMUNOL, V41, P992, DOI 10.1002/eji.201040940; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Choi H, 2013, J INVEST DERMATOL, V133, P528, DOI 10.1038/jid.2012.331; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Egom EE, 2013, CURR OPIN LIPIDOL, V24, P351, DOI 10.1097/MOL.0b013e328361f822; Feig JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039790; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2009, CURR OPIN INVEST DR, V10, P232; Frias MA, 2009, CARDIOVASC RES, V82, P313, DOI 10.1093/cvr/cvp024; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Hatch FT, 1968, ADV LIPID RES, V6, P1; Hewing B, 2012, CIRC RES, V111, P1117, DOI 10.1161/CIRCRESAHA.112.280958; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Liu YH, 2012, BBA-MOL CELL BIOL L, V1821, P522, DOI 10.1016/j.bbalip.2011.08.015; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Reis ED, 2001, J VASC SURG, V34, P541, DOI 10.1067/mva.2001.115963; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Sankaranarayanan S, 2010, J LIPID RES, V51, P3243, DOI 10.1194/jlr.M008441; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stutz AM, 2003, J IMMUNOL, V170, P1789, DOI 10.4049/jimmunol.170.4.1789; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Thomas AC, 2007, ARTERIOSCL THROM VAS, V27, P571, DOI 10.1161/01.ATV.0000256470.23842.94; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Williams HJ, 2012, J INNATE IMMUN, V4, P498, DOI 10.1159/000336618; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	46	63	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e74676	10.1371/journal.pone.0074676	http://dx.doi.org/10.1371/journal.pone.0074676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991225	gold, Green Submitted, Green Published			2022-12-25	WOS:000324470100135
J	Zhong, G; Bolitho, S; Grunstein, R; Naismith, SL; Lewis, SJG				Zhong, George; Bolitho, Samuel; Grunstein, Ronald; Naismith, Sharon Linda; Lewis, Simon John Geoffrey			The Relationship between Thermoregulation and REM Sleep Behaviour Disorder in Parkinson's Disease	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; SCREENING QUESTIONNAIRE; MELATONIN; DISTURBANCES; THERAPY; BODY; TEMPERATURE; RELEVANCE; PATHWAYS	Background: This study explored the relationship between symptoms of rapid eye movement sleep behaviour disorder, thermoregulation and sleep in Parkinson's Disease. Methods: The study group comprised 12 patients with Parkinson's Disease and 11 healthy age-matched controls. We investigated markers of thermoregulation (core-body temperature profile), circadian rhythm (locomotor actigraphy) and sleep (polysomnography). Results: The mesor (the mean value around which the core temperature rhythm oscillates) of the core-body temperature in patients with Parkinson's Disease was significantly lower than that of controls. In addition, the nocturnal fall in CBT (the difference between the mesor and the nadir temperature) was also significantly reduced in PD patients relative to controls. Furthermore, in patients the reduction in the amplitude of their core-body temperature profile was strongly correlated with the severity of self-reported rapid eye movement sleep behaviour disorder symptom, reduction in the percentage of REM sleep and prolonged sleep latency. By contrast, these disturbances of thermoregulation and sleep architecture were not found in controls and were not related to other markers of circadian rhythm or times of sleep onset and offset. Conclusions: These findings suggest that the brainstem pathology associated with disruption of thermoregulation in Parkinson's disease may also contribute to rapid eye movement sleep behavioural disorder. It is possible that detailed analysis of the core-body temperature profile in at risk populations such as those patients with idiopathic rapid eye movement sleep behaviour disorder might help identify those who are at high risk of transitioning to Parkinson's Disease.	[Zhong, George; Bolitho, Samuel; Naismith, Sharon Linda; Lewis, Simon John Geoffrey] Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Res Clin, Sydney, NSW 2006, Australia; [Grunstein, Ronald] Univ Sydney, Woolcock Inst Med Res, Sleep & Circadian Res Grp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Lewis, SJG (corresponding author), Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Res Clin, Sydney, NSW 2006, Australia.	simonl@med.usyd.edu.au	Lewis, Simon/R-9469-2016	Lewis, Simon/0000-0002-4093-7071; Naismith, Sharon/0000-0001-9076-2778; Zhong, George/0000-0003-0286-4606	NHMRC [632689]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project is supported by an NHMRC Project Grant No. 632689 (Website: nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; ASAMI T, 1988, BRAIN RES BULL, V20, P581, DOI 10.1016/0361-9230(88)90217-1; Beck A.T., 1996, PSYCHOL ASSESS, DOI DOI 10.1037/T00742-000; Bodis-Wollner I, 2005, PARKINSONS DIS NONMO, P159; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Boeve BF, 2003, SLEEP MED, V4, P281, DOI 10.1016/S1389-9457(03)00072-8; Bordet R, 2003, CLIN NEUROPHARMACOL, V26, P65, DOI 10.1097/00002826-200303000-00005; Braak H, 2009, ADV ANAT EMBRYOL CEL, V201, P1; BRUCK K, 1980, J PHYSIOL-LONDON, V304, P193; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chesson AL, 1997, SLEEP, V20, P406; Comella CL, 1998, NEUROLOGY, V51, P526, DOI 10.1212/WNL.51.2.526; Comella CL, 2007, MOVEMENT DISORD, V22, pS367, DOI 10.1002/mds.21682; De Cock VC, 2008, NAT CLIN PRACT NEURO, V4, P254, DOI 10.1038/ncpneuro0775; DEPAULO JR, 1978, ANN NEUROL, V4, P225, DOI 10.1002/ana.410040306; Fronczek R, 2007, BRAIN, V130, P1577, DOI 10.1093/brain/awm090; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; Garcia-Borreguero D, 2003, SLEEP MED REV, V7, P115, DOI 10.1053/smrv.2002.0229; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Gunn DG, 2010, J GERIATR PSYCHIAT N; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kales Rechtschaffen, 1968, MANUAL STANDARDIZED; Katzenschlager R, 2005, MOVEMENT DISORD, V20, P151, DOI 10.1002/mds.20276; Kunz D, 1999, MOVEMENT DISORD, V14, P507, DOI 10.1002/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8; LANGSTON JW, 1978, ANN NEUROL, V3, P129, DOI 10.1002/ana.410030207; Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Naismith SL, 2010, CLIN NEUROL NEUROSUR, V112, P420, DOI 10.1016/j.clineuro.2010.02.011; Naismith SL, 2010, J GERIATR PSYCHIAT N; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nomura T, 2011, SLEEP MED, V12, P711, DOI 10.1016/j.sleep.2011.01.015; Olson EJ, 2000, BRAIN, V123, P331, DOI 10.1093/brain/123.2.331; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Pierangeli G, 2001, MOVEMENT DISORD, V16, P226, DOI 10.1002/mds.1039; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Suzuki K, 2007, NEUROPSYCHOBIOLOGY, V56, P172, DOI 10.1159/000119735; Takeuchi N, 2001, PSYCHIAT CLIN NEUROS, V55, P267, DOI 10.1046/j.1440-1819.2001.00854.x; WEBB WB, 1982, SLEEP, V5, P195, DOI 10.1093/sleep/5.2.195; Wolkove N, 2007, CAN MED ASSOC J, V176, P1299, DOI 10.1503/cmaj.060792; Zhong G, 2011, J NEUROL SCI; Zhong G, 2011, J NEUROL SCI, V307, P9, DOI 10.1016/j.jns.2011.04.020	45	35	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72661	10.1371/journal.pone.0072661	http://dx.doi.org/10.1371/journal.pone.0072661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991135	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100111
J	Peel, JS; Stein, M; Kristensen, RM				Peel, John S.; Stein, Martin; Kristensen, Reinhardt Mobjerg			Life Cycle and Morphology of a Cambrian Stem-Lineage Loriciferan	PLOS ONE			English	Article							SIRIUS PASSET LAGERSTATTE; NORTH GREENLAND; ARTHROPOD; PHYLUM; LARVA; PLICILORICIDAE; NANALORICIDAE; PHYLOGENY; AFFINITY; ANATOMY	Cycloneuralians form a rich and diverse element within Cambrian assemblages of exceptionally preserved fossils. Most resemble priapulid worms whereas other Cycloneuralia (Nematoda, Nematomorpha, Kinorhyncha, Loricifera), well known at the present day, have little or no fossil record. First reports of Sirilorica Peel, 2010 from the lower Cambrian Sirius Passet fauna of North Greenland described a tubular lorica covering the abdomen and part of a well developed introvert with a circlet of 6 grasping denticles near the lorica. The introvert is now known to terminate in a narrow mouth tube, while a conical anal field is also developed. Broad muscular bands between the plates in the lorica indicate that it was capable of movement by rhythmic expansion and contraction of the lorica. Sirilorica is regarded as a macrobenthic member of the stem-lineage of the miniaturised, interstitial, present day Loricifera. Like loriciferans, Sirilorica is now known to have grown by moulting. Evidence of the life cycle of Sirilorica is described, including a large post-larval stage and probably an initial larva similar to that of the middle Cambrian fossil Orstenoloricus shergoldii.	[Peel, John S.] Uppsala Univ, Dept Earth Sci Palaeobiol, Uppsala, Sweden; [Stein, Martin; Kristensen, Reinhardt Mobjerg] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	Uppsala University; University of Copenhagen	Peel, JS (corresponding author), Uppsala Univ, Dept Earth Sci Palaeobiol, Uppsala, Sweden.	john.peel@pal.uu.se	Kristensen, Reinhardt M/A-8772-2013	Kristensen, Reinhardt M/0000-0001-9549-1188; Stein, Martin/0000-0002-8218-8232	Swedish Research Council [621 2008-3446 (80344601)]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was funded by Swedish Research Council, www.vr.se, grant no. 621 2008-3446 (80344601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang-Berthelsen I.H., 2013, HDB ZOOLOGY GASTROTR, V1 1, P307; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 2011, J SYST PALAEONTOL, V9, P217, DOI 10.1080/14772019.2010.492644; Chen JY, 2012, EARTH LIFE, P239, DOI DOI 10.1007/978-90-481-3428-1_10; Conway Morris S, 1977, SP PAP PALAEONTOL, V20, P95; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Dong XP, 2010, PALAEONTOLOGY, V53, P1291, DOI 10.1111/j.1475-4983.2010.01006.x; Dong XP, 2005, EVOL DEV, V7, P468, DOI 10.1111/j.1525-142X.2005.05050.x; Gad G, 2005, ORG DIVERS EVOL, V5, P59, DOI 10.1016/j.ode.2004.10.005; Gad G, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2096.1.6; Harvey THP, 2010, EVOL DEV, V12, P177, DOI 10.1111/j.1525-142X.2010.00403.x; Heiner I, 2008, SYST BIODIVERS, V6, P225, DOI 10.1017/S147720000800265X; Heiner I, 2009, J MORPHOL, V270, P129, DOI 10.1002/jmor.10671; Higgins RP, 1986, SMITHSON CONTR ZOOL, V438, P1, DOI [10.5479/si.00810282.438, DOI 10.5479/SI.00810282.438]; Hou X. -G., 1999, CHENGJIANG FAUNA EXC; Hou XG, 2004, CAMBRIAN FOSSILS CHE, P233; Huang DY, 2004, GEOBIOS-LYON, V37, P217, DOI 10.1016/j.geobios.2003.04.004; Ineson JR, 2011, CAN J EARTH SCI, V48, P1259, DOI 10.1139/E11-018; Janssen R, 2009, INVERTEBR BIOL, V128, P1; Janssen R, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-8; Kristensen R.M., 1991, P351; Kristensen Reinhardt M., 2002, P179; Kristensen RM, 2007, INVERTEBR BIOL, V126, P120, DOI 10.1111/j.1744-7410.2007.00083.x; KRISTENSEN RM, 1983, Z ZOOL SYST EVOL, V21, P163; Kristensen RM, 2004, CAH BIOL MAR, V45, P121; KRISTENSEN RM, 1988, ZOOL SCI, V5, P875; Kristensen RM, 2002, INTEGR COMP BIOL, V42, P641, DOI 10.1093/icb/42.3.641; Kristensen RM, 1991, VERH DTSCH ZOOL GES, V84, P231; Lemburg Christian, 1995, Microfauna Marina, V10, P7; LUO H., 1999, EARLY CAMBRIAN CHENG; Maas A, 2007, MEM ASS AUSTR PALAEO, P499; Maas A, 2007, PALAEOGEOGR PALAEOCL, V254, P288, DOI 10.1016/j.palaeo.2007.03.019; Maas A, 2013, HBK ZOOL, P11; Maas A, 2009, MEM ASSOC AUSTRALAS, V37, P281; Mangano MG, 2012, GEOLOGY, V40, P519, DOI 10.1130/G32853.1; MORRIS SC, 1979, ANNU REV ECOL SYST, V10, P327, DOI 10.1146/annurev.es.10.110179.001551; Morris SC, 2008, ACTA PALAEONTOL POL, V53, P135; NEUHAUS B, 2013, HDB ZOOLOGY GASTROTR, V1, P181, DOI DOI 10.1515/9783110272536.1; Neves RC, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-19; Pardos F, 2013, HELGOLAND MAR RES, V67, P623, DOI 10.1007/s10152-013-0349-0; Park JK, 2006, ZOOL SCI, V23, P943, DOI 10.2108/zsj.23.943; Peel John S., 2011, Palaeontographica Canadiana, V31, P109; Peel JS, 2011, B GEOSCI, V86, P535, DOI 10.3140/bull.geosci.1269; Peel JS, 2010, B GEOSCI, V85, P385, DOI 10.3140/bull.geosci.1207; Peel JS, 2010, J PALEONTOL, V84, P332, DOI 10.1666/09-102R.1; Shirley Thomas, 2002, P189; Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x; Sorensen MV, 2000, MEDDR GRONLAND BIOSC, V51, P49; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Valkov A.K., 1983, POZDNIJ DOKEMBRIJ RA, P37; van der Land J., 1985, Systematics Association Special Volume Series, P261; Wills MA, 1998, PALEOBIOLOGY, V24, P177; Zhao Y.L., 2011, KAILI BIOTA MARINE O; Zhuravlev Andrey Yu., 2011, Palaeontographica Canadiana, V31, P177	54	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73583	10.1371/journal.pone.0073583	http://dx.doi.org/10.1371/journal.pone.0073583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23991198	Green Published, gold, Green Submitted			2022-12-25	WOS:000326473200096
J	Bunce, MW; Bos, MHA; Krishnaswamy, S; Camire, RM				Bunce, Matthew W.; Bos, Mettine H. A.; Krishnaswamy, Sriram; Camire, Rodney M.			Restoring the Procofactor State of Factor Va-like Variants by Complementation with B-domain Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Coagulation Factors; Enzyme Mechanisms; Hemostasis; Protein Engineering; Recombinant Protein Expression; Autoinhibition; Factor V; Factor Va; Prothrombinase	FACTOR PATHWAY INHIBITOR; COAGULATION-FACTOR-V; FACTOR XA-BINDING; BOVINE FACTOR-V; THROMBIN-CATALYZED ACTIVATION; CLOTTING FACTOR-V; ELECTRON-MICROSCOPY; BLOOD-COAGULATION; COFACTOR FUNCTION; PROTHROMBINASE COMPLEX	Background: B-domain fragments of factor V (FV) were used to assess the mechanism by which it is maintained as a procofactor. Results: A basic region fragment binds to FV containing an intact acidic region and inhibits FXa binding. Conclusion: B-domain sequences function as cis- and trans-acting elements to suppress FV(a) procoagulant function. Significance: The results provide mechanistic insight into FV autoinhibition and activation. Coagulation factor V (FV) circulates as an inactive procofactor and is activated to FVa by proteolytic removal of a large inhibitory B-domain. Conserved basic and acidic sequences within the B-domain appear to play an important role in keeping FV as an inactive procofactor. Here, we utilized recombinant B-domain fragments to elucidate the mechanism of this FV autoinhibition. We show that a fragment encoding the basic region (BR) of the B-domain binds with high affinity to cofactor-like FV(a) variants that harbor an intact acidic region. Furthermore, the BR inhibits procoagulant function of the variants, thereby restoring the procofactor state. The BR competes with FXa for binding to FV(a), and limited proteolysis of the B-domain, specifically at Arg(1545), ablates BR binding to promote high affinity association between FVa and FXa. These results provide new insight into the mechanism by which the B-domain stabilizes FV as an inactive procofactor and reveal how limited proteolysis of FV progressively destabilizes key regulatory regions of the B-domain to produce an active form of the molecule.	[Bunce, Matthew W.; Bos, Mettine H. A.; Krishnaswamy, Sriram; Camire, Rodney M.] Univ Penn, Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram; Camire, Rodney M.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Colket Translat Res Ctr 5018, 3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Bos, Mettine/S-5317-2016; Krishnaswamy, Sriram/Z-4380-2019	Bos, Mettine/0000-0002-8164-817X; 	National Institutes of Health [R01 HL88010, P01 HL74124]; NHLBI [T32 HL-07439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL108933, T32HL007439, R01HL088010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL88010 and P01 HL74124 (Project 2; to R. M. C.) and Grant T32 HL-07439 from NHLBI (to M. W. B.).	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington P. R., 1992, DATA REDUCTION ERROR, P141; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; DENNIS S, 1990, EUR J BIOCHEM, V188, P61, DOI 10.1111/j.1432-1033.1990.tb15371.x; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; ESMON CT, 1979, J BIOL CHEM, V254, P964; ESMON CT, 1973, BIOCHIM BIOPHYS ACTA, V310, P289, DOI 10.1016/0005-2795(73)90034-2; FOSTER WB, 1983, J BIOL CHEM, V258, P3970; FOWLER WE, 1990, P NATL ACAD SCI USA, V87, P7648, DOI 10.1073/pnas.87.19.7648; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KANE WH, 1981, J BIOL CHEM, V256, P1002; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Khan AR, 1998, PROTEIN SCI, V7, P815; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAMPE PD, 1984, J BIOL CHEM, V259, P9959; LAUE TM, 1984, BIOCHEMISTRY-US, V23, P1339, DOI 10.1021/bi00302a001; Mann K G, 1976, Methods Enzymol, V45, P123; MANN KG, 1981, METHOD ENZYMOL, V80, P286; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1990, BLOOD, V76, P1; Maroney SA, 2007, BLOOD, V109, P1931, DOI 10.1182/blood-2006-07-037283; Mast AE, 1996, BLOOD, V87, P1845; Mast Alan E, 2011, Front Biosci (Schol Ed), V3, P1457; MOSESSON MW, 1985, BLOOD, V65, P1158; MOSESSON MW, 1990, J BIOL CHEM, V265, P8863; Ndonwi M, 2012, J THROMB HAEMOST, V10, P1944, DOI 10.1111/j.1538-7836.2012.04834.x; NESHEIM ME, 1979, J BIOL CHEM, V254, P508; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NOVOTNY WF, 1988, BLOOD, V72, P2020; OTTO A, 1991, EUR J BIOCHEM, V202, P67, DOI 10.1111/j.1432-1033.1991.tb16345.x; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; Siigur J, 2001, HAEMOSTASIS, V31, P123; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Steen M, 2008, J BIOL CHEM, V283, P20805, DOI 10.1074/jbc.M802703200; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Thorelli E, 1998, THROMB HAEMOSTASIS, V80, P92, DOI 10.1055/s-0037-1615145; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; Yun TH, 2009, J CELL MOL MED, V13, P4146, DOI 10.1111/j.1582-4934.2009.00884.x; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	68	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30151	30160		10.1074/jbc.M113.506840	http://dx.doi.org/10.1074/jbc.M113.506840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014022	Green Published, hybrid			2022-12-25	WOS:000329868100015
J	Dave, JM; Kang, HJ; Abbey, CA; Maxwell, SA; Bayless, KJ				Dave, Jui M.; Kang, Hojin; Abbey, Colette A.; Maxwell, Steve A.; Bayless, Kayla J.			Proteomic Profiling of Endothelial Invasion Revealed Receptor for Activated C Kinase 1 (RACK1) Complexed with Vimentin to Regulate Focal Adhesion Kinase (FAK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Collagen; Endothelial Cell; Focal Adhesion Kinase; Morphogenesis; RACK1; Vimentin	SCAFFOLDING PROTEIN; INTERMEDIATE-FILAMENTS; CONDITIONAL KNOCKOUT; EXTRACELLULAR-MATRIX; INTERACTING PROTEIN; MEDIATED REGULATION; LUMEN FORMATION; AKT ACTIVATION; CELL-MIGRATION; IN-VITRO	Angiogenesis is critical for many physiological and pathological processes. To identify molecules relevant to angiogenesis, we performed a proteomic screen comparing invading versus non-invading endothelial cells in three-dimensional collagen matrices. We found up-regulated levels of receptor for activated C kinase 1 (RACK1) and the intermediate filament protein vimentin that correlated with increased endothelial cell invasion. Because both RACK1 and vimentin have been linked to focal adhesion kinase (FAK), we investigated whether this pathway regulated invasion. RACK1 depletion reduced invasion responses, and this was associated with attenuated activation of FAK. Knockdown of vimentin significantly decreased levels of phosphorylated and total FAK. Treatment with a pharmacological inhibitor of FAK dose-dependently reduced invasion, indicating a crucial role for FAK activity during invasion. Because RACK1 and vimentin were both up-regulated with sphingosine 1-phosphate treatment, required for invasion, and regulated FAK, we tested whether they complexed together. RACK1 complexed with vimentin, and growth factors enhanced this interaction. In addition, RACK1, vimentin, and FAK formed an intermolecular complex in invading endothelial cultures in three dimensions in response to stimulation by sphingosine 1-phosphate and growth factors. Moreover, depletion of RACK1 decreased the association of vimentin and FAK, suggesting that RACK1 was required for stabilizing vimentin-FAK interactions during sprouting. Silencing of vimentin and RACK1 decreased cell adhesion and focal contact formation. Taken together, these results demonstrate that proangiogenic signals converge to enhance expression and association of RACK1 and vimentin, which regulated FAK, resulting in successful endothelial sprout formation in three-dimensional collagen matrices.	[Dave, Jui M.; Kang, Hojin; Abbey, Colette A.; Maxwell, Steve A.; Bayless, Kayla J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bayless, KJ (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, 440 Reynolds Med Bldg, College Stn, TX 77843 USA.	kbayless@medicine.tamhsc.edu		Dave, Jui/0000-0002-5448-4798	National Institutes of Health, Public Health Service from NHLBI [HL-095786]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095786] Funding Source: NIH RePORTER	National Institutes of Health, Public Health Service from NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-095786, a Public Health Service grant from the NHLBI (to K. J. B.).	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Al-Reefy S, 2010, BREAST CANCER RES TR, V123, P911, DOI 10.1007/s10549-010-1020-y; Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 1997, PROTEIN EXPRES PURIF, V9, P309, DOI 10.1006/prep.1996.0699; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; BERSHADSKY AD, 1987, CELL MOTIL CYTOSKEL, V8, P274, DOI 10.1002/cm.970080308; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cao XX, 2010, BREAST CANCER RES TR, V123, P375, DOI 10.1007/s10549-009-0657-x; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Guo JJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-108; Hakim ZS, 2007, MOL CELL BIOL, V27, P5352, DOI 10.1128/MCB.00068-07; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Ili D, 1995, NATURE, V377, P539, DOI 10.1038/377539a07566154; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Koehler JA, 2001, BIOCHEM BIOPH RES CO, V283, P888, DOI 10.1006/bbrc.2001.4889; Kwak HI, 2012, ANGIOGENESIS, V15, P287, DOI 10.1007/s10456-012-9262-4; Lee HS, 2002, OSTEOARTHR CARTILAGE, V10, P890, DOI 10.1053/joca.2002.0842; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Martin GM, 1996, JPN J CANC RES, P87; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Montesano R, 1992, EXS, V61, P129; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nicosia RF, 1999, INT REV CYTOL, V185, P1; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Rigas AC, 2003, J BIOL CHEM, V278, P46087, DOI 10.1074/jbc.M306219200; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Serrels A, 2011, CELL ADHES MIGR, V5, P360, DOI 10.4161/cam.5.4.17290; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Singh S, 2003, CANCER RES, V63, P2306; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Usacheva A, 2003, J IMMUNOL, V171, P2989, DOI 10.4049/jimmunol.171.6.2989; VERNON RB, 1995, AM J PATHOL, V147, P873; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002	73	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30720	30733		10.1074/jbc.M113.512467	http://dx.doi.org/10.1074/jbc.M113.512467			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005669	Green Published, hybrid			2022-12-25	WOS:000329868100072
J	Macdonald-Obermann, JL; Adak, S; Landgraf, R; Piwnica-Worms, D; Pike, LJ				Macdonald-Obermann, Jennifer L.; Adak, Sangeeta; Landgraf, Ralf; Piwnica-Worms, David; Pike, Linda J.			Dynamic Analysis of the Epidermal Growth Factor (EGF) Receptor-ErbB2-ErbB3 Protein Network by Luciferase Fragment Complementation Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Epidermal Growth Factor (EGF); Epidermal Growth Factor Receptor (EGFR); Growth Factors; Receptor Tyrosine Kinase; ErbB2; ErbB3	FACTOR RECEPTOR EGFR; KINASE DOMAIN; BREAST-CANCER; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; DIMER FORMATION; ERBB RECEPTORS; ACTIVATION; DIMERIZATION	Background: The EGF receptor, ErbB2, and ErbB3 can interact to form dimers. Results: Analyses of these interactions show that ErbB3 interacts strongly with ErbB2 but weakly with the EGF receptor. All ErbB receptor interactions are enhanced by erlotinib and lapatinib. Conclusion: ErbB3 binds and is functionally affected by tyrosine kinase inhibitors. Significance: Tyrosine kinase inhibitors restructure the network of ErbB interactions. ErbB3 is a member of the ErbB family of receptor tyrosine kinases. It is unique because it is the only member of the family whose kinase domain is defective. As a result, it is obliged to form heterodimers with other ErbB receptors to signal. In this study, we characterized the interaction of ErbB3 with the EGF receptor and ErbB2 and assessed the effects of Food and Drug Administration-approved therapeutic agents on these interactions. Our findings support the concept that ErbB3 exists in preformed clusters that can be dissociated by NRG-1 and that it interacts with other ErbB receptors in a distinctly hierarchical fashion. Our study also shows that all pairings of the EGF receptor, ErbB2, and ErbB3 form ligand-independent dimers/oligomers. The small-molecule tyrosine kinase inhibitors erlotinib and lapatinib differentially enhance the dimerization of the various ErbB receptor pairings, with the EGFR/ErbB3 heterodimer being particularly sensitive to the effects of erlotinib. The data suggest that the physiological effects of these drugs may involve not only inhibition of tyrosine kinase activity but also a dynamic restructuring of the entire network of receptors.	[Macdonald-Obermann, Jennifer L.; Adak, Sangeeta; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Bridging Res Imaging Genom & High Throughput Tech, St Louis, MO 63110 USA; [Landgraf, Ralf] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Miami	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu		ADAK, SANGEETA/0000-0003-3855-9099	National Institutes of Health [R01GM082824, P50 CA94056]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM082824 (to L. J. P.) and P50 CA94056 (to D. P. W.).	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Blakely BT, 2000, NAT BIOTECHNOL, V18, P218, DOI 10.1038/72686; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Carter P, 2000, Breast Dis, V11, P103; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Graham J, 2004, NAT REV DRUG DISCOV, V3, P549, DOI 10.1038/nrd1445; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kani K, 2005, J BIOL CHEM, V280, P8238, DOI 10.1074/jbc.M410944200; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Landgraf R, 2000, BIOCHEMISTRY-US, V39, P8503, DOI 10.1021/bi000953+; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Li Y, 2012, J BIOL CHEM, V287, P31116, DOI 10.1074/jbc.M112.373647; Lichtner RB, 2001, CANCER RES, V61, P5790; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Park E, 2008, BIOCHEMISTRY-US, V47, P11992, DOI 10.1021/bi8004208; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang KS, 2010, J BIOL CHEM, V285, P24014, DOI 10.1074/jbc.M110.103317; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30773	30784		10.1074/jbc.M113.489534	http://dx.doi.org/10.1074/jbc.M113.489534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014028	Green Published, hybrid			2022-12-25	WOS:000329868100077
J	Wang, F; Xu, ZW; Zhou, J; Lo, WS; Lau, CF; Nangle, LA; Yang, XL; Zhang, MJ; Schimmel, P				Wang, Feng; Xu, Zhiwen; Zhou, Jie; Lo, Wing-Sze; Lau, Ching-Fun; Nangle, Leslie A.; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul			Regulated Capture by Exosomes of mRNAs for Cytoplasmic tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSLATION; CELLS; MICRORNAS; MECHANISM; PATHWAY; COMPLEX	Although tRNA synthetases are enzymes that catalyze the first step of translation in the cytoplasm, surprising functions unrelated to translation have been reported. These studies, and the demonstration of novel activities of splice variants, suggest a far broader reach of tRNA synthetases into cell biology than previously recognized. Here we show that mRNAs for most tRNA synthetases can be detected in exosomes. Also detected in exosomes was an mRNA encoding a unique splice variant that others had associated with prostate cancer. The exosomal mRNAs encoding the native synthetase and its cancer-associated splice variant could be translated in vitro and in mammalian cells into stable proteins. Other results showed that selection by exosomes of the splice variant mRNA could be regulated by an external stimulus. Thus, a broad and diverse regulated pool of tRNA synthetase-derived mRNAs is packaged for genetic exchange.	[Wang, Feng; Xu, Zhiwen; Zhou, Jie; Lo, Wing-Sze; Zhang, Mingjie; Schimmel, Paul] HKUST, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] HKUST, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wang, Feng; Xu, Zhiwen; Zhou, Jie; Lo, Wing-Sze; Lau, Ching-Fun] Pangu Biopharma, Hong Kong, Hong Kong, Peoples R China; [Nangle, Leslie A.] aTyr Pharma, San Diego, CA 92121 USA; [Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, La Jolla, CA 92037 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Scripps Research Institute	Schimmel, P (corresponding author), HKUST, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; Lo, Cario Wing Sze/DGZ-8810-2022	Zhang, Mingjie/0000-0001-9404-0190; Yang, Xiang-Lei/0000-0003-2554-084X	Innovation and Technology Fund of Hong Kong [UIM181, UIM192, UIM199]; NCI [CA092577]; National Institutes of Health [GM 088278]; aTyr Pharma; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	Innovation and Technology Fund of Hong Kong; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); aTyr Pharma; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Innovation and Technology Fund of Hong Kong (UIM181, UIM192, and UIM199), Grant CA092577 from the NCI (to P. S.) and Grant GM 088278 from the National Institutes of Health (to Y.-X.L.), aTyr Pharma, and by a fellowship from the National Foundation for Cancer Research. Professors Mingjie Zhang, Xiang-Lei Yang, and Paul Schimmel have a financial benefit from aTyr Pharma in the form of compensation or stock ownership or both. The partial support of this work by aTyr Pharma is stated in this footnote. The rest of the authors have affiliations that are annotated, and these affiliations include aTyr Pharma and Pangu Biopharma.	Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; King RW, 1997, SCIENCE, V277, P973, DOI 10.1126/science.277.5328.973; LEDBETTER JA, 1987, MOL CELL BIOL, V7, P650, DOI 10.1128/MCB.7.2.650; Leygue Etienne, 2007, Nucl Recept Signal, V5, pe006; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	33	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29223	29228		10.1074/jbc.C113.490599	http://dx.doi.org/10.1074/jbc.C113.490599			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003230	Green Published, hybrid			2022-12-25	WOS:000330615300001
J	Cabiati, M; Raucci, S; Liistro, T; Belcastro, E; Prescimone, T; Caselli, C; Matteucci, M; Iozzo, P; Mattii, L; Giannessi, D; Del Ry, S				Cabiati, Manuela; Raucci, Serena; Liistro, Tiziana; Belcastro, Eugenia; Prescimone, Tommaso; Caselli, Chiara; Matteucci, Marco; Iozzo, Patricia; Mattii, Letizia; Giannessi, Daniela; Del Ry, Silvia			Impact of Obesity on the Expression Profile of Natriuretic Peptide System in a Rat Experimental Model	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; NECROSIS-FACTOR-ALPHA; RECEPTOR NPR-B; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; INTERLEUKIN-6; HYPERTENSION; DYSFUNCTION; ENDOCRINE; ORGAN	Natriuretic peptides (NPs) play an important role in obesity and aim of this study was to evaluate, in cardiac tissue of obese Zucker rats (O, n = 29) their transcriptomic profile compared to controls (CO, n = 24) by Real-Time PCR study; CNP protein expression was evaluated by immunostaining and immunometric tests. Myocardial histology was performed, confirming no alteration of organ structure. While ANP and BNP are cardiac peptides, CNP is mainly an endothelial hormone; thus its expression, as well as that of NPR-B and NPR-C, was also evaluated in kidney and lung of an animal subgroup (n = 20). In heart, lower BNP mRNA levels in O vs CO (p = 0.02) as well as ANP and CNP (p = ns), were detected. NPR-B/NPR-A mRNA was similar in O and CO, while NPR-C was numerically lower (p = ns) in O than in CO. In kidney, CNP/NPR-B/NPR-C mRNA was similar in O and CO, while in lung CNP/NPR-C expression decreased and NPR-B increased (p = ns) in O vs CO. Subdividing into fasting and hyperglycemic rats, the pattern of mRNA expression for each gene analyzed remained unchanged. The trend observed in heart, kidney and lung for CNP protein concentrations and immunohistochemistry reflected the mRNA expression. TNF-alpha and IL-6 mRNA were measured in each tissue and no significant genotype effect was detected in any tissue. The main NP variations were observed at the cardiac level, suggesting a reduced release by cardiac cells. The understanding of mechanisms involved in the modulation of the NP system in obesity could be a useful starting point for future clinical study devoted to identifying new obesity treatment strategies.	[Cabiati, Manuela; Raucci, Serena; Belcastro, Eugenia; Prescimone, Tommaso; Caselli, Chiara; Iozzo, Patricia; Giannessi, Daniela; Del Ry, Silvia] CNR Inst Clin Physiol, Pisa, Italy; [Liistro, Tiziana] Scuola Super Sant Anna, Pisa, Italy; [Matteucci, Marco] Scuola Super Sant Anna, Inst Life Sci, Lab Med Sci, Pisa, Italy; [Mattii, Letizia] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embryol, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; Scuola Superiore Sant'Anna; University of Pisa	Del Ry, S (corresponding author), CNR Inst Clin Physiol, Pisa, Italy.	delry@ifc.cnr.it	Caselli, Chiara/AAN-6227-2021; Mattii, Letizia/AAZ-4735-2021; Iozzo, P/O-2893-2015; MATTII, LETIZIA/B-6123-2018; BELCASTRO, EUGENIA/ABE-6125-2020; Caselli, Chiara/I-7922-2014; Cabiati, Manuela/K-1306-2014; Del Ry, Silvia/C-1149-2015; mattii, letizia/K-3023-2019; MATTEUCCI, MARCO/G-3566-2014	Caselli, Chiara/0000-0001-6705-2460; Iozzo, P/0000-0001-6443-7074; MATTII, LETIZIA/0000-0001-6835-7987; Cabiati, Manuela/0000-0002-0811-6257; Del Ry, Silvia/0000-0001-7163-245X; MATTEUCCI, MARCO/0000-0002-7224-2522; BELCASTRO, EUGENIA/0000-0002-8154-3730; Prescimone, Tommaso/0000-0002-2733-7514	Regione Toscana (Tuscany Region) under the Research Call "Innovation in Medicine" [B55E09000560002]	Regione Toscana (Tuscany Region) under the Research Call "Innovation in Medicine"(Regione Toscana)	This study was conducted within the context of the project entitled "Early diagnosis of organ metabolic and inflammatory damage related with cancer and cardio-metabolic risk in childhood obesity. Validation of panel-oriented biomarkers in obese animals and implementation in children and adolescents'' (Unique Project Code B55E09000560002), supported by the Regione Toscana (Tuscany Region) under the Research Call "Innovation in Medicine 2009''. The funders had no role in study design, data collection and analysis or preparation of the manuscript. They accepted to publish it.	Abassi Z, 2004, PHARMACOL THERAPEUT, V102, P223, DOI 10.1016/j.pharmthera.2004.04.004; Ahn Min Soo, 2010, Korean Circ J, V40, P550, DOI 10.4070/kcj.2010.40.11.550; Antic Vladan, 2003, Heart Lung Circ, V12, P84; Barr CS, 1996, PEPTIDES, V17, P1243, DOI 10.1016/S0196-9781(96)00110-6; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bayes-Genis A, 2008, AM J CARDIOL, V101, p89A, DOI 10.1016/j.amjcard.2007.11.030; BRAY GA, 1977, FED PROC, V36, P148; Cabiati M, 2012, J MOL ENDOCRINOL, V48, P251, DOI 10.1530/JME-12-0024; Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Cozzi Jean, 2009, Methods Mol Biol, V561, P73, DOI 10.1007/978-1-60327-019-9_5; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Del Ry S, 2011, PEPTIDES, V32, P1713, DOI 10.1016/j.peptides.2011.06.014; Del Ry S, 2009, PEPTIDES, V30, P1710, DOI 10.1016/j.peptides.2009.06.013; Del Ry S, 2008, PEPTIDES, V29, P2208, DOI 10.1016/j.peptides.2008.09.005; Dessi-Fulgheri P, 2003, NUTR METAB CARDIOVAS, V13, P244, DOI 10.1016/S0939-4753(03)80018-2; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eckel RH, 2006, DIABETES CARE, V29, P1697, DOI 10.2337/dc06-9911; Einhorn Daniel, 2003, Endocr Pract, V9, P237; Frisbee JC, 2005, MICROCIRCULATION, V12, P383, DOI 10.1080/10739680590960241; Frisbee JC, 2006, ESSAYS BIOCHEM, V42, P145, DOI 10.1042/bse0420145; Funahashi T, 2007, ANN MED, V39, P482, DOI 10.1080/07853890701491026; Gardner DG, 2003, TRENDS ENDOCRIN MET, V14, P411, DOI 10.1016/S1043-2760(03)00113-9; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guiducci L, 2011, NUTR METAB CARDIOVAS, V21, P726, DOI 10.1016/j.numecd.2010.11.006; Horwich TB, 2006, J AM COLL CARDIOL, V47, P85, DOI 10.1016/j.jacc.2005.08.050; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Johnson FK, 2006, AM J PHYSIOL-REG I, V290, pR601, DOI 10.1152/ajpregu.00308.2005; Kalra PR, 2002, INT J CARDIOL, V85, P125, DOI 10.1016/S0167-5273(02)00241-3; Katafuchi T, 2010, PEPTIDES, V31, P1906, DOI 10.1016/j.peptides.2010.06.025; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuchta Kenneth F, 2005, Anesthesiol Clin North Am, V23, P421, DOI 10.1016/j.atc.2005.03.004; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; Levin ER, 1998, NEW ENGL J MED, V339, P321; LICATA G, 1994, HYPERTENSION, V23, pI20, DOI 10.1161/01.HYP.23.1_Suppl.I20; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maccio A, 2009, OBES REV, V10, P660, DOI 10.1111/j.1467-789X.2009.00592.x; Maisel Alan, 2008, Congest Heart Fail, V14, P4; Martin LF, 2000, PHARMACOECONOMICS, V18, P335, DOI 10.2165/00019053-200018040-00003; MIFUNE H, 1992, CELL TISSUE RES, V267, P267, DOI 10.1007/BF00302964; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moro C, 2009, DIABETES, V58, P2726, DOI 10.2337/db09-1335; Nunes S, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-44; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PILO A, 1982, J NUCL MED ALLIED S, V26, P235; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Rubenstein Arthur H, 2005, Trans Am Clin Climatol Assoc, V116, P103; Savoia C, 2010, CLIN SCI, V118, P231, DOI 10.1042/CS20090204; Scotland RS, 2005, PHARMACOL THERAPEUT, V105, P85, DOI 10.1016/j.pharmthera.2004.08.011; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Singer G, 2007, MICROCIRCULATION, V14, P375, DOI 10.1080/10739680701283158; Strohacker K, 2010, Front Biosci (Elite Ed), V2, P98, DOI 10.2741/e70; Vaziri ND, 2005, KIDNEY INT, V68, P2787, DOI 10.1111/j.1523-1755.2005.00750.x; Vykoukal D, 2011, J VASC SURG, V54, P819, DOI 10.1016/j.jvs.2011.01.003; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Yasunari Kenichi, 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS180, DOI 10.1111/j.1440-1681.1995.tb02872.x; Yoshimoto T, 1996, ENDOCRINOLOGY, V137, P5552, DOI 10.1210/en.137.12.5552	61	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72959	10.1371/journal.pone.0072959	http://dx.doi.org/10.1371/journal.pone.0072959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009719	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600045
J	Lajoie, DM; Zobel-Thropp, PA; Kumirov, VK; Bandarian, V; Binford, GJ; Cordes, MHJ				Lajoie, Daniel M.; Zobel-Thropp, Pamela A.; Kumirov, Vlad K.; Bandarian, Vahe; Binford, Greta J.; Cordes, Matthew H. J.			Phospholipase D Toxins of Brown Spider Venom Convert Lysophosphatidylcholine and Sphingomyelin to Cyclic Phosphates	PLOS ONE			English	Article							LOXOSCELES-RECLUSA VENOM; MEMBRANE PHOSPHOLIPIDS; DERMONECROTIC TOXIN; ACID RECEPTORS; UP-REGULATION; HUMAN SERUM; EXPRESSION; INTERMEDIA; MECHANISM; AUTOTAXIN	Venoms of brown spiders in the genus Loxosceles contain phospholipase D enzyme toxins that can cause severe dermonecrosis and even death in humans. These toxins cleave the substrates sphingomyelin and lysophosphatidylcholine in mammalian tissues, releasing the choline head group. The other products of substrate cleavage have previously been reported to be monoester phospholipids, which would result from substrate hydrolysis. Using P-31 NMR and mass spectrometry we demonstrate that recombinant toxins, as well as whole venoms from diverse Loxosceles species, exclusively catalyze transphosphatidylation rather than hydrolysis, forming cyclic phosphate products from both major substrates. Cyclic phosphates have vastly different biological properties from their monoester counterparts, and they may be relevant to the pathology of brown spider envenomation.	[Lajoie, Daniel M.; Kumirov, Vlad K.; Bandarian, Vahe; Cordes, Matthew H. J.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Zobel-Thropp, Pamela A.; Binford, Greta J.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA	University of Arizona	Cordes, MHJ (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	cordes@email.arizona.edu			Bio5 Institute; National Science Foundation (NSF) CAREER award [IOB-0546858]; National Institutes of Health (NIH) [GM 72623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008804] Funding Source: NIH RePORTER	Bio5 Institute; National Science Foundation (NSF) CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a seed grant from the Bio5 Institute (bio5.org; to MC, VB and GJB) and by National Science Foundation (NSF) CAREER award IOB-0546858 (to GJB). In addition, support from National Institutes of Health (NIH) grant GM 72623 (to VB) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; BERNHEIMER AW, 1985, SCIENCE, V228, P590, DOI 10.1126/science.3983643; Bey TA, 1997, ANN EMERG MED, V30, P701, DOI 10.1016/S0196-0644(97)70092-1; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; BOUDKER O, 1993, J BIOL CHEM, V268, P22150; Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005; CLARKE N, 1976, BIOCHEM J, V153, P745, DOI 10.1042/bj1530745; Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; Dennis EA, 1984, PHOSPHORUS 31 NMR PR, P423; Dragulev B, 2007, J INVEST DERMATOL, V127, P1264, DOI 10.1038/sj.jid.5700644; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; Friedman P, 1996, J BIOL CHEM, V271, P953, DOI 10.1074/jbc.271.2.953; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039; Kishimoto T, 2003, CLIN CHIM ACTA, V333, P59, DOI 10.1016/S0009-8981(03)00165-7; Kobayashi T, 1999, LIFE SCI, V65, P2185, DOI 10.1016/S0024-3205(99)00483-X; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Wille ACM, 2013, TOXICON, V67, P17, DOI 10.1016/j.toxicon.2013.01.027; Merchant ML, 1997, AM J TROP MED HYG, V56, P335, DOI 10.4269/ajtmh.1997.56.335; Merchant ML, 1998, TOXICON, V36, P537, DOI 10.1016/S0041-0101(97)00078-0; Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; Rosen JL, 2012, ANN EMERG MED, V60, P439, DOI 10.1016/j.annemergmed.2011.12.011; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shan L, 2008, J CHROMATOGR B, V862, P161, DOI 10.1016/j.jchromb.2007.12.003; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2002, IMMUNOLOGY, V107, P93, DOI 10.1046/j.1365-2567.2002.01483.x; Tsuda S, 2006, J BIOL CHEM, V281, P26081, DOI 10.1074/jbc.M602925200; Tsukahara T, 2013, J LIPIDS, DOI [10.1155/2013/2465897, DOI 10.1155/2013/2465897]; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; van den Berg CW, 2012, IMMUNOBIOLOGY, V217, P935, DOI 10.1016/j.imbio.2012.01.005; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; van Meeteren LA, 2007, J INVEST DERMATOL, V127, P1266, DOI 10.1038/sj.jid.5700745; YANG SF, 1967, J BIOL CHEM, V242, P477; Zobel-Thropp PA, 2012, TOXICON, V60, P265, DOI 10.1016/j.toxicon.2012.04.350	43	31	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72372	10.1371/journal.pone.0072372	http://dx.doi.org/10.1371/journal.pone.0072372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009677	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600017
J	Yang, LG; Tucker, JD; Liu, FY; Ren, XQ; Hong, X; Wang, C; McLaughlin, MM; Bien, CH; Chen, XS; Yang, B				Yang, Li-Gang; Tucker, Joseph D.; Liu, Feng-Ying; Ren, Xu-Qi; Hong, Xuan; Wang, Cheng; McLaughlin, Megan M.; Bien, Cedric H.; Chen, Xiang-Sheng; Yang, Bin			Syphilis Screening among 27,150 Pregnant Women in South Chinese Rural Areas Using Point-of-Care Tests	PLOS ONE			English	Article							NATIONAL SURVEILLANCE; BLOOD-DONORS; HIV; PREVALENCE; INFECTIONS; EPIDEMIC; TRENDS; RISK; INTEGRATION; MIGRATION	Objectives: To determine the prevalence and correlates of syphilis among pregnant women in rural areas of South China. Methods: Point-of-care syphilis testing was provided at 71 health facilities in less developed, rural areas of Guangdong Province. Positive samples were confirmed at a local referral center by toluidine red unheated serum tests (TRUST) and Treponema pallidum particle agglutination (TPPA) tests. Results: Altogether 27,150 pregnant women in rural Guangdong were screened for syphilis. 106 (0.39%) syphilis cases were diagnosed, of which 78 (73.6%) received treatment for syphilis. Multivariate analysis revealed that older pregnant women (31-35 years old, aOR 2.7, 95% CI 0.99-7.32; older than 35 years old, aOR 5.9, 95% CI 2.13-16.34) and those with a history of adverse pregnant outcomes (aOR 3.64, 95% CI 2.30-5.76) were more likely to be infected with syphilis. Conclusions: A high prevalence of syphilis exists among pregnant women living in rural areas of South China. Enhanced integration of syphilis screening with other routine women's health services (OB GYN, family planning) may be useful for controlling China's syphilis epidemic.	[Yang, Li-Gang; Tucker, Joseph D.; Liu, Feng-Ying; Ren, Xu-Qi; Hong, Xuan; Wang, Cheng; McLaughlin, Megan M.; Bien, Cedric H.; Yang, Bin] Guangdong Prov Ctr STI & Skin Dis Control & Preve, Div STD Control, Guangzhou, Guangdong, Peoples R China; [Chen, Xiang-Sheng] Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China		Yang, LG (corresponding author), Guangdong Prov Ctr STI & Skin Dis Control & Preve, Div STD Control, Guangzhou, Guangdong, Peoples R China.	yanglg3@yahoo.com	Ren, Xu-Qi/GRX-4131-2022	Tucker, Joseph/0000-0003-2804-1181	Guangdong Provincial Medical Science and Technology Research Funding Award [C2009020]; WHO Rapid Syphilis Test Project [UNICEF/UNDP/World Bank/WHO A70577]; National STD Control Centre; National Institutes of Health (NIH) Fogarty K01 Award [US NIH 1K01TW008200-01A1]; FOGARTY INTERNATIONAL CENTER [D43TW009532, K01TW008200] Funding Source: NIH RePORTER	Guangdong Provincial Medical Science and Technology Research Funding Award; WHO Rapid Syphilis Test Project; National STD Control Centre; National Institutes of Health (NIH) Fogarty K01 Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by the Guangdong Provincial Medical Science and Technology Research Funding Award (C2009020), the WHO Rapid Syphilis Test Project (UNICEF/UNDP/World Bank/WHO A70577), the National STD Control Centre, and a National Institutes of Health (NIH) Fogarty K01 Award (US NIH 1K01TW008200-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzaken AS, 2011, INT J STD AIDS, V22, P15, DOI 10.1258/ijsa.2010.010145; Berg AO, 2004, ANN FAM MED, V2, P362, DOI 10.1370/afm.215; Bradley H, 2008, AIDS CARE, V20, P61, DOI 10.1080/09540120701449112; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; Chen S. M., 2002, Sexually Transmitted Infections, V78, pe3, DOI 10.1136/sti.78.3.e3; Chen XS, 2006, SEX TRANSM DIS, V33, P296, DOI 10.1097/01.olq.0000194580.02116.6b; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Cheng JQ, 2007, SEX TRANSM INFECT, V83, P347, DOI 10.1136/sti.2006.023655; Criniti SM, 2011, J MIDWIFERY WOM HEAL, V56, P395, DOI 10.1111/j.1542-2011.2011.00031.x; Finelli L, 1998, Bull World Health Organ, V76 Suppl 2, P126; Hong Y, 2009, AIDS CARE, V21, P212, DOI 10.1080/09540120801932165; Ji ZH, 2012, INT J INFECT DIS; Kirakoya-Samadoulougou F, 2011, SEX TRANSM INFECT, V87, P35, DOI 10.1136/sti.2010.042465; Kumogola Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-553; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liambila W, 2009, AIDS, V23, pS115, DOI 10.1097/01.aids.0000363784.96321.43; Liu J, 2012, TRANSFUSION, V52, P1741, DOI 10.1111/j.1537-2995.2011.03527.x; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; Makasa M, 2012, SEX TRANSM DIS, V39, P173, DOI 10.1097/OLQ.0b013e31823b23a4; Menendez C, 2010, INFECT DIS OBSTET GY, V2010; Minichiello V, 2012, PERSPECT PUBLIC HEAL, V132, P178, DOI 10.1177/1757913912445688; Ministry of Health People's Republic of China, 2010, NAT SYPH PREV CONTR; Myer L, 2003, SEX TRANSM INFECT, V79, P208, DOI 10.1136/sti.79.3.208; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Pearline RV, 2010, AIDS PATIENT CARE ST; Rasch V, 2006, TROP MED INT HEALTH, V11, P697, DOI 10.1111/j.1365-3156.2006.01607.x; Schmid G, 2004, B WHO, P82; Sudhinaraset M, 2012, J ADOLESCENT HEALTH, V50, pS68, DOI 10.1016/j.jadohealth.2011.12.007; Swai RO, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-91; Tan NX, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001375; THOMAS JC, 1995, AM J PUBLIC HEALTH, V85, P1119, DOI 10.2105/AJPH.85.8_Pt_1.1119; Tucker JD, 2011, CURR OPIN INFECT DIS, V24, P50, DOI 10.1097/QCO.0b013e32834204bf; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; Walker GJA, 2007, SEMIN FETAL NEONAT M, V12, P198, DOI 10.1016/j.siny.2007.01.019; Wang B, 2012, NAT ANN HIV STI CONT; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wong SPY, 2007, SEX TRANSM INFECT, V83, P351, DOI 10.1136/sti.2007.025015; World Health Organization, 2007, GLOB EL CONG SYPH RA; World Health Organization, 2012, INV CAS EL MOTH TO C; Yahya-Malima KI, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-75; Yang LG, 2012, ANN STD SURVEILLANCE; Yang LG, 2011, B WORLD HEALTH ORGAN, V89, P798, DOI 10.2471/BLT.11.089813; Yang LG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-793; Yechao Z, 2008, MATERN CHILD HLTH J, V21, P3022; Zhu L, 2010, INT J INFECT DIS	47	16	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72149	10.1371/journal.pone.0072149	http://dx.doi.org/10.1371/journal.pone.0072149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009673	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600013
J	Yeh, YC; Cheng, HC; Yang, HB; Chang, WL; Sheu, BS				Yeh, Yi-Chun; Cheng, Hsiu-Chi; Yang, Hsiao-Bai; Chang, Wei-Lun; Sheu, Bor-Shyang			H-pylori CagL-Y58/E59 Prime Higher Integrin alpha 5 beta 1 in Adverse pH Condition to Enhance Hypochlorhydria Vicious Cycle for Gastric Carcinogenesis	PLOS ONE			English	Article							IV SECRETION SYSTEMS; EPITHELIAL-CELLS; INTESTINAL METAPLASIA; EXPRESSION; CANCER; CAGA; ACTIVATION; INFECTION; PATHWAY; PHOSPHORYLATION	Background/Aims: H. pylori CagL amino acid polymorphisms such as Y58/E59 can increase integrin alpha 5 beta 1 expression and gastric cancer risk. Hypochlorhydria during chronic H. pylori infection promotes gastric carcinogenesis. The study test whether CagL-Y58/E59 isolates may regulate integrin alpha 5 beta 1 to translocate CagA via the type IV secretory system even under adverse pH conditions, and whether the integrin alpha 5 beta 1 expression primed by H. pylori is a pH-dependent process involving hypochlorhydria in a vicious cycle to promote gastric carcinogenesis. Methods: The expressions of integrin alpha 5 and beta 1, CagA phosphorylation, IL-8, FAK, EGFR, and AKT activation of AGS cells exposed to CagL-Y58/E59 H. pylori, isogenic mutants, and different H. pylori CagL amino acid replacement mutants under different pH values were determined. Differences in the pepsinogen I/II ratio (indirectly indicating gastric acidity) and gastric integrin alpha 5 beta 1 expression were compared among the 172 H. pylori-infected patients with different cancer risks. Results: Even under adversely low pH condition, H. pylori CagL-Y58/E59 still keep active integrin beta 1 with stronger binding affinity, CagA translocation, IL-8, FAK, EGFR, and AKT activation than the other mutants (p<0.05). The in vitro assay revealed higher priming of integrin alpha 5 beta 1 by H. pylori under elevated pH as hypochlorhydria (p<0.05). In the H. pylori-infected patients, the gastric integrin alpha 5 beta 1 expressions were higher in those with pepsinogen I/II ratio,6 than in those without (p<0.05). Conclusions: H. pylori CagL-Y58/E59 prime higher integrin under adverse pH and may involve to enhance hypochlorhydria vicious cycle for gastric carcinogenesis, and thus require an early eradication.	[Yeh, Yi-Chun; Cheng, Hsiu-Chi; Chang, Wei-Lun; Sheu, Bor-Shyang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan; [Yeh, Yi-Chun; Cheng, Hsiu-Chi; Chang, Wei-Lun; Sheu, Bor-Shyang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Yang, Hsiao-Bai] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70101, Taiwan; [Yang, Hsiao-Bai] Ton Yen Gen Hosp, Dept Pathol, Hsinchu, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Sheu, BS (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan.	sheubs@mail.ncku.edu.tw			National Health Research Institute [NHRI-EX99-9908BI]; National Science Council [NSC 101-2314-B-006-016-MY3]; Department of Health, Taiwan [DOH100-TD-C-111-003]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	The study was supported by grants NHRI-EX99-9908BI from the National Health Research Institute, NSC 101-2314-B-006-016-MY3 from the National Science Council, and DOH100-TD-C-111-003 from the Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2011, BIOPHYS J, V100, P2595, DOI 10.1016/j.bpj.2011.03.028; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Backert S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-28; Barillari G, 2001, ATHEROSCLEROSIS, V154, P377, DOI 10.1016/S0021-9150(00)00506-2; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chuang CH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-121; GRAHAM DY, 1988, AM J GASTROENTEROL, V83, P974; Hung KH, 2009, J MED MICROBIOL, V58, P567, DOI 10.1099/jmm.0.007310-0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lai CH, 2011, FEMS MICROBIOL LETT, V323, P155, DOI 10.1111/j.1574-6968.2011.02372.x; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lu PJ, 2010, WORLD J GASTROENTERO, V16, P5496, DOI 10.3748/wjg.v16.i43.5496; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Murillo CA, 2004, SURGERY, V136, P143, DOI 10.1016/j.surg.2004.04.006; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; O'Toole D, 2005, J CELL BIOCHEM, V96, P589, DOI 10.1002/jcb.20539; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; OHASHI H, 1995, EXP CELL RES, V218, P418, DOI 10.1006/excr.1995.1174; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Saha A, 2008, AM J PHYSIOL-GASTR L, V294, pG795, DOI 10.1152/ajpgi.00431.2007; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sheu BS, 2006, AM J CLIN NUTR, V83, P864, DOI 10.1093/ajcn/83.4.864; Sheu BS, 2006, AM J GASTROENTEROL, V101, P36, DOI 10.1111/j.1572-0241.2006.00358.x; Sheu BS, 2003, GUT, V52, P927, DOI 10.1136/gut.52.7.927; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Tabassam FH, 2009, CELL MICROBIOL, V11, P70, DOI 10.1111/j.1462-5822.2008.01237.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Wen S, 2012, ONCOGENE, V31, P1771, DOI 10.1038/onc.2011.362; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407	43	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72735	10.1371/journal.pone.0072735	http://dx.doi.org/10.1371/journal.pone.0072735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009701	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600035
J	Zhang, Z; Lange, OF				Zhang, Zhe; Lange, Oliver F.			Replica Exchange Improves Sampling in Low-Resolution Docking Stage of RosettaDock	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; DISPLACEMENT; SIMULATIONS; PERFORMANCE; PREDICTION; ZDOCK	Many protein-protein docking protocols are based on a shotgun approach, in which thousands of independent random-start trajectories minimize the rigid-body degrees of freedom. Another strategy is enumerative sampling as used in ZDOCK. Here, we introduce an alternative strategy, ReplicaDock, using a small number of long trajectories of temperature replica exchange. We compare replica exchange sampling as low-resolution stage of RosettaDock with RosettaDock's original shotgun sampling as well as with ZDOCK. A benchmark of 30 complexes starting from structures of the unbound binding partners shows improved performance for ReplicaDock and ZDOCK when compared to shotgun sampling at equal or less computational expense. ReplicaDock and ZDOCK consistently reach lower energies and generate significantly more near-native conformations than shotgun sampling. Accordingly, they both improve typical metrics of prediction quality of complex structures after refinement. Additionally, the refined ReplicaDock ensembles reach significantly lower interface energies and many previously hidden features of the docking energy landscape become visible when ReplicaDock is applied.	[Zhang, Zhe; Lange, Oliver F.] Tech Univ Munich, Biomol NMR, Garching, Germany; [Zhang, Zhe; Lange, Oliver F.] Tech Univ Munich, Munich Ctr Integrated Prot Sci, Dept Chem, Garching, Germany; [Lange, Oliver F.] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lange, OF (corresponding author), Tech Univ Munich, Biomol NMR, Garching, Germany.	oliver.lange@tum.de		zhang, zhe/0000-0003-3983-1226	DFG [LA 1817/3-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant LA 1817/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2001, J MOL BIOL, V311, P395, DOI 10.1006/jmbi.2001.4870; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cowieson NP, 2008, CURR OPIN STRUC BIOL, V18, P617, DOI 10.1016/j.sbi.2008.07.004; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Gao Y, 2007, PROTEINS, V69, P845, DOI 10.1002/prot.21714; Garma L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038913; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Karaca E, 2013, METHODS, V59, P372, DOI 10.1016/j.ymeth.2012.12.004; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kleinjung J, 2005, NUCLEIC ACIDS RES, V33, pW342, DOI 10.1093/nar/gki369; Koehler J, 2011, PROG NUCL MAG RES SP, V59, P360, DOI 10.1016/j.pnmrs.2011.05.001; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Lorenzen S, 2007, PROTEIN SCI, V16, P2716, DOI 10.1110/ps.072847207; Lorenzen S, 2007, PROTEINS, V68, P187, DOI 10.1002/prot.21442; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Melquiond ASJ, 2012, WIRES COMPUT MOL SCI, V2, P642, DOI 10.1002/wcms.91; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moreira IS, 2010, J COMPUT CHEM, V31, P317, DOI 10.1002/jcc.21276; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Rathore N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1831273; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Sanbonmatsu KY, 2002, PROTEINS, V46, P225, DOI 10.1002/prot.1167; Schneider S, 2012, J MOL RECOGNIT, V25, P15, DOI 10.1002/jmr.1165; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Stratmann D, 2011, PROTEINS, V79, P2662, DOI 10.1002/prot.23090; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tyka MD, 2012, J COMPUT CHEM, V33, P2483, DOI 10.1002/jcc.23069; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303	46	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72096	10.1371/journal.pone.0072096	http://dx.doi.org/10.1371/journal.pone.0072096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009670	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600011
J	Kutywayo, D; Chemura, A; Kusena, W; Chidoko, P; Mahoya, C				Kutywayo, Dumisani; Chemura, Abel; Kusena, Winmore; Chidoko, Pardon; Mahoya, Caleb			The Impact of Climate Change on the Potential Distribution of Agricultural Pests: The Case of the Coffee White Stem Borer (Monochamus leuconotus P.) in Zimbabwe	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; MANAGEMENT; UNCERTAINTY; PREDICTION; GUIDE	The production of agricultural commodities faces increased risk of pests, diseases and other stresses due to climate change and variability. This study assesses the potential distribution of agricultural pests under projected climatic scenarios using evidence from the African coffee white stem borer (CWB), Monochamus leuconotus (Pascoe) (Coleoptera: Cerambycidae), an important pest of coffee in Zimbabwe. A species distribution modeling approach utilising Boosted Regression Trees (BRT) and Generalized Linear Models (GLM) was applied on current and projected climate data obtained from the WorldClim database and occurrence data (presence and absence) collected through on-farm biological surveys in Chipinge, Chimanimani, Mutare and Mutasa districts in Zimbabwe. Results from both the BRT and GLM indicate that precipitation-related variables are more important in determining species range for the CWB than temperature related variables. The CWB has extensive potential habitats in all coffee areas with Mutasa district having the largest model average area suitable for CWB under current and projected climatic conditions. Habitat ranges for CWB will increase under future climate scenarios for Chipinge, Chimanimani and Mutare districts while it will decrease in Mutasa district. The highest percentage change in area suitable for the CWB was for Chimanimani district with a model average of 49.1% (3 906 ha) increase in CWB range by 2080. The BRT and GLM predictions gave similar predicted ranges for Chipinge, Chimanimani and Mutasa districts compared to the high variation in current and projected habitat area for CWB in Mutare district. The study concludes that suitable area for CWB will increase significantly in Zimbabwe due to climate change and there is need to develop adaptation mechanisms.	[Kutywayo, Dumisani; Chidoko, Pardon; Mahoya, Caleb] Coffee Res Inst, DR & SS, Chipinge, Zimbabwe; [Chemura, Abel] Chinhoyi Univ Technol, Dept Environm Sci & Technol, Chinhoyi, Zimbabwe; [Kusena, Winmore] Midlands State Univ, GES Dept, Gweru, Zimbabwe		Chemura, A (corresponding author), Chinhoyi Univ Technol, Dept Environm Sci & Technol, Chinhoyi, Zimbabwe.	achemura@gmail.com	Chemura, Abel/H-3263-2019; Chidoko, Pardon/AAF-2942-2019; Winmore, Kusena/ABF-8045-2021	Chemura, Abel/0000-0002-9622-5524; Winmore, Kusena/0000-0001-9883-4334				Abeare S, 2009, COMP BOOSTED REGRESS; African Development Bank Group, 2010, COFF PROD AFR GLOB M; Alves MD, 2011, PROCEDIA ENVIRON SCI, V6, P35, DOI 10.1016/j.proenv.2011.05.005; Arendse A, 2010, INT S CONS 29 31 MAR, P29; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Baker P, 2007, LONG BEACH SCAA C HA, P14; Baker P. S., 2001, Coffee futures: a source book of some critical issues confronting the coffee industry; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown H. B., 2008, SMALLHOLDER COFFEE P; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cammell M, 1997, ADV ECOL RES, V22, P117; Chemura A, 2010, 23 C ASS SCI INF COF, P11; Chemura A, 2013, 1 CLIM SCI S ZIMB, P1; Clowes JM, 1979, RHODESIA J AGR RES, V71, P53; Clowes R, 2001, SIMPLY COFFEE PRACTI; Colcagno V, 2010, J STAT SOFTW, V34; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Deka S, 2010, ISPRS ARCH, P147; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESRI, 2012, ARCGIS REL 10 1; Evangelista PH, 2011, FOREST ECOL MANAG, V262, P307, DOI 10.1016/j.foreco.2011.03.036; Falk W, 2011, J VEG SCI, V22, P621, DOI 10.1111/j.1654-1103.2011.01294.x; Ghini R, 2011, PLANT PATHOL, V60, P122, DOI 10.1111/j.1365-3059.2010.02403.x; Gillison AN, 2004, ECOL SOC, V9; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hagar J, 2011, COFFEE CLIMATE CHANG; Hall D, 2006, CHEM AFRICAN COFFEE, P306; Hijmans R, 2006, WORLDCLIM GLOBAL CLI; Hijmans RJ, 2013, SPECIES DISTRIBUTION; Hillocks RJ, 1999, CROP PROT, V18, P199, DOI 10.1016/S0261-2194(99)00017-4; International Coffee Organization, 2009, CLIM CHANG COFF, P14; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kutywayo D, 2002, 19 C ASS SCI INF COF, P8; Kutywayo D, 1999, ECOLOGICAL ROUND TAB, P544; Kutywayo D, 2002, COFFEE WHITE STEM BO, P96; Kutywayo V, 2006, Commun Agric Appl Biol Sci, V71, P245; Ladanyi M, 2010, APPL ECOL ENV RES, V8, P143, DOI 10.15666/aeer/0802_143151; Lastuvka Zdenek, 2009, Plant Protection Science, V45, pS53; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Logan W. J. C., 1987, COFFEE HDB; Maravanyika E, 1998, EC TOBACCO CONTROL O, P192; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Mendelsohn R., 2008, J NAT RESOUR POLICY, V1, P5, DOI [10.1080/19390450802495882, DOI 10.1080/19390450802495882]; Murphy TS, 2008, INTEGRATED STEM BORE; Naimi B, 2011, J BIOGEOGR, V38, P1497, DOI 10.1111/j.1365-2699.2011.02523.x; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PEARSON RG, 2007, SPECIES DISTRIBUTION; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson A. T., 2006, BIODIVERSITY INFORM, V3, P59, DOI DOI 10.17161/BI.V3I0.29; R Core Team, 2016, R FDN STAT COMP; Rao K. P. C., 2007, Journal of SAT Agricultural Research, V4, P1; Schoeman PS, 1998, AFR ENTOMOL, V6, P83; Schroth G, 2009, MITIGATION ADAPTATIO, V14; Schroth G, 2009, MITIG ADAPT STRAT GL, V14, P605, DOI 10.1007/s11027-009-9186-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Trumble JT, 2009, CALIF AGR, V63, P73, DOI 10.3733/ca.v063n02p73; Wheeler D., 2012, QUANTIFYING VULNERAB, DOI 10.2139/ssrn.1824611; Ziervogel G, 2009, CLIM RES, V40, P133, DOI 10.3354/cr00804	68	46	47	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73432	10.1371/journal.pone.0073432	http://dx.doi.org/10.1371/journal.pone.0073432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014222	Green Published, Green Submitted, gold			2022-12-25	WOS:000323815200079
J	Lenarduzzi, M; Hui, ABY; Yue, SJ; Ito, E; Shi, W; Williams, J; Bruce, J; Sakemura-Nakatsugawa, N; Xu, W; Schimmer, A; Liu, FF				Lenarduzzi, Michelle; Hui, Angela B. Y.; Yue, Shijun; Ito, Emma; Shi, Wei; Williams, Justin; Bruce, Jeff; Sakemura-Nakatsugawa, Noriko; Xu, Wei; Schimmer, Aaron; Liu, Fei-Fei			Hemochromatosis Enhances Tumor Progression via Upregulation of Intracellular Iron in Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HEREDITARY HEMOCHROMATOSIS; PROTEIN HFE; MOLECULAR-MECHANISM; HEPCIDIN; TRANSFERRIN; EXPRESSION; GENE; FERRITIN; IDENTIFICATION	Introduction: Despite improvements in treatment strategies for head and neck squamous cell carcinoma (HNSCC), outcomes have not significantly improved; highlighting the importance of identifying novel therapeutic approaches to target this disease. To address this challenge, we proceeded to evaluate the role of iron in HNSCC. Experimental Design: Expression levels of iron-related genes were evaluated in HNSCC cell lines using quantitative RT-PCR. Cellular phenotypic effects were assessed using viability (MTS), clonogenic survival, BrdU, and tumor formation assays. The prognostic significance of iron-related proteins was determined using immunohistochemistry. Results: In a panel of HNSCC cell lines, hemochromatosis (HFE) was one of the most overexpressed genes involved in iron regulation. In vitro knockdown of HFE in HNSCC cell lines significantly decreased hepcidin (HAMP) expression and intracellular iron level. This in turn, resulted in a significant decrease in HNSCC cell viability, clonogenicity, DNA synthesis, and Wnt signalling. These cellular changes were reversed by re-introducing iron back into HNSCC cells after HFE knockdown, indicating that iron was mediating this phenotype. Concordantly, treating HNSCC cells with an iron chelator, ciclopirox olamine (CPX), significantly reduced viability and clonogenic survival. Finally, patients with high HFE expression experienced a reduced survival compared to patients with low HFE expression. Conclusions: Our data identify HFE as potentially novel prognostic marker in HNSCC that promotes tumour progression via HAMP and elevated intracellular iron levels, leading to increased cellular proliferation and tumour formation. Hence, these findings suggest that iron chelators might have a therapeutic role in HNSCC management.	[Lenarduzzi, Michelle; Hui, Angela B. Y.; Yue, Shijun; Ito, Emma; Shi, Wei; Williams, Justin; Bruce, Jeff; Sakemura-Nakatsugawa, Noriko; Xu, Wei; Schimmer, Aaron; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Lenarduzzi, Michelle; Bruce, Jeff; Schimmer, Aaron; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Liu, Fei-Fei] Univ Hlth Network, Radiat Med Program, Toronto, ON, Canada; [Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Liu, FF (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca	Bruce, Jeff/AAF-1350-2019	Bruce, Jeff/0000-0001-5509-9990; Spence, Tara/0000-0001-7098-4103; Schimmer, Aaron/0000-0003-4023-3899; Liu, Fei-Fei/0000-0003-4344-6486	Ontario Institute of Cancer Research; Canadian Institutes of Health Research; Dr. Mariano Elia Chair in Head and Neck Cancer Research; Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR); Ontario Graduate Scholarship (OGS); Medical Biophysics Excellence award; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	Ontario Institute of Cancer Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dr. Mariano Elia Chair in Head and Neck Cancer Research; Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Medical Biophysics Excellence award; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	This work has been supported by funds from the Ontario Institute of Cancer Research, the Canadian Institutes of Health Research, and the Dr. Mariano Elia Chair in Head and Neck Cancer Research. The authors also gratefully acknowledge the philanthropic support from the Wharton Family, Joe's Team, and Gordon Tozer. Michelle Lenarduzzi is a recipient of scholarships from the Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR), the Ontario Graduate Scholarship (OGS) and the Medical Biophysics Excellence award. Support is also provided from the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-term Planning. CIHR - http://www.cihr-irsc.gc.ca/e/193.html, EIRR21 - http://www.eirr21.utoronto.ca/, OGS - https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/TCONT003465.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Bystrom LM, 2013, ANTIOXID REDOX SIGNA; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Davies PS, 2004, J BIOL CHEM, V279, P25085, DOI 10.1074/jbc.M400537200; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Drakesmith H, 2002, P NATL ACAD SCI USA, V99, P15602, DOI 10.1073/pnas.242614699; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; FAULK WP, 1980, LANCET, V2, P390; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Ferlay J SH, 2008, GLOBOCAN 2008 V2 0 C; Fracanzani AL, 2001, HEPATOLOGY, V33, P647, DOI 10.1053/jhep.2001.22506; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; GUNER G, 1992, CANCER LETT, V67, P103, DOI 10.1016/0304-3835(92)90132-F; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hower V, 2009, MOL BIOSYST, V5, P422, DOI 10.1039/b816714c; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Ito E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001922; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kamai T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-270; KONDO K, 1990, CHEST, V97, P1367, DOI 10.1378/chest.97.6.1367; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lenarduzzi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053765; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Lui GYL, 2013, MOL PHARMACOL, V83, P179, DOI 10.1124/mol.112.081893; Maehata Y, 2010, FREE RADICAL RES, V44, P913, DOI 10.3109/10715762.2010.490836; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Montosi G, 2000, BLOOD, V96, P1125, DOI 10.1182/blood.V96.3.1125.015k19_1125_1129; Nagler RM, 2001, RADIAT RES, V156, P205, DOI 10.1667/0033-7587(2001)156[0205:RMCARI]2.0.CO;2; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PEKKOLAHEINO K, 1992, HEAD NECK-J SCI SPEC, V14, P196, DOI 10.1002/hed.2880140306; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rhee CS, 2002, ONCOGENE, V21, P6598, DOI 10.1038/sj.onc.1205920; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Song S, 2011, CANCER RES, V71, P7628, DOI 10.1158/0008-5472.CAN-11-2745; VAUGHN CB, 1987, CANCER INVEST, V5, P7, DOI 10.3109/07357908709020300; Wada S, 2006, ANN SURG ONCOL, V13, P961, DOI 10.1245/ASO.2006.08.006; Ward DG, 2008, WORLD J GASTROENTERO, V14, P1339, DOI 10.3748/wjg.14.1339; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74075	10.1371/journal.pone.0074075	http://dx.doi.org/10.1371/journal.pone.0074075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991213	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800114
J	Tian, HJ; Bi, XD; Li, CS; Zhao, KW; Brochmann, EJ; Montgomery, SR; Aghdasi, B; Chen, DY; Daubs, MD; Wang, JC; Murray, SS				Tian, Haijun; Bi, Xiaoda; Li, Chen-Shuang; Zhao, Ke-Wei; Brochmann, Elsa J.; Montgomery, Scott R.; Aghdasi, Bayan; Chen, Deyu; Daubs, Michael D.; Wang, Jeffrey C.; Murray, Samuel S.			Secreted Phosphoprotein 24 kD (Spp24) and Spp14 Affect TGF-beta Induced Bone Formation Differently	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MORPHOGENETIC PROTEIN-2; LIGAND-BINDING; TRANSFORMING GROWTH-FACTOR-BETA-1; CRYSTAL-STRUCTURE; RECEPTOR; MATRIX; ANTAGONISTS; MUTAGENESIS; EXPRESSION	Transforming growth factor-beta (TGF-beta) and bone morphogenetic proteins (BMPs) have opposing but complementary functions in directing bone growth, repair, and turnover. Both are found in the bone matrix. Proteins that bind to and affect the activity of these growth factors will determine the relative abundance of the growth factors and, therefore, regulate bone formation. Secreted phosphoprotein 24 kD (Spp24) is a bone matrix protein that has been demonstrated to bind to and affect the activity of BMPs. The arginine-rich carboxy terminus of Spp24 is proteolytically processed to produce three other predictable truncation products (Spp18.1, Spp16.0, and Spp14.5). In this work, we report that kinetic data obtained by surface plasmon resonance demonstrate that Spp24 and the three C-terminal truncation products all bind to TGF-beta 1 and TGF-beta 2 with a similar but somewhat less affinity than they bind BMP-2; that, as in the case of BMP-2, the full-length (FL) form of Spp24 binds TGF-beta with greater affinity than do the truncation products; that FL-Spp24 inhibits TGF-beta 2 induced bone formation in vivo, but Spp14.5 does not; and that co-administration of FL-Spp24 or Spp14.5 with TGF-beta 2 in vivo is associated with a reduction in the amount of cartilage, relative to new bone, present at the site of injection. This finding is consistent with the observation that low-dose TGF-beta administration in vivo is associated with greater bone formation than high-dose TGF-beta administration, and suggests that one function of Spp24 and its truncation products is to down-regulate local TGF-beta activity or availability during bone growth and development. The similarities and differences of the interactions between Spp24 proteins and TGF-beta compared to the interaction of the Spp24 proteins and BMPs have significant implications with respect to the regulation of bone metabolism and with respect to engineering therapeutic proteins for skeletal disorders.	[Tian, Haijun; Chen, Deyu] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China; [Bi, Xiaoda] 309th Hosp PLA, Dept Ophthalmol, Beijing, Peoples R China; [Li, Chen-Shuang] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China; [Zhao, Ke-Wei; Brochmann, Elsa J.; Murray, Samuel S.] VA Greater Los Angeles Healthcare Syst, Res Serv, Educ & Clin Ctr, North Hills, CA USA; [Brochmann, Elsa J.; Murray, Samuel S.] VA Greater Los Angeles Healthcare Syst, Educ & Clin Ctr, Geriatr Res, North Hills, CA USA; [Brochmann, Elsa J.; Murray, Samuel S.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Bi, Xiaoda] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Montgomery, Scott R.; Daubs, Michael D.; Wang, Jeffrey C.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA; [Aghdasi, Bayan] Methodist Hosp Syst, Dept Orthopaed Surg, Houston, TX USA	Naval Medical University; Peking University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; The Methodist Hospital System; The Methodist Hospital - Houston	Tian, HJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	haijuntianmd@gmail.com	Li, Chenshuang/Q-2389-2019	Li, Chenshuang/0000-0001-6331-6983	Department of Veterans Affairs Biomedical Laboratory Research; Development and Rehabilitation Research and Development Services [1I01BX000511, 1I0RX000383]	Department of Veterans Affairs Biomedical Laboratory Research; Development and Rehabilitation Research and Development Services	This work was supported by the Department of Veterans Affairs Biomedical Laboratory Research (http://www.research.va.gov/services/blrd/#.UW8XKqV9FFg) and Development and Rehabilitation Research and Development Services (http://www.research.va.gov/services/rrd.cfm#.UW8XV6V9FFg) (1I01BX000511 and 1I0RX000383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behnam K, 2005, J ORTHOP RES, V23, P175, DOI 10.1016/j.orthres.2004.05.001; Blum B, 2004, ORTHOPEDICS, V27, pS161; Boesen CC, 2002, STRUCTURE, V10, P913, DOI 10.1016/S0969-2126(02)00780-3; Brochmann EJ, 2010, J ORTHOP RES, V28, P1200, DOI 10.1002/jor.21102; Brochmann EJ, 2009, METABOLISM, V58, P644, DOI 10.1016/j.metabol.2009.01.001; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2003, PRIMER METABOLIC BON, P28; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Guimond A, 2002, FEBS LETT, V515, P13, DOI 10.1016/S0014-5793(02)02378-5; Guimond A, 1999, FEBS LETT, V456, P79, DOI 10.1016/S0014-5793(99)00869-8; HU B, 1995, J BIOL CHEM, V270, P431, DOI 10.1074/jbc.270.1.431; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195; KAWAMURA M, 1988, CLIN ORTHOP RELAT R, P302; Kotzsch A, 2008, J BIOL CHEM, V283, P5876, DOI 10.1074/jbc.M706029200; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Murray EJB, 2007, CONNECT TISSUE RES, V48, P292, DOI 10.1080/03008200701692404; Murray SS, 2007, ATLA-ALTERN LAB ANIM, V35, P405, DOI 10.1177/026119290703500412; Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7; SEN S, 1985, MICROBIOS, V42, P67; Sintuu C, 2008, J ORTHOP RES, V26, P753, DOI 10.1002/jor.20580; Sintuu C, 2011, J BONE JOINT SURG AM, V93A, P1022, DOI 10.2106/JBJS.J.00081; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Sun A, 2010, CONNECT TISSUE RES, V51, P445, DOI 10.3109/03008201003615734; Sykaras Nikitas, 2003, J Oral Sci, V45, P57; Taghavi CE, 2010, SPINE, V35, P2049, DOI 10.1097/BRS.0b013e3181cc0220; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Zhao KW, 2013, J CELL BIOCHEM, V114, P378, DOI 10.1002/jcb.24376	31	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72645	10.1371/journal.pone.0072645	http://dx.doi.org/10.1371/journal.pone.0072645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991133	Green Published, gold, Green Submitted			2022-12-25	WOS:000324228800081
J	Lepore, S; Waiczies, H; Hentschel, J; Ji, YY; Skodowski, J; Pohlmann, A; Millward, JM; Paul, F; Wuerfel, J; Niendorf, T; Waiczies, S				Lepore, Stefano; Waiczies, Helmar; Hentschel, Jan; Ji, Yiyi; Skodowski, Julia; Pohlmann, Andreas; Millward, Jason M.; Paul, Friedemann; Wuerfel, Jens; Niendorf, Thoralf; Waiczies, Sonia			Enlargement of Cerebral Ventricles as an Early Indicator of Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; P-SELECTIN; TIGHT JUNCTIONS; WATER-CONTENT; MOUSE-BRAIN; T-CELLS; TRAFFICKING; MODEL	Inflammatory disorders of the central nervous system such as multiple sclerosis and acute disseminated encephalomyelitis involve an invasion of immune cells that ultimately leads to white matter demyelination, neurodegeneration and development of neurological symptoms. A clinical diagnosis is often made when neurodegenerative processes are already ongoing. In an attempt to seek early indicators of disease, we studied the temporal and spatial distribution of brain modifications in experimental autoimmune encephalomyelitis (EAE). In a thorough magnetic resonance imaging study performed with EAE mice, we observed significant enlargement of the ventricles prior to disease clinical manifestation and an increase in free water content within the cerebrospinal fluid as demonstrated by changes in T-2 relaxation times. The increase in ventricle size was seen in the lateral, third and fourth ventricles. In some EAE mice the ventricle size started returning to normal values during disease remission. In parallel to this macroscopic phenomenon, we studied the temporal evolution of microscopic lesions commonly observed in the cerebellum also starting prior to disease onset. Our data suggest that changes in ventricle size during the early stages of brain inflammation could be an early indicator of the events preceding neurological disease and warrant further exploration in preclinical and clinical studies.	[Lepore, Stefano; Waiczies, Helmar; Hentschel, Jan; Ji, Yiyi; Skodowski, Julia; Pohlmann, Andreas; Niendorf, Thoralf; Waiczies, Sonia] Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany; [Lepore, Stefano; Waiczies, Helmar; Skodowski, Julia; Millward, Jason M.; Niendorf, Thoralf; Waiczies, Sonia] ECRC, Berlin, Germany; [Millward, Jason M.] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Paul, Friedemann; Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Wuerfel, Jens] Univ Med, Inst Neuroradiol, Gottingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Waiczies, S (corresponding author), Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany.	sonia.waiczies@charite.de	Paul, Friedemann/ABF-9415-2020; Niendorf, Thoralf/H-7738-2013; Waiczies, Sonia/H-4181-2012; Pohlmann, Andreas/K-7869-2016	Niendorf, Thoralf/0000-0001-7584-6527; Waiczies, Sonia/0000-0002-9916-9572; Pohlmann, Andreas/0000-0002-8572-2568; Wuerfel, Jens/0000-0002-0034-8053; Waiczies, Helmar/0000-0001-6651-4790; Millward, Jason/0000-0003-4484-2798; Ji, Yiyi/0000-0002-8721-5025; paul, friedemann/0000-0002-6378-0070	Experimental and Clinical Research Center [ECRC2010-2013]; Novartis; German Research Foundation [DFG Exc 257, WA 2804/1-1]	Experimental and Clinical Research Center; Novartis(Novartis); German Research Foundation(German Research Foundation (DFG))	This work was supported by a university grant from the Experimental and Clinical Research Center (ECRC2010-2013), a research grant from Novartis and research grants from the German Research Foundation (DFG Exc 257 to FP, WA 2804/1-1 to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2002, AM J NEURORADIOL, V23, P376; Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; Furtado GC, 2008, J IMMUNOL, V181, P4648, DOI 10.4049/jimmunol.181.7.4648; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2005, 11 ANN M ORG HUM BRA; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KAMMAN RL, 1988, MAGNET RESON MED, V6, P265, DOI 10.1002/mrm.1910060304; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Lukas C, 2010, J NEUROL NEUROSUR PS, V81, P1351, DOI 10.1136/jnnp.2009.199968; Lusse S, 2000, MAGN RESON IMAGING, V18, P423, DOI 10.1016/S0730-725X(99)00144-7; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Morgan L, 2007, NEUROSCIENCE, V147, P664, DOI 10.1016/j.neuroscience.2007.04.051; Nouls JC, 2008, J MAGN RESON, V191, P231, DOI 10.1016/j.jmr.2007.12.018; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Plumb J, 2002, BRAIN PATHOL, V12, P154; Qiao M, 2001, STROKE, V32, P958, DOI 10.1161/01.STR.32.4.958; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wagenhaus B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042383; Waiczies H, 2013, SCI REP, p[3, 1280]; Waiczies H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032796; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Wuerfel J, 2007, J NEUROL SCI, V259, P16, DOI 10.1016/j.jns.2007.02.011; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	39	21	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72841	10.1371/journal.pone.0072841	http://dx.doi.org/10.1371/journal.pone.0072841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991157	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000324470700051
J	Jankowski, MD; Williams, CJ; Fair, JM; Owen, JC				Jankowski, Mark D.; Williams, Christopher J.; Fair, Jeanne M.; Owen, Jennifer C.			Birds Shed RNA-Viruses According to the Pareto Principle	PLOS ONE			English	Article							WEST-NILE-VIRUS; EQUINE ENCEPHALOMYELITIS; RECRUDESCENCE HYPOTHESIS; EXPERIMENTAL-INFECTION; TRANSMISSION; DISEASES; CORTICOSTERONE; RESISTANCE; CHALLENGE; EVOLUTION	A major challenge in disease ecology is to understand the role of individual variation of infection load on disease transmission dynamics and how this influences the evolution of resistance or tolerance mechanisms. Such information will improve our capacity to understand, predict, and mitigate pathogen-associated disease in all organisms. In many host-pathogen systems, particularly macroparasites and sexually transmitted diseases, it has been found that approximately 20% of the population is responsible for approximately 80% of the transmission events. Although host contact rates can account for some of this pattern, pathogen transmission dynamics also depend upon host infectiousness, an area that has received relatively little attention. Therefore, we conducted a meta-analysis of pathogen shedding rates of 24 host (avian) - pathogen (RNA-virus) studies, including 17 bird species and five important zoonotic viruses. We determined that viral count data followed the Weibull distribution, the mean Gini coefficient (an index of inequality) was 0.687 (0.036 SEM), and that 22.0% (0.90 SEM) of the birds shed 80% of the virus across all studies, suggesting an adherence of viral shedding counts to the Pareto Principle. The relative position of a bird in a distribution of viral counts was affected by factors extrinsic to the host, such as exposure to corticosterone and to a lesser extent reduced food availability, but not to intrinsic host factors including age, sex, and migratory status. These data provide a quantitative view of heterogeneous virus shedding in birds that may be used to better parameterize epidemiological models and understand transmission dynamics.	[Jankowski, Mark D.] US Fish & Wildlife Serv, Pocatello, ID USA; [Jankowski, Mark D.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Williams, Christopher J.] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Fair, Jeanne M.] Los Alamos Natl Lab, Los Alamos, NM USA; [Owen, Jennifer C.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Owen, Jennifer C.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	United States Department of the Interior; US Fish & Wildlife Service; University of Wisconsin System; University of Wisconsin Madison; Idaho; University of Idaho; United States Department of Energy (DOE); Los Alamos National Laboratory; Michigan State University; Michigan State University	Owen, JC (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	owenj@msu.edu		Williams, Christopher/0000-0001-6346-8100; Owen, Jennifer/0000-0003-1383-4816				Allen LJS, 2012, NAT RESOUR MODEL, V25, P5, DOI 10.1111/j.1939-7445.2011.00104.x; ANDERSON R M, 1991; Bellosta C. J. G., 2011, ADGOFTEST ANDERSON D; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; DOBSON AP, 1986, PARASITOLOGY, V92, P675, DOI 10.1017/S0031182000065537; Doeschl-Wilson AB, 2011, GENETICS, V188, P683, DOI 10.1534/genetics.110.125625; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Dwyer G, 1997, AM NAT, V150, P685, DOI 10.1086/286089; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Flint PL, 2009, P ROY SOC B-BIOL SCI, V276, P2345, DOI 10.1098/rspb.2008.1962; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hall JS, 2011, INFLUENZA OTHER RESP, V5, P365, DOI 10.1111/j.1750-2659.2011.00238.x; Hall JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007555; HAMBURGER M, 1945, J INFECT DIS, V77, P96, DOI 10.1093/infdis/77.2.96; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Handcock M.S., 2011, RELATIVE DISTRIBUTIO; Hawley DM, 2007, FUNCT ECOL, V21, P520, DOI 10.1111/j.1365-2435.2007.01254.x; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Jankowski MD, 2010, TOXICOLOGY, V269, P81, DOI 10.1016/j.tox.2010.01.010; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling M.J., 2008, MODELING INFECT DIS; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Manzin A, 2000, J VIROL, V74, P4327, DOI 10.1128/JVI.74.9.4327-4334.2000; Matthews L, 2006, EPIDEMIOL INFECT, V134, P131, DOI 10.1017/S0950268805004590; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nemeth NM, 2006, AVIAN DIS, V50, P252, DOI 10.1637/7466-110105R1.1; Nemeth NM, 2010, AVIAN PATHOL, V39, P411, DOI 10.1080/03079457.2010.513043; Owen JC, 2010, J MED ENTOMOL, V47, P451, DOI 10.1603/ME09035; Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Owen JC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-34; Owen JC, 2011, J MED ENTOMOL, V48, P896, DOI 10.1603/ME10274; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; POULIN R, 1993, INT J PARASITOL, V23, P937, DOI 10.1016/0020-7519(93)90060-C; Reed Kurt D, 2003, Clin Med Res, V1, P5; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Sovada MA, 2008, BIOL CONSERV, V141, P1021, DOI 10.1016/j.biocon.2008.01.019; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Zhang LQ, 1997, J VIROL, V71, P2555, DOI 10.1128/JVI.71.3.2555-2561.1997	59	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72611	10.1371/journal.pone.0072611	http://dx.doi.org/10.1371/journal.pone.0072611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991129	gold, Green Published, Green Submitted			2022-12-25	WOS:000324470100108
J	Breyton, C; Flayhan, A; Gabel, F; Lethier, M; Durand, G; Boulanger, P; Chami, M; Ebel, C				Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Durand, Gregory; Boulanger, Pascale; Chami, Mohamed; Ebel, Christine			Assessing the Conformational Changes of pb5, the Receptor-binding Protein of Phage T5, upon Binding to Its Escherichia coli Receptor FhuA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Biophysics; Electron Microscopy (EM); Membrane Proteins; Viral Protein; Fluorinated Surfactant; Small Angle Neutron Scattering	LOW-RESOLUTION STRUCTURE; OUTER-MEMBRANE PROTEIN; TAIL FIBER PROTEIN; X-RAY; BACTERIOPHAGE-LAMBDA; NEUTRON-SCATTERING; STRUCTURAL-CHANGES; SURFACTANTS; HOST; PURIFICATION	Background: Little is known about the very first steps of infection of bacterial viruses. Results: We specifically access the structure of phage T5 receptor-binding protein bound to its membrane receptor using specific techniques in small angle neutron scattering. Conclusion: There are no large conformational changes. Significance: Signal transduction within T5 appears different from that of phages binding cell wall saccharides. Within tailed bacteriophages, interaction of the receptor-binding protein (RBP) with the target cell triggers viral DNA ejection into the host cytoplasm. In the case of phage T5, the RBP pb5 and the receptor FhuA, an outer membrane protein of Escherichia coli, have been identified. Here, we use small angle neutron scattering and electron microscopy to investigate the FhuA-pb5 complex. Specific deuteration of one of the partners allows the complete masking in small angle neutron scattering of the surfactant and unlabeled proteins when the complex is solubilized in the fluorinated surfactant F-6-DigluM. Thus, individual structures within a membrane protein complex can be described. The solution structure of FhuA agrees with its crystal structure; that of pb5 shows an elongated shape. Neither displays significant conformational changes upon interaction. The mechanism of signal transduction within phage T5 thus appears different from that of phages binding cell wall saccharides, for which structural information is available.	[Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] Univ Grenoble Alpes, IBS, F-38027 Grenoble, France; [Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] CNRS, IBS, UMR5075, F-38027 Grenoble, France; [Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] CEA, DSV, IBS, F-38027 Grenoble, France; [Durand, Gregory] Univ Avignon, Equipe Chim Bioorgan & Syst Amphiphiles, F-84029 Avignon, France; [Durand, Gregory] Inst Biomol Max Mousseron, UMR 5247, F-34093 Montpellier, France; [Boulanger, Pascale] Univ Paris 11, UMR CNRS 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Chami, Mohamed] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Universite Paris Saclay; University of Basel	Breyton, C (corresponding author), Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble 01, France.	Cecile.Breyton@ibs.fr		Durand, Gregory/0000-0001-6680-2821; Gabel, Frank/0000-0003-3446-2601; Ebel, Christine/0000-0002-6912-500X	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	FRISBI; GRAL	We are grateful to H. Stahlberg (Center for Cellular Imaging and NanoAnalytics) for support. We thank A. Le Roy (IBS) for performing AUC experiments and S. Raynal (University of Avignon) for the synthesis of F<INF>6</INF>-DigluM. We also thank the Laue-Langevin Institute for BAG beamtime on D22, P. Callow and G. Zaccai for local contacting, and the European Synchrotron Radiation Facility for BAG beamtime on ID14-3. This work used the Analytical Ultracentrifugation, Surface Plasmon Resonance, Mass Spectrometry, and Membrane Protein Purification platforms of the Grenoble Instruct Centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	Abla M, 2008, J ORG CHEM, V73, P8142, DOI 10.1021/jo801379e; Abla M, 2012, J FLUORINE CHEM, V134, P63, DOI 10.1016/j.jfluchem.2011.05.015; Basit H, 2012, CHEM COMMUN, V48, P6037, DOI 10.1039/c2cc31107k; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; Braun V, 2009, J BACTERIOL, V191, P3431, DOI 10.1128/JB.00106-09; Breyton C, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13071-6; Breyton C, 2010, METHODS MOL BIOL, V601, P219, DOI 10.1007/978-1-60761-344-2_14; Breyton C, 2009, BIOPHYS J, V97, P1077, DOI 10.1016/j.bpj.2009.05.053; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Cho KH, 2013, CHEMBIOCHEM, V14, P452, DOI 10.1002/cbic.201200759; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533; Dai W, 2010, P NATL ACAD SCI USA, V107, P4347, DOI 10.1073/pnas.0915008107; Ebel C, 2011, METHODS, V54, P56, DOI 10.1016/j.ymeth.2010.11.003; Ferguson AD, 1998, PROTEIN SCI, V7, P1636, DOI 10.1002/pro.5560070719; Flayhan A, 2012, BIOCHIMIE, V94, P1982, DOI 10.1016/j.biochi.2012.05.021; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Ghosh R., 2006, COMPUTING GUIDE SMAL, P35; Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360; HELLER KJ, 1984, J VIROL, V49, P20, DOI 10.1128/JVI.49.1.20-25.1984; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; MONTAG D, 1989, J BACTERIOL, V171, P4378, DOI 10.1128/JB.171.8.4378-4384.1989; Nehme R, 2010, BBA-BIOMEMBRANES, V1798, P1100, DOI 10.1016/j.bbamem.2010.02.015; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; ROESSNER CA, 1983, J BIOL CHEM, V258, P643; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Soto CM, 2010, CURR OPIN BIOTECH, V21, P426, DOI 10.1016/j.copbio.2010.07.004; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Stone R, 2002, SCIENCE, V298, P730, DOI 10.1126/science.298.5594.730; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Talbot JC, 2009, J BIOENERG BIOMEMBR, V41, P349, DOI 10.1007/s10863-009-9235-5; TIMMINS PA, 1988, EUR BIOPHYS J BIOPHY, V15, P257, DOI 10.1007/BF00256476; Udho E, 2012, BIOCHEMISTRY-US, V51, P6753, DOI 10.1021/bi300493u; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Vinga I, 2012, MOL MICROBIOL, V83, P289, DOI 10.1111/j.1365-2958.2011.07931.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	54	31	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30763	30772		10.1074/jbc.M113.501536	http://dx.doi.org/10.1074/jbc.M113.501536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014030	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000329868100076
J	Perez-Basterrechea, M; Obaya, AJ; Meana, A; Otero, J; Esteban, MM				Perez-Basterrechea, Marcos; Obaya, Alvaro J.; Meana, Alvaro; Otero, Jesus; Esteban, Manuel M.			Cooperation by Fibroblasts and Bone Marrow-Mesenchymal Stem Cells to Improve Pancreatic Rat-to-Mouse Islet Xenotransplantation	PLOS ONE			English	Article							TRANSPLANTATION; SURVIVAL; MATRIX; ANGIOGENESIS; APOPTOSIS; CULTURE; MODEL; MICE; IMMUNOSUPPRESSION; IMMUNOMODULATION	Experimental and clinical experiences highlight the need to review some aspects of islet transplantation, especially with regard to site of grafting and control of the immune response. The subcutaneous space could be a good alternative to liver but its sparse vasculature is its main limitation. Induction of graft tolerance by using cells with immunoregulatory properties is a promising approach to avoid graft rejection. Both Fibroblasts and Mesenchymal Stem Cells (MSCs) have shown pro-angiogenic and immunomodulatory properties. Transplantation of islets into the subcutaneous space using plasma as scaffold and supplemented with fibroblasts and/or Bone Marrow-MSCs could be a promising strategy to achieve a functional extra-hepatic islet graft, without using immunosuppressive drugs. Xenogenic rat islets, autologous fibroblasts and/or allogenic BM-MSCs, were mixed with plasma, and coagulation was induced to constitute a Plasma-based Scaffold containing Islets (PSI), which was transplanted subcutaneously both in immunodeficient and immunocompetent diabetic mice. In immunodeficient diabetic mice, PSI itself allowed hyperglycemia reversion temporarily, but the presence of pro-angiogenic cells (fibroblasts or BM-MSCs) within PSI was necessary to improve graft re-vascularization and, thus, consistently maintain normoglycemia. In immunocompetent diabetic mice, only PSI containing BM-MSCs, but not those containing fibroblasts, normalized glycemia lasting up to one week after transplantation. Interestingly, when PSI contained both fibroblasts and BM-MSCs, the normoglycemia period showed an increase of 4-times with a physiological-like response in functional tests. Histology of immunocompetent mice showed an attenuation of the immune response in those grafts with BM-MSCs, which was improved by co-transplantation with fibroblasts, since they increased BM-MSC survival. In summary, fibroblasts and BM-MSCs showed similar pro-angiogenic properties in this model of islet xenotransplantation, whereas only BM-MSCs exerted an immunomodulatory effect, which was improved by the presence of fibroblasts. These results suggest that cooperation of different cell types with islets will be required to achieve a long-term functional graft.	[Perez-Basterrechea, Marcos; Otero, Jesus] Hosp Univ Cent Asturias, Transplants Cell Therapy & Regenerat Med Unit, Oviedo, Spain; [Perez-Basterrechea, Marcos; Obaya, Alvaro J.; Esteban, Manuel M.] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Meana, Alvaro] Ctr Comunitario Sangre & Tejidos Asturias, CIBERER U714, Oviedo, Spain	Central University Hospital Asturias; University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Perez-Basterrechea, M (corresponding author), Hosp Univ Cent Asturias, Transplants Cell Therapy & Regenerat Med Unit, Oviedo, Spain.	marcos.perez@sespa.princast.es	Meana, Alvaro/D-9710-2019; Obaya, Alvaro J./AAQ-6115-2021; Basterrechea, Marcos Perez/L-9052-2014; Otero, Jesus/J-1858-2017	Meana, Alvaro/0000-0001-9434-6042; Obaya, Alvaro J./0000-0002-4163-2173; Basterrechea, Marcos Perez/0000-0002-8242-5365; Otero, Jesus/0000-0003-4097-3846	FICYT [PEST08-12]; FIS [PI03/1439]	FICYT; FIS(Instituto de Salud Carlos III)	This work was supported by a grant from the FICYT (PEST08-12) and FIS (PI03/1439). M. Perez-Basterrechea was awarded a grant from FIS and FYCIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Andrades P, 2007, TRANSPL P, V39, P191, DOI 10.1016/j.transproceed.2006.10.019; Badger JL, 2012, REGEN MED, V7, P675, DOI [10.2217/RME.12.55, 10.2217/rme.12.55]; Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Bharat A, 2005, TRANSPLANTATION, V79, P1627, DOI 10.1097/01.TP.0000159145.86990.44; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9; Cappellesso-Fleury S, 2010, J CLIN IMMUNOL, V30, P607, DOI 10.1007/s10875-010-9415-4; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654; Coppens V, 2013, DIABETOLOGIA, V56, P382, DOI 10.1007/s00125-012-2754-3; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Deshpande M, 2010, HUM IMMUNOL, V71, P1089, DOI 10.1016/j.humimm.2010.08.003; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323; English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560; Halberstadt CR, 2005, CELL TRANSPLANT, V14, P595, DOI 10.3727/000000005783982792; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Hoogduijn MJ, 2010, TRANSPLANTATION, V90, P124, DOI 10.1097/TP.0b013e3181ea4240; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Ikari Y, 2000, THROMB HAEMOSTASIS, V84, P701; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Jacobson S, 2008, ANN NY ACAD SCI, V1150, P213, DOI 10.1196/annals.1447.042; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Kobayashi T, 2006, CELL TRANSPLANT, V15, P359, DOI 10.3727/000000006783981954; Larrivee B, 2003, J BIOL CHEM, V278, P22006, DOI 10.1074/jbc.M212158200; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Melzi R, 2007, TRANSPLANTATION, V83, P167, DOI 10.1097/01.tp.0000250659.24286.43; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; O'Sullivan ES, 2011, ENDOCR REV; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Oudina K, 2011, METHODS MOL BIOL, V740, P165, DOI 10.1007/978-1-61779-108-6_18; Perez-Basterrechea M, 2009, TISSUE ENG PT A, V15, P569, DOI 10.1089/ten.tea.2008.0088; Poulios E, 2006, ANTICANCER RES, V26, P2165; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P211, DOI 10.1007/BF01062525; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Ramji QA, 2011, TRANSPLANTATION, V92, P1309, DOI 10.1097/TP.0b013e3182384ab0; Rickels MR, 2005, DIABETES, V54, P100, DOI 10.2337/diabetes.54.1.100; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; Stenmark KR, 2002, CHEST, V122, p326S, DOI 10.1378/chest.122.6_suppl.326S; Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426; VANDERVLIET JA, 1988, TRANSPLANTATION, V45, P493; Wada N, 2011, STEM CELLS DEV, V20, P647, DOI 10.1089/scd.2010.0246; Wang J, 2011, EXPERT OPIN BIOL TH, V11, P893, DOI 10.1517/14712598.2011.574119; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	60	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73526	10.1371/journal.pone.0073526	http://dx.doi.org/10.1371/journal.pone.0073526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009755	Green Published, gold, Green Submitted			2022-12-25	WOS:000323734600070
J	Tang, XL; Wen, SC; Zheng, D; Tucker, L; Cao, LL; Pantazatos, D; Moss, SF; Ramratnam, B				Tang, Xiaoli; Wen, Sicheng; Zheng, Dong; Tucker, Lynne; Cao, Lulu; Pantazatos, Dennis; Moss, Steven F.; Ramratnam, Bharat			Acetylation of Drosha on the N-Terminus Inhibits Its Degradation by Ubiquitination	PLOS ONE			English	Article							SMALL RNAS; MICRORNA BIOGENESIS; HELICOBACTER-PYLORI; DICER; COMPLEX; PHOSPHORYLATION; DEACETYLATION; RECOGNITION; PATHWAY	The RNase III enzyme Drosha initiates microRNA (miRNA) biogenesis in the nucleus by cleaving primary miRNA transcripts into shorter precursor molecules that are subsequently exported into the cytoplasm for further processing. While numerous disease states appear to be associated with aberrant expression of Drosha, the molecular mechanisms that regulate its protein levels are largely unknown. Here, we report that ubiquitination and acetylation regulate Drosha protein levels oppositely. Deacetylase inhibitors trichostatin A (TSA) and nicotinamide (NIA) increase Drosha protein level as measured by western blot but have no effects on its mRNA level in HEK293T cells. TSA increases miRNA-143 production in a miRNA sensor assay and in a qPCR analysis in HEK293T cells. Treatment of AGS and HEK293T cells with proteasome inhibitors MG132 or Omuralide increases Drosha protein levels. Furthermore, the N-terminal, but not the C-terminal Drosha can be acetylated by multiple acetyl transferases including p300, CBP and GCN5. Acetylation of Drosha competes with its ubquitination, inhibiting the degradation induced by the ubiquitin-proteasome pathway, thereby increasing Drosha protein levels. Infection of the gastric mucosa AGS cells by H. pylori, the gastric cancer associated carcinogen, leads to the ubiquitination and reduction of Drosha protein levels. H. pylori infection of AGS cells has no significant effects on Drosha mRNA levels. Our findings establish a central mechanism of protein homeostasis as playing a critical role in miRNA biogenesis.	[Tang, Xiaoli; Zheng, Dong; Tucker, Lynne; Ramratnam, Bharat] Brown Univ, Dept Med, Warren Alpert Med Sch, Lab Retrovirol,Div Infect Dis, Providence, RI 02912 USA; [Cao, Lulu; Pantazatos, Dennis; Ramratnam, Bharat] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, COBRE Ctr Canc Res,Div Hematol & Oncol, Providence, RI 02903 USA; [Wen, Sicheng; Moss, Steven F.] Brown Univ, Dept Med, Warren Alpert Med Sch, Div Gastroenterol, Providence, RI 02912 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Ramratnam, B (corresponding author), Brown Univ, Dept Med, Warren Alpert Med Sch, Lab Retrovirol,Div Infect Dis, Providence, RI 02912 USA.	BRamratnam@Lifespan.org			National Institutes of Health (NIH) [P20RR025179, R01AI058697]; Lifespan/Brown/Tufts CFAR [P30AI042853]; NIH [T32DA013911]; National Center for Research Resources (NCRR); National Institute of General Medical Sciences (NIGMS) [8P20GM103468, 8P20GM103421]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, R01AI058697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103468, P20GM103421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan/Brown/Tufts CFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by funding from National Institutes of Health (NIH) (P20RR025179 and R01AI058697); Lifespan/Brown/Tufts CFAR (P30AI042853); and NIH T32DA013911 (XT); National Center for Research Resources (NCRR) and the National Institute of General Medical Sciences (NIGMS) 8P20GM103468 and 8P20GM103421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Dedes KJ, 2011, EUR J CANCER, V47, P138, DOI 10.1016/j.ejca.2010.08.007; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Eguchi H, 2003, CANCER RES, V63, P4739; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Kim SS, 2011, CANCER LETT, V305, P228, DOI 10.1016/j.canlet.2010.07.014; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Merritt WM, 2010, CANCER RES, V70, P2571, DOI 10.1158/0008-5472.CAN-09-2536; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020391; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Torres A, 2011, TUMOR BIOL, V32, P769, DOI 10.1007/s13277-011-0179-0; Wada T, 2012, EMBO REP, V13, P142, DOI 10.1038/embor.2011.247; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228	36	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72503	10.1371/journal.pone.0072503	http://dx.doi.org/10.1371/journal.pone.0072503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009686	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600024
J	Cai, BL; Miao, Y; Liu, Y; Xu, XF; Guan, SM; Wu, JZ; Liu, YP				Cai, Bolei; Miao, Ye; Liu, Yuan; Xu, Xiaofang; Guan, Sumin; Wu, Junzheng; Liu, Yanpu			Nuclear Multidrug-Resistance Related Protein 1 Contributes to Multidrug-Resistance of Mucoepidermoid Carcinoma Mainly via Regulating Multidrug-Resistance Protein 1: A Human Mucoepidermoid Carcinoma Cells Model and Spearman's Rank Correlation Analysis	PLOS ONE			English	Article							SALIVARY-GLAND TUMORS; BREAST-CANCER; KINASE PATHWAY; ACTIVATION; POLYMORPHISMS; RAC1; PROLIFERATION; MRP1/ABCC1; INHIBITOR; P38-MAPK	Background: Multidrug resistance-related protein 1 (MRP1/ABCC1) and multidrug resistance protein 1 (MDR1/P-glycoprotein/ABCB1) are both membrane-bound drug transporters. In contrast to MDR1, MRP1 also transports glutathione (GSH) and drugs conjugated to GSH. Due to its extraordinary transport properties, MRP1/ABCC1 contributes to several physiological functions and pathophysiological incidents. We previously found that nuclear translocation of MRP1 contributes to multidrug-resistance (MDR) of mucoepidermoid carcinoma (MEC). The present study investigated how MRP1 contributes to MDR in the nuclei of MEC cells. Methods: Western blot and RT-PCR was carried out to investigate the change of multidrug-resistance protein 1 (MDR1) in MC3/5FU cells after MRP1 was downregulated through RNA interference (RNAi). Immunohistochemistry (IHC) staining of 127 cases of MEC tissues was scored with the expression index (EI). The EI of MDR1 and MRP1 (or nuclear MRP1) was analyzed with Spearman's rank correlation analysis. Using multiple tumor tissue assays, the location of MRP1 in other tissues was checked by HIC. Luciferase reporter assays of MDR1 promoter was carried out to check the connection between MRP1 and MDR1 promoter. Results: MRP1 downregulation led to a decreased MDR1 expression in MC3/5FU cells which was caused by decreased activity of MDR1 promoter. IHC study of 127 cases of MEC tissues demonstrated a strong positive correlation between nuclear MRP1 expression and MDR1 expression. Furthermore, IHC study of multiple tumor tissue array sections showed that although nuclear MRP1 widely existed in MEC tissues, it was not found in normal tissues or other tumor tissues. Conclusions: Our findings indicate that nuclear MRP1 contributes to MDR mainly through regulating MDR1 expression in MEC. And the unique location of MRP1 made it an available target in identifying MEC from other tumors.	[Miao, Ye; Wu, Junzheng] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Biol, Xian 710032, Peoples R China; [Cai, Bolei; Xu, Xiaofang; Liu, Yanpu] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China; [Guan, Sumin] Fourth Mil Med Univ, Sch Stomatol, Dept Prevent Dent, Xian 710032, Peoples R China; [Guan, Sumin] Fourth Mil Med Univ, Sch Stomatol, Infect Control Off, Xian 710032, Peoples R China; [Liu, Yuan] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Histol & Pathol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wu, JZ (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral Biol, Xian 710032, Peoples R China.	caibolei@gmail.com; liuyanpu@fmmu.edu.cn			National Natural Science Foundation of China [81070820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81070820 to Prof. Yan-Pu Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Bell RB, 2005, J ORAL MAXIL SURG, V63, P917, DOI 10.1016/j.joms.2005.03.006; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Cai BL, 2011, ORAL ONCOL, V47, P1134, DOI 10.1016/j.oraloncology.2011.08.005; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Gonzalez-Santiago L, 2006, CELL DEATH DIFFER, V13, P1968, DOI 10.1038/sj.cdd.4401898; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; Guzzo M, 2002, ANN SURG ONCOL, V9, P688, DOI 10.1007/BF02574486; He SM, 2011, CURR MED CHEM, V18, P439, DOI 10.2174/092986711794839197; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Hicks J, 2000, ORAL ONCOL, V36, P454, DOI 10.1016/S1368-8375(00)00033-6; HICKS MJ, 1995, HEAD NECK-J SCI SPEC, V17, P89, DOI 10.1002/hed.2880170203; Hideshima T, 2004, ONCOGENE, V23, P8766, DOI 10.1038/sj.onc.1208118; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Lee SH, 2010, J CLIN PSYCHOPHARM, V30, P116, DOI 10.1097/JCP.0b013e3181d2ef42; Leschziner G, 2006, PHARMACOGENET GENOM, V16, P439, DOI 10.1097/01.fpc.0000197467.21964.67; Liu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053795; Lopes MA, 1999, J ORAL PATHOL MED, V28, P264; Mahjoubi F, 2008, GENET MOL RES, V7, P1369, DOI 10.4238/vol7-4gmr482; Manuel ER, 2011, CANCER RES, V71, P4183, DOI 10.1158/0008-5472.CAN-10-4676; Orata H, 2006, ANTICANCER RES, V26, P2227; Paillas S, 2011, CANCER RES, V71, P1041, DOI 10.1158/0008-5472.CAN-10-2726; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Speight PM, 2002, ORAL DIS, V8, P229, DOI 10.1034/j.1601-0825.2002.02870.x; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; WALDRON CA, 1988, ORAL SURG ORAL MED O, V66, P323, DOI 10.1016/0030-4220(88)90240-X; Wen DS, 2008, ORAL ONCOL, V44, P545, DOI 10.1016/j.oraloncology.2007.06.016; Wen Y, 2001, Hua Xi Kou Qiang Yi Xue Za Zhi, V19, P296; Yin JY, 2009, PHARMACOGENET GENOM, V19, P206, DOI 10.1097/FPC.0b013e328323f680; Yin WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021030	36	11	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e69611	10.1371/journal.pone.0069611	http://dx.doi.org/10.1371/journal.pone.0069611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013781	Green Submitted, Green Published, gold			2022-12-25	WOS:000323815200003
J	Ilieva, M; Dufva, M				Ilieva, Mirolyuba; Dufva, Martin			SOX2 and OCT4 mRNA-Expressing Cells, Detected by Molecular Beacons, Localize to the Center of Neurospheres during Differentiation	PLOS ONE			English	Article							NEURAL STEM-CELLS; TRANSCRIPTIONAL NETWORK; PROGENITOR CELLS; FORMING CELLS; SELF-RENEWAL; IN-VITRO; PROLIFERATION; ASSAY; PLURIPOTENCY; POPULATION	Neurospheres are used as in vitro assay to measure the properties of neural stem cells. To investigate the molecular and phenotypic heterogeneity of neurospheres, molecular beacons (MBs) targeted against the stem cell markers OCT4 and SOX2 were designed, and synthesized with a 2'-O-methyl RNA backbone. OCT4 and SOX2 MBs were transfected into human embryonic mesencephalon derived cells, which spontaneously form neurospheres when grown on poly-L-ornitine/fibronectin matrix and medium complemented with bFGF. OCT4 and SOX2 gene expression were tracked in individual cell using the MBs. Quantitative image analysis every day for seven days showed that the OCT4 and SOX2 mRNA-expressing cells clustered in the centre of the neurospheres cultured in differentiation medium. By contrast, cells at the periphery of the differentiating spheres developed neurite outgrowths and expressed the tyrosine hydroxylase protein, indicating terminal differentiation. Neurospheres cultured in growth medium contained OCT4 and SOX2-positive cells distributed throughout the entire sphere, and no differentiating neurones. Gene expression of SOX2 and OCT4 mRNA detected by MBs correlated well with gene and protein expression measured by qRT-PCR and immunostaining, respectively. These experimental data support the theoretical model that stem cells cluster in the centre of neurospheres, and demonstrate the use of MBs for the spatial localization of specific gene-expressing cells within heterogeneous cell populations.	[Ilieva, Mirolyuba; Dufva, Martin] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Dufva, M (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012	Dufva, Martin/0000-0001-5449-0189; Ilieva, Mirolyuba/0000-0002-7992-8885	Danish Research Council [FTP-09-070568]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was financially supported by the Danish Research Council, Grant-no FTP-09-070568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Binello E, 2012, J CANCER, V3, P166, DOI 10.7150/jca.4149; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen AK, 2011, METHODS MOL BIOL, V714, P159, DOI 10.1007/978-1-61779-005-8_10; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin JH, 2009, BIOCHEM BIOPH RES CO, V388, P247, DOI 10.1016/j.bbrc.2009.07.165; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; De Filippis L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003310; Deleyrolle LP, 2008, ACTA NEUROPSYCHIATR, V20, P2, DOI 10.1111/j.1601-5215.2007.00251.x; Desai HV, 2013, TISSUE ENG PT A, V19, P40, DOI [10.1089/ten.tea.2012.0127, 10.1089/ten.TEA.2012.0127]; FERCHER A, 2012, PHOSPHORESCENCE OXYG; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hill EJ, 2008, TOXICOLOGY, V249, P243, DOI 10.1016/j.tox.2008.05.014; Kerosuo L, 2008, J CELL SCI, V121, P3941, DOI 10.1242/jcs.024802; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Larsson HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049874; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lee SH, 2010, J ANAT, V217, P203, DOI 10.1111/j.1469-7580.2010.01269.x; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Massa D, 2012, TRANSL NEUROSCI, V3, P242, DOI 10.2478/s13380-012-0033-x; MOHYELDIN A, 2010, CELL STEM CELL, V7, DOI DOI 10.1016/J.STEM.2010.07007.PUBMED:20682444; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; PACEY L, 2006, NAT PROTOC, DOI DOI 10.1038/NPR0T.2006.215; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rhee WJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-30; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; Santangelo P, 2006, J VIROL, V80, P682, DOI 10.1128/JVI.80.2.682-688.2006; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Takehara T, 2009, STEM CELLS DEV, V18, P1433, DOI 10.1089/scd.2008.0239; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; Wang TY, 2006, BRAIN RES, V1107, P82, DOI 10.1016/j.brainres.2006.05.110	44	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73669	10.1371/journal.pone.0073669	http://dx.doi.org/10.1371/journal.pone.0073669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013403	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200087
J	Xu, JL; Liu, SY; Zhang, SQ; Guo, WQ; Wang, J				Xu, Junli; Liu, Shiyin; Zhang, Shiqiang; Guo, Wanqin; Wang, Jian			Recent Changes in Glacial Area and Volume on Tuanjiefeng Peak Region of Qilian Mountains, China	PLOS ONE			English	Article							DEGREE-DAY MODEL; ELEVATION CHANGES; HAILUOGOU GLACIER; RUNOFF CHANGES; CLIMATE-CHANGE; SRTM; IMPACT; PENETRATION; EXTENT; ASTER	Glaciers' runoff in the Qilian Mountains serves as a critical water resource in the northern sections of the Gansu province, the northeastern sections of the Qinghai province, and the northeastern fringe of the Tibetan Plateau. Changes in the glacial area and volume around the highest peak of the Qilian Mountains, i.e., Tuanjiefeng Peak, were estimated using multi-temporal remote-sensing images and digital elevation models, and all possible sources of uncertainty were considered in detail. The total glacier area decreased by 16.1 +/- 6.34 km(2) (9.9 +/- 3.9%) during 1966 to 2010. The average annual glacier shrinkage was -0.15% a(-1) from 1966 to 1995, -0.61% a(-1) from 1995 to 2000, -0.20% a(-1) from 2000 to 2006, and -0.45% a(-1) from 2006 to 2010. A comparison of glacier surface elevations using digital elevation models derived from topographic maps in 1966 and from the Shuttle Radar Topography Mission in 1999 suggests that 65% of the grid cells has decreased, thereby indicating that the glacier thickness has declined. The average change in glacier thickness was -7.3 +/- 1.5 m (-0.21 +/- 0.04 m.a(-1)) from 1966 to 1999. Glaciers with northeastern aspects thinned by 8.3 +/- 1.4 m from 1966 to 1999, i.e., almost twice as much as those with southwestern aspects (4.3 +/- 1.3 m). The ice volume decreased by 11.72 +/- 2.38x10(8) m(3) from 1966 to 1999, which was about 17.4% more than the value calculated from the statistical relationship between glacier area and volume. The relationship between glacier area change and elevation zone indicates that glacier change is not only dominated by climate change but also affected by glacier dynamics, which are related to local topography. The varied response of a single glacier to climate change indicates that the glacier area change scheme used in some models must be improved.	[Xu, Junli; Liu, Shiyin; Zhang, Shiqiang; Guo, Wanqin; Wang, Jian] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryosphere Sci, Lanzhou, Peoples R China; [Zhang, Shiqiang] Max Planck Inst Meteorol, D-20146 Hamburg, Germany	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Max Planck Society	Zhang, SQ (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryosphere Sci, Lanzhou, Peoples R China.	zhangsq@lzb.ac.cn	Liu, Shiyin/AAT-4278-2020; Guo, Wanqin/E-7553-2015	Guo, Wanqin/0000-0002-3211-9300; LIU, Shiyin/0000-0002-9625-7497	CAS [XDA05090302, KZCX2-YW-GJ04]; China National Natural Science Foundation [41030638, 41271090, 41121001]	CAS(Chinese Academy of Sciences); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the CAS Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues (Grant No. XDA05090302, http://www.cas.cn/), and the Innovation Project of the Chinese Academy of Sciences (Grant No. KZCX2-YW-GJ04, http://www.cas.cn/). The China National Natural Science Foundation (Grants No. 41030638, 41271090, and 41121001, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt A, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000436; Benn I. D., 1998, GLACIERS GLACIATION, P734; Berthier E, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025862; Bolch T, 2005, NEW STRATEGIES FOR EUROPEAN REMOTE SENSING, P119; Bolch T, 2010, REMOTE SENS ENVIRON, V114, P127, DOI 10.1016/j.rse.2009.08.015; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Casassa G, 2009, HYDROL PROCESS, V23, P31, DOI 10.1002/hyp.7194; Cuffey K.M., 2010, PHYS GLACIERS, P453; [杜文涛 DU Wentao], 2008, [冰川冻土, Journal of Glaciology and Geocryology], V30, P373; Farinotti D, 2009, GLOBAL PLANET CHANGE, V68, P225, DOI 10.1016/j.gloplacha.2009.05.004; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fujita K, 2008, J GLACIOL, V54, P220, DOI 10.3189/002214308784886162; Fujita K, 2008, EARTH PLANET SC LETT, V276, P14, DOI 10.1016/j.epsl.2008.08.028; Gao Y. J., 2009, ENG SURVEYING MAPPIN, V18, P55; Gardelle J, 2012, J GLACIOL, V58, P419, DOI 10.3189/2012JoG11J175; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/NGEO1450, 10.1038/ngeo1450]; [郭万钦 Guo Wanqin], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P765; Haeberli W, 2007, ANN GLACIOL-SER, V46, P150, DOI 10.3189/172756407782871512; Helsen MM, 2008, SCIENCE, V320, P1626, DOI 10.1126/science.1153894; Hoelzle M, 2003, GLOBAL PLANET CHANGE, V36, P295, DOI 10.1016/S0921-8181(02)00223-0; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; Kaab A, 2008, IEEE T GEOSCI REMOTE, V46, P2823, DOI 10.1109/TGRS.2008.2000627; [李占玲 Li Zhanling], 2011, [资源科学, Resources Science], V33, P1877; Liu GK, 2006, GEOMATICS SPATIAL IN, V29, P40; Liu QA, 2010, J GLACIOL, V56, P215, DOI 10.3189/002214310791968520; Liu SY, 2009, J GLACIOL, V55, P353, DOI 10.3189/002214309788608778; Liu SY, 2003, J GLACIOL, V49, P117, DOI 10.3189/172756503781830926; LIU SY, 2000, GLACIERS THEIR ENV C, P101; Luo Y, 2013, J HYDROL, V477, P72, DOI 10.1016/j.jhydrol.2012.11.005; Ma LL, 2010, CHINESE SCI BULL, V55, P2088, DOI 10.1007/s11434-010-3211-7; Miller PE, 2009, IEEE T GEOSCI REMOTE, V47, P1971, DOI 10.1109/TGRS.2009.2012702; Moller M, 2010, J GEOPHYS RES, V116; Narama C, 2010, GLOBAL PLANET CHANGE, V71, P42, DOI 10.1016/j.gloplacha.2009.08.002; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Paul F., 2002, EARSEL EPROCEEDINGS, V2, P15; Paul F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034718; Paul F, 2008, J GLACIOL, V54, P945, DOI 10.3189/002214308787779960; Pieczonka T, 2012, REMOTE SENS ENVIRON, V130, P233; Rignot E, 2001, GEOPHYS RES LETT, V28, P3501, DOI 10.1029/2000GL012484; ROTT H, 1993, ADV SPACE RES-SERIES, V14, P217; Sauber J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023943; Schenk T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024328; Schiefer E, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030780; Shangguan DH, 2010, J GLACIOL, V56, P309, DOI 10.3189/002214310791968566; Shangguan D, 2009, PROG NAT SCI-MATER, V19, P727, DOI 10.1016/j.pnsc.2008.11.002; Shi Y.F., 2008, CONCISE GLACIER INVE; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Silverio W, 2005, REMOTE SENS ENVIRON, V95, P342, DOI 10.1016/j.rse.2004.12.012; Summerfield L, 1991, WOMANS PLACE MEMOIRS; Sund M, 2009, ANN GLACIOL, V50, P50, DOI 10.3189/172756409789624265; Surazakov AB, 2006, IEEE T GEOSCI REMOTE, V44, P2991, DOI 10.1109/TGRS.2006.875357; [田洪阵 Tian Hongzhen], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P277; Van Niel TG, 2008, REMOTE SENS ENVIRON, V112, P2430, DOI 10.1016/j.rse.2007.11.003; Wang YC, 2008, MODERN SURVEYING MAP, V31, P13; Wang YT, 2008, J MT SCI-ENGL, V5, P299, DOI 10.1007/s11629-008-0224-7; Wang Z, 1983, ACTA GEOGRAPHICA SIN, V38, P141; Wang ZT, 1981, GLACIER INVENTORY CH, P1; Yao TD, 2004, SCI CHINA SER D, V47, P1065, DOI 10.1360/03yd0256; Zhang SQ, 2012, HYDROL PROCESS, V26, P1697, DOI 10.1002/hyp.8291; Zhang SQ, 2012, HYDROL PROCESS, V26, P1686, DOI 10.1002/hyp.8286; Zhang Y, 2010, J GLACIOL, V56, P65, DOI 10.3189/002214310791190884	62	28	34	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70574	10.1371/journal.pone.0070574	http://dx.doi.org/10.1371/journal.pone.0070574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015174	Green Published, gold, Green Submitted			2022-12-25	WOS:000323815200006
J	Turner, C; Carrara, V; Thein, NAM; Win, NCMM; Turner, P; Bancone, G; White, NJ; McGready, R; Nosten, F				Turner, Claudia; Carrara, Verena; Thein, Naw Aye Mya; Win, Naw Chit Mo Mo; Turner, Paul; Bancone, Germana; White, Nicholas J.; McGready, Rose; Nosten, Francois			Neonatal Intensive Care in a Karen Refugee Camp: A 4 Year Descriptive Study	PLOS ONE			English	Article							CHILD-MORTALITY; SYSTEMATIC ANALYSIS; NATIONAL CAUSES; SURVIVAL; BIRTH; INTERVENTIONS; BURMESE; COUNTRY; BABIES; COST	Background: A third of all deaths in children aged <5 years occur in the neonatal period. Neonatal intensive care is often considered too complex and expensive to be implemented in resource poor settings. Consequently the reductions that have been made in infant mortality in the poorest countries have not been made in the neonatal period. This manuscript describes the activities surrounding the introduction of special care baby unit (SCBU) in a refugee setting and the resulting population impact. Methods: A SCBU was developed in Maela refugee camp on the Thailand-Myanmar border. This unit comprised of a dedicated area, basic equipment, drugs and staff training. Training was built around neonatal guidelines, comprising six clinical steps: recognition, resuscitation, examination, supportive medical care, specialised medical care, and counselling of parents with sick newborns. Results: From January 2008 until December 2011, 952 infants were admitted to SCBU. The main admission diagnoses were early onset neonatal sepsis, jaundice and prematurity. Early prematurity (<34 weeks) carried the highest risk of mortality (OR 9.5, 95% CI 5.4-16.5, p<0.001). There was a significant decrease in mortality from 19.3% (2008) to 4.8% (2011) among the infants admitted for prematurity (p=0.03). The neonatal mortality in Maela camp as a whole declined by 51% from 21.8 to 10.7 deaths per 1000 live births over the corresponding period (p=0.04). Staff expressed more confidence in their ability to take care of neonates and there was a more positive attitude towards premature infants. Conclusion: Neonatal mortality can be reduced in a resource poor setting by introduction of a simple low cost unit specialising in care of sick neonates and run by local health workers following adequate training. Training in recognition and provision of simple interventions at a high standard can increase staff confidence and reduce fatalistic attitudes towards premature neonates.	[Turner, Claudia; Carrara, Verena; Thein, Naw Aye Mya; Win, Naw Chit Mo Mo; Turner, Paul; Bancone, Germana; McGready, Rose; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Claudia; Turner, Paul; White, Nicholas J.; McGready, Rose; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Claudia; Turner, Paul; White, Nicholas J.; McGready, Rose; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford	Turner, C (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	claudia@tropmedres.ac	Nosten, Francois/AAC-5509-2019; Carrara, Verena/R-6492-2019; McGready, Rose/A-3290-2014; White, Nick/AAC-6527-2019	Nosten, Francois/0000-0002-7951-0745; Carrara, Verena/0000-0002-2758-0872; McGready, Rose/0000-0003-1621-3257; White, Nick/0000-0002-1897-1978; Turner, Paul/0000-0002-1013-7815; Bancone, Germana/0000-0003-4550-0431	Wellcome Trust of Great Britain [077166/Z/05]	Wellcome Trust of Great Britain(Wellcome Trust)	CT, RM and FN are supported by the Wellcome Trust of Great Britain (Grant No. 077166/Z/05). Shoklo Malaria Research Unit is part of the Mahidol-Oxford University Tropical Medicine Research Program at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, and supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Ballot DE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-11; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cheah PY, 2010, INT HEALTH, V2, P123, DOI 10.1016/j.inhe.2010.02.001; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Jalloh S, 2005, PEDIATR INT, V47, P258, DOI 10.1111/j.1442-200x.2005.02052.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; McGready R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040244; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; Rijken MJ, 2012, ULTRASOUND OBST GYN, V40, P151, DOI 10.1002/uog.11091; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; St John EB, 2000, AM J OBSTET GYNECOL, V182, P170, DOI 10.1016/S0002-9378(00)70509-6; UNICEF, 2012, THAIL STAT; UNICEF, 2012, REP UN MYANM STAT	21	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72721	10.1371/journal.pone.0072721	http://dx.doi.org/10.1371/journal.pone.0072721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991145	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470700049
J	Urayama, KY; Chokkalingam, AP; Metayer, C; Hansen, H; May, S; Ramsay, P; Wiemels, JL; Wiencke, JK; Trachtenberg, E; Thompson, P; Ishida, Y; Brennan, P; Jolly, KW; Termuhlen, AM; Taylor, M; Barcellos, LF; Buffler, PA				Urayama, Kevin Y.; Chokkalingam, Anand P.; Metayer, Catherine; Hansen, Helen; May, Suzanne; Ramsay, Patricia; Wiemels, Joseph L.; Wiencke, John K.; Trachtenberg, Elizabeth; Thompson, Pamela; Ishida, Yasushi; Brennan, Paul; Jolly, Kent W.; Termuhlen, Amanda M.; Taylor, Malcolm; Barcellos, Lisa F.; Buffler, Patricia A.			SNP Association Mapping across the Extended Major Histocompatibility Complex and Risk of B-Cell Precursor Acute Lymphoblastic Leukemia in Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS-II REGION; CHILDHOOD LEUKEMIA; JAPANESE POPULATION; SUSCEPTIBILITY LOCI; TRIPARTITE MOTIF; HUMAN MHC; HLA-DOA; RECOMBINATION; FAMILY	The extended major histocompatibility complex (xMHC) is the most gene-dense region of the genome and harbors a disproportionately large number of genes involved in immune function. The postulated role of infection in the causation of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) suggests that the xMHC may make an important contribution to the risk of this disease. We conducted association mapping across an approximately 4 megabase region of the xMHC using a validated panel of single nucleotide polymorphisms (SNPs) in childhood BCP-ALL cases (n=567) enrolled in the Northern California Childhood Leukemia Study (NCCLS) compared with population controls (n=892). Logistic regression analyses of 1,145 SNPs, adjusted for age, sex, and Hispanic ethnicity indicated potential associations between several SNPs and childhood BCP-ALL. After accounting for multiple comparisons, one of these included a statistically significant increased risk associated with rs9296068 (OR=1.40, 95% CI=1.19-1.66, corrected p=0.036), located in proximity to HLA-DOA. Sliding window haplotype analysis identified an additional locus located in the extended class I region in proximity to TRIM27 tagged by a haplotype comprising rs1237485, rs3118361, and rs2032502 (corrected global p=0.046). Our findings suggest that susceptibility to childhood BCP-ALL is influenced by genetic variation within the xMHC and indicate at least two important regions for future evaluation.	[Urayama, Kevin Y.; Chokkalingam, Anand P.; Metayer, Catherine; Buffler, Patricia A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Urayama, Kevin Y.] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Hansen, Helen; Wiemels, Joseph L.; Wiencke, John K.] Univ Calif San Francisco, Lab Mol & Neuroepidemiol, San Francisco, CA 94143 USA; [May, Suzanne; Ramsay, Patricia; Barcellos, Lisa F.] Univ Calif Berkeley, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA; [Trachtenberg, Elizabeth] Childrens Hosp Oakland, Res Inst, Ctr Genet, Oakland, CA 94609 USA; [Thompson, Pamela] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France; [Jolly, Kent W.] Kaiser Permanente, Dept Pediat, Roseville, CA USA; [Termuhlen, Amanda M.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Termuhlen, Amanda M.] Miller Childrens Hosp, Jonathan Jaques Childrens Canc Ctr, Long Beach, CA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Manchester; World Health Organization; International Agency for Research on Cancer (IARC); Kaiser Permanente; University of Southern California	Urayama, KY (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	kurayama@luke.or.jp		Thompson, Pamela/0000-0002-2660-6348; Metayer, Catherine/0000-0003-3467-4145	US National Institute of Environmental Health Sciences [R01ES09137, P42ES0470518]; National Cancer Institute [R03CA125823]; Children with Cancer Foundation, United Kingdom [2005/027, 2005/028, 2006/051, 2006/052]; NATIONAL CANCER INSTITUTE [R03CA125823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009137] Funding Source: NIH RePORTER	US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children with Cancer Foundation, United Kingdom; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the US National Institute of Environmental Health Sciences (R01ES09137, P42ES0470518), the National Cancer Institute (R03CA125823), and the Children with Cancer Foundation (2005/027, 2005/028, 2006/051, 2006/052), United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich MC, 2006, CANCER EPIDEM BIOMAR, V15, P578, DOI 10.1158/1055-9965.EPI-05-0833; Alper CA, 2006, HUM IMMUNOL, V67, P73, DOI 10.1016/j.humimm.2005.11.006; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartley K, 2010, INT J EPIDEMIOL, V39, P1628, DOI 10.1093/ije/dyq162; Cai XJ, 2011, P NATL ACAD SCI USA, V108, P20072, DOI 10.1073/pnas.1111233109; Chang JS, 2012, INT J EPIDEMIOL, V41, P1050, DOI 10.1093/ije/dys113; Chokkalingam Anand P, 2011, Epidemiology (Sunnyvale), V1, P101; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Crouch S, 2012, AM J EPIDEMIOL, V176, P402, DOI 10.1093/aje/kws180; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; Di L, 2010, J BIOL CHEM, V285, P38765, DOI 10.1074/jbc.M110.168070; Do TN, 2009, CANCER GENET CYTOGEN, V195, P31, DOI 10.1016/j.cancergencyto.2009.05.009; Dorak MT, 2009, PEDIATR BLOOD CANCER, V53, P1242, DOI 10.1002/pbc.22236; Dorak MT, 1999, BLOOD, V94, P694, DOI 10.1182/blood.V94.2.694.414k07_694_700; Dorak MT, 2002, LEUKEMIA RES, V26, P651, DOI 10.1016/S0145-2126(01)00189-8; Douek DC, 1997, INT IMMUNOL, V9, P355, DOI 10.1093/intimm/9.3.355; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; GREAVES MF, 1993, LEUKEMIA, V7, P27; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Han S, 2010, LEUKEMIA RES, V34, P1271, DOI 10.1016/j.leukres.2010.02.001; Hansen HM, 2007, CANCER EPIDEM BIOMAR, V16, P1686, DOI 10.1158/1055-9965.EPI-06-1024; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hosking FJ, 2011, BLOOD, V117, P1633, DOI 10.1182/blood-2010-08-301598; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; Klitz W, 2012, IMMUNOGENETICS, V64, P409, DOI 10.1007/s00251-012-0605-5; Ma XM, 2004, AM J EPIDEMIOL, V159, P915, DOI 10.1093/aje/kwh136; Oliphant A, 2002, BIOTECHNIQUES, P56; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pasaniuc B, 2010, GENET EPIDEMIOL, V34, P773, DOI 10.1002/gepi.20505; Paynter RA, 2006, CANCER EPIDEM BIOMAR, V15, P2533, DOI 10.1158/1055-9965.EPI-06-0219; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Santin I, 2009, GENES IMMUN, V10, P596, DOI 10.1038/gene.2009.41; Sindhi R, 2008, GASTROENTEROLOGY, V135, P830, DOI 10.1053/j.gastro.2008.05.080; Souwer Y, 2009, BRIT J HAEMATOL, V145, P334, DOI 10.1111/j.1365-2141.2009.07625.x; Taylor GM, 2009, BRIT J HAEMATOL, V145, P87, DOI 10.1111/j.1365-2141.2008.07571.x; Taylor GM, 2002, HUM MOL GENET, V11, P1585; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Ucisik-Akkaya E, 2010, CELL STRESS CHAPERON, V15, P475, DOI 10.1007/s12192-009-0161-6; Urayama KY, 2013, INT J HEMATOL, V97, P3, DOI 10.1007/s12185-012-1220-9; Urayama KY, 2012, BLOOD, V120, P3039, DOI 10.1182/blood-2012-01-404723; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; van Ham M, 2000, J EXP MED, V191, P1127, DOI 10.1084/jem.191.7.1127; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhao T, 2004, HUM MUTAT, V23, P534, DOI 10.1002/humu.20049	59	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72557	10.1371/journal.pone.0072557	http://dx.doi.org/10.1371/journal.pone.0072557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991122	Green Published, gold			2022-12-25	WOS:000324470700041
J	Yamane, T; Nakagami, G; Yoshino, S; Muramatsu, A; Matsui, S; Oishi, Y; Kanazawa, T; Minematsu, T; Sanada, H				Yamane, Takumi; Nakagami, Gojiro; Yoshino, Sawako; Muramatsu, Aimi; Matsui, Sho; Oishi, Yuichi; Kanazawa, Toshiki; Minematsu, Takeo; Sanada, Hiromi			Hydrocellular Foam Dressing Promotes Wound Healing along with Increases in Hyaluronan Synthase 3 and PPAR alpha Gene Expression in Epidermis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN SKIN; HOMEOSTASIS; CYTOKINES	Background: Hydrocellular foam dressing, modern wound dressing, induces moist wound environment and promotes wound healing: however, the regulatory mechanisms responsible for these effects are poorly understood. This study was aimed to reveal the effect of hydrocellular foam dressing on hyaluronan, which has been shown to have positive effects on wound healing, and examined its regulatory mechanisms in rat skin. Methodology/Principal Findings: We created two full-thickness wounds on the dorsolateral skin of rats. Each wound was covered with either a hydrocellular foam dressing or a film dressing and hyaluronan levels in the periwound skin was measured. We also investigated the mechanism by which the hydrocellular foam dressing regulates hyaluronan production by measuring the gene expression of hyaluronan synthase 3 (Has3), peroxisome proliferator-activated receptor alpha (PPAR alpha), and CD44. Hydrocellular foam dressing promoted wound healing and upregulated hyaluronan synthesis, along with an increase in the mRNA levels of Has3, which plays a primary role in hyaluronan synthesis in epidermis. In addition, hydrocellular foam dressing enhanced the mRNA levels of PPAR alpha, which upregulates Has3 gene expression, and the major hyaluronan receptor CD44. Conclusions/Significance: These findings suggests that hydrocellular foam dressing may be beneficial for wound healing along with increases in hyaluronan synthase 3 and PPARa gene expression in epidermis. We believe that the present study would contribute to the elucidation of the mechanisms underlying the effects of hydrocellular foam dressing-induced moist environment on wound healing and practice evidence-based wound care.	[Yamane, Takumi; Nakagami, Gojiro; Kanazawa, Toshiki; Minematsu, Takeo; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan; [Yamane, Takumi; Yoshino, Sawako; Muramatsu, Aimi; Matsui, Sho; Oishi, Yuichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan	University of Tokyo; Tokyo University of Agriculture	Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan.	hsanada-tky@umin.ac.jp	Yamane, Takumi/N-7442-2019; Nakagami, Gojiro/V-9093-2019	Nakagami, Gojiro/0000-0002-9650-2464; Minematsu, Takeo/0000-0001-5859-7290				Banks V, 1997, J Wound Care, V6, P266; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Fang XM, 2012, ARCH TOXICOL, V86, P1515, DOI 10.1007/s00204-012-0877-4; Frenkel JS, 2012, INT WOUND J; Grimstad O, 2011, WOUND REPAIR REGEN, V19, P337, DOI 10.1111/j.1524-475X.2011.00668.x; HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200378a0; Jones V, 2000, Nurs Times, V96, P2; JONKMAN MF, 1990, J INVEST DERMATOL, V94, P477, DOI 10.1111/1523-1747.ep12874624; Karlsmark T, 2003, J Wound Care, V12, P351; Kim SH, 2006, ARCH DERMATOL RES, V298, P273, DOI 10.1007/s00403-006-0684-y; Kuenzli S, 2003, BRIT J DERMATOL, V149, P229, DOI 10.1046/j.1365-2133.2003.05532.x; Kunugiza Y, 2010, J WOUND CARE, V19, P10, DOI 10.12968/jowc.2010.19.1.46093; Luo XM, 2011, MOL CANCER RES, V9, P1018, DOI 10.1158/1541-7786.MCR-10-0472; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Oishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P736, DOI 10.1271/bbb.67.736; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785; SALISBURY RE, 1979, ARCH SURG-CHICAGO, V114, P1188; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0	21	11	11	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73988	10.1371/journal.pone.0073988	http://dx.doi.org/10.1371/journal.pone.0073988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991211	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470700066
J	Mangus, CW; Massey, PR; Fowler, DH; Amarnath, S				Mangus, Courtney W.; Massey, Paul R.; Fowler, Daniel H.; Amarnath, Shoba			Rapamycin Resistant Murine Th9 Cells Have a Stable In Vivo Phenotype and Inhibit Graft-Versus-Host Reactivity	PLOS ONE			English	Article							T-CELLS; PROMOTES; INDUCTION; REJECTION; AUTOPHAGY; TH1/TC1; IL-9; BETA	The cytokine micro-environment can direct murine CD4(+) T cells towards various differentiation lineages such as Th1, Th2 and Tregs even in the presence of rapamycin, which results in T cells that mediate increased in vivo effects. Recently, a new lineage of T cells known as Th9 cells that secrete increased IL-9 have been described. However, it is not known whether Th9 differentiation occurs in the presence of rapamycin or whether adoptively transferred donor Th9 cells would augment or restrict alloreactivity after experimental bone marrow transplantation. We found that CD4(+) T cells that were co-stimulated and polarized with TGF-beta and IL-4 in the presence or absence of rapamycin each yielded effector cells of Th9 phenotype that secreted increased IL-9 and expressed a transcription factor profile characteristic of both Th9 and Th2 cells (high GATA-3/low T-bet). Augmentation of T cell replete allografts with manufactured rapamycin resistant Th9 cells markedly reduced both CD4(+) and CD8(+) T cell engraftment and strongly inhibited allo-specific T cell secretion of IFN-gamma. The potency of Th9 cell inhibition of alloreactivity was similar to that of rapamycin resistant Th2 cells. Importantly, rapamycin resistant Th9 cells persisted and maintained their cytokine phenotype, thereby indicating limited differentiation plasticity of the Th9 subset. As such, Th9 differentiation proceeds in the presence of rapamycin to generate a cell therapy product that maintains high IL-9 expression in vivo while inhibiting IFN-gamma driven alloreactivity.	[Mangus, Courtney W.; Massey, Paul R.; Fowler, Daniel H.; Amarnath, Shoba] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Mangus, Courtney W.] NIH, Howard Hughes Med Inst, Res Scholars Program, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Amarnath, S (corresponding author), NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA.	samarnath@mail.nih.gov	amarnath, shoba/AAP-4391-2020		Center for Cancer Research, National Cancer Institute, Intramural Research Program; Howard Hughes Research Scholars Program	Center for Cancer Research, National Cancer Institute, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Research Scholars Program	This work was supported by the Center for Cancer Research, National Cancer Institute, Intramural Research Program and by the Howard Hughes Research Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Amarnath S, 2012, IMMUNOTHERAPY-UK, V4, P1, DOI [10.2217/IMT.11.144, 10.2217/imt.11.144]; Amarnath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018885; Amarnath S, 2010, AUTOPHAGY, V6, P523, DOI 10.4161/auto.6.4.11811; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; Fowler DH, 2013, BLOOD, V121, P2864, DOI 10.1182/blood-2012-08-446872; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Khan WI, 2003, INFECT IMMUN, V71, P2430, DOI 10.1128/IAI.71.5.2430-2438.2003; Laurence A, 2012, IMMUNITY, V37, P209, DOI 10.1016/j.immuni.2012.05.027; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Mariotti J, 2008, BLOOD, V112, P4765, DOI 10.1182/blood-2008-05-154278; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Poulin LF, 2003, TRANSPLANTATION, V76, P572, DOI 10.1097/01.TP.0000071201.32424.D2; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Tan C, 2012, CRIT REV IMMUNOL, V32, P1; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133	25	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72305	10.1371/journal.pone.0072305	http://dx.doi.org/10.1371/journal.pone.0072305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991087	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100097
J	Noorbakhsh, J; Lang, AH; Mehta, P				Noorbakhsh, Javad; Lang, Alex H.; Mehta, Pankaj			Intrinsic Noise of microRNA-Regulated Genes and the ceRNA Hypothesis	PLOS ONE			English	Article							CHAIN-ELONGATION RATE; SMALL RNAS; ESCHERICHIA-COLI; ANIMAL DEVELOPMENT; EXPRESSION; STOCHASTICITY; TRANSLATION; MIRNAS; ACTIVATION; REPRESSION	MicroRNAs are small noncoding RNAs that regulate genes post-transciptionally by binding and degrading target eukaryotic mRNAs. We use a quantitative model to study gene regulation by inhibitory microRNAs and compare it to gene regulation by prokaryotic small non-coding RNAs (sRNAs). Our model uses a combination of analytic techniques as well as computational simulations to calculate the mean-expression and noise profiles of genes regulated by both microRNAs and sRNAs. We find that despite very different molecular machinery and modes of action (catalytic vs stoichiometric), the mean expression levels and noise profiles of microRNA-regulated genes are almost identical to genes regulated by prokaryotic sRNAs. This behavior is extremely robust and persists across a wide range of biologically relevant parameters. We extend our model to study crosstalk between multiple mRNAs that are regulated by a single microRNA and show that noise is a sensitive measure of microRNA-mediated interaction between mRNAs. We conclude by discussing possible experimental strategies for uncovering the microRNA-mRNA interactions and testing the competing endogenous RNA (ceRNA) hypothesis.	[Noorbakhsh, Javad; Lang, Alex H.; Mehta, Pankaj] Boston Univ, Dept Phys, Boston, MA 02215 USA	Boston University	Mehta, P (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	pankajm@bu.edu		Mehta, Pankaj/0000-0003-1290-5897	National Institutes of Health [K25GM086909]; Boston University; National Science Foundation [DGE- 0741448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K25GM086909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants K25GM086909 (to PM), a Boston University Dean's Fellowship and a National Science Foundation Graduate Research Fellowship under Grant No. DGE- 0741448 (AHL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baehrecke EH, 2003, CURR BIOL, V13, pR473, DOI 10.1016/S0960-9822(03)00405-6; Baker C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061915; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Deneke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055442; Elgart V, 2010, BIOPHYS J, V98, P2780, DOI 10.1016/j.bpj.2010.03.022; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gottesman S, 2011, COLD SPRING HARBOR P, V3; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Hao Y, 2011, J MOL BIOL, V406, P195, DOI 10.1016/j.jmb.2010.12.008; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jia Y, 2009, BIOPHYS CHEM, V143, P60, DOI 10.1016/j.bpc.2009.04.001; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kampen NGV, 2007, STOCHASTIC PROCESSES, V3; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Niepmann M, 2009, CELL CYCLE, V8, P1473, DOI 10.4161/cc.8.10.8349; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Platini T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021928; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185	64	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72676	10.1371/journal.pone.0072676	http://dx.doi.org/10.1371/journal.pone.0072676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991139	Green Submitted, Green Published, gold			2022-12-25	WOS:000324470100112
J	Bjerke, GA; Yang, CS; Frierson, HF; Paschal, BM; Wotton, D				Bjerke, G. A.; Yang, C-S; Frierson, H. F.; Paschal, B. M.; Wotton, D.			Activation of Akt signaling in prostate induces a TGF beta-mediated restraint on cancer progression and metastasis	ONCOGENE			English	Article						TGF beta; Akt; Pten; prostate cancer; signaling	TUMOR-SUPPRESSOR GENE; INTRAEPITHELIAL NEOPLASIA; CELL-PROLIFERATION; II RECEPTORS; PTEN; GROWTH; MOUSE; INACTIVATION; PTEN/MMAC1; EXPRESSION	Mutations in the PTEN tumor suppressor gene are found in a high proportion of human prostate cancers, and in mice, Pten deletion induces high-grade prostate intraepithelial neoplasia (HGPIN). However, progression from HGPIN to invasive cancer occurs slowly, suggesting that tumorigenesis is subject to restraint. We show that Pten deletion, or constitutive activation of the downstream kinase AKT, activates the transforming growth factor (TGF)beta pathway in prostate epithelial cells. TGF beta signaling is known to have a tumor suppressive role in many cancer types, and reduced expression of TGF beta receptors correlates with advanced human prostate cancer. We demonstrate that in combination either with loss of Pten or expression of constitutively active AKT1, inactivation of TGF beta signaling by deletion of the TGF beta type II receptor gene relieves a restraint on tumorigenesis. This results in rapid progession to lethal prostate cancer, including metastasis to lymph node and lung. In prostate epithelium, inactivation of TGF beta signaling alone is insufficient to initiate tumorigenesis, but greatly accelerates cancer progression. The activation of TGF beta signaling by Pten loss or AKT activation suggests that the same signaling events that have key roles in tumor initiation also induce the activity of a pathway that restrains disease progression.	[Bjerke, G. A.; Yang, C-S; Paschal, B. M.; Wotton, D.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Bjerke, G. A.; Yang, C-S; Paschal, B. M.; Wotton, D.] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Frierson, H. F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Wotton, D (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Ctr Cell Signaling, Box 800577, Charlottesville, VA 22908 USA.	dw2p@virginia.edu		Wotton, David/0000-0002-4652-5350	National Cancer Institute [2P01CA104106]; UVA Cancer Center; James and Rebecca Craig Foundation [CCSG P30 CA44579]; UVA Women's Oncology fund; NATIONAL CANCER INSTITUTE [P30CA044579, P01CA104106] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UVA Cancer Center; James and Rebecca Craig Foundation; UVA Women's Oncology fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Sharon Birdsall and Marya Brown for technical assistance, Doug DeSimone for use of the Zeiss microscope, Anindya Dutta and Dan Gioeli for helpful discussions and Tiffany Melhuish for expert advice and assistance. This work was supported by a Program Project Grant from the National Cancer Institute (2P01CA104106 to B Paschal and D Wotton), and by a pilot grant from the UVA Cancer Center (funded from the CCSG P30 CA44579, the James and Rebecca Craig Foundation, and UVA Women's Oncology fund) to D Wotton.	Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Bartholin L, 2008, DEV BIOL, V319, P285, DOI 10.1016/j.ydbio.2008.04.027; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; Cairns P, 1997, CANCER RES, V57, P4997; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Guo YP, 1997, INT J CANCER, V71, P573, DOI 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.3.CO;2-1; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim J, 2012, ONCOGENE, V31, P322, DOI 10.1038/onc.2011.236; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Powers SE, 2010, DEVELOPMENT, V137, P249, DOI 10.1242/dev.040782; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki H, 1998, CANCER RES, V58, P204; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Williams RH, 1996, CLIN CANCER RES, V2, P635; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yamada KM, 2001, J CELL SCI, V114, P2375; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2; Zhao H, 2005, CANCER-AM CANCER SOC, V104, P44, DOI 10.1002/cncr.21135	42	23	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 10	2014	33	28					3660	3667		10.1038/onc.2013.342	http://dx.doi.org/10.1038/onc.2013.342			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL2GC	23995785	Green Accepted			2022-12-25	WOS:000338942900005
J	Billings, SE; Pierzchalski, K; Tjaden, NEB; Pang, XY; Trainor, PA; Kane, MA; Moise, AR				Billings, Sara E.; Pierzchalski, Keely; Tjaden, Naomi E. Butler; Pang, Xiao-Yan; Trainor, Paul A.; Kane, Maureen A.; Moise, Alexander R.			The retinaldehyde reductase DHRS3 is essential for preventing the formation of excess retinoic acid during embryonic development	FASEB JOURNAL			English	Article						development; metabolism; nuclear receptors; retinoid; vitamin A	SHORT-CHAIN DEHYDROGENASE/REDUCTASE; VITAMIN-A; RESPONSE ELEMENT; GENE-EXPRESSION; TARGETED DISRUPTION; METABOLIZING ENZYME; CERVICAL-VERTEBRAE; IN-VIVO; HINDBRAIN; HEART	Oxidation of retinol via retinaldehyde results in the formation of the essential morphogen all-trans-retinoic acid (ATRA). Previous studies have identified critical roles in the regulation of embryonic ATRA levels for retinol, retinaldehyde, and ATRA-oxidizing enzymes; however, the contribution of retinaldehyde reductases to ATRA metabolism is not completely understood. Herein, we investigate the role of the retinaldehyde reductase Dhrs3 in embryonic retinoid metabolism using a Dhrs3-deficient mouse. Lack of DHRS3 leads to a 40% increase in the levels of ATRA and a 60% and 55% decrease in the levels of retinol and retinyl esters, respectively, in Dhrs3(-/-) embryos compared to wild-type littermates. Furthermore, accumulation of excess ATRA is accompanied by a compensatory 30-50% reduction in the expression of ATRA synthetic genes and a 120% increase in the expression of the ATRA catabolic enzyme Cyp26a1 in Dhrs3(-/-) embryos vs. controls. Excess ATRA also leads to alterations (40-80%) in the expression of several developmentally important ATRA target genes. Consequently, Dhrs3(-/-) embryos die late in gestation and display defects in cardiac outflow tract formation, atrial and ventricular septation, skeletal development, and palatogenesis. These data demonstrate that the reduction of retinaldehyde by DHRS3 is critical for preventing formation of excess ATRA during embryonic development.	[Billings, Sara E.; Pang, Xiao-Yan; Moise, Alexander R.] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Pierzchalski, Keely; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Tjaden, Naomi E. Butler; Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Tjaden, Naomi E. Butler; Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	University of Kansas; University System of Maryland; University of Maryland Baltimore; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Moise, AR (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, 5060 Malott Hall,1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	alexmoise@ku.edu	Tjaden, Naomi/GVU-6515-2022; AR, Moise/P-2474-2019; Moise, Alexander R/C-9498-2009	AR, Moise/0000-0003-2307-6035; Moise, Alexander R/0000-0003-2307-6035; Trainor, Paul/0000-0003-2774-3624; Pierzchalski, Keely/0000-0002-2456-0382	University of Kansas School of Pharmacy; U.S. National Center for Research Resources (NCRR); National Institute of General Medical Sciences (NIGMS) [5P20RR017708-10, 8 P20 GM103420-10]; University of Kansas Center for Research; University of Maryland School of Pharmacy; U.S. National Instittue of Allergy and Infectious Diseases [HHSN272202000046C]; Stowers Institute for Medical Research; National Institute for Dental and Craniofacial Research [DE016082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD077260] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420] Funding Source: NIH RePORTER	University of Kansas School of Pharmacy; U.S. National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Kansas Center for Research; University of Maryland School of Pharmacy; U.S. National Instittue of Allergy and Infectious Diseases; Stowers Institute for Medical Research; National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Joseph Napoli, Rick Dobrowsky and Jeff Staudinger for valuable suggestions. The authors thank Dr. Janet Rossant (University of Toronto, the Hospital for Sick Children, Toronto, ON, Canada) for the gift of the RARE-LacZ reporter mice and Dr. Fred de Sauvage (Genentech, South San Francisco, CA, USA) and Lexicon Pharmaceuticals (The Woodlands, TX, USA) for sharing the Dhrs3<SUP>-/-</SUP> strain. The authors also thank Dr. David Moore, Ms. Heather Shinogle and Dr. Jennifer Hueston for help with microscopy and the use of a dissecting microscope. This work was supported by new faculty startup funds from the University of Kansas School of Pharmacy (A. R. M.); by grants from the U.S. National Center for Research Resources (NCRR) and National Institute of General Medical Sciences (NIGMS; 5P20RR017708-10 and 8 P20 GM103420-10; A. R. M.); by an award from the General Research Fund from the University of Kansas Center for Research (A. R. M.); by new faculty startup funds from the University of Maryland School of Pharmacy (M. A. K.) and U.S. National Instittue of Allergy and Infectious Diseases contract HHSN272202000046C (M. A. K.); and by the Stowers Institute for Medical Research and the National Institute for Dental and Craniofacial Research (DE016082; P.A.T.).	ABBOTT BD, 1989, TERATOLOGY, V40, P533, DOI 10.1002/tera.1420400602; Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Ackermans MMG, 2011, NUTR REV, V69, P613, DOI 10.1111/j.1753-4887.2011.00425.x; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Cerignoli F, 2002, CANCER RES, V62, P1196; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; COHLAN SQ, 1953, SCIENCE, V117, P535, DOI 10.1126/science.117.3046.535; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; Costaridis P, 1996, DEV DYNAM, V205, P41; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; DAVIS LA, 1981, TERATOLOGY, V24, P139, DOI 10.1002/tera.1420240205; Deisenroth C, 2011, J BIOL CHEM, V286, P28343, DOI 10.1074/jbc.M111.254227; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Dupe V, 1997, DEVELOPMENT, V124, P399; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Inman K. E., 2010, HEART DEV REGENERATI, V1, P417; Irie T, 2002, COMP BIOCHEM PHYS B, V131, P209, DOI 10.1016/S1096-4959(01)00496-1; Kam RKT, 2010, INT J DEV BIOL, V54, P1355, DOI 10.1387/ijdb.092984rk; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kastner P, 1997, DEVELOPMENT, V124, P313; KAUR S, 1992, J EXP ZOOL, V264, P323, DOI 10.1002/jez.1402640311; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Keyte A, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.005; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Kolodzinska A, 2013, KARDIOL POL, V71, P447, DOI 10.5603/KP.2013.0090; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Levi L, 2012, AM J PHYSIOL-ENDOC M, V302, pE626, DOI 10.1152/ajpendo.00310.2011; Li Y, 2008, BRIT J CANCER, V98, P1380, DOI 10.1038/sj.bjc.6604320; Lin SC, 2010, P NATL ACAD SCI USA, V107, P9234, DOI 10.1073/pnas.0910430107; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Maclean G, 2009, DEV DYNAM, V238, P732, DOI 10.1002/dvdy.21878; MCLAIN K, 1992, MECH DEVELOP, V39, P3, DOI 10.1016/0925-4773(92)90021-B; Moise AR, 2010, FASEB J, V24, P1261, DOI 10.1096/fj.09-147207; Moise AR, 2005, J BIOL CHEM, V280, P27815, DOI 10.1074/jbc.M503520200; Moise AR, 2004, J BIOL CHEM, V279, P50230, DOI 10.1074/jbc.M409130200; Mou C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001028; Nagy A., 2003, MANIPULATING MOUSE E; Nakajima Y, 1996, CARDIOVASC RES, V31, pE77; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Okano J, 2012, DEV DYNAM, V241, P1744, DOI 10.1002/dvdy.23862; Papaioannou VE, 2005, MOUSE PHENOTYPES HDB; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Porte S, 2013, CHEM-BIOL INTERACT, V202, P186, DOI 10.1016/j.cbi.2012.11.014; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Reeves PG, 1997, J NUTR, V127, pS838; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Ross AC, 2010, METHODS MOL BIOL, V652, P295, DOI 10.1007/978-1-60327-325-1_17; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sandell LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030698; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Shimizu H, 2007, BIRTH DEFECTS RES A, V79, P465, DOI 10.1002/bdra.20358; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Spiegler E., 2011, BIOCHIM BIOPHYS ACTA, V1821, P88; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tahayato A, 2003, GENE EXPR PATTERNS, V3, P449, DOI 10.1016/S1567-133X(03)00066-8; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; Williams SS, 2004, PHYSIOL GENOMICS, V19, P184, DOI 10.1152/physiolgenomics.00136.2004; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Wong YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045725; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; YASUI H, 1995, CIRCULATION, V91, P2478, DOI 10.1161/01.CIR.91.9.2478; Yasui H, 1997, TERATOLOGY, V55, P353; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhang Y, 2010, GENE, V464, P32, DOI 10.1016/j.gene.2010.05.004; Zhang YX, 2003, DEV DYNAM, V226, P618, DOI 10.1002/dvdy.10267; Zhou HQ, 2010, CELL CYCLE, V9, P2709; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Zolfaghari R, 2012, AM J PHYSIOL-GASTR L, V303, pG578, DOI 10.1152/ajpgi.00234.2012; Zolfaghari R, 2009, ARCH BIOCHEM BIOPHYS, V489, P1, DOI 10.1016/j.abb.2009.08.001	106	75	76	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4877	4889		10.1096/fj.13-227967	http://dx.doi.org/10.1096/fj.13-227967			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24005908	Green Published			2022-12-25	WOS:000329999000022
J	Madec, AM; Cassel, R; Dubois, S; Ducreux, S; Vial, G; Chauvin, MA; Mesnier, A; Chikh, K; Bosco, D; Rieusset, J; Van Coppenolle, F; Thivolet, C				Madec, Anne-Marie; Cassel, Romeo; Dubois, Severine; Ducreux, Sylvie; Vial, Guillaume; Chauvin, Marie-Agnes; Mesnier, Aurelia; Chikh, Karim; Bosco, Domenico; Rieusset, Jennifer; Van Coppenolle, Fabien; Thivolet, Charles			Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway	FASEB JOURNAL			English	Article						diabetes; human pancreatic; beta-cells; RAS; AT1R inhibitor; ER stress; calcium homeostasis; PLC-IP3-calcium pathway	ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; OXIDATIVE STRESS; INSULIN-SECRETION; PPAR-GAMMA; DYSFUNCTION; ANTAGONISM; MECHANISMS; INHIBITORS; ISOFORMS	As shown in a large clinical prospective trial, inhibition of the renin-angiotensin system (RAS) can delay the onset of type 2 diabetes in high-risk individuals. We evaluated the beneficial effects of RAS inhibition on beta-cell function under glucotoxic conditions. Human islets from 13 donors were cultured in 5.5 mM (controls) or 16.7 mM glucose [high glucose (HG)] for 4 d with or without losartan (5 mu M), a selective AT1R blocker, and/or U73122 (2 mu M), a selective PLC inhibitor, during the last 2 d. HG induced RAS activation with overexpression of AT1R (P<0.05) and angiotensinogen (P<0.001) mRNAs. HG increased endoplasmic reticulum (ER) stress markers (P<0.001) such as GRP78, sXBP1, and ATF4 mRNAs and Grp78 protein levels (P<0.01). HG also decreased reticular calcium concentration (P<0.0001) and modified protein expressions of ER calcium pumps with reduction of SERCA2b (P<0.01) and increase of IP3R2 (P<0.05). Losartan prevented these deleterious effects and was associated with improved insulin secretion despite HG exposure. AT1R activation triggers the PLC-IP3-calcium pathway. Losartan prevented the increase of PLC beta 1 and gamma 1 protein levels induced by HG (P<0.05). U73122 reproduced all the protective effects of losartan. AT1R blockade protects human islets from the deleterious effects of glucose through inhibition of the PLC-IP3-calcium pathway.	[Madec, Anne-Marie; Cassel, Romeo; Dubois, Severine; Vial, Guillaume; Chauvin, Marie-Agnes; Mesnier, Aurelia; Chikh, Karim; Rieusset, Jennifer; Thivolet, Charles] Univ Lyon 1, INSERM, U1060, Lyon Sud Med Fac, F-69921 Oullins, France; [Ducreux, Sylvie; Van Coppenolle, Fabien] Univ Lyon 1, INSERM, U1060, Rockefeller Med Fac, F-69365 Lyon, France; [Bosco, Domenico] Univ Hosp Geneva, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Thivolet, Charles] Univ Lyon 1, HCL, Dept Endocrinol & Diabet, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Geneva; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Madec, AM (corresponding author), Univ Lyon 1, INSERM, U1060, Inra 1235,Lyon Sud Med Fac, 165 Chemin Grand Revoyet,BP 12, F-69921 Oullins, France.	anne-marie.coquelet-madec@univ-lyon1.fr	Rieusset, Jennifer/F-1595-2018; DUCREUX, SYLVIE/D-6257-2013	Rieusset, Jennifer/0000-0002-1587-2253; DUCREUX, SYLVIE/0000-0003-3207-9537; Vial, Guillaume/0000-0002-7333-8526; CHIKH, Karim/0000-0002-1217-4193; Bosco, Domenico/0000-0003-3453-9613; BERGER, Marie-Agnes/0000-0003-4189-6029	Juvenile Diabetes Research Foundation (JDRF) from Geneva University Hospital [31-2008-413]; INSERM; University Claude Bernard Lyon (UCBL); Centaure Transplantation Research Network	Juvenile Diabetes Research Foundation (JDRF) from Geneva University Hospital; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Claude Bernard Lyon (UCBL); Centaure Transplantation Research Network	Human islets were provided through Juvenile Diabetes Research Foundation (JDRF) award 31-2008-413 [European Consortium for Islet Transplantation (ECIT) Islet for Basic Research program] from Geneva University Hospital and from the cell isolation laboratory at Grenoble University Hospital (Grenoble, France). The authors thank the genomic platform of INSERM 1060-Cardiovasculaire, Metabolisme, Diabetologie, et Nutrition (CARMEN). This work was supported by grants from both INSERM and University Claude Bernard Lyon (UCBL) and Centaure Transplantation Research Network. The authors declare no conflicts of interest.	Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Chu KY, 2007, ANTIOXID REDOX SIGN, V9, P869, DOI 10.1089/ars.2007.1590; Chu KY, 2009, CURR PROTEIN PEPT SC, V10, P75, DOI 10.2174/138920309787315176; Chu KY, 2006, DIABETES, V55, P367, DOI 10.2337/diabetes.55.02.06.db05-1022; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dubois S, 2010, J MOL ENDOCRINOL, V45, P99, DOI 10.1677/JME-10-0020; Ducreux S, 2006, BIOCHEM J, V395, P259, DOI 10.1042/BJ20051282; Fiume R, 2012, FASEB J, V26, P203, DOI 10.1096/fj.11-186510; Geng DF, 2012, INT J CARDIOL, V155, P236, DOI 10.1016/j.ijcard.2010.10.011; Gillespie EL, 2005, DIABETES CARE, V28, P2261, DOI 10.2337/diacare.28.9.2261; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Lau T, 2004, DIABETOLOGIA, V47, P240, DOI 10.1007/s00125-003-1295-1; Lee B, 1999, ENDOCRINOLOGY, V140, P2173, DOI 10.1210/en.140.5.2173; Lee YY, 2010, BIOCHEM BIOPH RES CO, V397, P735, DOI 10.1016/j.bbrc.2010.06.022; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Lupi R, 2006, EUR J ENDOCRINOL, V154, P355, DOI 10.1530/eje.1.02086; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Mekahli D, 2011, COLD SPRING HARB PER, V3, P1; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Ramracheya RD, 2006, DIABETOLOGIA, V49, P321, DOI 10.1007/s00125-005-0101-7; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989; Varadi A, 1999, DIABETOLOGIA, V42, P1240, DOI 10.1007/s001250051298; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; Yamazaki H, 2010, J NUTR SCI VITAMINOL, V56, P1, DOI 10.3177/jnsv.56.1	36	23	25	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					5122	5130		10.1096/fj.13-234104	http://dx.doi.org/10.1096/fj.13-234104			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24008754				2022-12-25	WOS:000329999000044
J	Hahn, A; Stevanovic, M; Mirus, O; Lytvynenko, I; Pos, KM; Schleiff, E				Hahn, Alexander; Stevanovic, Mara; Mirus, Oliver; Lytvynenko, Iryna; Pos, Klaas Martinus; Schleiff, Enrico			The Outer Membrane TolC-like Channel HgdD Is Part of Tripartite Resistance-Nodulation-Cell Division (RND) Efflux Systems Conferring Multiple-drug Resistance in the Cyanobacterium Anabaena sp PCC7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEXA-MEXB-OPRM; ESCHERICHIA-COLI; HETEROCYST-DIFFERENTIATION; PSEUDOMONAS-AERUGINOSA; I SECRETION; PROTEIN; TOLERANCE; EXPORT; PUMPS; PATS	The TolC-like protein HgdD of the filamentous, heterocyst-forming cyanobacterium Anabaena sp. PCC 7120 is part of multiple three-component "AB-D" systems spanning the inner and outer membranes and is involved in secretion of various compounds, including lipids, metabolites, antibiotics, and proteins. Several components of HgdD-dependent tripartite transport systems have been identified, but the diversity of inner membrane energizing systems is still unknown. Here we identified six putative resistance-nodulation-cell division (RND) type factors. Four of them are expressed during late exponential and stationary growth phase under normal growth conditions, whereas the other two are induced upon incubation with erythromycin or ethidium bromide. The constitutively expressed RND component Alr4267 has an atypical predicted topology, and a mutant strain (I-alr4267) shows a reduction in the content of monogalactosyldiacylglycerol as well as an altered filament shape. An insertion mutant of the ethidium bromide-induced all7631 did not show any significant phenotypic alteration under the conditions tested. Mutants of the constitutively expressed all3143 and alr1656 exhibited a Fox(-) phenotype. The phenotype of the insertion mutant I-all3143 parallels that of the I-hgdD mutant with respect to antibiotic sensitivity, lipid profile, and ethidium efflux. In addition, expression of the RND genes all3143 and all3144 partially complements the capability of Escherichia coli Delta acrAB to transport ethidium. We postulate that the RND transporter All3143 and the predicted membrane fusion protein All3144, as homologs of E. coli AcrB and AcrA, respectively, are major players for antibiotic resistance in Anabaena sp. PCC 7120.	[Hahn, Alexander; Stevanovic, Mara; Mirus, Oliver; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60439 Frankfurt, Germany; [Lytvynenko, Iryna; Pos, Klaas Martinus] Goethe Univ Frankfurt, Inst Biochem, D-60439 Frankfurt, Germany; [Pos, Klaas Martinus; Schleiff, Enrico] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60439 Frankfurt, Germany; [Pos, Klaas Martinus; Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60439 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, Max von Laue Str 9, D-60438 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489; Hahn, Alexander/0000-0003-4118-5438	Centre of Membrane Proteomics (Goethe University Frankfurt); Deutsche Forschungsgemeinschaft-EXC115 (Cluster of Excellence Macromolecular Complexes); Deutsche Forschungsgemeinschaft [DFG SCHL 585/2, SFB 807]; Innovative Medicine Initiative (IMI) Project TRANSLOCATION	Centre of Membrane Proteomics (Goethe University Frankfurt); Deutsche Forschungsgemeinschaft-EXC115 (Cluster of Excellence Macromolecular Complexes); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medicine Initiative (IMI) Project TRANSLOCATION	This work was supported by the Centre of Membrane Proteomics (Goethe University Frankfurt) (to A. H.), Deutsche Forschungsgemeinschaft-EXC115 (Cluster of Excellence Macromolecular Complexes) (to E. S. and K. M. P.), Deutsche Forschungsgemeinschaft Grants DFG SCHL 585/2 (to E. S.) and SFB 807 (to K. M. P. and E. S.), and Innovative Medicine Initiative (IMI) Project TRANSLOCATION (to K. M. P.).	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Bohnert JA, 2007, J ANTIMICROB CHEMOTH, V59, P1216, DOI 10.1093/jac/dkl426; Bolhuis H, 1997, FEMS MICROBIOL REV, V21, P55, DOI 10.1016/S0168-6445(97)00051-X; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; CHRASTIL J, 1993, COMPUT CHEM, V17, P103, DOI 10.1016/0097-8485(93)80035-C; Corrales-Guerrero L, 2013, MOL MICROBIOL, V88, P1093, DOI 10.1111/mmi.12244; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Ermakova M, 2013, FEBS LETT, V587, P82, DOI 10.1016/j.febslet.2012.11.006; Feldmann EA, 2012, BIOCHEMISTRY-US, V51, P2436, DOI 10.1021/bi300228n; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Fiedler G, 1998, MOL MICROBIOL, V27, P1193, DOI 10.1046/j.1365-2958.1998.00762.x; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Hahn A, 2012, J BIOL CHEM, V287, P41126, DOI 10.1074/jbc.M112.396010; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huang H, 2004, ACTA BOT SIN, V46, P1186; Kang HJ, 2005, APPL ENVIRON MICROB, V71, P5056, DOI 10.1128/AEM.71.9.5056-5065.2005; Kieboom J, 2001, MICROBIOL-SGM, V147, P43, DOI 10.1099/00221287-147-1-43; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; LIESEGANG H, 1993, J BACTERIOL, V175, P767, DOI 10.1128/JB.175.3.767-778.1993; LOMOVSKAYA O, 1992, P NATL ACAD SCI USA, V89, P8938, DOI 10.1073/pnas.89.19.8938; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; Masi M, 2005, J BACTERIOL, V187, P3894, DOI 10.1128/JB.187.11.3894-3897.2005; Mirus O, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P175, DOI 10.1007/978-3-642-05062-6_6; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Moslavac S, 2007, J BACTERIOL, V189, P7887, DOI 10.1128/JB.00750-07; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Nicolaisen K, 2010, BBA-BIOMEMBRANES, V1798, P2131, DOI 10.1016/j.bbamem.2010.07.008; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Nicolalsen K, 2009, J BASIC MICROB, V49, P5, DOI 10.1002/jobm.200800300; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Ocaktan A, 1997, J BIOL CHEM, V272, P21964, DOI 10.1074/jbc.272.35.21964; OMATA T, 1983, PLANT CELL PHYSIOL, V24, P1101; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pernil R, 2008, MOL MICROBIOL, V67, P1067, DOI 10.1111/j.1365-2958.2008.06107.x; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Provence David L., 1994, P317; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; Rensing C, 1997, J BACTERIOL, V179, P6871, DOI 10.1128/jb.179.22.6871-6879.1997; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rosenberg EY, 2000, J BACTERIOL, V182, P1754, DOI 10.1128/JB.182.6.1754-1756.2000; Staron P, 2011, J BIOL CHEM, V286, P38202, DOI 10.1074/jbc.M111.269332; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tian T, 2010, MICROBIOL-SGM, V156, P39, DOI 10.1099/mic.0.031161-0; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valladares A, 2011, J BACTERIOL, V193, P1172, DOI 10.1128/JB.01202-10; Wilk L, 2011, CELL MICROBIOL, V13, P1744, DOI 10.1111/j.1462-5822.2011.01655.x; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Xue LG, 2011, CURR MICROBIOL, V62, P1253, DOI 10.1007/s00284-010-9850-8; Zhang YL, 2011, J BIOL CHEM, V286, P26576, DOI 10.1074/jbc.M111.243261	80	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31192	31205		10.1074/jbc.M113.495598	http://dx.doi.org/10.1074/jbc.M113.495598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014018	hybrid, Green Published			2022-12-25	WOS:000330778900036
J	Snider, NT; Park, H; Omary, MB				Snider, Natasha T.; Park, Haewon; Omary, M. Bishr			A Conserved Rod Domain Phosphotyrosine That Is Targeted by the Phosphatase PTP1B Promotes Keratin 8 Protein Insolubility and Filament Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENTS; ALEXANDER-DISEASE; TYROSINE PHOSPHORYLATION; CULTURED-CELLS; STRESS; TISSUE; MICE; GFAP; MIGRATION; VIMENTIN	Post-translational modifications are important functional determinants for intermediate filament (IF) proteins. Phosphorylation of IF proteins regulates filament organization, solubility, and cell-protective functions. Most known IF protein phosphorylation sites are serines localized in the variable "head" and "tail" domain regions. By contrast, little is known about site-specific tyrosine phosphorylation or its implications on IF protein function. We used available proteomic data from large scale studies to narrow down potential phospho-tyrosine sites on the simple epithelial IF protein keratin 8 (K8). Validation of the predicted sites using a pan-phosphotyrosine and a site-specific antibody, which we generated, revealed that the highly conserved Tyr-267 in the K8 "rod" domain was basally phosphorylated. The charge at this site was critically important, as demonstrated by altered filament organization of site-directed mutants, Y267F and Y267D, the latter exhibiting significantly diminished solubility. Pharmacological inhibition of the protein-tyrosine phosphatase PTP1B increased K8 Tyr-267 phosphorylation, decreased solubility, and increased K8 filament bundling, whereas PTP1B overexpression had the opposite effects. Furthermore, there was significant co-localization between K8 and a "substrate-trapping" mutant of PTP1B (D181A). Because K8 Tyr-267 is conserved in many IFs (QYE motif), we tested the effect of the paralogous Tyr in glial fibrillary acidic protein (GFAP), which is mutated in Alexander disease (Y242D). Similar to K8, Y242D GFAP exhibited highly irregular filament organization and diminished solubility. Our results implicate the rod domain QYE motif tyrosine as an important determinant of IF assembly and solubility properties that can be dynamically modulated by phosphorylation.	[Snider, Natasha T.; Park, Haewon; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Snider, NT (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	nsnider@umich.edu		Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [R01 DK52951, K01 DK093776]; Department of Veterans Affairs Merit Review Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951, K01DK093776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK52951 (to M. B. O.) and K01 DK093776 (to N. T. S.). This work was also supported by a Department of Veterans Affairs Merit Review Award (to M. B. O.).	Angelastro JM, 1998, J NEUROCHEM, V70, P540; Artemenko KA, 2011, ANALYST, V136, P1971, DOI 10.1039/c0an00649a; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; Chung BM, 2012, J BIOL CHEM, V287, P7573, DOI 10.1074/jbc.M111.301549; Ding SJ, 2007, EXPERT REV PROTEOMIC, V4, P13, DOI 10.1586/14789450.4.1.13; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Felkl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045280; Feng L, 1999, J CELL SCI, V112, P2081; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gorospe JR, 2002, NEUROLOGY, V58, P1494, DOI 10.1212/WNL.58.10.1494; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Kwan R, 2012, FASEB J, V26, P2318, DOI 10.1096/fj.11-198580; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Lind SB, 2011, CELL SIGNAL, V23, P1387, DOI 10.1016/j.cellsig.2011.03.021; Majumder A, 2011, BIOCHEMISTRY-US, V50, P7774, DOI 10.1021/bi200847n; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pan XO, 2011, J BIOL CHEM, V286, P42403, DOI 10.1074/jbc.M111.302042; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028; Snider NT, 2011, J BIOL CHEM, V286, P2273, DOI 10.1074/jbc.M110.171314; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Utermark T, 2005, NEUROBIOL DIS, V19, P1, DOI 10.1016/j.nbd.2004.11.015; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013538	51	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31329	31337		10.1074/jbc.M113.502724	http://dx.doi.org/10.1074/jbc.M113.502724			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24003221	hybrid, Green Published			2022-12-25	WOS:000330778900049
J	Crognier, L; Skoura, X; Vinter, A; Papaxanthis, C				Crognier, Lionel; Skoura, Xanthi; Vinter, Annie; Papaxanthis, Charalambos			Mental Representation of Arm Motion Dynamics in Children and Adolescents	PLOS ONE			English	Article							MOTOR IMAGERY; IMAGINED MOVEMENT; BRAIN-DEVELOPMENT; SIMULATION; CHILDHOOD; PERFORMANCE; IMPROVEMENT; EXECUTION; EMERGENCE; PATTERNS	Motor imagery, i.e., a mental state during which an individual internally represents an action without any overt motor output, is a potential tool to investigate action representation during development. Here, we took advantage of the inertial anisotropy phenomenon to investigate whether children can generate accurate motor predictions for movements with varying dynamics. Children (9 and 11 years), adolescents (14 years) and young adults (21 years) carried-out actual and mental arm movements in two different directions in the horizontal plane: rightwards (low inertia) and leftwards (high inertia). We recorded and compared actual and mental movement times. We found that actual movement times were greater for leftward than rightward arm movements in all groups. For mental movements, differences between leftward versus rightward movements were observed in the adults and adolescents, but not among the children. Furthermore, significant differences between actual and mental times were found at 9 and 11 years of age in the leftward direction. The ratio R/L (rightward direction/leftward direction), which indicates temporal differences between low inertia and high inertia movements, was inferior to 1 at all ages, except for the mental movements at 9 years of age, indicating than actual and mental movements were shorter for the rightward than leftward direction. Interestingly, while the ratio R/L of actual movements was constant across ages, it gradually decreased with age for mental movements. The ratio A/M (actual movement/mental movement), which indicates temporal differences between actual and mental movements, was near to 1 in the adults' groups, denoting accurate mental timing. In children and adolescents, an underestimation of mental movement times appeared for the leftward movements only. However, this overestimation gradually decreased with age. Our results showed a refinement in the motor imagery ability during development. Action representation reached maturation at adolescence, during which mental actions were tightly related to their actual production.	[Crognier, Lionel; Papaxanthis, Charalambos] Univ Bourgogne, Unite Format & Rech Sci & Tech Activites Phys & S, Dijon, France; [Crognier, Lionel; Papaxanthis, Charalambos] INSERM, U1093, Dijon, France; [Skoura, Xanthi; Vinter, Annie] Univ Bourgogne, CNRS, LEAD, UMR 5022, Dijon, France	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bourgogne	Papaxanthis, C (corresponding author), Univ Bourgogne, Unite Format & Rech Sci & Tech Activites Phys & S, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr			Conseil Regional de Bourgogne	Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte)	This work has been supported by the 'Conseil Regional de Bourgogne'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Avanzino L, 2009, NEUROSCI LETT, V466, P11, DOI 10.1016/j.neulet.2009.09.036; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Berthier NE, 2006, EXP BRAIN RES, V169, P507, DOI 10.1007/s00221-005-0169-9; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; Caeyenberghs K, 2009, DEV NEUROPSYCHOL, V34, P103, DOI 10.1080/87565640802499183; Cerritelli B, 2000, BEHAV BRAIN RES, V108, P91, DOI 10.1016/S0166-4328(99)00138-2; Choudhury S, 2007, CONSCIOUS COGN, V16, P886, DOI 10.1016/j.concog.2006.11.001; Choudhury S, 2007, NEUROPSYCHOLOGIA, V45, P255, DOI 10.1016/j.neuropsychologia.2006.07.010; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; Danckert J, 2002, NEUROCASE, V8, P194, DOI 10.1076/neur.8.2.194.16204; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety J, 1996, BEHAV BRAIN RES, V72, P127; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Demougeot L, 2011, J NEUROSCI, V31, P10712, DOI 10.1523/JNEUROSCI.6032-10.2011; Demougeot L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006769; DESCHAUMESMOLINARO C, 1992, PHYSIOL BEHAV, V51, P1021, DOI 10.1016/0031-9384(92)90086-H; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Di Rienzo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047207; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Flanagan JR, 2001, J NEUROSCI, V21, P1361; Gabbard C, 2004, EXP BRAIN RES, V156, P325, DOI 10.1007/s00221-003-1792-y; Gabbard C, 2009, BRAIN COGNITION, V71, P234, DOI 10.1016/j.bandc.2009.08.011; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Konczak J, 1997, EXP BRAIN RES, V113, P465, DOI 10.1007/PL00005599; Kunz BR, 2009, J EXP PSYCHOL HUMAN, V35, P1458, DOI 10.1037/a0015786; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Molina M, 2008, J EXP CHILD PSYCHOL, V99, P196, DOI 10.1016/j.jecp.2007.10.001; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Ochipa C, 1997, NEUROLOGY, V49, P474, DOI 10.1212/WNL.49.2.474; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Papaxanthis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051191; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Rodriguez M, 2008, BEHAV NEUROSCI, V122, P910, DOI 10.1037/0735-7044.122.4.910; Rodriguez M, 2009, NEUROPSYCHOLOGIA, V47, P489, DOI 10.1016/j.neuropsychologia.2008.10.009; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Schmitz C, 2002, EXP BRAIN RES, V142, P354, DOI 10.1007/s00221-001-0910-y; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skoura X, 2009, DEV NEUROPSYCHOL, V34, P356, DOI 10.1080/87565640902801874; Slifkin AB, 2008, EXP BRAIN RES, V185, P297, DOI 10.1007/s00221-007-1154-2; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zijdewind I, 2003, MUSCLE NERVE, V28, P168, DOI 10.1002/mus.10406	64	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73042	10.1371/journal.pone.0073042	http://dx.doi.org/10.1371/journal.pone.0073042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009727	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600051
J	Foster, F; Collard, M				Foster, Frederick; Collard, Mark			A Reassessment of Bergmann's Rule in Modern Humans	PLOS ONE			English	Article							BODY-SIZE; CLIMATE; PROPORTIONS; WEIGHT; MALES; SHAPE; AREA	It is widely accepted that modern humans conform to Bergmann's rule, which holds that body size in endothermic species will increase as temperature decreases. However, there are reasons to question the reliability of the findings on which this consensus is based. One of these is that the main studies that have reported that modern humans conform to Bergmann's rule have employed samples that contain a disproportionately large number of warm-climate and northern hemisphere groups. With this in mind, we used latitudinally-stratified and hemisphere-specific samples to re-assess the relationship between modern human body size and temperature. We found that when groups from north and south of the equator were analyzed together, Bergmann's rule was supported. However, when groups were separated by hemisphere, Bergmann's rule was only supported in the northern hemisphere. In the course of exploring these results further, we found that the difference between our northern and southern hemisphere subsamples is due to the limited latitudinal and temperature range in the latter subsample. Thus, our study suggests that modern humans do conform to Bergmann's rule but only when there are major differences in latitude and temperature among groups. Specifically, groups must span more than 50 degrees of latitude and/or more than 30 degrees C for it to hold. This finding has important implications for work on regional variation in human body size and its relationship to temperature.	[Collard, Mark] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada; Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Collard, M (corresponding author), Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada.	mcollard@sfu.ca		Collard, Mark/0000-0002-2725-4989	Simon Fraser University; Social Sciences and Humanities Research Council; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund	Simon Fraser University; Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund	FF is supported by Simon Fraser University and the Social Sciences and Humanities Research Council. MC is supported by the Canada Research Chairs Program, the Social Sciences and Humanities Research Council, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BEALL CM, 1992, AM J HUM BIOL, V4, P747, DOI 10.1002/ajhb.1310040606; Benjamini Y, 2001, ANN STAT, V29, P1165; CROGNIER E, 1981, ANN HUM BIOL, V8, P99, DOI 10.1080/03014468100004841; Cross A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016107; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Eveleth P. B, 1976, WORLDWIDE VARIATIONS; Eveleth PB, 1990, WORLDWIDE VARIATIONS; Fukase H, 2012, AM J PHYS ANTHROPOL, V149, P125, DOI 10.1002/ajpa.22112; Gilligan I, 2007, AM J PHYS ANTHROPOL, V134, P75, DOI 10.1002/ajpa.20640; Gladwin T, 1949, AM ANTHROPOL, V49, P601; Hanna J.M., 1989, HUMAN POPULATION BIO, P132; HIERNAUX J, 1976, HUM BIOL, V48, P757; Ivanhoe F, 1998, INT J OSTEOARCHAEOL, V8, P135, DOI 10.1002/(SICI)1099-1212(199805/06)8:3<135::AID-OA408>3.0.CO;2-4; Jurmain R, 2012, ESSENTIALS PHYS ANTH; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Lewin R, 2004, PRINCIPLES HUMAN EVO; Motulsky H, 2003, PRACTICAL GUIDE CURV; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Newman MT, 1953, AM ANTHROPOL, V55, P311, DOI 10.1525/aa.1953.55.3.02a00020; Newman RW, 1955, AM J PHYS ANTHROP-NE, V13, P1, DOI 10.1002/ajpa.1330130102; Quinlan RJ, 2007, P ROY SOC B-BIOL SCI, V274, P121, DOI 10.1098/rspb.2006.3690; Roberts DF, 1953, AM J PHYS ANTHROP-NE, V11, P533, DOI 10.1002/ajpa.1330110404; Roberts D. F., 1978, CLIMATE HUMAN VARIAB; Ruff CB, 1994, AM J PHYS ANTHROPOL, V37, P65, DOI DOI 10.1002/AJPA.1330370605; SCHREIDER E, 1951, NATURE, V167, P823, DOI 10.1038/167823a0; SCHREIDER E, 1950, NATURE, V165, P286, DOI 10.1038/165286b0; Stanford C, 2012, EXPLORING BIOL ANTHR; STINSON S, 1990, AM J HUM BIOL, V2, P37, DOI 10.1002/ajhb.1310020105; Stinson S., 2000, HUMAN BIOL EVOLUTION, P434; Temple DH, 2011, INT J OSTEOARCHAEOL, V21, P268, DOI 10.1002/oa.1129; WALTER H, 1976, Zeitschrift fuer Morphologie und Anthropologie, V67, P241; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591	34	44	45	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72269	10.1371/journal.pone.0072269	http://dx.doi.org/10.1371/journal.pone.0072269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015229	Green Published, gold			2022-12-25	WOS:000323733800043
J	Junkins, RD; Shen, A; Rosen, K; McCormick, C; Lin, TJ				Junkins, Robert D.; Shen, Ann; Rosen, Kirill; McCormick, Craig; Lin, Tong-Jun			Autophagy Enhances Bacterial Clearance during P. aeruginosa Lung Infection	PLOS ONE			English	Article							HUMAN MAST-CELLS; CYSTIC-FIBROSIS PATIENTS; TOLL-LIKE RECEPTORS; PSEUDOMONAS-AERUGINOSA; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; MAMMALIAN AUTOPHAGY; CLINICAL-OUTCOMES; IMMUNE-RESPONSE; INFLAMMATION	Pseudomonas aeruginosa is an opportunistic bacterial pathogen which is the leading cause of morbidity and mortality among cystic fibrosis patients. Although P. aeruginosa is primarily considered an extacellular pathogen, recent reports have demonstrated that throughout the course of infection the bacterium acquires the ability to enter and reside within host cells. Normally intracellular pathogens are cleared through a process called autophagy which sequesters and degrades portions of the cytosol, including invading bacteria. However the role of autophagy in host defense against P. aeruginosa in vivo remains unknown. Understanding the role of autophagy during P. aeruginosa infection is of particular importance as mutations leading to cystic fibrosis have recently been shown to cause a blockade in the autophagy pathway, which could increase susceptibility to infection. Here we demonstrate that P. aeruginosa induces autophagy in mast cells, which have been recognized as sentinels in the host defense against bacterial infection. We further demonstrate that inhibition of autophagy through pharmacological means or protein knockdown inhibits clearance of intracellular P. aeruginosa in vitro, while pharmacologic induction of autophagy significantly increased bacterial clearance. Finally we find that pharmacological manipulation of autophagy in vivo effectively regulates bacterial clearance of P. aeruginosa from the lung. Together our results demonstrate that autophagy is required for an effective immune response against P. aeruginosa infection in vivo, and suggest that pharmacological interventions targeting the autophagy pathway could have considerable therapeutic potential in the treatment of P. aeruginosa lung infection.	[Junkins, Robert D.; Shen, Ann; McCormick, Craig; Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Junkins, Robert D.; Lin, Tong-Jun] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Junkins, Robert D.; McCormick, Craig; Lin, Tong-Jun] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada; [Rosen, Kirill] Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Lin, TJ (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	tong-jun.lin@dal.ca	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722; Rosen, Kirill/0000-0002-4317-9907	Cystic Fibrosis Canada; Izaak Walton Killam Health Centre	Cystic Fibrosis Canada; Izaak Walton Killam Health Centre	This work was supported by funding from Cystic Fibrosis Canada grant to TJL (www.cysticfibrosis.ca). RDJ is supported by a graduate student scholarship from the Izaak Walton Killam Health Centre (www.iwk.nshealth.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Bradbury R, 2008, RESPIROLOGY, V13, P886, DOI 10.1111/j.1440-1843.2008.01383.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Campoy E, 2009, CURR TOP MICROBIOL, V335, P227, DOI 10.1007/978-3-642-00302-8_11; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; CRIPPS AW, 1995, IMMUNOL CELL BIOL, V73, P418, DOI 10.1038/icb.1995.65; Cutler NS, 1999, MOL CELL ENDOCRINOL, V155, P135, DOI 10.1016/S0303-7207(99)00121-5; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Eskelinen EL, 2011, AUTOPHAGY, V7, P935, DOI 10.4161/auto.7.9.15760; Faulkner G, 2002, J BACTERIOL, V184, P7025, DOI 10.1128/JB.184.24.7025-7041.2002; Fleiszig SMJ, 1996, INFECT IMMUN, V64, P2288, DOI 10.1128/IAI.64.6.2288-2294.1996; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P3485, DOI 10.1128/IAI.62.8.3485-3493.1994; FOX B, 1981, J CLIN PATHOL, V34, P1333, DOI 10.1136/jcp.34.12.1333; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Hashimoto S, 1996, AM J PHYSIOL-LUNG C, V270, pL819, DOI 10.1152/ajplung.1996.270.5.L819; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Jenkins CE, 2006, J IMMUNOL, V177, P8000, DOI 10.4049/jimmunol.177.11.8000; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; Kirkegaard K, 2009, CURR TOP MICROBIOL, V335, P323, DOI 10.1007/978-3-642-00302-8_16; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Le BV, 2012, EUR J CLIN MICROBIOL, V31, P1983, DOI 10.1007/s10096-011-1530-5; Leida AM, 2012, CELL HOST MICROBE, V11, P167, DOI 10.1016/j.chom.2012.01.005; Li B, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610859200; Lin TJ, 2000, J IMMUNOL, V165, P211, DOI 10.4049/jimmunol.165.1.211; Lin TJ, 2003, INFECT IMMUN, V71, P365, DOI 10.1128/IAI.71.1.365-373.2003; Lin TJ, 2002, J IMMUNOL, V169, P4522, DOI 10.4049/jimmunol.169.8.4522; Lin TJ, 1999, J LEUKOCYTE BIOL, V66, P1031, DOI 10.1002/jlb.66.6.1031; Liu G, 2012, J LEUKOC BIOL; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mayer ML, 2013, J IMMUNOL, V190, P1227, DOI 10.4049/jimmunol.1201404; McIsaac SM, 2012, J LEUKOCYTE BIOL, V92, P977, DOI 10.1189/jlb.0811410; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moser C, 1997, APMIS, V105, P838, DOI 10.1111/j.1699-0463.1997.tb05092.x; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Nichols DP, 2008, CLIN REV ALLERG IMMU, V35, P135, DOI 10.1007/s12016-008-8081-2; Obritsch MD, 2005, PHARMACOTHERAPY, V25, P1353, DOI 10.1592/phco.2005.25.10.1353; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patterson NL, 2012, PROTEIN CELL, V3, P911, DOI 10.1007/s13238-012-2097-3; Plantinga TS, 2012, CURR OPIN PHARMACOL, V12, P497, DOI 10.1016/j.coph.2012.01.017; Plotkowski MC, 1999, AM J RESP CELL MOL, V20, P880, DOI 10.1165/ajrcmb.20.5.3408; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Skindersoe ME, 2009, FEMS IMMUNOL MED MIC, V55, P335, DOI 10.1111/j.1574-695X.2008.00533.x; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tete S, 2012, J BIOL REG HOMEOS AG, V26, P193; Ushio H, 2011, J ALLERGY CLIN IMMUN, V127, P1267, DOI 10.1016/j.jaci.2010.12.1078; Villella VR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00001; Weber S, 1996, ARCH DERMATOL RES, V288, P778, DOI 10.1007/BF02505297; Wolf P, 2009, INT J MED MICROBIOL, V299, P161, DOI 10.1016/j.ijmm.2008.08.003; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang MA, 2011, J KOREAN MED SCI, V26, P612, DOI 10.3346/jkms.2011.26.5.612; Yang YJ, 2009, J EXP MED, V206, P195, DOI 10.1084/jem.20081140; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573	69	64	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72263	10.1371/journal.pone.0072263	http://dx.doi.org/10.1371/journal.pone.0072263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015228	Green Submitted, Green Published, gold			2022-12-25	WOS:000323733800042
J	Spelios, MG; Kenna, LA; Wall, B; Akirav, EM				Spelios, Michael G.; Kenna, Lauren A.; Wall, Bonnie; Akirav, Eitan M.			In Vitro Formation of beta Cell Pseudoislets Using Islet-Derived Endothelial Cells	PLOS ONE			English	Article							INSULIN SECRETORY RESPONSES; PANCREATIC-ISLET; EXTRACELLULAR-MATRIX; MIN6 PSEUDOISLETS; EMERGING ROLES; TRANSPLANTATION; EXPRESSION; APOPTOSIS; PROLIFERATION; CONFIGURATION	beta-cell pseudoislets (PIs) are used for the in vitro study of beta-cells in a three-dimensional (3-D) configuration. Current methods of PI induction require unique culture conditions and extensive mechanical manipulations. Here we report a novel co-culture system consisting of high passage beta-cells and islet-derived endothelial cells (iECs) that results in a rapid and spontaneous formation of free-floating PIs. PI structures were formed as early as 72 h following co-culture setup and were preserved for more than 14 d. These PIs, composed solely of beta-cells, were similar in size to that of native islets and showed an increased percentage of proinsulin-positive cells, increased insulin gene expression in response to glucose stimulation, and restored glucose-stimulated insulin secretion when compared to beta-cells cultured as monolayers. Key extracellular matrix proteins that were absent in beta-cells cultured alone were deposited by iECs on PIs and were found in and around the PIs. iEC-induced PIs are a readily available tool for examining beta cell function in a native 3-D configuration and can be used for examining beta-cell/iEC interactions in vitro.	[Spelios, Michael G.; Kenna, Lauren A.; Wall, Bonnie; Akirav, Eitan M.] Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA; [Akirav, Eitan M.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Akirav, EM (corresponding author), Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA.	eakirav@winthrop.org			Winthrop University Hospital	Winthrop University Hospital	This work was supported by Winthrop University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2011, DIABETES, V60, P876, DOI 10.2337/db10-0793; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Cavallari G, 2007, TRANSPL P, V39, P2018, DOI 10.1016/j.transproceed.2007.05.016; Daoud J, 2010, CELL TRANSPLANT, V19, P1523, DOI 10.3727/096368910X515872; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Guo-Parke H, 2012, J ENDOCRINOL, V214, P257, DOI 10.1530/JOE-12-0188; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Jiang FX, 2002, J HISTOCHEM CYTOCHEM, V50, P1625, DOI 10.1177/002215540205001206; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Josefsen K, 1999, DIABETOLOGIA, V42, P195, DOI 10.1007/s001250051139; Kelly C, 2010, PANCREAS, V39, P1016, DOI 10.1097/MPA.0b013e3181dafaa2; Kitsou-Mylona I, 2008, CELL PHYSIOL BIOCHEM, V22, P557, DOI 10.1159/000185540; Lock LT, 2011, J BIOTECHNOL, V151, P278, DOI 10.1016/j.jbiotec.2010.12.015; Luther MJ, 2006, BIOCHEM BIOPH RES CO, V343, P99, DOI 10.1016/j.bbrc.2006.02.003; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; Maillard E, 2009, ISLETS, V1, P232, DOI 10.4161/isl.1.3.9754; Nanji SA, 2006, DIABETES OBES METAB, V8, P15, DOI 10.1111/j.1463-1326.2005.00476.x; Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8; Ogata T, 2004, ENDOCR J, V51, P381, DOI 10.1507/endocrj.51.381; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P710, DOI 10.1016/j.biocel.2006.02.004; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P492, DOI 10.1016/j.biocel.2005.06.021; Paraskevas S, 1997, TRANSPL P, V29, P750, DOI 10.1016/S0041-1345(96)00452-6; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Persaud SJ, 2010, ISLETS, V2, P236, DOI 10.4161/isl.2.4.12557; Reers C, 2011, ISLETS, V3, P80, DOI 10.4161/isl.3.3.15428; Roderigo-Milne H, 2002, BIOCHEM BIOPH RES CO, V296, P589, DOI 10.1016/S0006-291X(02)00913-0; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Squires PE, 2000, CELL CALCIUM, V27, P287, DOI 10.1054/ceca.2000.0117; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; TAL M, 1992, MOL CELL BIOL, V12, P422, DOI 10.1128/MCB.12.1.422	31	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72260	10.1371/journal.pone.0072260	http://dx.doi.org/10.1371/journal.pone.0072260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015227	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800041
J	Christopoulos, KA; Massey, AD; Lopez, AM; Hare, CB; Johnson, MO; Pilcher, CD; Fielding, H; Dawson-Rose, C				Christopoulos, Katerina A.; Massey, Amina D.; Lopez, Andrea M.; Hare, C. Bradley; Johnson, Mallory O.; Pilcher, Christopher D.; Fielding, Hegla; Dawson-Rose, Carol			Patient Perspectives on the Experience of Being Newly Diagnosed with HIV in the Emergency Department/Urgent Care Clinic of a Public Hospital	PLOS ONE			English	Article							INFECTION; PERCEPTIONS; ACCEPTANCE; ENGAGEMENT; RESPONSES; LINKAGE	We sought to understand patient perceptions of the emergency department/urgent care (ED/UC) HIV diagnosis experience as well as factors that may promote or discourage linkage to HIV care. We conducted in-depth interviews with patients (n=24) whose HIV infection was diagnosed in the ED/UC of a public hospital in San Francisco at least six months prior and who linked to HIV care at the hospital HIV clinic. Key diagnosis experience themes included physical discomfort and limited functionality, presence of comorbid diagnoses, a wide spectrum of HIV risk perception, and feelings of isolation and anxiety. Patients diagnosed with HIV in the ED/UC may not have their desired emotional supports with them, either because they are alone or they are with family members or friends to whom they do not want to immediately disclose. Other patients may have no one they can rely on for immediate support. Nearly all participants described compassionate disclosure of test results by ED/UC providers, although several noted logistical issues that complicated the disclosure experience. Key linkage to care themes included the importance of continuity between the testing site and HIV care, hospital admission as an opportunity for support and HIV education, and thoughtful matching by linkage staff to a primary care provider. ED/UC clinicians and testing programs should be sensitive to the unique roles of sickness, risk perception, and isolation in the ED/UC diagnosis experience, as these things may delay acceptance of HIV diagnosis. The disclosure and linkage to care experience is crucial in forming patient attitudes towards HIV and HIV care, thus staff involved in disclosure and linkage activities should be trained to deliver compassionate, informed, and thoughtful care that bridges HIV testing and treatment sites.	[Christopoulos, Katerina A.; Massey, Amina D.; Lopez, Andrea M.; Hare, C. Bradley; Pilcher, Christopher D.; Fielding, Hegla] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Johnson, Mallory O.; Dawson-Rose, Carol] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Christopoulos, KA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	christopoulosk@php.ucsf.edu	Lopez, Andrea/GQQ-3059-2022		 [K23 MH092220];  [R34 096606]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092220, R34MH096606] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by K23 MH092220 (KAC) and R34 096606 (CDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2010, AIDS CARE, V22, P1493, DOI 10.1080/09540121.2010.482125; Batey DS, 2012, AIDS RES HUM RETROV, V28, P352, DOI 10.1089/aid.2011.0074; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S304; Christopoulos KA, 2013, AIDS PATIENT CARE ST, V27, P223, DOI 10.1089/apc.2012.0418; Christopoulos KA, 2013, JAIDS-J ACQ IMM DEF, V62, pE30, DOI 10.1097/QAI.0b013e31827a0b0d; Christopoulos KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-3; Christopoulos KA, 2011, AIDS PATIENT CARE ST, V25, P439, DOI 10.1089/apc.2011.0041; Corbin J., 2015, BASICS QUALITATIVE R; Donnell-Fink L, 2011, ANN EMERG MED, V58, pS49, DOI 10.1016/j.annemergmed.2011.03.024; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Haukoos JS, 2011, ANN EMERG MED, V58, pS96, DOI 10.1016/j.annemergmed.2011.03.017; Hult JR, 2009, AIDS CARE, V21, P185, DOI 10.1080/09540120802017602; Leider J, 2011, AIDS PATIENT CARE ST, V25, P89, DOI 10.1089/apc.2010.0205; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Stevens PE, 2006, ADV NURS SCI, V29, P207, DOI 10.1097/00012272-200607000-00004	18	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74199	10.1371/journal.pone.0074199	http://dx.doi.org/10.1371/journal.pone.0074199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215RU	23991214	gold, Green Published			2022-12-25	WOS:000324228800115
J	Fiore, CL; Baker, DM; Lesser, MP				Fiore, Cara L.; Baker, David M.; Lesser, Michael P.			Nitrogen Biogeochemistry in the Caribbean Sponge, Xestospongia muta: A Source or Sink of Dissolved Inorganic Nitrogen?	PLOS ONE			English	Article							MARINE SPONGES; FLORIDA-KEYS; CONCH REEF; PROCHLOROCOCCUS; NITRIFICATION; DIVERSITY; BACTERIAL; FIXATION; AMMONIUM; NITRATE	Background: Sponges have long been known to be ecologically important members of the benthic fauna on coral reefs. Recently, it has been shown that sponges are also important contributors to the nitrogen biogeochemistry of coral reefs. The studies that have been done show that most sponges are net sources of dissolved inorganic nitrogen (DIN; NH4+ and NO3-) and that nitrification, mediated by their symbiotic prokaryotes, is the primary process involved in supplying DIN to adjacent reefs. Methodology/Principal Findings: A natural experiment was conducted with the Caribbean sponge Xestospongia muta from three different locations (Florida Keys, USA; Lee Stocking Island, Bahamas and Little Cayman, Cayman Islands). The DIN fluxes of sponges were studied using nutrient analysis, stable isotope ratios, and isotope tracer experiments. Results showed that the fluxes of DIN were variable between locations and that X. muta can be either a source or sink of DIN. Stable isotope values of sponge and symbiotic bacterial fractions indicate that the prokaryotic community is capable of taking up both NH4+ and NO3- while the differences in delta N-15 between the sponge and bacterial fractions from the NH4+ tracer experiment suggest that there is translocation of labeled N from the symbiotic bacteria to the host. Conclusions/Significance: Nitrogen cycling in X. muta appears to be more complex than previous studies have shown and our results suggest that anaerobic processes such as denitrification or anammox occur in these sponges in addition to aerobic nitrification. Furthermore, the metabolism of this sponge and its prokaryotic symbionts may have a significant impact on the nitrogen biogeochemistry on Caribbean coral reefs by releasing large amounts of DIN, including higher NH4+ concentrations that previously reported.	[Fiore, Cara L.; Lesser, Michael P.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Baker, David M.] Carnegie Inst Sci, Geophys Lab, Washington, DC USA	University System Of New Hampshire; University of New Hampshire; Carnegie Institution for Science	Lesser, MP (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	mpl@unh.edu	Baker, David/B-2512-2010	Baker, David/0000-0002-0308-4954	National Oceanic and Atmospheric Administration Ocean Exploration Program; Undersea Research Program; National Institute for Undersea Science and Technology; National Science Foundation	National Oceanic and Atmospheric Administration Ocean Exploration Program; Undersea Research Program; National Institute for Undersea Science and Technology; National Science Foundation(National Science Foundation (NSF))	This project was funded by grants from the National Oceanic and Atmospheric Administration Ocean Exploration Program, Undersea Research Program, National Institute for Undersea Science and Technology as well as the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bonin PC, 2006, MAR ECOL PROG SER, V322, P75, DOI 10.3354/meps322075; CAFFREY JM, 1993, FEMS MICROBIOL ECOL, V12, P159; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; CAPONE DG, 1992, MAR ECOL PROG SER, V80, P75, DOI 10.3354/meps080075; Carpenter EJ, 1997, DEEP-SEA RES PT I, V44, P27, DOI 10.1016/S0967-0637(96)00091-X; CORREDOR JE, 1988, LIMNOL OCEANOGR, V33, P114, DOI 10.4319/lo.1988.33.1.0114; DeLorenzo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046695; Diamond J., 1986, COMMUNITY ECOL, P3; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Diaz MC, 2001, B MAR SCI, V69, P535; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Fiore CL, 2010, TRENDS MICROBIOL, V18, P455, DOI 10.1016/j.tim.2010.07.001; Freeman CJ, 2013, ISME J, V7, P1116, DOI 10.1038/ismej.2013.7; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; Fry B, 2006, STABLE ISOTOPE ECOLO, P308; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Mackey KRM, 2011, PROG OCEANOGR, V91, P545, DOI 10.1016/j.pocean.2011.09.001; Maguer JF, 2011, CONT SHELF RES, V31, P1620, DOI 10.1016/j.csr.2011.07.005; MARIOTTI A, 1983, NATURE, V303, P685, DOI 10.1038/303685a0; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; Michener R.H., 1994, P138; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; O'Neil JM, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P949, DOI 10.1016/B978-0-12-372522-6.00021-9; Perea-Blazquez A, 2012, HYDROBIOLOGIA, V687, P237, DOI 10.1007/s10750-011-0798-x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Porubsky WP, 2009, ESTUAR COAST SHELF S, V83, P392, DOI 10.1016/j.ecss.2009.04.012; R Core Team, 2012, R LANG ENV STAT COMP; REISWIG H M, 1981, Marine Ecology, V2, P273, DOI 10.1111/j.1439-0485.1981.tb00271.x; REISWIG HM, 1971, MAR BIOL, V9, P38, DOI 10.1007/BF00348816; Ribeiro SM, 2003, ESTUAR COAST SHELF S, V57, P951, DOI 10.1016/S0272-7714(02)00425-0; Ribes M, 2005, LIMNOL OCEANOGR, V50, P1480, DOI 10.4319/lo.2005.50.5.1480; Ribes M, 2003, MAR ECOL PROG SER, V257, P13, DOI 10.3354/meps257013; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; SHIEH WY, 1994, B MAR SCI, V54, P557; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Sokal R.R., 1998, BIOMETRY, V3rd ed., P880; Southwell M.W, 2007, THESIS U N CAROLINA; Southwell MW, 2008, LIMNOL OCEANOGR, V53, P986, DOI 10.4319/lo.2008.53.3.0986; Southwell MW, 2008, MAR CHEM, V108, P96, DOI 10.1016/j.marchem.2007.10.005; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Wilkinson Clive R., 1999, Memoirs of the Queensland Museum, V44, P667; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Yellowlees D., 1994, Pacific Science, V48, P291	73	67	67	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72961	10.1371/journal.pone.0072961	http://dx.doi.org/10.1371/journal.pone.0072961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991166	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800090
J	Luo, X; Sun, XL; Liu, BH; Zhu, D; Bai, X; Cai, H; Ji, W; Cao, L; Wu, J; Wang, MC; Ding, XD; Zhu, YM				Luo, Xiao; Sun, Xiaoli; Liu, Baohui; Zhu, Dan; Bai, Xi; Cai, Hua; Ji, Wei; Cao, Lei; Wu, Jing; Wang, Mingchao; Ding, Xiaodong; Zhu, Yanming			Ectopic Expression of a WRKY Homolog from Glycine soja Alters Flowering Time in Arabidopsis	PLOS ONE			English	Article							MADS-BOX GENE; TRANSCRIPTION FACTOR; ABSCISIC-ACID; DISEASE RESISTANCE; FLORAL TRANSITION; DROUGHT TOLERANCE; STRESS TOLERANCE; DOMAIN PROTEIN; BINDING; VERNALIZATION	Flowering is a critical event in the life cycle of plants; the WRKY-type transcription factors are reported to be involved in many developmental processes sunch as trichome development and epicuticular wax loading, but whether they are involved in flowering time regulation is still unknown. Within this study, we provide clear evidence that GsWRKY20, a member of WRKY gene family from wild soybean, is involved in controlling plant flowering time. Expression of GsWRKY20 was abundant in the shoot tips and inflorescence meristems of wild soybean. Phenotypic analysis showed that GsWRKY20 over-expression lines flowered earlier than the wild-type plants under all conditions: long-day and short-day photoperiods, vernalization, or exogenous GA(3) application, indicating that GsWRKY20 may mainly be involved in an autonomous flowering pathway. Further analyses by qRT-PCR and microarray suggests that GsWRKY20 accelerating plant flowering might primarily be through the regulation of flowering-related genes (i.e., FLC, FT, SOC1 and CO) and floral meristem identity genes (i.e., AP1, SEP3, AP3, PI and AG). Our results provide the evidence demonstrating the effectiveness of manipulating GsWRKY20 for altering plant flowering time.	[Luo, Xiao; Sun, Xiaoli; Zhu, Dan; Bai, Xi; Cai, Hua; Ji, Wei; Cao, Lei; Wu, Jing; Wang, Mingchao; Zhu, Yanming] Northeast Agr Univ, Plant Bioengn Lab, Harbin, Heilong Jiang, Peoples R China; [Luo, Xiao; Liu, Baohui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Heilong Jiang, Peoples R China; [Ding, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	Northeast Agricultural University - China; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, YM (corresponding author), Northeast Agr Univ, Plant Bioengn Lab, Harbin, Heilong Jiang, Peoples R China.	ymzhu@neau.edu.cn	Sun, Xiaoli/AAH-2265-2020	Sun, Xiaoli/0000-0003-1134-3976	National Natural Science Foundation of China [31201223, 31171578]; Research Fund for the Doctoral Program of Higher Education of China [20102325120002]; Key Project of the Ministry of National Education [212049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of the Ministry of National Education	This work was supported by the National Natural Science Foundation of China (31201223, 31171578); the Research Fund for the Doctoral Program of Higher Education of China (20102325120002); the Key Project of the Ministry of National Education (212049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Cai M, 2008, PLANT CELL ENVIRON, V31, P86, DOI 10.1111/j.1365-3040.2007.01739.x; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Ebine K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042239; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kang XJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003347; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Li W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021364; Liu ZC, 2010, SEMIN CELL DEV BIOL, V21, P80, DOI 10.1016/j.semcdb.2009.11.012; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Luo X, 2012, J PLANT PHYSIOL, V169, P1192, DOI 10.1016/j.jplph.2012.03.019; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pelaz S, 2001, PLANT J, V26, P385, DOI 10.1046/j.1365-313X.2001.2641042.x; Pernas M, 2007, PLANT J, V51, P763, DOI 10.1111/j.1365-313X.2007.03179.x; Razafimandimbison SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040851; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shin B, 2002, PLANT J, V30, P23, DOI 10.1046/j.1365-313X.2002.01264.x; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Tong Z, 2009, PLANT MOL BIOL, V71, P115, DOI 10.1007/s11103-009-9513-y; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Urbanus SL, 2010, PLANT J, V63, P60, DOI 10.1111/j.1365-313X.2010.04221.x; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wei W, 2008, PLANT CELL REP, V27, P795, DOI 10.1007/s00299-007-0499-0; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Wuest SE, 2012, P NATL ACAD SCI USA, V109, P13452, DOI 10.1073/pnas.1207075109; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047399; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zhao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043705; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758; Zheng ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053924; Zhu D, 2011, PLANT MOL BIOL, V77, P285, DOI 10.1007/s11103-011-9810-0	56	38	48	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73295	10.1371/journal.pone.0073295	http://dx.doi.org/10.1371/journal.pone.0073295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991184	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800097
J	Salotti, J; Dias, MH; Koga, MM; Armelin, HA				Salotti, Jacqueline; Dias, Matheus H.; Koga, Marianna M.; Armelin, Hugo A.			Fibroblast Growth Factor 2 Causes G2/M Cell Cycle Arrest in Ras-Driven Tumor Cells through a Src-Dependent Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; FACTOR RECEPTORS; GENE-EXPRESSION; FGF RECEPTOR; CANCER CELLS; ACTIVATION; PROLIFERATION; FAMILY; INACTIVATION; REQUIREMENT	We recently reported that paracrine Fibroblast Growth Factor 2 (FGF2) triggers senescence in Ras-driven Y1 and 3T3(Ras) mouse malignant cell lines. Here, we show that although FGF2 activates mitogenic pathways in these Ras-dependent malignant cells, it can block cell proliferation and cause a G2/M arrest. These cytostatic effects of FGF2 are inhibited by PD173074, an FGF receptor (FGFR) inhibitor. To determine which downstream pathways are induced by FGF2, we tested specific inhibitors targeting mitogen-activated protein kinase (MEK), phosphatidylinositol 3 kinase (PI3K) and protein kinase C (PKC). We show that these classical mitogenic pathways do not mediate the cytostatic activity of FGF2. On the other hand, the inhibition of Src family kinases rescued Ras-dependent malignant cells from the G2/M irreversible arrest induced by FGF2. Taken together, these data indicate a growth factor-sensitive point in G2/M that likely involves FGFR/Ras/Src pathway activation in a MEK, PI3K and PKC independent manner.	[Salotti, Jacqueline; Dias, Matheus H.; Koga, Marianna M.; Armelin, Hugo A.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Dias, Matheus H.; Armelin, Hugo A.] CATcepid, Inst Butantan, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Armelin, HA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	haarmeli@iq.usp.br	Dias, Matheus/B-7271-2018; Armelin, Hugo/P-4390-2015; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Salotti, Jacqueline/M-4515-2019	Armelin, Hugo/0000-0001-9557-0804; Salotti, Jacqueline/0000-0001-6009-6751; Koga, Marianna/0000-0003-3244-9059; Dias, Matheus/0000-0002-2961-1142	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) and Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; Costa ET, 2008, CANCER RES, V68, P6215, DOI 10.1158/0008-5472.CAN-08-0342; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Forti FL, 2002, BIOCHEMISTRY-US, V41, P10133, DOI 10.1021/bi0258086; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Jackson TA, 2006, MOL CELL ENDOCRINOL, V247, P183, DOI 10.1016/j.mce.2006.01.002; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; Kim I, 2001, BBA-GENE STRUCT EXPR, V1518, P152, DOI 10.1016/S0167-4781(00)00282-7; Korc M, 2009, CURR CANCER DRUG TAR, V9, P639, DOI 10.2174/156800909789057006; KOVARY K, 1989, ONCOGENE RES, V4, P55; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Lee HH, 2010, J CELL SCI, V123, P3368, DOI 10.1242/jcs.071555; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotfi CFP, 2001, J ENDOCRINOL, V168, P381, DOI 10.1677/joe.0.1680381; MANSUKHANI A, 1992, P NATL ACAD SCI USA, V89, P3305, DOI 10.1073/pnas.89.8.3305; MARET A, 1995, CANCER RES, V55, P5075; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Polnaszek N, 2003, CANCER RES, V63, P5754; Ribatti D, 2007, CYTOKINE GROWTH F R, V18, P327, DOI 10.1016/j.cytogfr.2007.04.011; Sahni M, 2001, DEVELOPMENT, V128, P2119; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Sandilands E, 2012, NAT CELL BIOL, V14, P51, DOI 10.1038/ncb2386; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Smits VAJ, 2000, J BIOL CHEM, V275, P19375, DOI 10.1074/jbc.M001764200; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tanji M, 2010, MOL CELL BIOL, V30, P4604, DOI 10.1128/MCB.00197-10; Wang HS, 1997, CANCER RES, V57, P1750; Westwood G, 2002, ONCOGENE, V21, P809, DOI 10.1038/sj.onc.1205128; Williamson AJK, 2004, J BIOL CHEM, V279, P47912, DOI 10.1074/jbc.M409035200; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; YASUMURA Y, 1966, CANCER RES, V26, P529; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	58	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72582	10.1371/journal.pone.0072582	http://dx.doi.org/10.1371/journal.pone.0072582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991123	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800079
J	Vergallo, C; Dini, L; Szamosvoelgyi, Z; Tenuzzo, BA; Carata, E; Panzarini, E; Laszlo, JF				Vergallo, Cristian; Dini, Luciana; Szamosvoelgyi, Zsuzsanna; Tenuzzo, Bernardetta Anna; Carata, Elisabetta; Panzarini, Elisa; Laszlo, Janos F.			In Vitro Analysis of the Anti-Inflammatory Effect of Inhomogeneous Static Magnetic Field-Exposure on Human Macrophages and Lymphocytes	PLOS ONE			English	Article							U937 CELLS; DIFFERENTIATION; RELEASE; MICE	The effect of inhomogeneous static magnetic field (SMF)-exposure on the production of different cytokines from human peripheral blood mononuclear cells (PMBC), i.e., lymphocytes and macrophages, was tested in vitro. Some cultures were activated with lipopolysaccharide (LPS) at time point 23 h and were either left alone (positive control) or exposed to SMF continuously from 0 until 6, 18, or 24 h. The secretion of interleukin IL-6, IL-8, tumor necrosis factor TNF-alpha, and IL-10 was tested by ELISA. SMF-exposure caused visible morphological changes on macrophages as well as on lymphocytes, and also seemed to be toxic to lymphocytes ([36.58; 41.52]%, 0.308 <= p <= 0.444), but not to macrophages (<1.43%, p >= 0.987). Analysis of concentrations showed a significantly reduced production of pro-inflammatory cytokines IL-6, IL-8, and TNF-alpha from macrophages compared to negative control ([56.78; 87.52]%, p = 0.031) and IL-6 compared to positive control ([45.15; 56.03]%, p = 0.035). The production of anti-inflammatory cytokine IL-10 from macrophages and from lymphocytes was enhanced compared to negative control, significantly from lymphocytes ([-183.62; -28.75]%, p = 0.042). The secretion of IL-6 from lymphocytes was significantly decreased compared to positive control ([-115.15; -26.84]%, p = 0.039). This massive in vitro evidence supports the hypotheses that SMF-exposure (i) is harmful to lymphocytes in itself, (ii) suppresses the release of pro-inflammatory cytokines IL-6, IL-8, and TNF-alpha, and (iii) assists the production of anti-inflammatory cytokine IL-10; thus providing a background mechanism of the earlier in vivo demonstrated anti-inflammatory effects of SMF-exposure.	[Vergallo, Cristian; Dini, Luciana; Tenuzzo, Bernardetta Anna; Carata, Elisabetta; Panzarini, Elisa] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Szamosvoelgyi, Zsuzsanna] Natl Inst Pharm, Budapest, Hungary; [Laszlo, Janos F.] Univ Debrecen, Dept Comp Sci, H-4012 Debrecen, Hungary	University of Salento; University of Debrecen	Dini, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	luciana.dini@unisalento.it	CARATA, Elisabetta/M-2845-2019; Vergallo, Cristian/J-4303-2019; Carata, Elisabetta/J-9621-2016; Laszlo, Janos F/B-6996-2008	CARATA, Elisabetta/0000-0002-3801-5457; Vergallo, Cristian/0000-0002-0264-4753; Carata, Elisabetta/0000-0002-3801-5457; Panzarini, Elisa/0000-0003-4219-4272	European Social Fund; European Regional Development Fund;  [TAMOP-4.2.2.C-11/1/KONV-2012-0001]	European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission); 	JFL was partially supported by the TAMOP-4.2.2.C-11/1/KONV-2012-0001 project. (The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund and the European Regional Development Fund.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci C, 2003, BIOELECTROMAGNETICS, V24, P109, DOI 10.1002/bem.10071; Antal M, 2009, BIOELECTROMAGNETICS, V30, P438, DOI 10.1002/bem.20498; Chao PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043680; Chionna A, 2005, BIOELECTROMAGNETICS, V26, P275, DOI 10.1002/bem.20081; Chionna A, 2003, EUR J HISTOCHEM, V47, P299, DOI 10.4081/840; Cunha FQ, 1999, BRIT J PHARMACOL, V127, P671, DOI 10.1038/sj.bjp.0702601; Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009; Dini L, 2010, EXP BIOL MED, V235, P1432, DOI 10.1258/ebm.2010.010122; Dini Luciana, 2009, P409, DOI 10.1007/978-1-4020-9292-3_15; Dini L, 2009, BIOELECTROMAGNETICS, V30, P352, DOI 10.1002/bem.20474; Gyires K, 2008, BIOELECTROMAGNETICS, V29, P456, DOI 10.1002/bem.20413; Laszlo JF, 2012, ACTA BIOL HUNG, V63, P441, DOI 10.1556/ABiol.63.2012.4.3; Laszlo J, 2007, BIOELECTROMAGNETICS, V28, P615, DOI 10.1002/bem.20341; Laszlo J, 2009, LIFE SCI, V84, P12, DOI 10.1016/j.lfs.2008.10.009; Laszlo JF, 2012, INT J RADIAT BIOL, V88, P430, DOI 10.3109/09553002.2012.661916; Laszlo JF, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.012; Laszlo JF, 2011, INT J RADIAT BIOL, V87, P36, DOI 10.3109/09553002.2010.518200; Lee J, 2011, BIOELECTROMAGNETICS, V32, P535, DOI 10.1002/bem.20664; Lin SL, 2010, BEHAV BRAIN RES, V207, P30, DOI 10.1016/j.bbr.2009.09.034; Lin SL, 2009, INT J RADIAT BIOL, V85, P633, DOI 10.1080/09553000902993908; Luferova N B, 2011, Vopr Kurortol Fizioter Lech Fiz Kult, P52; Nichols TW, 2012, MED HYPOTHESES, V79, P287, DOI 10.1016/j.mehy.2012.05.006; Pagliara P, 2005, EUR J HISTOCHEM, V49, P75; Salerno S, 1999, INT J RADIAT BIOL, V75, P457, DOI 10.1080/095530099140384; Sandor K, 2007, LIFE SCI, V81, P97, DOI 10.1016/j.lfs.2007.04.029; *SCI COMM EM NEWL, 2009, HLTH EFF EXP EMF; Sontag W, 2001, INT J RADIAT BIOL, V77, P723, DOI 10.1080/095530000110046376; Tenuzzo B, 2009, TISSUE CELL, V41, P169, DOI 10.1016/j.tice.2008.09.004; Tenuzzo B, 2006, BIOELECTROMAGNETICS, V27, P560, DOI 10.1002/bem.20252; Wang Z, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-383; World Health Organization, 2006, ENV HLTH CRIT MON	31	28	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72374	10.1371/journal.pone.0072374	http://dx.doi.org/10.1371/journal.pone.0072374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991101	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800065
J	Gardner, C; Mills, DJ				Gardner, Caleb; Mills, David J.			Determination of Moulting Events in Rock Lobsters from Pleopod Clipping	PLOS ONE			English	Article							JASUS-EDWARDSII; PSEUDOCARCINUS-GIGAS; GROWTH; LALANDII; RATES; SIZE	Rock lobster growth is routinely measured for research to optimise management measures such as size limits and quotas. The process of estimating growth is complicated in crustaceans as growth only occurs when the animal moults. As data are typically collected by tag-recapture methods, the timing of moulting events can bias results. For example, if annual moulting events take place within a very short time-at-large after tagging, or if time-at-large is long and no moulting occurs. Classifying data into cases where moulting has / has not occurred during time-at-large can be required and can generally be determined by change in size between release and recapture. However, in old or slow growth individuals the moult increment can be too small to provide surety that moulting has occurred. A method that has been used since the 1970's to determine moulting in rock lobsters involves clipping the distal portion of a pleopod so that any regeneration observed at recapture can be used as evidence of a moult. We examined the use of this method in both tank and long-duration field trials within a marine protected area, which provided access to large animals with smaller growth increments. Our results emphasised that determination of moulting by change in size was unreliable with larger lobsters and that pleopod clipping can assist in identifying moulting events. However, regeneration was an unreliable measure of moulting if clipping occurred less than three months before the moult.	[Gardner, Caleb] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Mills, David J.] WorldFish, George Town, Malaysia; [Mills, David J.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of Tasmania; CGIAR; Worldfish; James Cook University	Gardner, C (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Caleb.Gardner@utas.edu.au	Gardner, Caleb/I-7086-2013; Mills, David/GXF-1821-2022	Gardner, Caleb/0000-0003-0324-4337; Mills, David/0000-0003-0181-843X	Fisheries Research and Development Corporation (FRDC) [2002/238]	Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp)	The research was funded by the Fisheries Research and Development Corporation (FRDC), project 2002/238 (www.frdc.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARE, 2012, AUSTR FISH STAT 2011, V2011, P113; ARNASON A N, 1973, Researches on Population Ecology (Tokyo), V15, P1; Buxton CD, 2004, 1999162 FISH RES DEV, P384; Cockcroft AC, 1995, S AFR J MARINE SCI, V16, P195; Comeau M, 2001, J CRUSTACEAN BIOL, V21, P923, DOI 10.1651/0278-0372(2001)021[0923:GIAMFO]2.0.CO;2; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Foyle TP, 1989, CAN IND REP FISH AQU, V193; Gardner C., 2006, Journal of Aquatic Food Product Technology, V15, P17, DOI 10.1300/J030v15n02_03; Gardner C, 2002, LOW WAKE FI, V19, P17; Gardner C, 2010, TASMANIAN ROCK LOBST; Goosen PC, 1995, S AFR J MARINE SCI, V16, P377; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; McGarvey R, 2002, MAR FRESHWATER RES, V53, P869, DOI 10.1071/MF00074; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; Musgrove RJB, 2000, J CRUSTACEAN BIOL, V20, P44, DOI 10.1651/0278-0372(2000)020[0044:MSITSR]2.0.CO;2; Phillips BF, 1992, MEASUREMENT AGE GROW, P142; Punt AE, 1997, MAR FRESHWATER RES, V48, P981, DOI 10.1071/MF97017; SCHWARZ CJ, 1993, BIOMETRICS, V49, P177, DOI 10.2307/2532612; Seber JAF, 1965, BIOMETRIKA, V52, P249, DOI [10.2307/2333827., DOI 10.2307/2333827.PUBMED:14341277]; Turnbull CT., 1989, MAR FRESHWATER RES, V40, P285, DOI DOI 10.1071/MF9890285; WINSTANLEY R H, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P355	22	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74146	10.1371/journal.pone.0074146	http://dx.doi.org/10.1371/journal.pone.0074146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009769	Green Accepted, gold, Green Published			2022-12-25	WOS:000324403200053
J	Gontier, E; Hasuo, E; Mitsudo, T; Grondin, S				Gontier, Emilie; Hasuo, Emi; Mitsudo, Takako; Grondin, Simon			EEG Investigations of Duration Discrimination: The Intermodal Effect Is Induced by an Attentional Bias	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; CONTINGENT NEGATIVE-VARIATION; SUPPLEMENTARY MOTOR AREA; TEMPORAL ACCUMULATION; ORIENTING ATTENTION; NEURAL MECHANISMS; TIME PERCEPTION; INTERVAL; BRAIN; ERPS	Previous studies indicated that empty time intervals are better discriminated in the auditory than in the visual modality, and when delimited by signals delivered from the same (intramodal intervals) rather than from different sensory modalities (intermodal intervals). The present electrophysiological study was conducted to determine the mechanisms which modulated the performances in inter-and intramodal conditions. Participants were asked to categorise as short or long empty intervals marked by auditory (A) and/or visual (V) signals (intramodal intervals: AA, VV; intermodal intervals: AV, VA). Behavioural data revealed that the performances were higher for the AA intervals than for the three other intervals and lower for inter-compared to intramodal intervals. Electrophysiological results indicated that the CNV amplitude recorded at fronto-central electrodes increased significantly until the end of the presentation of the long intervals in the AA conditions, while no significant change in the time course of this component was observed for the other three modalities of presentation. They also indicated that the N1 and P2 amplitudes recorded after the presentation of the signals which delimited the beginning of the intervals were higher for the inter-(AV/VA) compared to the intramodal intervals (AA/VV). The time course of the CNV revealed that the high performances observed with AA intervals would be related to the effectiveness of the neural mechanisms underlying the processing of the ongoing interval. The greater amplitude of the N1 and P2 components during the intermodal intervals suggests that the weak performances observed in these conditions would be caused by an attentional bias induced by the cognitive load and the necessity to switch between modalities.	[Gontier, Emilie; Grondin, Simon] Univ Laval, Lab Rech Psychol Percept, Quebec City, PQ, Canada; [Hasuo, Emi] Kyushu Univ, JSPS, Fac Med Sci, Fukuoka 812, Japan; [Mitsudo, Takako] Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 812, Japan	Laval University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University	Gontier, E (corresponding author), Univ Laval, Lab Rech Psychol Percept, Quebec City, PQ, Canada.	emilie.gontier.1@ulaval.ca		Mitsudo, Takako/0000-0002-4123-4247	Natural Sciences and Engineering Council of Canada [656-2131, 6227]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was made possible by a research grant awarded to Simon Grondin by the Natural Sciences and Engineering Council of Canada (656-2131#6227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, PERCEPT PSYCHOPHYS, V56, P501, DOI 10.3758/BF03206947; Bendixen A, 2005, NEUROSCI LETT, V383, P284, DOI 10.1016/j.neulet.2005.04.034; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Davranche K, 2011, J COGNITIVE NEUROSCI, V23, P3318, DOI 10.1162/jocn_a_00030; DIAYE KN, 2004, COGNITIVE BRAIN RES, V21, P250, DOI DOI 10.1016/J.C0GBRAINRES.2004.04.006; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; GAILLARD AWK, 1976, BIOL PSYCHOL, V4, P139, DOI 10.1016/0301-0511(76)90013-2; Genovesio A, 2009, NEURON, V63, P254, DOI 10.1016/j.neuron.2009.06.018; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gontier E, 2007, BRAIN RES, V1170, P79, DOI 10.1016/j.brainres.2007.07.022; Gontier E, 2009, NEUROPSYCHOLOGY, V23, P668, DOI 10.1037/a0015757; GRONDIN S, 1993, PERCEPT PSYCHOPHYS, V54, P383, DOI 10.3758/BF03205274; Grondin S, 1996, PERCEPT PSYCHOPHYS, V58, P424, DOI 10.3758/BF03206818; Grondin S, 2005, PERCEPTION, V34, P45, DOI 10.1068/p5369; GRONDIN S, 1992, NATO ADV SCI INST SE, V66, P119; Grondin S, 2004, CAN J EXP PSYCHOL, V58, P1, DOI 10.1037/h0087436; Grondin S, 2003, Q J EXP PSYCHOL-A, V56, P731, DOI 10.1080/02724980244000611; Grondin S., 2001, Acoustical Science and Technology, V22, P370, DOI 10.1250/ast.22.370; GRONDIN S, 1991, PERCEPT PSYCHOPHYS, V49, P245, DOI 10.3758/BF03214309; Grondin S, 1998, PSYCHOL RES-PSYCH FO, V61, P261, DOI 10.1007/s004260050030; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Grondin S, 2009, PERCEPTION, V38, P1542, DOI 10.1068/p6359; Grondin S, 2008, PSYCHOLOGY OF TIME, P51, DOI 10.1016/B978-0-08046-977-5.00002-8; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jantzen KJ, 2005, NEUROIMAGE, V25, P1031, DOI 10.1016/j.neuroimage.2004.12.029; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Key APF, 2005, DEV NEUROPSYCHOL, V27, P183, DOI 10.1207/s15326942dn2702_1; Kononowicz TW, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00048; Kushnerenko E, 2001, NEUROREPORT, V12, P3777, DOI 10.1097/00001756-200112040-00035; LADANYI M, 1985, INT J NEUROSCI, V26, P253, DOI 10.3109/00207458508985622; Le Dantec C, 2007, ACTA PSYCHOL, V125, P85, DOI 10.1016/j.actpsy.2006.07.003; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Macar F, 2004, COGNITIVE BRAIN RES, V21, P206, DOI 10.1016/j.cogbrainres.2004.01.005; Macar F, 2003, PSYCHOPHYSIOLOGY, V40, P950, DOI 10.1111/1469-8986.00113; Macar F, 2009, CAN J EXP PSYCHOL, V63, P227, DOI 10.1037/a0014457; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Mento G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062896; Mitsudo T, 2012, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00084; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Neelon MF, 2006, BRAIN RES, V1118, P94, DOI 10.1016/j.brainres.2006.08.006; NELSON DA, 1968, J ACOUST SOC AM, V44, P1529, DOI 10.1121/1.1911292; Ng KK, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00077; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Paul I, 2011, BIOL PSYCHOL, V88, P94, DOI 10.1016/j.biopsycho.2011.06.013; Penney T.B., 2005, PSYCHOL FRANCA, V50, P131, DOI [10.1016/j.psfr.2004.10.011, DOI 10.1016/J.PSFR.2004.10.011]; Penney TB, 2004, COGNITIVE BRAIN RES, V21, P234, DOI 10.1016/j.cogbrainres.2004.07.005; Pfeuty M, 2005, NEUROSCI LETT, V382, P106, DOI 10.1016/j.neulet.2005.02.067; Pfeuty M, 2003, EXP BRAIN RES, V151, P372, DOI 10.1007/s00221-003-1505-6; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; PICTON TW, 1977, J OTOLARYNGOL, V6, P90; Praamstra P, 2006, J NEUROSCI, V26, P5448, DOI 10.1523/JNEUROSCI.0440-06.2006; ROCKSTROH B, 1982, PSYCHOPHYSIOLOGY, V19, P211, DOI 10.1111/j.1469-8986.1982.tb02549.x; Rohrbaugh J, 1983, TUTORIALS ERP RES EN, V10, P269; ROUSSEAU R, 1983, PERCEPT PSYCHOPHYS, V34, P541, DOI 10.3758/BF03205907; Shelton J., 2010, NEUROSCIENCE MED, V1, P30, DOI [10.4236/nm.2010.11004, DOI 10.4236/NM.2010.11004]; Shih LYL, 2009, NEUROREPORT, V20, P897, DOI 10.1097/WNR.0b013e3283270b6e; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; STEENHUIS RE, 1989, CORTEX, V25, P289, DOI 10.1016/S0010-9452(89)80044-9; Vallesi A, 2009, J COGNITIVE NEUROSCI, V21, P1116, DOI 10.1162/jocn.2009.21098; van Rijn H, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00091; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wiener M, 2010, NEUROPSYCHOLOGIA, V48, P3967, DOI 10.1016/j.neuropsychologia.2010.09.014; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wittmann M, 2013, NAT REV NEUROSCI, V14, P217, DOI 10.1038/nrn3452; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2	85	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74073	10.1371/journal.pone.0074073	http://dx.doi.org/10.1371/journal.pone.0074073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009766	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200052
J	Gray, BP; McGuire, MJ; Brown, KC				Gray, Bethany Powell; McGuire, Michael J.; Brown, Kathlynn C.			A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RANDOMIZED PHASE-III; THERAPEUTIC-EFFICACY; TUMOR VASCULATURE; ALPHA(V)BETA(6) INTEGRIN; ALPHA-V-BETA-6 INTEGRIN; MESENCHYMAL TRANSITION; ANTITUMOR-ACTIVITY; MODELING ANALYSIS; MULTIPLE-MYELOMA	One method for improving cancer treatment is the use of nanoparticle drugs functionalized with targeting ligands that recognize receptors expressed selectively by tumor cells. In theory such targeting ligands should specifically deliver the nanoparticle drug to the tumor, increasing drug concentration in the tumor and delivering the drug to its site of action within the tumor tissue. However, the leaky vasculature of tumors combined with a poor lymphatic system allows the passive accumulation, and subsequent retention, of nanosized materials in tumors. Furthermore, a large nanoparticle size may impede tumor penetration. As such, the role of active targeting in nanoparticle delivery is controversial, and it is difficult to predict how a targeted nanoparticle drug will behave in vivo. Here we report in vivo studies for a(v)beta(6)-specific H2009.1 peptide targeted liposomal doxorubicin, which increased liposomal delivery and toxicity to lung cancer cells in vitro. We systematically varied ligand affinity, ligand density, ligand stability, liposome dosage, and tumor models to assess the role of active targeting of liposomes to a(v)beta(6). In direct contrast to the in vitro results, we demonstrate no difference in in vivo targeting or efficacy for H2009.1 tetrameric peptide liposomal doxorubicin, compared to control peptide and no peptide liposomes. Examining liposome accumulation and distribution within the tumor demonstrates that the liposome, and not the H2009.1 peptide, drives tumor accumulation, and that both targeted H2009.1 and untargeted liposomes remain in perivascular regions, with little tumor penetration. Thus H2009.1 targeted liposomes fail to improve drug efficacy because the liposome drug platform prevents the H2009.1 peptide from both actively targeting the tumor and binding to tumor cells throughout the tumor tissue. Therefore, using a high affinity and high specificity ligand targeting an over-expressed tumor biomarker does not guarantee enhanced efficacy of a liposomal drug. These results highlight the complexity of in vivo targeting.	[Brown, Kathlynn C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, KC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Kathlynn.Brown@UTSouthwestern.edu	Gray, Bethany/AAS-4913-2021	Brown, Kathlynn/0000-0003-0012-9675	Welch Foundation [I-1622]; National Institutes of Health/National Cancer Institute (NCI) [1R01CA164447]; Cancer Research and Prevention Institute of Texas [RP 101496]; NCI [P30 CA142543]; NATIONAL CANCER INSTITUTE [R01CA164447, P30CA142543] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research and Prevention Institute of Texas; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Welch Foundation grant # I-1622 and the National Institutes of Health/National Cancer Institute (NCI) grant # 1R01CA164447 (to KCB). BPG was supported by a fellowship from the Cancer Research and Prevention Institute of Texas (RP 101496). The shared imaging resources of UT Southwestern are supported in part by a NCI support grant to the Harold Simmons Cancer Center (P30 CA142543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, J HISTOCHEM CYTOCHEM, V50, P1371, DOI 10.1177/002215540205001010; Allen Theresa M., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P513, DOI 10.2174/187152006778699121; Allen TM, 2005, CLIN CANCER RES, V11, P3567, DOI 10.1158/1078-0432.CCR-04-2517; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arihiro K, 2000, Breast Cancer, V7, P19, DOI 10.1007/BF02967183; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BREUSS JM, 1995, J CELL SCI, V108, P2241; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Chang DK, 2009, J BIOL CHEM, V284, P12905, DOI 10.1074/jbc.M900280200; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; de Menezes DEL, 1998, CANCER RES, V58, P3320; DREHER MR, 2006, J NCI, P335; Duggan ST, 2011, DRUGS, V71, P2531, DOI 10.2165/11207510-000000000-00000; FUJIMORI K, 1990, J NUCL MED, V31, P1191; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 2002, J DRUG TARGET, V10, P539, DOI 10.1080/1061186021000072447; Garde SV, 2007, ANTI-CANCER DRUG, V18, P1189, DOI 10.1097/CAD.0b013e3282a213ce; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; Gray BP, 2013, BIOCONJUGATE CHEM, V24, P85, DOI 10.1021/bc300498d; Hamidi S, 2000, BRIT J CANCER, V82, P1433, DOI 10.1054/bjoc.1999.1130; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; Hecht JL, 2008, APPL IMMUNOHISTO M M, V16, P543, DOI 10.1097/PAI.0b013e31816bc5ee; Herringson TP, 2011, INT J PHARMACEUT, V411, P206, DOI 10.1016/j.ijpharm.2011.03.044; Herringson TP, 2011, J DRUG TARGET, V19, P681, DOI 10.3109/1061186X.2010.536984; Hussain S, 2007, MOL CANCER THER, V6, P3019, DOI 10.1158/1535-7163.MCT-07-0615; INABA M, 1989, CANCER, V64, P1577, DOI 10.1002/1097-0142(19891015)64:8<1577::AID-CNCR2820640803>3.0.CO;2-I; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Katanasaka Y, 2010, INT J CANCER, V127, P2685, DOI 10.1002/ijc.25276; Kawashima A, 2003, PATHOL RES PRACT, V199, P57, DOI 10.1078/0344-0338-00355; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Kwon IK, 2012, J CONTROL RELEASE, V164, P108, DOI 10.1016/j.jconrel.2012.07.010; Lammers T, 2007, J CONTROL RELEASE, V117, P333, DOI 10.1016/j.jconrel.2006.10.032; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Li S, 2011, BIOORGAN MED CHEM, V19, P5480, DOI 10.1016/j.bmc.2011.07.046; Li SZ, 2009, MOL CANCER THER, V8, P1239, DOI 10.1158/1535-7163.MCT-08-1098; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Lowery A, 2011, J CONTROL RELEASE, V150, P117, DOI 10.1016/j.jconrel.2010.11.006; Mamot C, 2005, CANCER RES, V65, P11631, DOI 10.1158/0008-5472.CAN-05-1093; MAMOT C, 2011, 2011 ASCO ANN M CHIC; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Medina OP, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/160515; Northfelt DW, 1997, J CLIN ONCOL, V15, P653, DOI 10.1200/JCO.1997.15.2.653; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Oyama T, 2003, CANCER LETT, V202, P219, DOI 10.1016/j.canlet.2003.08.011; Park JH, 2010, P NATL ACAD SCI USA, V107, P981, DOI 10.1073/pnas.0909565107; Pastorino F, 2003, CANCER RES, V63, P7400; Pastorino F, 2003, CANCER RES, V63, P86; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Phelps RM, 1996, J CELL BIOCHEM, P32; Pirollo KF, 2008, TRENDS BIOTECHNOL, V26, P552, DOI 10.1016/j.tibtech.2008.06.007; Popovic Z, 2010, ANGEW CHEM INT EDIT, V49, P8649, DOI 10.1002/anie.201003142; Prudkin L, 2009, MODERN PATHOL, V22, P668, DOI 10.1038/modpathol.2009.19; Regezi JA, 2002, ORAL ONCOL, V38, P332, DOI 10.1016/S1368-8375(01)00062-8; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Ruenraroengsak P, 2010, J CONTROL RELEASE, V141, P265, DOI 10.1016/j.jconrel.2009.10.032; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Seki T, 2011, J CONTROL RELEASE, V156, P381, DOI 10.1016/j.jconrel.2011.08.022; Seynhaeve ALB, 2007, CANCER RES, V67, P9455, DOI 10.1158/0008-5472.CAN-07-1599; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song SX, 2008, INT J PHARMACEUT, V363, P155, DOI 10.1016/j.ijpharm.2008.07.012; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Tuscano JM, 2010, CLIN CANCER RES, V16, P2760, DOI 10.1158/1078-0432.CCR-09-3199; WICKHAM T, 2012, CANC RES, V72; Zhang LZ, 2012, BIOL PHARM BULL, V35, P761, DOI 10.1248/bpb.35.761	73	28	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72938	10.1371/journal.pone.0072938	http://dx.doi.org/10.1371/journal.pone.0072938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009717	gold, Green Published, Green Submitted			2022-12-25	WOS:000324403200037
J	Panigrahi, R; Hazari, S; Chandra, S; Chandra, PK; Datta, S; Kurt, R; Cameron, CE; Huang, ZH; Zhang, HT; Garry, RF; Balart, LA; Dash, S				Panigrahi, Rajesh; Hazari, Sidhartha; Chandra, Sruti; Chandra, Partha K.; Datta, Sibnarayan; Kurt, Ramazan; Cameron, Craig E.; Huang, Zhuhui; Zhang, Haitao; Garry, Robert F.; Balart, Luis A.; Dash, Srikanta			Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							HEPATITIS-C-VIRUS; ACTIVATED PROTEIN-KINASE; ANTIVIRAL ACTIVITY; ALPHA-INTERFERON; CELL-CULTURE; IFN-ALPHA; MECHANISM; REPLICATION; EXPRESSION; SEQUENCES	Purpose: Although chronic hepatitis C virus (HCV) infection has been treated with the combination of interferon alpha (IFN-alpha) and ribavirin (RBV) for over a decade, the mechanism of antiviral synergy is not well understood. We aimed to determine the synergistic antiviral mechanisms of IFN-alpha and RBV combination treatment using HCV cell culture. Methods: The antiviral efficacy of IFN-alpha, RBV alone and in combination was quantitatively measured using HCV infected and replicon cell culture. Direct antiviral activity of these two drugs at the level of HCV internal ribosome entry site (IRES) mediated translation in Huh-7 cell culture was investigated. The synergistic antiviral effect of IFN-alpha and RBV combination treatment was verified using both the CalcuSyn Software and MacSynergy Software. Results: RBV combination with IFN-alpha efficiently inhibits HCV replication cell culture. Our results demonstrate that IFN-alpha, interferon lambda (IFN-lambda) and RBV each inhibit the expression of HCV IRES-GFP and that they have a minimal effect on the expression of GFP in which the translation is not IRES dependent. The combination treatments of RBV along with IFN-alpha or IFN-lambda were highly synergistic with combination indexes <1. We show that IFN-alpha treatment induce levels of PKR and eIF2 alpha phosphorylation that prevented ribosome loading of the HCV IRES-GFP mRNA. Silencing of PKR expression in Huh-7 cells prevented the inhibitory effect of IFN-alpha on HCV IRES-GFP expression. RBV also blocked polyribosome loading of HCV-IRES mRNA through the inhibition of cellular IMPDH activity, and induced PKR and eIF2 alpha phosphorylation. Knockdown of PKR or IMPDH prevented RBV induced HCV IRES-GFP translation. Conclusions: We demonstrated both IFN-alpha and RBV inhibit HCV IRES through prevention of polyribosome formation. The combination of IFN-alpha and RBV treatment synergistically inhibits HCV IRES translation via using two different mechanisms involving PKR activation and depletion of intracellular guanosine pool through inhibition of IMPDH.	[Panigrahi, Rajesh; Hazari, Sidhartha; Chandra, Sruti; Chandra, Partha K.; Datta, Sibnarayan; Kurt, Ramazan; Zhang, Haitao; Garry, Robert F.; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Huang, Zhuhui] So Res Inst, Hepatitis Res Program, Frederick, MD USA	Tulane University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dash, S (corresponding author), Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	sdash@tulane.edu	Datta, S./E-7036-2010	Datta, S./0000-0001-6953-1510; Garry, Robert/0000-0002-5683-3250; Panigrahi, Rajesh/0000-0002-6704-0029	National Institutes of Health [CA127481, CA089121, AI 103106]; Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA089121, R01CA127481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104621, R01AI103106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from National Institutes of Health grant CA127481, CA089121, AI 103106 and bridge funding received from Tulane University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; CHOU TC, 1977, J BIOL CHEM, V252, P6438; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; Dash S, 2005, LIVER INT, V25, P580, DOI 10.1111/j.1478-3231.2005.01082.x; Datta S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-351; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hazari S, 2005, J GEN VIROL, V86, P3047, DOI 10.1099/vir.0.81132-0; Hazari S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-36; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kanda T, 2012, VIRAL IMMUNOL, V25, P379, DOI 10.1089/vim.2012.0021; Kato J, 2002, J INFECT DIS, V186, P155, DOI 10.1086/341467; Koev G, 2002, VIROLOGY, V297, P195, DOI 10.1006/viro.2002.1455; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Liu WL, 2007, J INFECT DIS, V196, P425, DOI 10.1086/518894; Liu WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043824; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Prichard M N, 1996, Antivir Ther, V1, P9; Prichard MN, MACSYNERGY 2 VERSION; Qi ZT, 2003, ARCH VIROL, V148, P449, DOI 10.1007/s00705-002-0933-0; Rivas-Estilla AM, 2002, J VIROL, V76, P10637, DOI 10.1128/JVI.76.21.10637-10653.2002; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shimazaki T, 2002, HEPATOLOGY, V35, P199, DOI 10.1053/jhep.2002.30202; Shu QN, 2008, MED RES REV, V28, P219, DOI 10.1002/med.20104; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Stevenson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027866; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	46	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72791	10.1371/journal.pone.0072791	http://dx.doi.org/10.1371/journal.pone.0072791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009705	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200032
J	Vanderford, NL; Weiss, LT; Weiss, HL				Vanderford, Nathan L.; Weiss, L. Todd; Weiss, Heidi L.			A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization	PLOS ONE			English	Article								Commercialization within the academic setting is associated with many challenges and barriers. Previous studies investigating these challenges/barriers have, in general, broadly focused on multiple disciplines and, oftentimes, several institutions simultaneously. The goal of the study presented here was to analyze a range of barriers that may be broadly associated with commercializing academic-based cancer research. This goal was addressed via a study of the barriers associated with cancer research commercialization at the University of Kentucky (UK). To this end, a research instrument in the form of an electronic survey was developed. General demographic information was collected on study participants and two research questions were addressed: 1) What are the general barriers inhibiting cancer research commercialization at UK? and 2) Would mitigation of the barriers potentially enhance faculty engagement in commercialization activities? Descriptive and statistical analysis of the data reveal that multiple barriers likely inhibit cancer research commercialization at UK with expense, time, infrastructure, and lack of industry partnerships being among the most commonly cited factors. The potential alleviation of these factors in addition to revised University policies/procedures, risk mitigation, more emphasis on commercialization by academia research field, and increased information on how to commercialize significantly correlated with the potential for increased commercialization activity. Furthermore, multivariate logistic regression modeling demonstrated that research commercialization would incrementally increase as barriers to the process are removed and that PhD-holding respondents and respondents in commercialization-supportive research fields would be more likely to commercialize their research upon barrier removal. Overall, as with other disciplines, these data suggest that for innovations derived from academic cancer-research to move more effectively and efficiently into the marketplace, university administrators and external agents, such as policymakers, need to address what are well-documented and defined issues.	[Vanderford, Nathan L.; Weiss, L. Todd; Weiss, Heidi L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Vanderford, Nathan L.] Midway Coll, Business Div, Midway, KY USA; [Weiss, Heidi L.] Univ Kentucky, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky	Vanderford, NL (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.	nathan.vanderford@uky.edu			NCATS NIH HHS [UL1 TR001998, UL1 TR000117] Funding Source: Medline; NCRR NIH HHS [UL1 RR033173] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Breznitz SM, 2013, CREATING COMPETITIVE, P88; ERA- Net NEURON, 2011, TRANSF TECHN BENCH B; Garcia P, 2012, US LIC ACT SURV FY20; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kesselheim AS, 2011, NEW ENGL J MED, V365, P1167, DOI 10.1056/NEJMp1109168; Kirschenbaum SR, 2002, NAT NEUROSCI, V5, P1025, DOI 10.1038/nn932; Klein R, 2010, J TECHNOL TRANSFER, V35, P671, DOI 10.1007/s10961-009-9143-1; Kumar MN, 2010, ETHICS BEHAV, V20, P324, DOI 10.1080/10508422.2010.491759; Lawson C, 2013, J TECHNOL TRANSFER, V38, P509, DOI 10.1007/s10961-012-9266-7; Locke W., 2002, U RES ACTIVITY PRIVA; Loise V, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001481; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; O'Shea RP, 2005, RES POLICY, V34, P994, DOI 10.1016/j.respol.2005.05.011; Powers JB, 2011, RES HIGH EDUC, V52, P245, DOI 10.1007/s11162-010-9195-y; Rae-Dupree Janet, 2008, NY TIMES; Shane Scott, 2012, BLOOMBERG BUSINESSWE; Swedish Institute for Growth Policy Studies, 2006, COMM LIF SCI RES U U; Thursby JG, 2003, SCIENCE, V301, P1052, DOI 10.1126/science.1087473	18	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72268	10.1371/journal.pone.0072268	http://dx.doi.org/10.1371/journal.pone.0072268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23991077	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100092
J	Michee, S; Brignole-Baudouin, F; Riancho, L; Rostene, W; Baudouin, C; Labbe, A				Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine			Effects of Benzalkonium Chloride on THP-1 Differentiated Macrophages In Vitro	PLOS ONE			English	Article							TOPICAL ANTIGLAUCOMA MEDICATION; CONJUNCTIVAL EPITHELIAL-CELLS; MONOCYTE-DERIVED MACROPHAGES; OCULAR SURFACE; DENDRITIC CELLS; TNF-ALPHA; INFLAMMATORY CYTOKINES; GLAUCOMA PATIENTS; EXPRESSION; LINE	Purpose: To characterize the effects of benzalkonium chloride (BAK) in THP-1 differentiated cells in vitro. Methods: Macrophages were obtained after differentiation of THP-1 cells, a human monocytic leukemia cell line. Macrophages were exposed for 24 h to 33 nM (10(-5)%) benzalkonium chloride (BAK), 10 nM dinitrochlorobenzene (DNCB), 100 ng/mL lipopolysaccharide (LPS), 5 ng/mL tumor necrosis factor alpha (TNF-alpha) or phosphate buffered saline (PBS) as controls. The expression of CD11b, CD11c, CD33 and CD54 was evaluated using immunohistochemistry and flow cytometry (FCM). Phagocytosis function was analyzed using carboxylate-modified fluorescent microspheres and quantified by FCM. Migration was evaluated in cocultures with conjunctival epithelial cells. Cytokine production was detected and quantified in culture supernatants using a human cytokine array. Results: Stimulation of THP-1-derived macrophages with a low concentration of BAK increased CD11b and CD11c expression and decreased CD33. Macrophages exposed to BAK, LPS and TNF-alpha had increased phagocytosis. In contrast to LPS, BAK and TNF-alpha increased macrophage migration. Cytokines in supernatants of macrophages exposed to BAK revealed an increased release of CCL1, CCL4/MIP-1 beta, TNF-alpha, soluble CD54/ICAM-1 and IL-1 beta. Conclusion: In vitro, BAK has a direct stimulating effect on macrophages, increasing phagocytosis, cytokine release, migration and expression of CD11b and CD11c. Long-term exposure to low concentrations of BAK should be considered as a stimulating factor responsible for inflammation through macrophage activation.	[Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine] INSERM, U968, Paris, France; [Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine] Univ Paris 06, UMR S 968, Inst Vis, Paris, France; [Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine] CNRS, UMR 7210, Paris, France; [Michee, Sylvain; Brignole-Baudouin, Francoise; Baudouin, Christophe; Labbe, Antoine] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, Paris, France; [Baudouin, Christophe; Labbe, Antoine] Univ Versailles St Quentin En Yvelines, Versailles, France; [Brignole-Baudouin, Francoise] Univ Paris 05, Fac Sci Pharmaceut & Biol, Sorbonne Paris Cite, Paris, France; [Baudouin, Christophe; Labbe, Antoine] Hop Ambroise Pare, AP HP, Serv Ophtalmol, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Michee, S (corresponding author), INSERM, U968, Paris, France.	alabbe@quinze-vingts.fr	Rostene, William/F-2754-2017	Baudouin, Christophe/0000-0003-1743-6698; Labbe, Antoine/0000-0003-3057-3558; ROSTENE, WILLIAM/0000-0003-0409-5361; BRIGNOLE-BAUDOUIN, FRANCOISE/0000-0002-2006-5384				Abu El-Asrar AM, 2006, EYE, V20, P362, DOI 10.1038/sj.eye.6701884; Alt C, 2009, CURR HIV RES, V7, P639, DOI 10.2174/157016209789973682; Ammar DA, 2011, ADV THER, V28, P501, DOI 10.1007/s12325-011-0029-x; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baudouin C, 1999, OPHTHALMOLOGY, V106, P556, DOI 10.1016/S0161-6420(99)90116-1; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Boisleve F, 2004, J INVEST DERMATOL, V123, P494, DOI 10.1111/j.0022-202X.2004.23229.x; Brasnu E, 2008, MOL VIS, V14, P394; Brignole-Baudouin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050180; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1437, DOI 10.1001/archopht.1994.01090230051020; Buron N, 2006, INVEST OPHTH VIS SCI, V47, P4221, DOI 10.1167/iovs.05-1460; Byamba D, 2010, ANN DERMATOL, V22, P269, DOI 10.5021/ad.2010.22.3.269; Chung SH, 2009, EXP EYE RES, V88, P47, DOI 10.1016/j.exer.2008.09.017; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dekaris I, 1999, J IMMUNOL, V162, P4235; DINARELLO CA, 1991, CURR OPIN IMMUNOL, V3, P941, DOI 10.1016/S0952-7915(05)80018-4; Epstein SP, 2009, J OCUL PHARMACOL TH, V25, P415, DOI 10.1089/jop.2008.0140; Estrella JL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00067; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Garnache-Ottou F, 2005, BLOOD, V105, P1256, DOI 10.1182/blood-2004-06-2416; Hamanaka T, 2011, INVEST OPHTH VIS SCI, V52, P8849, DOI 10.1167/iovs.11-7591; Helin M, 2011, J GLAUCOMA, V20, P172, DOI 10.1097/IJG.0b013e3181d9ccb0; Hirota M, 2006, TOXICOL IN VITRO, V20, P736, DOI 10.1016/j.tiv.2005.10.013; HOLTER W, 1987, J IMMUNOL, V138, P2917; Ishida W, 2010, MOL VIS, V16, P1280; Kurosaka K, 1998, J IMMUNOL, V161, P6245; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Liang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033913; Lim YM, 2008, CONTACT DERMATITIS, V58, P193, DOI 10.1111/j.1600-0536.2007.01311.x; Malvitte L, 2007, BRIT J OPHTHALMOL, V91, P29, DOI 10.1136/bjo.2006.101485; Miyazawa M, 2008, J TOXICOL SCI, V33, P71, DOI 10.2131/jts.33.71; NUZZI R, 1995, GRAEF ARCH CLIN EXP, V233, P154, DOI 10.1007/BF00166608; Pong JCF, 2011, ARCH OPHTHALMOL-CHIC, V129, P453, DOI 10.1001/archophthalmol.2011.41; Roebrock K, 2012, BRIT J DERMATOL, V166, P306, DOI 10.1111/j.1365-2133.2011.10637.x; Schultz CL, 1997, EXP EYE RES, V64, P3, DOI 10.1006/exer.1996.0190; SHERWOOD MB, 1989, OPHTHALMOLOGY, V96, P327, DOI 10.1016/S0161-6420(89)32888-0; STEWART M, 1995, CURR OPIN CELL BIOL, V7, P690, DOI 10.1016/0955-0674(95)80111-1; Tesavibul N, 1998, INVEST OPHTH VIS SCI, V39, P982; Tominaga T, 1998, TOHOKU J EXP MED, V186, P99, DOI 10.1620/tjem.186.99; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; VANDESANDT JJM, 1995, FUND APPL TOXICOL, V25, P20, DOI 10.1006/faat.1995.1036; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Zhang EY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007703; 2007, OCUL SURF, V5, P179	47	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72459	10.1371/journal.pone.0072459	http://dx.doi.org/10.1371/journal.pone.0072459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23991114	Green Published, gold, Green Submitted			2022-12-25	WOS:000323425700173
J	Hsieh, YC; Chen, MC; Hsu, CC; Chan, SI; Yang, YS; Chen, CJ				Hsieh, Yin-Cheng; Chen, Mei-Chun; Hsu, Ching-Chen; Chan, Sunney I.; Yang, Yuh-Shyong; Chen, Chun-Jung			Crystal Structures of Vertebrate Dihydropyrimidinase and Complexes from Tetraodon nigroviridis with Lysine Carbamylation METAL AND STRUCTURAL REQUIREMENTS FOR POST-TRANSLATIONAL MODIFICATION AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Crystallography; Metalloenzymes; Post-translational Modification; Protein Carboxylation; Protein Complexes	D-HYDANTOINASE; ESCHERICHIA-COLI; BETA-LACTAMASES; POSTTRANSLATIONAL MODIFICATIONS; AMIDOHYDROLASE SUPERFAMILY; SUBSTRATE-SPECIFICITY; PYRUVATE-CARBOXYLASE; CATALYTIC MECHANISM; MOLECULAR-STRUCTURE; PROTEIN	Lysine carbamylation, a post-translational modification, facilitates metal coordination for specific enzymatic activities. We have determined structures of the vertebrate dihydropyrimidinase from Tetraodon nigroviridis (TnDhp) in various states: the apoenzyme as well as two forms of the holoenzyme with one and two metals at the catalytic site. The essential active-site structural requirements have been identified for the possible existence of four metal-mediated stages of lysine carbamylation. Only one metal is sufficient for stabilizing lysine carbamylation; however, the post-translational lysine carbamylation facilitates additional metal coordination for the regulation of specific enzymatic activities through controlling the conformations of two dynamic loops, Ala(69)-Arg(74) and Met(158)-Met(165), located in the tunnel for the substrate entrance. The substrate/product tunnel is in the open form in the apo-TnDhp, in the intermediate state in the monometal TnDhp, and in the closed form in the dimetal TnDhp structure, respectively. Structural comparison also suggests that the C-terminal tail plays a role in the enzymatic function through interactions with the Ala(69)-Arg(74) dynamic loop. In addition, the structures of the dimetal TnDhp in complexes with hydantoin, N-carbamyl--alanine, and N-carbamyl--amino isobutyrate as well as apo-TnDhp in complex with a product analog, N-(2-acetamido)-iminodiacetic acid, have been determined. These structural results illustrate how a protein exploits unique lysines and the metal distribution to accomplish lysine carbamylation as well as subsequent enzymatic functions.	[Hsieh, Yin-Cheng; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Chen, Mei-Chun; Hsu, Ching-Chen; Yang, Yuh-Shyong] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan; [Chan, Sunney I.] Acad Sinica, Inst Chem, Taipei 11529, Taiwan; [Chan, Sunney I.] CALTECH, Div Chem & Chem Engn, Pasadena, CA USA; [Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30043, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 701, Taiwan	National Synchrotron Radiation Research Center; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; California Institute of Technology; National Tsing Hua University; National Cheng Kung University; National Cheng Kung University	Yang, YS (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan.	ysyang@mail.nctu.edu.tw; cjchen@nsrrc.org.tw	Chen, Chun-Jung/A-6880-2011; Yang, Yuh-Shyong/L-7401-2019	Chen, Chun-Jung/0000-0002-5157-4288; Yang, Yuh-Shyong/0000-0003-0177-473X	National Science Council (NSC) [NSC 98-2311-B-213-MY3, NSC 101-2628-B-213-MY4]; National Synchrotron Radiation Center [1003RSB02, 1013RSB02]; NSC [NSC 99-2311-B-009-004-MY3]; Aiming for the Top University and Elite Research Center Development Plan of Ministry of Education (MOE-ATU Plan)	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Center; NSC(Ministry of Science and Technology, Taiwan); Aiming for the Top University and Elite Research Center Development Plan of Ministry of Education (MOE-ATU Plan)	This work was supported in part by National Science Council (NSC) Grants NSC 98-2311-B-213-MY3 and NSC 101-2628-B-213-MY4 and National Synchrotron Radiation Center Grants 1003RSB02 and 1013RSB02 (to C. J. C.) and NSC Grant NSC 99-2311-B-009-004-MY3 and the Aiming for the Top University and Elite Research Center Development Plan of Ministry of Education (MOE-ATU Plan) (to Y. S. Y.).	Altenbuchner J, 2001, CURR OPIN BIOTECH, V12, P559, DOI 10.1016/S0958-1669(01)00263-4; An Woojin, 2007, Subcell Biochem, V41, P351; BENNING MM, 1995, BIOCHEMISTRY-US, V34, P7973, DOI 10.1021/bi00025a002; BROOKS KP, 1983, ARCH BIOCHEM BIOPHYS, V226, P469, DOI 10.1016/0003-9861(83)90316-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush K, 1998, ADV EXP MED BIOL, V456, P71; Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610; Che T, 2012, J AM CHEM SOC, V134, P11206, DOI 10.1021/ja303168n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheon YH, 2004, BIOCHEMISTRY-US, V43, P7413, DOI 10.1021/bi036330o; Cheon YH, 2002, BIOCHEMISTRY-US, V41, P9410, DOI 10.1021/bi0201567; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewing S. P., 1980, J AM CHEM SOC, V102, P3071; Gaucher SP, 2008, J PROTEOME RES, V7, P2320, DOI 10.1021/pr700772s; Gojkovic Z, 2003, NUCLEIC ACIDS RES, V31, P1683, DOI 10.1093/nar/gkg258; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Huang CY, 2009, J BIOL INORG CHEM, V14, P111, DOI 10.1007/s00775-008-0428-x; Huq MDM, 2009, J PROTEOME RES, V8, P1156, DOI 10.1021/pr800569c; JAHNKE K, 1993, BIOCHEMISTRY-US, V32, P5160, DOI 10.1021/bi00070a027; KAUTZ J, 1989, EUR J BIOCHEM, V181, P431, DOI 10.1111/j.1432-1033.1989.tb14743.x; KIKUGAWA M, 1994, EUR J BIOCHEM, V219, P393, DOI 10.1111/j.1432-1033.1994.tb19951.x; Kim GJ, 1998, BIOCHEM BIOPH RES CO, V243, P96, DOI 10.1006/bbrc.1997.8037; Kim K, 2009, J MOL BIOL, V387, P1067, DOI 10.1016/j.jmb.2009.02.041; Kishan KVR, 2005, J MOL BIOL, V347, P95, DOI 10.1016/j.jmb.2005.01.025; Kotra L P., 2002, BACTERIAL RESISTANCE, P123; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lee M, 2007, BIOCHEMISTRY-US, V46, P10538, DOI 10.1021/bi701098e; Liaw SH, 2003, J BIOL CHEM, V278, P4957, DOI 10.1074/jbc.M210795200; Lohkamp B, 2006, J BIOL CHEM, V281, P13762, DOI 10.1074/jbc.M513266200; LORIMER GH, 1983, TRENDS BIOCHEM SCI, V8, P65, DOI 10.1016/0968-0004(83)90393-6; Martinez-Rodriguez S, 2010, J STRUCT BIOL, V169, P200, DOI 10.1016/j.jsb.2009.10.013; Martinez-Rodriguez S, 2009, BIOPHYS CHEM, V139, P42, DOI 10.1016/j.bpc.2008.10.003; Niu LX, 2007, BIOTECHNOL LETT, V29, P303, DOI 10.1007/s10529-006-9238-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Su TM, 2000, PROTEIN EXPRES PURIF, V19, P289, DOI 10.1006/prep.2000.1250; Syldatk C, 1999, APPL MICROBIOL BIOT, V51, P293, DOI 10.1007/s002530051395; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vagin J., 1997, J APPL CRYSTALLOGR, V30, P1022; van Kuilenburg ABP, 2010, BBA-MOL BASIS DIS, V1802, P639, DOI 10.1016/j.bbadis.2010.03.013; WALLACH DP, 1957, J BIOL CHEM, V226, P277; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang D., 2009, GENEREVIEWS; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P3730, DOI 10.1021/bi900111q; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang XY, 2008, APPL BIOCHEM BIOTECH, V144, P237, DOI 10.1007/s12010-007-8004-3	55	21	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30645	30658		10.1074/jbc.M113.496778	http://dx.doi.org/10.1074/jbc.M113.496778			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005677	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000329868100065
J	Pan, WW; Zhou, JJ; Yu, C; Xu, Y; Guo, LJ; Zhang, HY; Zhou, DW; Song, FZ; Fan, HY				Pan, Wei-Wei; Zhou, Jian-Jie; Yu, Chao; Xu, Ying; Guo, Lian-Jun; Zhang, Hai-Yi; Zhou, Dawang; Song, Fang-Zhou; Fan, Heng-Yu			Ubiquitin E3 Ligase CRL4(CDT2/DCAF2) as a Potential Chemotherapeutic Target for Ovarian Surface Epithelial Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MLN4924 INDUCES AUTOPHAGY; CULLIN-RING LIGASES; NEDD8-ACTIVATING ENZYME; CELLS; INHIBITOR; DDB1; REPLICATION; INDUCTION; APOPTOSIS; DELETION	Cullin-RING ubiquitin ligases (CRLs) are the largest family of E3 ligases and require cullin neddylation for their activation. The NEDD8-activating enzyme inhibitor MLN4924 reportedly blocked cullin neddylation and inactivated CRLs, which resulted in apoptosis induction and tumor suppression. However, CRL roles in ovarian cancer cell survival and the ovarian tumor repressing effects of MLN4924 are unknown. We show here that CRL4 components are highly expressed in human epithelial ovarian cancer tissues. MLN4924-induced DNA damage, cell cycle arrest, and apoptosis in ovarian cancer cells in a time- and dose-dependent manner. In addition, MLN4924 sensitized ovarian cancer cells to other chemotherapeutic drug treatments. Depletion of CRL4 components Roc1/2, Cul4a, and DDB1 had inhibitory effects on ovarian cancer cells similar to MLN4924 treatment, which suggested that CRL4 inhibition contributed to the chemotherapeutic effect of MLN4924 in ovarian cancers. We also investigated for key CRL4 substrate adaptors required for ovarian cancer cells. Depleting Vprbp/Dcaf1 did not significantly affect ovarian cancer cell growth, even though it was expressed by ovarian cancer tissues. However, depleting Cdt2/Dcaf2 mimicked the pharmacological effects of MLN4924 and caused the accumulation of its substrate, CDT1, both in vitro and in vivo. MLN4924-induced DNA damage and apoptosis were partially rescued by Cdt1 depletion, suggesting that CRL4(CDT2) repression and CDT1 accumulation were key biochemical events contributing to the genotoxic effects of MLN4924 in ovarian cancer cells. Taken together, these results indicate that CRL4CDT2 is a potential drug target in ovarian cancers and that MLN4924 may be an effective anticancer agent for targeted ovarian cancer therapy.	[Pan, Wei-Wei; Yu, Chao; Zhang, Hai-Yi; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Pan, Wei-Wei; Song, Fang-Zhou] Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China; [Zhou, Jian-Jie; Zhou, Dawang] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China; [Pan, Wei-Wei; Xu, Ying; Guo, Lian-Jun] Jiaxing Univ, Sch Med, Jiaxing 314001, Peoples R China	Zhejiang University; Chongqing Medical University; Xiamen University; Jiaxing University	Song, FZ (corresponding author), Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China.	fzsongcq@163.com; hyfan@zju.edu.cn	Xu, Ying/AAF-3081-2019; Xu, Ying/A-3009-2013	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768; Zhou, Dawang/0000-0002-9053-5249	National Basic Research Program of China [2011CB944504, 2012CB944403]; National Natural Science Foundation of China [81172473]; Zhejiang University [2011QN81001]; Natural Science Foundation of Zhejiang Province [LQ13H160020]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2013KF001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang University; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	This work was supported by National Basic Research Program of China Grants 2011CB944504 and 2012CB944403, National Natural Science Foundation of China Grant 81172473, Basic Scientific Research Funding of Zhejiang University Grant 2011QN81001 (to H. Y. F.), and Natural Science Foundation of Zhejiang Province Grant LQ13H160020 (to W. W. P.). This project was also supported by the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2013KF001.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Endo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031846; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Jia LJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-16; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Kim Y, 2007, MOL CELL BIOL, V27, P1394, DOI 10.1128/MCB.00736-06; Kopanja D, 2011, DEV BIOL, V352, P278, DOI 10.1016/j.ydbio.2011.01.028; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Luo ZG, 2012, AUTOPHAGY, V8, P1677, DOI 10.4161/auto.21484; Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1638, DOI 10.1210/en.2011-2131; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1585, DOI 10.1210/en.2011-2121; Pines A, 2009, DNA REPAIR, V8, P153, DOI 10.1016/j.dnarep.2008.09.011; Richards JS, 2012, ONCOGENE, V31, P1504, DOI 10.1038/onc.2011.341; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Wei DP, 2012, TRANSL ONCOL, V5, P305, DOI 10.1593/tlo.12229; Xu H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001132; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yoon T, 2005, ONCOGENE, V24, P469, DOI 10.1038/sj.onc.1208211; Zhao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.125; Zhao YC, 2013, CURR PHARM DESIGN, V19, P3215, DOI 10.2174/13816128113199990300	37	57	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29680	29691		10.1074/jbc.M113.495069	http://dx.doi.org/10.1074/jbc.M113.495069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995842	hybrid, Green Published			2022-12-25	WOS:000330615300043
J	Geiser, J; De Lisle, RC; Finkelstein, D; Adlard, PA; Bush, AI; Andrews, GK				Geiser, Jim; De Lisle, Robert C.; Finkelstein, David; Adlard, Paul A.; Bush, Ashley I.; Andrews, Glen K.			Clioquinol Synergistically Augments Rescue by Zinc Supplementation in a Mouse Model of Acrodermatitis Enteropathica	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COPPER DEFICIENCY; BETA; ZIP4; GROWTH; PBT2; MICE; PHOSPHORYLATION; PROLIFERATION; INVOLVEMENT	Background: Zinc deficiency due to poor nutrition or genetic mutations in zinc transporters is a global health problem and approaches to providing effective dietary zinc supplementation while avoiding potential toxic side effects are needed. Methods/Principal Findings: Conditional knockout of the intestinal zinc transporter Zip4 (Slc39a4) in mice creates a model of the lethal human genetic disease acrodermatitis enteropathica (AE). This knockout leads to acute zinc deficiency resulting in rapid weight loss, disrupted intestine integrity and eventually lethality, and therefore provides a model system in which to examine novel approaches to zinc supplementation. We examined the efficacy of dietary clioquinol (CQ), a well characterized zinc chelator/ionophore, in rescuing the Zip4 (intest) (KO) phenotype. By 8 days after initiation of the knockout neither dietary CQ nor zinc supplementation in the drinking water was found to be effective at improving this phenotype. In contrast, dietary CQ in conjunction with zinc supplementation was highly effective. Dietary CQ with zinc supplementation rapidly restored intestine stem cell division and differentiation of secretory and the absorptive cells. These changes were accompanied by rapid growth and dramatically increased longevity in the majority of mice, as well as the apparent restoration of the homeostasis of several essential metals in the liver. Conclusions: These studies suggest that oral CQ (or other 8-hydroxyquinolines) coupled with zinc supplementation could provide a facile approach toward treating zinc deficiency in humans by stimulating stem cell proliferation and differentiation of intestinal epithelial cells.	[Geiser, Jim; Andrews, Glen K.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA; [De Lisle, Robert C.; Andrews, Glen K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Finkelstein, David; Adlard, Paul A.; Bush, Ashley I.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Finkelstein, David; Adlard, Paul A.; Bush, Ashley I.] Univ Melbourne, Melbourne, Vic 3010, Australia	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Andrews, GK (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	gandrews@kumc.edu	Bush, Ashley I/A-1186-2007; Finkelstein, David/B-9617-2009; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Finkelstein, David/0000-0002-8167-4917; Bush, Ashley/0000-0001-8259-9069	National Institutes of Health [R01 DK063975, R01 AI 083479]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health to GKA (R01 DK063975) and RCD (R01 AI 083479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2012, FRONT PSYCHIATRY, V3, P1; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Afrin LB, 2010, AM J MED SCI, V340, P164, DOI 10.1097/MAJ.0b013e3181e3648c; AGGETT PJ, 1979, BIOCHEM BIOPH RES CO, V87, P513, DOI 10.1016/0006-291X(79)91825-4; ANDREWS RCR, 1992, LANCET, V340, P1160; Arbiser JL, 1998, MOL MED, V4, P665, DOI 10.1007/BF03401927; ATHERTON DJ, 1979, CLIN SCI, V56, P505, DOI 10.1042/cs0560505; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Black MM, 1998, AM J CLIN NUTR, V68, p464S, DOI 10.1093/ajcn/68.2.464S; Black RE, 2003, J NUTR, V133, p1485S, DOI 10.1093/jn/133.5.1485S; BLOOM D, 1955, J INVEST DERMATOL, V24, P167, DOI 10.1038/jid.1955.29; Bloxam DL, 1996, AM J OBSTET GYNECOL, V175, P1078, DOI 10.1016/S0002-9378(96)80062-7; Blundell R, 2013, VET REC, V172, P17, DOI 10.1136/vr.100376; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; Dhawan SS, 2008, J EMERG MED, V35, P33, DOI 10.1016/j.jemermed.2007.11.023; Di Vaira M, 2004, INORG CHEM, V43, P3795, DOI 10.1021/ic0494051; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Doherty K, 2011, BRIT DENT J, V210, P523, DOI 10.1038/sj.bdj.2011.428; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Ferrada E, 2007, NEUROTOXICOLOGY, V28, P445, DOI 10.1016/j.neuro.2007.02.004; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hambidge KM, 2003, PEDIATRICS, V112, P1419, DOI 10.1542/peds.112.6.1419; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; JACKSON MJ, 1977, J CLIN PATHOL, V30, P284, DOI 10.1136/jcp.30.3.284; Kelleher SL, 2006, J NUTR, V136, P1185; Kilic M, 2012, JIMD REP, V2, P25, DOI 10.1007/8904_2011_38; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Li M, 2007, P NATL ACAD SCI USA, V104, P18636, DOI 10.1073/pnas.0709307104; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; MOYNAHAN EJ, 1974, LANCET, V2, P399; NEGGERS YH, 1990, AM J CLIN NUTR, V51, P678, DOI 10.1093/ajcn/51.4.678; NELDNER KH, 1974, ARCH DERMATOL, V110, P711, DOI 10.1001/archderm.110.5.711; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; Opazo C, 2006, AGING CELL, V5, P69, DOI 10.1111/j.1474-9726.2006.00196.x; Prasad AS, 2007, J NUTR, V137, P1345, DOI 10.1093/jn/137.5.1345; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; PRASAD AS, 1984, FED PROC, V43, P2829; Ryu JM, 2009, J CELL PHYSIOL, V218, P558, DOI 10.1002/jcp.21628; Salgueiro MJ, 2004, BIOL TRACE ELEM RES, V99, P49, DOI 10.1385/BTER:99:1-3:049; Schafer S, 2007, J MOL MED, V85, P405, DOI 10.1007/s00109-006-0140-7; Seok SH, 2013, J APPL TOXI IN PRESS; Sharir H, 2010, J BIOL CHEM, V285, P26097, DOI 10.1074/jbc.M110.107490; STURTEVANT FM, 1980, PEDIATRICS, V65, P610; SUNDAL A, 1957, Ann Paediatr Fenn, V3, P486; Tamura T, 2000, AM J CLIN NUTR, V71, P109; Tang ZH, 2006, BONE, V38, P181, DOI 10.1016/j.bone.2005.08.010; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Weaver Benjamin P, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0013158; WEISMANN K, 1978, J INVEST DERMATOL, V71, P242, DOI 10.1111/1523-1747.ep12515094; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhang YQ, 2010, CLIN CANCER RES, V16, P1423, DOI 10.1158/1078-0432.CCR-09-2405	67	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72543	10.1371/journal.pone.0072543	http://dx.doi.org/10.1371/journal.pone.0072543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015258	Green Published, gold			2022-12-25	WOS:000323733800063
J	Lee, TM; Lin, SZ; Chang, NC				Lee, Tsung-Ming; Lin, Shinn-Zong; Chang, Nen-Chung			Both PKA and Epac Pathways Mediate N-Acetylcysteine-Induced Connexin43 Preservation in Rats with Myocardial Infarction	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3; HEART CELL PAIRS; CYCLIC-AMP; VENTRICULAR-ARRHYTHMIAS; JUNCTIONAL CONDUCTANCE; CARDIAC MYOCYTES; CAMP; STIMULATION; PHOSPHORYLATION	Cardiac remodeling was shown to be associated with reduced gap junction expression after myocardial infarction. A reduction in gap junctional proteins between myocytes may trigger ventricular arrhythmia. Therefore, we investigated whether N-acetylcysteine exerted antiarrhythmic effect by preserving connexin43 expression in postinfarcted rats, focusing on cAMP downstream molecules such as protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac). Male Wistar rats after ligating coronary artery were randomized to either vehicle, or N-acetylcysteine for 4 weeks starting 24 hours after operation. Infarct size was similar between two groups. Compared with vehicle, cAMP levels were increased by N-acetylcysteine treatment after infarction. Myocardial connexin43 expression was significantly decreased in vehicle-treated infarcted rats compared with sham operated rats. Attenuated connexin43 expression and function were blunted after administering N-acetylcysteine, assessed by immunofluorescent analysis, dye coupling, Western blotting, and real-time quantitative RT-PCR of connexin43. Arrhythmic scores during programmed stimulation in the N-acetylcysteine-treated rats were significantly lower than those treated with vehicle. In an ex vivo study, enhanced connexin43 levels afforded by N-acetylcysteine were partially blocked by either H-89 (a PKA inhibitor) or brefeldin A (an Epac-signaling inhibitor) and completely blocked when H-89 and brefeldin A were given in combination. Addition of either the PKA specific activator N6Bz or Epac specific activator 8-CPT did not have additional increased connexin43 levels compared with rats treated with lithium chloride alone. These findings suggest that N-acetylcysteine protects ventricular arrhythmias by attenuating reduced connexin43 expression and function via both PKA- and Epac-dependent pathways, which converge through the inactivation of glycogen synthase kinase-3 beta.	[Lee, Tsung-Ming] China Med Univ, Tainan Municipal An Nan Hospital, Dept Med, Cardiol Sect, Tainan, Taiwan; [Lee, Tsung-Ming] China Med Univ, Dept Med, Taichung, Taiwan; [Lee, Tsung-Ming; Chang, Nen-Chung] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Lin, Shinn-Zong] China Med Univ Hosp, Neuropsychiat Ctr, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Taina Municipal An Nan Hosp, Dept Neurosurg, Tainan, Taiwan; [Chang, Nen-Chung] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigan Hosp, Dept Neurosurg, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan	Chang, NC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	ncchang@tmu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020		National Health Research Institutes [NHRI-EX100-9841SI]; National Science Council, Taiwan [NSC100-2314-B-384-003]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants of National Health Research Institutes (NHRI-EX100-9841SI) and National Science Council (NSC100-2314-B-384-003), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bailey J, 2002, J CLIN ENDOCR METAB, V87, P1717, DOI 10.1210/jcem.87.4.8360; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Beauchamp P, 2012, CIRC RES, V110, P1445, DOI 10.1161/CIRCRESAHA.111.259705; BELICHARD P, 1994, J AM COLL CARDIOL, V23, P505; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEMELLO WC, 1988, BIOCHEM BIOPH RES CO, V154, P509, DOI 10.1016/0006-291X(88)90169-6; DEMELLO WC, 1989, BIOCHIM BIOPHYS ACTA, V1012, P291, DOI 10.1016/0167-4889(89)90111-0; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Ding WQ, 2003, CELL SIGNAL, V15, P27, DOI 10.1016/S0898-6568(02)00051-7; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Greener ID, 2012, J AM COLL CARDIOL, V60, P1103, DOI 10.1016/j.jacc.2012.04.042; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; HERRE JM, 1988, J AM COLL CARDIOL, V11, P414, DOI 10.1016/0735-1097(88)90110-6; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; ISSELS RD, 1988, BIOCHEM PHARMACOL, V37, P881, DOI 10.1016/0006-2952(88)90176-1; Karelson E, 2002, ANN NY ACAD SCI, V973, P537, DOI 10.1111/j.1749-6632.2002.tb04696.x; Kitamura H, 2002, J CARDIOVASC ELECTR, V13, P865, DOI 10.1046/j.1540-8167.2002.00865.x; Lee TM, 2004, CARDIOVASC RES, V63, P109, DOI 10.1016/j.cardiores.2004.03.009; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; Lee TM, 2010, CARDIOVASC RES, V85, P137, DOI 10.1093/cvr/cvp286; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Paulson AF, 2000, J CELL SCI, V113, P3037; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Rocher A, 2009, J PHYSIOL-LONDON, V587, P4015, DOI 10.1113/jphysiol.2009.172072; Ruiz-Meana M, 2001, AM J PHYSIOL-HEART C, V280, pH2563, DOI 10.1152/ajpheart.2001.280.6.H2563; Saffitz JE, 2012, J AM COLL CARDIOL, V60, P1111, DOI 10.1016/j.jacc.2012.05.020; Schulz R, 2004, CARDIOVASC RES, V62, P335, DOI 10.1016/j.cardiores.2003.12.017; SMITH WT, 1995, CIRCULATION, V92, P3051, DOI 10.1161/01.CIR.92.10.3051; Smyrniotis V, 2005, J SURG RES, V129, P31, DOI 10.1016/j.jss.2005.07.028; Somekawa S, 2005, CIRC RES, V97, P655, DOI 10.1161/01.RES.0000183880.49270.f9; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Sun X, 2010, TOXICOLOGY, V271, P5, DOI 10.1016/j.tox.2010.01.001; TenBroek EM, 2001, J CELL BIOL, V155, P1307, DOI 10.1083/jcb.200102017; Xia QG, 2001, CARDIOVASC RES, V49, P110, DOI 10.1016/S0008-6363(00)00227-3; Yusta B, 2002, J BIOL CHEM, V277, P24896, DOI 10.1074/jbc.M201358200; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418	46	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71878	10.1371/journal.pone.0071878	http://dx.doi.org/10.1371/journal.pone.0071878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015194	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800016
J	Hliscs, M; Nahar, C; Frischknecht, F; Matuschewski, K				Hliscs, Marion; Nahar, Carolin; Frischknecht, Friedrich; Matuschewski, Kai			Expression Profiling of Plasmodium berghei HSP70 Genes for Generation of Bright Red Fluorescent Parasites	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MALARIA PARASITE; LIFE-CYCLE; FALCIPARUM; HEAT-SHOCK-PROTEIN-70; MOSQUITO; TRANSMISSION; TRANSFECTION; SPOROZOITES; INFECTIVITY	Live cell imaging of recombinant malarial parasites encoding fluorescent probes provides critical insights into parasite-host interactions and life cycle progression. In this study, we generated a red fluorescent line of the murine malarial parasite Plasmodium berghei. To allow constitutive and abundant expression of the mCherry protein we profiled expression of all members of the P. berghei heat shock protein 70 (HSP70) family. We identified PbHSP70/1, an invariant ortholog of Plasmodium falciparum HSP70-1, as the protein with the highest expression levels during Plasmodium blood, mosquito, and liver infection. Stable allelic insertion of a mCherry expression cassette into the PbHsp70/1 locus created constitutive red fluorescent P. berghei lines, termed Pbred. We show that these parasites can be used for live imaging of infected host cells and organs, including hepatocytes, erythrocytes, and whole Anopheles mosquitoes. Quantification of the fluorescence intensity of several Pbred parasite stages revealed significantly enhanced signal intensities in comparison to GFP expressed under the control of the constitutive EF1alpha promoter. We propose that systematic transcript profiling permits generation of reporter parasites, such as the Pbred lines described herein.	[Hliscs, Marion; Nahar, Carolin; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany; [Hliscs, Marion] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany; [Matuschewski, Kai] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Max Planck Society; University of Melbourne; Ruprecht Karls University Heidelberg; Humboldt University of Berlin	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de		Matuschewski, Kai/0000-0001-6147-8591; Frischknecht, Friedrich/0000-0002-8332-6668	Max Planck Society; European Commission (EviMalaR) [34]	Max Planck Society(Max Planck Society); European Commission (EviMalaR)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Max Planck Society and partly by the European Commission (EviMalaR, #2 and #34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Akaki M, 2005, J EXP BIOL, V208, P3211, DOI 10.1242/jeb.01756; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; ARDESHIR F, 1987, EMBO J, V6, P493, DOI 10.1002/j.1460-2075.1987.tb04780.x; BEHR C, 1992, J IMMUNOL, V149, P3321; Bell SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020047; BIANCO AE, 1986, P NATL ACAD SCI USA, V83, P8713, DOI 10.1073/pnas.83.22.8713; Engelmann S, 2009, EUKARYOT CELL, V8, P640, DOI 10.1128/EC.00347-08; Fan JY, 1996, AM J TROP MED HYG, V55, P570, DOI 10.4269/ajtmh.1996.55.570; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; Graewe Stefanie, 2009, Biotechnology Journal, V4, P895, DOI 10.1002/biot.200900035; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P525, DOI 10.1073/pnas.79.2.525; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kenthirapalan S, 2012, INT J PARASITOL, V42, P1185, DOI 10.1016/j.ijpara.2012.10.006; Knop M, 2002, BIOTECHNIQUES, V33, P592, DOI 10.2144/02333rr02_11819a; Kooij TWA, 2012, MOL BIOCHEM PARASIT, V185, P19, DOI 10.1016/j.molbiopara.2012.06.001; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; KUMAR N, 1988, P NATL ACAD SCI USA, V85, P6277, DOI 10.1073/pnas.85.17.6277; Lyons RE, 1998, INT J PARASITOL, V28, P1041, DOI 10.1016/S0020-7519(98)00074-5; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Montagna GN, 2012, J BIOL CHEM, V287, P2410, DOI 10.1074/jbc.M111.302109; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; MOTARD A, 1995, INT IMMUNOL, V7, P147, DOI 10.1093/intimm/7.1.147; Na BK, 2007, CLIN VACCINE IMMUNOL, V14, P320, DOI 10.1128/CVI.00424-06; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Stanway RR, 2009, BIOL CELL, V101, P415, DOI 10.1042/BC20080202; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Sultan AA, 1999, INFECT IMMUN, V67, P2602, DOI 10.1128/IAI.67.5.2602-2606.1999; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; YANG YF, 1987, MOL BIOCHEM PARASIT, V26, P61, DOI 10.1016/0166-6851(87)90130-7	45	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72771	10.1371/journal.pone.0072771	http://dx.doi.org/10.1371/journal.pone.0072771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013507	gold, Green Submitted, Green Published			2022-12-25	WOS:000323815200057
J	Chen, N; Liu, C; Yan, N; Hu, W; Zhang, JG; Ge, Y; Meng, FG				Chen, Ning; Liu, Chong; Yan, Na; Hu, Wei; Zhang, Jian-guo; Ge, Yan; Meng, Fan-gang			A Macaque Model of Mesial Temporal Lobe Epilepsy Induced by Unilateral Intrahippocampal Injection of Kainic Acid	PLOS ONE			English	Article							GRANULE CELL DISPERSION; STATUS EPILEPTICUS; MOUSE MODEL; ELECTRICAL-STIMULATION; HIPPOCAMPAL SCLEROSIS; NONHUMAN PRIMATE; SEIZURES; BRAIN; EPILEPTOGENESIS; PILOCARPINE	Objective: In order to better investigate the cause/effect relationships of human mesial temporal lobe epilepsy (mTLE), we hereby describe a new non-human primate model of mTLE. Methods: Ten macaques were studied and divided into 2 groups: saline control group (n = 4) and kainic acid (KA) injection group (n = 6). All macaques were implanted bilaterally with subdural electrodes over temporal cortex and depth electrodes in CA3 hippocampal region. KA was stereotaxically injected into the right hippocampus of macaques. All animals were monitored by video and electrocorticography (ECoG) to assess status epilepticus (SE) and subsequent spontaneous recurrent seizures (SRS). Additionally, in order to evaluate brain injury produced by SE or SRS, we used both neuroimaging, including magnetic resonance image (MRI) & magnetic resonance spectroscopy (MRS), and histological pathology, including Nissl stainning and glial fibrillary acid protein (GFAP) immunostaining. Results: The typical seizures were observed in the KA-injected animal model. Hippocampal sclerosis could be found by MRI & MRS. Hematoxylin and eosin (H&E) staining and GFAP immunostaining showed neuronal loss, proliferation of glial cells, formation of glial scars, and hippocampal atrophy. Electron microscopic analysis of hippocampal tissues revealed neuronal pyknosis, partial ribosome depolymerization, an abnormal reduction in rough endoplasmic reticulum size, expansion of Golgi vesicles and swollen star-shaped cells. Furthermore, we reported that KA was able to induce SE followed by SRS after a variable period of time. Similar to human mTLE, brain damage is confined to the hippocampus. Accordingly, hippocampal volume is in positive correlations with the neuronal cells count in the CA3, especially the ratio of neuron/glial cell. Conclusions: The results suggest that a model of mTLE can be developed in macaques by intra-hippocampal injection of KA. Brain damage is confined to the hippocampus which is similar to the human mTLE. The hippocampal volume correlates with the extension of the hippocampal damage.	[Chen, Ning; Zhang, Jian-guo] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Chong; Ge, Yan; Meng, Fan-gang] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Yan, Na] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Hu, Wei] Mayo Clin, Dept Neurol, Rochester, MN USA	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University; Mayo Clinic	Meng, FG (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.	fgmeng@ccmu.edu.cn	yan, na/HDM-3747-2022		National Natural Science Foundation of China [81071224, 81241048]; Beijing Natural Science Foundation, China [7123209]; Beijing health system advanced health technology talent cultivation plan [2011-3-032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation, China(Beijing Natural Science Foundation); Beijing health system advanced health technology talent cultivation plan	This work was supported partly by National Natural Science Foundation of China (Grant No. 81071224, 81241048), Beijing Natural Science Foundation, China (Grant No. 7123209), and Beijing health system advanced health technology talent cultivation plan (Grant No. 2011-3-032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Valenca LPA, 2008, EPILEPSIA, V49, P1046, DOI 10.1111/j.1528-1167.2008.01551.x; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Bachiega JC, 2008, EPILEPSY BEHAV, V13, P70, DOI 10.1016/j.yebeh.2008.02.010; Bartolomei F, 1999, CLIN NEUROPHYSIOL, V110, P1741, DOI 10.1016/S1388-2457(99)00107-8; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Blauwblomme T, 2011, NEUROSURGERY, V68, P482, DOI 10.1227/NEU.0b013e3181ff9d14; Blumcke I, 2009, ACTA NEUROPATHOL, V117, P535, DOI 10.1007/s00401-009-0512-5; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Brandt C, 2003, EPILEPSY RES, V55, P83, DOI 10.1016/S0920-1211(03)00114-1; Briellmann RS, 2002, NEUROLOGY, V58, P265, DOI 10.1212/WNL.58.2.265; Cilio MR, 2001, NEUROPHARMACOLOGY, V40, P139, DOI 10.1016/S0028-3908(00)00103-9; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Dugladze T, 2007, P NATL ACAD SCI USA, V104, P17530, DOI 10.1073/pnas.0708301104; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; GADIAN DC, 1994, ACTA NEUROL SCAND, V89, P116, DOI 10.1111/j.1600-0404.1994.tb05202.x; Garcia-Finana M, 2006, AM J NEURORADIOL, V27, P1046; Gunderson VM, 1999, DEV NEUROSCI-BASEL, V21, P352, DOI 10.1159/000017385; Halonen T, 2001, NEUROPHARMACOLOGY, V40, P536, DOI 10.1016/S0028-3908(00)00183-0; Hasboun D, 1996, AM J NEURORADIOL, V17, P1091; KUZNIECKY R, 1987, ANN NEUROL, V22, P341, DOI 10.1002/ana.410220310; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Li JM, 2010, BRAIN RES, V1311, P166, DOI 10.1016/j.brainres.2009.11.024; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Paxions G., 2009, RHESUS MONKEY BRAIN; Perez-Mendes P, 2005, EPILEPSIA, V46, P148, DOI 10.1111/j.1528-1167.2005.01023.x; Perez-Mendes P, 2011, EPILEPSY RES, V96, P45, DOI 10.1016/j.eplepsyres.2011.04.015; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raedt R, 2009, ACTA NEUROL SCAND, V119, P293, DOI 10.1111/j.1600-0404.2008.01108.x; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Caboclo LOSF, 2012, ARQ NEURO-PSIQUIAT, V70, P945, DOI 10.1590/S0004-282X2012001200009; Seo J, 2013, EXP NEUROL, V241, P38, DOI 10.1016/j.expneurol.2012.11.024; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; Smithson W. H., 2012, ABC EPILEPSY; SOPER HV, 1978, EXP NEUROL, V62, P99, DOI 10.1016/0014-4886(78)90044-4; Tokumitsu T, 1997, BRAIN RES, V744, P57, DOI 10.1016/S0006-8993(96)01071-2; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; WADA JA, 1974, EPILEPSIA, V15, P465, DOI 10.1111/j.1528-1157.1974.tb04022.x; WADA JA, 1976, NEUROLOGY, V26, P273, DOI 10.1212/WNL.26.3.273; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Wenzel HJ, 2000, EPILEPSIA, V41, pS70, DOI 10.1111/j.1528-1157.2000.tb01560.x	46	25	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72336	10.1371/journal.pone.0072336	http://dx.doi.org/10.1371/journal.pone.0072336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991095	gold, Green Published, Green Submitted			2022-12-25	WOS:000324228800060
J	Nielsen, MT; Klejnstrup, ML; Rohlfs, M; Anyaogu, DC; Nielsen, JB; Gotfredsen, CH; Andersen, MR; Hansen, BG; Mortensen, UH; Larsen, TO				Nielsen, Morten Thrane; Klejnstrup, Marie Louise; Rohlfs, Marko; Anyaogu, Diana Chinyere; Nielsen, Jakob Blsbjerg; Gotfredsen, Charlotte Held; Andersen, Mikael Rordam; Hansen, Bjarne Gram; Mortensen, Uffe Hasbro; Larsen, Thomas Ostenfeld			Aspergillus nidulans Synthesize Insect Juvenile Hormones upon Expression of a Heterologous Regulatory Protein and in Response to Grazing by Drosophila melanogaster Larvae	PLOS ONE			English	Article							FILAMENTOUS FUNGI; GENE CLUSTERS; LIFE-HISTORY; BIOSYNTHESIS; POLYKETIDES; PENICILLIUM; SYSTEM	Secondary metabolites are known to serve a wide range of specialized functions including communication, developmental control and defense. Genome sequencing of several fungal model species revealed that the majority of predicted secondary metabolite related genes are silent in laboratory strains, indicating that fungal secondary metabolites remain an underexplored resource of bioactive molecules. In this study, we combine heterologous expression of regulatory proteins in Aspergillus nidulans with systematic variation of growth conditions and observe induced synthesis of insect juvenile hormone-III and methyl farnesoate. Both compounds are sesquiterpenes belonging to the juvenile hormone class. Juvenile hormones regulate developmental and metabolic processes in insects and crustaceans, but have not previously been reported as fungal metabolites. We found that feeding by Drosophila melanogaster larvae induced synthesis of juvenile hormone in A. nidulans indicating a possible role of juvenile hormone biosynthesis in affecting fungal-insect antagonisms.	[Nielsen, Morten Thrane; Klejnstrup, Marie Louise; Anyaogu, Diana Chinyere; Nielsen, Jakob Blsbjerg; Andersen, Mikael Rordam; Hansen, Bjarne Gram; Mortensen, Uffe Hasbro; Larsen, Thomas Ostenfeld] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Rohlfs, Marko] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Gotfredsen, Charlotte Held] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark; University of Gottingen; Technical University of Denmark	Mortensen, UH (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	um@bio.dtu.dk; tol@bio.dtu.dk	Andersen, Mikael Rørdam/P-6743-2019; Gotfredsen, Charlotte Held/ABC-8211-2021; Andersen, Mikael R/F-9377-2013; Rohlfs, Marko/AAF-6749-2019; Hoof, Jakob Blæsbjerg/L-6019-2015; Mortensen, Uffe/AAQ-1150-2021	Andersen, Mikael Rørdam/0000-0003-4794-6808; Andersen, Mikael R/0000-0003-4794-6808; Hoof, Jakob Blæsbjerg/0000-0002-7650-9300; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Rohlfs, Marko/0000-0002-8767-1629; Gotfredsen, Charlotte Held/0000-0002-7386-119X	Danish Research Agency for Technology and Production [09-064967]; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	Danish Research Agency for Technology and Production; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	This work was supported by the Danish Research Agency for Technology and Production, grant # 09-064967, and the Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Belles X, 2005, PALO ALTO ANN REV, P199; Bergmann S, 2010, APPL ENVIRON MICROB, V76, P8143, DOI 10.1128/AEM.00683-10; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Chiang YM, 2011, CURR OPIN CHEM BIOL, V15, P137, DOI 10.1016/j.cbpa.2010.10.011; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Frisvad JC, 2004, STUD MYCOL, P1; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Gross H, 2007, APPL MICROBIOL BIOT, V75, P267, DOI 10.1007/s00253-007-0900-5; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Kempken F, 2010, FUNGAL ECOL, V3, P107, DOI 10.1016/j.funeco.2009.08.001; KUHNZ W, 1981, ORG MAGN RESONANCE, V16, P138, DOI 10.1002/mrc.1270160216; LAATSCH H, 2009, ANTIBASE 2009 NATURA; LARSEN TO, 1994, J MICROBIOL METH, V19, P297, DOI 10.1016/0167-7012(94)90032-9; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Marrs TC, 2012, PEST MANAG SCI, V68, P1332, DOI 10.1002/ps.3362; Minakuchi C, 2006, J PESTIC SCI, V31, P77, DOI 10.1584/jpestics.31.77; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nielsen ML, 2011, FEMS MICROBIOL LETT, V321, P157, DOI 10.1111/j.1574-6968.2011.02327.x; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Panagiotou G, 2008, PLOS ONE, P3; Panagiotou G, 2009, APPL ENVIRON MICROB, V75, P2212, DOI 10.1128/AEM.01461-08; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Reddy KRN, 2010, TOXIN REV, V29, P3, DOI 10.3109/15569541003598553; Rohlfs M, 2006, EVOL ECOL, V20, P271, DOI 10.1007/s10682-006-0002-3; Rohlfs M, 2011, FUNGAL GENET BIOL, V48, P23, DOI 10.1016/j.fgb.2010.08.008; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; TOONG YC, 1988, NATURE, V333, P170, DOI 10.1038/333170a0; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004	41	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73369	10.1371/journal.pone.0073369	http://dx.doi.org/10.1371/journal.pone.0073369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991191	Green Submitted, Green Published, gold			2022-12-25	WOS:000324228800101
J	Xiang, GM; Pu, XY; Jiang, DN; Liu, LL; Liu, C; Liu, XB				Xiang, Guiming; Pu, Xiaoyun; Jiang, Dongneng; Liu, Linlin; Liu, Chang; Liu, Xiaobo			Development of a Real-Time Resistance Measurement for Vibrio parahaemolyticus Detection by the Lecithin-Dependent Hemolysin Gene	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MEDIATED ISOTHERMAL AMPLIFICATION; VULNIFICUS; ASSAY; DNA; PCR	The marine bacterium Vibrio parahaemolyticus (V. parahaemolyticus) causes gastroenteritis in humans via the ingestion of raw or undercooked contaminated seafood, and early diagnosis and prompt treatment are important for the prevention of V. parahaemolyticus-related diseases. In this study, a real-time resistance measurement based on loop-mediated isothermal amplification (LAMP), electrochemical ion bonding (Crystal violet and Mg2+), real-time monitoring, and derivative analysis was developed. V. parahaemolyticus DNA was first amplified by LAMP, and the products (DNA and pyrophosphate) represented two types of negative ions that could combine with a positive dye (Crystal violet) and positive ions (Mg2+) to increase the resistance of the reaction liquid. This resistance was measured in real-time using a specially designed resistance electrode, thus permitting the quantitative detection of V. parahaemolyticus. The results were obtained in 1-2 hours, with a minimum bacterial density of 10 CFU.mL(-1) and high levels of accuracy (97%), sensitivity (96.08%), and specificity (97.96%) when compared to cultivation methods. Therefore, this simple and rapid method has a potential application in the detection of V. parahaemolyticus on a gene chip or in point-of-care testing.	[Xiang, Guiming; Pu, Xiaoyun; Jiang, Dongneng; Liu, Linlin; Liu, Chang; Liu, Xiaobo] Third Mil Med Univ, Xinqiao Hosp, Dept Clin Lab, Chongqing, Peoples R China	Army Medical University	Pu, XY (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Clin Lab, Chongqing, Peoples R China.	1598225545@qq.com			Chongqing Science and Technology Commission [CSTC2011AB5035]	Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC)	This work was supported by the research project of Chongqing Science and Technology Commission (CSTC2011AB5035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell KD, 2008, J MICROBIOL, V46, P146, DOI 10.1007/s12275-007-0216-2; Blanco-Abad V, 2009, INT J FOOD MICROBIOL, V129, P229, DOI 10.1016/j.ijfoodmicro.2008.11.028; Chizhikov V, 2001, APPL ENVIRON MICROB, V67, P3258, DOI 10.1128/AEM.67.7.3258-3263.2001; Di Pinto A, 2012, LETT APPL MICROBIOL, V54, P494, DOI 10.1111/j.1472-765X.2012.03231.x; Ham H, 2012, J MICROBIOL, V50, P719, DOI 10.1007/s12275-012-2550-2; Iwamoto M, 2010, CLIN MICROBIOL REV, V23, P399, DOI 10.1128/CMR.00059-09; Jiang DN, 2012, INT J ELECTROCHEM SC, V7, P5273; Jones JL, 2012, FOOD MICROBIOL, V30, P105, DOI 10.1016/j.fm.2011.12.011; Kadhim HM, 2012, EUR J CLIN MICROBIOL, V31, P431, DOI 10.1007/s10096-011-1324-9; Kang MH, 2011, DIAGN MICR INFEC DIS, V69, P21, DOI 10.1016/j.diagmicrobio.2010.08.020; Kim DG, 2008, J MICROBIOL BIOTECHN, V18, P1841, DOI 10.4014/jmb.0800.176; Long YM, 2012, ANALYST, V137, P805, DOI 10.1039/c2an15740c; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; RUIMY R, 1994, INT J SYST BACTERIOL, V44, P416, DOI 10.1099/00207713-44-3-416; Talavera D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-260; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; Venkateswaran K, 1998, APPL ENVIRON MICROB, V64, P681; Wang B, 2011, J VET DIAGN INVEST, V23, P516, DOI 10.1177/1040638711403427; Wang HP, 2011, DIAGN MICR INFEC DIS, V69, P7, DOI 10.1016/j.diagmicrobio.2010.08.016	20	17	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72342	10.1371/journal.pone.0072342	http://dx.doi.org/10.1371/journal.pone.0072342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991096	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800061
J	Hannah, L; Ikegami, M; Hole, DG; Seo, C; Butchart, SHM; Peterson, AT; Roehrdanz, PR				Hannah, Lee; Ikegami, Makihiko; Hole, David G.; Seo, Changwan; Butchart, Stuart H. M.; Peterson, A. Townsend; Roehrdanz, Patrick R.			Global Climate Change Adaptation Priorities for Biodiversity and Food Security	PLOS ONE			English	Article							IMPACTS; DIVERSITY	International policy is placing increasing emphasis on adaptation to climate change, including the allocation of new funds to assist adaptation efforts. Climate change adaptation funding may be most effective where it meets integrated goals, but global geographic priorities based on multiple development and ecological criteria are not well characterized. Here we show that human and natural adaptation needs related to maintaining agricultural productivity and ecosystem integrity intersect in ten major areas globally, providing a coherent set of international priorities for adaptation funding. An additional seven regional areas are identified as worthy of additional study. The priority areas are locations where changes in crop suitability affecting impoverished farmers intersect with changes in ranges of restricted-range species. Agreement among multiple climate models and emissions scenarios suggests that these priorities are robust. Adaptation funding directed to these areas could simultaneously address multiple international policy goals, including poverty reduction, protecting agricultural production and safeguarding ecosystem services.	[Hannah, Lee; Hole, David G.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Hannah, Lee; Roehrdanz, Patrick R.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Ikegami, Makihiko] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Hole, David G.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Seo, Changwan] Seoul Natl Univ, Environm Planning Inst, Seoul 151, South Korea; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Conservation International; University of California System; University of California Santa Barbara; Lincoln University - New Zealand; Durham University; Seoul National University (SNU); BirdLife International; University of Kansas	Hannah, L (corresponding author), Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA.	Lhannah@conservation.org	Hole, David/Q-1692-2019; IKEGAMI, Makihiko/E-6612-2012; Butchart, Stuart/AAJ-1852-2021; Peterson, A. Townsend/I-5697-2013; Butchart, Stuart HM/Y-2711-2018	IKEGAMI, Makihiko/0000-0002-7760-7973; Butchart, Stuart/0000-0002-1140-4049; Peterson, A. Townsend/0000-0003-0243-2379; 				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bank World, 2010, EC AD CLIM CHANG SYN; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell A, 2009, ENVIRON RES LETT, V124, P7; Cavendish W, 2000, WORLD DEV, V28, P1979, DOI 10.1016/S0305-750X(00)00066-8; Center for International Earth Science Information Network [CIESIN], 2011, GLOB RUR URB MAPP PR; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FAO, 2007, FAO MED SER; Fischer G, 2002, GLOBAL AGROECOLOGICA; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gornall J, 2010, PHILOS T R SOC B, V365, P2973, DOI 10.1098/rstb.2010.0158; Hastie T.J., 2017, STAT SCI; Hertel TW, 2010, APPL ECON PERSPECT P, V32, P355, DOI 10.1093/aepp/ppq016; International Food Policy Research Institute, 2010, GLOB HUNG IND 2010 D; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Lane A., 2007, Journal of SAT Agricultural Research, V4, P1; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Lin BB, 2008, BIOSCIENCE, V58, P847, DOI 10.1641/B580911; Liverman D, 2010, ENVIRONMENT, V52, P28, DOI 10.1080/00139151003761579; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Long AJ, 1996, GLOBAL ECOL BIOGEOGR, V5, P281, DOI 10.2307/2997796; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mooney H, 2009, CURR OPIN ENV SUST, V1, P46, DOI 10.1016/j.cosust.2009.07.006; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niehof A, 2004, FOOD POLICY, V29, P321, DOI 10.1016/j.foodpol.2004.07.009; O'Neill BC, 2002, SCIENCE, V296, P1971, DOI 10.1126/science.1071238; OPPENHEIMER M, 1989, CLIMATIC CHANGE, V15, P255, DOI 10.1007/BF00138854; Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1; Parry M, 2009, NATURE, V458, P1102, DOI 10.1038/4581102a; Parry ML, 2007, CLIMATE CHANGE 2007; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Seabrook L, 2011, LANDSCAPE URBAN PLAN, V100, P407, DOI 10.1016/j.landurbplan.2011.02.015; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stattersfield AJ, 1998, ENDEMIC BIRD AREAS W, P1; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Turner WR, 2010, CONSERV LETT, V3, P304, DOI 10.1111/j.1755-263X.2010.00128.x; UNFCCC, 2007, INV FIN FLOWS ADDR C; Warren R, 2011, PHILOS T R SOC A, V369, P217, DOI 10.1098/rsta.2010.0271; You L, 2000, J SEMIARID TROP AGR	54	32	32	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72590	10.1371/journal.pone.0072590	http://dx.doi.org/10.1371/journal.pone.0072590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991125	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000324470100106
J	Kuliawat, R; Klein, L; Gong, ZW; Nicoletta-Gentile, M; Nemkal, A; Cui, LG; Bastie, C; Su, K; Huffman, D; Surana, M; Barzilai, N; Fleischer, N; Muzumdar, R				Kuliawat, Regina; Klein, Laura; Gong, Zhenwei; Nicoletta-Gentile, Marianna; Nemkal, Anjana; Cui, Lingguang; Bastie, Claire; Su, Kai; Huffman, Derek; Surana, Manju; Barzilai, Nir; Fleischer, Norman; Muzumdar, Radhika			Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the beta cell	FASEB JOURNAL			English	Article						hyperglycemic clamps; pancreatic islets; diabetes	NADH SHUTTLE SYSTEM; ALZHEIMERS-DISEASE; NEUROPROTECTIVE FACTOR; PHOSPHATE DEHYDROGENASE; MEMORY IMPAIRMENT; GLUCOKINASE GENE; PEPTIDE; ACTIVATION; MITOCHONDRIAL; DEATH	Humanin (HN) is a 24-aa polypeptide that offers protection from Alzheimer's disease and myocardial infarction, increases insulin sensitivity, improves survival of beta cells, and delays onset of diabetes. Here we examined the acute effects of HN on insulin secretion and potential mechanisms through which they are mediated. Effects of a potent HN analog, HNGF6A, on glucose-stimulated insulin secretion (GSIS) were assessed in vivo and in isolated pancreatic islets and cultured murine beta cell line (beta TC3) in vitro. Sprague-Dawley rats (3 mo old) that received HNGF6A required a significantly higher glucose infusion rate and demonstrated higher insulin levels during hyperglycemic clamps compared to saline controls. In vitro, compared to scrambled peptide controls, HNGF6A increased GSIS in isolated islets from both normal and diabetic mice as well as in beta TC3 cells. Effects of HNGF6A on GSIS were dose dependent, K-ATP channel independent, and associated with enhanced glucose metabolism. These findings demonstrate that HNGF6A increases GSIS in whole animals, from isolated islets and from cells in culture, which suggests a direct effect on the beta cell. The glucose-dependent effects on insulin secretion along with the established effects on insulin action suggest potential for HN and its analogs in the treatment of diabetes.	[Klein, Laura; Gong, Zhenwei; Nicoletta-Gentile, Marianna; Nemkal, Anjana; Cui, Lingguang; Su, Kai; Muzumdar, Radhika] Childrens Hosp Montefiore, Dept Pediat, Bronx, NY USA; [Kuliawat, Regina] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Bastie, Claire; Huffman, Derek; Surana, Manju; Barzilai, Nir; Fleischer, Norman] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Bastie, Claire] Warwick Med Sch, Div Metab & Vasc Hlth, Coventry, W Midlands, England	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Warwick	Muzumdar, R (corresponding author), Albert Einstein Coll Med, Dept Pediat, Golding Bldg 705,1300 Morris Pk Ave, Bronx, NY 10461 USA.	radhika.muzumdar@einstein.yu.edu	Muzumdar, Radhika/D-9860-2014	Bastie, Claire/0000-0001-8178-4748	U.S. National Institutes of Health [K08-AG-027462, K08-AG-027462-03S1, R01-AG-035114, P30-AG-038072, R01-AG-618381, K99/R00, AG-037574]; Core laboratories of the Albert Einstein Diabetes Research and Training Center [DK 20541]; Einstein Nathan Shock Center, Cellular and Tissue Aging Core [P30-AG-038072]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081412, P30DK020541, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072, K08AG027462, K99AG037574, R01AG035114] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core laboratories of the Albert Einstein Diabetes Research and Training Center; Einstein Nathan Shock Center, Cellular and Tissue Aging Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Natalia V. Cheshenko (Department of Pediatrics, Albert Einstein College of Medicine) for assistance with determination of intracellular calcium concentrations. This work was supported by grants from the U.S. National Institutes of Health, K08-AG-027462, K08-AG-027462-03S1, and R01-AG-035114 to R. H. M.; P30-AG-038072 to R. K.; R01-AG-618381 and P30-AG-038072 to N.B.; K99/R00 award AG-037574 to D. M. H.; and by the Core laboratories of the Albert Einstein Diabetes Research and Training Center (DK 20541) and Einstein Nathan Shock Center, Cellular and Tissue Aging Core P30-AG-038072. Disclosure: N.B. is a consultant and a shareholder of CoHBar.	Arakawa T, 2011, CURR MED CHEM, V18, P5554, DOI 10.2174/092986711798347261; Arakawa T, 2006, J PEPT SCI, V12, P639, DOI 10.1002/psc.773; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Cline GW, 2011, DIABETES METAB J, V35, P458, DOI 10.4093/dmj.2011.35.5.458; Cunningham BA, 2003, BIOCHEM J, V369, P173, DOI 10.1042/BJ20021196; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; Doliba NM, 2012, AM J PHYSIOL-ENDOC M, V302, pE87, DOI 10.1152/ajpendo.00218.2011; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Eto K, 1999, J BIOL CHEM, V274, P25386, DOI 10.1074/jbc.274.36.25386; Fleischer N, 1998, DIABETES, V47, P1419, DOI 10.2337/diabetes.47.9.1419; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Gong ZW, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/320482; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Yuichi, 2004, Eur J Neurosci, V19, P2356, DOI 10.1111/j.0953-816X.2004.03298.x; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Ishihara H, 1996, DIABETES, V45, P1238, DOI 10.2337/diabetes.45.9.1238; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x; Kinasiewicz A, 2004, PHYSIOL RES, V53, P327; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2011, HANDB EXP PHARMACOL, V203, P357, DOI 10.1007/978-3-642-17214-4_15; Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2; Muzumdar RH, 2010, ARTERIOSCL THROM VAS, V30, P1940, DOI 10.1161/ATVBAHA.110.205997; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Niikura T, 2006, CURR NEUROPHARMACOL, V4, P139, DOI 10.2174/157015906776359577; Nurse P, 2003, NATURE, V424, P883, DOI 10.1038/424883a; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; RHODES CJ, 1987, J CELL BIOL, V105, P145, DOI 10.1083/jcb.105.1.145; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Terashita K, 2003, J NEUROCHEM, V85, P1521, DOI 10.1046/j.1471-4159.2003.01797.x; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; Tinoco AD, 2011, BIOCHEMISTRY-US, V50, P7447, DOI 10.1021/bi200417k; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamagishi Y, 2003, PEPTIDES, V24, P585, DOI 10.1016/S0196-9781(03)00106-2; Yoshida S, 2010, BIOCHEM BIOPH RES CO, V402, P280, DOI 10.1016/j.bbrc.2010.10.015	50	46	51	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					4890	4898		10.1096/fj.13-231092	http://dx.doi.org/10.1096/fj.13-231092			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	23995290	Green Published			2022-12-25	WOS:000329999000023
J	Chacon, MG; Fournier, AE; Tran, F; Dittrich-Domergue, F; Pulsifer, IP; Domergue, F; Rowland, O				Chacon, Micaela G.; Fournier, Ashley E.; Tran, Frances; Dittrich-Domergue, Franziska; Pulsifer, Ian P.; Domergue, Frederic; Rowland, Owen			Identification of Amino Acids Conferring Chain Length Substrate Specificities on Fatty Alcohol-forming Reductases FAR5 and FAR8 from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Structure; Lipid Metabolism; Plant Biochemistry; Protein Engineering; Site-directed Mutagenesis; Fatty Acyl Reductase; Fatty Alcohol	ACYL-COENZYME; WAX BIOSYNTHESIS; YEAST; GENE; ACYLTRANSFERASE; PURIFICATION; EXPRESSION; ENCODES; SUBERIN; FAMILY	Fatty alcohols play a variety of biological roles in all kingdoms of life. Fatty acyl reductase (FAR) enzymes catalyze the reduction of fatty acyl-coenzyme A (CoA) or fatty acyl-acyl carrier protein substrates to primary fatty alcohols. FAR enzymes have distinct substrate specificities with regard to chain length and degree of saturation. FAR5 (At3g44550) and FAR8 (At3g44560) from Arabidopsis thaliana are 85% identical at the amino acid level and are of equal length, but they possess distinct specificities for 18:0 or 16:0 acyl chain length, respectively. We used Saccharomyces cerevisiae as a heterologous expression system to assess FAR substrate specificity determinants. We identified individual amino acids that affect protein levels or 16:0-CoA versus 18:0-CoA specificity by expressing in yeast FAR5 and FAR8 domain-swap chimeras and site-specific mutants. We found that a threonine at position 347 and a serine at position 363 were important for high FAR5 and FAR8 protein accumulation in yeast and thus are likely important for protein folding and stability. Amino acids at positions 355 and 377 were important for dictating 16:0-CoA versus 18:0-CoA chain length specificity. Simultaneously converting alanine 355 and valine 377 of FAR5 to the corresponding FAR8 residues, leucine and methionine, respectively, almost fully converted FAR5 specificity from 18:0-CoA to 16:0-CoA. The reciprocal amino acid conversions, L355A and M377V, made in the active FAR8-S363P mutant background converted its specificity from 16:0-CoA to 18:0-CoA. This study is an important advancement in the engineering of highly active FAR proteins with desired specificities for the production of fatty alcohols with industrial value.	[Chacon, Micaela G.; Fournier, Ashley E.; Tran, Frances; Pulsifer, Ian P.; Rowland, Owen] Carleton Univ, Inst Biochem, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Dittrich-Domergue, Franziska; Domergue, Frederic] Univ Bordeaux Segalen, CNRS UMR 5200, Lab Biogenese Membranaire, F-33883 Villenave Dornon, France	Carleton University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Rowland, O (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	owen_rowland@carleton.ca	Rowland, Owen/ABH-2744-2021	Rowland, Owen/0000-0002-2752-2584; Domergue, Frederic/0000-0002-0183-7000	Natural Sciences and Engineering Research Council of Canada; France-Canada Research Fund grant from the Embassy of France in Canada; European Commission	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); France-Canada Research Fund grant from the Embassy of France in Canada; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (to O. R.), by a France-Canada Research Fund grant from the Embassy of France in Canada (to F. D. and O. R.), and by European Commission Framework 7 Project entitled "Industrial Crops Producing Added Value Oils for Novel Chemicals" (ICON).	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; ANTIA NJ, 1974, J PROTOZOOL, V21, P768, DOI 10.1111/j.1550-7408.1974.tb03749.x; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Doan TTP, 2012, BBA-MOL CELL BIOL L, V1821, P1244, DOI 10.1016/j.bbalip.2011.10.019; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hajra A. K., 1983, ETHER LIPIDS, P85; Hellenbrand J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-64; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Khannoon ER, 2011, CHEMOECOLOGY, V21, P143, DOI 10.1007/s00049-011-0076-4; KOLATTUK.PE, 1970, BIOCHEMISTRY-US, V9, P1095, DOI 10.1021/bi00807a007; Kosma DK, 2012, PLANT PHYSIOL, V160, P237, DOI 10.1104/pp.112.201822; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LABESSE G, 1994, BIOCHEM J, V304, P95, DOI 10.1042/bj3040095; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; POLLARD MR, 1979, LIPIDS, V14, P651, DOI 10.1007/BF02533451; Pulsifer IP, 2012, PLANT PHYSIOL BIOCH, V51, P31, DOI 10.1016/j.plaphy.2011.10.003; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Rowland O, 2012, PLANT SCI, V193, P28, DOI 10.1016/j.plantsci.2012.05.002; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SPENCER GF, 1979, J AM OIL CHEM SOC, V56, P642, DOI 10.1007/BF02679341; Teerawanichpan P, 2010, INSECT BIOCHEM MOLEC, V40, P641, DOI 10.1016/j.ibmb.2010.06.004; Teerawanichpan P, 2010, LIPIDS, V45, P263, DOI 10.1007/s11745-010-3395-2; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107	35	15	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30345	30355		10.1074/jbc.M113.499715	http://dx.doi.org/10.1074/jbc.M113.499715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005667	hybrid, Green Published			2022-12-25	WOS:000329868100031
J	Khodai-Kalaki, M; Aubert, DF; Valvano, MA				Khodai-Kalaki, Maryam; Aubert, Daniel F.; Valvano, Miguel A.			Characterization of the AtsR Hybrid Sensor Kinase Phosphorelay Pathway and Identification of Its Response Regulator in Burkholderia cenocepacia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Protein Kinases; Cystic Fibrosis; Histidine Kinases; Macrophages; Phosphorylation; Protease; Transcription Regulation; Virulence Factors	VI SECRETION SYSTEM; QUORUM-SENSING SYSTEM; ESCHERICHIA-COLI; PHOSPHATASE-ACTIVITY; IN-VITRO; VIRULENCE; COMPLEX; PROTEIN; PHOSPHORYLATION; BACTERIA	AtsR is a membrane-bound hybrid sensor kinase of Burkholderia cenocepacia that negatively regulates quorum sensing and virulence factors such as biofilm production, type 6-secretion, and protease secretion. Here we elucidate the mechanism of AtsR phosphorelay by site-directed mutagenesis of predicted histidine and aspartic acid phosphoacceptor residues. We demonstrate by in vitro phosphorylation that histidine 245 and aspartic acid 536 are conserved sites of phosphorylation in AtsR, and we also identify the cytosolic response regulator AtsT (BCAM0381) as a key component of the AtsR phosphorelay pathway. Monitoring the function of AtsR and its derivatives in vivo by measuring extracellular protease activity and swarming motility confirmed the in vitro phosphorylation results. Together we find that the AtsR receiver domain plays a fine-tuning role in determining the levels of phosphotransfer from its sensor kinase domain to the AtsT response regulator.	[Khodai-Kalaki, Maryam; Aubert, Daniel F.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, Ctr Human Immunol, Schulich Sch Med, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 5GZ, Antrim, North Ireland	Western University (University of Western Ontario); Queens University Belfast	Valvano, MA (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	m.valvano@qub.ac.uk	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Aubert DF, 2013, ENVIRON MICROBIOL, V15, P372, DOI 10.1111/j.1462-2920.2012.02828.x; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bevivino A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-228; BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Chang CH, 1996, J BACTERIOL, V178, P4710, DOI 10.1128/jb.178.15.4710-4716.1996; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamothe J, 2004, CELL MICROBIOL, V6, P1127, DOI 10.1111/j.1462-5822.2004.00424.x; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Lee YA, 2007, PHYTOPATHOLOGY, V97, P195, DOI 10.1094/PHYTO-97-2-0195; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Malott RJ, 2009, J BACTERIOL, V191, P2447, DOI 10.1128/JB.01746-08; Malott RJ, 2005, INFECT IMMUN, V73, P4982, DOI 10.1128/IAI.73.8.4982-4992.2005; McNeely D, 2009, INT J ENVIRON HEAL R, V19, P157, DOI 10.1080/09603120802392876; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Perraud AL, 1998, MOL MICROBIOL, V27, P875, DOI 10.1046/j.1365-2958.1998.00716.x; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Sambrook J., 2006, CONDENSED PROTOCOLS; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Wolanin PM, 2002, GENOME BIOL, V3; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	46	11	11	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30473	30484		10.1074/jbc.M113.489914	http://dx.doi.org/10.1074/jbc.M113.489914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014026	Green Published, hybrid			2022-12-25	WOS:000329868100043
J	Angonin, D; Van Raay, TJ				Angonin, Diane; Van Raay, Terence J.			Nkd1 Functions as a Passive Antagonist of Wnt Signaling	PLOS ONE			English	Article							PLANAR CELL-POLARITY; CONVERGENT EXTENSION; NEGATIVE REGULATOR; INDUCIBLE ANTAGONIST; BETA-CATENIN/TCF; ZEBRAFISH DKK1; AXIS FORMATION; EXPRESSION; PATHWAY; PROTEIN	Wnt signaling is involved in many aspects of development and in the homeostasis of stem cells. Its importance is underscored by the fact that misregulation of Wnt signaling has been implicated in numerous diseases, especially colorectal cancer. However, how Wnt signaling regulates itself is not well understood. There are several Wnt negative feedback regulators, which are active antagonists of Wnt signaling, but one feedback regulator, Nkd1, has reduced activity compared to other antagonists, yet is still a negative feedback regulator. Here we describe our efforts to understand the role of Nkd1 using Wnt signaling compromised zebrafish mutant lines. In several of these lines, Nkd1 function was not any more active than it was in wild type embryos. However, we found that Nkd1's ability to antagonize canonical Wnt/beta-catenin signaling was enhanced in the Wnt/Planar Cell Polarity mutants silberblick (slb/wnt11) and trilobite (tri/vangl2). While slb and tri mutants do not display alterations in canonical Wnt signaling, we found that they are hypersensitive to it. Overexpression of the canonical Wnt/beta-catenin ligand Wnt8a in slb or tri mutants resulted in dorsalized embryos, with tri mutants being much more sensitive to Wnt8a than slb mutants. Furthermore, the hyperdorsalization caused by Wnt8a in tri could be rescued by Nkd1. These results suggest that Nkd1 functions as a passive antagonist of Wnt signaling, functioning only when homeostatic levels of Wnt signaling have been breached or when Wnt signaling becomes destabilized.	[Angonin, Diane; Van Raay, Terence J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Van Raay, TJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	tvanraay@uoguelph.ca	Van Raay, Terry/AAA-7342-2021; angonin, diane/M-8081-2014	Van Raay, Terence/0000-0003-0196-1041	NSERC Discovery Grant	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by an NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fekany K, 1999, DEVELOPMENT, V126, P1427; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Henderson DJ, 2006, TRENDS CARDIOVAS MED, V16, P38, DOI 10.1016/j.tcm.2005.11.005; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; JESSEN JR, 2005, ADV DEV BIOL BIOCH; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108; Lum WM, 2011, ZEBRAFISH, V8, P65, DOI 10.1089/zeb.2011.0691; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schepers A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007989; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; Solnica-Krezel L, 2001, INT J DEV BIOL, V45, P299; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018; Van Raay TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018650; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Wu SY, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001403; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177; Zhang S, 2007, MOL CELL BIOL, V27, P4454, DOI 10.1128/MCB.00133-07	53	27	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74666	10.1371/journal.pone.0074666	http://dx.doi.org/10.1371/journal.pone.0074666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009776	Green Submitted, gold, Green Published			2022-12-25	WOS:000323734600086
J	Chou, WL; Galmozzi, A; Partida, D; Kwan, K; Yeung, H; Su, AI; Saez, E				Chou, Wen-Ling; Galmozzi, Andrea; Partida, David; Kwan, Kevin; Yeung, Hui; Su, Andrew I.; Saez, Enrique			Identification of Regulatory Elements That Control PPAR gamma Expression in Adipocyte Progenitors	PLOS ONE			English	Article							ADIPOSE-TISSUE; IN-VIVO; TRANSCRIPTIONAL CONTROL; WHITE FAT; CELLS; DIFFERENTIATION; VASCULATURE; DIVERSITY; ENHANCERS; ZFP423	Adipose tissue renewal and obesity-driven expansion of fat cell number are dependent on proliferation and differentiation of adipose progenitors that reside in the vasculature that develops in coordination with adipose depots. The transcriptional events that regulate commitment of progenitors to the adipose lineage are poorly understood. Because expression of the nuclear receptor PPAR gamma defines the adipose lineage, isolation of elements that control PPAR gamma expression in adipose precursors may lead to discovery of transcriptional regulators of early adipocyte determination. Here, we describe the identification and validation in transgenic mice of 5 highly conserved non-coding sequences from the PPAR gamma locus that can drive expression of a reporter gene in a manner that recapitulates the tissue-specific pattern of PPAR gamma expression. Surprisingly, these 5 elements appear to control PPAR gamma expression in adipocyte precursors that are associated with the vasculature of adipose depots, but not in mature adipocytes. Characterization of these five PPAR gamma regulatory sequences may enable isolation of the transcription factors that bind these cis elements and provide insight into the molecular regulation of adipose tissue expansion in normal and pathological states.	[Chou, Wen-Ling; Galmozzi, Andrea; Partida, David; Kwan, Kevin; Yeung, Hui; Saez, Enrique] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Chou, Wen-Ling; Galmozzi, Andrea; Partida, David; Kwan, Kevin; Yeung, Hui; Saez, Enrique] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Su, Andrew I.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Saez, E (corresponding author), Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA.	esaez@scripps.edu		Su, Andrew I./0000-0002-9859-4104	National Institutes for Health [DK081003]; American Diabetes Association [1-08-CD-18]; McDonald's Center for Obesity and Type 2 Diabetes; National Science Council of the R.O.C. Fellowship [NSC97-2917-I-564-106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081003] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); McDonald's Center for Obesity and Type 2 Diabetes; National Science Council of the R.O.C. Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes for Health (DK081003), the American Diabetes Association (1-08-CD-18), The McDonald's Center for Obesity and Type 2 Diabetes, and the National Science Council of the R.O.C. Fellowship (NSC97-2917-I-564-106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cristancho AG, 2011, P NATL ACAD SCI USA, V108, P16271, DOI 10.1073/pnas.1109409108; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Quach JM, 2011, J BIOL CHEM, V286, P4186, DOI 10.1074/jbc.M110.178251; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72511	10.1371/journal.pone.0072511	http://dx.doi.org/10.1371/journal.pone.0072511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009687	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600025
J	Islam, S; Shimizu, N; Hoque, SA; Jinno-Oue, A; Tanaka, A; Hoshino, H				Islam, Salequl; Shimizu, Nobuaki; Hoque, Sheikh Ariful; Jinno-Oue, Atsushi; Tanaka, Atsushi; Hoshino, Hiroo			CCR6 Functions as a New Coreceptor for Limited Primary Human and Simian Immunodeficiency Viruses	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BRAIN-DERIVED CELLS; CHEMOKINE RECEPTOR; T-CELLS; ALTERNATIVE CORECEPTORS; ENV GENE; HIV-1; ENTRY; EXPRESSION; CLONING	More than 12 chemokine receptors (CKRs) have been identified as coreceptors for the entry of human immunodeficiency virus type 1 (HIV-1), type 2 (HIV-2), and simian immunodeficiency viruses (SIVs) into target cells. The expression of CC chemokine receptor 6 (CCR6) on Th17 cells and regulatory T cells make the host cells vulnerable to HIV/SIV infection preferentially. However, only limited information is available concerning the specific role of CCR6 in HIV/SIV infection. We examined CCR6 as a coreceptor candidate in this study using NP-2 cell line-based in-vitro studies. Normally, CD4-transduced cell line, NP-2/CD4, is strictly resistant to all HIV/SIV infection. When CCR6 was transduced there, the resultant NP-2/CD4/CCR6 cells became susceptible to HIV-1HAN2, HIV-2MIR and SIVsmE660, indicating coreceptor roles of CCR6. Viral antigens in infected cells were detected by IFA and confirmed by detection of proviral DNA. Infection-induced syncytia in NP-2/CD4/CCR6 cells were detected by Giemsa staining. Amount of virus release through CCR6 has been detected by RT assay in spent culture medium. Sequence analysis of proviral DNA showed two common amino acid substitutions in the C2 envelope region of HIV-2MIR clones propagated through NP-2/CD4/CCR6 cells. Conversely, CCR6-origin SIVsmE660 clones resulted two amino acid changes in the V1 region and one change in the C2 region. The substitutions in the C2 region for HIV-2MIR and the V1 region of SIVsmE660 may confer selection advantage for CCR6-use. Together, the results describe CCR6 as an independent coreceptor for HIV and SIV in strain-specific manner. The alteration of CCR6 uses by viruses may influence the susceptibility of CD4+ CCR6+ T-cells and dendritic cell subsets in vivo and therefore, is important for viral pathogenesis in establishing latent infections, trafficking, and transmission. However, clinical relevance of CCR6 as coreceptor in HIV/SIV infections should be investigated further.	[Islam, Salequl; Shimizu, Nobuaki; Hoque, Sheikh Ariful; Jinno-Oue, Atsushi; Hoshino, Hiroo] Gunma Univ, Grad Sch Med, Dept Virol & Prevent Med, Maebashi, Gunma 371, Japan; [Hoque, Sheikh Ariful] Univ Dhaka, Ctr Adv Res Sci, Cell & Tissue Culture Lab, Dhaka 1000, Bangladesh; [Tanaka, Atsushi] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Gunma University; University of Dhaka; Osaka University	Islam, S (corresponding author), Jahangirnagar Univ, Dept Microbiol, Dhaka, Bangladesh.	salequl@gmail.com			Gunma University Graduate Program (GP); Heiwa Nakajima Foundation, Japan; 21st Century COE Program, "Biomedical Research using Accelerated Technology"; Gunma University Graduate School of Medicine; Grants-in-Aid for Scientific Research [23659250] Funding Source: KAKEN	Gunma University Graduate Program (GP); Heiwa Nakajima Foundation, Japan; 21st Century COE Program, "Biomedical Research using Accelerated Technology"; Gunma University Graduate School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to Gunma University Graduate Program (GP) and Heiwa Nakajima Foundation, Japan, for their financial assistance to conduct this study. This work was supported in part by grants-in-aid from 21st Century COE Program, "Biomedical Research using Accelerated Technology" and Gunma University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LS, 2004, J BIOMED SCI, V11, P818, DOI 10.1159/000081829; ALMOND N, 1993, J GEN VIROL, V74, P865, DOI 10.1099/0022-1317-74-5-865; Ancuta P, 2010, CURR OPIN HIV AIDS, V5, P158, DOI 10.1097/COH.0b013e3283364733; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Choe H, 1998, J VIROL, V72, P6113, DOI 10.1128/JVI.72.7.6113-6118.1998; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dehghani H, 2003, J VIROL, V77, P6405, DOI 10.1128/JVI.77.11.6405-6418.2003; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Elliott STC, 2012, J VIROL, V86, P898, DOI 10.1128/JVI.06415-11; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fortgang IS, 2001, AIDS RES HUM RETROV, V17, P459, DOI 10.1089/088922201750102580; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Hoque SA, 2012, MICROBES INFECT, V14, P357, DOI 10.1016/j.micinf.2011.11.005; HOSHINO H, 1983, P NATL ACAD SCI-BIOL, V80, P6061, DOI 10.1073/pnas.80.19.6061; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Islam S, 2013, MICROBIOL IMMUNOL, DOI [10.1111/j.1348-0421.12051, DOI 10.1111/J.1348-0421.12051]; JAVAHERIAN K, 1992, P NATL ACAD SCI USA, V89, P1418, DOI 10.1073/pnas.89.4.1418; Jinno A, 1998, BIOCHEM BIOPH RES CO, V243, P497, DOI 10.1006/bbrc.1998.8130; JOHNSON PR, 1992, AIDS RES HUM RETROV, V8, P367, DOI 10.1089/aid.1992.8.367; Kanbe K, 1999, VIROLOGY, V265, P264, DOI 10.1006/viro.1999.0036; KLEIN E, 1968, CANCER RES, V28, P1300; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; Liao F, 1997, GENOMICS, V40, P175, DOI 10.1006/geno.1996.4544; Liao F, 1999, J IMMUNOL, V162, P186; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nedellec R, 2009, J VIROL, V83, P8353, DOI 10.1128/JVI.00780-09; Neil SJD, 2005, J VIROL, V79, P9618, DOI 10.1128/JVI.79.15.9618-9624.2005; Nolan GP, 1998, CURR OPIN BIOTECH, V9, P447, DOI 10.1016/S0958-1669(98)80027-X; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Ratner L, 1987, Haematol Blood Transfus, V31, P404; Reeves JD, 1998, J GEN VIROL, V79, P1793, DOI 10.1099/0022-1317-79-7-1793; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Schneider U, 1997, BRIT J HAEMATOL, V97, P56, DOI 10.1046/j.1365-2141.1997.d01-2115.x; Shimizu N, 2000, AIDS RES HUM RETROV, V16, P611, DOI 10.1089/088922200309034; Shimizu N, 1999, J VIROL, V73, P5231, DOI 10.1128/JVI.73.6.5231-5239.1999; Shimizu N, 2000, GENE, V259, P199, DOI 10.1016/S0378-1119(00)00432-7; Shimizu N, 2008, J GEN VIROL, V89, P3126, DOI 10.1099/vir.0.2008/002188-0; Shimizu N, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-52; Shimizu N, 2009, AIDS, V23, P761, DOI 10.1097/QAD.0b013e328326cc0d; SHIMIZU NS, 1994, J VIROL, V68, P6130, DOI 10.1128/JVI.68.9.6130-6135.1994; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Steinfelder S, 2011, BLOOD, V117, P2839, DOI 10.1182/blood-2010-06-293027; SYLWESTER A, 1993, J CELL SCI, V106, P941; YAMAGUCHI K, 1995, BBA-PROTEIN STRUCT M, V1253, P136, DOI 10.1016/0167-4838(95)00167-1; Zaballos A, 1996, BIOCHEM BIOPH RES CO, V227, P846, DOI 10.1006/bbrc.1996.1595	57	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73116	10.1371/journal.pone.0073116	http://dx.doi.org/10.1371/journal.pone.0073116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009735	Green Published, Green Submitted, gold			2022-12-25	WOS:000323734600057
J	Lim, SW; Doh, KC; Jin, L; Piao, SG; Heo, SB; Zheng, YF; Bae, SK; Chung, BH; Yang, CW				Lim, Sun Woo; Doh, Kyoung Chan; Jin, Long; Piao, Shang Guo; Heo, Seong Beom; Zheng, Yu Fen; Bae, Soo Kyung; Chung, Byung Ha; Yang, Chul Woo			Oral Administration of Ginseng Ameliorates Cyclosporine-Induced Pancreatic Injury in an Experimental Mouse Model	PLOS ONE			English	Article							KOREAN RED GINSENG; POSTTRANSPLANT DIABETES-MELLITUS; BETA-CELLS; OXIDATIVE STRESS; INDUCED NEPHROTOXICITY; ISLET DYSFUNCTION; GLUCOSE TOXICITY; ANTIAGING GENE; IN-VIVO; RATS	Background: This study was performed to investigate whether ginseng has a protective effect in an experimental mouse model of cyclosporine-induced pancreatic injury. Methods: Mice were treated with cyclosporine (30 mg/kg/day, subcutaneously) and Korean red ginseng extract (0.2 or 0.4 g/kg/day, oral gavage) for 4 weeks while on a 0.01% salt diet. The effect of ginseng on cyclosporine-induced pancreatic islet dysfunction was investigated by an intraperitoneal glucose tolerance test and measurements of serum insulin level, beta cell area, macrophage infiltration, and apoptosis. Using an in vitro model, we further examined the effect of ginseng on a cyclosporine-treated insulin-secreting cell line. Oxidative stress was measured by the concentration of 8-hydroxy-2'-deoxyguanosine in serum, tissue sections, and culture media. Results: Four weeks of cyclosporine treatment increased blood glucose levels and decreased insulin levels, but cotreatment with ginseng ameliorated the cyclosporine-induced glucose intolerance and hyperglycemia. Pancreatic beta cell area was also greater with ginseng cotreatment compared with cyclosporine monotherapy. The production of proinflammatory molecules, such as induced nitric oxide synthase and cytokines, and the level of apoptotic cell death also decreased in pancreatic beta cell with ginseng treatment. Consistent with the in vivo results, the in vitro study showed that the addition of ginseng protected against cyclosporine-induced cytotoxicity, inflammation, and apoptotic cell death. These in vivo and in vitro changes were accompanied by decreases in the levels of 8-hydroxy-2'-deoxyguanosine in pancreatic beta cell in tissue section, serum, and culture media during cotreatment of ginseng with cyclosporine. Conclusions: The results of our in vivo and in vitro studies demonstrate that ginseng has a protective effect against cyclosporine-induced pancreatic beta cell injury via reducing oxidative stress.	[Lim, Sun Woo; Doh, Kyoung Chan; Jin, Long; Piao, Shang Guo; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Doh, Kyoung Chan; Jin, Long; Piao, Shang Guo; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Bae, Soo Kyung] Catholic Univ Korea, Coll Pharm, Seoul, South Korea; [Zheng, Yu Fen] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Piao, Shang Guo] YanBian Univ Hosp, Dept Internal Med, Nephrol & Dialysis Unit, Yanji, Jilin, Peoples R China	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul National University (SNU); Yanbian University	Yang, CW (corresponding author), Catholic Univ Korea, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yangch@catholic.ac.kr			Korean Society of Ginseng; Korea Ginseng Corporation, Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A3001890]; Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A092258]	Korean Society of Ginseng; Korea Ginseng Corporation, Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This work was supported by the 2011 grant from the Korean Society of Ginseng funded by Korea Ginseng Corporation, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A3001890), and the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A092258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajabnoor MA, 2007, LIFE SCI, V80, P345, DOI 10.1016/j.lfs.2006.09.034; BANISACCHI T, 1990, TRANSPLANTATION, V49, P982, DOI 10.1097/00007890-199005000-00028; BASADONNA G, 1988, AM J SURG, V156, P191, DOI 10.1016/S0002-9610(88)80064-3; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Bollheimer LC, 2005, BIOCHEM BIOPH RES CO, V330, P327, DOI 10.1016/j.bbrc.2005.01.168; Bugliani M, 2009, ISLETS, V1, P106, DOI 10.4161/isl.1.2.9142; Capasso G, 2008, NEPHROL DIAL TRANSPL, V23, P1186, DOI 10.1093/ndt/gfm784; Chen M, 2002, ENDOCRINOLOGY, V143, P2341, DOI 10.1210/en.143.6.2341; Chung BH, 2005, AM J TRANSPLANT, V5, P1856, DOI 10.1111/j.1600-6143.2005.00979.x; Duclos A, 2006, DRUG AGING, V23, P781, DOI 10.2165/00002512-200623100-00002; Erbagci AB, 2001, CLIN BIOCHEM, V34, P645, DOI 10.1016/S0009-9120(01)00275-2; First MR, 2002, TRANSPLANTATION, V73, P379, DOI 10.1097/00007890-200202150-00011; Han DH, 2010, TRANSPLANTATION, V90, P135, DOI 10.1097/TP.0b013e3181e117b4; Hong Chang-Eui, 2011, Immune Netw, V11, P42, DOI 10.4110/in.2011.11.1.42; ISHIZUKA J, 1993, TRANSPLANTATION, V56, P1486, DOI 10.1097/00007890-199312000-00039; Joo KR, 2009, PANCREAS, V38, P661, DOI 10.1097/MPA.0b013e3181a9eb85; Kaneto H, 1996, BIOCHEM J, V320, P855, DOI 10.1042/bj3200855; Kim JW, 2009, BIOCHEM BIOPH RES CO, V390, P763, DOI 10.1016/j.bbrc.2009.10.046; Kim SH, 2011, NEPHROL DIAL TRANSPL, V26, P1502, DOI 10.1093/ndt/gfq640; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Li SY, 2012, APOPTOSIS, V17, P113, DOI 10.1007/s10495-011-0671-4; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Piao SG, 2012, TRANSPLANTATION, V93, P383, DOI 10.1097/TP.0b013e3182421604; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Ryu JK, 2005, UROLOGY, V65, P611, DOI 10.1016/j.urology.2004.10.038; Satyanarayana PSV, 2002, RENAL FAILURE, V24, P259, DOI 10.1081/JDI-120005360; Shihab FS, 1999, KIDNEY INT, V56, P2147, DOI 10.1046/j.1523-1755.1999.00794.x; Song HK, 2009, AM J TRANSPLANT, V9, P2024, DOI 10.1111/j.1600-6143.2009.02751.x; Sung JD, 2000, AM J CHINESE MED, V28, P205, DOI 10.1142/S0192415X00000258; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tariq M, 1999, NEPHROL DIAL TRANSPL, V14, P923, DOI 10.1093/ndt/14.4.923; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vuksan V, 2008, NUTR METAB CARDIOVAS, V18, P46, DOI 10.1016/j.numecd.2006.04.003; Yang ZD, 2005, AM J TRANSPLANT, V5, P475, DOI 10.1111/j.1600-6143.2005.00707.x; Yang ZG, 2006, CHEM BIODIVERS, V3, P187, DOI 10.1002/cbdv.200690022; Yoon HE, 2012, NEPHRON EXP NEPHROL, V120, pE123, DOI 10.1159/000342117; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81; Zhang DX, 1996, FREE RADICAL BIO MED, V20, P145, DOI 10.1016/0891-5849(95)02020-9	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72685	10.1371/journal.pone.0072685	http://dx.doi.org/10.1371/journal.pone.0072685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009697	Green Submitted, gold, Green Published			2022-12-25	WOS:000323734600033
J	Zhang, J; Wu, D; Xie, C; Wang, H; Wang, W; Zhang, H; Liu, R; Xu, LX; Mei, XP				Zhang, Jin; Wu, Dan; Xie, Cheng; Wang, Huan; Wang, Wei; Zhang, Hui; Liu, Rui; Xu, Li-Xian; Mei, Xiao-Peng			Tramadol and Propentofylline Coadministration Exerted Synergistic Effects on Rat Spinal Nerve Ligation-Induced Neuropathic Pain	PLOS ONE			English	Article							NEURONAL-GLIAL INTERACTIONS; PROINFLAMMATORY CYTOKINES; PERSISTENT PAIN; DOUBLE-BLIND; CORD-INJURY; MODEL; MORPHINE; MICROGLIA; ACTIVATION; RECEPTORS	Neuropathic pain is an intractable clinical problem. Drug treatments such as tramadol have been reported to effectively decrease neuropathic pain by inhibiting the activity of nociceptive neurons. It has also been reported that modulating glial activation could also prevent or reverse neuropathic pain via the administration of a glial modulator or inhibitor, such as propentofylline. Thus far, there has been no clinical strategy incorporating both neuronal and glial participation for treating neuropathic pain. Therefore, the present research study was designed to assess whether coadministration of tramadol and propentofylline, as neuronal and glial activation inhibitors, respectively, would exert a synergistic effect on the reduction of rat spinal nerve ligation (SNL)-induced neuropathic pain. Rats underwent SNL surgery to induce neuropathic pain. Pain behavioral tests were conducted to ascertain the effect of drugs on SNL-induced mechanical allodynia with von-Frey hairs. Proinflammatory factor interleukin-1 beta (IL-1 beta) expression was also detected by Real-time RT-PCR. Intrathecal tramadol and propentofylline administered alone relieved SNL-induced mechanical allodynia in a dose-dependent manner. Tramadol and propentofylline coadministration exerted a more potent effect in a synergistic and dose dependent manner than the intrathecal administration of either drug alone. Real-time RT-PCR demonstrated IL-1 beta up-expression in the ipsilateral spinal dorsal horn after the lesion, which was significantly decreased by tramadol and propentofylline coadministration. Inhibiting proinflammatory factor IL-1 beta contributed to the synergistic effects of tramadol and propentofylline coadministration on rat peripheral nerve injury-induced neuropathic pain. Thus, our study provided a rationale for utilizing a novel strategy for treating neuropathic pain by blocking the proinflammatory factor related pathways in the central nervous system.	[Zhang, Jin; Wang, Wei; Zhang, Hui; Liu, Rui; Xu, Li-Xian; Mei, Xiao-Peng] Fourth Mil Med Univ, Sch Stomatol, Dept Anesthesiol, Xian 710032, Peoples R China; [Wu, Dan; Xie, Cheng] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China; [Wang, Huan] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, R (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Anesthesiol, Xian 710032, Peoples R China.	liuruiliurui1976@126.com; kqmzk@126.com; meixiaopengmxp@126.com			National Natural Science Foundation of China [30901400, 81270016, 81100732, 81071528, 81271229, 81070997]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (30901400, 81270016, 81100732, 81071528, 81271229, 81070997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P, 2003, ANESTHESIOLOGY, V99, P969, DOI 10.1097/00000542-200310000-00033; Arguelles CF, 2002, ANESTHESIOLOGY, V96, P921, DOI 10.1097/00000542-200204000-00020; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Berrocoso E, 2007, PSYCHOPHARMACOLOGY, V193, P97, DOI 10.1007/s00213-007-0761-8; Brattwall M, 2010, ANESTH ANALG, V111, P544, DOI 10.1213/ANE.0b013e3181e3d87c; Cavazzini F, 2008, Minerva Med, V99, P631; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Erichsen HK, 2005, PAIN, V116, P347, DOI 10.1016/j.pain.2005.05.004; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Ikeda H, 2007, EUR J NEUROSCI, V25, P1297, DOI 10.1111/j.1460-9568.2007.05386.x; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Inoue K, 2003, LIFE SCI, V74, P189, DOI 10.1016/j.lfs.2003.09.006; Inoue K, 2007, J NEUROCHEM, V102, P1447, DOI 10.1111/j.1471-4159.2007.04824.x; Iyengar S, 2004, J PHARMACOL EXP THER, V311, P576, DOI 10.1124/jpet.104.070656; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kino Y, 2005, J PHARMACOL SCI, V99, P52, DOI 10.1254/jphs.FP0050520; Kraychete Durval Campos, 2009, Rev. Bras. Anestesiol., V59, P297, DOI 10.1590/S0034-70942009000300004; Li YK, 2000, J NEUROSCI, V20, P149, DOI 10.1523/JNEUROSCI.20-01-00149.2000; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Mei XP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-6; Mika J, 2008, PHARMACOL REP, V60, P297; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2008, J NEUROIMMUNOL, V198, P113, DOI 10.1016/j.jneuroim.2008.04.011; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; Norrbrink C, 2009, CLIN J PAIN, V25, P177, DOI 10.1097/AJP.0b013e31818a744d; Onal A, 2007, PHARMACOL BIOCHEM BE, V88, P171, DOI 10.1016/j.pbb.2007.08.001; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Sweitzer Sarah, 2011, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-642-13443-2_8; Sweitzer SM, 2001, J PHARMACOL EXP THER, V297, P1210; TALLARIDA RJ, 1989, LIFE SCI, V45, P947, DOI 10.1016/0024-3205(89)90148-3; Tawfik VL, 2008, NEUROSCIENCE, V152, P1086, DOI 10.1016/j.neuroscience.2008.01.065; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wang W, 2011, BRAIN BEHAV IMMUN, V25, P1355, DOI 10.1016/j.bbi.2011.04.002; WILDERSMITH CH, 1994, ANN ONCOL, V5, P141, DOI 10.1093/oxfordjournals.annonc.a058765; Wrzosek A, 2009, J PHYSIOL PHARMACOL, V60, P71; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72943	10.1371/journal.pone.0072943	http://dx.doi.org/10.1371/journal.pone.0072943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009718	Green Submitted, Green Published, gold			2022-12-25	WOS:000323734600044
J	Aerts, L; Hamelin, ME; Rheaume, C; Lavigne, S; Couture, C; Kim, W; Susan-Resiga, D; Prat, A; Seidah, NG; Vergnolle, N; Riteau, B; Boivin, G				Aerts, Laetitia; Hamelin, Marie-Eve; Rheaume, Chantal; Lavigne, Sophie; Couture, Christian; Kim, WooJin; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.; Vergnolle, Nathalie; Riteau, Beatrice; Boivin, Guy			Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IMMUNE-RESPONSE; SECONDARY PREVENTION; TRANSPLANT RECIPIENT; BALB/C MICE; INFECTION; PATHOGENESIS; PROPROTEIN; CELLS; INFLAMMATION	Human metapneumovirus (hMPV) infection causes acute respiratory tract infections (RTI) which can result in hospitalization of both children and adults. To date, no antiviral or vaccine is available for this common viral infection. Immunomodulators could represent an interesting strategy for the treatment of severe viral infection. Recently, the role of protease-activated receptors (PAR) in inflammation, coagulation and infection processes has been of growing interest. Herein, the effects of a PAR1 agonist and a PAR1 antagonist on hMPV infection were investigated in BALB/c mice. Intranasal administration of the PAR1 agonist resulted in increased weight loss and mortality of infected mice. Conversely, the PAR1 antagonist was beneficial to hMPV infection by decreasing weight loss and clinical signs and by significantly reducing pulmonary inflammation, pro-inflammatory cytokine levels (including IL-6, KC and MCP-1) and recruitment of immune cells to the lungs. In addition, a significant reduction in pulmonary viral titers was also observed in the lungs of PAR1 antagonist-treated mice. Despite no apparent direct effect on virus replication during in vitro experiments, an important role for PAR1 in the regulation of furin expression in the lungs was shown for the first time. Further experiments indicated that the hMPV fusion protein can be cleaved by furin thus suggesting that PAR1 could have an effect on viral infectivity in addition to its immunomodulatory properties. Thus, inhibition of PAR1 by selected antagonists could represent an interesting strategy for decreasing the severity of paramyxovirus infections.	[Aerts, Laetitia; Hamelin, Marie-Eve; Rheaume, Chantal; Boivin, Guy] Ctr Hosp Univ Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Aerts, Laetitia; Hamelin, Marie-Eve; Rheaume, Chantal; Boivin, Guy] Univ Laval, Quebec City, PQ, Canada; [Lavigne, Sophie; Couture, Christian] Univ Laval, Dept Anatomopathol, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Kim, WooJin; Susan-Resiga, Delia; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Vergnolle, Nathalie] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, Inst Natl Sante & Rech Med, Ctr Natl Rech Sci,Univ Toulouse, F-31062 Toulouse, France; [Vergnolle, Nathalie] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Riteau, Beatrice] Univ Lyon, Fac Med RTH Laennec, Lyon, France; [Riteau, Beatrice] Nouzilly Inst Natl Rech Agron, Ctr Tours, Nouzilly, France	Laval University; Laval University; Laval University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Calgary; INRAE	Boivin, G (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada.	Guy.Boivin@crchul.ulaval.ca	Vergnolle, Nathalie/C-7677-2018; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Vergnolle, Nathalie/0000-0003-1825-6015; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [273261, 733598]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by grant No. 273261 from the Canadian Institutes of Health Research (to G. B.), and by grant No. 733598 from the Canadian Institutes of Health Research (to N.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2011, BRAIN, V134, P3209, DOI 10.1093/brain/awr242; Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Alvarez R, 2004, J VIROL, V78, P14003, DOI 10.1128/JVI.78.24.14003-14011.2004; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Antoniak S, 2013, J CLIN INVEST, V123, P1310, DOI 10.1172/JCI66125; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Atzori L, 2009, AM J RESP CELL MOL, V41, P680, DOI 10.1165/rcmb.2007-0386OC; Bar-Shavit R, 2002, IMMUNOLOGY, V105, P35, DOI 10.1046/j.0019-2805.2001.01351.x; Barik S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-104; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berri F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003229; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Cabello-Guterrez C, 2009, THROMB HAEMOSTASIS, V101, P916, DOI 10.1160/TH08-04-0271; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Cenac N, 2005, INFLAMM BOWEL DIS, V11, P792, DOI 10.1097/01.mib.0000177506.71784.bd; Chin AC, 2003, P NATL ACAD SCI USA, V100, P11104, DOI 10.1073/pnas.1831452100; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Darniot M, 2005, VACCINE, V23, P4473, DOI 10.1016/j.vaccine.2005.04.027; de Swart RL, 2007, VACCINE, V25, P8518, DOI 10.1016/j.vaccine.2007.10.022; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Di Serio C, 2007, BASIC CLIN PHARMACOL, V101, P63, DOI 10.1111/j.1742-7843.2007.00078.x; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Feuillet F, 2012, J CLIN VIROL, V53, P97, DOI 10.1016/j.jcv.2011.10.002; Foucault ML, 2011, J CLIN VIROL, V51, P155, DOI 10.1016/j.jcv.2011.04.013; Ganachari M, 2012, GENES IMMUN, V13, P605, DOI 10.1038/gene.2012.39; Hamelin ME, 2007, J GEN VIROL, V88, P3391, DOI 10.1099/vir.0.83250-0; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Hamelin ME, 2006, ANTIMICROB AGENTS CH, V50, P774, DOI 10.1128/AAC.50.2.774-777.2006; Hamelin ME, 2005, J VIROL, V79, P8894, DOI 10.1128/JVI.79.14.8894-8903.2005; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Herfst S, 2008, J CLIN VIROL, V41, P45, DOI 10.1016/j.jcv.2007.10.022; Kamboj M, 2008, J INFECTION, V57, P464, DOI 10.1016/j.jinf.2008.10.003; Khoufache K, 2013, J CLIN INVEST, V123, P206, DOI 10.1172/JCI61667; Khoufache K, 2009, J IMMUNOL, V182, P7795, DOI 10.4049/jimmunol.0803743; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Lan RS, 2004, AM J PHYSIOL-LUNG C, V286, pL388, DOI 10.1152/ajplung.00286.2003; Li T, 2006, IMMUNOL CELL BIOL, V84, P461, DOI 10.1111/j.1440-1711.2006.01456.x; Louie JK, 2007, J INFECT DIS, V196, P705, DOI 10.1086/519846; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Min JY, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649570; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Pelletier G, 2002, EMERG INFECT DIS, V8, P976, DOI 10.3201/eid0809.020238; Raza K, 2007, J HEART LUNG TRANSPL, V26, P862, DOI 10.1016/j.healun.2007.05.020; Rullier A, 2008, AM J PHYSIOL-GASTR L, V294, pG226, DOI 10.1152/ajpgi.00444.2007; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Shahda S, 2011, TRANSPL INFECT DIS, V13, P324, DOI 10.1111/j.1399-3062.2010.00575.x; Sookoian Silvia, 2004, Ann Hepatol, V3, P104; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Strande JL, 2007, BASIC RES CARDIOL, V102, P350, DOI 10.1007/s00395-007-0653-4; Sumino KC, 2005, J INFECT DIS, V192, P1052, DOI 10.1086/432728; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Sutherland MR, 2007, J THROMB HAEMOST, V5, P1055, DOI 10.1111/j.1538-7836.2007.02441.x; Sutherland MR, 2012, BLOOD, V119, P3638, DOI 10.1182/blood-2011-08-376814; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; Vargas SO, 2004, PEDIATR DEVEL PATHOL, V7, P478, DOI 10.1007/s10024-004-1011-2; Ventre K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000181.pub3; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Wang HY, 2007, EUR J CELL BIOL, V86, P233, DOI 10.1016/j.ejcb.2006.12.003; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Williams JV, 2005, J VIROL, V79, P10944, DOI 10.1128/JVI.79.17.10944-10951.2005; Wyde PR, 2005, ANTIVIR RES, V66, P57, DOI 10.1016/j.antiviral.2004.12.009; Wyde PR, 2003, ANTIVIR RES, V60, P51, DOI 10.1016/S0166-3542(03)00153-0; Yanagita M, 2007, BIOCHEM BIOPH RES CO, V364, P318, DOI 10.1016/j.bbrc.2007.10.002; Yoshikawa Y, 2010, CYTOTECHNOLOGY, V62, P325, DOI 10.1007/s10616-010-9275-z	80	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72529	10.1371/journal.pone.0072529	http://dx.doi.org/10.1371/journal.pone.0072529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015257	Green Published, Green Submitted, gold			2022-12-25	WOS:000323733800062
J	Haselhuhn, MP; Wong, EM; Ormiston, ME				Haselhuhn, Michael P.; Wong, Elaine M.; Ormiston, Margaret E.			Self-Fulfilling Prophecies as a Link between Men's Facial Width-to-Height Ratio and Behavior	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATIONS; STRUCTURE PREDICTS; AGGRESSIVE-BEHAVIOR; FACE; COOPERATION; TRUSTWORTHINESS; CONFIRMATION; STEREOTYPES; COMPETITION; PERCEPTION	The facial width-to-height ratio (fWHR) has been identified as a reliable predictor of men's behavior, with researchers focusing on evolutionary selection pressures as the underlying mechanism explaining these relationships. In this paper, we complement this approach and examine the extent to which social processes also determine the extent to which men's fWHR serves as a behavioral cue. Specifically, we propose that observers' treatment of target men based on the targets' fWHR subsequently affects behavior, leading the targets to behave in ways that are consistent with the observers' expectations (i.e., a self-fulfilling prophecy). Results from four studies demonstrate that individuals behave more selfishly when interacting with men with greater fWHRs, and this selfish behavior, in turn, elicits selfish behavior in others.	[Haselhuhn, Michael P.; Wong, Elaine M.] Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA; [Ormiston, Margaret E.] London Business Sch, Org Behav Area, London NW1 4SA, England	University of California System; University of California Riverside; University of London; London Business School	Haselhuhn, MP (corresponding author), Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA.	michael.haselhuhn@ucr.edu	Ormiston, Margaret/O-3819-2014		University of California, Riverside; London Business School	University of California, Riverside(University of California System); London Business School	This work was funded via research support from University of California, Riverside and London Business School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carre JM, 2013, SOC COGN AFFECT NEUR, V8, P224, DOI 10.1093/scan/nsr096; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; DARLEY JM, 1980, AM PSYCHOL, V35, P867, DOI 10.1037/0003-066X.35.10.867; Efferson C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01047; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; JONES SC, 1971, J EXP SOC PSYCHOL, V7, P356, DOI 10.1016/0022-1031(71)90034-5; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Lefevre CE, EVOL HUM BE IN PRESS; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Olekalns M, 1999, PERS SOC PSYCHOL B, V25, P657, DOI 10.1177/0146167299025006002; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; SNYDER M, 1978, J EXP SOC PSYCHOL, V14, P148, DOI 10.1016/0022-1031(78)90021-5; SNYDER M, 1977, J PERS SOC PSYCHOL, V35, P656, DOI 10.1037/0022-3514.35.9.656; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tinsley CH, 2002, ORGAN BEHAV HUM DEC, V88, P621, DOI 10.1016/S0749-5978(02)00005-5; van Dijk E, 2006, PERS SOC PSYCHOL B, V32, P1352, DOI 10.1177/0146167206290338; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 1998, J PERS SOC PSYCHOL, V75, P1300, DOI 10.1037/0022-3514.75.5.1300; Zebrowitz LA, 1996, PERS SOC PSYCHOL B, V22, P1258, DOI 10.1177/01461672962212006	31	36	38	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72259	10.1371/journal.pone.0072259	http://dx.doi.org/10.1371/journal.pone.0072259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015226	Green Published, gold, Green Submitted			2022-12-25	WOS:000323733800040
J	Kuno, T; Numasawa, Y; Miyata, H; Takahashi, T; Sueyoshi, K; Ohki, T; Negishi, K; Kawamura, A; Kohsaka, S; Fukuda, K				Kuno, Toshiki; Numasawa, Yohei; Miyata, Hiroaki; Takahashi, Toshiyuki; Sueyoshi, Koichiro; Ohki, Takahiro; Negishi, Koji; Kawamura, Akio; Kohsaka, Shun; Fukuda, Keiichi			Impact of Coronary Dominance on In-Hospital Outcomes after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; ASSOCIATION; ANGIOGRAPHY; GUIDELINES; OCCLUSION; FLOW	Objective: This study evaluated the manner in which coronary dominance affects in-hospital outcomes of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). Background: Previous studies have shown that left dominant coronary anatomies are associated with worse prognoses in patients with coronary artery disease. Methods: Data were analyzed from 4873 ACS patients undergoing PCI between September 2008 and April 2013 at 14 hospitals participating in the Japanese Cardiovascular Database Registry. The patients were grouped based on diagnostic coronary angiograms performed prior to PCI; those with right- or co-dominant anatomy (RD group) and those with left-dominant anatomy (LD group). Results: The average patient age was 67.6 +/- 11.8 years and both patient groups had similar ages, coronary risk factors, comorbidities, and prior histories. The numbers of patients presenting with symptoms of heart failure, cardiogenic shock, or cardiopulmonary arrest were significantly higher in the LD group than in the RD group (heart failure: 650 RD patients [14.7%] vs. 87 LD patients [18.8%], P = 0.025; cardiogenic shock: 322 RD patients [7.3%] vs. 48 LD patients [10.3%], P = 0.021; and cardiopulmonary arrest: 197 RD patients [4.5%] vs. 36 LD patients [7.8%], P = 0.003). In-hospital mortality was significantly higher among LD patients than among RD patients (182 RD patients [4.1%] vs. 36 LD patients [7.8%], P = 0.001). Multivariate logistic regression analysis revealed that LD anatomy was an independent predictor for in-hospital mortality (odds ratio, 1.75; 95% confidence interval, 1.06-2.89; P = 0.030). Conclusion: Among ACS patients who underwent PCI, LD patients had significantly worse in-hospital outcomes compared with RD patients, and LD anatomy was an independent predictor of in-hospital mortality.	[Kuno, Toshiki; Numasawa, Yohei; Takahashi, Toshiyuki] Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga Shi, Tochigi, Japan; [Miyata, Hiroaki] Univ Tokyo, Tokyo, Japan; [Sueyoshi, Koichiro] Kawasaki City Municipal Hosp, Dept Cardiol, Kawasaki, Kanagawa, Japan; [Ohki, Takahiro] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Cardiol, Chiba, Japan; [Negishi, Koji] Yokohama Municipal Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kawamura, Akio; Kohsaka, Shun; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan	University of Tokyo; Tokyo Dental College; Keio University	Kuno, T (corresponding author), Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga Shi, Tochigi, Japan.	kuno-toshiki@hotmail.co.jp	Kuno, Toshiki/E-5619-2018; Fukuda, Keiichi/L-3777-2013; Numasawa, Yohei/AAC-9604-2020; Kohsaka, Shun/L-8695-2013	Kuno, Toshiki/0000-0002-2487-8366; Numasawa, Yohei/0000-0002-1739-2800; Kohsaka, Shun/0000-0003-3779-2972				Anderson HV, 2007, AM J CARDIOL, V99, P189, DOI 10.1016/j.amjcard.2006.07.083; Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Arai T, 2012, HEART VESSELS; Auriti A, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-34; Bazzocchi G, 2011, RADIOL MED, V116, P675, DOI 10.1007/s11547-011-0627-3; Chen YL, 2011, CLIN CARDIOL, V34, P249, DOI 10.1002/clc.20844; Eren S, 2008, J COMPUT ASSIST TOMO, V32, P929, DOI 10.1097/RCT.0b013e3181593d5b; Goldberg A, 2007, AM HEART J, V154, P1116, DOI 10.1016/j.ahj.2007.07.041; Gorlin R, 1976, Major Probl Intern Med, V11, P40; Goto M, 2011, J CARDIOVASC SURG, V52, P863; Kim SS, 2011, J CARDIOL, V57, P290, DOI 10.1016/j.jjcc.2011.01.014; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Mogi S, 2011, INT J CARDIOL, V153, P85, DOI 10.1016/j.ijcard.2011.08.075; Numasawa Y, 2013, CARDIOVAS INTERV THE; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P148, DOI 10.1007/s12928-012-0138-8; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; Ong P, 2011, J AM COLL CARDIOL, V57, P147, DOI 10.1016/j.jacc.2010.08.626; Pierrakos CN, 2011, ARTIF ORGANS, V35, P867, DOI 10.1111/j.1525-1594.2011.01241.x; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; SMITH RL, 1972, J APPL PHYSIOL, V32, P261, DOI 10.1152/jappl.1972.32.2.261; Stribling WK, 2011, J INTERV CARDIOL, V24, P27, DOI 10.1111/j.1540-8183.2010.00599.x; Vasheghani-Farahani A, 2008, CLIN ANAT, V21, P519, DOI 10.1002/ca.20669; Veltman CE, 2012, EUR HEART J, V33, P1367, DOI 10.1093/eurheartj/ehs034; Yip HK, 2002, CHEST, V122, P2068, DOI 10.1378/chest.122.6.2068; YU SK, 1979, THROMB HAEMOSTASIS, V40, P551	25	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72672	10.1371/journal.pone.0072672	http://dx.doi.org/10.1371/journal.pone.0072672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991136	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800082
J	Tavazoie, S				Tavazoie, Saeed			Synaptic State Matching: A Dynamical Architecture for Predictive Internal Representation and Feature Detection	PLOS ONE			English	Article							NEURAL-NETWORKS; IN-VIVO; PLASTICITY; OSCILLATIONS; NEURONS; SYSTEMS; CORTEX; SLEEP; INHIBITION; RHYTHM	Here we explore the possibility that a core function of sensory cortex is the generation of an internal simulation of sensory environment in real-time. A logical elaboration of this idea leads to a dynamical neural architecture that oscillates between two fundamental network states, one driven by external input, and the other by recurrent synaptic drive in the absence of sensory input. Synaptic strength is modified by a proposed synaptic state matching (SSM) process that ensures equivalence of spike statistics between the two network states. Remarkably, SSM, operating locally at individual synapses, generates accurate and stable network-level predictive internal representations, enabling pattern completion and unsupervised feature detection from noisy sensory input. SSM is a biologically plausible substrate for learning and memory because it brings together sequence learning, feature detection, synaptic homeostasis, and network oscillations under a single unifying computational framework.	Columbia Univ, Dept Biochem & Mol Biophys, Dept Syst Biol, New York, NY 10027 USA	Columbia University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Dept Syst Biol, New York, NY 10027 USA.	st2744@columbia.edu			NIH Director's Pioneer Award [5DP1OD003787]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003787] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH Director's Pioneer Award (5DP1OD003787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Berg HC, 2004, E COLI MOTION, Vxi, P131; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HAWKINS JBS, 2004, INTELLIGENCE TIMES B, P261; Hebb DO, 1949, ORG BEHAV NEUROPSYCH, Vxix; Hinton G. E., 1986, PARALLEL DISTRIBUTED, V1, DOI DOI 10.1234/12345678; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Klopf AH, 1982, HEDONISTIC NEURON TH, Vxvii; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009	33	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72865	10.1371/journal.pone.0072865	http://dx.doi.org/10.1371/journal.pone.0072865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991161	Green Published, Green Submitted, gold			2022-12-25	WOS:000324228800089
J	Marques, TEBS; de Mendonca, LR; Pereira, MG; de Andrade, TG; Garcia-Cairasco, N; Paco-Larson, ML; Gitai, DLG				Batista Sales Marques, Thalita Ewellyn; de Mendonca, Leila Rodrigues; Pereira, Marilia Gabriela; de Andrade, Tiago Gomes; Garcia-Cairasco, Norberto; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Validation of Suitable Reference Genes for Expression Studies in Different Pilocarpine-Induced Models of Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; TIME QUANTITATIVE PCR; REAL-TIME; RT-PCR; MESSENGER-RNA; HOUSEKEEPING GENES; CHRONIC PHASE; SEIZURES; EPILEPTOGENESIS; QUANTIFICATION	It is well recognized that the reference gene in a RT-qPCR should be properly validated to ensure that gene expression is unaffected by the experimental condition. We investigated eight potential reference genes in two different pilocarpine PILO-models of mesial temporal lobe epilepsy (MTLE) performing a stability expression analysis using geNorm, NormFinder and BestKepeer softwares. Then, as a validation strategy, we conducted a relative expression analysis of the Gfap gene. Our results indicate that in the systemic PILO-model Actb, Gapdh, Rplp1, Tubb2a and Polr1a mRNAs were highly stable in hippocampus of rats from all experimental and control groups, whereas Gusb revealed to be the most variable one. In fact, we observed that using Gusb for normalization, the relative mRNA levels of the Gfap gene differed from those obtained with stable genes. On the contrary, in the intrahippocampal PILO-model, all softwares included Gusb as a stable gene, whereas B2m was indicated as the worst candidate gene. The results obtained for the other reference genes were comparable to those observed for the systemic Pilo-model. The validation of these data by the analysis of the relative expression of Gfap showed that the upregulation of the Gfap gene in the hippocampus of rats sacrificed 24 hours after status epilepticus (SE) was undetected only when B2m was used as the normalizer. These findings emphasize that a gene that is stable in one pathology model may not be stable in a different experimental condition related to the same pathology and therefore, the choice of reference genes depends on study design.	[Batista Sales Marques, Thalita Ewellyn; de Mendonca, Leila Rodrigues; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Mol Cell Biol, Maceio, AL, Brazil; [Pereira, Marilia Gabriela; Garcia-Cairasco, Norberto] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Sch Med, Sao Paulo, Brazil; [de Andrade, Tiago Gomes] Univ Fed Alagoas, Maceio, AL, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Dept Cellular & Mol Biol, Ribeirao Preto Sch Med, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Mol Cell Biol, Maceio, AL, Brazil.	danielgitai@gmail.com.br	Pereira, Marilia GAG/H-4797-2013; de Andrade, Tiago/I-3522-2013; Gitai, Daniel LG/A-7982-2019; Cairasco, Norberto Garcia/E-3250-2015; De Andrade, Tiago G/I-5572-2015; Paço-Larson, Maria L/I-8613-2012	Gitai, Daniel LG/0000-0001-7056-2373; Cairasco, Norberto Garcia/0000-0001-8857-3775; De Andrade, Tiago G/0000-0003-0948-6329; 	Brazilian Agency FAPESP [2007/50261-4]; Brazilian Agency FAEPA-HCRP; FAPEAL; CNPq	Brazilian Agency FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Agency FAEPA-HCRP; FAPEAL(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the Brazilian Agencies FAPESP grant #2007/50261-4 (http://www.fapesp.br/) and FAEPA-HCRP (http://www.faepa.br/). TEBSM received fellowships from FAPEAL. LRM received fellowships from CNPq. TGA, NGC and MLPL are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Castro OW, 2011, BRAIN RES, V1374, P43, DOI 10.1016/j.brainres.2010.12.012; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; Cordoba EM, 2011, ANAL BIOCHEM, V409, P236, DOI 10.1016/j.ab.2010.10.031; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Erickson HS, 2007, LAB INVEST, V87, P951, DOI 10.1038/labinvest.3700659; Ermolinsky B, 2008, BRAIN RES, V1226, P173, DOI 10.1016/j.brainres.2008.05.073; Fellin T, 2005, TRENDS MOL MED, V11, P530, DOI 10.1016/j.molmed.2005.10.007; Garzillo CL, 2002, EPILEPSIA, V43, P107, DOI 10.1046/j.1528-1157.43.s.5.40.x; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; Holmberg KH, 2006, BRAIN RES, V1075, P26, DOI 10.1016/j.brainres.2005.12.103; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Li Guo-liang, 2003, Hunan Yike Daxue Xuebao, V28, P29; Li YQ, 2009, NEUROL RES, V31, P1108, DOI 10.1179/174313209X389839; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maurer-Morelli CV, 2012, J NEUROSCI METH, V208, P44, DOI 10.1016/j.jneumeth.2012.04.020; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PINEL JPJ, 1978, EXP NEUROL, V58, P335, DOI 10.1016/0014-4886(78)90145-0; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Romcy-Pereira RN, 2008, REV ASSOC MED BRAS, V54, P461; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STEWARD O, 1990, J NEUROSCI, V10, P2373; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Torres E, 1992, BRAIN RES, V631, P256; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YY, 2010, BRAIN PATHOL, V20, P1, DOI 10.1111/j.1750-3639.2008.00254.x; Wierschke S, 2010, BIOCHEM BIOPH RES CO, V403, P385, DOI 10.1016/j.bbrc.2010.10.138; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1	44	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71892	10.1371/journal.pone.0071892	http://dx.doi.org/10.1371/journal.pone.0071892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009668	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200015
J	Francis, JH; Gobin, YP; Dunkel, IJ; Marr, BP; Brodie, SE; Jonna, G; Abramson, DH				Francis, Jasmine H.; Gobin, Y. Pierre; Dunkel, Ira J.; Marr, Brian P.; Brodie, Scott E.; Jonna, Gowtham; Abramson, David H.			Carboplatin +/- Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma	PLOS ONE			English	Article							SUBCONJUNCTIVAL CARBOPLATIN; INTRAARTERIAL CHEMOTHERAPY; BILATERAL RETINOBLASTOMA; RETINAL FUNCTION; PHASE-I/II; OTOTOXICITY; MANAGEMENT; INJECTION; SURVIVORS; THERAPY	Purpose: Carboplatin administered systemically or periocularly can result in dramatic and prompt regression of retinoblastoma. However, both routes are rarely curative alone and have undesirable side effects. We aimed to assess the efficacy and toxicity of carboplatin +/- topotecan delivered by ophthalmic artery chemosurgery whereby chemotherapy is infused into the eye via the ophthalmic artery. Methods: This retrospective, IRB-approved study investigated retinoblastoma patients whom received carboplatin +/- topotecan ophthalmic artery chemosurgery. Patient survival, ocular survival, hematologic toxicity, ocular toxicity, second cancer development and electroretinogram response were all evaluated. Results: 57 carboplatin +/- topotecan infusions (of 111 total) were performed in 31 eyes of 24 patients. The remaining infusions were melphalan-containing. All patients were alive and no patient developed a second malignancy at a median follow up of 25 months. The Kaplan-Meier estimate of ocular survival at two years was 89.9% (95% confidence interval [CI], 82.1-97.9%) for all eyes. Grade 3 or 4 neutropenia developed in two patients and one patient developed metastatic disease. By univariate analysis, neither increasing maximum carboplatin/ topotecan dose nor cumulative carboplatin/ topotecan dose was associated with statistically significant reduction in the electroretinogram responses. Conclusion: Carboplatin +/- topotecan infusions are effective for ophthalmic artery chemosurgery in retinoblastoma: they demonstrate low hematologic and ocular toxicity and no statistically significant influence on electroretinogram responses, and used in conjunction with melphalan-containing OAC, demonstrate excellent patient survival and satisfactory ocular survival.	[Francis, Jasmine H.; Marr, Brian P.; Brodie, Scott E.; Jonna, Gowtham; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurosurg Neurol, Serv Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Marr, Brian P.; Abramson, David H.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai	Francis, JH (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	francij1@mskcc.org		Brodie, Scott/0000-0002-3303-4552; Dunkel, Ira/0000-0001-8091-6067; Francis, Jasmine/0000-0002-7637-3108	Fund for Ophthalmic Knowledge; New York Community Trust	Fund for Ophthalmic Knowledge; New York Community Trust	This work was supported by The Fund for Ophthalmic Knowledge and The New York Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4; Abramson DH, 2005, BRIT J OPHTHALMOL, V89, P1616, DOI 10.1136/bjo.2005.072033; ABRAMSON DH, 1976, T AM ACAD OPHTHALMOL, V81, pP454; Benz MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P577; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Calvaruso G, 2001, INT J ONCOL, V18, P1233; Chantada Guillermo L, 2004, Ophthalmic Genet, V25, P37, DOI 10.1076/opge.25.1.37.28996; DOZ F, 1995, J CLIN ONCOL, V13, P902, DOI 10.1200/JCO.1995.13.4.902; Dunkel IJ, 2007, PEDIATR BLOOD CANCER, V49, P643, DOI 10.1002/pbc.21163; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; Francis JH, 2012, ARCH OPHTHALMOL-CHIC, V130, P1605, DOI 10.1001/archophthalmol.2012.2284; FRANCIS JH, 2012, BR J OPHTHALMOL; Gallie BL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1321, DOI 10.1001/archopht.1996.01100140521001; Gobin YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044322; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2006, BRIT J OPHTHALMOL, V90, P1168, DOI 10.1136/bjo.2006.091223; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Graeber CP, 2011, OPEN OPHTHALMOL J, V5, P1, DOI 10.2174/1874364101105010001; Harbour JW, 1996, INVEST OPHTH VIS SCI, V37, P1892; INOMATA M, 1987, JPN J CANCER RES, V78, P858; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kim Jeong Hun, 2003, Korean J Ophthalmol, V17, P35; KLUFAS MA, 2012, AJNR AM J NEURORADIO; KUPFER C, 1953, AM J OPHTHALMOL, V36, P1721, DOI 10.1016/0002-9394(53)90009-9; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Marees T, 2008, J NATL CANCER I, V100, P1771, DOI 10.1093/jnci/djn394; MARR BP, 2012, BR J OPHTHALMOL; Marr B, 2010, MIDDLE EAST AFR J OP, V17, P207, DOI 10.4103/0974-9233.65492; Mendelsohn ME, 1998, ARCH OPHTHALMOL-CHIC, V116, P1209, DOI 10.1001/archopht.116.9.1209; Mulvihill A, 2003, ARCH OPHTHALMOL-CHIC, V121, P1120, DOI 10.1001/archopht.121.8.1120; Murphree AL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1348, DOI 10.1001/archopht.1996.01100140548005; PALIOURA S, 2012, PEDIAT BLOOD CANC; Pardue MT, 2004, RETINA-J RET VIT DIS, V24, P776, DOI 10.1097/00006982-200410000-00015; Liberman PHP, 2011, CLIN TRANSL ONCOL, V13, P348, DOI 10.1007/s12094-011-0665-2; PRATT CB, 1994, J CLIN ONCOL, V12, P539, DOI 10.1200/JCO.1994.12.3.539; Qaddoumi I, 2012, J CLIN ONCOL, V30, P1034, DOI 10.1200/JCO.2011.36.9744; REESE AB, 1954, AMA ARCH OPHTHALMOL, V153, P505; Schaiquevich P, 2012, INVEST OPHTH VIS SCI, V53, P4205, DOI 10.1167/iovs.12-9501; Schefler AC, 2008, CURR OPIN OPHTHALMOL, V19, P526, DOI 10.1097/ICU.0b013e328312975b; Schmack I, 2006, AM J OPHTHALMOL, V142, P310, DOI 10.1016/j.ajo.2006.02.044; Shearer P, 2009, PEDIATR BLOOD CANCER, V53, P517, DOI 10.1002/pbc.22095; Shields CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1330, DOI 10.1001/archopht.1996.01100140530002; STEWART DJ, 1992, NEUROSURGERY, V30, P512; Suzuki Shigenobu, 2004, Int J Clin Oncol, V9, P1, DOI 10.1007/s10147-003-0366-0; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060; Wilson MW, 2001, OPHTHALMOLOGY, V108, P2106, DOI 10.1016/S0161-6420(01)00805-3; Yamane Takashi, 2004, Int J Clin Oncol, V9, P69, DOI 10.1007/s10147-004-0392-6; ZLIOBA A, 1988, ANN OPHTHALMOL, V20, P71	53	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72441	10.1371/journal.pone.0072441	http://dx.doi.org/10.1371/journal.pone.0072441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991112	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100103
J	Saravanan, S; Geurden, I; Figueiredo-Silva, AC; Nusantoro, S; Kaushik, S; Verreth, J; Schrama, JW				Saravanan, Subramanian; Geurden, Inge; Figueiredo-Silva, A. Claudia; Nusantoro, Suluh; Kaushik, Sadasivam; Verreth, Johan; Schrama, Johan W.			Oxygen Consumption Constrains Food Intake in Fish Fed Diets Varying in Essential Amino Acid Composition	PLOS ONE			English	Article							RAINBOW-TROUT; DISSOLVED-OXYGEN; FEED-INTAKE; ONCORHYNCHUS-MYKISS; SELF-SELECTION; NILE TILAPIA; PROTEIN; GROWTH; REQUIREMENTS; METHIONINE	Compromisation of food intake when confronted with diets deficient in essential amino acids is a common response of fish and other animals, but the underlying physiological factors are poorly understood. We hypothesize that oxygen consumption of fish is a possible physiological factor constraining food intake. To verify, we assessed the food intake and oxygen consumption of rainbow trout fed to satiation with diets which differed in essential amino acid (methionine and lysine) compositions: a balanced vs. an imbalanced amino acid diet. Both diets were tested at two water oxygen levels: hypoxia vs. normoxia. Trout consumed 29% less food under hypoxia compared to normoxia (p < 0.001). Under both hypoxia and normoxia trout significantly reduced food intake by 11% and 16% respectively when fed the imbalanced compared to the balanced amino acid diet. Oxygen consumption of the trout per unit body mass remained identical for both diet groups not only under hypoxia but also under normoxia (p > 0.05). This difference in food intake between diets under normoxia together with the identical oxygen consumption supports the hypothesis that food intake in fish can be constrained by a set-point value of oxygen consumption, as seen here on a six-week time scale.	[Saravanan, Subramanian; Nusantoro, Suluh; Verreth, Johan; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen Inst Anim Sci, NL-6700 AP Wageningen, Netherlands; [Saravanan, Subramanian; Geurden, Inge; Figueiredo-Silva, A. Claudia; Kaushik, Sadasivam] Pole Hydrobiol INRA, INRA, UR 1067, Nutr Metab & Aquaculture NuMeA, St Pee Sur Nivelle, France	Wageningen University & Research; INRAE; Universite de Pau et des Pays de l'Adour	Schrama, JW (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen Inst Anim Sci, NL-6700 AP Wageningen, Netherlands.	johan.schrama@wur.nl	Verreth, Johan/ABD-7198-2020; Nusantoro, Suluh/AAE-3386-2021; Kaushik, Sadasivam J/B-9824-2009	Verreth, Johan/0000-0001-7277-5129; Kaushik, Sadasivam J/0000-0001-7856-8374; Nusantoro, Suluh/0000-0002-8789-497X; Schrama, Johan/0000-0001-7156-8806	NWO, The Netherlands [805-34.025]; Wageningen University	NWO, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Wageningen University(European Commission)	This work was carried out in the aquatic metabolic unit co-funded by NWO (code 805-34.025; Den Haag, The Netherlands). This study was funded by Wageningen University and performed in the framework of collaborative INRA-WUR Platform for Sustainable Aquaculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GH, 1979, CAN J PHYSIOL PHARM, V57, P1043, DOI 10.1139/y79-158; [Anonymous], 2003, AMINO ACIDS ANIMAL N; [Anonymous], 1995, AQUACULTURE RES; Buentello JA, 2000, AQUACULTURE, V182, P339, DOI 10.1016/S0044-8486(99)00274-4; DAVIS JC, 1975, J FISH RES BOARD CAN, V32, P2295, DOI 10.1139/f75-268; de la Higuera M, 2000, FOOD INTAKE IN FISH, P250; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Elango R, 2008, J NUTR, V138, P243, DOI 10.1093/jn/138.2.243; Evans DO, 2007, CAN J FISH AQUAT SCI, V64, P345, DOI 10.1139/F07-007; FLETCHER DJ, 1984, COMP BIOCHEM PHYS A, V78, P617, DOI 10.1016/0300-9629(84)90608-X; Fortes-Silva R, 2012, PHYSIOL BEHAV, V105, P639, DOI 10.1016/j.physbeh.2011.09.023; Gietzen DW, 2007, ANNU REV NUTR, V27, P63, DOI 10.1146/annurev.nutr.27.061406.093726; Glencross BD, 2009, AQUACULT NUTR, V15, P1, DOI 10.1111/j.1365-2095.2007.00562.x; Illius AW, 2002, P NUTR SOC, V61, P465, DOI 10.1079/PNS2002179; Kaczanowski TC, 1996, FISH PHYSIOL BIOCHEM, V15, P105, DOI 10.1007/BF01875590; KAUSHIK SJ, 1980, REPROD NUTR DEV, V20, P1751, DOI 10.1051/rnd:19801002; Ketelaars JJMH, 1996, J ANIM SCI, V74, P3036; KIM KI, 1992, AQUACULTURE, V101, P95, DOI 10.1016/0044-8486(92)90235-D; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; KROM MD, 1980, ANALYST, V105, P305, DOI 10.1039/an9800500305; Mallekh R, 2002, J FISH BIOL, V60, P1105, DOI 10.1111/j.1095-8649.2002.tb01707.x; MELLINKOFF SM, 1956, J APPL PHYSIOL, V8, P535, DOI 10.1152/jappl.1956.8.5.535; MOORE S, 1951, J BIOL CHEM, V192, P663; NODA K, 1976, AM J PHYSIOL, V231, P1263, DOI 10.1152/ajplegacy.1976.231.4.1263; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; PEDERSEN CL, 1987, AQUACULTURE, V62, P289, DOI 10.1016/0044-8486(87)90171-2; PETERS JC, 1985, J NUTR, V115, P382, DOI 10.1093/jn/115.3.382; Pichavant K, 2001, J FISH BIOL, V59, P875, DOI [10.1006/jfbi.2001.1702, 10.1111/j.1095-8649.2001.tb00158.x]; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; Rodehutscord M, 1997, J NUTR, V127, P1166, DOI 10.1093/jn/127.6.1166; RUMSEY GL, 1983, PROG FISH CULT, V45, P139, DOI 10.1577/1548-8659(1983)45[139:MACROR]2.0.CO;2; Saravanan S, 2012, BRIT J NUTR, V108, P1519, DOI 10.1017/S0007114511006842; Thetmeyer H, 1999, AQUACULTURE, V174, P355, DOI 10.1016/S0044-8486(99)00028-9; Tran-Duy A, 2008, AQUACULTURE, V275, P152, DOI 10.1016/j.aquaculture.2007.12.024; WALTON MJ, 1984, BRIT J NUTR, V52, P115, DOI 10.1079/BJN19840077; Yamamoto T, 2001, AQUAC RES, V32, P83, DOI 10.1046/j.1355-557x.2001.00007.x	36	22	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72757	10.1371/journal.pone.0072757	http://dx.doi.org/10.1371/journal.pone.0072757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991148	Green Published, gold, Green Submitted			2022-12-25	WOS:000324470100115
J	Takagi, S; Sato, S; Oh-hara, T; Takami, M; Koike, S; Mishima, Y; Hatake, K; Fujita, N				Takagi, Satoshi; Sato, Shigeo; Oh-hara, Tomoko; Takami, Miho; Koike, Sumie; Mishima, Yuji; Hatake, Kiyohiko; Fujita, Naoya			Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2	PLOS ONE			English	Article							AGGREGATION-INDUCING FACTOR; MOLECULAR-WEIGHT HEPARIN; IN-VIVO ROLES; RECEPTOR CLEC-2; PODOPLANIN; LUNG; ACTIVATION; SURVIVAL; CELLS; EXPRESSION	The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently upregulated in several types of tumors and enhances hematogenous metastasis by interacting with and activating the platelet receptor CLEC-2. Thus, Aggrus-CLEC-2 binding could be a therapeutic molecular mechanism for cancer therapy. We generated a new anti-human Aggrus monoclonal antibody, MS-1, that suppressed Aggrus-CLEC-2 binding, Aggrus-induced platelet aggregation, and Aggrus-mediated tumor metastasis. Interestingly, the MS-1 monoclonal antibody attenuated the growth of Aggrus-positive tumors in vivo. Moreover, the humanized chimeric MS-1 antibody, ChMS-1, also exhibited strong antitumor activity against Aggrus-positive lung squamous cell carcinoma xenografted into NOD-SCID mice compromising antibody-dependent cellular cytotoxic and complement-dependent cytotoxic activities. Because Aggrus knockdown suppressed platelet-induced proliferation in vitro and tumor growth of the lung squamous cell carcinoma in vivo, Aggrus may be involved in not only tumor metastasis but also tumor growth by promoting platelet-tumor interaction, platelet activation, and secretion of platelet-derived factors in vivo. Our results indicate that molecular target drugs inhibiting specific platelet-tumor interactions can be developed as antitumor drugs that suppress both metastasis and proliferation of tumors such as lung squamous cell carcinoma.	[Takagi, Satoshi; Sato, Shigeo; Oh-hara, Tomoko; Takami, Miho; Koike, Sumie; Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Expt Chemotherapy, Tokyo 170, Japan; [Mishima, Yuji; Hatake, Kiyohiko] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Clin Chemotherapy, Tokyo 170, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Fujita, N (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Expt Chemotherapy, Tokyo 170, Japan.	naoya.fujita@jfcr.or.jp			National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25830125] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO) (to NF), by a Grant-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to NF), and by a Grant-in-Aid for Young Scientists (B) (to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Atsumi N, 2008, BIOCHEM BIOPH RES CO, V373, P36, DOI 10.1016/j.bbrc.2008.05.163; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bobek V, 2004, BIOMED PHARMACOTHER, V58, P213, DOI 10.1016/j.biopha.2003.11.007; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Cueni LN, 2010, BLOOD, V116, P4376, DOI 10.1182/blood-2010-04-278564; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Fujita N, 2012, J BIOCHEM, V152, P407, DOI 10.1093/jb/mvs108; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Ho-Tin-Noe B, 2009, CANCER RES, V69, P5623, DOI 10.1158/0008-5472.CAN-09-1370; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kaneko MK, 2012, CANCER SCI, V103, P1913, DOI 10.1111/j.1349-7006.2012.02385.x; Karpatkin S, 1981, Ann N Y Acad Sci, V370, P101, DOI 10.1111/j.1749-6632.1981.tb29726.x; Kato Y, 2005, TUMOR BIOL, V26, P195, DOI 10.1159/000086952; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2006, BIOCHEM BIOPH RES CO, V349, P1301, DOI 10.1016/j.bbrc.2006.08.171; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Lazo-Langner A, 2007, J THROMB HAEMOST, V5, P729, DOI 10.1111/j.1538-7836.2007.02427.x; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; Nakazawa Y, 2011, CANCER SCI, V102, P2051, DOI 10.1111/j.1349-7006.2011.02058.x; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Shimada Y, 2009, CANCER SCI, V100, P2054, DOI 10.1111/j.1349-7006.2009.01295.x; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199	35	127	147	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73609	10.1371/journal.pone.0073609	http://dx.doi.org/10.1371/journal.pone.0073609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991201	Green Published, Green Submitted, gold			2022-12-25	WOS:000324470100130
J	Singh, RR; Lankadeva, YR; Denton, KM; Moritz, KM				Singh, Reetu R.; Lankadeva, Yugeesh R.; Denton, Kate M.; Moritz, Karen M.			Improvement in Renal Hemodynamics following Combined Angiotensin II Infusion and AT1R Blockade in Aged Female Sheep following Fetal Unilateral Nephrectomy	PLOS ONE			English	Article							LOW-PROTEIN DIET; REDUCED NEPHRON NUMBER; LIVING KIDNEY DONORS; BLOOD-PRESSURE; ADULT SHEEP; PRENATAL EXPOSURE; GLUCOCORTICOID TREATMENT; ANTENATAL BETAMETHASONE; CARDIOVASCULAR-DISEASE; ARTERIAL-PRESSURE	Renin-angiotensin system (RAS) is a powerful modulator of renal hemodynamic and fluid homeostasis. Up-regulation in components of intra-renal RAS occurs with ageing. Recently we reported that 2 year old uninephrectomised (uni-x) female sheep have low renin hypertension and reduced renal function. By 5 years of age, these uni-x sheep had augmented decrease in renal blood flow (RBF) compared to sham. We hypothesised that this decrease in RBF in 5 year old uni-x sheep was due to an up-regulation in components of the intra-renal RAS. In this study, renal responses to angiotensin II (AngII) infusion and AngII type 1 receptor (AT1R) blockade were examined in the same 5 year old sheep. We also administered AngII in the presence of losartan to increase AngII bioavailability to the AT2R in order to understand AT2R contribution to renal function in this model. Uni-x animals had significantly lower renal cortical content of renin, AngII (similar to 40%) and Ang 1-7 (similar to 60%) and reduced cortical expression of AT1R gene than sham animals. In response to both AngII infusion and AT1R blockade via losartan, renal hemodynamic responses and tubular sodium excretion were significantly attenuated in uni-x animals compared to sham. However, AngII infusion in the presence of losartan caused similar to 33% increase in RBF in uni-x sheep compared to similar to 14% in sham (P<0.05). This was associated with a significant decrease in renal vascular resistance in the uni-x animals (22% vs 15%, P<0.05) without any changes in systemic blood pressure. The present study shows that majority of the intra-renal RAS components are suppressed in this model of low renin hypertension. However, increasing the availability of AngII to AT2R by AT1R blockade improved renal blood flow in uni-x sheep. This suggests that manipulation of the AT2R maybe a potential therapeutic target for treatment of renal dysfunction associated with a congenital nephron deficit.	[Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Singh, Reetu R.; Lankadeva, Yugeesh R.; Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Singh, Reetu R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Queensland; Monash University; Monash University	Singh, RR (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	Reetu.Singh@monash.edu	Moritz, Karen/G-2508-2015; Lankadeva, Yugeesh/R-9253-2019; Denton, Kate/AAG-2423-2019	Moritz, Karen/0000-0002-8085-0034; Lankadeva, Yugeesh/0000-0002-3589-9111; RAMAKRISHNA, RACHUMALLU/0000-0002-8112-2450; singh, RAJBIR/0000-0002-2307-2360; Denton, Kate/0000-0002-5929-4387	Monash University Bridging Post-Doctoral Fellowship; Faculty Scholarship, Monash University; NH&MRC Senior Research Fellowships; National Heart Foundation; Monash University Strategic Grant Scheme	Monash University Bridging Post-Doctoral Fellowship; Faculty Scholarship, Monash University; NH&MRC Senior Research Fellowships; National Heart Foundation(National Heart Foundation of Australia); Monash University Strategic Grant Scheme(Monash University)	R.R.S was supported by a Monash University Bridging Post-Doctoral Fellowship. Y.R.L was supported by a Faculty Scholarship, Monash University. K. M. M and K. M. D were supported by NH&MRC Senior Research Fellowships. The project was funded by the National Heart Foundation and Monash University Strategic Grant Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J PHYSIOL-RENAL, V283, pF236, DOI 10.1152/ajprenal.00336.2001; Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160; Brenner BM, 1997, KIDNEY INT, pS124; Bucher BS, 2012, THER UMSCH, V69, P295, DOI 10.1024/0040-5930/a000288; Dodic M, 2006, J PHYSIOL-LONDON, V571, P651, DOI 10.1113/jphysiol.2005.102186; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Dodic M, 1999, CLIN EXP PHARMACOL P, V26, P550, DOI 10.1046/j.1440-1681.1999.03076.x; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; Fehrman-Ekholm I, 2001, TRANSPLANTATION, V72, P444, DOI 10.1097/00007890-200108150-00015; Ferrario CM, 1998, AM J HYPERTENS, V11, P137, DOI 10.1016/S0895-7061(97)00400-7; Gossmann J, 2005, AM J TRANSPLANT, V5, P2417, DOI 10.1111/j.1600-6143.2005.01037.x; Herrera M, 2013, HYPERTENSION, V61; Hilliard LM, 2012, HYPERTENSION, V59, P409, DOI 10.1161/HYPERTENSIONAHA.111.184986; Hilliard LM, 2011, HYPERTENSION, V58, pE94; Hilliard LM, 2011, HYPERTENSION, V57, P275, DOI 10.1161/HYPERTENSIONAHA.110.166827; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; Ibrahim HN, 1998, J AM SOC NEPHROL, V9, P72; Joly E, 2006, AM J PHYSIOL-REG I, V291, pR977, DOI 10.1152/ajpregu.00401.2005; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lankadeva YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047528; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; McInnes GT, 1999, J CARDIOVASC PHARM, V33, pS29, DOI 10.1097/00005344-199900001-00006; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; Miller JA, 2006, J AM SOC NEPHROL, V17, P2554, DOI 10.1681/ASN.2005101095; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Moritz KM, 2002, ENDOCRINOLOGY, V143, P4455, DOI 10.1210/en.2002-220534; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Moritz KM, 1999, PEDIATR NEPHROL, V13, P171, DOI 10.1007/s004670050587; Navar LG, 2004, KIDNEY INT, V65, P1522, DOI 10.1111/j.1523-1755.2004.00539.x; Sahajpal V, 2005, J PHYSIOL-LONDON, V563, P193, DOI 10.1113/jphysiol.2004.078642; Salazar F, 2008, HYPERTENSION, V51, P1184, DOI 10.1161/HYPERTENSIONAHA.107.100750; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Schreuder MF, 2008, J PAEDIATR CHILD H, V44, P363, DOI 10.1111/j.1440-1754.2008.01315.x; Schulman IH, 2010, AM J NEPHROL, V32, P249, DOI 10.1159/000318607; Shaltout HA, 2010, AM J PHYSIOL-HEART C, V299, pH541, DOI 10.1152/ajpheart.00100.2010; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Singh RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042400; Singh RR, 2012, AM J PHYSIOL-REG I, V302, pR868, DOI 10.1152/ajpregu.00579.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF1168, DOI 10.1152/ajprenal.00463.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF319, DOI 10.1152/ajprenal.00139.2011; Singh RR, 2009, J HYPERTENS, V27, P386, DOI 10.1097/HJH.0b013e32831bc778; Steckelings UM, 2012, CURR OPIN NEPHROL HY, V21, P142, DOI 10.1097/MNH.0b013e328350261b; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; Westland R, PEDIATRICS, V131, pe478; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Yanes LL, 2006, AM J PHYSIOL-REG I, V291, pR383, DOI 10.1152/ajpregu.00510.2005; Zhang J, 2010, REPROD SCI, V17, P186, DOI 10.1177/1933719109351098	53	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68036	10.1371/journal.pone.0068036	http://dx.doi.org/10.1371/journal.pone.0068036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840884	Green Published, Green Submitted, gold			2022-12-25	WOS:000321271900023
J	Yang, JK; Liu, LY; Dai, JH; Li, Q				Yang, Jiang-Ke; Liu, Li-Ying; Dai, Jiang-Hong; Li, Qin			de novo Design and Synthesis of Candida antarctica Lipase B Gene and alpha-Factor Leads to High-Level Expression in Pichia pastoris	PLOS ONE			English	Article							WHOLE-CELL BIOCATALYST; CODON OPTIMIZATION; ESCHERICHIA-COLI; PROTEIN	Candida antarctica lipase B (CALB) is one of the most widely used and studied enzymes in the world. In order to achieve the high-level expression of CALB in Pichia, we optimized the codons of CALB gene and alpha-factor by using a de novo design and synthesis strategy. Through comparative analysis of a series of recombinants with different expression components, we found that the methanol-inducible expression recombinant carrying the codon-optimized alpha-factor and mature CALB gene (pPIC9K alpha M-CalBM) has the highest lipase production capacity. After fermentation parameters optimization, the lipase activity and protein content of the recombinant pPIC9K alpha M-CalBM reached 6,100 U/mL and 3.0 g/L, respectively, in a 5-L fermentor. We believe this strategy could be of special interest due to its capacity to improve the expression level of target gene, and the Pichia transformants carrying the codon-optimized gene had great potential for the industrial-scale production of CALB lipase.	[Yang, Jiang-Ke; Dai, Jiang-Hong; Li, Qin] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Liu, Li-Ying] Huazhong Univ Sci & Technol, Sch Life Sci, Wuhan 430074, Hubei, Peoples R China	Wuhan Polytechnic University; Huazhong University of Science & Technology	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China.	jiangke.yang@gmail.com	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Li, Hong Tao/0000-0002-1290-0917	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education [212118]	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education(Ministry of Education, China)	This work was financially supported by Human Recourse Foundation of Wuhan Polytechnic University and the Key Project of Chinese Ministry of Education (No. 212118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcapinar GB, 2011, BIOTECHNOL PROGR, V27, P1257, DOI 10.1002/btpr.663; Anderson EM, 1998, BIOCATAL BIOTRANSFOR, V16, P181, DOI 10.3109/10242429809003198; Andrade LH, 2009, ORG LETT, V11, P3052, DOI 10.1021/ol901091f; Blank K, 2006, J BIOTECHNOL, V125, P474, DOI 10.1016/j.jbiotec.2006.04.004; Budisa N, 2010, MOL BIOSYST, V6, P1630, DOI 10.1039/c002256j; Chang SW, 2011, J AGR FOOD CHEM, V59, P6710, DOI 10.1021/jf200537w; Benaiges MD, 2010, BIOTECHNOL PROGR, V26, P1252, DOI 10.1002/btpr.444; Fernandez L, 2006, PROTEIN EXPRES PURIF, V49, P256, DOI 10.1016/j.pep.2006.06.015; HOEGH I, 1995, CAN J BOT, V73, pS869; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jahic M, 2003, J BIOTECHNOL, V102, P45, DOI 10.1016/S0168-1656(03)00003-8; Jahic M, 2002, BIOPROC BIOSYST ENG, V24, P385, DOI 10.1007/s00449-001-0274-5; Jung SY, 2008, BIOTECHNOL LETT, V30, P717, DOI 10.1007/s10529-007-9591-3; Kittl R, 2012, BIOENGINEERED, V3, P232, DOI 10.4161/bioe.20037; Ko MJ, 2012, BIOPROC BIOSYST ENG, V35, P69, DOI 10.1007/s00449-011-0604-1; Koganesawa N, 2001, PROTEIN ENG, V14, P705, DOI 10.1093/protein/14.9.705; Kruger N J, 1994, Methods Mol Biol, V32, P9; Larsen MW, 2008, PROTEIN EXPRES PURIF, V62, P90, DOI 10.1016/j.pep.2008.07.012; Oberg F, 2011, MOL MEMBR BIOL, V28, P398, DOI 10.3109/09687688.2011.602219; PATKAR SA, 1993, INDIAN J CHEM B, V32, P76; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rotticci-Mulder JC, 2001, PROTEIN EXPRES PURIF, V21, P386, DOI 10.1006/prep.2000.1387; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Shu ZY, 2009, BIOTECHNOL PROGR, V25, P409, DOI 10.1002/btpr.147; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Surribas A, 2007, J BIOTECHNOL, V130, P291, DOI 10.1016/j.jbiotec.2007.04.009; Tamalampudi S, 2007, APPL MICROBIOL BIOT, V75, P387, DOI 10.1007/s00253-006-0814-7; Tanino T, 2009, APPL MICROBIOL BIOT, V82, P59, DOI 10.1007/s00253-008-1764-z; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yang JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036607; Yang JK, 2007, J MOL CATAL B-ENZYM, V45, P91, DOI 10.1016/j.molcatb.2006.12.007; Yang JK, 2010, J MOL CATAL B-ENZYM, V63, P164, DOI 10.1016/j.molcatb.2010.01.011; Yang JK, 2009, APPL BIOCHEM BIOTECH, V159, P355, DOI 10.1007/s12010-008-8419-5; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Yu Y, 2010, BIOTECHNOL BIOENG, V105, P44, DOI 10.1002/bit.22471	36	76	82	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53939	10.1371/journal.pone.0053939	http://dx.doi.org/10.1371/journal.pone.0053939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326544	Green Published, gold, Green Submitted			2022-12-25	WOS:000313552400063
J	Hu, YF; Jiang, HS; Wang, Q; Xie, ZS; Pan, SY				Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue			Identification of a Novel Nonsense Mutation p.Tyr1957Ter of CACNA1A in a Chinese Family with Episodic Ataxia 2	PLOS ONE			English	Article							CALCIUM-CHANNEL; CLINICAL SPECTRUM; TYPE-2; GENE; SCA6	Type 2 episodic ataxia (EA2) is the most common subtype among a group of rare hereditary syndromes characterized by recurrent attacks of ataxia. More than 60 mutations and several gene rearrangements due to large deletions in CACNA1A gene have been reported so far for the cause of EA2. Because CACNA1A gene is a large gene containing 47 exons and there is no hot spot mutation, direct sequencing will be a challenge in clinical genetic testing. In this study, we used next generation sequencing technology to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncated protein without 305 amino acids in the c-terminus. Sanger sequencing confirmed the heterozygous mutation of CACNA1A in a Chinese family with 11 affected individuals. Affected individuals experienced recurrent attacks with or without nystagmus, dysarthria, seizure, myokymia, dystonia, weakness, blurred vision, visual field defects, diplopia, migraine, dizziness, nausea and vomiting, sweating and abdominal pain. This is the first report of EA2 in a Chinese family that carries a novel mutation in CACNA1A gene and had abdominal pain as a novel phenotype associated with EA2.	[Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue] So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Pan, SY (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	pansuyue82@yahoo.com.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Nanfang Hospital, Southern Medical University, China	Nanfang Hospital, Southern Medical University, China	This work was supported by the chief program funding of Nanfang Hospital, Southern Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Eunson LH, 2005, NEUROLOGY, V65, P308, DOI 10.1212/01.wnl.0000169020.82223.dd; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Jen J, 2004, NEUROLOGY, V62, P17, DOI 10.1212/01.WNL.0000101675.61074.50; Jen JC, 2007, BRAIN, V130, P2484, DOI 10.1093/brain/awm126; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Labrum RW, 2009, J MED GENET, V46, P786, DOI 10.1136/jmg.2009.067967; Mantuano E, 2010, J NEUROL SCI, V291, P30, DOI 10.1016/j.jns.2010.01.010; Matsuyama Z, 2003, J NEUROL SCI, V210, P91, DOI 10.1016/S0022-510X(03)00008-X; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Riant F, 2008, ARCH NEUROL-CHICAGO, V65, P817, DOI 10.1001/archneur.65.6.817; Riant F, 2010, NEUROGENETICS, V11, P101, DOI 10.1007/s10048-009-0208-y; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wan Jijun, 2011, Front Neurol, V2, P51, DOI 10.3389/fneur.2011.00051; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	25	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56362	10.1371/journal.pone.0056362	http://dx.doi.org/10.1371/journal.pone.0056362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441182	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200039
J	Hu, YJ; Rillig, MC; Xiang, D; Hao, ZP; Chen, BD				Hu, Yajun; Rillig, Matthias C.; Xiang, Dan; Hao, Zhipeng; Chen, Baodong			Changes of AM Fungal Abundance along Environmental Gradients in the Arid and Semi-Arid Grasslands of Northern China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SOIL ORGANIC-CARBON; PARTICLE-SIZE; NITROGEN; GROWTH; TEMPERATURE; PLANT; PHOSPHORUS; DISTRIBUTIONS; COMMUNITIES	Arbuscular mycorrhizal (AM) fungi are ubiquitous symbionts of higher plants in terrestrial ecosystems, while the occurrence of the AM symbiosis is influenced by a complex set of abiotic and biotic factors. To reveal the regional distribution pattern of AM fungi as driven by multiple environmental factors, and to understand the ecological importance of AM fungi in natural ecosystems, we conducted a field investigation on AM fungal abundance along environmental gradients in the arid and semi-arid grasslands of northern China. In addition to plant parameters recorded in situ, soil samples were collected, and soil chemo-physical and biological parameters were measured in the lab. Statistical analyses were performed to reveal the relative contribution of climatic, edaphic and vegetation factors to AM fungal abundance, especially for extraradical hyphal length density (HLD) in the soil. The results indicated that HLD were positively correlated with mean annual temperature (MAT), soil clay content and soil pH, but negatively correlated with both soil organic carbon (SOC) and soil available N. The multiple regressions and structural equation model showed that MAT was the key positive contributor and soil fertility was the key negative contributor to HLD. Furthermore, both the intraradical AM colonization (IMC) and relative abundance of AM fungi, which was quantified by real-time PCR assay, tended to decrease along the increasing SOC content. With regard to the obvious negative correlation between MAT and SOC in the research area, the positive correlation between MAT and HLD implied that AM fungi could potentially mitigate soil carbon losses especially in infertile soils under global warming. However, direct evidence from long-term experiments is still expected to support the AM fungal contribution to soil carbon pools.	[Hu, Yajun; Xiang, Dan; Hao, Zhipeng; Chen, Baodong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, Berlin, Germany; [Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Free University of Berlin	Chen, BD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bdchen@rcees.ac.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-JC403, KZCX2-YW-BR-17]; Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences [STSN-21-04]; State Key Laboratory of Urban and Regional Ecology, P.R. China [SKLURE2008-1-03]; Alexander-von-Humboldt Foundation fellowship	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Urban and Regional Ecology, P.R. China; Alexander-von-Humboldt Foundation fellowship(Alexander von Humboldt Foundation)	The study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-JC403 and KZCX2-YW-BR-17), Joint Project of Ministry of Environmental Protection, P.R. China and the Chinese Academy of Sciences (STSN-21-04) and State Key Laboratory of Urban and Regional Ecology, P.R. China (Project SKLURE2008-1-03). BC was supported by an Alexander-von-Humboldt Foundation fellowship during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; Cai Xiaobu, 2005, Yingyong Shengtai Xuebao, V16, P859; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Gaur A, 2000, MYCORRHIZA, V10, P43, DOI 10.1007/s005720050286; Gavito ME, 2005, NEW PHYTOL, V168, P179, DOI 10.1111/j.1469-8137.2005.01481.x; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; HAYMAN DS, 1982, PHYTOPATHOLOGY, V72, P1119; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; Hooper D, 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.21427/D7CF7R; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jennings D.H., 1995, PHYSL FUNGAL NUTR; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KOSKE RE, 1987, MYCOLOGIA, V79, P55, DOI 10.2307/3807744; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liu A, 2000, PLANT SOIL, V221, P157, DOI 10.1023/A:1004777821422; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; SOEDARJO M, 1995, MYCORRHIZA, V5, P337, DOI 10.1007/BF00207406; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tian H, 2009, LAND DEGRAD DEV, V20, P41, DOI 10.1002/ldr.876; Treseder KK, 2006, ECOSYSTEMS, V9, P305, DOI 10.1007/s10021-005-0110-x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot A., 1986, PHYSL GENETICAL ASPE, V39, P217, DOI DOI 10.1177/004057368303900411; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Verbruggen E, 2013, NEW PHYTOL, V197, P366, DOI 10.1111/nph.12079; Wan YF, 2011, AGR ECOSYST ENVIRON, V141, P23, DOI 10.1016/j.agee.2011.02.004; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Yang HS, 2011, CATENA, V87, P70, DOI 10.1016/j.catena.2011.05.009; [周涛 Zhou Tao], 2003, [地理学报, Acta Geographica Sinica], V58, P727; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	55	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57593	10.1371/journal.pone.0057593	http://dx.doi.org/10.1371/journal.pone.0057593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23441182	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500118
